Citrus Sinensis ID: 008108

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------
Protein Sequence
MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGSPDPVTPEPPPRKKNHTILITVIVSVVASVILITGICIFLRVGKLKLEDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKPAFFMKCSVIPETSSPLDVITGSTESGGHGIGNVPLSKNEASITELSPR
Secondary Structure (PSIPRED)
ccHHHHHHHHHHHHHHHHHccccccEEEEEEcccccccEEEEEcccccccccccccEEEEEccccccccHHHHHHHHHHHHHHHHHHHHcccccccEEEEEEcccccccEEEEEEccccccHHHHHHHHHHHHHHHHHHccccccEEEEcccccEEEEccccccccccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHEEEccccccccHHHHHccccccccHHHHHHHHcccccccccccccccccEEEEcccccEEEEEEccccccHHHHHHHHHHHHHHHccccccccEEcccccccEEEEEEEccccccccEEcccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEccccccccccccccccccccccccccccccccccccccEEEccccccHHHHccccccccccccccEEEEEEEEEcccccccccccccccHHHHHHHHccccccccccccccccccHHHHHHHHHHHHccccccccccccHHHHHHHHccccccccccccccEEEcccccccccccccccccccccccccccccccccccEEEEccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHcccccEEEEEEcccccccEEEEEccccHcccccccccEEEEccccccccHHHHHHHHHHHHHHHHHHHHccccccHEcccccccccccEEEEEEEEcccccHHHHHHHHHHHHHHcHHHcccccccEEEcccEEEEEEEEccccccccccccccccccccccccccccEEEEEEEHHHHHHHHHHHHHHHHHHHHcccccccccccccccccEEcHHHHHHHHccccHHccccccccccEEccEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHHEEcccccEEEEEEEcccccccEEEEcHHHcccccHHHHHHHHHHHHHHHHHHHHccHccEEcccccHHHEEEcccccEEEccccccEEccHHHcEccccEEEEEcccccHHHHHHccccHHHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHHcccccEEccHccccccHHHHHHHHHHHHHHccccccccccHHHHEEEEccccEEcccccccEEEEEcccccccccccccccccccccccccccccccccccEEcccccc
Coil and Loop (DISEMBL)
mepsscrdCINVARKNLtslcpnkvtaiggyddrgynncmlryanydifglmenapyFFVYAESNISENLIEFNQTRQRLLERLFSeaaarpspnkyatgkeAVSDIVTMYALVQctpdlseadckeCLHDTTKLMskccdrrqggrvinpscsfryetnkffkpsiagppgspdpvtpeppprkknhtILITVIVSVVASVILITGICIFLRvgklkledeNVEETIAKSLQFDFETIRVAtdnfsdanklgqggfgaVYKGMLSNGETIAVKRLSknskqgeiEFKNEVLLLARLQHRNLVRLLGFCLERKERILvyefvpnasldhfifdpinrehmTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNilldsemnpkisdfGMARLFEMdqthsdtnrvvgtfgymapeyvmhgrfsvksdiFSFGVLVLEIVSgqkrssfgteeETEDLLTYAWRNWNegaalnlmdptmrggstseMMKCIHIGLLCvqenvsnrpgmASVVNMLngdtvtlpapskpaffmkcsvipetsspldvitgstesgghgignvplskneasitelspr
Flexible Loop (DISEMBL)
MEPSSCRDCINVArknltslcpnkvtaiggyddrgynNCMLRYANYDIFGLMENAPYFFVYAESNISENLIEFNQTRQRLLERLFSeaaarpspnkyatgkEAVSDIVTMYALVQCTPDLSEADCKECLHDTTKlmskccdrrqggrvinpscsFRYETNKFfkpsiagppgsPDPVTPEPPPRKKNHTILITVIVSVVASVILITGICIFLRVGKLKLEDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEfvpnasldhfifdPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKasnilldsemnpKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVsgqkrssfgteeETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKPAFFMKCSVIPETSSPLDVITGSTEsgghgignvplskneasitelspr
Low Complexity Region (SEG)
MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGSPDPVTPEPPPRKKNHtilitvivsvvasvilitGICIFLRVGKLKLEDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKPAFFMKCSVIPETSSPLDVITGSTESGGHGIGNVPLSKNEASITELSPR
Disordered region (IsUnstruct)
******RDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESNISENLIEFNQTRQRLLERLF*************TGKEAVSDIVTMYALVQCTPDLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFF************************HTILITVIVSVVASVILITGICIFLRVGKLKLEDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRL******GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ**********TEDLLTYAWRNWNEGAALNLMDPTMRG**TSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKPAFFMKCSVIP**************************************
Disordered Region (DISOPRED)
*EPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPS*************************ITVIVSVVASVILITGICIFLR*******************QFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKPAFFM******************************LSKNEASITELSPR
Disordered Region (DISEMBL)
MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGP*************RKKNHTILITVIVSVVASVILITGICIFLRVGKLKLEDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ************DLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKPAFFMKCSVIPETSSPLDVITGSTESGGHGIGNVPLSK***********
Disordered Region (DISPRO)
MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPS********************NHTILITVIVSVVASVILITGICIFLRVGKL***********AKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKPAFFMKCS*****************************************
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGSPDPVTPEPPPRKKNHTILITVIVSVVASVILITGICIFLRVGKLKLEDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKPAFFMKCSVIPETSSPLDVITGSTESGGHGIGNVPLSKNEASITELSPR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	577	2.2.26 [Sep-21-2011]
Q9M0X5	675	Cysteine-rich receptor-li	yes	no	0.972	0.831	0.484	1e-157
Q8S9L6	679	Cysteine-rich receptor-li	no	no	0.960	0.815	0.469	1e-152
Q9T0J1	665	Cysteine-rich receptor-li	no	no	0.951	0.825	0.487	1e-151
O65405	683	Cysteine-rich receptor-li	no	no	0.960	0.811	0.466	1e-144
Q8GYA4	669	Cysteine-rich receptor-li	no	no	0.953	0.822	0.458	1e-142
O23081	665	Cysteine-rich receptor-li	no	no	0.885	0.768	0.500	1e-141
Q9C5S9	674	Cysteine-rich receptor-li	no	no	0.961	0.823	0.443	1e-141
Q8W4G6	627	Cysteine-rich receptor-li	no	no	0.897	0.826	0.469	1e-141
O65468	676	Cysteine-rich receptor-li	no	no	0.967	0.825	0.458	1e-140
Q8H199	658	Cysteine-rich receptor-li	no	no	0.974	0.854	0.440	1e-140

>sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1

 Score =  556 bits (1432), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 286/590 (48%), Positives = 388/590 (65%), Gaps = 29/590 (4%)

Query: 6   CRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESN 65
           CRDC+  A       CP +  A+  YD+     CM+RY+N  I G M   P  F+  + N
Sbjct: 97  CRDCVAFAANETLQRCPREKVAVIWYDE-----CMVRYSNQSIVGQMRIRPGVFLTNKQN 151

Query: 66  ISENLI-EFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSEAD 124
           I+EN +  FN++   LL  +  +AA   S  K+AT K   +   T+Y+LVQCTPDL+  D
Sbjct: 152 ITENQVSRFNESLPALLIDVAVKAAL--SSRKFATEKANFTVFQTIYSLVQCTPDLTNQD 209

Query: 125 CKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSI---------AGPPGSPD 175
           C+ CL      + +CCDR  GGRVI PSCSFRYE   F+  +I         +    +P 
Sbjct: 210 CESCLRQVINYLPRCCDRSVGGRVIAPSCSFRYELYPFYNETIAAAPMAPPPSSTVTAPP 269

Query: 176 PVTPEPPPRKKNHTILITVI-VSVVASVILITGICIFL---RVGKLKLEDENVEE---TI 228
              P    + KN T+++T I V V   V+L+  +C  L   R  KL  E E+++E   T 
Sbjct: 270 LNIPSEKGKGKNLTVIVTAIAVPVSVCVLLLGAMCWLLARRRNNKLSAETEDLDEDGITS 329

Query: 229 AKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFK 288
            ++LQF F  I  AT+ FS++NKLG GGFG VYKG L  GET+A+KRLS+ S QG  EFK
Sbjct: 330 TETLQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQGSTQGAEEFK 389

Query: 289 NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI 348
           NEV ++A+LQHRNL +LLG+CL+ +E+ILVYEFVPN SLD+F+FD   R  + W++RYKI
Sbjct: 390 NEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKRRVLDWQRRYKI 449

Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV 408
           IEGIARG+LYLH DSRL IIHRDLKASNILLD++M+PKISDFGMAR+F +DQT ++T R+
Sbjct: 450 IEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGVDQTQANTKRI 509

Query: 409 VGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWN 468
           VGT+GYM+PEY +HG++SVKSD++SFGVLVLE+++G+K SSF  E+   DL+TY W+ W 
Sbjct: 510 VGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNSSFYEEDGLGDLVTYVWKLWV 569

Query: 469 EGAALNLMDPTMRGG-STSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPS 527
           E + L L+D  MRG   T+E+++CIHI LLCVQE+ S RP M  ++ M+N  TVTLP P 
Sbjct: 570 ENSPLELVDEAMRGNFQTNEVIRCIHIALLCVQEDSSERPSMDDILVMMNSFTVTLPIPK 629

Query: 528 KPAFFMKCSVIPETSSPLDVITGSTESGGHGIGNVPLSKNEASITELSPR 577
           +  F ++   + ++  P     GS         ++PLS +++SIT + PR
Sbjct: 630 RSGFLLR--TMKDSRDPRS--GGSASDHSATSKSLPLSVDDSSITIVYPR 675

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q8S9L6|CRK29_ARATH Cysteine-rich receptor-like protein kinase 29 OS=Arabidopsis thaliana GN=CRK29 PE=2 SV=1

 Score =  537 bits (1383), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 282/601 (46%), Positives = 383/601 (63%), Gaps = 47/601 (7%)

Query: 6   CRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESN 65
           C  CI  A +NLT  CP    A+       Y +CM RY+N  I+G  E  P     A   
Sbjct: 97  CVSCIQTAARNLTKQCPLTKQAV-----VWYTHCMFRYSNRTIYGRKETNPTKAFIAGEE 151

Query: 66  ISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGK-EAVSDIVTMYALVQCTPDLSEAD 124
           IS N  +F + ++ LL+RL   AAA     KYA G   A +     Y  VQCTPDLSE D
Sbjct: 152 ISANRDDFERLQRGLLDRLKGIAAAGGPNRKYAQGNGSASAGYRRFYGTVQCTPDLSEQD 211

Query: 125 CKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFK--------PSIAGPPGSPDP 176
           C +CL    + +  CCD   G R  +PSC+FR+ET +F++        P    P  SP  
Sbjct: 212 CNDCLVFGFENIPSCCDAEIGLRWFSPSCNFRFETWRFYEFDADLEPDPPAIQPADSPQS 271

Query: 177 V--TPEPPPRKKNHTILITVIVSVVASVILITGICIFLR------------VGKLKLEDE 222
              T      K    ++I +++ ++   +L   +C+ L+            +GK  L   
Sbjct: 272 AARTERTGKGKGGSKVIIAIVIPILLVALLAICLCLVLKWRKNKSGYKNKVLGKSPLSGS 331

Query: 223 NVEETIA--KSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS 280
             E+  +  +SL   FET++ ATDNFS  N+LG+GGFG+VYKG+   G+ IAVKRLS NS
Sbjct: 332 IAEDEFSNTESLLVHFETLKTATDNFSSENELGRGGFGSVYKGVFPQGQEIAVKRLSGNS 391

Query: 281 KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM 340
            QG+ EFKNE+LLLA+LQHRNLVRL+GFC++ +ER+LVYEF+ NASLD FIFD   R+ +
Sbjct: 392 GQGDNEFKNEILLLAKLQHRNLVRLIGFCIQGEERLLVYEFIKNASLDQFIFDTEKRQLL 451

Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
            W  RYK+I GIARGLLYLHEDSR RIIHRDLKASNILLD EMNPKI+DFG+A+LF+  Q
Sbjct: 452 DWVVRYKMIGGIARGLLYLHEDSRFRIIHRDLKASNILLDQEMNPKIADFGLAKLFDSGQ 511

Query: 401 --THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGT--EEET 456
             TH  T+R+ GT+GYMAPEY MHG+FSVK+D+FSFGVLV+EI++G++ ++ G+  +E+ 
Sbjct: 512 TMTHRFTSRIAGTYGYMAPEYAMHGQFSVKTDVFSFGVLVIEIITGKRNNNGGSNGDEDA 571

Query: 457 EDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNML 516
           EDLL++ WR+W E   L+++DP++  GS +E+++CIHIGLLCVQE+ + RP MA+V  ML
Sbjct: 572 EDLLSWVWRSWREDTILSVIDPSLTAGSRNEILRCIHIGLLCVQESAATRPTMATVSLML 631

Query: 517 NGDTVTLPAPSKPAFFMKCSVIPETSSPLDVITGSTESGGHGIGNVPLSKNEASITELSP 576
           N  + TLP P +PAF ++  VIP        ++ STE        + +S N+ +++E SP
Sbjct: 632 NSYSFTLPTPLRPAFVLESVVIPSN------VSSSTEG-------LQMSSNDVTVSEFSP 678

Query: 577 R 577
           R
Sbjct: 679 R 679

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9T0J1|CRK26_ARATH Cysteine-rich receptor-like protein kinase 26 OS=Arabidopsis thaliana GN=CRK26 PE=2 SV=1

 Score =  534 bits (1375), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 291/597 (48%), Positives = 383/597 (64%), Gaps = 48/597 (8%)

Query: 6   CRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESN 65
           C +CI +A K L +LCP +  AI  YD      C  RY+N  IF  +E +P+  +    N
Sbjct: 92  CINCIAMAGKRLVTLCPVQKEAIIWYD-----KCTFRYSNRTIFNRLEISPHTSITGTRN 146

Query: 66  ISENLIEFNQTRQRLLERLFSEAAA-RPSPNKYATGKEAVSDIVTMYALVQCTPDLSEAD 124
            + +   + ++ + LLE L + A+    S   +  G+ +     T++ LVQCTPD+SE D
Sbjct: 147 FTGDRDSWEKSLRGLLEGLKNRASVIGRSKKNFVVGETSGPSFQTLFGLVQCTPDISEED 206

Query: 125 CKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGSPDPVTPEPPPR 184
           C  CL      +  CCD + G  V++PSC   Y   +F+ P     P S  P TP  PP+
Sbjct: 207 CSYCLSQGIAKIPSCCDMKMGSYVMSPSCMLAYAPWRFYDPVDTDDPSSV-PATPSRPPK 265

Query: 185 KKNHTI------------LITVIVSVVASVILITGICIF--------LRVGKLKLEDENV 224
            +  ++            LI    SV   V+ I  + +F        +R  + K E+EN+
Sbjct: 266 NETRSVTQGDKNRGVPKALIFASASVAIVVLFIVLLVVFLKLRRKENIRNSENKHENENI 325

Query: 225 EETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGE 284
                 S++FDF  ++ AT +FS  NKLG+GGFGAVYKG+LS+G+ IAVKRLSKN++QGE
Sbjct: 326 S---TDSMKFDFSVLQDATSHFSLENKLGEGGFGAVYKGVLSDGQKIAVKRLSKNAQQGE 382

Query: 285 IEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEK 344
            EFKNE LL+A+LQHRNLV+LLG+ +E  ER+LVYEF+P+ SLD FIFDPI    + WE 
Sbjct: 383 TEFKNEFLLVAKLQHRNLVKLLGYSIEGTERLLVYEFLPHTSLDKFIFDPIQGNELEWEI 442

Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ-THS 403
           RYKII G+ARGLLYLH+DSRLRIIHRDLKASNILLD EM PKI+DFGMARLF++D  T  
Sbjct: 443 RYKIIGGVARGLLYLHQDSRLRIIHRDLKASNILLDEEMTPKIADFGMARLFDIDHTTQR 502

Query: 404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA 463
            TNR+VGTFGYMAPEYVMHG+FS K+D++SFGVLVLEI+SG+K S F +E+   DL+++A
Sbjct: 503 YTNRIVGTFGYMAPEYVMHGQFSFKTDVYSFGVLVLEIISGKKNSGFSSEDSMGDLISFA 562

Query: 464 WRNWNEGAALNLMDP---TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDT 520
           WRNW EG ALNL+D    TM   S++ +M+CI+IGLLCVQE V+ RP MASVV ML+G T
Sbjct: 563 WRNWKEGVALNLVDKILMTMSSYSSNMIMRCINIGLLCVQEKVAERPSMASVVLMLDGHT 622

Query: 521 VTLPAPSKPAFFMKCSVIPETSSPLDVITGSTESGGHGIGNVPLSKNEASITELSPR 577
           + L  PSKPAFF   + + ++SS L              G+   + N  S TEL PR
Sbjct: 623 IALSEPSKPAFFSHSNAVSDSSSSL--------------GHNAKTSNYNSNTELYPR 665

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65405|CRK28_ARATH Cysteine-rich receptor-like protein kinase 28 OS=Arabidopsis thaliana GN=CRK28 PE=3 SV=2

 Score =  513 bits (1321), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 281/603 (46%), Positives = 386/603 (64%), Gaps = 49/603 (8%)

Query: 6   CRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESN 65
           C  CI +A +NL   CP    A+       Y +CM RY+N  I+G  E  P     A  N
Sbjct: 99  CLSCIQIAARNLIEQCPLTNQAV-----VWYTHCMFRYSNMIIYGRKETTPTLSFQAGKN 153

Query: 66  ISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGK-EAVSDIVTMYALVQCTPDLSEAD 124
           IS N  EF++ +  LL+RL   AAA     KYA G    V+     Y    CTPDLSE D
Sbjct: 154 ISANRDEFDRLQIELLDRLKGIAAAGGPNRKYAQGSGSGVAGYPQFYGSAHCTPDLSEQD 213

Query: 125 CKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFK--------PSIAGPPGSPDP 176
           C +CL    + +  CC  + G R   PSCS+R+ET +F++        P    P  SP  
Sbjct: 214 CNDCLVFGFEKIPGCCAGQVGLRWFFPSCSYRFETWRFYEFDADLEPDPPAIQPADSPTS 273

Query: 177 V--TPEPPPRKKNHTILITVIVSVVASVILITGICIFLR------VGKLKLEDENV---- 224
              T      K    +++ +++ +V   +    +C+ L+      VG++K    N+    
Sbjct: 274 AARTERTGKGKGGSKVIVAIVIPIVFVALFAICLCLLLKWKKNKSVGRVKGNKHNLLLLV 333

Query: 225 ------EETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSK 278
                 ++  + SL  DFET++ ATDNFS  N+LG+GGFG+VYKG+ S G+ IAVKRLS 
Sbjct: 334 IVILLQKDEFSDSLVVDFETLKAATDNFSPENELGRGGFGSVYKGVFSGGQEIAVKRLSC 393

Query: 279 NSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE 338
            S QG+ EFKNE+LLLA+LQHRNLVRLLGFC+E +ERILVYEF+ NASLD+FIFD   R+
Sbjct: 394 TSGQGDSEFKNEILLLAKLQHRNLVRLLGFCIEGQERILVYEFIKNASLDNFIFDLKKRQ 453

Query: 339 HMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM 398
            + W  RYK+I G+ARGLLYLHEDSR RIIHRDLKASNILLD EMNPKI+DFG+A+L++ 
Sbjct: 454 LLDWGVRYKMIGGVARGLLYLHEDSRYRIIHRDLKASNILLDQEMNPKIADFGLAKLYDT 513

Query: 399 DQ--THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGT--EE 454
           DQ  TH  T+++ GT+GYMAPEY ++G+FSVK+D+FSFGVLV+EI++G+  ++  +  +E
Sbjct: 514 DQTSTHRFTSKIAGTYGYMAPEYAIYGQFSVKTDVFSFGVLVIEIITGKGNNNGRSNDDE 573

Query: 455 ETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN 514
           E E+LL++ WR W E   L+++DP++  GS SE+++CIHIGLLCVQE+ ++RP M SV  
Sbjct: 574 EAENLLSWVWRCWREDIILSVIDPSLTTGSRSEILRCIHIGLLCVQESPASRPTMDSVAL 633

Query: 515 MLNGDTVTLPAPSKPAFFMKCSVIPETSSPLDVITGSTESGGHGIGNVPLSKNEASITEL 574
           MLN  + TLP PS+PAF ++ SV+P  +     ++ STE        + +S N+ +++EL
Sbjct: 634 MLNSYSYTLPTPSRPAFALE-SVMPSMN-----VSSSTEP-------LLMSLNDVTVSEL 680

Query: 575 SPR 577
           SPR
Sbjct: 681 SPR 683

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3

 Score =  507 bits (1305), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 269/587 (45%), Positives = 378/587 (64%), Gaps = 37/587 (6%)

Query: 6   CRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESN 65
           CR C++ A  +  + CPN+  A   YD+     C+LRY+N +I   +       +    N
Sbjct: 105 CRRCVSFAVNDTLTRCPNQKEATLYYDE-----CVLRYSNQNILSTLITTGGVILVNTRN 159

Query: 66  ISENLIEFNQTRQRLLERLFSEAA--ARPSPNKYATGKEAVSDIVTMYALVQCTPDLSEA 123
           ++ N ++       L+    ++AA  A  S  K+ T K   + + + Y LVQCTPDL+  
Sbjct: 160 VTSNQLDL---LSDLVLPTLNQAATVALNSSKKFGTRKNNFTALQSFYGLVQCTPDLTRQ 216

Query: 124 DCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGSPDPVTPE--- 180
           DC  CL     ++++    R G R+INPSC+ RYE   F+  S   PP  P  ++     
Sbjct: 217 DCSRCLQ---LVINQIPTDRIGARIINPSCTSRYEIYAFYTESAVPPPPPPPSISTPPVS 273

Query: 181 PPPRK-----KNHTILITVIVSVVASVILITGICIFLRVGKLKLEDENV----EETIAKS 231
            PPR          ++  V+  +VA ++ I G C   R  +      +     + T A S
Sbjct: 274 APPRSGKDGNSKVLVIAIVVPIIVAVLLFIAGYCFLTRRARKSYYTPSAFAGDDITTADS 333

Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEV 291
           LQ D+ TI+ ATD+F ++NK+GQGGFG VYKG LS+G  +AVKRLSK+S QGE+EFKNEV
Sbjct: 334 LQLDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQGEVEFKNEV 393

Query: 292 LLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG 351
           +L+A+LQHRNLVRLLGFCL+ +ER+LVYE+VPN SLD+F+FDP  +  + W +RYKII G
Sbjct: 394 VLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWTRRYKIIGG 453

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +ARG+LYLH+DSRL IIHRDLKASNILLD++MNPKI+DFGMAR+F +DQT  +T+R+VGT
Sbjct: 454 VARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRIVGT 513

Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGA 471
           +GYM+PEY MHG++S+KSD++SFGVLVLEI+SG+K SSF   +   DL++YAW  W+ G 
Sbjct: 514 YGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSYAWGLWSNGR 573

Query: 472 ALNLMDPTM-RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKPA 530
            L L+DP +      +E+++C+HIGLLCVQE+ + RP ++++V ML  +TVTLP P +P 
Sbjct: 574 PLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNTVTLPVPRQPG 633

Query: 531 FFMKCSVIPETSSPLDVITGSTESGGHGIGNVPLSKNEASITELSPR 577
            F +  +  +   PLD  T S    G        S ++ASIT++ PR
Sbjct: 634 LFFQSRIGKD---PLDTDTTSKSLLG--------SVDDASITDIHPR 669

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O23081|CRK41_ARATH Cysteine-rich receptor-like protein kinase 41 OS=Arabidopsis thaliana GN=CRK41 PE=3 SV=2

 Score =  502 bits (1293), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 271/541 (50%), Positives = 352/541 (65%), Gaps = 30/541 (5%)

Query: 6   CRDCINVARKNLTSL-CPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAES 64
           C +CI  A  NLT++ CP      G Y       CM RY++  IFG +E +P       S
Sbjct: 110 CLNCIAQAAVNLTTMYCPQHR---GAY--VRATKCMFRYSDKPIFGKLETSPVLEAPNPS 164

Query: 65  NISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSD-IVTMYALVQCTPDLSEA 123
           N + +  EF + +  LL RL S AA+  S  KYA G +  S    T +  VQCTPDLSE 
Sbjct: 165 NATGDRNEFIRLQSELLNRLRSMAASGGSKRKYAQGTDPGSPPYTTFFGAVQCTPDLSEK 224

Query: 124 DCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETN-KFFKPSIAGPPGSPDPVTPEPP 182
           DC +CL   +   S     R G R   PSC+F+ E++ +FF               P+P 
Sbjct: 225 DCNDCL---SYGFSNATKGRVGIRWFCPSCNFQIESDLRFFLLD--------SEYEPDPK 273

Query: 183 PRKKNHTILITVIVSVVASVILITGICIFL----RVGKLKLEDENVEETIAKS---LQFD 235
           P      I+I  + SV+   I+   +  F+    R  K + E +++EE + K    LQ D
Sbjct: 274 PGNDKVKIIIATVCSVIGFAIIAVFLYFFMTRNRRTAKQRHEGKDLEELMIKDAQLLQLD 333

Query: 236 FETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLA 295
           F+TIR+AT++FS  N+LG+GGFGAVYKG+L  GE IAVKRLS  S QG+ EF NEV L+A
Sbjct: 334 FDTIRLATNDFSRDNQLGEGGFGAVYKGVLDYGEEIAVKRLSMKSGQGDNEFINEVSLVA 393

Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
           +LQHRNLVRLLGFCL+ +ERIL+YEF  N SLDH+IFD   R  + WE RY+II G+ARG
Sbjct: 394 KLQHRNLVRLLGFCLQGEERILIYEFFKNTSLDHYIFDSNRRMILDWETRYRIISGVARG 453

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD--TNRVVGTFG 413
           LLYLHEDSR +I+HRD+KASN+LLD  MNPKI+DFGMA+LF+ DQT     T++V GT+G
Sbjct: 454 LLYLHEDSRFKIVHRDMKASNVLLDDAMNPKIADFGMAKLFDTDQTSQTRFTSKVAGTYG 513

Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAAL 473
           YMAPEY M G FSVK+D+FSFGVLVLEI+ G+K +    E+ +  LL+Y W++W EG  L
Sbjct: 514 YMAPEYAMSGEFSVKTDVFSFGVLVLEIIKGKKNNWSPEEDSSLFLLSYVWKSWREGEVL 573

Query: 474 NLMDPTMRG--GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKPAF 531
           N++DP++    G + E+MKCIHIGLLCVQEN  +RP MASVV MLN ++ TLP PS+PAF
Sbjct: 574 NIVDPSLVETIGVSDEIMKCIHIGLLCVQENAESRPTMASVVVMLNANSFTLPRPSQPAF 633

Query: 532 F 532
           +
Sbjct: 634 Y 634

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9C5S9|CRK6_ARATH Cysteine-rich receptor-like protein kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1

 Score =  501 bits (1290), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 269/607 (44%), Positives = 376/607 (61%), Gaps = 52/607 (8%)

Query: 1   MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGL-MENAPYFF 59
           + P  CR+C+  +     +LCP    A+  Y+      C+LRY++ +I    + N   F 
Sbjct: 90  VSPEVCRNCVAFSVNQTLNLCPKVREAVFYYE-----QCILRYSHKNILSTAITNEGEFI 144

Query: 60  VYAESNISENLIEFNQTRQRLLERLFSEAAARP--SPNKYATGKEAVSDIVTMYALVQCT 117
           +   + IS N  + +      +    SEAA +   S  K  T    ++    +Y L+QCT
Sbjct: 145 LSNTNTISPNQKQIDGFTS-FVSSTMSEAAGKAANSSRKLYTVNTELTAYQNLYGLLQCT 203

Query: 118 PDLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPS----------- 166
           PDL+ ADC  CL  +   M+     R G R+  PSC+ RYE   F+  S           
Sbjct: 204 PDLTRADCLSCLQSSINGMAL---SRIGARLYWPSCTARYELYPFYNESAIETPPLPPPP 260

Query: 167 ---------IAGPPGSPDPVTPEPPPRKKNHTILITVIVSVVAS-VILITGICIFLRVGK 216
                    ++ PP S   +    P +  N T+L+  +V +     I + G C   +  K
Sbjct: 261 PPPPPRESLVSTPPISSSSL----PGKSGNSTVLVVAVVVLAVLLFIALVGYCFLAKKKK 316

Query: 217 LKLEDENVEE-----TIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETI 271
              +  +  E       A SLQ D+ TI+ AT++F+++NK+G+GGFG VYKG  SNG+ +
Sbjct: 317 KTFDTASASEVGDDMATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEV 376

Query: 272 AVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
           AVKRLSKNS+QGE EFK EV+++A+LQHRNLVRLLGF L+ +ERILVYE++PN SLD  +
Sbjct: 377 AVKRLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLL 436

Query: 332 FDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG 391
           FDP  +  + W +RY II GIARG+LYLH+DSRL IIHRDLKASNILLD+++NPKI+DFG
Sbjct: 437 FDPTKQIQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFG 496

Query: 392 MARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFG 451
           MAR+F +DQT  +T+R+VGT+GYMAPEY MHG+FS+KSD++SFGVLVLEI+SG+K SSFG
Sbjct: 497 MARIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFG 556

Query: 452 TEEETEDLLTYAWRNWNEGAALNLMDPTM-RGGSTSEMMKCIHIGLLCVQENVSNRPGMA 510
             +  +DLLT+AWR W    AL+L+DP +      SE+++CIHIGLLCVQE+ + RP ++
Sbjct: 557 ESDGAQDLLTHAWRLWTNKKALDLVDPLIAENCQNSEVVRCIHIGLLCVQEDPAKRPAIS 616

Query: 511 SVVNMLNGDTVTLPAPSKPAFFMKCSVIPETSSPLDVITGSTESGGHGIGNVPLSKNEAS 570
           +V  ML  +TVTLP P +P FF++C  + +   PLD    +T        + P S ++ S
Sbjct: 617 TVFMMLTSNTVTLPVPRQPGFFIQCRAVKD---PLDSDQSTTTK------SFPASIDDES 667

Query: 571 ITELSPR 577
           IT+L PR
Sbjct: 668 ITDLYPR 674

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2

 Score =  501 bits (1289), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 258/550 (46%), Positives = 362/550 (65%), Gaps = 32/550 (5%)

Query: 1   MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFV 60
           + P+ CR+C+  +  +    CP++  ++  YD+     CMLRY++ +I   +     + +
Sbjct: 87  VSPAVCRNCVAFSINDTLVQCPSERKSVFYYDE-----CMLRYSDQNILSTLAYDGAW-I 140

Query: 61  YAESNISENLIEFNQTRQRLLERLFSEAA--ARPSPNKYATGKEAVSDIVTMYALVQCTP 118
               NIS +  + N+ +   +    ++AA  A  SP K+ T K   + + T+Y LVQCTP
Sbjct: 141 RMNGNISIDQNQMNRFKD-FVSSTMNQAAVKAASSPRKFYTVKATWTALQTLYGLVQCTP 199

Query: 119 DLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGSPDP-- 176
           DL+  DC  CL  + KLM      + GGR +  SC+ RYE   F+  +      +P P  
Sbjct: 200 DLTRQDCFSCLESSIKLMPL---YKTGGRTLYSSCNSRYELFAFYNETTVRTQQAPPPLP 256

Query: 177 -------VTPEPPPRKKNHTILITVIV--SVVASVILITGICIFLRVGKLKLEDENV--- 224
                   +P  P +  N  +L+  IV   +VA+++LI G C   RV   K   +N    
Sbjct: 257 PSSTPLVTSPSLPGKSWNSNVLVVAIVLTILVAALLLIAGYCFAKRV---KNSSDNAPAF 313

Query: 225 --EETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ 282
             ++   +SLQ D+  IR AT+ FS+ NK+GQGGFG VYKG  SNG  +AVKRLSK+S Q
Sbjct: 314 DGDDITTESLQLDYRMIRAATNKFSENNKIGQGGFGEVYKGTFSNGTEVAVKRLSKSSGQ 373

Query: 283 GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTW 342
           G+ EFKNEV+++A+LQHRNLVRLLGF +   ERILVYE++PN SLD+F+FDP  +  + W
Sbjct: 374 GDTEFKNEVVVVAKLQHRNLVRLLGFSIGGGERILVYEYMPNKSLDYFLFDPAKQNQLDW 433

Query: 343 EKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
            +RYK+I GIARG+LYLH+DSRL IIHRDLKASNILLD++MNPK++DFG+AR+F MDQT 
Sbjct: 434 TRRYKVIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKLADFGLARIFGMDQTQ 493

Query: 403 SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTY 462
            +T+R+VGTFGYMAPEY +HG+FSVKSD++SFGVLVLEI+SG+K +SF   +   DL+T+
Sbjct: 494 ENTSRIVGTFGYMAPEYAIHGQFSVKSDVYSFGVLVLEIISGKKNNSFYETDGAHDLVTH 553

Query: 463 AWRNWNEGAALNLMDP-TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTV 521
           AWR W+ G AL+L+DP  +     SE+++CIHI LLCVQE+ + RP ++++  ML  +TV
Sbjct: 554 AWRLWSNGTALDLVDPIIIDNCQKSEVVRCIHICLLCVQEDPAERPILSTIFMMLTSNTV 613

Query: 522 TLPAPSKPAF 531
           TLP P +P F
Sbjct: 614 TLPVPLQPGF 623

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2

 Score =  500 bits (1287), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 273/596 (45%), Positives = 380/596 (63%), Gaps = 38/596 (6%)

Query: 1   MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFV 60
           + P  C +C+  +     + CPN+  A+  Y++     C+LRY++ +    +       +
Sbjct: 100 LSPEVCSNCVAFSVNESLTRCPNQREAVFYYEE-----CILRYSHKNFLSTVTYEGELIM 154

Query: 61  YAESNISENLIEFNQTRQ--RLLERLFSEAA--ARPSPNKYATGKEAVSDIVTMYALVQC 116
              +NIS   I+ NQ  Q   L++   ++AA  A  S  K++T K  ++ + T+Y LVQC
Sbjct: 155 RNPNNISS--IQ-NQRDQFIDLVQSNMNQAANEAANSSRKFSTIKTELTSLQTLYGLVQC 211

Query: 117 TPDLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPP----- 171
           TPDL+  DC  CL  +   M      R G R   PSC+ RYE   F+  +  G P     
Sbjct: 212 TPDLARQDCFSCLTSSINRMMPLF--RIGARQFWPSCNSRYELYAFYNETAIGTPSPPPL 269

Query: 172 --GSPDPVT-PEPPPRKKNHTILITVIVSVVAS-VILITGICIFLRVGKLKLEDENVEE- 226
             GS  P+T P  P +  N T+L+  IV +     I + G C   +  K   +  +  E 
Sbjct: 270 FPGSTPPLTSPSIPGKSGNSTVLVVAIVVLAVLLFIALVGYCFLAQRTKKTFDTASASEV 329

Query: 227 ----TIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ 282
                 A SLQ D+ TI+ AT++F+++NK+G+GGFG VYKG  SNG+ +AVKRLSKNS+Q
Sbjct: 330 GDDMATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQ 389

Query: 283 GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTW 342
           GE EFK EV+++A+LQHRNLVRLLGF L+ +ERILVYE++PN SLD  +FDP  +  + W
Sbjct: 390 GEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLDW 449

Query: 343 EKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
            +RY II GIARG+LYLH+DSRL IIHRDLKASNILLD+++NPKI+DFGMAR+F +DQT 
Sbjct: 450 MQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQ 509

Query: 403 SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTY 462
            +T+R+VGT+GYMAPEY MHG+FS+KSD++SFGVLVLEI+SG+K SSF   +  +DLLT+
Sbjct: 510 DNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGAQDLLTH 569

Query: 463 AWRNWNEGAALNLMDPTMRGG-STSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTV 521
            WR W    AL+L+DP +      SE+++CIHIGLLCVQE+ + RP +++V  ML  +TV
Sbjct: 570 TWRLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVFMMLTSNTV 629

Query: 522 TLPAPSKPAFFMKCSVIPETSSPLDVITGSTESGGHGIGNVPLSKNEASITELSPR 577
           TLP P +P FF++       SSP+   T S +S      + P S ++  IT+L PR
Sbjct: 630 TLPVPRQPGFFIQ-------SSPVKDPTDSDQS--TTTKSTPASIDDELITDLYPR 676

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8H199|CRK14_ARATH Cysteine-rich receptor-like protein kinase 14 OS=Arabidopsis thaliana GN=CRK14 PE=2 SV=2

 Score =  498 bits (1282), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 261/592 (44%), Positives = 366/592 (61%), Gaps = 30/592 (5%)

Query: 2   EPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVY 61
           EP  C DCI  A   L   C N+   +   + R    CM+RY+N   FG ++  P+F+++
Sbjct: 81  EPDVCSDCIEYASNLLLDTCLNQTEGLAWPEKRIL--CMVRYSNSSFFGSLKAEPHFYIH 138

Query: 62  AESNISENLIEFNQTRQRLLERLFSEAAARPSPNKY-ATGKEAVSDIVTMYALVQCTPDL 120
              +I+ NL EF+Q  + L  R+ +   +  S  KY A    A++    +YAL+QCTPDL
Sbjct: 139 NVDDITSNLTEFDQVWEELARRMIASTTSPSSKRKYYAADVAALTAFQIIYALMQCTPDL 198

Query: 121 SEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYE----TNKFFKPSIAGPPGSPDP 176
           S  DC  CL  +      CC+ +QGG V   SC FR+E    +  F + S+A PP SP  
Sbjct: 199 SLEDCHICLRQSVGDYETCCNGKQGGIVYRASCVFRWELFPFSEAFSRISLAPPPQSPAF 258

Query: 177 VTPEPPPRKKNHTILITVIVSVVASVILITGICIFLRVGKLKL---------EDENVEET 227
            T             IT+ + +V ++I+ T I +FL +  L           +  + + T
Sbjct: 259 PTLPAVTNTATKKGSITISIGIVWAIIIPTVIVVFLVLLALGFVVYRRRKSYQGSSTDIT 318

Query: 228 IAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEF 287
           I  SLQFDF+ I  AT+ FS++N +G+GGFG V+ G+L NG  +A+KRLSK S+QG  EF
Sbjct: 319 ITHSLQFDFKAIEDATNKFSESNIIGRGGFGEVFMGVL-NGTEVAIKRLSKASRQGAREF 377

Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
           KNEV+++A+L HRNLV+LLGFCLE +E+ILVYEFVPN SLD+F+FDP  +  + W KRY 
Sbjct: 378 KNEVVVVAKLHHRNLVKLLGFCLEGEEKILVYEFVPNKSLDYFLFDPTKQGQLDWTKRYN 437

Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           II GI RG+LYLH+DSRL IIHRDLKASNILLD++MNPKI+DFGMAR+F +DQ+ ++T +
Sbjct: 438 IIRGITRGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGIDQSGANTKK 497

Query: 408 VVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ-KRSSFGTEEETEDLLTYAWRN 466
           + GT GYM PEYV  G+FS +SD++SFGVLVLEI+ G+  R    ++   E+L+TYAWR 
Sbjct: 498 IAGTRGYMPPEYVRQGQFSTRSDVYSFGVLVLEIICGRNNRFIHQSDTTVENLVTYAWRL 557

Query: 467 WNEGAALNLMDPTM-RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPA 525
           W   + L L+DPT+     T E+ +CIHI LLCVQ N ++RP ++++  ML  ++  LP 
Sbjct: 558 WRNDSPLELVDPTISENCETEEVTRCIHIALLCVQHNPTDRPSLSTINMMLINNSYVLPD 617

Query: 526 PSKPAFFMKCSVIPETSSPLDVITGSTESGGHGIGNVPLSKNEASITELSPR 577
           P +P FF    +  +    LD +  S           P + N+ +IT+  PR
Sbjct: 618 PQQPGFFFPI-ISNQERDGLDSMNRSN----------PQTINDVTITDFEPR 658

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	577
224076544	652	predicted protein [Populus trichocarpa]	0.989	0.875	0.591	0.0
255555051	1390	serine-threonine protein kinase, plant-t	0.928	0.385	0.567	0.0
296085636	660	unnamed protein product [Vitis vinifera]	0.980	0.857	0.578	0.0
147811956	839	hypothetical protein VITISV_019620 [Viti	0.984	0.676	0.555	0.0
359496752	751	PREDICTED: cysteine-rich receptor-like p	0.986	0.757	0.549	1e-178
359497268	675	PREDICTED: cysteine-rich receptor-like p	0.984	0.841	0.548	1e-177
356575759	687	PREDICTED: cysteine-rich receptor-like p	0.986	0.828	0.543	1e-177
356575761	679	PREDICTED: cysteine-rich receptor-like p	0.980	0.833	0.546	1e-176
356575767	675	PREDICTED: cysteine-rich receptor-like p	0.989	0.845	0.559	1e-175
359496707	678	PREDICTED: cysteine-rich receptor-like p	0.939	0.799	0.553	1e-175

>gi|224076544|ref|XP_002304959.1| predicted protein [Populus trichocarpa] gi|222847923|gb|EEE85470.1| predicted protein [Populus trichocarpa]

 Score =  684 bits (1766), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 346/585 (59%), Positives = 435/585 (74%), Gaps = 14/585 (2%)

Query: 1   MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFV 60
           ++P +CRDC+N + + LT+LCP +  AI G+D     +C+LRYA+  IFGL E APYFFV
Sbjct: 74  VKPDACRDCLNYSSRVLTALCPTQKEAIIGFD-----SCILRYASRSIFGLNEVAPYFFV 128

Query: 61  YAESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDL 120
           Y+ +N+S+    FN++   LL+ L  EAAA  S  KYAT K +  +  T+YAL QCTPDL
Sbjct: 129 YSLTNVSDEK-GFNRSLNSLLDSLQDEAAAGDSRRKYATRKISAPNFQTIYALSQCTPDL 187

Query: 121 SEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIA------GPPGSP 174
           S+ +C  CL + +  + +CC  RQGGRVI PSC+FRYE N+F++  I            P
Sbjct: 188 SQTECSSCLRNASARVGQCCQERQGGRVIYPSCNFRYEINQFYEIPIGEDPSPPPSKVPP 247

Query: 175 DPVTPEPPPRKKNHTILITVIVSVVASVILITGICIFLRVGKLKLEDENVEETI-AKSLQ 233
            P   E   R    TI+I V+ +V   +++I+ IC++LR+ K + + E VEE I A+SLQ
Sbjct: 248 PPPPAEGKKRNNARTIIIIVVSTVSVVILMISCICLYLRIRKPEEKVETVEEMITAESLQ 307

Query: 234 FDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLL 293
           FDF TIR ATDNFS+ NKLGQGGFG+VYKG LSNG+ +AVKRLSK+S QG++EFKNEVLL
Sbjct: 308 FDFSTIRAATDNFSEENKLGQGGFGSVYKGTLSNGQEVAVKRLSKDSGQGDLEFKNEVLL 367

Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +A+LQHRNLVRL GFCL+  ER+L+YEFVPNASLDHFIF+   R  + WE+RYKII GIA
Sbjct: 368 VAKLQHRNLVRLQGFCLQGIERLLIYEFVPNASLDHFIFNQARRAQLDWERRYKIIGGIA 427

Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
           RGLLYLHEDSRLRIIHRDLKASNILLD++MNPKISDFGMARLF MD+T  +T+R+VGT+G
Sbjct: 428 RGLLYLHEDSRLRIIHRDLKASNILLDADMNPKISDFGMARLFVMDETQGNTSRIVGTYG 487

Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAAL 473
           YMAPEY MHG+FSVKSD+FSFGVL+LEIVSGQK + F   E  EDLL+YAWRNW EG  L
Sbjct: 488 YMAPEYAMHGQFSVKSDVFSFGVLILEIVSGQKNNCFRNGETVEDLLSYAWRNWREGTGL 547

Query: 474 NLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKPAFFM 533
           N++DP +  GS +EMM+CIHIGLLCVQEN+++RP MAS+V ML+  ++TLP PS+PAFFM
Sbjct: 548 NVIDPALSTGSRTEMMRCIHIGLLCVQENIADRPTMASIVLMLSSYSLTLPVPSQPAFFM 607

Query: 534 KCSVI-PETSSPLDVITGSTESGGHGIGNVPLSKNEASITELSPR 577
             S    + SS +D  +  T S       +PLS NEASITEL PR
Sbjct: 608 NSSTYQSDISSSMDYNSRVTNSSEAKTEALPLSANEASITELYPR 652

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255555051|ref|XP_002518563.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223542408|gb|EEF43950.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  642 bits (1655), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 319/562 (56%), Positives = 410/562 (72%), Gaps = 26/562 (4%)

Query: 6   CRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESN 65
           CR CI  + + +T  CPN+   +G YD     +CM RY+N  IFG+ME  P   +  E N
Sbjct: 62  CRGCIRNSTREITQHCPNQKEVLGFYD-----SCMFRYSNRSIFGVMETQPTIHMKNEEN 116

Query: 66  ISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSEADC 125
           +++ + +FNQ  Q LL RL S+AAA  S  K+ATG E+ +   T++ L+QCTPD++E DC
Sbjct: 117 VTD-VNQFNQALQTLLSRLRSKAAAGNSTRKFATGNES-AGFETIFGLMQCTPDITEQDC 174

Query: 126 KECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSI---AGPPGSP-DPVTPEP 181
            +C+   T+ +  CC+ + GGRVI PSC+FRYE  +F++P+    A  P  P DP    P
Sbjct: 175 NDCIVAATRDIPICCNGKLGGRVIKPSCNFRYENYRFYQPTSDDDATHPSLPVDPSVSPP 234

Query: 182 PPRKKNHTILITVIVSVVASVI-LITGICIFLRVGKLKLEDENVEETI-AKSLQFDFETI 239
            P++ N+   I +IV +  S++ LI  + IF++V K +   E  EE +  +SLQFDFETI
Sbjct: 235 APKEGNNRRNIIIIVVLTVSIVSLIICVGIFIKVRKARKRIETAEEIMNVESLQFDFETI 294

Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH 299
           R+ TD+FS+ NKLG+GGFG+VYKG L  G+ IAVKRLS  SKQG++EFKNEVLL+A+LQH
Sbjct: 295 RICTDDFSEENKLGEGGFGSVYKGTLPMGQDIAVKRLSNGSKQGDLEFKNEVLLVAKLQH 354

Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           RNLVRLLGFCL+  ER+L+YEFVPNASLD +IFDP+    + WEKRYKII GIARGLLYL
Sbjct: 355 RNLVRLLGFCLQGIERLLIYEFVPNASLDQYIFDPVRCVQLDWEKRYKIIGGIARGLLYL 414

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           HEDSRLRIIHRDLKASNILLDS+MNPKISDFGMARLF MDQTHS+T+R+VGTFGYMAPEY
Sbjct: 415 HEDSRLRIIHRDLKASNILLDSDMNPKISDFGMARLFIMDQTHSNTSRIVGTFGYMAPEY 474

Query: 420 VMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT 479
            MHG+FS KSDIFSFGVL+LEIVSG + S +  E   EDLL+YAW+NW EG + NL+D  
Sbjct: 475 AMHGQFSFKSDIFSFGVLILEIVSGIRNSCYYNEGTMEDLLSYAWKNWGEGTSSNLIDHN 534

Query: 480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKPAFFMKCS--- 536
           +R GST+E+M+CIHIGLLCVQEN++ RP +AS+V ML+  + TLP PS+PAF+M  S   
Sbjct: 535 LRSGSTAEIMRCIHIGLLCVQENIAERPSVASIVLMLSSHSHTLPVPSQPAFYMYSSTEI 594

Query: 537 ----------VIPETSSPLDVI 548
                     VI  T +P+D++
Sbjct: 595 SMLPSINNSRVINTTRAPIDML 616

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296085636|emb|CBI29430.3| unnamed protein product [Vitis vinifera]

 Score =  640 bits (1650), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 340/588 (57%), Positives = 422/588 (71%), Gaps = 22/588 (3%)

Query: 1   MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFV 60
           + P +CR CIN + +++  LCPN   A+  YD      C LRY+N  IFG ++ +  + +
Sbjct: 84  LTPDTCRSCINNSSQDIRRLCPNYKEAVLYYD-----QCTLRYSNRSIFGTVDTSDSYAL 138

Query: 61  YAESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDL 120
               N+S+ +  F Q R  LL  L  +AA+     KYATG EAV+D +T+YALVQCTPDL
Sbjct: 139 QNTQNVSD-IDLFTQQRDDLLLDLREKAASGGLLKKYATG-EAVADFITIYALVQCTPDL 196

Query: 121 SEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKP-----SIAGPPGSPD 175
            + +C +C+ D +K  S     +QGGRV+ PSC+FR+ET +F+         +    SP 
Sbjct: 197 EDQECSDCVADLSKSYSDFLKYKQGGRVMAPSCNFRFETYRFYDTLPDAPPPSPANSSPP 256

Query: 176 PVTPEPPPRKKNHT-ILITVIVSVVASVILITG--ICIFLRVGKLKLEDENVEETI-AKS 231
           P        K N T  ++ ++ + V SVILI+   ICIFLR+GK K +DE  +E +  +S
Sbjct: 257 PNDATAGDGKSNRTRTVVIIVAATVVSVILISCVCICIFLRMGKPKDKDETEDEILEVES 316

Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEV 291
           LQF+  +IR ATDNFSD+NKLGQGGFGAVYKG LSNG+ IAVKRLSK S QGE+EFKNEV
Sbjct: 317 LQFNLGSIRNATDNFSDSNKLGQGGFGAVYKGTLSNGQDIAVKRLSKGSGQGELEFKNEV 376

Query: 292 LLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG 351
           LL+A+LQHRNL RLLGFCLE  ER+L+YEFVPNASLDHF+FDPI    + WE+RYKII G
Sbjct: 377 LLVAKLQHRNLARLLGFCLEGIERLLIYEFVPNASLDHFLFDPIKCSQLYWERRYKIIVG 436

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           IARGLLYLHEDSRLRIIHRDLKASNILLD EMNPKISDFGMARLF +DQT  DT R+VGT
Sbjct: 437 IARGLLYLHEDSRLRIIHRDLKASNILLDEEMNPKISDFGMARLFSLDQTQGDTKRIVGT 496

Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGA 471
           +GYMAPEY + G FSVKSD++SFGVLVLEIVSGQK +SFG EE  E L+++AWR+W EG+
Sbjct: 497 YGYMAPEYAIRGNFSVKSDVYSFGVLVLEIVSGQKNTSFGDEENMEGLISFAWRSWREGS 556

Query: 472 ALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKPAF 531
           A NL+DP+M  GS S +M+CIHIGLLCVQENV++RP MAS+V ML+  ++TLP PS+P F
Sbjct: 557 ASNLIDPSMNSGSRSGIMRCIHIGLLCVQENVADRPTMASIVLMLSSYSLTLPLPSQPGF 616

Query: 532 FMKCSVIPETSSPLDVITGSTESGGHGIGNVP--LSKNEASITELSPR 577
           FM  S  PET  PL  + GS     +   NV   +S NE SITEL PR
Sbjct: 617 FMHSSTNPET--PL--LQGSDSGVINASNNVSARVSVNETSITELRPR 660

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147811956|emb|CAN74851.1| hypothetical protein VITISV_019620 [Vitis vinifera]

 Score =  639 bits (1649), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 329/592 (55%), Positives = 417/592 (70%), Gaps = 24/592 (4%)

Query: 3   PSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYA 62
           P++CR CIN +R  LT LCPN+  AIG YD     NCMLRY+N  IFG  +++PYF++  
Sbjct: 255 PTACRSCINDSRIQLTQLCPNQKEAIGWYD-----NCMLRYSNDSIFGTQQSSPYFYMRN 309

Query: 63  ESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSE 122
             N S+ + EFNQ    ++  L S+AA+     K+ATG+  V+   ++Y L+QCTPDLSE
Sbjct: 310 SKNASD-VEEFNQVLGNMMASLRSKAASGDWRRKFATGEANVTSFQSIYGLMQCTPDLSE 368

Query: 123 ADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGS--------- 173
             C  CL   T  +  CCD R+GGRV+ PSC+ RYET +F+  + A  P           
Sbjct: 369 LSCSNCLEGATNEIPTCCDSRKGGRVVKPSCNLRYETYRFYDFTAANAPPPSPPSADLSP 428

Query: 174 ---PDPVTPEPPPRKKNHTILITVIVSVVASVILITG-ICIFLR----VGKLKLEDENVE 225
               +  + +      + TI++ ++ SV+  +I++ G IC F R    + KL+  DE+ E
Sbjct: 429 PPLANTTSTQETRSNSSRTIILIIVPSVIILIIILVGFICFFSRKRSSMEKLETHDED-E 487

Query: 226 ETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI 285
            T  +SL FDF+TIRVAT+NFSD+NKLGQGGFG VYKG LSNG+ +AVKRLS  S QGE+
Sbjct: 488 ITNVESLHFDFDTIRVATNNFSDSNKLGQGGFGPVYKGKLSNGQYVAVKRLSSGSAQGEL 547

Query: 286 EFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR 345
           EFKNE +L+A+LQHRNLVRLLGFCL+  ER+L+YEFVPN SLDHFIFD I R  + WE+R
Sbjct: 548 EFKNEAVLVAKLQHRNLVRLLGFCLDGAERLLIYEFVPNTSLDHFIFDLIRRAQLDWERR 607

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
           YKII GIARGLLYLHEDSRLRIIHRDLKASNILLD+EMNPKISDFGMARLF +DQT   T
Sbjct: 608 YKIIGGIARGLLYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARLFLVDQTQGST 667

Query: 406 NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWR 465
           +R+VGT+GYMAPEY MHG FSVK+D++SFGVLVLE+VSGQ+ + F   E  E LL+YAW+
Sbjct: 668 SRIVGTYGYMAPEYAMHGHFSVKTDVYSFGVLVLELVSGQRNNCFRVSENIEHLLSYAWK 727

Query: 466 NWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPA 525
           NW EG A NL+DPTMR  S SE+M+CIHIGLLCVQEN ++RP MAS+  MLN  +++LP 
Sbjct: 728 NWREGTATNLIDPTMRISSISEIMRCIHIGLLCVQENEADRPTMASIALMLNSYSLSLPV 787

Query: 526 PSKPAFFMKCSVIPETSSPLDVITGSTESGGHGIGNVPLSKNEASITELSPR 577
           PS PAFFM  S+  + S  L+  +   +S      +   S NEASIT+  PR
Sbjct: 788 PSHPAFFMNTSMNRDMSLELEDNSRVAQSNYLPSRSSHFSVNEASITDPYPR 839

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359496752|ref|XP_003635322.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like [Vitis vinifera]

 Score =  630 bits (1625), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 328/597 (54%), Positives = 416/597 (69%), Gaps = 28/597 (4%)

Query: 3   PSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYA 62
           P++CR CIN +R  LT LCPN+  AIG YD      CMLRY+N  IFG  + +P F ++ 
Sbjct: 161 PTACRSCINDSRIQLTRLCPNQKEAIGWYD-----GCMLRYSNDSIFGKAQTSPSFTMWN 215

Query: 63  ESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSE 122
             N+S N+ +FNQ    L+  L S+AA+     K+AT +  V+   ++Y L+QCTPDLSE
Sbjct: 216 LQNVS-NVEDFNQVLGNLMASLRSKAASGDWRRKFATEEANVTSFQSIYGLMQCTPDLSE 274

Query: 123 ADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPG---------- 172
             C  CL      +  CC+RR+ GRV+ PSC+ RY T +F+  + A  P           
Sbjct: 275 LSCSNCLEGAINEIPTCCNRRKAGRVVKPSCNLRYGTYRFYYFTAANAPPPTATPQPSPP 334

Query: 173 ----SPDPV----TPEPPPRKKNHTILITVIVSVVASVILITG-ICIF--LRVGKLKLED 221
               SP P+    + +      + TI++ ++ SV+  +I++ G IC F   R    KLE 
Sbjct: 335 SADLSPQPLANTTSTQETRSNSSRTIILIIVPSVIILIIILVGFICFFSRKRSSMEKLET 394

Query: 222 ENVEETI-AKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS 280
            + ++ I  +SL FDF+TIRVAT+NFSD+NKLGQGGFG VYKG LSNG+ IAVKRLS  S
Sbjct: 395 NDEDDIINVESLHFDFDTIRVATNNFSDSNKLGQGGFGPVYKGKLSNGQDIAVKRLSSGS 454

Query: 281 KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM 340
            QGE+EFKNEV+L+A+LQHRNLVRLLGFCL+  ER+L+YEFVPN SLDHFIFDPI R  +
Sbjct: 455 GQGELEFKNEVVLVAKLQHRNLVRLLGFCLDGAERLLIYEFVPNTSLDHFIFDPIRRAQL 514

Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
            WE+RYKII GIARGLLYLHEDSRLRIIHRDLKASNILLD+EMNPKISDFGMARLF +DQ
Sbjct: 515 DWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARLFLVDQ 574

Query: 401 THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
           T  +T+R+VGT+GYMAPEY MHG FSVK+D++SFGVLVLE+VSGQ+ + F   E  E LL
Sbjct: 575 TQGNTSRIVGTYGYMAPEYAMHGHFSVKTDVYSFGVLVLELVSGQRNNCFRVSENIEHLL 634

Query: 461 TYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDT 520
           +YAW+NW EG A NL+DPTMR  S SE+M+CIHIGLLCVQEN ++RP MAS+  MLN  +
Sbjct: 635 SYAWKNWREGTATNLIDPTMRISSISEIMRCIHIGLLCVQENEADRPTMASIALMLNSYS 694

Query: 521 VTLPAPSKPAFFMKCSVIPETSSPLDVITGSTESGGHGIGNVPLSKNEASITELSPR 577
           ++LP PS PAFFM  S+  + S  L+  +   +S      +   S NEASIT+  PR
Sbjct: 695 LSLPLPSHPAFFMNTSMNRDMSLELEDNSRVAQSNYLPSRSSHFSVNEASITDPYPR 751

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359497268|ref|XP_003635466.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like [Vitis vinifera]

 Score =  626 bits (1615), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 325/592 (54%), Positives = 412/592 (69%), Gaps = 24/592 (4%)

Query: 3   PSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYA 62
           P++CR CIN +R  LT LCPN+  AIG YD      CMLRY+N  IFG  + +P F ++ 
Sbjct: 91  PTACRSCINDSRIQLTRLCPNQKEAIGWYD-----GCMLRYSNDSIFGKAQTSPTFTMWN 145

Query: 63  ESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSE 122
             N+S N+ +FNQ    L+  L S+AA+     K+AT +  V+   ++Y L+QCTPDLSE
Sbjct: 146 LQNVS-NVEDFNQVLGNLMASLRSKAASGDWRRKFATEEANVTSFQSIYGLMQCTPDLSE 204

Query: 123 ADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGS--------- 173
             C  CL      +  CC+RR+ GRV+ PSC+ RY T  F+  + A  P           
Sbjct: 205 LSCSNCLEGAINEIPTCCNRRKAGRVVKPSCNLRYATYHFYDITAANAPPPSPPSADLSP 264

Query: 174 ---PDPVTPEPPPRKKNHTILITVIVSVVASVILITG-ICIFLR----VGKLKLEDENVE 225
               +  + +      + TI++ ++ SV+  +I++ G IC F R    + KL+  DE+ E
Sbjct: 265 PPLANTTSTQETRSNSSRTIILIIVPSVIILIIILVGFICFFSRKRSSMEKLETHDED-E 323

Query: 226 ETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI 285
            T  +SL FDF+TIRVAT+NFSD+NKLGQGGFG VYKG LSNG+ +AVKRLS  S QGE+
Sbjct: 324 ITNVESLHFDFDTIRVATNNFSDSNKLGQGGFGPVYKGKLSNGQNVAVKRLSSGSAQGEL 383

Query: 286 EFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR 345
           EFKNEV+L+A+LQHRNLVRLLGFCL+  ER+L+YEFVPN SLDHFIFD I R  + WE+R
Sbjct: 384 EFKNEVVLVAKLQHRNLVRLLGFCLDGAERLLIYEFVPNTSLDHFIFDLIRRAQLDWERR 443

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
           YKII GIARGLLYLHEDSRLRIIHRDLKASNILLD+EMNPKISDFGMARLF +DQT   T
Sbjct: 444 YKIIGGIARGLLYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGMARLFLVDQTQGST 503

Query: 406 NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWR 465
           +R+VGT+GYMAPEY MHG FSVK+D++SFGVLVLE+VSGQ+ + F   E  E LL+YAW+
Sbjct: 504 SRIVGTYGYMAPEYAMHGHFSVKTDVYSFGVLVLELVSGQRNNCFRVSENIEHLLSYAWK 563

Query: 466 NWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPA 525
           NW EG A NL+DPTMR  S SE+M+CIHIGLLCVQEN ++RP MAS+  MLN  +++LP 
Sbjct: 564 NWREGTATNLIDPTMRISSISEIMRCIHIGLLCVQENEADRPTMASIALMLNSYSLSLPV 623

Query: 526 PSKPAFFMKCSVIPETSSPLDVITGSTESGGHGIGNVPLSKNEASITELSPR 577
           PS PAFFM  S+  + S  L+  +   +S      +   S NEASIT+  PR
Sbjct: 624 PSHPAFFMNTSMNRDMSLELEDNSRVAQSNYLPSRSSHFSVNEASITDPYPR 675

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356575759|ref|XP_003556004.1| PREDICTED: cysteine-rich receptor-like protein kinase 29-like isoform 1 [Glycine max]

 Score =  626 bits (1615), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 323/594 (54%), Positives = 419/594 (70%), Gaps = 25/594 (4%)

Query: 1   MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFV 60
           +EP  CR C+N AR NLT  CPN+  AI  +D     NCMLRY+N  IFG +EN P  ++
Sbjct: 102 VEPDKCRSCLNYARSNLTQDCPNQKEAIIHFD-----NCMLRYSNRTIFGQVENFPGLYM 156

Query: 61  YAESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDL 120
           +   N ++ + EFNQ    L+  L   AA+  S  KYAT  +   +  T+Y LVQCTPDL
Sbjct: 157 WNLKNATD-VDEFNQVLANLMRNLKGVAASGDSRRKYATDDQTSGNFETIYGLVQCTPDL 215

Query: 121 SEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPP--------- 171
           SE  C +CL  T   +  CC+ + GGRVI PSC+ RYE  +F++ +    P         
Sbjct: 216 SETQCNDCLDGTISEIPTCCNDKVGGRVIRPSCNIRYEVYRFYEQTTVLDPEIPPSSPAP 275

Query: 172 GSPDPVTPEPPPRKKNHTILITVIVSVVASVILITGICIFLRVGK----LKLEDENVEE- 226
                 +PEP     N  +++  IV     V+L+  +C++LR  K    L +++ +VE+ 
Sbjct: 276 PPFADTSPEPE-ESGNTIVIVISIVVPTVVVVLLICLCLYLRRRKARKNLVVKENDVEDE 334

Query: 227 -TIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI 285
             IA+SLQF+F TI+VAT++FSD+NKLGQGGFGAVY+G LS G+ IAVKRLS++S QG+ 
Sbjct: 335 IKIAESLQFNFNTIQVATEDFSDSNKLGQGGFGAVYRGRLSTGQMIAVKRLSRDSGQGDT 394

Query: 286 EFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR 345
           EFKNEVLL+A+LQHRNLVRLLGFCLER ER+LVYEFVPN SLD+FIFDP  +  + W  R
Sbjct: 395 EFKNEVLLVAKLQHRNLVRLLGFCLERNERLLVYEFVPNKSLDYFIFDPNMKAQLDWNSR 454

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
           YKII GIARGLLYLHEDSRLRIIHRDLKASNILLD EM+PKI+DFGMARL  +DQT ++T
Sbjct: 455 YKIIRGIARGLLYLHEDSRLRIIHRDLKASNILLDEEMSPKIADFGMARLVLVDQTQTNT 514

Query: 406 NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWR 465
           +R+VGT+GYMAPEY MHG+FSVKSD+FSFGVLVLEI+SGQK S F   E  EDLL++AWR
Sbjct: 515 SRIVGTYGYMAPEYAMHGQFSVKSDVFSFGVLVLEILSGQKNSGFHHGENVEDLLSFAWR 574

Query: 466 NWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPA 525
           +W EG A+N++DP++   S +EMM+CIHIGLLCVQEN+++RP MA+++ MLN  +++LP 
Sbjct: 575 SWKEGTAINIVDPSLNNNSRNEMMRCIHIGLLCVQENLADRPTMATIMLMLNSYSLSLPI 634

Query: 526 PSKPAFFM--KCSVIPETSSPLDVITGSTESGGHGIGNVPLSKNEASITELSPR 577
           P+KPAF+M  +   +P+  S  +  +  T S    I +   S+NEASITEL  R
Sbjct: 635 PAKPAFYMNSRTGSLPDMQS-WEYNSRETGSSESIIKSAQESENEASITELYAR 687

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356575761|ref|XP_003556005.1| PREDICTED: cysteine-rich receptor-like protein kinase 29-like isoform 2 [Glycine max]

 Score =  626 bits (1614), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 322/589 (54%), Positives = 417/589 (70%), Gaps = 23/589 (3%)

Query: 1   MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFV 60
           +EP  CR C+N AR NLT  CPN+  AI  +D     NCMLRY+N  IFG +EN P  ++
Sbjct: 102 VEPDKCRSCLNYARSNLTQDCPNQKEAIIHFD-----NCMLRYSNRTIFGQVENFPGLYM 156

Query: 61  YAESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDL 120
           +   N ++ + EFNQ    L+  L   AA+  S  KYAT  +   +  T+Y LVQCTPDL
Sbjct: 157 WNLKNATD-VDEFNQVLANLMRNLKGVAASGDSRRKYATDDQTSGNFETIYGLVQCTPDL 215

Query: 121 SEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPP--------- 171
           SE  C +CL  T   +  CC+ + GGRVI PSC+ RYE  +F++ +    P         
Sbjct: 216 SETQCNDCLDGTISEIPTCCNDKVGGRVIRPSCNIRYEVYRFYEQTTVLDPEIPPSSPAP 275

Query: 172 GSPDPVTPEPPPRKKNHTILITVIVSVVASVILITGICIFLRVGKLKLEDENVEET-IAK 230
                 +PEP     N  +++  IV     V+L+  +C++LR  K +   +N++E  IA+
Sbjct: 276 PPFADTSPEPE-ESGNTIVIVISIVVPTVVVVLLICLCLYLRRRKAR---KNLDEIKIAE 331

Query: 231 SLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNE 290
           SLQF+F TI+VAT++FSD+NKLGQGGFGAVY+G LS G+ IAVKRLS++S QG+ EFKNE
Sbjct: 332 SLQFNFNTIQVATEDFSDSNKLGQGGFGAVYRGRLSTGQMIAVKRLSRDSGQGDTEFKNE 391

Query: 291 VLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE 350
           VLL+A+LQHRNLVRLLGFCLER ER+LVYEFVPN SLD+FIFDP  +  + W  RYKII 
Sbjct: 392 VLLVAKLQHRNLVRLLGFCLERNERLLVYEFVPNKSLDYFIFDPNMKAQLDWNSRYKIIR 451

Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG 410
           GIARGLLYLHEDSRLRIIHRDLKASNILLD EM+PKI+DFGMARL  +DQT ++T+R+VG
Sbjct: 452 GIARGLLYLHEDSRLRIIHRDLKASNILLDEEMSPKIADFGMARLVLVDQTQTNTSRIVG 511

Query: 411 TFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEG 470
           T+GYMAPEY MHG+FSVKSD+FSFGVLVLEI+SGQK S F   E  EDLL++AWR+W EG
Sbjct: 512 TYGYMAPEYAMHGQFSVKSDVFSFGVLVLEILSGQKNSGFHHGENVEDLLSFAWRSWKEG 571

Query: 471 AALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKPA 530
            A+N++DP++   S +EMM+CIHIGLLCVQEN+++RP MA+++ MLN  +++LP P+KPA
Sbjct: 572 TAINIVDPSLNNNSRNEMMRCIHIGLLCVQENLADRPTMATIMLMLNSYSLSLPIPAKPA 631

Query: 531 FFM--KCSVIPETSSPLDVITGSTESGGHGIGNVPLSKNEASITELSPR 577
           F+M  +   +P+  S  +  +  T S    I +   S+NEASITEL  R
Sbjct: 632 FYMNSRTGSLPDMQS-WEYNSRETGSSESIIKSAQESENEASITELYAR 679

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356575767|ref|XP_003556008.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like isoform 1 [Glycine max]

 Score =  622 bits (1604), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 331/592 (55%), Positives = 410/592 (69%), Gaps = 21/592 (3%)

Query: 1   MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFV 60
           ++P +CR C N ++  LT LCPN+  AIG YD     NCMLRY+N  IF  ME  P F +
Sbjct: 90  VKPDACRICFNDSKVLLTQLCPNQKEAIGWYD-----NCMLRYSNRSIFNTMEALPSFSM 144

Query: 61  YAESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDL 120
               N ++ + +FNQ  + LL  L  + ++  S +K+A    +     T+Y LVQCTPDL
Sbjct: 145 RNHGNTTD-VDQFNQVLRTLLYSLVGQGSSGDSRHKFAAANVSGPGFETIYGLVQCTPDL 203

Query: 121 SEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGSPDP-VTP 179
           SE +C  CL D    + +CCD ++GGRV+ PSC+FRYET  F+ P+    P +P P V+ 
Sbjct: 204 SEQECTSCLVDAISEIPRCCDSKKGGRVVRPSCNFRYETYPFYTPTNVAIPQAPAPKVSA 263

Query: 180 EPP-------PRKKNHTILITVIVSVVASVILITGICIF----LRVGK--LKLEDENVEE 226
            PP       P  K++T LI + + V     +I  I I     +R  +  +++E EN +E
Sbjct: 264 LPPSSTDTLSPEGKSNTSLIVIAIVVPIIAFVILVILILIYLRMRRSREHIEVELENDDE 323

Query: 227 T-IAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI 285
              A++LQ DF TI  AT+NFSDAN+LGQGGFG VYKG LSNG+ +AVKRLS+NS QG+I
Sbjct: 324 IRSAETLQLDFSTIVAATNNFSDANELGQGGFGPVYKGTLSNGKEVAVKRLSRNSLQGDI 383

Query: 286 EFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR 345
           EFKNEVLL+A+LQHRNLV+LLGFCLER ER+LVYEFVPN SLD FIFD   R  + WEKR
Sbjct: 384 EFKNEVLLVAKLQHRNLVKLLGFCLERSERLLVYEFVPNKSLDFFIFDQNRRAQLDWEKR 443

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
           YKII GIARGL+YLHEDSRLRIIHRDLKASNILLD+EM+PKISDFGMARLFE+DQT  +T
Sbjct: 444 YKIIGGIARGLVYLHEDSRLRIIHRDLKASNILLDAEMHPKISDFGMARLFEVDQTQGNT 503

Query: 406 NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWR 465
           +R+VGTFGYMAPEY MHG+FSVKSD+FSFGVL+LEIVSGQK S     E   DLLT+ W+
Sbjct: 504 SRIVGTFGYMAPEYAMHGQFSVKSDVFSFGVLILEIVSGQKNSWVCKGENAGDLLTFTWQ 563

Query: 466 NWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPA 525
           NW  G A N++DPT+  GS +E+M+CIHI LLCVQENV++RP MASVV MLN  +VTLP 
Sbjct: 564 NWRGGTASNIVDPTITDGSRNEIMRCIHIALLCVQENVADRPTMASVVLMLNSYSVTLPL 623

Query: 526 PSKPAFFMKCSVIPETSSPLDVITGSTESGGHGIGNVPLSKNEASITELSPR 577
           PS PAFF+     P   S       +  S      +V  S NEASITE  PR
Sbjct: 624 PSLPAFFIDSRSFPAIQSEEYNPMAAGASDESNARSVQESINEASITEPFPR 675

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359496707|ref|XP_003635308.1| PREDICTED: cysteine-rich receptor-like protein kinase 29-like [Vitis vinifera]

 Score =  622 bits (1603), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 316/571 (55%), Positives = 405/571 (70%), Gaps = 29/571 (5%)

Query: 6   CRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESN 65
           C  C+N +R  L   CP +  AIGGYD+     CMLRY+N  IF  +E  P F+V   +N
Sbjct: 98  CHSCLNDSRLQLPQRCPYQNEAIGGYDE-----CMLRYSNRSIFRTLEILPSFYVSNPNN 152

Query: 66  ISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSEADC 125
           +S   + FNQ  + LL+ L S+AA+  S  K+ATG+   +    +Y  +QCTPDL+E+ C
Sbjct: 153 VSNEDV-FNQALKTLLDSLRSKAASGNSLLKFATGEATGTGDKRIYGFMQCTPDLNESSC 211

Query: 126 KECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGP--------------- 170
             CL      +  CC  ++GGR+  PSCS R+ET +F+  + A                 
Sbjct: 212 SICLEGAINDVPACCGNKEGGRIFKPSCSLRFETFRFYDFTAANTPPPATWPPSSPSPSD 271

Query: 171 ---PGSPDPVTPEPPPRKKNHTILITVIV-SVVASVILITGICIFLRVGKLK---LEDEN 223
              P SP  VTP    +      LI ++V +V+ SV+LI+ IC FL+  + +   L  E 
Sbjct: 272 NLTPPSPAIVTPTKGKKSNTSRTLILIVVPTVIISVLLISFICFFLKKRRPRGQFLSFEG 331

Query: 224 VEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG 283
              T+ +SLQF F TIRVATDNFSDANKLG+GGFG+VYKG LS+G+ IAVKRLS  SKQG
Sbjct: 332 ETRTL-ESLQFQFSTIRVATDNFSDANKLGEGGFGSVYKGRLSDGQEIAVKRLSAGSKQG 390

Query: 284 EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWE 343
           E+EFKNEVLL+A+LQHRNLVRLLGFCLER ER+L+YEF+PN SL  FIFDPI +  + WE
Sbjct: 391 ELEFKNEVLLMAKLQHRNLVRLLGFCLERSERLLIYEFMPNLSLHGFIFDPIKQTQLNWE 450

Query: 344 KRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
           KRYKII GIARGLLYLHEDSRLRIIHRDLKASNILLD+EMNPKISDFG+ARLF +DQT  
Sbjct: 451 KRYKIIGGIARGLLYLHEDSRLRIIHRDLKASNILLDAEMNPKISDFGIARLFAVDQTQE 510

Query: 404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA 463
           +T+R++GT+GYMAPEYV+HG+FSVKSD++S GVL+LEI+SGQK + F   E TE LLT+A
Sbjct: 511 NTSRIMGTYGYMAPEYVLHGKFSVKSDVYSLGVLILEIISGQKNNCFHVGENTEYLLTHA 570

Query: 464 WRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTL 523
           W +W EG A +++DPT+R GSTSE+M+CIHIGLLCVQENV++RP MASV+ MLN  +++L
Sbjct: 571 WISWREGTASSMIDPTLRDGSTSEIMRCIHIGLLCVQENVADRPTMASVMLMLNSYSLSL 630

Query: 524 PAPSKPAFFMKCSVIPETSSPLDVITGSTES 554
           P PS PA F++ ++    SS L+  + ST+S
Sbjct: 631 PIPSHPASFLRSNIDQNISSGLEHNSRSTDS 661

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	577
TAIR|locus:2115728	675	CRK25 "cysteine-rich RLK (RECE	0.972	0.831	0.486	8.9e-141
TAIR|locus:2141201	679	CRK29 "cysteine-rich RLK (RECE	0.608	0.516	0.562	1.1e-135
TAIR|locus:2121676	669	CRK10 "cysteine-rich RLK (RECE	0.954	0.823	0.455	1.3e-130
TAIR|locus:2123126	666	CRK31 "cysteine-rich RLK (RECE	0.977	0.846	0.459	3.6e-128
TAIR|locus:2121691	667	CRK11 "cysteine-rich RLK (RECE	0.682	0.590	0.507	7e-128
TAIR|locus:2121636	659	CRK7 "cysteine-rich RLK (RECEP	0.968	0.848	0.451	4.2e-127
TAIR|locus:2121651	676	CRK8 "cysteine-rich RLK (RECEP	0.963	0.822	0.449	6.1e-126
TAIR|locus:2141762	665	CRK26 "cysteine-rich RLK (RECE	0.785	0.681	0.526	1.6e-125
TAIR|locus:2127323	642	CRK27 "cysteine-rich RLK (RECE	0.902	0.811	0.481	8.1e-125
TAIR|locus:2134603	665	CRK41 "cysteine-rich RLK (RECE	0.885	0.768	0.493	4.9e-124

TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 1377 (489.8 bits), Expect = 8.9e-141, P = 8.9e-141
 Identities = 287/590 (48%), Positives = 382/590 (64%)

Query:     6 CRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESN 65
             CRDC+  A       CP +  A+  YD+     CM+RY+N  I G M   P  F+  + N
Sbjct:    97 CRDCVAFAANETLQRCPREKVAVIWYDE-----CMVRYSNQSIVGQMRIRPGVFLTNKQN 151

Query:    66 ISENLIE-FNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSEAD 124
             I+EN +  FN++   LL  +  +AA   S  K+AT K   +   T+Y+LVQCTPDL+  D
Sbjct:   152 ITENQVSRFNESLPALLIDVAVKAAL--SSRKFATEKANFTVFQTIYSLVQCTPDLTNQD 209

Query:   125 CKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGSPDP---VTPEP 181
             C+ CL      + +CCDR  GGRVI PSCSFRYE   F+  +IA  P +P P   VT  P
Sbjct:   210 CESCLRQVINYLPRCCDRSVGGRVIAPSCSFRYELYPFYNETIAAAPMAPPPSSTVTAPP 269

Query:   182 ---PPRK---KNHXXXXXXXXXXXXXXXXXXG-ICIFL---RVGKLKLEDENVEE---TI 228
                P  K   KN                   G +C  L   R  KL  E E+++E   T 
Sbjct:   270 LNIPSEKGKGKNLTVIVTAIAVPVSVCVLLLGAMCWLLARRRNNKLSAETEDLDEDGITS 329

Query:   229 AKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFK 288
              ++LQF F  I  AT+ FS++NKLG GGFG VYKG L  GET+A+KRLS+ S QG  EFK
Sbjct:   330 TETLQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQGSTQGAEEFK 389

Query:   289 NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI 348
             NEV ++A+LQHRNL +LLG+CL+ +E+ILVYEFVPN SLD+F+FD   R  + W++RYKI
Sbjct:   390 NEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKRRVLDWQRRYKI 449

Query:   349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV 408
             IEGIARG+LYLH DSRL IIHRDLKASNILLD++M+PKISDFGMAR+F +DQT ++T R+
Sbjct:   450 IEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGVDQTQANTKRI 509

Query:   409 VGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWN 468
             VGT+GYM+PEY +HG++SVKSD++SFGVLVLE+++G+K SSF  E+   DL+TY W+ W 
Sbjct:   510 VGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNSSFYEEDGLGDLVTYVWKLWV 569

Query:   469 EGAALNLMDPTMRGG-STSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPS 527
             E + L L+D  MRG   T+E+++CIHI LLCVQE+ S RP M  ++ M+N  TVTLP P 
Sbjct:   570 ENSPLELVDEAMRGNFQTNEVIRCIHIALLCVQEDSSERPSMDDILVMMNSFTVTLPIPK 629

Query:   528 KPAFFMKCSVIPETSSPLDVITGSTESGGHGIGNVPLSKNEASITELSPR 577
             +  F ++   + ++  P     GS         ++PLS +++SIT + PR
Sbjct:   630 RSGFLLR--TMKDSRDPRS--GGSASDHSATSKSLPLSVDDSSITIVYPR 675

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2141201 CRK29 "cysteine-rich RLK (RECEPTOR-like protein kinase) 29" [Arabidopsis thaliana (taxid:3702)]

 Score = 1070 (381.7 bits), Expect = 1.1e-135, Sum P(2) = 1.1e-135
 Identities = 208/370 (56%), Positives = 278/370 (75%)

Query:   214 VGKLKLEDENVEETIA--KSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETI 271
             +GK  L     E+  +  +SL   FET++ ATDNFS  N+LG+GGFG+VYKG+   G+ I
Sbjct:   323 LGKSPLSGSIAEDEFSNTESLLVHFETLKTATDNFSSENELGRGGFGSVYKGVFPQGQEI 382

Query:   272 AVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
             AVKRLS NS QG+ EFKNE+LLLA+LQHRNLVRL+GFC++ +ER+LVYEF+ NASLD FI
Sbjct:   383 AVKRLSGNSGQGDNEFKNEILLLAKLQHRNLVRLIGFCIQGEERLLVYEFIKNASLDQFI 442

Query:   332 FDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG 391
             FD   R+ + W  RYK+I GIARGLLYLHEDSR RIIHRDLKASNILLD EMNPKI+DFG
Sbjct:   443 FDTEKRQLLDWVVRYKMIGGIARGLLYLHEDSRFRIIHRDLKASNILLDQEMNPKIADFG 502

Query:   392 MARLFEMDQT--HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSS 449
             +A+LF+  QT  H  T+R+ GT+GYMAPEY MHG+FSVK+D+FSFGVLV+EI++G++ ++
Sbjct:   503 LAKLFDSGQTMTHRFTSRIAGTYGYMAPEYAMHGQFSVKTDVFSFGVLVIEIITGKRNNN 562

Query:   450 FGT--EEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRP 507
              G+  +E+ EDLL++ WR+W E   L+++DP++  GS +E+++CIHIGLLCVQE+ + RP
Sbjct:   563 GGSNGDEDAEDLLSWVWRSWREDTILSVIDPSLTAGSRNEILRCIHIGLLCVQESAATRP 622

Query:   508 GMASVVNMLNGDTVTLPAPSKPAFFMKCSVIPETSSPLDVITGSTESGGHGIGNVPLSKN 567
              MA+V  MLN  + TLP P +PAF ++  VIP        ++ STE        + +S N
Sbjct:   623 TMATVSLMLNSYSFTLPTPLRPAFVLESVVIPSN------VSSSTEG-------LQMSSN 669

Query:   568 EASITELSPR 577
             + +++E SPR
Sbjct:   670 DVTVSEFSPR 679

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005773 "vacuole" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 1281 (456.0 bits), Expect = 1.3e-130, P = 1.3e-130
 Identities = 267/586 (45%), Positives = 370/586 (63%)

Query:     6 CRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAESN 65
             CR C++ A  +  + CPN+  A   YD+     C+LRY+N +I   +       +    N
Sbjct:   105 CRRCVSFAVNDTLTRCPNQKEATLYYDE-----CVLRYSNQNILSTLITTGGVILVNTRN 159

Query:    66 ISENLIEFNQTRQRLLERLFSEAA-ARPSPNKYATGKEAVSDIVTMYALVQCTPDLSEAD 124
             ++ N ++       +L  L   A  A  S  K+ T K   + + + Y LVQCTPDL+  D
Sbjct:   160 VTSNQLDL--LSDLVLPTLNQAATVALNSSKKFGTRKNNFTALQSFYGLVQCTPDLTRQD 217

Query:   125 CKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGSPDPVTPEP--- 181
             C  CL     ++++    R G R+INPSC+ RYE   F+  S   PP  P  ++  P   
Sbjct:   218 CSRCLQ---LVINQIPTDRIGARIINPSCTSRYEIYAFYTESAVPPPPPPPSISTPPVSA 274

Query:   182 PPR--KKNHXXXXXXXXXX---XXXXXXXXGICIFLRVGKLKLEDENV----EETIAKSL 232
             PPR  K  +                     G C   R  +      +     + T A SL
Sbjct:   275 PPRSGKDGNSKVLVIAIVVPIIVAVLLFIAGYCFLTRRARKSYYTPSAFAGDDITTADSL 334

Query:   233 QFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVL 292
             Q D+ TI+ ATD+F ++NK+GQGGFG VYKG LS+G  +AVKRLSK+S QGE+EFKNEV+
Sbjct:   335 QLDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQGEVEFKNEVV 394

Query:   293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
             L+A+LQHRNLVRLLGFCL+ +ER+LVYE+VPN SLD+F+FDP  +  + W +RYKII G+
Sbjct:   395 LVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWTRRYKIIGGV 454

Query:   353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF 412
             ARG+LYLH+DSRL IIHRDLKASNILLD++MNPKI+DFGMAR+F +DQT  +T+R+VGT+
Sbjct:   455 ARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRIVGTY 514

Query:   413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAA 472
             GYM+PEY MHG++S+KSD++SFGVLVLEI+SG+K SSF   +   DL++YAW  W+ G  
Sbjct:   515 GYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSYAWGLWSNGRP 574

Query:   473 LNLMDPTM-RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKPAF 531
             L L+DP +      +E+++C+HIGLLCVQE+ + RP ++++V ML  +TVTLP P +P  
Sbjct:   575 LELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNTVTLPVPRQPGL 634

Query:   532 FMKCSVIPETSSPLDVITGSTESGGHGIGNVPLSKNEASITELSPR 577
             F +  +      PLD  T S       +G+V    ++ASIT++ PR
Sbjct:   635 FFQSRI---GKDPLDTDTTSKSL----LGSV----DDASITDIHPR 669

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

TAIR|locus:2123126 CRK31 "cysteine-rich RLK (RECEPTOR-like protein kinase) 31" [Arabidopsis thaliana (taxid:3702)]

 Score = 1258 (447.9 bits), Expect = 3.6e-128, P = 3.6e-128
 Identities = 274/596 (45%), Positives = 358/596 (60%)

Query:     2 EPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNN-CMLRYANYDIFGLMENAPYFFV 60
             +P  C DCI +A + L   CPN+  +     D      C +RY+N   F  M   P   V
Sbjct:    83 DPRVCSDCIQLASQGLLQTCPNQTDSFYWTGDNADKTLCFVRYSNNSFFNKMALEPTHAV 142

Query:    61 YAESNISENLIEFNQTRQRLLERLFSEAA-----ARPSPNKYATGKEAVS-DIVTMYALV 114
             Y       NL  + +T    +  +F+        A  SP      +E +S D++  YAL+
Sbjct:   143 YNTMRFQGNLTAYTRTWDAFMNFMFTRVGQTRYLADISPR---INQEPLSPDLI--YALM 197

Query:   115 QCTPDLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKF---FKPSIAGPP 171
             QC P +S  DC+ CL         CC+   GG V  P C FR++  K+   F       P
Sbjct:   198 QCIPGISSEDCETCLGKCVDDYQSCCNGFIGGVVNKPVCYFRWDGYKYYGAFGDEAPSQP 257

Query:   172 GSPDPVTPEPPPR----KK--NHXXXXXXXXXXXXXXXXXXGICIFLRVGKLKLEDENVE 225
              +P P+ P PPPR    KK                      G+ I+ R    K    + +
Sbjct:   258 PTPLPLPP-PPPRDPDGKKISTGVIVAIVVSAVIFVVLVALGLVIWKRRQSYKTLKYHTD 316

Query:   226 E--TIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG 283
             +  T  +SLQFDF TI VATDNFS  NKLGQGGFG VYKGML N   IAVKRLS NS QG
Sbjct:   317 DDMTSPQSLQFDFTTIEVATDNFSRNNKLGQGGFGEVYKGMLPNETEIAVKRLSSNSGQG 376

Query:   284 EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWE 343
               EFKNEV+++A+LQH+NLVRLLGFC+ER E+ILVYEFV N SLD+F+FDP  +  + W+
Sbjct:   377 TQEFKNEVVIVAKLQHKNLVRLLGFCIERDEQILVYEFVSNKSLDYFLFDPKMKSQLDWK 436

Query:   344 KRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
             +RY II G+ RGLLYLH+DSRL IIHRD+KASNILLD++MNPKI+DFGMAR F +DQT  
Sbjct:   437 RRYNIIGGVTRGLLYLHQDSRLTIIHRDIKASNILLDADMNPKIADFGMARNFRVDQTED 496

Query:   404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE-DLLTY 462
              T RVVGTFGYM PEYV HG+FS KSD++SFGVL+LEIV G+K SSF   +++  +L+T+
Sbjct:   497 QTGRVVGTFGYMPPEYVTHGQFSTKSDVYSFGVLILEIVCGKKNSSFFQMDDSGGNLVTH 556

Query:   463 AWRNWNEGAALNLMDPTMRGG-STSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTV 521
              WR WN  + L+L+DP ++      E+++CIHIG+LCVQE  ++RP M+++  ML   ++
Sbjct:   557 VWRLWNNDSPLDLIDPAIKESYDNDEVIRCIHIGILCVQETPADRPEMSTIFQMLTNSSI 616

Query:   522 TLPAPSKPAFFMKCSVIPETSSPLDVITGSTESGGHGIGNVPLSKNEASITELSPR 577
             TLP P  P FF +    P     LD +T  +E G     +VP S + ASIT  +PR
Sbjct:   617 TLPVPRPPGFFFRNR--PN----LDPLTYGSEQGQSSSMSVPFSIDSASITRATPR 666

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2121691 CRK11 "cysteine-rich RLK (RECEPTOR-like protein kinase) 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 1011 (360.9 bits), Expect = 7.0e-128, Sum P(2) = 7.0e-128
 Identities = 212/418 (50%), Positives = 278/418 (66%)

Query:   159 TNKFFKPSIAGPPGSPDPVT-PEPPPRK----KNHXXXXXXXXXXXXXXXXXXGICIFLR 213
             +N F   ++A PP  P PVT P+P   +     N                    I I L 
Sbjct:   249 SNAFDNLTVASPPPEP-PVTVPQPAGDQDNPTNNDSKGISAGVVVAITVPTVIAILILLV 307

Query:   214 VG-----------KLKLEDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYK 262
             +G           + K E E+   T   SL +DF+TI  AT+ FS +NKLG+GGFGAVYK
Sbjct:   308 LGFVLFRRRKSYQRTKTESESDIST-TDSLVYDFKTIEAATNKFSTSNKLGEGGFGAVYK 366

Query:   263 GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV 322
             G LSNG  +AVKRLSK S QG  EF+NE +L+ +LQHRNLVRLLGFCLER+E+IL+YEFV
Sbjct:   367 GKLSNGTDVAVKRLSKKSGQGTREFRNEAVLVTKLQHRNLVRLLGFCLEREEQILIYEFV 426

Query:   323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE 382
              N SLD+F+FDP  +  + W +RYKII GIARG+LYLH+DSRL+IIHRDLKASNILLD++
Sbjct:   427 HNKSLDYFLFDPEKQSQLDWTRRYKIIGGIARGILYLHQDSRLKIIHRDLKASNILLDAD 486

Query:   383 MNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIV 442
             MNPKI+DFG+A +F ++QT  +TNR+ GT+ YM+PEY MHG++S+KSDI+SFGVLVLEI+
Sbjct:   487 MNPKIADFGLATIFGVEQTQGNTNRIAGTYAYMSPEYAMHGQYSMKSDIYSFGVLVLEII 546

Query:   443 SGQKRSSFGTEEETE---DLLTYAWRNWNEGAALNLMDPTM-RGGSTSEMMKCIHIGLLC 498
             SG+K S     +ET    +L+TYA R W   + L L+DPT  R   ++E+ +CIHI LLC
Sbjct:   547 SGKKNSGVYQMDETSTAGNLVTYASRLWRNKSPLELVDPTFGRNYQSNEVTRCIHIALLC 606

Query:   499 VQENVSNRPGMASVVNMLNGDTVTLPAPSKPAFFMKCSVIPETS--SPLDVITGSTES 554
             VQEN  +RP +++++ ML  +T+TLP P  P FF +   +   S  S  D  T  + S
Sbjct:   607 VQENPEDRPMLSTIILMLTSNTITLPVPRLPGFFPRSRQLKLVSEGSESDQYTSKSSS 664

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IEP;RCA

GO:0009816 "defense response to bacterium, incompatible interaction" evidence=IEP

GO:0016020 "membrane" evidence=ISS

GO:0009611 "response to wounding" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2121636 CRK7 "cysteine-rich RLK (RECEPTOR-like protein kinase) 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 1248 (444.4 bits), Expect = 4.2e-127, P = 4.2e-127
 Identities = 266/589 (45%), Positives = 372/589 (63%)

Query:     1 MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGL-MENAPYFF 59
             + P  CR+C+  A  N  S CPN+  A+  Y++     C+LRY++ +I    + N   F 
Sbjct:    89 VSPEVCRNCVTFAVNNTFSRCPNQREAVFYYEE-----CILRYSHKNILSTAITNEGEFI 143

Query:    60 VYAESNISENLIEFNQTRQRLLERLFSEAA-ARPSPNKYATGKEAVSDIVTMYALVQCTP 118
             +   ++IS    + NQ    +L  +   A  A  +P K++T K  ++ + T Y LVQCTP
Sbjct:   144 LRNPNHISPIQNQINQFTNLVLSNMNQIAIEAADNPRKFSTIKTELTALQTFYGLVQCTP 203

Query:   119 DLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGSPDPVT 178
             DLS  +C  CL   T  +++    R G R   PSC+ RYE   F+  +  G P  P P  
Sbjct:   204 DLSRQNCMNCL---TSSINRMPFSRIGARQFWPSCNSRYELYDFYNETAIGTPPPPLPPL 260

Query:   179 PEPPPRKK----NHXXXXXXXXXXXXXXXXXXGICIFLR-----VGKLKLEDENVEETIA 229
               P    K    N                   G C F +      G     DE+ + TI 
Sbjct:   261 ASPSLSDKSGNSNVVVVAVVVPIIVAVLIFIAGYCFFAKRAKKTYGTTPALDEDDKTTI- 319

Query:   230 KSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKN 289
             +SLQ D+  I+ AT++FS+ NK+G+GGFG VYKG  SNG  +AVKRLSK S+QG+ EFKN
Sbjct:   320 ESLQLDYRAIQAATNDFSENNKIGRGGFGDVYKGTFSNGTEVAVKRLSKTSEQGDTEFKN 379

Query:   290 EVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
             EV+++A L+H+NLVR+LGF +ER+ERILVYE+V N SLD+F+FDP  +  + W +RY II
Sbjct:   380 EVVVVANLRHKNLVRILGFSIEREERILVYEYVENKSLDNFLFDPAKKGQLYWTQRYHII 439

Query:   350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
              GIARG+LYLH+DSRL IIHRDLKASNILLD++MNPKI+DFGMAR+F MDQT  +T+R+V
Sbjct:   440 GGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGMDQTQQNTSRIV 499

Query:   410 GTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNE 469
             GT+GYM+PEY M G+FS+KSD++SFGVLVLEI+SG+K +SF   ++ +DL+T+AWR W  
Sbjct:   500 GTYGYMSPEYAMRGQFSMKSDVYSFGVLVLEIISGRKNNSFIETDDAQDLVTHAWRLWRN 559

Query:   470 GAALNLMDPTMRGGST-SEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSK 528
             G AL+L+DP +      SE+++C HIGLLCVQE+   RP M+++  ML  +T+ LPAP +
Sbjct:   560 GTALDLVDPFIADSCRKSEVVRCTHIGLLCVQEDPVKRPAMSTISVMLTSNTMALPAPQQ 619

Query:   529 PAFFMKCSVIPETSSPLDVITGSTESGGHGIGNVPLSKNEASITELSPR 577
             P FF++    P T+  LD    +T        +V +S ++ S+++L PR
Sbjct:   620 PGFFVRSR--PGTNR-LDSDQSTTNK------SVTVSIDDKSMSDLDPR 659

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0034976 "response to endoplasmic reticulum stress" evidence=RCA

TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 1237 (440.5 bits), Expect = 6.1e-126, P = 6.1e-126
 Identities = 269/598 (44%), Positives = 371/598 (62%)

Query:     1 MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFV 60
             + P  C +C+  +     + CPN+  A+  Y++     C+LRY++ +    +       +
Sbjct:   100 LSPEVCSNCVAFSVNESLTRCPNQREAVFYYEE-----CILRYSHKNFLSTVTYEGELIM 154

Query:    61 YAESNISENLIEFNQTRQ--RLLERLFSEAA--ARPSPNKYATGKEAVSDIVTMYALVQC 116
                +NIS   I+ NQ  Q   L++   ++AA  A  S  K++T K  ++ + T+Y LVQC
Sbjct:   155 RNPNNISS--IQ-NQRDQFIDLVQSNMNQAANEAANSSRKFSTIKTELTSLQTLYGLVQC 211

Query:   117 TPDLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAGPPGSPDP 176
             TPDL+  DC  CL  +   M      R G R   PSC+ RYE   F+  +  G P SP P
Sbjct:   212 TPDLARQDCFSCLTSSINRMMPLF--RIGARQFWPSCNSRYELYAFYNETAIGTP-SPPP 268

Query:   177 VTP--EPP------PRKKNHXXXXXXXXXXXXXXXXXX--GICIFLRVGKLKLEDENVEE 226
             + P   PP      P K  +                    G C   +  K   +  +  E
Sbjct:   269 LFPGSTPPLTSPSIPGKSGNSTVLVVAIVVLAVLLFIALVGYCFLAQRTKKTFDTASASE 328

Query:   227 T-----IAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSK 281
                    A SLQ D+ TI+ AT++F+++NK+G+GGFG VYKG  SNG+ +AVKRLSKNS+
Sbjct:   329 VGDDMATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSR 388

Query:   282 QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMT 341
             QGE EFK EV+++A+LQHRNLVRLLGF L+ +ERILVYE++PN SLD  +FDP  +  + 
Sbjct:   389 QGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLD 448

Query:   342 WEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
             W +RY II GIARG+LYLH+DSRL IIHRDLKASNILLD+++NPKI+DFGMAR+F +DQT
Sbjct:   449 WMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQT 508

Query:   402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLT 461
               +T+R+VGT+GYMAPEY MHG+FS+KSD++SFGVLVLEI+SG+K SSF   +  +DLLT
Sbjct:   509 QDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGAQDLLT 568

Query:   462 YAWRNWNEGAALNLMDPTMRGG-STSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDT 520
             + WR W    AL+L+DP +      SE+++CIHIGLLCVQE+ + RP +++V  ML  +T
Sbjct:   569 HTWRLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVFMMLTSNT 628

Query:   521 VTLPAPSKPAFFMKCSVIPE-TSSPLDVITGSTESGGHGIGNVPLSKNEASITELSPR 577
             VTLP P +P FF++ S + + T S     T ST          P S ++  IT+L PR
Sbjct:   629 VTLPVPRQPGFFIQSSPVKDPTDSDQSTTTKST----------PASIDDELITDLYPR 676

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2141762 CRK26 "cysteine-rich RLK (RECEPTOR-like protein kinase) 26" [Arabidopsis thaliana (taxid:3702)]

 Score = 1233 (439.1 bits), Expect = 1.6e-125, P = 1.6e-125
 Identities = 249/473 (52%), Positives = 321/473 (67%)

Query:    93 SPNKYATGKEAVSDIVTMYALVQCTPDLSEADCKECLHDTTKLMSKCCDRRQGGRVINPS 152
             S   +  G+ +     T++ LVQCTPD+SE DC  CL      +  CCD + G  V++PS
Sbjct:   175 SKKNFVVGETSGPSFQTLFGLVQCTPDISEEDCSYCLSQGIAKIPSCCDMKMGSYVMSPS 234

Query:   153 CSFRYETNKFFKPSIAGPPGSPDPVTPEPPPRK--------KNHXXXXXXXXXXXXXXXX 204
             C   Y   +F+ P     P S       PP  +        KN                 
Sbjct:   235 CMLAYAPWRFYDPVDTDDPSSVPATPSRPPKNETRSVTQGDKNRGVPKALIFASASVAIV 294

Query:   205 XXGIC---IFLRVGKLK----LEDENVEETIAK-SLQFDFETIRVATDNFSDANKLGQGG 256
                I    +FL++ + +     E+++  E I+  S++FDF  ++ AT +FS  NKLG+GG
Sbjct:   295 VLFIVLLVVFLKLRRKENIRNSENKHENENISTDSMKFDFSVLQDATSHFSLENKLGEGG 354

Query:   257 FGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI 316
             FGAVYKG+LS+G+ IAVKRLSKN++QGE EFKNE LL+A+LQHRNLV+LLG+ +E  ER+
Sbjct:   355 FGAVYKGVLSDGQKIAVKRLSKNAQQGETEFKNEFLLVAKLQHRNLVKLLGYSIEGTERL 414

Query:   317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASN 376
             LVYEF+P+ SLD FIFDPI    + WE RYKII G+ARGLLYLH+DSRLRIIHRDLKASN
Sbjct:   415 LVYEFLPHTSLDKFIFDPIQGNELEWEIRYKIIGGVARGLLYLHQDSRLRIIHRDLKASN 474

Query:   377 ILLDSEMNPKISDFGMARLFEMDQTHSD-TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFG 435
             ILLD EM PKI+DFGMARLF++D T    TNR+VGTFGYMAPEYVMHG+FS K+D++SFG
Sbjct:   475 ILLDEEMTPKIADFGMARLFDIDHTTQRYTNRIVGTFGYMAPEYVMHGQFSFKTDVYSFG 534

Query:   436 VLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP---TMRGGSTSEMMKCI 492
             VLVLEI+SG+K S F +E+   DL+++AWRNW EG ALNL+D    TM   S++ +M+CI
Sbjct:   535 VLVLEIISGKKNSGFSSEDSMGDLISFAWRNWKEGVALNLVDKILMTMSSYSSNMIMRCI 594

Query:   493 HIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKPAFFMKCSVIPETSSPL 545
             +IGLLCVQE V+ RP MASVV ML+G T+ L  PSKPAFF   + + ++SS L
Sbjct:   595 NIGLLCVQEKVAERPSMASVVLMLDGHTIALSEPSKPAFFSHSNAVSDSSSSL 647

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2127323 CRK27 "cysteine-rich RLK (RECEPTOR-like protein kinase) 27" [Arabidopsis thaliana (taxid:3702)]

 Score = 1210 (431.0 bits), Expect = 8.1e-125, Sum P(2) = 8.1e-125
 Identities = 265/550 (48%), Positives = 338/550 (61%)

Query:     1 MEPSS-CRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFF 59
             ++P+  C  CI  A K L   CPN + A     +     CM RY +  I G ME  P  F
Sbjct:    87 VKPNQDCISCITTAAKQLVESCPNIIEA-----NIWLEKCMFRYTSRIILGQMEPVP--F 139

Query:    60 VYAESNISENLIE-FNQTRQRLLERLFS--EAAARPSPNKYATGKEAVSDIVTMYALVQC 116
              Y  SN+S    E F++    LL+ L +  +AA      K+A G +      T+YAL QC
Sbjct:   140 SYTSSNVSVTDKEGFSKGLGDLLDSLGAKIDAANETKEVKFAAGVKG-----TIYALAQC 194

Query:   117 TPDLSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKFFKPSIAG----PPG 172
             TPDLSE+DC+ CL      +  CCD + GG   NPSC FR+E   FF  S+      P  
Sbjct:   195 TPDLSESDCRICLAQIFAGVPTCCDGKTGGWWTNPSCYFRFEVYPFFDLSVTSEQKQPLS 254

Query:   173 SPDPVTPEPPPRKKNHXXXXXXXXXXXXXXXXXXGICIFL---RVGKLKLEDENVEETIA 229
             S +  T      K                      + +F+   R  K K   EN E    
Sbjct:   255 SHNNNTRRSDQGKSKDRSKTLIFAVVPIVAIILGLVFLFIYLKRRRKKKTLKENAENEFE 314

Query:   230 K--SLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEF 287
                SL FDFETIRVATD+FS  NK+G+GGFG VYKG L +G  IAVKRLS +S QG  EF
Sbjct:   315 STDSLHFDFETIRVATDDFSLTNKIGEGGFGVVYKGHLPDGLEIAVKRLSIHSGQGNAEF 374

Query:   288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
             K EVLL+ +LQH+NLV+L GF ++  ER+LVYEF+PN SLD F+FDPI ++ + WEKRY 
Sbjct:   375 KTEVLLMTKLQHKNLVKLFGFSIKESERLLVYEFIPNTSLDRFLFDPIKQKQLDWEKRYN 434

Query:   348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
             II G++RGLLYLHE S   IIHRDLK+SN+LLD +M PKISDFGMAR F+ D T + T R
Sbjct:   435 IIVGVSRGLLYLHEGSEFPIIHRDLKSSNVLLDEQMLPKISDFGMARQFDFDNTQAVTRR 494

Query:   408 VVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNW 467
             VVGT+GYMAPEY MHGRFSVK+D++SFGVLVLEI++G++ S  G  E T DL T+AW+NW
Sbjct:   495 VVGTYGYMAPEYAMHGRFSVKTDVYSFGVLVLEIITGKRNSGLGLGEGT-DLPTFAWQNW 553

Query:   468 NEGAALNLMDPTM-RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVT--LP 524
              EG ++ L+DP + +     E M+C+ I L CVQEN + RP M SVV+ML+ D+ +  LP
Sbjct:   554 IEGTSMELIDPVLLQTHDKKESMQCLEIALSCVQENPTKRPTMDSVVSMLSSDSESRQLP 613

Query:   525 APSKPAFFMK 534
              PS+P FF +
Sbjct:   614 KPSQPGFFRR 623

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

TAIR|locus:2134603 CRK41 "cysteine-rich RLK (RECEPTOR-like protein kinase) 41" [Arabidopsis thaliana (taxid:3702)]

 Score = 1219 (434.2 bits), Expect = 4.9e-124, P = 4.9e-124
 Identities = 267/541 (49%), Positives = 344/541 (63%)

Query:     6 CRDCINVARKNLTSL-CPNKVTAIGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYAES 64
             C +CI  A  NLT++ CP      G Y  R    CM RY++  IFG +E +P       S
Sbjct:   110 CLNCIAQAAVNLTTMYCPQHR---GAYV-RA-TKCMFRYSDKPIFGKLETSPVLEAPNPS 164

Query:    65 NISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSD-IVTMYALVQCTPDLSEA 123
             N + +  EF + +  LL RL S AA+  S  KYA G +  S    T +  VQCTPDLSE 
Sbjct:   165 NATGDRNEFIRLQSELLNRLRSMAASGGSKRKYAQGTDPGSPPYTTFFGAVQCTPDLSEK 224

Query:   124 DCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETN-KFFKPSIAGPPGSPDPVTPEPP 182
             DC +CL   +   S     R G R   PSC+F+ E++ +FF               P+P 
Sbjct:   225 DCNDCL---SYGFSNATKGRVGIRWFCPSCNFQIESDLRFFLLD--------SEYEPDPK 273

Query:   183 PRKKNHXXXXXXXXXXXXXXXXXXGICIFL----RVGKLKLEDENVEETIAKS---LQFD 235
             P                        +  F+    R  K + E +++EE + K    LQ D
Sbjct:   274 PGNDKVKIIIATVCSVIGFAIIAVFLYFFMTRNRRTAKQRHEGKDLEELMIKDAQLLQLD 333

Query:   236 FETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLA 295
             F+TIR+AT++FS  N+LG+GGFGAVYKG+L  GE IAVKRLS  S QG+ EF NEV L+A
Sbjct:   334 FDTIRLATNDFSRDNQLGEGGFGAVYKGVLDYGEEIAVKRLSMKSGQGDNEFINEVSLVA 393

Query:   296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
             +LQHRNLVRLLGFCL+ +ERIL+YEF  N SLDH+IFD   R  + WE RY+II G+ARG
Sbjct:   394 KLQHRNLVRLLGFCLQGEERILIYEFFKNTSLDHYIFDSNRRMILDWETRYRIISGVARG 453

Query:   356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD--TNRVVGTFG 413
             LLYLHEDSR +I+HRD+KASN+LLD  MNPKI+DFGMA+LF+ DQT     T++V GT+G
Sbjct:   454 LLYLHEDSRFKIVHRDMKASNVLLDDAMNPKIADFGMAKLFDTDQTSQTRFTSKVAGTYG 513

Query:   414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAAL 473
             YMAPEY M G FSVK+D+FSFGVLVLEI+ G+K +    E+ +  LL+Y W++W EG  L
Sbjct:   514 YMAPEYAMSGEFSVKTDVFSFGVLVLEIIKGKKNNWSPEEDSSLFLLSYVWKSWREGEVL 573

Query:   474 NLMDPTMRG--GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKPAF 531
             N++DP++    G + E+MKCIHIGLLCVQEN  +RP MASVV MLN ++ TLP PS+PAF
Sbjct:   574 NIVDPSLVETIGVSDEIMKCIHIGLLCVQENAESRPTMASVVVMLNANSFTLPRPSQPAF 633

Query:   532 F 532
             +
Sbjct:   634 Y 634

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9M0X5	CRK25_ARATH	2, ., 7, ., 1, 1, ., -	0.4847	0.9722	0.8311	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	577
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-54
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-53
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-52
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-52
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-52
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	9e-51
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-50
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-43
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-40
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-36
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-35
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-35
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-33
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	8e-33
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	9e-33
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-32
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-32
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-32
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-31
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-31
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-31
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	9e-31
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-30
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-30
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-29
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-29
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-29
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-29
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-29
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-28
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-28
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-28
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-28
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-28
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-28
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-28
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-27
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-27
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-27
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-27
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-27
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-27
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-27
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-27
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	6e-27
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	8e-27
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-26
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-26
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-26
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-26
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-26
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-25
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-25
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-25
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-25
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-25
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-25
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	7e-25
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-25
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-25
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-24
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-24
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-24
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-24
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-24
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-24
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-24
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	9e-24
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	9e-24
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-23
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-23
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-23
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-23
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-23
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-23
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	3e-23
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-23
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-23
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	7e-23
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-23
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-22
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-22
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-22
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-22
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-22
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-22
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-22
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-22
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-22
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-22
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-22
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-22
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-22
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-22
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-22
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-22
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	8e-22
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	9e-22
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-21
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-21
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-21
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-21
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-21
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-21
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-21
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-21
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-21
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-21
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-21
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-21
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-21
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-21
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-20
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-20
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-20
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-20
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-20
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-20
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-20
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-20
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-19
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-19
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-19
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-19
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-19
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-19
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-19
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-19
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-19
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	7e-19
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-19
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	8e-19
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-19
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-19
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	9e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-18
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-18
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-18
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-18
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-18
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-18
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-18
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-18
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-18
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-18
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-18
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-18
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-18
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-18
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-18
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	9e-18
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	9e-18
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-17
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-17
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-17
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-17
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-17
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-17
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-17
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-17
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-17
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-17
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-17
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-17
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-17
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-17
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	6e-17
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	7e-17
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	9e-17
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-16
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-16
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-16
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-16
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-16
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-16
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-16
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-16
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-16
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-15
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-15
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-15
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-15
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-15
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-15
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-15
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-15
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-15
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-15
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-15
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-15
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	7e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-15
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	9e-15
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-14
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-14
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-14
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-14
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	8e-14
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-13
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-13
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-13
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-13
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-13
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-13
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-13
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-13
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	6e-13
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	9e-13
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-12
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-12
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-12
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-12
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-12
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-12
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	6e-12
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	8e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	9e-12
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-11
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-11
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	7e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-11
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-10
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-10
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-10
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	6e-10
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	7e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	8e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	7e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-08
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-08
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	8e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	8e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-07
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	5e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-06
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	4e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	4e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	9e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	1e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	4e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	9e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-04
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-04
pfam01636	238	pfam01636, APH, Phosphotransferase enzyme family	5e-04
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	6e-04
pfam01163	186	pfam01163, RIO1, RIO1 family	7e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.002
cd05151	170	cd05151, ChoK, Choline Kinase (ChoK)	0.004

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  185 bits (471), Expect = 2e-54
 Identities = 74/202 (36%), Positives = 107/202 (52%), Gaps = 18/202 (8%)

Query: 251 KLGQGGFGAVYKGML-----SNGETIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVR 304
           KLG+G FG VYKG L          +AVK L +++ + +I EF  E  ++ +L H N+V+
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           LLG C E +   +V E++    L  ++    NR  ++          IARG+ YL     
Sbjct: 66  LLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLE---S 120

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT---FGYMAPEYVM 421
              IHRDL A N L+   +  KISDFG++R    D    D  R  G      +MAPE + 
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAPESLK 176

Query: 422 HGRFSVKSDIFSFGVLVLEIVS 443
            G+F+ KSD++SFGVL+ EI +
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFT 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  181 bits (462), Expect = 3e-53
 Identities = 72/199 (36%), Positives = 105/199 (52%), Gaps = 12/199 (6%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSK--NSKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           KLG G FG VYK      G+ +AVK L K     + +   + E+ +L RL H N+VRL+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
              ++    LV E+     L  ++        ++ ++  KI   I RGL YLH      I
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHS---NGI 119

Query: 368 IHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR-FS 426
           IHRDLK  NILLD     KI+DFG+A+      +   T   VGT  YMAPE ++ G  + 
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGYG 177

Query: 427 VKSDIFSFGVLVLEIVSGQ 445
            K D++S GV++ E+++G+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  180 bits (458), Expect = 1e-52
 Identities = 74/202 (36%), Positives = 110/202 (54%), Gaps = 17/202 (8%)

Query: 251 KLGQGGFGAVYKGMLSNG-----ETIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVR 304
           KLG+G FG VYKG L          +AVK L +++ + +I EF  E  ++ +L H N+V+
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           LLG C E +  ++V E++P   L  ++     +E ++          IARG+ YL     
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLE---S 121

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT---FGYMAPEYVM 421
              IHRDL A N L+   +  KISDFG++R    D    D  +V G      +MAPE + 
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAPESLK 177

Query: 422 HGRFSVKSDIFSFGVLVLEIVS 443
            G+F+ KSD++SFGVL+ EI +
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  178 bits (453), Expect = 2e-52
 Identities = 71/194 (36%), Positives = 105/194 (54%), Gaps = 11/194 (5%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLLGFC 309
           LG+GGFG VY       G+ +A+K + K      +E    E+ +L +L H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            +     LV E+    SL   + +  N   ++ ++  +I+  I  GL YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 370 RDLKASNILLDS-EMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH-GRFSV 427
           RDLK  NILLDS     K++DFG+++L       S    +VGT  YMAPE ++  G +S 
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLL--TSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 428 KSDIFSFGVLVLEI 441
           KSDI+S GV++ E+
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  178 bits (454), Expect = 4e-52
 Identities = 72/201 (35%), Positives = 110/201 (54%), Gaps = 13/201 (6%)

Query: 251 KLGQGGFGAVYKGML-----SNGETIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVR 304
           KLG+G FG VYKG L          +AVK L + + + E  EF  E  ++ +L H N+VR
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           LLG C + +   +V E++P   L  F+    + E +T +   ++   IA+G+ YL     
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLES--- 120

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
              +HRDL A N L+   +  KISDFG++R ++E D         +    +MAPE +  G
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK-WMAPESLKDG 179

Query: 424 RFSVKSDIFSFGVLVLEIVSG 444
           +F+ KSD++SFGVL+ EI + 
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  175 bits (445), Expect = 9e-51
 Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 13/203 (6%)

Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLV 303
           +    KLG+G FG VY       G+ +A+K + K   + + E    E+ +L +L+H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK-IIEGIARGLLYLHED 362
           RL     +  +  LV E+     L   +     R  ++ E   +  +  I   L YLH  
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLS-EDEARFYLRQILSALEYLHS- 115

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH 422
               I+HRDLK  NILLD + + K++DFG+AR  +  +  +     VGT  YMAPE ++ 
Sbjct: 116 --KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT---FVGTPEYMAPEVLLG 170

Query: 423 GRFSVKSDIFSFGVLVLEIVSGQ 445
             +    DI+S GV++ E+++G+
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  174 bits (444), Expect = 2e-50
 Identities = 70/206 (33%), Positives = 110/206 (53%), Gaps = 16/206 (7%)

Query: 250 NKLGQGGFGAVYKGMLSNGETI----AVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVR 304
            KLG+G FG VYKG L   +      AVK L ++ S++   +F  E  ++ +L H N+VR
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 305 LLGFCLERKERILVYEFVPNASLDHFI------FDPINREHMTWEKRYKIIEGIARGLLY 358
           LLG C E +   LV E++    L  ++      F    +  ++ +        IA+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSDTNRVVGTFGYMAP 417
           L      + +HRDL A N L+  ++  KISDFG++R +++ D     T   +    +MAP
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176

Query: 418 EYVMHGRFSVKSDIFSFGVLVLEIVS 443
           E +  G F+ KSD++SFGVL+ EI +
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  154 bits (391), Expect = 6e-43
 Identities = 69/205 (33%), Positives = 114/205 (55%), Gaps = 19/205 (9%)

Query: 250 NKLGQGGFGAVYKGM-LSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQHRNLVRLL 306
             LG+G FG+VY  +    GE +AVK   LS +S++     + E+ +L+ LQH N+VR  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 307 GFCLERKER-ILVY-EFVPNASLDHFI--FDPINREHMTWEKRY--KIIEGIARGLLYLH 360
           G   + ++  + ++ E+V   SL   +  F  +  E +   ++Y  +I+EG+A    YLH
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP-EPVI--RKYTRQILEGLA----YLH 118

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV 420
                 I+HRD+K +NIL+DS+   K++DFG A+     +T   T  V GT  +MAPE +
Sbjct: 119 ---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175

Query: 421 MHGRFSVKSDIFSFGVLVLEIVSGQ 445
               +   +DI+S G  V+E+ +G+
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  146 bits (371), Expect = 2e-40
 Identities = 72/207 (34%), Positives = 112/207 (54%), Gaps = 17/207 (8%)

Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE--IEFKNEVLLLARLQHRN 301
           N+   + +G+G FG VYKG+ L  G+ +A+K++S    + E       E+ LL  L+H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFI--FDPINREHMTWEKRYKIIEGIARGLLYL 359
           +V+ +G         ++ E+  N SL   I  F P   E +     Y  +  + +GL YL
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFP-ESLV--AVY--VYQVLQGLAYL 115

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           HE     +IHRD+KA+NIL   +   K++DFG+A   +++    D   VVGT  +MAPE 
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVAT--KLNDVSKDDASVVGTPYWMAPEV 170

Query: 420 V-MHGRFSVKSDIFSFGVLVLEIVSGQ 445
           + M G  S  SDI+S G  V+E+++G 
Sbjct: 171 IEMSGA-STASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  136 bits (343), Expect = 3e-36
 Identities = 72/221 (32%), Positives = 115/221 (52%), Gaps = 7/221 (3%)

Query: 246 FSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRL 305
           F+   KLG G FG V++G+  N   +A+K L  +    + +F+ EV  L RL+H++L+ L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 306 LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
              C   +   ++ E +   SL  F+  P  +  +       +   +A G+ YL E    
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ--- 123

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRF 425
             IHRDL A NIL+  ++  K++DFG+ARL + D   S   ++   + + APE   HG F
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181

Query: 426 SVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWR 465
           S KSD++SFG+L+ E+ + GQ         E  D +T  +R
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR 222

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  133 bits (338), Expect = 1e-35
 Identities = 67/203 (33%), Positives = 108/203 (53%), Gaps = 13/203 (6%)

Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           F    K+G+GGFG VYK      G+ +A+K +   SK+ + +  NE+ +L + +H N+V+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY--KIIEGIARGLLYLHED 362
             G  L++ E  +V EF    SL     D +   + T  +     + + + +GL YLH  
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLK----DLLKSTNQTLTESQIAYVCKELLKGLEYLHS- 116

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH 422
               IIHRD+KA+NILL S+   K+ DFG++            N +VGT  +MAPE +  
Sbjct: 117 --NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS---DTKARNTMVGTPYWMAPEVING 171

Query: 423 GRFSVKSDIFSFGVLVLEIVSGQ 445
             +  K+DI+S G+  +E+  G+
Sbjct: 172 KPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  132 bits (335), Expect = 7e-35
 Identities = 66/204 (32%), Positives = 107/204 (52%), Gaps = 16/204 (7%)

Query: 250 NKLGQGGFGAVYKGMLSN-----GETIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLV 303
            +LG+G FG V            GE +AVK L+ + ++    +F+ E+ +L  L H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 304 RLLGFCLERKERI--LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +  G C +   R   L+ E++P+ SL  ++    +R+ +  ++       I +G+ YL  
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN--RVVGTFGYMAPEY 419
               R IHRDL A NIL++SE   KISDFG+A++   D+ +           F Y APE 
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183

Query: 420 VMHGRFSVKSDIFSFGVLVLEIVS 443
           +   +FS  SD++SFGV + E+ +
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  131 bits (328), Expect = 2e-33
 Identities = 73/276 (26%), Positives = 121/276 (43%), Gaps = 20/276 (7%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQH-RNLVRLL 306
           KLG+G FG VY     + + +A+K L+K   +  +    F  E+ +LA L H  N+V+L 
Sbjct: 7   KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
            F  +     LV E+V   SL+  +     +  ++  +   I+  I   L YLH      
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KG 121

Query: 367 IIHRDLKASNILLDSEMN-PKISDFGMARLFEMDQTHS----DTNRVVGTFGYMAPEYVM 421
           IIHRD+K  NILLD +    K+ DFG+A+L     + S      +  VGT GYMAPE ++
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 422 H---GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP 478
                  S  SDI+S G+ + E+++G                          +  + + P
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241

Query: 479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN 514
           +     +      +      + ++  NR   +S ++
Sbjct: 242 SNPELISKAASDLL---KKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  126 bits (319), Expect = 8e-33
 Identities = 68/227 (29%), Positives = 108/227 (47%), Gaps = 39/227 (17%)

Query: 252 LGQGGFGAVYKGMLSNGET------IAVKRLSK-NSKQGEIEFKNEVLLLARLQHRNLVR 304
           LG+G FG V+ G   + E       +AVK L +  S     +F+ E  LL   QH N+V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 305 LLGFCLERKERILVYEFVPNASLDHFI----------------FDPINREHMTWEKRYKI 348
             G C E    I+V+E++ +  L+ F+                   +    +       I
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ-----I 127

Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV 408
              IA G++YL   +    +HRDL   N L+  ++  KI DFGM+R    D   +D  RV
Sbjct: 128 AVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRV 180

Query: 409 VGT----FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFG 451
            G       +M PE +M+ +F+ +SD++SFGV++ EI +  K+  +G
Sbjct: 181 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYG 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  126 bits (319), Expect = 9e-33
 Identities = 68/208 (32%), Positives = 119/208 (57%), Gaps = 25/208 (12%)

Query: 252 LGQGGFGAVYKGM-LSNGETI----AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRL 305
           LG G FG VYKG+ +  GE +    A+K L + +      E  +E  ++A + H ++VRL
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 306 LGFCLERKERILVYEFVPNASLDHFIFDP---INREHM-TWEKRYKIIEGIARGLLYLHE 361
           LG CL   +  L+ + +P   L  ++ +    I  +++  W  +      IA+G+ YL E
Sbjct: 75  LGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT--HSDTNRVVGTFGYMAPEY 419
               R++HRDL A N+L+ +  + KI+DFG+A+L ++D+   H++  +V     +MA E 
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV--PIKWMALES 182

Query: 420 VMHGRFSVKSDIFSFGVLVLEIVS-GQK 446
           ++H  ++ KSD++S+GV V E+++ G K
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  125 bits (315), Expect = 2e-32
 Identities = 71/198 (35%), Positives = 104/198 (52%), Gaps = 16/198 (8%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE---FKNEVLLLARLQHRNLVRLLG 307
           KLG G FG V+ G  +    +AVK L    K G +    F  E  ++ +L+H  LV+L  
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
            C E +   +V E++   SL  F+     +  +   +   +   IA G+ YL        
Sbjct: 69  VCSEEEPIYIVTEYMSKGSLLDFLKSGEGK-KLRLPQLVDMAAQIAEGMAYLE---SRNY 124

Query: 368 IHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEYVMHGRF 425
           IHRDL A NIL+   +  KI+DFG+ARL E D+    T R    F   + APE   +GRF
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEY---TAREGAKFPIKWTAPEAANYGRF 181

Query: 426 SVKSDIFSFGVLVLEIVS 443
           ++KSD++SFG+L+ EIV+
Sbjct: 182 TIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  123 bits (312), Expect = 5e-32
 Identities = 70/205 (34%), Positives = 103/205 (50%), Gaps = 16/205 (7%)

Query: 250 NKLGQGGFGAVYKG---MLSNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG G FG+V KG   M S  E  +AVK L +     G+ EF  E  ++A+L H  +VR
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           L+G C   +  +LV E  P   L  ++     R  +      ++   +A G+ YL     
Sbjct: 61  LIGVCKG-EPLMLVMELAPLGPLLKYL---KKRREIPVSDLKELAHQVAMGMAYLESK-- 114

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEYVMH 422
              +HRDL A N+LL +    KISDFGM+R       +       G +   + APE + +
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY-RATTAGRWPLKWYAPECINY 172

Query: 423 GRFSVKSDIFSFGVLVLEIVS-GQK 446
           G+FS KSD++S+GV + E  S G K
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAK 197

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  123 bits (311), Expect = 7e-32
 Identities = 65/207 (31%), Positives = 116/207 (56%), Gaps = 23/207 (11%)

Query: 252 LGQGGFGAVYKGMLS-NGE---TIAVKRL-SKNSKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G FG V +G L   G+    +A+K L + +S +  ++F  E  ++ +  H N++RL 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   + +  +++ E++ N SLD F+ +  N    T  +   ++ GIA G+ YL   S + 
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYL---SEMN 126

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG------YMAPEYV 420
            +HRDL A NIL++S +  K+SDFG++R  E      D+     T G      + APE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLE------DSEATYTTKGGKIPIRWTAPEAI 180

Query: 421 MHGRFSVKSDIFSFGVLVLEIVS-GQK 446
            + +F+  SD++SFG+++ E++S G++
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  123 bits (311), Expect = 1e-31
 Identities = 71/216 (32%), Positives = 110/216 (50%), Gaps = 31/216 (14%)

Query: 252 LGQGGFGAVYKGML---SNGE---TIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVR 304
           LG+G FG VYKG L   +      ++A+K L +N   + + EF+ E  L++ LQH N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIF--DPINREHMTWEKR-----------YKIIEG 351
           LLG C + +   +++E++ +  L  F+    P +                      I   
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           IA G+ YL   S    +HRDL A N L+   +  KISDFG++R    D   +D  RV   
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR----DIYSADYYRVQSK 185

Query: 412 ----FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
                 +M PE +++G+F+ +SDI+SFGV++ EI S
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  122 bits (308), Expect = 2e-31
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 19/206 (9%)

Query: 250 NKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEF-KNEVLLLARLQHRNLVRLL 306
            ++G+G FG VY     S+G+   +K +   N  + E E   NEV +L +L H N+++  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 307 GFCLERKERILVYEFVPNASLDHFI------FDPINREHMTWEKRYKIIEGIARGLLYLH 360
               E+ +  +V E+     L   I        P   E             +   L YLH
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPF-PEEQIL----DWFVQLCLALKYLH 120

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV 420
                +I+HRD+K  NI L S    K+ DFG++++       + T  VVGT  Y++PE  
Sbjct: 121 SR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPELC 175

Query: 421 MHGRFSVKSDIFSFGVLVLEIVSGQK 446
            +  ++ KSDI+S G ++ E+ + + 
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKH 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  121 bits (305), Expect = 4e-31
 Identities = 63/194 (32%), Positives = 99/194 (51%), Gaps = 15/194 (7%)

Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           +G+G FG V  G    G+ +AVK L  +S   +  F  E  ++  L+H NLV+LLG  L+
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 312 RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRD 371
                +V E++   SL  ++     R  +T  ++      +  G+ YL E      +HRD
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127

Query: 372 LKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEYVMHGRFSVKS 429
           L A N+L+  ++  K+SDFG+A+     Q         G     + APE +   +FS KS
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQD-------SGKLPVKWTAPEALREKKFSTKS 180

Query: 430 DIFSFGVLVLEIVS 443
           D++SFG+L+ EI S
Sbjct: 181 DVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  120 bits (302), Expect = 9e-31
 Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 19/201 (9%)

Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           LG G FG V+ G       +A+K + + +   E +F  E  ++ +L H NLV+L G C +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 312 RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE---GIARGLLYLHEDSRLRII 368
           ++   +V E++ N  L +++     RE         +++    +   + YL  +     I
Sbjct: 71  QRPIFIVTEYMANGCLLNYL-----RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FI 122

Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT---FGYMAPEYVMHGRF 425
           HRDL A N L+  +   K+SDFG+AR    DQ  S      GT     +  PE   + RF
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRF 178

Query: 426 SVKSDIFSFGVLVLEIVSGQK 446
           S KSD++SFGVL+ E+ S  K
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  118 bits (299), Expect = 3e-30
 Identities = 65/200 (32%), Positives = 109/200 (54%), Gaps = 16/200 (8%)

Query: 252 LGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQGEIEF-KNEVLLLARLQHRNLVRLLG 307
           LG+G FG V      +   + A+K L K    K+ E+E    E  +L+R+ H  +V+L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 308 FCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRL 365
           +  + +E++ LV E+ P   L    F  +++E    E+R +     I   L YLH    L
Sbjct: 60  YAFQTEEKLYLVLEYAPGGEL----FSHLSKEGRFSEERARFYAAEIVLALEYLH---SL 112

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRF 425
            II+RDLK  NILLD++ + K++DFG+A+    + + ++T    GT  Y+APE ++   +
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKGY 170

Query: 426 SVKSDIFSFGVLVLEIVSGQ 445
               D +S GVL+ E+++G+
Sbjct: 171 GKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  119 bits (301), Expect = 3e-30
 Identities = 60/208 (28%), Positives = 105/208 (50%), Gaps = 17/208 (8%)

Query: 243 TDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN 301
            + + +  K+G+G  G VYK      G+ +A+K++    +  E+   NE+L++   +H N
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL-IINEILIMKDCKHPN 76

Query: 302 LVRLLGFCLERKERILVYEFVPNASL----DHFIFDPINREHMTWEKRYKIIEGIARGLL 357
           +V      L   E  +V E++   SL           +N   + +     +   + +GL 
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR-MNEPQIAY-----VCREVLQGLE 130

Query: 358 YLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAP 417
           YLH      +IHRD+K+ NILL  + + K++DFG A   ++ +  S  N VVGT  +MAP
Sbjct: 131 YLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAA--QLTKEKSKRNSVVGTPYWMAP 185

Query: 418 EYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           E +    +  K DI+S G++ +E+  G+
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  116 bits (293), Expect = 2e-29
 Identities = 74/199 (37%), Positives = 113/199 (56%), Gaps = 19/199 (9%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE---FKNEVLLLARLQHRNLVRLLG 307
           KLG G FG V+ G  +    +A+K L    KQG +    F  E  L+ +LQH  LVRL  
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRL-- 66

Query: 308 FCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           + +  +E I ++ E++ N SL  F+  P   + +T  K   +   IA G+ ++    R  
Sbjct: 67  YAVVTQEPIYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIE---RKN 122

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEYVMHGR 424
            IHRDL+A+NIL+   +  KI+DFG+ARL E ++    T R    F   + APE + +G 
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGT 179

Query: 425 FSVKSDIFSFGVLVLEIVS 443
           F++KSD++SFG+L+ EIV+
Sbjct: 180 FTIKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  116 bits (293), Expect = 3e-29
 Identities = 75/222 (33%), Positives = 114/222 (51%), Gaps = 27/222 (12%)

Query: 241 VATDNFSDANKLGQGGFGAVYKGMLS--NGET----IAVKRLSKN-SKQGEIEFKNEVLL 293
           V  D+ +    LG G FG VY+G+    +G+     +AVK L ++ S+Q E +F  E L+
Sbjct: 3   VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALI 62

Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++  H+N+VRL+G   ER  R ++ E +    L  F+ +    P     +T +      
Sbjct: 63  MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMARLFEMDQTHSDT 405
             +A+G  YL E+     IHRD+ A N LL  +  P    KI+DFGMAR    D   +  
Sbjct: 123 RDVAKGCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMAR----DIYRASY 174

Query: 406 NRVVGT----FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            R  G       +M PE  + G F+ K+D++SFGVL+ EI S
Sbjct: 175 YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  116 bits (293), Expect = 4e-29
 Identities = 61/206 (29%), Positives = 109/206 (52%), Gaps = 23/206 (11%)

Query: 250 NKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQG-EIEFKNEVLLLARLQHRNLVRLL 306
            ++G+G +G VYK      GE +A+K++  +N K+G  I    E+ LL +L+H N+VRL 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 307 GFCLERKER--ILVYEFVPN--ASLDH---FIFDPINREHMTWEKRYKIIEGIARGLLYL 359
                + +    +V+E++ +    L       F     +        +++EG+     YL
Sbjct: 65  EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYM----KQLLEGLQ----YL 116

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H +    I+HRD+K SNIL++++   K++DFG+AR +    +   TNRV+ T  Y  PE 
Sbjct: 117 HSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPEL 172

Query: 420 VMHG-RFSVKSDIFSFGVLVLEIVSG 444
           ++   R+  + D++S G ++ E+  G
Sbjct: 173 LLGATRYGPEVDMWSVGCILAELFLG 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  115 bits (290), Expect = 5e-29
 Identities = 64/219 (29%), Positives = 110/219 (50%), Gaps = 31/219 (14%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK-QGEIEFKNEVL 292
           D E ++V          LGQG  G VYK      G+  A+K++  +   +   +   E+ 
Sbjct: 2   DLERVKV----------LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELK 51

Query: 293 LLARLQHRNLVRLLG-FCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE 350
            L   +   +V+  G F   ++  I +V E++   SL   +     ++     +   ++ 
Sbjct: 52  TLRSCESPYVVKCYGAFY--KEGEISIVLEYMDGGSLADLL-----KKVGKIPEP--VLA 102

Query: 351 GIAR----GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            IAR    GL YLH  ++  IIHRD+K SN+L++S+   KI+DFG++++  ++ T    N
Sbjct: 103 YIARQILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLDQCN 158

Query: 407 RVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
             VGT  YM+PE +    +S  +DI+S G+ +LE   G+
Sbjct: 159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  116 bits (291), Expect = 5e-29
 Identities = 72/208 (34%), Positives = 112/208 (53%), Gaps = 17/208 (8%)

Query: 252 LGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLL 306
           LG+G FG+V    Y  +  N GE +AVK+L  ++ +   +F+ E+ +L  LQH N+V+  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 307 GFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           G C    R+   LV E++P  SL  ++    +RE +   K       I +G+ YL     
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYL---GS 126

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG---TFGYMAPEYVM 421
            R +HRDL   NIL++SE   KI DFG+ ++   D+ +    R  G    F Y APE + 
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYY-KVREPGESPIFWY-APESLT 184

Query: 422 HGRFSVKSDIFSFGVLVLEIVSGQKRSS 449
             +FSV SD++SFGV++ E+ +   +S 
Sbjct: 185 ESKFSVASDVWSFGVVLYELFTYSDKSC 212

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  113 bits (286), Expect = 1e-28
 Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 14/197 (7%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
           KLG+G +G+VYK +    G+ +A+K +       EI    E+ +L +     +V+  G  
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEII--KEISILKQCDSPYIVKYYGSY 67

Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTW-EKRYKII-EGIARGLLYLHEDSRLRI 367
            +  +  +V E+    S    + D +   + T  E+    I     +GL YLH     + 
Sbjct: 68  FKNTDLWIVMEYCGAGS----VSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKK 120

Query: 368 IHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSV 427
           IHRD+KA NILL+ E   K++DFG++   ++  T +  N V+GT  +MAPE +    ++ 
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNN 178

Query: 428 KSDIFSFGVLVLEIVSG 444
           K+DI+S G+  +E+  G
Sbjct: 179 KADIWSLGITAIEMAEG 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score =  115 bits (288), Expect = 2e-28
 Identities = 75/221 (33%), Positives = 128/221 (57%), Gaps = 13/221 (5%)

Query: 252 LGQGGFGAVYKGM-LSNGETI----AVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRL 305
           LG G FG VYKG+ +  GET+    A+K L++ +  +  +EF +E L++A + H +LVRL
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 306 LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
           LG CL    + LV + +P+  L  ++ +  +++++  +        IA+G++YL E    
Sbjct: 75  LGVCLSPTIQ-LVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER--- 128

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRF 425
           R++HRDL A N+L+ S  + KI+DFG+ARL E D+   + +       +MA E + + +F
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188

Query: 426 SVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWR 465
           + +SD++S+GV + E+++ G K        E  DLL    R
Sbjct: 189 THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGER 229

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  113 bits (285), Expect = 2e-28
 Identities = 80/274 (29%), Positives = 125/274 (45%), Gaps = 37/274 (13%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           ++G G FG V+ G       +A+K + + +   E +F  E  ++ +L H  LV+L G C 
Sbjct: 11  EIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE-DFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           ER    LV+EF+ +  L  ++     R   + E    +   +  G+ YL   +   +IHR
Sbjct: 70  ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124

Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT---FGYMAPEYVMHGRFSV 427
           DL A N L+      K+SDFGM R    DQ  S T    GT     + +PE     ++S 
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSS 180

Query: 428 KSDIFSFGVLVLEIVSGQK-----RSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG 482
           KSD++SFGVL+ E+ S  K     RS+    E  E +           A   L  P +  
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVETI----------NAGFRLYKPRLAS 227

Query: 483 GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNML 516
            S  E+M+       C +E   +RP  + +++ L
Sbjct: 228 QSVYELMQ------HCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  114 bits (286), Expect = 2e-28
 Identities = 66/208 (31%), Positives = 109/208 (52%), Gaps = 30/208 (14%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLS-----KNSKQGEIEFKNEVLLLARLQHRNLVRL 305
           LG G FG+VY+G+ L +G+  AVK +S     +  ++   + + E+ LL++LQH N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 306 LGFCLERKERILVY-EFVPNASLDHFI--FDPINREHMTWEKRYKII----EGIARGLLY 358
           LG   E ++ + ++ E VP  SL   +  +               +I      I  GL Y
Sbjct: 68  LGTERE-EDNLYIFLELVPGGSLAKLLKKYGSF---------PEPVIRLYTRQILLGLEY 117

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
           LH+      +HRD+K +NIL+D+    K++DFGMA+        S      G+  +MAPE
Sbjct: 118 LHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV---EFSFAKSFKGSPYWMAPE 171

Query: 419 YVMH-GRFSVKSDIFSFGVLVLEIVSGQ 445
            +   G + + +DI+S G  VLE+ +G+
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  113 bits (285), Expect = 2e-28
 Identities = 72/209 (34%), Positives = 112/209 (53%), Gaps = 22/209 (10%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRL---SKNSKQGEIEFKN---EVLLLARLQHRNLV 303
             LG+G +G VY G+ + G+ IAVK++   + N    E E++    EV LL  L+H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFI--FDPINREHMTWEKRYK-IIEGIARGLLYLH 360
           + LG CL+     +  EFVP  S+   +  F P+      + K  K I++G+A    YLH
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPL--PEPVFCKYTKQILDGVA----YLH 119

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM---DQTHSDTNRVV-GTFGYMA 416
            +    ++HRD+K +N++L      K+ DFG AR         THS+  + + GT  +MA
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           PE +    +  KSDI+S G  V E+ +G+
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  113 bits (284), Expect = 3e-28
 Identities = 62/195 (31%), Positives = 104/195 (53%), Gaps = 10/195 (5%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLG G FG V++G+ +N   +AVK L   +   + +F  E  ++ +L+H  L++L   C 
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
             +   +V E +   SL  ++     R  +   +   +   +A G+ YL   +    IHR
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVASGMAYLEAQN---YIHR 127

Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEYVMHGRFSVK 428
           DL A N+L+      K++DFG+AR+ + D   +   R    F   + APE  ++ RFS+K
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEA---REGAKFPIKWTAPEAALYNRFSIK 184

Query: 429 SDIFSFGVLVLEIVS 443
           SD++SFG+L+ EIV+
Sbjct: 185 SDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  113 bits (285), Expect = 3e-28
 Identities = 70/223 (31%), Positives = 112/223 (50%), Gaps = 35/223 (15%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--------SKQGEI--EFKNEVLLLARLQHR 300
           +G+G +G VY  + ++ GE +AVK++           S+Q ++    ++E+  L  L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 301 NLVRLLGFCLERKERIL--VYEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
           N+V+ LGF  E  E  L    E+VP  S+   +     F+       T        E + 
Sbjct: 69  NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFT--------EQVL 118

Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
            GL YLH      I+HRDLKA N+L+D++   KISDFG+++  +    +     + G+  
Sbjct: 119 EGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVF 175

Query: 414 YMAPEYV--MHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEE 454
           +MAPE +      +S K DI+S G +VLE+ +G  R  +  EE
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAG--RRPWSDEE 216

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  111 bits (279), Expect = 2e-27
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 20/209 (9%)

Query: 250 NKLGQGGFGAVYKGM-LSNGETIAVKRLS--KNSKQGEIEFKNEVLLLARLQHRNLVRLL 306
             +G+G FG V K    S+G+ +  K +     +++ + +  +EV +L  L+H N+VR  
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 307 GFCLER-KERI-LVYEFVPNASLDHFI------FDPINREHMTWEKRYKIIEGIARGLLY 358
              ++R  + + +V E+     L   I         I  E   W    +I+  +   L  
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIE-EEFIW----RILTQLLLALYE 120

Query: 359 LH--EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            H   D    ++HRDLK +NI LD+  N K+ DFG+A++  +    S     VGT  YM+
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI--LGHDSSFAKTYVGTPYYMS 178

Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           PE + H  +  KSDI+S G L+ E+ +  
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  111 bits (278), Expect = 2e-27
 Identities = 71/198 (35%), Positives = 111/198 (56%), Gaps = 12/198 (6%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRL-SKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
           K+G+G FG VYKG+L     +AVK   S      + +F  E  +L +  H N+V+L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
           ++++   +V E VP  SL  F+    NR  +T +K  ++    A G+ YL  +S+   IH
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNR--LTVKKLLQMSLDAAAGMEYL--ESK-NCIH 116

Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQ---THSDTNRVVGTFGYMAPEYVMHGRFS 426
           RDL A N L+      KISDFGM+R  E +    T SD  + +    + APE + +GR++
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQI-PIKWTAPEALNYGRYT 173

Query: 427 VKSDIFSFGVLVLEIVSG 444
            +SD++S+G+L+ E  S 
Sbjct: 174 SESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 2e-27
 Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 36/211 (17%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE---IEFKNEVLLLARLQHRNLVRLL 306
           KLG+G +G VYK      GE +A+K++ +   + E        E+ LL  L+H N+V+LL
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKELKHPNIVKLL 64

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG---------IARGLL 357
                 ++  LV+E+     L  ++           +KR   +           + RGL 
Sbjct: 65  DVIHTERKLYLVFEYCDM-DLKKYL-----------DKRPGPLSPNLIKSIMYQLLRGLA 112

Query: 358 YLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAP 417
           Y H  S  RI+HRDLK  NIL++ +   K++DFG+AR F +    + T+ VV T  Y AP
Sbjct: 113 YCH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIP-LRTYTHEVV-TLWYRAP 167

Query: 418 EYVMHGRF---SVKSDIFSFGVLVLEIVSGQ 445
           E ++  +    +V  DI+S G +  E+++G+
Sbjct: 168 EILLGSKHYSTAV--DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  110 bits (277), Expect = 2e-27
 Identities = 66/203 (32%), Positives = 107/203 (52%), Gaps = 7/203 (3%)

Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           +  ++     KLG G FG V+ G  +    +AVK L   +   E  F  E  ++ +L+H 
Sbjct: 3   IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHD 61

Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LV+L     E    I V E++   SL  F+ D   R  +       +   +A G+ Y+ 
Sbjct: 62  KLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKDGEGR-ALKLPNLVDMAAQVAAGMAYIE 119

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV 420
              R+  IHRDL+++NIL+   +  KI+DFG+ARL E D  ++          + APE  
Sbjct: 120 ---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 175

Query: 421 MHGRFSVKSDIFSFGVLVLEIVS 443
           ++GRF++KSD++SFG+L+ E+V+
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  110 bits (277), Expect = 2e-27
 Identities = 71/210 (33%), Positives = 99/210 (47%), Gaps = 26/210 (12%)

Query: 251 KLGQGGFGAVYKG--MLSNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRL 305
           KLG G FG V +G    S G+ I  AVK L  +     + +F  E  ++  L H NL+RL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 306 LGFCLERKERILVYEFVPNASL------DHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            G  L     ++V E  P  SL      D      I+         Y +   IA G+ YL
Sbjct: 62  YGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLC-----DYAV--QIANGMRYL 113

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH--SDTNRVVGTFGYMAP 417
                 R IHRDL A NILL S+   KI DFG+ R    ++ H   + +  V  F + AP
Sbjct: 114 ESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAP 169

Query: 418 EYVMHGRFSVKSDIFSFGVLVLEIVS-GQK 446
           E +    FS  SD++ FGV + E+ + G++
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEE 199

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  110 bits (276), Expect = 4e-27
 Identities = 68/206 (33%), Positives = 107/206 (51%), Gaps = 16/206 (7%)

Query: 250 NKLGQGGFGAVYKGM-LSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQHRNLVRLL 306
           NK+G G FG VY  + L  GE +AVK  R+  N  +   E  +E+ +L  L+H NLV+  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 307 GFCLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
           G  + R++  +  E+    +L+  +    I  EH+   + Y +   +  GL YLH     
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVI--RVYTL--QLLEGLAYLHSH--- 118

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT--HSDTNRVVGTFGYMAPEYVMHG 423
            I+HRD+K +NI LD     K+ DFG A   + + T    +   + GT  YMAPE +  G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178

Query: 424 RFSVK---SDIFSFGVLVLEIVSGQK 446
           +       +DI+S G +VLE+ +G++
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  110 bits (278), Expect = 4e-27
 Identities = 64/231 (27%), Positives = 106/231 (45%), Gaps = 41/231 (17%)

Query: 244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN--SKQGEIEF-KNEVLLLARL-Q 298
           D+F     +G+G F  V         +  A+K L K    K+ ++++ K E  +L RL  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 299 HRNLVRLLGFCLERKERI-LVYEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGI 352
           H  +++L  +  + +E +  V E+ PN  L  +I      D    E  T   R+   E I
Sbjct: 61  HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLD----EKCT---RFYAAE-I 111

Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV---- 408
              L YLH      IIHRDLK  NILLD +M+ KI+DFG A++ + + +           
Sbjct: 112 LLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168

Query: 409 --------------VGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
                         VGT  Y++PE +        SD+++ G ++ ++++G+
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  110 bits (277), Expect = 5e-27
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 29/212 (13%)

Query: 252 LGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQGE-IEFKNEVLLLARLQHRNLVR 304
           LGQG FG VY+G+            +A+K +++N+   E IEF NE  ++      ++VR
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 305 LLGFCLERKERILVYEFVPNASLDHFI------------FDPINREHMTWEKRYKIIEGI 352
           LLG     +  ++V E +    L  ++              P   +        ++   I
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF-----IQMAAEI 128

Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSDTNRVVGT 411
           A G+ YL      + +HRDL A N ++  ++  KI DFGM R ++E D        ++  
Sbjct: 129 ADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL-P 184

Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +MAPE +  G F+ KSD++SFGV++ E+ +
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  109 bits (274), Expect = 6e-27
 Identities = 73/273 (26%), Positives = 146/273 (53%), Gaps = 27/273 (9%)

Query: 252 LGQGGFGAVYKGMLS----NGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G FG V++G+L         +A+K L    +++   +F +E  ++ +  H N++RL 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   + K  +++ E++ N +LD ++ D  +    +  +   ++ GIA G+ YL   S + 
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYL---SDMN 127

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMD--QTHSDTNRVVGTFGYMAPEYVMHGR 424
            +HRDL A NIL++S +  K+SDFG++R+ E D   T++ +   +    + APE + + +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI-PIRWTAPEAIAYRK 186

Query: 425 FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGS 484
           F+  SD++SFG+++ E++S  +R  +  +    +++    +  N+G    L  P     +
Sbjct: 187 FTSASDVWSFGIVMWEVMSFGERPYW--DMSNHEVM----KAINDG--FRLPAPMDCPSA 238

Query: 485 TSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
             ++M      L C Q++ + RP    +VN+L+
Sbjct: 239 VYQLM------LQCWQQDRARRPRFVDIVNLLD 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score =  109 bits (274), Expect = 8e-27
 Identities = 77/218 (35%), Positives = 125/218 (57%), Gaps = 17/218 (7%)

Query: 252 LGQGGFGAVYKGM-LSNGETI----AVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRL 305
           LG G FG VYKG+ + +GE +    A+K L +N S +   E  +E  ++A +    + RL
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 306 LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
           LG CL    + LV + +P   L  ++ +  N++ +  +        IA+G+ YL E   +
Sbjct: 75  LGICLTSTVQ-LVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEE---V 128

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT--HSDTNRVVGTFGYMAPEYVMHG 423
           R++HRDL A N+L+ S  + KI+DFG+ARL ++D+T  H+D  +V     +MA E ++H 
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV--PIKWMALESILHR 186

Query: 424 RFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLL 460
           RF+ +SD++S+GV V E+++ G K        E  DLL
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL 224

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  108 bits (272), Expect = 1e-26
 Identities = 75/213 (35%), Positives = 120/213 (56%), Gaps = 32/213 (15%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRL--------SKNSKQGEIE-FKNEVLLLARLQHRN 301
           +G G FG+VY GM  S+GE +AVK++        SK+ K+  ++    E+ LL  LQH N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 302 LVRLLGFCLERKERILVYEFVPNAS----LDHF--IFDPINREHMTWEKRYKIIEGIARG 355
           +V+ LG  L+     +  E+VP  S    L+++    + + R           +  I +G
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR---------NFVRQILKG 118

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR----VVGT 411
           L YLH  +R  IIHRD+K +NIL+D++   KISDFG+++  E +   + TN     + G+
Sbjct: 119 LNYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175

Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
             +MAPE V    ++ K+DI+S G LV+E+++G
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  108 bits (272), Expect = 1e-26
 Identities = 74/217 (34%), Positives = 113/217 (52%), Gaps = 29/217 (13%)

Query: 252 LGQGGFGAVYKGML------SNGET-IAVKRLSKNSKQGE-IEFKNEVLLLARLQHRNLV 303
           LG G FG VY+G         +G   +AVK L K +   E  EF  E  L++   H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREH----MTWEKRYKIIEGIARGLLYL 359
           +LLG CL  + + ++ E +    L  ++ D          +T ++   I   +A+G +YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 360 HEDSRLRIIHRDLKASNILL-----DSEMNPKISDFGMARLFEMDQTHSDTNRVVGT--- 411
               ++  IHRDL A N L+     D++   KI DFG+AR    D   SD  R  G    
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR----DIYKSDYYRKEGEGLL 175

Query: 412 -FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQK 446
              +MAPE ++ G+F+ +SD++SFGVL+ EI++ GQ+
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQ 212

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  107 bits (269), Expect = 2e-26
 Identities = 67/193 (34%), Positives = 105/193 (54%), Gaps = 7/193 (3%)

Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLGFCL 310
           LG+G FG V+KG L +   +AVK   ++  Q  +I+F +E  +L +  H N+V+L+G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           +R+   +V E VP    D   F    ++ +  ++  K     A G+ YL   +    IHR
Sbjct: 63  QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117

Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSD 430
           DL A N L+      KISDFGM+R  E D  +S +        + APE + +GR+S +SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQ-EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176

Query: 431 IFSFGVLVLEIVS 443
           ++S+G+L+ E  S
Sbjct: 177 VWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  108 bits (270), Expect = 3e-26
 Identities = 63/195 (32%), Positives = 108/195 (55%), Gaps = 7/195 (3%)

Query: 250 NKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +KLG G +G VY+G+      T+AVK L +++ + E EF  E  ++  ++H NLV+LLG 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 70

Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C       ++ EF+   +L  ++ +  NR+ +       +   I+  + YL + +    I
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 126

Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVK 428
           HRDL A N L+      K++DFG++RL   D T++          + APE + + +FS+K
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIK 185

Query: 429 SDIFSFGVLVLEIVS 443
           SD+++FGVL+ EI +
Sbjct: 186 SDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  107 bits (268), Expect = 6e-26
 Identities = 70/224 (31%), Positives = 112/224 (50%), Gaps = 39/224 (17%)

Query: 251 KLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           +LG+G FG V+     N         +AVK L + S+    +F+ E  LL  LQH+++VR
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREH-----------------MTWEKRYK 347
             G C E +  ++V+E++ +  L+ F+     R H                 +T  +   
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFL-----RSHGPDAKILAGGEDVAPGQLTLGQMLA 126

Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           I   IA G++YL   + L  +HRDL   N L+   +  KI DFGM+R    D   +D  R
Sbjct: 127 IASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYR 179

Query: 408 VVG----TFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKR 447
           V G       +M PE +++ +F+ +SDI+SFGV++ EI +  K+
Sbjct: 180 VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  105 bits (264), Expect = 1e-25
 Identities = 67/193 (34%), Positives = 107/193 (55%), Gaps = 7/193 (3%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV L     
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V EF+   SL  F+ +  + +++   +   +   IA G+ Y+    R+  IHR
Sbjct: 72  EEPIYI-VTEFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126

Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSD 430
           DL+A+NIL+   +  KI+DFG+ARL E D  ++          + APE  ++GRF++KSD
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 431 IFSFGVLVLEIVS 443
           ++SFG+L+ E+V+
Sbjct: 186 VWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  106 bits (266), Expect = 1e-25
 Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 17/205 (8%)

Query: 252 LGQGGFGAVYKGML-----SNGET-IAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNLVR 304
           LG+G FG V+           GET + VK L K   +  + EF+ E+ +  +L H+N+VR
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 305 LLGFCLERKERILVYEFVPNASLDHFI------FDPINREHMTWEKRYKIIEGIARGLLY 358
           LLG C E +   ++ E+     L  F+       + +    ++ +++  +   IA G+ +
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
           L   S  R +HRDL A N L+ S+   K+S   +++     + +   N ++    ++APE
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPE 188

Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVS 443
            V    FS KSD++SFGVL+ E+ +
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  105 bits (265), Expect = 2e-25
 Identities = 58/202 (28%), Positives = 104/202 (51%), Gaps = 13/202 (6%)

Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNLV 303
           F+    +G+G FG VYK +     + +A+K +     + EIE    E+  L++ +   + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           +  G  L+  +  ++ E+    S    +    ++  ++ +     I+  +  GL YLHE+
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-----ILREVLLGLEYLHEE 117

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH 422
                IHRD+KA+NILL  E + K++DFG++   ++  T S  N  VGT  +MAPE +  
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSG--QLTSTMSKRNTFVGTPFWMAPEVIKQ 172

Query: 423 GRFSVKSDIFSFGVLVLEIVSG 444
             +  K+DI+S G+  +E+  G
Sbjct: 173 SGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  105 bits (262), Expect = 2e-25
 Identities = 67/195 (34%), Positives = 103/195 (52%), Gaps = 10/195 (5%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLG G FG V+ G  +N   +AVK L   +   +  F  E  L+  LQH  LVRL     
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ-AFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           + +   ++ E++   SL  F+      + +   K       IA G+ Y+    R   IHR
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLL-PKLIDFSAQIAEGMAYIE---RKNYIHR 127

Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEYVMHGRFSVK 428
           DL+A+N+L+   +  KI+DFG+AR+ E ++    T R    F   + APE +  G F++K
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFTIK 184

Query: 429 SDIFSFGVLVLEIVS 443
           SD++SFG+L+ EIV+
Sbjct: 185 SDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  105 bits (263), Expect = 2e-25
 Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 22/210 (10%)

Query: 244 DNFSDANKLGQGGFGAVYKGML--SNGETIAVKRL---SKNSKQGEIEFKNEVLLLARLQ 298
           D+     +LG G  G V K +L    G+ +AVK +      + Q +I  + ++L   +  
Sbjct: 1   DDLEYLGELGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILH--KCN 57

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHF---IFDPINREHMTWEKRYKIIEGIARG 355
              +V   G      +  +  E++   SLD     +   I    +      KI   + +G
Sbjct: 58  SPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKG 112

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYM 415
           L YLHE    +IIHRD+K SNIL++S    K+ DFG++   ++  + + T   VGT  YM
Sbjct: 113 LTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSG--QLVNSLAKTF--VGTSSYM 166

Query: 416 APEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           APE +    +SVKSDI+S G+ ++E+ +G+
Sbjct: 167 APERIQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  104 bits (261), Expect = 3e-25
 Identities = 59/196 (30%), Positives = 104/196 (53%), Gaps = 7/196 (3%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           +LG G FG V+ G       +A+K +++ +   E +F  E  ++ +L H  LV+L G C 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           ++K   +V EF+ N  L +++     +  ++ +    + + +  G+ YL  +S    IHR
Sbjct: 70  QQKPLYIVTEFMENGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124

Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSD 430
           DL A N L+ S    K+SDFGM R + +D  ++ ++       +  PE     ++S KSD
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183

Query: 431 IFSFGVLVLEIVSGQK 446
           ++SFGVL+ E+ +  K
Sbjct: 184 VWSFGVLMWEVFTEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  104 bits (262), Expect = 7e-25
 Identities = 65/227 (28%), Positives = 105/227 (46%), Gaps = 31/227 (13%)

Query: 251 KLGQGGFGAVY----------------KGMLSNGET-IAVKRLSKN-SKQGEIEFKNEVL 292
           KLG+G FG V+                +   ++    +AVK L  + S     +F  EV 
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI--------FDPINREHMTWEK 344
           +L+RL   N+ RLLG C       ++ E++ N  L+ F+            N + +++  
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131

Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHS 403
              +   IA G+ YL     L  +HRDL   N L+      KI+DFGM+R L+  D    
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188

Query: 404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSF 450
              R      +MA E V+ G+F+ KSD+++FGV + EI++  +   +
Sbjct: 189 Q-GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY 234

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  103 bits (259), Expect = 7e-25
 Identities = 64/196 (32%), Positives = 107/196 (54%), Gaps = 13/196 (6%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE---GIARGLLYLHEDSRLRI 367
           E    I V E++   SL  F+      E   + +  ++++    IA G+ Y+    R+  
Sbjct: 72  EEPIYI-VTEYMSKGSLLDFL----KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 123

Query: 368 IHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSV 427
           +HRDL+A+NIL+   +  K++DFG+ARL E D  ++          + APE  ++GRF++
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 428 KSDIFSFGVLVLEIVS 443
           KSD++SFG+L+ E+ +
Sbjct: 183 KSDVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  104 bits (260), Expect = 8e-25
 Identities = 78/293 (26%), Positives = 135/293 (46%), Gaps = 55/293 (18%)

Query: 252 LGQGGFGAVYK----GMLSNGE--TIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVR 304
           +GQG FG V++    G+L       +AVK L +  S   + +F+ E  L+A   H N+V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFD-------------------PINREHMTWEKR 345
           LLG C   K   L++E++    L+ F+                      +N   ++  ++
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSD 404
             I + +A G+ YL E    + +HRDL   N L+   M  KI+DFG++R ++  D   + 
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAW 464
            N  +    +M PE + + R++ +SD++++GV++ EI S   +  +G   E    + Y  
Sbjct: 190 ENDAI-PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE---VIYYV 245

Query: 465 RNWN-----EGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASV 512
           R+ N     +   L L +  MR               LC  +  S+RP  AS+
Sbjct: 246 RDGNVLSCPDNCPLELYN-LMR---------------LCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score =  103 bits (258), Expect = 1e-24
 Identities = 72/204 (35%), Positives = 111/204 (54%), Gaps = 20/204 (9%)

Query: 252 LGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRL 305
           LG+G FG V    Y     N GE +AVK L   S    I + K E+ +L  L H N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 306 LGFCLERKER--ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            G C E       L+ EF+P+ SL  ++  P N+  +  +++ K    I +G+ YL   S
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYL--GS 127

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH----SDTNRVVGTFGYMAPEY 419
           R + +HRDL A N+L++SE   KI DFG+ +  E D+ +     D +  V  F Y APE 
Sbjct: 128 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV--FWY-APEC 183

Query: 420 VMHGRFSVKSDIFSFGVLVLEIVS 443
           ++  +F + SD++SFGV + E+++
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 2e-24
 Identities = 67/205 (32%), Positives = 110/205 (53%), Gaps = 25/205 (12%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKR-----LSKNSKQGEIEFKNEVLLLARLQHRNLVRL 305
           LGQG FG VY    +  G  +AVK+      S  +K+     + E+ LL  LQH  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 306 LGFCLERKERILVY-EFVPNASLDHFI--FDPINREHMTWEKRYKIIEGIARGLLYLHED 362
            G CL   E + ++ E++P  S+   +  +  +  E +T +   +I+EG+     YLH +
Sbjct: 70  YG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALT-ETVTRKYTRQILEGVE----YLHSN 123

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMA-RLFEMDQTHSDTNRVVGTFGYMAPEYVM 421
               I+HRD+K +NIL DS  N K+ DFG + RL  +  + +    V GT  +M+PE + 
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180

Query: 422 ---HGRFSVKSDIFSFGVLVLEIVS 443
              +GR   K+D++S G  V+E+++
Sbjct: 181 GEGYGR---KADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score =  103 bits (257), Expect = 2e-24
 Identities = 70/230 (30%), Positives = 124/230 (53%), Gaps = 35/230 (15%)

Query: 239 IRVATDNFSDANKLGQGGFGAVYKGML---SNGE---TIAVKRLSKNSKQGEI--EFKNE 290
           I ++T  F +  +LG+  FG VYKG L   + GE    +A+K L K+  +G +  EFK+E
Sbjct: 2   INLSTVRFME--ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLREEFKHE 58

Query: 291 VLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIF-------------DPINR 337
            ++ +RLQH N+V LLG   + +   +++ +  ++ L  F+              D   +
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 338 EHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
             +       I+  IA G+ +L   S   ++H+DL   N+L+  ++N KISD G+ R   
Sbjct: 119 STLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR--- 172

Query: 398 MDQTHSDTNRVVGT----FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            +   +D  +++G       +M+PE +M+G+FS+ SDI+S+GV++ E+ S
Sbjct: 173 -EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  102 bits (255), Expect = 2e-24
 Identities = 60/204 (29%), Positives = 112/204 (54%), Gaps = 9/204 (4%)

Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKR--LSKNSKQGEIEFKNEVLLLARLQHRN 301
           +F   NK+G+G FG V+K +  ++    A+K+  LSK +++   E  +E  +LA+L    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++R     L++ +  +V E+  N  L   +     R  +  ++ ++    I  GL +LH 
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRP-LPEDQVWRFFIQILLGLAHLHS 119

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM 421
               +I+HRD+K+ N+ LD+  N KI D G+A+L   +   ++T  +VGT  Y++PE   
Sbjct: 120 K---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCE 174

Query: 422 HGRFSVKSDIFSFGVLVLEIVSGQ 445
              ++ KSD+++ GV++ E  +G+
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  102 bits (255), Expect = 3e-24
 Identities = 60/200 (30%), Positives = 112/200 (56%), Gaps = 17/200 (8%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEI-EFKNEVLLLARLQH---RNLVRLL 306
           +G+G +GAVY+G  +  G  +A+K ++ ++   ++ + + EV LL++L+     N+ +  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 307 GFCLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
           G  L+     ++ E+    S+   +   PI  ++++      II  +   L Y+H+    
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYIS-----VIIREVLVALKYIHKVG-- 121

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR- 424
            +IHRD+KA+NIL+ +  N K+ DFG+A L   +Q  S  +  VGT  +MAPE +  G+ 
Sbjct: 122 -VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEVITEGKY 178

Query: 425 FSVKSDIFSFGVLVLEIVSG 444
           +  K+DI+S G+ + E+ +G
Sbjct: 179 YDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  101 bits (253), Expect = 5e-24
 Identities = 73/275 (26%), Positives = 136/275 (49%), Gaps = 29/275 (10%)

Query: 252 LGQGGFGAVYKGMLS----NGETIAVKRL-SKNSKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G FG V +G L         +A+K L S  +++   +F +E  ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   + +  +++ EF+ N +LD F+    N    T  +   ++ GIA G+ YL E   + 
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYLSE---MN 126

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG---TFGYMAPEYVMHG 423
            +HRDL A NIL++S +  K+SDFG++R  E D +       +G      + APE + + 
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186

Query: 424 RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGG 483
           +F+  SD++S+G+++ E++S  +R                W   N+   +N ++   R  
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERPY--------------WDMSNQDV-INAIEQDYRLP 231

Query: 484 STSEMMKCIHIGLL-CVQENVSNRPGMASVVNMLN 517
              +    +H  +L C Q++ + RP    +V+ L+
Sbjct: 232 PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  101 bits (252), Expect = 6e-24
 Identities = 60/196 (30%), Positives = 105/196 (53%), Gaps = 13/196 (6%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           +LG G FG V  G       +A+K + + S   E EF  E  ++ +L H  LV+L G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           +++   +V E++ N  L +++ +  + +     +  ++ + +  G+ YL      + IHR
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLRE--HGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHR 124

Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT---FGYMAPEYVMHGRFSV 427
           DL A N L+D +   K+SDFG++R    D+  S     VG+     +  PE +++ +FS 
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKFSS 180

Query: 428 KSDIFSFGVLVLEIVS 443
           KSD+++FGVL+ E+ S
Sbjct: 181 KSDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  100 bits (251), Expect = 9e-24
 Identities = 64/207 (30%), Positives = 112/207 (54%), Gaps = 13/207 (6%)

Query: 246 FSDANKLGQGGFGAVYKGMLSNG-ETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLV 303
           F+   ++G+G FG VYKG+ +   E +A+K +     + EIE  + E+ +L++     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 304 RLLGFCLERKERILVYEFVPNAS-LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           R  G  L+  +  ++ E++   S LD     P+   ++       I+  I +GL YLH +
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLHSE 120

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH 422
              R IHRD+KA+N+LL  + + K++DFG+A   ++  T    N  VGT  +MAPE +  
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQ 175

Query: 423 GRFSVKSDIFSFGVLVLEIVSGQKRSS 449
             +  K+DI+S G+  +E+  G+  +S
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNS 202

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =  100 bits (251), Expect = 9e-24
 Identities = 78/274 (28%), Positives = 141/274 (51%), Gaps = 29/274 (10%)

Query: 252 LGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G FG V  G L      E  +A+K L    +++   +F +E  ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   + K  ++V E++ N SLD F+    +    T  +   ++ GIA G+ YL   S + 
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFLRK--HDGQFTVIQLVGMLRGIASGMKYL---SDMG 126

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG---TFGYMAPEYVMHG 423
            +HRDL A NIL++S +  K+SDFG++R+ E D   + T R  G      + APE + + 
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR--GGKIPIRWTAPEAIAYR 184

Query: 424 RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGG 483
           +F+  SD++S+G+++ E++S  +R  +  E   +D++    +   EG    L  P     
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERPYW--EMSNQDVI----KAIEEG--YRLPAPMDCPA 236

Query: 484 STSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
           +  ++M      L C Q++ + RP    +V++L+
Sbjct: 237 ALHQLM------LDCWQKDRNERPKFEQIVSILD 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  100 bits (250), Expect = 1e-23
 Identities = 67/227 (29%), Positives = 114/227 (50%), Gaps = 32/227 (14%)

Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNE 290
           L++++E      D   +   LG+G +G VY    LS    IA+K + +   +       E
Sbjct: 1   LEYEYEY-----DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEE 55

Query: 291 VLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI---FDPI--NREHMTWEKR 345
           + L + L+HRN+V+ LG   E     +  E VP  SL   +   + P+  N + + +  +
Sbjct: 56  IALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK 115

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFG----MARLFEMDQ 400
            +I+E    GL YLH+    +I+HRD+K  N+L+++     KISDFG    +A +    +
Sbjct: 116 -QILE----GLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE 167

Query: 401 THSDTNRVVGTFGYMAPEYVMHGR--FSVKSDIFSFGVLVLEIVSGQ 445
           T +      GT  YMAPE +  G   +   +DI+S G  ++E+ +G+
Sbjct: 168 TFT------GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 99.6 bits (248), Expect = 1e-23
 Identities = 66/194 (34%), Positives = 108/194 (55%), Gaps = 15/194 (7%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            +G+G FGAV +G  + G+ +AVK +  + + Q    F  E  ++ +L H+NLVRLLG  
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68

Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
           L     I V E +   +L +F+     R  ++  +  +    +A G+ YL      +++H
Sbjct: 69  LHNGLYI-VMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123

Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKS 429
           RDL A NIL+  +   K+SDFG+AR+  M     D +++     + APE + H +FS KS
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMG---VDNSKL--PVKWTAPEALKHKKFSSKS 178

Query: 430 DIFSFGVLVLEIVS 443
           D++S+GVL+ E+ S
Sbjct: 179 DVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  100 bits (251), Expect = 2e-23
 Identities = 66/232 (28%), Positives = 103/232 (44%), Gaps = 26/232 (11%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRN 301
           +   + ++LG+G  G+V K  L N   I   +        ++  +   E+ +    +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 302 LVRLLGFCLERKERIL--VYEFVPNASLDHFIFDPINREHMTWEKRY-KIIEGIARGLLY 358
           +V+  G  L+     +    E+    SLD        R     EK   KI E + +GL Y
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG----Y 414
           LH     +IIHRD+K SNILL  +   K+ DFG++            N + GTF     Y
Sbjct: 121 LHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL--------VNSLAGTFTGTSFY 169

Query: 415 MAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE----DLLTY 462
           MAPE +    +S+ SD++S G+ +LE+     R  F  E E      +LL+Y
Sbjct: 170 MAPERIQGKPYSITSDVWSLGLTLLEVAQN--RFPFPPEGEPPLGPIELLSY 219

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 2e-23
 Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 18/202 (8%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN--EVLLLARLQHRNLVRLLG 307
           K+G+G +G VYK      GE +A+K++    +   I      E+ LL  L H N+++LL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
               + +  LV+EF+ +  L   I D   +  +        +  + +GL + H      I
Sbjct: 66  VFRHKGDLYLVFEFM-DTDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCH---SHGI 119

Query: 368 IHRDLKASNILLDSEMNPKISDFGMARLFEMDQ---THSDTNRVVGTFGYMAPEYVMHGR 424
           +HRDLK  N+L+++E   K++DFG+AR F       TH      V T  Y APE ++  +
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY-----VVTRWYRAPELLLGDK 174

Query: 425 F-SVKSDIFSFGVLVLEIVSGQ 445
             S   DI+S G +  E++S +
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 99.7 bits (249), Expect = 2e-23
 Identities = 63/201 (31%), Positives = 103/201 (51%), Gaps = 10/201 (4%)

Query: 250 NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEF-KNEVLLLARLQHRNLVRLLG 307
             +G G    VY  + L N E +A+KR+     Q  ++  + EV  +++  H N+V+   
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
             +   E  LV  ++   SL   +     R  +       +++ + +GL YLH + +   
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ--- 123

Query: 368 IHRDLKASNILLDSEMNPKISDFGM-ARLFE-MDQTHSDTNRVVGTFGYMAPEYVMHGR- 424
           IHRD+KA NILL  + + KI+DFG+ A L +  D+T       VGT  +MAPE VM    
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VMEQVH 182

Query: 425 -FSVKSDIFSFGVLVLEIVSG 444
            +  K+DI+SFG+  +E+ +G
Sbjct: 183 GYDFKADIWSFGITAIELATG 203

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 99.4 bits (248), Expect = 2e-23
 Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 28/217 (12%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS----KNSKQGEIEFKNEVLLLARL 297
             NF    K+G+G F  VYK + L +G  +A+K++      ++K  +   K E+ LL +L
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQL 59

Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR-------YKIIE 350
            H N+++ L   +E  E  +V E      L   I      +H   +KR       +K   
Sbjct: 60  DHPNVIKYLASFIENNELNIVLELADAGDLSRMI------KHFKKQKRLIPERTIWKYFV 113

Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT--HSDTNRV 408
            +   L ++H     RI+HRD+K +N+ + +    K+ D G+ R F    T  HS    +
Sbjct: 114 QLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS----L 166

Query: 409 VGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           VGT  YM+PE +    ++ KSDI+S G L+ E+ + Q
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 99.7 bits (248), Expect = 3e-23
 Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 25/214 (11%)

Query: 251 KLGQGGFGAVYKGML-----SNGETIAVKRLSK-NSKQGEIEFKNEVLLLARLQHRNLVR 304
           +LG+  FG +YKG L      + + +A+K L   N+ Q   EF+ E  L+A L H N+V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIF--------------DPINREHMTWEKRYKIIE 350
           LLG   + +   +++E++    L  F+               D   +  +       I  
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSDTNRVV 409
            IA G+ YL   S    +H+DL A NIL+  +++ KISD G++R ++  D        ++
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 410 GTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
               +M PE +M+G+FS  SDI+SFGV++ EI S
Sbjct: 189 -PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score = 94.1 bits (234), Expect = 3e-23
 Identities = 34/101 (33%), Positives = 45/101 (44%), Gaps = 2/101 (1%)

Query: 62  AESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLS 121
              N +     F      LL  L S AA+       A    A  D  T+Y L QC  DLS
Sbjct: 8   TSGNYTTANSTFESNLNALLSSLSSNAASSSGKGFAAGTSGAAPD--TVYGLAQCRGDLS 65

Query: 122 EADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRYETNKF 162
            +DC+ CL      + +CC  ++GGR+   SC  RYE+  F
Sbjct: 66  ASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 99.1 bits (247), Expect = 4e-23
 Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 27/214 (12%)

Query: 252 LGQGGFGAVYKGMLSNGET----IAVKRLS-KNSKQGEIE-FKNEVLLLARLQHRNLVRL 305
           LG+G FG+V +G LS  +     +AVK +        EIE F +E   +    H N+++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 306 LGFCLERKER------ILVYEFVPNASLDHFIFDP---INREHMTWEKRYKIIEGIARGL 356
           +G C E          +++  F+ +  L  F+         E +  +   K +  IA G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD---QTHSDTNRVVGTF 412
            YL   S    IHRDL A N +L  +M   ++DFG+++ ++  D   Q       V    
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV---- 179

Query: 413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQ 445
            ++A E +    ++ KSD+++FGV + EI + GQ
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 98.6 bits (245), Expect = 5e-23
 Identities = 63/194 (32%), Positives = 106/194 (54%), Gaps = 9/194 (4%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLG G FG V+    +    +AVK +   S   E  F  E  ++  LQH  LV+L    +
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHA-VV 70

Query: 311 ERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            ++   ++ EF+   SL  F+  D  +++ +   K       IA G+ ++ + +    IH
Sbjct: 71  TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN---YIH 125

Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKS 429
           RDL+A+NIL+ + +  KI+DFG+AR+ E D  ++          + APE +  G F++KS
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184

Query: 430 DIFSFGVLVLEIVS 443
           D++SFG+L++EIV+
Sbjct: 185 DVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 98.6 bits (245), Expect = 7e-23
 Identities = 68/222 (30%), Positives = 107/222 (48%), Gaps = 37/222 (16%)

Query: 251 KLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           +LG+G FG V+     N         +AVK L   S     +F  E  LL  LQH ++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREH---------------MTWEKRYKII 349
             G C+E    I+V+E++ +  L+ F+     R H               +T  +   I 
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFL-----RAHGPDAVLMAEGNRPAELTQSQMLHIA 126

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
           + IA G++YL   +    +HRDL   N L+   +  KI DFGM+R    D   +D  RV 
Sbjct: 127 QQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYRVG 179

Query: 410 G----TFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKR 447
           G       +M PE +M+ +F+ +SD++S GV++ EI +  K+
Sbjct: 180 GHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 98.7 bits (246), Expect = 8e-23
 Identities = 67/203 (33%), Positives = 106/203 (52%), Gaps = 19/203 (9%)

Query: 246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHRN 301
           F+D  ++G G FGAVY        E +A+K++S + KQ   ++++   EV  L +L+H N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
            +   G  L      LV E+   ++ D  I + ++++ +   +   I  G  +GL YLH 
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASD--ILE-VHKKPLQEVEIAAICHGALQGLAYLHS 133

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM 421
             R   IHRD+KA NILL      K++DFG A L       S  N  VGT  +MAPE ++
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASLV------SPANSFVGTPYWMAPEVIL 184

Query: 422 ---HGRFSVKSDIFSFGVLVLEI 441
               G++  K D++S G+  +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 98.0 bits (244), Expect = 1e-22
 Identities = 66/216 (30%), Positives = 104/216 (48%), Gaps = 18/216 (8%)

Query: 252 LGQGGFGAVYK-GMLSNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           LG+GGFG V    + + G+  A K+L K     ++GE    NE  +L ++  R +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 308 FCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           +  E K+ + LV   +    L + I++            +   + I  GL +LH   + R
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLH---QRR 115

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS 426
           I++RDLK  N+LLD   N +ISD G+A   +  +         GT GYMAPE +    + 
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQGEVYD 172

Query: 427 VKSDIFSFGVLVLEIVSGQKRSSF---GTEEETEDL 459
              D F+ G  + E+++G  RS F     + E E+L
Sbjct: 173 FSVDWFALGCTLYEMIAG--RSPFRQRKEKVEKEEL 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 98.5 bits (245), Expect = 1e-22
 Identities = 63/206 (30%), Positives = 116/206 (56%), Gaps = 16/206 (7%)

Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 69  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 125

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT--HSDTNRVVGTFGYMAP 417
            E    R++HRDL A N+L+ +  + KI+DFG+A+L   D+   H++  +V     +MA 
Sbjct: 126 EER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV--PIKWMAL 180

Query: 418 EYVMHGRFSVKSDIFSFGVLVLEIVS 443
           E ++H  ++ +SD++S+GV V E+++
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 97.6 bits (243), Expect = 1e-22
 Identities = 61/206 (29%), Positives = 110/206 (53%), Gaps = 20/206 (9%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLS----KNSKQGEI--EFKNEVLLLARLQHRNLVR 304
           LG G F + Y+   +  G  +AVK+++     +S+Q E+    + E+ L+ARL H +++R
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 305 LLGFCLERKERILVYEFVPNASLDHFI--FDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           +LG   E     L  E++   S+ H +  +    +E +         E + RGL YLHE+
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAF-KEAVI----INYTEQLLRGLSYLHEN 122

Query: 363 SRLRIIHRDLKASNILLDSE-MNPKISDFGMARLFEMDQTHSD--TNRVVGTFGYMAPEY 419
              +IIHRD+K +N+L+DS     +I+DFG A       T +     +++GT  +MAPE 
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179

Query: 420 VMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           +   ++    D++S G +++E+ + +
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 98.2 bits (245), Expect = 1e-22
 Identities = 71/217 (32%), Positives = 111/217 (51%), Gaps = 31/217 (14%)

Query: 242 ATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKR-LSKNSKQG-EIEFKNEVLLLARLQ 298
              ++    KLG+G FG VYK   +  G  +A+K+ L  N K G  I    E+ +L +L+
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65

Query: 299 HRNLVRLLGFCLER-----KERILVYEFVP--NASLDHFIFDPINREHMTWEKRY--KII 349
           H N+V L+   +ER     ++R  VY   P  +  L   + +P  +   +  K Y  +++
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ--------- 400
           EGI     YLHE+    I+HRD+KA+NIL+D++   KI+DFG+AR ++            
Sbjct: 126 EGIN----YLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178

Query: 401 -THSDTNRVVGTFGYMAPEYVMHGR-FSVKSDIFSFG 435
            T   TN VV T  Y  PE ++  R ++   DI+  G
Sbjct: 179 GTRKYTNLVV-TRWYRPPELLLGERRYTTAVDIWGIG 214

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 57/202 (28%), Positives = 109/202 (53%), Gaps = 17/202 (8%)

Query: 251 KLGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHRNLVRLLG 307
           ++G+G  G V+K      GET+A+K+++    +G I  +   E+  L   QH  +V+LL 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 308 FCLERKERILVYEFVPN--ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
                   +LV E++P+  + +      P+    +   K Y  +  + +G+ Y+H     
Sbjct: 67  VFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQV---KSYMRM--LLKGVAYMHA---N 118

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG-- 423
            I+HRDLK +N+L+ ++   KI+DFG+ARLF  ++    +++ V T  Y APE +++G  
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE-LLYGAR 176

Query: 424 RFSVKSDIFSFGVLVLEIVSGQ 445
           ++    D+++ G +  E+++G 
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 96.9 bits (241), Expect = 2e-22
 Identities = 71/222 (31%), Positives = 115/222 (51%), Gaps = 25/222 (11%)

Query: 252 LGQGGFGAVYKGM-LSNGETI----AVKRL-SKNSKQGEIEFKNEVLLLARLQHRNLVRL 305
           LG G FG V+KG+ +  G++I    A+K +  ++ +Q   E  + +L +  L H  +VRL
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 306 LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
           LG C     + LV +  P  SL   +    +R+ +  ++       IA+G+ YL E    
Sbjct: 75  LGICPGASLQ-LVTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRF 425
           R++HR+L A NILL S+   +I+DFG+A L   D      +       +MA E ++ GR+
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188

Query: 426 SVKSDIFSFGVLVLEIVSGQKRSSFGTE-------EETEDLL 460
           + +SD++S+GV V E++      S+G E        E  DLL
Sbjct: 189 THQSDVWSYGVTVWEMM------SYGAEPYAGMRPHEVPDLL 224

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 97.4 bits (242), Expect = 2e-22
 Identities = 67/223 (30%), Positives = 109/223 (48%), Gaps = 30/223 (13%)

Query: 251 KLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           +LG+G FG V+     N         +AVK L   +     +F+ E  LL  LQH ++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 305 LLGFCLERKERILVYEFVPNASLDHF----------IFDPINRE---HMTWEKRYKIIEG 351
             G C +    I+V+E++ +  L+ F          + D   R+    +   +   I   
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG- 410
           IA G++YL   +    +HRDL   N L+ + +  KI DFGM+R    D   +D  RV G 
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGGH 184

Query: 411 ---TFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSF 450
                 +M PE +M+ +F+ +SD++SFGV++ EI +  K+  F
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 96.7 bits (241), Expect = 3e-22
 Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 12/222 (5%)

Query: 239 IRVATDNFSDANKLGQGGFGAVYKG--MLSNGETI--AVKRLSKNSKQGEIE-FKNEVLL 293
             +  ++ +    +G+G FG VY+G  M    E I  AVK     +     E F  E  +
Sbjct: 1   YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI 60

Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           + +  H ++V+L+G   E    I V E  P   L  ++   +N+  +           ++
Sbjct: 61  MRQFDHPHIVKLIGVITENPVWI-VMELAPLGELRSYL--QVNKYSLDLASLILYSYQLS 117

Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             L YL      R +HRD+ A N+L+ S    K+ DFG++R  E D+++   ++      
Sbjct: 118 TALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIK 173

Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEE 455
           +MAPE +   RF+  SD++ FGV + EI+    +   G +  
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN 215

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 96.8 bits (242), Expect = 3e-22
 Identities = 73/228 (32%), Positives = 112/228 (49%), Gaps = 53/228 (23%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNS--KQGEIE-F 287
           DFE I+           LG G FG V   ML     +G+  A+K LSK    K  ++E  
Sbjct: 2   DFEFIKT----------LGTGSFGRV---MLVRHKGSGKYYALKILSKAKIVKLKQVEHV 48

Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
            NE  +L  ++H  LV L G   +     LV E+VP   L    F  + +         +
Sbjct: 49  LNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGEL----FSHLRKSG-------R 97

Query: 348 IIEGIAR--------GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
             E +AR         L YLH    L I++RDLK  N+LLDS+   KI+DFG A+  +  
Sbjct: 98  FPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK-G 153

Query: 400 QTHSDTNRVVGTFGYMAPEYVM---HGRFSVKSDIFSFGVLVLEIVSG 444
           +T++    + GT  Y+APE ++   +G+ +V  D ++ G+L+ E+++G
Sbjct: 154 RTYT----LCGTPEYLAPEIILSKGYGK-AV--DWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 96.8 bits (241), Expect = 3e-22
 Identities = 71/222 (31%), Positives = 119/222 (53%), Gaps = 19/222 (8%)

Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQHRN 301
           NF    K+G+G +G VYK      GE +A+K  RL   ++        E+ LL  L H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY--KIIEGIARGLLY 358
           +V+LL       +  LV+EF+ +  L  F+   P++   +   K Y  ++++G+A    +
Sbjct: 61  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA----F 115

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
            H     R++HRDLK  N+L+++E   K++DFG+AR F +    + T+ VV T  Y APE
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPE 170

Query: 419 YVMHGRF-SVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDL 459
            ++  ++ S   DI+S G +  E+V+  +R+ F  + E + L
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQL 210

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 96.4 bits (240), Expect = 4e-22
 Identities = 63/206 (30%), Positives = 103/206 (50%), Gaps = 18/206 (8%)

Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNL 302
              +  K+G+G  G V      S G  +AVK++    +Q  E+ F NEV+++   QH N+
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF-NEVVIMRDYQHPNI 78

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           V +    L   E  +V EF+   +L     D +    M  E+   +   + + L +LH  
Sbjct: 79  VEMYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ 134

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFGYMAPEY 419
               +IHRD+K+ +ILL S+   K+SDFG        Q   +  R   +VGT  +MAPE 
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFGFC-----AQVSKEVPRRKSLVGTPYWMAPEV 186

Query: 420 VMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           +    +  + DI+S G++V+E+V G+
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 96.1 bits (239), Expect = 4e-22
 Identities = 69/204 (33%), Positives = 104/204 (50%), Gaps = 22/204 (10%)

Query: 252 LGQGGFGAV--YKGMLSN---GETIAVKRL-SKNSKQGEIEFKNEVLLLARLQHRNLVRL 305
           LG+G FG V  Y    +N   GE +AVK L  +  +Q    +K E+ +L  L H N+V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 306 LGFCLERKERI--LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            G C E+  +   L+ E+VP  SL     D + +  +   +     + I  G+ YLH   
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSL----RDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ- 126

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLF----EMDQTHSDTNRVVGTFGYMAPEY 419
               IHRDL A N+LLD++   KI DFG+A+      E  +   D +  V  F Y A E 
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV--FWY-AVEC 181

Query: 420 VMHGRFSVKSDIFSFGVLVLEIVS 443
           +   +FS  SD++SFGV + E+++
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 96.3 bits (240), Expect = 4e-22
 Identities = 66/219 (30%), Positives = 117/219 (53%), Gaps = 12/219 (5%)

Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHRN 301
           +++   K+G+G +G VYKG     G+ +A+K++   S++  +      E+ LL  LQH N
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +V L    ++     L++EF+ +  L  ++      ++M  E     +  I +G+L+ H 
Sbjct: 61  IVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH- 118

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM 421
               R++HRDLK  N+L+D++   K++DFG+AR F +      T+ VV T  Y APE ++
Sbjct: 119 --SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVV-TLWYRAPEVLL 174

Query: 422 HG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDL 459
              R+S   DI+S G +  E+ +  K+  F  + E + L
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMAT--KKPLFHGDSEIDQL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 95.4 bits (238), Expect = 5e-22
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 17/203 (8%)

Query: 250 NKLGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
            ++G G +G VYK   ++ GE +A+K +           + E+ +L   +H N+V   G 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 309 CLERKERILVYEFVPNASLD---HFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
            L R +  +V E+    SL         P++   + +  R  +     +GL YLHE    
Sbjct: 69  YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KGLAYLHE---T 120

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV---MH 422
             IHRD+K +NILL  + + K++DFG++   ++  T +     +GT  +MAPE       
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSA--QLTATIAKRKSFIGTPYWMAPEVAAVERK 178

Query: 423 GRFSVKSDIFSFGVLVLEIVSGQ 445
           G +  K DI++ G+  +E+   Q
Sbjct: 179 GGYDGKCDIWALGITAIELAELQ 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 95.2 bits (237), Expect = 6e-22
 Identities = 70/213 (32%), Positives = 108/213 (50%), Gaps = 29/213 (13%)

Query: 245 NFSDANKLGQGGFGAVYK-GMLSNGETIAVKR-----LSKNSKQGEIEFKNEVLLLARLQ 298
           +F    KLG+G +G+VYK   LS+ +  A+K      +S+  ++  +   NE+ +LA + 
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV---NEIRILASVN 57

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI------FDPINREHMTWEKRYKIIEGI 352
           H N++      L+  +  +V E+ P   L   I         I  E   W  R  I   +
Sbjct: 58  HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLI-PEQEIW--RIFI--QL 112

Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF 412
            RGL  LHE    +I+HRDLK++NILL +    KI D G++++       +     +GT 
Sbjct: 113 LRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTP 165

Query: 413 GYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSG 444
            YMAPE V  GR +S KSDI+S G L+ E+ + 
Sbjct: 166 HYMAPE-VWKGRPYSYKSDIWSLGCLLYEMATF 197

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 95.8 bits (238), Expect = 7e-22
 Identities = 70/284 (24%), Positives = 127/284 (44%), Gaps = 38/284 (13%)

Query: 251 KLGQGGFGAV----------YKGMLSNGET-----IAVKRLSKN-SKQGEIEFKNEVLLL 294
           KLG+G FG V          + G  +         +AVK L  + +K    +F  E+ ++
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE---- 350
           +RL++ N++RLLG C+      ++ E++ N  L+ F+         T       +     
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131

Query: 351 -----GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
                 IA G+ YL   + L  +HRDL   N L+ +    KI+DFGM+R       +   
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188

Query: 406 NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFG--TEEETEDLLTYA 463
            R V    +MA E ++ G+F+  SD+++FGV + E+ +  K   +   ++E+  +     
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEF 248

Query: 464 WRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRP 507
           +R  N+G  + L    +      ++M      + C   ++ +RP
Sbjct: 249 FR--NQGRQIYLSQTPLCPSPVFKLM------MRCWSRDIKDRP 284

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 95.5 bits (238), Expect = 8e-22
 Identities = 73/217 (33%), Positives = 112/217 (51%), Gaps = 21/217 (9%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           K+G+G +G VYK      GE +A+K  RL    +        E+ LL  L H N+VRLL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 308 FCLERKERILVYEFVP---NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                 +  LV+EF+       +D      ++   +     Y++++GIA    Y H  S 
Sbjct: 66  VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPP-LIKSYLYQLLQGIA----YCH--SH 118

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD-QTHSDTNRVVGTFGYMAPEYVMHG 423
            R++HRDLK  N+L+D E   K++DFG+AR F +  +T+  T+ VV T  Y APE ++  
Sbjct: 119 -RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY--THEVV-TLWYRAPEILLGS 174

Query: 424 R-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDL 459
           R +S   DI+S G +  E+V   +R  F  + E + L
Sbjct: 175 RQYSTPVDIWSIGCIFAEMV--NRRPLFPGDSEIDQL 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 94.6 bits (235), Expect = 9e-22
 Identities = 69/207 (33%), Positives = 113/207 (54%), Gaps = 22/207 (10%)

Query: 251 KLGQGGFGAVYKG---MLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRNLVRL 305
           +LG G FG V KG   M  + +T+AVK L  ++    +  E   E  ++ +L +  +VR+
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 306 LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
           +G C E +  +LV E      L+ F+    N+ H+T +   +++  ++ G+ YL E +  
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFLQK--NK-HVTEKNITELVHQVSMGMKYLEETN-- 115

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG-----YMAPEYV 420
             +HRDL A N+LL ++   KISDFG+++    D+ +        T G     + APE +
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK----THGKWPVKWYAPECM 170

Query: 421 MHGRFSVKSDIFSFGVLVLEIVS-GQK 446
            + +FS KSD++SFGVL+ E  S GQK
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 95.8 bits (239), Expect = 1e-21
 Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 34/216 (15%)

Query: 251 KLGQGGFGAVYKGMLSNGET---IAVKRLSKNSKQGE-IEFKN--EVLLLARLQHRNLVR 304
            +G+G +G VYK    NG+     A+K+   + +Q   I      E+ LL  L+H N+V 
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66

Query: 305 LLGFCLERKERI--LVYEFVPNASLD--HFIFDPINREHMTWEKRY-------KIIEGIA 353
           L+   LE  ++   L++++   A  D    I     + H   ++          ++  I 
Sbjct: 67  LVEVFLEHADKSVYLLFDY---AEHDLWQII-----KFHRQAKRVSIPPSMVKSLLWQIL 118

Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMARLF-EMDQTHSDTNRV 408
            G+ YLH +    ++HRDLK +NIL+  E       KI D G+ARLF    +  +D + V
Sbjct: 119 NGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175

Query: 409 VGTFGYMAPEYVMHGRFSVKS-DIFSFGVLVLEIVS 443
           V T  Y APE ++  R   K+ DI++ G +  E+++
Sbjct: 176 VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 95.5 bits (237), Expect = 1e-21
 Identities = 64/203 (31%), Positives = 106/203 (52%), Gaps = 19/203 (9%)

Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHRN 301
           F+D  ++G G FGAVY    +   E +A+K++S + KQ   ++++   EV  L R++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
            +   G  L      LV E+   ++ D      ++++ +   +   I  G  +GL YLH 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM 421
            +   +IHRD+KA NILL      K++DFG A +       S  N  VGT  +MAPE ++
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASIA------SPANSFVGTPYWMAPEVIL 194

Query: 422 ---HGRFSVKSDIFSFGVLVLEI 441
               G++  K D++S G+  +E+
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 95.7 bits (238), Expect = 2e-21
 Identities = 73/222 (32%), Positives = 109/222 (49%), Gaps = 28/222 (12%)

Query: 242 ATDNFSD---ANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQG-EIEFKNEVLLLAR 296
           A  + S+    N++G G  G VYK +    G   A+K +  N +     +   E+ +L  
Sbjct: 69  AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRD 128

Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLD--HFIFDPINREHMTWEKRYKIIEGIAR 354
           + H N+V+         E  ++ EF+   SL+  H     I  E    +   +I+ GIA 
Sbjct: 129 VNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIA- 182

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY 414
              YLH   R  I+HRD+K SN+L++S  N KI+DFG++R+  + QT    N  VGT  Y
Sbjct: 183 ---YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQTMDPCNSSVGTIAY 234

Query: 415 MAPEYV----MHGRFS-VKSDIFSFGVLVLEIVSGQKRSSFG 451
           M+PE +     HG +     DI+S GV +LE   G  R  FG
Sbjct: 235 MSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLG--RFPFG 274

Length = 353

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 94.3 bits (234), Expect = 3e-21
 Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 19/203 (9%)

Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHRN 301
           FSD  ++G G FGAVY    + N E +A+K++S + KQ   ++++   EV  L +L+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
            ++  G  L      LV E+   ++ D      ++++ +   +   +  G  +GL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM 421
            +   +IHRD+KA NILL      K+ DFG A +       +  N  VGT  +MAPE ++
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184

Query: 422 ---HGRFSVKSDIFSFGVLVLEI 441
               G++  K D++S G+  +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 93.9 bits (233), Expect = 3e-21
 Identities = 83/301 (27%), Positives = 137/301 (45%), Gaps = 47/301 (15%)

Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSN---GET---IAVKRLSKNSKQGE-IEFKNEVLL 293
           V+ +  +   +LGQG FG VY+G   +   GE    +AVK +++++   E IEF NE  +
Sbjct: 3   VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 62

Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIF-------DPINREHMTWEKRY 346
           +      ++VRLLG   + +  ++V E + +  L  ++        +   R   T ++  
Sbjct: 63  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 122

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
           ++   IA G+ YL+     + +HRDL A N ++  +   KI DFGM R    D   +D  
Sbjct: 123 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYY 175

Query: 407 RVVGT----FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTY 462
           R  G       +MAPE +  G F+  SD++SFGV++ EI S  ++   G   E       
Sbjct: 176 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------- 228

Query: 463 AWRNWNEGAALNLMDPTMRGGSTSEMMKC---IH-IGLLCVQENVSNRPGMASVVNMLNG 518
                       ++   M GG   +   C   +  +  +C Q N   RP    +VN+L  
Sbjct: 229 -----------QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277

Query: 519 D 519
           D
Sbjct: 278 D 278

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 94.0 bits (234), Expect = 3e-21
 Identities = 61/197 (30%), Positives = 103/197 (52%), Gaps = 25/197 (12%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKR-LSKNSKQG-EIEFKNEVLLLARLQHR 300
             +    K+GQG FG V+K       + +A+K+ L +N K+G  I    E+ +L  L+H 
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71

Query: 301 NLVRLLGFCLERKER--------ILVYEFVPNASLDHFIFDPINREH--MTWEKRYKIIE 350
           N+V L+  C  +            LV+EF      +H +   ++ ++   T  +  K+++
Sbjct: 72  NVVNLIEICRTKATPYNRYKGSFYLVFEFC-----EHDLAGLLSNKNVKFTLSEIKKVMK 126

Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF---EMDQTHSDTNR 407
            +  GL Y+H   R +I+HRD+KA+NIL+  +   K++DFG+AR F   +  + +  TNR
Sbjct: 127 MLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183

Query: 408 VVGTFGYMAPEYVMHGR 424
           VV T  Y  PE ++  R
Sbjct: 184 VV-TLWYRPPELLLGER 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 93.5 bits (232), Expect = 4e-21
 Identities = 61/220 (27%), Positives = 106/220 (48%), Gaps = 31/220 (14%)

Query: 252 LGQGGFGAVYKGM------LSNGETIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVR 304
           LG+G FG V K         +   T+AVK L +N+   E+ +  +E  LL ++ H ++++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 305 LLGFCLERKERILVYEFVPNASLDHFI---------------------FDPINREHMTWE 343
           L G C +    +L+ E+    SL  F+                      D  +   +T  
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 344 KRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
                   I+RG+ YL E   ++++HRDL A N+L+      KISDFG++R    + ++ 
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             ++      +MA E +    ++ +SD++SFGVL+ EIV+
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 93.2 bits (231), Expect = 4e-21
 Identities = 60/203 (29%), Positives = 108/203 (53%), Gaps = 13/203 (6%)

Query: 246 FSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLV 303
           F+   K+G+G FG V+KG+ +  +  +A+K +     + EIE  + E+ +L++     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 304 RLLGFCLERKERILVYEFVPNAS-LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           +  G  L+  +  ++ E++   S LD     P++   +       I+  I +GL YLH +
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLHSE 120

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH 422
            +   IHRD+KA+N+LL      K++DFG+A   ++  T    N  VGT  +MAPE +  
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQ 175

Query: 423 GRFSVKSDIFSFGVLVLEIVSGQ 445
             +  K+DI+S G+  +E+  G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 92.9 bits (231), Expect = 4e-21
 Identities = 66/205 (32%), Positives = 109/205 (53%), Gaps = 23/205 (11%)

Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  S+G+ I  AVK L++ +   E+E F  E +++    H N++ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 307 GFCLERK-ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG----IARGLLYLHE 361
           G CL  +   ++V  ++ +  L +FI    +   +      K + G    +A+G+ YL  
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV------KDLIGFGLQVAKGMEYLAS 116

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF---EMDQTHSDTNRVVGTFGYMAPE 418
               + +HRDL A N +LD     K++DFG+AR     E    H+ T        +MA E
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTG-AKLPVKWMALE 172

Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVS 443
            +   +F+ KSD++SFGVL+ E+++
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 97.6 bits (243), Expect = 4e-21
 Identities = 88/359 (24%), Positives = 162/359 (45%), Gaps = 50/359 (13%)

Query: 181 PPPRKKNHT----ILITVIVSVVASVILITGICIFLRVGKLKLEDENVE-ETIAKSLQFD 235
           PP ++   T      IT  +     + L+    +F+R G+  LE + VE E     LQF 
Sbjct: 617 PPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIR-GRNNLELKRVENEDGTWELQF- 674

Query: 236 FE-------TIRVATDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGEIEF 287
           F+       TI     +  + N + +G  GA YKG  + NG    VK ++  +     E 
Sbjct: 675 FDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEI 734

Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
            +    + +LQH N+V+L+G C   K   L++E++   +L   +       +++WE+R K
Sbjct: 735 AD----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL------RNLSWERRRK 784

Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           I  GIA+ L +LH      ++  +L    I++D +  P +    +  L   D     ++ 
Sbjct: 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS- 842

Query: 408 VVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRS--SFGTEEETEDLLTYAWR 465
                 Y+APE       + KSDI+ FG++++E+++G+  +   FG      +   Y + 
Sbjct: 843 -----AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYS 897

Query: 466 N-----WNEGAALNLMDPTMRGGSTS---EMMKCIHIGLLCVQENVSNRPGMASVVNML 516
           +     W        +DP++RG  +    E+++ +++ L C   + + RP    V+  L
Sbjct: 898 DCHLDMW--------IDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 93.2 bits (231), Expect = 4e-21
 Identities = 59/207 (28%), Positives = 112/207 (54%), Gaps = 13/207 (6%)

Query: 246 FSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLV 303
           F+   ++G+G FG V+KG+ +  + + A+K +     + EIE  + E+ +L++     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 304 RLLGFCLERKERILVYEFVPNAS-LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           +  G  L+  +  ++ E++   S LD     P +   +       +++ I +GL YLH +
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA-----TMLKEILKGLDYLHSE 120

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH 422
            +   IHRD+KA+N+LL  + + K++DFG+A   ++  T    N  VGT  +MAPE +  
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIQQ 175

Query: 423 GRFSVKSDIFSFGVLVLEIVSGQKRSS 449
             +  K+DI+S G+  +E+  G+  +S
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPNS 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 92.4 bits (230), Expect = 5e-21
 Identities = 74/264 (28%), Positives = 112/264 (42%), Gaps = 29/264 (10%)

Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIE-FKNEVLLLARLQHR 300
           +F     +G+G FG V         +  A+K ++K    ++G +    NE  +L  L H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 301 NLVRL-LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEK-RYKIIEGIARGLLY 358
            LV L   F  + +   LV + +    L + +     +   + E+ ++ I E I   L Y
Sbjct: 61  FLVNLWYSFQ-DEENMYLVVDLLLGGDLRYHL---SQKVKFSEEQVKFWICE-IVLALEY 115

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
           LH      IIHRD+K  NILLD + +  I+DF +A     D     T    GT GYMAPE
Sbjct: 116 LHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTPGYMAPE 169

Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVSGQ----KRSSFGTEEETEDLLTYA---WRNWNEGA 471
            +    +SV  D +S GV   E + G+      S    ++      T        W+  A
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEA 229

Query: 472 --ALNL---MDPTMRGGSTSEMMK 490
             A+N     DP  R G   + +K
Sbjct: 230 IDAINKLLERDPQKRLGDNLKDLK 253

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 92.3 bits (229), Expect = 6e-21
 Identities = 62/203 (30%), Positives = 107/203 (52%), Gaps = 14/203 (6%)

Query: 251 KLGQGGFGAVYKG---MLSNGETIAVKRL-SKNSKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +LG G FG V KG   M      +A+K L ++N K    E   E  ++ +L +  +VR++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G C E +  +LV E      L+ F+     ++ +T     +++  ++ G+ YL   +   
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN--- 115

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEYVMHGR 424
            +HRDL A N+LL ++   KISDFG+++    D ++    R  G +   + APE +   +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY-KARSAGKWPLKWYAPECINFRK 174

Query: 425 FSVKSDIFSFGVLVLEIVS-GQK 446
           FS +SD++S+G+ + E  S GQK
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 92.0 bits (228), Expect = 7e-21
 Identities = 61/196 (31%), Positives = 101/196 (51%), Gaps = 9/196 (4%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE--FKNEVLLLARLQHRNLVRLLGF 308
           ++G+G FG V+ G L    T    +  + +   +++  F  E  +L +  H N+VRL+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C +++   +V E V     D   F       +  ++  +++E  A G+ YL        I
Sbjct: 62  CTQKQPIYIVMELVQGG--DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116

Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-FGYMAPEYVMHGRFSV 427
           HRDL A N L+  +   KISDFGM+R  E D  ++ T  +      + APE + +GR+S 
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175

Query: 428 KSDIFSFGVLVLEIVS 443
           +SD++SFG+L+ E  S
Sbjct: 176 ESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 92.2 bits (229), Expect = 1e-20
 Identities = 63/211 (29%), Positives = 114/211 (54%), Gaps = 25/211 (11%)

Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNL 302
           NF    KLG+G +  VYKG   + GE +A+K +  ++++G       E+ L+  L+H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFI--------FDPINREHMTWEKRYKIIEGIAR 354
           VRL        + +LV+E++    L  ++         DP   +  T++        + +
Sbjct: 61  VRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQ--------LLK 111

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY 414
           G+ + HE+   R++HRDLK  N+L++     K++DFG+AR F +   ++ +N VV T  Y
Sbjct: 112 GIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGI-PVNTFSNEVV-TLWY 166

Query: 415 MAPEYVMHGR-FSVKSDIFSFGVLVLEIVSG 444
            AP+ ++  R +S   DI+S G ++ E+++G
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITG 197

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 92.2 bits (229), Expect = 1e-20
 Identities = 76/230 (33%), Positives = 120/230 (52%), Gaps = 32/230 (13%)

Query: 244 DNFSDANKLGQGGFGAVYKGM--LSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQH 299
           D +    K+G+G +G VYK    ++N ETIA+K  RL +  +        E+ LL  +QH
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTN-ETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60

Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM----TWEKRYKIIEG---- 351
            N+VRL       K   LV+E++    LD        ++HM     + K  ++I+     
Sbjct: 61  GNIVRLQDVVHSEKRLYLVFEYL---DLDL-------KKHMDSSPDFAKNPRLIKTYLYQ 110

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVVG 410
           I RG+ Y H     R++HRDLK  N+L+D   N  K++DFG+AR F +    + T+ VV 
Sbjct: 111 ILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVV- 165

Query: 411 TFGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDL 459
           T  Y APE ++  R +S   DI+S G +  E+V+  ++  F  + E ++L
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN--QKPLFPGDSEIDEL 213

Length = 294

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 92.4 bits (229), Expect = 2e-20
 Identities = 65/203 (32%), Positives = 106/203 (52%), Gaps = 19/203 (9%)

Query: 246 FSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHRN 301
           F   +++G G FGAVY    S+  E +AVK++S + KQ   ++++   EV  L +L+H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
            +   G  L+     LV E+   ++ D      ++++ +   +   I  G  +GL YLH 
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 139

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM 421
            +   +IHRD+KA NILL      K++DFG A         S  N  VGT  +MAPE ++
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASK------SSPANSFVGTPYWMAPEVIL 190

Query: 422 ---HGRFSVKSDIFSFGVLVLEI 441
               G++  K D++S G+  +E+
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 92.1 bits (229), Expect = 2e-20
 Identities = 70/237 (29%), Positives = 123/237 (51%), Gaps = 37/237 (15%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLS-KNSKQG-EIEFKNEVLLLARLQHR 300
           D F    ++G+G +G VYK    + GE +A+K++   N K+G  I    E+ +L +L HR
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66

Query: 301 NLVRL----------LGFCLERKERILVYEFVPN-------ASLDHFIFDPINREHMTWE 343
           N+V L          L F  ++    LV+E++ +       + L HF     + +H+   
Sbjct: 67  NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHF-----SEDHIK-- 119

Query: 344 KRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
                ++ +  GL Y H+ + L   HRD+K SNILL+++   K++DFG+ARL+  +++  
Sbjct: 120 ---SFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173

Query: 404 DTNRVVGTFGYMAPEYVM-HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDL 459
            TN+V+ T  Y  PE ++   R+    D++S G ++ E+ +  K+  F   +E   L
Sbjct: 174 YTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT--KKPIFQANQELAQL 227

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 67/216 (31%), Positives = 113/216 (52%), Gaps = 37/216 (17%)

Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQG-EIEFKNEVLLLARLQ---H 299
           + +  ++G+G +G VYK   L+ G  +A+K++    S++G  +    E+ LL +L+   H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 300 RNLVRLLGFC----LERKERI-LVYEFVPNASLDHFI-------FDPINREHMTWEKRYK 347
            N+VRLL  C     +R+ ++ LV+E V +  L  ++         P   + +  +    
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQ---- 115

Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL--FEMDQTHSDT 405
               + RG+ +LH     RI+HRDLK  NIL+ S+   KI+DFG+AR+  FEM  T    
Sbjct: 116 ----LLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALT---- 164

Query: 406 NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEI 441
             VV T  Y APE ++   ++   D++S G +  E+
Sbjct: 165 -SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 91.5 bits (227), Expect = 2e-20
 Identities = 59/201 (29%), Positives = 106/201 (52%), Gaps = 10/201 (4%)

Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           ++   K+GQG  G VY  + ++ G+ +A+K+++   +  +    NE+L++   +H N+V 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
            L   L   E  +V E++   SL     D +    M   +   +     + L +LH +  
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 134

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
            ++IHRD+K+ NILL  + + K++DFG       +Q+   T  +VGT  +MAPE V    
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 191

Query: 425 FSVKSDIFSFGVLVLEIVSGQ 445
           +  K DI+S G++ +E+V G+
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 91.5 bits (227), Expect = 2e-20
 Identities = 69/244 (28%), Positives = 116/244 (47%), Gaps = 39/244 (15%)

Query: 251 KLGQGGFGAVYKGMLSNGET-----------------IAVKRLSKN-SKQGEIEFKNEVL 292
           KLG+G FG V+   + N +                  +AVK L  + +K    +F  EV 
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI------------FDPINREH- 339
           +L+RL+  N++RLLG C++     ++ E++ N  L+ F+             D +   H 
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131

Query: 340 ---MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
              +++     +   IA G+ YL   S L  +HRDL   N L+   +  KI+DFGM+R  
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188

Query: 397 EMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFG--TEE 454
                +    R V    +MA E ++ G+F+  SD+++FGV + EI+   K   +G  T+E
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE 248

Query: 455 ETED 458
           +  +
Sbjct: 249 QVIE 252

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 91.0 bits (226), Expect = 2e-20
 Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 17/207 (8%)

Query: 243 TDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN 301
            D +    +LG G FG VYK      G   A K +   S++   +F  E+ +L+  +H N
Sbjct: 4   NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63

Query: 302 LVRLL-GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
           +V L   +  E K  IL+ EF    +LD  I   + R     + RY +   +   L +LH
Sbjct: 64  IVGLYEAYFYENKLWILI-EFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLH 120

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGM-ARLFEMDQTHSDTNRVVGTFGYMAPEY 419
                ++IHRDLKA NILL  + + K++DFG+ A+     Q        +GT  +MAPE 
Sbjct: 121 SH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEV 174

Query: 420 VMHGRFS-----VKSDIFSFGVLVLEI 441
           V    F       K+DI+S G+ ++E+
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 90.8 bits (226), Expect = 3e-20
 Identities = 63/223 (28%), Positives = 100/223 (44%), Gaps = 30/223 (13%)

Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QH 299
            T  F     +G+G +G VYK      G+ +A+K +    +  E E K E  +L +   H
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIM-DIIEDEEEEIKEEYNILRKYSNH 62

Query: 300 RNLVRLLGFCLERKERI------LVYEFVPNASLDHFIFDPINREHMTWEKRYK------ 347
            N+    G  +++          LV E     S    + D +        KR K      
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGS----VTDLVKGLRKK-GKRLKEEWIAY 117

Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           I+    RGL YLHE+   ++IHRD+K  NILL      K+ DFG++   ++D T    N 
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNT 172

Query: 408 VVGTFGYMAPEYVM-----HGRFSVKSDIFSFGVLVLEIVSGQ 445
            +GT  +MAPE +         +  +SD++S G+  +E+  G+
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 89.1 bits (221), Expect = 1e-19
 Identities = 64/200 (32%), Positives = 104/200 (52%), Gaps = 19/200 (9%)

Query: 252 LGQGGFGAVYK-GMLSNGETIAVKRL---SKNSKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           LG G  G+V K   +  G  +A K +   +K+S + +I    E+ ++   +   +V   G
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQI--LRELQIMHECRSPYIVSFYG 70

Query: 308 FCLERKERILVYEFVPNASLDHFI--FDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
             L      +  EF+   SLD       PI  E +      KI   +  GL YL+     
Sbjct: 71  AFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLYN--VH 123

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRF 425
           RI+HRD+K SNIL++S    K+ DFG++   E+  + +DT   VGT  YM+PE +  G++
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSG--ELINSIADT--FVGTSTYMSPERIQGGKY 179

Query: 426 SVKSDIFSFGVLVLEIVSGQ 445
           +VKSD++S G+ ++E+  G+
Sbjct: 180 TVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 89.3 bits (221), Expect = 1e-19
 Identities = 68/215 (31%), Positives = 108/215 (50%), Gaps = 34/215 (15%)

Query: 252 LGQGGFGAVYKGMLS---NGETIAVKRLSK-NSKQGEIEFKNEVLLLARL-QHRNLVRLL 306
           +G+G FG V + M+         A+K L +  S+    +F  E+ +L +L  H N++ LL
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 307 GFCLERKERILVYEFVPNASLDHFI-------FDP-INREH-----MTWEKRYKIIEGIA 353
           G C  R    +  E+ P  +L  F+        DP   +EH     +T ++  +    +A
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129

Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
            G+ YL E    + IHRDL A N+L+   +  KI+DFG++R  E+         V  T G
Sbjct: 130 TGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEV--------YVKKTMG 178

Query: 414 -----YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
                +MA E + +  ++ KSD++SFGVL+ EIVS
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 88.6 bits (219), Expect = 1e-19
 Identities = 78/291 (26%), Positives = 136/291 (46%), Gaps = 37/291 (12%)

Query: 241 VATDNFSDANKLGQGGFGAVYKGMLS-----NGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           VA +  + + +LGQG FG VY+G+         ET +A+K +++ +   E IEF NE  +
Sbjct: 3   VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 62

Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM-------TWEKRY 346
           +      ++VRLLG   + +  +++ E +    L  ++                + +K  
Sbjct: 63  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSDT 405
           ++   IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R ++E D      
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179

Query: 406 NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWR 465
             ++    +M+PE +  G F+  SD++SFGV++ EI +  ++   G   E         R
Sbjct: 180 KGLL-PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ------VLR 232

Query: 466 NWNEGAALNLMD--PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN 514
              EG  L+  D  P M      E+M+      +C Q N   RP    +++
Sbjct: 233 FVMEGGLLDKPDNCPDM----LFELMR------MCWQYNPKMRPSFLEIIS 273

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 88.6 bits (219), Expect = 2e-19
 Identities = 57/201 (28%), Positives = 107/201 (53%), Gaps = 10/201 (4%)

Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           ++   K+GQG  G V+  + ++ G+ +A+K+++   +  +    NE+L++  L++ N+V 
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
            L   L   E  +V E++   SL     D +    M   +   +     + L +LH +  
Sbjct: 81  FLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQALEFLHAN-- 134

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
            ++IHRD+K+ N+LL  + + K++DFG       +Q+   T  +VGT  +MAPE V    
Sbjct: 135 -QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 191

Query: 425 FSVKSDIFSFGVLVLEIVSGQ 445
           +  K DI+S G++ +E+V G+
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 32/211 (15%)

Query: 252 LGQGGFGAVY---KGMLSNGETIAVKRLSKNSKQGEIEF---KNEVLLLARLQHRNLVRL 305
           + +G +G V+   K   S G+  A+K + K     + +      E  +L++ Q   +V+L
Sbjct: 1   ISKGAYGRVFLAKKK--STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 306 LGFCLERKERI-LVYEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIARGLLYL 359
             +  + K+ + LV E++P   L   +      D    E +    R  I E I   L YL
Sbjct: 59  Y-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLD----EDVA---RIYIAE-IVLALEYL 109

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFG------MARLFEMDQTHSDTNRVVGTFG 413
           H      IIHRDLK  NIL+DS  + K++DFG      + R   ++    +  R+VGT  
Sbjct: 110 H---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166

Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           Y+APE ++    S   D +S G ++ E + G
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 88.2 bits (218), Expect = 2e-19
 Identities = 76/229 (33%), Positives = 110/229 (48%), Gaps = 27/229 (11%)

Query: 246 FSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRN 301
           F     LG+GGFG V    + + G+  A K+L K     ++GE    NE  +L ++  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 302 LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTW----EKRYKIIEG-IARG 355
           +V L  +  E K+ + LV   +    L   I+      HM      E R       I  G
Sbjct: 62  VVSL-AYAYETKDALCLVLTLMNGGDLKFHIY------HMGEAGFEEGRAVFYAAEICCG 114

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYM 415
           L  LH++   RI++RDLK  NILLD   + +ISD G+A      QT       VGT GYM
Sbjct: 115 LEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYM 168

Query: 416 APEYVMHGRFSVKSDIFSFGVLVLEIVSG----QKRSSFGTEEETEDLL 460
           APE V + R++   D ++ G L+ E+++G    Q+R      EE E L+
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV 217

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 87.3 bits (216), Expect = 3e-19
 Identities = 63/193 (32%), Positives = 102/193 (52%), Gaps = 13/193 (6%)

Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           +G+G FG V  G    G  +AVK + KN    +  F  E  ++ +L+H NLV+LLG  +E
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQ-AFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 312 RKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
            K  + +V E++   SL  ++     R  +  +   K    +   + YL  ++    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126

Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSD 430
           DL A N+L+  +   K+SDFG+ +  E   T  DT ++     + APE +   +FS KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK--EASSTQ-DTGKL--PVKWTAPEALREKKFSTKSD 181

Query: 431 IFSFGVLVLEIVS 443
           ++SFG+L+ EI S
Sbjct: 182 VWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 87.2 bits (217), Expect = 5e-19
 Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 25/203 (12%)

Query: 250 NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN-----EVLLLARLQHRNLV 303
            KLG+G +  VYK      G  +A+K++    ++   +  N     E+ LL  L+H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            LL     +    LV+EF+    L+  I D          K Y ++    RGL YLH   
Sbjct: 66  GLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLM--TLRGLEYLH--- 119

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLF-----EMDQTHSDTNRVVGTFGYMAPE 418
              I+HRDLK +N+L+ S+   K++DFG+AR F     +M      T++VV T  Y APE
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM------THQVV-TRWYRAPE 172

Query: 419 YVMHGR-FSVKSDIFSFGVLVLE 440
            +   R + V  D++S G +  E
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAE 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 87.4 bits (217), Expect = 6e-19
 Identities = 68/210 (32%), Positives = 113/210 (53%), Gaps = 20/210 (9%)

Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQG-EIEFKNEVLLLARLQHRN 301
            F   N++G+G +G VY+    ++GE +A+K++   N + G  I    E+ LL  L+H N
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 302 LVRLLGFCLERK-ERI-LVYEFVPN--ASLDHFIFDPINREHMTWEKRYK-IIEGIARGL 356
           +V L    + +  + I LV E+     ASL   +  P +      E + K ++  + RGL
Sbjct: 68  IVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFS------ESQVKCLMLQLLRGL 121

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            YLHE+    IIHRDLK SN+LL  +   KI+DFG+AR + +      T +VV T  Y A
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM-TPKVV-TLWYRA 176

Query: 417 PEYVMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           PE ++       + D+++ G ++ E+++ +
Sbjct: 177 PELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 87.1 bits (215), Expect = 7e-19
 Identities = 58/201 (28%), Positives = 106/201 (52%), Gaps = 10/201 (4%)

Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           ++   K+GQG  G VY  + ++ G+ +A+K+++   +  +    NE+L++   ++ N+V 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
            L   L   E  +V E++   SL     D +    M   +   +     + L +LH +  
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSN-- 134

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
            ++IHRD+K+ NILL  + + K++DFG       +Q+   T  +VGT  +MAPE V    
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 191

Query: 425 FSVKSDIFSFGVLVLEIVSGQ 445
           +  K DI+S G++ +E+V G+
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 87.3 bits (216), Expect = 7e-19
 Identities = 76/286 (26%), Positives = 132/286 (46%), Gaps = 41/286 (14%)

Query: 251 KLGQGGFGAVY----KGMLSNGET-------------IAVKRLSKNS-KQGEIEFKNEVL 292
           KLG+G FG V+    +GM    +              +AVK L +++ K    +F  E+ 
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIF------DPINREHMT--WEK 344
           +++RL+  N++RLL  C+      ++ E++ N  L+ F+            + +T  +  
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD 404
              +   IA G+ YL   S L  +HRDL   N L+      KI+DFGM+R       +  
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188

Query: 405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS---GQKRSSFGTEEETEDLLT 461
             R V    +M+ E ++ G+F+  SD+++FGV + EI++    Q  S    E+  E+   
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGE 248

Query: 462 YAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRP 507
           + +R  ++G  + L  P +   S  ++M      L C + N   RP
Sbjct: 249 F-FR--DQGRQVYLPKPALCPDSLYKLM------LSCWRRNAKERP 285

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 86.3 bits (214), Expect = 7e-19
 Identities = 65/291 (22%), Positives = 133/291 (45%), Gaps = 48/291 (16%)

Query: 236 FETIRVATDNFSDANKLGQGGFG-AVYKGMLSNGETIAVKR--LSKNSKQGEIEFKNEVL 292
           +  IRV          LG+G FG A       +   +  K   L++ S++   +  NE++
Sbjct: 2   YIPIRV----------LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIV 51

Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMT-WEKRYKI--I 349
           +L+ LQH N++      ++    ++  E+    +L    +D I R+    +E+   +  +
Sbjct: 52  ILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTL----YDKIVRQKGQLFEEEMVLWYL 107

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
             I   + Y+H+     I+HRD+K  NI L      K+ DFG++++   + + ++T  VV
Sbjct: 108 FQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VV 162

Query: 410 GTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWR---- 465
           GT  YM+PE     +++ KSDI++ G ++ E+++ ++  +F    +  + L    +    
Sbjct: 163 GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR--TF----DATNPLNLVVKIVQG 216

Query: 466 NWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNML 516
           N+                 +SE++  +H     +Q++   RP    V++  
Sbjct: 217 NYTPV----------VSVYSSELISLVH---SLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 87.0 bits (215), Expect = 8e-19
 Identities = 66/200 (33%), Positives = 111/200 (55%), Gaps = 19/200 (9%)

Query: 251 KLGQGGFGAVYKGMLSNGET--IAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLLG 307
           +LG G FG VYK    N ET  +A  ++ +   + E+E +  E+ +LA   H  +V+LLG
Sbjct: 19  ELGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLG 76

Query: 308 -FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
            F  + K  I++ EF P  ++D  + + ++R  +T  +   I   +   L YLH    ++
Sbjct: 77  AFYWDGKLWIMI-EFCPGGAVDAIMLE-LDR-GLTEPQIQVICRQMLEALQYLHS---MK 130

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM----- 421
           IIHRDLKA N+LL  + + K++DFG++   +  +T    +  +GT  +MAPE VM     
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSA--KNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188

Query: 422 HGRFSVKSDIFSFGVLVLEI 441
              +  K+DI+S G+ ++E+
Sbjct: 189 DTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 86.4 bits (215), Expect = 8e-19
 Identities = 72/257 (28%), Positives = 117/257 (45%), Gaps = 31/257 (12%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSK--NSKQGEIEFKNEVLLLARLQ-HRNLVRLL 306
           +LG G FG+VY       GE +A+K++ K   S +  +  + EV  L +L  H N+V+L 
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR-EVKSLRKLNEHPNIVKLK 64

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTW-EKRYK-IIEGIARGLLYLHEDSR 364
               E  E   V+E++   +L   + D   R+   + E   + II  I +GL ++H   +
Sbjct: 65  EVFRENDELYFVFEYM-EGNLYQLMKD---RKGKPFSESVIRSIIYQILQGLAHIH---K 117

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
               HRDLK  N+L+      KI+DFG+AR       ++D    V T  Y APE ++   
Sbjct: 118 HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD---YVSTRWYRAPEILLRST 174

Query: 425 F-SVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL-------TYAWRNWNEG----AA 472
             S   DI++ G ++ E+ +   R  F    E + L        T   ++W EG    + 
Sbjct: 175 SYSSPVDIWALGCIMAELYTL--RPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232

Query: 473 LNLMDPTMRGGSTSEMM 489
           L    P     S  +++
Sbjct: 233 LGFRFPQFAPTSLHQLI 249

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 86.8 bits (215), Expect = 8e-19
 Identities = 68/214 (31%), Positives = 105/214 (49%), Gaps = 24/214 (11%)

Query: 244 DNFSDANKLGQGGFGAVYKGM---LSNGE---TIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
           +N S    LG G FG V +     LS  +    +AVK L   +   E E   +E+ +++ 
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM-TWEKRYKIIEGIAR 354
           L  H N+V LLG C      +++ E+     L +F+     RE   T E        +A+
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRR--KRESFLTLEDLLSFSYQVAK 152

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV--GTF 412
           G+ +L   +    IHRDL A N+LL      KI DFG+AR    D  + D+N VV     
Sbjct: 153 GMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR----DIMN-DSNYVVKGNAR 204

Query: 413 ---GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
               +MAPE + +  ++ +SD++S+G+L+ EI S
Sbjct: 205 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 86.0 bits (213), Expect = 9e-19
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 19/208 (9%)

Query: 252 LGQGGFGAVYKGMLSNG--ETIAVKRLS-------KNSKQGEIEFKNEV----LLLARLQ 298
           LG G FG VYK    N     +A+K ++       K+ ++ +    + V    ++  +L+
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLL 357
           H N+VR     LE     +V + +  A L +HF      ++  T E+ + I   +   L 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 358 YLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAP 417
           YLH++ R  I+HRDL  +NI+L  +    I+DFG+A+     Q  S    VVGT  Y  P
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILYSCP 182

Query: 418 EYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           E V +  +  K+D+++FG ++ ++ + Q
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCTLQ 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 19/203 (9%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFK---NEVLLLARLQHRNLVRLL 306
            +G+G +G V K    + GE +A+K+  K S+  E   K    EV +L +L+H N+V L 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
                +    LV+E+V    L+       +   +  +     I  + + + Y H      
Sbjct: 67  EAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAYCH---SHN 120

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE----YVMH 422
           IIHRD+K  NIL+      K+ DFG AR          T+ V  T  Y APE       +
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELLVGDTNY 179

Query: 423 GRFSVKSDIFSFGVLVLEIVSGQ 445
           G   V  D+++ G ++ E++ G+
Sbjct: 180 G-KPV--DVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 86.3 bits (213), Expect = 1e-18
 Identities = 57/201 (28%), Positives = 106/201 (52%), Gaps = 10/201 (4%)

Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           ++   K+GQG  G VY  M ++ G+ +A+++++   +  +    NE+L++   ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
            L   L   E  +V E++   SL     D +    M   +   +     + L +LH +  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
            ++IHRD+K+ NILL  + + K++DFG       +Q  S  + +VGT  +MAPE V    
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKA 192

Query: 425 FSVKSDIFSFGVLVLEIVSGQ 445
           +  K DI+S G++ +E++ G+
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 78/295 (26%), Positives = 127/295 (43%), Gaps = 54/295 (18%)

Query: 252 LGQGGFGAVYKGML------SNGETIAVKRLSKNSKQGE-IEFKNEVLLLARL-QHRNLV 303
           LG+G FG V K         +   T+AVK L  ++ + +  +  +E+ ++  + +H+N++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE------------- 350
            LLG C +     +V E+  + +L  F+     R    +                     
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRDFLRA--RRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 351 --GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV 408
              +ARG+ +L   S+ + IHRDL A N+L+  +   KI+DFG+AR    D  H D  R 
Sbjct: 138 AYQVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYYRK 190

Query: 409 VGT----FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS--GQKRSSFGTEEETEDLLTY 462
                    +MAPE +    ++ +SD++SFGVL+ EI +  G         EE   LL  
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-EELFKLLKE 249

Query: 463 AWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
            +R          M+       T E+    H+   C  E  S RP    +V  L+
Sbjct: 250 GYR----------MEKPQN--CTQELY---HLMRDCWHEVPSQRPTFKQLVEDLD 289

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 86.8 bits (216), Expect = 1e-18
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 47/218 (21%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---------EVLLLARLQHRN 301
           +G G +G V   +    G  +A+K++S         F +         E+ LL  L+H N
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60

Query: 302 LVRLL---------GFCLERKERILVYEFVPNASLDHFIF---DPINREHMTWEKRYKII 349
           ++ LL          F     +  +V E +    L H +     P+  +H+    +Y  +
Sbjct: 61  IIGLLDILRPPSPEDF----NDVYIVTELME-TDL-HKVIKSPQPLTDDHI----QY-FL 109

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD--TNR 407
             I RGL YLH  +   +IHRDLK SNIL++S  + KI DFG+AR  + D+      T  
Sbjct: 110 YQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166

Query: 408 VVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSG 444
           VV T  Y APE ++   R++   DI+S G +  E+++ 
Sbjct: 167 VV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 69/215 (32%), Positives = 107/215 (49%), Gaps = 34/215 (15%)

Query: 252 LGQGGFGAVYKGML-SNGETI--AVKRLSK-NSKQGEIEFKNEVLLLARL-QHRNLVRLL 306
           +G+G FG V K  +  +G  +  A+KR+ +  SK    +F  E+ +L +L  H N++ LL
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 307 GFCLERKERILVYEFVPNASLDHFI-----------FDPINREHMTW--EKRYKIIEGIA 353
           G C  R    L  E+ P+ +L  F+           F   N    T   ++       +A
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
           RG+ YL   S+ + IHRDL A NIL+      KI+DFG++R  E+         V  T G
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--------YVKKTMG 183

Query: 414 -----YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
                +MA E + +  ++  SD++S+GVL+ EIVS
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 85.5 bits (211), Expect = 2e-18
 Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 13/207 (6%)

Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           R   +N+    K+G+G  G V       +G  +AVK +    +Q      NEV+++   Q
Sbjct: 20  RSLLENYI---KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ 76

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H+N+V +    L  +E  ++ EF+   +L     D +++  +  E+   + E + + L Y
Sbjct: 77  HQNVVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCY 132

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
           LH      +IHRD+K+ +ILL  +   K+SDFG       D     +  +VGT  +MAPE
Sbjct: 133 LHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPE 187

Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
            +    +  + DI+S G++V+E+V G+
Sbjct: 188 VISRTPYGTEVDIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 84.9 bits (210), Expect = 2e-18
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 27/215 (12%)

Query: 236 FETIRVATDNFSDANKLGQGGFGAVY--KGMLSNGETI----AVKRLSKNSKQGEIEFKN 289
           +E IRV          +G+G FG V+  +        I     V++++K+ +      +N
Sbjct: 2   YEKIRV----------VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAA---QN 48

Query: 290 EVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
           E  +L  L H N++      LE K  ++V E+ P  +L  +I        +  E    I+
Sbjct: 49  ECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQK--RCNSLLDED--TIL 104

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDS-EMNPKISDFGMARLFEMDQTHSDTNRV 408
               + LL LH      I+HRDLK  NILLD  +M  KI DFG++++     + S    V
Sbjct: 105 HFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSKAYTV 161

Query: 409 VGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           VGT  Y++PE      ++ KSDI++ G ++ E+ S
Sbjct: 162 VGTPCYISPELCEGKPYNQKSDIWALGCVLYELAS 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 86.3 bits (214), Expect = 2e-18
 Identities = 71/262 (27%), Positives = 119/262 (45%), Gaps = 35/262 (13%)

Query: 251 KLGQGGFGAVYKGMLSN-GETIAVKRLSKNS--KQGEI-EFKNEVLLLARLQHRNLVRLL 306
           ++GQGG+G V+     + GE +A+KR+ K+   K  E+     E  +L   +   LV+LL
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67

Query: 307 GFCLERKERI-LVYEFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDSR 364
            +  +  E + L  E+VP       + +  +  E      R+ + E     +  LH    
Sbjct: 68  -YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED---HARFYMAEMFE-AVDALH---E 119

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
           L  IHRDLK  N L+D+  + K++DFG+++        +  N VVG+  YMAPE +    
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPEVLRGKG 174

Query: 425 FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET-EDLL----TYAWRNWNE-GAALN---- 474
           +    D +S G ++ E + G    S  T  ET E+L     T     +++    L+    
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234

Query: 475 ------LMDPTMRGGSTSEMMK 490
                 + DP+ R GS  ++  
Sbjct: 235 DLITKLINDPSRRFGSLEDIKN 256

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 85.5 bits (211), Expect = 2e-18
 Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 13/207 (6%)

Query: 240 RVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           R   DNF    K+G+G  G V    + S+G+ +AVK++    +Q      NEV+++   Q
Sbjct: 19  RTYLDNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ 75

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H N+V +    L   E  +V EF+   +L     D +    M  E+   +   + + L  
Sbjct: 76  HENVVEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSV 131

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
           LH      +IHRD+K+ +ILL  +   K+SDFG     ++ +       +VGT  +MAPE
Sbjct: 132 LHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPE 186

Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
            +    +  + DI+S G++V+E+V G+
Sbjct: 187 LISRLPYGPEVDIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 85.1 bits (210), Expect = 3e-18
 Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 13/207 (6%)

Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           R   D+F    K+G+G  G V      + G+ +AVK++    +Q      NEV+++    
Sbjct: 21  REYLDSFI---KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH 77

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H N+V +    L   E  +V EF+   +L     D +    M  E+   +   + R L Y
Sbjct: 78  HENVVDMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSY 133

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
           LH      +IHRD+K+ +ILL S+   K+SDFG     ++ +       +VGT  +MAPE
Sbjct: 134 LHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKSLVGTPYWMAPE 188

Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
            +    +  + DI+S G++V+E++ G+
Sbjct: 189 VISRLPYGTEVDIWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 84.7 bits (209), Expect = 3e-18
 Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 17/202 (8%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-----FKNEVLLLARLQHRNLVRL 305
           LGQG FG VY       G  +AVK++  + +  E        + E+ LL  L H  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 306 LGFCLERKERIL--VYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
            G   +  ER L    E +P  S+ D         E++T +   +I+EG+     YLH +
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGV----SYLHSN 125

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMA-RLFEMDQTHSDTNRVVGTFGYMAPEYVM 421
               I+HRD+K +NIL DS  N K+ DFG + RL  +  + +    V GT  +M+PE + 
Sbjct: 126 ---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182

Query: 422 HGRFSVKSDIFSFGVLVLEIVS 443
              +  K+DI+S G  V+E+++
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 84.7 bits (209), Expect = 3e-18
 Identities = 58/209 (27%), Positives = 107/209 (51%), Gaps = 16/209 (7%)

Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKR------LSKNSKQGEIEFKNEVLLLARL 297
           NF    K+G+G F  VY+   L + + +A+K+      +   ++Q  ++   E+ LL +L
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK---EIDLLKQL 59

Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR-YKIIEGIARGL 356
            H N+++ L   +E  E  +V E      L   I     ++ +  E+  +K    +   +
Sbjct: 60  NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            ++H  SR R++HRD+K +N+ + +    K+ D G+ R F    T + +  +VGT  YM+
Sbjct: 120 EHMH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMS 174

Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           PE +    ++ KSDI+S G L+ E+ + Q
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQ 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 84.4 bits (208), Expect = 3e-18
 Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 34/215 (15%)

Query: 252 LGQGGFGAVYKGMLSNG---ETIAVKRLSKNSKQGE-IEFKNEVLLLARL-QHRNLVRLL 306
           +G+G FG V K  +         A+KR+ + + + +  +F  E+ +L +L  H N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 307 GFCLERKERILVYEFVPNASLDHFI-------FDP-INREH-----MTWEKRYKIIEGIA 353
           G C  R    L  E+ P+ +L  F+        DP     +     ++ ++       +A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
           RG+ YL +    + IHRDL A NIL+      KI+DFG++R  E+         V  T G
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEV--------YVKKTMG 171

Query: 414 -----YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
                +MA E + +  ++  SD++S+GVL+ EIVS
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 84.4 bits (209), Expect = 4e-18
 Identities = 60/206 (29%), Positives = 108/206 (52%), Gaps = 23/206 (11%)

Query: 254 QGGFGAVYKGML-----SNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLLG 307
           +G FG ++ G+L        E + VK +  ++ + ++     E  LL  L H+N++ +L 
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 308 FCLERKERILV-YEFVPNASLDHFIFD----PINREH-MTWEKRYKIIEGIARGLLYLHE 361
            C+E  E   V Y ++   +L  F+        N    ++ ++   +   IA G+ YLH 
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHS---DTNRVVGTFGYMAP 417
             +  +IH+D+ A N ++D E+  KI+D  ++R LF MD  H    + NR V    +MA 
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDY-HCLGDNENRPV---KWMAL 188

Query: 418 EYVMHGRFSVKSDIFSFGVLVLEIVS 443
           E +++  +S  SD++SFGVL+ E+++
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 84.0 bits (207), Expect = 5e-18
 Identities = 64/202 (31%), Positives = 105/202 (51%), Gaps = 17/202 (8%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-----FKNEVLLLARLQHRNLVRL 305
           LGQG FG VY    +  G  +A K++  + +  E        + E+ LL  LQH  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 306 LGFCLERKERILV--YEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
            G   +R E+ L    E++P  S+ D         E +T +   +I+EG++    YLH +
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMS----YLHSN 125

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMA-RLFEMDQTHSDTNRVVGTFGYMAPEYVM 421
               I+HRD+K +NIL DS  N K+ DFG + RL  +  + +    V GT  +M+PE + 
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182

Query: 422 HGRFSVKSDIFSFGVLVLEIVS 443
              +  K+D++S G  V+E+++
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 84.6 bits (209), Expect = 5e-18
 Identities = 63/202 (31%), Positives = 103/202 (50%), Gaps = 19/202 (9%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQ---HRNLVR 304
           ++G G +G VYK     +G  +A+K  R+  N     +    EV LL RL+   H N+VR
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 305 LLGFC----LERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           L+  C     +R+ ++ LV+E V +  L  ++ D +    +  E    ++    RGL +L
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H +    I+HRDLK  NIL+ S    K++DFG+AR++           VV T  Y APE 
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEV 178

Query: 420 VMHGRFSVKSDIFSFGVLVLEI 441
           ++   ++   D++S G +  E+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 83.9 bits (207), Expect = 7e-18
 Identities = 62/199 (31%), Positives = 104/199 (52%), Gaps = 17/199 (8%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLL-GF 308
           +LG G FG VYK        +A  ++     + E+E +  E+ +LA   H N+V+LL  F
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII-EGIARGLLYLHEDSRLRI 367
             E    IL+ EF    ++D  + +    E    E + +++ +     L YLHE+   +I
Sbjct: 72  YYENNLWILI-EFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KI 124

Query: 368 IHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM-----H 422
           IHRDLKA NIL   + + K++DFG++   +  +T    +  +GT  +MAPE VM      
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182

Query: 423 GRFSVKSDIFSFGVLVLEI 441
             +  K+D++S G+ ++E+
Sbjct: 183 RPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 83.1 bits (206), Expect = 9e-18
 Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 26/220 (11%)

Query: 252 LGQGGFGAVYKGML-SNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           LG GGFG V    + S   T A+K + K        +    +E  +L    H  +V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHM-TWEKRYKIIEGIARGLLYLHEDSRLR 366
              ++K   ++ E+     L   + D   R     +  R+  I  +     YLH      
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRD---RGLFDEYTARF-YIACVVLAFEYLH---NRG 113

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSDTNRVVGTFGYMAPEYVM---H 422
           II+RDLK  N+LLDS    K+ DFG A+ L    +T +      GT  Y+APE ++   +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT----FCGTPEYVAPEIILNKGY 169

Query: 423 GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTY 462
                  D +S G+L+ E+++G  R  FG E++ + +  Y
Sbjct: 170 DFS---VDYWSLGILLYELLTG--RPPFG-EDDEDPMEIY 203

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 83.0 bits (205), Expect = 9e-18
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 22/208 (10%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIA---VKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRL 305
           +++G G FG V  G    G + A   VK L  ++    ++ F  EV     L H N+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 306 LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE----GIARGLLYLHE 361
           LG C+E    +LV EF P   L +++    NR  +    +  +++     +A GLL+LH 
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRS--NRGMVAQMAQKDVLQRMACEVASGLLWLH- 117

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMA-RLFEMDQTHSDTNRVVGTFGYMAPEYV 420
             +   IH DL   N  L ++++ KI D+G+A   +  D   +     V    ++APE V
Sbjct: 118 --QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELV 174

Query: 421 --MHGRFSV-----KSDIFSFGVLVLEI 441
                         KS+I+S GV + E+
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 83.0 bits (205), Expect = 1e-17
 Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 17/204 (8%)

Query: 252 LGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           LG G FG + +G L   S  E  +A+  L    S +    F  E L L +  H N+VRL 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREH---MTWEKRYKIIEGIARGLLYLHEDS 363
           G        ++V E++ N +LD F+     R+H   +   +   ++ G+A G+ YL E  
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFL-----RKHEGQLVAGQLMGMLPGLASGMKYLSE-- 125

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
            +  +H+ L A  +L++S++  KIS F   +  + +  ++ T        + APE + + 
Sbjct: 126 -MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYT-TMSGKSPVLWAAPEAIQYH 183

Query: 424 RFSVKSDIFSFGVLVLEIVSGQKR 447
            FS  SD++SFG+++ E++S  +R
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 67/206 (32%), Positives = 108/206 (52%), Gaps = 26/206 (12%)

Query: 251 KLGQGGFGAVYKGMLSN-GETIAVKRL--SKNSKQ-GEIEFKNEVLLLARLQHRNLVRLL 306
            +G+G +G V K      G+ +A+K+   S++ K   +I  + E+ +L +L+H NLV L+
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHENLVNLI 66

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINR-EHMTWEKRY-KIIEGIARGLLYLHEDSR 364
                +K   LV+EFV     DH + D + +  +   E R  K +  I RG+ + H  + 
Sbjct: 67  EVFRRKKRLYLVFEFV-----DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN- 120

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSDTNRVVGTFGYMAPEYVM-- 421
             IIHRD+K  NIL+      K+ DFG AR L    + ++D    V T  Y APE ++  
Sbjct: 121 --IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD---YVATRWYRAPELLVGD 175

Query: 422 --HGRFSVKSDIFSFGVLVLEIVSGQ 445
             +GR     DI++ G LV E+++G+
Sbjct: 176 TKYGR---AVDIWAVGCLVTEMLTGE 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 77/217 (35%), Positives = 110/217 (50%), Gaps = 27/217 (12%)

Query: 252 LGQGGFGAV----YKGMLSNGETIAVKRLSKNS--KQGEIEF---KNEVLLLARLQHRNL 302
           LG+G FG V     KG     E  AVK L K+   +  ++E    +  VL LA  +H  L
Sbjct: 3   LGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFL 58

Query: 303 VRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLH 360
            +L   C + K+R+  V E+V    L   +F  I R     E R +     I  GL +LH
Sbjct: 59  TQLHS-CFQTKDRLFFVMEYVNGGDL---MFH-IQRSGRFDEPRARFYAAEIVLGLQFLH 113

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV 420
           E     II+RDLK  N+LLDSE + KI+DFGM +  E       T+   GT  Y+APE +
Sbjct: 114 ERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPEIL 168

Query: 421 MHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE 457
            +  +    D ++ GVL+ E+++GQ  S F  ++E E
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQ--SPFEGDDEDE 203

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 82.3 bits (203), Expect = 1e-17
 Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 18/207 (8%)

Query: 245 NFSDANKLGQGGFGAVY--KGMLSNGETIAVKR--LSKNSKQGEIEFKNEVLLLARLQHR 300
            +    K+G+G FG +Y  K   S+ E   +K   L+K   + +   K EV+LLA+++H 
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59

Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE---GIARGLL 357
           N+V       E     +V E+     L       INR+        +I+     I+ GL 
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDL----MKRINRQRGVLFSEDQILSWFVQISLGLK 115

Query: 358 YLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
           ++H+    +I+HRD+K+ NI L    M  K+ DFG+AR  +++ +       VGT  Y++
Sbjct: 116 HIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIAR--QLNDSMELAYTCVGTPYYLS 170

Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           PE   +  ++ K+DI+S G ++ E+ +
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 67/223 (30%), Positives = 104/223 (46%), Gaps = 38/223 (17%)

Query: 252 LGQGGFGAVYKGMLS----NGETIAVKRLSKNSKQGEIEFKNEV----------LLLARL 297
           LG+G FG V   +L+     GE  A+K L    K+G+I  ++EV                
Sbjct: 7   LGRGHFGKV---LLAEYKKTGELYAIKAL----KKGDIIARDEVESLMCEKRIFETANSE 59

Query: 298 QHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARG 355
           +H  LV L   C + ++ +  V E+     L   I        +  E R       +  G
Sbjct: 60  RHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHI-----HTDVFSEPRAVFYAACVVLG 113

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD-TNRVVGTFGY 414
           L YLHE+   +I++RDLK  N+LLD+E   KI+DFG   L +      D T+   GT  +
Sbjct: 114 LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFG---LCKEGMGFGDRTSTFCGTPEF 167

Query: 415 MAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE 457
           +APE +    ++   D +  GVL+ E++ G+  S F  ++E E
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGE--SPFPGDDEEE 208

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 83.0 bits (205), Expect = 2e-17
 Identities = 69/200 (34%), Positives = 103/200 (51%), Gaps = 15/200 (7%)

Query: 252 LGQGGFGAVYKGML-SNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           LG+GGFG V    + + G+  A K+L K     ++GE    NE  +L ++  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66

Query: 308 FCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRL 365
           +  E K+ + LV   +    L   I++  N      E+R       I  GL  LH   R 
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD--EERAVFYAAEITCGLEDLH---RE 121

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRF 425
           RI++RDLK  NILLD   + +ISD G+A   E+ +  +   RV GT GYMAPE V + R+
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRV-GTVGYMAPEVVKNERY 178

Query: 426 SVKSDIFSFGVLVLEIVSGQ 445
           +   D +  G L+ E++ G+
Sbjct: 179 TFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 61/212 (28%), Positives = 105/212 (49%), Gaps = 24/212 (11%)

Query: 252 LGQGGFGAVYKGMLSNGETI---AVKRLS-KNSKQGEIE-FKNEVLLLARLQHRNLVRLL 306
           LG+G FG+V +G L+  ++I   AVK +      + E+E F +E + +    H N++RL+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 307 GFCLERKER------ILVYEFVPNASLDHFIF------DPINREHMTWEKRYKIIEGIAR 354
           G CL+  E       +++  F+ +  L  F+        P    ++  +   K +  IA 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ---YLPTQMLVKFMTDIAS 123

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY 414
           G+ YL   S    IHRDL A N +L+  MN  ++DFG+++       +           +
Sbjct: 124 GMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180

Query: 415 MAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQ 445
           +A E +    ++ KSD++SFGV + EI + GQ
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQ 212

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 69/201 (34%), Positives = 104/201 (51%), Gaps = 18/201 (8%)

Query: 252 LGQGGFGAVY---KGMLSN-GETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRL 305
           LGQG FG V+   K    + G+  A+K L K + +    +  K E  +LA + H  +V+L
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 306 -LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGLLYLHEDS 363
              F  E K   L+ +F+    L    F  +++E M  E+  K  +  +A  L +LH   
Sbjct: 64  HYAFQTEGK-LYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH--- 115

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
            L II+RDLK  NILLD E + K++DFG+++  E            GT  YMAPE V   
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRR 173

Query: 424 RFSVKSDIFSFGVLVLEIVSG 444
             +  +D +SFGVL+ E+++G
Sbjct: 174 GHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 63/201 (31%), Positives = 104/201 (51%), Gaps = 14/201 (6%)

Query: 252 LGQGGFGAVYK-GMLSNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           LG+GGFG V    M + G+  A K+L+K     ++G      E  +LA++  R +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59

Query: 308 FCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKII--EGIARGLLYLHEDSR 364
           +  + K  + LV   +    L + I++ ++ E+  + +         I  GL +LH+   
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYN-VDEENPGFPEPRACFYTAQIISGLEHLHQR-- 116

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
            RII+RDLK  N+LLD++ N +ISD G+A   E+    S T    GT G+MAPE +    
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELLQGEE 173

Query: 425 FSVKSDIFSFGVLVLEIVSGQ 445
           +    D F+ GV + E+++ +
Sbjct: 174 YDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 83.1 bits (206), Expect = 3e-17
 Identities = 68/224 (30%), Positives = 112/224 (50%), Gaps = 31/224 (13%)

Query: 236 FETIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKN---EV 291
            +T+    D + + + +G G +G V     +  G  +A+K+LS+   Q  I  K    E+
Sbjct: 7   NKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSR-PFQSAIHAKRTYREL 65

Query: 292 LLLARLQHRNLVRLLG-FC----LERKERI-LVYEFVPNASLDHFI-FDPINREHMTWEK 344
            LL  + H N++ LL  F     LE  + + LV   +  A L++ +    ++ +H+ +  
Sbjct: 66  RLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQF-- 122

Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD 404
              ++  I RGL Y+H      IIHRDLK SNI ++ +   KI DFG+AR      T  +
Sbjct: 123 ---LVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDE 171

Query: 405 TNRVVGTFGYMAPEYV---MHGRFSVKSDIFSFGVLVLEIVSGQ 445
               V T  Y APE +   MH   +V  DI+S G ++ E+++G+
Sbjct: 172 MTGYVATRWYRAPEIMLNWMHYNQTV--DIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 82.7 bits (204), Expect = 3e-17
 Identities = 65/224 (29%), Positives = 116/224 (51%), Gaps = 28/224 (12%)

Query: 244 DNFSDANKLGQGGFGAVYK----GMLSNGE----TIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D       LG+G FG V +    G+  +      T+AVK L  N+   ++ +  +E+ L+
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71

Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FD--PINREHM 340
             + +H+N++ LLG C +     ++ E+    +L  F+           FD   +  E +
Sbjct: 72  KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131

Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
           +++        +ARG+ YL  +SR R IHRDL A N+L+  +   KI+DFG+AR + ++D
Sbjct: 132 SFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188

Query: 400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
                +N  +    +MAPE +    ++ +SD++SFG+L+ EI +
Sbjct: 189 YYKKTSNGRL-PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 4e-17
 Identities = 64/248 (25%), Positives = 111/248 (44%), Gaps = 59/248 (23%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNS--KQGEIE-FKNE 290
           DFE I+V          +G+G FG V+       G+  A+K L K+   K+ +I   + E
Sbjct: 2   DFEVIKV----------IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAE 51

Query: 291 VLLLARLQHRNLVRLLGFCLERKERI-LVYEFVP-----NASLDHFIFDPINREHMTWEK 344
             +LA      +V+L  +  + +E + LV E++P     N  +   +F           +
Sbjct: 52  RDILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE------ETAR 104

Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA--------RLF 396
            Y     IA  +L L    +L  IHRD+K  NIL+D++ + K++DFG+         R +
Sbjct: 105 FY-----IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159

Query: 397 EMDQTHSDTNR-------------------VVGTFGYMAPEYVMHGRFSVKSDIFSFGVL 437
            ++ +H+   R                    VGT  Y+APE +    + ++ D +S GV+
Sbjct: 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVI 219

Query: 438 VLEIVSGQ 445
           + E++ G 
Sbjct: 220 LYEMLYGF 227

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 81.2 bits (200), Expect = 4e-17
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 16/209 (7%)

Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKR------LSKNSKQGEIEFKNEVLLLARL 297
           NF    K+G+G F  VY+   L +G  +A+K+      +   ++   I+   E+ LL +L
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK---EIDLLKQL 59

Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR-YKIIEGIARGL 356
            H N+++     +E  E  +V E      L   I     ++ +  EK  +K    +   L
Sbjct: 60  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            ++H  SR R++HRD+K +N+ + +    K+ D G+ R F    T + +  +VGT  YM+
Sbjct: 120 EHMH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMS 174

Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           PE +    ++ KSDI+S G L+ E+ + Q
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQ 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 81.1 bits (200), Expect = 5e-17
 Identities = 69/232 (29%), Positives = 114/232 (49%), Gaps = 26/232 (11%)

Query: 251 KLGQGGFGAVYKGMLSNGET---IAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           ++G G FG V  G +++G T   + VK L  + S Q +++F  E      LQH NL++ L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR--YKIIEGIARGLLYLHEDSR 364
           G C E    +LV EF P   L  ++      E MT +     ++   IA GLL+LH+++ 
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV--MH 422
              IH DL   N LL +++  KI D+G++     +  +   +++     ++APE V  +H
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178

Query: 423 GRFSV-----KSDIFSFGVLVLEIVSGQKRSSFGTEE----ETEDLLTYAWR 465
           G   V     +S+++S GV + E+         G++       E +LTY  R
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELF------ELGSQPYRHLSDEQVLTYTVR 224

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 80.8 bits (199), Expect = 6e-17
 Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 15/209 (7%)

Query: 252 LGQGGFGAVYKGMLSN-GETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           LG+GGFG V    + N G+  A K+L K     K GE     E  +L ++    +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59

Query: 308 FCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           +  E K  + LV   +    L + I++ +    +  E+       I  G+L+LH    + 
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHS---MD 115

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS 426
           I++RD+K  N+LLD + N ++SD G+A   E+    + T R  GT GYMAPE +    +S
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQR-AGTNGYMAPEILKEEPYS 172

Query: 427 VKSDIFSFGVLVLEIVSGQKRSSFGTEEE 455
              D F+ G  + E+V+G  R+ F   +E
Sbjct: 173 YPVDWFAMGCSIYEMVAG--RTPFKDHKE 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 80.5 bits (198), Expect = 7e-17
 Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 24/208 (11%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFC 309
           +G G +G VYKG  +  G+  A+K +     + E E K E+ +L +   HRN+    G  
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-EIKQEINMLKKYSHHRNIATYYGAF 72

Query: 310 LERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRY--KIIEGIARGLLYLHE 361
           +++       +  LV EF    S+   I    N +  T ++ +   I   I RGL +LH+
Sbjct: 73  IKKNPPGMDDQLWLVMEFCGAGSVTDLI---KNTKGNTLKEEWIAYICREILRGLSHLHQ 129

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM 421
               ++IHRD+K  N+LL      K+ DFG++   ++D+T    N  +GT  +MAPE + 
Sbjct: 130 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPEVIA 184

Query: 422 -----HGRFSVKSDIFSFGVLVLEIVSG 444
                   +  KSD++S G+  +E+  G
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 81.1 bits (200), Expect = 9e-17
 Identities = 81/256 (31%), Positives = 122/256 (47%), Gaps = 36/256 (14%)

Query: 252 LGQGGFGAVYKG-MLSNGETIAVKRLSKNS--KQGEIE---FKNEVLLLARLQHRNLVRL 305
           LG+G FG V    +  +G   AVK L K+   +  ++E    +  +L LAR  H  L +L
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61

Query: 306 LGFCLERKERIL-VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDS 363
              C +  +R+  V EFV    L   +F  I +     E R +     I   L++LH+  
Sbjct: 62  Y-CCFQTPDRLFFVMEFVNGGDL---MFH-IQKSRRFDEARARFYAAEITSALMFLHDKG 116

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
              II+RDLK  N+LLD E + K++DFGM +  E       T+   GT  Y+APE +   
Sbjct: 117 ---IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEM 171

Query: 424 RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRN-------WNEGAALNLM 476
            +    D ++ GVL+ E++ G   + F  E E ED L  A  N       W    A++++
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGH--APF--EAENEDDLFEAILNDEVVYPTWLSQDAVDIL 227

Query: 477 ------DPTMRGGSTS 486
                 +PTMR GS +
Sbjct: 228 KAFMTKNPTMRLGSLT 243

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 80.8 bits (199), Expect = 1e-16
 Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 25/214 (11%)

Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           A  ++ +  KLG+G +  VYKG+   NG+ +A+K +S  +++G + F    E  LL  L+
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLK 61

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
           H N+V L      ++    V+E++      + I       P N     ++        + 
Sbjct: 62  HANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQ--------LL 113

Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM-DQTHSDTNRVVGTF 412
           RGL Y+H      I+HRDLK  N+L+      K++DFG+AR   +  QT+S     V T 
Sbjct: 114 RGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE---VVTL 167

Query: 413 GYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
            Y  P+ ++    +S   DI+  G + +E++ GQ
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 80.0 bits (197), Expect = 1e-16
 Identities = 65/202 (32%), Positives = 100/202 (49%), Gaps = 21/202 (10%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLS--KNSKQGE------IEFKNEVLLLARLQHRNL 302
           +LG+G FG VY  ++ + + +A +RL   K    GE      ++   E  LL++L H  +
Sbjct: 7   RLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY---KIIEGIARGLLYL 359
           V+     LER    ++ E+     LD  +      E     K     ++ E   + LL +
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKL-----EELKHTGKTLSENQVCEWFIQLLLGV 119

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H   + RI+HRDLKA NI L + +  KI DFG++RL  M      T    GT  YM+PE 
Sbjct: 120 HYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATT-FTGTPYYMSPEA 176

Query: 420 VMHGRFSVKSDIFSFGVLVLEI 441
           + H  +  KSDI+S G ++ E+
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 80.3 bits (199), Expect = 1e-16
 Identities = 64/217 (29%), Positives = 109/217 (50%), Gaps = 34/217 (15%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE---IEFKNEVLLLARLQH 299
           D +   N++ +G +G VY+      GE +A+K+L K  K+ E   I    E+ +L +LQH
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-KMEKEKEGFPITSLREINILLKLQH 63

Query: 300 RNLVRL----LGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE---- 350
            N+V +    +G      ++I +V E+V     +H +   +  E M   + +   E    
Sbjct: 64  PNIVTVKEVVVG---SNLDKIYMVMEYV-----EHDLKSLM--ETMK--QPFLQSEVKCL 111

Query: 351 --GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV 408
              +  G+ +LH++    I+HRDLK SN+LL++    KI DFG+AR +        T  V
Sbjct: 112 MLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLV 167

Query: 409 VGTFGYMAPEYVM-HGRFSVKSDIFSFGVLVLEIVSG 444
           V T  Y APE ++    +S   D++S G +  E+++ 
Sbjct: 168 V-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 80.0 bits (197), Expect = 1e-16
 Identities = 65/205 (31%), Positives = 103/205 (50%), Gaps = 13/205 (6%)

Query: 246 FSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRN 301
           F     LG+GGFG V    + + G+  A KRL K     ++GE    NE  +L ++  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 302 LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
           +V L  +  E K+ + LV   +    L   I++ +       E+       I  GL  LH
Sbjct: 62  VVNL-AYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFEEERALFYAAEILCGLEDLH 119

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV 420
            ++    ++RDLK  NILLD   + +ISD G+A   ++ +  S   RV GT GYMAPE +
Sbjct: 120 REN---TVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRV-GTVGYMAPEVL 173

Query: 421 MHGRFSVKSDIFSFGVLVLEIVSGQ 445
            + R+++  D +  G L+ E++ GQ
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 80.4 bits (198), Expect = 1e-16
 Identities = 61/203 (30%), Positives = 106/203 (52%), Gaps = 20/203 (9%)

Query: 251 KLGQGGFGAVYKG--MLSNGETIAVKRLS-KNSKQG-EIEFKNEVLLLARLQ---HRNLV 303
           ++G+G +G V+K   + + G  +A+KR+  +  ++G  +    EV +L  L+   H N+V
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 304 RLLGFC-LERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           RL   C + R +R     LV+E V +  L  ++ D +    +  E    ++  + RGL +
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
           LH     R++HRDLK  NIL+ S    K++DFG+AR++           VV T  Y APE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPE 179

Query: 419 YVMHGRFSVKSDIFSFGVLVLEI 441
            ++   ++   D++S G +  E+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 80.5 bits (198), Expect = 1e-16
 Identities = 62/224 (27%), Positives = 108/224 (48%), Gaps = 28/224 (12%)

Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D  +    LG+G FG V         K       T+AVK L  ++ + ++ +  +E+ ++
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74

Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPINR---EH 339
             + +H+N++ LLG C +     ++ E+    +L  ++           +D I R   E 
Sbjct: 75  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-IARVPDEQ 133

Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           MT++        +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR     
Sbjct: 134 MTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNI 190

Query: 400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +  T        +MAPE +    ++ +SD++SFGVL+ EI +
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 80.3 bits (198), Expect = 2e-16
 Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 28/220 (12%)

Query: 236 FETIRVATDNFSDANKLGQGGFGAV--YKGMLSNGETIAVKRLSK------NSKQGEIEF 287
           F T+   T+ + D   +G G FG V   +  L+ G+ +A+K++ K       +K+   E 
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYREL 60

Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRY 346
           K    LL  L+H N++ L    +   E I  V E +           P+ ++ + +    
Sbjct: 61  K----LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQY---- 112

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
             +  I RGL Y+H      ++HRDLK SNIL++   + KI DFG+AR+    Q    T 
Sbjct: 113 -FLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTG 164

Query: 407 RVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE ++   ++ V+ DI+S G +  E++ G+
Sbjct: 165 -YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 79.9 bits (198), Expect = 3e-16
 Identities = 69/212 (32%), Positives = 119/212 (56%), Gaps = 30/212 (14%)

Query: 250 NKLGQGGFGAVYKGM-LSNGETIAVKRLS---KNSKQGEIEFKNEVLLLARL-QHRNLVR 304
            KLG+G +G V+K +     E +A+K++    +N+   +  F+ E++ L  L  H N+V+
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVK 71

Query: 305 LLG-FCLERKERI-LVYEFVP---NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           LL     E  + I LV+E++    +A +   I + +   H    KRY I+  + + L Y+
Sbjct: 72  LLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDV---H----KRY-IMYQLLKALKYI 123

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF-EMDQTHSD---TNRVVGTFGYM 415
           H  S   +IHRDLK SNILL+S+   K++DFG+AR   E+++   +   T+  V T  Y 
Sbjct: 124 H--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD-YVATRWYR 179

Query: 416 APEYVMHG--RFSVKSDIFSFGVLVLEIVSGQ 445
           APE ++ G  R++   D++S G ++ E++ G+
Sbjct: 180 APE-ILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 64/199 (32%), Positives = 101/199 (50%), Gaps = 13/199 (6%)

Query: 252 LGQGGFGAVYKGML-SNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           LG+GGFG V    + + G+  A K+L K     ++GE    NE  +L ++  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66

Query: 308 FCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           +  E K+ + LV   +    L   I++  N         +   E +  GL  L    R R
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAE-LCCGLEDLQ---RER 122

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS 426
           I++RDLK  NILLD   + +ISD G+A   ++ +  +   R VGT GYMAPE + + +++
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGR-VGTVGYMAPEVINNEKYT 179

Query: 427 VKSDIFSFGVLVLEIVSGQ 445
              D +  G L+ E++ GQ
Sbjct: 180 FSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 78.7 bits (194), Expect = 4e-16
 Identities = 65/236 (27%), Positives = 110/236 (46%), Gaps = 33/236 (13%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQHR 300
           D +    K+G+G +G VYK    + G+ +A+K  RL  + +        E+ LL  L   
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 301 N-LVRLLGFCLERKER-------ILVYEFVPNASLDHFIFDPINREHMTWEKR------Y 346
             +VRLL   +E  E         LV+E++ ++ L  F+             +      Y
Sbjct: 61  IYIVRLL--DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMY 117

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDT 405
           ++++G+A    + H   +  ++HRDLK  N+L+D +    KI+D G+ R F +    S T
Sbjct: 118 QLLKGVA----HCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSYT 169

Query: 406 NRVVGTFGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
           + +V T  Y APE ++    +S   DI+S G +  E+   Q    F  + E + LL
Sbjct: 170 HEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ--PLFPGDSELQQLL 222

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 78.5 bits (193), Expect = 6e-16
 Identities = 63/209 (30%), Positives = 107/209 (51%), Gaps = 11/209 (5%)

Query: 250 NKLGQGGFGAVYKGMLSNGET-IAVKRLSKNSKQGE-IEFKNEVLLLARLQHRNLVRLLG 307
           +KLG+G +  VYKG     +  +A+K +    ++G       EV LL  L+H N+V L  
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
                K   LV+E++ +  L  ++ D  N  +M   K +  +  + RGL Y H   R ++
Sbjct: 72  IIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCH---RRKV 125

Query: 368 IHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG-RFS 426
           +HRDLK  N+L++     K++DFG+AR   +  T + +N VV T  Y  P+ ++    +S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYSNEVV-TLWYRPPDILLGSTDYS 183

Query: 427 VKSDIFSFGVLVLEIVSGQKRSSFGTEEE 455
            + D++  G +  E+ +G+      T EE
Sbjct: 184 TQIDMWGVGCIFYEMSTGRPLFPGSTVEE 212

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 77.9 bits (192), Expect = 1e-15
 Identities = 72/215 (33%), Positives = 106/215 (49%), Gaps = 23/215 (10%)

Query: 252 LGQGGFGAVYKGMLSN-GETIAVKRLSKNS--KQGEIE---FKNEVLLLARLQHRNLVRL 305
           LG+G FG V    L    E  A+K L K+   +  ++E    +  VL LA  +H  L  L
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-WEHPFLTHL 61

Query: 306 LGFC-LERKERIL-VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHED 362
             FC  + KE +  V E++    L   I      +    E R +     I  GL +LH+ 
Sbjct: 62  --FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFD----EARARFYAAEIICGLQFLHKK 115

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH 422
               II+RDLK  N+LLD + + KI+DFGM +     +  + T    GT  Y+APE +  
Sbjct: 116 G---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAPEILKG 170

Query: 423 GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE 457
            +++   D +SFGVL+ E++ GQ  S F  E+E E
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQ--SPFHGEDEDE 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 66/211 (31%), Positives = 109/211 (51%), Gaps = 21/211 (9%)

Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKRL-----SKNSKQGEIEFKNEVLLLARLQ 298
           N+     LG+G FG VY       G  +AVK++     S+ + +     + E+ LL  L+
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 299 HRNLVRLLGFCL----ERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIA 353
           H  +V+  G CL    E+K  I V E++P  S+ D         E++T  +RY     I 
Sbjct: 63  HDRIVQYYG-CLRDPEEKKLSIFV-EYMPGGSIKDQLKAYGALTENVT--RRYT--RQIL 116

Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA-RLFEMDQTHSDTNRVVGTF 412
           +G+ YLH +    I+HRD+K +NIL DS  N K+ DFG + R+  +  + +    V GT 
Sbjct: 117 QGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173

Query: 413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            +M+PE +    +  K+D++S    V+E+++
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 55/212 (25%), Positives = 103/212 (48%), Gaps = 16/212 (7%)

Query: 240 RVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           R   ++F    ++G G +G VYK   ++ GE  A+K +     +     + E++++   +
Sbjct: 5   RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK 64

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLD--HFIFDPINREHMTWEKRYKIIEGIARGL 356
           H N+V   G  L R +  +  EF    SL   + +  P++   + +  R  +     +GL
Sbjct: 65  HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGL 119

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            YLH   +   +HRD+K +NILL    + K++DFG++   ++  T +     +GT  +MA
Sbjct: 120 YYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSA--QITATIAKRKSFIGTPYWMA 174

Query: 417 PEYVM---HGRFSVKSDIFSFGVLVLEIVSGQ 445
           PE       G ++   DI++ G+  +E+   Q
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIELAELQ 206

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 40/99 (40%), Positives = 60/99 (60%), Gaps = 8/99 (8%)

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH-SDT 405
           KI   + RGL YL E  + +I+HRD+K SNIL++S    K+ DFG++      Q   S  
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMA 155

Query: 406 NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           N  VGT  YM+PE +    ++V+SDI+S G+ ++E+  G
Sbjct: 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 67/251 (26%), Positives = 110/251 (43%), Gaps = 34/251 (13%)

Query: 254 QGGFGAVYKGM-LSNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
           +G FG+VY     S G+  A+K L K+   +K      K E  ++        V  L + 
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65

Query: 310 LERKERI-LVYEFVPNASLDHFI--FDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
            + K+ + LV E++        I     +  +   W K+Y  I  +  G+  LH+     
Sbjct: 66  FQSKDYLYLVMEYLNGGDCASLIKTLGGLPED---WAKQY--IAEVVLGVEDLHQRG--- 117

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS 426
           IIHRD+K  N+L+D   + K++DFG++R    ++      + VGT  Y+APE ++     
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPETILGVGDD 171

Query: 427 VKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGA-------ALNL---- 475
             SD +S G ++ E + G       T +   D +     NW E         A++L    
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL 231

Query: 476 --MDPTMRGGS 484
             MDP  R G+
Sbjct: 232 LCMDPAKRLGA 242

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 56/198 (28%), Positives = 99/198 (50%), Gaps = 12/198 (6%)

Query: 251 KLGQGGFGAVYKGMLSN-GETIAVKRLS-KNSKQGEIEFK-NEVLLLARLQHRNLVRLLG 307
           K+G+G +G V+K       E +A+KR+   +  +G       E+ LL  L+H+N+VRL  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
                K+  LV+E+  +  L  + FD  N + +  E     +  + +GL + H      +
Sbjct: 67  VLHSDKKLTLVFEYC-DQDLKKY-FDSCNGD-IDPEIVKSFMFQLLKGLAFCHSH---NV 120

Query: 368 IHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR-FS 426
           +HRDLK  N+L++     K++DFG+AR F +      +  VV T  Y  P+ +   + +S
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGI-PVRCYSAEVV-TLWYRPPDVLFGAKLYS 178

Query: 427 VKSDIFSFGVLVLEIVSG 444
              D++S G +  E+ + 
Sbjct: 179 TSIDMWSAGCIFAELANA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 42/108 (38%), Positives = 63/108 (58%), Gaps = 11/108 (10%)

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR--LFEMDQTHSDTNRVV 409
           IA GL +LH      II+RDLK  N++LD+E + KI+DFGM +  +F    T +      
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT----FC 162

Query: 410 GTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE 457
           GT  Y+APE + +  +    D ++FGVL+ E+++GQ    F  E+E E
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ--PPFDGEDEDE 208

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 77.3 bits (190), Expect = 3e-15
 Identities = 64/227 (28%), Positives = 110/227 (48%), Gaps = 39/227 (17%)

Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    D + D  ++G G +G V   +    G  +A+K+L +   Q E+  K    E+ 
Sbjct: 8   KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYR-PFQSELFAKRAYRELR 66

Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHF----IFDP---------INREH 339
           LL  ++H N++ LL              F P+ SLD F    +  P         +  E 
Sbjct: 67  LLKHMKHENVIGLLDV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK 114

Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           ++ ++   ++  + +GL Y+H      IIHRDLK  N+ ++ +   KI DFG+AR     
Sbjct: 115 LSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR----- 166

Query: 400 QTHSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
           QT S+    V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 167 QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 76.4 bits (188), Expect = 3e-15
 Identities = 75/245 (30%), Positives = 108/245 (44%), Gaps = 56/245 (22%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVY----KGMLSNGETIAVKRLSKNS---KQGEIEF 287
           +FE +RV          LG G +G V+     G    G+  A+K L K +   K    E 
Sbjct: 1   NFELLRV----------LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEH 50

Query: 288 -KNEVLLLARLQHRN-LVRLLGFCLERKERILVYEFVPNASLDHFIFDPIN--------- 336
            + E  +L  ++    LV L             Y F  +  L H I D +N         
Sbjct: 51  TRTERQVLEAVRRCPFLVTLH------------YAFQTDTKL-HLILDYVNGGELFTHLY 97

Query: 337 -REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL 395
            REH T  +    I  I   L +LH+   L II+RD+K  NILLDSE +  ++DFG+++ 
Sbjct: 98  QREHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKE 154

Query: 396 F---EMDQTHSDTNRVVGTFGYMAPEYVMHGR--FSVKSDIFSFGVLVLEIVSGQKRSSF 450
           F   E ++ +S      GT  YMAPE +  G        D +S GVL  E+++G   S F
Sbjct: 155 FLAEEEERAYS----FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGA--SPF 208

Query: 451 GTEEE 455
             + E
Sbjct: 209 TVDGE 213

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 59/226 (26%), Positives = 108/226 (47%), Gaps = 26/226 (11%)

Query: 226 ETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE 284
           + + ++ Q D+E I+          ++G G +G VYK   L  GE  AVK +        
Sbjct: 1   DILRRNPQHDYELIQ----------RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDF 50

Query: 285 IEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD--HFIFDPINREHMTW 342
              + E+ ++   +H N+V   G  L R++  +  E+    SL   + +  P++   + +
Sbjct: 51  SLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY 110

Query: 343 EKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
             R  +     +GL YLH   ++   HRD+K +NILL    + K++DFG+A   ++  T 
Sbjct: 111 VCRETL-----QGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAA--KITATI 160

Query: 403 SDTNRVVGTFGYMAPEYVM---HGRFSVKSDIFSFGVLVLEIVSGQ 445
           +     +GT  +MAPE      +G ++   DI++ G+  +E+   Q
Sbjct: 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQ 206

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 77.0 bits (189), Expect = 3e-15
 Identities = 61/216 (28%), Positives = 110/216 (50%), Gaps = 28/216 (12%)

Query: 252 LGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLLARL-QHRN 301
           LG+G FG V         K   +   T+AVK L  ++   ++ +  +E+ ++  + +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDP--INREHMTWEKRYKI 348
           ++ LLG C +     ++ E+    +L  ++           FD   +  E +T++     
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSDTNR 407
              +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR +  +D     TN 
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 408 VVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            +    +MAPE +    ++ +SD++SFGVL+ EI +
Sbjct: 197 RL-PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 76.9 bits (189), Expect = 3e-15
 Identities = 66/216 (30%), Positives = 100/216 (46%), Gaps = 48/216 (22%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHRNLVRLLG 307
           +G G +G+V   +    GE +A+K+LS+   Q EI  K    E+ LL  +QH N++ LL 
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSR-PFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81

Query: 308 FCLERKERILVYEFVPNASLDHFI------------FDPINREHMTWEKRYKIIEGIARG 355
                        F    S D F                I    ++ +K   ++  +  G
Sbjct: 82  V------------FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCG 129

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD---TNRVVGTF 412
           L Y+H      IIHRDLK  N+ ++ +   KI DFG+AR       H+D   T  VV T 
Sbjct: 130 LKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVV-TR 178

Query: 413 GYMAPEYV---MHGRFSVKSDIFSFGVLVLEIVSGQ 445
            Y APE +   MH   +V  DI+S G ++ E+++G+
Sbjct: 179 WYRAPEVILNWMHYNQTV--DIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 24/225 (10%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLL 293
           D   +R     F     +G G +G VYKG  +  G+  A+K +     + E E K E+ +
Sbjct: 7   DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE-EIKLEINM 65

Query: 294 LARL-QHRNLVRLLGFCLERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRY 346
           L +   HRN+    G  +++       +  LV EF    S+   +    N +    ++ +
Sbjct: 66  LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV---KNTKGNALKEDW 122

Query: 347 --KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD 404
              I   I RGL +LH     ++IHRD+K  N+LL      K+ DFG++   ++D+T   
Sbjct: 123 IAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGR 177

Query: 405 TNRVVGTFGYMAPEYVM-----HGRFSVKSDIFSFGVLVLEIVSG 444
            N  +GT  +MAPE +         +  +SDI+S G+  +E+  G
Sbjct: 178 RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 38/221 (17%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSN--GETIAVKRLSKNSKQGE-IEFKNEVLLLARLQH- 299
           ++  D  ++G+G FG V K ML    G  +AVKR+     + E      ++ ++ R    
Sbjct: 4   EDLKDLGEIGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC 62

Query: 300 RNLVRLLG---------FCLERKERILVYEFVPNASLDHF--IFDPINREHMTWEKRYKI 348
             +V+  G          C+E          + + SLD F      + +  +  E   KI
Sbjct: 63  PYIVKFYGALFREGDCWICME----------LMDISLDKFYKYVYEVLKSVIPEEILGKI 112

Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE--MDQTHSDTN 406
                + L YL E+  L+IIHRD+K SNILLD   N K+ DFG++      + +T     
Sbjct: 113 AVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD--- 167

Query: 407 RVVGTFGYMAPEYVMHGR---FSVKSDIFSFGVLVLEIVSG 444
              G   YMAPE +       + V+SD++S G+ + E+ +G
Sbjct: 168 --AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 76.6 bits (188), Expect = 3e-15
 Identities = 67/226 (29%), Positives = 106/226 (46%), Gaps = 29/226 (12%)

Query: 243 TDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNS--KQGEIEFKN-EVLLLARLQ 298
             NF     LG+G FG V         E  A+K L K+   +  ++E    E  +LA   
Sbjct: 1   DFNFLMV--LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58

Query: 299 HRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG------ 351
               +  L  C +  +R+  V E+V    L +         H+    ++K  +       
Sbjct: 59  KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMY---------HIQQVGKFKEPQAVFYAAE 109

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           I+ GL +LH      II+RDLK  N++LDSE + KI+DFGM +   +D   + T    GT
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT--FCGT 164

Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE 457
             Y+APE + +  +    D +++GVL+ E+++GQ    F  E+E E
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ--PPFDGEDEDE 208

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 75.3 bits (185), Expect = 5e-15
 Identities = 58/197 (29%), Positives = 100/197 (50%), Gaps = 18/197 (9%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLLG-F 308
           LG G  G VYK   L     +AVK +  + + + + +  +E+ +L +     ++   G F
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
            +E +  I   EF+   SLD +   P   EH+      +I   + +GL YL     L+I+
Sbjct: 69  FVENRISICT-EFMDGGSLDVYRKIP---EHVLG----RIAVAVVKGLTYLWS---LKIL 117

Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVK 428
           HRD+K SN+L+++    K+ DFG++        +S     VGT  YMAPE +   ++ + 
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQYGIH 173

Query: 429 SDIFSFGVLVLEIVSGQ 445
           SD++S G+  +E+  G+
Sbjct: 174 SDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 75.2 bits (185), Expect = 5e-15
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 26/215 (12%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRL--SKNSKQGEIEFKNEVLLLARLQH- 299
           D+     +LG+G +G V K       TI AVKR+  + NS Q +     ++ +  R    
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQKRLLMDLDISMRSVDC 59

Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHF---IFDPINREHMTWEKRYKIIEGIARGL 356
              V   G  L R+  + +   V + SLD F   ++D      +  +   KI   I + L
Sbjct: 60  PYTVTFYG-ALFREGDVWICMEVMDTSLDKFYKKVYDK--GLTIPEDILGKIAVSIVKAL 116

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGY 414
            YLH   +L +IHRD+K SN+L++     K+ DFG++      + +T        G   Y
Sbjct: 117 EYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID-----AGCKPY 169

Query: 415 MAPEYV-----MHGRFSVKSDIFSFGVLVLEIVSG 444
           MAPE +       G + VKSD++S G+ ++E+ +G
Sbjct: 170 MAPERINPELNQKG-YDVKSDVWSLGITMIELATG 203

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 75.5 bits (186), Expect = 5e-15
 Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 57/222 (25%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE---IEFKNEVLLLARLQHR--NLVR- 304
           +G G  G VYK      G  +AVK++ +   + E   I    +V+L +   H    +V+ 
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS---HDCPYIVKC 79

Query: 305 ---------------LLGFCLER-KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI 348
                          L+  CL++  +RI     +P   L                   K+
Sbjct: 80  YGYFITDSDVFICMELMSTCLDKLLKRI--QGPIPEDILG------------------KM 119

Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA-RLFEMDQTHSDTNR 407
              I + L YL E     +IHRD+K SNILLD+  N K+ DFG++ RL +  +  +   R
Sbjct: 120 TVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVD-SKAKT---R 173

Query: 408 VVGTFGYMAPEYV----MHGRFSVKSDIFSFGVLVLEIVSGQ 445
             G   YMAPE +     + ++ +++D++S G+ ++E+ +GQ
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 75.1 bits (185), Expect = 6e-15
 Identities = 64/223 (28%), Positives = 109/223 (48%), Gaps = 23/223 (10%)

Query: 251 KLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQG----EIEFKNEVLLLARLQHRNLVRL 305
           KLG+G +  VYKG     G+ +A+K +    ++G     I    E  LL  L+H N+V L
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR---EASLLKDLKHANIVTL 68

Query: 306 LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEK--RYKIIEGIARGLLYLHEDS 363
                 +K   LV+E++ +  L  ++ D      M   +   ++++    RGL Y H   
Sbjct: 69  HDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLL----RGLAYCH--- 120

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
           + R++HRDLK  N+L+      K++DFG+AR   +  + + +N VV T  Y  P+ ++  
Sbjct: 121 QRRVLHRDLKPQNLLISERGELKLADFGLARAKSV-PSKTYSNEVV-TLWYRPPDVLLGS 178

Query: 424 R-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWR 465
             +S   D++  G +  E+ +G  R  F    + ED L   +R
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATG--RPLFPGSTDVEDQLHKIFR 219

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 75.1 bits (184), Expect = 7e-15
 Identities = 60/210 (28%), Positives = 105/210 (50%), Gaps = 23/210 (10%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGE-IEFKNEVLLLARLQHRN 301
           D++    KLG+G +  VYKG    NG+ +A+K +    ++G       E  LL  L+H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFI------FDPINREHMTWEKRYKIIEGIARG 355
           +V L      ++   LV+E+V +  L  ++        P N +   ++        + RG
Sbjct: 65  IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQ--------LLRG 115

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYM 415
           L Y+H+     I+HRDLK  N+L+      K++DFG+AR   +  +H+ +N VV T  Y 
Sbjct: 116 LSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVV-TLWYR 170

Query: 416 APEYVMHG-RFSVKSDIFSFGVLVLEIVSG 444
            P+ ++    +S   D++  G + +E++ G
Sbjct: 171 PPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 75.0 bits (184), Expect = 8e-15
 Identities = 60/227 (26%), Positives = 113/227 (49%), Gaps = 28/227 (12%)

Query: 241 VATDNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEV 291
           V  D       LG+G FG V         K   +    +AVK L  ++ + ++ +  +E+
Sbjct: 15  VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEM 74

Query: 292 LLLARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDP--INR 337
            ++  + +H+N++ LLG C +     ++ E+    +L  ++           ++P  +  
Sbjct: 75  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPE 134

Query: 338 EHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LF 396
           E ++++        +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR + 
Sbjct: 135 EQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 191

Query: 397 EMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            +D     TN  +    +MAPE +    ++ +SD++SFGVL+ EI +
Sbjct: 192 HIDYYKKTTNGRL-PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 75.0 bits (184), Expect = 9e-15
 Identities = 62/199 (31%), Positives = 102/199 (51%), Gaps = 11/199 (5%)

Query: 250 NKLGQGGFGAVYKGMLSNGET-IAVKRLSKNSKQGE-IEFKNEVLLLARLQHRNLVRLLG 307
            KLG+G +  V+KG     E  +A+K +    ++G       EV LL  L+H N+V L  
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
                K   LV+E++ +  L  ++ D  N   M   K +  +  I RGL Y H   R ++
Sbjct: 72  IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCH---RRKV 125

Query: 368 IHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM-HGRFS 426
           +HRDLK  N+L++     K++DFG+AR   +  T + +N VV T  Y  P+ ++    +S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDVLLGSSEYS 183

Query: 427 VKSDIFSFGVLVLEIVSGQ 445
            + D++  G +  E+ SG+
Sbjct: 184 TQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 74.6 bits (184), Expect = 2e-14
 Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 49/226 (21%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE-IEFKNEVLLLARLQHRN 301
             + + + +G+G +G V        G  +A+K++S    Q        E+ +L R +H N
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64

Query: 302 LVRLL------GFCLERKERILVYEFVP----------NASLDH---FIFDPINREHMTW 342
           ++ +L       F     +  +V E +           + S DH   F+           
Sbjct: 65  IIGILDIIRPPSFE-SFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFL----------- 112

Query: 343 EKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
              Y+I+    RGL Y+H  +   ++HRDLK SN+LL++  + KI DFG+AR+   D  H
Sbjct: 113 ---YQIL----RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEH 160

Query: 403 SDTNRV---VGTFGYMAPEYVMHGRFSVKS-DIFSFGVLVLEIVSG 444
             T  +   V T  Y APE +++ +   K+ DI+S G ++ E++S 
Sbjct: 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 28/207 (13%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFK---NEVLLLARLQHRNLVRLL 306
           K+G+G +G V+K      G+ +A+K+  ++     I+ K    E+ +L +L+H NLV L+
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK-KIALREIRMLKQLKHPNLVNLI 66

Query: 307 GFCLERKERI-LVYEFVPNASLDHFIFDPINR------EHMTWEKRYKIIEGIARGLLYL 359
                RK ++ LV+E+      DH + + + +      EH+      KII    + + + 
Sbjct: 67  E-VFRRKRKLHLVFEYC-----DHTVLNELEKNPRGVPEHLI----KKIIWQTLQAVNFC 116

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H   +   IHRD+K  NIL+  +   K+ DFG AR+  +     D    V T  Y APE 
Sbjct: 117 H---KHNCIHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVATRWYRAPEL 171

Query: 420 -VMHGRFSVKSDIFSFGVLVLEIVSGQ 445
            V   ++    D+++ G +  E+++GQ
Sbjct: 172 LVGDTQYGPPVDVWAIGCVFAELLTGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 5/95 (5%)

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           I RGL YLH      I+HRD+K  N+L++S    KI DFG+AR+ E D++   T  VV  
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 412 FGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQ 445
           + Y APE +M  R ++   DI+S G +  E++  +
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 66/228 (28%), Positives = 103/228 (45%), Gaps = 19/228 (8%)

Query: 230 KSLQFDFETIRVATDNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEFK 288
            S     E++   TD +     +G+G +G VYK     +G   AVK L   S   E E +
Sbjct: 8   NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE-EIE 66

Query: 289 NEVLLLARL-QHRNLVRLLGFCLERKERI-----LVYEFVPNASLDHFIFDPINREHMTW 342
            E  +L  L  H N+V+  G   +  + +     LV E     S+   +   +       
Sbjct: 67  AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLD 126

Query: 343 EKRYK-IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
           E     I+ G   GL +LH +   RIIHRD+K +NILL +E   K+ DFG++   ++  T
Sbjct: 127 EAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSA--QLTST 181

Query: 402 HSDTNRVVGTFGYMAPEYVM-----HGRFSVKSDIFSFGVLVLEIVSG 444
               N  VGT  +MAPE +         +  + D++S G+  +E+  G
Sbjct: 182 RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 71/219 (32%), Positives = 105/219 (47%), Gaps = 31/219 (14%)

Query: 252 LGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIE---FKNEVLLLARLQHRNLVRL 305
           LG+G FG V+   L    +  A+K L K+      ++E    +  VL LA  +H  L  L
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHL 61

Query: 306 LGFC-LERKERIL-VYEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIARGLLY 358
             +C  + KE +  V E++    L   I     FD         E        I  GL +
Sbjct: 62  --YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAE--------IICGLQF 111

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
           LH      I++RDLK  NILLD++ + KI+DFGM +  E     + T    GT  Y+APE
Sbjct: 112 LHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPE 166

Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE 457
            ++  +++   D +SFGVL+ E++ GQ  S F   +E E
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQ--SPFHGHDEEE 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 73.9 bits (181), Expect = 3e-14
 Identities = 66/229 (28%), Positives = 107/229 (46%), Gaps = 43/229 (18%)

Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 10  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 68

Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHF-------------IFDPINREH 339
           LL  ++H N++ LL              F P  SL+ F             + + +  + 
Sbjct: 69  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 116

Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           +T +    +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR     
Sbjct: 117 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----- 168

Query: 400 QTHSDTNRVVGTFGYMAPEYV---MHGRFSVKSDIFSFGVLVLEIVSGQ 445
            T  +    V T  Y APE +   MH  ++   DI+S G ++ E+++G+
Sbjct: 169 HTDDEMTGYVATRWYRAPEIMLNWMH--YNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 72.5 bits (178), Expect = 5e-14
 Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 27/211 (12%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGET-IAVKRLSKNS----KQGEIEFKNEVLLLARLQ 298
           D+      +G G FG V+       E   A+K ++       KQ +    NE  +L  + 
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQ-HVHNEKRVLKEVS 59

Query: 299 HRNLVRLLGFCLERKERIL--VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           H  ++RL  F  E  +R L  + E+VP   L  F +   +         +   E I   L
Sbjct: 60  HPFIIRL--FWTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASE-IVCAL 114

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            YLH      I++RDLK  NILLD E + K++DFG A+     +    T  + GT  Y+A
Sbjct: 115 EYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLA 166

Query: 417 PEYVM---HGRFSVKSDIFSFGVLVLEIVSG 444
           PE +    H +     D ++ G+L+ E++ G
Sbjct: 167 PEVIQSKGHNK---AVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 72.0 bits (176), Expect = 8e-14
 Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 34/210 (16%)

Query: 252 LGQGGFGAVYKGMLSN-GETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLG 307
           +G+GGFG VY    ++ G+  A+K L K     KQGE    NE ++L+ +   +   ++ 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV- 60

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTW-----------EKRYKIIEGIARGL 356
                    + Y F     L  FI D +N   + +           E R+   E I  GL
Sbjct: 61  --------CMTYAFHTPDKL-CFILDLMNGGDLHYHLSQHGVFSEKEMRFYATE-IILGL 110

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            ++H  +R  +++RDLK +NILLD   + +ISD G+A  F   + H+     VGT GYMA
Sbjct: 111 EHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMA 163

Query: 417 PEYVMHGR-FSVKSDIFSFGVLVLEIVSGQ 445
           PE +  G  +   +D FS G ++ +++ G 
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGH 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 71.8 bits (176), Expect = 1e-13
 Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 25/205 (12%)

Query: 252 LGQGGFGAVYKGMLS----NGETIAVKRLSKNS--KQGEIE---FKNEVLLLARLQHRNL 302
           LG+G FG V   ML+      E  A+K L K+   +  +++    +  +L LA  +H  L
Sbjct: 3   LGKGSFGKV---MLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFL 58

Query: 303 VRLLGFCLERKERIL-VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLH 360
             L   C + K+R+  V E+V    L   +F  I R     E R +     +   L++LH
Sbjct: 59  TALHC-CFQTKDRLFFVMEYVNGGDL---MFQ-IQRSRKFDEPRSRFYAAEVTLALMFLH 113

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV 420
                 +I+RDLK  NILLD+E + K++DFGM +  E       T    GT  Y+APE +
Sbjct: 114 RHG---VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEIL 168

Query: 421 MHGRFSVKSDIFSFGVLVLEIVSGQ 445
               +    D ++ GVL+ E+++GQ
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 69/220 (31%), Positives = 105/220 (47%), Gaps = 33/220 (15%)

Query: 252 LGQGGFGAVYKGMLSN----GETIAVKRLSKNS--KQGEIEFKN-EVLLLARLQHRNLVR 304
           LG+G FG V   ML+      E  A+K L K+   +  ++E    E  +LA       + 
Sbjct: 8   LGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLT 64

Query: 305 LLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYK------IIEGIARGLL 357
            L  C +  +R+  V E+V    L +          +    R+K          IA GL 
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGGDLMY---------QIQQVGRFKEPHAVFYAAEIAIGLF 115

Query: 358 YLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAP 417
           +LH      II+RDLK  N++LDSE + KI+DFGM +    D   + T    GT  Y+AP
Sbjct: 116 FLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT--FCGTPDYIAP 170

Query: 418 EYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE 457
           E + +  +    D ++FGVL+ E+++GQ  + F  E+E E
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ--APFEGEDEDE 208

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 67/210 (31%), Positives = 105/210 (50%), Gaps = 34/210 (16%)

Query: 252 LGQGGFGAVYKGMLSN-GETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLG 307
           +G+GGFG VY    ++ G+  A+K L K     KQGE    NE ++L+ +   +   ++ 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV- 60

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPIN--------REHMTW---EKRYKIIEGIARGL 356
            C+        Y F     L  FI D +N         +H  +   E R+   E I  GL
Sbjct: 61  -CMS-------YAFHTPDKLS-FILDLMNGGDLHYHLSQHGVFSEAEMRFYAAE-IILGL 110

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            ++H  +R  +++RDLK +NILLD   + +ISD G+A  F   + H+     VGT GYMA
Sbjct: 111 EHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMA 163

Query: 417 PEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
           PE +  G  +   +D FS G ++ +++ G 
Sbjct: 164 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 19/210 (9%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLGFC 309
           K+G+G +G VYK    +G+      L +    G  +    E+ LL  L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 310 LERKER--ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY-----LHED 362
           L   +R   L++++  +  L H I    +R     +K  ++  G+ + LLY     +H  
Sbjct: 68  LSHADRKVWLLFDYAEH-DLWHII--KFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 363 SRLRIIHRDLKASNILLDSEMNP-----KISDFGMARLFEMD-QTHSDTNRVVGTFGYMA 416
               ++HRDLK +NIL+  E  P     KI+D G ARLF    +  +D + VV TF Y A
Sbjct: 125 HANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 417 PEYVMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           PE ++  R   K+ DI++ G +  E+++ +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 71.8 bits (176), Expect = 2e-13
 Identities = 40/154 (25%), Positives = 74/154 (48%), Gaps = 9/154 (5%)

Query: 290 EVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
           E +LL  + H +++R+    +      +V   +P+ S D + +       +  ++   I 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
           + I  GL YLH     RIIHRD+K  NI ++      I D G A+   +         + 
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---PAFLGLA 217

Query: 410 GTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           GT    APE +   +++ K+DI+S G+++ E+++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 68/225 (30%), Positives = 112/225 (49%), Gaps = 29/225 (12%)

Query: 236 FETIRVATDNFSDANK------LGQGGFGAVYKGMLSN-GETIAVKRLSK---NSKQGEI 285
           F +++VA   F+   +      +G G  G V     +  G  +AVK+LS+   N    + 
Sbjct: 7   FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKR 66

Query: 286 EFKNEVLLLARLQHRNLVRLLGFCLERK------ERILVYEFVPNASLDHFIFDPINREH 339
            ++ E++LL  + H+N++ LL     +K      +  LV E + +A+L   I   ++ E 
Sbjct: 67  AYR-ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHER 124

Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           M++   Y+++ GI     +LH      IIHRDLK SNI++ S+   KI DFG+AR     
Sbjct: 125 MSY-LLYQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 173

Query: 400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            T+      V T  Y APE ++   +    DI+S G ++ E+V G
Sbjct: 174 CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 70.3 bits (172), Expect = 2e-13
 Identities = 54/219 (24%), Positives = 99/219 (45%), Gaps = 25/219 (11%)

Query: 246 FSDANKLGQGGFGAVYKGML----SNGETIAVKRLSK--NSKQGEIEFKNEVLLLARLQH 299
           F+    LG+G FG+V +  L     + + +AVK L     S     EF  E   +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 300 RNLVRLLGFCLERKER------ILVYEFVPNASLDHFIF------DPINREHMTWEKRYK 347
            N+++L+G  L  + +      +++  F+ +  L  F+       +P     +  +   +
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFT---LPLQTLVR 117

Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
            +  IA G+ YL   S    IHRDL A N +L+  M   ++DFG+++       +     
Sbjct: 118 FMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174

Query: 408 VVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQ 445
                 ++A E +    ++  SD+++FGV + EI++ GQ
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 52/201 (25%), Positives = 99/201 (49%), Gaps = 9/201 (4%)

Query: 246 FSDANKLGQGGFG-AVYKGMLSNGETIAVKRL--SKNSKQGEIEFKNEVLLLARLQHRNL 302
           +    K+G+G FG A+      +G+   +K +  SK S +   E + EV +L+ ++H N+
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           V+      E     +V ++     L    +  IN +        +I++   +  L L   
Sbjct: 62  VQYQESFEENGNLYIVMDYCEGGDL----YKKINAQRGVLFPEDQILDWFVQICLALKHV 117

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH 422
              +I+HRD+K+ NI L  +   K+ DFG+AR+  ++ T       +GT  Y++PE   +
Sbjct: 118 HDRKILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLSPEICEN 175

Query: 423 GRFSVKSDIFSFGVLVLEIVS 443
             ++ KSDI++ G ++ E+ +
Sbjct: 176 RPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 71.1 bits (174), Expect = 2e-13
 Identities = 68/218 (31%), Positives = 101/218 (46%), Gaps = 29/218 (13%)

Query: 252 LGQGGFGAVYKGMLS-NGETIAVKRLSKNSK--QGEIE---FKNEVLLLARLQHRNLVRL 305
           LG+G FG V    L   GE  AVK L K+      ++E    +  VL LA  ++  L  L
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA-WENPFLTHL 61

Query: 306 LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG------IARGLLYL 359
                 ++    V EF+    L   I D         + R+ +         I  GL +L
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDLMFHIQD---------KGRFDLYRATFYAAEIVCGLQFL 112

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H      II+RDLK  N++LD + + KI+DFGM +        + T    GT  Y+APE 
Sbjct: 113 HSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST--FCGTPDYIAPEI 167

Query: 420 VMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE 457
           +   +++   D +SFGVL+ E++ GQ  S F  ++E E
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQ--SPFHGDDEDE 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 70.1 bits (171), Expect = 3e-13
 Identities = 57/199 (28%), Positives = 103/199 (51%), Gaps = 11/199 (5%)

Query: 250 NKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGE-IEFKNEVLLLARLQHRNLVRLLG 307
           +KLG+G +  V+KG        +A+K +    ++G       EV LL  L+H N+V L  
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
                +   LV+E++ ++ L  ++ +  N   M   K +     + RGL Y H   + +I
Sbjct: 71  IIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMF--QLLRGLSYCH---KRKI 124

Query: 368 IHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG-RFS 426
           +HRDLK  N+L++ +   K++DFG+AR   +  T + +N VV T  Y  P+ ++    +S
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDVLLGSTEYS 182

Query: 427 VKSDIFSFGVLVLEIVSGQ 445
              D++  G ++ E+ +G+
Sbjct: 183 TPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 25/204 (12%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEV--------LLLARLQHRNL 302
           +G+G FG V      ++G+  AVK L K +    I  K E         +LL  ++H  L
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKA----ILKKKEQKHIMAERNVLLKNVKHPFL 58

Query: 303 VRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLH 360
           V L  +  +  +++  V ++V    L    F  + RE    E R +     IA  L YLH
Sbjct: 59  VGL-HYSFQTADKLYFVLDYVNGGEL----FFHLQRERSFPEPRARFYAAEIASALGYLH 113

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV 420
               L II+RDLK  NILLDS+ +  ++DFG+ +  E  +    T+   GT  Y+APE +
Sbjct: 114 S---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVL 168

Query: 421 MHGRFSVKSDIFSFGVLVLEIVSG 444
               +    D +  G ++ E++ G
Sbjct: 169 RKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 70.1 bits (171), Expect = 5e-13
 Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 29/215 (13%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLGFC 309
           K+G+G +G VYK    +G+      L +    G  +    E+ LL  L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 310 LERKER--ILVYEFVPNASLDHFI----FDPINREHMTWEKR------YKIIEGIARGLL 357
           L   +R   L++++  +  L H I        N++ M   +       Y+I++GI     
Sbjct: 68  LSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH---- 122

Query: 358 YLHEDSRLRIIHRDLKASNILLDSEMNP-----KISDFGMARLFEMD-QTHSDTNRVVGT 411
           YLH +    ++HRDLK +NIL+  E  P     KI+D G ARLF    +  +D + VV T
Sbjct: 123 YLHAN---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178

Query: 412 FGYMAPEYVMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           F Y APE ++  R   K+ DI++ G +  E+++ +
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 70.1 bits (172), Expect = 5e-13
 Identities = 54/218 (24%), Positives = 102/218 (46%), Gaps = 35/218 (16%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSK------NSKQGEIEFKNEVLLLAR 296
             +     +G G +G V   +   +G+ +A+K++         +K+   E K    +L  
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----ILRH 60

Query: 297 LQHRNLVRLLGFCL----ERKERILVYEFVPNASLDHFIF--DPINREHMTWEKRYKIIE 350
            +H N++ +         + K+  +V + + +  L H I    P+  EH+    RY + +
Sbjct: 61  FKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHI----RYFLYQ 115

Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV-- 408
            + RGL Y+H  +   +IHRDLK SN+L++ +   +I DFGMAR   +  + ++      
Sbjct: 116 -LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR--GLSSSPTEHKYFMT 169

Query: 409 --VGTFGYMAPE--YVMHGRFSVKSDIFSFGVLVLEIV 442
             V T  Y APE    +   ++   D++S G +  E++
Sbjct: 170 EYVATRWYRAPELLLSLP-EYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 69.7 bits (170), Expect = 6e-13
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 13/205 (6%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRN 301
           D+F   ++LG G  G V K        I  ++L     +  I  +   E+ +L       
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +V   G      E  +  E +   SLD  + +    + +  E   K+   + RGL YL E
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLRE 121

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMA-RLFEMDQTHSDTNRVVGTFGYMAPEYV 420
             + +I+HRD+K SNIL++S    K+ DFG++ +L +     S  N  VGT  YM+PE +
Sbjct: 122 --KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERL 174

Query: 421 MHGRFSVKSDIFSFGVLVLEIVSGQ 445
               +SV+SDI+S G+ ++E+  G+
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 68.9 bits (168), Expect = 9e-13
 Identities = 64/230 (27%), Positives = 107/230 (46%), Gaps = 21/230 (9%)

Query: 228 IAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSK-NSKQGEI 285
             K++ FD  +    +D +     +G+G +G V+K +   NG   AVK L   +    EI
Sbjct: 4   SGKTIIFD--SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEI 61

Query: 286 EFKNEVLLLARLQHRNLVRLLGFCLERKERI-----LVYEFVPNASLDHFIFDPINR-EH 339
           E +  +L  A   H N+V+  G   ++  +      LV E     S+   +   + R E 
Sbjct: 62  EAEYNILK-ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER 120

Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           M       I+     GL +LH +   + IHRD+K +NILL +E   K+ DFG++   ++ 
Sbjct: 121 MEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSA--QLT 175

Query: 400 QTHSDTNRVVGTFGYMAPEYV-----MHGRFSVKSDIFSFGVLVLEIVSG 444
            T    N  VGT  +MAPE +     +   +  + D++S G+  +E+  G
Sbjct: 176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 20/202 (9%)

Query: 250 NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE-IEFKNEVLLLARLQ-HRNLVRLL 306
            K+G+G F  V K      G+  A+K + K+ K  E +    E+  L RL  H N++RL+
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64

Query: 307 GFCLERKER--ILVYEFVPNASLDHFIFDPI-NREHMTWEKRYK-IIEGIARGLLYLHED 362
               +RK     LV+E      +D  +++ I  R+    EKR K  +  + + L ++H  
Sbjct: 65  EVLFDRKTGRLALVFEL-----MDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH-- 117

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM- 421
            R  I HRD+K  NIL+  +   K++DFG  R       +++    + T  Y APE ++ 
Sbjct: 118 -RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTE---YISTRWYRAPECLLT 172

Query: 422 HGRFSVKSDIFSFGVLVLEIVS 443
            G +  K DI++ G +  EI+S
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 54/227 (23%), Positives = 104/227 (45%), Gaps = 44/227 (19%)

Query: 246 FSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           + D   LG G  G V+  + S+  + +AVK++     Q       E+ ++ RL H N+V+
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 305 LLGFCLERKERILVYEFVPNA---------SLDHFIFDPINREHMTWEKRYKIIEG---- 351
                        VYE +  +         SL       I +E+M  +    + +G    
Sbjct: 67  -------------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSE 113

Query: 352 ---------IARGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMARLFEMDQT 401
                    + RGL Y+H  +   ++HRDLK +N+ +++E +  KI DFG+AR+ +   +
Sbjct: 114 EHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYS 170

Query: 402 HSD--TNRVVGTFGYMAPEYVMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           H    +  +V  + Y +P  ++      K+ D+++ G +  E+++G+
Sbjct: 171 HKGYLSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 28/208 (13%)

Query: 252 LGQGGFGAVYKGML----SNGETIAVKRLSK----NSKQGEIEFKNEVLLLARLQHRNLV 303
           LG+GG+G V++         G+  A+K L K     +++     K E  +L  ++H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGLLYLHED 362
            L+       +  L+ E++    L    F  + RE +  E      +  I+  L +LH  
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGEL----FMHLEREGIFMEDTACFYLSEISLALEHLH-- 117

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMAR--LFEMDQTHSDTNRVVGTFGYMAPEYV 420
            +  II+RDLK  NILLD++ + K++DFG+ +  + E   TH+      GT  YMAPE +
Sbjct: 118 -QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT----FCGTIEYMAPEIL 172

Query: 421 M---HGRFSVKSDIFSFGVLVLEIVSGQ 445
           M   HG+     D +S G L+ ++++G 
Sbjct: 173 MRSGHGK---AVDWWSLGALMYDMLTGA 197

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 18/205 (8%)

Query: 250 NKLGQGGFGAVYKGMLS-NGETIAVK--RLS-KNSKQGEIEFKNEVLLLARLQHRNLVRL 305
           ++LG+G +G+VYK +    G T+A+K  RL    SK  +I    E+ +L +     +V  
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIM--ELDILHKAVSPYIVDF 64

Query: 306 LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
            G         +  E++   SLD      +  E +  +   +I   + +GL +L E+   
Sbjct: 65  YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--H 122

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG-- 423
            IIHRD+K +N+L++     K+ DFG++    +  + + TN  +G   YMAPE +  G  
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTN--IGCQSYMAPERIKSGGP 178

Query: 424 ----RFSVKSDIFSFGVLVLEIVSG 444
                ++V+SD++S G+ +LE+  G
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALG 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 68.2 bits (166), Expect = 2e-12
 Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 29/207 (14%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHRNLVRLL- 306
           +G G +G+V         + +AVK+LS+   Q  I  +    E+ LL  ++H N++ LL 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSR-PFQSLIHARRTYRELRLLKHMKHENVIGLLD 81

Query: 307 ----GFCLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
                  +E    + +   +  A L++ +    ++ EH+ +     +I  + RGL Y+H 
Sbjct: 82  VFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-----LIYQLLRGLKYIHS 136

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV- 420
                IIHRDLK SN+ ++ +   +I DFG+AR     Q   +    V T  Y APE + 
Sbjct: 137 AG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYRAPEIML 188

Query: 421 --MHGRFSVKSDIFSFGVLVLEIVSGQ 445
             MH   +V  DI+S G ++ E++ G+
Sbjct: 189 NWMHYNQTV--DIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 69.9 bits (171), Expect = 2e-12
 Identities = 54/191 (28%), Positives = 91/191 (47%), Gaps = 20/191 (10%)

Query: 268 GETIAVKRLSKNSKQGEIE---FKNEVLLLARLQHRNLVRLL--GFCLERKERILVYEFV 322
           G  +A+K L  ++ + E +   F+ E  L ARL H N+V LL  G          V+E+V
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61

Query: 323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL--- 379
           P  +L   +        +   +  +++  +   L   H      I+HRDLK  NI++   
Sbjct: 62  PGRTLREVL---AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQT 115

Query: 380 DSEMNPKISDFGMARLF----EMD-QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSF 434
               + K+ DFG+  L     + D  T + T  V+GT  Y APE +     +  SD++++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175

Query: 435 GVLVLEIVSGQ 445
           G++ LE ++GQ
Sbjct: 176 GLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 67.8 bits (165), Expect = 3e-12
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 29/213 (13%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRN 301
           D+F   ++LG G  G V+K        I  ++L     +  I  +   E+ +L       
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE--------GIA 353
           +V   G      E  +  E +   SLD  +           +K  +I E         + 
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVL-----------KKAGRIPEQILGKVSIAVI 113

Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA-RLFEMDQTHSDTNRVVGTF 412
           +GL YL E  + +I+HRD+K SNIL++S    K+ DFG++ +L +     S  N  VGT 
Sbjct: 114 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTR 166

Query: 413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
            YM+PE +    +SV+SDI+S G+ ++E+  G+
Sbjct: 167 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 66.4 bits (162), Expect = 4e-12
 Identities = 69/261 (26%), Positives = 116/261 (44%), Gaps = 47/261 (18%)

Query: 252 LGQGGFGAVYKG----MLSNGET----IAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
           LGQG F  ++KG    +   GE     + +K L K+ +     F     ++++L H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
              G C+   E I+V E+V   SLD ++    N  +++W  + ++ + +A  L +L +  
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120

Query: 364 RLRIIHRDLKASNILLDSEM-----NP---KISDFGMARLFEMDQTHSDTNRVVGTFGYM 415
              + H ++ A N+LL  E      NP   K+SD G++       T      ++    ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS------ITVLPKEILLERIPWV 171

Query: 416 APEYVMHGR-FSVKSDIFSFGVLVLEIVSG----------QKRSSFGTEEETEDLLTYAW 464
            PE + + +  S+ +D +SFG  + EI SG          QK+  F      ED      
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-----YEDRHQLPA 226

Query: 465 RNWNEGAAL--NLMD--PTMR 481
             W E A L    MD  P  R
Sbjct: 227 PKWTELANLINQCMDYEPDFR 247

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 46/214 (21%)

Query: 252 LGQGGFGAV-YKGMLSNGETIAVKRLS-KNSKQGEIEF-KNEVLLLARLQHRNLVR---- 304
           +G+G +G V      ++G+   +K+L+ +N+ + E +  + E  LL++L+H N+V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 305 ----------LLGFC----LERKERILVYEFVP-NASLDHFIFDPINREHMTWEKRYKII 349
                     ++GFC    L  K +    + +P N  ++ F+                  
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFV------------------ 109

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
             IA  L YLHE     I+HRDLK  N+ L      K+ D G+AR+ E     + T  ++
Sbjct: 110 -QIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LI 163

Query: 410 GTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           GT  YM+PE   +  ++ KSD+++ G  V E+ +
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 66.8 bits (163), Expect = 5e-12
 Identities = 58/171 (33%), Positives = 88/171 (51%), Gaps = 40/171 (23%)

Query: 309 CLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR--------GLLYL 359
           C + + R+  V EFV    L   +F      HM  +++ K+ E  AR         L +L
Sbjct: 64  CFQTESRLFFVIEFVSGGDL---MF------HM--QRQRKLPEEHARFYSAEISLALNFL 112

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           HE     II+RDLK  N+LLD+E + K++D+GM +  E  +    T+   GT  Y+APE 
Sbjct: 113 HERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPE- 166

Query: 420 VMHGR---FSVKSDIFSFGVLVLEIVSGQKRSSF-------GTEEETEDLL 460
           ++ G    FSV  D ++ GVL+ E+++G  RS F         ++ TED L
Sbjct: 167 ILRGEDYGFSV--DWWALGVLMFEMMAG--RSPFDIVGMSDNPDQNTEDYL 213

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 67.0 bits (164), Expect = 6e-12
 Identities = 60/194 (30%), Positives = 99/194 (51%), Gaps = 36/194 (18%)

Query: 268 GETIAVKRLSK------NSKQGEIEFKNEVLLLARLQHRNLVRLLG-FCLERK-----ER 315
           G+ +A+K+LS+      ++K+   E      L+  + H+N++ LL  F  ++      + 
Sbjct: 41  GQNVAIKKLSRPFQNVTHAKRAYRELV----LMKLVNHKNIIGLLNVFTPQKSLEEFQDV 96

Query: 316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKAS 375
            LV E + +A+L   I   ++ E M++   Y+++ GI     +LH      IIHRDLK S
Sbjct: 97  YLVMELM-DANLCQVIQMDLDHERMSY-LLYQMLCGIK----HLHSAG---IIHRDLKPS 147

Query: 376 NILLDSEMNPKISDFGMARL----FEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDI 431
           NI++ S+   KI DFG+AR     F M      T  VV T  Y APE ++   +    DI
Sbjct: 148 NIVVKSDCTLKILDFGLARTAGTSFMM------TPYVV-TRYYRAPEVILGMGYKENVDI 200

Query: 432 FSFGVLVLEIVSGQ 445
           +S G ++ E++ G 
Sbjct: 201 WSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 66.8 bits (163), Expect = 6e-12
 Identities = 38/92 (41%), Positives = 52/92 (56%), Gaps = 3/92 (3%)

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +ARG+ +L   SR + IHRDL A NILL      KI DFG+AR    D  +         
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +MAPE +    ++ +SD++SFGVL+ EI S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 65.6 bits (160), Expect = 8e-12
 Identities = 62/234 (26%), Positives = 106/234 (45%), Gaps = 32/234 (13%)

Query: 252 LGQGGFGAVYKGMLSNG----------ETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN 301
           LGQG F  +YKG+L             E   V ++  +  +  + F     L+++L H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           LV+L G C+ R E I+V E+V    LD F+    N   + W  +  + + +A  L YL +
Sbjct: 63  LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119

Query: 362 DSRLRIIHRDLKASNILL----DSEMNP---KISDFGMARLFEMDQTHSDTNRVVGTFGY 414
               +++H ++   NIL+     +E      K+SD G+        T       V    +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI------TVLSREERVERIPW 170

Query: 415 MAPEYVMHGRFSVKS--DIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRN 466
           +APE + +G+ S+    D +SFG  +LEI S  +     T   +E    Y  ++
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGEE-PLSTLSSSEKERFYQDQH 223

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 65.8 bits (160), Expect = 9e-12
 Identities = 65/228 (28%), Positives = 101/228 (44%), Gaps = 26/228 (11%)

Query: 245 NFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           NF     LG G +G V+     +G         K  K+  I  K +     R + + L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 305 LLGFCLERKERILV---YEFVPNASLDHFIFDPINR----EHMTWEKRYK------IIEG 351
           +      R+   LV   Y F  +  L H I D IN      H++  +R+K          
Sbjct: 61  I------RQSPFLVTLHYAFQTDTKL-HLILDYINGGELFTHLSQRERFKEQEVQIYSGE 113

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           I   L +LH   +L II+RD+K  NILLDS  +  ++DFG+++ F  D+     +   GT
Sbjct: 114 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGT 169

Query: 412 FGYMAPEYVMHGR--FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE 457
             YMAP+ V  G        D +S GVL+ E+++G    +   E+ ++
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ 217

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 63/201 (31%), Positives = 97/201 (48%), Gaps = 19/201 (9%)

Query: 252 LGQGGFGAVYKGML-SNGETIAVKRLSKNS-----KQGEIEFKNEVLLLARLQHRNLVRL 305
           +G+G FG V      S+G   AVK L K +     +Q  I  +  VLL   L+H  LV L
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLL-KNLKHPFLVGL 61

Query: 306 LGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDS 363
             +  +  E++  V ++V    L    F  + RE    E R +     +A  + YLH   
Sbjct: 62  -HYSFQTAEKLYFVLDYVNGGEL----FFHLQRERCFLEPRARFYAAEVASAIGYLHS-- 114

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
            L II+RDLK  NILLDS+ +  ++DFG+ +  E  +    T+   GT  Y+APE +   
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKE 171

Query: 424 RFSVKSDIFSFGVLVLEIVSG 444
            +    D +  G ++ E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 28/216 (12%)

Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLSNGE--TIAVKRLSKNS--KQGEIEFK-NEVLLL 294
           ++  ++F+    LG G FG V      N +   +A+KR  K+   KQ +++   +E  +L
Sbjct: 26  KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKIL 85

Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG--- 351
             + H   V L G   +     LV EFV            I  E  T+ +R K       
Sbjct: 86  NYINHPFCVNLYGSFKDESYLYLVLEFV------------IGGEFFTFLRRNKRFPNDVG 133

Query: 352 ---IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV 408
               A+ +L       L I++RDLK  N+LLD +   K++DFG A++ +     + T  +
Sbjct: 134 CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD-----TRTYTL 188

Query: 409 VGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            GT  Y+APE +++      +D ++ G+ + EI+ G
Sbjct: 189 CGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 38/92 (41%), Positives = 52/92 (56%), Gaps = 3/92 (3%)

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +ARG+ +L   SR + IHRDL A NILL      KI DFG+AR    D  +         
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +MAPE +    ++ +SD++SFGVL+ EI S
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 64.3 bits (156), Expect = 4e-11
 Identities = 75/257 (29%), Positives = 119/257 (46%), Gaps = 30/257 (11%)

Query: 252 LGQGGFGAVYKGMLSNGETI-AVKRLSKNS---KQGEIEFKNEV-LLLARLQHRNLVRLL 306
           +G+G FG V        E   AVK L K +   K+ E    +E  +LL  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61

Query: 307 GFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSR 364
            F  +  +++  V +++    L    F  + RE    E R +     IA  L YLH    
Sbjct: 62  HFSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAEIASALGYLHS--- 114

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
           L I++RDLK  NILLDS+ +  ++DFG+ +  E  + +  T+   GT  Y+APE +    
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172

Query: 425 FSVKSDIFSFGVLVLEIVSG-QKRSSFGTEEETEDLL----------TYAWRNWNEGAAL 473
           +    D +  G ++ E++ G     S  T E  +++L          T + R+  EG  L
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEG--L 230

Query: 474 NLMDPTMRGGSTSEMMK 490
              D T R G+  + M+
Sbjct: 231 LQKDRTKRLGAKDDFME 247

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 63.9 bits (155), Expect = 5e-11
 Identities = 42/114 (36%), Positives = 64/114 (56%), Gaps = 10/114 (8%)

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           I+  L YLHE     II+RDLK  N+LLDSE + K++D+GM +  E  +    T+   GT
Sbjct: 105 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGT 159

Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKR-----SSFGTEEETEDLL 460
             Y+APE +    +    D ++ GVL+ E+++G+       SS   ++ TED L
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 213

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 63.9 bits (155), Expect = 5e-11
 Identities = 37/92 (40%), Positives = 53/92 (57%), Gaps = 3/92 (3%)

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +A+G+ +L   SR + IHRDL A NILL      KI DFG+AR    D  +         
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +MAPE +    ++++SD++SFGVL+ EI S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 12/213 (5%)

Query: 252 LGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEFKN--EVLLLARLQHRNLVRLLGF 308
           +G+G +G V K       E +A+K+   + +  E++     E+ +L  L+  N+V L   
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
              R +  LV+E+V    L+      +  E        K+   I + +  +H   +  I+
Sbjct: 69  FRRRGKLYLVFEYVEKNMLE------LLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIV 122

Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVK 428
           HRD+K  N+L+      K+ DFG AR    + ++++    V T  Y +PE ++   +   
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGAPYGKA 181

Query: 429 SDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLT 461
            D++S G ++ E+  GQ    F  E E + L T
Sbjct: 182 VDMWSVGCILGELSDGQPL--FPGESEIDQLFT 212

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 63.5 bits (154), Expect = 6e-11
 Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 17/200 (8%)

Query: 252 LGQGGFGAVYKGMLS-NGETIAVKRLSK----NSKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G+G FG V       +G+  AVK L K    N K+ +       +LL  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61

Query: 307 GFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGLLYLHEDSR 364
            +  +  E++  V +FV    L    F  + RE    E R +     IA  L YLH    
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGEL----FFHLQRERSFPEPRARFYAAEIASALGYLHS--- 114

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
           + I++RDLK  NILLDS+ +  ++DFG+ +  E       T    GT  Y+APE +    
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQP 172

Query: 425 FSVKSDIFSFGVLVLEIVSG 444
           +    D +  G ++ E++ G
Sbjct: 173 YDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 63.4 bits (154), Expect = 7e-11
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 26/204 (12%)

Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEV-------LLLARLQHRNLVR 304
           +G+G FG V +  +   +T  +  L K  ++  I  ++EV        +LA++    +V 
Sbjct: 1   IGKGSFGKVMQ--VRKRDTQRIYAL-KTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVP 57

Query: 305 LLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG---IARGLLYLH 360
           L  F  +  E++ LV  F+    L H         H+  E R+ +       A  L  L 
Sbjct: 58  L-KFSFQSPEKLYLVLAFINGGELFH---------HLQREGRFDLSRARFYTAELLCALE 107

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV 420
              +  +I+RDLK  NILLD + +  + DFG+ +L  M      TN   GT  Y+APE +
Sbjct: 108 NLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDK-TNTFCGTPEYLAPELL 165

Query: 421 MHGRFSVKSDIFSFGVLVLEIVSG 444
           +   ++   D ++ GVL+ E+++G
Sbjct: 166 LGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 63.4 bits (154), Expect = 8e-11
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 26/154 (16%)

Query: 317 LVYEFVPNASLDHFIFDPIN----------REHMTWEKRYKIIEG-IARGLLYLHEDSRL 365
           L Y F   A L H I D ++          R++ + E   +   G I   L +LH   +L
Sbjct: 70  LHYAFQTEAKL-HLILDYVSGGEMFTHLYQRDNFS-EDEVRFYSGEIILALEHLH---KL 124

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM---- 421
            I++RD+K  NILLDSE +  ++DFG+++ F + +    T    GT  YMAPE +     
Sbjct: 125 GIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCGTIEYMAPEIIRGKGG 183

Query: 422 HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEE 455
           HG+     D +S G+L+ E+++G   S F  E E
Sbjct: 184 HGK---AVDWWSLGILIFELLTGA--SPFTLEGE 212

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 63.2 bits (153), Expect = 1e-10
 Identities = 59/198 (29%), Positives = 101/198 (51%), Gaps = 22/198 (11%)

Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 29  AQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVF 85

Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++   Y+++ GI     +LH    
Sbjct: 86  TPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK----HLHSAG- 139

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
             IIHRDLK SNI++ S+   KI DFG+AR      +   T  VV  + Y APE ++   
Sbjct: 140 --IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-YRAPEVILGMG 194

Query: 425 FSVKSDIFSFGVLVLEIV 442
           +    DI+S G ++ E+V
Sbjct: 195 YKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 16/198 (8%)

Query: 252 LGQGGFG-AVYKGMLSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +G+G FG A+    +++ +  A+K  RL K+S   E   K E +LLA+++H N+V     
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK-EAVLLAKMKHPNIVAFKES 66

Query: 309 CLERKERILVYEFVPNASLDHFIFDPINR---EHMTWEKRYKIIEGIARGLLYLHEDSRL 365
                   +V E+     L   I     +   E    +   ++  G+     ++HE    
Sbjct: 67  FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ----HIHEK--- 119

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRF 425
           R++HRD+K+ NI L      K+ DFG ARL      ++ T   VGT  Y+ PE   +  +
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPY 177

Query: 426 SVKSDIFSFGVLVLEIVS 443
           + KSDI+S G ++ E+ +
Sbjct: 178 NNKSDIWSLGCILYELCT 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 62.8 bits (152), Expect = 1e-10
 Identities = 59/201 (29%), Positives = 102/201 (50%), Gaps = 22/201 (10%)

Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVF 92

Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++   Y+++ GI     +LH    
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK----HLHSAG- 146

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
             IIHRDLK SNI++ S+   KI DFG+AR      +   T  VV  + Y APE ++   
Sbjct: 147 --IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-YRAPEVILGMG 201

Query: 425 FSVKSDIFSFGVLVLEIVSGQ 445
           +    DI+S G ++ E++ G 
Sbjct: 202 YKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 63.2 bits (153), Expect = 1e-10
 Identities = 44/179 (24%), Positives = 88/179 (49%), Gaps = 19/179 (10%)

Query: 273 VKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRL--------LGFCLERKERILVYEFVPN 324
           + +  K   +  I+ +NE+L L RL H N++++          + + +K    +Y F+ +
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYD 255

Query: 325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            + D           +  + R  I++ +   + Y+H+    ++IHRD+K  NI L+ +  
Sbjct: 256 EAFDW------KDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGK 305

Query: 385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             + DFG A  FE ++   D    VGT    +PE +    +   +DI+S G+++L+++S
Sbjct: 306 IVLGDFGTAMPFEKEREAFDYGW-VGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 63.1 bits (153), Expect = 2e-10
 Identities = 63/239 (26%), Positives = 112/239 (46%), Gaps = 33/239 (13%)

Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSK 278
           EDE+ E+ I      D +  R    ++   N +G G FG VY+ + +   E +A+K++ +
Sbjct: 48  EDEDEEKMI------DNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ 101

Query: 279 NSKQGEIEFKN-EVLLLARLQHRNLVRLLGF----CLERKERIL----VYEFVPNASLDH 329
           +      ++KN E+L++  L H N++ L  +    C ++ E+ +    V EF+P     +
Sbjct: 102 DP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKY 156

Query: 330 FIFDPINREH--MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP-K 386
                 N     +   K Y     + R L Y+H      I HRDLK  N+L+D   +  K
Sbjct: 157 MKHYARNNHALPLFLVKLYSY--QLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLK 211

Query: 387 ISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSG 444
           + DFG A+     Q     + +   F Y APE ++    ++   D++S G ++ E++ G
Sbjct: 212 LCDFGSAKNLLAGQ--RSVSYICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 28/224 (12%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAV----YKGMLSNGETIAVKRLSKNS--KQGEIEFK 288
               +R+  ++F     +G+G FG V    +K   S+ +  A+K LSK    K+ +  F 
Sbjct: 34  KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHK---SSKQVYAMKLLSKFEMIKRSDSAFF 90

Query: 289 -NEVLLLARLQHRNLVRLLGFCLERKERIL--VYEFVPNASLDHFIFDPINREHMTWEKR 345
             E  ++A      +V+L      + ++ L  V E++P   L + + +    E   W + 
Sbjct: 91  WEERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK--WARF 146

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA-RLFEMDQTHSD 404
           Y      A  +L L     +  IHRD+K  N+LLD   + K++DFG   ++        D
Sbjct: 147 Y-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD 201

Query: 405 TNRVVGTFGYMAPEYVM----HGRFSVKSDIFSFGVLVLEIVSG 444
           T   VGT  Y++PE +      G +  + D +S GV + E++ G
Sbjct: 202 T--AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 62.2 bits (151), Expect = 2e-10
 Identities = 35/97 (36%), Positives = 55/97 (56%), Gaps = 13/97 (13%)

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG- 410
           +A+G+ +L   +    IHRD+ A N+LL      KI DFG+AR        +D+N VV  
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIM-----NDSNYVVKG 272

Query: 411 ----TFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
                  +MAPE +    ++V+SD++S+G+L+ EI S
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 61.8 bits (150), Expect = 3e-10
 Identities = 76/268 (28%), Positives = 114/268 (42%), Gaps = 54/268 (20%)

Query: 245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS----KQGEIEFKNEVLLLARLQH 299
           +F     LG G FG V        GE  A+K L K      KQ +     E  +L  L H
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQ-HVAQEKSILMELSH 77

Query: 300 RNLVRLL-GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR---- 354
             +V ++  F  E +   L+ EFV    L    F      H+   K  +    +A+    
Sbjct: 78  PFIVNMMCSFQDENRVYFLL-EFVVGGEL----F-----THL--RKAGRFPNDVAKFYHA 125

Query: 355 ----GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG 410
                  YLH      II+RDLK  N+LLD++ + K++DFG A+     +    T  + G
Sbjct: 126 ELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCG 177

Query: 411 TFGYMAPEYVM---HGRFSVKSDIFSFGVLVLEIVSGQ----KRSSFGTEEET-EDLLTY 462
           T  Y+APE +    HG+     D ++ GVL+ E ++G       + F   E+     L +
Sbjct: 178 TPEYLAPEVIQSKGHGK---AVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKF 234

Query: 463 AWRNWNEGAALNLM------DPTMRGGS 484
              NW +G A +L+      D T R G+
Sbjct: 235 P--NWFDGRARDLVKGLLQTDHTKRLGT 260

Length = 329

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 61.5 bits (149), Expect = 4e-10
 Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 30/208 (14%)

Query: 252 LGQGGFGAVYKGMLSNGETI-AVKRLSKNSKQGEIEFKNEVLLLARLQHRN-LVRLLGFC 309
           +G+G FG VY+    +   I A+K LSK     EI  K EV     +  RN LVR L   
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKK----EIVAKKEVA--HTIGERNILVRTL--- 51

Query: 310 LERKERILVYEFVPNASLD-HFIFDPINREHMTW---------EKRYKI-IEGIARGLLY 358
           L+    I+  +F      D + + D ++   + W         E R K  I  +   L +
Sbjct: 52  LDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEH 111

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD-TNRVVGTFGYMAP 417
           LH+     I++RDLK  NILLD+  +  + DFG+++    + T +  TN   GT  Y+AP
Sbjct: 112 LHKYD---IVYRDLKPENILLDATGHIALCDFGLSK---ANLTDNKTTNTFCGTTEYLAP 165

Query: 418 EYVMHGR-FSVKSDIFSFGVLVLEIVSG 444
           E ++  + ++   D +S GVLV E+  G
Sbjct: 166 EVLLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 37/225 (16%)

Query: 250 NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE------------IEFK--NEVLLL 294
             LG+G +G V K      G+ +A+K++       +            I F    E+ ++
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR 354
             ++H N++ L+   +E     LV + +  AS    + D   +  +T  +   I+  I  
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIM--ASDLKKVVD--RKIRLTESQVKCILLQILN 130

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF----EMDQTHSD------ 404
           GL  LH+      +HRDL  +NI ++S+   KI+DFG+AR +      D    D      
Sbjct: 131 GLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 405 ---TNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
              T++VV T  Y APE +M   ++    D++S G +  E+++G+
Sbjct: 188 EEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 61.1 bits (148), Expect = 6e-10
 Identities = 36/97 (37%), Positives = 55/97 (56%), Gaps = 13/97 (13%)

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG- 410
           +A+G+ +L   +    IHRDL A NILL      KI DFG+AR        +D+N VV  
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVVKG 274

Query: 411 ----TFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
                  +MAPE + +  ++ +SD++S+G+L+ EI S
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 59.9 bits (145), Expect = 7e-10
 Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 25/208 (12%)

Query: 251 KLGQGGFGAVYKGMLSNGETIA---VKRLSKNSKQGEIEFKNEVLLLAR----LQHRNLV 303
           ++G G FG V    +     +A   VK L  N+   E   +NE L        LQH N++
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKE---QNEFLQQGDPYRILQHPNIL 58

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIF--DPINREHMTWEKRYKIIEGIARGLLYLHE 361
           + LG C+E    +LV+E+     L  ++       R       +    E IA G+ ++H 
Sbjct: 59  QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACE-IAAGVTHMH- 116

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMA-RLFEMDQTHSDTNRVVGTFGYMAPEYV 420
             +   +H DL   N  L S++  K+ D+G+    ++ D   ++ ++ V    ++APE V
Sbjct: 117 --KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAPELV 173

Query: 421 --MHGRF-----SVKSDIFSFGVLVLEI 441
              HG       +  S++++ GV + E+
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 61.0 bits (148), Expect = 8e-10
 Identities = 32/88 (36%), Positives = 51/88 (57%)

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYM 415
           LL +H      +IHRD+K++NILL S    K+ DFG ++++    +        GT  Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 416 APEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           APE      +S K+D+FS GVL+ E+++
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLT 240

Length = 496

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 60.1 bits (146), Expect = 8e-10
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 28/212 (13%)

Query: 251 KLGQGGFGAV----YKGMLSNGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQ-HRNL 302
           +LGQG +G V         S  ET+A+K+++ N    +I  K    E+ LL   + H+N+
Sbjct: 7   ELGQGAYGIVCSARNAET-SEEETVAIKKIT-NVFSKKILAKRALRELKLLRHFRGHKNI 64

Query: 303 VRLLGFCLERKER---ILVYEFVPNASLDHFIFD--PINREHMTWEKRYKIIEGIARGLL 357
             L    +        + +YE +  A L   I    P+   H         I  I  GL 
Sbjct: 65  TCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQS-----FIYQILCGLK 119

Query: 358 YLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD---TNRVVGTFGY 414
           Y+H  +   ++HRDLK  N+L++++   KI DFG+AR F  +   +    T   V T  Y
Sbjct: 120 YIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTE-YVATRWY 175

Query: 415 MAPEYVMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
            APE ++  +   K+ D++S G ++ E++  +
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 48/212 (22%), Positives = 89/212 (41%), Gaps = 32/212 (15%)

Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGE--IEFKNEVLLLARLQHRNLVRLLGFC 309
                   + K        +AVK+++ +S   E     + E++   +LQH N++  +   
Sbjct: 10  FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68

Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTW---EK--RYKIIEGIARGLLYLHEDSR 364
           +   E  +V   +   S +  +     + H      E    + I++ +   L Y+H    
Sbjct: 69  IVDSELYVVSPLMAYGSCEDLL-----KTHFPEGLPELAIAF-ILKDVLNALDYIH---S 119

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG--------YMA 416
              IHR +KAS+ILL  +    +S  G+     M + H    RVV  F         +++
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLS--GLRYSVSMIK-HGKRQRVVHDFPKSSVKNLPWLS 176

Query: 417 PEYV---MHGRFSVKSDIFSFGVLVLEIVSGQ 445
           PE +   + G ++ KSDI+S G+   E+ +G 
Sbjct: 177 PEVLQQNLQG-YNEKSDIYSVGITACELANGH 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 59.7 bits (144), Expect = 1e-09
 Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 16/200 (8%)

Query: 252 LGQGGFGAV-YKGMLSNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           LG+G FG V      ++G+  A+K L K    +K        E  +L   +H  L  L  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL-K 61

Query: 308 FCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRL 365
           +  + K+R+  V E+V    L    F  ++RE +  E R +     I   L YLH     
Sbjct: 62  YSFQTKDRLCFVMEYVNGGEL----FFHLSRERVFSEDRTRFYGAEIVSALDYLHSG--- 114

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRF 425
           +I++RDLK  N++LD + + KI+DFG+ +    D     T    GT  Y+APE +    +
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLEDNDY 172

Query: 426 SVKSDIFSFGVLVLEIVSGQ 445
               D +  GV++ E++ G+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 11/154 (7%)

Query: 309 CLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
           C +   R+ LV E+V    L   +F    +  +  E        I   L +LHE     I
Sbjct: 64  CFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHERG---I 117

Query: 368 IHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSV 427
           I+RDLK  N+LLD++ + K++D+GM +  E       T+   GT  Y+APE +    +  
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEYGF 175

Query: 428 KSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLT 461
             D ++ GVL+ E+++G  RS F    +  D+ T
Sbjct: 176 SVDWWALGVLMFEMMAG--RSPFDIITDNPDMNT 207

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 26/207 (12%)

Query: 252 LGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHRNLVRLLG 307
           +G+G +G V     S   E +A+K+++ N+    I+ K    E+ LL  L H N++ +  
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIA-NAFDNRIDAKRTLREIKLLRHLDHENVIAIKD 71

Query: 308 FCLERKER------ILVYEFVPNASLDHFI--FDPINREHMTWEKRYKIIEGIARGLLYL 359
             +    R       +VYE + +  L   I     ++ +H     +Y + + + RGL Y+
Sbjct: 72  -IMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHC----QYFLYQ-LLRGLKYI 124

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H  +   ++HRDLK SN+LL++  + KI DFG+AR     +        V T  Y APE 
Sbjct: 125 HSAN---VLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVTRWYRAPEL 179

Query: 420 VMH-GRFSVKSDIFSFGVLVLEIVSGQ 445
           +++   ++   D++S G +  E++  +
Sbjct: 180 LLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 60/258 (23%), Positives = 103/258 (39%), Gaps = 72/258 (27%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNS---KQGEIEFKNE 290
           DFE+I+V          +G+G FG V        G   A+K+L K+    K+     + E
Sbjct: 2   DFESIKV----------IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAE 51

Query: 291 VLLLARLQHRNLVRLLGFCLERKER--ILVYEFVPNASLDHFIFDPINREHMTWEKRYKI 348
             +LA   +  +V+L  +   + E    L+ E++P   +            MT   +   
Sbjct: 52  RDILAEADNPWVVKL--YYSFQDENYLYLIMEYLPGGDM------------MTLLMKKDT 97

Query: 349 IEG------IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE----- 397
                    IA  +L +    +L  IHRD+K  N+LLD++ + K+SDFG+    +     
Sbjct: 98  FTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157

Query: 398 ------------------------MDQTHS-DTNR------VVGTFGYMAPEYVMHGRFS 426
                                     +  +   NR       VGT  Y+APE  +   ++
Sbjct: 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN 217

Query: 427 VKSDIFSFGVLVLEIVSG 444
            + D +S GV++ E++ G
Sbjct: 218 KECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 59.3 bits (143), Expect = 3e-09
 Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 3/92 (3%)

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +ARG+ +L   +    +HRDL A N+LL      KI DFG+AR    D  +         
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +MAPE +    ++  SD++S+G+L+ EI S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 22/207 (10%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSK--NSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +G+G +G V   +    GE +A+K+++              E+ LL  L+H ++V +   
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67

Query: 309 CL-----ERKERILVYEFVPNASLDHFI--FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
            L     E K+  +V+E +  + L   I   D +  EH  +      +  + R L Y+H 
Sbjct: 68  MLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQF-----FLYQLLRALKYIHT 121

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARL-FEMDQTHSDTNRVVGTFGYMAPEYV 420
            +   + HRDLK  NIL +++   KI DFG+AR+ F    T       V T  Y APE  
Sbjct: 122 AN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC 178

Query: 421 --MHGRFSVKSDIFSFGVLVLEIVSGQ 445
                +++   DI+S G +  E+++G+
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 58.7 bits (142), Expect = 3e-09
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 16/166 (9%)

Query: 290 EVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINR-EHMTWEKRYKI 348
           E+ +L  + HR ++ L+      + +  V   +P    D F +  ++R   +  E+   I
Sbjct: 136 EIDILKTISHRAIINLIH---AYRWKSTVCMVMPKYKCDLFTY--VDRSGPLPLEQAITI 190

Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV 408
              +   L YLH      IIHRD+K  NI LD   N  + DFG A   +    H DT + 
Sbjct: 191 QRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA---HPDTPQC 244

Query: 409 VGTFGYM---APEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFG 451
            G  G +   +PE +    +  K+DI+S G+++ E+ S +  + FG
Sbjct: 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM-SVKNVTLFG 289

Length = 392

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 58.5 bits (141), Expect = 4e-09
 Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 32/222 (14%)

Query: 239 IRVATDNFSDANKLGQGGFGAV----YKGMLSNGETIAVKRLSKNS---KQGEIEFKNEV 291
           +++  +++     +G+G FG V    +K   S+ +  A+K LSK     +     F  E 
Sbjct: 38  LQMKAEDYDVVKVIGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 292 LLLARLQHRNLVRLLGFCLERKERIL--VYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
            ++A      +V+L  FC  + ++ L  V E++P   L + + +    E   W K Y   
Sbjct: 95  DIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE--KWAKFYT-- 148

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT---HSDTN 406
              A  +L L     + +IHRD+K  N+LLD   + K++DFG     +MD+T     DT 
Sbjct: 149 ---AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDT- 202

Query: 407 RVVGTFGYMAPEYVMH----GRFSVKSDIFSFGVLVLEIVSG 444
             VGT  Y++PE +      G +  + D +S GV + E++ G
Sbjct: 203 -AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 58.6 bits (142), Expect = 6e-09
 Identities = 51/228 (22%), Positives = 92/228 (40%), Gaps = 45/228 (19%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEI---EFKNEVLLLARLQHRNLVRLL 306
            +G+GG G VY          +A+K++ ++  +  +    F  E  + A L H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR---------------YKIIEG 351
             C +         ++   +L   +          W+K                  I   
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLKSLL-------KSVWQKESLSKELAEKTSVGAFLSIFHK 121

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM---DQTHSDTN-- 406
           I   + Y+H  S+  ++HRDLK  NILL       I D+G A   ++   D    D +  
Sbjct: 122 ICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178

Query: 407 -----------RVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
                      ++VGT  YMAPE ++    S  +DI++ GV++ ++++
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 57.7 bits (139), Expect = 7e-09
 Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 3/92 (3%)

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +A G+ +L   +    +HRDL A N+L+      KI DFG+AR    D  +         
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +MAPE + +  ++  SD++SFG+L+ EI +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 56.5 bits (136), Expect = 2e-08
 Identities = 41/156 (26%), Positives = 72/156 (46%), Gaps = 8/156 (5%)

Query: 290 EVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
           E  +L  + H ++++L G     K   L+   +P    D + +    + ++       I 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLA-AKRNIAICDILAIE 188

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
             + R + YLHE+   RIIHRD+KA NI ++   +  + DFG A  F +D   +      
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYGWA 244

Query: 410 GTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           GT    APE +    +    DI+S G+++ E+ +  
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 32/211 (15%)

Query: 252 LGQGGFGAVYKGML-----------SNGETIAV--KRLSKNSKQGEIEFKNEVLLLARLQ 298
           LG+G    +Y G+L           S  + I V  K L  + +   + F     ++ ++ 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H+++V L G C+   E I+V EFV    LD F+    +     W  ++K+ + +A  L Y
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120

Query: 359 LHEDSRLRIIHRDLKASNILL-----DSEMNP--KISDFGMARLFEMDQTHSDTNRVVGT 411
           L ED  L  +H ++   NILL     D E  P  K+SD G+        T       V  
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIP------ITVLSRQECVER 171

Query: 412 FGYMAPEYVMHGR-FSVKSDIFSFGVLVLEI 441
             ++APE V   +  S+ +D +SFG  + EI
Sbjct: 172 IPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 32/208 (15%)

Query: 252 LGQGGFGAVYKGML----SNGETIAVKRLSKNSKQGEIEFKNEVL-------LLARLQHR 300
           LG+G FG V   +L    + G+  A+K L K      I  K+EV        +L   +H 
Sbjct: 3   LGKGTFGKV---ILVREKATGKYYAMKILKKEV----IIAKDEVAHTLTESRVLQNTRHP 55

Query: 301 NLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLY 358
            L  L  +  +  +R+  V E+     L    F  ++RE +  E R +     I   L Y
Sbjct: 56  FLTAL-KYSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVSALGY 110

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV-VGTFGYMAP 417
           LH      +++RDLK  N++LD + + KI+DFG+ +      +   T +   GT  Y+AP
Sbjct: 111 LHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAP 164

Query: 418 EYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           E +    +    D +  GV++ E++ G+
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 55/228 (24%), Positives = 106/228 (46%), Gaps = 26/228 (11%)

Query: 244 DNFSDANKLGQGGFGAVY----KGMLSNGETIAVKRLSKN---SKQGEIEFKNEVLLLAR 296
            +F   + +G+G FG V     K   + G+  A+K + K+   +++    F+ E  +L+ 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREK---ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57

Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI--FDPINREHMTWEKRYKIIEGIAR 354
                + +L     ++    LV E+ P   L   +  ++    E M    ++ + E +  
Sbjct: 58  SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMA---QFYLAELV-- 112

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY 414
             L +H   ++  +HRD+K  N+L+D   + K++DFG A     ++   ++   VGT  Y
Sbjct: 113 --LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPDY 169

Query: 415 MAPEYVM------HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
           +APE +        G + V+ D +S GV+  E++ G+     GT  +T
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT 217

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 67/265 (25%), Positives = 110/265 (41%), Gaps = 51/265 (19%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKN---SKQGEIEFKNEVLLLARLQH 299
           D+F     +G+G FG V      + G   A+K L K     K+     + E  +L     
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIF--DPINREHMTWEKRYKIIEGIARGLL 357
             +V++     +++   L+ EF+P   +   +   D ++ E      ++ I E +    L
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEE----ATQFYIAETV----L 112

Query: 358 YLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA--------RLFEMDQTH---SD-- 404
            +    +L  IHRD+K  N+LLD++ + K+SDFG+           F  + TH   SD  
Sbjct: 113 AIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172

Query: 405 --------------TNR------VVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
                          NR       VGT  Y+APE  M   ++   D +S GV++ E++ G
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Query: 445 QKRSSFGTEEETEDLLTYAWRNWNE 469
                  T +ET   +     NW E
Sbjct: 233 YPPFCSETPQETYRKVM----NWKE 253

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 55.4 bits (133), Expect = 5e-08
 Identities = 44/175 (25%), Positives = 88/175 (50%), Gaps = 2/175 (1%)

Query: 269 ETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           E +  K +  N ++     ++E+  LA   H  +V+         + +L+ E+     L+
Sbjct: 94  EKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLN 153

Query: 329 HFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKIS 388
             I   + +EH+ + + Y++     + +L L E    +++HRDLK++NI L      K+ 
Sbjct: 154 KQIKQRL-KEHLPF-QEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLG 211

Query: 389 DFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           DFG ++ +    +    +   GT  Y+APE     R+S K+D++S GV++ E+++
Sbjct: 212 DFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.4 bits (131), Expect = 6e-08
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 31/223 (13%)

Query: 235 DFETIRVATDNFSDANKLGQGGFG--AVYKGMLSNGETIAVKRLSKNS--KQGEIE-FKN 289
           DFE ++V          +G+G FG  AV K M + G+  A+K L+K    K+ E   F+ 
Sbjct: 2   DFEILKV----------IGRGAFGEVAVVK-MKNTGQVYAMKILNKWEMLKRAETACFRE 50

Query: 290 EVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI--FDPINREHMTWEKRYK 347
           E  +L     R +  L     +     LV ++     L   +  F+    E M    R+ 
Sbjct: 51  ERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMA---RFY 107

Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           + E +    L +    +L  +HRD+K  N+LLD   + +++DFG       D T   +N 
Sbjct: 108 LAEMV----LAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNV 162

Query: 408 VVGTFGYMAPEYVM-----HGRFSVKSDIFSFGVLVLEIVSGQ 445
            VGT  Y++PE +       GR+  + D +S GV + E++ G+
Sbjct: 163 AVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 54.8 bits (132), Expect = 8e-08
 Identities = 54/217 (24%), Positives = 84/217 (38%), Gaps = 50/217 (23%)

Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLSN-----GETIAVKRLSKNSKQGEIE-FKNEVLL 293
               D+F    KLG+G FG VYK  L N          +K   K ++ G +E + NE + 
Sbjct: 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLK---KATEYGAVEIWMNERVR 184

Query: 294 ------LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD---PINREHMTW-- 342
                  A   +  L  +     +  E  LV+ +   ++L   +     P N E      
Sbjct: 185 RACPNSCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGK 242

Query: 343 --------EKRYKIIEGIARGLLY----LHEDSRLRIIHRDLKASNILLDSEMNP-KISD 389
                   E+  KII+ I R +L+    LH      I+HRD+K  NI+        KI D
Sbjct: 243 VQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIID 299

Query: 390 FGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS 426
            G A            +  VG   Y+  E+++  R++
Sbjct: 300 LGAA-----------ADLRVG-INYIPKEFLLDPRYA 324

Length = 566

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 54.3 bits (130), Expect = 8e-08
 Identities = 69/274 (25%), Positives = 115/274 (41%), Gaps = 61/274 (22%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSK-----NSKQGEIEFK 288
           DFE+++V          +G+G FG V      + G   A+K L K       + G I  +
Sbjct: 2   DFESLKV----------IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAE 51

Query: 289 NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI 348
            ++L+ A      +V++     ++    L+ EF+P   +   +   + ++ +T E+    
Sbjct: 52  RDILVEA--DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL---MKKDTLTEEETQFY 106

Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA--------RLFEMDQ 400
           I   A  +L +    +L  IHRD+K  N+LLDS+ + K+SDFG+           F  + 
Sbjct: 107 I---AETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNL 163

Query: 401 THS-------------------DTNR------VVGTFGYMAPEYVMHGRFSVKSDIFSFG 435
            HS                     NR       VGT  Y+APE  M   ++   D +S G
Sbjct: 164 NHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLG 223

Query: 436 VLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNE 469
           V++ E++ G       T +ET   +     NW E
Sbjct: 224 VIMYEMLIGYPPFCSETPQETYKKVM----NWKE 253

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 13/199 (6%)

Query: 252 LGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN--LVRLLGF 308
           LG+G FG V      + G   A+K L K     + E  + +     LQ+     +  L +
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 309 CLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLR 366
             +  +R+  V E+     L    F  ++RE +  E R +     I   L YLH  S   
Sbjct: 63  SFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVSALDYLH--SEKN 116

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS 426
           +++RDLK  N++LD + + KI+DFG+ +  E  +  +      GT  Y+APE +    + 
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYG 174

Query: 427 VKSDIFSFGVLVLEIVSGQ 445
              D +  GV++ E++ G+
Sbjct: 175 RAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 20/202 (9%)

Query: 252 LGQGGFGAVYKGML----SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN--LVRL 305
           LG+G FG V   +L    + G   A+K L K     + E  + V     LQ+     +  
Sbjct: 3   LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59

Query: 306 LGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDS 363
           L +  +  +R+  V E+     L    F  ++RE +  E+R +     I   L YLH   
Sbjct: 60  LKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAEIVSALEYLHSRD 115

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
              +++RD+K  N++LD + + KI+DFG+ +    D     T    GT  Y+APE +   
Sbjct: 116 ---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDN 170

Query: 424 RFSVKSDIFSFGVLVLEIVSGQ 445
            +    D +  GV++ E++ G+
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 31/99 (31%), Positives = 54/99 (54%), Gaps = 6/99 (6%)

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           IA  +L +H   +L  +HRD+K  N+LLD   + +++DFG       D T   ++  VGT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGT 166

Query: 412 FGYMAPEYVM-----HGRFSVKSDIFSFGVLVLEIVSGQ 445
             Y++PE +       G++  + D +S GV + E++ G+
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 51.5 bits (123), Expect = 5e-07
 Identities = 34/109 (31%), Positives = 63/109 (57%), Gaps = 18/109 (16%)

Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           I+ G  RGL YLH++     IHR++KAS+IL+  +    +S  G++ L+ + + +    +
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLS--GLSHLYSLVR-NGQKAK 159

Query: 408 VVGTFG--------YMAPEYV---MHGRFSVKSDIFSFGVLVLEIVSGQ 445
           VV  F         +++PE +   ++G ++VKSDI+S G+   E+ +G+
Sbjct: 160 VVYDFPQFSTSVLPWLSPELLRQDLYG-YNVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 51.1 bits (123), Expect = 6e-07
 Identities = 65/257 (25%), Positives = 97/257 (37%), Gaps = 77/257 (29%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVY----KGMLSNGETIAVKRLSKN-----SKQGEI 285
            F+ I++          LG+G  G V+    KG    G+  A+K L K      +K   +
Sbjct: 2   HFKKIKL----------LGKGDVGRVFLVRLKG---TGKLFALKVLDKKEMIKRNKVKRV 48

Query: 286 EFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR 345
             + E+L  A L H  L  L           LV ++ P   L   +            K 
Sbjct: 49  LTEQEIL--ATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLL-------QRQPGKC 99

Query: 346 YKIIEGIAR--------GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDF------- 390
               E +AR         L YLH    L I++RDLK  NILL    +  +SDF       
Sbjct: 100 LS--EEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154

Query: 391 ---------------GMARLFEMDQTHSD-----TNRVVGTFGYMAPEYVM---HGRFSV 427
                            +      +T S+     +N  VGT  Y+APE +    HG  +V
Sbjct: 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHG-SAV 213

Query: 428 KSDIFSFGVLVLEIVSG 444
             D ++ G+L+ E++ G
Sbjct: 214 --DWWTLGILLYEMLYG 228

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 50.9 bits (122), Expect = 6e-07
 Identities = 58/236 (24%), Positives = 110/236 (46%), Gaps = 49/236 (20%)

Query: 234 FDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGET---IAVKRLSKNS----KQGEIE 286
            DFETI++ ++          G +GAVY  ++ + ET    A+K+++K +     Q +  
Sbjct: 1   EDFETIKLISN----------GAYGAVY--LVRHKETRQRFAMKKINKQNLILRNQIQQV 48

Query: 287 F-KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNAS----LDHFIFDPINREHMT 341
           F + ++L  A  ++  +V +      ++   +V E+V        L +    P++   M 
Sbjct: 49  FVERDILTFA--ENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMY 106

Query: 342 WEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
           + +    +E       YLH      I+HRDLK  N+L+ S  + K++DFG++++  M  T
Sbjct: 107 FAETVLALE-------YLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156

Query: 402 --------HSDT-----NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
                     DT      +V GT  Y+APE ++   +    D ++ G+++ E + G
Sbjct: 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 49.7 bits (118), Expect = 3e-06
 Identities = 59/234 (25%), Positives = 104/234 (44%), Gaps = 52/234 (22%)

Query: 251 KLGQGGFGAVYKGMLSNGET--------IAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL 302
           K+G G FG V+  ++ +  T        I+ + L +  K    +   EV ++  L+H+N+
Sbjct: 20  KIGNGRFGEVF--LVKHKRTQEFFCWKAISYRGLKEREKS---QLVIEVNVMRELKHKNI 74

Query: 303 VRLLGFCLERKERIL--VYEFVPNASLDHFI------FDPINREHMTWEKRYKIIEGIAR 354
           VR +   L +  + L  + EF     L   I      F  I  EH   +   +++  +A 
Sbjct: 75  VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKI-EEHAIVDITRQLLHALA- 132

Query: 355 GLLYLHE----DSRLRIIHRDLKASNILLDSEMN-----------------PKISDFGMA 393
              Y H      +  R++HRDLK  NI L + +                   KI DFG++
Sbjct: 133 ---YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189

Query: 394 RLFEMDQTHSDTNRVVGTFGYMAPEYVMH--GRFSVKSDIFSFGVLVLEIVSGQ 445
           +   ++   S  +  VGT  Y +PE ++H    +  KSD+++ G ++ E+ SG+
Sbjct: 190 KNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score = 45.5 bits (108), Expect = 4e-06
 Identities = 17/46 (36%), Positives = 20/46 (43%), Gaps = 5/46 (10%)

Query: 3   PSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDI 48
            S CR C+  A   L   CPNK      YD     +C LRY +Y  
Sbjct: 66  ASDCRSCLATAVSELRRCCPNKKGGRIWYD-----SCFLRYESYPF 106

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 46.6 bits (111), Expect = 4e-06
 Identities = 37/158 (23%), Positives = 60/158 (37%), Gaps = 19/158 (12%)

Query: 247 SDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV--R 304
           S    L  G    VY  + +  E   +K      K    + + EV +L  L  + L   +
Sbjct: 1   SSIKLLKGGLTNRVYL-LGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPK 57

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           +L          L+ E++   +LD            + E++  I E +A  L  LH+   
Sbjct: 58  VLASGESDGWSYLLMEWIEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPL 107

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMA----RLFEM 398
           L + H DL   NIL+D      I D+  A      F++
Sbjct: 108 LVLCHGDLHPGNILVDDGKILGIIDWEYAGYGPPAFDL 145

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 48.9 bits (116), Expect = 4e-06
 Identities = 59/227 (25%), Positives = 108/227 (47%), Gaps = 39/227 (17%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQGEIE-FKNE 290
           DFE ++V          +G+G FG V    L N + + A+K L+K    K+ E   F+ E
Sbjct: 2   DFEILKV----------IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 51

Query: 291 VLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE 350
             +L    ++  +  L +  + +  + +        +D+++   +      +E R  + E
Sbjct: 52  RDVLVNGDNQ-WITTLHYAFQDENNLYLV-------MDYYVGGDLLTLLSKFEDR--LPE 101

Query: 351 GIARGLLYLHE-----DS--RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
            +AR   YL E     DS  +L  +HRD+K  NIL+D   + +++DFG   L  M+    
Sbjct: 102 DMAR--FYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC-LKLMEDGTV 158

Query: 404 DTNRVVGTFGYMAPEYVM-----HGRFSVKSDIFSFGVLVLEIVSGQ 445
            ++  VGT  Y++PE +       G++  + D +S GV + E++ G+
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 48.5 bits (115), Expect = 6e-06
 Identities = 59/234 (25%), Positives = 103/234 (44%), Gaps = 33/234 (14%)

Query: 225 EETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAV----YKGMLSNGETIAVKRLSKNS 280
           ++TI K        +R+  +++     +G+G FG V    +K   S  +  A+K LSK  
Sbjct: 29  KDTINK-----IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHK---STRKVYAMKLLSKFE 80

Query: 281 ---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI--FDPI 335
              +     F  E  ++A      +V+L     + +   +V E++P   L + +  +D  
Sbjct: 81  MIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP 140

Query: 336 NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL 395
            +    W + Y      A  +L L     +  IHRD+K  N+LLD   + K++DFG    
Sbjct: 141 EK----WARFYT-----AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191

Query: 396 FEMD-QTHSDTNRVVGTFGYMAPEYVMH----GRFSVKSDIFSFGVLVLEIVSG 444
              +     DT   VGT  Y++PE +      G +  + D +S GV + E++ G
Sbjct: 192 MNKEGMVRCDT--AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.9 bits (114), Expect = 9e-06
 Identities = 61/265 (23%), Positives = 96/265 (36%), Gaps = 77/265 (29%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNS---KQGEIEFKNE 290
           DF T++V          +G+G FG V        G+  A+K L K+    K      K E
Sbjct: 2   DFHTVKV----------IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAE 51

Query: 291 VLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE 350
             +LA      +V L     + +   L+ EF+P   L            MT   +Y    
Sbjct: 52  RDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDL------------MTMLIKYDTFS 99

Query: 351 G------IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA----------- 393
                  +A  +L +    +L  IHRD+K  NIL+D   + K+SDFG++           
Sbjct: 100 EDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159

Query: 394 --RLFEMDQ-THSDTNR-------------------------------VVGTFGYMAPEY 419
             +L +     +   NR                                VGT  Y+APE 
Sbjct: 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEI 219

Query: 420 VMHGRFSVKSDIFSFGVLVLEIVSG 444
            +   +  + D +S G ++ E + G
Sbjct: 220 FLQQGYGQECDWWSLGAIMFECLIG 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 44/223 (19%)

Query: 252 LGQGGFGAVYKGML-----------------------SNGETIAV--KRLSKNSKQGEIE 286
           LGQG    +Y G L                       +NG  + V  K L  + +   + 
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 287 FKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY 346
           F     L++++ H +L  + G C+   E I+V EFV +  LD  +     R  + W  + 
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILL-------DSEMNPKISDFGMARLFEMD 399
            + + +A  L YL ED  L  +H ++ A NILL        +    K+SD G++  F   
Sbjct: 121 TVAQQLASALSYL-EDKNL--VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTAL 175

Query: 400 QTHSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEI 441
                  R+     ++APE V  G   S  +D +SFG  +LEI
Sbjct: 176 SREERVERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 60/256 (23%), Positives = 105/256 (41%), Gaps = 73/256 (28%)

Query: 246 FSDANKLGQGGFGAVYKGMLSNGET---IAVKRLSKNS---KQGEIEFKNEVLLLARLQH 299
           F     +G G FG V   ++   +T    A+K L K     +      K E  +LA   +
Sbjct: 3   FVKIKTIGIGAFGEVC--LVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN 60

Query: 300 RNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKII-EGIARGLL 357
             +V+L  +  + K+ +  V +++P   +            M+   R  I  E +AR   
Sbjct: 61  EWVVKLY-YSFQDKDNLYFVMDYIPGGDM------------MSLLIRLGIFEEDLAR--F 105

Query: 358 YLHE-----DS--RLRIIHRDLKASNILLDSEMNPKISDFGMARLF-------------- 396
           Y+ E     +S  ++  IHRD+K  NIL+D + + K++DFG+   F              
Sbjct: 106 YIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDH 165

Query: 397 ------EMDQTHSDTNR---------------------VVGTFGYMAPEYVMHGRFSVKS 429
                 E  +  S+ +R                     +VGT  Y+APE ++   ++   
Sbjct: 166 HRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 225

Query: 430 DIFSFGVLVLEIVSGQ 445
           D +S GV++ E++ GQ
Sbjct: 226 DWWSVGVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 60/271 (22%), Positives = 105/271 (38%), Gaps = 58/271 (21%)

Query: 246 FSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRN 301
           F     LG G FG V     +      A+K L K    ++      K E  +LA   +  
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFD-PINREHMTWEKRYKIIEGIARGLLYLH 360
           +V+L     ++     V +++P   +   +    +  E +    R+ I E      L + 
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLA---RFYIAELT----LAIE 115

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMA--------------------------- 393
              ++  IHRD+K  NIL+D + + K++DFG+                            
Sbjct: 116 SVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSD 175

Query: 394 ------------RLFEMDQTHSDTNR------VVGTFGYMAPEYVMHGRFSVKSDIFSFG 435
                       RL  ++Q  +  ++      +VGT  Y+APE ++   ++   D +S G
Sbjct: 176 LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235

Query: 436 VLVLEIVSGQKRSSFGTEEETEDLLTYAWRN 466
           V++ E++ GQ      T  ET+ L    W N
Sbjct: 236 VILFEMLVGQPPFLAPTPTETQ-LKVINWEN 265

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 46.1 bits (109), Expect = 4e-05
 Identities = 63/241 (26%), Positives = 104/241 (43%), Gaps = 52/241 (21%)

Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVK---RLSKNSKQGEIEFK-NEV 291
           E I V+T  F   + LG+G FG V +       E  AVK    + K ++  +IE +  E 
Sbjct: 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEK 181

Query: 292 LLLARLQHRNLVRLLGFCLERKER----------ILVYEFVPNASLDHFI-FDPINREHM 340
           +  A    R       F L + +R          I++ ++ P   LD  +   P +  H+
Sbjct: 182 VRQADPADR-------FPLMKIQRYFQNETGHMCIVMPKYGP-CLLDWIMKHGPFSHRHL 233

Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL---DSEMNP------------ 385
                 +II      L Y H  + L ++H DLK  NIL+   D+ ++P            
Sbjct: 234 A-----QIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCR 286

Query: 386 -KISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            +I D G       D+ HS T  +V T  Y +PE V+   +   +D++S G ++ E+ +G
Sbjct: 287 VRICDLGGC----CDERHSRT-AIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341

Query: 445 Q 445
           +
Sbjct: 342 K 342

Length = 467

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 44.8 bits (107), Expect = 5e-05
 Identities = 35/149 (23%), Positives = 68/149 (45%), Gaps = 15/149 (10%)

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLL 357
           + N ++L       K  +L+ +++ +  L    FD +     ++  +  KII  +   L 
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEALN 123

Query: 358 YLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            LH   +  IIH D+K  N+L D   +   + D+G+ ++      +       GT  Y +
Sbjct: 124 DLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYFS 174

Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           PE +    + V  D ++ GVL  E+++G+
Sbjct: 175 PEKIKGHNYDVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 44.9 bits (106), Expect = 9e-05
 Identities = 21/49 (42%), Positives = 32/49 (65%), Gaps = 3/49 (6%)

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL 395
           K I  +A  L YLH      IIHRDLK  N+L+ +E + K++DFG++++
Sbjct: 108 KYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 58/257 (22%), Positives = 96/257 (37%), Gaps = 71/257 (27%)

Query: 246 FSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRN 301
           F     LG G FG V     +      A+K L K     +      K E  +LA   +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII-EGIARGLLYLH 360
           +VRL     ++     V +++P   +            M+   R  I  E +AR   Y+ 
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDM------------MSLLIRMGIFPEDLAR--FYIA 108

Query: 361 EDS-------RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM----------DQTHS 403
           E +       ++  IHRD+K  NIL+D + + K++DFG+   F            D    
Sbjct: 109 ELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQ 168

Query: 404 DT-----------------------------------NRVVGTFGYMAPEYVMHGRFSVK 428
           D+                                   + +VGT  Y+APE ++   ++  
Sbjct: 169 DSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 228

Query: 429 SDIFSFGVLVLEIVSGQ 445
            D +S GV++ E++ GQ
Sbjct: 229 CDWWSVGVILYEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 43.0 bits (101), Expect = 4e-04
 Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 7/96 (7%)

Query: 349 IEGIARGLL----YLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD 404
           +  +AR LL    Y+H +    IIHRD+K  N+L++   +  + DFG A       +   
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318

Query: 405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLE 440
              + GT    APE +    ++   DI+S G+++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 42.0 bits (99), Expect = 4e-04
 Identities = 39/194 (20%), Positives = 89/194 (45%), Gaps = 20/194 (10%)

Query: 260 VYKGMLSNGETI--AVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKER-- 315
           +YKG+ +N E I    K+  K  K      +NE+  L R+   N++++ GF ++  +   
Sbjct: 36  IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95

Query: 316 --ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE-DSRLRIIHRDL 372
              L+ E+     L   +      + ++++ +  +     +GL  L++  ++    +++L
Sbjct: 96  RLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNK---PYKNL 149

Query: 373 KASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV--MHGRFSVKSD 430
            + + L+      KI   G+ ++       S   + V    Y + + +  +   +++K D
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKILS-----SPPFKNVNFMVYFSYKMLNDIFSEYTIKDD 204

Query: 431 IFSFGVLVLEIVSG 444
           I+S GV++ EI +G
Sbjct: 205 IYSLGVVLWEIFTG 218

Length = 283

>gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family

 Score = 41.8 bits (98), Expect = 5e-04
 Identities = 22/109 (20%), Positives = 38/109 (34%), Gaps = 19/109 (17%)

Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
           LLARL H      L      + R+ +   +  A                 ++  ++ E +
Sbjct: 101 LLARL-HSVPPEALPLARRLRRRLKLLRQLAAALRRL-------VAAELLDRLAELWERL 152

Query: 353 ARGLLYLHE---DSRLRIIHRDLKASNILLDSEMNPKIS---DFGMARL 395
                 L        L ++H DL   N+L+D     +++   DF  A L
Sbjct: 153 LA---ALLALLPALPLVLVHGDLHPGNLLVDP--GGRVTGVIDFEDAGL 196

This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 41.1 bits (97), Expect = 6e-04
 Identities = 39/192 (20%), Positives = 68/192 (35%), Gaps = 42/192 (21%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFK-------NEVLLLARLQHRNLV 303
            + QG    +Y         +  +R+ K  +  E++ K        E  +LA+       
Sbjct: 3   LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKA------ 56

Query: 304 RLLGFCLERKERILVYEFVPNASL--DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           R  G  +       VY+  P+  L    +I   + ++    E R  ++  + R +  LH+
Sbjct: 57  REAGVPVPI-----VYDVDPDNGLIVMEYIEGELLKD-ALEEARPDLLREVGRLVGKLHK 110

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-------------LFE--MDQTHSDTN 406
                I+H DL  SNI+L         DFG+               + E  ++ TH    
Sbjct: 111 AG---IVHGDLTTSNIILSGG-RIYFIDFGLGEFSDEVEDKAVDLHVLERALESTHEKAE 166

Query: 407 RVVGTF--GYMA 416
            +   F  GY  
Sbjct: 167 ELFAAFLEGYRE 178

Length = 204

>gnl|CDD|201633 pfam01163, RIO1, RIO1 family

 Score = 40.7 bits (96), Expect = 7e-04
 Identities = 43/176 (24%), Positives = 62/176 (35%), Gaps = 48/176 (27%)

Query: 260 VYKGMLSNGETIAVK--RLSKNS-------KQGEIEFKNE-------VLLLARLQHRNLV 303
           VY     +G+ +AVK  R    S       + G+  F++        V L A  + RNL 
Sbjct: 2   VYHAYSEDGKKVAVKIYRTGTTSFKKRKRYRDGDFRFRDSKTSWRYLVRLWAEKEFRNLK 61

Query: 304 RLLGFCL------ERKERILVYEFV-----PNASLDHFIFDPINREHMTWEKRYKIIEGI 352
           RL    +           +LV EF+     P   L       +  E    E   +II  +
Sbjct: 62  RLYEAGVPVPKPIAVNRHVLVMEFIGDDGVPAPRLKD-----VELEEEAEEIYDEIIREM 116

Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG--------MAR-LFEMD 399
            R  LY        ++H DL   N+L+D +  P I D           A    E D
Sbjct: 117 RR--LYQEA----GLVHGDLSEYNVLVDDD-KPVIIDVPQAVETDHPNALEFLERD 165

This is a family of atypical serine kinases which are found in archaea, bacteria and eukaryotes. Activity of Rio1 is vital in Saccharomyces cerevisiae for the processing of ribosomal RNA, as well as for proper cell cycle progression and chromosome maintenance. The structure of RIO1 has been determined. Length = 186

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 39.9 bits (93), Expect = 0.002
 Identities = 48/196 (24%), Positives = 89/196 (45%), Gaps = 29/196 (14%)

Query: 267 NGETIAVKRLSKNSKQGE-IEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYEFVPN 324
            GE + V+R++  +   E + F    L +++L  H N+V      +   E  +V  F+  
Sbjct: 24  TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83

Query: 325 AS-----LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL 379
            S       HF+ D ++   + +     I++G+ + L Y+H    +  +HR +KAS+IL+
Sbjct: 84  GSAKDLICTHFM-DGMSELAIAY-----ILQGVLKALDYIHH---MGYVHRSVKASHILI 134

Query: 380 DSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG--------YMAPEYVMHGR--FSVKS 429
              ++ K+   G+     M   H    RVV  F         +++PE +      +  KS
Sbjct: 135 --SVDGKVYLSGLRSNLSM-INHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKS 191

Query: 430 DIFSFGVLVLEIVSGQ 445
           DI+S G+   E+ +G 
Sbjct: 192 DIYSVGITACELANGH 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|240172 cd05151, ChoK, Choline Kinase (ChoK)

 Score = 38.0 bits (89), Expect = 0.004
 Identities = 27/114 (23%), Positives = 43/114 (37%), Gaps = 18/114 (15%)

Query: 273 VKRLSKNSKQGEIEFKNEVLLLARLQHRNLV-RLLGFCLERKERILVYEFVPNA-SLDHF 330
           V R+  N  +  I  +NE           +  +L  F  + +  +L+ EF+  +  L   
Sbjct: 25  VVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELLTED 82

Query: 331 IFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII--HRDLKASNILLDSE 382
             DP N E        KI + + +    LH      ++  H DL   N LLD  
Sbjct: 83  FSDPENLE--------KIAKLLKK----LHSSPLPDLVPCHNDLLPGNFLLDDG 124

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate and displays negligible activity towards N-methylated derivatives of Etn. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Length = 170

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	577
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.98
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.98
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.98
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.98
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.89
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.87
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.87
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.87
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.86
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.86
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.83
PRK12274	218	serine/threonine protein kinase; Provisional	99.83
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.81
PRK10345	210	hypothetical protein; Provisional	99.81
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.78
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.77
smart00090	237	RIO RIO-like kinase.	99.76
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.75
PRK14879	211	serine/threonine protein kinase; Provisional	99.75
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.74
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.74
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.73
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.73
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.7
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.67
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.66
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.65
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.62
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.62
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.48
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.4
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.4
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.35
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.34
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.24
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.24
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.16
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.13
KOG1243	690	consensus Protein kinase [General function predict	99.1
KOG3087	229	consensus Serine/threonine protein kinase [General	99.06
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.97
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.96
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.95
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.86
COG4248	637	Uncharacterized protein with protein kinase and he	98.76
PF01657	106	Stress-antifung: Salt stress response/antifungal;	98.73
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.71
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.62
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.57
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.56
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.51
PRK09902	216	hypothetical protein; Provisional	98.51
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.47
PF01636	239	APH: Phosphotransferase enzyme family This family	98.31
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.3
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.3
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.25
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.22
PLN02876	822	acyl-CoA dehydrogenase	98.18
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.1
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.06
PRK10593	297	hypothetical protein; Provisional	98.05
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.0
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.89
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.86
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.82
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.77
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.69
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.58
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.53
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.47
PRK05231	319	homoserine kinase; Provisional	97.46
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.3
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.3
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.25
PLN02236	344	choline kinase	97.03
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.01
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.0
PLN02756	418	S-methyl-5-thioribose kinase	96.85
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.62
PF11883	48	DUF3403: Domain of unknown function (DUF3403); Int	96.61
KOG2270	520	consensus Serine/threonine protein kinase involved	96.58
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.54
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.46
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.44
COG2334	331	Putative homoserine kinase type II (protein kinase	96.3
PRK12396	409	5-methylribose kinase; Reviewed	96.26
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.25
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.2
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.19
PRK11768	325	serine/threonine protein kinase; Provisional	95.51
PTZ00384	383	choline kinase; Provisional	95.35
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.34
PRK06148	1013	hypothetical protein; Provisional	95.3

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-59  Score=477.53  Aligned_cols=287  Identities=46%  Similarity=0.802  Sum_probs=254.6

Q ss_pred             ccCCCChHHHHHHhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEE
Q 008108          230 KSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC  309 (577)
Q Consensus       230 ~~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  309 (577)
                      ....|++.+++.+|++|+..+.||+|+||.||+|.+++|+.||||++.....+...+|.+|+.++.+++|||||+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            34568999999999999999999999999999999999999999998776544245699999999999999999999999


Q ss_pred             EcCC-eEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEe
Q 008108          310 LERK-ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKIS  388 (577)
Q Consensus       310 ~~~~-~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~  388 (577)
                      .+.+ +.+||||||++|+|+++|+..... .++|.+|++|+.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9999 599999999999999999875443 89999999999999999999999988899999999999999999999999


Q ss_pred             ccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcc
Q 008108          389 DFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWN  468 (577)
Q Consensus       389 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~  468 (577)
                      |||+|+..........+.. .||.+|+|||++..+..+.|+|||||||+|+||+||+++...........++.|++..+.
T Consensus       220 DFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             CccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            9999976543111111111 799999999999999999999999999999999999998876665556669999999999


Q ss_pred             cCCccccccCcCC-CCCh--HHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          469 EGAALNLMDPTMR-GGST--SEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       469 ~~~~~~~~d~~l~-~~~~--~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .+...+++||.+. ....  .++.++..++++|++.+|++||+|.||+++|+.
T Consensus       299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~  351 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEG  351 (361)
T ss_pred             CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence            9999999999987 4433  689999999999999999999999999999954

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=8e-48  Score=392.36  Aligned_cols=253  Identities=31%  Similarity=0.505  Sum_probs=205.2

Q ss_pred             cccccccCCcEEEEEeEecCCcEEEEEEeccCChhh--HHHHHHHHHHHHhcCCCCeEEEEeEEEcCC-eEEEEEEecCC
Q 008108          248 DANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLARLQHRNLVRLLGFCLERK-ERILVYEFVPN  324 (577)
Q Consensus       248 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~E~~~~  324 (577)
                      ..+.||+|+||+||+|.+.....||||++.......  ..+|.+|+.+|.+++|||||+++|+|.+.. ..+|||||+++
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            345699999999999999754459999998754332  458999999999999999999999999988 79999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC-CeEEeccCCcccccCCCccc
Q 008108          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-NPKISDFGMARLFEMDQTHS  403 (577)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~-~~kl~DfGla~~~~~~~~~~  403 (577)
                      |+|.++++.. ....+++..+++|+.|||+||.|||++++  ||||||||+||||+.++ ++||+|||+++......  .
T Consensus       125 GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~  199 (362)
T KOG0192|consen  125 GSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T  199 (362)
T ss_pred             CcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence            9999999763 46789999999999999999999999874  99999999999999998 99999999998765432  2


Q ss_pred             cccccccCCCCcChhhhh--cCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC
Q 008108          404 DTNRVVGTFGYMAPEYVM--HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR  481 (577)
Q Consensus       404 ~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  481 (577)
                      ......||+.|||||++.  ...|+.|+|||||||+||||+||+.||.......   ....   ....+..     |.+.
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~---~~~~---v~~~~~R-----p~~p  268 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ---VASA---VVVGGLR-----PPIP  268 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH---HHHH---HHhcCCC-----CCCC
Confidence            233368999999999999  6699999999999999999999999987544311   1111   1111111     1111


Q ss_pred             CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCC
Q 008108          482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD  519 (577)
Q Consensus       482 ~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~  519 (577)
                      ..   ....+..++.+||+.||+.||++.+++.+|+..
T Consensus       269 ~~---~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~  303 (362)
T KOG0192|consen  269 KE---CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI  303 (362)
T ss_pred             cc---CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence            11   223455666689999999999999999999853

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-47  Score=373.07  Aligned_cols=204  Identities=31%  Similarity=0.536  Sum_probs=182.4

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      .+|...++||+|.||+||+|++. ++..||||.+.+.  .....+.+..|+.+|+.++|||||+|++++..++..+||||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            67888899999999999999964 6899999999876  45555567899999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCC------CCeEEeccCCcc
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE------MNPKISDFGMAR  394 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~------~~~kl~DfGla~  394 (577)
                      ||.||+|.+||+   +++.+++..+..++.|||.||++||+++   ||||||||+||||+..      -.+||+|||+|+
T Consensus        90 yC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   90 YCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             eCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            999999999994   4668999999999999999999999998   9999999999999775      458999999999


Q ss_pred             cccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCcccc
Q 008108          395 LFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET  456 (577)
Q Consensus       395 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~  456 (577)
                      .+..+..   ....+|++.|||||+++.++|+.|+|+||+|+||||+++|+.||......+.
T Consensus       164 ~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL  222 (429)
T KOG0595|consen  164 FLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL  222 (429)
T ss_pred             hCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence            8875433   2347999999999999999999999999999999999999999976555443

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-47  Score=367.95  Aligned_cols=250  Identities=29%  Similarity=0.400  Sum_probs=203.5

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC-eEEEEEEe
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK-ERILVYEF  321 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~E~  321 (577)
                      +++..+.||+|..|+|||+.++ +++.+|+|.+... ......++.+|++++++.+|||||+++|.|..+. +..|+|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            4555789999999999999975 6888999999544 3445567899999999999999999999999988 59999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      |++|||+.++.   ..+.+++...-+|+.+|++||.|||+..  +||||||||+||||+..|.+||+|||.++.+...  
T Consensus       160 MDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  160 MDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--  232 (364)
T ss_pred             cCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence            99999999984   3477999999999999999999999632  3999999999999999999999999999876543  


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCC--ccccchhhhhhhhhcccCCccccccCc
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGT--EEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~--~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                        ..+..+||..|||||.+.+..|+.++||||||++++|+.+|+.|+....  .....+++.+.-...         -|.
T Consensus       233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p---------pP~  301 (364)
T KOG0581|consen  233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP---------PPR  301 (364)
T ss_pred             --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC---------CCC
Confidence              2345789999999999999999999999999999999999999987541  122233333221111         122


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      +..+  ....++..++-.|+++||.+||++.|+++
T Consensus       302 lP~~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  302 LPEG--EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             CCcc--cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            3222  12334556777999999999999998875

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.3e-47  Score=387.08  Aligned_cols=247  Identities=29%  Similarity=0.452  Sum_probs=209.3

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ..|...+.||+|||..||+++. .+|+.||+|++.+..   ......+.+|+++.++|+|||||+++++|++.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4688999999999999999996 889999999998743   233446889999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      |+|++++|.+++.   .++.+++.++..++.||+.||.|||+++   |+|||||..|++|++++++||+|||||..+..+
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999883   5788999999999999999999999998   999999999999999999999999999988755


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                      ....  ...+||+-|+|||++....++..+||||+|||||-||.|++||+...-.+....+....          .   .
T Consensus       172 ~Erk--~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~----------Y---~  236 (592)
T KOG0575|consen  172 GERK--KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE----------Y---S  236 (592)
T ss_pred             cccc--ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC----------c---c
Confidence            4333  34899999999999999999999999999999999999999998665544433332111          1   1


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      +......+   ..+++..+|+.||.+|||+++|+.
T Consensus       237 ~P~~ls~~---A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  237 MPSHLSAE---AKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             cccccCHH---HHHHHHHHhcCCcccCCCHHHHhc
Confidence            11112233   335666889999999999999985

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-46  Score=367.77  Aligned_cols=252  Identities=25%  Similarity=0.359  Sum_probs=202.6

Q ss_pred             HhcCCccccccccCCcEEEEEeE-ecCCcEEEEEEeccCChh-------hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQ-------GEIEFKNEVLLLARLQHRNLVRLLGFCLERK  313 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  313 (577)
                      ..+.|.+.+.||+|+||.|-+|. .++|+.||||++.+....       ......+|+++|++|+|||||++++++...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            44668889999999999999999 457999999999765221       2223579999999999999999999999999


Q ss_pred             eEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCC---CCeEEecc
Q 008108          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDF  390 (577)
Q Consensus       314 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~---~~~kl~Df  390 (577)
                      ..|+||||++||.|.+++.   ..+.+.+..-..++.|++.|+.|||++|   |+||||||+|||+..+   ..+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence            9999999999999988884   4677888888999999999999999999   9999999999999776   67999999


Q ss_pred             CCcccccCCCccccccccccCCCCcChhhhhcCCC---CccccEEecchhHhHHhhCCCCCCCCCccc-cchhhhhhhhh
Q 008108          391 GMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRF---SVKSDIFSFGVLVLEIVSGQKRSSFGTEEE-TEDLLTYAWRN  466 (577)
Q Consensus       391 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~SlGvil~elltG~~p~~~~~~~~-~~~l~~~~~~~  466 (577)
                      |+|+.....   ......+||+.|.|||++.++.+   ..|.|+||+||+||-+|+|..||+...... ..+.+......
T Consensus       324 GlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~  400 (475)
T KOG0615|consen  324 GLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA  400 (475)
T ss_pred             chhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc
Confidence            999987632   33445899999999999987643   348899999999999999999997654433 33333322222


Q ss_pred             cccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          467 WNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       467 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      +....+            .+-..+.++++-+++..||++|||+.|+++
T Consensus       401 f~p~~w------------~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  401 FGPLQW------------DRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             ccChhh------------hhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            211111            111234556777999999999999998875

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-46  Score=379.28  Aligned_cols=252  Identities=31%  Similarity=0.502  Sum_probs=206.0

Q ss_pred             CccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCC
Q 008108          246 FSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA  325 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  325 (577)
                      +...+.||+|.||+||.|.++....||+|.++.... ....|.+|+++|++|+|+|||+++|+|..++.++||||||+.|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            445789999999999999998878999999987643 3347889999999999999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccccc
Q 008108          326 SLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT  405 (577)
Q Consensus       326 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~  405 (577)
                      +|.++|.. ..+..+...+.+.++.|||+||+||++++   +|||||.++||||+++..+||+|||||+....+.... .
T Consensus       287 sLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~-~  361 (468)
T KOG0197|consen  287 SLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA-S  361 (468)
T ss_pred             cHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceee-c
Confidence            99999965 45678999999999999999999999998   9999999999999999999999999999555444332 2


Q ss_pred             cccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhC-CCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCC
Q 008108          406 NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG-QKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGS  484 (577)
Q Consensus       406 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  484 (577)
                      ....-+..|.|||.+..+.++.|||||||||+||||+|- +.|+......+....++...+.-.         |.   ..
T Consensus       362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~---------P~---~C  429 (468)
T KOG0197|consen  362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR---------PE---GC  429 (468)
T ss_pred             CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC---------CC---CC
Confidence            333457789999999999999999999999999999994 445444444443333333222111         11   12


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          485 TSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       485 ~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      +.   .+-+|+..||+.+|++|||++.+...|+.
T Consensus       430 P~---~vY~lM~~CW~~~P~~RPtF~~L~~~l~~  460 (468)
T KOG0197|consen  430 PD---EVYELMKSCWHEDPEDRPTFETLREVLED  460 (468)
T ss_pred             CH---HHHHHHHHHhhCCcccCCCHHHHHHHHHH
Confidence            33   34457779999999999999998888865

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.7e-46  Score=345.53  Aligned_cols=259  Identities=25%  Similarity=0.393  Sum_probs=204.0

Q ss_pred             cCCccccccccCCcEEEEEeE-ecCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEe-EEEcCCe-EEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLG-FCLERKE-RILV  318 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv  318 (577)
                      .+|++.++||+|.||+|||+. +.+|..||.|.+....  ......+..|+.+|++|+|||||++++ -+.++.+ ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            468889999999999999999 6689999999987542  334456789999999999999999999 4455555 7899


Q ss_pred             EEecCCCCcccccccC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CcEEEeccCCCcEEEcCCCCeEEeccCCcccc
Q 008108          319 YEFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDSR-LRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~-~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~  396 (577)
                      ||||..|+|..+|... ..++.++++.+|+++.|++.||.++|.+-+ ..|+||||||.||+|+.+|.+||+||||++++
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            9999999999988553 345679999999999999999999998421 13999999999999999999999999999998


Q ss_pred             cCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          397 EMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       397 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      ......  ....+||+.||+||.+....|+.||||||+||++|||+.-+.||....-.+...       ....+..    
T Consensus       179 ~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~-------KI~qgd~----  245 (375)
T KOG0591|consen  179 SSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCK-------KIEQGDY----  245 (375)
T ss_pred             cchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHH-------HHHcCCC----
Confidence            754433  345899999999999999999999999999999999999999997552211111       1112211    


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                       |.+.+  ......+..|+..|+..||+.||+...+++.+.+
T Consensus       246 -~~~p~--~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  246 -PPLPD--EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             -CCCcH--HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence             11111  1223344566778999999999996666655544

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=6.5e-45  Score=386.82  Aligned_cols=261  Identities=28%  Similarity=0.477  Sum_probs=214.9

Q ss_pred             HHHhcCCccccccccCCcEEEEEeEec------CCcEEEEEEeccCChh-hHHHHHHHHHHHHhcCCCCeEEEEeEEEcC
Q 008108          240 RVATDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLER  312 (577)
Q Consensus       240 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  312 (577)
                      .....+.+..+.||+|.||+||+|...      +...||||.++..... .+.+|++|+++|..++|||||+|+|+|.++
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~  561 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG  561 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence            344456677889999999999999843      3456999999887655 778899999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCcccccccCC-------C----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC
Q 008108          313 KERILVYEFVPNASLDHFIFDPI-------N----REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS  381 (577)
Q Consensus       313 ~~~~lv~E~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~  381 (577)
                      +.+++|+|||..|+|.+||....       .    ..+|+..+.+.|+.|||.||.||-++.   +|||||..+|+||.+
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGE  638 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceecc
Confidence            99999999999999999986421       1    234899999999999999999999887   999999999999999


Q ss_pred             CCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhh
Q 008108          382 EMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLL  460 (577)
Q Consensus       382 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~  460 (577)
                      +..|||+||||+|..-..+++.....-.-.++|||||.++.++||.+||||||||+|||++| |+.|+.....++....+
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i  718 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI  718 (774)
T ss_pred             ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence            99999999999997766555554434455789999999999999999999999999999998 66777655554443333


Q ss_pred             hhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          461 TYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       461 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .       .+..+.        .......++..|++.||+.+|++||+++||-..|+.
T Consensus       719 ~-------~g~lL~--------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~  761 (774)
T KOG1026|consen  719 R-------AGQLLS--------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA  761 (774)
T ss_pred             H-------cCCccc--------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence            2       222221        122233456678889999999999999999999975

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-44  Score=346.89  Aligned_cols=244  Identities=26%  Similarity=0.369  Sum_probs=199.5

Q ss_pred             HhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      ..++|++.++||+|+||+||.++.+ +++.+|+|.+++...   ......++|..+|.+++||.||+++..|.+.+.+||
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            3578999999999999999999954 688899999987643   234457899999999999999999999999999999


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      |+||+.||.|..+|   .+.+.+++..+.-++.+|+.||.|||+++   ||||||||+|||||.+|.++|+||||++...
T Consensus       103 Vld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen  103 VLDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             EEeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence            99999999999988   34678999999999999999999999998   9999999999999999999999999998654


Q ss_pred             CCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccccc
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD  477 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  477 (577)
                      ...  ..+...+||+.|||||++.+..|+..+|.||||+++|||++|..||.........+.+..       ++.     
T Consensus       177 ~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~-------~k~-----  242 (357)
T KOG0598|consen  177 KDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILK-------GKL-----  242 (357)
T ss_pred             cCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhc-------CcC-----
Confidence            332  234458999999999999999999999999999999999999999976554433222221       110     


Q ss_pred             CcCCCCChHHHHHHHHHHHhcccCCCCCCCC
Q 008108          478 PTMRGGSTSEMMKCIHIGLLCVQENVSNRPG  508 (577)
Q Consensus       478 ~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt  508 (577)
                      +........+..   +++...++.||++|..
T Consensus       243 ~~~p~~ls~~ar---dll~~LL~rdp~~RLg  270 (357)
T KOG0598|consen  243 PLPPGYLSEEAR---DLLKKLLKRDPRQRLG  270 (357)
T ss_pred             CCCCccCCHHHH---HHHHHHhccCHHHhcC
Confidence            000111223333   4455678999999963

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-43  Score=358.49  Aligned_cols=249  Identities=29%  Similarity=0.452  Sum_probs=207.6

Q ss_pred             cCCccccccccCCcEEEEEeE-ecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      ..|....+||+|..|.||.+. ..+++.||||++.........-+.+|+.+|+..+|+|||++++.|...+++|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            357788999999999999998 4578899999998877777777899999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      ++|+|.+.+    ....+++.++..|++++++||+|||.++   |+|||||.+|||++.+|.+||+|||++..+..... 
T Consensus       353 ~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-  424 (550)
T KOG0578|consen  353 EGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-  424 (550)
T ss_pred             CCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence            999999887    4456999999999999999999999998   99999999999999999999999999988776544 


Q ss_pred             ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCC
Q 008108          403 SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG  482 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  482 (577)
                       .....+||+.|||||++....|.+|.||||||++++||+-|..|+....+-      ...|.....+. .++-.+..  
T Consensus       425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl------rAlyLIa~ng~-P~lk~~~k--  494 (550)
T KOG0578|consen  425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------RALYLIATNGT-PKLKNPEK--  494 (550)
T ss_pred             -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH------HHHHHHhhcCC-CCcCCccc--
Confidence             344589999999999999999999999999999999999999998653332      22222222221 11111111  


Q ss_pred             CChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          483 GSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       483 ~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                       ..   ..+.++..+|++.|+++||++.|+++
T Consensus       495 -lS---~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  495 -LS---PELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             -cC---HHHHHHHHHHhhcchhcCCCHHHHhc
Confidence             12   23346777999999999999999885

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=344.17  Aligned_cols=255  Identities=29%  Similarity=0.436  Sum_probs=199.9

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC--eEEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK--ERILVYE  320 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~E  320 (577)
                      .++...+.||+|.||+||++... +|+..|||.+..........+.+|+.+|.+++|||||+.+|......  .++++||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            45777899999999999999965 48999999987764333556899999999999999999999855444  6899999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC-CCCeEEeccCCcccccC-
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS-EMNPKISDFGMARLFEM-  398 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~-~~~~kl~DfGla~~~~~-  398 (577)
                      |+++|+|.+++.+.  +..|++..+..+++||++||.|||+++   |+||||||+||||+. ++.+||+|||+++.... 
T Consensus        97 y~~~GsL~~~~~~~--g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRY--GGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             ccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            99999999998542  227999999999999999999999998   999999999999999 79999999999987664 


Q ss_pred             CCccccccccccCCCCcChhhhhcCCC-CccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccccc
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRF-SVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD  477 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  477 (577)
                      ...........||+.|||||++..+.. ..++|||||||++.||+||+.||...     .....+..........     
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~-----  241 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSL-----  241 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCC-----
Confidence            122223345789999999999986543 35999999999999999999998643     1111222222222211     


Q ss_pred             CcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 008108          478 PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNML  516 (577)
Q Consensus       478 ~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L  516 (577)
                      |.+....+.+.   .+++..|++.+|++|||+.++++-.
T Consensus       242 P~ip~~ls~~a---~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  242 PEIPDSLSDEA---KDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             CCCCcccCHHH---HHHHHHHhhcCcccCcCHHHHhhCh
Confidence            22222223333   3566799999999999999998754

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-43  Score=350.60  Aligned_cols=268  Identities=28%  Similarity=0.430  Sum_probs=202.4

Q ss_pred             hcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHh--cCCCCeEEEEeEEEcCC----eEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR--LQHRNLVRLLGFCLERK----ERI  316 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~  316 (577)
                      .+..+..++||+|+||.||||++. ++.||||++.....+   .|++|-++.+.  ++|+||+++++.-....    +++
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~kq---s~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQEKQ---SFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHHHHH---HHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            455667889999999999999996 599999999765544   46666666554  58999999999876655    889


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCcEEEeccCCCcEEEcCCCCeEEecc
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED------SRLRIIHRDLKASNILLDSEMNPKISDF  390 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~------~~~~iiHrDlkp~NiLl~~~~~~kl~Df  390 (577)
                      ||+||.++|+|.++|    +...++|....+|+..+++||+|||+.      .+++|+|||||++||||.+|++..|+||
T Consensus       285 LVt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             EEeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            999999999999998    567899999999999999999999975      3578999999999999999999999999


Q ss_pred             CCcccccCCCccccccccccCCCCcChhhhhcCC-CC-----ccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhh
Q 008108          391 GMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR-FS-----VKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAW  464 (577)
Q Consensus       391 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~  464 (577)
                      |||..+..+.....+...+||.+|||||++.+.. +.     .+.||||+|.+||||++.-.........+.+-.++...
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev  440 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV  440 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence            9999999888777777789999999999986642 22     36899999999999999875443222222211111000


Q ss_pred             hhc------ccCCccccccCcCCCC--ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          465 RNW------NEGAALNLMDPTMRGG--STSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       465 ~~~------~~~~~~~~~d~~l~~~--~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ...      ..-...+...|.++..  ....+.-+.+.+-.||+.||+-|.|+.=|-+.+..
T Consensus       441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~  502 (534)
T KOG3653|consen  441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAE  502 (534)
T ss_pred             cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHH
Confidence            000      0000111112222221  11233445567778999999999999888887765

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=9e-43  Score=355.61  Aligned_cols=265  Identities=26%  Similarity=0.458  Sum_probs=208.7

Q ss_pred             hHHHHHHhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC
Q 008108          236 FETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK  313 (577)
Q Consensus       236 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  313 (577)
                      .+++.+..+.+.+...||+|.||+||+|.+.  ..||||.+....  .+....|++|+..+++-+|.||+-+.|+|....
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            3455566667778899999999999999985  469999998764  334457999999999999999999999999887


Q ss_pred             eEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCc
Q 008108          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (577)
Q Consensus       314 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla  393 (577)
                      . .||+.+|+|.+|..+|+.  .+.+++..+.+.|++||++||.|||.++   |||||||+.||+|.+++.|||+||||+
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv--~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLa  535 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHV--QETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLA  535 (678)
T ss_pred             e-eeeehhccCchhhhhccc--hhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccce
Confidence            7 999999999999999976  3467999999999999999999999998   999999999999999999999999998


Q ss_pred             ccccCCCccccccccccCCCCcChhhhhcC---CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccC
Q 008108          394 RLFEMDQTHSDTNRVVGTFGYMAPEYVMHG---RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEG  470 (577)
Q Consensus       394 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  470 (577)
                      ..-..-..........|...|||||+++.+   .|+..+||||||+++|||+||..|+.....+..   +      |.-+
T Consensus       536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI---i------fmVG  606 (678)
T KOG0193|consen  536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI---I------FMVG  606 (678)
T ss_pred             eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe---E------EEec
Confidence            643321111222234678899999999755   589999999999999999999999873332221   1      2222


Q ss_pred             CccccccCcCC-CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCCC
Q 008108          471 AALNLMDPTMR-GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDT  520 (577)
Q Consensus       471 ~~~~~~d~~l~-~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~~  520 (577)
                      .-.-..|.... ...+.++.   +|...||..++++||.+.+|+.+|+...
T Consensus       607 rG~l~pd~s~~~s~~pk~mk---~Ll~~C~~~~~~eRP~F~~il~~l~~l~  654 (678)
T KOG0193|consen  607 RGYLMPDLSKIRSNCPKAMK---RLLSDCWKFDREERPLFPQLLSKLEELL  654 (678)
T ss_pred             ccccCccchhhhccCHHHHH---HHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence            21112222221 12333444   5666999999999999999999887643

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-42  Score=343.62  Aligned_cols=265  Identities=25%  Similarity=0.397  Sum_probs=202.1

Q ss_pred             hcCCccccccccCCcEEEEEeE-ecCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC--CeEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KERIL  317 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  317 (577)
                      .+.|+.+++||+|.||.||+++ ..+|+.||+|++..+.  .....-..+|+.+|++|.||||++|.+...+.  ..+||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            3567788999999999999999 5679999999998765  33334467999999999999999999988776  68999


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      |+|||+. +|.-++..  ..-.+++.++..++.||+.||.|+|.++   |+|||||.+|||||.+|.+||+|||||+++.
T Consensus       196 VFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence            9999977 67666632  2447999999999999999999999998   9999999999999999999999999999988


Q ss_pred             CCCccccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhh-hhh----hhhcccCC
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL-TYA----WRNWNEGA  471 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~-~~~----~~~~~~~~  471 (577)
                      .......++ .+-|.+|.|||.+.+. .|+.+.|+||.||||.||++|+..+....+-+....+ ...    ...|....
T Consensus       270 ~~~~~~~T~-rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  270 PSGSAPYTS-RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             CCCCccccc-ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence            766554444 5669999999999875 6999999999999999999999877655543322222 111    11122111


Q ss_pred             c--cccccCcCCCC-ChHHH-----HHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          472 A--LNLMDPTMRGG-STSEM-----MKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       472 ~--~~~~d~~l~~~-~~~~~-----~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      +  ...+.+.-... ...|.     ...++|+-.+|..||.+|.|+.++++
T Consensus       349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            1  12222221111 11111     23445666778889999999998764

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.6e-42  Score=355.30  Aligned_cols=261  Identities=29%  Similarity=0.441  Sum_probs=202.1

Q ss_pred             HHhcCCccccccccCCcEEEEEeEe------cCCcEEEEEEeccCCh-hhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcC
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNLVRLLGFCLER  312 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  312 (577)
                      ...++|++.++||+|+||.||+|..      .+++.||||++..... .....+.+|+.++..+ +||||+++++++...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            3457899999999999999999974      2356799999975433 2344688999999999 899999999988765


Q ss_pred             C-eEEEEEEecCCCCcccccccCCC-------------------------------------------------------
Q 008108          313 K-ERILVYEFVPNASLDHFIFDPIN-------------------------------------------------------  336 (577)
Q Consensus       313 ~-~~~lv~E~~~~gsL~~~l~~~~~-------------------------------------------------------  336 (577)
                      + ..++||||+++|+|.+++.....                                                       
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence            4 57899999999999888753211                                                       


Q ss_pred             ----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccccccccccCC
Q 008108          337 ----REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF  412 (577)
Q Consensus       337 ----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~  412 (577)
                          ...+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++...............++.
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                235889999999999999999999987   9999999999999999999999999998654333222233345678


Q ss_pred             CCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCChHHHHHH
Q 008108          413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKC  491 (577)
Q Consensus       413 ~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  491 (577)
                      .|+|||++.+..++.++||||||+++|||++ |+.||.......  ...    .....+...     ......   ...+
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~----~~~~~~~~~-----~~~~~~---~~~l  306 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFC----QRLKDGTRM-----RAPENA---TPEI  306 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHH----HHHhcCCCC-----CCCCCC---CHHH
Confidence            8999999999999999999999999999997 888886433211  111    111111110     011111   2245


Q ss_pred             HHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          492 IHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       492 ~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .+++..||+.||++|||+.|++++|+.
T Consensus       307 ~~li~~cl~~dp~~RPs~~el~~~l~~  333 (338)
T cd05102         307 YRIMLACWQGDPKERPTFSALVEILGD  333 (338)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            678889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-43  Score=349.97  Aligned_cols=265  Identities=26%  Similarity=0.355  Sum_probs=208.6

Q ss_pred             HhcCCccccccccCCcEEEEEeE-ecCCcEEEEEEeccCChhhHHH-HHHHHHHHHhcC-CCCeEEEEeEEEcCC-eEEE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQ-HRNLVRLLGFCLERK-ERIL  317 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~-~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l  317 (577)
                      ..++|..+++||.|.||.||+|+ ..+|+.||||++++.-...++. -.+|+..|++|+ ||||++|.+++.+.+ .+++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            34788899999999999999999 5579999999998765443322 368999999998 999999999999988 9999


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      |||||+. +|.+++.+.  +..+++..+..|+.||++||+|+|++|   +.||||||+|||+..+..+||+|||+||...
T Consensus        88 VfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence            9999955 898888653  778999999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCccccccccccCCCCcChhhhh-cCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhh-----hhhcccCC
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVM-HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA-----WRNWNEGA  471 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~-----~~~~~~~~  471 (577)
                      .....   +.++.|.+|.|||++. .+-|+.+.|||++|||++|+.+-+.-|....+-+....+-.+     +..|.++.
T Consensus       162 SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  162 SKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             cCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence            54433   3478899999999885 567999999999999999999998776544433222111111     22232221


Q ss_pred             ----ccccccCcCCCC-----ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          472 ----ALNLMDPTMRGG-----STSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       472 ----~~~~~d~~l~~~-----~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                          .+.+.-|...+.     .+....++++++..|+..||.+|||+.|.+++
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence                111112222221     22244567788889999999999999999876

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.2e-42  Score=327.34  Aligned_cols=261  Identities=20%  Similarity=0.339  Sum_probs=204.3

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhh--HHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQG--EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      +.|+.+.++|+|+||.|||.+.+ +|+.||||++.......  ..-..+|+.+|++++|+|+|.|+.+|.....++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45778899999999999999965 69999999997765432  2235799999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC-C
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM-D  399 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~-~  399 (577)
                      ||+..-|+++-.   ....++.+.+.+++.|+++|+.|+|+++   +|||||||+||||+.++.+||||||+|+.+.. +
T Consensus        82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence            999877766532   3445899999999999999999999998   99999999999999999999999999998873 3


Q ss_pred             CccccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhh--------hhhcccC
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA--------WRNWNEG  470 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~  470 (577)
                      +.   .+.++.|.+|.|||.+.+ .+|....|||++||++.||++|..-|....+-+...++...        ...+...
T Consensus       156 d~---YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N  232 (396)
T KOG0593|consen  156 DN---YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN  232 (396)
T ss_pred             ch---hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence            22   234788999999999987 68999999999999999999999887665544333333221        2222222


Q ss_pred             Ccc------ccccCcC-CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 008108          471 AAL------NLMDPTM-RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVV  513 (577)
Q Consensus       471 ~~~------~~~d~~l-~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~  513 (577)
                      ...      +.-++.- ....+....-+++++..|++.||.+|++-++++
T Consensus       233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll  282 (396)
T KOG0593|consen  233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL  282 (396)
T ss_pred             CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence            111      1111111 111223334567888999999999999999876

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.7e-41  Score=343.41  Aligned_cols=263  Identities=27%  Similarity=0.434  Sum_probs=201.5

Q ss_pred             cCCccccccccCCcEEEEEeEecC-----------------CcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSN-----------------GETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRL  305 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l  305 (577)
                      ++|...++||+|+||.||++.+.+                 +..||+|.+.... .....++.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578889999999999999997532                 3469999987653 3344578999999999999999999


Q ss_pred             EeEEEcCCeEEEEEEecCCCCcccccccCC----------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEE
Q 008108          306 LGFCLERKERILVYEFVPNASLDHFIFDPI----------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH  369 (577)
Q Consensus       306 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiH  369 (577)
                      ++++.+.+..++||||+++|+|.+++....                ....+++..+++++.||+.||.|||+.+   |+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence            999999999999999999999988774311                1235788999999999999999999987   999


Q ss_pred             eccCCCcEEEcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCC--CC
Q 008108          370 RDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ--KR  447 (577)
Q Consensus       370 rDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~--~p  447 (577)
                      |||||+|||++.++.+||+|||+++...............++..|+|||++..+.++.++||||||+++|||+++.  .|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            9999999999999999999999998665433323333455688999999999999999999999999999999754  45


Q ss_pred             CCCCCccccchhhhhhhhhcccCCc-cccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          448 SSFGTEEETEDLLTYAWRNWNEGAA-LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       448 ~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      +......   ..+......+..... .....+   ...   ...+.+++.+||+.+|++||||.+|.+.|++
T Consensus       242 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~---~~~---~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         242 YGELTDE---QVIENAGEFFRDQGRQVYLFRP---PPC---PQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCcCCHH---HHHHHHHHHhhhccccccccCC---CCC---CHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            4432222   222222111111100 000011   111   2345678889999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=8.1e-42  Score=316.68  Aligned_cols=278  Identities=23%  Similarity=0.369  Sum_probs=209.5

Q ss_pred             cCCccccccccCCcEEEEEeE-ecCCcEEEEEEeccCChh--hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      ++|...++||+|.||.||+|. .++|+.||||+++.....  -.....+|+..|+.++|+||+.++++|-..+.+-||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            467788999999999999999 567999999999765332  23346799999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      ||+. +|+..|.+  +...++..++..++.++++||+|||++.   |+||||||.|+|++++|.+||+|||+|+.+....
T Consensus        82 fm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             eccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            9965 89888865  4567999999999999999999999998   9999999999999999999999999999887554


Q ss_pred             ccccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhh--------hhhhcccCC
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTY--------AWRNWNEGA  471 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~~~~  471 (577)
                      .....  .+-|.+|.|||.+.+. .|+...||||.|||+.||+.|.+-+....+-+....+-.        .|..+..-.
T Consensus       156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence            43322  3679999999998775 699999999999999999998765443333222121111        122221100


Q ss_pred             -ccc---cccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCCCCCCCCCCCCcc
Q 008108          472 -ALN---LMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKPAF  531 (577)
Q Consensus       472 -~~~---~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~~~~~~~p~~p~~  531 (577)
                       ..+   .-.+.+..-.+......+++...++..||.+|.|++|++++=--  ..+|.|..|.-
T Consensus       234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf--~~~P~pt~~~~  295 (318)
T KOG0659|consen  234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYF--KSLPLPTPPSK  295 (318)
T ss_pred             cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhh--hcCCCCCChhh
Confidence             000   01111111122333445778889999999999999998865322  22455555443

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-41  Score=332.65  Aligned_cols=262  Identities=25%  Similarity=0.335  Sum_probs=204.0

Q ss_pred             hcCCccccccccCCcEEEEEeE-ecCCcEEEEEEeccCChhh-HHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      .++|+....||.|..++||+|. .+.++.||||++.-..-.. ...+.+|+..|+.++||||++++..|..+.++|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            4679999999999999999999 5678999999997654333 4678999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC-C
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM-D  399 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~-~  399 (577)
                      ||.+||+.+++..... ..+++..+..|++++++||.|||++|   .||||||+.||||+++|.+||+|||.+..+.. +
T Consensus       105 fMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            9999999998865433 34999999999999999999999998   99999999999999999999999998764433 3


Q ss_pred             Cccccc-cccccCCCCcChhhhhcC--CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          400 QTHSDT-NRVVGTFGYMAPEYVMHG--RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       400 ~~~~~~-~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      ...... +..+||+.|||||+++..  .|+.|+||||||++..||.+|..||....+-.  -++.... .-..-.....+
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk--vLl~tLq-n~pp~~~t~~~  257 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK--VLLLTLQ-NDPPTLLTSGL  257 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH--HHHHHhc-CCCCCcccccC
Confidence            222222 557899999999996554  59999999999999999999999987554322  1111100 00000000011


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      |..   .....-..+.+++..|++.||++|||++++++
T Consensus       258 ~~d---~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  258 DKD---EDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             ChH---HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            100   01111224556778999999999999999884

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=350.19  Aligned_cols=259  Identities=29%  Similarity=0.447  Sum_probs=202.7

Q ss_pred             HhcCCccccccccCCcEEEEEeEecC--C--cE-EEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLSN--G--ET-IAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK  313 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~~--~--~~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  313 (577)
                      ..++....++||+|.||.||+|.+..  +  .. ||||..+..   ......+|.+|.++|++++|||||+++|++....
T Consensus       155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~  234 (474)
T KOG0194|consen  155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE  234 (474)
T ss_pred             eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence            34455567999999999999999653  2  23 899998752   3566678999999999999999999999999999


Q ss_pred             eEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCc
Q 008108          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (577)
Q Consensus       314 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla  393 (577)
                      .++||||+|+||+|+++|..  +.+.++..+++.++.+.|.||+|||+++   +|||||.++|+|++.++.+||+||||+
T Consensus       235 Pl~ivmEl~~gGsL~~~L~k--~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs  309 (474)
T KOG0194|consen  235 PLMLVMELCNGGSLDDYLKK--NKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLS  309 (474)
T ss_pred             ccEEEEEecCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccc
Confidence            99999999999999999954  2336999999999999999999999998   999999999999999999999999998


Q ss_pred             ccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhh-hcccCC
Q 008108          394 RLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWR-NWNEGA  471 (577)
Q Consensus       394 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~-~~~~~~  471 (577)
                      +.-.  ..........-+..|+|||.+..+.|+.++|||||||++||+++ |..|+......+.   ..++.. .++.  
T Consensus       310 ~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v---~~kI~~~~~r~--  382 (474)
T KOG0194|consen  310 RAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV---KAKIVKNGYRM--  382 (474)
T ss_pred             cCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH---HHHHHhcCccC--
Confidence            8543  11111112245689999999999999999999999999999999 7777654433322   121111 1110  


Q ss_pred             ccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCCCCC
Q 008108          472 ALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVT  522 (577)
Q Consensus       472 ~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~~~~  522 (577)
                             ......+.++.   .+...||..+|++||+|.++.+.|+.....
T Consensus       383 -------~~~~~~p~~~~---~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~  423 (474)
T KOG0194|consen  383 -------PIPSKTPKELA---KVMKQCWKKDPEDRPTMSTIKKKLEALEKK  423 (474)
T ss_pred             -------CCCCCCHHHHH---HHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence                   01112334444   445599999999999999999999764433

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=342.33  Aligned_cols=254  Identities=25%  Similarity=0.323  Sum_probs=206.2

Q ss_pred             HHhcCCccccccccCCcEEEEEeE-ecCCcEEEEEEeccCChh---hHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeE
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQ---GEIEFKNEVLLLARL-QHRNLVRLLGFCLERKER  315 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  315 (577)
                      ....+|...+.||+|+|++|+++. ...++.+|||++.+.-.-   ....+..|-..|.+| .||.|++|+-.|.++..+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            445789999999999999999999 457899999999775322   223467788899999 899999999999999999


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      |+|+||+++|+|.++|.   +-+.+++.....++.+|+.||+|||+.|   ||||||||+|||||++|++||+|||-|+.
T Consensus       150 YFvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             EEEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence            99999999999999984   4578999999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCcc-----------ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhh
Q 008108          396 FEMDQTH-----------SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAW  464 (577)
Q Consensus       396 ~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~  464 (577)
                      +......           ......+||..|.+||++..+..+..+|+|+||||||+|+.|+.||....+--....+..  
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~--  301 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA--  301 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH--
Confidence            7653322           112458999999999999999999999999999999999999999875544222221111  


Q ss_pred             hhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 008108          465 RNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNML  516 (577)
Q Consensus       465 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L  516 (577)
                                 +|-.+....++.+..   |+...+..||.+|+|..++-+-.
T Consensus       302 -----------l~y~fp~~fp~~a~d---Lv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  302 -----------LDYEFPEGFPEDARD---LIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             -----------hcccCCCCCCHHHHH---HHHHHHccCccccccHHHHhhCc
Confidence                       122222233344444   44466789999999999887653

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-42  Score=358.58  Aligned_cols=254  Identities=28%  Similarity=0.457  Sum_probs=208.6

Q ss_pred             CCccccccccCCcEEEEEeEecC----CcEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          245 NFSDANKLGQGGFGAVYKGMLSN----GETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ...+.+.||.|.||+|++|.++-    ...||||.++.... ..+.+|..|..||.+++||||++|.|+.......+||.
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            45678899999999999999752    35699999987654 34557999999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      |||+||+||.||..  +.+++++.+...++++||.||.||-+.+   +|||||.++||||+.+...|++||||+|.++.+
T Consensus       710 EyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             hhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence            99999999999965  4467999999999999999999999988   999999999999999999999999999987655


Q ss_pred             Cccc-cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCcccccc
Q 008108          400 QTHS-DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD  477 (577)
Q Consensus       400 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  477 (577)
                      .... .+..-.-+.+|.|||.+...+++.+||||||||+|||.++ |.+|+=.....+....++..++            
T Consensus       785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyR------------  852 (996)
T KOG0196|consen  785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYR------------  852 (996)
T ss_pred             CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccC------------
Confidence            4222 2222233678999999999999999999999999999886 6777543333332222221111            


Q ss_pred             CcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          478 PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       478 ~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                         .+.+++....+-+|++.|||+|-.+||++.+++.+|.+
T Consensus       853 ---LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDk  890 (996)
T KOG0196|consen  853 ---LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDK  890 (996)
T ss_pred             ---CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence               12244555667789999999999999999999999875

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=342.77  Aligned_cols=250  Identities=24%  Similarity=0.369  Sum_probs=202.5

Q ss_pred             HHhcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccC----Ch-hhHHHHHHHHHHHHhcC-CCCeEEEEeEEEcCC
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN----SK-QGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERK  313 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  313 (577)
                      ....+|...+.||+|.||+|++|.. .+++.||+|.+.+.    .. .....+.+|+.++++++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3456899999999999999999984 46899999977654    11 22345678999999998 999999999999999


Q ss_pred             eEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCC-CCeEEeccCC
Q 008108          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGM  392 (577)
Q Consensus       314 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~-~~~kl~DfGl  392 (577)
                      ..++||||+.+|+|.+++.   +.+++.+.++..++.||+.|++|||+++   |+||||||+|||+|.+ +++||+|||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~---~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIV---NKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             eEEEEEEecCCccHHHHHH---HcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence            9999999999999999984   3678999999999999999999999998   9999999999999999 9999999999


Q ss_pred             cccccCCCccccccccccCCCCcChhhhhcCC-CC-ccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccC
Q 008108          393 ARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR-FS-VKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEG  470 (577)
Q Consensus       393 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  470 (577)
                      +....  .........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||...........+       ..+
T Consensus       168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki-------~~~  238 (370)
T KOG0583|consen  168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI-------RKG  238 (370)
T ss_pred             ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH-------hcC
Confidence            99774  1122233478999999999999877 76 7899999999999999999999763322221111       111


Q ss_pred             CccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 008108          471 AALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVV  513 (577)
Q Consensus       471 ~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~  513 (577)
                      .      -.+.... . ...+..++..|++.||..|+|+.+++
T Consensus       239 ~------~~~p~~~-~-S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  239 E------FKIPSYL-L-SPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             C------ccCCCCc-C-CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            0      0000011 0 33555777899999999999999998

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.5e-40  Score=333.18  Aligned_cols=251  Identities=27%  Similarity=0.384  Sum_probs=198.1

Q ss_pred             CCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      .|+..+.||+|+||+||++.. .+|+.||+|.+.....   .....+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            377889999999999999995 5789999999875432   233457889999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |+++|+|..++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||++.......
T Consensus        81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            99999998777432 2346899999999999999999999987   9999999999999999999999999998654322


Q ss_pred             ccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                      .   .....||..|+|||++.+..++.++|||||||++|||++|+.||...........+..   ......      ...
T Consensus       157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~---~~~~~~------~~~  224 (285)
T cd05631         157 T---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR---RVKEDQ------EEY  224 (285)
T ss_pred             e---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH---Hhhccc------ccC
Confidence            1   2235789999999999999999999999999999999999999875443221111111   010000      001


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRPG-----MASVVN  514 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RPt-----~~ev~~  514 (577)
                      ......   .+.+++..||+.||++||+     ++++++
T Consensus       225 ~~~~s~---~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         225 SEKFSE---DAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             CccCCH---HHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            111222   4456778999999999997     777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.3e-40  Score=332.99  Aligned_cols=244  Identities=17%  Similarity=0.307  Sum_probs=195.1

Q ss_pred             ccccccCCcEEEEEeEecCCcEEEEEEeccCChhh---HHHHHHHHHHHHhcCCCCeEEEEeEEEc----CCeEEEEEEe
Q 008108          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG---EIEFKNEVLLLARLQHRNLVRLLGFCLE----RKERILVYEF  321 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~E~  321 (577)
                      ...||+|++|.||+|.+ +|+.||||++.......   ...+.+|+.+|.+++||||++++|++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            47899999999999998 68999999997654332   3467899999999999999999999877    3467899999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      +++|+|.+++..   ...+++...+.++.+++.||.|||+. +   ++||||||+|||+++++.+||+|||+++......
T Consensus       104 ~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~  177 (283)
T PHA02988        104 CTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP  177 (283)
T ss_pred             CCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence            999999999843   45799999999999999999999974 5   7899999999999999999999999998654321


Q ss_pred             ccccccccccCCCCcChhhhhc--CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          401 THSDTNRVVGTFGYMAPEYVMH--GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                           ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||......+   +......   .+.     .+
T Consensus       178 -----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~~~~i~~---~~~-----~~  241 (283)
T PHA02988        178 -----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---IYDLIIN---KNN-----SL  241 (283)
T ss_pred             -----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHh---cCC-----CC
Confidence                 12468899999999976  689999999999999999999999987543322   1111110   000     01


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .+....+.   .+.+++.+||+.||++|||+.||++.|+.
T Consensus       242 ~~~~~~~~---~l~~li~~cl~~dp~~Rps~~ell~~l~~  278 (283)
T PHA02988        242 KLPLDCPL---EIKCIVEACTSHDSIKRPNIKEILYNLSL  278 (283)
T ss_pred             CCCCcCcH---HHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence            11111222   35567789999999999999999999864

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-41  Score=340.75  Aligned_cols=250  Identities=30%  Similarity=0.461  Sum_probs=201.7

Q ss_pred             cCCCChHHHHHHhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEE
Q 008108          231 SLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL  310 (577)
Q Consensus       231 ~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  310 (577)
                      .+...|++|.       .++-||.|..|.||+|++. ++.||||+++.-.       ..+++-|++|+|+||+.+.|+|.
T Consensus       118 ~WeiPFe~Is-------ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCt  182 (904)
T KOG4721|consen  118 LWEIPFEEIS-------ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCT  182 (904)
T ss_pred             hccCCHHHhh-------hhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeec
Confidence            3556666654       4688999999999999996 6899999875322       34678899999999999999999


Q ss_pred             cCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEecc
Q 008108          311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDF  390 (577)
Q Consensus       311 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~Df  390 (577)
                      ....++||||||..|-|...|   +.+..++......|..+||.||.|||.+.   |||||||+-||||..+..+||+||
T Consensus       183 qsPcyCIiMEfCa~GqL~~VL---ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDF  256 (904)
T KOG4721|consen  183 QSPCYCIIMEFCAQGQLYEVL---KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDF  256 (904)
T ss_pred             CCceeEEeeeccccccHHHHH---hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccc
Confidence            999999999999999999998   44678999999999999999999999987   999999999999999999999999


Q ss_pred             CCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccC
Q 008108          391 GMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEG  470 (577)
Q Consensus       391 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  470 (577)
                      |-++.....   ...-.++||..|||||++.....++|.|||||||+|||||||.-|+..-...   .+      .|.-+
T Consensus       257 GTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---AI------IwGVG  324 (904)
T KOG4721|consen  257 GTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---AI------IWGVG  324 (904)
T ss_pred             cchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh---ee------EEecc
Confidence            999876533   3334589999999999999999999999999999999999999987532211   11      22211


Q ss_pred             -CccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCC
Q 008108          471 -AALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD  519 (577)
Q Consensus       471 -~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~  519 (577)
                       ..+.+.-|.      ....-+.-|+.+||+..|.+||++++++.-|+-.
T Consensus       325 sNsL~LpvPs------tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  325 SNSLHLPVPS------TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             CCcccccCcc------cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence             111221111      1122333466799999999999999999988643

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.9e-40  Score=345.56  Aligned_cols=259  Identities=26%  Similarity=0.403  Sum_probs=200.9

Q ss_pred             hcCCccccccccCCcEEEEEeEe------cCCcEEEEEEeccCC-hhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKE  314 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  314 (577)
                      .++|++.++||+|+||.||++..      .++..||||+++... ......+.+|+.++..+ +||||+++++++.+.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45788899999999999999973      245689999987543 23344688999999999 89999999999999999


Q ss_pred             EEEEEEecCCCCcccccccCC-----------------------------------------------------------
Q 008108          315 RILVYEFVPNASLDHFIFDPI-----------------------------------------------------------  335 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~-----------------------------------------------------------  335 (577)
                      .++||||+++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999988875321                                                           


Q ss_pred             -------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          336 -------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       336 -------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                                   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                         1125789999999999999999999987   999999999999999999999999999866543322


Q ss_pred             ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC
Q 008108          403 SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR  481 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  481 (577)
                      .......++..|+|||++.+..++.++||||||+++|||++ |..|+.......  .....    ...+...  ..+.  
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~----~~~~~~~--~~~~--  340 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKM----IKEGYRM--LSPE--  340 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHH----HHhCccC--CCCC--
Confidence            22222345678999999999999999999999999999998 777764332211  11111    1111100  0011  


Q ss_pred             CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       482 ~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                       ..+   .++.+++.+|++.||++||++.||+++|+.
T Consensus       341 -~~~---~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         341 -CAP---SEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             -CCC---HHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence             112   245678889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.6e-40  Score=335.75  Aligned_cols=249  Identities=22%  Similarity=0.336  Sum_probs=200.5

Q ss_pred             HHHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChh---hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeE
Q 008108          240 RVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ---GEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (577)
Q Consensus       240 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  315 (577)
                      +...++|+.++.||+|+||.||+++.+ +|+.+|+|++++....   ....++.|-.+|....+++||+|+..|.+.+.+
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            345689999999999999999999954 6999999999887543   334577899999999999999999999999999


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      ||||||++||++..+|   .+.+.|++..+..++.+++.|+.-||+.|   +|||||||+|+|||..|++||+||||+.-
T Consensus       217 YLiMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g  290 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG  290 (550)
T ss_pred             EEEEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence            9999999999999998   45778999999999999999999999998   99999999999999999999999999853


Q ss_pred             ccCC----------------------Ccc-----cc------------------ccccccCCCCcChhhhhcCCCCcccc
Q 008108          396 FEMD----------------------QTH-----SD------------------TNRVVGTFGYMAPEYVMHGRFSVKSD  430 (577)
Q Consensus       396 ~~~~----------------------~~~-----~~------------------~~~~~gt~~y~aPE~~~~~~~~~~~D  430 (577)
                      +...                      +..     ..                  ....+|||.|||||++.+..|+..+|
T Consensus       291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD  370 (550)
T KOG0605|consen  291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD  370 (550)
T ss_pred             hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence            3210                      000     00                  01258999999999999999999999


Q ss_pred             EEecchhHhHHhhCCCCCCCCCccccc-hhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCC
Q 008108          431 IFSFGVLVLEIVSGQKRSSFGTEEETE-DLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPG  508 (577)
Q Consensus       431 v~SlGvil~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt  508 (577)
                      .||||||+||||.|-+||....+.+.. .++.|.. .|.-..     +    .....   +..+++.+|+. ||++|..
T Consensus       371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~-~l~fP~-----~----~~~s~---eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE-TLKFPE-----E----VDLSD---EAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh-hccCCC-----c----CcccH---HHHHHHHHHhc-CHHHhcC
Confidence            999999999999999999887766543 3443321 111100     0    00123   33456667776 9999976

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-40  Score=339.09  Aligned_cols=253  Identities=25%  Similarity=0.352  Sum_probs=201.9

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|++.++||+|+||.||+|... +++.||||++.+..   ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46889999999999999999965 58899999997642   223346788999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.... 
T Consensus        81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            9999999999883   3457899999999999999999999988   99999999999999999999999999986543 


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                          ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.    .+...    +..+.
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~----~~~~~----~~~~~  221 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK----YWKET----LQRPV  221 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH----hcccc----ccCCC
Confidence                2234679999999999999999999999999999999999999986544332211111    11100    00011


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      ...........+.+++..|++.+|.+||++.++++.
T Consensus       222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            100001112244567778999999999999999865

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-41  Score=314.72  Aligned_cols=201  Identities=29%  Similarity=0.391  Sum_probs=181.5

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChh---hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ---GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      .++|+..+.||.|+||.|.+++.+ +|..+|+|++.+...-   ......+|..+|+.+.||+++++++.+.+.+.+++|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            367889999999999999999954 6888999999876432   233467899999999999999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||++||.|..++   ++.+++++..+.-++.||+.||+|||+.+   |++|||||+|||||.+|.+||+|||+|+....
T Consensus       123 meyv~GGElFS~L---rk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  123 MEYVPGGELFSYL---RKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             EeccCCccHHHHH---HhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            9999999999998   35678999999999999999999999998   99999999999999999999999999997652


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCcc
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEE  454 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~  454 (577)
                           .+-..+||+.|+|||++....|..++|.|+|||++|||+.|..||......
T Consensus       197 -----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~  247 (355)
T KOG0616|consen  197 -----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI  247 (355)
T ss_pred             -----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH
Confidence                 344589999999999999999999999999999999999999999876653

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=7.2e-40  Score=337.08  Aligned_cols=201  Identities=30%  Similarity=0.407  Sum_probs=176.1

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      .++|+..+.||+|+||.||+++.. ++..+|+|.+..... .....+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            478999999999999999999965 688899999876532 334568999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+.+  .|+||||||+|||++.++.+||+|||++...... 
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  157 (331)
T cd06649          84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (331)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence            9999999998843   456899999999999999999999853  3999999999999999999999999999765322 


Q ss_pred             ccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCC
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGT  452 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~  452 (577)
                         ......||..|+|||++.+..++.++||||||+++|||++|+.|+....
T Consensus       158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~  206 (331)
T cd06649         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD  206 (331)
T ss_pred             ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence               1233579999999999999999999999999999999999999986544

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.4e-40  Score=345.92  Aligned_cols=262  Identities=25%  Similarity=0.388  Sum_probs=202.2

Q ss_pred             HHHhcCCccccccccCCcEEEEEeEe------cCCcEEEEEEeccCCh-hhHHHHHHHHHHHHhc-CCCCeEEEEeEEEc
Q 008108          240 RVATDNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNLVRLLGFCLE  311 (577)
Q Consensus       240 ~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  311 (577)
                      ....++|++.+.||+|+||.||++..      .++..||+|++..... .....+.+|+.+++.+ +|+||+++++++..
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            34456899999999999999999874      2345799999976533 3344688999999999 89999999999999


Q ss_pred             CCeEEEEEEecCCCCcccccccCC--------------------------------------------------------
Q 008108          312 RKERILVYEFVPNASLDHFIFDPI--------------------------------------------------------  335 (577)
Q Consensus       312 ~~~~~lv~E~~~~gsL~~~l~~~~--------------------------------------------------------  335 (577)
                      .+..++||||+++|+|.+++....                                                        
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            999999999999999988874311                                                        


Q ss_pred             -----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcccc
Q 008108          336 -----------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD  404 (577)
Q Consensus       336 -----------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~  404 (577)
                                 ....+++..+++++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++..........
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence                       1135789999999999999999999987   99999999999999999999999999986543322222


Q ss_pred             ccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCC
Q 008108          405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGG  483 (577)
Q Consensus       405 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  483 (577)
                      .....++..|||||++.++.++.++||||||+++|||++ |+.||.......  ....    ....+.     .+.....
T Consensus       271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~----~~~~~~-----~~~~~~~  339 (374)
T cd05106         271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYK----MVKRGY-----QMSRPDF  339 (374)
T ss_pred             ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHH----HHHccc-----CccCCCC
Confidence            222345678999999999999999999999999999997 998876433211  1111    111110     0001111


Q ss_pred             ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          484 STSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       484 ~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .+   ..+.+++..||+.+|++||++.+|+++|+.
T Consensus       340 ~~---~~l~~li~~cl~~dp~~RPs~~~l~~~l~~  371 (374)
T cd05106         340 AP---PEIYSIMKMCWNLEPTERPTFSQISQLIQR  371 (374)
T ss_pred             CC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            12   345577789999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6.3e-40  Score=329.59  Aligned_cols=257  Identities=28%  Similarity=0.493  Sum_probs=204.3

Q ss_pred             cCCccccccccCCcEEEEEeEecC------CcEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSN------GETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  316 (577)
                      ++|+..+.||+|+||.||+|....      ...||+|.+..... ....++.+|+.++.+++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468889999999999999998543      25799999875432 33456899999999999999999999999999999


Q ss_pred             EEEEecCCCCcccccccCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC
Q 008108          317 LVYEFVPNASLDHFIFDPIN-------------REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM  383 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~  383 (577)
                      ++|||+++++|.+++.....             ...+++..++.++.|++.||.|||+.+   ++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999988754211             156899999999999999999999987   99999999999999999


Q ss_pred             CeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhh
Q 008108          384 NPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTY  462 (577)
Q Consensus       384 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~  462 (577)
                      .+||+|||+++...............+++.|+|||++..+.++.++||||||+++|||++ |..|+......+....+  
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i--  239 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI--  239 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--
Confidence            999999999986544333333334567889999999999999999999999999999998 98887644333221111  


Q ss_pred             hhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          463 AWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       463 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                           ..+....     .....+   .++.+++..||+.||.+||++.||++.|++
T Consensus       240 -----~~~~~~~-----~~~~~~---~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         240 -----RSRQLLP-----CPEDCP---ARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             -----HcCCcCC-----CcccCC---HHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                 1111111     111122   345577789999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=364.80  Aligned_cols=258  Identities=31%  Similarity=0.501  Sum_probs=205.4

Q ss_pred             hcCCccccccccCCcEEEEEeEecC--Cc----EEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSN--GE----TIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  315 (577)
                      .++.+..+.||+|.||.||+|...+  |.    .||||.+.+. +.+...+|.+|..+|+.++|||||+++|+|.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            4556677899999999999999542  43    3899999876 455667899999999999999999999999999999


Q ss_pred             EEEEEecCCCCcccccccCC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccC
Q 008108          316 ILVYEFVPNASLDHFIFDPI----NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG  391 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfG  391 (577)
                      +|++|||++|+|..||.+.+    ....|+..+.+.++.|||+|+.||++++   +|||||..+|+||++...+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            99999999999999997642    2456999999999999999999999987   9999999999999999999999999


Q ss_pred             CcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCC-CCCCCCccccchhhhhhhhhcccC
Q 008108          392 MARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQK-RSSFGTEEETEDLLTYAWRNWNEG  470 (577)
Q Consensus       392 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~-p~~~~~~~~~~~l~~~~~~~~~~~  470 (577)
                      ||+.+...+.......-.-...|||||.+..+.++.|+|||||||+|||++|... |+......+   ++.    .+..+
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~---v~~----~~~~g  920 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE---VLL----DVLEG  920 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH---HHH----HHHhC
Confidence            9995544444443333334578999999999999999999999999999999655 443222221   111    11111


Q ss_pred             CccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          471 AALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       471 ~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .   .+++     +.....++.+++++||+.+|++||++..+++.+..
T Consensus       921 g---RL~~-----P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~  960 (1025)
T KOG1095|consen  921 G---RLDP-----PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPA  960 (1025)
T ss_pred             C---ccCC-----CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhh
Confidence            1   1111     11222355688899999999999999999997764

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.2e-39  Score=381.31  Aligned_cols=259  Identities=25%  Similarity=0.499  Sum_probs=212.7

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ...|...+.||+|+||.||+|.. .+++.||||++.......    ..|++.+++++|||||+++|+|.+.+..++||||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            45678889999999999999996 578999999986543322    3468889999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++|+|.+++.      .++|..+.+|+.||++||+|||....++|+||||||+||+++.++.+++. ||.......   
T Consensus       765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---  834 (968)
T PLN00113        765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---  834 (968)
T ss_pred             CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence            99999999883      38999999999999999999996655569999999999999999988875 666543321   


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR  481 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  481 (577)
                         .....||..|||||++.+..++.++|||||||++|||+||+.|+.... .....+..|+...+........+|+.+.
T Consensus       835 ---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  910 (968)
T PLN00113        835 ---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLDMWIDPSIR  910 (968)
T ss_pred             ---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccchhheeCcccc
Confidence               112368899999999999999999999999999999999999984322 2234556666555555555566777664


Q ss_pred             CC---ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCC
Q 008108          482 GG---STSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD  519 (577)
Q Consensus       482 ~~---~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~  519 (577)
                      ..   ...++.++.+++.+||+.+|++||||.||+++|+..
T Consensus       911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  951 (968)
T PLN00113        911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA  951 (968)
T ss_pred             CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence            43   456777888999999999999999999999999864

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.2e-40  Score=328.85  Aligned_cols=250  Identities=34%  Similarity=0.583  Sum_probs=191.9

Q ss_pred             cccccccCCcEEEEEeEec-----CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          248 DANKLGQGGFGAVYKGMLS-----NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       248 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ..+.||.|.||.||+|.+.     .+..|+||.+.... .....++.+|++.+++++||||++++|++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4678999999999999976     35779999996543 33467899999999999999999999999988889999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++|+|.++|... ....+++..++.|+.||++||.|||+++   ++|+||+++|||+++++.+||+|||+++.......
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999998652 3467999999999999999999999987   99999999999999999999999999987633222


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                      ........+...|+|||.+....++.++||||||+++|||++ |+.|+......+   +....    ..+.....     
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~~~~----~~~~~~~~-----  226 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---IIEKL----KQGQRLPI-----  226 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HHHHH----HTTEETTS-----
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccc----ccccccee-----
Confidence            222333457789999999999999999999999999999999 667765432222   22211    11111110     


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNML  516 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L  516 (577)
                      ....+.   .+..++..||+.+|++||+|.++++.|
T Consensus       227 ~~~~~~---~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  227 PDNCPK---DIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             BTTSBH---HHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ccchhH---HHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            111222   344677899999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=9.4e-40  Score=324.32  Aligned_cols=255  Identities=28%  Similarity=0.471  Sum_probs=205.2

Q ss_pred             hcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      .++|+..++||+|+||.||+|...+++.||+|.+..... ....+.+|+.+++.++|+||+++++.+.+.+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            467899999999999999999988888999999875433 3457889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      ++++|.+++... ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++........
T Consensus        84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            999999988542 3456899999999999999999999987   999999999999999999999999999876533221


Q ss_pred             ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC
Q 008108          403 SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR  481 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  481 (577)
                       ......++..|+|||++..+.++.++||||||+++|||+| |+.|+.......   ........+..        +. .
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~~~~~--------~~-~  226 (261)
T cd05072         160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQRGYRM--------PR-M  226 (261)
T ss_pred             -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHHcCCCC--------CC-C
Confidence             1222346778999999998999999999999999999998 888875433222   12111111100        10 0


Q ss_pred             CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       482 ~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ...+   ..+.+++.+|++.+|++||++++++++|+.
T Consensus       227 ~~~~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         227 ENCP---DELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCC---HHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            1112   345678889999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=8e-40  Score=326.07  Aligned_cols=255  Identities=24%  Similarity=0.388  Sum_probs=201.1

Q ss_pred             hcCCccccccccCCcEEEEEeEec----CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS----NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|.+..... .....+.+|+.++.+++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            457888999999999999999853    356899999876533 334568899999999999999999999999999999


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      ||||+++|+|++++..  ....+++..++.++.||+.||+|||+.+   ++||||||+|||++.++.+|++|||.+....
T Consensus        84 v~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          84 VTEYMSNGALDSFLRK--HEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEeCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            9999999999998853  2357899999999999999999999987   9999999999999999999999999876543


Q ss_pred             CCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      .... .......++..|+|||.+.++.++.++||||||+++||+++ |+.||......+   ++...    ..+..    
T Consensus       159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~~----~~~~~----  226 (266)
T cd05064         159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKAV----EDGFR----  226 (266)
T ss_pred             ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHH----HCCCC----
Confidence            2211 11112345678999999999999999999999999999875 998886443322   12111    11100    


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                       .......   ...+.+++..||+.+|++||++.++.+.|+.
T Consensus       227 -~~~~~~~---~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         227 -LPAPRNC---PNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             -CCCCCCC---CHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence             0011111   2345577889999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=8.7e-40  Score=323.69  Aligned_cols=252  Identities=27%  Similarity=0.473  Sum_probs=201.6

Q ss_pred             cCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecC
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVP  323 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  323 (577)
                      ++|+..+.||+|+||.||++.+.++..+|+|.+..... ....+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            46888899999999999999988888999998865432 34568899999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccc
Q 008108          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS  403 (577)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~  403 (577)
                      +|+|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++........ 
T Consensus        83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05114          83 NGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence            9999988753  2346899999999999999999999987   999999999999999999999999999865432221 


Q ss_pred             cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCC
Q 008108          404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG  482 (577)
Q Consensus       404 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  482 (577)
                      ......++..|+|||++....++.++||||||+++|||++ |+.|+......+   .+........      ...+..  
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~~i~~~~~------~~~~~~--  225 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVEMISRGFR------LYRPKL--  225 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHCCCC------CCCCCC--
Confidence            1222345678999999988899999999999999999999 888875433222   2221111110      011111  


Q ss_pred             CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          483 GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       483 ~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                       .   ...+.+++.+||+.+|++||++.+++++|.
T Consensus       226 -~---~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         226 -A---SMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             -C---CHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence             1   134568888999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-41  Score=333.39  Aligned_cols=248  Identities=24%  Similarity=0.390  Sum_probs=204.5

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhh-HHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ..|+....||+|.||.||+|.. ..++.||+|++.-..... ...+++|+.+|.+++++||.+++|.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            3577779999999999999995 468899999997665443 45689999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      |.+|++.+.|.   ....+++..+.-|+++++.||.|||.++   .+|||||+.||||..+|.+||+|||.+..+.....
T Consensus        93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            99999998883   3445588888899999999999999998   99999999999999999999999999987765433


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR  481 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  481 (577)
                      .  ....+||+.|||||++....|+.|+||||||++.+||.+|.+|+....+.....++.            +-.-|.+.
T Consensus       167 r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp------------k~~PP~L~  232 (467)
T KOG0201|consen  167 R--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP------------KSAPPRLD  232 (467)
T ss_pred             c--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc------------CCCCCccc
Confidence            3  355899999999999998899999999999999999999999987655432222211            11123333


Q ss_pred             CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       482 ~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      +...   ..+.+++..|++.||+.||++.++++
T Consensus       233 ~~~S---~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  233 GDFS---PPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             cccC---HHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            3222   23446777999999999999999884

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=6.4e-40  Score=328.66  Aligned_cols=260  Identities=26%  Similarity=0.463  Sum_probs=202.4

Q ss_pred             HHhcCCccccccccCCcEEEEEeEec------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK  313 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  313 (577)
                      +.+++|+..+.||+|+||.||+|...      .+..||+|++.... .....++.+|+.+++.++|+||+++++++.+..
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            35678999999999999999998753      35679999986543 234456889999999999999999999999999


Q ss_pred             eEEEEEEecCCCCcccccccCCC-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeE
Q 008108          314 ERILVYEFVPNASLDHFIFDPIN-------REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPK  386 (577)
Q Consensus       314 ~~~lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~k  386 (577)
                      ..++||||+++++|.+++.....       ...+++..++.++.|++.||.|||+.+   ++||||||+|||+++++.+|
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence            99999999999999988754211       234688999999999999999999987   99999999999999999999


Q ss_pred             EeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhh
Q 008108          387 ISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWR  465 (577)
Q Consensus       387 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~  465 (577)
                      |+|||+++...............++..|+|||++.++.++.++||||||+++|||++ |..|+.......   .+...  
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~~~~--  234 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLRFV--  234 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH--
Confidence            999999986543332222222355788999999999999999999999999999999 677765433222   11111  


Q ss_pred             hcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          466 NWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       466 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                        .......     +....+   ..+.+++.+|++.+|++|||+.|++++|++
T Consensus       235 --~~~~~~~-----~~~~~~---~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         235 --MEGGLLD-----KPDNCP---DMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             --HcCCcCC-----CCCCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence              0111000     011112   245678889999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1e-39  Score=327.37  Aligned_cols=258  Identities=28%  Similarity=0.463  Sum_probs=205.1

Q ss_pred             hcCCccccccccCCcEEEEEeEecC------CcEEEEEEeccCChh-hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  315 (577)
                      .++|.+.+.||+|+||.||+|...+      ++.||||.+...... ....+.+|+++++.++|+||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            3568888999999999999998633      478999999765444 456789999999999999999999999999999


Q ss_pred             EEEEEecCCCCcccccccC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCC
Q 008108          316 ILVYEFVPNASLDHFIFDP-----------INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN  384 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~-----------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~  384 (577)
                      ++||||+++++|.+++...           .....+++..+..++.||+.||.|||+++   ++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            9999999999999888532           12346899999999999999999999987   999999999999999999


Q ss_pred             eEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhh
Q 008108          385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYA  463 (577)
Q Consensus       385 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~  463 (577)
                      +||+|||+++...............+++.|+|||++.++.++.++||||||+++|||++ |+.|+......+   .+...
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~~  237 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIECI  237 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH
Confidence            99999999986543322222233456789999999999999999999999999999999 998875443322   22211


Q ss_pred             hhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          464 WRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       464 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .    .+....     .....   ...+.+++..||+.||++||++.||++.|++
T Consensus       238 ~----~~~~~~-----~~~~~---~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         238 T----QGRLLQ-----RPRTC---PSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             H----cCCcCC-----CCCCC---CHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            1    111100     00111   2345578889999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=8.8e-40  Score=334.25  Aligned_cols=254  Identities=28%  Similarity=0.505  Sum_probs=200.1

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCc----EEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGE----TIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      .+|+..+.||+|+||.||+|.+. +++    .||+|.+.... .....++.+|+.+++.++||||++++|++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            56899999999999999999853 343    38999987543 34455788999999999999999999999765 5679


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      ++||+++|+|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        86 v~e~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            9999999999998854  2346899999999999999999999987   9999999999999999999999999998765


Q ss_pred             CCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      ............++..|+|||++.+..++.++||||||+++|||++ |+.|+......+....+.       .+..  ..
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~~--~~  231 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGER--LP  231 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-------CCCC--CC
Confidence            4433222223345678999999999999999999999999999998 888876433222111111       1100  00


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .+      ......+..++..||+.+|++||++.+++..|..
T Consensus       232 ~~------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~  267 (316)
T cd05108         232 QP------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK  267 (316)
T ss_pred             CC------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            00      1112345678889999999999999999998864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-40  Score=340.09  Aligned_cols=247  Identities=26%  Similarity=0.386  Sum_probs=204.3

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      .-|+..+.||+|+-|.|-.|++ .+|+.+|||++.+...   .....+.+|+.+|+.+.|||++++++++++..++|||.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            3477889999999999999995 5799999999987632   22335789999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++|.|.+++   ..++.+++.++.+++.||+.|+.|+|..+   |+||||||+|+|||.++++||+|||+|.+...+
T Consensus        92 Eyv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   92 EYVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             EecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            999999999998   45788999999999999999999999987   999999999999999999999999999875544


Q ss_pred             CccccccccccCCCCcChhhhhcCCCC-ccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFS-VKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      .-.   ...+|++.|.+||++++..|. .++||||.|||||.||||+.||+++.   ...++..+.    .|.. +    
T Consensus       166 klL---eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---ir~LLlKV~----~G~f-~----  230 (786)
T KOG0588|consen  166 KLL---ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---IRVLLLKVQ----RGVF-E----  230 (786)
T ss_pred             ccc---cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc---HHHHHHHHH----cCcc-c----
Confidence            322   236899999999999999884 79999999999999999999997433   333333222    1110 1    


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                       +......+.+   +|+..|+..||++|-|+.||++-
T Consensus       231 -MPs~Is~eaQ---dLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  231 -MPSNISSEAQ---DLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             -CCCcCCHHHH---HHHHHHhccCccccccHHHHhhC
Confidence             1122334444   55668999999999999999864

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-40  Score=338.74  Aligned_cols=245  Identities=27%  Similarity=0.362  Sum_probs=202.3

Q ss_pred             HHHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCe
Q 008108          240 RVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKE  314 (577)
Q Consensus       240 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  314 (577)
                      ....++|..+++||+|.||+|+++..+ +++.+|||.+++...   ...+..+.|..++... +||.|++|+.+|...++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            345578999999999999999999965 678899999998743   3344567788888777 59999999999999999


Q ss_pred             EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      +++||||+.||++..++    ..+.+++..+.-++..|+.||.|||+++   ||+||||.+|||||.+|.+||+||||++
T Consensus       444 l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             EEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence            99999999999965544    4578999999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccc
Q 008108          395 LFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALN  474 (577)
Q Consensus       395 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  474 (577)
                      .--.  ....+..++||+.|||||++.+..|+...|.|||||+|||||.|+.||...++++..+-+..            
T Consensus       517 e~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~------------  582 (694)
T KOG0694|consen  517 EGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN------------  582 (694)
T ss_pred             ccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc------------
Confidence            5432  23456679999999999999999999999999999999999999999987666554332210            


Q ss_pred             cccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCH
Q 008108          475 LMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGM  509 (577)
Q Consensus       475 ~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~  509 (577)
                       .|+........   +.+.|+.+.+..||++|..+
T Consensus       583 -d~~~yP~~ls~---ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  583 -DEVRYPRFLSK---EAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             -CCCCCCCcccH---HHHHHHHHHhccCcccccCC
Confidence             11222212233   34456668889999999987

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=9.8e-40  Score=329.85  Aligned_cols=259  Identities=26%  Similarity=0.429  Sum_probs=207.4

Q ss_pred             cCCccccccccCCcEEEEEeEec------CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      .+|...+.||+|+||.||+++..      ++..+++|.+..........+.+|+.++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            46788899999999999999742      345689999877766666678999999999999999999999999999999


Q ss_pred             EEEecCCCCcccccccCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCC
Q 008108          318 VYEFVPNASLDHFIFDPI-------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN  384 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~  384 (577)
                      ||||+++++|.+++....             ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999885421             1245899999999999999999999988   999999999999999999


Q ss_pred             eEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhh
Q 008108          385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYA  463 (577)
Q Consensus       385 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~  463 (577)
                      +||+|||+++...............++..|+|||++.+..++.++||||||+++|||+| |+.|+.......   .+.  
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~--  236 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIE--  236 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH--
Confidence            99999999986544332222333557889999999999999999999999999999999 888875443322   111  


Q ss_pred             hhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCCC
Q 008108          464 WRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDT  520 (577)
Q Consensus       464 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~~  520 (577)
                        ....+......        ......+.+++.+||+.+|++||++.+|+++|+...
T Consensus       237 --~~~~~~~~~~~--------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~  283 (291)
T cd05094         237 --CITQGRVLERP--------RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG  283 (291)
T ss_pred             --HHhCCCCCCCC--------ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence              11111111110        111234568888999999999999999999998643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=8.8e-40  Score=335.24  Aligned_cols=241  Identities=21%  Similarity=0.260  Sum_probs=192.7

Q ss_pred             cccccCCcEEEEEeEe-cCCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCC
Q 008108          250 NKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA  325 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  325 (577)
                      +.||+|+||.||++.. .+|+.||+|++.+..   ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999985 468999999997542   223345778999999999999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccccc
Q 008108          326 SLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT  405 (577)
Q Consensus       326 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~  405 (577)
                      +|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~  152 (323)
T cd05571          81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence            9988874   3457899999999999999999999998   9999999999999999999999999997532211  122


Q ss_pred             cccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCCh
Q 008108          406 NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGST  485 (577)
Q Consensus       406 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  485 (577)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||........   .....    .+      +..+.....
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~---~~~~~----~~------~~~~p~~~~  219 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELIL----ME------EIRFPRTLS  219 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH---HHHHH----cC------CCCCCCCCC
Confidence            346799999999999999999999999999999999999999864332221   11111    00      011111122


Q ss_pred             HHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 008108          486 SEMMKCIHIGLLCVQENVSNRP-----GMASVVN  514 (577)
Q Consensus       486 ~~~~~~~~l~~~C~~~~p~~RP-----t~~ev~~  514 (577)
                      .   .+.+++..|++.||++||     ++.++++
T Consensus       220 ~---~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         220 P---EAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             H---HHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            2   345677799999999999     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1e-40  Score=336.78  Aligned_cols=246  Identities=26%  Similarity=0.392  Sum_probs=202.1

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChh--hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      ++|.+.+.||+|.||.||||..+ +.+.||+|.+.+..+.  ....+.+|++++++++|||||.++++|+...++++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888899999999999999954 6888999999875433  33457899999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |+.| +|..+|.   ..+.++++.+..|+.+++.||.|||+++   |+|||+||.||||+.++.+|++|||+|+....+.
T Consensus        82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            9977 9999984   4678999999999999999999999987   9999999999999999999999999999776532


Q ss_pred             ccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                        .....+.||+.|||||.+.++.|+..+|+||+|||+||+++|++||....   ...++..+.   .        ||..
T Consensus       155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s---i~~Lv~~I~---~--------d~v~  218 (808)
T KOG0597|consen  155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS---ITQLVKSIL---K--------DPVK  218 (808)
T ss_pred             --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH---HHHHHHHHh---c--------CCCC
Confidence              33456899999999999999999999999999999999999999986322   122222111   1        2222


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .+.  .....++.+....+++||..|.|-.+++.
T Consensus       219 ~p~--~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  219 PPS--TASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             Ccc--cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            111  22234445555778999999999888764

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=8.9e-40  Score=336.05  Aligned_cols=244  Identities=25%  Similarity=0.310  Sum_probs=197.4

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|++.+.||+|+||.||++... +++.||+|.+.+...   .....+.+|+.++++++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            67899999999999999999965 688999999875421   23345789999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++|+|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus        98 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLR---KAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            9999999998884   3457899999999999999999999988   999999999999999999999999999865432


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                           .....||+.|+|||++.+..++.++|||||||++|||++|+.||........   ..    ....+..      .
T Consensus       172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~----~i~~~~~------~  233 (329)
T PTZ00263        172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI---YE----KILAGRL------K  233 (329)
T ss_pred             -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH---HH----HHhcCCc------C
Confidence                 1235799999999999999999999999999999999999999864332211   11    1111110      0


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRPG-----MASVVN  514 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RPt-----~~ev~~  514 (577)
                      +.....   .++.+++..||+.||++||+     +.++++
T Consensus       234 ~p~~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        234 FPNWFD---GRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             CCCCCC---HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            111111   23457778999999999997     566653

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-40  Score=332.61  Aligned_cols=244  Identities=24%  Similarity=0.301  Sum_probs=197.2

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|++.++||+|+||.||++... +++.||+|++....   ......+.+|+.++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47889999999999999999965 68999999986532   223445789999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++|+|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLR---NSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            9999999998884   3457999999999999999999999988   999999999999999999999999999865421


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                           .....||+.|+|||++.+..++.++|||||||++|||++|+.||........   .....    .+.      ..
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~---~~~i~----~~~------~~  216 (291)
T cd05612         155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI---YEKIL----AGK------LE  216 (291)
T ss_pred             -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH----hCC------cC
Confidence                 2235799999999999988899999999999999999999999865433221   11110    000      00


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRPG-----MASVVN  514 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RPt-----~~ev~~  514 (577)
                      +.....   ..+.+++..|++.||.+||+     +.|+++
T Consensus       217 ~~~~~~---~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         217 FPRHLD---LYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             CCccCC---HHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence            111111   23456778999999999995     776664

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.5e-39  Score=325.44  Aligned_cols=257  Identities=28%  Similarity=0.440  Sum_probs=201.7

Q ss_pred             cCCccccccccCCcEEEEEeEe-----cCCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-----SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      ++|+..++||+|+||.||+|..     .++..+++|.+.... ......+.+|+.++++++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            5678889999999999999984     246789999997543 3344578899999999999999999999999999999


Q ss_pred             EEEecCCCCcccccccCC--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC
Q 008108          318 VYEFVPNASLDHFIFDPI--------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM  383 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~  383 (577)
                      ||||+++++|.+++....              ....+++.+++.++.|++.||.|||+++   |+||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            999999999998874211              1235889999999999999999999987   99999999999999999


Q ss_pred             CeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhh
Q 008108          384 NPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTY  462 (577)
Q Consensus       384 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~  462 (577)
                      .+||+|||+++...............++..|+|||++.++.++.++||||||+++|||++ |..|+.......   +...
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~---~~~~  238 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE---VIEM  238 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence            999999999986544332222333456778999999988899999999999999999999 887775433221   1111


Q ss_pred             hhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          463 AWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       463 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ..    .....     ......+   .++..++.+|++.+|++||++.+|.+.|.+
T Consensus       239 ~~----~~~~~-----~~~~~~~---~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         239 VR----KRQLL-----PCSEDCP---PRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HH----cCCcC-----CCCCCCC---HHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            11    11100     0111112   245567789999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=322.39  Aligned_cols=256  Identities=25%  Similarity=0.345  Sum_probs=199.8

Q ss_pred             HHhcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChh--------------hHHHHHHHHHHHHhcCCCCeEEE
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ--------------GEIEFKNEVLLLARLQHRNLVRL  305 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~h~niv~l  305 (577)
                      +..++|++.+.||+|.||.|-+|.. .+++.||||++.+....              ..+...+|+.+|++++|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            3457899999999999999999995 46899999999764211              12357899999999999999999


Q ss_pred             EeEEEcC--CeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC
Q 008108          306 LGFCLER--KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM  383 (577)
Q Consensus       306 ~~~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~  383 (577)
                      +.+..+.  +.+|||+|||..|.+...-   .....+++.+++++++++..||+|||.++   ||||||||+|+||+++|
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence            9998764  5789999999999886543   22334999999999999999999999998   99999999999999999


Q ss_pred             CeEEeccCCcccccCCC---ccccccccccCCCCcChhhhhcCC----CCccccEEecchhHhHHhhCCCCCCCCCcccc
Q 008108          384 NPKISDFGMARLFEMDQ---THSDTNRVVGTFGYMAPEYVMHGR----FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET  456 (577)
Q Consensus       384 ~~kl~DfGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~  456 (577)
                      ++||+|||.+..+..+.   ........+||+.|||||...++.    .+.+.||||+||+||.|+.|+.||.....-+.
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l  327 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL  327 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence            99999999998764321   112233478999999999987743    34688999999999999999999975443332


Q ss_pred             chhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 008108          457 EDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNML  516 (577)
Q Consensus       457 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L  516 (577)
                      .+.+-       .       +|..-+..+++-..+.+|++.+|++||+.|-+..+|..-.
T Consensus       328 ~~KIv-------n-------~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  328 FDKIV-------N-------DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             HHHHh-------c-------CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence            22111       0       1111122233334455788899999999999999987543

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-39  Score=331.17  Aligned_cols=243  Identities=23%  Similarity=0.297  Sum_probs=192.1

Q ss_pred             cccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCCCc
Q 008108          252 LGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASL  327 (577)
Q Consensus       252 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  327 (577)
                      ||+|+||.||++... +++.||+|.+.+..   ......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999965 58899999987532   23344578899999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccccccc
Q 008108          328 DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR  407 (577)
Q Consensus       328 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~  407 (577)
                      .+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~  152 (312)
T cd05585          81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT  152 (312)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence            988843   456999999999999999999999988   9999999999999999999999999998543222  12234


Q ss_pred             cccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCChHH
Q 008108          408 VVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSE  487 (577)
Q Consensus       408 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  487 (577)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .....   .. ..      ..+...... 
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~---~~~~~---~~-~~------~~~~~~~~~-  218 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE---MYRKI---LQ-EP------LRFPDGFDR-  218 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH---HHHHH---Hc-CC------CCCCCcCCH-
Confidence            679999999999999999999999999999999999999986433221   11111   11 00      011111222 


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          488 MMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       488 ~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                        .+.+++..|++.||++||+..++.+.|..
T Consensus       219 --~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         219 --DAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             --HHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence              34467779999999999876555555543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.9e-39  Score=349.65  Aligned_cols=252  Identities=20%  Similarity=0.252  Sum_probs=201.7

Q ss_pred             CCccccccccCCcEEEEEeEec-C-CcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-N-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      .|...+.||+|+||.||++... + ++.||+|.+..........+.+|+.+++.++||||+++++++...+..+|||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            3888899999999999999854 3 6788999876665555556788999999999999999999999999999999999


Q ss_pred             CCCCcccccccC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          323 PNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       323 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      ++|+|.+++.+. .....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999998877542 23456899999999999999999999987   99999999999999999999999999987654333


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR  481 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  481 (577)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.|+......+   ++....    .+..    ++ ..
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~~~~~~----~~~~----~~-~~  292 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---IMQQVL----YGKY----DP-FP  292 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----hCCC----CC-CC
Confidence            223344679999999999999999999999999999999999999986433221   111111    0100    01 01


Q ss_pred             CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       482 ~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ....   ..+.+++..|++.+|++||++.+++.
T Consensus       293 ~~~s---~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        293 CPVS---SGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ccCC---HHHHHHHHHHhccChhhCcCHHHHHh
Confidence            1112   24557778999999999999999864

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.9e-39  Score=335.58  Aligned_cols=248  Identities=26%  Similarity=0.388  Sum_probs=192.0

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ++|+..++||+|+||.||++... +++.||||++..... .....+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            45666789999999999999964 689999999865433 3345688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|....       ...+..+..++.||+.||.|||+.+   |+||||||+||||++++.+||+|||+++.......
T Consensus       154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            9999986532       3567788899999999999999988   99999999999999999999999999986543221


Q ss_pred             cccccccccCCCCcChhhhhc-----CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          402 HSDTNRVVGTFGYMAPEYVMH-----GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                        ......||..|+|||++..     ...+.++|||||||++|||++|+.||......+...+.....    ...     
T Consensus       224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~----~~~-----  292 (353)
T PLN00034        224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC----MSQ-----  292 (353)
T ss_pred             --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh----ccC-----
Confidence              1233579999999998743     234568999999999999999999987433222211111110    000     


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      .+......   ...+.+++..||+.||++||++.|+++.
T Consensus       293 ~~~~~~~~---~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        293 PPEAPATA---SREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             CCCCCCcc---CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            01111111   2345577789999999999999999863

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1e-39  Score=323.99  Aligned_cols=256  Identities=29%  Similarity=0.476  Sum_probs=208.5

Q ss_pred             HhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ...+|+..++||+|+||.||+|...+++.+++|.+.........++.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            44678889999999999999999888999999999877665566789999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|.+++.+. ....+++..++.++.||+.||.|||+.+   |+||||||+||++++++.+||+|||++........
T Consensus        84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            9999999998653 3456899999999999999999999987   99999999999999999999999999986643222


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                      .  .....++..|+|||.+..+.++.++||||||+++|+|++ |+.|+......+   .+........         +..
T Consensus       160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~~~~---------~~~  225 (261)
T cd05148         160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQITAGYR---------MPC  225 (261)
T ss_pred             c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHHHhCCc---------CCC
Confidence            1  113446778999999998899999999999999999998 788875433221   2221111000         000


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .   ......+.+++.+|++.+|++|||+.++++.|+.
T Consensus       226 ~---~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         226 P---AKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             C---CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            1   1112345578889999999999999999999974

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.5e-39  Score=332.45  Aligned_cols=242  Identities=23%  Similarity=0.277  Sum_probs=193.2

Q ss_pred             cccccCCcEEEEEeEe-cCCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCC
Q 008108          250 NKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA  325 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  325 (577)
                      +.||+|+||.||++.. .+|+.||+|++.+..   ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999985 468999999997642   223346788999999999999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccccc
Q 008108          326 SLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT  405 (577)
Q Consensus       326 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~  405 (577)
                      +|..++.   ....+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~  152 (328)
T cd05593          81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM  152 (328)
T ss_pred             CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence            9988773   3457999999999999999999999987   9999999999999999999999999987533211  122


Q ss_pred             cccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCCh
Q 008108          406 NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGST  485 (577)
Q Consensus       406 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  485 (577)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+   .   . .      +..+.....
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~---~---~-~------~~~~p~~~~  219 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI---L---M-E------DIKFPRTLS  219 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh---c---c-C------CccCCCCCC
Confidence            3357999999999999999999999999999999999999998644332211111   0   0 0      011111122


Q ss_pred             HHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 008108          486 SEMMKCIHIGLLCVQENVSNRP-----GMASVVNM  515 (577)
Q Consensus       486 ~~~~~~~~l~~~C~~~~p~~RP-----t~~ev~~~  515 (577)
                      .   .+.+++..|++.||++||     ++.|+++.
T Consensus       220 ~---~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         220 A---DAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             H---HHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            2   345677799999999997     78888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-39  Score=321.22  Aligned_cols=256  Identities=27%  Similarity=0.477  Sum_probs=203.5

Q ss_pred             hcCCccccccccCCcEEEEEeEecC----CcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSN----GETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      .++|+..+.||+|+||.||+|.+..    ...||||.+.... .....++.+|+.++++++|+||+++++++.+.+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            3578899999999999999999642    4579999987653 3334568899999999999999999999999999999


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      +|||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        83 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          83 ITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEcCCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            9999999999998854  2347999999999999999999999987   9999999999999999999999999998775


Q ss_pred             CCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |..|+...........+.   ..+..       
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~---~~~~~-------  227 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE---DGYRL-------  227 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH---cCCCC-------
Confidence            2222222222345678999999998999999999999999999998 888875433222111111   11000       


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                       +.    .......+.+++.+|++.+|++||++.||++.|+.
T Consensus       228 -~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~  264 (266)
T cd05033         228 -PP----PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK  264 (266)
T ss_pred             -CC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence             00    01112345688889999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-39  Score=318.98  Aligned_cols=271  Identities=25%  Similarity=0.357  Sum_probs=203.3

Q ss_pred             CChHHHHHHhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHH--hcCCCCeEEEEeEEEc
Q 008108          234 FDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLA--RLQHRNLVRLLGFCLE  311 (577)
Q Consensus       234 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~--~l~h~niv~l~~~~~~  311 (577)
                      .++-..+....+....+.||+|.||+||+|.+. |+.||||++......   ...+|.++.+  .|+|+||+.+++.-..
T Consensus       201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~---SWfrEtEIYqTvmLRHENILgFIaaD~~  276 (513)
T KOG2052|consen  201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDER---SWFRETEIYQTVMLRHENILGFIAADNK  276 (513)
T ss_pred             chhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccchh---hhhhHHHHHHHHHhccchhhhhhhcccc
Confidence            334445566678889999999999999999996 899999999765443   3355555554  4699999999987654


Q ss_pred             CC----eEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-----CCCCcEEEeccCCCcEEEcCC
Q 008108          312 RK----ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE-----DSRLRIIHRDLKASNILLDSE  382 (577)
Q Consensus       312 ~~----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-----~~~~~iiHrDlkp~NiLl~~~  382 (577)
                      +.    +++||.+|.+.|||.+||    ++..++.+..++++..+|.||++||.     +++|.|.|||||++||||.++
T Consensus       277 ~~gs~TQLwLvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn  352 (513)
T KOG2052|consen  277 DNGSWTQLWLVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN  352 (513)
T ss_pred             CCCceEEEEEeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC
Confidence            43    689999999999999998    56789999999999999999999994     578999999999999999999


Q ss_pred             CCeEEeccCCcccccCCC--ccccccccccCCCCcChhhhhcCC----C--CccccEEecchhHhHHhhCC---------
Q 008108          383 MNPKISDFGMARLFEMDQ--THSDTNRVVGTFGYMAPEYVMHGR----F--SVKSDIFSFGVLVLEIVSGQ---------  445 (577)
Q Consensus       383 ~~~kl~DfGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~Dv~SlGvil~elltG~---------  445 (577)
                      +...|+|+|||.....+.  .....+..+||.+|||||++...-    +  -..+||||||+++||+.-.-         
T Consensus       353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey  432 (513)
T KOG2052|consen  353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY  432 (513)
T ss_pred             CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence            999999999998776542  222345679999999999985542    1  24689999999999997542         


Q ss_pred             -CCCCCCCccccchhhhhhhhhcccCCccccccCcCCCC--ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          446 -KRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGG--STSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       446 -~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                       .|+....+.+..      +..+.+--..+.+-|.+..-  ..+.+..+.+++..||..||.-|-|+--+-+.|.+
T Consensus       433 ~~Pyyd~Vp~DPs------~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~  502 (513)
T KOG2052|consen  433 QLPYYDVVPSDPS------FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAK  502 (513)
T ss_pred             cCCcccCCCCCCC------HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHH
Confidence             222221111100      01111111222233333322  45667778899999999999999998888777764

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-39  Score=321.57  Aligned_cols=256  Identities=28%  Similarity=0.451  Sum_probs=203.9

Q ss_pred             HhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ..++|++.+.||+|++|.||+|...+++.||+|.+..... ...++.+|+.++++++|+||+++++++...+..+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            3467889999999999999999987788999999876543 345688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++.......
T Consensus        83 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          83 MKYGSLLEYLQGG-AGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             ccCCcHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            9999999988542 2346899999999999999999999987   99999999999999999999999999987653221


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                      . .......+..|+|||++....++.++||||||+++|||++ |+.|+.......   ++......+.    .    + .
T Consensus       159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~----~----~-~  225 (261)
T cd05068         159 E-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQQVDQGYR----M----P-C  225 (261)
T ss_pred             c-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCCC----C----C-C
Confidence            1 1111233468999999998899999999999999999999 888775432221   1111111100    0    0 0


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                         .......+.+++.+|++.+|++||++.++++.|+.
T Consensus       226 ---~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         226 ---PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             ---CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence               01112345678889999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3e-39  Score=332.67  Aligned_cols=201  Identities=29%  Similarity=0.409  Sum_probs=175.2

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      .++|+..++||+|+||.||++... +++.+|+|.+..... .....+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            478999999999999999999965 578899998876532 334568899999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |+++++|.+++.   ....+++..+..++.|++.||.|||+.+  +|+||||||+|||++.++.+||+|||++...... 
T Consensus        84 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-  157 (333)
T cd06650          84 HMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (333)
T ss_pred             cCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence            999999999884   3456899999999999999999999753  3999999999999999999999999999765322 


Q ss_pred             ccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCC
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGT  452 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~  452 (577)
                         ......||..|+|||++.+..++.++|||||||++|||++|+.|+....
T Consensus       158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~  206 (333)
T cd06650         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD  206 (333)
T ss_pred             ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence               1223578999999999998899999999999999999999999986544

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.9e-39  Score=336.64  Aligned_cols=254  Identities=25%  Similarity=0.397  Sum_probs=195.4

Q ss_pred             CCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      .|+.++.||+|+||+||+|.. .+++.||||++.+..   ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            588899999999999999985 468899999997643   2234468899999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            9999999988843   456899999999999999999999987   9999999999999999999999999986432110


Q ss_pred             c---------------------------------------------cccccccccCCCCcChhhhhcCCCCccccEEecc
Q 008108          401 T---------------------------------------------HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFG  435 (577)
Q Consensus       401 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG  435 (577)
                      .                                             ........||..|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0                                             0001235799999999999988999999999999


Q ss_pred             hhHhHHhhCCCCCCCCCccccc-hhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          436 VLVLEIVSGQKRSSFGTEEETE-DLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       436 vil~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      |++|||++|+.||......... .++.     +...  ...  +. ......+...++.- +.|+..++..||++.|+++
T Consensus       236 ~il~elltG~~Pf~~~~~~~~~~~i~~-----~~~~--~~~--~~-~~~~s~~~~dli~~-ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTETQLKVIN-----WENT--LHI--PP-QVKLSPEAVDLITK-LCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHHHHHHHc-----cccc--cCC--CC-CCCCCHHHHHHHHH-HccCcccccCCCCHHHHhc
Confidence            9999999999998654432211 1111     1100  000  00 00123334443321 2377778888999999986


Q ss_pred             H
Q 008108          515 M  515 (577)
Q Consensus       515 ~  515 (577)
                      -
T Consensus       305 h  305 (381)
T cd05626         305 H  305 (381)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.7e-39  Score=324.74  Aligned_cols=264  Identities=21%  Similarity=0.276  Sum_probs=199.9

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      ++|++.+.||+|+||.||++... +++.||+|++....  ......+.+|+.+++.++|+||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46899999999999999999975 57889999987542  2233457889999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |+++++|+.+..   ....+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            999987765542   2456999999999999999999999987   9999999999999999999999999998764322


Q ss_pred             ccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhh--------hhhccc-CC
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA--------WRNWNE-GA  471 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~-~~  471 (577)
                      . .......||..|+|||++.+..++.++|||||||++|||++|+.||......+....+...        +..+.. ..
T Consensus       155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            2 1223357899999999999889999999999999999999999998654332211111100        000000 00


Q ss_pred             ccccccCcCCCC-C------hHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          472 ALNLMDPTMRGG-S------TSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       472 ~~~~~d~~l~~~-~------~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ......+..... .      ......+.+++..|++.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000111000 0      001234668888999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.8e-39  Score=325.02  Aligned_cols=258  Identities=27%  Similarity=0.452  Sum_probs=204.5

Q ss_pred             hcCCccccccccCCcEEEEEeEec------CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  316 (577)
                      .++|.+.+.||+|+||+||++...      ++..+|+|.+..........+.+|+.++++++|+||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            357888999999999999999842      34568999988766655667899999999999999999999999999999


Q ss_pred             EEEEecCCCCcccccccCC----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeE
Q 008108          317 LVYEFVPNASLDHFIFDPI----------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPK  386 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~k  386 (577)
                      +||||+++++|.+++....          ....+++..++.++.|++.+|.|||+.+   ++||||||+|||+++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence            9999999999988875321          2235999999999999999999999987   99999999999999999999


Q ss_pred             EeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhh
Q 008108          387 ISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWR  465 (577)
Q Consensus       387 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~  465 (577)
                      |+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.|+.......   .+...  
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~~i--  235 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIECI--  235 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH--
Confidence            999999986543332222223456788999999998899999999999999999999 887775433222   11111  


Q ss_pred             hcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          466 NWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       466 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                        ..+....     ......   ..+.+++.+|++.+|.+|||+.||++.|+.
T Consensus       236 --~~~~~~~-----~~~~~~---~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~  278 (288)
T cd05093         236 --TQGRVLQ-----RPRTCP---KEVYDLMLGCWQREPHMRLNIKEIHSLLQN  278 (288)
T ss_pred             --HcCCcCC-----CCCCCC---HHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence              1111100     011112   346688889999999999999999988865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.3e-39  Score=339.03  Aligned_cols=261  Identities=25%  Similarity=0.388  Sum_probs=203.2

Q ss_pred             HHhcCCccccccccCCcEEEEEeEec------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhcC-CCCeEEEEeEEEcC
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQ-HRNLVRLLGFCLER  312 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  312 (577)
                      ...++|.+.++||+|+||.||+|...      .+..||||++..... .....+.+|+.++.++. ||||+++++++.+.
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            44568889999999999999999852      234799999976433 33446889999999996 99999999999999


Q ss_pred             CeEEEEEEecCCCCcccccccCC---------------------------------------------------------
Q 008108          313 KERILVYEFVPNASLDHFIFDPI---------------------------------------------------------  335 (577)
Q Consensus       313 ~~~~lv~E~~~~gsL~~~l~~~~---------------------------------------------------------  335 (577)
                      ...+|||||+++|+|.++|....                                                         
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            99999999999999988775321                                                         


Q ss_pred             ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEE
Q 008108          336 ------------------------------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL  379 (577)
Q Consensus       336 ------------------------------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl  379 (577)
                                                          ....+++..++.++.||++||.|||+.+   |+||||||+|||+
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill  270 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence                                                0134888999999999999999999987   9999999999999


Q ss_pred             cCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccch
Q 008108          380 DSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETED  458 (577)
Q Consensus       380 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~  458 (577)
                      +.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+........  
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--  348 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--  348 (400)
T ss_pred             eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--
Confidence            9999999999999986644333223333457788999999999999999999999999999997 8888754322111  


Q ss_pred             hhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          459 LLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       459 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      +..    ....+...     ......   ...+.+++..||+.+|++||++.+|+++|+.
T Consensus       349 ~~~----~~~~~~~~-----~~~~~~---~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~  396 (400)
T cd05105         349 FYN----KIKSGYRM-----AKPDHA---TQEVYDIMVKCWNSEPEKRPSFLHLSDIVES  396 (400)
T ss_pred             HHH----HHhcCCCC-----CCCccC---CHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence            111    11111000     001111   2345678889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.5e-39  Score=333.87  Aligned_cols=246  Identities=24%  Similarity=0.327  Sum_probs=197.9

Q ss_pred             hcCCccccccccCCcEEEEEeEecC--CcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSN--GETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      .++|++.+.||+|+||.||+|...+  +..||+|++.+..   ......+.+|+.++..++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            4679999999999999999998543  3689999986542   2233457889999999999999999999999999999


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      ||||+++|+|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       109 v~Ey~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            999999999999884   3457999999999999999999999988   9999999999999999999999999998654


Q ss_pred             CCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccccc
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD  477 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  477 (577)
                      ..     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+       ..+..     
T Consensus       183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i-------~~~~~-----  245 (340)
T PTZ00426        183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKI-------LEGII-----  245 (340)
T ss_pred             CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHH-------hcCCC-----
Confidence            22     22357999999999999888999999999999999999999998654332111111       11100     


Q ss_pred             CcCCCCChHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 008108          478 PTMRGGSTSEMMKCIHIGLLCVQENVSNRP-----GMASVVNM  515 (577)
Q Consensus       478 ~~l~~~~~~~~~~~~~l~~~C~~~~p~~RP-----t~~ev~~~  515 (577)
                       .+......   .+.+++..|++.+|++|+     +++++++.
T Consensus       246 -~~p~~~~~---~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 -YFPKFLDN---NCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             -CCCCCCCH---HHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence             01111222   345677799999999995     78887754

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5e-39  Score=324.80  Aligned_cols=261  Identities=28%  Similarity=0.426  Sum_probs=205.0

Q ss_pred             HHHhcCCccccccccCCcEEEEEeEec------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEc
Q 008108          240 RVATDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNS-KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLE  311 (577)
Q Consensus       240 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  311 (577)
                      ....++|+..+.||+|+||.||++...      ....+|+|.+.... .....++.+|+.++.++ +|+||+++++++..
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            344567889999999999999999864      23679999987643 23345688999999999 89999999999999


Q ss_pred             CCeEEEEEEecCCCCcccccccC-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEE
Q 008108          312 RKERILVYEFVPNASLDHFIFDP-------------INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNIL  378 (577)
Q Consensus       312 ~~~~~lv~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiL  378 (577)
                      .+..+++|||+++|+|..++...             .....+++..++.++.||+.||.|||+.+   |+||||||+|||
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil  164 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL  164 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence            99999999999999999887432             22457999999999999999999999987   999999999999


Q ss_pred             EcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccc
Q 008108          379 LDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETE  457 (577)
Q Consensus       379 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~  457 (577)
                      ++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+......+..
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  244 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF  244 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence            99999999999999987654333222223345678999999988899999999999999999998 88887543322221


Q ss_pred             hhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          458 DLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       458 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ..+       ..+....     .   .......+.+++..|++.+|++|||+.|+++.|+.
T Consensus       245 ~~~-------~~~~~~~-----~---~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~  290 (293)
T cd05053         245 KLL-------KEGYRME-----K---PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR  290 (293)
T ss_pred             HHH-------HcCCcCC-----C---CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence            111       1111000     0   11122356678889999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-39  Score=336.06  Aligned_cols=252  Identities=25%  Similarity=0.375  Sum_probs=195.3

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|+..++||+|+||+||++... +++.||||++....   ......+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47899999999999999999964 68999999997542   223345788999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            99999999998843   456999999999999999999999998   999999999999999999999999998754321


Q ss_pred             Cccc------------------------------------cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh
Q 008108          400 QTHS------------------------------------DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS  443 (577)
Q Consensus       400 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt  443 (577)
                      ....                                    ......||+.|+|||++....++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            1100                                    0112469999999999999999999999999999999999


Q ss_pred             CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 008108          444 GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPG---MASVVN  514 (577)
Q Consensus       444 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt---~~ev~~  514 (577)
                      |+.||........   .... ..|...  ...  +.. .....+..   +++..|+. +|.+|++   +.|+++
T Consensus       235 G~~Pf~~~~~~~~---~~~i-~~~~~~--~~~--~~~-~~~s~~~~---~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         235 GYPPFCSDNPQET---YRKI-INWKET--LQF--PDE-VPLSPEAK---DLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCCCHHHH---HHHH-HcCCCc--cCC--CCC-CCCCHHHH---HHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9999865443221   1111 011110  000  000 01223333   45556775 8999998   887765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-39  Score=324.55  Aligned_cols=264  Identities=24%  Similarity=0.409  Sum_probs=200.1

Q ss_pred             hcCCccccccccCCcEEEEEeEecC---------------CcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSN---------------GETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLL  306 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~  306 (577)
                      .++|++.++||+|+||.||++...+               ...||+|.+.... ......+.+|++++++++|+||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3578899999999999999987532               2348999987653 33345689999999999999999999


Q ss_pred             eEEEcCCeEEEEEEecCCCCcccccccCC---------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcE
Q 008108          307 GFCLERKERILVYEFVPNASLDHFIFDPI---------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNI  377 (577)
Q Consensus       307 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~Ni  377 (577)
                      +++......++||||+++++|.+++....         ....+++..++.++.|++.||.|||+.+   ++||||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence            99999999999999999999988874321         1124789999999999999999999987   99999999999


Q ss_pred             EEcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhC--CCCCCCCCccc
Q 008108          378 LLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG--QKRSSFGTEEE  455 (577)
Q Consensus       378 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG--~~p~~~~~~~~  455 (577)
                      ++++++.+||+|||+++...............++..|+|||++..+.++.++||||||+++|||+++  ..|+.......
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            9999999999999999865433322222334567889999999999999999999999999999984  44544322222


Q ss_pred             cchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          456 TEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       456 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                         .+......+.........  ..   .......+.+++.+|++.+|++||+|.+|++.|.
T Consensus       241 ---~~~~~~~~~~~~~~~~~~--~~---~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 ---VIENTGEFFRNQGRQIYL--SQ---TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             ---HHHHHHHhhhhccccccC--CC---CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence               121111111111000000  00   0011235678889999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-39  Score=334.18  Aligned_cols=253  Identities=25%  Similarity=0.383  Sum_probs=200.3

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|++.++||+|+||+||++... +|+.||||++.+..   ......+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47889999999999999999965 68999999997542   133446789999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            99999999998843   367999999999999999999999987   999999999999999999999999999866543


Q ss_pred             C---------------------------ccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCC
Q 008108          400 Q---------------------------THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGT  452 (577)
Q Consensus       400 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~  452 (577)
                      .                           .........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                           0012233579999999999999999999999999999999999999987544


Q ss_pred             ccccchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCC-HHHHHHH
Q 008108          453 EEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPG-MASVVNM  515 (577)
Q Consensus       453 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt-~~ev~~~  515 (577)
                      .......+.    .|....    .-|.. .....   .+..++..|++ +|++||+ +.++++.
T Consensus       235 ~~~~~~~i~----~~~~~~----~~p~~-~~~~~---~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 LQETYNKII----NWKESL----RFPPD-PPVSP---EAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHHHHHHh----ccCCcc----cCCCC-CCCCH---HHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            322111110    111100    00000 00123   34456668887 9999999 9999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.6e-39  Score=324.16  Aligned_cols=257  Identities=26%  Similarity=0.441  Sum_probs=200.4

Q ss_pred             cCCccccccccCCcEEEEEeEec------CCcEEEEEEeccCChh-hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  316 (577)
                      .+|++.++||+|+||.||+|...      .++.||+|++...... ....+.+|+.++..++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            34677899999999999999853      2578999999765433 3356889999999999999999999999999999


Q ss_pred             EEEEecCCCCcccccccC-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC
Q 008108          317 LVYEFVPNASLDHFIFDP-------------INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM  383 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~  383 (577)
                      +++||+++++|.+++...             ..+..+++..++.++.|++.||.|||+.+   |+||||||+|||+++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence            999999999998887421             11245889999999999999999999987   99999999999999999


Q ss_pred             CeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhh
Q 008108          384 NPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTY  462 (577)
Q Consensus       384 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~  462 (577)
                      .+||+|||+++...............+++.|+|||.+..+.++.++||||||+++|||++ |..|+......+   ++..
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~  238 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VIEM  238 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence            999999999886543332222333456789999999999999999999999999999998 766765432221   1111


Q ss_pred             hhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          463 AWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       463 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .    ..+...     ......+.   .+..++..|++.+|++||++.+|++.|+.
T Consensus       239 i----~~~~~~-----~~~~~~~~---~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         239 I----RNRQVL-----PCPDDCPA---WVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             H----HcCCcC-----CCCCCCCH---HHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            1    111100     01112223   34577789999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.1e-39  Score=325.75  Aligned_cols=263  Identities=22%  Similarity=0.367  Sum_probs=197.6

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ++|+..++||+|+||.||+|... +++.||+|.+..... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            57899999999999999999864 688999999865432 2334578999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++ +|.+++..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            975 88777643  2345899999999999999999999987   99999999999999999999999999976543221


Q ss_pred             cccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhh--------hhhhcccC-C
Q 008108          402 HSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTY--------AWRNWNEG-A  471 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~~~-~  471 (577)
                        ......|++.|+|||.+.+ ..++.++|||||||++|||+||+.||......+....+..        .|...... .
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence              1223568999999998865 4689999999999999999999999865443322211111        11111000 0


Q ss_pred             ccccccCcCCCCC-----hHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          472 ALNLMDPTMRGGS-----TSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       472 ~~~~~d~~l~~~~-----~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ......+......     ........+++..|++.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0111111111100     001124567888999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=6e-39  Score=319.09  Aligned_cols=254  Identities=29%  Similarity=0.455  Sum_probs=201.7

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      .+|+..++||+|+||.||+|... .++.||+|.+.... ....++.+|+.++++++|+||+++++++..++..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45788899999999999999965 58889999987543 33456889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      ++++|.+++.. .....+++..++.++.|+++||.|||+.+   ++||||||+||++++++.+||+|||++.........
T Consensus        85 ~~~~L~~~~~~-~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          85 TYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCcHHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            99999998744 23456899999999999999999999987   999999999999999999999999999876533221


Q ss_pred             ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC
Q 008108          403 SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR  481 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  481 (577)
                       ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.....++....+       ....     .+...
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-------~~~~-----~~~~~  227 (263)
T cd05052         161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------EKGY-----RMERP  227 (263)
T ss_pred             -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------HCCC-----CCCCC
Confidence             1122334678999999998999999999999999999998 88887543322211111       1110     01111


Q ss_pred             CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       482 ~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ...+   ..+.+++.+|++.+|++||++.+++++|+.
T Consensus       228 ~~~~---~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         228 EGCP---PKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             CCCC---HHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence            1122   345567789999999999999999999874

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=6.6e-39  Score=317.58  Aligned_cols=252  Identities=27%  Similarity=0.462  Sum_probs=201.1

Q ss_pred             cCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecC
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVP  323 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  323 (577)
                      ++|...+.||+|+||.||+|...++..+|+|.+..... ...++.+|+.++.+++||||+++++++.+.+..+++|||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            46788899999999999999987777899999875433 34578999999999999999999999999889999999999


Q ss_pred             CCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccc
Q 008108          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS  403 (577)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~  403 (577)
                      +++|.+++..  ....+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~l~~~i~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05113          83 NGCLLNYLRE--HGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence            9999998854  2336899999999999999999999987   999999999999999999999999998865433221 


Q ss_pred             cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCC
Q 008108          404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG  482 (577)
Q Consensus       404 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  482 (577)
                      ......++..|+|||.+..+.++.++||||||+++|||++ |+.|+...........+.       .+....  .+    
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-------~~~~~~--~~----  223 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-------QGLRLY--RP----  223 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh-------cCCCCC--CC----
Confidence            1122345678999999998899999999999999999999 888876433322111111       110000  00    


Q ss_pred             CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          483 GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       483 ~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                        ......+.+++.+||+.+|++||++.++++.|+
T Consensus       224 --~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         224 --HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             --CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence              011245567888999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=7.2e-39  Score=329.52  Aligned_cols=252  Identities=22%  Similarity=0.317  Sum_probs=197.0

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|++.+.||+|+||+||++... +|+.||+|++.....   .....+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47889999999999999999954 689999999976432   23445788999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++|+|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNR--YEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            99999999998843  2357999999999999999999999988   999999999999999999999999999876543


Q ss_pred             CccccccccccCCCCcChhhhh------cCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVM------HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAAL  473 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  473 (577)
                      ... ......||+.|+|||++.      ...++.++|||||||++|||++|+.||...........+      .......
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i------~~~~~~~  228 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI------MNFQRFL  228 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHH------HcCCCcc
Confidence            222 222357899999999986      456789999999999999999999998654332211110      1111101


Q ss_pred             ccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          474 NLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       474 ~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ...+   ......+   +..++..|++ +|++||++.++++
T Consensus       229 ~~~~---~~~~~~~---~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         229 KFPE---DPKVSSD---FLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CCCC---CCCCCHH---HHHHHHHHcc-ChhhCCCHHHHhC
Confidence            1000   0112233   3455567887 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=9e-39  Score=329.08  Aligned_cols=251  Identities=24%  Similarity=0.341  Sum_probs=195.3

Q ss_pred             CCccccccccCCcEEEEEeEe----cCCcEEEEEEeccCC----hhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeE
Q 008108          245 NFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNS----KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKER  315 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  315 (577)
                      +|++.++||+|+||.||++..    .+++.||+|++.+..    ......+.+|+.++..+ +|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            578899999999999999875    357899999986532    12234577899999999 599999999999999999


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      ++||||+++|+|.+++.   .+..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            99999999999988874   3457999999999999999999999988   99999999999999999999999999986


Q ss_pred             ccCCCccccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccc
Q 008108          396 FEMDQTHSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALN  474 (577)
Q Consensus       396 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  474 (577)
                      +...... ......||..|+|||++.+. .++.++|||||||++|||+||+.||...........+..   ....     
T Consensus       155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~---~~~~-----  225 (332)
T cd05614         155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR---RILK-----  225 (332)
T ss_pred             ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH---HHhc-----
Confidence            5432221 22346799999999998765 478999999999999999999999864433222111111   0000     


Q ss_pred             cccCcCCCCChHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 008108          475 LMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRP-----GMASVVN  514 (577)
Q Consensus       475 ~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RP-----t~~ev~~  514 (577)
                       .++.+......   .+.+++..|++.||++||     ++.++++
T Consensus       226 -~~~~~~~~~~~---~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         226 -CDPPFPSFIGP---EAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             -CCCCCCCCCCH---HHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence             11222222222   344677799999999999     5666664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.7e-39  Score=331.56  Aligned_cols=241  Identities=22%  Similarity=0.268  Sum_probs=191.6

Q ss_pred             cccccCCcEEEEEeEe-cCCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCC
Q 008108          250 NKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA  325 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  325 (577)
                      +.||+|+||.||++.. .+|+.||+|.+....   ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999995 468999999997542   223345678999999999999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccccc
Q 008108          326 SLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT  405 (577)
Q Consensus       326 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~  405 (577)
                      +|..++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~  152 (323)
T cd05595          81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence            9988773   3457899999999999999999999987   9999999999999999999999999987532221  112


Q ss_pred             cccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCCh
Q 008108          406 NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGST  485 (577)
Q Consensus       406 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  485 (577)
                      ....||+.|+|||++.++.++.++|||||||++|||++|+.||...........+   .    ...      ..+.....
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~---~----~~~------~~~p~~~~  219 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI---L----MEE------IRFPRTLS  219 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH---h----cCC------CCCCCCCC
Confidence            2357999999999999999999999999999999999999998644332211111   0    000      01111122


Q ss_pred             HHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 008108          486 SEMMKCIHIGLLCVQENVSNRP-----GMASVVN  514 (577)
Q Consensus       486 ~~~~~~~~l~~~C~~~~p~~RP-----t~~ev~~  514 (577)
                      .   .+.+++..|++.||++||     ++.++++
T Consensus       220 ~---~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         220 P---EAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             H---HHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            2   344677799999999998     7887764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=5.2e-39  Score=322.57  Aligned_cols=254  Identities=30%  Similarity=0.486  Sum_probs=199.1

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCc----EEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGE----TIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      ++|+..+.||+|+||+||+|.+. +++    .+++|.+..... ....++..|+..+++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            56888899999999999999964 344    478888764432 233567888889999999999999998754 45788


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      ++||+++|+|.+++..  ....+++..++.|+.||+.||.|||+.+   ++||||||+|||+++++.+||+|||+++...
T Consensus        86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            9999999999998853  3457999999999999999999999987   9999999999999999999999999998765


Q ss_pred             CCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      ............++..|+|||++.++.++.++||||||+++|||++ |+.|+.........+++.       .+...  .
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~~~~--~  231 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-------KGERL--A  231 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------CCCcC--C
Confidence            4433333334567889999999999999999999999999999998 888876543332222221       11100  1


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .+..   ..   ..+..++..|+..+|++|||+.|+++.|..
T Consensus       232 ~~~~---~~---~~~~~li~~c~~~~p~~Rps~~el~~~l~~  267 (279)
T cd05111         232 QPQI---CT---IDVYMVMVKCWMIDENVRPTFKELANEFTR  267 (279)
T ss_pred             CCCC---CC---HHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            1111   11   234567789999999999999999998875

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.4e-38  Score=321.95  Aligned_cols=264  Identities=26%  Similarity=0.417  Sum_probs=204.5

Q ss_pred             hcCCccccccccCCcEEEEEeEecC-----------------CcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSN-----------------GETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVR  304 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  304 (577)
                      ..+|++.++||+|+||.||++....                 +..||+|.+.... .....++.+|+.++++++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578899999999999999988542                 2458999987654 334557889999999999999999


Q ss_pred             EEeEEEcCCeEEEEEEecCCCCcccccccCC--------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCc
Q 008108          305 LLGFCLERKERILVYEFVPNASLDHFIFDPI--------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASN  376 (577)
Q Consensus       305 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~N  376 (577)
                      +++++..++..+++|||+++++|.+++....        ....+++..++.++.|++.||.|||+.+   |+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999885422        1236899999999999999999999987   9999999999


Q ss_pred             EEEcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh--CCCCCCCCCcc
Q 008108          377 ILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS--GQKRSSFGTEE  454 (577)
Q Consensus       377 iLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt--G~~p~~~~~~~  454 (577)
                      |+++.++.++|+|||+++...............++..|+|||++..+.++.++||||||+++|||++  |..|+..... 
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-  239 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-  239 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence            9999999999999999986544333333334567889999999998899999999999999999998  5555543222 


Q ss_pred             ccchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          455 ETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       455 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                        ...+......+.........+     .......++.+++.+|++.+|++|||+.||++.|+
T Consensus       240 --~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 --QQVIENAGHFFRDDGRQIYLP-----RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             --HHHHHHHHhccccccccccCC-----CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence              222222222221111111110     01111235678889999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-39  Score=335.67  Aligned_cols=203  Identities=25%  Similarity=0.365  Sum_probs=173.4

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|++.++||+|+||+||++.. .+++.||||++.+..   ......+++|+.++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4788999999999999999985 478999999986542   223345788999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++|+|.+++.   ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            9999999998884   3457899999999999999999999998   999999999999999999999999999643211


Q ss_pred             Ccc------------c---------------------------------cccccccCCCCcChhhhhcCCCCccccEEec
Q 008108          400 QTH------------S---------------------------------DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSF  434 (577)
Q Consensus       400 ~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~Sl  434 (577)
                      ...            .                                 ......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            000            0                                 0012469999999999999999999999999


Q ss_pred             chhHhHHhhCCCCCCCCC
Q 008108          435 GVLVLEIVSGQKRSSFGT  452 (577)
Q Consensus       435 Gvil~elltG~~p~~~~~  452 (577)
                      ||++|||++|+.||....
T Consensus       235 Gvil~elltG~~Pf~~~~  252 (377)
T cd05629         235 GAIMFECLIGWPPFCSEN  252 (377)
T ss_pred             chhhhhhhcCCCCCCCCC
Confidence            999999999999986544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.6e-39  Score=332.48  Aligned_cols=260  Identities=29%  Similarity=0.438  Sum_probs=201.0

Q ss_pred             HhcCCccccccccCCcEEEEEeEec------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcC-
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNLVRLLGFCLER-  312 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-  312 (577)
                      ..++|++.+.||+|+||.||+|...      +++.||+|++..... .....+.+|+.++.++ +|+||+++++++... 
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            3457899999999999999999632      357899999875432 2334577899999999 899999999988654 


Q ss_pred             CeEEEEEEecCCCCcccccccCCC--------------------------------------------------------
Q 008108          313 KERILVYEFVPNASLDHFIFDPIN--------------------------------------------------------  336 (577)
Q Consensus       313 ~~~~lv~E~~~~gsL~~~l~~~~~--------------------------------------------------------  336 (577)
                      ...+++|||+++++|.+++.....                                                        
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            567899999999999888743211                                                        


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccccccccccCCCC
Q 008108          337 --REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY  414 (577)
Q Consensus       337 --~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y  414 (577)
                        ...++|..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+.............++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence              136899999999999999999999987   999999999999999999999999999876543333333345667889


Q ss_pred             cChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHH
Q 008108          415 MAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIH  493 (577)
Q Consensus       415 ~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~  493 (577)
                      +|||++.+..++.++|||||||++|||++ |+.|+......+  .+.    .....+....     ..   .....++.+
T Consensus       242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~----~~~~~~~~~~-----~~---~~~~~~~~~  307 (337)
T cd05054         242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFC----RRLKEGTRMR-----AP---EYATPEIYS  307 (337)
T ss_pred             cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHH----HHHhccCCCC-----CC---ccCCHHHHH
Confidence            99999999999999999999999999998 888875422211  111    1111111000     00   111235668


Q ss_pred             HHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          494 IGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       494 l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ++.+|++.+|++||++.||+++|+.
T Consensus       308 l~~~cl~~~p~~RPs~~ell~~l~~  332 (337)
T cd05054         308 IMLDCWHNNPEDRPTFSELVEILGD  332 (337)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHH
Confidence            8899999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.5e-39  Score=323.02  Aligned_cols=266  Identities=27%  Similarity=0.454  Sum_probs=200.1

Q ss_pred             cCCccccccccCCcEEEEEeEe-----cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEc--CCeEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-----SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE--RKERI  316 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  316 (577)
                      .+|++.+.||+|+||.||++..     .+++.||+|++..........+.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            5788899999999999999974     3578999999987766666678999999999999999999998754  34688


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccc
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~  396 (577)
                      +||||+++++|.+++..  .+..+++..++.++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++..
T Consensus        84 lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            99999999999998843  2356899999999999999999999987   999999999999999999999999999876


Q ss_pred             cCCCccc-cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcc-cC---C
Q 008108          397 EMDQTHS-DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWN-EG---A  471 (577)
Q Consensus       397 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~-~~---~  471 (577)
                      ....... ......++..|+|||++.++.++.++||||||+++|||++|..++......    .......... ..   .
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~  234 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQMIVYH  234 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcccccccccchHH
Confidence            5432211 111223455699999999889999999999999999999998765322111    0000000000 00   0


Q ss_pred             ccccccCcCC-CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          472 ALNLMDPTMR-GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       472 ~~~~~d~~l~-~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ..+.+..... .........+.+++.+||+.+|++|||+.||++.|+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05081         235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA  282 (284)
T ss_pred             HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence            0000100000 0011112346678889999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=7.1e-39  Score=333.89  Aligned_cols=203  Identities=26%  Similarity=0.393  Sum_probs=175.1

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|+..+.||+|+||+||++... +++.||||++.+..   ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47899999999999999999854 68899999997542   222345788999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++|+|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            9999999999884   3567999999999999999999999988   999999999999999999999999999754321


Q ss_pred             Ccc---------------------------------ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCC
Q 008108          400 QTH---------------------------------SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQK  446 (577)
Q Consensus       400 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~  446 (577)
                      ...                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            100                                 00123579999999999999999999999999999999999999


Q ss_pred             CCCCCC
Q 008108          447 RSSFGT  452 (577)
Q Consensus       447 p~~~~~  452 (577)
                      ||....
T Consensus       235 Pf~~~~  240 (363)
T cd05628         235 PFCSET  240 (363)
T ss_pred             CCCCCC
Confidence            986544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4e-39  Score=347.49  Aligned_cols=262  Identities=23%  Similarity=0.303  Sum_probs=205.3

Q ss_pred             hHHHHHHhcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC
Q 008108          236 FETIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER  312 (577)
Q Consensus       236 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  312 (577)
                      ..+.+...++|.+.++||+|+||+||++.. .+|+.||||++....  ......+.+|+..+..++|+||+++++.+...
T Consensus        24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~  103 (496)
T PTZ00283         24 EATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK  103 (496)
T ss_pred             cccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence            344555668999999999999999999984 478999999986542  33445678999999999999999998877543


Q ss_pred             C--------eEEEEEEecCCCCcccccccCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC
Q 008108          313 K--------ERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM  383 (577)
Q Consensus       313 ~--------~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~  383 (577)
                      +        ..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+   |+||||||+||||+.++
T Consensus       104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~  180 (496)
T PTZ00283        104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNG  180 (496)
T ss_pred             cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCC
Confidence            2        3679999999999998885422 2356899999999999999999999987   99999999999999999


Q ss_pred             CeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhh
Q 008108          384 NPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA  463 (577)
Q Consensus       384 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~  463 (577)
                      .+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ++...
T Consensus       181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~---~~~~~  257 (496)
T PTZ00283        181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE---VMHKT  257 (496)
T ss_pred             CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHH
Confidence            999999999987654333333344679999999999999999999999999999999999999986433221   11111


Q ss_pred             hhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          464 WRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       464 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                          ..+.    .++ +.....   ..+..++..||+.+|++||++.++++.
T Consensus       258 ----~~~~----~~~-~~~~~~---~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        258 ----LAGR----YDP-LPPSIS---PEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             ----hcCC----CCC-CCCCCC---HHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                0111    111 111122   245567779999999999999998864

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-40  Score=330.80  Aligned_cols=265  Identities=26%  Similarity=0.408  Sum_probs=213.6

Q ss_pred             HhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChh-hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      ..+...+.++||+|-||+|.+.....+..||||+++..... ...+|..|+++|.+++||||++|+|+|..++.+++|+|
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            34456778999999999999999988899999999876544 45789999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      ||++|+|.+|+..... ..+.-.....|+.||+.||+||.+.+   ++||||.++|+|+|.++++||+|||++|-+-.++
T Consensus       616 YmEnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             HHhcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence            9999999999965322 22455667789999999999999887   9999999999999999999999999999777777


Q ss_pred             ccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh--CCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS--GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt--G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      .+....+.+-+++|||||.+..++++.++|||+|||++||+++  ..+|++....++   .++..-..+..+.....+  
T Consensus       692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~~~~l--  766 (807)
T KOG1094|consen  692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGRQVVL--  766 (807)
T ss_pred             ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCcceec--
Confidence            7766666777899999999999999999999999999999865  556765444332   222222222222111111  


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                         ..+.-....+.++++.||..+.++||+++++...|..
T Consensus       767 ---~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  767 ---SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE  803 (807)
T ss_pred             ---cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence               0112223455688999999999999999999988865

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.5e-39  Score=321.55  Aligned_cols=265  Identities=27%  Similarity=0.411  Sum_probs=199.6

Q ss_pred             CccccccccCCcEEEEEeEe-----cCCcEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC--CeEEE
Q 008108          246 FSDANKLGQGGFGAVYKGML-----SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KERIL  317 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  317 (577)
                      |+..+.||+|+||+||++..     .+++.||+|.+..... .....+.+|+.++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37889999999999988652     3578899999876532 3455688999999999999999999988654  35789


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      +|||+++++|.+++.    ...+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        86 v~e~~~~~~l~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLP----KHKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHH----HcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence            999999999998873    345999999999999999999999987   9999999999999999999999999998765


Q ss_pred             CCCcccc-ccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          398 MDQTHSD-TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       398 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      ....... .....++..|+|||.+....++.++||||||+++|||+||..|+...... ....+.............+.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIELL  237 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhhh
Confidence            4322111 12234567799999998889999999999999999999999987543221 112221111111111111112


Q ss_pred             cCcCCCC-ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          477 DPTMRGG-STSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       477 d~~l~~~-~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      +...... .......+.+++..|++.+|++|||+++|+++|+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~  280 (283)
T cd05080         238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE  280 (283)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence            2111111 11122456678889999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-39  Score=317.32  Aligned_cols=252  Identities=27%  Similarity=0.419  Sum_probs=199.7

Q ss_pred             cCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecC
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVP  323 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  323 (577)
                      .+|++.+.||+|+||.||++...++..+|+|.+.+... ....+.+|+.+++.++|+||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            35778899999999999999987778899999865433 23467889999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccc
Q 008108          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS  403 (577)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~  403 (577)
                      +++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+||++++++.+||+|||+++........ 
T Consensus        83 ~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-  156 (256)
T cd05059          83 NGCLLNYLRE--RKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-  156 (256)
T ss_pred             CCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence            9999998853  2347899999999999999999999988   999999999999999999999999999865432211 


Q ss_pred             cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCC
Q 008108          404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG  482 (577)
Q Consensus       404 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  482 (577)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+.   .....    ..     .......
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~----~~-----~~~~~~~  224 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---VESVS----AG-----YRLYRPK  224 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---HHHHH----cC-----CcCCCCC
Confidence            1112234568999999999999999999999999999999 7777754332221   11111    11     0001111


Q ss_pred             CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          483 GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       483 ~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                      .   ...++.+++.+|++.+|++||||.|++++|.
T Consensus       225 ~---~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         225 L---APTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             C---CCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            1   1235667888999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.9e-39  Score=333.36  Aligned_cols=263  Identities=22%  Similarity=0.323  Sum_probs=193.5

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC-----eEE
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK-----ERI  316 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  316 (577)
                      +|++.++||+|+||.||+|... +++.||||++...  .......+.+|+.+++.++||||+++++++....     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4788999999999999999954 6899999998743  2233446889999999999999999999886432     479


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccc
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~  396 (577)
                      +||||++ ++|.+++.   ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 58877773   3456999999999999999999999998   999999999999999999999999999864


Q ss_pred             cCCCcc-ccccccccCCCCcChhhhhc--CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhh--------hh
Q 008108          397 EMDQTH-SDTNRVVGTFGYMAPEYVMH--GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA--------WR  465 (577)
Q Consensus       397 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~--------~~  465 (577)
                      ...... .......||..|+|||++.+  ..++.++|||||||++|||++|+.||...........+...        +.
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            322211 11233579999999999876  67899999999999999999999998644322111111000        00


Q ss_pred             hcccCCccccc---cCcCCCC----ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          466 NWNEGAALNLM---DPTMRGG----STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       466 ~~~~~~~~~~~---d~~l~~~----~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .+......+.+   .+.....    .......+.+++..|++.||++|||++|+++
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            00000000000   0000000    0011124567888999999999999999885

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.8e-39  Score=329.48  Aligned_cols=242  Identities=22%  Similarity=0.267  Sum_probs=191.9

Q ss_pred             cccccCCcEEEEEeEe-cCCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCC
Q 008108          250 NKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA  325 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  325 (577)
                      +.||+|+||.||++.. .+|+.||+|.+.+..   ......+.+|+.++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999985 468999999997542   223345678999999999999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcccc
Q 008108          326 SLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE-DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD  404 (577)
Q Consensus       326 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~  404 (577)
                      +|..++.   ....+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~  152 (325)
T cd05594          81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--T  152 (325)
T ss_pred             cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--c
Confidence            9988773   34579999999999999999999997 56   99999999999999999999999999875332211  1


Q ss_pred             ccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCC
Q 008108          405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGS  484 (577)
Q Consensus       405 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  484 (577)
                      .....||+.|+|||++.++.++.++|||||||++|||++|+.||.....+.....+.   .  ..        ..+....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~---~--~~--------~~~p~~~  219 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL---M--EE--------IRFPRTL  219 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh---c--CC--------CCCCCCC
Confidence            223579999999999999999999999999999999999999986543322211111   0  00        0111112


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 008108          485 TSEMMKCIHIGLLCVQENVSNRP-----GMASVVNM  515 (577)
Q Consensus       485 ~~~~~~~~~l~~~C~~~~p~~RP-----t~~ev~~~  515 (577)
                      ..   .+.+++.+|++.||++|+     ++.++++-
T Consensus       220 ~~---~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         220 SP---EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CH---HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            22   344677799999999996     88888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=6.8e-39  Score=335.74  Aligned_cols=204  Identities=24%  Similarity=0.369  Sum_probs=173.8

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      .+|+++++||+|+||.||++... +++.||||.+.+...   .....+.+|+.++++++|+||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36899999999999999999954 688999999865422   22345789999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++|+|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          81 DYIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            9999999999884   3456899999999999999999999988   999999999999999999999999998533210


Q ss_pred             C-----------------------------------------ccccccccccCCCCcChhhhhcCCCCccccEEecchhH
Q 008108          400 Q-----------------------------------------THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLV  438 (577)
Q Consensus       400 ~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil  438 (577)
                      .                                         .........||+.|||||++.+..++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            0                                         00011235799999999999999999999999999999


Q ss_pred             hHHhhCCCCCCCCCc
Q 008108          439 LEIVSGQKRSSFGTE  453 (577)
Q Consensus       439 ~elltG~~p~~~~~~  453 (577)
                      |||++|+.||.....
T Consensus       235 yell~G~~Pf~~~~~  249 (376)
T cd05598         235 YEMLVGQPPFLADTP  249 (376)
T ss_pred             eehhhCCCCCCCCCH
Confidence            999999999875543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-39  Score=317.53  Aligned_cols=246  Identities=23%  Similarity=0.416  Sum_probs=205.5

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      .+|++.+.||+|.||.|-++.. ..|+.||||.++++..   ++...+.+|+++|+.|+||||+.++.+|++.+...|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            4678889999999999999984 6899999999987644   44556889999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||..+|.|.+++.   .++.|++.++..+++||..++.|+|+++   ++|||||.+|||||.|+++||+||||+..+..+
T Consensus       133 EYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  133 EYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             EecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            9999999999994   5778999999999999999999999987   999999999999999999999999999887654


Q ss_pred             CccccccccccCCCCcChhhhhcCCCC-ccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFS-VKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      ...   +.++|++.|.+||++.+..|. +..|-|||||+||-|+.|.-||.......   ++.    +...+...+   |
T Consensus       207 kfL---qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---lvr----QIs~GaYrE---P  273 (668)
T KOG0611|consen  207 KFL---QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---LVR----QISRGAYRE---P  273 (668)
T ss_pred             cHH---HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---HHH----HhhcccccC---C
Confidence            433   347999999999999998884 88999999999999999999987544322   222    222222111   1


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      .    .+..   ..-++.||+..||++|-|+.+|..-
T Consensus       274 ~----~PSd---A~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  274 E----TPSD---ASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             C----CCch---HHHHHHHHHhcCcccchhHHHHhhh
Confidence            1    1122   2346679999999999999999865

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.3e-38  Score=321.37  Aligned_cols=256  Identities=28%  Similarity=0.411  Sum_probs=200.5

Q ss_pred             CCccccccccCCcEEEEEeEec------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      +|++.+.||+|+||.||+|...      ....+++|.+..... .....+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999853      235789998876543 334568899999999999999999999999999999


Q ss_pred             EEEecCCCCcccccccCC---------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCc
Q 008108          318 VYEFVPNASLDHFIFDPI---------------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASN  376 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~N  376 (577)
                      ++||+++++|.+++....                     ....+++..++.++.|++.||.|||+.+   |+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999988864321                     1235889999999999999999999987   9999999999


Q ss_pred             EEEcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccc
Q 008108          377 ILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEE  455 (577)
Q Consensus       377 iLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~  455 (577)
                      ||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.|+.....+.
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999986543332222233456778999999988899999999999999999999 888875433222


Q ss_pred             cchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          456 TEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       456 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ....+       .....     ........   ..+.+++..|++.+|++||++.|+++.|++
T Consensus       238 ~~~~~-------~~~~~-----~~~~~~~~---~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~  285 (290)
T cd05045         238 LFNLL-------KTGYR-----MERPENCS---EEMYNLMLTCWKQEPDKRPTFADISKELEK  285 (290)
T ss_pred             HHHHH-------hCCCC-----CCCCCCCC---HHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            21111       11100     00111112   345678889999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.1e-39  Score=327.73  Aligned_cols=241  Identities=25%  Similarity=0.350  Sum_probs=191.4

Q ss_pred             cccccCCcEEEEEeEe----cCCcEEEEEEeccCC----hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          250 NKLGQGGFGAVYKGML----SNGETIAVKRLSKNS----KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ++||+|+||.||++..    .+++.||+|.+.+..    ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999985    357889999987532    12234577899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|.+++.   ....+.+..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (323)
T cd05584          82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-  154 (323)
T ss_pred             CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence            99999988873   3456889999999999999999999988   9999999999999999999999999987543222 


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR  481 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  481 (577)
                       .......||+.|+|||++.+..++.++||||||+++|||++|+.||........   +....    .+.      ..+.
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~---~~~~~----~~~------~~~~  220 (323)
T cd05584         155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT---IDKIL----KGK------LNLP  220 (323)
T ss_pred             -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH---HHHHH----cCC------CCCC
Confidence             122335799999999999988899999999999999999999999864332211   11110    110      0111


Q ss_pred             CCChHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 008108          482 GGSTSEMMKCIHIGLLCVQENVSNRP-----GMASVVN  514 (577)
Q Consensus       482 ~~~~~~~~~~~~l~~~C~~~~p~~RP-----t~~ev~~  514 (577)
                      ....   ..+.+++..|++.+|++||     ++.++++
T Consensus       221 ~~~~---~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         221 PYLT---PEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCC---HHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            1112   2345777899999999999     7777765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-38  Score=320.41  Aligned_cols=251  Identities=28%  Similarity=0.381  Sum_probs=197.6

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      +|+..++||+|+||+||++... +++.||+|++.....   .....+.+|+.++++++|+||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788899999999999999964 688999999875432   223456789999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |+++|+|.+++.. .....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||+++......
T Consensus        81 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYN-MGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHh-cCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            9999999887754 23356999999999999999999999987   9999999999999999999999999998654322


Q ss_pred             ccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                      .   .....|+..|+|||++.+..++.++||||||+++|||++|+.||...........+.   .......      ...
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~---~~~~~~~------~~~  224 (285)
T cd05605         157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE---RRVKEDQ------EEY  224 (285)
T ss_pred             c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH---HHhhhcc------ccc
Confidence            1   123478999999999998999999999999999999999999987543321111111   0000000      001


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRP-----GMASVVN  514 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RP-----t~~ev~~  514 (577)
                      ....   ...+.+++..|++.||++||     ++.++++
T Consensus       225 ~~~~---~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         225 SEKF---SEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             Cccc---CHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            1111   22345778899999999999     7777754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=9.7e-39  Score=320.73  Aligned_cols=257  Identities=28%  Similarity=0.436  Sum_probs=202.9

Q ss_pred             hcCCccccccccCCcEEEEEeEec------CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  316 (577)
                      .++|...++||+|+||.||++...      ++..+++|.+..........+.+|+++++.++|+||+++++++.+....+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            356788899999999999999732      35679999988776666678999999999999999999999999999999


Q ss_pred             EEEEecCCCCcccccccCCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCC
Q 008108          317 LVYEFVPNASLDHFIFDPIN------------REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN  384 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~  384 (577)
                      ++|||+++++|.+++.....            ...+++..++.++.||+.||.|||+.+   ++||||||+|||+++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence            99999999999988754211            135899999999999999999999987   999999999999999999


Q ss_pred             eEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhh
Q 008108          385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYA  463 (577)
Q Consensus       385 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~  463 (577)
                      +||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+......+....+.  
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~--  238 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT--  238 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH--
Confidence            99999999986543332222223445788999999999999999999999999999998 888775433222111111  


Q ss_pred             hhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          464 WRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       464 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                           .+....     .....+   ..+.+++.+||+.+|++||++.||++.|+
T Consensus       239 -----~~~~~~-----~~~~~~---~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         239 -----QGRELE-----RPRTCP---PEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             -----cCccCC-----CCCCCC---HHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                 100000     001112   23457888999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.2e-38  Score=321.51  Aligned_cols=262  Identities=24%  Similarity=0.401  Sum_probs=192.4

Q ss_pred             cCCccccccccCCcEEEEEeEec--CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhc---CCCCeEEEEeEEEc-----
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS--NGETIAVKRLSKNSK--QGEIEFKNEVLLLARL---QHRNLVRLLGFCLE-----  311 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----  311 (577)
                      ++|++.+.||+|+||+||++...  +++.||+|++.....  .....+.+|+.+++.+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888999999999999999853  467899999865432  2233456777777766   69999999998852     


Q ss_pred             CCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccC
Q 008108          312 RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG  391 (577)
Q Consensus       312 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfG  391 (577)
                      ....++||||++ ++|.+++.. .....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            346899999996 588777743 22345899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccc-hhhhhhh----hh
Q 008108          392 MARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE-DLLTYAW----RN  466 (577)
Q Consensus       392 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~-~l~~~~~----~~  466 (577)
                      +++.....   .......||+.|+|||.+....++.++|||||||++|||++|+.||......+.. .++....    ..
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~  232 (290)
T cd07862         156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  232 (290)
T ss_pred             ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence            99865433   2233457899999999999889999999999999999999999998755432211 1111100    00


Q ss_pred             cccCC--ccccccCcCCCCCh-----HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          467 WNEGA--ALNLMDPTMRGGST-----SEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       467 ~~~~~--~~~~~d~~l~~~~~-----~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      |....  ....+.+.. ....     .....+.+++.+|++.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         233 WPRDVALPRQAFHSKS-AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             chhhhcccchhccCCC-CCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00000  000000000 0001     11123457888999999999999999884

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=9.1e-39  Score=315.54  Aligned_cols=248  Identities=28%  Similarity=0.437  Sum_probs=194.1

Q ss_pred             cccccCCcEEEEEeEec-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCCCc
Q 008108          250 NKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASL  327 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  327 (577)
                      +.||+|+||.||+|... +++.+|+|.+.... ......+.+|++++++++|+||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999964 68899999886543 33445689999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccccccc
Q 008108          328 DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR  407 (577)
Q Consensus       328 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~  407 (577)
                      .+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..............
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            998843  2346899999999999999999999987   99999999999999999999999999875442211111111


Q ss_pred             cccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCChH
Q 008108          408 VVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTS  486 (577)
Q Consensus       408 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  486 (577)
                      ..++..|+|||.+..+.++.++||||||+++|||++ |..|+...........+.       ....     .......+ 
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-------~~~~-----~~~~~~~~-  222 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-------QGVR-----LPCPELCP-  222 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-------cCCC-----CCCcccCC-
Confidence            233567999999999999999999999999999998 777765333222111111       0000     00111112 


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          487 EMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       487 ~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                        ..+.+++.+|++.+|++|||+.+|.++|+
T Consensus       223 --~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         223 --DAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             --HHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence              24557888999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.2e-38  Score=334.47  Aligned_cols=202  Identities=25%  Similarity=0.386  Sum_probs=172.7

Q ss_pred             CCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      +|+.+++||+|+||+||+|.. .+++.||+|++.+..   ......+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            588899999999999999995 468899999987542   2233467899999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            9999999988843   456899999999999999999999988   9999999999999999999999999985432100


Q ss_pred             c---------------------------------------------cccccccccCCCCcChhhhhcCCCCccccEEecc
Q 008108          401 T---------------------------------------------HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFG  435 (577)
Q Consensus       401 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG  435 (577)
                      .                                             ........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence            0                                             0001235799999999999999999999999999


Q ss_pred             hhHhHHhhCCCCCCCCC
Q 008108          436 VLVLEIVSGQKRSSFGT  452 (577)
Q Consensus       436 vil~elltG~~p~~~~~  452 (577)
                      |++|||++|+.||....
T Consensus       236 vil~elltG~~Pf~~~~  252 (382)
T cd05625         236 VILYEMLVGQPPFLAQT  252 (382)
T ss_pred             HHHHHHHhCCCCCCCCC
Confidence            99999999999987543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-38  Score=316.64  Aligned_cols=255  Identities=24%  Similarity=0.420  Sum_probs=198.5

Q ss_pred             CccccccccCCcEEEEEeEecC----CcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCe-----
Q 008108          246 FSDANKLGQGGFGAVYKGMLSN----GETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE-----  314 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  314 (577)
                      |.+.+.||+|+||.||+|....    +..||+|++....  ......+.+|+..++.++|+||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998642    3679999987543  2334568899999999999999999998876554     


Q ss_pred             -EEEEEEecCCCCcccccccCC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEecc
Q 008108          315 -RILVYEFVPNASLDHFIFDPI---NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDF  390 (577)
Q Consensus       315 -~~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~Df  390 (577)
                       .+++|||+++++|..++....   ....+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             789999999999988875422   2346899999999999999999999987   999999999999999999999999


Q ss_pred             CCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhccc
Q 008108          391 GMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNE  469 (577)
Q Consensus       391 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  469 (577)
                      |+++...............++..|+|||++....++.++||||||+++|||++ |..|+......   .+......    
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~~~----  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYLRH----  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHc----
Confidence            99987654433222222345778999999988889999999999999999999 77776543322   22222111    


Q ss_pred             CCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          470 GAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       470 ~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      +...     ...   ......+.+++.+|++.||++||++.||++.|+.
T Consensus       231 ~~~~-----~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~  271 (273)
T cd05035         231 GNRL-----KQP---EDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN  271 (273)
T ss_pred             CCCC-----CCC---cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            1100     011   1122356677889999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-38  Score=318.79  Aligned_cols=258  Identities=28%  Similarity=0.472  Sum_probs=204.4

Q ss_pred             hcCCccccccccCCcEEEEEeEecC------CcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSN------GETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  315 (577)
                      .++|.+.+.||+|+||.||+|....      +..||+|.+.... ......+.+|+.++..++|+||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4678889999999999999998642      4679999987553 23445688999999999999999999999999999


Q ss_pred             EEEEEecCCCCcccccccCC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEe
Q 008108          316 ILVYEFVPNASLDHFIFDPI-------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKIS  388 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~  388 (577)
                      ++||||+++++|.+++....       ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            99999999999998885422       1235789999999999999999999987   9999999999999999999999


Q ss_pred             ccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhc
Q 008108          389 DFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNW  467 (577)
Q Consensus       389 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~  467 (577)
                      |||+++...............++..|+|||.+..+.++.++||||||+++|||+| |+.|+........   ....    
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~~~----  234 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV---LKFV----  234 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH---HHHH----
Confidence            9999986554332222333457889999999998999999999999999999998 8887754333222   1111    


Q ss_pred             ccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          468 NEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       468 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ..+....     .....   ...+.+++..|++.+|++|||+.++++.|+.
T Consensus       235 ~~~~~~~-----~~~~~---~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         235 IDGGHLD-----LPENC---PDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             hcCCCCC-----CCCCC---CHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            1111111     11111   2355678889999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.7e-38  Score=320.08  Aligned_cols=264  Identities=25%  Similarity=0.410  Sum_probs=200.8

Q ss_pred             hcCCccccccccCCcEEEEEeEec-----------------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-----------------NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVR  304 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  304 (577)
                      .++|++.++||+|+||.||++...                 ++..+|+|.+.... ......+.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            357899999999999999998532                 23468999987653 334457899999999999999999


Q ss_pred             EEeEEEcCCeEEEEEEecCCCCcccccccCC--------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCc
Q 008108          305 LLGFCLERKERILVYEFVPNASLDHFIFDPI--------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASN  376 (577)
Q Consensus       305 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~N  376 (577)
                      +++++...+..+++|||+++++|.+++....        ....+++.+++.++.||+.||.|||+.+   ++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence            9999999999999999999999998875421        1235788999999999999999999987   9999999999


Q ss_pred             EEEcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh--CCCCCCCCCcc
Q 008108          377 ILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS--GQKRSSFGTEE  454 (577)
Q Consensus       377 iLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt--G~~p~~~~~~~  454 (577)
                      ||++.++.++|+|||+++.+.............++..|++||....+.++.++||||||+++|||++  |..|+......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            9999999999999999986543322222223345678999999988999999999999999999998  55666433222


Q ss_pred             ccchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          455 ETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       455 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                      .   .+......+..... ....+.    .......+.+++.+||+.||++||+|.||++.|+
T Consensus       241 ~---~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         241 Q---VIENTGEFFRDQGR-QVYLPK----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             H---HHHHHHHHHhhccc-cccCCC----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            1   11111111111100 000011    1111235567888999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=9.1e-39  Score=333.61  Aligned_cols=255  Identities=21%  Similarity=0.289  Sum_probs=197.8

Q ss_pred             HHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEE
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  316 (577)
                      ...++|++.++||+|+||.||++... +++.||+|++.+..   ......+.+|+.+++.++||||+++++++.++...+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            34578999999999999999999964 68899999996532   223334778999999999999999999999999999


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccc
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~  396 (577)
                      +||||+++|+|.+++.    +..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       120 lv~Ey~~gg~L~~~l~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         120 MVMEYMPGGDLVNLMS----NYDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            9999999999998873    345889999999999999999999987   999999999999999999999999999865


Q ss_pred             cCCCccccccccccCCCCcChhhhhcC----CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCc
Q 008108          397 EMDQTHSDTNRVVGTFGYMAPEYVMHG----RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAA  472 (577)
Q Consensus       397 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  472 (577)
                      ..... .......||+.|+|||++...    .++.++|||||||++|||++|+.||........   .....   .....
T Consensus       193 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~~i~---~~~~~  265 (370)
T cd05596         193 DANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---YSKIM---DHKNS  265 (370)
T ss_pred             cCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH---HHHHH---cCCCc
Confidence            43221 122335799999999998653    478999999999999999999999865433211   11111   00000


Q ss_pred             cccccCcCCCCChHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 008108          473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSN--RPGMASVVNM  515 (577)
Q Consensus       473 ~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~--RPt~~ev~~~  515 (577)
                      ...  |   . .......+.+++..|++.+|++  ||++.|+++-
T Consensus       266 ~~~--~---~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         266 LTF--P---D-DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CCC--C---C-cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            000  0   0 0011234446777899999987  9999998754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.8e-38  Score=331.19  Aligned_cols=206  Identities=23%  Similarity=0.335  Sum_probs=175.5

Q ss_pred             HHHHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCe
Q 008108          239 IRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE  314 (577)
Q Consensus       239 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  314 (577)
                      +....++|+..++||+|+||.||++... +++.+|+|.+.+..   ......+.+|+.+++.++||||+++++++.+++.
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY  117 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence            3445678999999999999999999965 57889999986532   2233457889999999999999999999999999


Q ss_pred             EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      .++||||+++|+|.+++.    ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||++.
T Consensus       118 ~~lv~Ey~~gg~L~~~l~----~~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~  190 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMS----NYDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCM  190 (370)
T ss_pred             EEEEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccce
Confidence            999999999999999873    345899999999999999999999987   9999999999999999999999999998


Q ss_pred             cccCCCccccccccccCCCCcChhhhhcC----CCCccccEEecchhHhHHhhCCCCCCCCC
Q 008108          395 LFEMDQTHSDTNRVVGTFGYMAPEYVMHG----RFSVKSDIFSFGVLVLEIVSGQKRSSFGT  452 (577)
Q Consensus       395 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlGvil~elltG~~p~~~~~  452 (577)
                      ....... .......||+.|+|||++...    .++.++|||||||++|||++|+.||....
T Consensus       191 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~  251 (370)
T cd05621         191 KMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS  251 (370)
T ss_pred             ecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence            7643221 122346799999999998754    37899999999999999999999986543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.8e-39  Score=305.39  Aligned_cols=203  Identities=27%  Similarity=0.424  Sum_probs=171.6

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChh--hHHHHHHHHHHHHhcCCCCeEEEEeEEEc--CCeEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLE--RKERILV  318 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  318 (577)
                      ++|+.++.|++|.||.||+|+. ++++.||+|+++.....  -...-.+|+.+|.+.+|||||.+-.+...  -+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            5688899999999999999995 46889999999765322  12235799999999999999999988764  3579999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      ||||+. +|..++...  .+++...++.-++.|+++|++|||.+.   |+|||||++|+|++..|.+||+||||||.+..
T Consensus       156 Me~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             HHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence            999976 777766432  367999999999999999999999998   99999999999999999999999999998875


Q ss_pred             CCccccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCcc
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEE  454 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~  454 (577)
                      .  ....+..+-|.+|.|||.+.+. .|+...|+||+|||+.||+++++-|....+-
T Consensus       230 p--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~  284 (419)
T KOG0663|consen  230 P--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI  284 (419)
T ss_pred             C--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH
Confidence            4  2334457889999999999875 6999999999999999999999877655543

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.6e-39  Score=335.13  Aligned_cols=194  Identities=22%  Similarity=0.306  Sum_probs=167.1

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ..+|++.++||+|+||.||++.. .+++.||+|....      ..+.+|+.++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            35799999999999999999995 4688999996532      2467899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +. ++|..++.   ....+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++...... 
T Consensus       165 ~~-~~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-  236 (391)
T PHA03212        165 YK-TDLYCYLA---AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-  236 (391)
T ss_pred             CC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence            95 67777663   3456899999999999999999999987   9999999999999999999999999997533211 


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSF  450 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~  450 (577)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.|+..
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~  285 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE  285 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence            1122345799999999999999999999999999999999999987643

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.4e-38  Score=319.08  Aligned_cols=258  Identities=31%  Similarity=0.514  Sum_probs=200.9

Q ss_pred             HhcCCccccccccCCcEEEEEeEecC------CcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCe
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLSN------GETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE  314 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  314 (577)
                      .+++|.+.+.||+|+||.||+|...+      +..|++|.+.... ......+.+|+.++++++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            45778999999999999999999753      5678999887543 3344568999999999999999999999999999


Q ss_pred             EEEEEEecCCCCcccccccCCC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC---CeEE
Q 008108          315 RILVYEFVPNASLDHFIFDPIN----REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM---NPKI  387 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~---~~kl  387 (577)
                      .++||||+++++|.+++.....    ...+++..++.++.||+.||.|||+.+   ++||||||+|||++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence            9999999999999998854321    236899999999999999999999987   99999999999998765   5999


Q ss_pred             eccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhh
Q 008108          388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRN  466 (577)
Q Consensus       388 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~  466 (577)
                      +|||+++................+..|+|||++.++.++.++|||||||++|||++ |+.||...........+.   ..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~---~~  237 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT---GG  237 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---cC
Confidence            99999986633222222222334578999999999999999999999999999997 888876433322211111   00


Q ss_pred             cccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          467 WNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       467 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                         .. .     ......+   ..+.+++.+|++.+|++||++.+|++.|+
T Consensus       238 ---~~-~-----~~~~~~~---~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         238 ---GR-L-----DPPKGCP---GPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             ---Cc-C-----CCCCCCC---HHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence               00 0     0011112   34557888999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.2e-38  Score=316.37  Aligned_cols=255  Identities=25%  Similarity=0.431  Sum_probs=194.8

Q ss_pred             CccccccccCCcEEEEEeEecCC-c--EEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC------Ce
Q 008108          246 FSDANKLGQGGFGAVYKGMLSNG-E--TIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER------KE  314 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~~~~-~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  314 (577)
                      |.+.++||+|+||.||+|.+.+. +  .+|+|.++..  .......+.+|+.+++.++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            34578899999999999997543 2  5899988654  233445688999999999999999999987532      24


Q ss_pred             EEEEEEecCCCCcccccccC---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccC
Q 008108          315 RILVYEFVPNASLDHFIFDP---INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG  391 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfG  391 (577)
                      .+++|||+++|+|.+++...   .....+++..++.++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            68999999999998876321   12345899999999999999999999987   9999999999999999999999999


Q ss_pred             CcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccC
Q 008108          392 MARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEG  470 (577)
Q Consensus       392 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~  470 (577)
                      +++...............+++.|+|||++....++.++||||||+++|||++ |+.|+......   .+...    ...+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~----~~~~  230 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYDY----LRQG  230 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----HHcC
Confidence            9987654332222222346778999999999999999999999999999999 67776532221   11111    1111


Q ss_pred             CccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          471 AALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       471 ~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ....     .....   ...+.+++.+||+.+|++|||+.++++.|+.
T Consensus       231 ~~~~-----~~~~~---~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         231 NRLK-----QPPDC---LDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             CCCC-----CCCCC---CHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            1110     01111   2235678889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.6e-38  Score=322.96  Aligned_cols=262  Identities=24%  Similarity=0.377  Sum_probs=195.3

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      .++|++.++||+|+||.||+|... +++.||||++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999965 688999999875432 223356789999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |++ ++|.+++..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            996 566666532  3456899999999999999999999998   9999999999999999999999999997543221


Q ss_pred             ccccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhh--------cccCC
Q 008108          401 THSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRN--------WNEGA  471 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~--------~~~~~  471 (577)
                        .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....  ....+......        |....
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccchh
Confidence              12223568999999998865 4588999999999999999999999864322  11111111111        00000


Q ss_pred             ccccccCc-C---CCCChH-------HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          472 ALNLMDPT-M---RGGSTS-------EMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       472 ~~~~~d~~-l---~~~~~~-------~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ....+++. .   ......       ....+.+++..|++.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            00000000 0   000000       1124557788999999999999998874

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7e-40  Score=299.68  Aligned_cols=249  Identities=27%  Similarity=0.394  Sum_probs=206.6

Q ss_pred             HhcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      +.++|++.+.||+|.||.||.|.. +++-.||+|++.+...   +-..++.+|+++-+.|+||||++++++|.+....||
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            347899999999999999999995 4677899999977642   334568899999999999999999999999999999


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      ++||.++|+|...|.+ ....++++.....++.|+|.||.|+|..+   +|||||||+|+|++.++..||+|||.+..-+
T Consensus       100 ilEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             EEEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            9999999999888854 24567999999999999999999999887   9999999999999999999999999987543


Q ss_pred             CCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccccc
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD  477 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  477 (577)
                          .......+||..|.+||...+..++.+.|+|++|++.||++.|.+||......+...-+..          .++.+
T Consensus       176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k----------~~~~~  241 (281)
T KOG0580|consen  176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK----------VDLKF  241 (281)
T ss_pred             ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH----------ccccC
Confidence                2233457999999999999999999999999999999999999999986554333222221          12222


Q ss_pred             CcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          478 PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       478 ~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      |   .....   .+.+++..|+..+|.+|.+..||+.
T Consensus       242 p---~~is~---~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  242 P---STISG---GAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             C---cccCh---hHHHHHHHHhccCccccccHHHHhh
Confidence            2   11222   3446777999999999999999875

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.4e-38  Score=326.52  Aligned_cols=244  Identities=27%  Similarity=0.339  Sum_probs=190.1

Q ss_pred             CccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHH---HhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLL---ARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      |++.+.||+|+||.||++... +++.||||++.+..   ......+.+|..++   +.++||||+++++++.+.+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567899999999999999854 68999999997542   12223466666554   566899999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+++++|..++.    ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            99999999987763    357999999999999999999999987   99999999999999999999999999875332


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      ..  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+.       .+.      +
T Consensus       154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~-------~~~------~  218 (324)
T cd05589         154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV-------NDE------V  218 (324)
T ss_pred             CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------hCC------C
Confidence            11  22234679999999999999999999999999999999999999986543322111110       000      0


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPG-----MASVVN  514 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt-----~~ev~~  514 (577)
                      .......   ..+.+++.+|++.||++||+     +.++++
T Consensus       219 ~~p~~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         219 RYPRFLS---REAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             CCCCCCC---HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            1111112   23456778999999999994     555544

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.7e-38  Score=318.79  Aligned_cols=259  Identities=24%  Similarity=0.377  Sum_probs=204.2

Q ss_pred             HhcCCccccccccCCcEEEEEeEecC-----CcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEc-CCe
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLSN-----GETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLE-RKE  314 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  314 (577)
                      ..++|...+.||+|+||.||+|...+     +..|++|++.... ......+.+|+.++++++|+||+++++++.. ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            45788999999999999999999765     6889999987543 3334568899999999999999999998776 467


Q ss_pred             EEEEEEecCCCCcccccccCCCC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEec
Q 008108          315 RILVYEFVPNASLDHFIFDPINR-----EHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD  389 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~D  389 (577)
                      .++++||+++++|..++......     ..+++..++.++.||+.||.|||+.+   ++||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence            89999999999999988543222     56999999999999999999999987   99999999999999999999999


Q ss_pred             cCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcc
Q 008108          390 FGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWN  468 (577)
Q Consensus       390 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~  468 (577)
                      ||+++.+.............++..|+|||++....++.++||||||+++||+++ |+.|+......+   +..+..    
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~----  233 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLK----  233 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHH----
Confidence            999986654433322233456778999999988889999999999999999999 888875433221   111111    


Q ss_pred             cCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          469 EGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       469 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .+..     .......+   ..+.+++.+||+.+|++|||+.+|+++|+.
T Consensus       234 ~~~~-----~~~~~~~~---~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  275 (280)
T cd05043         234 DGYR-----LAQPINCP---DELFAVMACCWALDPEERPSFSQLVQCLTD  275 (280)
T ss_pred             cCCC-----CCCCCcCC---HHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence            1100     00000112   245678889999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.6e-39  Score=327.62  Aligned_cols=238  Identities=28%  Similarity=0.333  Sum_probs=189.8

Q ss_pred             cccccCCcEEEEEeEe----cCCcEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecC
Q 008108          250 NKLGQGGFGAVYKGML----SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVP  323 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  323 (577)
                      +.||+|+||.||++..    .+|+.+|+|++.+...  .....+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999874    3578999999976432  223456789999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccc
Q 008108          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS  403 (577)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~  403 (577)
                      +|+|.+++.   +...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  .
T Consensus        82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~  153 (318)
T cd05582          82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K  153 (318)
T ss_pred             CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence            999988873   3456999999999999999999999988   9999999999999999999999999998654321  1


Q ss_pred             cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCC
Q 008108          404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGG  483 (577)
Q Consensus       404 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  483 (577)
                      ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+.......   .......    ..      ..+...
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~i~~----~~------~~~p~~  220 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE---TMTMILK----AK------LGMPQF  220 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH---HHHHHHc----CC------CCCCCC
Confidence            2234679999999999998889999999999999999999999986443221   1111110    00      001111


Q ss_pred             ChHHHHHHHHHHHhcccCCCCCCCCHHH
Q 008108          484 STSEMMKCIHIGLLCVQENVSNRPGMAS  511 (577)
Q Consensus       484 ~~~~~~~~~~l~~~C~~~~p~~RPt~~e  511 (577)
                      ...   .+.+++..|++.||++||++.+
T Consensus       221 ~~~---~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         221 LSP---EAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCH---HHHHHHHHHhhcCHhHcCCCCC
Confidence            122   3446777999999999999665

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.1e-38  Score=317.68  Aligned_cols=255  Identities=22%  Similarity=0.354  Sum_probs=199.8

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      .++|++.++||+|+||.||+|.. .+++.||+|++..........+.+|+.++++++|+||+++++++..++..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            35789999999999999999995 46889999999765544555688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|.+++.   .+..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++...... 
T Consensus        88 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-  160 (267)
T cd06646          88 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI-  160 (267)
T ss_pred             CCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence            99999998874   3457899999999999999999999987   9999999999999999999999999998664322 


Q ss_pred             cccccccccCCCCcChhhhh---cCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          402 HSDTNRVVGTFGYMAPEYVM---HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                       .......|+..|+|||.+.   ...++.++||||||+++|||++|+.|+.........  ...     ....   ...+
T Consensus       161 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--~~~-----~~~~---~~~~  229 (267)
T cd06646         161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FLM-----SKSN---FQPP  229 (267)
T ss_pred             -cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--eee-----ecCC---CCCC
Confidence             1122356889999999874   345788999999999999999999987533221110  000     0000   0001


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNML  516 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L  516 (577)
                      .... .......+.+++.+|++.+|++||+++++++.|
T Consensus       230 ~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         230 KLKD-KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCcc-ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            1100 011123455778899999999999999998743

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.4e-38  Score=320.90  Aligned_cols=261  Identities=28%  Similarity=0.471  Sum_probs=202.9

Q ss_pred             HHhcCCccccccccCCcEEEEEeEec------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK  313 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  313 (577)
                      +..++|++.++||+|+||.||+|...      .+..||+|.+.... ......+.+|+.+++.++|+||+++++++.+..
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            45678999999999999999999743      24579999886543 233446789999999999999999999999999


Q ss_pred             eEEEEEEecCCCCcccccccCC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeE
Q 008108          314 ERILVYEFVPNASLDHFIFDPI-------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPK  386 (577)
Q Consensus       314 ~~~lv~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~k  386 (577)
                      ..++||||+++|+|.+++....       ....+++..+..++.|++.||.|||+++   |+||||||+|||+++++.+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence            9999999999999999985421       1245678889999999999999999987   99999999999999999999


Q ss_pred             EeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhh
Q 008108          387 ISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWR  465 (577)
Q Consensus       387 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~  465 (577)
                      |+|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |..|+.....++   ...... 
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~~~~-  235 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLKFVM-  235 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH-
Confidence            999999986543332222222345778999999999999999999999999999999 666764332221   111111 


Q ss_pred             hcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCC
Q 008108          466 NWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD  519 (577)
Q Consensus       466 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~  519 (577)
                         .+...     ......   ...+.+++.+|++.+|++|||+.++++.|++.
T Consensus       236 ---~~~~~-----~~~~~~---~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         236 ---DGGYL-----DQPDNC---PERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             ---cCCCC-----CCCCCC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence               01000     001111   23566788899999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.6e-38  Score=313.83  Aligned_cols=254  Identities=27%  Similarity=0.459  Sum_probs=201.0

Q ss_pred             hcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      .++|++.++||+|+||.||++...++..+|+|.+..... ....+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            457888999999999999999988888999999876443 3456899999999999999999999875 45678999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      ++++|.+++... ....+++..++.++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++..+......
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            999999988542 2346899999999999999999999987   999999999999999999999999999866433221


Q ss_pred             ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC
Q 008108          403 SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR  481 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  481 (577)
                       ......++..|+|||++....++.++||||||+++|||++ |+.|+......   +..........         +...
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~~~~---------~~~~  225 (260)
T cd05070         159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLEQVERGYR---------MPCP  225 (260)
T ss_pred             -cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHcCCC---------CCCC
Confidence             1122345678999999988899999999999999999999 77777543222   12221111000         0011


Q ss_pred             CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       482 ~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ...   ...+.+++.+|++.+|++|||+.++.+.|+.
T Consensus       226 ~~~---~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         226 QDC---PISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CcC---CHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            111   2346678889999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.7e-38  Score=324.00  Aligned_cols=243  Identities=23%  Similarity=0.313  Sum_probs=187.9

Q ss_pred             cccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEEEEEecCC
Q 008108          250 NKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYEFVPN  324 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  324 (577)
                      +.||+|+||.||++... +++.||+|++.+..   ......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999964 57899999997642   22334577888888877 899999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcccc
Q 008108          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD  404 (577)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~  404 (577)
                      |+|..++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~  152 (329)
T cd05618          81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT  152 (329)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence            99988773   3457999999999999999999999988   9999999999999999999999999997532211  12


Q ss_pred             ccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccc--cchhhhhhhhhcccCCccccccCcCCC
Q 008108          405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEE--TEDLLTYAWRNWNEGAALNLMDPTMRG  482 (577)
Q Consensus       405 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~  482 (577)
                      .....||..|+|||++.+..++.++||||||+++|||++|+.||.......  ......+.+.......      ..+..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~------~~~p~  226 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------IRIPR  226 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC------CCCCC
Confidence            234679999999999999999999999999999999999999985322111  1111111111111111      01111


Q ss_pred             CChHHHHHHHHHHHhcccCCCCCCCCH
Q 008108          483 GSTSEMMKCIHIGLLCVQENVSNRPGM  509 (577)
Q Consensus       483 ~~~~~~~~~~~l~~~C~~~~p~~RPt~  509 (577)
                      ...   ..+..++..|++.||++||+.
T Consensus       227 ~~~---~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         227 SLS---VKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCC---HHHHHHHHHHhcCCHHHcCCC
Confidence            112   344577789999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.9e-38  Score=314.58  Aligned_cols=258  Identities=23%  Similarity=0.373  Sum_probs=203.9

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|++.++||+|+||.||+|... +++.||||.+...   .......+.+|+.+++.++||||+++++++.+.+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57899999999999999999954 7899999987642   2233446889999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          320 EFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      ||+++++|.+++.... +...+++..++.++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999988774322 2356899999999999999999999987   99999999999999999999999999987653


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      ...  ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+...... ...+....    ....     .+
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~~~----~~~~-----~~  226 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQKI----EQCD-----YP  226 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHHHH----hcCC-----CC
Confidence            221  112346889999999999888999999999999999999999997543221 11111111    1100     11


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ...  .......+.+++.+||+.+|++||++.+|++.|++
T Consensus       227 ~~~--~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~  264 (267)
T cd08228         227 PLP--TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQ  264 (267)
T ss_pred             CCC--hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHH
Confidence            111  11122345577889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.6e-38  Score=318.86  Aligned_cols=258  Identities=28%  Similarity=0.485  Sum_probs=202.3

Q ss_pred             hcCCccccccccCCcEEEEEeEec------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  315 (577)
                      .++|+..+.||+|+||.||++...      ++..+|+|.+.... .....++.+|+.++++++||||+++++++.+++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467999999999999999999853      46789999987653 33445688999999999999999999999999999


Q ss_pred             EEEEEecCCCCcccccccCC-------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCc
Q 008108          316 ILVYEFVPNASLDHFIFDPI-------------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASN  376 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~N  376 (577)
                      +++|||+++++|.+++....                   ....+++..++.++.||+.||.|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999998885321                   1235789999999999999999999987   9999999999


Q ss_pred             EEEcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccc
Q 008108          377 ILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEE  455 (577)
Q Consensus       377 iLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~  455 (577)
                      |++++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+......+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999886543322222222345678999999998999999999999999999998 777764332221


Q ss_pred             cchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          456 TEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       456 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                         .+..    ...+....     ...   ....++.+++.+|++.+|++|||+.|+++.|+.
T Consensus       241 ---~~~~----~~~~~~~~-----~~~---~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 ---VIYY----VRDGNVLS-----CPD---NCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ---HHHH----HhcCCCCC-----CCC---CCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence               1111    11111110     001   112356678889999999999999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.9e-38  Score=325.34  Aligned_cols=241  Identities=28%  Similarity=0.317  Sum_probs=191.1

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEEEE
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      +|++.+.||+|+||.||+|... +++.||||.+.+...   .....+..|..++..+ +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5788999999999999999865 578999999876422   2233456778888777 5899999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++|+|..++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            9999999988873   3456999999999999999999999987   999999999999999999999999999754322


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                      .  .......||+.|+|||++.+..++.++|||||||++|||+||+.||.......   +......    ..      ..
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~~~i~~----~~------~~  219 (323)
T cd05616         155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSIME----HN------VA  219 (323)
T ss_pred             C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HHHHHHh----CC------CC
Confidence            1  12234679999999999999999999999999999999999999986543322   2211111    00      00


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCCCH
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGM  509 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~  509 (577)
                      +.....   .++..++..|++.+|++|++.
T Consensus       220 ~p~~~s---~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         220 YPKSMS---KEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CCCcCC---HHHHHHHHHHcccCHHhcCCC
Confidence            111122   245577789999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-39  Score=326.51  Aligned_cols=251  Identities=25%  Similarity=0.373  Sum_probs=206.4

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCe-EEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE-RILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~  319 (577)
                      ++|..++++|+|+||.++....+ +++.+++|.+.-..  ........+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57888999999999999998854 57889999886543  2233356899999999999999999999999888 89999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      +|++||+|.+.|.+. ++..++++.+.+|+.||+.|+.|||++.   |+|||||+.||+++.+..+||+|||+|+.....
T Consensus        84 ~Y~eGg~l~~~i~~~-k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQ-KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            999999999998653 3567999999999999999999999776   999999999999999999999999999988765


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                      ..  ......||+.||.||.+.+..|..|+|||||||++|||++-+++|...+...   ++....+        ..++| 
T Consensus       160 ~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~ki~~--------~~~~P-  225 (426)
T KOG0589|consen  160 DS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LILKINR--------GLYSP-  225 (426)
T ss_pred             hh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHHHHhh--------ccCCC-
Confidence            42  2334899999999999999999999999999999999999999886544432   2221111        01122 


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      +   .......+..++..|++.+|+.||++.+++.+
T Consensus       226 l---p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  226 L---PSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             C---CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            1   22333445566678999999999999999876

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.2e-38  Score=324.60  Aligned_cols=242  Identities=26%  Similarity=0.343  Sum_probs=191.0

Q ss_pred             cccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEEEEEecCC
Q 008108          250 NKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYEFVPN  324 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  324 (577)
                      ++||+|+||.||+|... +++.||+|++.+..   ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999965 57899999987642   22334567788888876 799999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcccc
Q 008108          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD  404 (577)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~  404 (577)
                      |+|..++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~  152 (321)
T cd05591          81 GDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--T  152 (321)
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--c
Confidence            99988774   3456899999999999999999999988   99999999999999999999999999875432221  2


Q ss_pred             ccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCC
Q 008108          405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGS  484 (577)
Q Consensus       405 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  484 (577)
                      .....||..|+|||++.+..++.++||||||+++|||++|+.||........   +....    .+.   ...|   ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~---~~~i~----~~~---~~~p---~~~  219 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL---FESIL----HDD---VLYP---VWL  219 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH---HHHHH----cCC---CCCC---CCC
Confidence            2335799999999999988999999999999999999999999875443221   11111    000   0001   111


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCC-------CHHHHHHH
Q 008108          485 TSEMMKCIHIGLLCVQENVSNRP-------GMASVVNM  515 (577)
Q Consensus       485 ~~~~~~~~~l~~~C~~~~p~~RP-------t~~ev~~~  515 (577)
                      .   ..+.+++..|++.+|++||       ++.++++.
T Consensus       220 ~---~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         220 S---KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             C---HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            2   2445677799999999999       77777643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.1e-38  Score=312.81  Aligned_cols=246  Identities=31%  Similarity=0.484  Sum_probs=193.4

Q ss_pred             ccccCCcEEEEEeEe---cCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCC
Q 008108          251 KLGQGGFGAVYKGML---SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA  325 (577)
Q Consensus       251 ~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  325 (577)
                      +||+|+||.||+|.+   .+++.+|+|++....  .....++.+|+.+++.++|+||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            699999999999974   357889999986543  233457889999999999999999999885 45678999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccc-c
Q 008108          326 SLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS-D  404 (577)
Q Consensus       326 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~-~  404 (577)
                      +|.+++.   ....+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++......... .
T Consensus        81 ~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            9999883   3456899999999999999999999987   9999999999999999999999999998765433221 1


Q ss_pred             ccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCC
Q 008108          405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGG  483 (577)
Q Consensus       405 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  483 (577)
                      .....++..|+|||.+....++.++||||||+++|||++ |+.||......+....+.       .+...     .....
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-------~~~~~-----~~~~~  222 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-------SGERM-----ECPQR  222 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------CCCCC-----CCCCC
Confidence            122344678999999988889999999999999999998 888886443322211111       11100     11111


Q ss_pred             ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          484 STSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       484 ~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .+   ..+.+++.+|++.||++||++.+|+++|++
T Consensus       223 ~~---~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         223 CP---PEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CC---HHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            22   244578889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=341.16  Aligned_cols=253  Identities=24%  Similarity=0.313  Sum_probs=203.2

Q ss_pred             cCCccccccccCCcEEEEEeEecCC-cEEEEEEeccCChhhHHHHHHHHHHHHhcC-CCCeEEEEe-EEEc------CCe
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSNG-ETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLG-FCLE------RKE  314 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~------~~~  314 (577)
                      .++++.+.|.+|||+.||.+....+ ..+|+|++-.........+++|+++|+.|+ |+|||.+++ ....      .-+
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            4566789999999999999997765 999999998888888888999999999996 999999999 3322      237


Q ss_pred             EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      ++|+||||+||.|-+++..... ..|++.++++|+.++++|+.+||... ++|||||||-+||||+.+++.||||||-|.
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq-~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQ-TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHh-ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            7899999999999999865333 34999999999999999999999985 679999999999999999999999999987


Q ss_pred             cccCCCccc-c------ccccccCCCCcChhhh---hcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhh
Q 008108          395 LFEMDQTHS-D------TNRVVGTFGYMAPEYV---MHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAW  464 (577)
Q Consensus       395 ~~~~~~~~~-~------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~  464 (577)
                      ......... .      .-....|+.|.|||.+   .+...++|+|||+|||+||-|+....||+....           
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-----------  263 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-----------  263 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----------
Confidence            433222111 0      0113569999999987   455789999999999999999999999864322           


Q ss_pred             hhcccCCccccccCcCCC-CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          465 RNWNEGAALNLMDPTMRG-GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       465 ~~~~~~~~~~~~d~~l~~-~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                              ..+++....- ..+....++..|+..||+.||.+||++-+|+..+.
T Consensus       264 --------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~  309 (738)
T KOG1989|consen  264 --------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF  309 (738)
T ss_pred             --------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence                    1222222211 13455666777888999999999999999987764

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.1e-38  Score=323.92  Aligned_cols=240  Identities=26%  Similarity=0.348  Sum_probs=187.1

Q ss_pred             cccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEEEEEecCC
Q 008108          250 NKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYEFVPN  324 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  324 (577)
                      +.||+|+||.||+|... +++.||+|.+....   ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999964 57889999987542   12223445666666654 899999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcccc
Q 008108          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD  404 (577)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~  404 (577)
                      |+|..++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~  152 (316)
T cd05592          81 GDLMFHIQ---SSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK  152 (316)
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence            99988874   3457999999999999999999999987   9999999999999999999999999998643322  22


Q ss_pred             ccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCC
Q 008108          405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGS  484 (577)
Q Consensus       405 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  484 (577)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||........   +....    ..      .+.+....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~---~~~i~----~~------~~~~~~~~  219 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL---FDSIL----ND------RPHFPRWI  219 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH---HHHHH----cC------CCCCCCCC
Confidence            3346799999999999988999999999999999999999999865433221   11110    00      01111112


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 008108          485 TSEMMKCIHIGLLCVQENVSNRPGMA-SVV  513 (577)
Q Consensus       485 ~~~~~~~~~l~~~C~~~~p~~RPt~~-ev~  513 (577)
                      ..   .+.+++..|++.+|++||++. +++
T Consensus       220 ~~---~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         220 SK---EAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CH---HHHHHHHHHccCCHHHcCCChHHHH
Confidence            22   344667799999999999976 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.8e-38  Score=325.71  Aligned_cols=241  Identities=27%  Similarity=0.320  Sum_probs=190.8

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCC-CCeEEEEeEEEcCCeEEEEE
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQH-RNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  319 (577)
                      +|++.+.||+|+||.||+|... +++.||||++.+..   ......+..|..++..++| ++|+++++++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5788999999999999999965 57889999987542   2233457789999999976 56888999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++|+|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            9999999988874   3456899999999999999999999987   999999999999999999999999998753221


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                      .  .......||+.|+|||++.+..++.++|||||||++|||+||+.||......+   ++.....    ..      ..
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i~~----~~------~~  219 (324)
T cd05587         155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQSIME----HN------VS  219 (324)
T ss_pred             C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHHc----CC------CC
Confidence            1  12233579999999999999999999999999999999999999986443222   1211111    00      11


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCCCH
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGM  509 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~  509 (577)
                      +.....   ..+.+++..|++.||++|++.
T Consensus       220 ~~~~~~---~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         220 YPKSLS---KEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCCCCC---HHHHHHHHHHhhcCHHHcCCC
Confidence            111122   244567789999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.3e-38  Score=314.17  Aligned_cols=258  Identities=23%  Similarity=0.379  Sum_probs=203.9

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|++.+.||+|+||.||++.. .+++.+|||.+....   .....++.+|+.+++.++|+||+++++++.+++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688889999999999999995 578999999886532   233456889999999999999999999999999999999


Q ss_pred             EecCCCCcccccccC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          320 EFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       320 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      ||+++++|.+++... .....+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999887532 23456899999999999999999999988   99999999999999999999999999886643


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      ...  ......|+..|+|||++.+..++.++||||||+++|||++|..|+...... .......    ..     ....+
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~----~~-----~~~~~  226 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKK----IE-----QCDYP  226 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhh----hh-----cCCCC
Confidence            322  122356889999999998889999999999999999999999997533221 1111111    00     00111


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .+...  .....+.+++.+|++.+|++||||.+|++++++
T Consensus       227 ~~~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~  264 (267)
T cd08229         227 PLPSD--HYSEELRQLVNMCINPDPEKRPDITYVYDVAKR  264 (267)
T ss_pred             CCCcc--cccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence            11111  122345577789999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.8e-38  Score=312.67  Aligned_cols=255  Identities=29%  Similarity=0.462  Sum_probs=202.9

Q ss_pred             HhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ..++|++.++||+|+||.||+|...+++.||+|.+...... ...+.+|+.++++++|+||+++++++. .+..+++|||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc-HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            35678999999999999999999888999999998765433 347889999999999999999999874 4568999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|.+++.. .....+++.+++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~~L~~~~~~-~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          82 MENGSLVDFLKT-PEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            999999988754 23457899999999999999999999987   99999999999999999999999999986653222


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                      . ......++..|+|||++..+.++.++||||||+++|||++ |+.|+........   ...    ...+..     ...
T Consensus       158 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~----~~~~~~-----~~~  224 (260)
T cd05067         158 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQN----LERGYR-----MPR  224 (260)
T ss_pred             c-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HHH----HHcCCC-----CCC
Confidence            1 1222346788999999998999999999999999999999 8888864332221   111    111100     001


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ....+   ..+.+++.+|++.+|++||+++++++.|+.
T Consensus       225 ~~~~~---~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         225 PDNCP---EELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCC---HHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            11122   246678889999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6e-38  Score=322.45  Aligned_cols=247  Identities=23%  Similarity=0.303  Sum_probs=191.2

Q ss_pred             cccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEEEEEecCC
Q 008108          250 NKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYEFVPN  324 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  324 (577)
                      +.||+|+||.||++... +++.||+|++++..   ......+.+|..++..+ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999964 68899999997642   22234577899999988 799999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcccc
Q 008108          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD  404 (577)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~  404 (577)
                      |+|..++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~  152 (329)
T cd05588          81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDT  152 (329)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCc
Confidence            99988773   3457999999999999999999999988   999999999999999999999999998742211  112


Q ss_pred             ccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccc--cchhhhhhhhhcccCCccccccCcCCC
Q 008108          405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEE--TEDLLTYAWRNWNEGAALNLMDPTMRG  482 (577)
Q Consensus       405 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~  482 (577)
                      .....||..|+|||++.+..++.++|||||||++|||++|+.||......+  ......+.........      ..+..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~p~  226 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ------IRIPR  226 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC------CCCCC
Confidence            234679999999999999999999999999999999999999986432211  1111111111111111      01111


Q ss_pred             CChHHHHHHHHHHHhcccCCCCCCCC------HHHHH
Q 008108          483 GSTSEMMKCIHIGLLCVQENVSNRPG------MASVV  513 (577)
Q Consensus       483 ~~~~~~~~~~~l~~~C~~~~p~~RPt------~~ev~  513 (577)
                      ...   ..+.+++..|++.||++||+      +.+++
T Consensus       227 ~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~  260 (329)
T cd05588         227 SLS---VKASSVLKGFLNKDPKERLGCHPQTGFRDIK  260 (329)
T ss_pred             CCC---HHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence            112   24556778999999999997      56665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.1e-38  Score=322.51  Aligned_cols=241  Identities=24%  Similarity=0.311  Sum_probs=187.5

Q ss_pred             cccccCCcEEEEEeEe-cCCcEEEEEEeccCC---hhhHHHHHHHHH-HHHhcCCCCeEEEEeEEEcCCeEEEEEEecCC
Q 008108          250 NKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVL-LLARLQHRNLVRLLGFCLERKERILVYEFVPN  324 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  324 (577)
                      +.||+|+||+||++.. .+|+.+|+|++.+..   .....++..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999985 468999999987542   222334555554 46778999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcccc
Q 008108          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD  404 (577)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~  404 (577)
                      |+|..++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~  152 (325)
T cd05604          81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT  152 (325)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence            99987773   3557999999999999999999999988   9999999999999999999999999987532211  12


Q ss_pred             ccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCC
Q 008108          405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGS  484 (577)
Q Consensus       405 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  484 (577)
                      .....||..|+|||++.+..++.++|||||||++|||++|+.||.......   +.....    ...      ..+.+..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~~~----~~~------~~~~~~~  219 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---MYDNIL----HKP------LVLRPGA  219 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---HHHHHH----cCC------ccCCCCC
Confidence            234679999999999999999999999999999999999999986543222   111111    110      0111112


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          485 TSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       485 ~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .   ..+.+++..|++.+|++||++.+.++
T Consensus       220 ~---~~~~~ll~~ll~~~p~~R~~~~~~~~  246 (325)
T cd05604         220 S---LTAWSILEELLEKDRQRRLGAKEDFL  246 (325)
T ss_pred             C---HHHHHHHHHHhccCHHhcCCCCCCHH
Confidence            2   23456777999999999999864433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.6e-38  Score=312.65  Aligned_cols=254  Identities=26%  Similarity=0.422  Sum_probs=200.3

Q ss_pred             hcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      .++|++.++||+|+||.||+|...++..||+|++..... ....+.+|+.+++.++|+||+++++++. ....++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            356899999999999999999987777899999875432 3346889999999999999999999875 45679999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      ++|+|.+++... ....+++..++.++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++........
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            999999988542 2346899999999999999999999987   999999999999999999999999999866533221


Q ss_pred             ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC
Q 008108          403 SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR  481 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  481 (577)
                       ......++..|+|||+..++.++.++||||||+++|||+| |+.|+........   ......    ..     .... 
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~---~~~~~~----~~-----~~~~-  224 (262)
T cd05071         159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LDQVER----GY-----RMPC-  224 (262)
T ss_pred             -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH---HHHHhc----CC-----CCCC-
Confidence             1222456778999999998999999999999999999999 6767654332221   111100    00     0000 


Q ss_pred             CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       482 ~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                        .......+.+++..|++.+|++||++.+++++|+.
T Consensus       225 --~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         225 --PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             --ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence              11122345688889999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.7e-38  Score=310.24  Aligned_cols=249  Identities=25%  Similarity=0.431  Sum_probs=201.7

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      +|+..+.||+|++|.||++... +++.|++|.+...  ......++.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778899999999999999964 6899999998653  334455788999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|.+++... ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.......
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            9999999988542 2457999999999999999999999987   99999999999999999999999999986654322


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR  481 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  481 (577)
                      .  .....|+..|+|||++.++.++.++||||||+++|||++|+.|+.......   ......    .+..     +.+.
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~----~~~~-----~~~~  222 (256)
T cd08529         157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LILKII----RGVF-----PPVS  222 (256)
T ss_pred             h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----cCCC-----CCCc
Confidence            2  223568899999999999999999999999999999999999986443211   111111    1110     0111


Q ss_pred             CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       482 ~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .   .....+.+++.+||+.+|++||++.++++
T Consensus       223 ~---~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         223 Q---MYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             c---ccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence            1   12235567888999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.8e-38  Score=315.73  Aligned_cols=245  Identities=25%  Similarity=0.330  Sum_probs=191.5

Q ss_pred             cccCCcEEEEEeEec-CCcEEEEEEeccCChh---hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCCCc
Q 008108          252 LGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ---GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASL  327 (577)
Q Consensus       252 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  327 (577)
                      ||+|+||+||++... +++.+|+|.+.+....   ....+..|+.+++.++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999854 6889999998754322   234567899999999999999999999999999999999999999


Q ss_pred             ccccccCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcccccc
Q 008108          328 DHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN  406 (577)
Q Consensus       328 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~  406 (577)
                      ..++.... ....+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++........  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            87764322 3456999999999999999999999987   99999999999999999999999999986544322  223


Q ss_pred             ccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCcccc-chhhhhhhhhcccCCccccccCcCCCCCh
Q 008108          407 RVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET-EDLLTYAWRNWNEGAALNLMDPTMRGGST  485 (577)
Q Consensus       407 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  485 (577)
                      ...||+.|+|||++.++.++.++||||||+++|||++|+.||........ ..+...   .. ...      .......+
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~---~~-~~~------~~~~~~~~  225 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR---IL-NDS------VTYPDKFS  225 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHh---hc-ccC------CCCcccCC
Confidence            35789999999999999999999999999999999999999864332111 111110   00 000      00111122


Q ss_pred             HHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 008108          486 SEMMKCIHIGLLCVQENVSNRP-----GMASVVN  514 (577)
Q Consensus       486 ~~~~~~~~l~~~C~~~~p~~RP-----t~~ev~~  514 (577)
                         ..+.+++..|++.||++||     +++++++
T Consensus       226 ---~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         226 ---PASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             ---HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence               3455677799999999999     6666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.7e-38  Score=321.86  Aligned_cols=258  Identities=27%  Similarity=0.402  Sum_probs=200.5

Q ss_pred             hcCCccccccccCCcEEEEEeEec--------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcC
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS--------NGETIAVKRLSKNS-KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLER  312 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  312 (577)
                      .++|.+.+.||+|+||.||++...        ++..+|+|.+.... .....++.+|+.++..+ +|+||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            467999999999999999999742        23569999997643 33345688899999999 799999999999999


Q ss_pred             CeEEEEEEecCCCCcccccccCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEE
Q 008108          313 KERILVYEFVPNASLDHFIFDPI-------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL  379 (577)
Q Consensus       313 ~~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl  379 (577)
                      +..++||||+++|+|.+++....             ....+++.+++.++.||+.||.|||+.+   ++||||||+|||+
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            99999999999999999885422             1235899999999999999999999987   9999999999999


Q ss_pred             cCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccch
Q 008108          380 DSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETED  458 (577)
Q Consensus       380 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~  458 (577)
                      +.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.|+.....++...
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~  253 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK  253 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence            9999999999999976543222222222234578999999998899999999999999999998 777765433222111


Q ss_pred             hhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          459 LLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       459 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .+.       .....+     ......   ..+.+++..|++.+|++||+|.+|++.|..
T Consensus       254 ~~~-------~~~~~~-----~~~~~~---~~~~~li~~~l~~~p~~Rps~~evl~~l~~  298 (307)
T cd05098         254 LLK-------EGHRMD-----KPSNCT---NELYMMMRDCWHAVPSQRPTFKQLVEDLDR  298 (307)
T ss_pred             HHH-------cCCCCC-----CCCcCC---HHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence            111       111000     011112   344567889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.2e-38  Score=324.48  Aligned_cols=236  Identities=26%  Similarity=0.343  Sum_probs=187.5

Q ss_pred             cccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEEEEEecCC
Q 008108          250 NKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYEFVPN  324 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  324 (577)
                      +.||+|+||.||++... +++.||||++.+..   ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 58899999987542   22334567788888876 699999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcccc
Q 008108          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD  404 (577)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~  404 (577)
                      |+|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~  152 (320)
T cd05590          81 GDLMFHIQ---KSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT  152 (320)
T ss_pred             chHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence            99988874   3457999999999999999999999988   9999999999999999999999999987543221  12


Q ss_pred             ccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCC
Q 008108          405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGS  484 (577)
Q Consensus       405 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  484 (577)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||........   .....    .+.      ..+....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~~~i~----~~~------~~~~~~~  219 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL---FEAIL----NDE------VVYPTWL  219 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---HHHHh----cCC------CCCCCCC
Confidence            2345799999999999988999999999999999999999999865443221   11111    110      0011111


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCCH
Q 008108          485 TSEMMKCIHIGLLCVQENVSNRPGM  509 (577)
Q Consensus       485 ~~~~~~~~~l~~~C~~~~p~~RPt~  509 (577)
                      ..   .+.+++..|++.||++||++
T Consensus       220 ~~---~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         220 SQ---DAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CH---HHHHHHHHHcccCHHHCCCC
Confidence            22   34567779999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=7e-38  Score=308.71  Aligned_cols=247  Identities=28%  Similarity=0.445  Sum_probs=196.4

Q ss_pred             cccccCCcEEEEEeEecCCcEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCCCcc
Q 008108          250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD  328 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~  328 (577)
                      ++||+|+||.||+|...+++.+|+|.+..... .....+.+|+.+++.++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36999999999999988889999999876543 33446889999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcccccccc
Q 008108          329 HFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV  408 (577)
Q Consensus       329 ~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~  408 (577)
                      +++..  ....+++..++.++.|++.+|.|||+.+   ++||||||+||+++.++.+||+|||++......... .....
T Consensus        81 ~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~  154 (250)
T cd05085          81 SFLRK--KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK  154 (250)
T ss_pred             HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence            88743  2346899999999999999999999987   999999999999999999999999999754432211 11123


Q ss_pred             ccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCChHH
Q 008108          409 VGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSE  487 (577)
Q Consensus       409 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  487 (577)
                      .++..|+|||++..+.++.++||||||+++||+++ |..|+...........+   .    .+...     ...   ...
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~---~----~~~~~-----~~~---~~~  219 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV---E----KGYRM-----SCP---QKC  219 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH---H----cCCCC-----CCC---CCC
Confidence            44678999999998999999999999999999998 88887543322211111   1    11000     000   111


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          488 MMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       488 ~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                      ...+.+++..|++.+|++||++.|+++.|.
T Consensus       220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         220 PDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            235667888999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=9.1e-38  Score=313.48  Aligned_cols=251  Identities=22%  Similarity=0.356  Sum_probs=196.3

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ++|+..++||+|+||.||+|.. .+++.||+|.+.... .....++.+|+.++.+++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3678889999999999999985 468899999987653 33445688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|..+       ..+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.+||+|||++......  
T Consensus        81 ~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          81 MDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             CCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            999998654       24788899999999999999999987   999999999999999999999999999765422  


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR  481 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  481 (577)
                        ......||..|+|||++.+..++.++||||||+++|||++|+.||.......................     .+.+.
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~  221 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVLP  221 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCCC
Confidence              12235789999999999988999999999999999999999999864322111100000001110000     11111


Q ss_pred             CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       482 ~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      ..  .....+.+++..|++.+|++||++.|+++.
T Consensus       222 ~~--~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         222 VG--QFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CC--cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            11  112245677889999999999999998863

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.4e-38  Score=320.66  Aligned_cols=260  Identities=27%  Similarity=0.412  Sum_probs=202.6

Q ss_pred             HHhcCCccccccccCCcEEEEEeEec--------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhc-CCCCeEEEEeEEE
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGMLS--------NGETIAVKRLSKNS-KQGEIEFKNEVLLLARL-QHRNLVRLLGFCL  310 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  310 (577)
                      ...++|.+.+.||+|+||.||++...        ++..||+|.+.... ......+.+|+.++..+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            34567888999999999999999731        24579999987543 33445688999999999 8999999999999


Q ss_pred             cCCeEEEEEEecCCCCcccccccCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcE
Q 008108          311 ERKERILVYEFVPNASLDHFIFDPI-------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNI  377 (577)
Q Consensus       311 ~~~~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~Ni  377 (577)
                      .....+++|||+++|+|.+++....             ....+++.+++.++.||++||.|||+++   |+||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence            9999999999999999999885421             1246889999999999999999999987   99999999999


Q ss_pred             EEcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCcccc
Q 008108          378 LLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEET  456 (577)
Q Consensus       378 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~  456 (577)
                      |++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+......+ 
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-  247 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-  247 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-
Confidence            999999999999999987654333323333456778999999988899999999999999999998 666664332222 


Q ss_pred             chhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          457 EDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       457 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                        +....    ..+....     ......   ..+.+++..||+.+|++||+|.||++.|+.
T Consensus       248 --~~~~~----~~~~~~~-----~~~~~~---~~~~~li~~cl~~~p~~Rps~~e~l~~l~~  295 (304)
T cd05101         248 --LFKLL----KEGHRMD-----KPANCT---NELYMMMRDCWHAIPSHRPTFKQLVEDLDR  295 (304)
T ss_pred             --HHHHH----HcCCcCC-----CCCCCC---HHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence              11111    1111000     001122   345567789999999999999999999865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5.2e-38  Score=313.08  Aligned_cols=256  Identities=28%  Similarity=0.524  Sum_probs=201.5

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CC---cEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NG---ETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      .++|+..+.||+|+||.||+|... ++   ..+|+|.+.... ......+.+|+.++++++|+||+++++++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            457888999999999999999965 23   369999987653 3334568899999999999999999999999999999


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      ||||+++++|.+++..  ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence            9999999999998843  3457999999999999999999999987   9999999999999999999999999998664


Q ss_pred             CCCcccc-ccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCcccc
Q 008108          398 MDQTHSD-TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNL  475 (577)
Q Consensus       398 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  475 (577)
                      ....... ......+..|+|||++..+.++.++||||||+++|||++ |+.|+......+   +...    .....    
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~~----i~~~~----  227 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMKA----INDGF----  227 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHH----HhcCC----
Confidence            3322111 111233567999999998899999999999999999998 998875433221   1111    11110    


Q ss_pred             ccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       476 ~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ..+.    .......+.+++.+|++.+|++||+|.+|++.|++
T Consensus       228 ~~~~----~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~  266 (268)
T cd05063         228 RLPA----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK  266 (268)
T ss_pred             CCCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            0000    01112345688889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=308.90  Aligned_cols=265  Identities=23%  Similarity=0.346  Sum_probs=199.7

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEec--cCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEc-----CCe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLS--KNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE-----RKE  314 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~  314 (577)
                      ...|..++.||+|.||.|..+.. .+|+.||||++.  ....-...+-.+|+.+|+.++|+||+.+++.+..     -..
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            34566678999999999999995 478999999997  3444445567899999999999999999998865     347


Q ss_pred             EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      .|+|+|+| +.+|...|.   .++.|+...+..++.||++||.|+|+.+   |+||||||+|+|++.+..+||+|||+|+
T Consensus       101 vYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             eEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence            89999999 668888873   3455999999999999999999999988   9999999999999999999999999999


Q ss_pred             cccCCCccccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhh--------
Q 008108          395 LFEMDQTHSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWR--------  465 (577)
Q Consensus       395 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~--------  465 (577)
                      ...........+..+.|.+|.|||++.. ..|+...||||.|||+.||++|+.-|.+...-....++.....        
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~  253 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ  253 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence            8765422333356788999999998865 4799999999999999999999988765554333222221110        


Q ss_pred             hcccCCcccccc--CcCCCCCh-----HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          466 NWNEGAALNLMD--PTMRGGST-----SEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       466 ~~~~~~~~~~~d--~~l~~~~~-----~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ..........+.  |.......     ..-...+++...++..||.+|+|++|.++
T Consensus       254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            001000111111  11111111     11124456666899999999999999875

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.2e-37  Score=310.88  Aligned_cols=254  Identities=27%  Similarity=0.406  Sum_probs=192.3

Q ss_pred             cccccCCcEEEEEeEecC---CcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCC
Q 008108          250 NKLGQGGFGAVYKGMLSN---GETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA  325 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  325 (577)
                      +.||+|+||.||+|...+   +..+|+|.+.... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            469999999999998543   4579999887654 233456889999999999999999999999999999999999999


Q ss_pred             CcccccccCC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccc
Q 008108          326 SLDHFIFDPI--NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS  403 (577)
Q Consensus       326 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~  403 (577)
                      +|.+++....  ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999885422  2235678888899999999999999987   9999999999999999999999999997544333222


Q ss_pred             cccccccCCCCcChhhhhcC-------CCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCcccc
Q 008108          404 DTNRVVGTFGYMAPEYVMHG-------RFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNL  475 (577)
Q Consensus       404 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  475 (577)
                      ......++..|+|||++...       .++.++||||||+++|||++ |+.||......+.   ......    +.....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~~~~----~~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTYTVR----EQQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHHHhh----cccCCC
Confidence            23345678899999988542       35789999999999999996 9988864433221   111111    111122


Q ss_pred             ccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       476 ~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                      .++.+.....++   +.+++..|+ .+|++|||+.||+..|+
T Consensus       231 ~~~~~~~~~~~~---~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLKLPLSDR---WYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccCCCCChH---HHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            233332222333   334666888 58999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.1e-37  Score=310.28  Aligned_cols=258  Identities=24%  Similarity=0.396  Sum_probs=205.1

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|+..++||+|+||.||+|... +|+.||+|.++..   .......+.+|++++++++|+||+++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57899999999999999999976 7899999988642   2233456889999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          320 EFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      ||+++++|..++.+.. ....+++..++.++.+++.||.|||+.+   |+||||||+||+++.++.++|+|||+++....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999988875422 2456899999999999999999999987   99999999999999999999999999986543


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      ....  .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ...+..    ....+..    .+
T Consensus       159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~----~~~~~~~----~~  227 (267)
T cd08224         159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCK----KIEKCDY----PP  227 (267)
T ss_pred             CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHh----hhhcCCC----CC
Confidence            2211  22346889999999999889999999999999999999999987543211 111111    1111111    01


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                       +..  ......+.+++.+|++.+|++||++.+|+++|++
T Consensus       228 -~~~--~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~  264 (267)
T cd08224         228 -LPA--DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE  264 (267)
T ss_pred             -CCh--hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence             100  1122345578889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.1e-37  Score=319.62  Aligned_cols=237  Identities=24%  Similarity=0.300  Sum_probs=185.6

Q ss_pred             cccccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHH-HHHhcCCCCeEEEEeEEEcCCeEEEEEEecCC
Q 008108          250 NKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVL-LLARLQHRNLVRLLGFCLERKERILVYEFVPN  324 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  324 (577)
                      +.||+|+||+||++... +|+.||+|++.+...   ....++.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999964 689999999875422   22233445544 56788999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcccc
Q 008108          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD  404 (577)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~  404 (577)
                      |+|..++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....  ...
T Consensus        81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~  152 (323)
T cd05575          81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKT  152 (323)
T ss_pred             CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCc
Confidence            99988874   3457899999999999999999999988   999999999999999999999999998753221  122


Q ss_pred             ccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCC
Q 008108          405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGS  484 (577)
Q Consensus       405 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  484 (577)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.   .....    ...      ..+....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~~~i~----~~~------~~~~~~~  219 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM---YDNIL----NKP------LRLKPNI  219 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH---HHHHH----cCC------CCCCCCC
Confidence            3345799999999999999999999999999999999999999864432221   11110    000      0111112


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCCHH
Q 008108          485 TSEMMKCIHIGLLCVQENVSNRPGMA  510 (577)
Q Consensus       485 ~~~~~~~~~l~~~C~~~~p~~RPt~~  510 (577)
                      .   ..+.+++..|++.||++||++.
T Consensus       220 ~---~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         220 S---VSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             C---HHHHHHHHHHhhcCHHhCCCCC
Confidence            2   2455677799999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.3e-38  Score=315.11  Aligned_cols=255  Identities=31%  Similarity=0.523  Sum_probs=199.1

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCc----EEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGE----TIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  316 (577)
                      .++|+..++||+|+||+||+|.+ .+|+    .||+|.+.... .....++.+|+.++..++|+||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            46788899999999999999985 3454    48999987543 3345578899999999999999999999875 4578


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccc
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~  396 (577)
                      +++||+++|+|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        85 l~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          85 LVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            99999999999988854  2456999999999999999999999987   999999999999999999999999999876


Q ss_pred             cCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCcccc
Q 008108          397 EMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNL  475 (577)
Q Consensus       397 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  475 (577)
                      .............++..|+|||.+.+..++.++||||||+++|||++ |..|+...........+.       .+.... 
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~~~~-  231 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-------KGERLP-  231 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------CCCcCC-
Confidence            54332222222345678999999998999999999999999999998 888875433222111111       110000 


Q ss_pred             ccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       476 ~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                          .....   ...+.+++..|++.||++||++.++++.|..
T Consensus       232 ----~~~~~---~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~  267 (279)
T cd05109         232 ----QPPIC---TIDVYMIMVKCWMIDSECRPRFRELVDEFSR  267 (279)
T ss_pred             ----CCccC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                00111   2245578889999999999999999998864

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1e-37  Score=308.83  Aligned_cols=250  Identities=32%  Similarity=0.506  Sum_probs=201.2

Q ss_pred             cccccCCcEEEEEeEecC----CcEEEEEEeccCChhh-HHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCC
Q 008108          250 NKLGQGGFGAVYKGMLSN----GETIAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPN  324 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  324 (577)
                      ++||+|+||.||++....    +..+++|.+....... ...+.+|+..+..++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            479999999999999654    7889999997664433 56789999999999999999999999999999999999999


Q ss_pred             CCcccccccCCC------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          325 ASLDHFIFDPIN------REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       325 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      ++|.+++.....      ...+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999855311      367999999999999999999999987   99999999999999999999999999987765


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCcccccc
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD  477 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  477 (577)
                      ...........++..|+|||.+....++.++||||||+++|||++ |..|+......+.   .....    .+...    
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~----~~~~~----  226 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV---LEYLR----KGYRL----  226 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHH----cCCCC----
Confidence            432223334567889999999988899999999999999999999 5888765432221   11111    11100    


Q ss_pred             CcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          478 PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       478 ~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                       ......   ...+.+++..|++.+|++||++.|+++.|+
T Consensus       227 -~~~~~~---~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         227 -PKPEYC---PDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -CCCccC---ChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence             001111   235567788999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.9e-38  Score=315.15  Aligned_cols=246  Identities=27%  Similarity=0.369  Sum_probs=191.2

Q ss_pred             cccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCCCc
Q 008108          252 LGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASL  327 (577)
Q Consensus       252 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  327 (577)
                      ||+|+||.||++... +|+.+|+|.+.....   .....+..|++++++++||||+++++++.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999854 689999999865322   2233456799999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccccccc
Q 008108          328 DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR  407 (577)
Q Consensus       328 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~  407 (577)
                      .+++... ....+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.++|+|||++........   ...
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~  153 (277)
T cd05607          81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQ  153 (277)
T ss_pred             HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eec
Confidence            8877442 3345899999999999999999999987   99999999999999999999999999986543221   123


Q ss_pred             cccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCcccc-chhhhhhhhhcccCCccccccCcCCCCChH
Q 008108          408 VVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET-EDLLTYAWRNWNEGAALNLMDPTMRGGSTS  486 (577)
Q Consensus       408 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  486 (577)
                      ..|+..|+|||++.+..++.++|||||||++|||++|+.|+........ ..+..   ..... .    +.. .......
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~---~~~~~-~----~~~-~~~~~~~  224 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR---RTLED-E----VKF-EHQNFTE  224 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHH---Hhhcc-c----ccc-ccccCCH
Confidence            5689999999999999999999999999999999999999864332111 11111   11110 0    000 0001222


Q ss_pred             HHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 008108          487 EMMKCIHIGLLCVQENVSNRPGMASVVNML  516 (577)
Q Consensus       487 ~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L  516 (577)
                         .+.+++..|++.||++||++.|+++.+
T Consensus       225 ---~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         225 ---ESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             ---HHHHHHHHHhccCHhhCCCCccchhhh
Confidence               345777899999999999998776443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.2e-37  Score=317.40  Aligned_cols=260  Identities=25%  Similarity=0.359  Sum_probs=200.1

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ++|++.++||+|+||.||++... ++..+|+|.+.... .....++.+|++++.+++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46889999999999999999954 67889999887543 23344688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      +++++|.+++..   ...+++..+..++.||++||.|||+. +   ++||||||+|||++.++.+||+|||++.......
T Consensus        81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (308)
T cd06615          81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  154 (308)
T ss_pred             cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence            999999999843   46789999999999999999999974 5   9999999999999999999999999987543221


Q ss_pred             ccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCc--------
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAA--------  472 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--------  472 (577)
                          .....|+..|+|||.+.+..++.++||||||+++|||++|+.|+...........+............        
T Consensus       155 ----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         155 ----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             ----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence                22357899999999998888999999999999999999999998644322222212111100000000        


Q ss_pred             ---------cccc-------cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          473 ---------LNLM-------DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       473 ---------~~~~-------d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                               .+..       .+.+...  .....+.+++.+|++.+|++||++.+|++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPKLPSG--AFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCccCcCc--ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                     0000       0000000  012246688889999999999999998864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5.3e-38  Score=313.28  Aligned_cols=255  Identities=27%  Similarity=0.479  Sum_probs=199.2

Q ss_pred             cCCccccccccCCcEEEEEeEecC-C---cEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSN-G---ETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      .+|++.+.||+|+||.||+|.... +   ..||||.+... ......+|.+|+.+++.++||||+++++++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            357788999999999999999653 3   36999998765 333455789999999999999999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+++++|++++..  ..+.+++.+++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++....
T Consensus        84 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          84 TEFMENGALDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EecCCCCcHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            999999999998753  2456899999999999999999999987   99999999999999999999999999986543


Q ss_pred             CCccccc-cccc--cCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccc
Q 008108          399 DQTHSDT-NRVV--GTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALN  474 (577)
Q Consensus       399 ~~~~~~~-~~~~--gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  474 (577)
                      ....... ....  .+..|+|||++..+.++.++||||||+++|||++ |..|+......+   ...+....+..     
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i~~~~~~-----  230 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAIEQDYRL-----  230 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHHHcCCcC-----
Confidence            3221111 1111  2457999999999999999999999999999886 888875433221   22211111100     


Q ss_pred             cccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          475 LMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       475 ~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                         + .....+   ..+.+++..|++.+|.+||+|.+|+.+|+.
T Consensus       231 ---~-~~~~~~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         231 ---P-PPMDCP---TALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             ---C-CcccCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence               0 001112   234578889999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.8e-38  Score=307.43  Aligned_cols=264  Identities=26%  Similarity=0.384  Sum_probs=198.9

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChh--hHHHHHHHHHHHHhcCCCC-eEEEEeEEEcCC-----
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRN-LVRLLGFCLERK-----  313 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~-----  313 (577)
                      ...|..+++||+|.||+||+|+. .+|+.||+|++.-....  ......+|+.++++++|+| ||+|++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            34567788899999999999994 57899999998765432  2223578999999999999 999999998877     


Q ss_pred             -eEEEEEEecCCCCcccccccCCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccC
Q 008108          314 -ERILVYEFVPNASLDHFIFDPINR-EHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG  391 (577)
Q Consensus       314 -~~~lv~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfG  391 (577)
                       ..++|+||+.. +|..++...... ..++...+..++.||+.||+|||+++   |+||||||+||||+++|.+||+|||
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence             78899999954 888877542211 45777899999999999999999998   9999999999999999999999999


Q ss_pred             CcccccCCCccccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhh----
Q 008108          392 MARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRN----  466 (577)
Q Consensus       392 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~----  466 (577)
                      +|+.+.....  ..+..++|.+|.|||++.+. .|+...||||+|||+.||++++.-|....+.   +.+...++.    
T Consensus       166 lAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~---~ql~~If~~lGtP  240 (323)
T KOG0594|consen  166 LARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI---DQLFRIFRLLGTP  240 (323)
T ss_pred             hHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH---HHHHHHHHHcCCC
Confidence            9997653322  23446889999999999887 7999999999999999999988766544442   222222221    


Q ss_pred             ----cccCCccccccCcCCC----CC-hH----HHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          467 ----WNEGAALNLMDPTMRG----GS-TS----EMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       467 ----~~~~~~~~~~d~~l~~----~~-~~----~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                          |+......-.++....    .. ..    ......+++..|++.+|.+|.|++..+++
T Consensus       241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence                2211111111111110    00 01    11245678889999999999999988864

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.5e-38  Score=322.30  Aligned_cols=241  Identities=27%  Similarity=0.374  Sum_probs=188.9

Q ss_pred             cccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEEEEEecCC
Q 008108          250 NKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYEFVPN  324 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  324 (577)
                      +.||+|+||+||+|... +++.||||.+....   ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 57899999987642   12233456677777764 899999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcccc
Q 008108          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD  404 (577)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~  404 (577)
                      |+|..++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05619          81 GDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK  152 (316)
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence            99988874   3457899999999999999999999987   9999999999999999999999999987533221  12


Q ss_pred             ccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCC
Q 008108          405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGS  484 (577)
Q Consensus       405 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  484 (577)
                      .....||..|+|||++.+..++.++|||||||++|||++|+.||......+   +.....    ..      .+......
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~i~----~~------~~~~~~~~  219 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQSIR----MD------NPCYPRWL  219 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----hC------CCCCCccC
Confidence            234579999999999998899999999999999999999999986543322   111110    00      01111111


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCCHH-HHHH
Q 008108          485 TSEMMKCIHIGLLCVQENVSNRPGMA-SVVN  514 (577)
Q Consensus       485 ~~~~~~~~~l~~~C~~~~p~~RPt~~-ev~~  514 (577)
                      ..   .+.+++..|++.+|++||++. ++.+
T Consensus       220 ~~---~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         220 TR---EAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CH---HHHHHHHHHhccCHhhcCCChHHHHc
Confidence            22   345677899999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.2e-37  Score=319.21  Aligned_cols=237  Identities=24%  Similarity=0.306  Sum_probs=184.8

Q ss_pred             cccccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHH-HHHhcCCCCeEEEEeEEEcCCeEEEEEEecCC
Q 008108          250 NKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVL-LLARLQHRNLVRLLGFCLERKERILVYEFVPN  324 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  324 (577)
                      ++||+|+||.||++... +++.||+|++.+...   .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999964 688999999875422   22233445544 67888999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcccc
Q 008108          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD  404 (577)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~  404 (577)
                      ++|..++.   ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.....  ...
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~  152 (321)
T cd05603          81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EET  152 (321)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCc
Confidence            99987763   3456899999999999999999999987   999999999999999999999999998753221  122


Q ss_pred             ccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCC
Q 008108          405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGS  484 (577)
Q Consensus       405 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  484 (577)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +.....    ...      ..+....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~----~~~------~~~~~~~  219 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ---MYDNIL----HKP------LQLPGGK  219 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH---HHHHHh----cCC------CCCCCCC
Confidence            334679999999999998899999999999999999999999986543221   111111    000      0111111


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCCHH
Q 008108          485 TSEMMKCIHIGLLCVQENVSNRPGMA  510 (577)
Q Consensus       485 ~~~~~~~~~l~~~C~~~~p~~RPt~~  510 (577)
                         ...+.+++..|++.+|++||+..
T Consensus       220 ---~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         220 ---TVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             ---CHHHHHHHHHHccCCHhhcCCCC
Confidence               23455778899999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.1e-37  Score=320.14  Aligned_cols=243  Identities=23%  Similarity=0.302  Sum_probs=189.1

Q ss_pred             cccccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEEEEEecCC
Q 008108          250 NKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYEFVPN  324 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  324 (577)
                      ++||+|+||+||++... +++.||+|++.+...   .....+.+|+.++.++ +|+||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999964 578899999976432   2234577899999888 699999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcccc
Q 008108          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD  404 (577)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~  404 (577)
                      |+|..++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~  152 (327)
T cd05617          81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT  152 (327)
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence            99988773   3457999999999999999999999988   9999999999999999999999999987532211  12


Q ss_pred             ccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCC
Q 008108          405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGS  484 (577)
Q Consensus       405 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  484 (577)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.............+.+........      .+....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~p~~~  226 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------RIPRFL  226 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------CCCCCC
Confidence            23467999999999999999999999999999999999999998643322221112222222211110      011111


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCCH
Q 008108          485 TSEMMKCIHIGLLCVQENVSNRPGM  509 (577)
Q Consensus       485 ~~~~~~~~~l~~~C~~~~p~~RPt~  509 (577)
                      .   ..+.+++..|++.||++||++
T Consensus       227 ~---~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         227 S---VKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             C---HHHHHHHHHHhccCHHHcCCC
Confidence            2   234567789999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.5e-38  Score=329.84  Aligned_cols=262  Identities=23%  Similarity=0.327  Sum_probs=195.6

Q ss_pred             CCccccccccCCcEEEEEeEe-cCCcEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC-----eEE
Q 008108          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK-----ERI  316 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  316 (577)
                      +|+..++||+|+||.||++.. .+|+.||||++...  .......+.+|+.+++.++|+||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999995 47899999998653  2233456889999999999999999999998776     789


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccc
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~  396 (577)
                      +||||+. ++|..++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999997 46766653   3457999999999999999999999988   999999999999999999999999999865


Q ss_pred             cCCCccccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhh------------
Q 008108          397 EMDQTHSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA------------  463 (577)
Q Consensus       397 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~------------  463 (577)
                      ...... ......+|..|+|||++.+. .++.++|||||||++|||++|+.||......+....+...            
T Consensus       154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            433221 22234688999999998774 4789999999999999999999998654432221111100            


Q ss_pred             ----hhhccc-CCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          464 ----WRNWNE-GAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       464 ----~~~~~~-~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                          ...+.. ........ .+..........+.+++.+|++.||++|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         233 CEGARAHILRGPHKPPSLP-VLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hHHHHHHHHhCCCCCCchH-HhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                000000 00000000 0000001112345678889999999999999999863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.4e-38  Score=315.41  Aligned_cols=262  Identities=27%  Similarity=0.428  Sum_probs=199.3

Q ss_pred             cCCccccccccCCcEEEEEeEe-----cCCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC--CeE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-----SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KER  315 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  315 (577)
                      ..|++.++||+|+||.||++..     .+++.||+|.+.... ......+.+|+.+++.++|+||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3578889999999999999974     357889999987553 33345689999999999999999999998775  567


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      ++||||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPR--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            899999999999998743  2346899999999999999999999988   99999999999999999999999999986


Q ss_pred             ccCCCcc-ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccc--------cchhhhhhhhh
Q 008108          396 FEMDQTH-SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEE--------TEDLLTYAWRN  466 (577)
Q Consensus       396 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~--------~~~l~~~~~~~  466 (577)
                      ....... .......++..|+|||++.+..++.++||||||+++|||+|++.|........        ...........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            6533221 11223457778999999988899999999999999999999876543211100        00000000001


Q ss_pred             cccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          467 WNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       467 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ...+...        +........+.+++.+|++.+|++||++.++++.|+.
T Consensus       239 ~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         239 LEEGKRL--------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             HHcCccC--------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            1111000        0011123456678889999999999999999998864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5e-38  Score=327.17  Aligned_cols=204  Identities=25%  Similarity=0.405  Sum_probs=175.0

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|+..+.||+|+||+||++... +++.||+|++....   ......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47889999999999999999964 68899999997532   223345788999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++|+|.+++.   +...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.....
T Consensus        81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            9999999999884   3567999999999999999999999988   999999999999999999999999998754321


Q ss_pred             Cc---------------------------------cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCC
Q 008108          400 QT---------------------------------HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQK  446 (577)
Q Consensus       400 ~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~  446 (577)
                      ..                                 ........||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            10                                 000123579999999999999999999999999999999999999


Q ss_pred             CCCCCCc
Q 008108          447 RSSFGTE  453 (577)
Q Consensus       447 p~~~~~~  453 (577)
                      ||.....
T Consensus       235 Pf~~~~~  241 (360)
T cd05627         235 PFCSETP  241 (360)
T ss_pred             CCCCCCH
Confidence            9865443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.5e-38  Score=322.32  Aligned_cols=240  Identities=28%  Similarity=0.367  Sum_probs=188.5

Q ss_pred             cccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEEEEEecCC
Q 008108          250 NKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYEFVPN  324 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  324 (577)
                      ++||+|+||.||++... +|+.||+|.+.+..   ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999965 68899999997642   12233456777777765 899999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcccc
Q 008108          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD  404 (577)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~  404 (577)
                      |+|..++.   ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 g~L~~~i~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~  152 (316)
T cd05620          81 GDLMFHIQ---DKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--R  152 (316)
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--c
Confidence            99988874   3457899999999999999999999988   99999999999999999999999999874322211  2


Q ss_pred             ccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCC
Q 008108          405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGS  484 (577)
Q Consensus       405 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  484 (577)
                      .....||..|+|||++.+..++.++|||||||++|||++|+.||.......   +.....    ..      .+.+....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~~~~~----~~------~~~~~~~~  219 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LFESIR----VD------TPHYPRWI  219 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHH----hC------CCCCCCCC
Confidence            234679999999999999999999999999999999999999986443221   111111    00      11111112


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 008108          485 TSEMMKCIHIGLLCVQENVSNRPGMA-SVV  513 (577)
Q Consensus       485 ~~~~~~~~~l~~~C~~~~p~~RPt~~-ev~  513 (577)
                      ..   ++.+++..|++.||++||++. ++.
T Consensus       220 ~~---~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         220 TK---ESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CH---HHHHHHHHHccCCHHHcCCChHHHH
Confidence            22   344677799999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=8e-38  Score=326.49  Aligned_cols=261  Identities=21%  Similarity=0.291  Sum_probs=197.9

Q ss_pred             hHHHHHHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEc
Q 008108          236 FETIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLE  311 (577)
Q Consensus       236 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  311 (577)
                      +..+....++|++.+.||+|+||.||++... +++.+|+|.+.+..   ......+.+|+.+++.++||||+++++.+.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            3345556689999999999999999999965 67889999986532   2223457789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccC
Q 008108          312 RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG  391 (577)
Q Consensus       312 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfG  391 (577)
                      +...++||||+++|+|.+++.    ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG  187 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMS----NYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG  187 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence            999999999999999998873    345889999999999999999999998   9999999999999999999999999


Q ss_pred             CcccccCCCccccccccccCCCCcChhhhhcC----CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhc
Q 008108          392 MARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG----RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNW  467 (577)
Q Consensus       392 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~  467 (577)
                      +++....... .......||+.|+|||++...    .++.++|||||||++|||++|+.||........   ...   ..
T Consensus       188 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~~---i~  260 (371)
T cd05622         188 TCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---YSK---IM  260 (371)
T ss_pred             ceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH---HHH---HH
Confidence            9986643221 122346799999999998654    378999999999999999999999865433211   111   11


Q ss_pred             ccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCC--CCCHHHHHHHh
Q 008108          468 NEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSN--RPGMASVVNML  516 (577)
Q Consensus       468 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~--RPt~~ev~~~L  516 (577)
                      .........+.   .....+   +..++..|++.++.+  ||++.|+++..
T Consensus       261 ~~~~~~~~~~~---~~~s~~---~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         261 NHKNSLTFPDD---NDISKE---AKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             cCCCcccCCCc---CCCCHH---HHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            11111111110   112233   335566788744433  78888888753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=8.4e-38  Score=310.28  Aligned_cols=253  Identities=28%  Similarity=0.457  Sum_probs=199.2

Q ss_pred             cCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecC
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVP  323 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  323 (577)
                      ++|.+..+||+|++|.||++....+..+|+|.+..... ....+.+|+.++++++|+|++++++++. .+..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            56888999999999999999987777899998865432 3446889999999999999999999875 456789999999


Q ss_pred             CCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccc
Q 008108          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS  403 (577)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~  403 (577)
                      +++|.+++... ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++........ 
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05069          84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence            99999988542 2345899999999999999999999987   999999999999999999999999999866433221 


Q ss_pred             cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCC
Q 008108          404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG  482 (577)
Q Consensus       404 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  482 (577)
                      ......++..|+|||++.++.++.++||||||+++|||+| |+.|+......+   ...+....+.         +....
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~---------~~~~~  226 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQVERGYR---------MPCPQ  226 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCC---------CCCCc
Confidence            1122346778999999998999999999999999999999 787775433221   1111111100         00111


Q ss_pred             CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          483 GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       483 ~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ..   ...+.+++.+|++.+|++||++.+|++.|+.
T Consensus       227 ~~---~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         227 GC---PESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             cc---CHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            11   2345577789999999999999999999864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.8e-38  Score=312.24  Aligned_cols=255  Identities=26%  Similarity=0.445  Sum_probs=200.9

Q ss_pred             cCCccccccccCCcEEEEEeEec-C---CcEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-N---GETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      .+|++.+.||+|+||.||+|... +   +..+|+|.+..... .....+.+|+.++.+++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            57888999999999999999863 2   33699999876432 3345688999999999999999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+++++|.+++..  ....+++.+++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++....
T Consensus        84 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRK--HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            999999999998853  2356899999999999999999999987   99999999999999999999999999987654


Q ss_pred             CCcccc-ccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          399 DQTHSD-TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       399 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      ...... .....++..|+|||++.++.++.++||||||+++||+++ |+.|+......+.   .......+.        
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~~~~~~--------  227 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAIEEGYR--------  227 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHHhCCCc--------
Confidence            332211 122234568999999998899999999999999999887 9988764433221   111111100        


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                       .......+   ..+.+++..|++.+|++||+|.++++.|+.
T Consensus       228 -~~~~~~~~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         228 -LPAPMDCP---AALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             -CCCCCCCC---HHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence             00001112   244578889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=7.4e-38  Score=309.66  Aligned_cols=252  Identities=28%  Similarity=0.514  Sum_probs=201.2

Q ss_pred             cCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecC
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVP  323 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  323 (577)
                      .+|+..+.||+|+||.||++.+.+++.+|+|.+..... ....+.+|++++++++|||++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            46788899999999999999987788999999875433 23468899999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccc
Q 008108          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS  403 (577)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~  403 (577)
                      +++|.+++..  ....+++..++.++.|++.+|.|||+.+   ++||||||+||+++.++.+||+|||+++....... .
T Consensus        83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~  156 (256)
T cd05112          83 HGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-T  156 (256)
T ss_pred             CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc-c
Confidence            9999988743  2346899999999999999999999987   99999999999999999999999999986543221 1


Q ss_pred             cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCC
Q 008108          404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG  482 (577)
Q Consensus       404 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  482 (577)
                      ......++.+|+|||.+.++.++.++||||||+++|||++ |+.|+.......   ++...    ..+  .....+..  
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~--~~~~~~~~--  225 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVETI----NAG--FRLYKPRL--  225 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHH----hCC--CCCCCCCC--
Confidence            1112345678999999998999999999999999999998 888875433222   11111    111  01111111  


Q ss_pred             CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          483 GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       483 ~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                       .   ...+.+++.+||+.+|++||++.||+++|.
T Consensus       226 -~---~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         226 -A---SQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             -C---CHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence             1   235667889999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.5e-37  Score=308.02  Aligned_cols=247  Identities=26%  Similarity=0.447  Sum_probs=192.4

Q ss_pred             ccccCCcEEEEEeEec---CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCCC
Q 008108          251 KLGQGGFGAVYKGMLS---NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNAS  326 (577)
Q Consensus       251 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs  326 (577)
                      .||+|+||.||+|.+.   .+..||+|.+..... ....++.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999854   355699999876543 33456899999999999999999999885 457899999999999


Q ss_pred             cccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccc-cc
Q 008108          327 LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS-DT  405 (577)
Q Consensus       327 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~-~~  405 (577)
                      |.+++..  ....+++..+++++.||+.||.|||+++   ++||||||+|||++.++.+||+|||+++......... ..
T Consensus        81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            9998743  3457999999999999999999999987   9999999999999999999999999998654432221 11


Q ss_pred             cccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCC
Q 008108          406 NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGS  484 (577)
Q Consensus       406 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  484 (577)
                      ....++..|+|||.+....++.++||||||+++|||++ |+.|+......+....+       ..+...     ......
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~~~~-----~~~~~~  223 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI-------EQGKRL-----DCPAEC  223 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-------HCCCCC-----CCCCCC
Confidence            12234678999999988889999999999999999996 98887644332211111       111110     011112


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          485 TSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       485 ~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .   ..+.+++..||+.+|++||++.+|.+.|+.
T Consensus       224 ~---~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         224 P---PEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             C---HHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence            2   344467789999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.1e-38  Score=331.55  Aligned_cols=263  Identities=24%  Similarity=0.380  Sum_probs=202.2

Q ss_pred             HHHHhcCCccccccccCCcEEEEEeEec------CCcEEEEEEeccCChhh-HHHHHHHHHHHHhcC-CCCeEEEEeEEE
Q 008108          239 IRVATDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSKQG-EIEFKNEVLLLARLQ-HRNLVRLLGFCL  310 (577)
Q Consensus       239 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-h~niv~l~~~~~  310 (577)
                      .....++|.+.++||+|+||.||+|.+.      .++.||+|++....... ...+.+|+.+|.++. ||||+++++++.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            3344567888899999999999999853      34679999997653332 346889999999997 999999999999


Q ss_pred             cCCeEEEEEEecCCCCcccccccCC-------------------------------------------------------
Q 008108          311 ERKERILVYEFVPNASLDHFIFDPI-------------------------------------------------------  335 (577)
Q Consensus       311 ~~~~~~lv~E~~~~gsL~~~l~~~~-------------------------------------------------------  335 (577)
                      ..+..++||||+++|+|.++++...                                                       
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            9999999999999999988885421                                                       


Q ss_pred             ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCC
Q 008108          336 ----------------------------------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKAS  375 (577)
Q Consensus       336 ----------------------------------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~  375 (577)
                                                              ....+++..++.++.||+.||.|||+.+   |+||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence                                                    1124788889999999999999999887   999999999


Q ss_pred             cEEEcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCcc
Q 008108          376 NILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEE  454 (577)
Q Consensus       376 NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~  454 (577)
                      |||+++++.+||+|||+++...............++..|+|||.+....++.++||||||+++|||++ |+.|+......
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            99999999999999999986543222222223457889999999998899999999999999999998 78887543221


Q ss_pred             ccchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          455 ETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       455 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      +.  +.....    .+..     +.......   ..+.+++..||+.+|++||+++||++.|+.
T Consensus       349 ~~--~~~~~~----~~~~-----~~~p~~~~---~~l~~li~~cl~~~P~~RPs~~ell~~L~~  398 (401)
T cd05107         349 EQ--FYNAIK----RGYR-----MAKPAHAS---DEIYEIMQKCWEEKFEIRPDFSQLVHLVGD  398 (401)
T ss_pred             HH--HHHHHH----cCCC-----CCCCCCCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            11  111111    1100     00111122   345567779999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.2e-37  Score=318.11  Aligned_cols=259  Identities=27%  Similarity=0.415  Sum_probs=200.9

Q ss_pred             hcCCccccccccCCcEEEEEeEec--------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcC
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS--------NGETIAVKRLSKNS-KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLER  312 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  312 (577)
                      .++|.+.++||+|+||.||++...        ....+|+|.+.... .....++.+|+.+++++ +||||+++++++.+.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            357888999999999999999742        24568999987543 33345688999999999 699999999999999


Q ss_pred             CeEEEEEEecCCCCcccccccCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEE
Q 008108          313 KERILVYEFVPNASLDHFIFDPI-------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL  379 (577)
Q Consensus       313 ~~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl  379 (577)
                      ...+++|||+++|+|.+++....             ....+++.++..++.||+.||.|||+++   |+||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence            99999999999999999885421             1246899999999999999999999987   9999999999999


Q ss_pred             cCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccch
Q 008108          380 DSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETED  458 (577)
Q Consensus       380 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~  458 (577)
                      +.++.+||+|||+++...............++..|+|||++.++.++.++||||||+++|||++ |..|+......+...
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~  247 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK  247 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999999999986543222222222234567999999998999999999999999999999 777775433222221


Q ss_pred             hhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCC
Q 008108          459 LLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD  519 (577)
Q Consensus       459 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~  519 (577)
                      .+.       .+...+.     .....   ..+.+++.+|++.+|++||++.|+++.|...
T Consensus       248 ~~~-------~~~~~~~-----~~~~~---~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~  293 (314)
T cd05099         248 LLR-------EGHRMDK-----PSNCT---HELYMLMRECWHAVPTQRPTFKQLVEALDKV  293 (314)
T ss_pred             HHH-------cCCCCCC-----CCCCC---HHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            111       1111111     11112   2455788899999999999999999999753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4.2e-38  Score=322.11  Aligned_cols=241  Identities=29%  Similarity=0.338  Sum_probs=191.0

Q ss_pred             cccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEEEEEecCC
Q 008108          250 NKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYEFVPN  324 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  324 (577)
                      +.||+|+||+||++... +++.||||.+.+..   ......+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999865 57899999997642   22334567888888888 799999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcccc
Q 008108          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD  404 (577)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~  404 (577)
                      |+|..++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~  152 (318)
T cd05570          81 GDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT  152 (318)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence            99988773   3457999999999999999999999987   9999999999999999999999999987532221  12


Q ss_pred             ccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCC
Q 008108          405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGS  484 (577)
Q Consensus       405 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  484 (577)
                      .....||..|+|||++.+..++.++|||||||++|||++|+.||........   .....    ...      .......
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~---~~~i~----~~~------~~~~~~~  219 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL---FQSIL----EDE------VRYPRWL  219 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH---HHHHH----cCC------CCCCCcC
Confidence            2335789999999999999999999999999999999999999864432221   11110    000      0111111


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 008108          485 TSEMMKCIHIGLLCVQENVSNRPGM-----ASVVN  514 (577)
Q Consensus       485 ~~~~~~~~~l~~~C~~~~p~~RPt~-----~ev~~  514 (577)
                      .   ..+.+++..||+.||++||++     .++++
T Consensus       220 ~---~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         220 S---KEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             C---HHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            2   244577789999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=7.5e-38  Score=316.95  Aligned_cols=249  Identities=24%  Similarity=0.411  Sum_probs=201.3

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      .+|+..+.||+|+||.||+|.. .+++.|++|.+..........+.+|+.+++.++|+||+++++.+..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            5788999999999999999985 468899999998766555667889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      ++++|.+++.    ...+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++........ 
T Consensus       100 ~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-  171 (296)
T cd06654         100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (296)
T ss_pred             CCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence            9999999873    346899999999999999999999988   99999999999999999999999999886543221 


Q ss_pred             ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCC
Q 008108          403 SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG  482 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  482 (577)
                       ......|++.|+|||.+.+..++.++|||||||++|||++|+.||.......  .+..    .+....      +.+. 
T Consensus       172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~----~~~~~~------~~~~-  237 (296)
T cd06654         172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYL----IATNGT------PELQ-  237 (296)
T ss_pred             -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHH----HhcCCC------CCCC-
Confidence             1223468899999999998889999999999999999999999986433211  1111    111000      0000 


Q ss_pred             CChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          483 GSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       483 ~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ........+.+++.+|++.+|++||++.|+++
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            01111234557788999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=8.1e-38  Score=317.63  Aligned_cols=260  Identities=25%  Similarity=0.384  Sum_probs=202.7

Q ss_pred             HHhcCCccccccccCCcEEEEEeEec------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcC
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNLVRLLGFCLER  312 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  312 (577)
                      ...++|...+.||+|+||.||++...      .+..||+|.++.... .....+.+|+.+++++ +|+||+++++++...
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            34467999999999999999999741      345799999876533 3344688999999999 799999999999999


Q ss_pred             CeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCC
Q 008108          313 KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (577)
Q Consensus       313 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGl  392 (577)
                      +..+++|||+++|+|.+++... ....+++.++..++.||+.||.|||+++   |+|+||||+|||++.++.+||+|||+
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcc
Confidence            9999999999999999988542 2234899999999999999999999987   99999999999999999999999999


Q ss_pred             cccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCC
Q 008108          393 ARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGA  471 (577)
Q Consensus       393 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~  471 (577)
                      ++...............++..|+|||.+.++.++.++||||||+++|||++ |+.|+........  ......    .+.
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~~~----~~~  261 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKLIK----EGY  261 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHHHH----cCC
Confidence            986543322222223456788999999999999999999999999999998 8888754332111  111111    110


Q ss_pred             ccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          472 ALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       472 ~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                           .+.......   .++.+++..|++.+|++||++.||++.|..
T Consensus       262 -----~~~~~~~~~---~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         262 -----RMAQPEHAP---AEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             -----cCCCCCCCC---HHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence                 000001112   345678889999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=6.2e-38  Score=312.32  Aligned_cols=253  Identities=23%  Similarity=0.380  Sum_probs=198.9

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      .++|+..++||+|+||.||++... +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++||||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            357888899999999999999854 6889999998766555555678999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|.+++.   ..+.+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++......  
T Consensus        88 ~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--  159 (267)
T cd06645          88 CGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT--  159 (267)
T ss_pred             cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc--
Confidence            99999999873   3457999999999999999999999987   999999999999999999999999998765422  


Q ss_pred             cccccccccCCCCcChhhhh---cCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          402 HSDTNRVVGTFGYMAPEYVM---HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      ........|+..|+|||++.   .+.++.++|||||||++|||++|+.|+........  +..........        +
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~~~~~~~~~~~--------~  229 (267)
T cd06645         160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLMTKSNFQP--------P  229 (267)
T ss_pred             ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--HHhhhccCCCC--------C
Confidence            12223457899999999874   45688999999999999999999998754332111  11100000000        0


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ..... ......+.+++..|++.+|++||++.+|++
T Consensus       230 ~~~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         230 KLKDK-MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             ccccc-CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            01000 001123457888999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.5e-37  Score=309.93  Aligned_cols=254  Identities=24%  Similarity=0.382  Sum_probs=188.1

Q ss_pred             cccccCCcEEEEEeEecC---CcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCC
Q 008108          250 NKLGQGGFGAVYKGMLSN---GETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA  325 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  325 (577)
                      ++||+|+||.||+|...+   ...+++|.+.... ......+.+|+.+++.++|+||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999997543   3568888876543 333456889999999999999999999999999999999999999


Q ss_pred             CcccccccCCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccc
Q 008108          326 SLDHFIFDPIN--REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS  403 (577)
Q Consensus       326 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~  403 (577)
                      +|.+++.....  ....++...+.++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99998855322  234578888999999999999999987   9999999999999999999999999987543332222


Q ss_pred             cccccccCCCCcChhhhhc-------CCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCcccc
Q 008108          404 DTNRVVGTFGYMAPEYVMH-------GRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNL  475 (577)
Q Consensus       404 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  475 (577)
                      ......++..|+|||++..       ..++.++||||||+++|||++ |..|+......+   .+....   . .....+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~~~---~-~~~~~~  230 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VLKQVV---R-EQDIKL  230 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHHh---h-ccCccC
Confidence            2233456778999998753       356789999999999999999 666664332221   111111   1 111122


Q ss_pred             ccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       476 ~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                      .++.+......+.   ..+...|+ .+|++|||++||+++|.
T Consensus       231 ~~~~~~~~~~~~~---~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKPQLDLKYSDRW---YEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCcccccCCHHH---HHHHHHHh-cCcccccCHHHHHHHhc
Confidence            2222222222333   34556777 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-37  Score=306.99  Aligned_cols=248  Identities=29%  Similarity=0.467  Sum_probs=196.9

Q ss_pred             cccccCCcEEEEEeEecCCcEEEEEEeccCChh-hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCCCcc
Q 008108          250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD  328 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~  328 (577)
                      ++||+|+||.||++...+++.|++|++...... ....+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            479999999999999877999999998765443 4557899999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcccccccc
Q 008108          329 HFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV  408 (577)
Q Consensus       329 ~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~  408 (577)
                      +++..  ....+++..++.++.+++.+|.|||+++   ++||||||+|||++.++.+||+|||+++..............
T Consensus        81 ~~l~~--~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRK--KKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            88743  2346899999999999999999999987   999999999999999999999999999865432222111223


Q ss_pred             ccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCChHH
Q 008108          409 VGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSE  487 (577)
Q Consensus       409 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  487 (577)
                      .++..|+|||.+.++.++.++||||||+++|||+| |..|+...........+..   .+      ..   ......   
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~---~~------~~---~~~~~~---  220 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES---GY------RM---PAPQLC---  220 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc---CC------CC---CCCccC---
Confidence            34667999999998899999999999999999999 7777654332221111110   00      00   000011   


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          488 MMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       488 ~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                      ...+.+++.+|++.+|++||++.||++.|+
T Consensus       221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            235667888999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.8e-38  Score=315.12  Aligned_cols=269  Identities=28%  Similarity=0.430  Sum_probs=202.6

Q ss_pred             cCCccccccccCCcEEEEEeEec-----CCcEEEEEEeccCChh-hHHHHHHHHHHHHhcCCCCeEEEEeEEEc--CCeE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-----NGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLE--RKER  315 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  315 (577)
                      ++|+..+.||+|+||.||++.+.     +++.+|||.+...... ....+.+|+.+++.++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45777899999999999999853     3688999999766543 45678999999999999999999999887  5578


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      +++|||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQR--HRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHh--CccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            999999999999999853  2336999999999999999999999987   99999999999999999999999999987


Q ss_pred             ccCCCcc-ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccc
Q 008108          396 FEMDQTH-SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALN  474 (577)
Q Consensus       396 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  474 (577)
                      ....... .......++..|+|||.+....++.++||||||+++|||+||+.|+......... ...............+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~  237 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-MIGIAQGQMIVTRLLE  237 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc-ccccccccccHHHHHH
Confidence            6532221 1112234566799999998889999999999999999999999887543221110 0000000000000001


Q ss_pred             cccCcCCC-CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          475 LMDPTMRG-GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       475 ~~d~~l~~-~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .+...... .......++.+++.+|++.+|++||||.||+++|+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05038         238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR  282 (284)
T ss_pred             HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence            11111000 011112456688889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.4e-37  Score=309.20  Aligned_cols=240  Identities=25%  Similarity=0.408  Sum_probs=186.8

Q ss_pred             cccccCCcEEEEEeEecC-------------CcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEE
Q 008108          250 NKLGQGGFGAVYKGMLSN-------------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  316 (577)
                      +.||+|+||.||+|.+..             ...|++|.+..........+.+|+.++..++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532             2358999887665555557889999999999999999999999999999


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCC-------eEEec
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN-------PKISD  389 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~-------~kl~D  389 (577)
                      +||||+++++|+.++..  ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.       +|++|
T Consensus        81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            99999999999888743  3456999999999999999999999987   999999999999987664       89999


Q ss_pred             cCCcccccCCCccccccccccCCCCcChhhhh-cCCCCccccEEecchhHhHHh-hCCCCCCCCCccccchhhhhhhhhc
Q 008108          390 FGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM-HGRFSVKSDIFSFGVLVLEIV-SGQKRSSFGTEEETEDLLTYAWRNW  467 (577)
Q Consensus       390 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~ell-tG~~p~~~~~~~~~~~l~~~~~~~~  467 (577)
                      ||++......      ....++..|+|||.+. ...++.++||||||+++|||+ +|+.|+......+...       .+
T Consensus       156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-------~~  222 (262)
T cd05077         156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-------FY  222 (262)
T ss_pred             CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-------HH
Confidence            9998754321      2245788999999886 456899999999999999998 4666654322111110       00


Q ss_pred             ccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          468 NEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       468 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                      .. . ....     ...   ...+.+++..||+.||++||++.++++.|+
T Consensus       223 ~~-~-~~~~-----~~~---~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         223 EG-Q-CMLV-----TPS---CKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             hc-C-ccCC-----CCC---hHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            00 0 0000     011   234557888999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.8e-38  Score=308.92  Aligned_cols=250  Identities=27%  Similarity=0.448  Sum_probs=202.4

Q ss_pred             hcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      .++|+..+.||+|+||.||++... |+.||+|.+..... ...++.+|+.++++++|+||+++++++.+....++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            457888999999999999999875 78999999976654 4557889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      ++++|.+++... ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++....... 
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          83 AKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            999999988432 2236999999999999999999999988   99999999999999999999999999986632211 


Q ss_pred             ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC
Q 008108          403 SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR  481 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  481 (577)
                          ...++..|+|||++..+.++.++||||||+++|||++ |+.|+......+   +.......+.    ..     ..
T Consensus       158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~~~~----~~-----~~  221 (256)
T cd05039         158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHVEKGYR----ME-----AP  221 (256)
T ss_pred             ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHhcCCC----CC-----Cc
Confidence                2335678999999998899999999999999999998 888875443222   2111111110    00     01


Q ss_pred             CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       482 ~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ...+   ..+.+++.+|++.+|++||++.|++++|+.
T Consensus       222 ~~~~---~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         222 EGCP---PEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             cCCC---HHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            1112   345577889999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=7.9e-38  Score=316.92  Aligned_cols=254  Identities=28%  Similarity=0.432  Sum_probs=196.9

Q ss_pred             cCCccccccccCCcEEEEEeEecC-Cc--EEEEEEeccC-ChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSN-GE--TIAVKRLSKN-SKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  318 (577)
                      ++|++.+.||+|+||.||+|...+ +.  .+++|.++.. .......+.+|+.++.++ +||||+++++++......+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578889999999999999998653 33  4788888753 333445688999999999 799999999999999999999


Q ss_pred             EEecCCCCcccccccCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCe
Q 008108          319 YEFVPNASLDHFIFDPI-------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP  385 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~  385 (577)
                      |||+++++|.+++....             ....+++..++.++.||+.||.|||+.+   |+||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999998885321             1135899999999999999999999987   9999999999999999999


Q ss_pred             EEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhh
Q 008108          386 KISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAW  464 (577)
Q Consensus       386 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~  464 (577)
                      ||+|||++......   ........+..|+|||++....++.++|||||||++|||++ |+.||......+   +...  
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~~~~--  230 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---LYEK--  230 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH--
Confidence            99999998643211   11111223567999999988899999999999999999998 988886443322   1111  


Q ss_pred             hhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          465 RNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       465 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                        ...+.     .+.......   ..+.+++..|++.+|.+||++.++++.|..
T Consensus       231 --~~~~~-----~~~~~~~~~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  274 (297)
T cd05089         231 --LPQGY-----RMEKPRNCD---DEVYELMRQCWRDRPYERPPFAQISVQLSR  274 (297)
T ss_pred             --HhcCC-----CCCCCCCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence              11110     001111112   245578889999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.8e-37  Score=312.44  Aligned_cols=251  Identities=27%  Similarity=0.380  Sum_probs=196.4

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      .|+..+.||+|+||+||++... +++.+|+|.+.....   .....+.+|+.++++++|+|++++++.+.+.+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3677899999999999999964 688999999865432   223356789999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |+++++|.+++.. .....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~g~~L~~~l~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          81 LMNGGDLKFHIYH-MGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             ecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            9999999888743 22346899999999999999999999987   9999999999999999999999999997654322


Q ss_pred             ccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                      .   .....|+..|+|||++.++.++.++||||||+++|||++|+.||....................         ...
T Consensus       157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~---------~~~  224 (285)
T cd05630         157 T---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ---------EEY  224 (285)
T ss_pred             c---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh---------hhc
Confidence            1   1234789999999999999999999999999999999999999864332211111111100000         001


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRPG-----MASVVN  514 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RPt-----~~ev~~  514 (577)
                      ......   .+.+++..|++.||++|||     +.|+++
T Consensus       225 ~~~~~~---~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         225 SEKFSP---DARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             CccCCH---HHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            111222   3456777999999999999     777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.9e-37  Score=312.23  Aligned_cols=245  Identities=27%  Similarity=0.386  Sum_probs=192.6

Q ss_pred             CccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      |+..+.||+|+||+||++... +++.+|+|.+.....   .....+.+|+.+++.++|+||+++.+.+..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            677889999999999999864 688999999865432   2233467899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|..++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++........
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            9999998877542 2346999999999999999999999987   99999999999999999999999999976542211


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR  481 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  481 (577)
                         .....|+..|+|||++.+..++.++||||||+++|||++|+.||...........+.   .......      ....
T Consensus       158 ---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~---~~~~~~~------~~~~  225 (285)
T cd05632         158 ---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD---RRVLETE------EVYS  225 (285)
T ss_pred             ---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---Hhhhccc------cccC
Confidence               123578999999999998999999999999999999999999986543321111111   1111100      0111


Q ss_pred             CCChHHHHHHHHHHHhcccCCCCCCCCH
Q 008108          482 GGSTSEMMKCIHIGLLCVQENVSNRPGM  509 (577)
Q Consensus       482 ~~~~~~~~~~~~l~~~C~~~~p~~RPt~  509 (577)
                      .....   .+.+++..|++.||++||++
T Consensus       226 ~~~~~---~~~~li~~~l~~~P~~R~~~  250 (285)
T cd05632         226 AKFSE---EAKSICKMLLTKDPKQRLGC  250 (285)
T ss_pred             ccCCH---HHHHHHHHHccCCHhHcCCC
Confidence            11222   34567779999999999994

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=309.39  Aligned_cols=252  Identities=25%  Similarity=0.373  Sum_probs=198.5

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCCh-----hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK-----QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      ++|...+.||+|++|.||++.. .+++.+|+|.+.....     .....+.+|+.++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5789999999999999999985 4689999998865421     123457889999999999999999999999999999


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      |+||+++++|.+++.   ....+++..+..++.|++.||.|||+.+   |+||||+|+||++++++.++|+|||+++...
T Consensus        82 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLK---AYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            999999999988874   3456899999999999999999999988   9999999999999999999999999997654


Q ss_pred             CCCcccc-ccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          398 MDQTHSD-TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       398 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      ....... .....|+..|+|||.+.+..++.++||||||+++|||++|+.|+.......   ....   ......     
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~---~~~~~~-----  224 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA---AIFK---IATQPT-----  224 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH---HHHH---HhccCC-----
Confidence            3221111 123567889999999999889999999999999999999999875332211   1111   000000     


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      .+.+......   .+.+++..|++.+|.+|||+.++++.
T Consensus       225 ~~~~~~~~~~---~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         225 NPQLPSHVSP---DARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CCCCCccCCH---HHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            0111111222   34567779999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-39  Score=326.37  Aligned_cols=260  Identities=27%  Similarity=0.423  Sum_probs=210.5

Q ss_pred             HHHHHHhcCCccccccccCCcEEEEEeEecC-CcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeE
Q 008108          237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (577)
Q Consensus       237 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  315 (577)
                      +.++....+....++||-|.||.||.|+|+. .-.||||.++++... ..+|..|..+|+.++|||+|+|+|+|..+...
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            3444444566677999999999999999864 567999999876554 45899999999999999999999999999999


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      |||+|||.+|+|.++|.+ .++..++.-..+.++.||+.||.||..++   +|||||..+|+|+.++..+|++||||+++
T Consensus       339 YIiTEfM~yGNLLdYLRe-cnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRE-CNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             EEEEecccCccHHHHHHH-hchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence            999999999999999976 46677888999999999999999999887   99999999999999999999999999998


Q ss_pred             ccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccc
Q 008108          396 FEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALN  474 (577)
Q Consensus       396 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  474 (577)
                      +..+.+ .......-.+.|.|||.+....++.|+|||+|||+||||.| |..|+..-...+..++++..++.-.      
T Consensus       415 MtgDTY-TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~------  487 (1157)
T KOG4278|consen  415 MTGDTY-TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDG------  487 (1157)
T ss_pred             hcCCce-ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccC------
Confidence            864432 22222334678999999999999999999999999999988 5556544333444445543332111      


Q ss_pred             cccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          475 LMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       475 ~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                               ......++.+++++||+.+|++||++.|+.+.++
T Consensus       488 ---------PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE  521 (1157)
T KOG4278|consen  488 ---------PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE  521 (1157)
T ss_pred             ---------CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence                     1112235567888999999999999999887654

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.2e-37  Score=316.56  Aligned_cols=255  Identities=29%  Similarity=0.433  Sum_probs=197.6

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCc--EEEEEEeccC-ChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGE--TIAVKRLSKN-SKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  317 (577)
                      .++|++.+.||+|+||.||+|... ++.  .+++|.+... .......+.+|+.++.++ +|+||+++++++.+.+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            367888999999999999999964 454  4688877653 233445788999999999 89999999999999999999


Q ss_pred             EEEecCCCCcccccccCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCC
Q 008108          318 VYEFVPNASLDHFIFDPI-------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN  384 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~  384 (577)
                      ||||+++++|.+++....             ....+++.+++.++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence            999999999998885421             1236899999999999999999999987   999999999999999999


Q ss_pred             eEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhh
Q 008108          385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYA  463 (577)
Q Consensus       385 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~  463 (577)
                      +||+|||+++.....   .......++..|+|||++....++.++||||||+++|||+| |..||......+.   ....
T Consensus       163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~~  236 (303)
T cd05088         163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YEKL  236 (303)
T ss_pred             EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH---HHHH
Confidence            999999998643211   11111234678999999988889999999999999999998 8888754332221   1111


Q ss_pred             hhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          464 WRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       464 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                          ..+...+     ......   ..+.+++.+|++.+|++||++.+++++|..
T Consensus       237 ----~~~~~~~-----~~~~~~---~~~~~li~~~l~~~p~~Rp~~~~il~~l~~  279 (303)
T cd05088         237 ----PQGYRLE-----KPLNCD---DEVYDLMRQCWREKPYERPSFAQILVSLNR  279 (303)
T ss_pred             ----hcCCcCC-----CCCCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                1100000     000111   245678889999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.6e-37  Score=307.42  Aligned_cols=249  Identities=31%  Similarity=0.451  Sum_probs=197.5

Q ss_pred             cccccCCcEEEEEeEecC--C--cEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCC
Q 008108          250 NKLGQGGFGAVYKGMLSN--G--ETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPN  324 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  324 (577)
                      ++||+|++|.||+|.+.+  +  ..||+|.+..... .....+.+|+.++++++|+||+++++++.+ ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  3  3689999987765 555678999999999999999999999988 888999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc-c
Q 008108          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH-S  403 (577)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~-~  403 (577)
                      ++|.+++.+... ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.+...... .
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999998855322 57899999999999999999999987   999999999999999999999999999876543221 1


Q ss_pred             cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCC
Q 008108          404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG  482 (577)
Q Consensus       404 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  482 (577)
                      ......++..|+|||++....++.++||||||+++|||++ |+.|+......+   +......   ....  ...     
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~---~~~~--~~~-----  222 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKKIDK---EGER--LER-----  222 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHh---cCCc--CCC-----
Confidence            1223467889999999998999999999999999999999 998875433222   1111111   0000  000     


Q ss_pred             CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          483 GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       483 ~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                       .......+.+++.+|++.+|++||++.+|++.|.
T Consensus       223 -~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         223 -PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             -CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence             0111234567888999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.3e-37  Score=306.02  Aligned_cols=250  Identities=21%  Similarity=0.305  Sum_probs=199.1

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      +|++.++||+|+||.||++... +++.+|+|.+.... ......+.+|+.+++.++|+||+++++.+.+.+..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999999954 68899999986432 334456788999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      ++++|.+++.. .....+++..++.++.||+.||.|||+.+   |+|+||||+||++++++.++|+|||+++....... 
T Consensus        81 ~~~~l~~~~~~-~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          81 DGGDLMQKIKL-QRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence            99999887743 23446899999999999999999999987   99999999999999999999999999986643222 


Q ss_pred             ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCC
Q 008108          403 SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG  482 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  482 (577)
                       ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.......   .+...    ..+...    + +..
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~~----~~~~~~----~-~~~  222 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN---LILKV----CQGSYK----P-LPS  222 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH---HHHHH----hcCCCC----C-CCc
Confidence             1223578999999999988889999999999999999999999986433211   11111    011110    0 111


Q ss_pred             CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          483 GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       483 ~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      ...   ..+.+++.+||+.+|++||++.|++..
T Consensus       223 ~~~---~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         223 HYS---YELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ccC---HHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            111   235577789999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-37  Score=307.06  Aligned_cols=247  Identities=30%  Similarity=0.466  Sum_probs=193.9

Q ss_pred             cccccCCcEEEEEeEecC----CcEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCC
Q 008108          250 NKLGQGGFGAVYKGMLSN----GETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPN  324 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  324 (577)
                      ++||+|+||.||+|....    +..+|+|.+..... ....++.+|+.+++.+.|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            479999999999998432    26899999876654 34456889999999999999999999876 4568999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcccc
Q 008108          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD  404 (577)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~  404 (577)
                      ++|.+++..   ...+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++..........
T Consensus        80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            999999853   347999999999999999999999987   99999999999999999999999999987654332211


Q ss_pred             -ccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCC
Q 008108          405 -TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG  482 (577)
Q Consensus       405 -~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  482 (577)
                       .....++..|+|||.+....++.++||||||+++|||++ |+.|+......+   +......    .....     ...
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~~----~~~~~-----~~~  221 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLES----GERLP-----RPE  221 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHc----CCcCC-----CCC
Confidence             112234568999999998999999999999999999998 888875433222   2222111    11000     001


Q ss_pred             CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          483 GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       483 ~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ..   ...+.+++.+|++.+|++||++.+|++.|++
T Consensus       222 ~~---~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~  254 (257)
T cd05060         222 EC---PQEIYSIMLSCWKYRPEDRPTFSELESTFRR  254 (257)
T ss_pred             CC---CHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            11   1345578889999999999999999999976

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=9.8e-38  Score=320.40  Aligned_cols=242  Identities=24%  Similarity=0.279  Sum_probs=186.8

Q ss_pred             cccccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHH-HHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCC
Q 008108          250 NKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEV-LLLARLQHRNLVRLLGFCLERKERILVYEFVPN  324 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  324 (577)
                      +.||+|+||+||++... +++.||+|++.+...   .....+..|. .+++.++|+||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999965 578899999875421   2222344444 456778999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcccc
Q 008108          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD  404 (577)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~  404 (577)
                      ++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~  152 (325)
T cd05602          81 GELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT  152 (325)
T ss_pred             CcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence            99988874   3456888999999999999999999988   9999999999999999999999999997533211  12


Q ss_pred             ccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCC
Q 008108          405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGS  484 (577)
Q Consensus       405 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  484 (577)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||........   ......    ..      ..+....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~----~~------~~~~~~~  219 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YDNILN----KP------LQLKPNI  219 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---HHHHHh----CC------cCCCCCC
Confidence            3346799999999999999999999999999999999999999864433221   111110    00      0011112


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          485 TSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       485 ~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      ..   .+.+++..|++.+|.+||++.+.+..
T Consensus       220 ~~---~~~~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         220 TN---SARHLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             CH---HHHHHHHHHcccCHHHCCCCCCCHHH
Confidence            22   34467779999999999998754433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-37  Score=309.11  Aligned_cols=256  Identities=29%  Similarity=0.472  Sum_probs=204.4

Q ss_pred             HhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ..++|++.++||+|+||.||++..++++.+|||.+..... ...++.+|+.++++++|+||+++++++......++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            4578999999999999999999988888999999875443 345789999999999999999999999998999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|.+++... ....+++..+..++.|++.||.|||+++   ++|+||||+||++++++.+||+|||++........
T Consensus        83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            9999999988542 2346899999999999999999999987   99999999999999999999999999986653221


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                      . ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+......   ..+......+..         ..
T Consensus       159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~~~~~~~---------~~  225 (261)
T cd05034         159 T-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQVERGYRM---------PR  225 (261)
T ss_pred             h-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCCCC---------CC
Confidence            1 1112335678999999998899999999999999999999 88887533222   122211111100         00


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ....   ...+.+++.+|++.+|++||++.++++.|+.
T Consensus       226 ~~~~---~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         226 PPNC---PEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCC---CHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            0111   2345678889999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=8.7e-38  Score=320.42  Aligned_cols=241  Identities=27%  Similarity=0.330  Sum_probs=190.4

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcC-CCCeEEEEeEEEcCCeEEEEE
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  319 (577)
                      +|+..+.||+|+||+||++... +|+.||+|++.+..   ......+..|..++..+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4778899999999999999854 68899999987542   222345677888888885 577888999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++|+|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            9999999988873   3457999999999999999999999987   999999999999999999999999999754322


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                      .  .......||+.|+|||++.++.++.++|||||||++|||++|+.||.......   +......    ..      ..
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i~~----~~------~~  219 (323)
T cd05615         155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQSIME----HN------VS  219 (323)
T ss_pred             C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHHh----CC------CC
Confidence            1  12233579999999999999899999999999999999999999986543322   1211111    00      00


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCCCH
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGM  509 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~  509 (577)
                      ......   ..+.+++..|++.+|++|++.
T Consensus       220 ~p~~~~---~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         220 YPKSLS---KEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             CCccCC---HHHHHHHHHHcccCHhhCCCC
Confidence            111112   244567789999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-37  Score=311.93  Aligned_cols=239  Identities=25%  Similarity=0.364  Sum_probs=186.8

Q ss_pred             ccccCCcEEEEEeEecC-------------------------CcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEE
Q 008108          251 KLGQGGFGAVYKGMLSN-------------------------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRL  305 (577)
Q Consensus       251 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  305 (577)
                      +||+|+||.||+|.+..                         ...|++|.+.........++.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997421                         13489999876655555678899999999999999999


Q ss_pred             EeEEEcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC--
Q 008108          306 LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM--  383 (577)
Q Consensus       306 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~--  383 (577)
                      ++++.+....++||||+++|+|+.++..  ....+++..++.++.||++||.|||+.+   |+||||||+|||++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            9999999999999999999999988743  3457899999999999999999999987   99999999999997654  


Q ss_pred             -----CeEEeccCCcccccCCCccccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHh-hCCCCCCCCCcccc
Q 008108          384 -----NPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIV-SGQKRSSFGTEEET  456 (577)
Q Consensus       384 -----~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~ell-tG~~p~~~~~~~~~  456 (577)
                           .+|++|||++......      ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+......+.
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  230 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK  230 (274)
T ss_pred             cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence                 3799999998643211      12357888999998865 56899999999999999995 68887754333221


Q ss_pred             chhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          457 EDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       457 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                      ...+..   .           ..+....   ...+.+++..||+.+|++||++.+|++.|.
T Consensus       231 ~~~~~~---~-----------~~~~~~~---~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 ERFYEK---K-----------HRLPEPS---CKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHHHHh---c-----------cCCCCCC---ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            111110   0           0000111   124567888999999999999999998773

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=7.1e-37  Score=314.76  Aligned_cols=203  Identities=23%  Similarity=0.337  Sum_probs=173.6

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|++.++||+|+||+||++... +++.||+|.+.+..   ......+.+|..++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999965 67889999987532   222334788999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++|+|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999998853  2357899999999999999999999987   999999999999999999999999999865433


Q ss_pred             CccccccccccCCCCcChhhhhc-----CCCCccccEEecchhHhHHhhCCCCCCCCC
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMH-----GRFSVKSDIFSFGVLVLEIVSGQKRSSFGT  452 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltG~~p~~~~~  452 (577)
                      ... ......||+.|+|||++.+     +.++.++||||||+++|||++|+.||....
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~  212 (331)
T cd05624         156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES  212 (331)
T ss_pred             Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence            221 1223579999999999875     568899999999999999999999986433

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2e-38  Score=307.83  Aligned_cols=257  Identities=24%  Similarity=0.364  Sum_probs=193.4

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC-----eEEEE
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK-----ERILV  318 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv  318 (577)
                      .|...+++|.|.||.||+|++. +++.||||++-.+.+..    .+|+++|+.++|||||+|+-+|....     ...||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4667899999999999999964 57899999987665432    46899999999999999999886433     23489


Q ss_pred             EEecCCCCcccccccC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCC-CCeEEeccCCcccc
Q 008108          319 YEFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMARLF  396 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~-~~~kl~DfGla~~~  396 (577)
                      |||||. +|.+++... ..+..++...+.-+..||.+||.|||+.+   |+||||||+|+|+|.+ |.+||||||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999987 787777432 23567888888889999999999999987   9999999999999987 89999999999988


Q ss_pred             cCCCccccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCC----
Q 008108          397 EMDQTHSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGA----  471 (577)
Q Consensus       397 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~----  471 (577)
                      ..++..   .....|..|.|||.+.+. .|+.+.||||.||++.||+-|+.-|......+.   +....+.+....    
T Consensus       177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ---L~eIik~lG~Pt~e~I  250 (364)
T KOG0658|consen  177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ---LVEIIKVLGTPTREDI  250 (364)
T ss_pred             ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH---HHHHHHHhCCCCHHHH
Confidence            765543   235678899999998775 699999999999999999999987765443222   211111211111    


Q ss_pred             ------ccccccCcCCCCC------hHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          472 ------ALNLMDPTMRGGS------TSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       472 ------~~~~~d~~l~~~~------~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                            ..+.-.|.+....      ...-.+.+++..++++.+|.+|.++.|++..
T Consensus       251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence                  1112222222211      1223456677889999999999999988754

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1e-37  Score=317.03  Aligned_cols=255  Identities=31%  Similarity=0.551  Sum_probs=198.9

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCc----EEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGE----TIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  316 (577)
                      .++|+..+.||+|+||.||+|.+. +|+    .||+|.+..... ....++.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            356788899999999999999853 444    478998876533 3334688999999999999999999998754 467


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccc
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~  396 (577)
                      +++||+++|+|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        85 ~v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          85 LVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eeehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence            99999999999988743  2346899999999999999999999987   999999999999999999999999999876


Q ss_pred             cCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCcccc
Q 008108          397 EMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNL  475 (577)
Q Consensus       397 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  475 (577)
                      .............++..|+|||++.+..++.++||||||+++|||++ |+.|+..........++.       .+...  
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~~~--  230 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-------KGERL--  230 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------CCCCC--
Confidence            54333222333456788999999998899999999999999999998 888875433222222211       11000  


Q ss_pred             ccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       476 ~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ..+   .   .....+..++..||..+|++||++.+++++|+.
T Consensus       231 ~~~---~---~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~  267 (303)
T cd05110         231 PQP---P---ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR  267 (303)
T ss_pred             CCC---C---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            000   1   112345678889999999999999999999874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=292.16  Aligned_cols=265  Identities=24%  Similarity=0.285  Sum_probs=207.5

Q ss_pred             HHHhcCCccccccccCCcEEEEEeE-ecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC-----
Q 008108          240 RVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK-----  313 (577)
Q Consensus       240 ~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  313 (577)
                      .+..++|.+.++||+|||.-||+++ ..+++.+|+|++.-...++....++|++..++++|||+++++++...+.     
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            3456789999999999999999999 6678999999998888777778899999999999999999999876443     


Q ss_pred             eEEEEEEecCCCCcccccccC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCC
Q 008108          314 ERILVYEFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (577)
Q Consensus       314 ~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGl  392 (577)
                      +.||+++|...|+|.+.+... .++..+++.+++.|+.+|++||.+||+.. ++++||||||.|||+.+.+.++|.|||.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence            489999999999998887543 34458999999999999999999999986 4799999999999999999999999999


Q ss_pred             cccccCCCccc-------cccccccCCCCcChhhhhc---CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhh
Q 008108          393 ARLFEMDQTHS-------DTNRVVGTFGYMAPEYVMH---GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTY  462 (577)
Q Consensus       393 a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~  462 (577)
                      +......-...       .-.....|..|.|||.+.-   ...++++|||||||+||+|+.|..||+..... ... +. 
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-GgS-la-  252 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-GGS-LA-  252 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-CCe-EE-
Confidence            87544211111       1112356899999998743   45789999999999999999999998632221 111 11 


Q ss_pred             hhhhcccCCccccccCcCC-CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          463 AWRNWNEGAALNLMDPTMR-GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       463 ~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                                ..+..+.+. +........+.+++.+|++.||..||++.+++..+..
T Consensus       253 ----------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~  299 (302)
T KOG2345|consen  253 ----------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD  299 (302)
T ss_pred             ----------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence                      111111111 1111233456678889999999999999999988764

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=8.8e-38  Score=323.10  Aligned_cols=259  Identities=29%  Similarity=0.433  Sum_probs=197.9

Q ss_pred             hcCCccccccccCCcEEEEEeEe------cCCcEEEEEEeccCCh-hhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcC-C
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNLVRLLGFCLER-K  313 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  313 (577)
                      .++|++.++||+|+||.||+|..      .+++.||||++..... .....+.+|+.++.++ +|+||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            46799999999999999999973      3578899999976433 2344678999999999 789999999988654 4


Q ss_pred             eEEEEEEecCCCCcccccccCC----------------------------------------------------------
Q 008108          314 ERILVYEFVPNASLDHFIFDPI----------------------------------------------------------  335 (577)
Q Consensus       314 ~~~lv~E~~~~gsL~~~l~~~~----------------------------------------------------------  335 (577)
                      ..+++|||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6789999999999988874321                                                          


Q ss_pred             ------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccccccccc
Q 008108          336 ------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV  409 (577)
Q Consensus       336 ------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  409 (577)
                            ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++...............
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                  0134788999999999999999999987   9999999999999999999999999998654332222222344


Q ss_pred             cCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCChHHH
Q 008108          410 GTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEM  488 (577)
Q Consensus       410 gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  488 (577)
                      ++..|+|||.+.+..++.++||||||+++|||++ |..|+.......  .+..    ....+.....  +   ....   
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~----~~~~~~~~~~--~---~~~~---  308 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR----RLKEGTRMRA--P---DYTT---  308 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHHH----HHhccCCCCC--C---CCCC---
Confidence            6778999999999999999999999999999997 887775322111  1111    1111111000  1   0111   


Q ss_pred             HHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          489 MKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       489 ~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ..+.+++..||+.+|++||++.||++.|+.
T Consensus       309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~  338 (343)
T cd05103         309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGN  338 (343)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            245678889999999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.1e-37  Score=311.29  Aligned_cols=253  Identities=26%  Similarity=0.401  Sum_probs=196.4

Q ss_pred             HHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcC------
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLER------  312 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------  312 (577)
                      .+++.|+..+.||+|+||.||+|... +++.||+|++.... ....++.+|+.++.++ +|+||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35677888999999999999999864 57889999986553 3345688999999998 799999999998753      


Q ss_pred             CeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCC
Q 008108          313 KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (577)
Q Consensus       313 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGl  392 (577)
                      ...+++|||+++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence            4578999999999999987542 2356899999999999999999999987   99999999999999999999999999


Q ss_pred             cccccCCCccccccccccCCCCcChhhhh-----cCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhc
Q 008108          393 ARLFEMDQTHSDTNRVVGTFGYMAPEYVM-----HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNW  467 (577)
Q Consensus       393 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~  467 (577)
                      +.......  .......|+..|+|||++.     ...++.++|||||||++|||++|+.|+..........      ...
T Consensus       158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~------~~~  229 (272)
T cd06637         158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF------LIP  229 (272)
T ss_pred             ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH------HHh
Confidence            98654322  1223467899999999986     3458889999999999999999999885332211110      001


Q ss_pred             ccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          468 NEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       468 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .. .     .+.+...  .....+.+++.+|++.+|.+|||+.|+++
T Consensus       230 ~~-~-----~~~~~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         230 RN-P-----APRLKSK--KWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             cC-C-----CCCCCCC--CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            00 0     0111111  11124567888999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.7e-37  Score=306.71  Aligned_cols=255  Identities=27%  Similarity=0.438  Sum_probs=201.8

Q ss_pred             HhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ..++|+..++||+|+||.||++...++..+|+|.+..... ....+.+|+.++++++|+||+++++++.+ ...+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh-HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            3467889999999999999999987788899998875432 34468899999999999999999999887 778999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|.+++... ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++..+.....
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          82 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             CCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence            9999999988542 3456899999999999999999999987   99999999999999999999999999986643322


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                      . ......++..|+|||++..+.++.++||||||+++|+++| |+.|+.......   +....    ..+....     .
T Consensus       158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~----~~~~~~~-----~  224 (260)
T cd05073         158 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRAL----ERGYRMP-----R  224 (260)
T ss_pred             c-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----hCCCCCC-----C
Confidence            1 1222345678999999998899999999999999999999 887775432221   11111    1110000     0


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ..   .....+.+++.+|++.+|++||++.++.++|+.
T Consensus       225 ~~---~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         225 PE---NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             cc---cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            01   112345677889999999999999999999864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-37  Score=319.26  Aligned_cols=257  Identities=23%  Similarity=0.336  Sum_probs=194.2

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|++.+.||+|+||+||++... +++.||+|.+.+..   ......+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47899999999999999999964 58899999987532   223345788999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++|+|.+++..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            99999999998843  2456899999999999999999999998   999999999999999999999999998765432


Q ss_pred             CccccccccccCCCCcChhhhhc-----CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMH-----GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALN  474 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  474 (577)
                      ... ......||+.|+|||++..     +.++.++|||||||++|||++|+.||......+..   ..   .+.......
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~---~~---i~~~~~~~~  228 (331)
T cd05597         156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY---GK---IMNHKEHFQ  228 (331)
T ss_pred             CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH---HH---HHcCCCccc
Confidence            221 1223469999999999863     45788999999999999999999998643322111   11   111111111


Q ss_pred             cccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          475 LMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       475 ~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      + .+. ......+...+++- ++|...++..||++.++++.
T Consensus       229 ~-~~~-~~~~~~~~~~li~~-ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         229 F-PPD-VTDVSEEAKDLIRR-LICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             C-CCc-cCCCCHHHHHHHHH-HccCcccccCCCCHHHHhcC
Confidence            1 111 11133444444432 23556666668899988865

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-37  Score=310.13  Aligned_cols=254  Identities=29%  Similarity=0.530  Sum_probs=201.1

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCc----EEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGE----TIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      .+|+..+.||+|+||.||+|... +|+    .+|+|.+..... ....++.+|+.++.+++|+||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            56888899999999999999864 333    589998876643 344578899999999999999999999987 78899


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      ||||+++|+|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        86 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            9999999999998854  3446999999999999999999999987   9999999999999999999999999998765


Q ss_pred             CCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      ............++..|+|||.+..+.++.++||||||+++||+++ |+.|+......+....+.       .+..  .-
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~--~~  231 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-------KGER--LP  231 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-------CCCC--CC
Confidence            4332222222334678999999988899999999999999999999 999886544332222111       1100  00


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .+      ......+..++..||..+|++||++.++++.|+.
T Consensus       232 ~~------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~  267 (279)
T cd05057         232 QP------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSK  267 (279)
T ss_pred             CC------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence            01      1111345577889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.3e-37  Score=306.40  Aligned_cols=248  Identities=26%  Similarity=0.421  Sum_probs=196.0

Q ss_pred             cCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEE-cCCeEEEEEEec
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL-ERKERILVYEFV  322 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~E~~  322 (577)
                      ++|.+.+.||+|+||.||++... |+.+|+|.+.....  ...+.+|+.++++++|+|++++++++. ++...+++|||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCch--HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            57888999999999999999875 78899999865432  346889999999999999999999765 456789999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      ++++|.+++.. .....+++..++.++.||+.||.|||+++   ++||||||+||++++++.+||+|||+++......  
T Consensus        83 ~~~~L~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          83 AKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCcHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            99999998754 22345899999999999999999999987   9999999999999999999999999987543221  


Q ss_pred             ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC
Q 008108          403 SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR  481 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  481 (577)
                         ....++..|+|||++....++.++||||||+++|||++ |+.|+......   .+.......+.         +...
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~~~~~~---------~~~~  221 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEKGYK---------MDAP  221 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHhcCCC---------CCCC
Confidence               12345678999999998899999999999999999998 88877533221   12211111110         0111


Q ss_pred             CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       482 ~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ...+   ..+.+++.+|++.+|++|||+.++++.|+.
T Consensus       222 ~~~~---~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         222 DGCP---PVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCC---HHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            1122   345577889999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-37  Score=328.20  Aligned_cols=261  Identities=20%  Similarity=0.249  Sum_probs=198.3

Q ss_pred             hcCCccccccccCCcEEEEEeEec---CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS---NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ..+|++.++||+|+||.||++...   .++.||+|.+....     ...+|+.++++++||||+++++++......+++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-----~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-----TPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-----cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            357999999999999999999743   35789999886532     3468999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      |++. ++|.+++   .....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       166 e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        166 PKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9996 5777776   23567999999999999999999999988   999999999999999999999999999866544


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCC-------c
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGA-------A  472 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-------~  472 (577)
                      ..........||+.|+|||++....++.++|||||||++|||++|+.||...........+....+......       .
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            333333346799999999999999999999999999999999999999865443322222211111110000       0


Q ss_pred             cc------cccCcCCCC--C------hHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          473 LN------LMDPTMRGG--S------TSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       473 ~~------~~d~~l~~~--~------~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      ..      .+....+..  .      ......+..++..|++.+|++|||+.|++..
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            00      000000000  0      0011244567789999999999999998864

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6.6e-38  Score=333.94  Aligned_cols=262  Identities=20%  Similarity=0.328  Sum_probs=189.6

Q ss_pred             HhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC--------
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER--------  312 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  312 (577)
                      ...+|+..++||+|+||.||+|... +++.||||++.....    ...+|+.+|+.++|+||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ----YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3467999999999999999999964 688999999865432    235799999999999999999886432        


Q ss_pred             CeEEEEEEecCCCCccccccc-CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC-CeEEecc
Q 008108          313 KERILVYEFVPNASLDHFIFD-PINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-NPKISDF  390 (577)
Q Consensus       313 ~~~~lv~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~-~~kl~Df  390 (577)
                      ...++||||+++ +|.+++.. ......+++..+..++.||+.||.|||+.+   |+||||||+||||+.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence            245689999986 56555432 123467999999999999999999999988   99999999999999765 6999999


Q ss_pred             CCcccccCCCccccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCcccc-chhhhhh----h
Q 008108          391 GMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET-EDLLTYA----W  464 (577)
Q Consensus       391 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~-~~l~~~~----~  464 (577)
                      |+++.+.....   .....||+.|+|||++.+. .++.++|||||||++|||++|..||......+. ..++...    .
T Consensus       216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            99986653322   2235789999999998764 689999999999999999999999865433221 1111100    0


Q ss_pred             hhcc--cCCccccccCcCCCC------ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          465 RNWN--EGAALNLMDPTMRGG------STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       465 ~~~~--~~~~~~~~d~~l~~~------~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ..+.  .....++--+.....      ......++++++..||+.+|++|||+.|+++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            0000  000000000111000      0001134667888999999999999999874

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.3e-37  Score=317.27  Aligned_cols=263  Identities=24%  Similarity=0.382  Sum_probs=196.5

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ++|...++||+|+||.||+|... +++.||+|.+..... .....+.+|+.++++++|+||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            57889999999999999999864 678899999875432 2233577899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++ +|.+++..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            975 77666643  2345899999999999999999999987   99999999999999999999999999976433221


Q ss_pred             cccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhh--------hhhhcccCCc
Q 008108          402 HSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTY--------AWRNWNEGAA  472 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~~~~~  472 (577)
                        ......+|..|+|||.+.+ ..++.++||||||+++|||+||+.||......+....+..        .|..+.....
T Consensus       160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence              1223467899999998865 4688999999999999999999999875544322222111        1111111000


Q ss_pred             cccc-cCcCCCC-----ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          473 LNLM-DPTMRGG-----STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       473 ~~~~-d~~l~~~-----~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .... .+.....     .......+.+++..|++.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000 0000000     0011123457888999999999999999885

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=5.8e-38  Score=310.80  Aligned_cols=252  Identities=29%  Similarity=0.484  Sum_probs=199.8

Q ss_pred             CccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHH--HHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      |+..+.||+|+||+||++... +++.+|+|++.........  ...+|+.++++++|+||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            567899999999999999965 4668999999877654433  3456999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      ++++|.+++.   ....+++..++.++.||++||.+||+.+   |+|+||||+||++++++.++|+|||.+....  ...
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENN  152 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STT
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--ccc
Confidence            9999999884   4567899999999999999999999997   9999999999999999999999999997641  122


Q ss_pred             ccccccccCCCCcChhhhh-cCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC
Q 008108          403 SDTNRVVGTFGYMAPEYVM-HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR  481 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  481 (577)
                      .......++..|+|||++. +..++.++||||||+++|+|++|..|+......+....+.......       ...... 
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~-  224 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP-------LPSSSQ-  224 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH-------HHHHTT-
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccc-------cccccc-
Confidence            2333467899999999998 7889999999999999999999999987542222222221111000       000000 


Q ss_pred             CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       482 ~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                       ........+.+++..|++.||++||++.++++
T Consensus       225 -~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  225 -QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             -SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             -ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             00001156668888999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.7e-37  Score=318.37  Aligned_cols=259  Identities=27%  Similarity=0.398  Sum_probs=200.7

Q ss_pred             hcCCccccccccCCcEEEEEeEec--------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcC
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS--------NGETIAVKRLSKNS-KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLER  312 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  312 (577)
                      ..+|.+.+.||+|+||.||++...        .+..||+|.+.... .....++.+|+.++.++ +|+||+++++++...
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            356888999999999999999742        12368999887543 33345788999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCCcccccccCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEE
Q 008108          313 KERILVYEFVPNASLDHFIFDPI-------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL  379 (577)
Q Consensus       313 ~~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl  379 (577)
                      +..+++|||+++|+|.+++....             ....+++.+++.++.||+.||.|||+++   |+||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence            99999999999999998875421             2345899999999999999999999987   9999999999999


Q ss_pred             cCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccch
Q 008108          380 DSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETED  458 (577)
Q Consensus       380 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~  458 (577)
                      +.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+.....++   
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---  244 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---  244 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---
Confidence            9999999999999986543322222222344678999999999999999999999999999998 777764332222   


Q ss_pred             hhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCC
Q 008108          459 LLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD  519 (577)
Q Consensus       459 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~  519 (577)
                      +...    ...+.....     ....   ...+.+++..|++.+|++||+|.|+++.|...
T Consensus       245 ~~~~----~~~~~~~~~-----~~~~---~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~  293 (334)
T cd05100         245 LFKL----LKEGHRMDK-----PANC---THELYMIMRECWHAVPSQRPTFKQLVEDLDRV  293 (334)
T ss_pred             HHHH----HHcCCCCCC-----CCCC---CHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            1111    111111010     1111   23455788899999999999999999999754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.8e-37  Score=312.02  Aligned_cols=264  Identities=25%  Similarity=0.390  Sum_probs=195.3

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      +|+..+.||+|++|.||+|... +++.||+|++....  ......+.+|+.++++++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788899999999999999964 68999999986542  22335678999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      ++ ++|.+++........+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            97 578777644333467999999999999999999999987   99999999999999999999999999976543221


Q ss_pred             cccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCcccc-chhhhhh----hhhcccCCcc--
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET-EDLLTYA----WRNWNEGAAL--  473 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~-~~l~~~~----~~~~~~~~~~--  473 (577)
                        ......+++.|+|||++.+. .++.++||||||+++|||+||+.|+........ ...+...    ...|......  
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence              12234678899999988654 478999999999999999999988864332111 0110000    0001000000  


Q ss_pred             --ccccC----cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          474 --NLMDP----TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       474 --~~~d~----~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                        ..++.    .+.........++.+++..|++.||++|||+.+|++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence              00000    000000001234457888999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-37  Score=305.61  Aligned_cols=254  Identities=24%  Similarity=0.364  Sum_probs=203.4

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      .++|+..+.||+|+||.||++... +++.+++|.+..........+.+|+.++++++||||+++++++.+....+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            367899999999999999999964 5788999999876655666789999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|.+++..  ....+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||++........
T Consensus        82 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  156 (262)
T cd06613          82 CGGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA  156 (262)
T ss_pred             CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence            999999988743  2357999999999999999999999987   99999999999999999999999999976543221


Q ss_pred             cccccccccCCCCcChhhhhcC---CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHG---RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                        ......++..|+|||.+...   .++.++||||||+++|||++|+.|+...........+  .....        ..+
T Consensus       157 --~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~--~~~~~--------~~~  224 (262)
T cd06613         157 --KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI--SKSNF--------PPP  224 (262)
T ss_pred             --ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhccC--------CCc
Confidence              12235688899999998776   8899999999999999999999998643322111110  00000        001


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .+. ........+.+++.+|++.+|.+|||+.+|+.
T Consensus       225 ~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         225 KLK-DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ccc-chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            111 11222345678889999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.3e-37  Score=306.44  Aligned_cols=238  Identities=26%  Similarity=0.467  Sum_probs=187.2

Q ss_pred             cccccCCcEEEEEeEecCCc-----------EEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          250 NKLGQGGFGAVYKGMLSNGE-----------TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      +.||+|+||.||+|...+..           .+++|.+...... ...+.+|+.++++++|+||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999976433           4788877655433 5678899999999999999999999988 778999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC-------CeEEeccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-------NPKISDFG  391 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~-------~~kl~DfG  391 (577)
                      |||+++|+|++++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            9999999999988542  237899999999999999999999987   99999999999999888       79999999


Q ss_pred             CcccccCCCccccccccccCCCCcChhhhhcC--CCCccccEEecchhHhHHhhC-CCCCCCCCccccchhhhhhhhhcc
Q 008108          392 MARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG--RFSVKSDIFSFGVLVLEIVSG-QKRSSFGTEEETEDLLTYAWRNWN  468 (577)
Q Consensus       392 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~elltG-~~p~~~~~~~~~~~l~~~~~~~~~  468 (577)
                      ++.....      .....++..|+|||++...  .++.++||||||+++|||++| ..|+...........       +.
T Consensus       154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~-------~~  220 (259)
T cd05037         154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF-------YQ  220 (259)
T ss_pred             ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH-------Hh
Confidence            9986542      1224567889999998876  789999999999999999995 555543321111110       00


Q ss_pred             cCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          469 EGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       469 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                      ....       +....   ...+.+++..|++.+|.+|||+.+|++.|+
T Consensus       221 ~~~~-------~~~~~---~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 DQHR-------LPMPD---CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             cCCC-------CCCCC---chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0000       00001   145667888999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.1e-37  Score=309.17  Aligned_cols=249  Identities=27%  Similarity=0.394  Sum_probs=195.8

Q ss_pred             CccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCC
Q 008108          246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPN  324 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  324 (577)
                      |++.++||+|+||.||+|... ++..+++|.+..........+.+|+++++.++|+||+++++++......++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            567789999999999999965 4778899998776655566788999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcccc
Q 008108          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD  404 (577)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~  404 (577)
                      ++|..++..  ....+++..+..++.||++||.|||+.+   ++||||||+|||++.++.+||+|||++.......  ..
T Consensus        87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~  159 (282)
T cd06643          87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR  159 (282)
T ss_pred             CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cc
Confidence            999887643  2457999999999999999999999987   9999999999999999999999999987643221  12


Q ss_pred             ccccccCCCCcChhhhh-----cCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          405 TNRVVGTFGYMAPEYVM-----HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       405 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                      .....|+..|+|||++.     ...++.++|||||||++|||++|+.|+.......  ......     .........+ 
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~~-----~~~~~~~~~~-  231 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLLKIA-----KSEPPTLAQP-  231 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHHHHh-----hcCCCCCCCc-
Confidence            23356899999999874     3457889999999999999999999875432211  111110     0000001011 


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                        ....   ..+.+++..||+.+|.+||++.++++
T Consensus       232 --~~~~---~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         232 --SRWS---SEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             --cccC---HHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0112   24557778999999999999998874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.6e-37  Score=321.72  Aligned_cols=198  Identities=29%  Similarity=0.402  Sum_probs=167.4

Q ss_pred             HhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC-----
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK-----  313 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  313 (577)
                      ..++|+..+.||+|+||.||++... +|+.||+|++...  .......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3478999999999999999999864 6899999998654  2233456789999999999999999999986543     


Q ss_pred             -eEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCC
Q 008108          314 -ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (577)
Q Consensus       314 -~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGl  392 (577)
                       ..++||||+++ +|...+     ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVI-----HMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHH-----hccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence             47999999976 454444     234889999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCC
Q 008108          393 ARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFG  451 (577)
Q Consensus       393 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~  451 (577)
                      ++......   ......||..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~  225 (359)
T cd07876         170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT  225 (359)
T ss_pred             ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            97543221   223357899999999999999999999999999999999999998754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=5.8e-37  Score=305.59  Aligned_cols=255  Identities=25%  Similarity=0.390  Sum_probs=199.0

Q ss_pred             HHHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          240 RVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       240 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      +.+++++.....||+|+||.||+|... ++..|++|.+..........+.+|+.++++++|+||+++++++..++..++|
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            455677777889999999999999954 5788999999877666667889999999999999999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC-CCCeEEeccCCccc
Q 008108          319 YEFVPNASLDHFIFDPINREHM--TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS-EMNPKISDFGMARL  395 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l--~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~-~~~~kl~DfGla~~  395 (577)
                      +||+++++|.+++...  ...+  ++..+..++.||+.||.|||+.+   |+||||||+||+++. ++.+||+|||++..
T Consensus        84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          84 MEQVPGGSLSALLRSK--WGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             EecCCCCCHHHHHHHh--cccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            9999999999988542  2334  88889999999999999999987   999999999999986 67899999999876


Q ss_pred             ccCCCccccccccccCCCCcChhhhhcCC--CCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcc
Q 008108          396 FEMDQTHSDTNRVVGTFGYMAPEYVMHGR--FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAAL  473 (577)
Q Consensus       396 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  473 (577)
                      ......  ......|+..|+|||++....  ++.++||||||+++|||++|+.|+........   ..+......     
T Consensus       159 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~-----  228 (268)
T cd06624         159 LAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFK-----  228 (268)
T ss_pred             cccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhc-----
Confidence            543221  122346899999999986654  78999999999999999999998753221111   000000000     


Q ss_pred             ccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          474 NLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       474 ~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                        ..+.+.....   ..+..++.+|++.+|++|||+.|+++
T Consensus       229 --~~~~~~~~~~---~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         229 --IHPEIPESLS---AEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             --cCCCCCcccC---HHHHHHHHHHcCCCchhCCCHHHHHh
Confidence              0111111112   23456778999999999999999885

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-37  Score=319.50  Aligned_cols=240  Identities=24%  Similarity=0.301  Sum_probs=182.9

Q ss_pred             cccCCcEEEEEeEec-CCcEEEEEEeccCChh---hHHHHHHHHHHHHhc---CCCCeEEEEeEEEcCCeEEEEEEecCC
Q 008108          252 LGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ---GEIEFKNEVLLLARL---QHRNLVRLLGFCLERKERILVYEFVPN  324 (577)
Q Consensus       252 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~E~~~~  324 (577)
                      ||+|+||+||+|... +++.||||++.+....   ....+..|..++...   +||||+++++++.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999964 6899999998654222   122344566666655   699999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcccc
Q 008108          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD  404 (577)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~  404 (577)
                      |+|..++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~  152 (330)
T cd05586          81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT  152 (330)
T ss_pred             ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence            99988873   3567999999999999999999999988   9999999999999999999999999997543222  12


Q ss_pred             ccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCC
Q 008108          405 TNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGG  483 (577)
Q Consensus       405 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  483 (577)
                      .....||..|+|||++.+. .++.++|||||||++|||++|+.||........   ..    ....+.. .+...    .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~---~~----~i~~~~~-~~~~~----~  220 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM---YR----NIAFGKV-RFPKN----V  220 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH---HH----HHHcCCC-CCCCc----c
Confidence            2346799999999998765 489999999999999999999999864332221   11    1111100 00000    1


Q ss_pred             ChHHHHHHHHHHHhcccCCCCCCCC----HHHHHH
Q 008108          484 STSEMMKCIHIGLLCVQENVSNRPG----MASVVN  514 (577)
Q Consensus       484 ~~~~~~~~~~l~~~C~~~~p~~RPt----~~ev~~  514 (577)
                      ...   .+.+++..|++.||++||+    +.++++
T Consensus       221 ~~~---~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         221 LSD---EGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CCH---HHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            122   3446777999999999995    555443

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.5e-37  Score=311.04  Aligned_cols=257  Identities=25%  Similarity=0.371  Sum_probs=202.0

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      .++|++.++||+|+||+||++... +|+.||+|++.... ......+.+|+++++.++||||+++++++......++|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            357888999999999999999954 68899999886543 3345578999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |+++++|.+++.   ..+.+++..+..++.+++.+|.|||+..  .++||||||+||++++++.++|+|||++...... 
T Consensus        84 ~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-  157 (284)
T cd06620          84 FMDCGSLDRIYK---KGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-  157 (284)
T ss_pred             cCCCCCHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence            999999988873   3457899999999999999999999742  3999999999999999999999999998754321 


Q ss_pred             ccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccc-----cchhhhhhhhhcccCCcccc
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEE-----TEDLLTYAWRNWNEGAALNL  475 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~-----~~~l~~~~~~~~~~~~~~~~  475 (577)
                         ......|+..|+|||++.++.++.++|||||||++|||++|+.||.......     ...+...........     
T Consensus       158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  229 (284)
T cd06620         158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-----  229 (284)
T ss_pred             ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-----
Confidence               1223578999999999988899999999999999999999999987544321     111111111111110     


Q ss_pred             ccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 008108          476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNML  516 (577)
Q Consensus       476 ~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L  516 (577)
                       .+.+..  ......+.+++.+|++.||++|||+.||+++.
T Consensus       230 -~~~~~~--~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         230 -PPRLPS--SDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             -CCCCCc--hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence             011110  11223456777899999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.8e-37  Score=317.00  Aligned_cols=202  Identities=22%  Similarity=0.339  Sum_probs=172.1

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|++.++||+|+||+||++... +++.+|+|.+.+..   ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47889999999999999999965 57889999986532   222334788999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++|+|.+++.+  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            99999999999853  2356899999999999999999999987   999999999999999999999999999765332


Q ss_pred             CccccccccccCCCCcChhhhh-----cCCCCccccEEecchhHhHHhhCCCCCCCC
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVM-----HGRFSVKSDIFSFGVLVLEIVSGQKRSSFG  451 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltG~~p~~~~  451 (577)
                      .. .......||+.|+|||++.     .+.++.++|||||||++|||++|+.||...
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~  211 (332)
T cd05623         156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (332)
T ss_pred             Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence            22 1222357999999999986     346889999999999999999999998644

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.1e-37  Score=313.81  Aligned_cols=250  Identities=25%  Similarity=0.407  Sum_probs=201.0

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ..+|+..+.||+|+||.||++.. .+++.||+|.+..........+.+|+.+++.++|+||+++++++..++..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            36789999999999999999995 57899999999776555556788999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|.+++.    ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++........
T Consensus        98 ~~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          98 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             cCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            99999998873    346899999999999999999999987   99999999999999999999999999976543322


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR  481 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  481 (577)
                        ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||........  +..    .+..+. .....+   
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~~----~~~~~~-~~~~~~---  238 (297)
T cd06656         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYL----IATNGT-PELQNP---  238 (297)
T ss_pred             --CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--eee----eccCCC-CCCCCc---
Confidence              12235688999999999988999999999999999999999999854332111  110    000000 000000   


Q ss_pred             CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       482 ~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                         ......+.+++..|++.+|++||++.+|++
T Consensus       239 ---~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         239 ---ERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             ---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               111123446778999999999999999886

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.2e-37  Score=310.73  Aligned_cols=262  Identities=25%  Similarity=0.410  Sum_probs=191.0

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChh--hHHHHHHHHHHHHhc---CCCCeEEEEeEEEc-----CC
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ--GEIEFKNEVLLLARL---QHRNLVRLLGFCLE-----RK  313 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~  313 (577)
                      +|++.+.||+|+||+||++... +++.||+|.+......  ....+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999865 6889999998754221  223456677777665   69999999998864     24


Q ss_pred             eEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCc
Q 008108          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (577)
Q Consensus       314 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla  393 (577)
                      ..+++|||+++ +|..++.. .....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDK-VPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            57899999985 77777643 23345899999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccc-hhhhhh----hhhcc
Q 008108          394 RLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE-DLLTYA----WRNWN  468 (577)
Q Consensus       394 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~-~l~~~~----~~~~~  468 (577)
                      +......   ......||..|+|||++.+..++.++|||||||++|||++|+.||......+.. .+....    ...|.
T Consensus       156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            8664322   122356899999999999999999999999999999999999887644332211 111110    00111


Q ss_pred             cCC--ccccccCcCCCC----ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          469 EGA--ALNLMDPTMRGG----STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       469 ~~~--~~~~~d~~l~~~----~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ...  ....+.+.....    .......+.+++..|++.||++|||+.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            000  000011100000    0111234567888999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-37  Score=316.91  Aligned_cols=250  Identities=25%  Similarity=0.331  Sum_probs=204.0

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChh---hHHHHHHHHHHHHhcC-CCCeEEEEeEEEcCCeEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ---GEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  317 (577)
                      .+.|++.+.||+|.||.||+++.+ +|+.+|+|.+.+....   ....+.+|+.+|++++ |||||.+.+.+.+....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            456888899999999999999966 4999999999876543   3357899999999998 9999999999999999999


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCC----CCeEEeccCCc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE----MNPKISDFGMA  393 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~----~~~kl~DfGla  393 (577)
                      |||++.||.|.+.|...    .+++..+..++.||+.++.|||+.+   |+||||||+|+|+...    +.+|++|||++
T Consensus       114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            99999999999888553    3999999999999999999999988   9999999999999544    47999999999


Q ss_pred             ccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcc
Q 008108          394 RLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAAL  473 (577)
Q Consensus       394 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  473 (577)
                      .....   .......+||+.|+|||++....|+..+||||+||++|.|++|..||...........+......+..+.+ 
T Consensus       187 ~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w-  262 (382)
T KOG0032|consen  187 KFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPW-  262 (382)
T ss_pred             eEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCc-
Confidence            98775   23344589999999999999999999999999999999999999999766544332222111111111111 


Q ss_pred             ccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          474 NLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       474 ~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                              +...   ...-+++..++..||..|+|+.++++
T Consensus       263 --------~~is---~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  263 --------DDIS---ESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             --------cccC---HHHHHHHHHhcccCcccCCCHHHHhc
Confidence                    0112   23335667899999999999999987

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4e-37  Score=304.14  Aligned_cols=250  Identities=26%  Similarity=0.409  Sum_probs=201.1

Q ss_pred             hcCCccccccccCCcEEEEEeEecC-CcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      .++|+..++||+|+||.||+|...+ ++.+++|.+.....  ..++.+|++++++++|+||+++++++......++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            3678999999999999999999764 78999999875533  56789999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|.+++..  ....+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++........
T Consensus        80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            999999998743  3457899999999999999999999987   99999999999999999999999999986653321


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR  481 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  481 (577)
                        ......|+..|+|||++.+..++.++||||||+++|||++|+.|+.........  ..     .....     .+.+.
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~--~~-----~~~~~-----~~~~~  220 (256)
T cd06612         155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI--FM-----IPNKP-----PPTLS  220 (256)
T ss_pred             --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh--hh-----hccCC-----CCCCC
Confidence              222356889999999999889999999999999999999999998643322111  00     00000     00000


Q ss_pred             CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       482 ~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                       ........+.+++.+|++.+|++|||+.||++
T Consensus       221 -~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         221 -DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             -chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence             01111134567778999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.2e-37  Score=327.91  Aligned_cols=195  Identities=22%  Similarity=0.271  Sum_probs=167.2

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ..+|.+.+.||+|+||.||++... .++.||||....      ..+.+|+.+|++++|+|||++++++...+..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            347999999999999999999965 478899996432      2356899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +. ++|..++..  ....+++..++.|+.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.......
T Consensus       242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            95 677777633  2346999999999999999999999988   99999999999999999999999999987643322


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSS  449 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~  449 (577)
                      ........||..|+|||++.+..++.++|||||||+||||++|..++.
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf  363 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF  363 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence            222234679999999999999999999999999999999999987653

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.6e-37  Score=312.97  Aligned_cols=249  Identities=25%  Similarity=0.420  Sum_probs=200.9

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      .+|+..++||.|++|.||+|.. .+++.|++|.+..........+.+|+.+++.++|+||+++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4689999999999999999985 578999999997665555667889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      ++++|..++.    ...+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........ 
T Consensus        99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  170 (296)
T cd06655          99 AGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-  170 (296)
T ss_pred             CCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence            9999998873    346899999999999999999999987   99999999999999999999999999886543322 


Q ss_pred             ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCC
Q 008108          403 SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG  482 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  482 (577)
                       ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.........  . .....   . ......+   .
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~--~-~~~~~---~-~~~~~~~---~  239 (296)
T cd06655         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--Y-LIATN---G-TPELQNP---E  239 (296)
T ss_pred             -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--H-HHHhc---C-CcccCCc---c
Confidence             122356889999999999888999999999999999999999998654332111  1 11100   0 0000000   0


Q ss_pred             CChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          483 GSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       483 ~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ...   ..+.+++.+||+.+|++||++.++++
T Consensus       240 ~~~---~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         240 KLS---PIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             cCC---HHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            112   23446778999999999999999885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.1e-37  Score=310.42  Aligned_cols=247  Identities=26%  Similarity=0.426  Sum_probs=198.3

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      .|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++|+||+++++++......++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            4667788999999999999864 57889999987543 333456889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      ++++|.+++.    ...+++..+..++.||++||.|||+++   ++|+||+|+||++++++.++|+|||++........ 
T Consensus        85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06642          85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence            9999988873    356899999999999999999999987   99999999999999999999999999986543221 


Q ss_pred             ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCC
Q 008108          403 SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG  482 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  482 (577)
                       ......|+..|+|||++.+..++.++||||||+++|||++|+.|+........   ...    ....     ..+.+..
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~----~~~~-----~~~~~~~  223 (277)
T cd06642         157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---LFL----IPKN-----SPPTLEG  223 (277)
T ss_pred             -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---Hhh----hhcC-----CCCCCCc
Confidence             12234688999999999988999999999999999999999998753322111   110    0011     0111111


Q ss_pred             CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          483 GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       483 ~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                         .....+.+++..|++.+|++||+|.+|++.
T Consensus       224 ---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         224 ---QYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             ---ccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence               122345678889999999999999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.6e-37  Score=310.11  Aligned_cols=252  Identities=25%  Similarity=0.411  Sum_probs=197.1

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ++|++.+.||+|+||.||++... +++.||+|.+... .......+.+|+.++++++|+||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            46888999999999999999965 7899999988754 233345688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      +++++|..++........+++..+..++.||+.||.|||+. +   |+||||||+||+++.++.+||+|||++..+....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            99999988875433345799999999999999999999964 5   9999999999999999999999999997653221


Q ss_pred             ccccccccccCCCCcChhhhhcCC------CCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccc
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGR------FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALN  474 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  474 (577)
                          .....++..|+|||.+.+..      ++.++|||||||++|||++|+.||...........+.    ....+.   
T Consensus       158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~----~~~~~~---  226 (286)
T cd06622         158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS----AIVDGD---  226 (286)
T ss_pred             ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH----HHhhcC---
Confidence                22346888999999985543      5889999999999999999999986433221111111    000110   


Q ss_pred             cccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          475 LMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       475 ~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                        .+.+..   .....+..++..|++.+|++||++.++++
T Consensus       227 --~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         227 --PPTLPS---GYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             --CCCCCc---ccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence              011111   12234456778999999999999999886

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-37  Score=306.74  Aligned_cols=248  Identities=30%  Similarity=0.449  Sum_probs=191.3

Q ss_pred             cccccCCcEEEEEeEecC-Cc--EEEEEEeccCC-hhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEEEEEecCC
Q 008108          250 NKLGQGGFGAVYKGMLSN-GE--TIAVKRLSKNS-KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYEFVPN  324 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  324 (577)
                      +.||+|+||.||+|.+.+ +.  .+++|.+.... ......+.+|+.++.++ +||||+++++++......+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            369999999999999753 43  46888887543 34445788999999999 899999999999999999999999999


Q ss_pred             CCcccccccCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccC
Q 008108          325 ASLDHFIFDPI-------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG  391 (577)
Q Consensus       325 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfG  391 (577)
                      |+|.+++....             ....+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99998875421             1235889999999999999999999987   9999999999999999999999999


Q ss_pred             CcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccC
Q 008108          392 MARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEG  470 (577)
Q Consensus       392 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~  470 (577)
                      ++......   ........+..|+|||++....++.++||||||+++|||++ |+.||......+   ....    ...+
T Consensus       158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~----~~~~  227 (270)
T cd05047         158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEK----LPQG  227 (270)
T ss_pred             Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHHH----HhCC
Confidence            98632211   11111234567999999988899999999999999999997 888875432221   1111    1111


Q ss_pred             CccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          471 AALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       471 ~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ...+     .....   ...+.+++.+|++.+|.+||++.++++.|+.
T Consensus       228 ~~~~-----~~~~~---~~~~~~li~~~l~~~p~~Rps~~~il~~l~~  267 (270)
T cd05047         228 YRLE-----KPLNC---DDEVYDLMRQCWREKPYERPSFAQILVSLNR  267 (270)
T ss_pred             CCCC-----CCCcC---CHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence            0000     00111   1245678889999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.4e-37  Score=343.04  Aligned_cols=259  Identities=20%  Similarity=0.304  Sum_probs=198.5

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|++.++||+|+||.||+|... +|+.||+|++.....   ....++.+|+.++++++||||+++++++.+.+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57899999999999999999964 589999999975422   23446889999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCC--------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccC
Q 008108          320 EFVPNASLDHFIFDPI--------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG  391 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfG  391 (577)
                      ||+++++|.+++....        ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999998875311        1234677888999999999999999987   9999999999999999999999999


Q ss_pred             CcccccCCCc----------------cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccc
Q 008108          392 MARLFEMDQT----------------HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEE  455 (577)
Q Consensus       392 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~  455 (577)
                      +++.......                ........||+.|||||++.+..++.++|||||||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9987622110                001123579999999999999999999999999999999999999985422111


Q ss_pred             cchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHhcC
Q 008108          456 TEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRP-GMASVVNMLNG  518 (577)
Q Consensus       456 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RP-t~~ev~~~L~~  518 (577)
                         +..   ..       .+.++.-..........+.+++.+|++.||++|| ++.++++.|+.
T Consensus       239 ---i~~---~~-------~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~  289 (932)
T PRK13184        239 ---ISY---RD-------VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP  289 (932)
T ss_pred             ---hhh---hh-------hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence               100   00       0001100000001112345678899999999996 56777766643

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.1e-37  Score=308.70  Aligned_cols=250  Identities=31%  Similarity=0.510  Sum_probs=194.9

Q ss_pred             cccccCCcEEEEEeEecC-------CcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          250 NKLGQGGFGAVYKGMLSN-------GETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      +.||+|+||.||+|...+       ++.+|+|.+.... .....++.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            469999999999998642       2579999886543 23445688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC-----CeEEeccCC
Q 008108          322 VPNASLDHFIFDPI----NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-----NPKISDFGM  392 (577)
Q Consensus       322 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~-----~~kl~DfGl  392 (577)
                      +++++|.+++.+..    ....+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++     .+||+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999885422    2245899999999999999999999987   99999999999999887     899999999


Q ss_pred             cccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCC
Q 008108          393 ARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGA  471 (577)
Q Consensus       393 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~  471 (577)
                      ++...............++..|+|||++.++.++.++||||||+++|||++ |+.|+......+   .....    ..+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~----~~~~  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHV----TAGG  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHH----hcCC
Confidence            986543332222223456788999999999999999999999999999998 888875433221   11111    0000


Q ss_pred             ccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          472 ALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       472 ~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                      ..     ......+   ..+.+++.+|++.+|++||++.+|+++|+
T Consensus       231 ~~-----~~~~~~~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         231 RL-----QKPENCP---DKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             cc-----CCcccch---HHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            00     0001122   34457888999999999999999999986

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6.3e-37  Score=305.55  Aligned_cols=254  Identities=21%  Similarity=0.344  Sum_probs=187.9

Q ss_pred             cccccCCcEEEEEeEecCC---cEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCC
Q 008108          250 NKLGQGGFGAVYKGMLSNG---ETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA  325 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  325 (577)
                      ++||+|+||+||+|...++   ..+++|.+.... ......+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999985443   346677766543 334557899999999999999999999999999999999999999


Q ss_pred             CcccccccCCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcccc
Q 008108          326 SLDHFIFDPIN-REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD  404 (577)
Q Consensus       326 sL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~  404 (577)
                      +|.+++.+... ...+++..+..++.||++||.|||+.+   ++||||||+|||++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99998854321 245677788899999999999999987   99999999999999999999999999864322222222


Q ss_pred             ccccccCCCCcChhhhhc-------CCCCccccEEecchhHhHHhhCC-CCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          405 TNRVVGTFGYMAPEYVMH-------GRFSVKSDIFSFGVLVLEIVSGQ-KRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       405 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlGvil~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      .....++..|+|||++..       ..++.++||||||+++|||+++. .|+......   ..+....    .+....+.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~~~----~~~~~~~~  230 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---EVLNHVI----KDQQVKLF  230 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH----hhcccccC
Confidence            234568899999998743       24578999999999999999864 455322211   1121111    11122334


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                      ++.+.....+.   +.+++..|| .+|.+||++.+|++.|.
T Consensus       231 ~~~~~~~~~~~---~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 KPQLELPYSER---WYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCccCCCCcHH---HHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            44443333333   334556788 57999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.4e-37  Score=321.47  Aligned_cols=262  Identities=23%  Similarity=0.287  Sum_probs=194.3

Q ss_pred             HhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC------
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER------  312 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  312 (577)
                      ..++|+..+.||+|+||.||++... .++.||||++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4578999999999999999999854 68899999997542  23344677899999999999999999988643      


Q ss_pred             CeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCC
Q 008108          313 KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (577)
Q Consensus       313 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGl  392 (577)
                      ...++||||+++ +|.+.+     ...+++..+..++.||++||.|||+++   |+||||||+||||+.++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHH-----hhcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence            356999999976 555544     235889999999999999999999988   99999999999999999999999999


Q ss_pred             cccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccc-hhhhh---------
Q 008108          393 ARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE-DLLTY---------  462 (577)
Q Consensus       393 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~-~l~~~---------  462 (577)
                      ++......   ......||..|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+..         
T Consensus       166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            98654321   223357899999999999889999999999999999999999998644321110 00000         


Q ss_pred             -----hhhhccc--CCccccccCc-----CCC----CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          463 -----AWRNWNE--GAALNLMDPT-----MRG----GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       463 -----~~~~~~~--~~~~~~~d~~-----l~~----~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                           ....+..  .....+..+.     +.+    ........+.+++.+|++.||++|||+.|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                 0000000  0000000000     000    011112345678889999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=7.6e-37  Score=304.13  Aligned_cols=251  Identities=27%  Similarity=0.447  Sum_probs=197.8

Q ss_pred             CCccccccccCCcEEEEEeEecCCcEEEEEEeccCCh------hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          245 NFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSK------QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      +|...+.||+|+||+||+|...+++.+|+|.+.....      .....+.+|++++++++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4778899999999999999988899999998865421      1223578899999999999999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+++++|.+++.+   ...+++..+..++.|++.||.|||+.+   |+|+||+|+||++++++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            999999999998843   356899999999999999999999987   99999999999999999999999999886532


Q ss_pred             CCc----cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccc
Q 008108          399 DQT----HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALN  474 (577)
Q Consensus       399 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  474 (577)
                      ...    ........|+..|+|||++.+..++.++||||||+++|||++|+.||.......  ......    ..    .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~~~----~~----~  224 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--AMFYIG----AH----R  224 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--HHHHhh----hc----c
Confidence            111    111223568999999999998889999999999999999999999986432211  111000    00    0


Q ss_pred             cccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          475 LMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       475 ~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ...+.+.....   ..+..++..|++.+|++||++.|+++
T Consensus       225 ~~~~~~~~~~~---~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         225 GLMPRLPDSFS---AAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCCCCCCCCCC---HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00111222222   23456778999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6.5e-37  Score=309.34  Aligned_cols=251  Identities=27%  Similarity=0.399  Sum_probs=198.3

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      +.|++.++||+|+||.||+|... +++.+++|.+..........+.+|+.+++.++|+||+++++.+..+...++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            66889999999999999999965 58899999998776666667889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      ++++|..++.+  ....+++..+..++.|++.+|.|||+.+   ++||||||+||+++.++.+||+|||++.......  
T Consensus        92 ~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--  164 (292)
T cd06644          92 PGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--  164 (292)
T ss_pred             CCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence            99999887643  2356899999999999999999999987   9999999999999999999999999987543221  


Q ss_pred             ccccccccCCCCcChhhhh-----cCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccccc
Q 008108          403 SDTNRVVGTFGYMAPEYVM-----HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD  477 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  477 (577)
                      .......++..|+|||++.     ...++.++|||||||++|||++|+.|+........  ...     ......     
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~-----~~~~~~-----  232 (292)
T cd06644         165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLK-----IAKSEP-----  232 (292)
T ss_pred             cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HHH-----HhcCCC-----
Confidence            1122356889999999884     34568899999999999999999998754332111  111     111100     


Q ss_pred             CcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          478 PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       478 ~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      +.+. ........+.+++..||+.+|++||++.++++
T Consensus       233 ~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         233 PTLS-QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ccCC-CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0000 01111234567788999999999999998875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5e-37  Score=308.78  Aligned_cols=263  Identities=22%  Similarity=0.348  Sum_probs=198.9

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      ++|+..+.||+|+||.||+|... +|+.||+|++.....  .....+.+|+.+++.++|+||+++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888999999999999999975 589999999865432  233457899999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |+++++|+.++.   ....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            999998887763   3446999999999999999999999987   9999999999999999999999999998765432


Q ss_pred             ccccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhh--------hhhcccCC
Q 008108          401 THSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA--------WRNWNEGA  471 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~~  471 (577)
                      .  ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+....+...        ...+....
T Consensus       155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence            1  1223467889999999876 45789999999999999999999998644332211111100        00011110


Q ss_pred             cc-ccccCcCCCC-C-----hHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          472 AL-NLMDPTMRGG-S-----TSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       472 ~~-~~~d~~l~~~-~-----~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .. ....+..... .     ......+.+++.+|++.+|++||++.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            00 0000110000 0     011235667888999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.7e-37  Score=306.26  Aligned_cols=256  Identities=27%  Similarity=0.436  Sum_probs=200.1

Q ss_pred             cCCccccccccCCcEEEEEeEec------CCcEEEEEEeccCChh-hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  316 (577)
                      ++|+....||+|+||.||+|...      +.+.|++|.+...... ...++.+|+.++++++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57889999999999999999854      2467999988765443 3457899999999999999999999999999999


Q ss_pred             EEEEecCCCCcccccccCCCC------CCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEecc
Q 008108          317 LVYEFVPNASLDHFIFDPINR------EHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDF  390 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~Df  390 (577)
                      +||||+++++|.+++......      ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999988543211      26899999999999999999999987   999999999999999999999999


Q ss_pred             CCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhccc
Q 008108          391 GMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNE  469 (577)
Q Consensus       391 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  469 (577)
                      |++....... ........++..|+|||.+.++.++.++||||||+++|||++ |..|+.......   .+..    ...
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~----~~~  233 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNR----LQA  233 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHH----HHc
Confidence            9987543222 112223456788999999988889999999999999999999 666764322211   1111    111


Q ss_pred             CCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          470 GAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       470 ~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                      +......    ....+   ..+.+++.+|++.+|++||++.|++.+|.
T Consensus       234 ~~~~~~~----~~~~~---~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 GKLELPV----PEGCP---SRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCcCCCC----CCCCC---HHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            1110000    01111   24567888999999999999999999886

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=8.8e-37  Score=301.97  Aligned_cols=251  Identities=22%  Similarity=0.336  Sum_probs=201.0

Q ss_pred             CCccccccccCCcEEEEEeEe-cCCcEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      +|+..+.||+|+||.||.+.. .+++.+++|.+...  ......++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            578899999999999999884 46889999988654  234445688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQ-KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            9999999988542 2456899999999999999999999987   99999999999999999999999999987644332


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR  481 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  481 (577)
                        ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+......+   ....   . ..+.....      
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~---~~~~---~-~~~~~~~~------  221 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN---LVVK---I-VQGNYTPV------  221 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH---HHHH---H-HcCCCCCC------
Confidence              2233568999999999988889999999999999999999999875433221   1111   0 11111100      


Q ss_pred             CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 008108          482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNML  516 (577)
Q Consensus       482 ~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L  516 (577)
                        .......+.+++..|++.+|.+||++.++++.+
T Consensus       222 --~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         222 --VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             --ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence              011123455777899999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-36  Score=303.33  Aligned_cols=249  Identities=31%  Similarity=0.476  Sum_probs=196.4

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChh---------hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCe
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ---------GEIEFKNEVLLLARLQHRNLVRLLGFCLERKE  314 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  314 (577)
                      +|.+...||+|++|.||+|... +++.+|+|.+......         ....+.+|+.++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3677889999999999999864 5789999988654321         12357889999999999999999999999999


Q ss_pred             EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      .+++|||+++++|.+++.   ....+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHH---hccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            999999999999999883   3456899999999999999999999987   9999999999999999999999999998


Q ss_pred             cccCCCccc----cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccC
Q 008108          395 LFEMDQTHS----DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEG  470 (577)
Q Consensus       395 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  470 (577)
                      .........    ......|+..|+|||.+.++.++.++||||||+++|||++|+.|+.......  . +.   ... . 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~-~~---~~~-~-  226 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--A-IF---KIG-E-  226 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--H-HH---HHh-c-
Confidence            765322111    1123468899999999998899999999999999999999999986432211  1 11   000 0 


Q ss_pred             CccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          471 AALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       471 ~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                          ...+.+......   .+..++.+||+.+|.+||++.||++
T Consensus       227 ----~~~~~~~~~~~~---~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         227 ----NASPEIPSNISS---EAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ----cCCCcCCcccCH---HHHHHHHHHccCCchhCcCHHHHhh
Confidence                111111112223   3446677999999999999999885

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.3e-37  Score=320.70  Aligned_cols=199  Identities=26%  Similarity=0.377  Sum_probs=167.8

Q ss_pred             HhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC------
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER------  312 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  312 (577)
                      ..++|+..+.||+|+||.||++... .++.||||++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3578999999999999999999954 58889999997542  23344678899999999999999999987543      


Q ss_pred             CeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCC
Q 008108          313 KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (577)
Q Consensus       313 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGl  392 (577)
                      ...++||||+++ +|..++     ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHH-----HhcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence            357999999976 565554     235889999999999999999999987   99999999999999999999999999


Q ss_pred             cccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCC
Q 008108          393 ARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGT  452 (577)
Q Consensus       393 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~  452 (577)
                      ++......   ......||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  229 (364)
T cd07875         173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD  229 (364)
T ss_pred             ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence            98654321   2233578999999999999999999999999999999999999986543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-37  Score=306.43  Aligned_cols=248  Identities=25%  Similarity=0.407  Sum_probs=200.0

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ++|+..+.||.|++|.||+|... +++.||+|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            46888899999999999999965 68899999987653 33345688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|.+++..    ..+++..++.++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||+++...... 
T Consensus        81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  152 (274)
T cd06609          81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-  152 (274)
T ss_pred             eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence            999999988742    37999999999999999999999987   9999999999999999999999999998765432 


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR  481 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  481 (577)
                       .......|+..|+|||++.+..++.++||||||+++|||+||+.|+.......   .+....    ...     .+.+.
T Consensus       153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~----~~~-----~~~~~  219 (274)
T cd06609         153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---VLFLIP----KNN-----PPSLE  219 (274)
T ss_pred             -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH---HHHHhh----hcC-----CCCCc
Confidence             12233578899999999999899999999999999999999999985433211   111111    110     11111


Q ss_pred             CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       482 ~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ..  .....+.+++..|++.+|++|||++++++
T Consensus       220 ~~--~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         220 GN--KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             cc--ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            11  01224556778999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=318.17  Aligned_cols=245  Identities=27%  Similarity=0.443  Sum_probs=197.6

Q ss_pred             ccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCCCccc
Q 008108          251 KLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDH  329 (577)
Q Consensus       251 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~  329 (577)
                      +||+|.||+||-|... +...+|||-+.........-+.+|+.+-+.|+|+|||+++|.+.+++..-|.||-+|||+|..
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            6999999999999954 456799999988776666678999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC-CCCeEEeccCCcccccCCCcccccc
Q 008108          330 FIFDPINREHM--TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS-EMNPKISDFGMARLFEMDQTHSDTN  406 (577)
Q Consensus       330 ~l~~~~~~~~l--~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~-~~~~kl~DfGla~~~~~~~~~~~~~  406 (577)
                      +|..  +-+++  ++.++-.+.+||++||.|||++.   |||||||-+||||+. .|.+||+|||-++.+..  ....+.
T Consensus       662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TE  734 (1226)
T KOG4279|consen  662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTE  734 (1226)
T ss_pred             HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccc
Confidence            8853  33455  78888889999999999999997   999999999999964 57899999999986643  223344


Q ss_pred             ccccCCCCcChhhhhcCC--CCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCC
Q 008108          407 RVVGTFGYMAPEYVMHGR--FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGS  484 (577)
Q Consensus       407 ~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  484 (577)
                      ...||..|||||++..|.  |..++|||||||++.||.||++||......... .+.       -|  .-.+.|.+   +
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-MFk-------VG--myKvHP~i---P  801 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-MFK-------VG--MYKVHPPI---P  801 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-hhh-------hc--ceecCCCC---c
Confidence            578999999999998774  889999999999999999999998643332211 111       00  00112222   2


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          485 TSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       485 ~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      .+-..++..++++|+.++|.+||++.++++-
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence            3334566678999999999999999998864

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.5e-37  Score=312.46  Aligned_cols=248  Identities=25%  Similarity=0.374  Sum_probs=196.7

Q ss_pred             CccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCC
Q 008108          246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPN  324 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  324 (577)
                      |.....||+|+||.||++... +++.||||.+..........+.+|+.+++.++|+||+++++.+...+..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            444577999999999999864 6889999998766555566788999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcccc
Q 008108          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD  404 (577)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~  404 (577)
                      ++|.+++.    ...+++..++.++.||+.||.|||+.+   |+||||||+||++++++.+||+|||++........  .
T Consensus       104 ~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~  174 (292)
T cd06658         104 GALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--K  174 (292)
T ss_pred             CcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--c
Confidence            99988773    346899999999999999999999987   99999999999999999999999999876543221  2


Q ss_pred             ccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCC
Q 008108          405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGS  484 (577)
Q Consensus       405 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  484 (577)
                      .....|+..|+|||.+.+..++.++||||||+++|||++|+.|+........   +.....         .+.+.+... 
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~~~~~---------~~~~~~~~~-  241 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---MRRIRD---------NLPPRVKDS-  241 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHh---------cCCCccccc-
Confidence            2235689999999999888999999999999999999999999864332111   111000         011111110 


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          485 TSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       485 ~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      ......+..++..|++.+|++|||+.|+++.
T Consensus       242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         242 HKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            0111234466778999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.1e-37  Score=333.39  Aligned_cols=262  Identities=20%  Similarity=0.261  Sum_probs=190.6

Q ss_pred             HHHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCC------CCeEEEEeEEEcC
Q 008108          240 RVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH------RNLVRLLGFCLER  312 (577)
Q Consensus       240 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~  312 (577)
                      ...+++|++.++||+|+||+||++... .++.||||++..... ...++..|+.++..++|      .+++++++++...
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            345688999999999999999999864 578899999965322 22345667777777654      4588999988765


Q ss_pred             -CeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCcEEEeccCCCcEEEcCCC-------
Q 008108          313 -KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-SRLRIIHRDLKASNILLDSEM-------  383 (577)
Q Consensus       313 -~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiHrDlkp~NiLl~~~~-------  383 (577)
                       ...++|||++ +++|.+++.   ....+++..+..|+.||+.||.|||++ +   |+||||||+||||+.++       
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~  276 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVT  276 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccc
Confidence             4688999988 667777764   345799999999999999999999974 6   99999999999998765       


Q ss_pred             ---------CeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCcc
Q 008108          384 ---------NPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEE  454 (577)
Q Consensus       384 ---------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~  454 (577)
                               .+||+|||++.....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       277 ~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~  351 (467)
T PTZ00284        277 NRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL  351 (467)
T ss_pred             ccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence                     499999998864321     223468999999999999999999999999999999999999998754432


Q ss_pred             ccchhhhhhhh----hccc----CCccccc------cCcCCC---------CCh---HHHHHHHHHHHhcccCCCCCCCC
Q 008108          455 ETEDLLTYAWR----NWNE----GAALNLM------DPTMRG---------GST---SEMMKCIHIGLLCVQENVSNRPG  508 (577)
Q Consensus       455 ~~~~l~~~~~~----~~~~----~~~~~~~------d~~l~~---------~~~---~~~~~~~~l~~~C~~~~p~~RPt  508 (577)
                      +...++.....    .|..    ....+++      ++....         ...   .+...+.+++..||+.||++|||
T Consensus       352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t  431 (467)
T PTZ00284        352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN  431 (467)
T ss_pred             HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence            22222111100    0000    0000000      010000         000   01234568889999999999999


Q ss_pred             HHHHHH
Q 008108          509 MASVVN  514 (577)
Q Consensus       509 ~~ev~~  514 (577)
                      +.|+++
T Consensus       432 a~e~L~  437 (467)
T PTZ00284        432 ARQMTT  437 (467)
T ss_pred             HHHHhc
Confidence            999885

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=9.5e-37  Score=304.14  Aligned_cols=253  Identities=26%  Similarity=0.422  Sum_probs=197.5

Q ss_pred             CCccccccccCCcEEEEEeEecC--CcEEEEEEeccCC----------hhhHHHHHHHHHHHHh-cCCCCeEEEEeEEEc
Q 008108          245 NFSDANKLGQGGFGAVYKGMLSN--GETIAVKRLSKNS----------KQGEIEFKNEVLLLAR-LQHRNLVRLLGFCLE  311 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  311 (577)
                      +|++.+.||+|+||.||+|....  ++.+|+|.+....          .....++.+|+.++.+ ++|+||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999764  6889999875321          2223346778888875 699999999999999


Q ss_pred             CCeEEEEEEecCCCCcccccccC-CCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCcEEEeccCCCcEEEcCCCCeEEec
Q 008108          312 RKERILVYEFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHE-DSRLRIIHRDLKASNILLDSEMNPKISD  389 (577)
Q Consensus       312 ~~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlkp~NiLl~~~~~~kl~D  389 (577)
                      ++..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+ .+   ++||||+|+||+++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence            99999999999999998876431 234569999999999999999999996 44   99999999999999999999999


Q ss_pred             cCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhccc
Q 008108          390 FGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNE  469 (577)
Q Consensus       390 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  469 (577)
                      ||++.......   ......|+..|+|||.+.++.++.++||||||+++|||++|+.|+........   ....    ..
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~---~~~~----~~  227 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL---ATKI----VE  227 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH---HHHH----hh
Confidence            99998654332   22345789999999999998999999999999999999999998754322111   1100    00


Q ss_pred             CCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          470 GAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       470 ~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                      ...    .+.......   ..+.+++.+|++.||++||++.||.+++.
T Consensus       228 ~~~----~~~~~~~~~---~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         228 AVY----EPLPEGMYS---EDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ccC----CcCCcccCC---HHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            100    010000111   34557778999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.7e-36  Score=301.46  Aligned_cols=256  Identities=26%  Similarity=0.421  Sum_probs=202.9

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ++|++.+.||.|+||+||+|... ++..+++|++.... ......+.+|+.+++.++|+||+++++.+...+..++||||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47889999999999999999954 67889999987543 23445689999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|.+++........+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999998854333357899999999999999999999987   99999999999999999999999999987654332


Q ss_pred             cc--cccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          402 HS--DTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       402 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      ..  ......|+..|+|||++... .++.++||||||+++|||++|+.|+........  ...    .....      .+
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~----~~~~~------~~  225 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LML----TLQND------PP  225 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHH----HhcCC------CC
Confidence            21  22335689999999999877 789999999999999999999999864332211  111    11100      01


Q ss_pred             cCCCCC--hHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          479 TMRGGS--TSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       479 ~l~~~~--~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .+....  ......+.+++..|++.||++||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            111110  112234567888999999999999999885

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.1e-36  Score=301.42  Aligned_cols=249  Identities=24%  Similarity=0.349  Sum_probs=196.8

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEc-CCeEEEEEE
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLE-RKERILVYE  320 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~E  320 (577)
                      +|++.+.||+|++|.||++... +++.+|+|++....  ......+.+|++++++++|+|++++++.+.. +...+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788999999999999999964 57889999986543  2334468899999999999999999998764 446789999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |+++++|.+++... ....+++.+++.++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            99999999888542 3456899999999999999999999988   9999999999999999999999999998664322


Q ss_pred             ccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                      .  ......|++.|+|||++.+..++.++||||||++++||++|+.|+.......   ...   ... .+..     +.+
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~---~~~---~~~-~~~~-----~~~  222 (257)
T cd08223         157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS---LVY---RII-EGKL-----PPM  222 (257)
T ss_pred             C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH---HHH---HHH-hcCC-----CCC
Confidence            2  2223568999999999999999999999999999999999999875432211   111   111 1111     011


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ..   .....+.+++..|++.+|++||++.++++
T Consensus       223 ~~---~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         223 PK---DYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             cc---ccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            11   12234557888999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4e-38  Score=292.50  Aligned_cols=255  Identities=22%  Similarity=0.328  Sum_probs=198.9

Q ss_pred             HHHHhcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCCh----hh----HHHHHHHHHHHHhc-CCCCeEEEEeE
Q 008108          239 IRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK----QG----EIEFKNEVLLLARL-QHRNLVRLLGF  308 (577)
Q Consensus       239 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~----~~~~~~E~~~l~~l-~h~niv~l~~~  308 (577)
                      -+.....|...+.||.|..+.|-+... .+|+++|+|++.....    ..    .++-.+|+.+|+++ .||||+++.++
T Consensus        12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~   91 (411)
T KOG0599|consen   12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV   91 (411)
T ss_pred             HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence            334456788889999999999988874 4788999998854321    11    12345799999998 69999999999


Q ss_pred             EEcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEe
Q 008108          309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKIS  388 (577)
Q Consensus       309 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~  388 (577)
                      +..+...++|+|.|+.|.|.++|.   ..-.++++...+|++|+.+|+.|||.++   |+||||||+|||+|++.++||+
T Consensus        92 yes~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~is  165 (411)
T KOG0599|consen   92 YESDAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKIS  165 (411)
T ss_pred             ccCcchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEe
Confidence            999999999999999999999983   4567999999999999999999999998   9999999999999999999999


Q ss_pred             ccCCcccccCCCccccccccccCCCCcChhhhhc------CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhh
Q 008108          389 DFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH------GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTY  462 (577)
Q Consensus       389 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~  462 (577)
                      |||++..+..+....   ..+||++|+|||.+..      ..|+...|+|++|||||-|+.|..||-....--...++..
T Consensus       166 DFGFa~~l~~GekLr---elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime  242 (411)
T KOG0599|consen  166 DFGFACQLEPGEKLR---ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME  242 (411)
T ss_pred             ccceeeccCCchhHH---HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh
Confidence            999999887765443   3799999999998843      3578899999999999999999998742211111111111


Q ss_pred             hhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          463 AWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       463 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ....+....+.            +......+++.+|++.||.+|-|.+|+++
T Consensus       243 GkyqF~speWa------------dis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  243 GKYQFRSPEWA------------DISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             cccccCCcchh------------hccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            11111111111            11223446778999999999999999874

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=9.7e-37  Score=311.79  Aligned_cols=197  Identities=28%  Similarity=0.459  Sum_probs=159.9

Q ss_pred             ccccccCCcEEEEEeEec---CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEc--CCeEEEEEEecC
Q 008108          249 ANKLGQGGFGAVYKGMLS---NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE--RKERILVYEFVP  323 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E~~~  323 (577)
                      .++||+|+||+||+|...   +++.+|+|.+.....  ...+.+|+.++++++||||+++++++..  +...+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999854   467899999865432  2356789999999999999999998864  456789999986


Q ss_pred             CCCcccccccC------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEE----cCCCCeEEeccCCc
Q 008108          324 NASLDHFIFDP------INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL----DSEMNPKISDFGMA  393 (577)
Q Consensus       324 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl----~~~~~~kl~DfGla  393 (577)
                      + +|.+++...      .....+++..+..++.||+.||.|||+++   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 665554321      12235899999999999999999999988   9999999999999    45678999999999


Q ss_pred             ccccCCCc-cccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCC
Q 008108          394 RLFEMDQT-HSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFG  451 (577)
Q Consensus       394 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~  451 (577)
                      +.+..... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            87654322 1223346789999999998774 5899999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.5e-36  Score=304.29  Aligned_cols=248  Identities=24%  Similarity=0.406  Sum_probs=200.3

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ..|+..++||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++|+||+++++++.+....++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35777899999999999999964 58899999987553 34455688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|.+++.    ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          84 LGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            99999988873    346899999999999999999999987   99999999999999999999999999976643321


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR  481 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  481 (577)
                        ......++..|+|||++.+..++.++||||||+++|||++|+.|+...........+       ....     .+.+ 
T Consensus       157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-------~~~~-----~~~~-  221 (277)
T cd06640         157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-------PKNN-----PPTL-  221 (277)
T ss_pred             --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-------hcCC-----CCCC-
Confidence              222356888999999998889999999999999999999999987643322111100       0000     0111 


Q ss_pred             CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       482 ~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                        .......+.+++..||+.+|++||++.++++.
T Consensus       222 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         222 --TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             --chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence              12233456678889999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=7.2e-37  Score=305.26  Aligned_cols=254  Identities=24%  Similarity=0.397  Sum_probs=198.9

Q ss_pred             hcCCccccccccCCcEEEEEeEecC----CcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSN----GETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      .++|...++||+|+||.||+|...+    ...|+||...... ......+.+|+.++++++|+||+++++++.+ +..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            3568888999999999999998643    2468999887655 4445578999999999999999999998875 45789


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      ||||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++...
T Consensus        84 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          84 VMELAPLGELRSYLQV--NKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEEcCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence            9999999999999843  2346899999999999999999999987   9999999999999999999999999998665


Q ss_pred             CCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      ....... ....++..|+|||.+....++.++||||||+++|||++ |+.||......+.   ....    ..+...   
T Consensus       159 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~~----~~~~~~---  227 (270)
T cd05056         159 DESYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGRI----ENGERL---  227 (270)
T ss_pred             cccceec-CCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHH----HcCCcC---
Confidence            4322221 12345578999999988889999999999999999996 9998864433221   1111    111100   


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                        ......+.   .+.+++.+|+..+|.+|||+.++++.|+.
T Consensus       228 --~~~~~~~~---~~~~li~~~l~~~P~~Rpt~~~~~~~l~~  264 (270)
T cd05056         228 --PMPPNCPP---TLYSLMTKCWAYDPSKRPRFTELKAQLSD  264 (270)
T ss_pred             --CCCCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence              01111222   45567789999999999999999999875

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=6.7e-37  Score=303.91  Aligned_cols=250  Identities=26%  Similarity=0.410  Sum_probs=189.5

Q ss_pred             cccccCCcEEEEEeEec----CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEE-cCCeEEEEEEecC
Q 008108          250 NKLGQGGFGAVYKGMLS----NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCL-ERKERILVYEFVP  323 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~E~~~  323 (577)
                      +.||+|+||.||+|.+.    +...+|+|++.... ......+.+|+.+++.++||||+++++++. .+...+++|||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    23579999986433 334456889999999999999999999876 4556789999999


Q ss_pred             CCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc-
Q 008108          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH-  402 (577)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~-  402 (577)
                      +++|.+++..  ....+++..++.++.||+.||.|||+.+   ++||||||+|||+++++.+||+|||+++........ 
T Consensus        81 ~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRS--ETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            9999998853  2345788889999999999999999987   999999999999999999999999999755332111 


Q ss_pred             -ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC
Q 008108          403 -SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR  481 (577)
Q Consensus       403 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  481 (577)
                       .......++..|+|||++....++.++||||||+++|||++|+.|+....  ....+....+.   ...      +...
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~--~~~~~~~~~~~---~~~------~~~~  224 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--DSFDITVYLLQ---GRR------LLQP  224 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHhc---CCC------CCCC
Confidence             11123456778999999988899999999999999999999765543221  11122222111   000      0000


Q ss_pred             CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       482 ~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ...+   ..+.+++..||+.+|++||++.||++.|+.
T Consensus       225 ~~~~---~~~~~li~~cl~~~p~~Rp~~~~il~~l~~  258 (262)
T cd05058         225 EYCP---DPLYEVMLSCWHPKPEMRPTFSELVSRIEQ  258 (262)
T ss_pred             CcCC---HHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence            1111   245678889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-39  Score=294.01  Aligned_cols=250  Identities=25%  Similarity=0.355  Sum_probs=197.9

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      +++|++-+.||+|.|+.|++... ++|+.+|+|++...  +..+..++.+|+.+.+.|+|||||+|.+.+.+....+||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            46788889999999999999884 57899999987543  3345667899999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC---CeEEeccCCcccc
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM---NPKISDFGMARLF  396 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~---~~kl~DfGla~~~  396 (577)
                      |+|.|++|..-|   ..+...++..+-..++||+++|.|+|.++   |+|||+||.|+||-+..   -+||+|||+|..+
T Consensus        90 e~m~G~dl~~eI---V~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   90 DLVTGGELFEDI---VAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             ecccchHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            999999995544   23456788889999999999999999998   99999999999995443   4999999999987


Q ss_pred             cCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          397 EMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       397 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      ..+..   -...+||++|||||++....|+..+|||+.|||||-|+.|..||.........+.+......+....     
T Consensus       164 ~~g~~---~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~-----  235 (355)
T KOG0033|consen  164 NDGEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPE-----  235 (355)
T ss_pred             CCccc---cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcc-----
Confidence            73322   2246899999999999999999999999999999999999999875444333222221111111100     


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVV  513 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~  513 (577)
                         . +...++..   .++.+|+..||++|.|+.|.+
T Consensus       236 ---w-~~is~~Ak---~LvrrML~~dP~kRIta~EAL  265 (355)
T KOG0033|consen  236 ---W-DTVTPEAK---SLIRRMLTVNPKKRITADEAL  265 (355)
T ss_pred             ---c-CcCCHHHH---HHHHHHhccChhhhccHHHHh
Confidence               0 11223333   566689999999999999876

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=9e-37  Score=307.14  Aligned_cols=261  Identities=25%  Similarity=0.379  Sum_probs=199.9

Q ss_pred             hHHHHHHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEE---
Q 008108          236 FETIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCL---  310 (577)
Q Consensus       236 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~---  310 (577)
                      ++.+..+.++|++.+.||+|+||.||++... +++.+|+|.+..... ...++.+|+.+++++ +|+||+++++++.   
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            4455567789999999999999999999864 578999998765332 234678899999999 6999999999874   


Q ss_pred             --cCCeEEEEEEecCCCCcccccccC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEE
Q 008108          311 --ERKERILVYEFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI  387 (577)
Q Consensus       311 --~~~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl  387 (577)
                        .++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl  165 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL  165 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence              345689999999999998876432 23456899999999999999999999987   999999999999999999999


Q ss_pred             eccCCcccccCCCccccccccccCCCCcChhhhhc-----CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhh
Q 008108          388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH-----GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTY  462 (577)
Q Consensus       388 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~  462 (577)
                      +|||+++.......  ......|+..|+|||++..     ..++.++|||||||++|||++|+.|+.......  .+.. 
T Consensus       166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~~-  240 (286)
T cd06638         166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALFK-  240 (286)
T ss_pred             ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHhh-
Confidence            99999986543222  1223468999999998753     457899999999999999999999986433211  1111 


Q ss_pred             hhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          463 AWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       463 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                          ..........++..   ..   ..+..++.+|++.+|++||++.||++-
T Consensus       241 ----~~~~~~~~~~~~~~---~~---~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         241 ----IPRNPPPTLHQPEL---WS---NEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             ----ccccCCCcccCCCC---cC---HHHHHHHHHHccCCcccCCCHHHHhhc
Confidence                11111111111111   11   245578889999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.8e-36  Score=301.85  Aligned_cols=250  Identities=26%  Similarity=0.393  Sum_probs=191.4

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC-----hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC--CeE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS-----KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KER  315 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  315 (577)
                      .+|+..+.||+|+||.||++... +++.|++|++....     ......+.+|+.++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47888999999999999999864 68899999886432     12234578899999999999999999988753  567


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      ++++||+++++|.+++..   ...+++...+.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            899999999999988843   456899999999999999999999887   99999999999999999999999999976


Q ss_pred             ccCCCc-cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccc
Q 008108          396 FEMDQT-HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALN  474 (577)
Q Consensus       396 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  474 (577)
                      ...... ........++..|+|||++.+..++.++||||||+++|||++|+.|+.......  ....    .....    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~--~~~~----~~~~~----  225 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA--AIFK----IATQP----  225 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH--HHHH----HhcCC----
Confidence            543211 111223568899999999998889999999999999999999999986332111  1110    00000    


Q ss_pred             cccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          475 LMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       475 ~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                       ..+.+.......    ++.+..|+..+|++||+++||++
T Consensus       226 -~~~~~~~~~~~~----~~~li~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 -TNPQLPSHISEH----ARDFLGCIFVEARHRPSAEELLR  260 (266)
T ss_pred             -CCCCCchhcCHH----HHHHHHHhcCChhhCcCHHHHhc
Confidence             011111111222    22223688899999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.4e-37  Score=302.49  Aligned_cols=247  Identities=29%  Similarity=0.435  Sum_probs=197.2

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC-----hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS-----KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      +|+..+.||+|+||.||+|... +++.|++|.+....     ......+.+|+.+++.++|+||+++++++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999976 78999999886543     22345688999999999999999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999998843   346899999999999999999999987   99999999999999999999999999886543


Q ss_pred             CCccccccccccCCCCcChhhhhcCC-CCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccccc
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD  477 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  477 (577)
                      ..   ......|+..|++||.+.... ++.++|+||||+++|+|++|+.|+......  ......    ......     
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~--~~~~~~----~~~~~~-----  220 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--AAVFKI----GRSKEL-----  220 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH--HHHHHH----HhcccC-----
Confidence            32   223456899999999987776 899999999999999999999998543311  111111    000000     


Q ss_pred             CcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          478 PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       478 ~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      +.+....   ...+.+++.+|++.+|.+||++.++++
T Consensus       221 ~~~~~~~---~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         221 PPIPDHL---SDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             CCcCCCc---CHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            0111111   134456778999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.2e-37  Score=304.61  Aligned_cols=253  Identities=25%  Similarity=0.435  Sum_probs=198.2

Q ss_pred             CCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC------hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS------KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      +|+..+.||+|++|.||++.. .+++.||+|.+....      ......+.+|+.++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999985 578999999986533      1123468899999999999999999999999999999


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC-CeEEeccCCcccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-NPKISDFGMARLF  396 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~-~~kl~DfGla~~~  396 (577)
                      ||||+++++|.+++.+   ...+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++ .+||+|||++...
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999999999998843   457899999999999999999999987   99999999999998876 5999999999876


Q ss_pred             cCCCcc--ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccc
Q 008108          397 EMDQTH--SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALN  474 (577)
Q Consensus       397 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  474 (577)
                      ......  .......|+..|+|||.+.+..++.++||||||+++|+|++|+.|+...........+   +......    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~----  227 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI---FKIASAT----  227 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH---HHHhccC----
Confidence            543211  1122356889999999998888999999999999999999999988543322111111   1100000    


Q ss_pred             cccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          475 LMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       475 ~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                       ..+.+.   ......+.+++.+|++.+|++||++.|+++
T Consensus       228 -~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         228 -TAPSIP---EHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             -CCCCCc---hhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence             001111   112234557888999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.8e-37  Score=307.55  Aligned_cols=240  Identities=23%  Similarity=0.403  Sum_probs=187.4

Q ss_pred             cccccCCcEEEEEeEecC--------CcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          250 NKLGQGGFGAVYKGMLSN--------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      +.||+|+||.||+|....        ...+++|.+.........++.+|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999998532        234888888765555556788999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCC--------eEEeccCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN--------PKISDFGMA  393 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~--------~kl~DfGla  393 (577)
                      +++|+|..++..  .+..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKK--NKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            999999999854  2346899999999999999999999987   999999999999987765        599999988


Q ss_pred             ccccCCCccccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCC-CCCCccccchhhhhhhhhcccCC
Q 008108          394 RLFEMDQTHSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRS-SFGTEEETEDLLTYAWRNWNEGA  471 (577)
Q Consensus       394 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~-~~~~~~~~~~l~~~~~~~~~~~~  471 (577)
                      .....      .....++..|+|||++.+. .++.++||||||+++|||++|..++ ............       ... 
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-------~~~-  221 (258)
T cd05078         156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-------EDR-  221 (258)
T ss_pred             cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-------Hcc-
Confidence            65432      1224678899999998764 5799999999999999999996443 221111110000       000 


Q ss_pred             ccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          472 ALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       472 ~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                            ..+....   ..++.+++..|++.+|++|||++++++.|+
T Consensus       222 ------~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 ------HQLPAPK---WTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ------ccCCCCC---cHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                  0111111   134567888999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-37  Score=307.19  Aligned_cols=252  Identities=25%  Similarity=0.374  Sum_probs=199.7

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      .++|++.++||+|+||.||++... +++.+|+|.+..........+.+|+.++++++|+||+++++.+..+...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            467889999999999999999964 6889999999876666666788999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          84 CDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             cCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            999999998743  2346999999999999999999999998   99999999999999999999999999876543221


Q ss_pred             cccccccccCCCCcChhhhhc-----CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          402 HSDTNRVVGTFGYMAPEYVMH-----GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                        ......|+..|+|||.+..     ..++.++||||||+++|||++|+.|+.......  .+..     +.......+.
T Consensus       159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~~~-----~~~~~~~~~~  229 (280)
T cd06611         159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VLLK-----ILKSEPPTLD  229 (280)
T ss_pred             --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HHHH-----HhcCCCCCcC
Confidence              2233568999999999853     346789999999999999999999986432211  1111     1111100000


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .+   ....   ..+.+++..|++.+|.+||++.+|++
T Consensus       230 ~~---~~~~---~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         230 QP---SKWS---SSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             Cc---ccCC---HHHHHHHHHHhccChhhCcCHHHHhc
Confidence            00   0112   23456777999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.1e-36  Score=304.32  Aligned_cols=255  Identities=23%  Similarity=0.393  Sum_probs=196.4

Q ss_pred             CccccccccCCcEEEEEeEec----CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC------
Q 008108          246 FSDANKLGQGGFGAVYKGMLS----NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK------  313 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  313 (577)
                      |.+.+.||+|+||.||+|.+.    +++.||||++....  .....++.+|+.++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            566789999999999999853    36889999987542  334556889999999999999999999886542      


Q ss_pred             eEEEEEEecCCCCcccccccCC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEecc
Q 008108          314 ERILVYEFVPNASLDHFIFDPI---NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDF  390 (577)
Q Consensus       314 ~~~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~Df  390 (577)
                      ..++++||+++|+|..++....   +...+++...+.++.||+.||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            2478899999999987764321   2235899999999999999999999987   999999999999999999999999


Q ss_pred             CCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhccc
Q 008108          391 GMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNE  469 (577)
Q Consensus       391 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  469 (577)
                      |+++...............++..|++||.+....++.++||||||+++|||++ |+.|+......   .+..+...    
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~~~----  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYLIK----  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHHHc----
Confidence            99987654332222233456678999999998899999999999999999999 77776533221   12221111    


Q ss_pred             CCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          470 GAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       470 ~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .....     .   .......+.+++.+|++.+|++||++.|+++.|++
T Consensus       231 ~~~~~-----~---~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~  271 (273)
T cd05074         231 GNRLK-----Q---PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL  271 (273)
T ss_pred             CCcCC-----C---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            10000     0   01122356688889999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=6.2e-37  Score=310.91  Aligned_cols=263  Identities=23%  Similarity=0.365  Sum_probs=195.7

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ++|+..++||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++|+||+++++++......++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            57889999999999999999864 67899999986543 22334577899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      ++ ++|..++..  ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        86 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          86 LD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            97 588777643  2446899999999999999999999987   99999999999999999999999999976433221


Q ss_pred             cccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhh--------hhhhhcccCCc
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLT--------YAWRNWNEGAA  472 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~--------~~~~~~~~~~~  472 (577)
                        ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+....+.        ..|..+.....
T Consensus       160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (301)
T cd07873         160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  237 (301)
T ss_pred             --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence              12234578999999988654 57889999999999999999999986544322111110        11111110000


Q ss_pred             cccc-cCcCCCC-----ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          473 LNLM-DPTMRGG-----STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       473 ~~~~-d~~l~~~-----~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .... .+.....     ...-...+.+++.+|++.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0000 0110000     0001123456788999999999999999886

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=7.8e-37  Score=302.17  Aligned_cols=247  Identities=30%  Similarity=0.503  Sum_probs=195.9

Q ss_pred             cCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecC
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVP  323 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  323 (577)
                      ++|++.+.||+|+||.||++.. +++.||+|.+....  ....+.+|+.++++++|||++++++++... ..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4688899999999999999975 67889999986543  234688999999999999999999998764 4799999999


Q ss_pred             CCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccc
Q 008108          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS  403 (577)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~  403 (577)
                      +++|.+++... ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......    
T Consensus        82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----  153 (254)
T cd05083          82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----  153 (254)
T ss_pred             CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence            99999988542 3346899999999999999999999987   999999999999999999999999998754321    


Q ss_pred             cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCC
Q 008108          404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG  482 (577)
Q Consensus       404 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  482 (577)
                       ......+..|+|||++.++.++.++||||||+++|||++ |+.|+......+....+.       .+..   +++  ..
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~---~~~--~~  220 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-------KGYR---MEP--PE  220 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-------CCCC---CCC--CC
Confidence             112334678999999998999999999999999999998 888875443322211111       1100   011  11


Q ss_pred             CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          483 GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       483 ~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ..+   ..+.+++.+|++.+|++||++.++++.|+.
T Consensus       221 ~~~---~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         221 GCP---ADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             cCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            112   344578889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.4e-36  Score=300.49  Aligned_cols=249  Identities=22%  Similarity=0.362  Sum_probs=198.3

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      +|+..++||+|+||.||++... +|+.||+|.+...  ......++.+|+.++++++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4788999999999999999854 6889999998653  233345788999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|.+++.. .....+++..++.++.|++.||.|||+.+   ++|+||+|+|||++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINA-QRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            999999887743 22346899999999999999999999987   99999999999999999999999999986543222


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR  481 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  481 (577)
                      .  .....|+..|+|||++.++.++.++||||||+++++|++|+.|+......   +.+...    ..+..     +...
T Consensus       157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~~~~~~----~~~~~-----~~~~  222 (256)
T cd08218         157 L--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK---NLVLKI----IRGSY-----PPVS  222 (256)
T ss_pred             h--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH---HHHHHH----hcCCC-----CCCc
Confidence            1  22346889999999999889999999999999999999999987543221   111110    01110     0011


Q ss_pred             CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       482 ~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                         ......+.+++.+|++.+|.+||+|.+|++
T Consensus       223 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         223 ---SHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             ---ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence               111224557778999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.6e-36  Score=301.10  Aligned_cols=253  Identities=26%  Similarity=0.395  Sum_probs=205.3

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ++|+..+.||+|++|.||++... +++.|++|++..... .....+.+|+..+.+++|+||+++++++......++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            46888999999999999999976 589999999877654 3456789999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE-DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      +++++|.+++..   ...+++..++.++.|+++||.|||+ .+   ++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            999999999843   3679999999999999999999999 87   9999999999999999999999999998765433


Q ss_pred             ccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                      ...  ....++..|+|||.+..+.++.++||||||+++|||++|+.|+..........++.....    ..     .+.+
T Consensus       155 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~----~~-----~~~~  223 (264)
T cd06623         155 DQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD----GP-----PPSL  223 (264)
T ss_pred             Ccc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc----CC-----CCCC
Confidence            221  235688999999999999999999999999999999999999865443222222222211    10     0111


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      ...  .....+.+++..|++.+|++||++.|+++.
T Consensus       224 ~~~--~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         224 PAE--EFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             Ccc--cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            111  022355677789999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.3e-37  Score=318.95  Aligned_cols=194  Identities=23%  Similarity=0.358  Sum_probs=165.7

Q ss_pred             HHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ....+|++.+.||+|+||.||+|... +++.||+|......      ...|+.++++++|+||+++++++......++||
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            34568999999999999999999965 56789999754332      356899999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+. ++|.+++..  ....+++..++.|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            9995 577777643  3457999999999999999999999987   999999999999999999999999999753321


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCC
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSS  449 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~  449 (577)
                         .......||..|+|||++.+..++.++|||||||++|||+++..++.
T Consensus       211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f  257 (357)
T PHA03209        211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF  257 (357)
T ss_pred             ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence               11223579999999999999999999999999999999999876653

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.4e-36  Score=307.67  Aligned_cols=261  Identities=24%  Similarity=0.345  Sum_probs=196.4

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChh-----hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ-----GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      +|+..++||+|+||.||+|... +++.||||++......     ....+.+|+.++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778899999999999999964 6899999999765432     234567899999999999999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+ +++|.+++...  ...+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus        81 ~e~~-~~~L~~~i~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 89999988432  236999999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCccccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccc-hhhhh-------hhhhccc
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE-DLLTY-------AWRNWNE  469 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~-~l~~~-------~~~~~~~  469 (577)
                      ....  .....++..|+|||.+.+ ..++.++||||||+++|||++|..++......+.. .....       .|..+..
T Consensus       155 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (298)
T cd07841         155 PNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS  232 (298)
T ss_pred             CCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence            3211  122356788999998865 45789999999999999999997665433321111 11100       0000000


Q ss_pred             CCccccccCcCCCC------ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          470 GAALNLMDPTMRGG------STSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       470 ~~~~~~~d~~l~~~------~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                        ............      .......+.+++..|++.+|++|||+.||++.
T Consensus       233 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         233 --LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             --ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence              000000000000      11223456788899999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.7e-36  Score=311.56  Aligned_cols=199  Identities=21%  Similarity=0.288  Sum_probs=164.7

Q ss_pred             cccccccC--CcEEEEEeEe-cCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          248 DANKLGQG--GFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       248 ~~~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      ++++||+|  +||+||++.. .+|+.||+|++....  ......+++|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            46789999  7899999985 578999999997543  233345788999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      ++|+|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.++++||+...........
T Consensus        82 ~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            999999987432 2345899999999999999999999987   999999999999999999999999865433211100


Q ss_pred             -----ccccccccCCCCcChhhhhc--CCCCccccEEecchhHhHHhhCCCCCCC
Q 008108          403 -----SDTNRVVGTFGYMAPEYVMH--GRFSVKSDIFSFGVLVLEIVSGQKRSSF  450 (577)
Q Consensus       403 -----~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltG~~p~~~  450 (577)
                           .......++..|+|||++.+  ..++.++|||||||++|||++|+.||..
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence                 01112356788999999876  4589999999999999999999999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.5e-36  Score=301.62  Aligned_cols=254  Identities=27%  Similarity=0.409  Sum_probs=195.5

Q ss_pred             CCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChh----------hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC
Q 008108          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ----------GEIEFKNEVLLLARLQHRNLVRLLGFCLERK  313 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  313 (577)
                      +|...+.||+|+||.||+|.. .+|+.+|+|.+......          ....+.+|+.+++.++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            467788999999999999985 46899999987542111          1235788999999999999999999999999


Q ss_pred             eEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCc
Q 008108          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (577)
Q Consensus       314 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla  393 (577)
                      ..++||||+++++|.+++..   ...+++..+..++.||+.||.|||+++   ++||||+|+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            99999999999999998843   357999999999999999999999987   999999999999999999999999999


Q ss_pred             ccccCCCccccccccccCCCCcChhhhhcCC--CCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCC
Q 008108          394 RLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR--FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGA  471 (577)
Q Consensus       394 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  471 (577)
                      +...............|+..|+|||.+....  ++.++||||||+++||+++|+.|+......  ..+    ........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~----~~~~~~~~  229 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--AAM----FKLGNKRS  229 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--HHH----HHhhcccc
Confidence            7654322222223356889999999987655  889999999999999999999997532211  111    11111110


Q ss_pred             ccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          472 ALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       472 ~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                       ...++......   ....+.+++..|++.+|.+||++.+|++
T Consensus       230 -~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         230 -APPIPPDVSMN---LSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             -CCcCCcccccc---CCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence             11111111111   1234556778999999999999999885

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.2e-37  Score=316.86  Aligned_cols=260  Identities=23%  Similarity=0.354  Sum_probs=192.5

Q ss_pred             HhcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC------
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLER------  312 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  312 (577)
                      ..++|+..+.||+|+||.||++.. .+++.||||++.....  .....+.+|+.+++.++|+||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            357899999999999999999985 4688999999875422  2334577899999999999999999987543      


Q ss_pred             CeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCC
Q 008108          313 KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (577)
Q Consensus       313 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGl  392 (577)
                      ...++++|++ +++|.+++    ....+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus        93 ~~~~~~~~~~-~~~l~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIV----KCQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             CcEEEEeecC-CCCHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence            3568999988 77887766    2456999999999999999999999988   99999999999999999999999999


Q ss_pred             cccccCCCccccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccc-hhhhhh-------
Q 008108          393 ARLFEMDQTHSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE-DLLTYA-------  463 (577)
Q Consensus       393 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~-~l~~~~-------  463 (577)
                      ++.....     .....||..|+|||++.+ ..++.++||||||+++|||++|+.||......+.. .+....       
T Consensus       165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07878         165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV  239 (343)
T ss_pred             ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9865422     223578999999999876 56899999999999999999999998643321110 000000       


Q ss_pred             hhhcccCCcccccc--CcCCCCChH-----HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          464 WRNWNEGAALNLMD--PTMRGGSTS-----EMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       464 ~~~~~~~~~~~~~d--~~l~~~~~~-----~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ............+.  +........     ....+.+++..|++.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00000000000000  000000000     0123557888999999999999999885

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.3e-37  Score=299.26  Aligned_cols=270  Identities=23%  Similarity=0.285  Sum_probs=211.1

Q ss_pred             cCCccccccccCCcEEEEEeEecC-CcEEEEEEeccCChhhH---HHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGE---IEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|+.++.||.|.-|+||++.+.+ +..+|+|++.+......   .+.+.|-+||+.++||.++.||+.+..+...+|+|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            457778999999999999999764 58899999988654433   34567999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      |||+||+|..+.+. +..+.+++..+.-++.+++-||+|||-.|   ||.|||||+||||.++|.+.|+||.|+......
T Consensus       157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            99999999887643 56678999999999999999999999998   999999999999999999999999987533110


Q ss_pred             ---------------------------------Cc---------------------cccccccccCCCCcChhhhhcCCC
Q 008108          400 ---------------------------------QT---------------------HSDTNRVVGTFGYMAPEYVMHGRF  425 (577)
Q Consensus       400 ---------------------------------~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~  425 (577)
                                                       ..                     ...+...+||..|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                             00                     011234689999999999999999


Q ss_pred             CccccEEecchhHhHHhhCCCCCCCCCcccc-chhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCC
Q 008108          426 SVKSDIFSFGVLVLEIVSGQKRSSFGTEEET-EDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVS  504 (577)
Q Consensus       426 ~~~~Dv~SlGvil~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~  504 (577)
                      +.+.|+|+|||+|||||.|+.||.....++. .+++..              ++.+. ..+.....+.+|+...+.+||+
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~--------------~l~Fp-~~~~vs~~akDLIr~LLvKdP~  377 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ--------------PLKFP-EEPEVSSAAKDLIRKLLVKDPS  377 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC--------------CCcCC-CCCcchhHHHHHHHHHhccChh
Confidence            9999999999999999999999976655433 222211              11111 1223334555777788999999


Q ss_pred             CCCC----HHHHHH--HhcCCCCCCCCCCCCccc
Q 008108          505 NRPG----MASVVN--MLNGDTVTLPAPSKPAFF  532 (577)
Q Consensus       505 ~RPt----~~ev~~--~L~~~~~~~~~p~~p~~~  532 (577)
                      +|..    +.||-+  ..++..+.+..-..|++.
T Consensus       378 kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~i  411 (459)
T KOG0610|consen  378 KRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEI  411 (459)
T ss_pred             hhhccccchHHhhcCccccCCChhheeccCCCcC
Confidence            9998    666653  245555555444455543

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=6.3e-37  Score=310.31  Aligned_cols=248  Identities=24%  Similarity=0.375  Sum_probs=197.0

Q ss_pred             CccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCC
Q 008108          246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPN  324 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  324 (577)
                      |....+||+|+||.||++... +++.||+|.+..........+.+|+.++..++||||+++++++..++..+++|||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            344568999999999999864 6899999998765555556788999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcccc
Q 008108          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD  404 (577)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~  404 (577)
                      ++|..++    ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........  .
T Consensus       103 ~~L~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~  173 (297)
T cd06659         103 GALTDIV----SQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K  173 (297)
T ss_pred             CCHHHHH----hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--c
Confidence            9998876    2356899999999999999999999987   99999999999999999999999999976543221  1


Q ss_pred             ccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCC
Q 008108          405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGS  484 (577)
Q Consensus       405 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  484 (577)
                      .....|+..|+|||++.+..++.++||||||+++|||++|+.|+......+.   +...    ........   ......
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~~~----~~~~~~~~---~~~~~~  243 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MKRL----RDSPPPKL---KNAHKI  243 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH----hccCCCCc---cccCCC
Confidence            2235689999999999988999999999999999999999999864332211   1111    00000000   000011


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          485 TSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       485 ~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      .   ..+.+++..|++.+|++||++.++++.
T Consensus       244 ~---~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         244 S---PVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             C---HHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            1   234567779999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.7e-36  Score=299.80  Aligned_cols=251  Identities=32%  Similarity=0.535  Sum_probs=197.5

Q ss_pred             CccccccccCCcEEEEEeEecC-----CcEEEEEEeccCChh-hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          246 FSDANKLGQGGFGAVYKGMLSN-----GETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      |++.+.||.|+||.||++...+     +..||+|.+...... ....+.+|+.++..++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4567899999999999999653     388999999766543 4567899999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++++|.+++... ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||+++.....
T Consensus        81 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKN-RPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhh-hhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            999999999988542 1122999999999999999999999987   999999999999999999999999999876544


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      ...... ...++..|+|||.+....++.++||||||++++||++ |+.|+......   .+.....    .....     
T Consensus       157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~~----~~~~~-----  223 (258)
T smart00219      157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVLEYLK----KGYRL-----  223 (258)
T ss_pred             cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHh----cCCCC-----
Confidence            222221 2337889999999988889999999999999999999 66665432221   1121111    11100     


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNML  516 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L  516 (577)
                      ......   ...+.+++.+|++.+|++|||+.|+++.|
T Consensus       224 ~~~~~~---~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 PKPENC---PPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCCcC---CHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            001112   23455688899999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.8e-37  Score=309.75  Aligned_cols=262  Identities=24%  Similarity=0.382  Sum_probs=197.9

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChh--hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      ++|+..++||+|+||.||++... +++.||+|++.+....  ....+.+|+++++.++|+||+++++++..+...++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999975 5899999998654322  34467899999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |+++++|+.+..   ....+++..++.++.||++||.|||+.+   |+||||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            999999987763   2345899999999999999999999987   9999999999999999999999999998654332


Q ss_pred             ccccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCcccc-chhhhhhhhhccc--------C
Q 008108          401 THSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET-EDLLTYAWRNWNE--------G  470 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~--------~  470 (577)
                      .  ......++..|+|||++.+ ..++.++||||||+++|||++|+.|+......+. ..+.... ..+..        .
T Consensus       155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  231 (286)
T cd07846         155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCL-GNLIPRHQEIFQKN  231 (286)
T ss_pred             c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHh-CCCchhhHHHhccc
Confidence            1  2223568899999999875 4578899999999999999999988754332111 1111100 00000        0


Q ss_pred             Cc-cccccCcCCCC------ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          471 AA-LNLMDPTMRGG------STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       471 ~~-~~~~d~~l~~~------~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .. .....+.....      .......+.+++.+|++.+|++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            00 00000110000      0111245667888999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-38  Score=328.40  Aligned_cols=251  Identities=31%  Similarity=0.498  Sum_probs=209.1

Q ss_pred             CccccccccCCcEEEEEeEe-cCCc----EEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          246 FSDANKLGQGGFGAVYKGML-SNGE----TIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ....++||+|.||+||+|.+ +.|+    +||||.+... ..+...++.+|+..|.+++||||++|+|+|.... +.||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            44578999999999999995 4444    5899988665 3455678999999999999999999999998776 78999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      +||+.|+|.+++..  .+..+-.+..+.|..|||+||.|||++.   ++||||..+||||.+-..+||.|||+++....+
T Consensus       777 q~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            99999999999864  5678999999999999999999999887   999999999999999999999999999998877


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      ..........-.+.|||-|.+....|+.++|||||||++||++| |.+|......++..++++...+             
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-------------  918 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-------------  918 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-------------
Confidence            66655555566788999999999999999999999999999998 6677765555555555543221             


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                        .+..+.-...+-.+++.||..|+..||+++++...+.
T Consensus       919 --LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs  955 (1177)
T KOG1025|consen  919 --LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFS  955 (1177)
T ss_pred             --CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHH
Confidence              1123333455667888999999999999999887754

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.1e-36  Score=309.16  Aligned_cols=197  Identities=28%  Similarity=0.461  Sum_probs=159.2

Q ss_pred             ccccccCCcEEEEEeEec---CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEc--CCeEEEEEEecC
Q 008108          249 ANKLGQGGFGAVYKGMLS---NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE--RKERILVYEFVP  323 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E~~~  323 (577)
                      ..+||+|+||+||+|...   ++..||+|.+.....  ...+.+|+.++++++||||+++++++..  +...++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            468999999999999964   357899999875432  2357889999999999999999998854  457789999987


Q ss_pred             CCCcccccccC------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEE----cCCCCeEEeccCCc
Q 008108          324 NASLDHFIFDP------INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL----DSEMNPKISDFGMA  393 (577)
Q Consensus       324 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl----~~~~~~kl~DfGla  393 (577)
                      + +|.+++...      .....+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 555544211      12235899999999999999999999987   9999999999999    56678999999999


Q ss_pred             ccccCCCcc-ccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCC
Q 008108          394 RLFEMDQTH-SDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFG  451 (577)
Q Consensus       394 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~  451 (577)
                      +........ .......||..|+|||++.+. .++.++||||||+++|||+||+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            876543221 222345789999999998764 5899999999999999999999998643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.6e-36  Score=306.23  Aligned_cols=261  Identities=26%  Similarity=0.398  Sum_probs=200.7

Q ss_pred             ChHHHHHHhcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcC
Q 008108          235 DFETIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLER  312 (577)
Q Consensus       235 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  312 (577)
                      .+..+..++++|++.+.||+|+||.||++.. .+++.+|+|.+..... ....+.+|+.++.++ +|||++++++++...
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            3455556788999999999999999999996 4688999999865432 234677899999999 899999999998754


Q ss_pred             -----CeEEEEEEecCCCCcccccccC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeE
Q 008108          313 -----KERILVYEFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPK  386 (577)
Q Consensus       313 -----~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~k  386 (577)
                           ...++||||+++++|.+++... .....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+|
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k  168 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK  168 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence                 3579999999999998877432 23457899999999999999999999987   99999999999999999999


Q ss_pred             EeccCCcccccCCCccccccccccCCCCcChhhhhcCC-----CCccccEEecchhHhHHhhCCCCCCCCCccccchhhh
Q 008108          387 ISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR-----FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLT  461 (577)
Q Consensus       387 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~  461 (577)
                      |+|||++.........  .....|+..|+|||.+..+.     ++.++|||||||++|||++|+.|+.......  .+..
T Consensus       169 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~--~~~~  244 (291)
T cd06639         169 LVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK--TLFK  244 (291)
T ss_pred             Eeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH--HHHH
Confidence            9999999865432221  12346889999999886543     6899999999999999999999876432211  1111


Q ss_pred             hhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          462 YAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       462 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                           +.......+.++      ......+.+++.+|++.+|++||++.|+++
T Consensus       245 -----~~~~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         245 -----IPRNPPPTLLHP------EKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             -----HhcCCCCCCCcc------cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                 001111111111      111234667888999999999999999885

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.3e-36  Score=309.21  Aligned_cols=257  Identities=21%  Similarity=0.288  Sum_probs=200.2

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|+..+.||+|+||.||++... .++.|++|.+.....   .....+.+|+.+++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888999999999999999964 578999999876532   23346788999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++++|.+++.   ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~g~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLK---NIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            9999999999984   3457899999999999999999999987   999999999999999999999999998742111


Q ss_pred             Ccc-------------ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhh
Q 008108          400 QTH-------------SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRN  466 (577)
Q Consensus       400 ~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~  466 (577)
                      ...             .......|+..|+|||++....++.++||||||+++|||++|+.|+......   .+.....  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---~~~~~~~--  229 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELFGQVI--  229 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH--
Confidence            100             0111246788999999998889999999999999999999999998543222   1111110  


Q ss_pred             cccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCC
Q 008108          467 WNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD  519 (577)
Q Consensus       467 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~  519 (577)
                        .+   ....+......+   ..+..++.+|++.+|++||++.++.+.|+..
T Consensus       230 --~~---~~~~~~~~~~~~---~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~  274 (305)
T cd05609         230 --SD---DIEWPEGDEALP---ADAQDLISRLLRQNPLERLGTGGAFEVKQHR  274 (305)
T ss_pred             --hc---ccCCCCccccCC---HHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence              00   001111111112   2345778899999999999988788877763

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.7e-36  Score=299.34  Aligned_cols=254  Identities=25%  Similarity=0.397  Sum_probs=198.5

Q ss_pred             CCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEc--CCeEEEEE
Q 008108          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLE--RKERILVY  319 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  319 (577)
                      +|++.+.||.|+||.||++.. .+++.+|+|.+....  ......+.+|+.+++.++|+||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            478889999999999999985 467899999986542  3334568899999999999999999998764  44678999


Q ss_pred             EecCCCCcccccccC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCcEEEeccCCCcEEEcCCCCeEEeccCCcccc
Q 008108          320 EFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDS--RLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (577)
Q Consensus       320 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~  396 (577)
                      ||+++++|.+++... .....+++..++.++.||+.||.|||..+  ..+++|+||||+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999888542 22457999999999999999999999332  223999999999999999999999999999876


Q ss_pred             cCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          397 EMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       397 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      ......  .....|+..|+|||.+....++.++||||||+++|+|++|+.|+......   .+....    ..+..    
T Consensus       161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~----~~~~~----  227 (265)
T cd08217         161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASKI----KEGKF----  227 (265)
T ss_pred             cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHHH----hcCCC----
Confidence            543321  22356899999999999889999999999999999999999998654321   111111    11110    


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                       +.+.   ......+.+++..|++.+|++||++.+|++.
T Consensus       228 -~~~~---~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         228 -RRIP---YRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             -CCCc---cccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence             1111   1222455678889999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=314.28  Aligned_cols=243  Identities=29%  Similarity=0.443  Sum_probs=194.4

Q ss_pred             CccccccccCCcEEEEEeEe-cCCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          246 FSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      |+.++.||.|+||.||.+.. .+.+.||||++.-..+   ..+..+..|+..|.+++|||++.+.|+|..+...||||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            66678999999999999994 5778899999976544   3455788999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      |-| |-.+++.  ..++++.+.++..|..+.+.||+|||+.+   .||||||..||||++.|.|||+|||.|....+   
T Consensus       108 ClG-SAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---  178 (948)
T KOG0577|consen  108 CLG-SASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP---  178 (948)
T ss_pred             Hhc-cHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence            955 5555542  24678999999999999999999999998   99999999999999999999999999987553   


Q ss_pred             cccccccccCCCCcChhhhh---cCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          402 HSDTNRVVGTFGYMAPEYVM---HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                         .+.++||+.|||||++.   .|+|+-|+||||||++..||.-.++|....+.-.  .+.     ....+     -.|
T Consensus       179 ---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS--ALY-----HIAQN-----esP  243 (948)
T KOG0577|consen  179 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALY-----HIAQN-----ESP  243 (948)
T ss_pred             ---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH--HHH-----HHHhc-----CCC
Confidence               33478999999999984   5899999999999999999999887754322111  111     11111     123


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .|..  .+-...+..++-.|++.-|.+|||..+++.
T Consensus       244 tLqs--~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  244 TLQS--NEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             CCCC--chhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            3432  233334456777999999999999998764

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.4e-36  Score=298.13  Aligned_cols=250  Identities=25%  Similarity=0.360  Sum_probs=192.1

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC-----hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC--CeE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS-----KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KER  315 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  315 (577)
                      .+|+..++||+|+||.||+|... +++.||||.+....     ......+.+|+.++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57889999999999999999964 58999999875321     12234678899999999999999999998764  467


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      +++|||+++++|.+++.   ....+++..+++++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLK---SYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            89999999999998874   3356899999999999999999999987   99999999999999999999999999986


Q ss_pred             ccCCCc-cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccc
Q 008108          396 FEMDQT-HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALN  474 (577)
Q Consensus       396 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  474 (577)
                      ...... ........|+..|+|||.+.+..++.++||||||+++|||++|+.|+.......  ....    .....    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~----~~~~~----  225 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA--AIFK----IATQP----  225 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH--HHHH----HhcCC----
Confidence            542211 112223568899999999988889999999999999999999999985332111  1111    00000    


Q ss_pred             cccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          475 LMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       475 ~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                       ..+...   ......+..++..|+. +|++||+++||++
T Consensus       226 -~~~~~~---~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         226 -TNPVLP---PHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             -CCCCCc---hhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence             011111   1222344456667774 8999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-36  Score=338.89  Aligned_cols=255  Identities=23%  Similarity=0.384  Sum_probs=195.4

Q ss_pred             HHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC--CeE
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KER  315 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  315 (577)
                      ...++|.+.++||+|+||+||++... +++.||+|.+....  ......+..|+.++..++|||||++++++.+.  ...
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            44578999999999999999999964 57789999886542  23345688999999999999999999988643  568


Q ss_pred             EEEEEecCCCCcccccccCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCC----CcEEEeccCCCcEEEcCC--------
Q 008108          316 ILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSR----LRIIHRDLKASNILLDSE--------  382 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~----~~iiHrDlkp~NiLl~~~--------  382 (577)
                      +|||||+++|+|.++|.... ....+++..++.|+.||+.||.|||+.+.    .+|+||||||+||||+.+        
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            99999999999998885422 23579999999999999999999998541    249999999999999642        


Q ss_pred             ---------CCeEEeccCCcccccCCCccccccccccCCCCcChhhhhc--CCCCccccEEecchhHhHHhhCCCCCCCC
Q 008108          383 ---------MNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH--GRFSVKSDIFSFGVLVLEIVSGQKRSSFG  451 (577)
Q Consensus       383 ---------~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltG~~p~~~~  451 (577)
                               +.+||+|||++.......   ......||+.|+|||++.+  ..++.++||||||||||||+||+.||...
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             ccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                     348999999998654322   1223579999999999864  45889999999999999999999998543


Q ss_pred             CccccchhhhhhhhhcccCCccccccCcCC-CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          452 TEEETEDLLTYAWRNWNEGAALNLMDPTMR-GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       452 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ..  ...++.    .....       +.+. ....   ..+.+|+..||+.+|.+||++.|++.
T Consensus       247 ~~--~~qli~----~lk~~-------p~lpi~~~S---~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        247 NN--FSQLIS----ELKRG-------PDLPIKGKS---KELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             Cc--HHHHHH----HHhcC-------CCCCcCCCC---HHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            22  111111    11111       1111 1112   34557778999999999999999983

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.6e-36  Score=301.68  Aligned_cols=253  Identities=26%  Similarity=0.404  Sum_probs=199.9

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ++|+..+.||+|++|.||++... +++.+|+|++.... .....++.+|++++++++||||+++++.+......++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36788899999999999999975 68899999987654 34455688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE-DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      +++++|.+++...  ...+++..+..++.|++.+|.|||+ .+   ++||||||+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            9999999988542  2678999999999999999999999 76   9999999999999999999999999987654221


Q ss_pred             ccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                      ..    ...++..|+|||.+.+..++.++||||||+++|+|++|+.|+...... ............ ...     .+.+
T Consensus       156 ~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~-~~~-----~~~~  224 (265)
T cd06605         156 AK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIV-NEP-----PPRL  224 (265)
T ss_pred             hh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHh-cCC-----CCCC
Confidence            11    156889999999999999999999999999999999999998644211 111111111111 110     0111


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ...  .....+.+++..|+..+|++|||+.+++.
T Consensus       225 ~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         225 PSG--KFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             Chh--hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            111  01234557778999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=305.67  Aligned_cols=264  Identities=20%  Similarity=0.334  Sum_probs=199.9

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      ++|+..++||+|+||.||+|... +++.||+|++....  ......+.+|++++++++|+||+++++++..++..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999965 58899999886542  2334568899999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |++++.|..++.   +...+++..+..++.||+.||.|||+.+   ++||||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            999887766552   3456899999999999999999999987   9999999999999999999999999998765443


Q ss_pred             ccccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhh--------hhcccCC
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAW--------RNWNEGA  471 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~~~  471 (577)
                      .. ......++..|+|||++... .++.++||||||+++|+|++|+.|+......+....+...+        ..+....
T Consensus       155 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         155 AS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             cc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence            21 22235688999999999888 88999999999999999999998886443221111111100        0000000


Q ss_pred             cc---ccccCcCCC----CCh-HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          472 AL---NLMDPTMRG----GST-SEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       472 ~~---~~~d~~l~~----~~~-~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ..   +..+.....    ... ....++.+++..||+.+|++||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            00   000000000    000 11345678888999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.3e-36  Score=297.59  Aligned_cols=248  Identities=24%  Similarity=0.383  Sum_probs=197.2

Q ss_pred             CCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      +|+..+.||+|+||.||++.. .+++.+|+|.+....  ......+.+|+.++++++|+||+++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            578899999999999999985 468889999986543  23345688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC-CeEEeccCCcccccCCC
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-NPKISDFGMARLFEMDQ  400 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~-~~kl~DfGla~~~~~~~  400 (577)
                      +++++|.+++... ....+++..+..++.+++.+|.|||+++   ++||||||+||+++.++ .+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            9999999988542 2345899999999999999999999987   99999999999998654 58999999998764332


Q ss_pred             ccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                         ......|+..|+|||.+.+..++.++||||||+++|+|++|+.|+.......   ......    ......+     
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~----~~~~~~~-----  221 (256)
T cd08220         157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVLKIM----SGTFAPI-----  221 (256)
T ss_pred             ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHHHHH----hcCCCCC-----
Confidence               1223568899999999998889999999999999999999999875433211   111111    0000011     


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ...   ....+..++..||+.+|++|||+.|+++
T Consensus       222 ~~~---~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         222 SDR---YSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CCC---cCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            111   1224557888999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-36  Score=305.43  Aligned_cols=253  Identities=25%  Similarity=0.308  Sum_probs=198.2

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChh---hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ---GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|+..+.||+|+||.||++... +++.+|+|.+......   ....+.+|++++..++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            46888999999999999999965 4899999999765432   3446889999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+.+++|.+++.. .....+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            99999999998743 23457999999999999999999999987   999999999999999999999999998755322


Q ss_pred             Ccc---------------------------ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCC
Q 008108          400 QTH---------------------------SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGT  452 (577)
Q Consensus       400 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~  452 (577)
                      ...                           .......||..|+|||++.+..++.++||||||+++|+|++|+.|+....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            110                           01123468999999999998889999999999999999999999986433


Q ss_pred             ccccchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCC----HHHHHH
Q 008108          453 EEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPG----MASVVN  514 (577)
Q Consensus       453 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt----~~ev~~  514 (577)
                      ....   ....   ....       .... ........+.+++.+|++.+|++||+    +.|+++
T Consensus       237 ~~~~---~~~~---~~~~-------~~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         237 RDET---FSNI---LKKE-------VTFP-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             hHHH---HHHH---hcCC-------ccCC-CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            2211   1100   0000       0000 01112235567778999999999999    555444

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=6.2e-36  Score=299.80  Aligned_cols=247  Identities=26%  Similarity=0.421  Sum_probs=197.4

Q ss_pred             CCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      -|+..++||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.++.+++|+||+++++++..++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            366788999999999999985 468899999986543 233456889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      ++++|.+++.    ...+++..+..++.|++.+|.|||+.+   ++|+||||+||+++.++.++|+|||++........ 
T Consensus        85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06641          85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence            9999998873    346899999999999999999999987   99999999999999999999999999876543221 


Q ss_pred             ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCC
Q 008108          403 SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG  482 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  482 (577)
                       ......++..|+|||++.+..++.++||||||+++|+|++|..|+.......   ....    .....     .+.+..
T Consensus       157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~----~~~~~-----~~~~~~  223 (277)
T cd06641         157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---VLFL----IPKNN-----PPTLEG  223 (277)
T ss_pred             -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---HHHH----HhcCC-----CCCCCc
Confidence             1223568899999999988889999999999999999999999875332211   1110    00000     011111


Q ss_pred             CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          483 GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       483 ~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      ..   ...+.+++.+|++.+|.+||++.++++.
T Consensus       224 ~~---~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         224 NY---SKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             cc---CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            11   2345577889999999999999999974

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-36  Score=303.76  Aligned_cols=261  Identities=23%  Similarity=0.389  Sum_probs=195.1

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChh-hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ++|+..++||+|++|.||+|... +++.||+|.+...... ....+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            67899999999999999999965 6889999998754322 223567899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++ +|.+++.+  ....+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++.......
T Consensus        85 ~~~-~L~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LDT-DLKQYMDD--CGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            985 88887743  2347899999999999999999999987   99999999999999999999999999875432211


Q ss_pred             cccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccC---Ccccc--
Q 008108          402 HSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEG---AALNL--  475 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~--  475 (577)
                      .  .....++..|+|||++.+ ..++.++||||||+++|||++|+.||......  .+.+...+..+...   .....  
T Consensus       159 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         159 T--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             c--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhhhhh
Confidence            1  112346889999998875 45889999999999999999999988543311  11111111111000   00000  


Q ss_pred             -----------c-cCcCCCC--ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          476 -----------M-DPTMRGG--STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       476 -----------~-d~~l~~~--~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                                 . ...+...  .......+.+++..|++.+|++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                       0 0000000  0111245667888999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.5e-36  Score=302.23  Aligned_cols=248  Identities=25%  Similarity=0.380  Sum_probs=198.1

Q ss_pred             CCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecC
Q 008108          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVP  323 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  323 (577)
                      .|...++||+|++|.||++.. .+++.+++|++..........+.+|+.+++.++|+||+++++++...+..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            455568999999999999985 4688999999876555555668899999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccc
Q 008108          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS  403 (577)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~  403 (577)
                      +++|.+++..    ..+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.++|+|||++........  
T Consensus       100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--  170 (285)
T cd06648         100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--  170 (285)
T ss_pred             CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence            9999988743    56899999999999999999999987   99999999999999999999999999875543221  


Q ss_pred             cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCC
Q 008108          404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGG  483 (577)
Q Consensus       404 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  483 (577)
                      ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+........   .....    ...     .+.+.. 
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~---~~~~~----~~~-----~~~~~~-  237 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA---MKRIR----DNL-----PPKLKN-  237 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH---HHHHH----hcC-----CCCCcc-
Confidence            12235689999999999888899999999999999999999999754332111   11111    000     011110 


Q ss_pred             ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          484 STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       484 ~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .......+.+++.+|++.+|++||++.++++
T Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            0011235667888999999999999998885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-36  Score=299.52  Aligned_cols=247  Identities=25%  Similarity=0.428  Sum_probs=196.7

Q ss_pred             CCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcC---CCCeEEEEeEEEcCCeEEEEE
Q 008108          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQ---HRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  319 (577)
                      .|+..++||+|+||.||+|.. .+++.+|+|.+.... .....++.+|+.++++++   |||++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477889999999999999995 568999999987543 333456889999999996   999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++++|.+++.    ...+++..++.++.|++.||.|||+.+   |+||||+|+||++++++.++|+|||++......
T Consensus        82 e~~~~~~L~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMK----AGPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            9999999988873    237999999999999999999999988   999999999999999999999999999876543


Q ss_pred             CccccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      ..  ......|+..|+|||.+..+ .++.++||||||+++|+|++|+.|+...........+       ..     ...+
T Consensus       155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~-------~~-----~~~~  220 (277)
T cd06917         155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI-------PK-----SKPP  220 (277)
T ss_pred             cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc-------cc-----CCCC
Confidence            32  22235689999999998765 4689999999999999999999998643221111000       00     0111


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .+...  .....+.+++..|++.+|++||++.|+++
T Consensus       221 ~~~~~--~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         221 RLEDN--GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCCcc--cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            12111  02234557778999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4.6e-36  Score=303.39  Aligned_cols=250  Identities=25%  Similarity=0.417  Sum_probs=200.8

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      ++|...+.||+|+||.||++.. .+++.|++|.+..........+.+|+.++++++||||+++++++...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            6788999999999999999985 467899999987655555567889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      ++++|.+++.    +..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........ 
T Consensus        99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-  170 (293)
T cd06647          99 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (293)
T ss_pred             CCCcHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence            9999998873    346889999999999999999999988   99999999999999999999999999876543322 


Q ss_pred             ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCC
Q 008108          403 SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG  482 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  482 (577)
                       ......|++.|+|||.+..+.++.++||||||+++||+++|+.||........   +....   ..+.      +... 
T Consensus       171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~---~~~~~---~~~~------~~~~-  236 (293)
T cd06647         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYLIA---TNGT------PELQ-  236 (293)
T ss_pred             -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh---eeehh---cCCC------CCCC-
Confidence             12234688999999999888899999999999999999999999864332111   11000   0000      0000 


Q ss_pred             CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          483 GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       483 ~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      ........+.+++..||+.+|++||++.+++..
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            001112245577889999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.9e-36  Score=304.53  Aligned_cols=259  Identities=22%  Similarity=0.359  Sum_probs=193.0

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      +|+..++||+|+||.||++... +|+.+|+|++.....  .....+.+|+.++++++|+||+++++++.+....++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999964 689999999865422  2234577899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++ +|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++.......
T Consensus        81 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          81 CDQ-DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            975 67666532  2456999999999999999999999987   99999999999999999999999999986543221


Q ss_pred             cccccccccCCCCcChhhhhcCC-CCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhh-----------hhhccc
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA-----------WRNWNE  469 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~-----------~~~~~~  469 (577)
                        ......++..|+|||++.+.. ++.++||||||+++|||+||+.|+.......  ..+...           |.....
T Consensus       155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhh
Confidence              122346789999999987654 7899999999999999999999864332211  111111           110000


Q ss_pred             CCccccccCcCCCC------ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          470 GAALNLMDPTMRGG------STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       470 ~~~~~~~d~~l~~~------~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ....... +.....      .......+.+++..|++.||.+|||+.++++
T Consensus       231 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         231 LPDYKPY-PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccccccc-CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0000000 000000      0111234557888999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4.2e-36  Score=301.68  Aligned_cols=259  Identities=27%  Similarity=0.420  Sum_probs=198.9

Q ss_pred             ChHHHHHHhcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEc-
Q 008108          235 DFETIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLE-  311 (577)
Q Consensus       235 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-  311 (577)
                      ++..+......|+..+.||+|+||.||+|.. .+++.+|+|.+..... ...++..|+.++.++ +|+||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            4455556678899999999999999999996 4688999999865433 334678899999998 79999999999853 


Q ss_pred             -----CCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeE
Q 008108          312 -----RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPK  386 (577)
Q Consensus       312 -----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~k  386 (577)
                           ....+++|||+++|+|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+||++++++.++
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence                 45789999999999999887542 2346889999999999999999999987   99999999999999999999


Q ss_pred             EeccCCcccccCCCccccccccccCCCCcChhhhh-----cCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhh
Q 008108          387 ISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM-----HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLT  461 (577)
Q Consensus       387 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~  461 (577)
                      |+|||++.......  .......|+..|+|||.+.     ...++.++||||||+++|||++|+.||........  +..
T Consensus       162 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~--~~~  237 (282)
T cd06636         162 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA--LFL  237 (282)
T ss_pred             EeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh--hhh
Confidence            99999987654221  1223357899999999875     34678899999999999999999999854322111  110


Q ss_pred             hhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          462 YAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       462 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                       ...         ...+.+...  .....+.+++..||+.||.+||++.|+++
T Consensus       238 -~~~---------~~~~~~~~~--~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         238 -IPR---------NPPPKLKSK--KWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             -Hhh---------CCCCCCccc--ccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence             000         000111100  11234567788999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-37  Score=316.93  Aligned_cols=247  Identities=27%  Similarity=0.381  Sum_probs=199.1

Q ss_pred             cccccccCCcEEEEEeEec--CCc--EEEEEEeccCChh-hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          248 DANKLGQGGFGAVYKGMLS--NGE--TIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       248 ~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      ..++||+|.||.|++|.|.  +|+  .||||.+...... ....|.+|+.+|.+|+|+|+++|||+..+ ....+|+|.+
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            3688999999999999975  344  4899999877554 45579999999999999999999999988 6778999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      +.|+|.+.|++ ..+..|-......++.|||.||.||..++   +|||||..+|+||-....+||+||||.+.+..++..
T Consensus       193 plGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~  268 (1039)
T KOG0199|consen  193 PLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM  268 (1039)
T ss_pred             ccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence            99999999976 56677888999999999999999999987   999999999999999999999999999988765544


Q ss_pred             ccc-cccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCC-CCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          403 SDT-NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ-KRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       403 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                      ... ....-.+.|.|||.+..+.++.++|||+|||+||||+|+. .||-.-..-                .+++.+|..-
T Consensus       269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~----------------qIL~~iD~~e  332 (1039)
T KOG0199|consen  269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI----------------QILKNIDAGE  332 (1039)
T ss_pred             eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH----------------HHHHhccccc
Confidence            322 2234467899999999999999999999999999999965 455332221                1222223111


Q ss_pred             -CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          481 -RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       481 -~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                       .........++.++++.||..+|++|||+..+.+.
T Consensus       333 rLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  333 RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence             11122334556688889999999999999999743

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-36  Score=306.57  Aligned_cols=205  Identities=28%  Similarity=0.423  Sum_probs=168.6

Q ss_pred             CCccccccccCCcEEEEEeEec---CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC--CeEE
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS---NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KERI  316 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  316 (577)
                      .|+..++||+|+||.||+|...   +++.||+|.+....   ......+.+|+.++..++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778899999999999999964   47899999998743   33334578899999999999999999999988  7899


Q ss_pred             EEEEecCCCCcccccccCC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC----CCCeEEecc
Q 008108          317 LVYEFVPNASLDHFIFDPI--NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS----EMNPKISDF  390 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~----~~~~kl~Df  390 (577)
                      +||||+++ +|..++....  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999976 5555443211  2236899999999999999999999987   999999999999999    899999999


Q ss_pred             CCcccccCCCc-cccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCc
Q 008108          391 GMARLFEMDQT-HSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTE  453 (577)
Q Consensus       391 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~  453 (577)
                      |+++....... ........++..|+|||++.+. .++.++||||||+++|||++|+.|+.....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~  221 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA  221 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence            99987643322 1223345788999999988764 578999999999999999999999865443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=9.1e-36  Score=295.85  Aligned_cols=252  Identities=27%  Similarity=0.442  Sum_probs=198.6

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChh--hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      +|+..+.||+|+||.||+|... +++.|++|.+......  ....+.+|+.++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4778899999999999999864 6889999998765443  556789999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|.+++..   ...+++..+..++.|+++||.|||+.+   |+|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            999999998843   446899999999999999999999988   99999999999999999999999999987654332


Q ss_pred             ccc--ccccccCCCCcChhhhhcCC---CCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          402 HSD--TNRVVGTFGYMAPEYVMHGR---FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       402 ~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      ...  .....++..|+|||++....   ++.++||||||+++|||++|+.||.......  ...   +... .+.     
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~--~~~---~~~~-~~~-----  223 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF--QIM---FHVG-AGH-----  223 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH--HHH---HHHh-cCC-----
Confidence            211  12356788999999998766   8899999999999999999999985432111  111   0000 000     


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .+.+... ......+.+++..|++.+|.+||++.|++.
T Consensus       224 ~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         224 KPPIPDS-LQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCCcc-cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            1111111 111233457778999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.5e-36  Score=302.95  Aligned_cols=243  Identities=27%  Similarity=0.339  Sum_probs=196.0

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|+..+.||+|+||.||++... +++.+|+|.+....   ......+.+|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888999999999999999965 68999999986542   223345789999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||+|+|||++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            99999999988743   467999999999999999999999987   999999999999999999999999999876433


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                           .....|++.|+|||.+.+...+.++||||||+++|+|++|+.|+.......   .....    ..+.      ..
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~----~~~~------~~  216 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ---IYEKI----LEGK------VR  216 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH----hcCC------cc
Confidence                 233568999999999988889999999999999999999999986443211   11110    0110      01


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCC-----CHHHHH
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRP-----GMASVV  513 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RP-----t~~ev~  513 (577)
                      +....   ...+.+++..|++.+|.+||     +++|++
T Consensus       217 ~~~~~---~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         217 FPSFF---SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             CCccC---CHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence            11111   13445677899999999999     566555

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.8e-35  Score=291.94  Aligned_cols=251  Identities=27%  Similarity=0.422  Sum_probs=202.1

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC--CeEEEEE
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KERILVY  319 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  319 (577)
                      +|...+.||+|++|.||+|... +++.|++|.+.....  .....+.+|+.++++++|+||+++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4777899999999999999976 689999999876543  3455788999999999999999999999988  8899999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++++|.+++..   ...+++..++.++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            99999999998843   348999999999999999999999987   999999999999999999999999999877654


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                      ..........++..|+|||.+.....+.++||||||+++|+|++|+.|+.....     .....+........     +.
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~-----~~  224 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIGSSGEP-----PE  224 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhccccCCC-----cC
Confidence            332122345788999999999888899999999999999999999999865431     11111111110111     11


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      +....   ...+.+++.+|++.+|.+||++.++++
T Consensus       225 ~~~~~---~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         225 IPEHL---SEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CCccc---CHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            11111   235567778999999999999999885

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4.3e-36  Score=301.94  Aligned_cols=260  Identities=23%  Similarity=0.342  Sum_probs=197.8

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      +|++.+.||+|+||.||+|... +|+.||+|++....  ......+.+|+.++++++|+||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788899999999999999964 68999999987654  23345688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      + +++|.+++..  ....+++.+++.++.||+++|.|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRD--EERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 9999988754  2356999999999999999999999987   99999999999999999999999999987654322


Q ss_pred             cccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccC----------
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEG----------  470 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~----------  470 (577)
                       .......|+..|+|||.+.+. .++.++||||||+++|||++|+.++.......   .+..........          
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccC
Confidence             112235689999999988654 46899999999999999999976664332211   111111111000          


Q ss_pred             --CccccccCcCCCC-----ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          471 --AALNLMDPTMRGG-----STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       471 --~~~~~~d~~l~~~-----~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                        ....+..+.....     ..+....+.+++.+|++.+|++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence              0000000000000     0112245667888999999999999999885

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=7.6e-36  Score=299.95  Aligned_cols=261  Identities=25%  Similarity=0.396  Sum_probs=197.8

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChh-hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      +|+..++||+|++|.||+|... +|+.||||.+...... ....+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5888999999999999999975 6889999998765432 2345678999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      ++ +|.+++........+++..+..++.||+.||.|||+.+   ++||||||+||++++++.++|+|||+++....... 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 78777754333457999999999999999999999987   99999999999999999999999999976543221 


Q ss_pred             ccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccch-hhhh-------hhhhcccCCcc
Q 008108          403 SDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETED-LLTY-------AWRNWNEGAAL  473 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~-l~~~-------~~~~~~~~~~~  473 (577)
                       ......++..|++||.+.+. .++.++||||||+++|||++|+.|+......+... ++..       .|..+...   
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  231 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL---  231 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcC---
Confidence             12234578899999988664 56899999999999999999999986544322111 1110       01111100   


Q ss_pred             ccccCcCCC---C-----ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          474 NLMDPTMRG---G-----STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       474 ~~~d~~l~~---~-----~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .........   .     .+.....+.+++..|++.+|.+||++.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000000000   0     0111234567888999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=6.2e-36  Score=301.98  Aligned_cols=263  Identities=24%  Similarity=0.363  Sum_probs=194.8

Q ss_pred             HhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChh-hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++++|...+.||+|+||.||+|... +|+.||+|++...... ....+.+|+.+++.++|+||+++++++..++..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            3578999999999999999999854 6889999998755332 2335678999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||++ ++|..++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            9996 566555532  2346888999999999999999999987   999999999999999999999999999754322


Q ss_pred             CccccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCC-------
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGA-------  471 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-------  471 (577)
                      ..  ......++..|+|||.+.+. .++.++||||||+++|||++|+.||......  ...+...|..+....       
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07870         157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGV  232 (291)
T ss_pred             CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhh
Confidence            11  12234578999999988754 5788999999999999999999998643321  122222221111000       


Q ss_pred             ------cccccc---C-cCCC--CChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          472 ------ALNLMD---P-TMRG--GSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       472 ------~~~~~d---~-~l~~--~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                            ..+...   + .+..  ........+.+++.+|++.||++|||+.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                  000000   0 0000  00011234557788999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-36  Score=298.72  Aligned_cols=255  Identities=26%  Similarity=0.422  Sum_probs=198.2

Q ss_pred             HHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCC-----
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERK-----  313 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-----  313 (577)
                      .++++|+..+.||+|++|.||+|... +++.+++|.+..... ....+.+|+.+++++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            35689999999999999999999974 578899999876544 335689999999999 7999999999997644     


Q ss_pred             -eEEEEEEecCCCCcccccccCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccC
Q 008108          314 -ERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG  391 (577)
Q Consensus       314 -~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfG  391 (577)
                       ..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence             4899999999999988875422 2457999999999999999999999987   9999999999999999999999999


Q ss_pred             CcccccCCCccccccccccCCCCcChhhhhc-----CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhh
Q 008108          392 MARLFEMDQTHSDTNRVVGTFGYMAPEYVMH-----GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRN  466 (577)
Q Consensus       392 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~  466 (577)
                      ++.......  .......|+..|+|||++..     ..++.++||||||+++|||++|+.|+.......  .+..     
T Consensus       159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~-----  229 (275)
T cd06608         159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--ALFK-----  229 (275)
T ss_pred             cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--HHHH-----
Confidence            987654322  12223568999999998754     346789999999999999999999985332211  1111     


Q ss_pred             cccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          467 WNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       467 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ......     +.+.. .......+.+++.+|+..||++|||+.++++
T Consensus       230 ~~~~~~-----~~~~~-~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         230 IPRNPP-----PTLKS-PENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hhccCC-----CCCCc-hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            001100     11110 1112235567888999999999999999985

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.8e-35  Score=298.09  Aligned_cols=258  Identities=25%  Similarity=0.353  Sum_probs=199.2

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC--CeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  319 (577)
                      ++|+..+.||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++++.+.  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46888999999999999999974 588899999875433 3455689999999999999999999998654  3689999


Q ss_pred             EecCCCCcccccccC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          320 EFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       320 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      ||+++++|.+++... .....+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999998876431 13456899999999999999999999987   99999999999999999999999999875432


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCc--cccchhhhhhhhhcccCCccccc
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTE--EETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~--~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      ..    .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.....  ....+...+...    .....+.
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~  229 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPELK  229 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhhc
Confidence            21    1234678899999999999999999999999999999999999875432  111122221111    0000110


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      + .. .........+.+++.+|++.+|++|||+.||++
T Consensus       230 ~-~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         230 D-EP-GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             c-CC-CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            0 00 000112345668889999999999999999886

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=9.2e-36  Score=299.20  Aligned_cols=251  Identities=24%  Similarity=0.357  Sum_probs=189.9

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC-hhhHHHHHHHHHH-HHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS-KQGEIEFKNEVLL-LARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      ++|++.+.||+|+||.||++... +|+.||+|++.... ......+..|+.+ ++.++|+||+++++++..+...+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            47889999999999999999965 68999999987653 2333455566665 566689999999999999999999999


Q ss_pred             ecCCCCcccccccC-CCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          321 FVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHED-SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       321 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |++ |+|.+++... .....+++..++.++.||+.||.|||++ +   ++||||||+||+++.++.+||+|||+++....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 5777666432 2345799999999999999999999986 5   99999999999999999999999999986542


Q ss_pred             CCccccccccccCCCCcChhhhhc----CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccc
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMH----GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALN  474 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  474 (577)
                      ..   ......|+..|+|||.+.+    ..++.++|+||||+++|||++|+.|+..... .. ..+...   . .+    
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~-~~~~~~---~-~~----  223 (283)
T cd06617         157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-PF-QQLKQV---V-EE----  223 (283)
T ss_pred             cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc-CH-HHHHHH---H-hc----
Confidence            21   1122468899999998854    4568899999999999999999999753221 11 111110   0 00    


Q ss_pred             cccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          475 LMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       475 ~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                       ..+.+...  .....+.+++..|++.+|++||++.++++
T Consensus       224 -~~~~~~~~--~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         224 -PSPQLPAE--KFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             -CCCCCCcc--ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             01111111  01124557778999999999999999885

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.5e-35  Score=291.40  Aligned_cols=249  Identities=30%  Similarity=0.465  Sum_probs=201.7

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecC
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVP  323 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  323 (577)
                      +|+..+.||+|++|.||++... +++.+++|++..........+.+|+..+++++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4777899999999999999975 688999999987665556678999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccc
Q 008108          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS  403 (577)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~  403 (577)
                      +++|.+++...  ...+++..+..++.|++.+|.|||+.+   ++||||+|+||++++++.++|+|||.+........  
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            99999887432  257999999999999999999999987   99999999999999999999999999987654332  


Q ss_pred             cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCC
Q 008108          404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGG  483 (577)
Q Consensus       404 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  483 (577)
                       .....++..|+|||++....++.++||||||+++|+|++|+.|+............   .    ........++     
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---~----~~~~~~~~~~-----  220 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI---A----TNGPPGLRNP-----  220 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---H----hcCCCCcCcc-----
Confidence             23457899999999998888999999999999999999999987643221111100   0    0101111110     


Q ss_pred             ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          484 STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       484 ~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                       ......+.+++.+|++.||++|||+.|+++
T Consensus       221 -~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         221 -EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             -cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             001234567788999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3e-36  Score=303.01  Aligned_cols=262  Identities=24%  Similarity=0.370  Sum_probs=194.3

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      +|+..+.||+|++|.||+|... +|+.||||++.....  .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            5888999999999999999864 689999999875432  2234688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +. ++|..++.. .....+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||+++.......
T Consensus        81 ~~-~~l~~~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDA-SPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            96 578777643 23457899999999999999999999987   99999999999999999999999999986543221


Q ss_pred             cccccccccCCCCcChhhhhcCC-CCccccEEecchhHhHHhhCCCCCCCCCcccc-chhhhh-------hhhhcccC-C
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET-EDLLTY-------AWRNWNEG-A  471 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~-~~l~~~-------~~~~~~~~-~  471 (577)
                        ......++..|+|||++.+.. ++.++||||||+++|||+||+.|+........ ...+..       .|..+... .
T Consensus       156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence              122245788999999886654 68899999999999999999998865432211 111110       00000000 0


Q ss_pred             ccccccCcCCCCC-----hHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          472 ALNLMDPTMRGGS-----TSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       472 ~~~~~d~~l~~~~-----~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ....+ +......     ......+.+++.+|++.||++|||+.++++
T Consensus       234 ~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         234 YKPSF-PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHhhc-ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            00000 0000000     001123457888999999999999999884

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-36  Score=300.86  Aligned_cols=246  Identities=24%  Similarity=0.352  Sum_probs=205.1

Q ss_pred             CCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      -|...+.||+|.|..|-++.+ -+|+.||||++.+...  .....+.+|+..|+.++|||||+||.+......+|||+|.
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            366678899999999999983 4899999999987643  3344688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEc-CCCCeEEeccCCcccccCCC
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~-~~~~~kl~DfGla~~~~~~~  400 (577)
                      -.+|+|.+||...  ...+.+....+++.||+.++.|+|+..   +|||||||+||.+- +-|-+||+|||++..+.+++
T Consensus        99 GD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~  173 (864)
T KOG4717|consen   99 GDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK  173 (864)
T ss_pred             cCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence            9999999999653  346999999999999999999999987   99999999999775 45789999999999887765


Q ss_pred             ccccccccccCCCCcChhhhhcCCCC-ccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGRFS-VKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                      ...   ..+|+..|.|||++.+..|. ++.||||||||||.|++|+.||....+.+..               ..++|-.
T Consensus       174 kL~---TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL---------------TmImDCK  235 (864)
T KOG4717|consen  174 KLT---TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL---------------TMIMDCK  235 (864)
T ss_pred             hhh---cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------------hhhhccc
Confidence            433   36899999999999999886 7899999999999999999999755543332               2234432


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .. -+..-..+|.+++..|++.||++|.+.+||+.
T Consensus       236 Yt-vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  236 YT-VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             cc-CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            21 12233456778888999999999999999885

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2e-35  Score=297.52  Aligned_cols=253  Identities=26%  Similarity=0.421  Sum_probs=202.0

Q ss_pred             HhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      .++.|+..+.||+|++|.||+|... +++.+++|.+..... ....+.+|+++++.++|+|++++++++......++++|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4567888999999999999999976 688999999976554 45568899999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |+++++|.+++...  ...+++..++.++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++.......
T Consensus        96 ~~~~~~L~~~l~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          96 YMDGGSLTDIITQN--FVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             ccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            99999999998542  137999999999999999999999987   9999999999999999999999999987554322


Q ss_pred             ccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                      .  ......++..|++||++.+..++.++||||||+++|+|++|+.|+........  ....     .........++  
T Consensus       171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~--~~~~-----~~~~~~~~~~~--  239 (286)
T cd06614         171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA--LFLI-----TTKGIPPLKNP--  239 (286)
T ss_pred             h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH-----HhcCCCCCcch--
Confidence            1  12234678899999999888899999999999999999999998754332211  1110     00000000010  


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                          ......+.+++.+|++.+|.+||++.+|++.
T Consensus       240 ----~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         240 ----EKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             ----hhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                0012345578889999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-36  Score=309.60  Aligned_cols=262  Identities=22%  Similarity=0.333  Sum_probs=194.1

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC-----eE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK-----ER  315 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  315 (577)
                      +++|++.++||+|+||.||+|.. .+|+.||+|.+.... ......+.+|+.++++++|+||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            47899999999999999999985 468999999986532 233445788999999999999999999876543     57


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      ++++||+++ +|..++    ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~~-~l~~~~----~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            999999975 666655    3457999999999999999999999988   99999999999999999999999999986


Q ss_pred             ccCCCccc-cccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccC---
Q 008108          396 FEMDQTHS-DTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEG---  470 (577)
Q Consensus       396 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---  470 (577)
                      ........ ......||..|+|||.+.+ ..++.++||||||+++|||++|+.|+.......   ............   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~  232 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQE  232 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHH
Confidence            54322211 1223578999999998755 468999999999999999999999885432211   111111100000   


Q ss_pred             CccccccCc-------C---CCC-----ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          471 AALNLMDPT-------M---RGG-----STSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       471 ~~~~~~d~~-------l---~~~-----~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      ....+.+..       +   ...     .+.....+.+++.+|++.+|++|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000000000       0   000     01112346688889999999999999999875

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.1e-35  Score=300.47  Aligned_cols=263  Identities=22%  Similarity=0.351  Sum_probs=195.6

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChh--hHHHHHHHHHHHHhcCCCCeEEEEeEEEcC--CeEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLER--KERILV  318 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  318 (577)
                      ++|+..+.||+|+||.||+|... +++.+++|.++.....  ....+.+|+.++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57888999999999999999975 5889999998754322  223467899999999999999999998877  789999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+++ +|.+++..  ....+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        85 ~e~~~~-~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVEH-DLKSLMET--MKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcCc-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999975 88777643  2336999999999999999999999987   99999999999999999999999999986654


Q ss_pred             CCccccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhh-hh-------hhhhccc
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL-TY-------AWRNWNE  469 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~-~~-------~~~~~~~  469 (577)
                      ...  ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...........+ ..       .|..+..
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            321  12234678899999988765 4689999999999999999999988754432211111 10       1111100


Q ss_pred             ------CCccccccCcCCCCChH--HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          470 ------GAALNLMDPTMRGGSTS--EMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       470 ------~~~~~~~d~~l~~~~~~--~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                            ..........+......  ....+.+++..|++.+|++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                  00000000001111111  1234557788999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=8.2e-36  Score=309.62  Aligned_cols=198  Identities=27%  Similarity=0.408  Sum_probs=168.9

Q ss_pred             CCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcC-C-----CCeEEEEeEEEcCCeEEE
Q 008108          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-H-----RNLVRLLGFCLERKERIL  317 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l  317 (577)
                      +|++.+.||+|.||.|.++.. .+++.||||+++....-. .+-..|+.+|..|+ |     -|+|+++++|...++.+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~-~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFL-RQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHH-HHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            789999999999999999994 569999999998765433 34467999999996 4     389999999999999999


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC--CeEEeccCCccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM--NPKISDFGMARL  395 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~--~~kl~DfGla~~  395 (577)
                      |+|.+ ..+|.++|.. .+...++...+..|+.||+.||..||+.+   |||+||||+||||.+..  .+||+|||.+.+
T Consensus       266 VfELL-~~NLYellK~-n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  266 VFELL-STNLYELLKN-NKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eehhh-hhhHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence            99988 4589999865 33456999999999999999999999988   99999999999997654  699999999987


Q ss_pred             ccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCc
Q 008108          396 FEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTE  453 (577)
Q Consensus       396 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~  453 (577)
                      ......     ...-+..|.|||++.+..|+.+.||||||||+.||++|..-|....+
T Consensus       341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne  393 (586)
T KOG0667|consen  341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE  393 (586)
T ss_pred             cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence            543222     35678899999999999999999999999999999999765554443

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=6.5e-36  Score=295.70  Aligned_cols=249  Identities=23%  Similarity=0.372  Sum_probs=196.5

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      +|+..+.||+|+||.||+|... +|..+|+|.+....  ......+.+|+.+++.++|+||+++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            5788899999999999999965 58889999986542  22344678999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCC-eEEeccCCcccccCCC
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN-PKISDFGMARLFEMDQ  400 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~-~kl~DfGla~~~~~~~  400 (577)
                      +++++|.+++.+ .....+++..+..++.|+++||.|||+.+   ++|+||||+||++++++. +||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINR-QRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            999999988754 22346899999999999999999999987   999999999999998864 6999999998665322


Q ss_pred             ccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                      ..  .....|++.|+|||++....++.++||||||+++|||++|+.|+.......   .+.   ... .+..    .+ .
T Consensus       157 ~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~---~~~-~~~~----~~-~  222 (257)
T cd08225         157 EL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ---LVL---KIC-QGYF----AP-I  222 (257)
T ss_pred             cc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHH---HHh-cccC----CC-C
Confidence            21  122468999999999988889999999999999999999999975432211   111   111 1111    10 0


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .+...   ..+.+++.+|++.+|++|||+.|+++
T Consensus       223 ~~~~~---~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         223 SPNFS---RDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             CCCCC---HHHHHHHHHHhccChhhCcCHHHHhh
Confidence            11112   24557778999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=308.45  Aligned_cols=251  Identities=27%  Similarity=0.453  Sum_probs=201.3

Q ss_pred             CCccccccccCCcEEEEEeEec---CCc--EEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS---NGE--TIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~---~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      .....++||+|-||.||+|+..   .|+  .||||.-+.+. ....+.|..|..+|++++||||++|+|+|.+. ..+||
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv  468 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV  468 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence            3445678999999999999953   333  38899888754 34455699999999999999999999999875 57999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      ||.++-|.|..||..  ++..|+......++.||+.+|.|||+..   .+||||..+|||+.+..-+||+||||+|.+..
T Consensus       469 mEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  469 MELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED  543 (974)
T ss_pred             EecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence            999999999999954  5567999999999999999999999986   99999999999999999999999999998876


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCcccccc
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD  477 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  477 (577)
                      +.....+ ...-++.|||||.+.-.+++.++|||.|||.+||++. |.+||..-...+....++       .|...    
T Consensus       544 ~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE-------nGeRl----  611 (974)
T KOG4257|consen  544 DAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE-------NGERL----  611 (974)
T ss_pred             cchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec-------CCCCC----
Confidence            6554433 3455788999999999999999999999999999876 788886544433322222       11111    


Q ss_pred             CcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          478 PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       478 ~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                          +.++.....+..+..+||..+|.+||++.|+...|.
T Consensus       612 ----P~P~nCPp~LYslmskcWayeP~kRPrftei~~~ls  647 (974)
T KOG4257|consen  612 ----PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS  647 (974)
T ss_pred             ----CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence                112223345557888999999999999998876653

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=9.3e-36  Score=295.09  Aligned_cols=247  Identities=26%  Similarity=0.313  Sum_probs=198.5

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      +|++.+.||+|+||.||++... +++.||+|.+.+..   ......+.+|+.++++++||||+++++++.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5788999999999999999965 58999999997543   2334578899999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |+++++|.+++..   ...+++..+..++.||++||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            9999999988843   357999999999999999999999987   9999999999999999999999999988654332


Q ss_pred             ccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                         ......|+..|+|||.+....++.++|+||||+++|+|++|+.|+..........+..    ....  ..    +..
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~~--~~----~~~  221 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA----KQET--AD----VLY  221 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH----Hhcc--cc----ccC
Confidence               1223568889999999988889999999999999999999999987554321111111    1000  00    001


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCCCH--HHHH
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRPGM--ASVV  513 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RPt~--~ev~  513 (577)
                      ..   .....+.+++.+|++.+|.+||++  +|++
T Consensus       222 ~~---~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         222 PA---TWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             cc---cCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            11   112455677889999999999999  5544

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.3e-35  Score=299.87  Aligned_cols=244  Identities=25%  Similarity=0.371  Sum_probs=195.0

Q ss_pred             ccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCCCc
Q 008108          249 ANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASL  327 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  327 (577)
                      ..+||+|+||.||++.. .+++.||||++..........+.+|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            46799999999999986 46899999998765555566789999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccccccc
Q 008108          328 DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR  407 (577)
Q Consensus       328 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~  407 (577)
                      .+++.    ...+++..+..++.|++.+|.|||+.+   ++||||+|+||++++++.++|+|||++........  ....
T Consensus       105 ~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~  175 (292)
T cd06657         105 TDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS  175 (292)
T ss_pred             HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence            88763    346899999999999999999999987   99999999999999999999999999876543221  1223


Q ss_pred             cccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCChHH
Q 008108          408 VVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSE  487 (577)
Q Consensus       408 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  487 (577)
                      ..|+..|+|||++....++.++||||||+++|||++|+.|+...........+..   ...         +.+.. ....
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~---~~~---------~~~~~-~~~~  242 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLP---------PKLKN-LHKV  242 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---hCC---------cccCC-cccC
Confidence            5688999999999888899999999999999999999999864332211111110   000         00000 0011


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          488 MMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       488 ~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ...+.+++.+|++.+|.+||++.++++
T Consensus       243 ~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         243 SPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            123456778999999999999999886

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.4e-35  Score=300.18  Aligned_cols=246  Identities=28%  Similarity=0.408  Sum_probs=192.6

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      +.|+..++||+|+||+||+|... +++.||+|.+....   .....++.+|+.+++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888899999999999999964 68999999986432   233346889999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++ +|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||+|+||++++++.+||+|||++......
T Consensus        95 e~~~g-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          95 EYCLG-SASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HhhCC-CHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            99974 66555432  2456999999999999999999999987   999999999999999999999999998764322


Q ss_pred             CccccccccccCCCCcChhhhh---cCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVM---HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                            ....++..|+|||++.   .+.++.++||||||+++|||+||+.|+...........+.     .  ..     
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~-----~--~~-----  230 (307)
T cd06607         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-----Q--ND-----  230 (307)
T ss_pred             ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh-----c--CC-----
Confidence                  2246788999999874   4568899999999999999999999875432211100000     0  00     


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      .+.+.  .......+.+++..||+.+|++||++.+|+..
T Consensus       231 ~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         231 SPTLS--SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CCCCC--chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            01111  11122345678889999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.5e-35  Score=301.57  Aligned_cols=263  Identities=24%  Similarity=0.395  Sum_probs=193.6

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC-------
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERK-------  313 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  313 (577)
                      ++|+..++||+|+||.||++... +++.||||.+.....  .....+.+|+.++++++||||+++++++...+       
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            57999999999999999999964 689999998865422  22334678999999999999999999987654       


Q ss_pred             -eEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCC
Q 008108          314 -ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (577)
Q Consensus       314 -~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGl  392 (577)
                       ..++||||+.+ +|.+++..  ....+++.+++.++.||+.||.|||+++   ++|+||||+||+++.++.+||+|||+
T Consensus        92 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          92 GSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             ceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence             34999999975 67666532  2346899999999999999999999987   99999999999999999999999999


Q ss_pred             cccccCCCcc--ccccccccCCCCcChhhhhcCC-CCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhccc
Q 008108          393 ARLFEMDQTH--SDTNRVVGTFGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNE  469 (577)
Q Consensus       393 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  469 (577)
                      +.........  .......++..|+|||.+.+.. ++.++||||||+++|||++|+.|+...........+.........
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            9866433221  1122346788999999886653 788999999999999999999888654433222222221111110


Q ss_pred             C-----Ccccccc-------------CcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          470 G-----AALNLMD-------------PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       470 ~-----~~~~~~d-------------~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .     ...+..+             ..+...  .+...+.+++.+|++.||++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPY--VKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccc--cCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            0     0000000             000000  01234557889999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2e-35  Score=298.75  Aligned_cols=264  Identities=25%  Similarity=0.345  Sum_probs=192.4

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      ++|+..+.||+|++|+||+|... +|+.||+|++.....  .....+.+|+.++++++|+||+++++++.+....++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57889999999999999999965 688999999865432  223467899999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC-CCCeEEeccCCcccccCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS-EMNPKISDFGMARLFEMD  399 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~-~~~~kl~DfGla~~~~~~  399 (577)
                      |+++ +|.+++.. .....+++..+..++.||+.||.|||+++   ++||||+|+||+++. ++.+||+|||++......
T Consensus        82 ~~~~-~l~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLDL-DLKKHMDS-SPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             cccc-cHHHHHHh-CCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            9964 67666532 22234688889999999999999999987   999999999999985 557999999999765432


Q ss_pred             CccccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccc-hhhhhhh----hhcccCC-c
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE-DLLTYAW----RNWNEGA-A  472 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~-~l~~~~~----~~~~~~~-~  472 (577)
                      ..  ......+++.|+|||++.+. .++.++||||||+++|+|+||+.|+......+.. ..+....    ..|.... .
T Consensus       157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence            11  11234678899999988664 5789999999999999999999988654332111 1110000    0000000 0


Q ss_pred             ccc--ccCcCCCC-----ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          473 LNL--MDPTMRGG-----STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       473 ~~~--~d~~l~~~-----~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .+.  .-+.....     ......++.+++.+|++.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000  00000000     0111234567888999999999999999986

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.5e-35  Score=299.70  Aligned_cols=264  Identities=21%  Similarity=0.313  Sum_probs=192.4

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhcC-CCCeEEEEeEEEcCCe-----
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKE-----  314 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----  314 (577)
                      ++|+..+.||+|+||.||+|... +++.||+|.+.....  .....+.+|+.+++.++ |+||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46889999999999999999964 689999998865432  22346788999999995 6999999999887665     


Q ss_pred             EEEEEEecCCCCcccccccCCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC-CCCeEEeccC
Q 008108          315 RILVYEFVPNASLDHFIFDPIN--REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS-EMNPKISDFG  391 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~-~~~~kl~DfG  391 (577)
                      .++||||+++ +|.+++.....  ...+++..++.++.||+.||.|||+.+   |+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999986 78777643221  346899999999999999999999987   999999999999998 8899999999


Q ss_pred             CcccccCCCccccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCcccc-chhhhh-------
Q 008108          392 MARLFEMDQTHSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET-EDLLTY-------  462 (577)
Q Consensus       392 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~-~~l~~~-------  462 (577)
                      +++.+.....  ......+++.|+|||++.+ ..++.++||||||+++|||++|..|+........ ..+...       
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ  234 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            9986543211  1122356889999998865 4578999999999999999999988864332111 111110       


Q ss_pred             hhhhcccCCccccccCcCCCC-----ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          463 AWRNWNEGAALNLMDPTMRGG-----STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       463 ~~~~~~~~~~~~~~d~~l~~~-----~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .|........... -+.....     ......++.+++..|++.||++||++.|++.
T Consensus       235 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         235 VWPGVSKLRDWHE-FPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hCcchhhccchhh-cCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0000000000000 0000000     0112234567888999999999999998875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=9e-36  Score=299.37  Aligned_cols=262  Identities=23%  Similarity=0.358  Sum_probs=193.9

Q ss_pred             CccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      |+..++||+|++|.||+|... +|+.||+|++.....  .....+.+|++++++++|+|++++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567889999999999999864 799999999875432  22346788999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      + ++|.+++... ....+++..++.++.|+++||.|||+.+   ++||||+|+||+++.++.++|+|||+++....... 
T Consensus        81 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-  154 (283)
T cd07835          81 D-LDLKKYMDSS-PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-  154 (283)
T ss_pred             C-cCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence            5 6888877431 2246899999999999999999999987   99999999999999999999999999976543221 


Q ss_pred             ccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCcccc-chhhhh-------hhhhcccC-C-
Q 008108          403 SDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET-EDLLTY-------AWRNWNEG-A-  471 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~-~~l~~~-------~~~~~~~~-~-  471 (577)
                       ......++..|+|||++.+. .++.++||||||+++|||++|+.||........ ......       .|...... . 
T Consensus       155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence             11223568899999987664 578999999999999999999998864432111 111110       00000000 0 


Q ss_pred             ---ccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          472 ---ALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       472 ---~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                         ......+............+.+++.+|++.+|++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence               0000000000001111235667888999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=290.71  Aligned_cols=247  Identities=24%  Similarity=0.400  Sum_probs=202.4

Q ss_pred             CccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCC
Q 008108          246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPN  324 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  324 (577)
                      |.++.+||+|+||.|||+.++ .|+.+|||.+...+.  ..++..|+.+|.+.+.|++|++||.+.....+++|||||.-
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD--LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD--LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch--HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            566889999999999999964 699999999976643  34688999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcccc
Q 008108          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD  404 (577)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~  404 (577)
                      |+..+.+.  ..+++|+++++..+++..++||+|||...   -||||||..||||+.+|.+||+|||.|-.+..  +-..
T Consensus       113 GSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAK  185 (502)
T KOG0574|consen  113 GSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAK  185 (502)
T ss_pred             CcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh--hHHh
Confidence            99999885  35678999999999999999999999875   79999999999999999999999999976542  3334


Q ss_pred             ccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCC
Q 008108          405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGS  484 (577)
Q Consensus       405 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  484 (577)
                      .+.+.||+.|||||++..-.|..++||||||++..||..|++|+..-.+-...-.+       ...     ..|.++ ..
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI-------PT~-----PPPTF~-KP  252 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI-------PTK-----PPPTFK-KP  252 (502)
T ss_pred             hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec-------cCC-----CCCCCC-Ch
Confidence            55689999999999999999999999999999999999999997643332110000       000     011111 12


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          485 TSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       485 ~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ..-..++-+++..|+-.+|+.|-|+.++++
T Consensus       253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  253 EEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             HhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            223345667888999999999999988765

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.2e-35  Score=304.37  Aligned_cols=262  Identities=23%  Similarity=0.305  Sum_probs=195.2

Q ss_pred             HhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC------
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER------  312 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  312 (577)
                      ..++|+..+.||+|+||.||++... +++.||+|.+.+.  ......++.+|+.++++++|+||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999954 6899999998653  223344677899999999999999999988643      


Q ss_pred             CeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCC
Q 008108          313 KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (577)
Q Consensus       313 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGl  392 (577)
                      ...++||||+.+ +|.+.+..     .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence            356999999965 77666521     2899999999999999999999987   99999999999999999999999999


Q ss_pred             cccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccch-hh-----------
Q 008108          393 ARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETED-LL-----------  460 (577)
Q Consensus       393 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~-l~-----------  460 (577)
                      ++.......   .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.......... ++           
T Consensus       165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            986543221   223468899999999999999999999999999999999999986443211100 00           


Q ss_pred             ---hhhhhhccc-------CCccccccCcCCCC-----ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          461 ---TYAWRNWNE-------GAALNLMDPTMRGG-----STSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       461 ---~~~~~~~~~-------~~~~~~~d~~l~~~-----~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                         ......+..       ....+++...+...     .......+.+++.+|++.||++|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence               000000000       00001111111000     11123445688889999999999999999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4e-35  Score=291.25  Aligned_cols=242  Identities=24%  Similarity=0.328  Sum_probs=191.8

Q ss_pred             cccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCCCc
Q 008108          252 LGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASL  327 (577)
Q Consensus       252 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  327 (577)
                      ||.|++|.||++... +++.+|+|.+.+...   .....+.+|+.+++.++|+||+++++.+.++...+++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999965 489999999876432   2345688999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccccccc
Q 008108          328 DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR  407 (577)
Q Consensus       328 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~  407 (577)
                      .+++..   ...+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......   ....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~  151 (262)
T cd05572          81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT  151 (262)
T ss_pred             HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence            998843   456899999999999999999999987   9999999999999999999999999998765432   2223


Q ss_pred             cccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCChHH
Q 008108          408 VVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSE  487 (577)
Q Consensus       408 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  487 (577)
                      ..|+..|++||.+....++.++|+||||+++|||++|+.|+.....+. ........   ....     .+......   
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~---~~~~-----~~~~~~~~---  219 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIYNDIL---KGNG-----KLEFPNYI---  219 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHHHHHh---ccCC-----CCCCCccc---
Confidence            568899999999988889999999999999999999999986544211 11111110   0000     00011011   


Q ss_pred             HHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 008108          488 MMKCIHIGLLCVQENVSNRPG-----MASVVN  514 (577)
Q Consensus       488 ~~~~~~l~~~C~~~~p~~RPt-----~~ev~~  514 (577)
                      ...+..++..||+.+|++||+     +.|+++
T Consensus       220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            235667888999999999999     555554

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-35  Score=298.14  Aligned_cols=262  Identities=24%  Similarity=0.382  Sum_probs=195.9

Q ss_pred             CccccccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC--CeEEEEEE
Q 008108          246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KERILVYE  320 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~E  320 (577)
                      |++.++||+|+||.||+|... +++.+|+|++....  ......+.+|+.++++++|+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999965 58899999998763  23344678999999999999999999999988  78999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |+++ +|..++..  ....+++..++.++.||++||.|||+.+   ++|+||||+||++++++.+||+|||++.......
T Consensus        81 ~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDS--PEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9975 78777643  2257999999999999999999999987   9999999999999999999999999998765433


Q ss_pred             ccccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhh--------hhhcccCC
Q 008108          401 THSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA--------WRNWNEGA  471 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~~  471 (577)
                      .. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...........+...        |..+..-.
T Consensus       155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07840         155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP  233 (287)
T ss_pred             cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence            21 1223456889999997765 45789999999999999999999988654432211111110        00000000


Q ss_pred             ccccccCc------CCCCChH-HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          472 ALNLMDPT------MRGGSTS-EMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       472 ~~~~~d~~------l~~~~~~-~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ......+.      +...... ....+.+++..|++.+|++||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            00000000      0000001 1346678899999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.6e-35  Score=296.93  Aligned_cols=253  Identities=26%  Similarity=0.404  Sum_probs=191.4

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcC-CCCeEEEEeEEEcCCeEEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      ++|...++||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            35666789999999999999954 68999999987543 234456889999999996 9999999999999999999999


Q ss_pred             ecCCCCccccccc--CCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          321 FVPNASLDHFIFD--PINREHMTWEKRYKIIEGIARGLLYLHED-SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       321 ~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      |++. +|.++...  ......+++..+..++.|++.||+|||+. +   |+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            9864 54433211  11235799999999999999999999975 5   9999999999999999999999999997654


Q ss_pred             CCCccccccccccCCCCcChhhhhcC---CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccc
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMHG---RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALN  474 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  474 (577)
                      ....   .....|+..|+|||++...   .++.++||||||+++|||++|+.||.....     ......... .+.   
T Consensus       160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~-~~~---  227 (288)
T cd06616         160 DSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVV-KGD---  227 (288)
T ss_pred             cCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhc-CCC---
Confidence            3221   1224688999999998776   689999999999999999999999864321     111111110 000   


Q ss_pred             cccCcCCCC-ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          475 LMDPTMRGG-STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       475 ~~d~~l~~~-~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                        .+.+... .......+.+++.+|++.+|++|||+.+|++
T Consensus       228 --~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         228 --PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             --CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              1111111 1112335667888999999999999999886

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.4e-35  Score=295.96  Aligned_cols=259  Identities=22%  Similarity=0.323  Sum_probs=190.7

Q ss_pred             CccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhcC-CCCeEEEEeEEEcC--CeEEEEEE
Q 008108          246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQ-HRNLVRLLGFCLER--KERILVYE  320 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~E  320 (577)
                      |+..++||+|+||.||+|... +++.||+|+++.... .......+|+.++.++. |+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567889999999999999954 688999999876422 22234457888899885 99999999999987  88999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |+++ +|.+++..  ....+++..++.++.||+.||.|||+.+   ++||||||+||+++. +.+||+|||+++......
T Consensus        81 ~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMDM-NLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCCc-cHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            9974 77666633  2357899999999999999999999987   999999999999999 999999999998664322


Q ss_pred             ccccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhh--------hhhcccCC
Q 008108          401 THSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA--------WRNWNEGA  471 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~~  471 (577)
                      ..   ....++..|+|||++.. +.++.++|||||||++|||++|+.|+......+....+...        ........
T Consensus       154 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         154 PY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             Cc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence            21   22467899999997654 55789999999999999999999988654332211111000        00111111


Q ss_pred             ccccccCcCCCC-----ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          472 ALNLMDPTMRGG-----STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       472 ~~~~~d~~l~~~-----~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ......+...+.     .......+.+++..|++.+|++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            011111110000     1122356678888999999999999999885

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-35  Score=290.45  Aligned_cols=245  Identities=21%  Similarity=0.272  Sum_probs=188.5

Q ss_pred             cccccCCcEEEEEeEec-CCcEEEEEEeccCChh---hHHHHHHHHHHH-HhcCCCCeEEEEeEEEcCCeEEEEEEecCC
Q 008108          250 NKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ---GEIEFKNEVLLL-ARLQHRNLVRLLGFCLERKERILVYEFVPN  324 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  324 (577)
                      +.||+|+||.||+|... +++.||+|.+.+....   ....+..|..++ ...+|+|++++++++...+..++||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999864 6889999998764322   122344454444 445899999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcccc
Q 008108          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD  404 (577)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~  404 (577)
                      ++|.+++.   ....+++..+..++.||+.||.|||+.+   ++||||+|+||+++.++.+||+|||+++....      
T Consensus        82 ~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------  149 (260)
T cd05611          82 GDCASLIK---TLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------  149 (260)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence            99999884   3456899999999999999999999987   99999999999999999999999999875432      


Q ss_pred             ccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCC
Q 008108          405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGS  484 (577)
Q Consensus       405 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  484 (577)
                      .....|+..|+|||.+.+..++.++||||||+++|||++|..|+........   ..    ....+...  ..+......
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~----~~~~~~~~--~~~~~~~~~  220 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV---FD----NILSRRIN--WPEEVKEFC  220 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH---HH----HHHhcccC--CCCcccccC
Confidence            2235688999999999888899999999999999999999999864332221   11    11111000  000011011


Q ss_pred             hHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          485 TSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       485 ~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                         ...+.+++..|++.+|++||++.++.+.|+.
T Consensus       221 ---~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         221 ---SPEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             ---CHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence               2345577889999999999998877777665

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.8e-35  Score=305.22  Aligned_cols=264  Identities=21%  Similarity=0.309  Sum_probs=195.7

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC-----Ce
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER-----KE  314 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  314 (577)
                      .++|.+.+.||+|+||+||++.. .+++.||||.+...  .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45789999999999999999995 46899999998753  222344577899999999999999999988654     34


Q ss_pred             EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      .++||||+. ++|.+++.   ....+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||+++
T Consensus        84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 57877763   3457999999999999999999999987   9999999999999999999999999998


Q ss_pred             cccCCCccccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhh--------
Q 008108          395 LFEMDQTHSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWR--------  465 (577)
Q Consensus       395 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~--------  465 (577)
                      ......  .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...........+.....        
T Consensus       157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            654322  11223567899999998875 4689999999999999999999999864432211111110000        


Q ss_pred             hcccCCccccc-------cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          466 NWNEGAALNLM-------DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       466 ~~~~~~~~~~~-------d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      ........+.+       ++.+..........+.+++.+|++.+|++|||+.|+++-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            00000000000       000000011223456688889999999999999998865

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4e-35  Score=298.83  Aligned_cols=265  Identities=24%  Similarity=0.382  Sum_probs=194.6

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChh--hHHHHHHHHHHHHhcCCCCeEEEEeEEEcC--CeEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLER--KERIL  317 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  317 (577)
                      .++|+..++||+|+||.||+|... +|+.||+|.+......  ....+.+|+.++++++|+||+++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467999999999999999999964 6899999998654322  223467899999999999999999998765  46899


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      ||||+.+ +|.+++..  ....+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        86 v~e~~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDN--MPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999975 77776643  2357999999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCccccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhh--------hhhhcc
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTY--------AWRNWN  468 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~  468 (577)
                      ....  ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+......+....+..        .|..+.
T Consensus       160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            3321  1122345788999998865 4578999999999999999999998865443222111111        111110


Q ss_pred             cCCccccc--cCcCCCC----ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          469 EGAALNLM--DPTMRGG----STSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       469 ~~~~~~~~--d~~l~~~----~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      .......+  .......    .......+.+++..|++.||++|||+.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00000000  0000000    00012344578889999999999999998853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.2e-35  Score=292.87  Aligned_cols=247  Identities=26%  Similarity=0.365  Sum_probs=195.7

Q ss_pred             cccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCCCc
Q 008108          252 LGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASL  327 (577)
Q Consensus       252 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  327 (577)
                      ||+|+||.||++... +|+.+++|.+.....   .....+.+|++++++++|+||+++++.+......+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999976 489999999876543   3445688999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc------
Q 008108          328 DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT------  401 (577)
Q Consensus       328 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~------  401 (577)
                      .+++..   ...+++..+..++.||++||.|||+.+   ++||||+|+||++++++.++|+|||++........      
T Consensus        81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            988843   347999999999999999999999987   99999999999999999999999999876543321      


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR  481 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  481 (577)
                      ........++..|+|||.+.....+.++||||||+++|||++|+.|+...........+.       .+..    .  ..
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-------~~~~----~--~~  221 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL-------NGKI----E--WP  221 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-------cCCc----C--CC
Confidence            112233567889999999988889999999999999999999999986443222111110       0000    0  00


Q ss_pred             CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       482 ~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                       ........+..++..|++.+|++|||+.+|.+.|+.
T Consensus       222 -~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         222 -EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             -ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence             000012345577889999999999999777777764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.6e-35  Score=297.86  Aligned_cols=267  Identities=25%  Similarity=0.404  Sum_probs=195.2

Q ss_pred             HHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC----
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK----  313 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  313 (577)
                      ...++|++.+.||+|+||.||+|... +|+.||+|++....  ......+.+|+.++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999975 58899999986543  223345788999999999999999999987655    


Q ss_pred             ------eEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEE
Q 008108          314 ------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI  387 (577)
Q Consensus       314 ------~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl  387 (577)
                            ..++|+||+++ +|..++..  ....+++..+..++.||+.||.|||+.+   |+||||||+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence                  78999999986 56555532  2346999999999999999999999987   999999999999999999999


Q ss_pred             eccCCcccccCCCccccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhh---
Q 008108          388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA---  463 (577)
Q Consensus       388 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~---  463 (577)
                      +|||++......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...........+...   
T Consensus       158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~  236 (302)
T cd07864         158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS  236 (302)
T ss_pred             CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            999999876543321 11223467889999988654 5789999999999999999999888643322111111111   


Q ss_pred             -----hhhcccCCccccccC------cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          464 -----WRNWNEGAALNLMDP------TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       464 -----~~~~~~~~~~~~~d~------~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                           |+.+.........++      ............+.+++..|++.+|++||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                 100000000000010      000000011234567888999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-35  Score=298.95  Aligned_cols=254  Identities=23%  Similarity=0.346  Sum_probs=199.6

Q ss_pred             HHHhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccC--ChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEE
Q 008108          240 RVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKN--SKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERI  316 (577)
Q Consensus       240 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  316 (577)
                      .+....|+++++||+||.+.||++...+.+.+|+|++...  ..+...-|.+|+.+|.+| .|.+||+|++|-..++.+|
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY  436 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY  436 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence            3445679999999999999999999888888999987543  334445699999999999 5999999999999999999


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccc
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~  396 (577)
                      +||||= ..+|..+|... ......| .+..+..||+.++.++|+++   |||.||||.|+|+-. |.+||+|||+|..+
T Consensus       437 mvmE~G-d~DL~kiL~k~-~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI  509 (677)
T KOG0596|consen  437 MVMECG-DIDLNKILKKK-KSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAI  509 (677)
T ss_pred             EEeecc-cccHHHHHHhc-cCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhccc
Confidence            999964 66898888542 2233345 77788999999999999998   999999999999854 58999999999988


Q ss_pred             cCCCccccccccccCCCCcChhhhhcCC-----------CCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhh
Q 008108          397 EMDQTHSDTNRVVGTFGYMAPEYVMHGR-----------FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWR  465 (577)
Q Consensus       397 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~  465 (577)
                      ..+.........+||+.||+||.+....           .+.++||||||||||+|+.|+.||...     ...+.    
T Consensus       510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-----~n~~a----  580 (677)
T KOG0596|consen  510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-----INQIA----  580 (677)
T ss_pred             CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-----HHHHH----
Confidence            8777666666789999999999985432           567899999999999999999998521     11111    


Q ss_pred             hcccCCccccccCcCC--CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          466 NWNEGAALNLMDPTMR--GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       466 ~~~~~~~~~~~d~~l~--~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                           ++..+.||.-.  -....+-.++++++..||+.||++||+..|+++
T Consensus       581 -----Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  581 -----KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             -----HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence                 12234444221  111111122788888999999999999999885

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-35  Score=287.38  Aligned_cols=247  Identities=29%  Similarity=0.432  Sum_probs=199.3

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      +|+..+.||+|++|.||++... +++.+++|.+.....  .....+.+|++++++++|+|++++++++.+....+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999865 578999999977654  3445789999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|.+++..   ...+++..+..++.|++.+|.|||+.+   |+||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            999999988743   367999999999999999999999987   99999999999999999999999999987654332


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR  481 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  481 (577)
                      .  .....++..|+|||.+....++.++||||||+++|+|++|+.|+......  ...    +... ....     +.+.
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~--~~~----~~~~-~~~~-----~~~~  220 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM--AAL----FRIV-QDDH-----PPLP  220 (254)
T ss_pred             c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH--HHH----HHHh-ccCC-----CCCC
Confidence            1  22356899999999998888899999999999999999999987533211  111    1110 0000     1111


Q ss_pred             CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       482 ~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ...   ...+..++.+|++.+|++||++.+++.
T Consensus       221 ~~~---~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         221 EGI---SPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCC---CHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            111   224457778999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=8.7e-35  Score=291.50  Aligned_cols=244  Identities=26%  Similarity=0.350  Sum_probs=188.8

Q ss_pred             cccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCCCc
Q 008108          252 LGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASL  327 (577)
Q Consensus       252 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  327 (577)
                      ||+|+||+||++... +|+.+|+|.+....   ......+.+|+++++.++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999854 68899999986542   22233467899999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccccccc
Q 008108          328 DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR  407 (577)
Q Consensus       328 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~  407 (577)
                      .+++... ....+++..++.++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||++.......   ....
T Consensus        81 ~~~l~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~  153 (277)
T cd05577          81 KYHIYNV-GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG  153 (277)
T ss_pred             HHHHHHc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence            9888542 2246899999999999999999999987   9999999999999999999999999997654321   1223


Q ss_pred             cccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCChHH
Q 008108          408 VVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSE  487 (577)
Q Consensus       408 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  487 (577)
                      ..++..|+|||++.++.++.++||||||+++|+|++|+.||...........+...   ...      .........   
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~------~~~~~~~~~---  221 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR---TLE------MAVEYPDKF---  221 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc---ccc------ccccCCccC---
Confidence            46788999999998888999999999999999999999998644332111111100   000      000111111   


Q ss_pred             HHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 008108          488 MMKCIHIGLLCVQENVSNRP-----GMASVVN  514 (577)
Q Consensus       488 ~~~~~~l~~~C~~~~p~~RP-----t~~ev~~  514 (577)
                      ...+.+++..|++.+|++||     +..++++
T Consensus       222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            22445777899999999999     5555553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-35  Score=303.61  Aligned_cols=248  Identities=24%  Similarity=0.356  Sum_probs=202.8

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChh--hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ...|.+..+||+|.|++|.++.. .++..||||.+.+....  ....+.+|+++|..++|||||+++.+......+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            45788999999999999999995 46999999999876433  2345789999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+.+|.+.+++   .+.+.+.+..+..++.|+.++++|||+++   |+|||||++||||+.++++||+|||++.++..+
T Consensus       135 eya~~ge~~~yl---~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  135 EYASGGELFDYL---VKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             EeccCchhHHHH---HhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence            999999999998   45667788999999999999999999998   999999999999999999999999999988754


Q ss_pred             CccccccccccCCCCcChhhhhcCCC-CccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRF-SVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      ..   ....+|++.|.|||++.+.+| .+.+|+||+|++||-|+.|..||+...-.+...-.-.     ..-.    ++ 
T Consensus       209 ~~---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~-----gk~r----Ip-  275 (596)
T KOG0586|consen  209 LM---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR-----GKYR----IP-  275 (596)
T ss_pred             cc---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee-----eeec----cc-
Confidence            33   334799999999999998876 5899999999999999999999975443322111100     0000    00 


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                            .--...|-+++...+-.+|.+|++++++..-
T Consensus       276 ------~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  276 ------FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             ------ceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence                  0111245566677888999999999998753

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.8e-35  Score=305.22  Aligned_cols=266  Identities=23%  Similarity=0.335  Sum_probs=195.7

Q ss_pred             HhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcC--CeE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKN--SKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLER--KER  315 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~  315 (577)
                      ..++|+..+.||+|+||.||+|... +++.+|+|++...  .......+.+|+.+++++ +|+||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3467889999999999999999965 5889999988643  223334577899999999 999999999998654  367


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      ++||||++ ++|..++..    ..+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999997 488777632    37899999999999999999999987   99999999999999999999999999986


Q ss_pred             ccCCCcc---ccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhh--------
Q 008108          396 FEMDQTH---SDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA--------  463 (577)
Q Consensus       396 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~--------  463 (577)
                      .......   .......|+..|+|||++.. ..++.++||||||+++|||++|+.|+...........+...        
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            6543221   12234578999999998755 45789999999999999999999988643322211111000        


Q ss_pred             hhhcccCCccccccCcC-------CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          464 WRNWNEGAALNLMDPTM-------RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       464 ~~~~~~~~~~~~~d~~l-------~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      +..+.......+++...       ..........+.+++..|++.+|++|||+.++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            00000000001111000       00001122456678889999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=310.19  Aligned_cols=251  Identities=27%  Similarity=0.394  Sum_probs=200.1

Q ss_pred             cCCccccccccCCcEEEEEeEecC-CcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      +.|+++..||.|.||.||+++.++ +-..|.|.+...+......|.-|++||....||+||+|++.|..++.++++.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            456778899999999999999764 3345778887777777778999999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      .||-.+.++..  -...|++.++..+++|++.+|.|||++.   |||||||+.|||++-+|.++|+|||.+....  ...
T Consensus       112 ~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~  184 (1187)
T KOG0579|consen  112 GGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STR  184 (1187)
T ss_pred             CCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hHH
Confidence            99999988754  3567999999999999999999999997   9999999999999999999999999976432  222


Q ss_pred             ccccccccCCCCcChhhhh-----cCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccccc
Q 008108          403 SDTNRVVGTFGYMAPEYVM-----HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD  477 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  477 (577)
                      .....+.||++|||||+++     ...|..++||||||++|.||..+.+|...-.+-  .-++..+     ...     .
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM--RVllKia-----KSe-----P  252 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLKIA-----KSE-----P  252 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH--HHHHHHh-----hcC-----C
Confidence            3344589999999999875     357899999999999999999999886432221  1111111     111     1


Q ss_pred             CcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          478 PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       478 ~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      |.|. .+..-...+-++...|+..||..||++.++++
T Consensus       253 PTLl-qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  253 PTLL-QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             Cccc-CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            2221 12233445557778999999999999998874

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.1e-34  Score=296.72  Aligned_cols=245  Identities=29%  Similarity=0.442  Sum_probs=191.2

Q ss_pred             CccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      |+..+.||+|+||.||++... +++.+|+|.+.....   .....+.+|+.+++.++|+|++++++++.++...++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            667889999999999999954 688999999875422   2234688899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++ +|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||+|+||+++.++.+||+|||++.....   
T Consensus       107 ~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---  177 (317)
T cd06635         107 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP---  177 (317)
T ss_pred             CCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence            975 66665532  2456999999999999999999999987   99999999999999999999999999875432   


Q ss_pred             cccccccccCCCCcChhhhh---cCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          402 HSDTNRVVGTFGYMAPEYVM---HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                         .....|+..|+|||++.   .+.++.++||||||+++|||++|+.|+........   +.    .+.....     +
T Consensus       178 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~----~~~~~~~-----~  242 (317)
T cd06635         178 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LY----HIAQNES-----P  242 (317)
T ss_pred             ---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HH----HHHhccC-----C
Confidence               12346889999999974   45789999999999999999999998754321111   11    0000000     0


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNML  516 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L  516 (577)
                      ...  .......+.+++.+|++.+|++||++.+|++.+
T Consensus       243 ~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         243 TLQ--SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             CCC--CccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence            010  111122455788899999999999999999754

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1e-34  Score=291.47  Aligned_cols=242  Identities=24%  Similarity=0.341  Sum_probs=183.8

Q ss_pred             ccccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHHHHH---hcCCCCeEEEEeEEEcCCeEEEEEEecC
Q 008108          251 KLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLA---RLQHRNLVRLLGFCLERKERILVYEFVP  323 (577)
Q Consensus       251 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lv~E~~~  323 (577)
                      .||+|+||.||++... +++.+|+|.+.+...   .....+.+|..++.   ..+|+||+.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999964 688999998865422   22223344544333   3479999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccc
Q 008108          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS  403 (577)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~  403 (577)
                      +++|.+++.   ....+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.++|+|||++.......   
T Consensus        81 ~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---  151 (279)
T cd05633          81 GGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (279)
T ss_pred             CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence            999988874   3457999999999999999999999988   9999999999999999999999999987554221   


Q ss_pred             cccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCC
Q 008108          404 DTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG  482 (577)
Q Consensus       404 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  482 (577)
                       .....|+..|+|||.+.. ..++.++||||||+++|||++|+.||.......... +.....         ..+..+..
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~---------~~~~~~~~  220 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTL---------TVNVELPD  220 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHHhh---------cCCcCCcc
Confidence             123468999999998864 458899999999999999999999986433222111 111000         01111211


Q ss_pred             CChHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 008108          483 GSTSEMMKCIHIGLLCVQENVSNRP-----GMASVVNM  515 (577)
Q Consensus       483 ~~~~~~~~~~~l~~~C~~~~p~~RP-----t~~ev~~~  515 (577)
                      ....   ++.+++..|++.||++||     ++.|+++.
T Consensus       221 ~~~~---~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         221 SFSP---ELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ccCH---HHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            2222   445667799999999999     59888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5e-35  Score=289.05  Aligned_cols=248  Identities=27%  Similarity=0.373  Sum_probs=199.9

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      +|++.++||+|+||.||++... +++.+++|.+....  .....++.+|+.+++.++|+||+++++++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788899999999999999854 68899999987543  23344678899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          322 VPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       322 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      +++++|..++.+.. ....+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++..... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999998874421 2356899999999999999999999988   999999999999999999999999999876543 


Q ss_pred             ccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                         ......++..|++||.+.+..++.++|+||||+++|||++|+.|+........   ...    ...+...     .+
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~~~----~~~~~~~-----~~  221 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL---RYK----VQRGKYP-----PI  221 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH----HhcCCCC-----CC
Confidence               11224588999999999988999999999999999999999999864432211   111    1111110     01


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                         .......+..++..|++.+|++||++.++++
T Consensus       222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         222 ---PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             ---chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence               1122345667888999999999999999885

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.5e-36  Score=309.49  Aligned_cols=246  Identities=25%  Similarity=0.396  Sum_probs=192.3

Q ss_pred             ccccccccCCcEEEEEeEec-CCcEEEEEEec--c--CChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCe--EEEEE
Q 008108          247 SDANKLGQGGFGAVYKGMLS-NGETIAVKRLS--K--NSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE--RILVY  319 (577)
Q Consensus       247 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~  319 (577)
                      +...+||+|.|-+||||... +|-+||--.++  +  .+......|..|+.+|+.|+|+||++++.++.+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            34578999999999999964 47777632222  1  122333579999999999999999999999987665  67899


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCC-CCeEEeccCCcccccC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMARLFEM  398 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~-~~~kl~DfGla~~~~~  398 (577)
                      |.+..|+|..|+.   +.+.++.+.+.+|++||++||.|||++. |+|||||||-+||+|+.+ |.|||+|+|||.....
T Consensus       123 EL~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  123 ELFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             ecccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            9999999999983   4567999999999999999999999986 689999999999999765 7899999999997654


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      ..    ...+.|||.|||||... ..|....||||||+.|+||+|+..|+.--..  ...+...+..-..+..+..+-||
T Consensus       199 s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n--~AQIYKKV~SGiKP~sl~kV~dP  271 (632)
T KOG0584|consen  199 SH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN--PAQIYKKVTSGIKPAALSKVKDP  271 (632)
T ss_pred             cc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC--HHHHHHHHHcCCCHHHhhccCCH
Confidence            32    22379999999999765 8899999999999999999999999753222  22333333322333333333344


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      .           +.+++-.|+.. .++|||+.|++.-
T Consensus       272 e-----------vr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  272 E-----------VREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             H-----------HHHHHHHHhcC-chhccCHHHHhhC
Confidence            3           33677799998 9999999999863

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-36  Score=295.31  Aligned_cols=207  Identities=30%  Similarity=0.436  Sum_probs=182.6

Q ss_pred             HHHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeE
Q 008108          240 RVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (577)
Q Consensus       240 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  315 (577)
                      ....+.|+.-+.||+||||.||-.+.. +|+-+|.|++.+..   +.++.-..+|-.+|.+++.+.||.+-..|+..+.+
T Consensus       181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L  260 (591)
T KOG0986|consen  181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL  260 (591)
T ss_pred             hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence            344567899999999999999999854 68889999886643   34444567899999999999999999999999999


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      +||+..|.||+|..+|++. ....++++.++-++.+|+.||++||+..   ||.|||||+|||||+.|+++|+|.|||..
T Consensus       261 ClVLtlMNGGDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAve  336 (591)
T KOG0986|consen  261 CLVLTLMNGGDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVE  336 (591)
T ss_pred             EEEEEeecCCceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEe
Confidence            9999999999999999764 3467999999999999999999999987   99999999999999999999999999998


Q ss_pred             ccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCc
Q 008108          396 FEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTE  453 (577)
Q Consensus       396 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~  453 (577)
                      +..++....   .+||.+|||||++..+.|+...|.|||||+||||+.|+.||.....
T Consensus       337 i~~g~~~~~---rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke  391 (591)
T KOG0986|consen  337 IPEGKPIRG---RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE  391 (591)
T ss_pred             cCCCCcccc---ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence            876654432   4899999999999999999999999999999999999999864443

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-34  Score=290.92  Aligned_cols=261  Identities=24%  Similarity=0.401  Sum_probs=192.1

Q ss_pred             CccccccccCCcEEEEEeEec-CCcEEEEEEeccCChh--hHHHHHHHHHHHHhc---CCCCeEEEEeEEEcCCe-----
Q 008108          246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ--GEIEFKNEVLLLARL---QHRNLVRLLGFCLERKE-----  314 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----  314 (577)
                      |++.+.||+|+||.||+|... +++.+|+|++......  ....+.+|+.++.++   +|+||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567889999999999999976 4899999999754222  233466788777666   59999999999988776     


Q ss_pred             EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      .+++|||+++ +|.+++... ....+++..++.++.||++||.|||+.+   ++|+||+|+||+++.++.+||+|||++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999975 787776432 2236999999999999999999999987   9999999999999999999999999998


Q ss_pred             cccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccch-hhhhhh----hhccc
Q 008108          395 LFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETED-LLTYAW----RNWNE  469 (577)
Q Consensus       395 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~-l~~~~~----~~~~~  469 (577)
                      ........   ....++..|+|||++.+..++.++||||||+++|||++|+.|+......+... +.....    ..|..
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         156 IYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             eccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence            76543221   22457889999999999999999999999999999999988876433322111 111000    00000


Q ss_pred             CCc--cccccCcCCC----CChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          470 GAA--LNLMDPTMRG----GSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       470 ~~~--~~~~d~~l~~----~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ...  ..........    ........+.+++.+||+.+|++||++.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            000  0000000000    01122345567888999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-35  Score=294.87  Aligned_cols=261  Identities=23%  Similarity=0.354  Sum_probs=196.9

Q ss_pred             CccccccccCCcEEEEEeEec-CCcEEEEEEeccCChh--hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      |+..+.||+|++|.||++... +++.+++|++......  ....+.+|+.++++++|+||+++++++..+...++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            566789999999999999964 6889999998765432  3456788999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      ++ +|.+++..  ....+++..++.++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||.+.......  
T Consensus        81 ~~-~l~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--  152 (283)
T cd05118          81 DT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--  152 (283)
T ss_pred             CC-CHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence            76 77777643  2357999999999999999999999987   9999999999999999999999999998765433  


Q ss_pred             ccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhh-h-------hhhhhccc---C
Q 008108          403 SDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL-T-------YAWRNWNE---G  470 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~-~-------~~~~~~~~---~  470 (577)
                      .......++..|+|||.+.+. .++.++||||||+++|+|+||+.||......+....+ .       ..|..+..   .
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN  232 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence            112234678899999998876 7899999999999999999999888654432211111 0       00111000   0


Q ss_pred             Ccccccc---CcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          471 AALNLMD---PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       471 ~~~~~~d---~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ......+   ............++.+++..|++.+|.+||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            0000000   0000001112345678899999999999999999885

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.7e-35  Score=299.84  Aligned_cols=266  Identities=23%  Similarity=0.359  Sum_probs=193.6

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChh--hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC------
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLERK------  313 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  313 (577)
                      .++|++.++||+|+||.||+|... +++.+|+|++......  ....+.+|++++++++|+||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            478999999999999999999964 6889999998654322  2235678999999999999999999875443      


Q ss_pred             --eEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccC
Q 008108          314 --ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG  391 (577)
Q Consensus       314 --~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfG  391 (577)
                        ..++||||+.+ +|...+..  ....+++..+..++.||++||.|||+.+   |+||||||+||++++++.+||+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              46999999975 55555432  2457999999999999999999999988   9999999999999999999999999


Q ss_pred             CcccccCCCccc---------cccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhh
Q 008108          392 MARLFEMDQTHS---------DTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLT  461 (577)
Q Consensus       392 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~  461 (577)
                      +++.........         ......|++.|+|||.+.+. .++.++||||||+++|||++|+.|+...........+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            998654322111         11234678899999988654 57899999999999999999998886444322211111


Q ss_pred             hh--------hhhcccCCccc--cccCcCCCC----ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          462 YA--------WRNWNEGAALN--LMDPTMRGG----STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       462 ~~--------~~~~~~~~~~~--~~d~~l~~~----~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ..        |..+.......  .........    .......+.+++.+|++.+|++|||+.|++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            11        11111000000  000011000    1111245678889999999999999998874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.1e-34  Score=286.39  Aligned_cols=250  Identities=24%  Similarity=0.372  Sum_probs=201.5

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      +|+..+.||+|+||.||++... +++.+++|++.....  ....++.+|+++++.++|+|++++++.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5788899999999999999965 688999999876533  4455688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          322 VPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       322 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      +++++|.+++.... ....+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999998875421 2367999999999999999999999987   9999999999999999999999999998765433


Q ss_pred             ccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                      .  ......|++.|+|||.+....++.++||||||+++++|++|+.|+.......   +....    .....     +.+
T Consensus       158 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~~----~~~~~-----~~~  223 (258)
T cd08215         158 D--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LALKI----LKGQY-----PPI  223 (258)
T ss_pred             c--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HHHHH----hcCCC-----CCC
Confidence            1  2223568899999999988899999999999999999999999875443221   11111    01110     011


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .....   ..+.+++.+|++.+|++||++.|+++
T Consensus       224 ~~~~~---~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         224 PSQYS---SELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCC---HHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            11112   34557788999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4e-35  Score=302.19  Aligned_cols=266  Identities=20%  Similarity=0.323  Sum_probs=195.9

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCeEEEEeEEEc----CCeE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLE----RKER  315 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  315 (577)
                      .++|++.+.||+|+||.||+|... +|+.||+|++.....  .....+.+|+.++++++|+||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            378999999999999999999954 689999999876432  234457789999999999999999998753    3467


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      ++||||+. ++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+||++++++.+||+|||+++.
T Consensus        84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence            99999996 58888773   3456999999999999999999999987   99999999999999999999999999976


Q ss_pred             ccCCCccc--cccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhh--------hh
Q 008108          396 FEMDQTHS--DTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTY--------AW  464 (577)
Q Consensus       396 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~--------~~  464 (577)
                      ........  ......|+..|+|||.+.. ..++.++||||||+++|||++|+.||...........+..        .+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            54322211  1123578999999998865 4688999999999999999999999864332211110000        00


Q ss_pred             hhcccCCccccccC--cCCCCC-----hHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          465 RNWNEGAALNLMDP--TMRGGS-----TSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       465 ~~~~~~~~~~~~d~--~l~~~~-----~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      .........+.++.  ......     ......+.+++..|++.+|++||++.+++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            00000000011100  000000     1123456678889999999999999998864

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.1e-34  Score=289.30  Aligned_cols=246  Identities=20%  Similarity=0.303  Sum_probs=186.8

Q ss_pred             HHHhcCCcccccc--ccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeE
Q 008108          240 RVATDNFSDANKL--GQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKER  315 (577)
Q Consensus       240 ~~~~~~f~~~~~l--G~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  315 (577)
                      ....++|++.+.+  |+|+||.||++.. .+++.+|+|.+.......     .|+.....+ +|+||+++++.+...+..
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~   84 (267)
T PHA03390         10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGH   84 (267)
T ss_pred             HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence            3344677777776  9999999999995 468889999986543221     122222222 799999999999999999


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC-CeEEeccCCcc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-NPKISDFGMAR  394 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~-~~kl~DfGla~  394 (577)
                      ++||||+++++|.+++..   ...+++..+..++.||++||.|||+.+   ++||||||+||+++.++ .++|+|||+++
T Consensus        85 ~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~  158 (267)
T PHA03390         85 VLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK  158 (267)
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence            999999999999998843   348999999999999999999999988   99999999999999998 99999999987


Q ss_pred             cccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccc
Q 008108          395 LFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALN  474 (577)
Q Consensus       395 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  474 (577)
                      .....      ....|+..|+|||++.+..++.++||||||+++|||++|+.|+........ ....+....  . ....
T Consensus       159 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~--~-~~~~  228 (267)
T PHA03390        159 IIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLESLLKRQ--Q-KKLP  228 (267)
T ss_pred             ecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHHHHHhh--c-ccCC
Confidence            65422      124689999999999998999999999999999999999999874332221 111111111  0 0000


Q ss_pred             cccCcCCCCChHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 008108          475 LMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPG-MASVVN  514 (577)
Q Consensus       475 ~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt-~~ev~~  514 (577)
                      ..        ......+.+++..|++.+|.+||+ ++|+++
T Consensus       229 ~~--------~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        229 FI--------KNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             cc--------cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            00        011234556777999999999996 688773

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4e-35  Score=317.23  Aligned_cols=202  Identities=24%  Similarity=0.420  Sum_probs=158.6

Q ss_pred             hcCCccccccccCCcEEEEEeEecC--CcEEEEEE--------------ecc---CChhhHHHHHHHHHHHHhcCCCCeE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSN--GETIAVKR--------------LSK---NSKQGEIEFKNEVLLLARLQHRNLV  303 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~--------------~~~---~~~~~~~~~~~E~~~l~~l~h~niv  303 (577)
                      .++|+++++||+|+||+||++..+.  +...++|.              +.+   ........+.+|+.+|++++|+||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            4689999999999999999987532  22222221              111   1122334578999999999999999


Q ss_pred             EEEeEEEcCCeEEEEEEecCCCCcccccccCC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC
Q 008108          304 RLLGFCLERKERILVYEFVPNASLDHFIFDPI--NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS  381 (577)
Q Consensus       304 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~  381 (577)
                      ++++++...+..++|+|++.+ +|..++....  .........+..|+.||+.||.|||+++   |+||||||+||||+.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~  302 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNC  302 (501)
T ss_pred             cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence            999999999999999999854 5655553311  1223446677889999999999999987   999999999999999


Q ss_pred             CCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCC
Q 008108          382 EMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSS  449 (577)
Q Consensus       382 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~  449 (577)
                      ++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|+.++.
T Consensus       303 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~  369 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI  369 (501)
T ss_pred             CCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence            999999999999876543221 2223679999999999999999999999999999999999986543

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.4e-34  Score=291.73  Aligned_cols=254  Identities=26%  Similarity=0.355  Sum_probs=197.7

Q ss_pred             CCccccccccCCcEEEEEeEe----cCCcEEEEEEeccCCh----hhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeE
Q 008108          245 NFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNSK----QGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKER  315 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  315 (577)
                      +|+..+.||+|++|.||++..    .+++.||||.+.+...    .....+.+|+.++.++ +|+||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            477889999999999999984    3578899999875321    2234578899999999 599999999999999999


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      ++||||+++++|.+++.   .+..+++..+..++.|++++|.|||+.+   ++||||||+||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLY---QREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHh---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            99999999999988874   2456899999999999999999999987   99999999999999999999999999986


Q ss_pred             ccCCCccccccccccCCCCcChhhhhcCC--CCccccEEecchhHhHHhhCCCCCCCCCcccc-chhhhhhhhhcccCCc
Q 008108          396 FEMDQTHSDTNRVVGTFGYMAPEYVMHGR--FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET-EDLLTYAWRNWNEGAA  472 (577)
Q Consensus       396 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~  472 (577)
                      +...... ......|+..|+|||.+.+..  .+.++||||||+++|||++|..|+........ ..+.....   ..   
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~---  227 (288)
T cd05583         155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL---KS---  227 (288)
T ss_pred             ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH---cc---
Confidence            5433221 122356899999999987665  78899999999999999999999864322111 11111110   00   


Q ss_pred             cccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       473 ~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                          .+.......   ..+.+++.+|++.+|++|||+.+|.+.|+.
T Consensus       228 ----~~~~~~~~~---~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 ----KPPFPKTMS---AEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ----CCCCCcccC---HHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                111111112   234567789999999999999999888876

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.4e-34  Score=292.58  Aligned_cols=259  Identities=15%  Similarity=0.200  Sum_probs=181.1

Q ss_pred             HhcCCccccccccCCcEEEEEeEecC----CcEEEEEEeccCChhhHH-----------HHHHHHHHHHhcCCCCeEEEE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLSN----GETIAVKRLSKNSKQGEI-----------EFKNEVLLLARLQHRNLVRLL  306 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~-----------~~~~E~~~l~~l~h~niv~l~  306 (577)
                      ..++|.+.++||+|+||+||+|...+    +..+|+|...........           ....+...+..++|+|+++++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            34679999999999999999999654    345666654332211111           112233445667899999999


Q ss_pred             eEEEcCC----eEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCC
Q 008108          307 GFCLERK----ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE  382 (577)
Q Consensus       307 ~~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~  382 (577)
                      +++....    ..++++|++.. ++.+.+.   .....++..+..++.|++.||.|||+.+   |+||||||+|||++.+
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~  162 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFK---RIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN  162 (294)
T ss_pred             EeeeEecCCceEEEEEEehhcc-CHHHHHH---hhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence            9766543    34677777643 4444432   1234678889999999999999999987   9999999999999999


Q ss_pred             CCeEEeccCCcccccCCCcc-----ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccc-c
Q 008108          383 MNPKISDFGMARLFEMDQTH-----SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEE-T  456 (577)
Q Consensus       383 ~~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~-~  456 (577)
                      +.++|+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~  242 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL  242 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence            99999999999876432211     11223579999999999999999999999999999999999999997542211 1


Q ss_pred             chhhhh-hhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          457 EDLLTY-AWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       457 ~~l~~~-~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                      ...... .+.....+..    .  + ...+   ..+.+++..|++.+|++||++.++++.|+
T Consensus       243 ~~~~~~~~~~~~~~~~~----~--~-~~~~---~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        243 IHAAKCDFIKRLHEGKI----K--I-KNAN---KFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHhHHHHHHHhhhhhh----c--c-CCCC---HHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            111100 0111111110    0  0 1122   34556777899999999999999998763

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.2e-34  Score=293.97  Aligned_cols=260  Identities=20%  Similarity=0.245  Sum_probs=190.5

Q ss_pred             cccccccCCcEEEEEeEecCCcEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCC
Q 008108          248 DANKLGQGGFGAVYKGMLSNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA  325 (577)
Q Consensus       248 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  325 (577)
                      +.+.+|.|+++.|+++.. +++.||||++...  .......+.+|+.+++.++|+||+++++++.+.+..+++|||++++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            344556666666666655 6899999998765  3344457899999999999999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc----
Q 008108          326 SLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT----  401 (577)
Q Consensus       326 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~----  401 (577)
                      +|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||.+........    
T Consensus        85 ~l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          85 SCEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            999988542 2346899999999999999999999987   99999999999999999999999999875532211    


Q ss_pred             -cccccccccCCCCcChhhhhcC--CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhh----cc------
Q 008108          402 -HSDTNRVVGTFGYMAPEYVMHG--RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRN----WN------  468 (577)
Q Consensus       402 -~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~----~~------  468 (577)
                       ........++..|+|||++...  .++.++||||||+++|||++|+.||.......  .+++.....    +.      
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  238 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPL  238 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhh
Confidence             1112234578899999998763  58899999999999999999999986433211  111110000    00      


Q ss_pred             -cCCccc----cccCcCCC-----CChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          469 -EGAALN----LMDPTMRG-----GSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       469 -~~~~~~----~~d~~l~~-----~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                       ......    ..++....     ........+.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence             000000    00111000     01122235667888999999999999999886

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2e-35  Score=322.03  Aligned_cols=253  Identities=30%  Similarity=0.469  Sum_probs=186.4

Q ss_pred             HHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC------
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER------  312 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  312 (577)
                      .-..+|+++..||+||||.|||++.+ +|+.+|||++.... ......+.+|+.+|++|+|||||+++..+.+.      
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            34578999999999999999999965 89999999997653 33344688999999999999999998543211      


Q ss_pred             --------------------------------------------------------------------------------
Q 008108          313 --------------------------------------------------------------------------------  312 (577)
Q Consensus       313 --------------------------------------------------------------------------------  312 (577)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------------CeEEEEEEecCCCCcccccccCCCCCCC--CHHHHHHHHHHHHHHHH
Q 008108          313 ---------------------------------KERILVYEFVPNASLDHFIFDPINREHM--TWEKRYKIIEGIARGLL  357 (577)
Q Consensus       313 ---------------------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~l--~~~~~~~i~~~ia~gl~  357 (577)
                                                       ..+||=||||+..+|.+++.+    ..+  .....++++++|++||.
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~----N~~~~~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR----NHFNSQRDEAWRLFREILEGLA  711 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh----cccchhhHHHHHHHHHHHHHHH
Confidence                                             013566778877777666633    122  36678999999999999


Q ss_pred             HhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC----------------CCccccccccccCCCCcChhhhh
Q 008108          358 YLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM----------------DQTHSDTNRVVGTFGYMAPEYVM  421 (577)
Q Consensus       358 yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~----------------~~~~~~~~~~~gt~~y~aPE~~~  421 (577)
                      |+|+.+   ||||||||.||+||++..+||+|||+|.....                +......+..+||.-|+|||.+.
T Consensus       712 YIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~  788 (1351)
T KOG1035|consen  712 YIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS  788 (1351)
T ss_pred             HHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence            999998   99999999999999999999999999987220                11111334578999999999986


Q ss_pred             cC---CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhc
Q 008108          422 HG---RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLC  498 (577)
Q Consensus       422 ~~---~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C  498 (577)
                      +.   .|+.|+|+|||||||+||+.   ||.  ..-+....+.    .++.+.+..-  +.+   ...+...-.+++.++
T Consensus       789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~--TsMERa~iL~----~LR~g~iP~~--~~f---~~~~~~~e~slI~~L  854 (1351)
T KOG1035|consen  789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFG--TSMERASILT----NLRKGSIPEP--ADF---FDPEHPEEASLIRWL  854 (1351)
T ss_pred             ccccccccchhhhHHHHHHHHHHhc---cCC--chHHHHHHHH----hcccCCCCCC--ccc---ccccchHHHHHHHHH
Confidence            54   49999999999999999994   432  2222222222    2333322221  111   223333445677899


Q ss_pred             ccCCCCCCCCHHHHHH
Q 008108          499 VQENVSNRPGMASVVN  514 (577)
Q Consensus       499 ~~~~p~~RPt~~ev~~  514 (577)
                      ++.||.+|||+.|+++
T Consensus       855 l~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  855 LSHDPSKRPTATELLN  870 (1351)
T ss_pred             hcCCCccCCCHHHHhh
Confidence            9999999999999885

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-35  Score=288.88  Aligned_cols=259  Identities=27%  Similarity=0.388  Sum_probs=197.4

Q ss_pred             HHHHhcCCccccccccCCcEEEEEeE-ecCCcEEEEEEeccCChhh-------HHHHHHHHHHHHhcCCCCeEEEEeEEE
Q 008108          239 IRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQG-------EIEFKNEVLLLARLQHRNLVRLLGFCL  310 (577)
Q Consensus       239 ~~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~  310 (577)
                      -....++|-.+++||+|||+.||++. +...+.||||+-..+..+.       .....+|..+-+.|.||.||++++++.
T Consensus       458 HptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs  537 (775)
T KOG1151|consen  458 HPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS  537 (775)
T ss_pred             CcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee
Confidence            34456678889999999999999998 5567889999754432221       112467999999999999999999985


Q ss_pred             -cCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC---CCCeE
Q 008108          311 -ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS---EMNPK  386 (577)
Q Consensus       311 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~---~~~~k  386 (577)
                       +.+..+-|+|||+|.+|+.+|.   ..+.++++++..|+.||+.+|.||.+.. ++|||-||||.||||-+   -|.+|
T Consensus       538 lDtdsFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIK  613 (775)
T KOG1151|consen  538 LDTDSFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIK  613 (775)
T ss_pred             eccccceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeE
Confidence             5667889999999999999984   4667999999999999999999999875 67999999999999954   46799


Q ss_pred             EeccCCcccccCCCccc-----cccccccCCCCcChhhhhcC----CCCccccEEecchhHhHHhhCCCCCCCCCccccc
Q 008108          387 ISDFGMARLFEMDQTHS-----DTNRVVGTFGYMAPEYVMHG----RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE  457 (577)
Q Consensus       387 l~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~  457 (577)
                      |+||||+++++.+....     -+....||.+|++||.+.-+    +.+.|.||||.|||+|+++.|++||.....  ..
T Consensus       614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQ  691 (775)
T KOG1151|consen  614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQ  691 (775)
T ss_pred             eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HH
Confidence            99999999887654432     24567899999999988655    578899999999999999999999875443  22


Q ss_pred             hhhhhhhhhcccCCccccccCcCCC--CChHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 008108          458 DLLTYAWRNWNEGAALNLMDPTMRG--GSTSEMMKCIHIGLLCVQENVSNRPGMASVV  513 (577)
Q Consensus       458 ~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~  513 (577)
                      +++.+       +.+...-.-.+..  ....+..   .++.+|++..-++|-...++.
T Consensus       692 dILqe-------NTIlkAtEVqFP~KPvVsseAk---aFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  692 DILQE-------NTILKATEVQFPPKPVVSSEAK---AFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             HHHhh-------hchhcceeccCCCCCccCHHHH---HHHHHHHHhhhhhhhhHHHHc
Confidence            33332       2222111111111  1223333   566799999999997655443

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=6.5e-35  Score=292.19  Aligned_cols=249  Identities=24%  Similarity=0.340  Sum_probs=199.0

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcC-CCCeEEEEeEEEcCCeEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  318 (577)
                      ++|...+.||+|+||.||++... +++.||+|.+.+..   ......+.+|+.++.+++ |+||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888999999999999999965 68999999987632   233456789999999998 99999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+++++|.+++..   ...+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            999999999998843   447999999999999999999999987   99999999999999999999999999986653


Q ss_pred             CCcc------------------ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhh
Q 008108          399 DQTH------------------SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL  460 (577)
Q Consensus       399 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~  460 (577)
                      ....                  .......++..|+|||.+....++.++||||||++++++++|+.|+.......   .+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~  231 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---TF  231 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH---HH
Confidence            3221                  22233567899999999988889999999999999999999999986443211   11


Q ss_pred             hhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCH----HHHHH
Q 008108          461 TYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGM----ASVVN  514 (577)
Q Consensus       461 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~----~ev~~  514 (577)
                      .....    .      ...+....   ...+.+++..|++.+|++||++    .++++
T Consensus       232 ~~~~~----~------~~~~~~~~---~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         232 QKILK----L------EYSFPPNF---PPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHHHh----c------CCCCCCcc---CHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            11110    0      00010011   2345678889999999999999    66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4.1e-34  Score=286.87  Aligned_cols=241  Identities=25%  Similarity=0.333  Sum_probs=184.6

Q ss_pred             ccccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHH---HHHhcCCCCeEEEEeEEEcCCeEEEEEEecC
Q 008108          251 KLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVL---LLARLQHRNLVRLLGFCLERKERILVYEFVP  323 (577)
Q Consensus       251 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  323 (577)
                      .||+|+||.||++... +++.||+|.+.+...   .....+.+|..   .++...||||+++++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999854 688999999876432   22222344433   3444579999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccc
Q 008108          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS  403 (577)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~  403 (577)
                      +++|..++.   ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..+....   
T Consensus        81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---  151 (278)
T cd05606          81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (278)
T ss_pred             CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence            999988873   3457999999999999999999999987   9999999999999999999999999987554221   


Q ss_pred             cccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCC
Q 008108          404 DTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG  482 (577)
Q Consensus       404 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  482 (577)
                       .....|+..|+|||.+..+ .++.++||||||+++|||++|+.||.............    ...      ..++.+..
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~------~~~~~~~~  220 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MTL------TMAVELPD  220 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH----Hhh------ccCCCCCC
Confidence             1234689999999998755 68999999999999999999999986543222111110    000      01111111


Q ss_pred             CChHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 008108          483 GSTSEMMKCIHIGLLCVQENVSNRP-----GMASVVN  514 (577)
Q Consensus       483 ~~~~~~~~~~~l~~~C~~~~p~~RP-----t~~ev~~  514 (577)
                      ..   ...+.+++..|++.+|++||     ++.++++
T Consensus       221 ~~---s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         221 SF---SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             cC---CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            11   23455677799999999999     8998875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-34  Score=284.57  Aligned_cols=250  Identities=24%  Similarity=0.372  Sum_probs=192.5

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccC-----ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC--CeE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN-----SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KER  315 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  315 (577)
                      .+|++.+.||+|+||.||+|.. .+++.||+|.+...     .......+++|+.++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4788999999999999999995 46899999987532     122334688999999999999999999998764  457


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      ++++||+++++|.+++.   +...+++.....++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLK---AYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            89999999999988874   3456899999999999999999999988   99999999999999999999999999986


Q ss_pred             ccCCCc-cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccc
Q 008108          396 FEMDQT-HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALN  474 (577)
Q Consensus       396 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  474 (577)
                      ...... ........|+..|+|||.+.+..++.++||||||+++|||++|+.||......  .....    .....    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~----~~~~~----  225 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--AAIFK----IATQP----  225 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--HHHHH----HHcCC----
Confidence            542211 11122356899999999998888999999999999999999999998533211  11111    11000    


Q ss_pred             cccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          475 LMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       475 ~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                       ..+.+.....+   .+.+++..|++ +|..||+..+++.
T Consensus       226 -~~~~~p~~~~~---~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         226 -TKPMLPDGVSD---ACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             -CCCCCCcccCH---HHHHHHHHHhc-CcccCccHHHHhc
Confidence             01112112223   34466678888 5799999997764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-35  Score=292.83  Aligned_cols=261  Identities=25%  Similarity=0.352  Sum_probs=194.2

Q ss_pred             CccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhcC-CCCeEEEEeEEEcCCeEEEEEEec
Q 008108          246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      |++.+.||+|++|+||+|... +++.|+||++..... .......+|+..+++++ |+||+++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567889999999999999975 578899999876533 22334567999999998 999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                       +|+|.+++... ....+++..+..++.|++.+|.|||+++   ++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 -~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (283)
T cd07830          81 -EGNLYQLMKDR-KGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-  154 (283)
T ss_pred             -CCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence             78888776432 2347899999999999999999999987   99999999999999999999999999986543222 


Q ss_pred             ccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccch-hhhhh----hhhcccCC-cccc
Q 008108          403 SDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETED-LLTYA----WRNWNEGA-ALNL  475 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~-l~~~~----~~~~~~~~-~~~~  475 (577)
                        .....++..|+|||++.. ..++.++||||||++++||++|+.|+......+... .....    ...|.... ....
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence              123568889999998754 457899999999999999999998875443322111 00000    00010000 0000


Q ss_pred             ccCcCCC---C-----ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          476 MDPTMRG---G-----STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       476 ~d~~l~~---~-----~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ++..+..   .     .......+.+++.+|++.+|++|||+.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            1100000   0     0111345778899999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.7e-34  Score=289.83  Aligned_cols=250  Identities=24%  Similarity=0.323  Sum_probs=192.4

Q ss_pred             CCccccccccCCcEEEEEeEe----cCCcEEEEEEeccCCh----hhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeE
Q 008108          245 NFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNSK----QGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKER  315 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  315 (577)
                      +|++.+.||+|+||.||++..    .+|+.||+|++.....    .....+.+|+.++.++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999985    3689999999875422    2234678899999999 699999999999999999


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      ++||||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            999999999999998843   456899999999999999999999987   99999999999999999999999999986


Q ss_pred             ccCCCccccccccccCCCCcChhhhhcC--CCCccccEEecchhHhHHhhCCCCCCCCCcccc-chhhhhhhhhcccCCc
Q 008108          396 FEMDQTHSDTNRVVGTFGYMAPEYVMHG--RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET-EDLLTYAWRNWNEGAA  472 (577)
Q Consensus       396 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~  472 (577)
                      ...... .......|+..|+|||.+..+  .++.++||||||+++|+|++|+.|+........ ..+...   ....   
T Consensus       155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~---~~~~---  227 (290)
T cd05613         155 FHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR---ILKS---  227 (290)
T ss_pred             cccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHH---hhcc---
Confidence            543221 122235689999999998754  467899999999999999999999864332211 111111   1100   


Q ss_pred             cccccCcCCCCChHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 008108          473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRP-----GMASVVN  514 (577)
Q Consensus       473 ~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RP-----t~~ev~~  514 (577)
                          .+......   ...+..++..|++.+|++||     ++.+++.
T Consensus       228 ----~~~~~~~~---~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         228 ----EPPYPQEM---SALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ----CCCCCccC---CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                01111111   12345677899999999997     5565543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.3e-34  Score=298.48  Aligned_cols=265  Identities=22%  Similarity=0.327  Sum_probs=193.6

Q ss_pred             cCCcc-ccccccCCcEEEEEeEec-CCcEEEEEEeccCChhh--------------HHHHHHHHHHHHhcCCCCeEEEEe
Q 008108          244 DNFSD-ANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQG--------------EIEFKNEVLLLARLQHRNLVRLLG  307 (577)
Q Consensus       244 ~~f~~-~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~  307 (577)
                      ++|.. .+.||+|+||+||+|... +++.||||.+.......              ...+.+|+.+++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            45553 467999999999999954 68999999986543221              124678999999999999999999


Q ss_pred             EEEcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEE
Q 008108          308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI  387 (577)
Q Consensus       308 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl  387 (577)
                      ++...+..++||||++ ++|.+++.   ....+++.....++.|++.||.|||+.+   |+||||+|+||+++.++.+||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence            9999999999999997 58887773   3456999999999999999999999987   999999999999999999999


Q ss_pred             eccCCcccccCCCc------------cccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCcc
Q 008108          388 SDFGMARLFEMDQT------------HSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEE  454 (577)
Q Consensus       388 ~DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~  454 (577)
                      +|||+++.......            ........++..|+|||.+.+. .++.++||||||+++|||++|+.|+......
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  240 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI  240 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999986541110            1111223568899999998764 4689999999999999999999988654432


Q ss_pred             ccch-hhhhhh----hhcccCCc---cccccCcCCC----CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          455 ETED-LLTYAW----RNWNEGAA---LNLMDPTMRG----GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       455 ~~~~-l~~~~~----~~~~~~~~---~~~~d~~l~~----~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      +... +.....    ..|.....   .....+....    ........+.+++..|++.+|++||++.|++..
T Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            2111 111000    00110000   0000000000    011112346678889999999999999999864

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-35  Score=304.96  Aligned_cols=201  Identities=29%  Similarity=0.474  Sum_probs=174.7

Q ss_pred             CccccccccCCcEEEEEeE-ecCCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC------eEEE
Q 008108          246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK------ERIL  317 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l  317 (577)
                      |...+.||+|+||.||+|+ ..+|+.||||.+.+.. ........+|+++|++++|+|||++++.-.+..      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            4456789999999999999 5579999999997753 333445678999999999999999999865543      5689


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEc--CCC--CeEEeccCCc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD--SEM--NPKISDFGMA  393 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~--~~~--~~kl~DfGla  393 (577)
                      |||||.+|||...|.++.+...|++.+.+.++.+++.||.|||+++   |+||||||.||++-  ++|  .-||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999999999999999999999999999999999988   99999999999993  333  4799999999


Q ss_pred             ccccCCCccccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCC
Q 008108          394 RLFEMDQTHSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGT  452 (577)
Q Consensus       394 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~  452 (577)
                      +..+.+.   .....+||..|.+||.+.. +.|+...|.|||||++||+.||..||....
T Consensus       172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~  228 (732)
T KOG4250|consen  172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG  228 (732)
T ss_pred             ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence            9877554   3445899999999999984 889999999999999999999999997544

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4.1e-34  Score=293.94  Aligned_cols=261  Identities=21%  Similarity=0.294  Sum_probs=189.4

Q ss_pred             cccccC--CcEEEEEeEe-cCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCC
Q 008108          250 NKLGQG--GFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPN  324 (577)
Q Consensus       250 ~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  324 (577)
                      ..||+|  +||+||++.. .+|+.||+|.+....  ......+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            457777  9999999996 478999999987543  22335688999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccc-
Q 008108          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS-  403 (577)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~-  403 (577)
                      ++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+|++||+.+.......... 
T Consensus        84 ~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTY-FPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            9999887542 2345899999999999999999999987   9999999999999999999999998654322111100 


Q ss_pred             ----cccccccCCCCcChhhhhcC--CCCccccEEecchhHhHHhhCCCCCCCCCcccc-chhhhhh-hhhccc------
Q 008108          404 ----DTNRVVGTFGYMAPEYVMHG--RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET-EDLLTYA-WRNWNE------  469 (577)
Q Consensus       404 ----~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~-~~l~~~~-~~~~~~------  469 (577)
                          ......++..|+|||++.++  .++.++||||||+++|||++|+.|+........ ...+... +..+..      
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence                01112356679999998764  478999999999999999999999864432111 0000000 000000      


Q ss_pred             ----------------------CCccccccCcCCCC-ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          470 ----------------------GAALNLMDPTMRGG-STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       470 ----------------------~~~~~~~d~~l~~~-~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                                            .......+..+... .......+.+++.+|++.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                                  00000111111111 1223446778999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.5e-35  Score=301.16  Aligned_cols=255  Identities=24%  Similarity=0.370  Sum_probs=189.9

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC------
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK------  313 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  313 (577)
                      .++|...+.||+|+||.||+|.. .+|+.||+|++....  ......+.+|+.+++.++|+||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            47899999999999999999995 468999999987542  222345788999999999999999999987543      


Q ss_pred             eEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCc
Q 008108          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (577)
Q Consensus       314 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla  393 (577)
                      ..++|+||+.. +|..++     ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            46899999964 565543     346899999999999999999999987   999999999999999999999999998


Q ss_pred             ccccCCCccccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhc-----
Q 008108          394 RLFEMDQTHSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNW-----  467 (577)
Q Consensus       394 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~-----  467 (577)
                      +....     ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......   .+...+...     
T Consensus       165 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~  236 (342)
T cd07879         165 RHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGP  236 (342)
T ss_pred             cCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCH
Confidence            75432     1223567889999999876 468899999999999999999999986543211   111111100     


Q ss_pred             ------ccCCcccccc--CcCCCC-----ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          468 ------NEGAALNLMD--PTMRGG-----STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       468 ------~~~~~~~~~d--~~l~~~-----~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                            ........++  +.....     .+.....+.+++.+|++.||++||++.|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~  296 (342)
T cd07879         237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE  296 (342)
T ss_pred             HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                  0000000000  000000     0011234567888999999999999999984

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.7e-35  Score=298.73  Aligned_cols=264  Identities=24%  Similarity=0.328  Sum_probs=199.1

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC-----eEE
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK-----ERI  316 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  316 (577)
                      +|++.+.||+|++|.||++... +++.||||++....  ......+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5788899999999999999965 48999999987643  333456889999999999999999999988775     789


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccc
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~  396 (577)
                      ++|||+++ +|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.++|+|||++...
T Consensus        81 lv~e~~~~-~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELMET-DLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchhh-hHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            99999984 78777733   347999999999999999999999988   999999999999999999999999999876


Q ss_pred             cCCCcc-ccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhh--------
Q 008108          397 EMDQTH-SDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRN--------  466 (577)
Q Consensus       397 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~--------  466 (577)
                      ...... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+......        
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  233 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF  233 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence            543210 112335678999999999887 7899999999999999999999998655432211111110000        


Q ss_pred             cccCCccccccCcCC--CC-----ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          467 WNEGAALNLMDPTMR--GG-----STSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       467 ~~~~~~~~~~d~~l~--~~-----~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      +......+.+.....  ..     .......+.+++.+||+.+|++||++.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            000001111100000  00     01112345678889999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.6e-34  Score=297.16  Aligned_cols=263  Identities=21%  Similarity=0.319  Sum_probs=191.6

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC----------
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER----------  312 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----------  312 (577)
                      .+|...+.||+|+||.||+|.. .+|+.||+|.+..........+.+|++++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            6799999999999999999996 46899999998766555566788999999999999999999876543          


Q ss_pred             ----CeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC-CCCeEE
Q 008108          313 ----KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS-EMNPKI  387 (577)
Q Consensus       313 ----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~-~~~~kl  387 (577)
                          ...++||||++ ++|.+++    ....+++..+..++.||+.||.|||+.+   |+||||||+||+++. ++.+||
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVL----EQGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence                35789999997 4787766    2346899999999999999999999987   999999999999974 557899


Q ss_pred             eccCCcccccCCCccc-cccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhh
Q 008108          388 SDFGMARLFEMDQTHS-DTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWR  465 (577)
Q Consensus       388 ~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~  465 (577)
                      +|||+++......... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||...........+.....
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  236 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP  236 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999997654321111 1123467889999998765 4578899999999999999999999864432211111000000


Q ss_pred             hccc---CCcc----c-cc-cCcCCCCCh-----HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          466 NWNE---GAAL----N-LM-DPTMRGGST-----SEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       466 ~~~~---~~~~----~-~~-d~~l~~~~~-----~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ....   ....    . .. +........     .....+.+++..|++.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            0000   0000    0 00 000000000     11234567888999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-34  Score=297.36  Aligned_cols=260  Identities=23%  Similarity=0.368  Sum_probs=193.1

Q ss_pred             HhcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC-----
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK-----  313 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  313 (577)
                      ..++|+..+.||+|+||.||++.. .+++.||||++....  ......+.+|+.++++++|+||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            467899999999999999999984 468999999986532  223345789999999999999999999987653     


Q ss_pred             -eEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCC
Q 008108          314 -ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (577)
Q Consensus       314 -~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGl  392 (577)
                       ..++||||+ +++|..++.    ...+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence             458999999 678877762    356999999999999999999999987   99999999999999999999999999


Q ss_pred             cccccCCCccccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCcccc-chhhhh-------h
Q 008108          393 ARLFEMDQTHSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET-EDLLTY-------A  463 (577)
Q Consensus       393 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~-~~l~~~-------~  463 (577)
                      +......     .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ..+...       .
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07880         165 ARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF  239 (343)
T ss_pred             ccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            9865321     223467899999999876 4588999999999999999999999864432111 111100       0


Q ss_pred             hhhcccCCcccccc--CcCCCC-----ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          464 WRNWNEGAALNLMD--PTMRGG-----STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       464 ~~~~~~~~~~~~~d--~~l~~~-----~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      +..+........+.  +.....     .......+.+++.+|++.||++|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00000000000000  000000     0011124567888999999999999999884

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-36  Score=327.91  Aligned_cols=256  Identities=27%  Similarity=0.380  Sum_probs=198.3

Q ss_pred             HHhcCCccccccccCCcEEEEEeE-ecCCcEEEEEEeccCChh--hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      ..+-++....+||.|.||.||-+. ..+|+..|+|-+......  ....+.+|..++..++|||+|+++|+-.+.+..+|
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            344567788999999999999999 557899999987654322  23357899999999999999999999999999999


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      .||||++|+|.+.+.   .....++.....+..|++.|+.|||++|   ||||||||.||+|+.+|.+|++|||.|..+.
T Consensus      1312 FMEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEec
Confidence            999999999999873   3445667777778899999999999998   9999999999999999999999999999776


Q ss_pred             CCC--ccccccccccCCCCcChhhhhcCC---CCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCc
Q 008108          398 MDQ--THSDTNRVVGTFGYMAPEYVMHGR---FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAA  472 (577)
Q Consensus       398 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  472 (577)
                      ...  .....+...||+-|||||++.+..   ..-+.||||+||+++||+||++||.....+  .. +   ......+..
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--~a-I---My~V~~gh~ 1459 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--WA-I---MYHVAAGHK 1459 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--hH-H---HhHHhccCC
Confidence            542  122334578999999999997643   457899999999999999999999633221  00 0   011111211


Q ss_pred             cccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 008108          473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNML  516 (577)
Q Consensus       473 ~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L  516 (577)
                           |.+......+   -.+++-.|++.||+.|.++.|+++--
T Consensus      1460 -----Pq~P~~ls~~---g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1460 -----PQIPERLSSE---GRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             -----CCCchhhhHh---HHHHHHHHHhcCchhhhHHHHHHHhh
Confidence                 2222112222   23566699999999999998887643

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.3e-34  Score=290.48  Aligned_cols=246  Identities=28%  Similarity=0.427  Sum_probs=190.7

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      +.|...+.||+|+||.||+|... +++.+|+|.+...   ......++.+|+.+++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34667889999999999999964 6788999998643   2233446788999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+. |+|.+++..  ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus        95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            9997 577665532  2346899999999999999999999987   999999999999999999999999998765422


Q ss_pred             CccccccccccCCCCcChhhhh---cCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVM---HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                            ....|+..|+|||.+.   .+.++.++||||||+++|||++|+.|+........  +..     +..+..    
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~-----~~~~~~----  231 (308)
T cd06634         169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYH-----IAQNES----  231 (308)
T ss_pred             ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH--HHH-----HhhcCC----
Confidence                  2346889999999975   35688999999999999999999998753221111  000     111110    


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                       +....  ......+.+++.+||+.+|++||++.+|++.
T Consensus       232 -~~~~~--~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         232 -PALQS--GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             -CCcCc--ccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence             11111  1122334577789999999999999999865

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.2e-34  Score=290.27  Aligned_cols=252  Identities=23%  Similarity=0.422  Sum_probs=190.6

Q ss_pred             hcCCccccccccCCcEEEEEeEecC-CcEEEEEEeccCCh-hhHHHHHHHHHHHHhcC-CCCeEEEEeEEEcCCeEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSK-QGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  319 (577)
                      .++|++.+.||+|+||.||+|...+ ++.||||++..... ....++..|+.++.+.. |+||+++++++.+....+++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3678889999999999999999764 88999999976432 33445667777777774 999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      ||+++ +|..++..  ....+++..+..++.||+.||.|||+. +   |+||||+|+||++++++.+||+|||++..+..
T Consensus        94 e~~~~-~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          94 ELMST-CLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             eccCc-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            99854 66655432  234799999999999999999999974 5   99999999999999999999999999976543


Q ss_pred             CCccccccccccCCCCcChhhhhcCC----CCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccc
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGR----FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALN  474 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  474 (577)
                      ....   ....++..|+|||.+....    ++.++||||||+++|||++|+.|+......  .+.+....   ... .  
T Consensus       168 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~---~~~-~--  236 (296)
T cd06618         168 SKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTKIL---QEE-P--  236 (296)
T ss_pred             CCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHHHh---cCC-C--
Confidence            2221   2245788999999986553    789999999999999999999998532211  11111111   110 0  


Q ss_pred             cccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          475 LMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       475 ~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                         +.+.. ......++.+++.+|++.+|++||++.++++.
T Consensus       237 ---~~~~~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         237 ---PSLPP-NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             ---CCCCC-CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence               00000 00112345678889999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3.1e-34  Score=294.68  Aligned_cols=263  Identities=24%  Similarity=0.336  Sum_probs=195.2

Q ss_pred             HHHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEc-CCeE
Q 008108          240 RVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLE-RKER  315 (577)
Q Consensus       240 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  315 (577)
                      ...+++|+..+.||+|+||.||++... +++.||+|++.+..  ......+.+|+.+++.++||||+++++++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            346788999999999999999999854 78999999886532  2234567889999999999999999998875 5578


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      ++++||+ +++|..++.    ...+++..+..++.||++||.|||+.+   |+||||+|+|||+++++.+||+|||++..
T Consensus        86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence            9999998 558877762    346888999999999999999999987   99999999999999999999999999875


Q ss_pred             ccCCCccccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhh--------hhhh
Q 008108          396 FEMDQTHSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTY--------AWRN  466 (577)
Q Consensus       396 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~--------~~~~  466 (577)
                      ....     .....++..|+|||++.+ ..++.++||||||+++|||++|+.|+...........+..        .+..
T Consensus       158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            4321     123467889999998766 5689999999999999999999988865433211111110        0011


Q ss_pred             cccCCccccccCc-CCCC-Ch-----HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          467 WNEGAALNLMDPT-MRGG-ST-----SEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       467 ~~~~~~~~~~d~~-l~~~-~~-----~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      +......+++... .... ..     .....+.+++..|++.+|++||++.+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            1111111111000 0000 00     112456678889999999999999998753

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3e-34  Score=296.98  Aligned_cols=266  Identities=24%  Similarity=0.343  Sum_probs=195.4

Q ss_pred             HHHHHHhcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC-
Q 008108          237 ETIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER-  312 (577)
Q Consensus       237 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-  312 (577)
                      ..+....++|...+.||+|+||.||++.. .+++.||+|++....  ......+.+|+.++.+++|+||+++++++... 
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            44556779999999999999999999985 478999999987542  22334578899999999999999999988643 


Q ss_pred             -----CeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEE
Q 008108          313 -----KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI  387 (577)
Q Consensus       313 -----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl  387 (577)
                           ...+++++++ +++|.+++.    ...+++..+..++.||++||.|||+.+   |+||||||+||++++++.+||
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl  161 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI  161 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence                 3467888876 778877662    346999999999999999999999988   999999999999999999999


Q ss_pred             eccCCcccccCCCccccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccch-hhhh---
Q 008108          388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETED-LLTY---  462 (577)
Q Consensus       388 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~-l~~~---  462 (577)
                      +|||+++....     ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.......... ++..   
T Consensus       162 ~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (345)
T cd07877         162 LDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT  236 (345)
T ss_pred             ecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            99999875432     1223568899999998866 468899999999999999999999885433221111 1110   


Q ss_pred             ----hhhhcccCCcccc---cc----CcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          463 ----AWRNWNEGAALNL---MD----PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       463 ----~~~~~~~~~~~~~---~d----~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                          .+..+........   ++    .............+.+++..|++.+|.+||++.++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                0000000000000   00    00000000112345678889999999999999988754

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=7.2e-34  Score=290.15  Aligned_cols=243  Identities=29%  Similarity=0.415  Sum_probs=188.4

Q ss_pred             CccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      |...++||+|+||+||+|... +++.|++|++.....   .....+.+|+.+++.++|+|++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            566788999999999999964 688999999875432   2334578899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +.+ +|.+++..  ....+++..++.++.||+.+|.|||+.+   ++||||+|+||+++.++.+||+|||++....    
T Consensus       103 ~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~----  172 (313)
T cd06633         103 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS----  172 (313)
T ss_pred             CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence            964 66665532  3456899999999999999999999987   9999999999999999999999999986432    


Q ss_pred             cccccccccCCCCcChhhhh---cCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          402 HSDTNRVVGTFGYMAPEYVM---HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                        ......|+..|+|||++.   .+.++.++||||||+++|||++|+.|+.......   .+....   . ........ 
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~---~~~~~~---~-~~~~~~~~-  242 (313)
T cd06633         173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHIA---Q-NDSPTLQS-  242 (313)
T ss_pred             --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHH---h-cCCCCCCc-
Confidence              122356899999999974   4568899999999999999999999875432211   111100   0 00000000 


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                         ....   ..+..++.+|++.+|++||++.++++
T Consensus       243 ---~~~~---~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         243 ---NEWT---DSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             ---cccC---HHHHHHHHHHccCChhhCcCHHHHhc
Confidence               0111   23556788999999999999999885

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.7e-34  Score=294.79  Aligned_cols=263  Identities=23%  Similarity=0.309  Sum_probs=189.2

Q ss_pred             CCccccccccCCcEEEEEeEec-C--CcEEEEEEeccCC--hhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcC----Ce
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-N--GETIAVKRLSKNS--KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLER----KE  314 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~  314 (577)
                      +|++.+.||+|+||.||++... .  +..||+|++....  ......+.+|+.+++++ +|+||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778899999999999999964 3  7789999987532  22244578899999999 599999999975432    35


Q ss_pred             EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      .++++||+. ++|..++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            688899886 58877773   3567999999999999999999999988   9999999999999999999999999998


Q ss_pred             cccCCCcc--ccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccch-hhh-------hh
Q 008108          395 LFEMDQTH--SDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETED-LLT-------YA  463 (577)
Q Consensus       395 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~-l~~-------~~  463 (577)
                      ........  .......||..|+|||++.+ ..++.++||||||+++|+|++|+.|+.......... .+.       ..
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            65432221  11234578999999998766 468999999999999999999998876433211100 000       00


Q ss_pred             hhhcccCCcccc---cc--C--cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          464 WRNWNEGAALNL---MD--P--TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       464 ~~~~~~~~~~~~---~d--~--~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      +..+........   .+  +  .+..........+..++.+|++.+|++|||+.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000000000   00  0  000000011234567888999999999999998863

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-34  Score=287.77  Aligned_cols=261  Identities=26%  Similarity=0.393  Sum_probs=196.5

Q ss_pred             CccccccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      |+..+.||+|++|.||+|+.. +++.+|+|.+....  ......+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566788999999999999965 58999999987653  233446788999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      + ++|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||+|+||++++++.+||+|||+++....... 
T Consensus        81 ~-~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          81 D-MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             C-cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence            8 5898888432  247999999999999999999999987   99999999999999999999999999987653322 


Q ss_pred             ccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccc-hhhh-------hhhhhcccCCcc
Q 008108          403 SDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE-DLLT-------YAWRNWNEGAAL  473 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~-~l~~-------~~~~~~~~~~~~  473 (577)
                       ......++..|+|||.+... .++.++||||||+++|||++|+.|+......+.. .+..       ..|..+..-...
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY  232 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence             12224567889999998776 7899999999999999999998887544322111 1110       111111100000


Q ss_pred             ccccCcCCCC-----ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          474 NLMDPTMRGG-----STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       474 ~~~d~~l~~~-----~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      +..-+.....     .+.....+.+++..|++.+|++||++.+|+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            0000000000     1111345678888999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.4e-34  Score=283.41  Aligned_cols=249  Identities=25%  Similarity=0.352  Sum_probs=190.8

Q ss_pred             CCccccccccCCcEEEEEeEecC-CcEEEEEEeccC-----ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          245 NFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKN-----SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      +|.+.++||+|+||.||++.... +..+++|.++..     ......++..|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47788999999999999998643 444555555432     222334567899999999999999999999999999999


Q ss_pred             EEecCCCCcccccccC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          319 YEFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      |||+++++|++++... .....+++..++.++.|++.||.|||+.+   ++|+||||+||+++. +.+||+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999998887542 23457999999999999999999999987   999999999999976 569999999998654


Q ss_pred             CCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccccc
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD  477 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  477 (577)
                      ....  ......|+..|+|||.+....++.++|+||||+++|+|++|+.|+......   .....   .. .+.     .
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---~~~~~---~~-~~~-----~  222 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL---SVVLR---IV-EGP-----T  222 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHHH---HH-cCC-----C
Confidence            3222  122356889999999998888999999999999999999999987532211   11111   10 110     1


Q ss_pred             CcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          478 PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       478 ~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      +.+.   ......+.+++.+|++.+|++||++.|+++
T Consensus       223 ~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         223 PSLP---ETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             CCCc---chhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            1111   112234557778999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=275.44  Aligned_cols=242  Identities=23%  Similarity=0.276  Sum_probs=195.2

Q ss_pred             HhcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHH---HHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEI---EFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      ..++|..+++||+|.||+|.+++- .+|+.+|+|++++...-...   .-..|-.+|...+||.+..|...|...+.+++
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            346788899999999999999984 47999999999887443333   34568889999999999999999999999999


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      ||||..||.|..+|.   ....+++....-+-..|+.+|.|||+++   ||.||||.+|.|||.+|.+||+||||++.--
T Consensus       246 VMeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  246 VMEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence            999999999988873   3556888888889999999999999987   9999999999999999999999999998432


Q ss_pred             CCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccccc
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD  477 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  477 (577)
                        .....+...+||+.|+|||++....|....|.|.+||++|||++|+.||.....+....++-..          ++  
T Consensus       320 --~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e----------d~--  385 (516)
T KOG0690|consen  320 --KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME----------DL--  385 (516)
T ss_pred             --cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh----------hc--
Confidence              2234456689999999999999999999999999999999999999999866655544444211          11  


Q ss_pred             CcCCCCChHHHHHHHHHHHhcccCCCCCCC
Q 008108          478 PTMRGGSTSEMMKCIHIGLLCVQENVSNRP  507 (577)
Q Consensus       478 ~~l~~~~~~~~~~~~~l~~~C~~~~p~~RP  507 (577)
                       ........+...+   ....+..||.+|.
T Consensus       386 -kFPr~ls~eAktL---LsGLL~kdP~kRL  411 (516)
T KOG0690|consen  386 -KFPRTLSPEAKTL---LSGLLKKDPKKRL  411 (516)
T ss_pred             -cCCccCCHHHHHH---HHHHhhcChHhhc
Confidence             1111123333333   3345678999995

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-34  Score=286.83  Aligned_cols=205  Identities=30%  Similarity=0.455  Sum_probs=174.6

Q ss_pred             ccccccCCcEEEEEeEe-cCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCC
Q 008108          249 ANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA  325 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  325 (577)
                      .+.||+|.||+||-|+. ++|+.||||.+.+-.  ...+..+.+|+.+|.++.||.||.|--.|+..+..++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            47899999999999995 579999999997643  344567899999999999999999999999999999999999776


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCC---CCeEEeccCCcccccCCCcc
Q 008108          326 SLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       326 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~---~~~kl~DfGla~~~~~~~~~  402 (577)
                      .|+-.|.  ...+.|++..-.-++.||+.||.|||.++   |+|.||||+||||.+.   .++||+|||+||++......
T Consensus       649 MLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  649 MLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             HHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            6655553  34667999988999999999999999998   9999999999999655   36999999999998754433


Q ss_pred             ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhh
Q 008108          403 SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA  463 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~  463 (577)
                         ..++||+.|+|||++..+.|...-|+||.|||+|--++|..||..  +++..+.++.+
T Consensus       724 ---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNA  779 (888)
T KOG4236|consen  724 ---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNA  779 (888)
T ss_pred             ---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhcc
Confidence               348999999999999999999999999999999999999998753  33444444443

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.4e-34  Score=273.44  Aligned_cols=202  Identities=27%  Similarity=0.455  Sum_probs=167.1

Q ss_pred             cCCccccccccCCcEEEEEeEecC-----CcEEEEEEeccCChh--hHHHHHHHHHHHHhcCCCCeEEEEeEEEc-CCeE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSN-----GETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLE-RKER  315 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  315 (577)
                      ..|+.+.+||+|.||.||++.-.+     .+.+|||+++.....  -....-+|+.+++.++||||+.|..++.. +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            468889999999999999996332     236899999765322  12245689999999999999999999887 7789


Q ss_pred             EEEEEecCCCCccccccc--CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCC----CCeEEec
Q 008108          316 ILVYEFVPNASLDHFIFD--PINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE----MNPKISD  389 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~----~~~kl~D  389 (577)
                      +|++||.+. +|.+.|+-  ......++...+..|+.||+.|+.|||++.   |+||||||.||||..+    |.+||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence            999999977 66665532  223457999999999999999999999998   9999999999999888    8999999


Q ss_pred             cCCcccccCCCcc-ccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCC
Q 008108          390 FGMARLFEMDQTH-SDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSS  449 (577)
Q Consensus       390 fGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~  449 (577)
                      ||++|.+...-.. .....++-|++|.|||.+.+. .||.+.|||+.|||+.||+|-++-|.
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~  241 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK  241 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence            9999988654332 245567889999999999876 58999999999999999999876554

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.9e-34  Score=295.90  Aligned_cols=260  Identities=23%  Similarity=0.354  Sum_probs=194.4

Q ss_pred             HhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCe----
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE----  314 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  314 (577)
                      ..++|+..+.||+|++|.||+|... +++.||+|++....  ......+.+|+.+++.++|+||+++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4578999999999999999999965 57899999986532  2233457789999999999999999998766554    


Q ss_pred             --EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCC
Q 008108          315 --RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (577)
Q Consensus       315 --~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGl  392 (577)
                        .++|+||+ +++|.+++.    ...+++..+..++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence              89999998 568887763    356999999999999999999999987   99999999999999999999999999


Q ss_pred             cccccCCCccccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCcccc-chhhhh-------h
Q 008108          393 ARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET-EDLLTY-------A  463 (577)
Q Consensus       393 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~-~~l~~~-------~  463 (577)
                      +......     .....++..|+|||.+.+. .++.++||||||+++|||++|+.||........ ..+...       .
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  239 (343)
T cd07851         165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL  239 (343)
T ss_pred             ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence            9865432     2234678899999988653 678999999999999999999998864432211 111110       0


Q ss_pred             hhhcccCCccccccCcC--CCC-----ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          464 WRNWNEGAALNLMDPTM--RGG-----STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       464 ~~~~~~~~~~~~~d~~l--~~~-----~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      +..+........+....  ...     .......+.+++..|++.+|++|||+.||++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            00010000000000000  000     0011346678889999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=310.13  Aligned_cols=265  Identities=28%  Similarity=0.411  Sum_probs=204.2

Q ss_pred             HHHHHhcCCccccccccCCcEEEEEeEec----C----CcEEEEEEeccCChh-hHHHHHHHHHHHHhc-CCCCeEEEEe
Q 008108          238 TIRVATDNFSDANKLGQGGFGAVYKGMLS----N----GETIAVKRLSKNSKQ-GEIEFKNEVLLLARL-QHRNLVRLLG  307 (577)
Q Consensus       238 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~  307 (577)
                      .++...++..+.+.||+|.||.|++|...    .    ...||||.++..... ....+..|+++|..+ +|+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            44455566667779999999999999843    1    356999999876443 445689999999999 7999999999


Q ss_pred             EEEcCCeEEEEEEecCCCCcccccccCC-----C------C--CCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCC
Q 008108          308 FCLERKERILVYEFVPNASLDHFIFDPI-----N------R--EHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKA  374 (577)
Q Consensus       308 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~-----~------~--~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp  374 (577)
                      +|...+..++|+||+..|+|..+|...+     .      .  ..++..+.+.++.|||.||+||++..   ++||||..
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence            9999999999999999999999986543     0      0  24999999999999999999999986   99999999


Q ss_pred             CcEEEcCCCCeEEeccCCcccccCCCccccc-cccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCc
Q 008108          375 SNILLDSEMNPKISDFGMARLFEMDQTHSDT-NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTE  453 (577)
Q Consensus       375 ~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~  453 (577)
                      +||||.++..+||+|||+|+........... ..-.-...|||||.+....|+.|+|||||||+||||+|...++.... 
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~-  525 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI-  525 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC-
Confidence            9999999999999999999966554433321 11013456999999999999999999999999999999765544321 


Q ss_pred             cccchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          454 EETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       454 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ....++++    ....|...+.        +.....++-.+++.||+.+|++||++.++++.+..
T Consensus       526 ~~~~~l~~----~l~~G~r~~~--------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  526 PPTEELLE----FLKEGNRMEQ--------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             CcHHHHHH----HHhcCCCCCC--------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence            11122222    2223322211        11112344478889999999999999999999987

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-34  Score=271.87  Aligned_cols=210  Identities=28%  Similarity=0.415  Sum_probs=177.3

Q ss_pred             CCChHHHHHHhcCCccccccccCCcEEEEEeE-ecCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEE
Q 008108          233 QFDFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCL  310 (577)
Q Consensus       233 ~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  310 (577)
                      .-.|+++-..|     .+.||+|.++.|--++ +.+|.++|||++.+.....+..+.+|++++... .|+||+.|++||+
T Consensus        72 ~g~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE  146 (463)
T KOG0607|consen   72 SGKFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFE  146 (463)
T ss_pred             cchHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence            33456665555     4789999999999888 678999999999998888888899999999998 5999999999999


Q ss_pred             cCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCC---eEE
Q 008108          311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN---PKI  387 (577)
Q Consensus       311 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~---~kl  387 (577)
                      ++...|||||-|.||+|..+|.   ++..+++.++.+++.+|+.||.+||.++   |.||||||+|||-.+-..   +||
T Consensus       147 dd~~FYLVfEKm~GGplLshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKi  220 (463)
T KOG0607|consen  147 DDTRFYLVFEKMRGGPLLSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKI  220 (463)
T ss_pred             ccceEEEEEecccCchHHHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceee
Confidence            9999999999999999988884   5778999999999999999999999998   999999999999966543   899


Q ss_pred             eccCCcccccCCCccc-----cccccccCCCCcChhhhh-----cCCCCccccEEecchhHhHHhhCCCCCCCCCc
Q 008108          388 SDFGMARLFEMDQTHS-----DTNRVVGTFGYMAPEYVM-----HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTE  453 (577)
Q Consensus       388 ~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~  453 (577)
                      +||.|..-........     .....+|+..|||||++.     ...|..+.|.||||||||-||+|..||...-.
T Consensus       221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg  296 (463)
T KOG0607|consen  221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG  296 (463)
T ss_pred             eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence            9999886543322111     122468899999999873     23578899999999999999999999975443

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-33  Score=276.03  Aligned_cols=236  Identities=27%  Similarity=0.342  Sum_probs=189.8

Q ss_pred             cccCCcEEEEEeEec-CCcEEEEEEeccCChh---hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCCCc
Q 008108          252 LGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ---GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASL  327 (577)
Q Consensus       252 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL  327 (577)
                      ||+|+||.||++... +++.+|+|.+......   ....+.+|+.++++++|+||+++++.+..+...+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            799999999999965 5899999998765332   344688999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccccccc
Q 008108          328 DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR  407 (577)
Q Consensus       328 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~  407 (577)
                      .+++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~  152 (250)
T cd05123          81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT  152 (250)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence            988843   346899999999999999999999987   9999999999999999999999999998654332  12234


Q ss_pred             cccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCChHH
Q 008108          408 VVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSE  487 (577)
Q Consensus       408 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  487 (577)
                      ..++..|++||...+...+.++|+||||+++|||++|+.|+......   ........    ..      ..+....   
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~----~~------~~~~~~~---  216 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---EIYEKILK----DP------LRFPEFL---  216 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHhc----CC------CCCCCCC---
Confidence            57889999999998888999999999999999999999998543321   11111110    00      0111111   


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHH
Q 008108          488 MMKCIHIGLLCVQENVSNRPGMAS  511 (577)
Q Consensus       488 ~~~~~~l~~~C~~~~p~~RPt~~e  511 (577)
                      ...+.+++..|++.+|++||++.+
T Consensus       217 ~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         217 SPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCccc
Confidence            234557888999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-34  Score=266.02  Aligned_cols=248  Identities=23%  Similarity=0.406  Sum_probs=190.5

Q ss_pred             ccccccccCCcEEEEEeEec-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcC-CCCeEEEEeEEEcCCeEEEEEEecC
Q 008108          247 SDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERILVYEFVP  323 (577)
Q Consensus       247 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~  323 (577)
                      +.+..||.|..|.|++.... +|..+|||.+.+.. .....++...+.++..-. .|+||+.+|||..+...++.||.|.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs  174 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS  174 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence            34577999999999999965 58899999998764 444456777888776664 8999999999999999999999884


Q ss_pred             CCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccc
Q 008108          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS  403 (577)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~  403 (577)
                      - .++.++..  -.+++++..+-++...+..||.||.+++  .|+|||+||+|||+|+.|++||+|||++-.+-....+ 
T Consensus       175 ~-C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh-  248 (391)
T KOG0983|consen  175 T-CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH-  248 (391)
T ss_pred             H-HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc-
Confidence            3 45555532  3456888888999999999999999876  5999999999999999999999999999876544333 


Q ss_pred             cccccccCCCCcChhhhhc---CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          404 DTNRVVGTFGYMAPEYVMH---GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       404 ~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                        ++..|-+.|||||.+.-   ..|..++||||||+.++||.||+.|+.....  ..+.+..+...         ..|.|
T Consensus       249 --trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t--dFe~ltkvln~---------ePP~L  315 (391)
T KOG0983|consen  249 --TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT--DFEVLTKVLNE---------EPPLL  315 (391)
T ss_pred             --ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc--cHHHHHHHHhc---------CCCCC
Confidence              33579999999999854   3688999999999999999999999864332  12222222211         11333


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ++.. .....+.++...|++.|+.+||...++++
T Consensus       316 ~~~~-gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  316 PGHM-GFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             Cccc-CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            3221 12334556777999999999999998775

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.6e-33  Score=311.26  Aligned_cols=145  Identities=30%  Similarity=0.396  Sum_probs=130.3

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|.+.++||+|+||+||+|... +++.||||++....   ......+.+|+.++..++|+||+++++++......+|||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            67899999999999999999965 68999999997543   222346788999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      ||+++++|.+++..   ...+++..++.|+.||+.||.|||..+   |+||||||+||||+.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999998843   356899999999999999999999987   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=4e-34  Score=277.83  Aligned_cols=264  Identities=23%  Similarity=0.342  Sum_probs=211.3

Q ss_pred             HHHHHHhcCCccccccccCCcEEEEEeEecC------CcEEEEEEeccCChhh-HHHHHHHHHHHHhcCCCCeEEEEeEE
Q 008108          237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLGFC  309 (577)
Q Consensus       237 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~  309 (577)
                      .++.....+++...++-+|.||.||+|.+.+      .+.|-+|.++....+- ...+..|--++..+.|||+..+.+++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            4455666778888999999999999997642      3457788776654332 33577888899999999999999998


Q ss_pred             EcC-CeEEEEEEecCCCCcccccc-----cCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC
Q 008108          310 LER-KERILVYEFVPNASLDHFIF-----DPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM  383 (577)
Q Consensus       310 ~~~-~~~~lv~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~  383 (577)
                      .++ +..+++|.++.-|+|..||.     +....+.++..+...++.|++.|+.|||+++   +||.||..+|++||+..
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence            654 56789999999999999997     5556677899999999999999999999998   99999999999999999


Q ss_pred             CeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhh
Q 008108          384 NPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTY  462 (577)
Q Consensus       384 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~  462 (577)
                      ++||+|=.++|.+-+.+.+.-......+..||+||.+....|+.++|||||||+||||+| |+.|...-++.+....+..
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd  513 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD  513 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc
Confidence            999999999998877777776666667889999999999999999999999999999998 6666654444433333322


Q ss_pred             hhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          463 AWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       463 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ..+.-         .|.   ..++   ++..++.-||...|++||+.++++.-|..
T Consensus       514 GyRla---------QP~---NCPD---eLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  514 GYRLA---------QPF---NCPD---ELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             cceec---------CCC---CCcH---HHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence            21111         111   1233   44567778999999999999999998864

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-34  Score=307.05  Aligned_cols=282  Identities=23%  Similarity=0.312  Sum_probs=212.3

Q ss_pred             hHHHHHHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEc
Q 008108          236 FETIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE  311 (577)
Q Consensus       236 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  311 (577)
                      ..+++...++|.+++.||+|+||.|..++.+ +++.+|+|++.+.   .......|..|-.+|..-+.+-|+.+.-.|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            4556667789999999999999999999965 5788999999873   23344468889999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccC
Q 008108          312 RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG  391 (577)
Q Consensus       312 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfG  391 (577)
                      +..+|+|||||+||+|-.++..   -..++++.+..++..|+-||.-||+.|   +|||||||+|||||..|++||+|||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG  220 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG  220 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence            9999999999999999888833   347999999999999999999999998   9999999999999999999999999


Q ss_pred             CcccccCCCccccccccccCCCCcChhhhhc-----CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhh
Q 008108          392 MARLFEMDQTHSDTNRVVGTFGYMAPEYVMH-----GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRN  466 (577)
Q Consensus       392 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~  466 (577)
                      .+-.+..+.. ......+|||.|++||++..     +.|...+|.||+||++|||+.|..||....-.+....+      
T Consensus       221 sClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KI------  293 (1317)
T KOG0612|consen  221 SCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKI------  293 (1317)
T ss_pred             hHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHH------
Confidence            9877664433 23344689999999999842     57999999999999999999999999754433332222      


Q ss_pred             cccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCC---HHHHHHH--hcCCCCCCCCCCCCccccccCC
Q 008108          467 WNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPG---MASVVNM--LNGDTVTLPAPSKPAFFMKCSV  537 (577)
Q Consensus       467 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt---~~ev~~~--L~~~~~~~~~p~~p~~~~~~~~  537 (577)
                      +.......+.|.   ...+++...+|.- +.   -+|+.|..   +.++-.-  ..+..+.--....||+.+..++
T Consensus       294 m~hk~~l~FP~~---~~VSeeakdLI~~-ll---~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevss  362 (1317)
T KOG0612|consen  294 MNHKESLSFPDE---TDVSEEAKDLIEA-LL---CDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSS  362 (1317)
T ss_pred             hchhhhcCCCcc---cccCHHHHHHHHH-Hh---cChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCC
Confidence            222222222111   1145556665542 22   36777776   7777643  3344443333444454443333

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-33  Score=295.60  Aligned_cols=261  Identities=25%  Similarity=0.417  Sum_probs=209.8

Q ss_pred             CChHHHHHHhcCCccccccccCCcEEEEEeE-ecCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEc
Q 008108          234 FDFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLE  311 (577)
Q Consensus       234 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  311 (577)
                      .+++.+...++-|++.+.||.|.+|.||+++ .++++.+|+|++....... .+++.|.++++.. .|||++.++|++..
T Consensus         9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen    9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            3455556667889999999999999999999 5678999999987765443 3677888999888 69999999999863


Q ss_pred             -----CCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeE
Q 008108          312 -----RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPK  386 (577)
Q Consensus       312 -----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~k  386 (577)
                           ++++|||||||.+||..+++.... ...+.|..+..|++.++.||.+||.+.   ++|||||-.||||+.++.+|
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK  163 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK  163 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence                 568999999999999999886644 778999999999999999999999987   99999999999999999999


Q ss_pred             EeccCCcccccCCCccccccccccCCCCcChhhhhcC-----CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhh
Q 008108          387 ISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG-----RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLT  461 (577)
Q Consensus       387 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~  461 (577)
                      |+|||++..+..  +....+...||+.|||||++...     .|+..+|+||||++..||--|.+|+....+...  ++.
T Consensus       164 LvDFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra--LF~  239 (953)
T KOG0587|consen  164 LVDFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA--LFL  239 (953)
T ss_pred             Eeeeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh--hcc
Confidence            999999987653  33445567899999999998543     477899999999999999999998765443211  110


Q ss_pred             hhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          462 YAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       462 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                           .....     .|.+. ....-..++.+++..|+..|-++||++.++++
T Consensus       240 -----IpRNP-----PPkLk-rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  240 -----IPRNP-----PPKLK-RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             -----CCCCC-----Ccccc-chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                 00000     11111 13345667889999999999999999998764

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-33  Score=265.22  Aligned_cols=248  Identities=23%  Similarity=0.270  Sum_probs=189.1

Q ss_pred             HhcCCccc-cccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEc----CCe
Q 008108          242 ATDNFSDA-NKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLE----RKE  314 (577)
Q Consensus       242 ~~~~f~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~  314 (577)
                      .+++|++. ++||-|-.|.|-.... .+|+.+|+|++....+     ..+|+++--.. .|||||.+++++.+    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~K-----ARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPK-----ARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHH-----HHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            34566554 5799999999999885 4789999999865433     36788776665 69999999998864    356


Q ss_pred             EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC---CeEEeccC
Q 008108          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM---NPKISDFG  391 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~---~~kl~DfG  391 (577)
                      +++|||.|+||.|...|.+ .....+++.++-.|+.||+.|+.|||+.+   |.||||||+|+|.....   .+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence            7899999999999888755 34567999999999999999999999988   99999999999996544   59999999


Q ss_pred             CcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCcc----ccchhhhhhhhhc
Q 008108          392 MARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEE----ETEDLLTYAWRNW  467 (577)
Q Consensus       392 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~----~~~~l~~~~~~~~  467 (577)
                      +|+.-..   .......+-|+.|.|||++...+|....|+||+||++|-||+|-.||......    +....+.-....+
T Consensus       210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F  286 (400)
T KOG0604|consen  210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF  286 (400)
T ss_pred             cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence            9985332   22333467899999999999999999999999999999999999998654321    1111111111111


Q ss_pred             ccCCccccccCcCCCCChHHHHHHH-HHHHhcccCCCCCCCCHHHHHH
Q 008108          468 NEGAALNLMDPTMRGGSTSEMMKCI-HIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       468 ~~~~~~~~~d~~l~~~~~~~~~~~~-~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .             ....+++.+.. +++...+..+|++|.|+.+++.
T Consensus       287 P-------------~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  287 P-------------EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             C-------------ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            1             11223333322 4666778999999999999885

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=269.00  Aligned_cols=255  Identities=25%  Similarity=0.377  Sum_probs=192.2

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCCh-hhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      ++.+.+..||.|.||+|+|-.+ +.|+..|||+++.... ..+.++..|.+...+- +.||||+++|.+..++..|+.||
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            3445567899999999999885 4799999999987654 4455677888776555 79999999999999999999999


Q ss_pred             ecCCCCccccccc--CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          321 FVPNASLDHFIFD--PINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       321 ~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      .| ..||+.+-..  ..++..+++...-+|...+..||.||.+.-  .|||||+||+|||||..|.+||+|||++-.+..
T Consensus       144 LM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  144 LM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             HH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            99 4466654311  134567899988899999999999998764  699999999999999999999999999876543


Q ss_pred             CCccccccccccCCCCcChhhhhc--CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMH--GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      +-   ..+.-.|-..|||||.+..  ..|..+|||||||++|||+.||+.|......  ..+.+..+    ..+..    
T Consensus       221 Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~V----v~gdp----  287 (361)
T KOG1006|consen  221 SI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQV----VIGDP----  287 (361)
T ss_pred             HH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHH----HcCCC----
Confidence            21   2233578889999999854  3489999999999999999999998753322  22222211    11111    


Q ss_pred             cCcCCCC--ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          477 DPTMRGG--STSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       477 d~~l~~~--~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                       |.+..+  ..+....+..++-.|+-+|-.+||...++.++
T Consensus       288 -p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  288 -PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             -CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence             111111  22344567778889999999999999987753

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.98  E-value=4.5e-33  Score=287.84  Aligned_cols=239  Identities=24%  Similarity=0.313  Sum_probs=187.9

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      ++.|.....+|.|+|+.|-.+.. .+++..++|++.+...+    -.+|+.++... +||||+++.+.+.+..+.++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccccc----cccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            56778888899999999999984 56888999999876332    24566555555 79999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEE-cCCCCeEEeccCCcccccCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL-DSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl-~~~~~~kl~DfGla~~~~~~  399 (577)
                      .+.++-|.+.+..   ..... ..+..|+.+|+.++.|||+++   ++||||||+|||+ ++.++++|+|||.++.....
T Consensus       397 ~l~g~ell~ri~~---~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRS---KPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hccccHHHHHHHh---cchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            9999988666632   23333 778889999999999999998   9999999999999 68899999999999876543


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                           ....+-|..|.|||++....|++++|+||||++||+||+|+.|+.....+  .++..    ....+...      
T Consensus       470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~----~i~~~~~s------  532 (612)
T KOG0603|consen  470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHT----RIQMPKFS------  532 (612)
T ss_pred             -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHH----hhcCCccc------
Confidence                 12245688999999999999999999999999999999999998755543  11111    11111111      


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                        ....++..   +++.+|++.||.+||+|.++..
T Consensus       533 --~~vS~~AK---dLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  533 --ECVSDEAK---DLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             --cccCHHHH---HHHHHhccCChhhCcChhhhcc
Confidence              11223333   5666999999999999998764

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.98  E-value=2.8e-32  Score=266.97  Aligned_cols=220  Identities=21%  Similarity=0.191  Sum_probs=172.7

Q ss_pred             CCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCCCccccccc
Q 008108          255 GGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD  333 (577)
Q Consensus       255 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~  333 (577)
                      |.+|.||++.. .+++.+|+|++.....     +.+|...+....||||+++++++.+.+..+++|||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            88999999995 4688999999976532     33455555566799999999999999999999999999999888743


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccccccccccCCC
Q 008108          334 PINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG  413 (577)
Q Consensus       334 ~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~  413 (577)
                         ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++++|||++......     .....++..
T Consensus        79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~  147 (237)
T cd05576          79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM  147 (237)
T ss_pred             ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence               346999999999999999999999987   999999999999999999999999988655422     112346778


Q ss_pred             CcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHH
Q 008108          414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIH  493 (577)
Q Consensus       414 y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~  493 (577)
                      |+|||.+..+.++.++||||+|+++|||++|+.|+.......            ....     ...+.....   ..+.+
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~~-----~~~~~~~~~---~~~~~  207 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTHT-----TLNIPEWVS---EEARS  207 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cccc-----ccCCcccCC---HHHHH
Confidence            999999988889999999999999999999997653211100            0000     000111111   23456


Q ss_pred             HHHhcccCCCCCCCCHH
Q 008108          494 IGLLCVQENVSNRPGMA  510 (577)
Q Consensus       494 l~~~C~~~~p~~RPt~~  510 (577)
                      ++.+|++.||++||++.
T Consensus       208 li~~~l~~dp~~R~~~~  224 (237)
T cd05576         208 LLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHccCCHHHhcCCC
Confidence            77899999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.6e-33  Score=274.90  Aligned_cols=207  Identities=31%  Similarity=0.364  Sum_probs=174.9

Q ss_pred             HhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERI  316 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  316 (577)
                      ...+|..+.+||+|+||.|.++.-+ +.+.+|||+++++..   ...+--+.|-.+|... +-|.++.+..+|..-+.+|
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            3457889999999999999999855 467799999988632   1222234567777766 6789999999999999999


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccc
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~  396 (577)
                      +||||+.||+|-..|.   +-+.+.+..+.-++..||-||-+||+++   ||.||||..|||||.+|.+||+|||+++.-
T Consensus       427 FVMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             eEEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence            9999999999988874   3467888899999999999999999998   999999999999999999999999999853


Q ss_pred             cCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCcccc
Q 008108          397 EMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET  456 (577)
Q Consensus       397 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~  456 (577)
                      -.+  ...+...+||+.|+|||++....|....|.|||||+||||+.|+.||+...+++.
T Consensus       501 i~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el  558 (683)
T KOG0696|consen  501 IFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL  558 (683)
T ss_pred             ccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence            322  2345568999999999999999999999999999999999999999976555443

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.98  E-value=8.8e-32  Score=286.08  Aligned_cols=201  Identities=22%  Similarity=0.359  Sum_probs=154.0

Q ss_pred             HhcCCccccccccCCcEEEEEeEe-----------------cCCcEEEEEEeccCChhhHHH--------------HHHH
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGML-----------------SNGETIAVKRLSKNSKQGEIE--------------FKNE  290 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E  290 (577)
                      ..++|++.++||+|+||+||+|..                 ..++.||||++.........+              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999964                 235679999987543322222              3347


Q ss_pred             HHHHHhcCCCCe-----EEEEeEEEc--------CCeEEEEEEecCCCCcccccccCC---------------------C
Q 008108          291 VLLLARLQHRNL-----VRLLGFCLE--------RKERILVYEFVPNASLDHFIFDPI---------------------N  336 (577)
Q Consensus       291 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~---------------------~  336 (577)
                      +.++.+++|.++     ++++++|..        .+..+|||||+++++|.++++...                     .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777788877654     677887753        356899999999999988875321                     1


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccccccccccCCCCcC
Q 008108          337 REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA  416 (577)
Q Consensus       337 ~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a  416 (577)
                      ...++|..+..++.|++.+|.|||+.+   |+||||||+|||++.++.+||+|||+++........ ......+|+.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence            124578889999999999999999987   999999999999999999999999999765432211 1112345789999


Q ss_pred             hhhhhcCCC----------------------CccccEEecchhHhHHhhCCC
Q 008108          417 PEYVMHGRF----------------------SVKSDIFSFGVLVLEIVSGQK  446 (577)
Q Consensus       417 PE~~~~~~~----------------------~~~~Dv~SlGvil~elltG~~  446 (577)
                      ||.+.....                      ..+.||||+||+++||++|..
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l  430 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPEL  430 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCC
Confidence            998754321                      235799999999999999985

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=9.5e-32  Score=262.35  Aligned_cols=238  Identities=25%  Similarity=0.361  Sum_probs=190.7

Q ss_pred             CcEEEEEeEec-CCcEEEEEEeccCChhh-HHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCCCccccccc
Q 008108          256 GFGAVYKGMLS-NGETIAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD  333 (577)
Q Consensus       256 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~  333 (577)
                      +||.||+|... +|+.+++|++....... ...+.+|++.+++++|+||+++++++......++++||+++++|..++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999976 48999999997765544 56789999999999999999999999999999999999999999998743


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccccccccccCCC
Q 008108          334 PINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG  413 (577)
Q Consensus       334 ~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~  413 (577)
                         ...+++..++.++.++++++.|||+.+   ++|+||+|+||++++++.++|+|||.+.......   ......++..
T Consensus        81 ---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       81 ---RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             ---ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence               223899999999999999999999987   9999999999999999999999999998765432   2234568889


Q ss_pred             CcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHH
Q 008108          414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIH  493 (577)
Q Consensus       414 y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~  493 (577)
                      |++||.+....++.++||||||+++++|++|..|+.....  ...+.....    ......      .........++.+
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~----~~~~~~------~~~~~~~~~~~~~  219 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIG----KPKPPF------PPPEWKISPEAKD  219 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHh----ccCCCC------ccccccCCHHHHH
Confidence            9999999988899999999999999999999988754211  111221111    110000      0000002235667


Q ss_pred             HHHhcccCCCCCCCCHHHHHH
Q 008108          494 IGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       494 l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ++.+|+..+|++||++.++++
T Consensus       220 ~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      220 LIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHccCCchhccCHHHHhh
Confidence            888999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=1.1e-31  Score=292.34  Aligned_cols=259  Identities=21%  Similarity=0.247  Sum_probs=166.2

Q ss_pred             HhcCCccccccccCCcEEEEEeEec-C----CcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeE------EE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLS-N----GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF------CL  310 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~  310 (577)
                      ..++|+..++||+|+||.||+|.+. +    +..||||++.......  ...+|  .+....+.++..++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e--~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE--IWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH--HHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4578999999999999999999965 4    6899999986532211  11111  1122222222222211      24


Q ss_pred             cCCeEEEEEEecCCCCcccccccCCC-----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccC
Q 008108          311 ERKERILVYEFVPNASLDHFIFDPIN-----------------REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLK  373 (577)
Q Consensus       311 ~~~~~~lv~E~~~~gsL~~~l~~~~~-----------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk  373 (577)
                      .....+|||||+++++|.+++.....                 .....+..+..++.||+.||.|||+++   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            56688999999999999888753210                 011223446689999999999999987   9999999


Q ss_pred             CCcEEEcC-CCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcC----------------------CCCcccc
Q 008108          374 ASNILLDS-EMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG----------------------RFSVKSD  430 (577)
Q Consensus       374 p~NiLl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D  430 (577)
                      |+|||++. ++.+||+|||+++.+...... ......+|+.|||||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 578999999999865433222 22346789999999976432                      2345679


Q ss_pred             EEecchhHhHHhhCCCCCCCCCccccchhhh---hhhhhcccCCccccccCcCCCC-------ChHHHHHHHHHHHhccc
Q 008108          431 IFSFGVLVLEIVSGQKRSSFGTEEETEDLLT---YAWRNWNEGAALNLMDPTMRGG-------STSEMMKCIHIGLLCVQ  500 (577)
Q Consensus       431 v~SlGvil~elltG~~p~~~~~~~~~~~l~~---~~~~~~~~~~~~~~~d~~l~~~-------~~~~~~~~~~l~~~C~~  500 (577)
                      ||||||+||||+++..+...... .....+.   .....|.     ..+.+.....       .........+++.+|++
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLI-QFNRQLKRNDYDLVAWR-----KLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHH-HHHHHHHhcCCcHHHHH-----HhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence            99999999999997765321100 0000000   0000110     0111110000       00011123468889999


Q ss_pred             CCCCCCCCHHHHHH
Q 008108          501 ENVSNRPGMASVVN  514 (577)
Q Consensus       501 ~~p~~RPt~~ev~~  514 (577)
                      .||++|||+.|+++
T Consensus       436 ~dP~kR~ta~e~L~  449 (566)
T PLN03225        436 FKGRQRISAKAALA  449 (566)
T ss_pred             CCcccCCCHHHHhC
Confidence            99999999999886

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-33  Score=280.09  Aligned_cols=245  Identities=24%  Similarity=0.303  Sum_probs=200.0

Q ss_pred             HHhcCCccccccccCCcEEEEEeEecCCc-EEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEE
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  316 (577)
                      ....+++.+..||-||||.|-++...+.. .+|+|++++..   ...+..+..|-.+|...+.|.||++|-.|.+....|
T Consensus       417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY  496 (732)
T KOG0614|consen  417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY  496 (732)
T ss_pred             cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence            34456777888999999999999875433 38999887652   333446788999999999999999999999999999


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccc
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~  396 (577)
                      ++||-|-||.|...|.   .++.++..+..-++..+++|+.|||.++   ||.|||||+|+|||.+|-+||.|||+|+.+
T Consensus       497 mLmEaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki  570 (732)
T KOG0614|consen  497 MLMEACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKI  570 (732)
T ss_pred             hhHHhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHh
Confidence            9999999999999984   5788999999999999999999999998   999999999999999999999999999988


Q ss_pred             cCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          397 EMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       397 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      ..+.   .+...+||+.|.|||++..+....++|.||||+++|||++|.+||....+-....++-.....|.-       
T Consensus       571 ~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~-------  640 (732)
T KOG0614|consen  571 GSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEF-------  640 (732)
T ss_pred             ccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhc-------
Confidence            7543   455689999999999999999999999999999999999999999877665555544433222211       


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCC
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPG  508 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt  508 (577)
                       |.   ...   ....+++......+|.+|..
T Consensus       641 -Pr---~I~---k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  641 -PR---RIT---KTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             -cc---ccc---hhHHHHHHHHHhcCcHhhhc
Confidence             00   011   12334555556789999976

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.7e-33  Score=257.69  Aligned_cols=265  Identities=25%  Similarity=0.456  Sum_probs=192.1

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEecc-CChh-hHHHHHHHHHHHHhcCCCCeEEEEeEEEcC--------
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSK-NSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLER--------  312 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  312 (577)
                      ..|+...+||+|.||+||++... +|+.||+|++-. +.+. -...-.+|+.+|..++|+|++.++..|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34666789999999999999954 577789887543 2211 122346899999999999999999887532        


Q ss_pred             CeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCC
Q 008108          313 KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (577)
Q Consensus       313 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGl  392 (577)
                      ...++|+++|+. +|.-+|.+  ....++..++.+++.+++.||.|+|...   |+|||+|+.|+||+.++.+||+|||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence            357999999976 66666632  2356999999999999999999999987   99999999999999999999999999


Q ss_pred             cccccCCCccc--cccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhh-------
Q 008108          393 ARLFEMDQTHS--DTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTY-------  462 (577)
Q Consensus       393 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~-------  462 (577)
                      ++.+...+...  ..+..+-|.+|.+||.+.+. +|+++.|||.-|||+.||.||.+-+....+.....++..       
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            98776443322  22234569999999988765 699999999999999999999887766655544444443       


Q ss_pred             -hhhhcccCCccccc--cCcCCCC---ChHHHH------HHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          463 -AWRNWNEGAALNLM--DPTMRGG---STSEMM------KCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       463 -~~~~~~~~~~~~~~--d~~l~~~---~~~~~~------~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                       +|.....-.+.+.+  .|...+.   ..+.+.      ..++++-.++..||.+|+.+++++.
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence             23332222222222  1111110   111111      2344555678899999999998875

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.4e-31  Score=273.45  Aligned_cols=208  Identities=25%  Similarity=0.375  Sum_probs=176.8

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      .-|..++.||-|.||+|.++.. ++...+|+|.+.+...   ......+.|-+||....++-||+|+-.|.+.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            3588899999999999999984 4466789999987643   33345788999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc--
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE--  397 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~--  397 (577)
                      ||++||++-.+|.   .-+.+.+..+..++.++..++++.|..|   +|||||||+|||||.+|.+||+||||+.-+.  
T Consensus       709 dYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             eccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence            9999999988884   4677889989999999999999999988   9999999999999999999999999986331  


Q ss_pred             -------CCCccc-------------------------------cccccccCCCCcChhhhhcCCCCccccEEecchhHh
Q 008108          398 -------MDQTHS-------------------------------DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVL  439 (577)
Q Consensus       398 -------~~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~  439 (577)
                             .++...                               .....+||..|+|||++....|+..+|.||.|||||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence                   110000                               011258999999999999999999999999999999


Q ss_pred             HHhhCCCCCCCCCccccc
Q 008108          440 EIVSGQKRSSFGTEEETE  457 (577)
Q Consensus       440 elltG~~p~~~~~~~~~~  457 (577)
                      ||+.|+.||....+.+..
T Consensus       863 em~~g~~pf~~~tp~~tq  880 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTPGETQ  880 (1034)
T ss_pred             HHhhCCCCccCCCCCcce
Confidence            999999999877765543

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-31  Score=234.86  Aligned_cols=198  Identities=27%  Similarity=0.463  Sum_probs=166.1

Q ss_pred             CCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      +|...++||+|.||+||+|+. ++++.||+|+++-+..  .-.....+|+-+++.++|+|||++++....+..+-||+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            456678999999999999995 4688899999865432  2233568999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      |.. +|..+. +. -++.++.+....++.|+++||.++|+++   +.||||||.|.||+.+|..|++|||+++.+.....
T Consensus        83 cdq-dlkkyf-ds-lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   83 CDQ-DLKKYF-DS-LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             hhH-HHHHHH-Hh-cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            954 666653 32 3567999999999999999999999998   99999999999999999999999999998764332


Q ss_pred             cccccccccCCCCcChhhhhcCC-CCccccEEecchhHhHHhhCCCCCCC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSF  450 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltG~~p~~~  450 (577)
                        .....+-|.+|.+|+++.+.+ |+...|+||-|||+.|+.....|...
T Consensus       157 --cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp  204 (292)
T KOG0662|consen  157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_pred             --eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC
Confidence              223356799999999998764 78999999999999999987776543

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-31  Score=258.43  Aligned_cols=261  Identities=20%  Similarity=0.278  Sum_probs=196.5

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcC--CCC----eEEEEeEEEcCCeE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ--HRN----LVRLLGFCLERKER  315 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~n----iv~l~~~~~~~~~~  315 (577)
                      +++|.+..++|+|.||.|-+.... .+..||||+++.-..-. ..-+-|+++|.++.  .|+    +|.+.+||...++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYr-eAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYR-EAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHh-hHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            688999999999999999999854 47889999986543332 23467899999993  232    78888999999999


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC--------------
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS--------------  381 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~--------------  381 (577)
                      +||+|.+ |.|+.++|.. .+-.+++...+..|+.|+++++++||+..   ++|-||||+|||+-+              
T Consensus       167 Civfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             EEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence            9999988 6688888844 23456889999999999999999999987   999999999999931              


Q ss_pred             ------CCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccc
Q 008108          382 ------EMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEE  455 (577)
Q Consensus       382 ------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~  455 (577)
                            +..+||+|||-|++.....     ..++.|..|.|||++.+-.++..+||||+||||+|+.||..-|......+
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                  2358999999998654322     34788999999999999999999999999999999999998776544322


Q ss_pred             cchhhhhh--------------hhhcccC-------C----ccccccCcC-----CCCChHHHHHHHHHHHhcccCCCCC
Q 008108          456 TEDLLTYA--------------WRNWNEG-------A----ALNLMDPTM-----RGGSTSEMMKCIHIGLLCVQENVSN  505 (577)
Q Consensus       456 ~~~l~~~~--------------~~~~~~~-------~----~~~~~d~~l-----~~~~~~~~~~~~~l~~~C~~~~p~~  505 (577)
                      -..+.+.+              .+.+..+       .    .....++-.     ......+..++.+++..++..||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence            11111111              1111111       0    001111111     0114456678889999999999999


Q ss_pred             CCCHHHHHH
Q 008108          506 RPGMASVVN  514 (577)
Q Consensus       506 RPt~~ev~~  514 (577)
                      |+|+.|++.
T Consensus       397 RiTl~EAL~  405 (415)
T KOG0671|consen  397 RITLREALS  405 (415)
T ss_pred             cccHHHHhc
Confidence            999999874

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=9.6e-32  Score=240.88  Aligned_cols=203  Identities=27%  Similarity=0.384  Sum_probs=166.0

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccC-ChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN-SKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      .++...+..||+|++|.|-+-++ .+|+..|+|++... ..+...+..+|+.+..+. .+|.+|.++|...+....++.|
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence            34455567899999999988884 57999999999754 344455678888887665 7999999999999999999999


Q ss_pred             EecCCCCcccccccC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          320 EFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       320 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |.|. .||+.+-.+. .....+++..+=+|+..+.+||.|||++-  .+||||+||+||||+.+|++||||||.+-.+..
T Consensus       125 E~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  125 ELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVD  201 (282)
T ss_pred             HHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence            9994 4777664332 24567899999999999999999999864  699999999999999999999999999976653


Q ss_pred             CCccccccccccCCCCcChhhhhc----CCCCccccEEecchhHhHHhhCCCCCCCC
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMH----GRFSVKSDIFSFGVLVLEIVSGQKRSSFG  451 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlGvil~elltG~~p~~~~  451 (577)
                      +-.   .+--.|-..|||||.+..    ..|+.|+||||||+++.||.+++.|+...
T Consensus       202 SiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  202 SIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             hhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            221   112367889999998854    36899999999999999999999997643

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-31  Score=279.86  Aligned_cols=246  Identities=28%  Similarity=0.407  Sum_probs=185.8

Q ss_pred             CccccccccCCcEE-EEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEEEEEecC
Q 008108          246 FSDANKLGQGGFGA-VYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYEFVP  323 (577)
Q Consensus       246 f~~~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~  323 (577)
                      |...+.+|.|..|+ ||+|..+ |+.||||++-....   .-..+|+..|+.- +|||||++++.-.+....||..|.| 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            44556789999986 7999984 78999999854432   2357899999888 6999999999999999999999999 


Q ss_pred             CCCcccccccC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC---C--CCeEEeccCCccccc
Q 008108          324 NASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS---E--MNPKISDFGMARLFE  397 (577)
Q Consensus       324 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~---~--~~~kl~DfGla~~~~  397 (577)
                      ..+|++++... .......-...+.+..|++.||++||+.+   ||||||||.||||+.   +  .+++|+|||+++.+.
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            45899988542 11111222456788999999999999977   999999999999976   3  469999999999887


Q ss_pred             CCCccc-cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhC-CCCCCCCCccccchhhhhhhhhcccCCcccc
Q 008108          398 MDQTHS-DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG-QKRSSFGTEEETEDLLTYAWRNWNEGAALNL  475 (577)
Q Consensus       398 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  475 (577)
                      .+...- ......||-+|+|||++....-+.++|||||||++|..++| .+||...-.. ..+++.       .......
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-~~NIl~-------~~~~L~~  734 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-QANILT-------GNYTLVH  734 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-hhhhhc-------Cccceee
Confidence            665432 34567899999999999999888999999999999999998 6787543221 111221       1111111


Q ss_pred             ccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       476 ~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      +.+.    ...   ...+++.+|++.+|..||++.+|+.
T Consensus       735 L~~~----~d~---eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  735 LEPL----PDC---EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             eccC----chH---HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            1111    111   4457778999999999999999983

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-30  Score=248.54  Aligned_cols=203  Identities=25%  Similarity=0.348  Sum_probs=175.1

Q ss_pred             HhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccC---ChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKN---SKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERI  316 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  316 (577)
                      ...+|..+++||+|+|.+|..+.+. +.+.+|+|++++.   ........+.|-.+.... +||.+|-|..+|..+..++
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            4478999999999999999999964 5778999998764   233333456677777666 7999999999999999999


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccc
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~  396 (577)
                      +|.||++||+|-.++   ..+.+|+++.+.-+...|.-+|.|||+.+   ||.||||..|+|||..|.+||+|+|+++.-
T Consensus       328 fvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             EEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence            999999999997666   45678999999999999999999999998   999999999999999999999999999742


Q ss_pred             cCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCC
Q 008108          397 EMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGT  452 (577)
Q Consensus       397 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~  452 (577)
                      -  .....+...+||+.|+|||++.+..|....|.|+|||+++||+.|+.||..-.
T Consensus       402 l--~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivg  455 (593)
T KOG0695|consen  402 L--GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVG  455 (593)
T ss_pred             C--CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceec
Confidence            2  22334566899999999999999999999999999999999999999997433

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.4e-31  Score=246.30  Aligned_cols=265  Identities=23%  Similarity=0.357  Sum_probs=193.1

Q ss_pred             CCccccccccCCcEEEEEeEe-cCCcEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC-----CeEE
Q 008108          245 NFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER-----KERI  316 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  316 (577)
                      +.+..+.||-|.||.||.+.. ++|+.||+|++..-  +......+.+|+.+|..++|.|++..++...-.     .+.|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            345578999999999999985 47999999998643  233445688999999999999999888765432     3567


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccc
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~  396 (577)
                      +++|.|. .+|+..|   .+.+.|+...+.-+++||++||.|||+.+   |.||||||.|.|+++|..+||+|||+|+..
T Consensus       134 V~TELmQ-SDLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  134 VLTELMQ-SDLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             HHHHHHH-hhhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence            8889884 4888888   45677999999999999999999999987   999999999999999999999999999987


Q ss_pred             cCCCccccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhh--------hhhc
Q 008108          397 EMDQTHSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA--------WRNW  467 (577)
Q Consensus       397 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~--------~~~~  467 (577)
                      +.++....+ ..+-|..|.|||++++. .|+.+.||||.|||+.||+..+--|....+-+..+++...        .+.-
T Consensus       207 e~d~~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A  285 (449)
T KOG0664|consen  207 DQRDRLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA  285 (449)
T ss_pred             chhhhhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence            765544333 34568899999999886 5899999999999999999888766655543333333211        1111


Q ss_pred             ccCCcccccc-----CcCC-----CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          468 NEGAALNLMD-----PTMR-----GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       468 ~~~~~~~~~d-----~~l~-----~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                      -++....++.     |.+.     ......-.+.+.+..+++..+|.+|-+..+.+..+.
T Consensus       286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            1111111111     1110     001111122334445678899999999888876543

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=1.8e-30  Score=235.99  Aligned_cols=196  Identities=23%  Similarity=0.456  Sum_probs=167.0

Q ss_pred             hcCCccccccccCCcEEEEEeE-ecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcC-CCCeEEEEeEEEcCC--eEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERK--ERILV  318 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~lv  318 (577)
                      .++|++.+++|+|.+++||.|. ..+.+.++||.++.-..   ..+++|+.+|..|. ||||++|++...+..  ...||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            4689999999999999999999 45788999999976543   36799999999997 999999999998765  45799


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC-CeEEeccCCccccc
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-NPKISDFGMARLFE  397 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~-~~kl~DfGla~~~~  397 (577)
                      +||+.+.+...+-      +.|+...+...+.+++.||.|+|+.|   |.|||+||.|++||... .++|+|+|||.++.
T Consensus       114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence            9999887765442      46888899999999999999999998   99999999999999765 59999999999988


Q ss_pred             CCCccccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCc
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTE  453 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~  453 (577)
                      ++.....   .+.+..|-.||.+..- .|...-|+|||||+|..|+..+.||..+..
T Consensus       185 p~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d  238 (338)
T KOG0668|consen  185 PGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD  238 (338)
T ss_pred             CCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC
Confidence            7655433   4567788999988664 578889999999999999999999865443

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=1.3e-28  Score=234.21  Aligned_cols=210  Identities=34%  Similarity=0.573  Sum_probs=181.7

Q ss_pred             cccCCcEEEEEeEecC-CcEEEEEEeccCChh-hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCCCccc
Q 008108          252 LGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDH  329 (577)
Q Consensus       252 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~  329 (577)
                      ||+|.+|.||++...+ ++.+++|++...... ....+.+|+..++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999754 899999999766543 34568899999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC-CCCeEEeccCCcccccCCCcccccccc
Q 008108          330 FIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS-EMNPKISDFGMARLFEMDQTHSDTNRV  408 (577)
Q Consensus       330 ~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~  408 (577)
                      ++...  ...+++..++.++.+++++|.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........  .....
T Consensus        81 ~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          81 LLKEN--EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            87431  146899999999999999999999987   999999999999999 89999999999986654321  12235


Q ss_pred             ccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCChHH
Q 008108          409 VGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSE  487 (577)
Q Consensus       409 ~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  487 (577)
                      .+...|++||..... ..+.++|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            678899999999887 888999999999999999                                              


Q ss_pred             HHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          488 MMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       488 ~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                       ..+.+++..|++.+|++||++.++++.
T Consensus       188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence             245578889999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-29  Score=255.57  Aligned_cols=196  Identities=27%  Similarity=0.420  Sum_probs=167.4

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHH--------HHHHHHHHHHhcC---CCCeEEEEeEEEc
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEI--------EFKNEVLLLARLQ---HRNLVRLLGFCLE  311 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--------~~~~E~~~l~~l~---h~niv~l~~~~~~  311 (577)
                      .+|...+.+|+|+||.|+.+..+ +...|+||.+.+...-...        .+-.|+.+|..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            46889999999999999999965 5677999988775432111        2456999999997   9999999999999


Q ss_pred             CCeEEEEEEecC-CCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEecc
Q 008108          312 RKERILVYEFVP-NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDF  390 (577)
Q Consensus       312 ~~~~~lv~E~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~Df  390 (577)
                      ++.+||+||-.. +.+|.++|   .-+..+++.++..|+.||+.|+++||+++   |||||||-+||.++.+|-+||+||
T Consensus       641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence            999999999764 55777777   34677999999999999999999999998   999999999999999999999999


Q ss_pred             CCcccccCCCccccccccccCCCCcChhhhhcCCCC-ccccEEecchhHhHHhhCCCCCC
Q 008108          391 GMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS-VKSDIFSFGVLVLEIVSGQKRSS  449 (577)
Q Consensus       391 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvil~elltG~~p~~  449 (577)
                      |.|.....+...    ..+||.+|.|||++.+..|- ..-|||++|++||-++....|+.
T Consensus       715 gsaa~~ksgpfd----~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  715 GSAAYTKSGPFD----VFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             cchhhhcCCCcc----eeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999876544432    37899999999999888874 56899999999999998877753

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-29  Score=261.24  Aligned_cols=252  Identities=24%  Similarity=0.327  Sum_probs=198.4

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      .++|+.+..+|.|.+|.|||++. ..++..|+|.++-.......-+++|+-+++..+|+|||.++|-+...+..++.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            46789999999999999999994 47899999999877666666678899999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      |.+|+|.+.-+   -.+.+++.++..+.+..++||.|||+.+   -+|||||-.|||+++.+.+|++|||.+-.+..  +
T Consensus        94 cgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita--t  165 (829)
T KOG0576|consen   94 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA--T  165 (829)
T ss_pred             cCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh--h
Confidence            99999998753   3678999999999999999999999998   79999999999999999999999999876543  2


Q ss_pred             cccccccccCCCCcChhhh---hcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          402 HSDTNRVVGTFGYMAPEYV---MHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      -.......||+.|||||+.   ..+.|..++|||++|+...|+---+.|.....+..  .+.     ...    ...++|
T Consensus       166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr--~l~-----LmT----kS~~qp  234 (829)
T KOG0576|consen  166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR--ALF-----LMT----KSGFQP  234 (829)
T ss_pred             hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH--HHH-----Hhh----ccCCCC
Confidence            2334457899999999987   45679999999999999999877665543222111  010     110    011222


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVV  513 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~  513 (577)
                      .-..+...-...+-+++..|+-.+|++||+++.++
T Consensus       235 p~lkDk~kws~~fh~fvK~altknpKkRptaeklL  269 (829)
T KOG0576|consen  235 PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL  269 (829)
T ss_pred             CcccCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence            22112112222333677788999999999998655

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=4.2e-28  Score=234.23  Aligned_cols=198  Identities=34%  Similarity=0.503  Sum_probs=171.8

Q ss_pred             CccccccccCCcEEEEEeEecC-CcEEEEEEeccCChh-hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecC
Q 008108          246 FSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVP  323 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  323 (577)
                      |...+.||+|++|.||++...+ ++.+++|.+...... ....+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567899999999999999765 889999999876544 55678899999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          324 NASLDHFIFDPINREH-MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       324 ~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      +++|.+++..   ... +++..+..++.+++.+|.+||+.+   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-  153 (225)
T smart00221       81 GGDLFDYLRK---KGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-  153 (225)
T ss_pred             CCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-
Confidence            9999988743   223 899999999999999999999987   99999999999999999999999999987654321 


Q ss_pred             ccccccccCCCCcChhhh-hcCCCCccccEEecchhHhHHhhCCCCCCC
Q 008108          403 SDTNRVVGTFGYMAPEYV-MHGRFSVKSDIFSFGVLVLEIVSGQKRSSF  450 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGvil~elltG~~p~~~  450 (577)
                      .......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            122335678899999998 666788899999999999999999999853

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=6.2e-28  Score=230.03  Aligned_cols=193  Identities=30%  Similarity=0.416  Sum_probs=160.5

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC------Ce
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER------KE  314 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  314 (577)
                      .+|..++.+|.|.- .|-.+.. -.++.||+|++...  .........+|+.++..++|+||++++.++.-.      .+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            46777888999988 5555553 35899999988543  233344568899999999999999999998644      35


Q ss_pred             EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      .|+|||||. .+|...+.     -.++-+++..|..|++.|+.|||+.+   |+||||||+||++..+..+||.|||+|+
T Consensus        96 ~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   96 VYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence            799999995 47777763     45788889999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCC
Q 008108          395 LFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSS  449 (577)
Q Consensus       395 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~  449 (577)
                      .-...   -..+.++.|..|.|||++.+-.+.+.+||||+||++.||++|+--|.
T Consensus       167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~  218 (369)
T KOG0665|consen  167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP  218 (369)
T ss_pred             ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence            65433   23445788999999999998889999999999999999999987654

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=7.6e-27  Score=230.66  Aligned_cols=203  Identities=26%  Similarity=0.426  Sum_probs=167.0

Q ss_pred             HHHHhcCCccccccccCCcEEEEEeEec----CCcEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCC
Q 008108          239 IRVATDNFSDANKLGQGGFGAVYKGMLS----NGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERK  313 (577)
Q Consensus       239 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  313 (577)
                      +....+.|..+++||+|.|++||++.+.    ..+.||+|.+...+...  .+.+|+++|..+ -+.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~--ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPS--RILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCch--HHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3445577899999999999999999853    46789999987655433  478999999999 5999999999999999


Q ss_pred             eEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCC-CCeEEeccCC
Q 008108          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGM  392 (577)
Q Consensus       314 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~-~~~kl~DfGl  392 (577)
                      ...+|+||++.-...+++.      .++...+...+..+..||.++|.+|   ||||||||+|+|.+.. +.-.|.||||
T Consensus       109 ~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             eeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence            9999999999988877763      3778899999999999999999998   9999999999999765 4678999999


Q ss_pred             cccccCCC------c-------c-----------------------------ccccccccCCCCcChhhhhc-CCCCccc
Q 008108          393 ARLFEMDQ------T-------H-----------------------------SDTNRVVGTFGYMAPEYVMH-GRFSVKS  429 (577)
Q Consensus       393 a~~~~~~~------~-------~-----------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~  429 (577)
                      |...+...      .       .                             .......||+||.|||++.. +..++++
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            97221100      0       0                             00112479999999999865 4678999


Q ss_pred             cEEecchhHhHHhhCCCCCCCCC
Q 008108          430 DIFSFGVLVLEIVSGQKRSSFGT  452 (577)
Q Consensus       430 Dv~SlGvil~elltG~~p~~~~~  452 (577)
                      ||||.|||++-+++++.||....
T Consensus       260 Diws~GVI~Lslls~~~PFf~a~  282 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFFKAK  282 (418)
T ss_pred             ceeeccceeehhhccccccccCc
Confidence            99999999999999999986433

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=9.7e-27  Score=216.79  Aligned_cols=253  Identities=19%  Similarity=0.320  Sum_probs=185.4

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCeEEEEeE-EEcCCeEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGF-CLERKERILVY  319 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~  319 (577)
                      .+.|.+.+.||+|.||.+-++.++ +.+.+++|-+..... ...+|.+|...--.| .|.||+.-++. |...+.+++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            367888999999999999999975 467799998876543 345788887765555 58999988775 56667888999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEc--CCCCeEEeccCCccccc
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD--SEMNPKISDFGMARLFE  397 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~--~~~~~kl~DfGla~~~~  397 (577)
                      ||+|.|+|..-+    ....+.+....+++.|++.|+.|+|+++   +||||||.+||||-  +..++||+|||+.+..+
T Consensus       102 E~aP~gdL~snv----~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  102 EFAPRGDLRSNV----EAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             ccCccchhhhhc----CcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence            999999997766    3456788888899999999999999998   99999999999993  33479999999987543


Q ss_pred             CCCccccccccccCCCCcChhhhhcC-----CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCc
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMHG-----RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAA  472 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  472 (577)
                      ..     .....-+..|.+||.....     ...+.+|||.||++++.++||+.||....   ..+.--|-|..|..+..
T Consensus       175 ~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~---~~d~~Y~~~~~w~~rk~  246 (378)
T KOG1345|consen  175 TT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS---IMDKPYWEWEQWLKRKN  246 (378)
T ss_pred             ce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh---ccCchHHHHHHHhcccC
Confidence            21     1223446679999977443     24678999999999999999999997332   23334455667766654


Q ss_pred             cccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 008108          473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNML  516 (577)
Q Consensus       473 ~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L  516 (577)
                      ..+.+ .++. ..+..+   ++...-+..++++|=...++-++-
T Consensus       247 ~~~P~-~F~~-fs~~a~---r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  247 PALPK-KFNP-FSEKAL---RLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             ccCch-hhcc-cCHHHH---HHHHHhcCCcccccchhHHHHHHH
Confidence            43322 1111 223333   344466788999985555555553

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=4.6e-27  Score=235.98  Aligned_cols=266  Identities=17%  Similarity=0.208  Sum_probs=200.1

Q ss_pred             HHHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcC------CCCeEEEEeEEEcC
Q 008108          240 RVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ------HRNLVRLLGFCLER  312 (577)
Q Consensus       240 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~  312 (577)
                      +....+|.+.-..|+|-|++|.+|... -|..||||++..+..-.. .=+.|+++|.+|+      .-|+++|+-.|...
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~K-tGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk  506 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHK-TGLKELEILKKLNDADPEDKFHCLRLFRHFKHK  506 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhh-hhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence            455678999999999999999999854 478999999987643211 2257899999995      34789999999999


Q ss_pred             CeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC-CeEEeccC
Q 008108          313 KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-NPKISDFG  391 (577)
Q Consensus       313 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~-~~kl~DfG  391 (577)
                      +++|||+|-+ ..+|.++|......-.|....+..++.|+.-+|..|...+   |+|.||||.||||++.- .+||||||
T Consensus       507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence            9999999977 4478888766555667889999999999999999999887   99999999999998765 58999999


Q ss_pred             CcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhh-----hh
Q 008108          392 MARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAW-----RN  466 (577)
Q Consensus       392 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~-----~~  466 (577)
                      .|-....++.    +.+.-+-.|.|||++.+..|+...|+||.||+||||.||+-.|..........+.....     +.
T Consensus       583 SA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km  658 (752)
T KOG0670|consen  583 SASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM  658 (752)
T ss_pred             cccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence            9987654332    22445667999999999999999999999999999999998776555443222221110     00


Q ss_pred             cccCC---------------------------ccccccC------------cCCCCChHHHHHHHHHHHhcccCCCCCCC
Q 008108          467 WNEGA---------------------------ALNLMDP------------TMRGGSTSEMMKCIHIGLLCVQENVSNRP  507 (577)
Q Consensus       467 ~~~~~---------------------------~~~~~d~------------~l~~~~~~~~~~~~~l~~~C~~~~p~~RP  507 (577)
                      +..+.                           .+..+.|            .+..+....+..+..|.-.|+..||++|-
T Consensus       659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi  738 (752)
T KOG0670|consen  659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI  738 (752)
T ss_pred             hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence            01100                           0001122            12223445566677788889999999999


Q ss_pred             CHHHHHH
Q 008108          508 GMASVVN  514 (577)
Q Consensus       508 t~~ev~~  514 (577)
                      |..+.++
T Consensus       739 t~nqAL~  745 (752)
T KOG0670|consen  739 TVNQALK  745 (752)
T ss_pred             CHHHHhc
Confidence            9987663

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=3.7e-26  Score=228.47  Aligned_cols=132  Identities=27%  Similarity=0.372  Sum_probs=107.8

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcC-----C---CCeEEEEeEEEc--
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-----H---RNLVRLLGFCLE--  311 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~--  311 (577)
                      ..+|.+.++||.|.|++||++.. .+.+.||+|+.+....- .+.-..|+.+|++++     |   .+||+|++.|..  
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY-tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY-TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH-HHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            36899999999999999999995 45678999988654322 223578999999983     3   369999999974  


Q ss_pred             --CCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEE
Q 008108          312 --RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL  379 (577)
Q Consensus       312 --~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl  379 (577)
                        +.++++|+|++ |-+|..+|.. .+-+.++...+.+|++||+.||.|||.+.  +|||-||||+||||
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence              45889999999 5567677644 23456999999999999999999999976  69999999999999

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=3.1e-27  Score=269.88  Aligned_cols=196  Identities=17%  Similarity=0.240  Sum_probs=138.1

Q ss_pred             hcCC-CCeEEEEeEE-------EcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcE
Q 008108          296 RLQH-RNLVRLLGFC-------LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI  367 (577)
Q Consensus       296 ~l~h-~niv~l~~~~-------~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~i  367 (577)
                      .++| +||++++++|       .+.+..++++||+ +++|.++|..  ....+++.+++.++.||++||.|||+++   |
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            3555 5788888877       2334567888987 5699999853  2356999999999999999999999988   9


Q ss_pred             EEeccCCCcEEEcC-------------------CCCeEEeccCCcccccCCCc--------------cccccccccCCCC
Q 008108          368 IHRDLKASNILLDS-------------------EMNPKISDFGMARLFEMDQT--------------HSDTNRVVGTFGY  414 (577)
Q Consensus       368 iHrDlkp~NiLl~~-------------------~~~~kl~DfGla~~~~~~~~--------------~~~~~~~~gt~~y  414 (577)
                      +||||||+||||+.                   ++.+||+|||+++.......              ........||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   44567777777764321000              0001124689999


Q ss_pred             cChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHH
Q 008108          415 MAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHI  494 (577)
Q Consensus       415 ~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l  494 (577)
                      ||||++.+..++.++|||||||+||||++|..|+....     ..+.    .+..    ..+.+.    ......+...+
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~----~~~~----~~~~~~----~~~~~~~~~~~  244 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMS----SLRH----RVLPPQ----ILLNWPKEASF  244 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHH----HHHH----hhcChh----hhhcCHHHHHH
Confidence            99999999999999999999999999999887643111     0110    0000    001111    11122334567


Q ss_pred             HHhcccCCCCCCCCHHHHHH
Q 008108          495 GLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       495 ~~~C~~~~p~~RPt~~ev~~  514 (577)
                      +.+||+.+|.+||+|.||++
T Consensus       245 ~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        245 CLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHhCCCChhhCcChHHHhh
Confidence            78899999999999999975

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=1.2e-24  Score=222.24  Aligned_cols=171  Identities=20%  Similarity=0.247  Sum_probs=132.9

Q ss_pred             HHHHHHhcCCccccccccCCcEEEEEeEec--CCcEEEEEEeccC-----ChhhHHHHHHHHHHHHhcCCCCeEE-EEeE
Q 008108          237 ETIRVATDNFSDANKLGQGGFGAVYKGMLS--NGETIAVKRLSKN-----SKQGEIEFKNEVLLLARLQHRNLVR-LLGF  308 (577)
Q Consensus       237 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~  308 (577)
                      +..+...++|...+.||+|+||+||+|...  +++.+|||++...     .......+.+|+++|++++|+|+++ ++++
T Consensus        11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~   90 (365)
T PRK09188         11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT   90 (365)
T ss_pred             cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence            345566788999999999999999999864  5777899987533     1223446899999999999999985 4432


Q ss_pred             EEcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEecc-CCCcEEEcCCCCeEE
Q 008108          309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDL-KASNILLDSEMNPKI  387 (577)
Q Consensus       309 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDl-kp~NiLl~~~~~~kl  387 (577)
                          +..+|||||+++++|....    ...      ...++.+++++|.|||+.+   |+|||| ||+|||++.++.+||
T Consensus        91 ----~~~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikL  153 (365)
T PRK09188         91 ----GKDGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAV  153 (365)
T ss_pred             ----CCcEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEE
Confidence                4579999999999996321    111      1467889999999999988   999999 999999999999999


Q ss_pred             eccCCcccccCCCcccc------ccccccCCCCcChhhhhcCC
Q 008108          388 SDFGMARLFEMDQTHSD------TNRVVGTFGYMAPEYVMHGR  424 (577)
Q Consensus       388 ~DfGla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~  424 (577)
                      +|||+|+.+........      -....+++.|+|||++...+
T Consensus       154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~  196 (365)
T PRK09188        154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE  196 (365)
T ss_pred             EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence            99999997754321111      12467889999999886543

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=4.3e-25  Score=205.62  Aligned_cols=164  Identities=20%  Similarity=0.208  Sum_probs=122.3

Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcccc
Q 008108          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD  404 (577)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~  404 (577)
                      |+|.+++..  .+..+++..++.|+.||+.||.|||+++         ||+|||++.++.+|+  ||+++......    
T Consensus         1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence            678887743  2456999999999999999999999875         999999999999999  99998654321    


Q ss_pred             ccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCC
Q 008108          405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGS  484 (577)
Q Consensus       405 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  484 (577)
                         ..||+.|||||++.+..++.++|||||||++|||+||+.|+.....  ....+..........      ++... ..
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~--~~~~~~~~~~~~~~~------~~~~~-~~  131 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE--LSAILEILLNGMPAD------DPRDR-SN  131 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch--hcHHHHHHHHHhccC------Ccccc-cc
Confidence               2589999999999999999999999999999999999999854322  111111111111110      01000 11


Q ss_pred             hHHH---HHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          485 TSEM---MKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       485 ~~~~---~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                      ....   ..+.+++..|++.+|++||++.|+++.+.
T Consensus       132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~  167 (176)
T smart00750      132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCR  167 (176)
T ss_pred             HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence            1112   24778999999999999999999998764

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=4.4e-23  Score=210.95  Aligned_cols=258  Identities=21%  Similarity=0.259  Sum_probs=189.5

Q ss_pred             CCccccccccCCcEEEEEeEecCC--cEEEEEEeccCChhhHHHHHHHHHHHHhcCC----CCeEEEEeEE-EcCCeEEE
Q 008108          245 NFSDANKLGQGGFGAVYKGMLSNG--ETIAVKRLSKNSKQGEIEFKNEVLLLARLQH----RNLVRLLGFC-LERKERIL  317 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l  317 (577)
                      +|.+.++||+|+||.||++.....  +.+|+|............+..|..++..+.+    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999996553  4788888766543332267888999988873    6889999988 47778899


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCC-----CCeEEeccCC
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE-----MNPKISDFGM  392 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~-----~~~kl~DfGl  392 (577)
                      ||+.+ |.+|.++.... ..+.++..+.+.|+.|++.+|.+||+.|   ++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~-~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRN-PPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhC-CCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99977 77998865332 2578999999999999999999999998   9999999999999765     3599999999


Q ss_pred             ccccc--CCCc----ccc--ccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhh
Q 008108          393 ARLFE--MDQT----HSD--TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAW  464 (577)
Q Consensus       393 a~~~~--~~~~----~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~  464 (577)
                      ++.+.  ....    ...  .....||..|.++....+...+.+.|+||++.++.|++.|..||...........+....
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~  253 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP  253 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence            99332  2211    111  123569999999999999999999999999999999999999985444322211111110


Q ss_pred             hhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          465 RNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       465 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .       ...... .....+.+...+...   +-..+..++|....+...|..
T Consensus       254 ~-------~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~Pdy~~~~~~l~~  296 (322)
T KOG1164|consen  254 R-------KLLTDR-FGDLKPEEFAKILEY---IDSLDYEDKPDYEKLAELLKD  296 (322)
T ss_pred             h-------hhcccc-ccCCChHHHHHHHHH---hhccCCcCCCCHHHHHHHHHH
Confidence            0       001110 111233444444333   334788899999988888654

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.89  E-value=2.8e-24  Score=200.26  Aligned_cols=247  Identities=20%  Similarity=0.317  Sum_probs=186.0

Q ss_pred             cccccccCCcEEEEEeEecCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCC
Q 008108          248 DANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA  325 (577)
Q Consensus       248 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g  325 (577)
                      ...+|.+...|+.|+|+++ |..+++|++....  ......|..|.-.|+-+.||||+.++|.|....++.++..||+.|
T Consensus       194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            3567999999999999996 5667778776442  223346889999999999999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccccc
Q 008108          326 SLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT  405 (577)
Q Consensus       326 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~  405 (577)
                      +|...|++. ..-.++..++.+++.+||+|++|||+..+ -|.---|.+..++||++.+++|+- +-+++.-      ..
T Consensus       273 slynvlhe~-t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarism-ad~kfsf------qe  343 (448)
T KOG0195|consen  273 SLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISM-ADTKFSF------QE  343 (448)
T ss_pred             HHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheec-ccceeee------ec
Confidence            999998763 34457788999999999999999999863 244456899999999999988752 2122100      01


Q ss_pred             cccccCCCCcChhhhhcCCC---CccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCC
Q 008108          406 NRVVGTFGYMAPEYVMHGRF---SVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG  482 (577)
Q Consensus       406 ~~~~gt~~y~aPE~~~~~~~---~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  482 (577)
                      ....-.+.||+||.+...+-   -.++|+|||++++|||.|...||....+-+....+           .++-+.+.+.+
T Consensus       344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki-----------aleglrv~ipp  412 (448)
T KOG0195|consen  344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI-----------ALEGLRVHIPP  412 (448)
T ss_pred             cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh-----------hhccccccCCC
Confidence            11234678999999977653   35789999999999999999999765544332222           12223344444


Q ss_pred             CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          483 GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       483 ~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      +....+.+   ++.-|+++||.+||.+..|+-.|++
T Consensus       413 gis~hm~k---lm~icmnedpgkrpkfdmivpilek  445 (448)
T KOG0195|consen  413 GISRHMNK---LMNICMNEDPGKRPKFDMIVPILEK  445 (448)
T ss_pred             CccHHHHH---HHHHHhcCCCCcCCCcceehhhHHH
Confidence            44444544   4557999999999999999988764

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=9.9e-22  Score=199.57  Aligned_cols=261  Identities=29%  Similarity=0.388  Sum_probs=194.3

Q ss_pred             CccccccccCCcEEEEEeEecCCcEEEEEEeccCChh---hHHHHHHHHHHHHhcCCC-CeEEEEeEEEcCCeEEEEEEe
Q 008108          246 FSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ---GEIEFKNEVLLLARLQHR-NLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~E~  321 (577)
                      |...+.||.|+||.||++...  ..+++|.+......   ....+.+|+.++..+.|+ +++++.+++......++++||
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            567789999999999999976  78999998765433   356789999999999988 799999999777778999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC-CeEEeccCCcccccCCC
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-NPKISDFGMARLFEMDQ  400 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~-~~kl~DfGla~~~~~~~  400 (577)
                      +.+++|.+++........+.......++.|++.++.|+|+.+   ++|||+||+||+++..+ .+++.|||+++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999866532111026899999999999999999999998   99999999999999998 69999999998655433


Q ss_pred             ccc----cccccccCCCCcChhhhhc---CCCCccccEEecchhHhHHhhCCCCCCCCCcc-ccchhhhhhhhhcccCCc
Q 008108          401 THS----DTNRVVGTFGYMAPEYVMH---GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEE-ETEDLLTYAWRNWNEGAA  472 (577)
Q Consensus       401 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~  472 (577)
                      ...    ......||..|++||.+..   ..++...|+||+|++++++++|..|+...... .........+..... ..
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~  235 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SL  235 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cc
Confidence            221    2345789999999999987   57889999999999999999999995543321 011111111111111 00


Q ss_pred             cccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       473 ~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      .....+..   .......+..++..|+..+|..|.++.+....
T Consensus       236 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         236 ASPLSPSN---PELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccccCccc---cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00000000   01112344566778888899999998877653

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.87  E-value=3e-22  Score=190.47  Aligned_cols=172  Identities=15%  Similarity=0.196  Sum_probs=135.4

Q ss_pred             HHhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHH---------HHHHHHHHHhcCCCCeEEEEeEEEc
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE---------FKNEVLLLARLQHRNLVRLLGFCLE  311 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~  311 (577)
                      ....+|+..+.||.|+||.||+... ++..+|||.+.......+..         +.+|+..+.+++|++|..+..++..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            4568999999999999999999665 57789999997653322222         6789999999999999999888654


Q ss_pred             C--------CeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC
Q 008108          312 R--------KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM  383 (577)
Q Consensus       312 ~--------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~  383 (577)
                      .        ...+|+|||++|.+|.++.       .++.    ....+++.+|..||+.+   ++|||+||+||+++.++
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g  172 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence            3        3578999999999997763       1222    34569999999999998   99999999999999988


Q ss_pred             CeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHh
Q 008108          384 NPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIV  442 (577)
Q Consensus       384 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ell  442 (577)
                       ++|+|||...........              ..++....+..++|+||||+++.-+.
T Consensus       173 -i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence             999999988754321111              11455566778999999999987665

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=5.6e-23  Score=223.51  Aligned_cols=253  Identities=21%  Similarity=0.288  Sum_probs=184.7

Q ss_pred             ccccccccCCcEEEEEeEec-CCcEEEEEEec----cC-Chh-hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          247 SDANKLGQGGFGAVYKGMLS-NGETIAVKRLS----KN-SKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       247 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----~~-~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ...+.+|.|.+|.|+..... ..+.++.|...    .. ... ....+..|+.+-..++|+|++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            35678999999977777632 33334444332    11 111 1112566777788889999998888877777776679


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      |||++ +|..++.   ....++..++..++.|++.|+.|||+.+   |.|||||++|++++.++.+||+|||.+..+...
T Consensus       401 E~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 9988773   2347999999999999999999999998   999999999999999999999999999877655


Q ss_pred             Ccc--ccccccccCCCCcChhhhhcCCCCc-cccEEecchhHhHHhhCCCCCCCCCccccch--hhhhhhhhcccCCccc
Q 008108          400 QTH--SDTNRVVGTFGYMAPEYVMHGRFSV-KSDIFSFGVLVLEIVSGQKRSSFGTEEETED--LLTYAWRNWNEGAALN  474 (577)
Q Consensus       400 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~SlGvil~elltG~~p~~~~~~~~~~~--l~~~~~~~~~~~~~~~  474 (577)
                      ...  ......+|+..|+|||++...+|.+ ..||||.|+++..|++|+.||......+...  .....+.....+    
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~----  549 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEG----  549 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccC----
Confidence            444  4455678999999999999999975 5799999999999999999987554433211  000000000000    


Q ss_pred             cccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          475 LMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       475 ~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                           ...-......+...++..+++.+|.+|-||.+|++.
T Consensus       550 -----~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  550 -----PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             -----hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence                 000011222345568889999999999999998863

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=9e-22  Score=188.67  Aligned_cols=201  Identities=24%  Similarity=0.366  Sum_probs=169.2

Q ss_pred             cCCccccccccCCcEEEEEeE-ecCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      -+|.+.++||+|.||.++.|+ +-+++.||||.-...+...  ++..|....+.| ..++|..++-|..++..-.||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP--QLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP--QLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCCcc--hHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            368889999999999999999 5689999999876554433  466778887777 579999999888888888999998


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC-----CeEEeccCCcccc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-----NPKISDFGMARLF  396 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~-----~~kl~DfGla~~~  396 (577)
                      + |.||+++. +- -...++.+++..++.|++.-++|+|++.   +|.|||||+|+||..-+     .+.|+|||+|+.+
T Consensus       106 L-GPSLEDLF-D~-CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  106 L-GPSLEDLF-DL-CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             h-CcCHHHHH-HH-hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            8 77898864 32 2457999999999999999999999998   99999999999996443     4899999999987


Q ss_pred             cCCCcc-----ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCC
Q 008108          397 EMDQTH-----SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGT  452 (577)
Q Consensus       397 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~  452 (577)
                      ....+.     .......||.+||+--...+.+.+.+.|+-|||-+++..|-|..||..-.
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK  240 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  240 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence            654332     23445789999999999999999999999999999999999999997544

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.86  E-value=1.1e-21  Score=184.44  Aligned_cols=139  Identities=19%  Similarity=0.199  Sum_probs=108.6

Q ss_pred             ccccccCCcEEEEEeEecCCcEEEEEEeccCChh--h------------------------HHHHHHHHHHHHhcCCCCe
Q 008108          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ--G------------------------EIEFKNEVLLLARLQHRNL  302 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ni  302 (577)
                      ...||+|+||.||+|...+|+.||||+++.....  .                        .....+|+..+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999999888999999998754211  0                        0112459999999987776


Q ss_pred             EEEEeEEEcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCcEEEeccCCCcEEEcC
Q 008108          303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL-HEDSRLRIIHRDLKASNILLDS  381 (577)
Q Consensus       303 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yL-H~~~~~~iiHrDlkp~NiLl~~  381 (577)
                      .....+..  ...+|||||+++++|...+.   ....+++..+..++.|++.+|.|| |+.+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence            43332222  23389999999987765432   235789999999999999999999 6877   99999999999998 


Q ss_pred             CCCeEEeccCCcccc
Q 008108          382 EMNPKISDFGMARLF  396 (577)
Q Consensus       382 ~~~~kl~DfGla~~~  396 (577)
                      ++.++|+|||+|...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=7.3e-22  Score=181.48  Aligned_cols=204  Identities=22%  Similarity=0.338  Sum_probs=168.8

Q ss_pred             hcCCccccccccCCcEEEEEeE-ecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCC-CCeEEEEeEEEcCCeEEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH-RNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E  320 (577)
                      ...|..+++||.|+||.+|.|. ..+|+.||||.-+......  ++..|..+...|++ ..|..+..|..+...-.+|||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp--qL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP--QLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc--chhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            4679999999999999999999 6789999999876655443  35668888888875 677788888888888899999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC---CeEEeccCCccccc
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM---NPKISDFGMARLFE  397 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~---~~kl~DfGla~~~~  397 (577)
                      .+ |.||+++..-  -...++.++.+-++-|++.-++|+|.++   +|||||||+|+|..-+.   .+.++|||+|+.+.
T Consensus        92 LL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   92 LL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             cc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence            88 7799887532  2346899999999999999999999998   99999999999996553   58999999999775


Q ss_pred             CCCcc-----ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCcc
Q 008108          398 MDQTH-----SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEE  454 (577)
Q Consensus       398 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~  454 (577)
                      ...+.     .......||.+|.+--...+.+.+.+.|+-|+|.+|..+.-|..||..-...
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~  227 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA  227 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence            43221     1233468999999988888888899999999999999999999999765443

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.85  E-value=1.1e-20  Score=178.12  Aligned_cols=140  Identities=21%  Similarity=0.244  Sum_probs=111.4

Q ss_pred             ccccccCCcEEEEEeEecCCcEEEEEEeccCChh---------------------h-----HHHHHHHHHHHHhcCCCCe
Q 008108          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ---------------------G-----EIEFKNEVLLLARLQHRNL  302 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~h~ni  302 (577)
                      ...||+|+||.||+|...+|+.||||++......                     .     ...+.+|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999999878999999998764211                     0     1124678999999999987


Q ss_pred             EEEEeEEEcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCcEEEeccCCCcEEEcC
Q 008108          303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE-DSRLRIIHRDLKASNILLDS  381 (577)
Q Consensus       303 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlkp~NiLl~~  381 (577)
                      .....+...  ..+|||||++++++.....   ....++......++.|++.+|.+||+ .+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            544433332  2489999999886543321   23467888999999999999999999 77   99999999999999 


Q ss_pred             CCCeEEeccCCccccc
Q 008108          382 EMNPKISDFGMARLFE  397 (577)
Q Consensus       382 ~~~~kl~DfGla~~~~  397 (577)
                      ++.++|+|||++....
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            7899999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=7.1e-21  Score=197.92  Aligned_cols=216  Identities=24%  Similarity=0.365  Sum_probs=161.6

Q ss_pred             HHhcCCCCeEEEEeEEEcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccC
Q 008108          294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLK  373 (577)
Q Consensus       294 l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk  373 (577)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+..  ....++|.....++++|+.||.|||...  -..|+.|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence            3568999999999999999999999999999999999864  3567999999999999999999999864  23999999


Q ss_pred             CCcEEEcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcC-------CCCccccEEecchhHhHHhhCCC
Q 008108          374 ASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG-------RFSVKSDIFSFGVLVLEIVSGQK  446 (577)
Q Consensus       374 p~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~SlGvil~elltG~~  446 (577)
                      ++|+++|..+.+||+|||+.................-...|.|||.+...       ..+.+.||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999998876431111111112234579999988663       14678999999999999999999


Q ss_pred             CCCCCCcccc-chhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCC
Q 008108          447 RSSFGTEEET-EDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD  519 (577)
Q Consensus       447 p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~  519 (577)
                      ||........ ..++.++....     ...+-|.+.... +....++.++..||..+|++||++.+|-..++..
T Consensus       157 ~~~~~~~~~~~~eii~~~~~~~-----~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKKGG-----SNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             ccccccccCChHHHHHHHHhcC-----CCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            9976443222 33444322201     111222221111 1122577888899999999999999999887653

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.83  E-value=5.1e-21  Score=161.80  Aligned_cols=103  Identities=38%  Similarity=0.660  Sum_probs=76.9

Q ss_pred             eeecc---cCCcccchHHHHHHHHHHHHHHHHHhhcCCCCCceeeeeeccCCCcceeEEEecCCCCChhchhHHHHHHHH
Q 008108           58 FFVYA---ESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSEADCKECLHDTTK  134 (577)
Q Consensus        58 ~~~~~---~~~~~~~~~~f~~~~~~ll~~l~~~a~~~~~~~~~a~~~~~~~~~~~vy~l~qC~~dls~~~C~~Cl~~~~~  134 (577)
                      |..|+   .++++.+.+.|..++.+||+.|+..|+... ..+|++++. ..+.++||||+||++||++.||+.||+.++.
T Consensus         1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~-~~~f~~~~~-~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~   78 (106)
T PF01657_consen    1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSS-SKGFATGSA-GSGPDTVYGLAQCRGDLSPSDCRACLADAVA   78 (106)
T ss_dssp             ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT--TEEEEEE---ST---EEEEEEE-TTS-HHHHHHHHHHHHC
T ss_pred             CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhcc-ccCcEEeec-CCCCCeEEEEEEcCCCCChhhhHHHHHHHHH
Confidence            44566   333422445599999999999999988653 468999987 4466799999999999999999999999999


Q ss_pred             hhhhhcCCCCCeEEeCCCCCCccccCcc
Q 008108          135 LMSKCCDRRQGGRVINPSCSFRYETNKF  162 (577)
Q Consensus       135 ~~~~~c~~~~gg~v~~~~C~~ry~~~~f  162 (577)
                      .++.+|+.++||++++++|++||++++|
T Consensus        79 ~~~~~C~~~~g~~v~~~~C~lRY~~~~F  106 (106)
T PF01657_consen   79 NISSCCPGSRGGRVWYDSCFLRYENYPF  106 (106)
T ss_dssp             CHHHHTTSBSSEEEEESSEEEEEESS--
T ss_pred             HHHHhCCCCceEEEECCCEEEEEECCCC
Confidence            9999999999999999999999999987

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=5.5e-20  Score=171.29  Aligned_cols=187  Identities=20%  Similarity=0.163  Sum_probs=141.8

Q ss_pred             ccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhH----HHHHHHHHHHHhcC-CCCeEEEEeEEEcCCeEEEEEEe
Q 008108          247 SDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGE----IEFKNEVLLLARLQ-HRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       247 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      .+...|++|+||+||.+.- .+.+++.+.+........    ..+.+|+++|++++ |+++++++++    ...+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3467899999999997765 678888888776554222    24789999999995 5889999886    456999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEecc-CCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDL-KASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDl-kp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      +.|.+|...+.    .      ....++.|++++|.++|+++   |+|||| ||+|||++.++.++|+|||+|.......
T Consensus        80 I~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            99998864431    1      12357889999999999998   999999 7999999999999999999998654332


Q ss_pred             cc----c--c-----ccccccCCCCcChhhhhcC-CCC-ccccEEecchhHhHHhhCCCCCCCC
Q 008108          401 TH----S--D-----TNRVVGTFGYMAPEYVMHG-RFS-VKSDIFSFGVLVLEIVSGQKRSSFG  451 (577)
Q Consensus       401 ~~----~--~-----~~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~SlGvil~elltG~~p~~~~  451 (577)
                      ..    .  +     +.....++.|++|+...-. ..+ ...+.++-|..+|.++|++.+.-.+
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            10    0  0     1112468889999865332 333 5679999999999999999875433

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.81  E-value=3.2e-21  Score=209.44  Aligned_cols=250  Identities=20%  Similarity=0.207  Sum_probs=179.1

Q ss_pred             CCccccccccCCcEEEEEeEecCCcEEEEEEeccCC-hhhHHHHHHHHHH--HHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          245 NFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS-KQGEIEFKNEVLL--LARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ++...+.||.+.|=+|.+++.++|. |+||++-+.. .-....|+++++-  ...++|||.+++.-+-..+...|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            4666788999999999999998887 9999986654 3333445544433  4455899999998887777777888888


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc-CCC
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE-MDQ  400 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~-~~~  400 (577)
                      ..+ +|.+.|   ..+.-|...+...|+.|++.||..+|..+   |+|||||.+||||+.-..+.|+||.--+..- +.+
T Consensus       103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            865 776666   45677888899999999999999999998   9999999999999999999999998665321 111


Q ss_pred             cccccccc----ccCCCCcChhhhhcC-----------CCCccccEEecchhHhHHhhCCCC-CCCCCccccchhhhhhh
Q 008108          401 THSDTNRV----VGTFGYMAPEYVMHG-----------RFSVKSDIFSFGVLVLEIVSGQKR-SSFGTEEETEDLLTYAW  464 (577)
Q Consensus       401 ~~~~~~~~----~gt~~y~aPE~~~~~-----------~~~~~~Dv~SlGvil~elltG~~p-~~~~~~~~~~~l~~~~~  464 (577)
                      ...+...+    ..-..|+|||.+...           ..+++.||||+||++.||++-..| |.      .-.++.+-.
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~------LSQL~aYr~  249 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT------LSQLLAYRS  249 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc------HHHHHhHhc
Confidence            12221111    223479999988542           267889999999999999986444 42      222332211


Q ss_pred             h-hcccCC-ccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCC
Q 008108          465 R-NWNEGA-ALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD  519 (577)
Q Consensus       465 ~-~~~~~~-~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~  519 (577)
                      . ....+. +.++-|+           .+..+++.|++.||++|.++++.++...+.
T Consensus       250 ~~~~~~e~~Le~Ied~-----------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  250 GNADDPEQLLEKIEDV-----------SLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             cCccCHHHHHHhCcCc-----------cHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence            1 000000 1112222           234788899999999999999999987664

>PRK10345 hypothetical protein; Provisional

Probab=99.81  E-value=1.8e-19  Score=171.03  Aligned_cols=137  Identities=21%  Similarity=0.323  Sum_probs=106.8

Q ss_pred             CccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-----CCCCeEEEEeEEEcCC---eEE-
Q 008108          246 FSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-----QHRNLVRLLGFCLERK---ERI-  316 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~-  316 (577)
                      ....++||+|+||.||. ...++.. +||++..........+.+|+.+++.+     .||||++++|++.++.   ..+ 
T Consensus         4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34568899999999996 2233444 79988765444556789999999999     5799999999998874   333 


Q ss_pred             EEEEe--cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCCcEEEeccCCCcEEEcC----CCCeEEec
Q 008108          317 LVYEF--VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL-LYLHEDSRLRIIHRDLKASNILLDS----EMNPKISD  389 (577)
Q Consensus       317 lv~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl-~yLH~~~~~~iiHrDlkp~NiLl~~----~~~~kl~D  389 (577)
                      +|+||  +++++|.+++.+    ..+++.  ..++.+++.++ .|||+++   |+||||||+|||++.    +.+++|+|
T Consensus        82 ~I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            78999  558999999843    235555  35678888887 8999998   999999999999974    34799999


Q ss_pred             cCCc
Q 008108          390 FGMA  393 (577)
Q Consensus       390 fGla  393 (577)
                      |+.+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            5444

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=1.2e-19  Score=201.31  Aligned_cols=199  Identities=22%  Similarity=0.264  Sum_probs=160.6

Q ss_pred             HHHhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcC---CCCeEEEEeEEEcCCeEE
Q 008108          240 RVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ---HRNLVRLLGFCLERKERI  316 (577)
Q Consensus       240 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~  316 (577)
                      ++..+.|.+.+.||+|+||+||+|...+|+.||+|.-+....+   +|.--.+++.+|+   -+-|.++.....-.+.-+
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~  770 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASV  770 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence            3445678899999999999999999888999999987766544   2222334455555   233445555556677789


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC-------CCCeEEec
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS-------EMNPKISD  389 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~-------~~~~kl~D  389 (577)
                      ||+||.+.|+|.+++.   ..+.++|...+.++.|+++-+..||..+   |||+||||+|+||..       ..-++|+|
T Consensus       771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence            9999999999999984   5678999999999999999999999998   999999999999932       23589999


Q ss_pred             cCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCC
Q 008108          390 FGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKR  447 (577)
Q Consensus       390 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p  447 (577)
                      ||.+..+..-.........++|-.+-.+|...+..++...|.|.|+-+++-||.|+..
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            9998755443333344557889999999999999999999999999999999999853

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.77  E-value=5.8e-20  Score=190.97  Aligned_cols=186  Identities=27%  Similarity=0.330  Sum_probs=155.2

Q ss_pred             ccccCCcEEEEEeE----ecCCcEEEEEEeccCChhh--HHHHHHHHHHHHhcC-CCCeEEEEeEEEcCCeEEEEEEecC
Q 008108          251 KLGQGGFGAVYKGM----LSNGETIAVKRLSKNSKQG--EIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERILVYEFVP  323 (577)
Q Consensus       251 ~lG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~  323 (577)
                      .+|+|.||.|+++.    .+.|..+|+|.+.+.....  ......|-.++...+ ||.+|++...+..+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999875    3346778898887643211  113456778888886 9999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccc
Q 008108          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS  403 (577)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~  403 (577)
                      +|.|...+   .+...+++.........++-++.++|+.+   |+|||+|++||+++.+|.+++.|||+++..-....  
T Consensus        81 gg~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--  152 (612)
T KOG0603|consen   81 GGDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--  152 (612)
T ss_pred             cchhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence            99997776   34556777778888889999999999988   99999999999999999999999999986543222  


Q ss_pred             cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCC
Q 008108          404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSF  450 (577)
Q Consensus       404 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~  450 (577)
                          .+||..|||||++.  ......|.||||++++||+||..||..
T Consensus       153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence                28999999999988  567789999999999999999999864

>smart00090 RIO RIO-like kinase

Probab=99.76  E-value=4.5e-18  Score=165.36  Aligned_cols=143  Identities=19%  Similarity=0.255  Sum_probs=112.4

Q ss_pred             CCccccccccCCcEEEEEeE--ecCCcEEEEEEeccCChh------------------------hHHHHHHHHHHHHhcC
Q 008108          245 NFSDANKLGQGGFGAVYKGM--LSNGETIAVKRLSKNSKQ------------------------GEIEFKNEVLLLARLQ  298 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  298 (577)
                      .|++.+.||+|+||.||+|.  ..+|+.||+|++......                        ....+.+|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47888999999999999998  568999999998753210                        0123568999999997


Q ss_pred             CCC--eEEEEeEEEcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCc
Q 008108          299 HRN--LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASN  376 (577)
Q Consensus       299 h~n--iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~N  376 (577)
                      +.+  +.+++++    ...++||||+++.+|.....   ....+.......++.||+.+|.+||+.+  .|+||||||+|
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~N  179 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYN  179 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhh
Confidence            533  4455543    23589999999988876542   2334666677899999999999999876  49999999999


Q ss_pred             EEEcCCCCeEEeccCCccccc
Q 008108          377 ILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       377 iLl~~~~~~kl~DfGla~~~~  397 (577)
                      |+++ ++.++|+|||.+....
T Consensus       180 Ili~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEEE-CCCEEEEEChhhhccC
Confidence            9999 8899999999987543

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.75  E-value=1.1e-17  Score=158.90  Aligned_cols=142  Identities=20%  Similarity=0.256  Sum_probs=111.2

Q ss_pred             HHhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChh----------------------hHHHHHHHHHHHHhcC
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ----------------------GEIEFKNEVLLLARLQ  298 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~  298 (577)
                      .....|...+.||+|+||.||++...+|+.||||++......                      ....+..|+.++..+.
T Consensus        12 ~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~   91 (198)
T cd05144          12 KRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY   91 (198)
T ss_pred             HcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence            333347788999999999999999888999999987643210                      1113567899999998


Q ss_pred             CCC--eEEEEeEEEcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCc
Q 008108          299 HRN--LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASN  376 (577)
Q Consensus       299 h~n--iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~N  376 (577)
                      |++  +.+.++.    ...++||||+++++|.....         ......++.+++.++.++|+.+   |+||||||+|
T Consensus        92 ~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~N  155 (198)
T cd05144          92 EEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSEFN  155 (198)
T ss_pred             HcCCCCCceeec----CCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCccc
Confidence            774  4444442    34589999999999876541         0235678899999999999987   9999999999


Q ss_pred             EEEcCCCCeEEeccCCcccccC
Q 008108          377 ILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       377 iLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |++++++.++|+|||++..+..
T Consensus       156 ill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         156 ILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             EEEcCCCcEEEEECCccccCCC
Confidence            9999999999999999975543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.75  E-value=6.6e-18  Score=162.08  Aligned_cols=134  Identities=21%  Similarity=0.316  Sum_probs=112.5

Q ss_pred             cccccCCcEEEEEeEecCCcEEEEEEeccCChh--------hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ--------GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      +.||+|++|.||+|.. .|..+++|+.......        ....+.+|+.++..++|+++.....++.+....+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            6799999999999987 6788999986543211        123477899999999999988777777777888999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      ++|++|.+++..      ..+ .+..++.+++.+|.+||+.+   ++|||++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~------~~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINS------NGM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHh------ccH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999888732      122 78899999999999999988   99999999999999 78899999999864

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.74  E-value=2.3e-19  Score=183.07  Aligned_cols=124  Identities=27%  Similarity=0.478  Sum_probs=110.5

Q ss_pred             eEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCc
Q 008108          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (577)
Q Consensus       314 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla  393 (577)
                      .+++.|++|...+|.+||.........++...+.++.|++.|+.|   ++   .+|||+||.||....+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            468999999999999999776777789999999999999999999   55   899999999999999999999999998


Q ss_pred             ccccCCC----ccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh
Q 008108          394 RLFEMDQ----THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS  443 (577)
Q Consensus       394 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt  443 (577)
                      .......    .....+...||..||+||.+.+..|+.|+||||||+||+||+.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            8765544    2234455789999999999999999999999999999999997

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.74  E-value=3.6e-18  Score=167.47  Aligned_cols=232  Identities=17%  Similarity=0.250  Sum_probs=141.6

Q ss_pred             CccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCC----------CCeEEEEeEE--
Q 008108          246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQH----------RNLVRLLGFC--  309 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~--  309 (577)
                      +.....||.|+++.||.+... +|+++|||.+....   .....++++|...+..+.+          -.++-.++..  
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            445678999999999999975 58999999875433   2234456666655544322          1222222211  


Q ss_pred             -------EcCC--------eEEEEEEecCCCCcccccc---cCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEe
Q 008108          310 -------LERK--------ERILVYEFVPNASLDHFIF---DPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR  370 (577)
Q Consensus       310 -------~~~~--------~~~lv~E~~~~gsL~~~l~---~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHr  370 (577)
                             ....        +.+++|+-+ -++|.+++.   ... ....+....++.+..|+++.+++||..+   ++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence                   1111        336777766 457766642   111 1123445566778899999999999998   9999


Q ss_pred             ccCCCcEEEcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcC--------CCCccccEEecchhHhHHh
Q 008108          371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG--------RFSVKSDIFSFGVLVLEIV  442 (577)
Q Consensus       371 Dlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~Dv~SlGvil~ell  442 (577)
                      ||||+|++++.+|.++|+||+...........     ...+..|.+||.....        .++.+.|.|+||+++|.|.
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            99999999999999999999877654321111     2345789999977542        4788999999999999999


Q ss_pred             hCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCC
Q 008108          443 SGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNR  506 (577)
Q Consensus       443 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~R  506 (577)
                      +|+.|+...........               .+. .-+ ..++.+.   .++...++.||++|
T Consensus       245 C~~lPf~~~~~~~~~~~---------------~f~-~C~-~~Pe~v~---~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW---------------DFS-RCR-DMPEPVQ---FLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG---------------GGT-TSS----HHHH---HHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc---------------cch-hcC-CcCHHHH---HHHHHHccCCcccC
Confidence            99999875433222111               000 001 2333333   45568889999988

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.73  E-value=1.5e-17  Score=157.99  Aligned_cols=130  Identities=22%  Similarity=0.372  Sum_probs=105.5

Q ss_pred             ccccCCcEEEEEeEecCCcEEEEEEeccCChh--------hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ--------GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       251 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      .||+|+||.||+|.+ +|..+++|........        ...++.+|+.++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999995 5788999986543211        1235678999999999887665555556667779999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      +|++|.+++...   .       ..++.+++.+|.+||+.+   ++|||++|+||+++ ++.+++.|||+++.
T Consensus        80 ~g~~l~~~~~~~---~-------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEG---N-------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhc---H-------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999998876321   1       078999999999999988   99999999999999 88999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.73  E-value=1.3e-17  Score=182.26  Aligned_cols=140  Identities=17%  Similarity=0.306  Sum_probs=113.0

Q ss_pred             HHHhcCCccccccccCCcEEEEEeEecCCcEEEEEE-eccCCh-------hhHHHHHHHHHHHHhcCCCCeEEEEeEEEc
Q 008108          240 RVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKR-LSKNSK-------QGEIEFKNEVLLLARLQHRNLVRLLGFCLE  311 (577)
Q Consensus       240 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~-~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  311 (577)
                      ......|...++||+|+||+||+|.+.... +++|+ +.+...       .....+.+|++++..++|++++....++..
T Consensus       329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~  407 (535)
T PRK09605        329 EEVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD  407 (535)
T ss_pred             cccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence            333445667899999999999999875443 44443 322111       122457899999999999999988888877


Q ss_pred             CCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccC
Q 008108          312 RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG  391 (577)
Q Consensus       312 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfG  391 (577)
                      ....++||||+++++|.+++.           ....++.+++++|.|||+.+   ++||||||+|||+ +++.++|+|||
T Consensus       408 ~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFG  472 (535)
T PRK09605        408 PEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFG  472 (535)
T ss_pred             CCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCc
Confidence            778899999999999988762           45778999999999999988   9999999999999 67799999999


Q ss_pred             Cccc
Q 008108          392 MARL  395 (577)
Q Consensus       392 la~~  395 (577)
                      +++.
T Consensus       473 la~~  476 (535)
T PRK09605        473 LGKY  476 (535)
T ss_pred             cccc
Confidence            9975

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.70  E-value=2.7e-17  Score=161.53  Aligned_cols=198  Identities=24%  Similarity=0.313  Sum_probs=132.4

Q ss_pred             CCCCeEEEEeEEEcC---------------------------CeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHH
Q 008108          298 QHRNLVRLLGFCLER---------------------------KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE  350 (577)
Q Consensus       298 ~h~niv~l~~~~~~~---------------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  350 (577)
                      +|||||++.++|.+.                           ..+|+||.-.+. +|..++.    ....+.....-|+.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~----~~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW----TRHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh----cCCCchHHHHHHHH
Confidence            699999999887542                           346788876643 7777762    34466667778999


Q ss_pred             HHHHHHHHhhcCCCCcEEEeccCCCcEEE--cCCC--CeEEeccCCcccccCC----CccccccccccCCCCcChhhhhc
Q 008108          351 GIARGLLYLHEDSRLRIIHRDLKASNILL--DSEM--NPKISDFGMARLFEMD----QTHSDTNRVVGTFGYMAPEYVMH  422 (577)
Q Consensus       351 ~ia~gl~yLH~~~~~~iiHrDlkp~NiLl--~~~~--~~kl~DfGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~  422 (577)
                      |+++|+.|||+++   |.|||+|++||||  |++.  ...|+|||++-..+.-    ...+..-..-|.-.-||||+...
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999998   9999999999999  4443  4788999987532220    01111112457778999998754


Q ss_pred             C--C----CCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHH
Q 008108          423 G--R----FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGL  496 (577)
Q Consensus       423 ~--~----~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~  496 (577)
                      -  .    --.|+|.|+.|-+.||+++...||....+. ..+.-.     +.+..     -|.+.+..+..   +.+++.
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~-----Yqe~q-----LPalp~~vpp~---~rqlV~  491 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRT-----YQESQ-----LPALPSRVPPV---ARQLVF  491 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhh-----hhhhh-----CCCCcccCChH---HHHHHH
Confidence            2  2    236899999999999999999888652221 111111     11111     12222222222   235666


Q ss_pred             hcccCCCCCCCCHHHHHHHhc
Q 008108          497 LCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       497 ~C~~~~p~~RPt~~ev~~~L~  517 (577)
                      ..++.||++|++..-....|+
T Consensus       492 ~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHhcCCccccCCccHHHhHHH
Confidence            778999999999776666654

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.67  E-value=6.9e-16  Score=138.94  Aligned_cols=135  Identities=25%  Similarity=0.243  Sum_probs=115.6

Q ss_pred             cccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCC--CCeEEEEeEEEcCCeEEEEEEecCCC
Q 008108          248 DANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH--RNLVRLLGFCLERKERILVYEFVPNA  325 (577)
Q Consensus       248 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~~~~g  325 (577)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+.+|+..+..++|  .++++++++....+..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999999854 7899999866543  4568899999999976  58999999988888899999999988


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          326 SLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       326 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      .+..+          +......++.+++++|.+||......++|+||+|+||++++.+.+++.|||.++.
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77543          5667788899999999999986545699999999999999989999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.66  E-value=4.9e-16  Score=146.08  Aligned_cols=137  Identities=22%  Similarity=0.277  Sum_probs=99.6

Q ss_pred             ccccccCCcEEEEEeEecCCcEEEEEEeccCChhh---HHH---------------------HHHHHHHHHhcCCCC--e
Q 008108          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG---EIE---------------------FKNEVLLLARLQHRN--L  302 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~---------------------~~~E~~~l~~l~h~n--i  302 (577)
                      .+.||+|+||+||++...+|+.||||++.......   ...                     ...|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999998889999999886532111   100                     135666666664433  4


Q ss_pred             EEEEeEEEcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCcEEEeccCCCcEEEcC
Q 008108          303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE-DSRLRIIHRDLKASNILLDS  381 (577)
Q Consensus       303 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlkp~NiLl~~  381 (577)
                      .+.+++    ...++||||++++.+......   ..... .....++.+++.++.++|. .+   |+||||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~---~~~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLK---DVRLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhh---hhhhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence            444443    245899999999655322111   00011 6678899999999999998 76   99999999999999 


Q ss_pred             CCCeEEeccCCccccc
Q 008108          382 EMNPKISDFGMARLFE  397 (577)
Q Consensus       382 ~~~~kl~DfGla~~~~  397 (577)
                      ++.++|+|||.+....
T Consensus       150 ~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCcEEEEECccccccc
Confidence            8899999999997544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.65  E-value=5e-17  Score=177.14  Aligned_cols=214  Identities=24%  Similarity=0.357  Sum_probs=140.7

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      .+|..+++|..|.+|.||...++ ..+.+|+| +.++..-    +++   ++.....|.+|                   
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li----lRn---ilt~a~npfvv-------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI----LRN---ILTFAGNPFVV-------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccchh----hhc---cccccCCccee-------------------
Confidence            57888999999999999999865 35668884 3332110    111   22222333333                   


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc-
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT-  401 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~-  401 (577)
                        |+=...+   .+-+.++..        ++.+++|||+.+   |+|||+||+|.||+.-|.+|++|||+.+..-.... 
T Consensus       136 --gDc~tll---k~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 --GDCATLL---KNIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             --chhhhhc---ccCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence              2222222   122333322        277899999987   99999999999999999999999999875322111 


Q ss_pred             ------------cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhccc
Q 008108          402 ------------HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNE  469 (577)
Q Consensus       402 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  469 (577)
                                  ......++||+.|+|||++....|....|+|++|+|+||.+-|..||..+.+++....+-.-.-.|.+
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE  279 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE  279 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence                        00123468999999999999999999999999999999999999999877666544333222222332


Q ss_pred             CCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 008108          470 GAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVV  513 (577)
Q Consensus       470 ~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~  513 (577)
                      +      |..    ...|..   .++.+.++.+|..|--...-+
T Consensus       280 ~------dea----~p~Ea~---dli~~LL~qnp~~Rlgt~ga~  310 (1205)
T KOG0606|consen  280 E------DEA----LPPEAQ---DLIEQLLRQNPLCRLGTGGAL  310 (1205)
T ss_pred             c------CcC----CCHHHH---HHHHHHHHhChHhhcccchhh
Confidence            2      111    223333   344456678888885433333

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.62  E-value=2.7e-15  Score=146.17  Aligned_cols=136  Identities=22%  Similarity=0.269  Sum_probs=105.3

Q ss_pred             ccccc-cCCcEEEEEeEecCCcEEEEEEeccCC-------------hhhHHHHHHHHHHHHhcCCCCe--EEEEeEEEcC
Q 008108          249 ANKLG-QGGFGAVYKGMLSNGETIAVKRLSKNS-------------KQGEIEFKNEVLLLARLQHRNL--VRLLGFCLER  312 (577)
Q Consensus       249 ~~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~  312 (577)
                      ...|| .||.|+||++... +..++||++....             ......+.+|+.++..++|++|  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35688 8999999999875 7789999885321             1222357889999999998875  6777765433


Q ss_pred             C----eEEEEEEecCC-CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEE
Q 008108          313 K----ERILVYEFVPN-ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI  387 (577)
Q Consensus       313 ~----~~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl  387 (577)
                      .    ..++||||+++ .+|.+++.+    ..++..    .+.+|+.+|.+||+.+   |+||||||.|||++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence            2    22599999997 688877632    345543    3578999999999998   999999999999999999999


Q ss_pred             eccCCcccc
Q 008108          388 SDFGMARLF  396 (577)
Q Consensus       388 ~DfGla~~~  396 (577)
                      +|||.+...
T Consensus       184 IDfg~~~~~  192 (239)
T PRK01723        184 IDFDRGELR  192 (239)
T ss_pred             EECCCcccC
Confidence            999998753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=1e-16  Score=174.72  Aligned_cols=255  Identities=21%  Similarity=0.314  Sum_probs=184.7

Q ss_pred             cCCccccccccCCcEEEEEeEecC--CcEEEEEEeccCC--hhhHHHHHHHHHHHHhcC-CCCeEEEEeEEEcCCeEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSN--GETIAVKRLSKNS--KQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  318 (577)
                      ..|...+.||+|.|+.|-......  ...+|+|.+....  .........|..+-..+. |+|++++++...+.+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            457778889999999998887643  3456777665543  222233455777777776 99999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCCcEEEeccCCCcEEEcCCC-CeEEeccCCcccc
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH-EDSRLRIIHRDLKASNILLDSEM-NPKISDFGMARLF  396 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH-~~~~~~iiHrDlkp~NiLl~~~~-~~kl~DfGla~~~  396 (577)
                      .||..++++...+.. ......+....-..+.|+..++.|+| ..+   +.||||||+|.+++..+ ..+++|||+|..+
T Consensus       100 ~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             cCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence            999999999887732 12224566667778999999999999 776   99999999999999999 9999999999987


Q ss_pred             cC-CCcccccccccc-CCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcc
Q 008108          397 EM-DQTHSDTNRVVG-TFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAAL  473 (577)
Q Consensus       397 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  473 (577)
                      .. +..........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+........ ...     .|......
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~-----~~~~~~~~  249 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYS-----SWKSNKGR  249 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cce-----eecccccc
Confidence            76 444444555678 9999999988874 446789999999999999999999886654431 111     11111100


Q ss_pred             ccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 008108          474 NLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVV  513 (577)
Q Consensus       474 ~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~  513 (577)
                      -...+  -.....   ....+...++..+|..|.+.+++-
T Consensus       250 ~~~~~--~~~~~~---~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  250 FTQLP--WNSISD---QAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             cccCc--cccCCh---hhhhcccccccCCchhcccccccc
Confidence            00000  000111   223444567778999999887754

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.48  E-value=2.3e-13  Score=144.11  Aligned_cols=141  Identities=22%  Similarity=0.310  Sum_probs=100.4

Q ss_pred             ccccccCCcEEEEEeEecCCcEEEEEEeccCChhh----------------------------------------HHHHH
Q 008108          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG----------------------------------------EIEFK  288 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~  288 (577)
                      .+.||.|++|.||+|++.+|+.||||+........                                        +..|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            36799999999999999999999999986542110                                        01244


Q ss_pred             HHHHHHHhc----CCCCeEEEEeEEE-cCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHH-HHHHhhcC
Q 008108          289 NEVLLLARL----QHRNLVRLLGFCL-ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR-GLLYLHED  362 (577)
Q Consensus       289 ~E~~~l~~l----~h~niv~l~~~~~-~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gl~yLH~~  362 (577)
                      +|...+.++    +|.+-+.+-..+. .....+|||||++|++|.++....  ....   .+..++..++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~--~~~~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD--EAGL---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH--hcCC---CHHHHHHHHHHHHHHHHHhC
Confidence            555555555    2333334333332 244579999999999998875321  1112   23456666666 46788988


Q ss_pred             CCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       363 ~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      +   ++|+|+||.||+++.++++++.|||++..+.
T Consensus       277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            7   9999999999999999999999999997654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.40  E-value=1.9e-13  Score=131.76  Aligned_cols=202  Identities=21%  Similarity=0.279  Sum_probs=138.1

Q ss_pred             HHHHHhcCCCCeEEEEeEEEcC-----CeEEEEEEecCCCCcccccccCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 008108          291 VLLLARLQHRNLVRLLGFCLER-----KERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSR  364 (577)
Q Consensus       291 ~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~  364 (577)
                      +.-|-.+-|.|||+++.|+.+.     ....++.|||..|+|..+|.+.. .+..+..+...+|+.||..||.|||+-. 
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence            3345566799999999987654     35689999999999999996533 3456888888899999999999999975 


Q ss_pred             CcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC---CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHH
Q 008108          365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD---QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEI  441 (577)
Q Consensus       365 ~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~el  441 (577)
                      ++|+|+++..+-|++..++-+||.--. -......   .....+....+-++|.+||+=...+.+..+|||+||+..+||
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence            679999999999999999988874211 1111100   011122334577899999987777788899999999999999


Q ss_pred             hhCCCCCCCC-CccccchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 008108          442 VSGQKRSSFG-TEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVV  513 (577)
Q Consensus       442 ltG~~p~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~  513 (577)
                      --|.--.... .....+.-+..+.        ..+-++.-           ..++..|++..|..||+|++++
T Consensus       276 ailEiq~tnseS~~~~ee~ia~~i--------~~len~lq-----------r~~i~kcl~~eP~~rp~ar~ll  329 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEVEENIANVI--------IGLENGLQ-----------RGSITKCLEGEPNGRPDARLLL  329 (458)
T ss_pred             HHheeccCCCcceeehhhhhhhhe--------eeccCccc-----------cCcCcccccCCCCCCcchhhhh
Confidence            8876432111 1111111111100        00001111           1344579999999999999866

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.40  E-value=1.3e-12  Score=120.59  Aligned_cols=131  Identities=22%  Similarity=0.205  Sum_probs=98.3

Q ss_pred             ccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeE-EEEeEEEcCCeEEEEEEecCCCCc
Q 008108          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV-RLLGFCLERKERILVYEFVPNASL  327 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~E~~~~gsL  327 (577)
                      ++.|+.|.++.||++... ++.+++|....... ....+..|+.++..+.+.+++ +++.+.  ....++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            467899999999999875 78899998765432 223467899999988665544 455443  2345899999999888


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          328 DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS--RLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       328 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      ....        .   ....++.+++++|..||..+  +..++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            5431        0   11245678999999999876  23469999999999999 66899999998863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.35  E-value=9.2e-13  Score=141.08  Aligned_cols=144  Identities=16%  Similarity=0.236  Sum_probs=95.0

Q ss_pred             cCCccccccccCCcEEEEEeEecC-CcEEEEEEeccCChhh----------------------------------H----
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQG----------------------------------E----  284 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~----  284 (577)
                      ..|+. +.||+|++|.||+|.+++ |+.||||++.+.-...                                  .    
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45665 789999999999999887 9999999997542110                                  0    


Q ss_pred             --HHHHHHHHHHHhcC----CCCeEEEEeEEEc-CCeEEEEEEecCCCCcccccc--c-CCCCCCCCHHHHHHHHHHHHH
Q 008108          285 --IEFKNEVLLLARLQ----HRNLVRLLGFCLE-RKERILVYEFVPNASLDHFIF--D-PINREHMTWEKRYKIIEGIAR  354 (577)
Q Consensus       285 --~~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~E~~~~gsL~~~l~--~-~~~~~~l~~~~~~~i~~~ia~  354 (577)
                        ..+.+|...+.+++    +.+.+.+-.++.+ ....+|||||++|+.+.++..  . ......+....+..++.|+  
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence              11344444444442    4444444343332 456789999999999976421  1 0011123333333333443  


Q ss_pred             HHHHhhcCCCCcEEEeccCCCcEEEcCCC----CeEEeccCCcccccC
Q 008108          355 GLLYLHEDSRLRIIHRDLKASNILLDSEM----NPKISDFGMARLFEM  398 (577)
Q Consensus       355 gl~yLH~~~~~~iiHrDlkp~NiLl~~~~----~~kl~DfGla~~~~~  398 (577)
                           +..|   ++|+|+||.||+++.++    ++++.|||++..++.
T Consensus       277 -----f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 -----FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -----HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                 3455   99999999999999988    999999999987654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.34  E-value=1.4e-12  Score=136.28  Aligned_cols=248  Identities=23%  Similarity=0.301  Sum_probs=176.4

Q ss_pred             CCcccccccc--CCcEEEEEeEe---cCCcEEEEEEeccC--ChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEE
Q 008108          245 NFSDANKLGQ--GGFGAVYKGML---SNGETIAVKRLSKN--SKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERI  316 (577)
Q Consensus       245 ~f~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  316 (577)
                      .|...+.+|.  |.+|.||.+..   .++..+|+|+-+..  .......=.+|+...+.+ .|+|.++....+...+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4566788999  99999999986   35788999974322  222222235666666677 5999999888999999999


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHH----HHHHhhcCCCCcEEEeccCCCcEEEcCC-CCeEEeccC
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR----GLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFG  391 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----gl~yLH~~~~~~iiHrDlkp~NiLl~~~-~~~kl~DfG  391 (577)
                      +-+|++. .+|..+.+.  ....++....+....+..+    ||.++|...   ++|-|+||.||++.++ ...+++|||
T Consensus       195 iqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             eeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence            9999885 566665532  2233667777788888888    999999987   9999999999999999 889999999


Q ss_pred             CcccccCCCccccc---cccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcc
Q 008108          392 MARLFEMDQTHSDT---NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWN  468 (577)
Q Consensus       392 la~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~  468 (577)
                      +...+..+......   .+..|...|++||. ..+.++.++|+|++|.++.+..+|...+...-.        -.|...+
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~-~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--------~~W~~~r  339 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKEL-LNGLATFASDIFSLGEVILEAILGSHLPSVGKN--------SSWSQLR  339 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChhh-hccccchHhhhcchhhhhHhhHhhcccccCCCC--------CCccccc
Confidence            99887765533221   23367889999994 567889999999999999999999876542211        1122222


Q ss_pred             cCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          469 EGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       469 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ..-   +-+....+. ..   ++.....++++.+|-.|++...+..
T Consensus       340 ~~~---ip~e~~~~~-s~---~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  340 QGY---IPLEFCEGG-SS---SLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ccc---CchhhhcCc-ch---hhhhHHHHhcCcchhhhhHHHHHhc
Confidence            211   111111111 11   2222666889999999998877664

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.24  E-value=1.8e-10  Score=107.56  Aligned_cols=137  Identities=15%  Similarity=0.133  Sum_probs=98.9

Q ss_pred             cccccCCcEEEEEeEecC-------CcEEEEEEeccCC----------------------hhhHHHH----HHHHHHHHh
Q 008108          250 NKLGQGGFGAVYKGMLSN-------GETIAVKRLSKNS----------------------KQGEIEF----KNEVLLLAR  296 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~----~~E~~~l~~  296 (577)
                      ..||.|--+.||.|...+       +..+|||+.+...                      ......+    ++|+..|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998543       4789999764210                      0011122    379999999


Q ss_pred             cCC--CCeEEEEeEEEcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCcEEEeccC
Q 008108          297 LQH--RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL-HEDSRLRIIHRDLK  373 (577)
Q Consensus       297 l~h--~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yL-H~~~~~~iiHrDlk  373 (577)
                      +..  -++.+++++    ...+|||||+.+..+....   .+...++.++...+..+++.+|..| |+.+   |+|+||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~---Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPK---LKDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchh---hhccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence            854  456666664    4568999999875442211   1122355566778889999999999 7777   9999999


Q ss_pred             CCcEEEcCCCCeEEeccCCccccc
Q 008108          374 ASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       374 p~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      +.|||++ ++.+.|+|||.+....
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCceeCC
Confidence            9999997 4679999999886543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.24  E-value=1e-10  Score=112.72  Aligned_cols=143  Identities=20%  Similarity=0.310  Sum_probs=111.9

Q ss_pred             ccccccCCcEEEEEeEecCCcEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCC--CeEEEEeEEEcCC---eEEEEEEec
Q 008108          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHR--NLVRLLGFCLERK---ERILVYEFV  322 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~---~~~lv~E~~  322 (577)
                      .+.|+.|..+.||++...+|+.+++|....... .....+.+|+.++..+++.  ++.+++.+.....   ..++||||+
T Consensus         3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            367899999999999987778999998765432 1344678999999999763  4567777766542   568999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC---------------------------------------
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS---------------------------------------  363 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~---------------------------------------  363 (577)
                      ++.++...+.    ...++......++.++++.|..||+..                                       
T Consensus        83 ~G~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          83 DGRVLRDRLL----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CCEecCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9999877652    145788888889999999999998531                                       


Q ss_pred             --------------CCcEEEeccCCCcEEEcC--CCCeEEeccCCccc
Q 008108          364 --------------RLRIIHRDLKASNILLDS--EMNPKISDFGMARL  395 (577)
Q Consensus       364 --------------~~~iiHrDlkp~NiLl~~--~~~~kl~DfGla~~  395 (577)
                                    ...++|+|+++.|||++.  ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          245799999999999998  56689999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.16  E-value=2.9e-11  Score=126.57  Aligned_cols=194  Identities=23%  Similarity=0.256  Sum_probs=149.4

Q ss_pred             HhcCCccccccccCCcEEEEEeEe--cCCcEEEEEEeccCChhhHHH--HHHHHHHHHhc-CCCCeEEEEeEEEcCCeEE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGML--SNGETIAVKRLSKNSKQGEIE--FKNEVLLLARL-QHRNLVRLLGFCLERKERI  316 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  316 (577)
                      ...+|..+.+||.|.|+.|++...  .++..+++|.+.+.......+  -..|+.+...+ .|.++++....+......+
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            445789999999999999999874  357789999887664433322  24566666666 6889898888777777788


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCC-CCeEEeccCCccc
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMARL  395 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~-~~~kl~DfGla~~  395 (577)
                      +=-||+.++++...+   .....+++..++++..|++.++.++|+..   ++|+|+||+||++..+ +.-++.|||++..
T Consensus       343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence            999999999887665   33456888899999999999999999877   9999999999999886 7889999999864


Q ss_pred             ccCCCccccccccccCCCCc--ChhhhhcCCCCccccEEecchhHhHHhhCCC
Q 008108          396 FEMDQTHSDTNRVVGTFGYM--APEYVMHGRFSVKSDIFSFGVLVLEIVSGQK  446 (577)
Q Consensus       396 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~SlGvil~elltG~~  446 (577)
                      +.....     ...+.-+++  +|+......+..+.|+||||.-+.|.++|..
T Consensus       417 ~~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~  464 (524)
T KOG0601|consen  417 LAFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP  464 (524)
T ss_pred             cceecc-----cccccccccccchhhccccccccccccccccccccccccCcc
Confidence            221111     112233444  5555556678899999999999999999875

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.13  E-value=3.5e-10  Score=102.04  Aligned_cols=131  Identities=21%  Similarity=0.355  Sum_probs=101.9

Q ss_pred             cccccCCcEEEEEeEecCCcEEEEEE-eccCChhh-------HHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          250 NKLGQGGFGAVYKGMLSNGETIAVKR-LSKNSKQG-------EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~~~~~vavK~-~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ..+++|+-..+|.+.+. |.++++|. +++.-...       ...-.+|..+|.+++--.|.-.+=+..+.+...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            45889999999999874 44566664 33332111       12356899999999766666666667788888999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      ++|..|.+.+...          ...++..+-.-+.-||..+   |+|+||.++||++..+. +.++||||+..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999998887432          3567888888899999998   99999999999998775 99999999974

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.10  E-value=2.5e-10  Score=120.75  Aligned_cols=166  Identities=17%  Similarity=0.209  Sum_probs=123.1

Q ss_pred             ecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCCCcccccccCCCCCCCCHHH
Q 008108          265 LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEK  344 (577)
Q Consensus       265 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~  344 (577)
                      ..++.+|.|...+..........++-+..|+.++||||++++..+..++..|||+|-+.  .|..++.      .+....
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk------~l~~~~  105 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLK------ELGKEE  105 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHH------HhHHHH
Confidence            44678888888876665334456788899999999999999999999999999999763  3444442      234556


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCC
Q 008108          345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR  424 (577)
Q Consensus       345 ~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  424 (577)
                      ...-+.||+.||.+||+.+  .++|++|.-+.|+|+..|..||++|-++........  ......--..|..|+.+....
T Consensus       106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence            6667899999999999766  599999999999999999999999988754332111  111111223466666543222


Q ss_pred             CCccccEEecchhHhHHhhC
Q 008108          425 FSVKSDIFSFGVLVLEIVSG  444 (577)
Q Consensus       425 ~~~~~Dv~SlGvil~elltG  444 (577)
                        -..|.|-||++++|++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              346999999999999999

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.06  E-value=8.6e-10  Score=99.00  Aligned_cols=143  Identities=28%  Similarity=0.390  Sum_probs=105.6

Q ss_pred             cccccccCCcEEEEEeEecCCcEEEEE-EeccCCh-------hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          248 DANKLGQGGFGAVYKGMLSNGETIAVK-RLSKNSK-------QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       248 ~~~~lG~G~~g~Vy~~~~~~~~~vavK-~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ....|-+|.-+.|+++.+. |+...|| ++.+.-+       -.....++|..+|.+++--.|.-..-++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4678899999999999985 7776776 3444322       12335678999999987656655555666777778999


Q ss_pred             EecCC-CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC---CeEEeccCCccc
Q 008108          320 EFVPN-ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM---NPKISDFGMARL  395 (577)
Q Consensus       320 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~---~~kl~DfGla~~  395 (577)
                      ||+++ .++.+++....... ........++..|-+.+.-||.++   |+|+||..+||+|..++   .+.+.|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 46777765432222 222333788999999999999998   99999999999997665   358999999864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.97  E-value=1.3e-10  Score=127.85  Aligned_cols=210  Identities=21%  Similarity=0.253  Sum_probs=147.3

Q ss_pred             HHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEE
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  316 (577)
                      ...+.|.+.+-+-+|.++.++.+.-. .|...++|.......   ........+-.++...+||-+++..--+.-....+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            45567888888999999999887633 243344443322211   11111122222222234566665554455567789


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccc
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~  396 (577)
                      |+++|..+++|...|+.   .+..+.......+..+...++|||...   +.|||++|.|+|+..++..+++|||.....
T Consensus       881 L~~~~~~~~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHN---SGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             hhhHHhccCCchhhhhc---CCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence            99999999999887743   345666666777888899999999875   899999999999999999999999844322


Q ss_pred             cCC---------------------C----cc----ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCC
Q 008108          397 EMD---------------------Q----TH----SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKR  447 (577)
Q Consensus       397 ~~~---------------------~----~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p  447 (577)
                      ..-                     .    ..    .......||+.|.+||...+......+|.|++|++++|.++|..|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            110                     0    00    012235789999999999999999999999999999999999999


Q ss_pred             CCCCCcccc
Q 008108          448 SSFGTEEET  456 (577)
Q Consensus       448 ~~~~~~~~~  456 (577)
                      +........
T Consensus      1035 ~na~tpq~~ 1043 (1205)
T KOG0606|consen 1035 FNAETPQQI 1043 (1205)
T ss_pred             CCCcchhhh
Confidence            876665443

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.96  E-value=2.4e-09  Score=109.96  Aligned_cols=170  Identities=22%  Similarity=0.354  Sum_probs=129.2

Q ss_pred             CcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEE----cCCeEEEEEEecCC-CCccc
Q 008108          256 GFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL----ERKERILVYEFVPN-ASLDH  329 (577)
Q Consensus       256 ~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~E~~~~-gsL~~  329 (577)
                      .-.+.||+.. .+|..+++|++..+..+.......-++.++++.|.|+|++.+++.    .+..++|||+|.|+ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            3467899884 479999999996554443333345678899999999999999886    34467999999987 46654


Q ss_pred             ccccC------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          330 FIFDP------------INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       330 ~l~~~------------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      .-+..            .+....++..+|.++.|+..||.++|+.|   +..+-|.+++||++.+.+++|+..|......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence            43331            23346788999999999999999999998   8889999999999999999999998887665


Q ss_pred             CCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCC
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKR  447 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p  447 (577)
                      .+...              |  +...   .+-|.=.||.+++.|.||...
T Consensus       445 ~d~~~--------------~--le~~---Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDPTE--------------P--LESQ---QQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCCc--------------c--hhHH---hhhhHHHHHHHHHHHhhcccc
Confidence            44311              0  1111   245777799999999999654

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.95  E-value=4.9e-09  Score=97.56  Aligned_cols=125  Identities=27%  Similarity=0.378  Sum_probs=82.9

Q ss_pred             EEEEeEecCCcEEEEEEeccCC--------------h-------h-----hHHHHHHHHHHHHhcCCC--CeEEEEeEEE
Q 008108          259 AVYKGMLSNGETIAVKRLSKNS--------------K-------Q-----GEIEFKNEVLLLARLQHR--NLVRLLGFCL  310 (577)
Q Consensus       259 ~Vy~~~~~~~~~vavK~~~~~~--------------~-------~-----~~~~~~~E~~~l~~l~h~--niv~l~~~~~  310 (577)
                      .||.|...+|+.+|||+.....              .       .     .....++|...|.++...  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899999899999999865320              0       0     112357899999999766  466776552 


Q ss_pred             cCCeEEEEEEecC--CCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHH-hhcCCCCcEEEeccCCCcEEEcCCCCeEE
Q 008108          311 ERKERILVYEFVP--NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY-LHEDSRLRIIHRDLKASNILLDSEMNPKI  387 (577)
Q Consensus       311 ~~~~~~lv~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~y-LH~~~~~~iiHrDlkp~NiLl~~~~~~kl  387 (577)
                         ...|||||++  |..+..+. +    ..++......++.+++..+.. +|..+   |+|+||.+.|||++++ .+.|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~-~----~~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLK-D----VDLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHH-H----CGGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHH-h----ccccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence               3479999998  65554432 1    112234456677788886665 56777   9999999999999988 9999


Q ss_pred             eccCCcccc
Q 008108          388 SDFGMARLF  396 (577)
Q Consensus       388 ~DfGla~~~  396 (577)
                      +|||.+...
T Consensus       148 IDf~qav~~  156 (188)
T PF01163_consen  148 IDFGQAVDS  156 (188)
T ss_dssp             --GTTEEET
T ss_pred             EecCcceec
Confidence            999988654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.86  E-value=2e-08  Score=99.12  Aligned_cols=140  Identities=16%  Similarity=0.143  Sum_probs=99.7

Q ss_pred             ccccCCcEEEEEeEecCCcEEEEEEeccCChh-----------hHHHHHHHHHHHHhcCCCCe--EEEEeEEEc-----C
Q 008108          251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ-----------GEIEFKNEVLLLARLQHRNL--VRLLGFCLE-----R  312 (577)
Q Consensus       251 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~-----~  312 (577)
                      .+-+-....|++..+ +|+.+.||+.......           ....+.+|...+.++...+|  .+++++...     .
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            333334445677665 5788999977443311           11136789999888854443  345555543     2


Q ss_pred             CeEEEEEEecCCC-CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC-------CCC
Q 008108          313 KERILVYEFVPNA-SLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS-------EMN  384 (577)
Q Consensus       313 ~~~~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~-------~~~  384 (577)
                      ..-+||+|++++. +|.+++.+.. ....+...+..++.+++..+.-||+.+   |+|+|++++|||++.       +..
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence            3568999999986 7888763211 234566777899999999999999998   999999999999975       467


Q ss_pred             eEEeccCCccc
Q 008108          385 PKISDFGMARL  395 (577)
Q Consensus       385 ~kl~DfGla~~  395 (577)
                      +.|+||+.++.
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999998863

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.76  E-value=2.5e-07  Score=93.00  Aligned_cols=192  Identities=18%  Similarity=0.216  Sum_probs=124.5

Q ss_pred             cccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCeEEEEeEE------EcCCe-EEEEE
Q 008108          248 DANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFC------LERKE-RILVY  319 (577)
Q Consensus       248 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~------~~~~~-~~lv~  319 (577)
                      ..+.||+|+-+.+|-.--  -...+.|+..........+   -+..|... .||-+-.=+.|=      -+... .-++|
T Consensus        15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecch--hhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            467899999999986431  1223456665543322222   12233333 455332211111      11222 45777


Q ss_pred             EecCCCCcccccccC----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          320 EFVPNASLDHFIFDP----INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       320 E~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      ..+++..=-..++..    ..-...+|.-.++.++.++.+.+-||+.|   .+-+|+.++|+|+.+++.+.|.|=..-..
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence            777664222222222    22345899999999999999999999998   88999999999999999999988544333


Q ss_pred             ccCCCccccccccccCCCCcChhhhhcC-----CCCccccEEecchhHhHHhhC-CCCCCC
Q 008108          396 FEMDQTHSDTNRVVGTFGYMAPEYVMHG-----RFSVKSDIFSFGVLVLEIVSG-QKRSSF  450 (577)
Q Consensus       396 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlGvil~elltG-~~p~~~  450 (577)
                      ...+   ....-.+|...|.+||.-.-+     .-+...|-|.|||++++++.| ++|++.
T Consensus       167 ~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG  224 (637)
T COG4248         167 NANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG  224 (637)
T ss_pred             ccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence            2211   122235788999999975422     346789999999999999888 888763

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=98.73  E-value=7.6e-09  Score=87.36  Aligned_cols=43  Identities=42%  Similarity=0.862  Sum_probs=38.8

Q ss_pred             CChhhhHHHHHHHHHHHhhcCCCCceeEEEecCCCCceeEEEecCCCC
Q 008108            1 MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDI   48 (577)
Q Consensus         1 ~~~~~C~~C~~~a~~~~~~~C~~~~~a~~~~d~~~~~~C~lrys~~~f   48 (577)
                      +++++|..|++.|...+.+.|++.++|+|||+     .|+|||++++|
T Consensus        64 ls~~dC~~Cl~~a~~~~~~~C~~~~g~~v~~~-----~C~lRY~~~~F  106 (106)
T PF01657_consen   64 LSPSDCRACLADAVANISSCCPGSRGGRVWYD-----SCFLRYENYPF  106 (106)
T ss_dssp             S-HHHHHHHHHHHHCCHHHHTTSBSSEEEEES-----SEEEEEESS--
T ss_pred             CChhhhHHHHHHHHHHHHHhCCCCceEEEECC-----CEEEEEECCCC
Confidence            47899999999999999999999999999999     99999999988

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.71  E-value=1.2e-07  Score=90.80  Aligned_cols=134  Identities=21%  Similarity=0.280  Sum_probs=95.3

Q ss_pred             CccccccccCCcEEEEEeEecCCcEEEEEEeccCC-----------------h-----hhHHHHHHHHHHHHhcCCC--C
Q 008108          246 FSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS-----------------K-----QGEIEFKNEVLLLARLQHR--N  301 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------~-----~~~~~~~~E~~~l~~l~h~--n  301 (577)
                      ..+.++||-|--+.||.|..++|.++|||.=+...                 .     -.....++|.+.|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            34568899999999999999999999999532110                 0     0122357899999999655  6


Q ss_pred             eEEEEeEEEcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC
Q 008108          302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS  381 (577)
Q Consensus       302 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~  381 (577)
                      +.+.+++    +...+||||++|-.|...-        ++.+..-.++..|++-+.-+-..|   |+|+|+.+=||++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence            6666655    3457999999997664431        123333344444555444444555   999999999999999


Q ss_pred             CCCeEEeccCCcc
Q 008108          382 EMNPKISDFGMAR  394 (577)
Q Consensus       382 ~~~~kl~DfGla~  394 (577)
                      +|.+.++||--+.
T Consensus       238 dg~~~vIDwPQ~v  250 (304)
T COG0478         238 DGDIVVIDWPQAV  250 (304)
T ss_pred             CCCEEEEeCcccc
Confidence            9999999996654

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.62  E-value=4.1e-08  Score=104.63  Aligned_cols=150  Identities=21%  Similarity=0.389  Sum_probs=98.4

Q ss_pred             HHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcccc-------ccccccCCCCcChhhhhc
Q 008108          350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD-------TNRVVGTFGYMAPEYVMH  422 (577)
Q Consensus       350 ~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~  422 (577)
                      .+++.||.|+|...  .+||++|.|++|.++.++..||+.|+.+...........       ..-..-...|.|||++.+
T Consensus       106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            44569999999864  699999999999999999999999998765433111100       001123457999999999


Q ss_pred             CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC---CCChHHHHHHHHHHHhcc
Q 008108          423 GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR---GGSTSEMMKCIHIGLLCV  499 (577)
Q Consensus       423 ~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~---~~~~~~~~~~~~l~~~C~  499 (577)
                      ...+.++|+||+|+++|-+..|.++.......    .+.+.....       ..+....   ...+.|+.+.+.   ..+
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~----~~~~~~~~~-------~~~~~~~~~s~~~p~el~~~l~---k~l  249 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGG----LLSYSFSRN-------LLNAGAFGYSNNLPSELRESLK---KLL  249 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCC----cchhhhhhc-------ccccccccccccCcHHHHHHHH---HHh
Confidence            88899999999999999999665543211111    111111100       0111111   124455555544   567


Q ss_pred             cCCCCCCCCHHHHHHH
Q 008108          500 QENVSNRPGMASVVNM  515 (577)
Q Consensus       500 ~~~p~~RPt~~ev~~~  515 (577)
                      ..++..||++.++...
T Consensus       250 ~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLSI  265 (700)
T ss_pred             cCCcccCcchhhhhcc
Confidence            8999999988877654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.57  E-value=2.4e-07  Score=88.38  Aligned_cols=106  Identities=27%  Similarity=0.362  Sum_probs=83.3

Q ss_pred             HHHHHHHHHHHhcCCCC--eEEEEeEEEcCC----eEEEEEEecCCC-CcccccccCCCCCCCCHHHHHHHHHHHHHHHH
Q 008108          285 IEFKNEVLLLARLQHRN--LVRLLGFCLERK----ERILVYEFVPNA-SLDHFIFDPINREHMTWEKRYKIIEGIARGLL  357 (577)
Q Consensus       285 ~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~----~~~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~  357 (577)
                      ....+|...+..+....  ..+.+++.....    ..+||+|++++. +|.+++.+   ...++......++.+++..+.
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~---~~~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ---WEQLDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh---hcccchhhHHHHHHHHHHHHH
Confidence            35678888888885433  456666665532    458999999884 78888743   122667778899999999999


Q ss_pred             HhhcCCCCcEEEeccCCCcEEEcCCC---CeEEeccCCcccc
Q 008108          358 YLHEDSRLRIIHRDLKASNILLDSEM---NPKISDFGMARLF  396 (577)
Q Consensus       358 yLH~~~~~~iiHrDlkp~NiLl~~~~---~~kl~DfGla~~~  396 (577)
                      -||+.+   |+|+|++++|||++.+.   .+.++||+-++..
T Consensus       133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999998   99999999999999887   8999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.56  E-value=5.2e-07  Score=96.51  Aligned_cols=141  Identities=18%  Similarity=0.295  Sum_probs=93.2

Q ss_pred             cccccCCcEEEEEeEecCCcEEEEEEeccCChhh----------------------------------------HHHHHH
Q 008108          250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG----------------------------------------EIEFKN  289 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~~  289 (577)
                      +.|+.++-|.||+|++++|+.||||+...+-...                                        +..+.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            7899999999999999999999999877542110                                        001334


Q ss_pred             HHHHHHhcC-----CCCeEEEEeEE-EcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 008108          290 EVLLLARLQ-----HRNLVRLLGFC-LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS  363 (577)
Q Consensus       290 E~~~l~~l~-----h~niv~l~~~~-~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~  363 (577)
                      |..-+.+++     .++ +++=.++ .-.....|+|||++|-.+.+...-  +...++.+.+.....++.  +..+=..+
T Consensus       211 EA~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l--~~~g~d~k~ia~~~~~~f--~~q~~~dg  285 (517)
T COG0661         211 EAANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL--KSAGIDRKELAELLVRAF--LRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEecccHHHH--HhcCCCHHHHHHHHHHHH--HHHHHhcC
Confidence            554454442     233 2332333 335567899999999999887421  223455433333222222  22222234


Q ss_pred             CCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       364 ~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                         +.|.|..|.||+++.++++.+.|||+...++.
T Consensus       286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence               99999999999999999999999999876653

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.51  E-value=1.5e-06  Score=84.04  Aligned_cols=132  Identities=17%  Similarity=0.166  Sum_probs=86.2

Q ss_pred             cccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCC--eEEEEeEEEcCCeEEEEEEecCCCC-
Q 008108          250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN--LVRLLGFCLERKERILVYEFVPNAS-  326 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~E~~~~gs-  326 (577)
                      .+||+|..+.||+.   .|..+++|......  ......+|.+++..+..-.  +.+.+++....+...+|||+++|.. 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            67899999999984   25567888876533  2334688999999986444  4677888877777889999999963 


Q ss_pred             cccccccCCCCCCCCHHHHHHHHHHHHHHHHHhh---------------------------------------c-CCCCc
Q 008108          327 LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH---------------------------------------E-DSRLR  366 (577)
Q Consensus       327 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH---------------------------------------~-~~~~~  366 (577)
                      +...+.       .+......++..+++.+.-||                                       . .....
T Consensus        82 ~~~~~~-------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~  154 (226)
T TIGR02172        82 FSRIIS-------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST  154 (226)
T ss_pred             hhhhhc-------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence            222111       011111111122222222222                                       1 11235


Q ss_pred             EEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          367 IIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       367 iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      ++|+|+.|.||++++++ +.|.||+.+.
T Consensus       155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       155 CLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            79999999999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PRK09902 hypothetical protein; Provisional

Probab=98.51  E-value=1.3e-06  Score=81.86  Aligned_cols=137  Identities=18%  Similarity=0.219  Sum_probs=101.5

Q ss_pred             cccCCcEEEEEeEecCCcEEEEEEeccCC------hhhHHHHHHHHHHHHhcCCCC--eEEEEeEEE-cC----CeEEEE
Q 008108          252 LGQGGFGAVYKGMLSNGETIAVKRLSKNS------KQGEIEFKNEVLLLARLQHRN--LVRLLGFCL-ER----KERILV  318 (577)
Q Consensus       252 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~-~~----~~~~lv  318 (577)
                      -|+||-+.|++..+. |+.+-+|+-....      ..+...|.+|+..|.++...+  +.+++ ++. ..    -.-+||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            477899999998764 5578889765221      234567999999999995433  44444 332 11    235799


Q ss_pred             EEecCC-CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCC--eEEeccCCcc
Q 008108          319 YEFVPN-ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN--PKISDFGMAR  394 (577)
Q Consensus       319 ~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~--~kl~DfGla~  394 (577)
                      +|-+++ .+|.+++.+. ...+.+...+..++.+++..+.-||+.+   +.|+|+.+.|||++.++.  ++++||--++
T Consensus       104 Te~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            997764 5787776331 2335678888899999999999999998   999999999999986666  9999997655

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.47  E-value=3.4e-06  Score=79.49  Aligned_cols=139  Identities=14%  Similarity=0.189  Sum_probs=94.5

Q ss_pred             HHhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHH---------HHHHHHHHhcCCCC---eEEEEeE
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEF---------KNEVLLLARLQHRN---LVRLLGF  308 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~h~n---iv~l~~~  308 (577)
                      ....+|...+.+-......|.+... +|+.+++|.........+..|         .+++..+.+++...   ...++-.
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            3456788888888888888877776 478899998876544333322         33444444443322   2222222


Q ss_pred             EE-----cCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC
Q 008108          309 CL-----ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM  383 (577)
Q Consensus       309 ~~-----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~  383 (577)
                      ..     -....+|+|||++|..|.++.       .++.    .+...|++.+.-||+.|   +.|+|..|+|+++++++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~  172 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG  172 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc
Confidence            22     234557999999998886653       1222    24566778899999998   99999999999999665


Q ss_pred             CeEEeccCCccc
Q 008108          384 NPKISDFGMARL  395 (577)
Q Consensus       384 ~~kl~DfGla~~  395 (577)
                       +++.||+..+.
T Consensus       173 -i~iID~~~k~~  183 (229)
T PF06176_consen  173 -IRIIDTQGKRM  183 (229)
T ss_pred             -EEEEECccccc
Confidence             99999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.31  E-value=4.2e-06  Score=81.02  Aligned_cols=144  Identities=22%  Similarity=0.220  Sum_probs=85.0

Q ss_pred             ccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCC--CeEEEEeEEEcC---CeEEEEEEecC
Q 008108          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR--NLVRLLGFCLER---KERILVYEFVP  323 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~E~~~  323 (577)
                      ++.|+.|..+.||+....+ ..+++|.....  .....+.+|..++..+...  .+.+++.+....   ...+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            4678999999999999877 69999987655  4455678899998888533  356777654332   34689999999


Q ss_pred             CCCcccc----------------c---ccC-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHhhc
Q 008108          324 NASLDHF----------------I---FDP-INREHMTWEK---------RYKI------------IEGIAR-GLLYLHE  361 (577)
Q Consensus       324 ~gsL~~~----------------l---~~~-~~~~~l~~~~---------~~~i------------~~~ia~-gl~yLH~  361 (577)
                      +..+...                +   +.. .....+.+..         ....            ...+.+ .+..+++
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            9887660                0   000 0001111110         0000            111222 2333332


Q ss_pred             ----CCCCcEEEeccCCCcEEEc-CCCCeEEeccCCccc
Q 008108          362 ----DSRLRIIHRDLKASNILLD-SEMNPKISDFGMARL  395 (577)
Q Consensus       362 ----~~~~~iiHrDlkp~NiLl~-~~~~~kl~DfGla~~  395 (577)
                          .....++|+|+.|+|||++ +++.+.|.||+.+..
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence                2345699999999999999 566667999988753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.30  E-value=1.9e-07  Score=98.51  Aligned_cols=188  Identities=18%  Similarity=0.154  Sum_probs=135.6

Q ss_pred             hcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCC-eEEEEeEEEcCCeEEEEEEe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN-LVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E~  321 (577)
                      +.-+...+.+++|.+++++|.+....+....+.+...     ....-++++|.+++||| .++.++-+..++..++++++
T Consensus       241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI  315 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence            3345556678999999999987433334445555433     34556888999999999 66666666777788899999


Q ss_pred             cCCC--CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          322 VPNA--SLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       322 ~~~g--sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      +..+  +.....   .....+...+...+.+.-+++|+|||+..   -+|||    ||+..+ +..|..||+....+...
T Consensus       316 ~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  316 CSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT  384 (829)
T ss_pred             hcCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence            9877  222111   11223444455666777788999999864   48998    777766 57899999998766543


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCC
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSS  449 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~  449 (577)
                      .   ......+|+.++|||+...+.+..+.|+|++|+--.++--|-.|..
T Consensus       385 ~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  385 M---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             c---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            3   2344679999999999999999999999999997777777766543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.30  E-value=1.2e-05  Score=76.72  Aligned_cols=152  Identities=21%  Similarity=0.248  Sum_probs=99.1

Q ss_pred             hHHHHHHhcCCccccc---cccCCcEEEEEeEecCCcEEEEEEeccCChhh-------------------HH-----HHH
Q 008108          236 FETIRVATDNFSDANK---LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG-------------------EI-----EFK  288 (577)
Q Consensus       236 ~~~~~~~~~~f~~~~~---lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------~~-----~~~  288 (577)
                      ++.+....++..+...   |+.|.-..||+|...++..+|||+........                   ..     ...
T Consensus        37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~  116 (268)
T COG1718          37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR  116 (268)
T ss_pred             HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence            4555555565555554   55677788999998889999999886432110                   00     124


Q ss_pred             HHHHHHHhcC--CCCeEEEEeEEEcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCc
Q 008108          289 NEVLLLARLQ--HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR  366 (577)
Q Consensus       289 ~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~  366 (577)
                      .|+.-|.++.  +-.+.+.+++.    .-.|||||+....+-.-.   .+.-.+...+...+..++++.+.-|-...  +
T Consensus       117 kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~---LkDv~~e~~e~~~~~~~~v~~~~~l~~~a--~  187 (268)
T COG1718         117 KEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPR---LKDVPLELEEAEGLYEDVVEYMRRLYKEA--G  187 (268)
T ss_pred             HHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCC---cccCCcCchhHHHHHHHHHHHHHHHHHhc--C
Confidence            5666677763  33344444443    347999999765221100   11122333366777788888888776632  3


Q ss_pred             EEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          367 IIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       367 iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      +||+||+.=|||+. ++.+.|+|||-|....
T Consensus       188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         188 LVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             cccccchhhheEEE-CCeEEEEECccccccC
Confidence            99999999999999 8899999999887544

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.25  E-value=9.5e-06  Score=79.53  Aligned_cols=139  Identities=16%  Similarity=0.149  Sum_probs=85.1

Q ss_pred             cccCCc-EEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcC-CCCeEEEEeEEEcCCeEEEEEEecCCCCccc
Q 008108          252 LGQGGF-GAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERILVYEFVPNASLDH  329 (577)
Q Consensus       252 lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~  329 (577)
                      |-.|.. ..||+.... +..+.||+.....   ...+.+|+.++..+. +--+.+++++....+..++|||+++|.+|..
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            445555 788999764 4788888876543   234677888888883 4446678888777667899999999988764


Q ss_pred             ccc-------------------cCC-CCCCCC--HHHHHHH-----------------------HHHHHHHHHHhh-cCC
Q 008108          330 FIF-------------------DPI-NREHMT--WEKRYKI-----------------------IEGIARGLLYLH-EDS  363 (577)
Q Consensus       330 ~l~-------------------~~~-~~~~l~--~~~~~~i-----------------------~~~ia~gl~yLH-~~~  363 (577)
                      ...                   ... ....+.  ....+..                       ...+..-|.... ...
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            321                   000 000111  0000000                       011111111111 112


Q ss_pred             CCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       364 ~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      .+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            3569999999999999998778899998775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.22  E-value=7.6e-06  Score=76.53  Aligned_cols=105  Identities=27%  Similarity=0.239  Sum_probs=83.5

Q ss_pred             HHHHHHHHhcCC-CCeEEEEeEEEcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCc
Q 008108          288 KNEVLLLARLQH-RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR  366 (577)
Q Consensus       288 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~  366 (577)
                      .+|..+|+.+++ +++.+++|+|-    .+++.||.+.+++...-.....--..+|..+.+|+.++++.+.+|+......
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            468888999976 69999999993    4789999987766421000011234799999999999999999999865445


Q ss_pred             EEEeccCCCcEEEcCCCCeEEeccCCcccc
Q 008108          367 IIHRDLKASNILLDSEMNPKISDFGMARLF  396 (577)
Q Consensus       367 iiHrDlkp~NiLl~~~~~~kl~DfGla~~~  396 (577)
                      +...|++++|+-+++++++|+.|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            899999999999999999999999877544

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=98.18  E-value=2.5e-05  Score=89.95  Aligned_cols=80  Identities=14%  Similarity=0.309  Sum_probs=59.5

Q ss_pred             ccccccCCcEEEEEeEecCC---cEEEEEEeccCCh-hhHHHHHHHHHHHHhcC-CCCe--EEEEeEEEcC---CeEEEE
Q 008108          249 ANKLGQGGFGAVYKGMLSNG---ETIAVKRLSKNSK-QGEIEFKNEVLLLARLQ-HRNL--VRLLGFCLER---KERILV  318 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv  318 (577)
                      .+.|+.|.+..+|+....++   ..+++|+...... .....+.+|+.+|+.+. |.++  .+++.++.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            57789999999999886554   4678887654322 23346789999999995 6665  7888888764   357899


Q ss_pred             EEecCCCCcc
Q 008108          319 YEFVPNASLD  328 (577)
Q Consensus       319 ~E~~~~gsL~  328 (577)
                      |||++|..+.
T Consensus       123 ME~v~G~~~~  132 (822)
T PLN02876        123 MEYLEGRIFV  132 (822)
T ss_pred             EEecCCcccC
Confidence            9999987543

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.10  E-value=4.6e-05  Score=71.63  Aligned_cols=129  Identities=19%  Similarity=0.345  Sum_probs=88.9

Q ss_pred             cccccccCCcEEEEEeEecCCcEEEEEEeccCC----------------hhhHHHHHHHHHHHHhcC------CCCeEEE
Q 008108          248 DANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS----------------KQGEIEFKNEVLLLARLQ------HRNLVRL  305 (577)
Q Consensus       248 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l  305 (577)
                      ....||+|+.-.||.-  ++.....||++....                .....+..+|+.....+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            4578999999999964  456667888887655                112334556666555554      8899999


Q ss_pred             EeEEEcCCeEEEEEEecCC--C----CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEE
Q 008108          306 LGFCLERKERILVYEFVPN--A----SLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL  379 (577)
Q Consensus       306 ~~~~~~~~~~~lv~E~~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl  379 (577)
                      +|+..++...-+|+|.+.+  |    +|.+++    ..+.++. ...+.+.++   ..||-+++   |+.+||+|+||++
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l----~~~~~~~-~~~~~L~~f---~~~l~~~~---Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYL----KEGGLTE-ELRQALDEF---KRYLLDHH---IVIRDLNPHNIVV  151 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHH----HcCCccH-HHHHHHHHH---HHHHHHcC---CeecCCCcccEEE
Confidence            9999999999999998743  3    445554    3344655 444444444   44555555   9999999999999


Q ss_pred             cCCC----CeEEec
Q 008108          380 DSEM----NPKISD  389 (577)
Q Consensus       380 ~~~~----~~kl~D  389 (577)
                      ....    .+.|+|
T Consensus       152 ~~~~~~~~~lvlID  165 (199)
T PF10707_consen  152 QRRDSGEFRLVLID  165 (199)
T ss_pred             EecCCCceEEEEEe
Confidence            5433    466666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.06  E-value=2.7e-05  Score=83.17  Aligned_cols=142  Identities=18%  Similarity=0.268  Sum_probs=92.2

Q ss_pred             ccccccCCcEEEEEeEecCCcEEEEEEeccCChhh-------------------------------------HHHHHHHH
Q 008108          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG-------------------------------------EIEFKNEV  291 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------------~~~~~~E~  291 (577)
                      .+.||.-+.|.||+|++++|+.||||+-+..-...                                     +..|.+|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            46799999999999999999999999866532111                                     01133344


Q ss_pred             HHHHh----cCCCCe---EEEEeEE-EcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 008108          292 LLLAR----LQHRNL---VRLLGFC-LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS  363 (577)
Q Consensus       292 ~~l~~----l~h~ni---v~l~~~~-~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~  363 (577)
                      +-..+    +.|-++   |.+=.++ .-.....|+||||+|..+.+...  .....++...+..-+.++..-+-+-|  |
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~--i~~~gi~~~~i~~~l~~~~~~qIf~~--G  321 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDA--IDKRGISPHDILNKLVEAYLEQIFKT--G  321 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHH--HHHcCCCHHHHHHHHHHHHHHHHHhc--C
Confidence            33333    345551   1122222 22346799999999998877632  23445666655544444333333333  4


Q ss_pred             CCcEEEeccCCCcEEEcC----CCCeEEeccCCccccc
Q 008108          364 RLRIIHRDLKASNILLDS----EMNPKISDFGMARLFE  397 (577)
Q Consensus       364 ~~~iiHrDlkp~NiLl~~----~~~~kl~DfGla~~~~  397 (577)
                         ++|.|-.|.||+++.    ++.+.+-|||+.....
T Consensus       322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             ---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence               999999999999984    5689999999987654

>PRK10593 hypothetical protein; Provisional

Probab=98.05  E-value=9.9e-05  Score=74.52  Aligned_cols=79  Identities=15%  Similarity=0.119  Sum_probs=57.6

Q ss_pred             CccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCC---CCeEEEEeEEEcC---CeEEEEE
Q 008108          246 FSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH---RNLVRLLGFCLER---KERILVY  319 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~---~~~~lv~  319 (577)
                      ....+.||+|..+.||+....++ .+.+|..+...  ....+..|...|+.+..   -.+.++++++...   +..+|||
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             hheeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            34467899999999999876555 46667643311  22367889999998853   3578888887543   5689999


Q ss_pred             EecCCCCc
Q 008108          320 EFVPNASL  327 (577)
Q Consensus       320 E~~~~gsL  327 (577)
                      |+++++++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99998766

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.00  E-value=6e-05  Score=73.42  Aligned_cols=76  Identities=18%  Similarity=0.211  Sum_probs=47.9

Q ss_pred             ccccccCCcE-EEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCC---CeEEEEeEEEcCC---eEEEEEEe
Q 008108          249 ANKLGQGGFG-AVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR---NLVRLLGFCLERK---ERILVYEF  321 (577)
Q Consensus       249 ~~~lG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~---~~~lv~E~  321 (577)
                      ++.|+.|+.. .||+.    +..+++|......  ....+.+|.+++..+...   -+.++++.....+   ..+++||+
T Consensus         2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           2 IEPVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             ceeccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            3567877776 48875    2457777654422  234688899999887532   2344444433322   34889999


Q ss_pred             cCCCCcccc
Q 008108          322 VPNASLDHF  330 (577)
Q Consensus       322 ~~~gsL~~~  330 (577)
                      ++|.++.+.
T Consensus        76 i~G~~l~~~   84 (235)
T cd05155          76 LEGETATAA   84 (235)
T ss_pred             ecCCCCCcc
Confidence            999888543

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.89  E-value=9.4e-05  Score=71.97  Aligned_cols=141  Identities=19%  Similarity=0.218  Sum_probs=83.5

Q ss_pred             ccccccCCcEEEEEeEecC--CcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCC-eEEEEeEEEcCCeEEEEEEecCCC
Q 008108          249 ANKLGQGGFGAVYKGMLSN--GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN-LVRLLGFCLERKERILVYEFVPNA  325 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E~~~~g  325 (577)
                      ++.|..|-...+|+....+  ++.+++|+....... .....+|+.++..+...+ ..++++.+.    ..++|||++|.
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~   77 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR   77 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence            4567888889999998764  678999977543222 223457888888885433 344544432    24899999998


Q ss_pred             Cccccc-----------------ccCCCC--------CCC-CHHHHHHHHHH----------------------H---HH
Q 008108          326 SLDHFI-----------------FDPINR--------EHM-TWEKRYKIIEG----------------------I---AR  354 (577)
Q Consensus       326 sL~~~l-----------------~~~~~~--------~~l-~~~~~~~i~~~----------------------i---a~  354 (577)
                      ++....                 +.....        ... -++.+..+...                      +   +.
T Consensus        78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  157 (235)
T cd05157          78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS  157 (235)
T ss_pred             cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence            774221                 000000        111 12222222111                      1   11


Q ss_pred             HHH-HhhcC-CCCcEEEeccCCCcEEEcC-CCCeEEeccCCcc
Q 008108          355 GLL-YLHED-SRLRIIHRDLKASNILLDS-EMNPKISDFGMAR  394 (577)
Q Consensus       355 gl~-yLH~~-~~~~iiHrDlkp~NiLl~~-~~~~kl~DfGla~  394 (577)
                      .|. .+... .+..++|+|+.+.|||+++ ++.+.|.||..|.
T Consensus       158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            111 12111 2346999999999999998 5789999998774

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.86  E-value=0.00012  Score=72.27  Aligned_cols=138  Identities=16%  Similarity=0.115  Sum_probs=79.8

Q ss_pred             ccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCe-EEEEeEEEcCCeEEEEEEecCCCCccc
Q 008108          251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL-VRLLGFCLERKERILVYEFVPNASLDH  329 (577)
Q Consensus       251 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~gsL~~  329 (577)
                      .+..|-...+|+... +++.+++|..............+|..+++.+....+ .+++....    -++||||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            456788889998874 567888887654432221235778888888864433 34444432    368999999977753


Q ss_pred             c-----------------cccCC-CCCCCCHHHH-HHHHHHH---------HHHHHHhhcC-----CCCcEEEeccCCCc
Q 008108          330 F-----------------IFDPI-NREHMTWEKR-YKIIEGI---------ARGLLYLHED-----SRLRIIHRDLKASN  376 (577)
Q Consensus       330 ~-----------------l~~~~-~~~~l~~~~~-~~i~~~i---------a~gl~yLH~~-----~~~~iiHrDlkp~N  376 (577)
                      -                 |+... ....++.... .....++         ..-+..+-..     .+..++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            2                 11100 0111222211 1111111         1111112111     12458999999999


Q ss_pred             EEEcCCCCeEEeccCCcc
Q 008108          377 ILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       377 iLl~~~~~~kl~DfGla~  394 (577)
                      |++++++ +.|.||..+.
T Consensus       158 il~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             EEEeCCC-CEEEeccccC
Confidence            9999877 7899998875

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.82  E-value=0.00024  Score=66.37  Aligned_cols=125  Identities=29%  Similarity=0.416  Sum_probs=89.1

Q ss_pred             cCCccccccccCCc-EEEEEeEecCCcEEEEEEecc---CC--------h----------hhHHHHHHHHHHHHhcC---
Q 008108          244 DNFSDANKLGQGGF-GAVYKGMLSNGETIAVKRLSK---NS--------K----------QGEIEFKNEVLLLARLQ---  298 (577)
Q Consensus       244 ~~f~~~~~lG~G~~-g~Vy~~~~~~~~~vavK~~~~---~~--------~----------~~~~~~~~E~~~l~~l~---  298 (577)
                      .+++.++.||.|.- |.||++... |+.+|+|.+..   ..        .          .....|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67888999999999 999999984 78999999332   10        0          00113778888887774   


Q ss_pred             CCCe--EEEEeEEEcC------------------CeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHH
Q 008108          299 HRNL--VRLLGFCLER------------------KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY  358 (577)
Q Consensus       299 h~ni--v~l~~~~~~~------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~y  358 (577)
                      +.++  |+.+||..-.                  ....||.||.+...            .++    .+-+.+|.+-|.-
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence            4566  8999987422                  12357777765532            122    2235677788889


Q ss_pred             hhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCc
Q 008108          359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (577)
Q Consensus       359 LH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla  393 (577)
                      +|..+   |+-+|+++.|..     .-||+|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            99988   999999999986     4589999864

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.77  E-value=0.00016  Score=65.33  Aligned_cols=128  Identities=18%  Similarity=0.235  Sum_probs=85.6

Q ss_pred             cccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeE-EEEeEEEcCCeEEEEEEecCCCC
Q 008108          248 DANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV-RLLGFCLERKERILVYEFVPNAS  326 (577)
Q Consensus       248 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~E~~~~gs  326 (577)
                      ..+.|++|++|.||+|.+. |..+|+|.-..++.  ...+..|.++|..++-.++. +++.|-.+    ++.|||+.|-.
T Consensus        26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~   98 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcc
Confidence            3578999999999999986 55888887655443  34578899999988766654 34444322    45599999988


Q ss_pred             cccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccC-CCcEEEcCCCCeEEeccCCccc
Q 008108          327 LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLK-ASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       327 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk-p~NiLl~~~~~~kl~DfGla~~  395 (577)
                      |.++-..      .+-+.+    ..+++.-.-|-..|   |-|+.|. |...+|-.+..+.|+||.-|..
T Consensus        99 L~~~~~~------~~rk~l----~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          99 LGKLEIG------GDRKHL----LRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhc------ccHHHH----HHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            8665311      122333    34444434444445   8888887 4444444555999999998874

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.69  E-value=0.00034  Score=70.63  Aligned_cols=143  Identities=18%  Similarity=0.157  Sum_probs=86.3

Q ss_pred             cccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCC--eEEEEeE------EEcCCeEEEEE
Q 008108          248 DANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN--LVRLLGF------CLERKERILVY  319 (577)
Q Consensus       248 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~  319 (577)
                      ..+.|..|....+|+....+ ..+++|+...   .....+..|+.++..+.+.+  +.+++..      ....+..++|+
T Consensus        18 ~i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          18 SFEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             heecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            35678888888999987654 4688898764   22335667888888875433  4444432      12344568999


Q ss_pred             EecCCCCccccc--------------ccCC---C-----CCCCCHHHHH----------HHHHHHHHHHHHhhc----CC
Q 008108          320 EFVPNASLDHFI--------------FDPI---N-----REHMTWEKRY----------KIIEGIARGLLYLHE----DS  363 (577)
Q Consensus       320 E~~~~gsL~~~l--------------~~~~---~-----~~~l~~~~~~----------~i~~~ia~gl~yLH~----~~  363 (577)
                      +|++|..+...-              +...   .     .....|....          .....+...+.++.+    ..
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            999998765410              0000   0     0111222211          011112334444443    12


Q ss_pred             CCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          364 RLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       364 ~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      +..++|+|+.|.|||++++..+.|.||+.+.
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            2359999999999999998777899998774

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.58  E-value=0.00067  Score=70.69  Aligned_cols=76  Identities=14%  Similarity=0.179  Sum_probs=53.5

Q ss_pred             ccccccCCcEEEEEeEecCC-cEEEEEEeccCC-------hhhHHHHHHHHHHHHhcC---CCCeEEEEeEEEcCCeEEE
Q 008108          249 ANKLGQGGFGAVYKGMLSNG-ETIAVKRLSKNS-------KQGEIEFKNEVLLLARLQ---HRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l  317 (577)
                      .+.||.|.+..||++...+| +.++||.-....       ......+..|.+.|..+.   ..++.+++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            46799999999999998777 589999854211       112334566777777762   2456777777  4455789


Q ss_pred             EEEecCCCC
Q 008108          318 VYEFVPNAS  326 (577)
Q Consensus       318 v~E~~~~gs  326 (577)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998643

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.53  E-value=0.0014  Score=66.50  Aligned_cols=143  Identities=19%  Similarity=0.190  Sum_probs=82.8

Q ss_pred             ccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCC--eEEEEeE------EEcCCeEEEEEE
Q 008108          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN--LVRLLGF------CLERKERILVYE  320 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~E  320 (577)
                      ++.++.|....+|+....+| .+++|+......  ..++..|+.++..|....  +.+++..      ....+..++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            56677887789999876555 577887654321  224456677777774322  3444432      122345789999


Q ss_pred             ecCCCCcccc--------------cccCCCC---------CCCCHHHHH------------HHHHHHHHHHHHhhc----
Q 008108          321 FVPNASLDHF--------------IFDPINR---------EHMTWEKRY------------KIIEGIARGLLYLHE----  361 (577)
Q Consensus       321 ~~~~gsL~~~--------------l~~~~~~---------~~l~~~~~~------------~i~~~ia~gl~yLH~----  361 (577)
                      |++|..+...              ++.....         ..-.|....            .....+.+.+.++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9998765321              0100000         001121111            011123334555532    


Q ss_pred             CCCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       362 ~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      .-+..++|+|+.+.||++++++...|.||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            223569999999999999998777899998874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.47  E-value=0.00068  Score=68.68  Aligned_cols=141  Identities=27%  Similarity=0.361  Sum_probs=84.6

Q ss_pred             ccccccCCcEEEEEeEecC-------CcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCe-EEEEeEEEcCCeEEEEEE
Q 008108          249 ANKLGQGGFGAVYKGMLSN-------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL-VRLLGFCLERKERILVYE  320 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E  320 (577)
                      ++.|..|-...+|+....+       ++.+++|+...... ......+|..++..+...++ .++++++..    .+|+|
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e   77 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEE   77 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhh
Confidence            3456667777899988654       57899998765432 22355788888888854333 355555532    36899


Q ss_pred             ecCCCCcccc-c----------------ccCCCCC------C--CCHHHHHHH--------------------------H
Q 008108          321 FVPNASLDHF-I----------------FDPINRE------H--MTWEKRYKI--------------------------I  349 (577)
Q Consensus       321 ~~~~gsL~~~-l----------------~~~~~~~------~--l~~~~~~~i--------------------------~  349 (577)
                      |++|..+... +                ++.....      .  .-|.....+                          .
T Consensus        78 ~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (302)
T cd05156          78 FIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFL  157 (302)
T ss_pred             eeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHH
Confidence            9998877431 1                1100000      0  011111111                          1


Q ss_pred             HHHHHHHHHhhc------CCCCcEEEeccCCCcEEEcCC----CCeEEeccCCcc
Q 008108          350 EGIARGLLYLHE------DSRLRIIHRDLKASNILLDSE----MNPKISDFGMAR  394 (577)
Q Consensus       350 ~~ia~gl~yLH~------~~~~~iiHrDlkp~NiLl~~~----~~~kl~DfGla~  394 (577)
                      ..+..-+..|..      ..+..++|+|+.+.|||++++    +.++++||..+.
T Consensus       158 ~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         158 EDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            122222334432      234579999999999999985    789999998875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.46  E-value=0.0028  Score=64.70  Aligned_cols=142  Identities=15%  Similarity=0.163  Sum_probs=78.0

Q ss_pred             ccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCC--eEEEEe------EEEcCCeEEEEEE
Q 008108          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN--LVRLLG------FCLERKERILVYE  320 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~------~~~~~~~~~lv~E  320 (577)
                      .+.|+.|....+|+....+| .+++|++....   ...+..|+.++..|...+  +.+++.      +....+..++++|
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            45677788889999887655 68889875211   223344556665553222  233332      1223456789999


Q ss_pred             ecCCCCccccc--------------ccCC--------CCCCCCH-HHHHH------------HHHH-HHHHHHHhhcC--
Q 008108          321 FVPNASLDHFI--------------FDPI--------NREHMTW-EKRYK------------IIEG-IARGLLYLHED--  362 (577)
Q Consensus       321 ~~~~gsL~~~l--------------~~~~--------~~~~l~~-~~~~~------------i~~~-ia~gl~yLH~~--  362 (577)
                      |++|..+...-              +...        +...+.| .....            .+.+ +...+..+.+.  
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            99997653210              0000        0001112 11111            1111 11122233211  


Q ss_pred             --CCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          363 --SRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       363 --~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                        -+..++|+|+.+.|||++.+...-|.||+.+.
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence              23459999999999999976556899999875

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.30  E-value=0.0016  Score=65.13  Aligned_cols=142  Identities=20%  Similarity=0.289  Sum_probs=73.2

Q ss_pred             CccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcC---CCCeEEEEeEEEcCCeEEEEEEec
Q 008108          246 FSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ---HRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      .+..+.|+.|....+|+.. .+++.+.||.-...   ....|..|..-|+.|.   --.+.+++++....+..+||+||+
T Consensus        19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eeeeEecCCCChhheEEEE-CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            3446779999999999987 56788999987622   2235677888888773   445778999988777789999999


Q ss_pred             CCCCcc--c---------cccc-CC------------------CCCCCCHHHHH-----HHH--------------HHHH
Q 008108          323 PNASLD--H---------FIFD-PI------------------NREHMTWEKRY-----KII--------------EGIA  353 (577)
Q Consensus       323 ~~gsL~--~---------~l~~-~~------------------~~~~l~~~~~~-----~i~--------------~~ia  353 (577)
                      +.+...  .         -|++ ..                  +.-.-+|.+-.     ...              ..+.
T Consensus        95 ~~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~  174 (288)
T PF03881_consen   95 EMGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLV  174 (288)
T ss_dssp             ------CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHH
T ss_pred             cCCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHH
Confidence            876111  0         0111 00                  00112333211     111              1122


Q ss_pred             HHHH-HhhcC-CCCcEEEeccCCCcEEEcCCCCeEEeccC
Q 008108          354 RGLL-YLHED-SRLRIIHRDLKASNILLDSEMNPKISDFG  391 (577)
Q Consensus       354 ~gl~-yLH~~-~~~~iiHrDlkp~NiLl~~~~~~kl~DfG  391 (577)
                      +.+. .|+.. .++.++|+||-+.|++.+.++.+.|.|-.
T Consensus       175 ~~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa  214 (288)
T PF03881_consen  175 ERLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA  214 (288)
T ss_dssp             HHHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred             HHHHHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence            2222 23322 25679999999999999999999998854

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.30  E-value=0.00082  Score=76.45  Aligned_cols=195  Identities=23%  Similarity=0.258  Sum_probs=131.9

Q ss_pred             HHHHHHHHhcCCCCeEEEEeEEEcCCeEE----EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 008108          288 KNEVLLLARLQHRNLVRLLGFCLERKERI----LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS  363 (577)
Q Consensus       288 ~~E~~~l~~l~h~niv~l~~~~~~~~~~~----lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~  363 (577)
                      .-|+..+..+.|+|++.++.|-.+....-    +..|++..-++...+   ..-..++....+.+..++.+||.|+|+..
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~---q~v~~i~~~~~r~~~~~~~~GL~~~h~~~  306 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL---QSVGSIPLETLRILHQKLLEGLAYLHSLS  306 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH---hhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence            44677788889999999999987665443    345777777776655   34456888899999999999999999875


Q ss_pred             CCcEEEeccCCC---cEEEcCCCCeEEe--ccCCcccccCCCccccccccccCCCCcChhhhhcCCCCc--cccEEecch
Q 008108          364 RLRIIHRDLKAS---NILLDSEMNPKIS--DFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSV--KSDIFSFGV  436 (577)
Q Consensus       364 ~~~iiHrDlkp~---NiLl~~~~~~kl~--DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~Dv~SlGv  436 (577)
                         ..|.=|..+   +--.+..+.+.++  ||+..+.........   ...-+..+.+||......+..  ..|+|.+|.
T Consensus       307 ---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  307 ---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLGL  380 (1351)
T ss_pred             ---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHHH
Confidence               555555555   5555667777777  898887655332221   123455677888776665544  479999999


Q ss_pred             hHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 008108          437 LVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNML  516 (577)
Q Consensus       437 il~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L  516 (577)
                      .+..+..|..+......                  ...+++..    ...   ........|+..++++|++..+++...
T Consensus       381 l~~~~~~~~~i~~~~~~------------------~~~~l~~~----~~~---~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  381 LLLQLSQGEDISEKSAV------------------PVSLLDVL----STS---ELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             HHhhhhhcCcccccccc------------------hhhhhccc----cch---hhhhhhhhhcchhhhhccchhhhhhch
Confidence            99999998765321110                  00111111    001   233455679999999999999998764

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.25  E-value=0.004  Score=62.75  Aligned_cols=137  Identities=18%  Similarity=0.267  Sum_probs=83.6

Q ss_pred             ccccccCCcEEEEEeEecCCcEEEEEEecc--CChhhHHHHHHHHHHHHhcCC--CCeEEEEeEEEcCC--eEEEEEEec
Q 008108          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSK--NSKQGEIEFKNEVLLLARLQH--RNLVRLLGFCLERK--ERILVYEFV  322 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~E~~  322 (577)
                      .+.+..|-.-.+|..... ++++++. ...  ..........+|+.+|+.+.-  --+.+.++.|.++.  ..+.||+|+
T Consensus        30 v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v  107 (321)
T COG3173          30 VEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV  107 (321)
T ss_pred             eeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence            344433333344444433 7788888 332  223333456788888888743  33455677777766  669999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHH-HHHHHHHHHhh-----------------------------------------
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKII-EGIARGLLYLH-----------------------------------------  360 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~-~~ia~gl~yLH-----------------------------------------  360 (577)
                      +|..+...+...    ...    ..++ ..+++.|.-||                                         
T Consensus       108 eGe~~~~~~~~~----~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~  179 (321)
T COG3173         108 EGEVVWSALPPE----SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL  179 (321)
T ss_pred             cceeccCcCCcc----cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence            886443332110    001    1111 23444444444                                         


Q ss_pred             ---------cC-----CCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          361 ---------ED-----SRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       361 ---------~~-----~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                               .+     ++..++|+|+.+.|++++.+.-+-+.||+++..
T Consensus       180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence                     22     245799999999999999998899999999864

>PLN02236 choline kinase

Probab=97.03  E-value=0.0056  Score=63.19  Aligned_cols=142  Identities=18%  Similarity=0.249  Sum_probs=84.4

Q ss_pred             ccccccCCcEEEEEeEecC-----CcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeE-EEEeEEEcCCeEEEEEEec
Q 008108          249 ANKLGQGGFGAVYKGMLSN-----GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV-RLLGFCLERKERILVYEFV  322 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~E~~  322 (577)
                      ...|-.|-.-.+|+....+     ++.+++|+....... .....+|..++..+...++. ++++.+...    .|+||+
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi  115 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVEL-FFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI  115 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCe-eechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence            3456567778899987532     367899988665422 22346788888888654443 556665332    589999


Q ss_pred             CCCCcccc-----------------cccCC--C-CCCCCHHHHHHHHHHH-----------------HHHHHH----hhc
Q 008108          323 PNASLDHF-----------------IFDPI--N-REHMTWEKRYKIIEGI-----------------ARGLLY----LHE  361 (577)
Q Consensus       323 ~~gsL~~~-----------------l~~~~--~-~~~l~~~~~~~i~~~i-----------------a~gl~y----LH~  361 (577)
                      ++.+|...                 ++...  . .....|.++.++..++                 ...+..    +..
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            88777422                 11100  0 1112233333333222                 111112    222


Q ss_pred             -CCCCcEEEeccCCCcEEEcC-CCCeEEeccCCccc
Q 008108          362 -DSRLRIIHRDLKASNILLDS-EMNPKISDFGMARL  395 (577)
Q Consensus       362 -~~~~~iiHrDlkp~NiLl~~-~~~~kl~DfGla~~  395 (577)
                       ..+..++|+|+++.|||+++ ++.+.++||..+..
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence             22346899999999999986 46799999988753

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.01  E-value=0.0012  Score=65.40  Aligned_cols=146  Identities=16%  Similarity=0.246  Sum_probs=98.5

Q ss_pred             CCCChHHHHHHhcC---CccccccccCCcEEEEEeEecCCcEEEEEEecc--C---------------Chh-----hHHH
Q 008108          232 LQFDFETIRVATDN---FSDANKLGQGGFGAVYKGMLSNGETIAVKRLSK--N---------------SKQ-----GEIE  286 (577)
Q Consensus       232 ~~~~~~~~~~~~~~---f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--~---------------~~~-----~~~~  286 (577)
                      ..+++-.|+....+   ++..++||-|.-+.||.+...+|++.++|.-.-  .               ...     ....
T Consensus        77 ~GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRla  156 (465)
T KOG2268|consen   77 AGYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLA  156 (465)
T ss_pred             ccchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHH
Confidence            34566555555443   678899999999999999999999999984211  0               001     1123


Q ss_pred             HHHHHHHHHhcCC-C-CeEEEEeEEEcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 008108          287 FKNEVLLLARLQH-R-NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR  364 (577)
Q Consensus       287 ~~~E~~~l~~l~h-~-niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~  364 (577)
                      ...|+..|+.|.. - -+.+.+++    ...++|||++.+-.|...-      ...+..++.   ..+..-+--|..+| 
T Consensus       157 a~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly---~~lm~~Iv~la~~G-  222 (465)
T KOG2268|consen  157 ATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPTLY---DDLMGLIVRLANHG-  222 (465)
T ss_pred             HHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeee------ecCChHHHH---HHHHHHHHHHHHcC-
Confidence            4678888888843 2 24444444    4568999999888775432      122333333   33333344566666 


Q ss_pred             CcEEEeccCCCcEEEcCCCCeEEeccCCc
Q 008108          365 LRIIHRDLKASNILLDSEMNPKISDFGMA  393 (577)
Q Consensus       365 ~~iiHrDlkp~NiLl~~~~~~kl~DfGla  393 (577)
                        +||+|..-=||+|++++.++++||--.
T Consensus       223 --lIHgDFNEFNimv~dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  223 --LIHGDFNEFNIMVKDDDKIVVIDFPQM  249 (465)
T ss_pred             --ceecccchheeEEecCCCEEEeechHh
Confidence              999999999999999999999999644

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.00  E-value=0.0096  Score=59.38  Aligned_cols=31  Identities=26%  Similarity=0.527  Sum_probs=25.7

Q ss_pred             CcEEEeccCCCcEEEcCCCC-eEEeccCCccc
Q 008108          365 LRIIHRDLKASNILLDSEMN-PKISDFGMARL  395 (577)
Q Consensus       365 ~~iiHrDlkp~NiLl~~~~~-~kl~DfGla~~  395 (577)
                      +.++|+|+++.|||+++++. .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45899999999999997555 46999998854

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.85  E-value=0.017  Score=60.15  Aligned_cols=73  Identities=12%  Similarity=0.138  Sum_probs=49.0

Q ss_pred             ccccccCCcEEEEEeEecCCcEEEEEEeccCCh-------hhHHHHHHHHHHHHhcC---CCCeEEEEeEEEcCCeEEEE
Q 008108          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSK-------QGEIEFKNEVLLLARLQ---HRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv  318 (577)
                      .+.||.|....||+.... ++.++||+-.....       .....-..|...|+.+.   ..++.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            578999999999998864 56799997652111       11222234456665553   357788888877  446788


Q ss_pred             EEecCC
Q 008108          319 YEFVPN  324 (577)
Q Consensus       319 ~E~~~~  324 (577)
                      |||+++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.62  E-value=0.0076  Score=57.52  Aligned_cols=123  Identities=25%  Similarity=0.326  Sum_probs=61.3

Q ss_pred             CcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCe-EEEEeEEEcCCeEEEEEEecCCCCcccccc-c------------
Q 008108          268 GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL-VRLLGFCLERKERILVYEFVPNASLDHFIF-D------------  333 (577)
Q Consensus       268 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~-~------------  333 (577)
                      .+.|+||+..... .......+|..+++.+...++ .++++++.++    +|+||+++..|..--. +            
T Consensus         2 ~~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~   76 (211)
T PF01633_consen    2 PEKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLA   76 (211)
T ss_dssp             TSEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHH
Confidence            4678888876653 333456788888888864444 5566665332    5779997776643111 0            


Q ss_pred             ------C--CCCCCCCHHHHHHH----------------------HHHHHHHHHHhh----c-CCCCcEEEeccCCCcEE
Q 008108          334 ------P--INREHMTWEKRYKI----------------------IEGIARGLLYLH----E-DSRLRIIHRDLKASNIL  378 (577)
Q Consensus       334 ------~--~~~~~l~~~~~~~i----------------------~~~ia~gl~yLH----~-~~~~~iiHrDlkp~NiL  378 (577)
                            .  .....--|.....+                      +..+..-+..+.    . ..+..++|+||.+.|||
T Consensus        77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil  156 (211)
T PF01633_consen   77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL  156 (211)
T ss_dssp             HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred             HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence                  0  00111112222222                      011111122211    1 11235899999999999


Q ss_pred             E-cCCCCeEEeccCCccc
Q 008108          379 L-DSEMNPKISDFGMARL  395 (577)
Q Consensus       379 l-~~~~~~kl~DfGla~~  395 (577)
                      + +.++.++++||..|..
T Consensus       157 ~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  157 INNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             ETSSSSCEEE--GTT-EE
T ss_pred             eccCCCeEEEecHHHHhh
Confidence            9 8889999999988753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins

Probab=96.61  E-value=0.0022  Score=44.88  Aligned_cols=47  Identities=38%  Similarity=0.480  Sum_probs=32.8

Q ss_pred             CCCCCCCCCCCccccccCCCCCCCCCcccccCCCCCCCCCCCCCCCCCCccccccccCC
Q 008108          519 DTVTLPAPSKPAFFMKCSVIPETSSPLDVITGSTESGGHGIGNVPLSKNEASITELSPR  577 (577)
Q Consensus       519 ~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r  577 (577)
                      +...+|.|++|+|+..+.......+            +........|.|++|+|.+++|
T Consensus         2 e~~~LP~PKqPgF~~~r~~~e~~sS------------ss~~~~~~~SvNevTiT~l~~R   48 (48)
T PF11883_consen    2 ETATLPQPKQPGFFTGRSPSETDSS------------SSKQRDESCSVNEVTITMLEAR   48 (48)
T ss_pred             CcccCCCCCCCCEEeEcCCCCcCCC------------cccccCCCCCeeeEEEEeEecC
Confidence            4568999999999987776533211            1010004678999999999998

; GO: 0004674 protein serine/threonine kinase activity

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.58  E-value=0.024  Score=57.42  Aligned_cols=139  Identities=20%  Similarity=0.265  Sum_probs=93.6

Q ss_pred             cccccCCcEEEEEeEecCCcEEEEEEeccC-----Ch----hh-----------------HHHHHHHHHHHHhcCCCCeE
Q 008108          250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKN-----SK----QG-----------------EIEFKNEVLLLARLQHRNLV  303 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-----~~----~~-----------------~~~~~~E~~~l~~l~h~niv  303 (577)
                      --|..|--..||.+.-.+|..+|||+.+-.     .+    .+                 ......|+.-|.+++...|.
T Consensus       150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP  229 (520)
T KOG2270|consen  150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP  229 (520)
T ss_pred             cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            457789999999999999999999986532     00    00                 01234577777777544432


Q ss_pred             EEEeEEEcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC
Q 008108          304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM  383 (577)
Q Consensus       304 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~  383 (577)
                      -.--...  ....|||+|+....   |-.-..+...++...+..+-.+++.-|.-|-+..  ++||.||.-=|+|+-+ |
T Consensus       230 ~PePIlL--k~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd-G  301 (520)
T KOG2270|consen  230 CPEPILL--KNHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD-G  301 (520)
T ss_pred             CCCceee--ecceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC-C
Confidence            1100000  13479999996422   2211234456788888888899999998887766  5999999999999854 5


Q ss_pred             CeEEeccCCcccc
Q 008108          384 NPKISDFGMARLF  396 (577)
Q Consensus       384 ~~kl~DfGla~~~  396 (577)
                      .+.|+|-+-+...
T Consensus       302 ~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  302 KLYIIDVSQSVEH  314 (520)
T ss_pred             EEEEEEccccccC
Confidence            7899998877543

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.54  E-value=0.018  Score=58.98  Aligned_cols=73  Identities=19%  Similarity=0.194  Sum_probs=45.8

Q ss_pred             ccccCCcEEEEEeEecCC-cEEEEEEeccC------C-hhhHHHHHHHHHHHHhcC--CC-CeEEEEeEEEcCCeEEEEE
Q 008108          251 KLGQGGFGAVYKGMLSNG-ETIAVKRLSKN------S-KQGEIEFKNEVLLLARLQ--HR-NLVRLLGFCLERKERILVY  319 (577)
Q Consensus       251 ~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~  319 (577)
                      .||.|....||++..++| +.|+||.-...      + .-...+..-|...|+...  -| .+.+++.+  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            579999999999998654 68999964321      1 112223345666665552  24 34444443  455567999


Q ss_pred             EecCCC
Q 008108          320 EFVPNA  325 (577)
Q Consensus       320 E~~~~g  325 (577)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            998653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.46  E-value=0.023  Score=57.74  Aligned_cols=29  Identities=28%  Similarity=0.357  Sum_probs=25.3

Q ss_pred             CcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          365 LRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       365 ~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      ..++|+|+.+.||+++. +.+.|.||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            46999999999999988 678999998764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.44  E-value=0.019  Score=58.99  Aligned_cols=141  Identities=17%  Similarity=0.293  Sum_probs=81.8

Q ss_pred             ccccccCCcEEEEEeEecC----CcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCe-EEEEeEEEcCCeEEEEEEecC
Q 008108          249 ANKLGQGGFGAVYKGMLSN----GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL-VRLLGFCLERKERILVYEFVP  323 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~  323 (577)
                      ++.|..|=.-.+|+....+    +..|++|+....... .....+|..+++.+...++ .++++++. .+   +|.+|++
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~   93 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFIN   93 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehhhc
Confidence            3455557777889887543    237889987664432 2334678888888865555 35666653 22   5899998


Q ss_pred             CCCcccc-----------------cccCC---CCCCCCHHHHHHHHHHH----------------------HHHHH----
Q 008108          324 NASLDHF-----------------IFDPI---NREHMTWEKRYKIIEGI----------------------ARGLL----  357 (577)
Q Consensus       324 ~gsL~~~-----------------l~~~~---~~~~l~~~~~~~i~~~i----------------------a~gl~----  357 (577)
                      +..|..-                 +++..   ....--|..+.++..++                      .+-+.    
T Consensus        94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~  173 (330)
T PLN02421         94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE  173 (330)
T ss_pred             CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence            7766321                 01100   00111233333322221                      11111    


Q ss_pred             Hhhc-CCCCcEEEeccCCCcEEEcC-CCCeEEeccCCcc
Q 008108          358 YLHE-DSRLRIIHRDLKASNILLDS-EMNPKISDFGMAR  394 (577)
Q Consensus       358 yLH~-~~~~~iiHrDlkp~NiLl~~-~~~~kl~DfGla~  394 (577)
                      ++.. ..+..++|.|+.+.|||+++ ++.++++||..|-
T Consensus       174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            1211 12345899999999999975 5689999998874

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.30  E-value=0.062  Score=54.78  Aligned_cols=140  Identities=21%  Similarity=0.280  Sum_probs=83.2

Q ss_pred             ccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCC------eEEEEe----EEEcCCeEEEEEE
Q 008108          251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN------LVRLLG----FCLERKERILVYE  320 (577)
Q Consensus       251 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~----~~~~~~~~~lv~E  320 (577)
                      .|.+ .-..+|+....+|+. ++|+....  ....++..|...|..|.-..      +..+=|    ........+-+++
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~  108 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE  108 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence            3444 556789988877777 88877665  34446677777777773222      122212    1112236788999


Q ss_pred             ecCCCCccc-ccc-----------------------cCCCCCCCCHHH-------------HHHHHHHHHHHHHHhhcC-
Q 008108          321 FVPNASLDH-FIF-----------------------DPINREHMTWEK-------------RYKIIEGIARGLLYLHED-  362 (577)
Q Consensus       321 ~~~~gsL~~-~l~-----------------------~~~~~~~l~~~~-------------~~~i~~~ia~gl~yLH~~-  362 (577)
                      |++|..+.. ...                       .+.......|..             ......++...+..+.+. 
T Consensus       109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~  188 (331)
T COG2334         109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL  188 (331)
T ss_pred             ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence            999988873 110                       000111334431             011233344444444432 


Q ss_pred             ---CC---CcEEEeccCCCcEEEcCCCC-eEEeccCCcc
Q 008108          363 ---SR---LRIIHRDLKASNILLDSEMN-PKISDFGMAR  394 (577)
Q Consensus       363 ---~~---~~iiHrDlkp~NiLl~~~~~-~kl~DfGla~  394 (577)
                         -+   ..+||+|+.|.||+++.+.. +-+.|||.+.
T Consensus       189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence               11   22999999999999999985 8899999875

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.26  E-value=0.013  Score=60.78  Aligned_cols=74  Identities=15%  Similarity=0.185  Sum_probs=47.7

Q ss_pred             ccccccCCcEEEEEeEecC-CcEEEEEEeccC-----C-hhhHHHHHHHHHHHHhcC--CC-CeEEEEeEEEcCCeEEEE
Q 008108          249 ANKLGQGGFGAVYKGMLSN-GETIAVKRLSKN-----S-KQGEIEFKNEVLLLARLQ--HR-NLVRLLGFCLERKERILV  318 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~-~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv  318 (577)
                      .+.||.|.-..||++...+ ++.|+||.-...     + .-...+..-|.+.|+...  -| .+.+++.+  +.+...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            5689999999999999753 568999964321     1 122334455667776652  34 45555544  45556788


Q ss_pred             EEecCC
Q 008108          319 YEFVPN  324 (577)
Q Consensus       319 ~E~~~~  324 (577)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998864

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.25  E-value=0.065  Score=50.85  Aligned_cols=76  Identities=18%  Similarity=0.254  Sum_probs=51.2

Q ss_pred             ccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcC---CCCeEEEEeEEEcCCeEEEEEEecCCC
Q 008108          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ---HRNLVRLLGFCLERKERILVYEFVPNA  325 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~E~~~~g  325 (577)
                      .+.+.-|.--..|.... ...++-||+=   .......|..|+.-|..+.   --++.+++.+-......|||+||++-+
T Consensus        21 r~~v~gG~inea~~v~d-g~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~   96 (286)
T COG3001          21 REEVSGGDINEAWRLRD-GTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG   96 (286)
T ss_pred             ccccCCccccceeEeec-CCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence            34555555555555443 3566788853   2223335677777766663   456778888888999999999999988


Q ss_pred             Ccc
Q 008108          326 SLD  328 (577)
Q Consensus       326 sL~  328 (577)
                      .++
T Consensus        97 ~~d   99 (286)
T COG3001          97 PLD   99 (286)
T ss_pred             CCC
Confidence            876

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.20  E-value=0.058  Score=54.80  Aligned_cols=32  Identities=25%  Similarity=0.359  Sum_probs=28.1

Q ss_pred             CCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          364 RLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       364 ~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      +..++|+|+.+.|+|+++++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            34699999999999999999999999988753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.19  E-value=0.00045  Score=80.14  Aligned_cols=159  Identities=13%  Similarity=-0.030  Sum_probs=113.8

Q ss_pred             HHHHHHHHhcCCCCeEEEEeEEE--cCCeEEEEEEecCCCCcccccccCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCC-
Q 008108          288 KNEVLLLARLQHRNLVRLLGFCL--ERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDS-  363 (577)
Q Consensus       288 ~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~-  363 (577)
                      ..|...++...|+++.....-..  +..+.+.+++|+.+|.+...|..+. +...++.........+......-.|... 
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence            34555666678998876655443  2345688999999999988876543 2334555554444444355555555432 


Q ss_pred             -CCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHh
Q 008108          364 -RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIV  442 (577)
Q Consensus       364 -~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ell  442 (577)
                       ..--+|++||+-|.+|..+.++|+.++|+.+...+..  .......+++.|+.|+....-.++.++|+|..|.-+|+.-
T Consensus      1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             CCccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence             2346999999999999999999999999998433221  2223357788999999998889999999999999999998


Q ss_pred             hCCCCC
Q 008108          443 SGQKRS  448 (577)
Q Consensus       443 tG~~p~  448 (577)
                      -|..++
T Consensus      1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred             cccHHH
Confidence            887654

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.51  E-value=0.38  Score=49.26  Aligned_cols=72  Identities=14%  Similarity=0.100  Sum_probs=45.1

Q ss_pred             CCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCC--eEEEE---e--EEEcCCeEEEEEEecCCCCc
Q 008108          255 GGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN--LVRLL---G--FCLERKERILVYEFVPNASL  327 (577)
Q Consensus       255 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~---~--~~~~~~~~~lv~E~~~~gsL  327 (577)
                      +.-..||+....+|+.+++|...... ....++..|+..+..|....  ++...   |  ....++..+.++++++|...
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            34467999988788889999875332 33446677888777763221  22211   1  12224567889999988754

>PTZ00384 choline kinase; Provisional

Probab=95.35  E-value=0.13  Score=53.79  Aligned_cols=76  Identities=18%  Similarity=0.299  Sum_probs=47.3

Q ss_pred             ccccccCCcEEEEEeEecCC--cE-----EEEEEeccCChhhHHHHHHHHHHHHhcCCCCe-EEEEeEEEcCCeEEEEEE
Q 008108          249 ANKLGQGGFGAVYKGMLSNG--ET-----IAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL-VRLLGFCLERKERILVYE  320 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E  320 (577)
                      .+.|..|-...+|++...++  ..     |.++.... .......-.+|+.+++.+...++ .++++.+..    ++++|
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e  129 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE  129 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccC-CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence            45666688889999876543  22     33333222 21212234678999999965555 456666543    59999


Q ss_pred             ecCCCCccc
Q 008108          321 FVPNASLDH  329 (577)
Q Consensus       321 ~~~~gsL~~  329 (577)
                      |++|.+|..
T Consensus       130 fIeGr~l~~  138 (383)
T PTZ00384        130 WVEGNTMGI  138 (383)
T ss_pred             EeccccCCh
Confidence            999987753

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.34  E-value=0.1  Score=49.25  Aligned_cols=117  Identities=17%  Similarity=0.193  Sum_probs=74.6

Q ss_pred             CCcEEEEEeEecCCcEEEEEEeccCChh-hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCCCccccccc
Q 008108          255 GGFGAVYKGMLSNGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD  333 (577)
Q Consensus       255 G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~  333 (577)
                      ++-.+.-+++.+-| +..+|++....-. ...-|+++..+++++.  .|+++..=  +...+-++.|+|-....      
T Consensus        73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------  141 (308)
T ss_pred             CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence            34455555554433 3456666544333 3445788899988875  46777622  33456688998843211      


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCc
Q 008108          334 PINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (577)
Q Consensus       334 ~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla  393 (577)
                            ..    ..++..=+..|.-.|+.+ ...+|+|-.|+||+-|+.|.+||.|-+..
T Consensus       142 ------~~----~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  142 ------NF----SNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             ------ch----hHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence                  11    122222246678889653 35999999999999999999999998754

The function of this family is unknown.

>PRK06148 hypothetical protein; Provisional

Probab=95.30  E-value=0.18  Score=59.69  Aligned_cols=141  Identities=18%  Similarity=0.258  Sum_probs=78.3

Q ss_pred             cccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcC-------CCCeEEEE-e----EEEc-CC--e
Q 008108          250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-------HRNLVRLL-G----FCLE-RK--E  314 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-------h~niv~l~-~----~~~~-~~--~  314 (577)
                      +.|+ |..-.+|+....+|+.+++|+.......  .+...|...|..|.       -|.+++.. |    .... ++  .
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            4564 3457789888878889999998765322  23344555555442       23333322 1    1111 22  4


Q ss_pred             EEEEEEecCCCCcccccc-----------------------cC-CCCCCCCHHH-----------------HHHHHHHHH
Q 008108          315 RILVYEFVPNASLDHFIF-----------------------DP-INREHMTWEK-----------------RYKIIEGIA  353 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~-----------------------~~-~~~~~l~~~~-----------------~~~i~~~ia  353 (577)
                      .+-+++|++|..|.+...                       .. .....+.|..                 ...++.++.
T Consensus       108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~  187 (1013)
T PRK06148        108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL  187 (1013)
T ss_pred             EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence            567899999987754110                       00 0111233321                 112223333


Q ss_pred             HHHH-----HhhcCCCCcEEEeccCCCcEEEcCCC--CeE-EeccCCcc
Q 008108          354 RGLL-----YLHEDSRLRIIHRDLKASNILLDSEM--NPK-ISDFGMAR  394 (577)
Q Consensus       354 ~gl~-----yLH~~~~~~iiHrDlkp~NiLl~~~~--~~k-l~DfGla~  394 (577)
                      +.+.     .|.+ -+..+||+|+.+.|||++.+.  ++. |+|||.+.
T Consensus       188 ~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        188 ARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             HHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            3222     1222 133599999999999999875  555 99999875

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	577
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-59
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		9e-58
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-45
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-44
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-41
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		6e-41
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-40
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-39
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-26
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-26
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-24
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-24
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-24
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-24
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-24
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-24
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-24
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-24
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-24
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-24
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-24
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-24
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-24
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-23
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-23
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-23
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-23
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-23
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-23
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-23
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-23
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-23
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-23
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		7e-23
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		8e-23
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		9e-23
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		9e-23
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-22
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-22
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-22
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-22
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-22
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-22
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-22
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-22
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-22
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-22
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-22
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-22
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-22
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-22
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-22
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-22
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-22
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-22
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-22
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-22
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-22
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-22
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-22
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-22
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-22
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-22
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-22
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-22
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-22
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-22
3a4o_X	286	Lyn Kinase Domain Length = 286		8e-22
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		8e-22
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		9e-22
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-21
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-21
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-21
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-21
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-21
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-21
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-21
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-21
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-21
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-21
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-21
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-21
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-21
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-21
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-21
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-21
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-21
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-21
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-21
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-21
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-21
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-21
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-21
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-21
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-21
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-21
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-21
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-21
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-21
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-21
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-21
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-21
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-21
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-21
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-21
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-21
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-21
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-21
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-21
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-21
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-21
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-21
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-21
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-21
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-21
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-21
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-21
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-21
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-21
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-21
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		6e-21
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-21
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-21
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-21
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		7e-21
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		7e-21
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-21
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		7e-21
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		7e-21
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		8e-21
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		8e-21
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		8e-21
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-21
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-20
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-20
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-20
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-20
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-20
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-20
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-20
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-20
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-20
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-20
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-20
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-20
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-20
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-20
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-20
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-20
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-20
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-20
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-20
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-20
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-20
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-20
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-20
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-20
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-20
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-20
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-20
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-20
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-20
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		7e-20
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		7e-20
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-20
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-20
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-20
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		8e-20
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-20
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		8e-20
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		8e-20
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		8e-20
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		9e-20
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-19
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-19
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-19
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-19
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-19
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-19
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-19
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-19
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-19
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-19
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-19
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-19
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-19
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-19
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-19
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-19
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-19
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-19
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-19
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-19
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-19
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-19
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		5e-19
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-19
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-19
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-19
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		6e-19
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-19
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-19
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		6e-19
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-19
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-19
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-19
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		8e-19
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		9e-19
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		9e-19
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		9e-19
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-19
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-18
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-18
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-18
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-18
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-18
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-18
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-18
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-18
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-18
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-18
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-18
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-18
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-18
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-18
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-18
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-18
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-18
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-18
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-18
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-18
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-18
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-18
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-18
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-18
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-18
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-18
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-18
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-18
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-18
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-18
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-18
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-18
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		7e-18
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-18
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-18
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		8e-18
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		8e-18
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		8e-18
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		8e-18
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		8e-18
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-18
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		9e-18
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		9e-18
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-17
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-17
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-17
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-17
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-17
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-17
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-17
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-17
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-17
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-17
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-17
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-17
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-17
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-17
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-17
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-17
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-17
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-17
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-17
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-17
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-17
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-17
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-17
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-17
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-17
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-17
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-17
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-17
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-17
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-17
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-17
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-17
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-17
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-17
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-17
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-17
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-17
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-17
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-17
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-17
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-17
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-17
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-17
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-17
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-17
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-17
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-17
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-17
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-17
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-17
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-17
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-17
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-17
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-17
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-17
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-17
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-17
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-17
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-17
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-17
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-17
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-17
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-17
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-17
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-17
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-17
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-17
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-17
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		7e-17
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-17
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		8e-17
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		8e-17
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		8e-17
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		9e-17
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		9e-17
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		9e-17
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-16
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-16
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-16
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-16
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-16
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-16
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-16
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-16
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-16
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-16
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-16
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-16
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-16
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-16
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-16
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-16
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-16
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-16
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-16
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-16
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-16
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-16
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-16
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-16
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-16
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-16
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		6e-16
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		6e-16
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-16
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-16
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-16
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-16
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-16
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-16
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		7e-16
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		7e-16
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-16
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-16
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-16
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		8e-16
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-16
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-16
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-15
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-15
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-15
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-15
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-15
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-15
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-15
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-15
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-15
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-15
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-15
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-15
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-15
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-15
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-15
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-15
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-15
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-15
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-15
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-15
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-15
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-15
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-15
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-15
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-15
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-15
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-15
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-15
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-15
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-15
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-15
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-15
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-15
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-15
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-15
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-15
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-15
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-15
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-15
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-15
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-15
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-15
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-15
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-15
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-15
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-15
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-15
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		7e-15
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		7e-15
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-15
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		8e-15
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-15
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		8e-15
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		9e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		9e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-15
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		9e-15
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-14
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-14
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-14
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-14
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-14
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-14
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-14
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-14
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-14
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-14
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-14
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-14
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-14
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-14
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-14
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-14
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-14
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-14
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-14
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-14
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-14
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-14
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-14
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-14
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-14
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-14
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-14
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-14
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-14
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-14
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-14
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-14
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-14
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-14
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-14
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-14
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-14
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-14
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-14
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-14
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-14
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-14
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-14
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-14
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-14
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-14
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-14
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-14
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-14
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-14
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-14
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-14
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-14
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-14
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-14
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-14
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-14
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-14
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-14
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-14
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-14
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-14
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-14
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-14
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-14
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-14
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-14
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-14
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		6e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		6e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		6e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-14
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-14
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-14
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-14
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		8e-14
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-14
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		8e-14
3kk8_A	284	Camkii Substrate Complex A Length = 284		9e-14
3kk9_A	282	Camkii Substrate Complex B Length = 282		9e-14
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		9e-14
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-13
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-13
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-13
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-13
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-13
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-13
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-13
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-13
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-13
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-13
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-13
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-13
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-13
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-13
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-13
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-13
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-13
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-13
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-13
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-13
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-13
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-13
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-13
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-13
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-13
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-13
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-13
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-13
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-13
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-13
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-13
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-13
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-13
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-13
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-13
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-13
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-13
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-13
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-13
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-13
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-13
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-13
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-13
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-13
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-13
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-13
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-13
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-13
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-13
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-13
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-13
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-13
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-13
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-13
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-13
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-13
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-13
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-13
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-13
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-13
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-13
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-13
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-13
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-13
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-13
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-13
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-13
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-13
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-13
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		5e-13
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-13
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-13
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-13
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-13
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-13
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-13
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-13
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		6e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-13
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		6e-13
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-13
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-13
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		6e-13
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-13
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-13
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		7e-13
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		7e-13
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-13
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		7e-13
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		7e-13
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		7e-13
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-13
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		8e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		8e-13
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		8e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		9e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		9e-13
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		9e-13
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		9e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-12
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-12
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-12
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-12
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-12
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-12
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-12
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-12
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-12
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-12
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-12
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-12
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-12
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-12
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-12
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-12
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-12
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		5e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-12
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-12
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-12
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-12
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-12
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-12
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-12
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		6e-12
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-12
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		7e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-12
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-12
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		8e-12
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		8e-12
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		9e-12
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		9e-12
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		9e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-11
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-11
3soa_A	444	Full-Length Human Camkii Length = 444		2e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-11
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-11
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-11
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-11
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-11
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-11
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-11
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-11
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-11
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-11
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-11
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-11
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-11
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-11
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-11
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-11
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-11
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-11
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-11
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		6e-11
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-11
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		7e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		7e-11
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-11
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		7e-11
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		8e-11
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		9e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		9e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		9e-11
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		9e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-10
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-10
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-10
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-10
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-10
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-10
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-10
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-10
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-10
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-10
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-10
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-10
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-10
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-10
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-10
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-10
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-10
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-10
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-10
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-10
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-10
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-10
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-10
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-10
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-10
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-10
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-10
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-10
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-10
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-10
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-10
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-10
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-10
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-10
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		4e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-10
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-10
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-10
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-10
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-10
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-10
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		7e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		7e-10
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		7e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		8e-10
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		8e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		8e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		8e-10
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		9e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		9e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		9e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-09
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-09
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-09
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-09
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-09
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-09
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-09
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		7e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		8e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		8e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		9e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		9e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		9e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		9e-09
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		9e-09
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-08
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-08
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		9e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-07
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-07
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-07
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		5e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-07

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  225 bits (574), Expect = 5e-59,   Method: Compositional matrix adjust.
 Identities = 121/307 (39%), Positives = 186/307 (60%), Gaps = 6/307 (1%)
Query: 221 DENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS 280
           +E+ E  + +  +F    ++VA+DNFS+ N LG+GGFG VYKG L++G  +AVKRL +  
Sbjct: 15  EEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEER 74
Query: 281 KQG-EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD-PINRE 338
            QG E++F+ EV +++   HRNL+RL GFC+   ER+LVY ++ N S+   + + P ++ 
Sbjct: 75  XQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 134
Query: 339 HMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM 398
            + W KR +I  G ARGL YLH+    +IIHRD+KA+NILLD E    + DFG+A+L + 
Sbjct: 135 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 194
Query: 399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETED 458
              H     V GT G++APEY+  G+ S K+D+F +GV++LE+++GQ+          +D
Sbjct: 195 KDXHV-XXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 253
Query: 459 LLTYAWRN--WNEGAALNLMDPTMRGG-STSEMMKCIHIGLLCVQENVSNRPGMASVVNM 515
           ++   W      E     L+D  ++G     E+ + I + LLC Q +   RP M+ VV M
Sbjct: 254 VMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 313
Query: 516 LNGDTVT 522
           L GD + 
Sbjct: 314 LEGDGLA 320

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  221 bits (563), Expect = 9e-58,   Method: Compositional matrix adjust.
 Identities = 119/307 (38%), Positives = 184/307 (59%), Gaps = 6/307 (1%)
Query: 221 DENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS 280
           +E+ E  + +  +F    ++VA+DNF + N LG+GGFG VYKG L++G  +AVKRL +  
Sbjct: 7   EEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEER 66
Query: 281 KQG-EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD-PINRE 338
            QG E++F+ EV +++   HRNL+RL GFC+   ER+LVY ++ N S+   + + P ++ 
Sbjct: 67  TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126
Query: 339 HMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM 398
            + W KR +I  G ARGL YLH+    +IIHRD+KA+NILLD E    + DFG+A+L + 
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186
Query: 399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETED 458
              H     V G  G++APEY+  G+ S K+D+F +GV++LE+++GQ+          +D
Sbjct: 187 KDXHV-XXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245
Query: 459 LLTYAWRN--WNEGAALNLMDPTMRGG-STSEMMKCIHIGLLCVQENVSNRPGMASVVNM 515
           ++   W      E     L+D  ++G     E+ + I + LLC Q +   RP M+ VV M
Sbjct: 246 VMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305
Query: 516 LNGDTVT 522
           L GD + 
Sbjct: 306 LEGDGLA 312

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  179 bits (454), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 111/301 (36%), Positives = 170/301 (56%), Gaps = 14/301 (4%)
Query: 223 NVEETIAKSLQFDFETIRV-------ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKR 275
           ++ + ++ S    FE+ RV       AT+NF     +G G FG VYKG+L +G  +A+KR
Sbjct: 11  SINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70
Query: 276 LSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD-HFIFDP 334
            +  S QG  EF+ E+  L+  +H +LV L+GFC ER E IL+Y+++ N +L  H     
Sbjct: 71  RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130
Query: 335 INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +    M+WE+R +I  G ARGL YLH  +   IIHRD+K+ NILLD    PKI+DFG+++
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK 187
Query: 395 L-FEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTE 453
              E+DQTH     V GT GY+ PEY + GR + KSD++SFGV++ E++  +        
Sbjct: 188 KGTELDQTHL-XXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246
Query: 454 EETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCI-HIGLLCVQENVSNRPGMASV 512
            E  +L  +A  + N G    ++DP +      E ++      + C+  +  +RP M  V
Sbjct: 247 REMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306
Query: 513 V 513
           +
Sbjct: 307 L 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  176 bits (446), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 110/301 (36%), Positives = 169/301 (56%), Gaps = 14/301 (4%)
Query: 223 NVEETIAKSLQFDFETIRV-------ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKR 275
           ++ + ++ S    FE+ RV       AT+NF     +G G FG VYKG+L +G  +A+KR
Sbjct: 11  SINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70
Query: 276 LSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD-HFIFDP 334
            +  S QG  EF+ E+  L+  +H +LV L+GFC ER E IL+Y+++ N +L  H     
Sbjct: 71  RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130
Query: 335 INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +    M+WE+R +I  G ARGL YLH  +   IIHRD+K+ NILLD    PKI+DFG+++
Sbjct: 131 LPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK 187
Query: 395 L-FEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTE 453
              E+ QTH     V GT GY+ PEY + GR + KSD++SFGV++ E++  +        
Sbjct: 188 KGTELGQTHL-XXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246
Query: 454 EETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCI-HIGLLCVQENVSNRPGMASV 512
            E  +L  +A  + N G    ++DP +      E ++      + C+  +  +RP M  V
Sbjct: 247 REMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306
Query: 513 V 513
           +
Sbjct: 307 L 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  166 bits (420), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 107/314 (34%), Positives = 170/314 (54%), Gaps = 18/314 (5%)
Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSD------ANKLGQGGFGAVYKGMLSNGETIAV 273
           E++++E +  +   F F  ++  T+NF +       NK+G+GGFG VYKG ++N  T+AV
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAV 59
Query: 274 KRLSK----NSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDH 329
           K+L+      +++ + +F  E+ ++A+ QH NLV LLGF  +  +  LVY ++PN SL  
Sbjct: 60  KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 330 FIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD 389
            +        ++W  R KI +G A G+ +LHE+     IHRD+K++NILLD     KISD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISD 176
Query: 390 FGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSS 449
           FG+AR  E        +R+VGT  YMAPE  + G  + KSDI+SFGV++LEI++G    +
Sbjct: 177 FGLARASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG--LPA 233
Query: 450 FGTEEETEDLL-TYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPG 508
                E + LL         E    + +D  M    ++ +     +   C+ E  + RP 
Sbjct: 234 VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPD 293
Query: 509 MASVVNMLNGDTVT 522
           +  V  +L   T +
Sbjct: 294 IKKVQQLLQEMTAS 307

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  165 bits (418), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 107/314 (34%), Positives = 169/314 (53%), Gaps = 18/314 (5%)
Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSD------ANKLGQGGFGAVYKGMLSNGETIAV 273
           E++++E +  +   F F  ++  T+NF +       NK+G+GGFG VYKG ++N  T+AV
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAV 59
Query: 274 KRLSK----NSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDH 329
           K+L+      +++ + +F  E+ ++A+ QH NLV LLGF  +  +  LVY ++PN SL  
Sbjct: 60  KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 330 FIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD 389
            +        ++W  R KI +G A G+ +LHE+     IHRD+K++NILLD     KISD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISD 176
Query: 390 FGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSS 449
           FG+AR  E         R+VGT  YMAPE  + G  + KSDI+SFGV++LEI++G    +
Sbjct: 177 FGLARASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG--LPA 233
Query: 450 FGTEEETEDLL-TYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPG 508
                E + LL         E    + +D  M    ++ +     +   C+ E  + RP 
Sbjct: 234 VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPD 293
Query: 509 MASVVNMLNGDTVT 522
           +  V  +L   T +
Sbjct: 294 IKKVQQLLQEMTAS 307

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  164 bits (414), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 161/300 (53%), Gaps = 18/300 (6%)
Query: 234 FDFETIRVATDNFSD------ANKLGQGGFGAVYKGMLSNGETIAVKRLSK----NSKQG 283
           F F  ++  T+NF +       NK+G+GGFG VYKG ++N  T+AVK+L+      +++ 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 284 EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWE 343
           + +F  E+ ++A+ QH NLV LLGF  +  +  LVY ++PN SL   +        ++W 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 344 KRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
            R KI +G A G+ +LHE+     IHRD+K++NILLD     KISDFG+AR  E      
Sbjct: 128 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL-TY 462
              R+VGT  YMAPE  + G  + KSDI+SFGV++LEI++G    +     E + LL   
Sbjct: 185 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG--LPAVDEHREPQLLLDIK 241
Query: 463 AWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVT 522
                 E    + +D  M    ++ +     +   C+ E  + RP +  V  +L   T +
Sbjct: 242 EEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 301

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  159 bits (402), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 103/300 (34%), Positives = 157/300 (52%), Gaps = 18/300 (6%)
Query: 234 FDFETIRVATDNFSD------ANKLGQGGFGAVYKGMLSNGETIAVKRLSK----NSKQG 283
           F F  ++  T+NF +       NK G+GGFG VYKG ++N  T+AVK+L+      +++ 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 284 EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWE 343
           + +F  E+ + A+ QH NLV LLGF  +  +  LVY + PN SL   +        ++W 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 344 KRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
            R KI +G A G+ +LHE+     IHRD+K++NILLD     KISDFG+AR  E      
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL-TY 462
             +R+VGT  Y APE  + G  + KSDI+SFGV++LEI++G    +     E + LL   
Sbjct: 182 XXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITG--LPAVDEHREPQLLLDIK 238
Query: 463 AWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVT 522
                 E    + +D       ++ +     +   C+ E  + RP +  V  +L   T +
Sbjct: 239 EEIEDEEKTIEDYIDKKXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQEXTAS 298

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 80/250 (32%), Positives = 137/250 (54%), Gaps = 14/250 (5%)
Query: 219 LEDENVEETIAKSLQFDFETIRVATDN-FSDANKLGQGGFGAVYKGM-LSNGETI----A 272
           LE E VE         +   +R+  +        LG G FG VYKG+ +  GET+    A
Sbjct: 12  LETELVEPLTPSGTAPNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVA 71
Query: 273 VKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
           +K L++ +  +  +EF +E L++A + H +LVRLLG CL    + LV + +P+  L  ++
Sbjct: 72  IKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYV 130
Query: 332 FDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG 391
            +  +++++  +        IA+G++YL E    R++HRDL A N+L+ S  + KI+DFG
Sbjct: 131 HE--HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFG 185
Query: 392 MARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSF 450
           +ARL E D+   + +       +MA E + + +F+ +SD++S+GV + E+++ G K    
Sbjct: 186 LARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 245
Query: 451 GTEEETEDLL 460
               E  DLL
Sbjct: 246 IPTREIPDLL 255

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score =  115 bits (289), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 74/216 (34%), Positives = 127/216 (58%), Gaps = 13/216 (6%)
Query: 252 LGQGGFGAVYKGM-LSNGETI----AVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRL 305
           LG G FG VYKG+ +  GET+    A+K L++ +  +  +EF +E L++A + H +LVRL
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 306 LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
           LG CL    + LV + +P+  L  ++ +  +++++  +        IA+G++YL E    
Sbjct: 83  LGVCLSPTIQ-LVTQLMPHGCLLEYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER--- 136
Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRF 425
           R++HRDL A N+L+ S  + KI+DFG+ARL E D+   + +       +MA E + + +F
Sbjct: 137 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 196
Query: 426 SVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLL 460
           + +SD++S+GV + E+++ G K        E  DLL
Sbjct: 197 THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 232

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 70/203 (34%), Positives = 111/203 (54%), Gaps = 7/203 (3%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           V  +      +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+
Sbjct: 20  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQ 78
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LVRL     +    I+  E++ N SL  F+  P   + +T  K   +   IA G+ ++ 
Sbjct: 79  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 136
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV 420
           E +    IHRDL+A+NIL+   ++ KI+DFG+ARL E D  ++          + APE +
Sbjct: 137 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAI 192
Query: 421 MHGRFSVKSDIFSFGVLVLEIVS 443
            +G F++KSD++SFG+L+ EIV+
Sbjct: 193 NYGTFTIKSDVWSFGILLTEIVT 215

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 70/203 (34%), Positives = 111/203 (54%), Gaps = 7/203 (3%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           V  +      +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+
Sbjct: 16  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 74
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LVRL     +    I+  E++ N SL  F+  P   + +T  K   +   IA G+ ++ 
Sbjct: 75  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 132
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV 420
           E +    IHRDL+A+NIL+   ++ KI+DFG+ARL E D  ++          + APE +
Sbjct: 133 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAI 188
Query: 421 MHGRFSVKSDIFSFGVLVLEIVS 443
            +G F++KSD++SFG+L+ EIV+
Sbjct: 189 NYGTFTIKSDVWSFGILLTEIVT 211

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 143/278 (51%), Gaps = 36/278 (12%)
Query: 252 LGQGGFGAVYKGML--SNGET---IAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRL 305
           +G G FG VYKGML  S+G+    +A+K L    +++  ++F  E  ++ +  H N++RL
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 306 LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
            G   + K  +++ E++ N +LD F+ +       +  +   ++ GIA G+ YL   + +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYL---ANM 166
Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMD--QTHSDTNRVVGTFGYMAPEYVMHG 423
             +HRDL A NIL++S +  K+SDFG++R+ E D   T++ +   +    + APE + + 
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI-PIRWTAPEAISYR 225
Query: 424 RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGG 483
           +F+  SD++SFG+++ E+                  +TY  R + E +   +M     G 
Sbjct: 226 KFTSASDVWSFGIVMWEV------------------MTYGERPYWELSNHEVMKAINDGF 267
Query: 484 STSEMMKC----IHIGLLCVQENVSNRPGMASVVNMLN 517
                M C      + + C Q+  + RP  A +V++L+
Sbjct: 268 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 305

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 70/203 (34%), Positives = 111/203 (54%), Gaps = 7/203 (3%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           V  +      +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+
Sbjct: 15  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 73
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LVRL     +    I+  E++ N SL  F+  P   + +T  K   +   IA G+ ++ 
Sbjct: 74  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 131
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV 420
           E +    IHRDL+A+NIL+   ++ KI+DFG+ARL E D  ++          + APE +
Sbjct: 132 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAI 187
Query: 421 MHGRFSVKSDIFSFGVLVLEIVS 443
            +G F++KSD++SFG+L+ EIV+
Sbjct: 188 NYGTFTIKSDVWSFGILLTEIVT 210

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 70/203 (34%), Positives = 111/203 (54%), Gaps = 7/203 (3%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           V  +      +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 68
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LVRL     +    I+  E++ N SL  F+  P   + +T  K   +   IA G+ ++ 
Sbjct: 69  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 126
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV 420
           E +    IHRDL+A+NIL+   ++ KI+DFG+ARL E D  ++          + APE +
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAI 182
Query: 421 MHGRFSVKSDIFSFGVLVLEIVS 443
            +G F++KSD++SFG+L+ EIV+
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/203 (34%), Positives = 111/203 (54%), Gaps = 7/203 (3%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           V  +      +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+
Sbjct: 5   VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 63
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LVRL     +    I+  E++ N SL  F+  P   + +T  K   +   IA G+ ++ 
Sbjct: 64  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 121
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV 420
           E +    IHRDL+A+NIL+   ++ KI+DFG+ARL E D  ++          + APE +
Sbjct: 122 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAI 177
Query: 421 MHGRFSVKSDIFSFGVLVLEIVS 443
            +G F++KSD++SFG+L+ EIV+
Sbjct: 178 NYGTFTIKSDVWSFGILLTEIVT 200

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 72/205 (35%), Positives = 113/205 (55%), Gaps = 11/205 (5%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           V  +      +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+
Sbjct: 18  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQ 76
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LVRL     +    I+  E++ N SL  F+  P   + +T  K   +   IA G+ ++ 
Sbjct: 77  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 134
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPE 418
           E +    IHRDL+A+NIL+   ++ KI+DFG+ARL E ++    T R    F   + APE
Sbjct: 135 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPE 188
Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVS 443
            + +G F++KSD++SFG+L+ EIV+
Sbjct: 189 AINYGTFTIKSDVWSFGILLTEIVT 213

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 72/205 (35%), Positives = 113/205 (55%), Gaps = 11/205 (5%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           V  +      +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+
Sbjct: 16  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQ 74
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LVRL     +    I+  E++ N SL  F+  P   + +T  K   +   IA G+ ++ 
Sbjct: 75  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 132
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPE 418
           E +    IHRDL+A+NIL+   ++ KI+DFG+ARL E ++    T R    F   + APE
Sbjct: 133 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPE 186
Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVS 443
            + +G F++KSD++SFG+L+ EIV+
Sbjct: 187 AINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 72/205 (35%), Positives = 113/205 (55%), Gaps = 11/205 (5%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           V  +      +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+
Sbjct: 19  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 77
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LVRL     +    I+  E++ N SL  F+  P   + +T  K   +   IA G+ ++ 
Sbjct: 78  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 135
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPE 418
           E +    IHRDL+A+NIL+   ++ KI+DFG+ARL E ++    T R    F   + APE
Sbjct: 136 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPE 189
Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVS 443
            + +G F++KSD++SFG+L+ EIV+
Sbjct: 190 AINYGTFTIKSDVWSFGILLTEIVT 214

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 72/205 (35%), Positives = 113/205 (55%), Gaps = 11/205 (5%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           V  +      +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 68
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LVRL     +    I+  E++ N SL  F+  P   + +T  K   +   IA G+ ++ 
Sbjct: 69  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 126
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPE 418
           E +    IHRDL+A+NIL+   ++ KI+DFG+ARL E ++    T R    F   + APE
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPE 180
Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVS 443
            + +G F++KSD++SFG+L+ EIV+
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 72/205 (35%), Positives = 113/205 (55%), Gaps = 11/205 (5%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           V  +      +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+
Sbjct: 12  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 70
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LVRL     +    I+  E++ N SL  F+  P   + +T  K   +   IA G+ ++ 
Sbjct: 71  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 128
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPE 418
           E +    IHRDL+A+NIL+   ++ KI+DFG+ARL E ++    T R    F   + APE
Sbjct: 129 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPE 182
Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVS 443
            + +G F++KSD++SFG+L+ EIV+
Sbjct: 183 AINYGTFTIKSDVWSFGILLTEIVT 207

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 72/205 (35%), Positives = 113/205 (55%), Gaps = 11/205 (5%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           V  +      +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+
Sbjct: 11  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 69
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LVRL     +    I+  E++ N SL  F+  P   + +T  K   +   IA G+ ++ 
Sbjct: 70  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 127
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPE 418
           E +    IHRDL+A+NIL+   ++ KI+DFG+ARL E ++    T R    F   + APE
Sbjct: 128 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPE 181
Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVS 443
            + +G F++KSD++SFG+L+ EIV+
Sbjct: 182 AINYGTFTIKSDVWSFGILLTEIVT 206

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  108 bits (271), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 72/205 (35%), Positives = 113/205 (55%), Gaps = 11/205 (5%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           V  +      +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 68
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LVRL     +    I+  E++ N SL  F+  P   + +T  K   +   IA G+ ++ 
Sbjct: 69  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 126
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPE 418
           E +    IHRDL+A+NIL+   ++ KI+DFG+ARL E ++    T R    F   + APE
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEX---TAREGAKFPIKWTAPE 180
Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVS 443
            + +G F++KSD++SFG+L+ EIV+
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 111/203 (54%), Gaps = 7/203 (3%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           V  +      +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+
Sbjct: 6   VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 64
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LVRL     +    I+  E++ N SL  F+  P   + +T  K   +   IA G+ ++ 
Sbjct: 65  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 122
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV 420
           E +    IHR+L+A+NIL+   ++ KI+DFG+ARL E D  ++          + APE +
Sbjct: 123 ERN---YIHRNLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAI 178
Query: 421 MHGRFSVKSDIFSFGVLVLEIVS 443
            +G F++KSD++SFG+L+ EIV+
Sbjct: 179 NYGTFTIKSDVWSFGILLTEIVT 201

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 76/218 (34%), Positives = 122/218 (55%), Gaps = 17/218 (7%)
Query: 252 LGQGGFGAVYKGM-LSNGETI----AVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRL 305
           LG G FG VYKG+ + +GE +    A+K L +N S +   E  +E  ++A +    + RL
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 306 LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
           LG CL    + LV + +P   L   + +  NR  +  +        IA+G+ YL +   +
Sbjct: 85  LGICLTSTVQ-LVTQLMPYGCLLDHVRE--NRGRLGSQDLLNWCMQIAKGMSYLED---V 138
Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT--HSDTNRVVGTFGYMAPEYVMHG 423
           R++HRDL A N+L+ S  + KI+DFG+ARL ++D+T  H+D  +V     +MA E ++  
Sbjct: 139 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV--PIKWMALESILRR 196
Query: 424 RFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLL 460
           RF+ +SD++S+GV V E+++ G K        E  DLL
Sbjct: 197 RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL 234

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 107/193 (55%), Gaps = 7/193 (3%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I++ E++   SL  F+   + + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 84  EEPIYIVI-EYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSD 430
           DL+A+NIL+   +  K++DFG+ARL E D  ++          + APE  ++GRF++KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 431 IFSFGVLVLEIVS 443
           ++SFG+L+ E+ +
Sbjct: 198 VWSFGILLTELTT 210

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 109/203 (53%), Gaps = 7/203 (3%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           V  +      +LG G  G V+ G  +    +AVK L + S   +  F  E  L+ +LQH+
Sbjct: 10  VPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQ 68
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
            LVRL     +    I+  E++ N SL  F+  P   + +T  K   +   IA G+ ++ 
Sbjct: 69  RLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 126
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV 420
           E +    IHRDL+A+NIL+   ++ KI+DFG+ARL E D   +          + APE +
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE-DAEXTAREGAKFPIKWTAPEAI 182
Query: 421 MHGRFSVKSDIFSFGVLVLEIVS 443
            +G F++KSD++SFG+L+ EIV+
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 105/193 (54%), Gaps = 7/193 (3%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+     + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 333 EEPIYI-VTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387
Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSD 430
           DL+A+NIL+   +  K++DFG+ARL E D  ++          + APE  ++GRF++KSD
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 431 IFSFGVLVLEIVS 443
           ++SFG+L+ E+ +
Sbjct: 447 VWSFGILLTELTT 459

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 106/193 (54%), Gaps = 7/193 (3%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+   + + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 73  EEPIYI-VTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 127
Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSD 430
           DL+A+NIL+   +  K++DFG+ARL E D  ++          + APE  ++GRF++KSD
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 186
Query: 431 IFSFGVLVLEIVS 443
           ++SFG+L+ E+ +
Sbjct: 187 VWSFGILLTELTT 199

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 149/285 (52%), Gaps = 37/285 (12%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
           N S    +G G FG V  G L   S  E ++A+K L    +++   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE------GIA 353
            N++RL G   + K  ++V E++ N SLD F+     R+H   + ++ +I+      GIA
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKH---DAQFTVIQLVGMLRGIA 157
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-F 412
            G+ YL   S +  +HRDL A NIL++S +  K+SDFG+AR+ E D   + T R      
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPI 214
Query: 413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAA 472
            + +PE + + +F+  SD++S+G+++ E++S  +R  +  E   +D++       +EG  
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW--EMSNQDVIKAV----DEG-- 266
Query: 473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
             L  P     +  ++M      L C Q++ +NRP    +V++L+
Sbjct: 267 YRLPPPMDCPAALYQLM------LDCWQKDRNNRPKFEQIVSILD 305

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 106/193 (54%), Gaps = 7/193 (3%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+   + + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 75  EEPIYI-VTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 129
Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSD 430
           DL+A+NIL+   +  K++DFG+ARL E D  ++          + APE  ++GRF++KSD
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 431 IFSFGVLVLEIVS 443
           ++SFG+L+ E+ +
Sbjct: 189 VWSFGILLTELTT 201

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 106/193 (54%), Gaps = 7/193 (3%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+   + + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 84  EEPIYI-VTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSD 430
           DL+A+NIL+   +  K++DFG+ARL E D  ++          + APE  ++GRF++KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 431 IFSFGVLVLEIVS 443
           ++SFG+L+ E+ +
Sbjct: 198 VWSFGILLTELTT 210

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 106/193 (54%), Gaps = 7/193 (3%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+   + + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 84  EEPIYI-VCEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSD 430
           DL+A+NIL+   +  K++DFG+ARL E D  ++          + APE  ++GRF++KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 431 IFSFGVLVLEIVS 443
           ++SFG+L+ E+ +
Sbjct: 198 VWSFGILLTELTT 210

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 125/270 (46%), Gaps = 25/270 (9%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG V+ G   N + +A+K + + +   E +F  E  ++ +L H  LV+L G 
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGV 70
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           CLE+    LV+EF+ +  L  ++     R     E    +   +  G+ YL E S   +I
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAS---VI 125
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVK 428
           HRDL A N L+      K+SDFGM R F +D  ++ +        + +PE     R+S K
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 429 SDIFSFGVLVLEIVSGQK--RSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTS 486
           SD++SFGVL+ E+ S  K    +    E  ED+ T             L  P +      
Sbjct: 185 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST----------GFRLYKPRLASTHVY 234
Query: 487 EMMKCIHIGLLCVQENVSNRPGMASVVNML 516
           ++M   H    C +E   +RP  + ++  L
Sbjct: 235 QIMN--H----CWKERPEDRPAFSRLLRQL 258

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  105 bits (262), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 105/193 (54%), Gaps = 7/193 (3%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+     + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 77  EEPIYI-VTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 131
Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSD 430
           DL+A+NIL+   +  K++DFG+ARL E D  ++          + APE  ++GRF++KSD
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 190
Query: 431 IFSFGVLVLEIVS 443
           ++SFG+L+ E+ +
Sbjct: 191 VWSFGILLTELTT 203

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 105/193 (54%), Gaps = 7/193 (3%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+     + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 250 EEPIYI-VTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSD 430
           DL+A+NIL+   +  K++DFG+ARL E D  ++          + APE  ++GRF++KSD
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 431 IFSFGVLVLEIVS 443
           ++SFG+L+ E+ +
Sbjct: 364 VWSFGILLTELTT 376

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 105/193 (54%), Gaps = 7/193 (3%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+     + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 250 EEPIYI-VTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSD 430
           DL+A+NIL+   +  K++DFG+ARL E D  ++          + APE  ++GRF++KSD
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 431 IFSFGVLVLEIVS 443
           ++SFG+L+ E+ +
Sbjct: 364 VWSFGILLTELTT 376

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 149/285 (52%), Gaps = 37/285 (12%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
           N S    +G G FG V  G L   S  E ++A+K L    +++   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE------GIA 353
            N++RL G   + K  ++V E++ N SLD F+     R+H   + ++ +I+      GIA
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKH---DAQFTVIQLVGMLRGIA 157
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-F 412
            G+ YL   S +  +HRDL A NIL++S +  K+SDFG++R+ E D   + T R      
Sbjct: 158 SGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAA 472
            + +PE + + +F+  SD++S+G+++ E++S  +R  +  E   +D++       +EG  
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW--EMSNQDVIKAV----DEG-- 266
Query: 473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
             L  P     +  ++M      L C Q++ +NRP    +V++L+
Sbjct: 267 YRLPPPMDCPAALYQLM------LDCWQKDRNNRPKFEQIVSILD 305

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 106/193 (54%), Gaps = 7/193 (3%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I++ E++   SL  F+   + + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 84  EEPIYIVI-EYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSD 430
           DL+A+NIL+   +  K++DFG+ARL E D   +          + APE  ++GRF++KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIE-DNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 431 IFSFGVLVLEIVS 443
           ++SFG+L+ E+ +
Sbjct: 198 VWSFGILLTELTT 210

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 149/285 (52%), Gaps = 37/285 (12%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
           N S    +G G FG V  G L   S  E ++A+K L    +++   +F  E  ++ +  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE------GIA 353
            N++RL G   + K  ++V E++ N SLD F+     R+H   + ++ +I+      GIA
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKH---DAQFTVIQLVGMLRGIA 128
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-F 412
            G+ YL   S +  +HRDL A NIL++S +  K+SDFG++R+ E D   + T R      
Sbjct: 129 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 185
Query: 413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAA 472
            + +PE + + +F+  SD++S+G+++ E++S  +R  +  E   +D++       +EG  
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW--EMSNQDVIKAV----DEG-- 237
Query: 473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
             L  P     +  ++M      L C Q++ +NRP    +V++L+
Sbjct: 238 YRLPPPMDCPAALYQLM------LDCWQKDRNNRPKFEQIVSILD 276

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 105/193 (54%), Gaps = 7/193 (3%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+   + + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 84  EEPIYI-VTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSD 430
           DL A+NIL+   +  K++DFG+ARL E D  ++          + APE  ++GRF++KSD
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 431 IFSFGVLVLEIVS 443
           ++SFG+L+ E+ +
Sbjct: 198 VWSFGILLTELTT 210

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 106/193 (54%), Gaps = 7/193 (3%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +++H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+   + + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 84  EEPIYI-VTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSD 430
           DL+A+NIL+   +  K++DFG+ARL E D  ++          + APE  ++GRF++KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 431 IFSFGVLVLEIVS 443
           ++SFG+L+ E+ +
Sbjct: 198 VWSFGILLTELTT 210

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 149/285 (52%), Gaps = 37/285 (12%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
           N S    +G G FG V  G L   S  E ++A+K L    +++   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE------GIA 353
            N++RL G   + K  ++V E++ N SLD F+     R+H   + ++ +I+      GIA
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKH---DAQFTVIQLVGMLRGIA 157
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-F 412
            G+ YL   S +  +HRDL A NIL++S +  K+SDFG++R+ E D   + T R      
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAA 472
            + +PE + + +F+  SD++S+G+++ E++S  +R  +  E   +D++       +EG  
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW--EMSNQDVIKAV----DEG-- 266
Query: 473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
             L  P     +  ++M      L C Q++ +NRP    +V++L+
Sbjct: 267 YRLPPPMDCPAALYQLM------LDCWQKDRNNRPKFEQIVSILD 305

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 149/285 (52%), Gaps = 37/285 (12%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
           N S    +G G FG V  G L   S  E ++A+K L    +++   +F  E  ++ +  H
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE------GIA 353
            N++RL G   + K  ++V E++ N SLD F+     R+H   + ++ +I+      GIA
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKH---DAQFTVIQLVGMLRGIA 155
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-F 412
            G+ YL   S +  +HRDL A NIL++S +  K+SDFG++R+ E D   + T R      
Sbjct: 156 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 212
Query: 413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAA 472
            + +PE + + +F+  SD++S+G+++ E++S  +R  +  E   +D++       +EG  
Sbjct: 213 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW--EMSNQDVIKAV----DEG-- 264
Query: 473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
             L  P     +  ++M      L C Q++ +NRP    +V++L+
Sbjct: 265 YRLPPPMDCPAALYQLM------LDCWQKDRNNRPKFEQIVSILD 303

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 105/193 (54%), Gaps = 7/193 (3%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+     + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 250 EEPIYI-VGEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSD 430
           DL+A+NIL+   +  K++DFG+ARL E D  ++          + APE  ++GRF++KSD
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 431 IFSFGVLVLEIVS 443
           ++SFG+L+ E+ +
Sbjct: 364 VWSFGILLTELTT 376

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 107/198 (54%), Gaps = 6/198 (3%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLLGF 308
           K+G G FG V++    +G  +AVK L +     E   EF  EV ++ RL+H N+V  +G 
Sbjct: 44  KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
             +     +V E++   SL   +     RE +   +R  +   +A+G+ YLH +    I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIV 161
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVK 428
           HR+LK+ N+L+D +   K+ DFG++RL     T   +    GT  +MAPE +     + K
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEK 219
Query: 429 SDIFSFGVLVLEIVSGQK 446
           SD++SFGV++ E+ + Q+
Sbjct: 220 SDVYSFGVILWELATLQQ 237

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 149/285 (52%), Gaps = 37/285 (12%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
           N S    +G G FG V  G L   S  E ++A+K L    +++   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE------GIA 353
            N++RL G   + K  ++V E++ N SLD F+     R+H   + ++ +I+      GIA
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKH---DAQFTVIQLVGMLRGIA 157
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-F 412
            G+ YL   S +  +HRDL A NIL++S +  K+SDFG++R+ E D   + T R      
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAA 472
            + +PE + + +F+  SD++S+G+++ E++S  +R  +  E   +D++       +EG  
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW--EMSNQDVIKAV----DEG-- 266
Query: 473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
             L  P     +  ++M      L C Q++ +NRP    +V++L+
Sbjct: 267 YRLPPPMDCPAALYQLM------LDCWQKDRNNRPKFEQIVSILD 305

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 149/285 (52%), Gaps = 37/285 (12%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
           N S    +G G FG V  G L   S  E ++A+K L    +++   +F  E  ++ +  H
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE------GIA 353
            N++RL G   + K  ++V E++ N SLD F+     R+H   + ++ +I+      GIA
Sbjct: 94  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKH---DAQFTVIQLVGMLRGIA 145
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-F 412
            G+ YL   S +  +HRDL A NIL++S +  K+SDFG++R+ E D   + T R      
Sbjct: 146 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 202
Query: 413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAA 472
            + +PE + + +F+  SD++S+G+++ E++S  +R  +  E   +D++       +EG  
Sbjct: 203 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW--EMSNQDVIKAV----DEG-- 254
Query: 473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
             L  P     +  ++M      L C Q++ +NRP    +V++L+
Sbjct: 255 YRLPPPMDCPAALYQLM------LDCWQKDRNNRPKFEQIVSILD 293

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 149/285 (52%), Gaps = 37/285 (12%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
           N S    +G G FG V  G L   S  E ++A+K L    +++   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE------GIA 353
            N++RL G   + K  ++V E++ N SLD F+     R+H   + ++ +I+      GIA
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKH---DAQFTVIQLVGMLRGIA 157
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-F 412
            G+ YL   S +  +HRDL A NIL++S +  K+SDFG++R+ E D   + T R      
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAA 472
            + +PE + + +F+  SD++S+G+++ E++S  +R  +  E   +D++       +EG  
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW--EMSNQDVIKAV----DEG-- 266
Query: 473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
             L  P     +  ++M      L C Q++ +NRP    +V++L+
Sbjct: 267 YRLPPPMDCPAALYQLM------LDCWQKDRNNRPKFEQIVSILD 305

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 149/285 (52%), Gaps = 37/285 (12%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
           N S    +G G FG V  G L   S  E ++A+K L    +++   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE------GIA 353
            N++RL G   + K  ++V E++ N SLD F+     R+H   + ++ +I+      GIA
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKH---DAQFTVIQLVGMLRGIA 157
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-F 412
            G+ YL   S +  +HRDL A NIL++S +  K+SDFG++R+ E D   + T R      
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAA 472
            + +PE + + +F+  SD++S+G+++ E++S  +R  +  E   +D++       +EG  
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW--EMSNQDVIKAV----DEG-- 266
Query: 473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
             L  P     +  ++M      L C Q++ +NRP    +V++L+
Sbjct: 267 YRLPPPMDCPAALYQLM------LDCWQKDRNNRPKFEQIVSILD 305

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 105/193 (54%), Gaps = 7/193 (3%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++    L  F+   + + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 84  EEPIYI-VMEYMSKGCLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSD 430
           DL+A+NIL+   +  K++DFG+ARL E D  ++          + APE  ++GRF++KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 431 IFSFGVLVLEIVS 443
           ++SFG+L+ E+ +
Sbjct: 198 VWSFGILLTELTT 210

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 124/270 (45%), Gaps = 25/270 (9%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG V+ G   N + +A+K + + S   E +F  E  ++ +L H  LV+L G 
Sbjct: 32  VQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQLYGV 90
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           CLE+    LV+EF+ +  L  ++     R     E    +   +  G+ YL E     +I
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 145
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVK 428
           HRDL A N L+      K+SDFGM R F +D  ++ +        + +PE     R+S K
Sbjct: 146 HRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 204
Query: 429 SDIFSFGVLVLEIVSGQK--RSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTS 486
           SD++SFGVL+ E+ S  K    +    E  ED+ T             L  P +      
Sbjct: 205 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST----------GFRLYKPRLASTHVY 254
Query: 487 EMMKCIHIGLLCVQENVSNRPGMASVVNML 516
           ++M   H    C +E   +RP  + ++  L
Sbjct: 255 QIMN--H----CWKERPEDRPAFSRLLRQL 278

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 104/193 (53%), Gaps = 7/193 (3%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+     + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 74  EEPIXI-VTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 128
Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSD 430
           DL+A+NIL+   +  K++DFG+ARL E D   +          + APE  ++GRF++KSD
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLIE-DNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 187
Query: 431 IFSFGVLVLEIVS 443
           ++SFG+L+ E+ +
Sbjct: 188 VWSFGILLTELTT 200

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 105/193 (54%), Gaps = 7/193 (3%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+     + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 81  EEPIYI-VTEYMNKGSLLDFLKGETGK-YLRLPQLVDMSAQIASGMAYVE---RMNYVHR 135
Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSD 430
           DL+A+NIL+   +  K++DFG+ARL E D  ++          + APE  ++GRF++KSD
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 431 IFSFGVLVLEIVS 443
           ++SFG+L+ E+ +
Sbjct: 195 VWSFGILLTELTT 207

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 148/285 (51%), Gaps = 37/285 (12%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
           N S    +G G FG V  G L   S  E ++A+K L    +++   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE------GIA 353
            N++RL G   + K  ++V E++ N SLD F+     R+H   + ++ +I+      GIA
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-----RKH---DAQFTVIQLVGMLRGIA 157
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-F 412
            G+ YL   S +  +HRDL A NIL++S +  K+SDFG+ R+ E D   + T R      
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI 214
Query: 413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAA 472
            + +PE + + +F+  SD++S+G+++ E++S  +R  +  E   +D++       +EG  
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW--EMSNQDVIKAV----DEG-- 266
Query: 473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
             L  P     +  ++M      L C Q++ +NRP    +V++L+
Sbjct: 267 YRLPPPMDCPAALYQLM------LDCWQKDRNNRPKFEQIVSILD 305

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 105/193 (54%), Gaps = 7/193 (3%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++    L  F+   + + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 84  EEPIYI-VTEYMSKGCLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSD 430
           DL+A+NIL+   +  K++DFG+ARL E D  ++          + APE  ++GRF++KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 431 IFSFGVLVLEIVS 443
           ++SFG+L+ E+ +
Sbjct: 198 VWSFGILLTELTT 210

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 124/270 (45%), Gaps = 25/270 (9%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG V+ G   N + +A+K + + +   E +F  E  ++ +L H  LV+L G 
Sbjct: 10  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGV 68
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           CLE+    LV+EF+ +  L  ++     R     E    +   +  G+ YL E     +I
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 123
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVK 428
           HRDL A N L+      K+SDFGM R F +D  ++ +        + +PE     R+S K
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 429 SDIFSFGVLVLEIVSGQK--RSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTS 486
           SD++SFGVL+ E+ S  K    +    E  ED+ T             L  P +      
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST----------GFRLYKPRLASTHVY 232
Query: 487 EMMKCIHIGLLCVQENVSNRPGMASVVNML 516
           ++M   H    C +E   +RP  + ++  L
Sbjct: 233 QIMN--H----CWKERPEDRPAFSRLLRQL 256

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 106/198 (53%), Gaps = 6/198 (3%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLLGF 308
           K+G G FG V++    +G  +AVK L +     E   EF  EV ++ RL+H N+V  +G 
Sbjct: 44  KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
             +     +V E++   SL   +     RE +   +R  +   +A+G+ YLH +    I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIV 161
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVK 428
           HRDLK+ N+L+D +   K+ DFG++RL         +    GT  +MAPE +     + K
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLRDEPSNEK 219
Query: 429 SDIFSFGVLVLEIVSGQK 446
           SD++SFGV++ E+ + Q+
Sbjct: 220 SDVYSFGVILWELATLQQ 237

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 105/193 (54%), Gaps = 7/193 (3%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+   + + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 251 EEPIYI-VTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 305
Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSD 430
           DL+A+NIL+   +  K++DFG+ RL E D  ++          + APE  ++GRF++KSD
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 364
Query: 431 IFSFGVLVLEIVS 443
           ++SFG+L+ E+ +
Sbjct: 365 VWSFGILLTELTT 377

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 124/270 (45%), Gaps = 25/270 (9%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG V+ G   N + +A+K + + +   E +F  E  ++ +L H  LV+L G 
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGV 70
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           CLE+    LV+EF+ +  L  ++     R     E    +   +  G+ YL E     +I
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 125
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVK 428
           HRDL A N L+      K+SDFGM R F +D  ++ +        + +PE     R+S K
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 429 SDIFSFGVLVLEIVSGQK--RSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTS 486
           SD++SFGVL+ E+ S  K    +    E  ED+ T             L  P +      
Sbjct: 185 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST----------GFRLYKPRLASTHVY 234
Query: 487 EMMKCIHIGLLCVQENVSNRPGMASVVNML 516
           ++M   H    C +E   +RP  + ++  L
Sbjct: 235 QIMN--H----CWKERPEDRPAFSRLLRQL 258

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 124/270 (45%), Gaps = 25/270 (9%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG V+ G   N + +A+K + + +   E +F  E  ++ +L H  LV+L G 
Sbjct: 15  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGV 73
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           CLE+    LV+EF+ +  L  ++     R     E    +   +  G+ YL E     +I
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 128
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVK 428
           HRDL A N L+      K+SDFGM R F +D  ++ +        + +PE     R+S K
Sbjct: 129 HRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 187
Query: 429 SDIFSFGVLVLEIVSGQK--RSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTS 486
           SD++SFGVL+ E+ S  K    +    E  ED+ T             L  P +      
Sbjct: 188 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST----------GFRLYKPRLASTHVY 237
Query: 487 EMMKCIHIGLLCVQENVSNRPGMASVVNML 516
           ++M   H    C +E   +RP  + ++  L
Sbjct: 238 QIMN--H----CWRERPEDRPAFSRLLRQL 261

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 110/207 (53%), Gaps = 23/207 (11%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG---EIE-FKNEVLLLARLQHRNLVRLLG 307
           +G GGFG VY+     G+ +AVK    +  +     IE  + E  L A L+H N++ L G
Sbjct: 15  IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
            CL+     LV EF     L+  +    + + +  +        IARG+ YLH+++ + I
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 368 IHRDLKASNILLDSEMNP--------KISDFGMARLFEMDQTHSDTN-RVVGTFGYMAPE 418
           IHRDLK+SNIL+  ++          KI+DFG+AR     + H  T     G + +MAPE
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAAGAYAWMAPE 184
Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
            +    FS  SD++S+GVL+ E+++G+
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 104/193 (53%), Gaps = 7/193 (3%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L     
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           E    I V E++   SL  F+     + ++   +   +   IA G+ Y+    R+  +HR
Sbjct: 81  EEPIYI-VTEYMNKGSLLDFLKGETGK-YLRLPQLVDMSAQIASGMAYVE---RMNYVHR 135
Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSD 430
           DL+A+NIL+   +  K++DFG+ARL E D   +          + APE  ++GRF++KSD
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIE-DNEWTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 431 IFSFGVLVLEIVS 443
           ++SFG+L+ E+ +
Sbjct: 195 VWSFGILLTELTT 207

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 148/285 (51%), Gaps = 37/285 (12%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
           N S    +G G FG V  G L   S  E ++A+K L    +++   +F  E  ++ +  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE------GIA 353
            N++RL G   + K  ++V E + N SLD F+     R+H   + ++ +I+      GIA
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-----RKH---DAQFTVIQLVGMLRGIA 128
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-F 412
            G+ YL   S +  +HRDL A NIL++S +  K+SDFG++R+ E D   + T R      
Sbjct: 129 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 185
Query: 413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAA 472
            + +PE + + +F+  SD++S+G+++ E++S  +R  +  E   +D++       +EG  
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW--EMSNQDVIKAV----DEG-- 237
Query: 473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
             L  P     +  ++M      L C Q++ +NRP    +V++L+
Sbjct: 238 YRLPPPMDCPAALYQLM------LDCWQKDRNNRPKFEQIVSILD 276

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 148/285 (51%), Gaps = 37/285 (12%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
           N S    +G G FG V  G L   S  E ++A+K L    +++   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE------GIA 353
            N++RL G   + K  ++V E + N SLD F+     R+H   + ++ +I+      GIA
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-----RKH---DAQFTVIQLVGMLRGIA 157
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-F 412
            G+ YL   S +  +HRDL A NIL++S +  K+SDFG++R+ E D   + T R      
Sbjct: 158 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAA 472
            + +PE + + +F+  SD++S+G+++ E++S  +R  +  E   +D++       +EG  
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW--EMSNQDVIKAV----DEG-- 266
Query: 473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
             L  P     +  ++M      L C Q++ +NRP    +V++L+
Sbjct: 267 YRLPPPMDCPAALYQLM------LDCWQKDRNNRPKFEQIVSILD 305

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 148/285 (51%), Gaps = 37/285 (12%)
Query: 245 NFSDANKLGQGGFGAVYKGML---SNGE-TIAVKRLSKN-SKQGEIEFKNEVLLLARLQH 299
           N S    +G G FG V  G L   S  E ++A+K L    +++   +F  E  ++ +  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE------GIA 353
            N++RL G   + K  ++V E + N SLD F+     R+H   + ++ +I+      GIA
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-----RKH---DAQFTVIQLVGMLRGIA 157
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-F 412
            G+ YL   S +  +HRDL A NIL++S +  K+SDFG++R+ E D   + T R      
Sbjct: 158 SGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 214
Query: 413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAA 472
            + +PE + + +F+  SD++S+G+++ E++S  +R  +  E   +D++       +EG  
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW--EMSNQDVIKAV----DEG-- 266
Query: 473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
             L  P     +  ++M      L C Q++ +NRP    +V++L+
Sbjct: 267 YRLPPPMDCPAALYQLM------LDCWQKDRNNRPKFEQIVSILD 305

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 113/207 (54%), Gaps = 13/207 (6%)
Query: 251 KLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRL 305
           +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 306 LGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            G C    R+   L+ EF+P  SL  ++    ++E +   K  +    I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYL--QKHKERIDHIKLLQYTSQICKGMEYL---G 134
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-FGYMAPEYVMH 422
             R IHRDL   NIL+++E   KI DFG+ ++   D+          +   + APE +  
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 423 GRFSVKSDIFSFGVLVLEIVSGQKRSS 449
            +FSV SD++SFGV++ E+ +  ++S 
Sbjct: 195 SKFSVASDVWSFGVVLYELFTYIEKSK 221

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 72/202 (35%), Positives = 109/202 (53%), Gaps = 16/202 (7%)
Query: 252 LGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRL 305
           LG+G FG V    Y     N GE +AVK L   S    I + K E+ +L  L H N+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 306 LGFCLERKER--ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            G C E       L+ EF+P+ SL  ++  P N+  +  +++ K    I +G+ YL   S
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL--GS 144
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT--NRVVGTFGYMAPEYVM 421
           R + +HRDL A N+L++SE   KI DFG+ +  E D+       +R    F Y APE +M
Sbjct: 145 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLM 202
Query: 422 HGRFSVKSDIFSFGVLVLEIVS 443
             +F + SD++SFGV + E+++
Sbjct: 203 QSKFYIASDVWSFGVTLHELLT 224

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 6/210 (2%)
Query: 234 FDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLL 293
           +D +   +  ++     +LG G FG V+ G  +N   +AVK L   +   +  F  E  L
Sbjct: 3   WDKDAWEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ-AFLEEANL 61
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +  LQH  LVRL       +   ++ E++   SL  F+      + +   K       IA
Sbjct: 62  MKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLL-PKLIDFSAQIA 120
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
            G+ Y+    R   IHRDL+A+N+L+   +  KI+DFG+AR+ E D  ++          
Sbjct: 121 EGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIK 176
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           + APE +  G F++KSD++SFG+L+ EIV+
Sbjct: 177 WTAPEAINFGCFTIKSDVWSFGILLYEIVT 206

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 123/270 (45%), Gaps = 25/270 (9%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG V+ G   N + +A+K + + +   E +F  E  ++ +L H  LV+L G 
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGV 71
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           CLE+    LV EF+ +  L  ++     R     E    +   +  G+ YL E     +I
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 126
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVK 428
           HRDL A N L+      K+SDFGM R F +D  ++ +        + +PE     R+S K
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 429 SDIFSFGVLVLEIVSGQK--RSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTS 486
           SD++SFGVL+ E+ S  K    +    E  ED+ T             L  P +      
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST----------GFRLYKPRLASTHVY 235
Query: 487 EMMKCIHIGLLCVQENVSNRPGMASVVNML 516
           ++M   H    C +E   +RP  + ++  L
Sbjct: 236 QIMN--H----CWRERPEDRPAFSRLLRQL 259

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 72/202 (35%), Positives = 109/202 (53%), Gaps = 16/202 (7%)
Query: 252 LGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRL 305
           LG+G FG V    Y     N GE +AVK L   S    I + K E+ +L  L H N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 306 LGFCLERKER--ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            G C E       L+ EF+P+ SL  ++  P N+  +  +++ K    I +G+ YL   S
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL--GS 132
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT--NRVVGTFGYMAPEYVM 421
           R + +HRDL A N+L++SE   KI DFG+ +  E D+       +R    F Y APE +M
Sbjct: 133 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLM 190
Query: 422 HGRFSVKSDIFSFGVLVLEIVS 443
             +F + SD++SFGV + E+++
Sbjct: 191 QSKFYIASDVWSFGVTLHELLT 212

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +KLG G +G VY G+      T+AVK L +++ + E EF  E  ++  ++H NLV+LLG 
Sbjct: 38  HKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 96
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C       +V E++P  +L  ++ +  NRE +T      +   I+  + YL + +    I
Sbjct: 97  CTLEPPFYIVTEYMPYGNLLDYLRE-CNREEVTAVVLLYMATQISSAMEYLEKKN---FI 152
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVK 428
           HRDL A N L+      K++DFG++RL   D T++          + APE + +  FS+K
Sbjct: 153 HRDLAARNCLVGENHVVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNTFSIK 211
Query: 429 SDIFSFGVLVLEIVS 443
           SD+++FGVL+ EI +
Sbjct: 212 SDVWAFGVLLWEIAT 226

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 113/208 (54%), Gaps = 13/208 (6%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 130
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-FGYMAPEYVM 421
              R IHRDL   NIL+++E   KI DFG+ ++   D+          +   + APE + 
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 422 HGRFSVKSDIFSFGVLVLEIVSGQKRSS 449
             +FSV SD++SFGV++ E+ +  ++S 
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSK 218

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 113/208 (54%), Gaps = 13/208 (6%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 135
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-FGYMAPEYVM 421
              R IHRDL   NIL+++E   KI DFG+ ++   D+          +   + APE + 
Sbjct: 136 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 195
Query: 422 HGRFSVKSDIFSFGVLVLEIVSGQKRSS 449
             +FSV SD++SFGV++ E+ +  ++S 
Sbjct: 196 ESKFSVASDVWSFGVVLYELFTYIEKSK 223

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 103/217 (47%), Gaps = 17/217 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSK-NSKQGEIEFKNEVLL 293
           V   N +    LG G FG VY+G +S          +AVK L +  S+Q E++F  E L+
Sbjct: 42  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 101
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++L H+N+VR +G  L+   R ++ E +    L  F+ +    P     +       + 
Sbjct: 102 ISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 161
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMARLFEMDQTHSDTN 406
             IA G  YL E+     IHRD+ A N LL         KI DFGMAR       +    
Sbjct: 162 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 218
Query: 407 RVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +    +M PE  M G F+ K+D +SFGVL+ EI S
Sbjct: 219 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 103/217 (47%), Gaps = 17/217 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSK-NSKQGEIEFKNEVLL 293
           V   N +    LG G FG VY+G +S          +AVK L +  S+Q E++F  E L+
Sbjct: 28  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 87
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++L H+N+VR +G  L+   R ++ E +    L  F+ +    P     +       + 
Sbjct: 88  ISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 147
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMARLFEMDQTHSDTN 406
             IA G  YL E+     IHRD+ A N LL         KI DFGMAR       +    
Sbjct: 148 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 204
Query: 407 RVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +    +M PE  M G F+ K+D +SFGVL+ EI S
Sbjct: 205 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 113/207 (54%), Gaps = 13/207 (6%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 137
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-FGYMAPEYVM 421
              R IHRDL   NIL+++E   KI DFG+ ++   D+          +   + APE + 
Sbjct: 138 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 197
Query: 422 HGRFSVKSDIFSFGVLVLEIVSGQKRS 448
             +FSV SD++SFGV++ E+ +  ++S
Sbjct: 198 ESKFSVASDVWSFGVVLYELFTYIEKS 224

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 104/194 (53%), Gaps = 7/194 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            +LG G FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L    
Sbjct: 15  KRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPE-SFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            E    I V E++   SL  F+ D   R  +       +   +A G+ Y+    R+  IH
Sbjct: 74  SEEPIYI-VTEYMNKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYIE---RMNYIH 128
Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKS 429
           RDL+++NIL+ + +  KI+DFG+ARL E D   +          + APE  ++GRF++KS
Sbjct: 129 RDLRSANILVGNGLICKIADFGLARLIE-DNEXTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 430 DIFSFGVLVLEIVS 443
           D++SFG+L+ E+V+
Sbjct: 188 DVWSFGILLTELVT 201

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 113/207 (54%), Gaps = 13/207 (6%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 161
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-FGYMAPEYVM 421
              R IHRDL   NIL+++E   KI DFG+ ++   D+          +   + APE + 
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 221
Query: 422 HGRFSVKSDIFSFGVLVLEIVSGQKRS 448
             +FSV SD++SFGV++ E+ +  ++S
Sbjct: 222 ESKFSVASDVWSFGVVLYELFTYIEKS 248

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 113/208 (54%), Gaps = 13/208 (6%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 133
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-FGYMAPEYVM 421
              R IHRDL   NIL+++E   KI DFG+ ++   D+          +   + APE + 
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 422 HGRFSVKSDIFSFGVLVLEIVSGQKRSS 449
             +FSV SD++SFGV++ E+ +  ++S 
Sbjct: 194 ESKFSVASDVWSFGVVLYELFTYIEKSK 221

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/194 (33%), Positives = 101/194 (52%), Gaps = 6/194 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            KLG G FG V+ G  +N   +AVK L   +   +  F  E  L+  LQH  LVRL    
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ-AFLEEANLMKTLQHDKLVRLYAVV 76
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            + +   ++ EF+   SL  F+      + +   K       IA G+ Y+    R   IH
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFLKSDEGGKVLL-PKLIDFSAQIAEGMAYIE---RKNYIH 132
Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKS 429
           RDL+A+N+L+   +  KI+DFG+AR+ E D  ++          + APE +  G F++KS
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGCFTIKS 191
Query: 430 DIFSFGVLVLEIVS 443
           +++SFG+L+ EIV+
Sbjct: 192 NVWSFGILLYEIVT 205

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 113/208 (54%), Gaps = 13/208 (6%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 129
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-FGYMAPEYVM 421
              R IHRDL   NIL+++E   KI DFG+ ++   D+          +   + APE + 
Sbjct: 130 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 189
Query: 422 HGRFSVKSDIFSFGVLVLEIVSGQKRSS 449
             +FSV SD++SFGV++ E+ +  ++S 
Sbjct: 190 ESKFSVASDVWSFGVVLYELFTYIEKSK 217

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 113/208 (54%), Gaps = 13/208 (6%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 128
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-FGYMAPEYVM 421
              R IHRDL   NIL+++E   KI DFG+ ++   D+          +   + APE + 
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 188
Query: 422 HGRFSVKSDIFSFGVLVLEIVSGQKRSS 449
             +FSV SD++SFGV++ E+ +  ++S 
Sbjct: 189 ESKFSVASDVWSFGVVLYELFTYIEKSK 216

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 113/208 (54%), Gaps = 13/208 (6%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 136
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-FGYMAPEYVM 421
              R IHRDL   NIL+++E   KI DFG+ ++   D+          +   + APE + 
Sbjct: 137 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 196
Query: 422 HGRFSVKSDIFSFGVLVLEIVSGQKRSS 449
             +FSV SD++SFGV++ E+ +  ++S 
Sbjct: 197 ESKFSVASDVWSFGVVLYELFTYIEKSK 224

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 113/208 (54%), Gaps = 13/208 (6%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 134
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-FGYMAPEYVM 421
              R IHRDL   NIL+++E   KI DFG+ ++   D+          +   + APE + 
Sbjct: 135 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 194
Query: 422 HGRFSVKSDIFSFGVLVLEIVSGQKRSS 449
             +FSV SD++SFGV++ E+ +  ++S 
Sbjct: 195 ESKFSVASDVWSFGVVLYELFTYIEKSK 222

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 113/208 (54%), Gaps = 13/208 (6%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 130
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-FGYMAPEYVM 421
              R IHRDL   NIL+++E   KI DFG+ ++   D+          +   + APE + 
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 422 HGRFSVKSDIFSFGVLVLEIVSGQKRSS 449
             +FSV SD++SFGV++ E+ +  ++S 
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSK 218

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 113/208 (54%), Gaps = 13/208 (6%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 148
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-FGYMAPEYVM 421
              R IHRDL   NIL+++E   KI DFG+ ++   D+          +   + APE + 
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 422 HGRFSVKSDIFSFGVLVLEIVSGQKRSS 449
             +FSV SD++SFGV++ E+ +  ++S 
Sbjct: 209 ESKFSVASDVWSFGVVLYELFTYIEKSK 236

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 113/208 (54%), Gaps = 13/208 (6%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 148
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-FGYMAPEYVM 421
              R IHRDL   NIL+++E   KI DFG+ ++   D+          +   + APE + 
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 422 HGRFSVKSDIFSFGVLVLEIVSGQKRSS 449
             +FSV SD++SFGV++ E+ +  ++S 
Sbjct: 209 ESKFSVASDVWSFGVVLYELFTYIEKSK 236

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 112/208 (53%), Gaps = 13/208 (6%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    + E +   K  +    I +G+ YL   
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QAHAERIDHIKLLQYTSQICKGMEYL--- 133
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-FGYMAPEYVM 421
              R IHRDL   NIL+++E   KI DFG+ ++   D+          +   + APE + 
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 422 HGRFSVKSDIFSFGVLVLEIVSGQKRSS 449
             +FSV SD++SFGV++ E+ +  ++S 
Sbjct: 194 ESKFSVASDVWSFGVVLYELFTYIEKSK 221

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 134/276 (48%), Gaps = 33/276 (11%)
Query: 252 LGQGGFGAVYKGMLS----NGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G FG V  G L         +A+K L    + +   +F +E  ++ +  H N++ L 
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   + K  +++ E++ N SLD F+    N    T  +   ++ GI  G+ YL   S + 
Sbjct: 97  GVVTKCKPVMIITEYMENGSLDAFLRK--NDGRFTVIQLVGMLRGIGSGMKYL---SDMS 151
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-FGYMAPEYVMHGRF 425
            +HRDL A NIL++S +  K+SDFGM+R+ E D   + T R       + APE + + +F
Sbjct: 152 AVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 211
Query: 426 SVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGST 485
           +  SD++S+G+++ E++S                  Y  R + + +  +++     G   
Sbjct: 212 TSASDVWSYGIVMWEVMS------------------YGERPYWDMSNQDVIKAIEEGYRL 253
Query: 486 SEMMKC---IHIGLL-CVQENVSNRPGMASVVNMLN 517
              M C   +H  +L C Q+  S+RP    +VNML+
Sbjct: 254 PPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLD 289

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 113/208 (54%), Gaps = 13/208 (6%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 130
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-FGYMAPEYVM 421
              R IHRDL   NIL+++E   KI DFG+ ++   D+          +   + APE + 
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 422 HGRFSVKSDIFSFGVLVLEIVSGQKRSS 449
             +FSV SD++SFGV++ E+ +  ++S 
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSK 218

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 115/218 (52%), Gaps = 33/218 (15%)
Query: 251 KLGQGGFGAVYKGML------SNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRNL 302
           +LG+  FG VYKG L         + +A+K L K+  +G +  EF++E +L ARLQH N+
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIF-------------DPINREHMTWEKRYKII 349
           V LLG   + +   +++ +  +  L  F+              D   +  +       ++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
             IA G+ YL   S   ++H+DL   N+L+  ++N KISD G+ R    +   +D  +++
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADYYKLL 187
Query: 410 GT----FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           G       +MAPE +M+G+FS+ SDI+S+GV++ E+ S
Sbjct: 188 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 115/218 (52%), Gaps = 33/218 (15%)
Query: 251 KLGQGGFGAVYKGML------SNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRNL 302
           +LG+  FG VYKG L         + +A+K L K+  +G +  EF++E +L ARLQH N+
Sbjct: 33  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIF-------------DPINREHMTWEKRYKII 349
           V LLG   + +   +++ +  +  L  F+              D   +  +       ++
Sbjct: 92  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
             IA G+ YL   S   ++H+DL   N+L+  ++N KISD G+ R    +   +D  +++
Sbjct: 152 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADYYKLL 204
Query: 410 GT----FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           G       +MAPE +M+G+FS+ SDI+S+GV++ E+ S
Sbjct: 205 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 137/275 (49%), Gaps = 29/275 (10%)
Query: 252 LGQGGFGAVYKGMLS-NGET---IAVKRL-SKNSKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G FG V  G L   G+    +A+K L S  +++   +F +E  ++ +  H N++ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   +    +++ EF+ N SLD F+    N    T  +   ++ GIA G+ YL +   + 
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLAD---MN 155
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG---TFGYMAPEYVMHG 423
            +HRDL A NIL++S +  K+SDFG++R  E D +       +G      + APE + + 
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 215
Query: 424 RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGG 483
           +F+  SD++S+G+++ E++S  +R                W   N+   +N ++   R  
Sbjct: 216 KFTSASDVWSYGIVMWEVMSYGERP--------------YWDMTNQD-VINAIEQDYRLP 260
Query: 484 STSEMMKCIHIGLL-CVQENVSNRPGMASVVNMLN 517
              +    +H  +L C Q++ ++RP    +VN L+
Sbjct: 261 PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 295

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 102/217 (47%), Gaps = 17/217 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSK-NSKQGEIEFKNEVLL 293
           V   N +    LG G FG VY+G +S          +AVK L +  S+Q E++F  E L+
Sbjct: 19  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 78
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++  H+N+VR +G  L+   R ++ E +    L  F+ +    P     +       + 
Sbjct: 79  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 138
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMARLFEMDQTHSDTN 406
             IA G  YL E+     IHRD+ A N LL         KI DFGMAR       +    
Sbjct: 139 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 195
Query: 407 RVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +    +M PE  M G F+ K+D +SFGVL+ EI S
Sbjct: 196 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 102/217 (47%), Gaps = 17/217 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSK-NSKQGEIEFKNEVLL 293
           V   N +    LG G FG VY+G +S          +AVK L +  S+Q E++F  E L+
Sbjct: 27  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 86
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++  H+N+VR +G  L+   R ++ E +    L  F+ +    P     +       + 
Sbjct: 87  ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMARLFEMDQTHSDTN 406
             IA G  YL E+     IHRD+ A N LL         KI DFGMAR       +    
Sbjct: 147 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 203
Query: 407 RVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +    +M PE  M G F+ K+D +SFGVL+ EI S
Sbjct: 204 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 102/217 (47%), Gaps = 17/217 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSK-NSKQGEIEFKNEVLL 293
           V   N +    LG G FG VY+G +S          +AVK L +  S+Q E++F  E L+
Sbjct: 27  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 86
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++  H+N+VR +G  L+   R ++ E +    L  F+ +    P     +       + 
Sbjct: 87  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMARLFEMDQTHSDTN 406
             IA G  YL E+     IHRD+ A N LL         KI DFGMAR       +    
Sbjct: 147 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 203
Query: 407 RVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +    +M PE  M G F+ K+D +SFGVL+ EI S
Sbjct: 204 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 102/217 (47%), Gaps = 17/217 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSK-NSKQGEIEFKNEVLL 293
           V   N +    LG G FG VY+G +S          +AVK L +  S+Q E++F  E L+
Sbjct: 44  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 103
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++  H+N+VR +G  L+   R ++ E +    L  F+ +    P     +       + 
Sbjct: 104 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 163
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMARLFEMDQTHSDTN 406
             IA G  YL E+     IHRD+ A N LL         KI DFGMAR       +    
Sbjct: 164 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 220
Query: 407 RVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +    +M PE  M G F+ K+D +SFGVL+ EI S
Sbjct: 221 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 114/208 (54%), Gaps = 13/208 (6%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V    Y  +  N GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 305 LLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C    R+   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 131
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-FGYMAPEYVM 421
              R IHR+L   NIL+++E   KI DFG+ ++   D+ +        +   + APE + 
Sbjct: 132 GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 191
Query: 422 HGRFSVKSDIFSFGVLVLEIVSGQKRSS 449
             +FSV SD++SFGV++ E+ +  ++S 
Sbjct: 192 ESKFSVASDVWSFGVVLYELFTYIEKSK 219

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 134/276 (48%), Gaps = 33/276 (11%)
Query: 252 LGQGGFGAVYKGMLS----NGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G FG V  G L         +A+K L    + +   +F +E  ++ +  H N++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   + K  +++ E++ N SLD F+    N    T  +   ++ GI  G+ YL   S + 
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLRK--NDGRFTVIQLVGMLRGIGSGMKYL---SDMS 136
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-FGYMAPEYVMHGRF 425
            +HRDL A NIL++S +  K+SDFGM+R+ E D   + T R       + APE + + +F
Sbjct: 137 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 196
Query: 426 SVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGST 485
           +  SD++S+G+++ E++S                  Y  R + + +  +++     G   
Sbjct: 197 TSASDVWSYGIVMWEVMS------------------YGERPYWDMSNQDVIKAIEEGYRL 238
Query: 486 SEMMKC---IHIGLL-CVQENVSNRPGMASVVNMLN 517
              M C   +H  +L C Q+  S+RP    +VNML+
Sbjct: 239 PPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLD 274

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 106/200 (53%), Gaps = 9/200 (4%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG VYKG       + +  ++  + Q    FKNEV +L + +H N++  +G+
Sbjct: 17  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
              + +  +V ++   +SL H +     +  M  +K   I    ARG+ YLH  S   II
Sbjct: 77  S-TKPQLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAKS---II 130
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM---HGRF 425
           HRDLK++NI L  +   KI DFG+A +           ++ G+  +MAPE +       +
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 190
Query: 426 SVKSDIFSFGVLVLEIVSGQ 445
           S +SD+++FG+++ E+++GQ
Sbjct: 191 SFQSDVYAFGIVLYELMTGQ 210

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 134/276 (48%), Gaps = 33/276 (11%)
Query: 252 LGQGGFGAVYKGMLS----NGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G FG V  G L         +A+K L    + +   +F +E  ++ +  H N++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   + K  +++ E++ N SLD F+    N    T  +   ++ GI  G+ YL   S + 
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFLRK--NDGRFTVIQLVGMLRGIGSGMKYL---SDMS 130
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-FGYMAPEYVMHGRF 425
            +HRDL A NIL++S +  K+SDFGM+R+ E D   + T R       + APE + + +F
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 190
Query: 426 SVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGST 485
           +  SD++S+G+++ E++S                  Y  R + + +  +++     G   
Sbjct: 191 TSASDVWSYGIVMWEVMS------------------YGERPYWDMSNQDVIKAIEEGYRL 232
Query: 486 SEMMKC---IHIGLL-CVQENVSNRPGMASVVNMLN 517
              M C   +H  +L C Q+  S+RP    +VNML+
Sbjct: 233 PPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLD 268

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 102/217 (47%), Gaps = 17/217 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSK-NSKQGEIEFKNEVLL 293
           V   N +    LG G FG VY+G +S          +AVK L +  S+Q E++F  E L+
Sbjct: 42  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALI 101
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++  H+N+VR +G  L+   R ++ E +    L  F+ +    P     +       + 
Sbjct: 102 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 161
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMARLFEMDQTHSDTN 406
             IA G  YL E+     IHRD+ A N LL         KI DFGMAR       +    
Sbjct: 162 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 218
Query: 407 RVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +    +M PE  M G F+ K+D +SFGVL+ EI S
Sbjct: 219 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 102/217 (47%), Gaps = 17/217 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSK-NSKQGEIEFKNEVLL 293
           V   N +    LG G FG VY+G +S          +AVK L +  S+Q E++F  E L+
Sbjct: 28  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 87
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++  H+N+VR +G  L+   R ++ E +    L  F+ +    P     +       + 
Sbjct: 88  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 147
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMARLFEMDQTHSDTN 406
             IA G  YL E+     IHRD+ A N LL         KI DFGMAR       +    
Sbjct: 148 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 204
Query: 407 RVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +    +M PE  M G F+ K+D +SFGVL+ EI S
Sbjct: 205 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 102/217 (47%), Gaps = 17/217 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSK-NSKQGEIEFKNEVLL 293
           V   N +    LG G FG VY+G +S          +AVK L +  S+Q E++F  E L+
Sbjct: 42  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 101
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++  H+N+VR +G  L+   R ++ E +    L  F+ +    P     +       + 
Sbjct: 102 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 161
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMARLFEMDQTHSDTN 406
             IA G  YL E+     IHRD+ A N LL         KI DFGMAR       +    
Sbjct: 162 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 218
Query: 407 RVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +    +M PE  M G F+ K+D +SFGVL+ EI S
Sbjct: 219 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 102/217 (47%), Gaps = 17/217 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSK-NSKQGEIEFKNEVLL 293
           V   N +    LG G FG VY+G +S          +AVK L +  S+Q E++F  E L+
Sbjct: 34  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 93
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++  H+N+VR +G  L+   R ++ E +    L  F+ +    P     +       + 
Sbjct: 94  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 153
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMARLFEMDQTHSDTN 406
             IA G  YL E+     IHRD+ A N LL         KI DFGMAR       +    
Sbjct: 154 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 210
Query: 407 RVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +    +M PE  M G F+ K+D +SFGVL+ EI S
Sbjct: 211 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 115/210 (54%), Gaps = 7/210 (3%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
           +++   +   + +  +KLG G +G VY+G+      T+AVK L +++ + E EF  E  +
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 67
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +  ++H NLV+LLG C       ++ EF+   +L  ++ +  NR+ ++      +   I+
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQIS 126
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             + YL + +    IHRDL A N L+      K++DFG++RL   D T++          
Sbjct: 127 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIK 182
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           + APE + + +FS+KSD+++FGVL+ EI +
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 138/280 (49%), Gaps = 23/280 (8%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
           +++   +   + +  +KLG G +G VY+G+      T+AVK L +++ + E EF  E  +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +  ++H NLV+LLG C       ++ EF+   +L  ++ +  NR+ ++      +   I+
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQIS 121
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             + YL + +    IHRDL A N L+      K++DFG++RL   D T++          
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIK 177
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTE-EETEDLLTYAWRNWNEGAA 472
           + APE + + +FS+KSD+++FGVL+ EI +       G +  +  +LL   +R       
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------- 230
Query: 473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASV 512
             +  P        E+M+       C Q N S+RP  A +
Sbjct: 231 --MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 262

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 102/217 (47%), Gaps = 17/217 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSK-NSKQGEIEFKNEVLL 293
           V   N +    LG G FG VY+G +S          +AVK L +  S+Q E++F  E L+
Sbjct: 45  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 104
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++  H+N+VR +G  L+   R ++ E +    L  F+ +    P     +       + 
Sbjct: 105 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 164
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMARLFEMDQTHSDTN 406
             IA G  YL E+     IHRD+ A N LL         KI DFGMAR       +    
Sbjct: 165 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGG 221
Query: 407 RVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +    +M PE  M G F+ K+D +SFGVL+ EI S
Sbjct: 222 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 115/210 (54%), Gaps = 7/210 (3%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
           +++   +   + +  +KLG G +G VY+G+      T+AVK L +++ + E EF  E  +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +  ++H NLV+LLG C       ++ EF+   +L  ++ +  NR+ ++      +   I+
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQIS 121
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             + YL + +    IHRDL A N L+      K++DFG++RL   D T++          
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIK 177
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           + APE + + +FS+KSD+++FGVL+ EI +
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 137/280 (48%), Gaps = 23/280 (8%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
           +++   +   + +  +KLG G +G VY+G+      T+AVK L +++ + E EF  E  +
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 67
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +  ++H NLV+LLG C       ++ EF+   +L  ++ +  NR+ +       +   I+
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 126
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             + YL + +    IHRDL A N L+      K++DFG++RL   D T++          
Sbjct: 127 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIK 182
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTE-EETEDLLTYAWRNWNEGAA 472
           + APE + + +FS+KSD+++FGVL+ EI +       G +  +  +LL   +R       
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------- 235
Query: 473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASV 512
             +  P        E+M+       C Q N S+RP  A +
Sbjct: 236 --MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 267

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 136/272 (50%), Gaps = 25/272 (9%)
Query: 252 LGQGGFGAVYKGMLS----NGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G FG V  G L         +A+K L    +++   +F  E  ++ +  H N++ L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   + K  ++V E++ N SLD F+    N    T  +   ++ GI+ G+ YL   S + 
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFLKK--NDGQFTVIQLVGMLRGISAGMKYL---SDMG 144
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-FGYMAPEYVMHGRF 425
            +HRDL A NIL++S +  K+SDFG++R+ E D   + T R       + APE +   +F
Sbjct: 145 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKF 204
Query: 426 SVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGST 485
           +  SD++S+G+++ E+VS  +R  +  E   +D++        EG    L  P     + 
Sbjct: 205 TSASDVWSYGIVMWEVVSYGERPYW--EMTNQDVIKAV----EEG--YRLPSPMDCPAAL 256
Query: 486 SEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
            ++M      L C Q+  ++RP    +VNML+
Sbjct: 257 YQLM------LDCWQKERNSRPKFDEIVNMLD 282

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 118/229 (51%), Gaps = 11/229 (4%)
Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKN 279
           ED N  +T+ +    D     +     +   ++G G FG VYKG       + +  ++  
Sbjct: 14  EDRNRMKTLGRRDSSD--DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAP 71
Query: 280 SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREH 339
           + Q    FKNEV +L + +H N++  +G+   + +  +V ++   +SL H +     +  
Sbjct: 72  TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFE 130
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           M   K   I    A+G+ YLH  S   IIHRDLK++NI L  ++  KI DFG+A +    
Sbjct: 131 MI--KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 185
Query: 400 QTHSDTNRVVGTFGYMAPEYV-MHGR--FSVKSDIFSFGVLVLEIVSGQ 445
                  ++ G+  +MAPE + M  +  +S +SD+++FG+++ E+++GQ
Sbjct: 186 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 115/210 (54%), Gaps = 7/210 (3%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
           +++   +   + +  +KLG G +G VY+G+      T+AVK L +++ + E EF  E  +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +  ++H NLV+LLG C       ++ EF+   +L  ++ +  NR+ ++      +   I+
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQIS 121
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             + YL + +    IHRDL A N L+      K++DFG++RL   D T++          
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIK 177
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           + APE + + +FS+KSD+++FGVL+ EI +
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 102/217 (47%), Gaps = 17/217 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSK-NSKQGEIEFKNEVLL 293
           V   N +    LG G FG VY+G +S          +AVK L +  S+Q E++F  E L+
Sbjct: 54  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 113
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++  H+N+VR +G  L+   R ++ E +    L  F+ +    P     +       + 
Sbjct: 114 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 173
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMARLFEMDQTHSDTN 406
             IA G  YL E+     IHRD+ A N LL         KI DFGMAR       +    
Sbjct: 174 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 230
Query: 407 RVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +    +M PE  M G F+ K+D +SFGVL+ EI S
Sbjct: 231 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 118/229 (51%), Gaps = 11/229 (4%)
Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKN 279
           ED N  +T+ +    D     +     +   ++G G FG VYKG       + +  ++  
Sbjct: 13  EDRNRMKTLGRRDSSD--DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAP 70
Query: 280 SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREH 339
           + Q    FKNEV +L + +H N++  +G+   + +  +V ++   +SL H +     +  
Sbjct: 71  TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFE 129
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           M   K   I    A+G+ YLH  S   IIHRDLK++NI L  ++  KI DFG+A +    
Sbjct: 130 MI--KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 184
Query: 400 QTHSDTNRVVGTFGYMAPEYV-MHGR--FSVKSDIFSFGVLVLEIVSGQ 445
                  ++ G+  +MAPE + M  +  +S +SD+++FG+++ E+++GQ
Sbjct: 185 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 102/217 (47%), Gaps = 17/217 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSK-NSKQGEIEFKNEVLL 293
           V   N +    LG G FG VY+G +S          +AVK L +  S+Q E++F  E L+
Sbjct: 68  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 127
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++  H+N+VR +G  L+   R ++ E +    L  F+ +    P     +       + 
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMARLFEMDQTHSDTN 406
             IA G  YL E+     IHRD+ A N LL         KI DFGMAR       +    
Sbjct: 188 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGG 244
Query: 407 RVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +    +M PE  M G F+ K+D +SFGVL+ EI S
Sbjct: 245 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 115/210 (54%), Gaps = 7/210 (3%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
           +++   +   + +  +KLG G +G VY+G+      T+AVK L +++ + E EF  E  +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +  ++H NLV+LLG C       ++ EF+   +L  ++ +  NR+ ++      +   I+
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQIS 121
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             + YL + +    IHRDL A N L+      K++DFG++RL   D T++          
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIK 177
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           + APE + + +FS+KSD+++FGVL+ EI +
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 137/280 (48%), Gaps = 23/280 (8%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
           +++   +   + +  +KLG G +G VY+G+      T+AVK L +++ + E EF  E  +
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 66
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +  ++H NLV+LLG C       ++ EF+   +L  ++ +  NR+ +       +   I+
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 125
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             + YL + +    IHRDL A N L+      K++DFG++RL   D T++          
Sbjct: 126 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIK 181
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTE-EETEDLLTYAWRNWNEGAA 472
           + APE + + +FS+KSD+++FGVL+ EI +       G +  +  +LL   +R       
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------- 234
Query: 473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASV 512
             +  P        E+M+       C Q N S+RP  A +
Sbjct: 235 --MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 266

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 108/200 (54%), Gaps = 9/200 (4%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG VYKG       + +  ++  + Q    FKNEV +L + +H N++  +G+
Sbjct: 18  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
              + +  +V ++   +SL H +     +  M   K   I    A+G+ YLH  S   II
Sbjct: 78  S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---II 131
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV-MHGR--F 425
           HRDLK++NI L  ++  KI DFG+A +           ++ G+  +MAPE + M  +  +
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 426 SVKSDIFSFGVLVLEIVSGQ 445
           S +SD+++FG+++ E+++GQ
Sbjct: 192 SFQSDVYAFGIVLYELMTGQ 211

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 109/197 (55%), Gaps = 11/197 (5%)
Query: 250 NKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +KLG G FG VY+G+      T+AVK L +++ + E EF  E  ++  ++H NLV+LLG 
Sbjct: 17  HKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 75
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C       ++ EF+   +L  ++ +  NR+ ++      +   I+  + YL + +    I
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 131
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEYVMHGRFS 426
           HRDL A N L+      K++DFG++RL   D   + T      F   + APE + + +FS
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGD---TXTAHAGAKFPIKWTAPESLAYNKFS 188
Query: 427 VKSDIFSFGVLVLEIVS 443
           +KSD+++FGVL+ EI +
Sbjct: 189 IKSDVWAFGVLLWEIAT 205

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 137/280 (48%), Gaps = 23/280 (8%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
           +++   +   + +  +KLG G +G VY+G+      T+AVK L +++ + E EF  E  +
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 67
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +  ++H NLV+LLG C       ++ EF+   +L  ++ +  NR+ +       +   I+
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 126
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             + YL + +    IHRDL A N L+      K++DFG++RL   D T++          
Sbjct: 127 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIK 182
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTE-EETEDLLTYAWRNWNEGAA 472
           + APE + + +FS+KSD+++FGVL+ EI +       G +  +  +LL   +R       
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------- 235
Query: 473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASV 512
             +  P        E+M+       C Q N S+RP  A +
Sbjct: 236 --MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 267

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 114/210 (54%), Gaps = 7/210 (3%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
           +++   +   + +  +KLG G +G VY+G+      T+AVK L +++ + E EF  E  +
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 63
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +  ++H NLV+LLG C       ++ EF+   +L  ++ +  NR+ +       +   I+
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 122
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             + YL + +    IHRDL A N L+      K++DFG++RL   D T++          
Sbjct: 123 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAPAGAKFPIK 178
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           + APE + + +FS+KSD+++FGVL+ EI +
Sbjct: 179 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 108/200 (54%), Gaps = 9/200 (4%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG VYKG       + +  ++  + Q    FKNEV +L + +H N++  +G+
Sbjct: 15  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
              + +  +V ++   +SL H +     +  M   K   I    A+G+ YLH  S   II
Sbjct: 75  S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---II 128
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV-MHGR--F 425
           HRDLK++NI L  ++  KI DFG+A +           ++ G+  +MAPE + M  +  +
Sbjct: 129 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 188
Query: 426 SVKSDIFSFGVLVLEIVSGQ 445
           S +SD+++FG+++ E+++GQ
Sbjct: 189 SFQSDVYAFGIVLYELMTGQ 208

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 108/200 (54%), Gaps = 9/200 (4%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG VYKG       + +  ++  + Q    FKNEV +L + +H N++  +G+
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
              + +  +V ++   +SL H +     +  M   K   I    A+G+ YLH  S   II
Sbjct: 73  S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---II 126
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV-MHGR--F 425
           HRDLK++NI L  ++  KI DFG+A +           ++ G+  +MAPE + M  +  +
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 426 SVKSDIFSFGVLVLEIVSGQ 445
           S +SD+++FG+++ E+++GQ
Sbjct: 187 SFQSDVYAFGIVLYELMTGQ 206

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 137/280 (48%), Gaps = 23/280 (8%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
           +++   +   + +  +KLG G +G VY+G+      T+AVK L +++ + E EF  E  +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +  ++H NLV+LLG C       ++ EF+   +L  ++ +  NR+ +       +   I+
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 121
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             + YL + +    IHRDL A N L+      K++DFG++RL   D T++          
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIK 177
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTE-EETEDLLTYAWRNWNEGAA 472
           + APE + + +FS+KSD+++FGVL+ EI +       G +  +  +LL   +R       
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------- 230
Query: 473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASV 512
             +  P        E+M+       C Q N S+RP  A +
Sbjct: 231 --MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 262

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 108/200 (54%), Gaps = 9/200 (4%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG VYKG       + +  ++  + Q    FKNEV +L + +H N++  +G+
Sbjct: 18  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
              + +  +V ++   +SL H +     +  M   K   I    A+G+ YLH  S   II
Sbjct: 78  S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---II 131
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV-MHGR--F 425
           HRDLK++NI L  ++  KI DFG+A +           ++ G+  +MAPE + M  +  +
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 426 SVKSDIFSFGVLVLEIVSGQ 445
           S +SD+++FG+++ E+++GQ
Sbjct: 192 SFQSDVYAFGIVLYELMTGQ 211

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 137/280 (48%), Gaps = 23/280 (8%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
           +++   +   + +  +KLG G +G VY+G+      T+AVK L +++ + E EF  E  +
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 64
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +  ++H NLV+LLG C       ++ EF+   +L  ++ +  NR+ +       +   I+
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 123
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             + YL + +    IHRDL A N L+      K++DFG++RL   D T++          
Sbjct: 124 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAPAGAKFPIK 179
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTE-EETEDLLTYAWRNWNEGAA 472
           + APE + + +FS+KSD+++FGVL+ EI +       G +  +  +LL   +R       
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------- 232
Query: 473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASV 512
             +  P        E+M+       C Q N S+RP  A +
Sbjct: 233 --MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 264

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 114/210 (54%), Gaps = 7/210 (3%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
           +++   +   + +  +KLG G +G VY+G+      T+AVK L +++ + E EF  E  +
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 67
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +  ++H NLV+LLG C       ++ EF+   +L  ++ +  NR+ +       +   I+
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 126
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             + YL + +    IHRDL A N L+      K++DFG++RL   D T++          
Sbjct: 127 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIK 182
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           + APE + + +FS+KSD+++FGVL+ EI +
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 137/280 (48%), Gaps = 23/280 (8%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
           +++   +   + +  +KLG G +G VY+G+      T+AVK L +++ + E EF  E  +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 62
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +  ++H NLV+LLG C       ++ EF+   +L  ++ +  NR+ +       +   I+
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 121
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             + YL + +    IHRDL A N L+      K++DFG++RL   D T++          
Sbjct: 122 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIK 177
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTE-EETEDLLTYAWRNWNEGAA 472
           + APE + + +FS+KSD+++FGVL+ EI +       G +  +  +LL   +R       
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------- 230
Query: 473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASV 512
             +  P        E+M+       C Q N S+RP  A +
Sbjct: 231 --MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 262

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 121/221 (54%), Gaps = 27/221 (12%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGEIE-------FKNEVL 292
           +A +      ++G+GGFG V+KG ++ +   +A+K L     +GE E       F+ EV 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREH-MTWEKRYKIIEG 351
           +++ L H N+V+L G  L      +V EFVP   L H + D   + H + W  + +++  
Sbjct: 76  IMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLD 130
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDS--EMNP---KISDFGMARLFEMDQTHSDTN 406
           IA G+ Y+ ++    I+HRDL++ NI L S  E  P   K++DFG+++     Q+    +
Sbjct: 131 IALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVS 184
Query: 407 RVVGTFGYMAPEYV--MHGRFSVKSDIFSFGVLVLEIVSGQ 445
            ++G F +MAPE +      ++ K+D +SF +++  I++G+
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 110/236 (46%), Gaps = 37/236 (15%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQGEIEFKNEVLL 293
            +   N     +LG+G FG V+     N         +AVK L   S     +F  E  L
Sbjct: 9   HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAEL 68
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREH-------------- 339
           L  LQH ++V+  G C+E    I+V+E++ +  L+ F+     R H              
Sbjct: 69  LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFL-----RAHGPDAVLMAEGNPPT 123
Query: 340 -MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM 398
            +T  +   I + IA G++YL   +    +HRDL   N L+   +  KI DFGM+R    
Sbjct: 124 ELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR---- 176
Query: 399 DQTHSDTNRVVGT----FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSF 450
           D   +D  RV G       +M PE +M+ +F+ +SD++S GV++ EI +  K+  +
Sbjct: 177 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY 232

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 114/210 (54%), Gaps = 7/210 (3%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
           +++   +   + +  +KLG G +G VY+G+      T+AVK L +++ + E EF  E  +
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 64
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +  ++H NLV+LLG C       ++ EF+   +L  ++ +  NR+ +       +   I+
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 123
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             + YL + +    IHRDL A N L+      K++DFG++RL   D T++          
Sbjct: 124 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIK 179
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           + APE + + +FS+KSD+++FGVL+ EI +
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 114/210 (54%), Gaps = 7/210 (3%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
           +++   +   + +  +KLG G +G VY+G+      T+AVK L +++ + E EF  E  +
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 64
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +  ++H NLV+LLG C       ++ EF+   +L  ++ +  NR+ +       +   I+
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 123
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             + YL + +    IHRDL A N L+      K++DFG++RL   D T++          
Sbjct: 124 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIK 179
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           + APE + + +FS+KSD+++FGVL+ EI +
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 109/197 (55%), Gaps = 11/197 (5%)
Query: 250 NKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +KLG G +G VY+G+      T+AVK L +++ + E EF  E  ++  ++H NLV+LLG 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 75
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C       ++ EF+   +L  ++ +  NR+ ++      +   I+  + YL + +    I
Sbjct: 76  CTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 131
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEYVMHGRFS 426
           HRDL A N L+      K++DFG++RL   D   + T      F   + APE + + +FS
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGD---TXTAHAGAKFPIKWTAPESLAYNKFS 188
Query: 427 VKSDIFSFGVLVLEIVS 443
           +KSD+++FGVL+ EI +
Sbjct: 189 IKSDVWAFGVLLWEIAT 205

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 114/210 (54%), Gaps = 7/210 (3%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
           +++   +   + +  +KLG G +G VY+G+      T+AVK L +++ + E EF  E  +
Sbjct: 17  NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 75
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +  ++H NLV+LLG C       ++ EF+   +L  ++ +  NR+ +       +   I+
Sbjct: 76  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 134
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             + YL + +    IHRDL A N L+      K++DFG++RL   D T++          
Sbjct: 135 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIK 190
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           + APE + + +FS+KSD+++FGVL+ EI +
Sbjct: 191 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 109/223 (48%), Gaps = 31/223 (13%)
Query: 251 KLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           +LG+G FG V+     N         +AVK L + S+    +F+ E  LL  LQH+++VR
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREH-----------------MTWEKRYK 347
             G C E +  ++V+E++ +  L+ F+     R H                 +   +   
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFL-----RSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           +   +A G++YL   + L  +HRDL   N L+   +  KI DFGM+R       +    R
Sbjct: 163 VASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 219
Query: 408 VVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSF 450
            +    +M PE +++ +F+ +SD++SFGV++ EI +  K+  +
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 262

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 137/282 (48%), Gaps = 27/282 (9%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
           +++   +   + +  +KLG G +G VY+G+      T+AVK L +++ + E EF  E  +
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 67
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +  ++H NLV+LLG C       ++ EF+   +L  ++ +  NR+ +       +   I+
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 126
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF- 412
             + YL + +    IHRDL A N L+      K++DFG++RL   D   + T      F 
Sbjct: 127 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TXTAHAGAKFP 180
Query: 413 -GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTE-EETEDLLTYAWRNWNEG 470
             + APE + + +FS+KSD+++FGVL+ EI +       G +  +  +LL   +R     
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR----- 235
Query: 471 AALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASV 512
               +  P        E+M+       C Q N S+RP  A +
Sbjct: 236 ----MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 267

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 102/217 (47%), Gaps = 17/217 (7%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGET------IAVKRLSK-NSKQGEIEFKNEVLL 293
           V   N +    LG G FG VY+G +S          +AVK L +  S+Q E++F  E L+
Sbjct: 28  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 87
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
           +++  H+N+VR +G  L+   R ++ E +    L  F+ +    P     +       + 
Sbjct: 88  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 147
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMARLFEMDQTHSDTN 406
             IA G  YL E+     IHRD+ A N LL         KI DFGMA+       +    
Sbjct: 148 RDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGG 204
Query: 407 RVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +    +M PE  M G F+ K+D +SFGVL+ EI S
Sbjct: 205 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 109/223 (48%), Gaps = 31/223 (13%)
Query: 251 KLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           +LG+G FG V+     N         +AVK L + S+    +F+ E  LL  LQH+++VR
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREH-----------------MTWEKRYK 347
             G C E +  ++V+E++ +  L+ F+     R H                 +   +   
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFL-----RSHGPDAKLLAGGEDVAPGPLGLGQLLA 133
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           +   +A G++YL   + L  +HRDL   N L+   +  KI DFGM+R       +    R
Sbjct: 134 VASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 190
Query: 408 VVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSF 450
            +    +M PE +++ +F+ +SD++SFGV++ EI +  K+  +
Sbjct: 191 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 233

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 9/200 (4%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG VYKG       + +  ++  + Q    FKNEV +L + +H N++  +G+
Sbjct: 29  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
              + +  +V ++   +SL H +     +  M  +K   I    ARG+ YLH  S   II
Sbjct: 89  S-TKPQLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAKS---II 142
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM---HGRF 425
           HRDLK++NI L  +   KI DFG+A             ++ G+  +MAPE +       +
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 426 SVKSDIFSFGVLVLEIVSGQ 445
           S +SD+++FG+++ E+++GQ
Sbjct: 203 SFQSDVYAFGIVLYELMTGQ 222

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 137/282 (48%), Gaps = 27/282 (9%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
           +++   +   + +  +KLG G +G VY+G+      T+AVK L +++ + E EF  E  +
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 63
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +  ++H NLV+LLG C       ++ EF+   +L  ++ +  NR+ +       +   I+
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 122
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF- 412
             + YL + +    IHRDL A N L+      K++DFG++RL   D   + T      F 
Sbjct: 123 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TXTAHAGAKFP 176
Query: 413 -GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTE-EETEDLLTYAWRNWNEG 470
             + APE + + +FS+KSD+++FGVL+ EI +       G +  +  +LL   +R     
Sbjct: 177 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR----- 231
Query: 471 AALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASV 512
               +  P        E+M+       C Q N S+RP  A +
Sbjct: 232 ----MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 263

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 138/280 (49%), Gaps = 23/280 (8%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
           +++   +   + +  +KLG G +G VY+G+      T+AVK L +++ + E EF  E  +
Sbjct: 211 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 269
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +  ++H NLV+LLG C       ++ EF+   +L  ++ +  NR+ ++      +   I+
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQIS 328
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             + YL + +    IHR+L A N L+      K++DFG++RL   D T++          
Sbjct: 329 SAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIK 384
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTE-EETEDLLTYAWRNWNEGAA 472
           + APE + + +FS+KSD+++FGVL+ EI +       G +  +  +LL   +R       
Sbjct: 385 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------- 437
Query: 473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASV 512
             +  P        E+M+       C Q N S+RP  A +
Sbjct: 438 --MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 469

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 109/223 (48%), Gaps = 31/223 (13%)
Query: 251 KLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           +LG+G FG V+     N         +AVK L + S+    +F+ E  LL  LQH+++VR
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREH-----------------MTWEKRYK 347
             G C E +  ++V+E++ +  L+ F+     R H                 +   +   
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFL-----RSHGPDAKLLAGGEDVAPGPLGLGQLLA 139
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           +   +A G++YL   + L  +HRDL   N L+   +  KI DFGM+R       +    R
Sbjct: 140 VASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR 196
Query: 408 VVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSF 450
            +    +M PE +++ +F+ +SD++SFGV++ EI +  K+  +
Sbjct: 197 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 239

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 117/229 (51%), Gaps = 11/229 (4%)
Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKN 279
           ED N  +T+ +    D     +     +   ++G G FG VYKG       + +  ++  
Sbjct: 14  EDRNRMKTLGRRDSSD--DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAP 71
Query: 280 SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREH 339
           + Q    FKNEV +L + +H N++  +G+   + +  +V ++   +SL H +     +  
Sbjct: 72  TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGSSLYHHLHIIETKFE 130
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           M   K   I    A+G+ YLH  S   IIHRDLK++NI L  ++  KI DFG+A      
Sbjct: 131 MI--KLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRW 185
Query: 400 QTHSDTNRVVGTFGYMAPEYV-MHGR--FSVKSDIFSFGVLVLEIVSGQ 445
                  ++ G+  +MAPE + M  +  +S +SD+++FG+++ E+++GQ
Sbjct: 186 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 133/275 (48%), Gaps = 29/275 (10%)
Query: 252 LGQGGFGAVYKGMLS----NGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G FG V +G L         +A+K L    +++   EF +E  ++ + +H N++RL 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G        +++ EF+ N +LD F+   +N    T  +   ++ GIA G+ YL E   + 
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFL--RLNDGQFTVIQLVGMLRGIASGMRYLAE---MS 138
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG---TFGYMAPEYVMHG 423
            +HRDL A NIL++S +  K+SDFG++R  E + +       +G      + APE +   
Sbjct: 139 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFR 198
Query: 424 RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGG 483
           +F+  SD +S+G+++ E++S  +R  +    +                 +N ++   R  
Sbjct: 199 KFTSASDAWSYGIVMWEVMSFGERPYWDMSNQD---------------VINAIEQDYRLP 243
Query: 484 STSEMMKCIHIGLL-CVQENVSNRPGMASVVNMLN 517
              +    +H  +L C Q++ + RP    VV+ L+
Sbjct: 244 PPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALD 278

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +KLG G +G VY+G+      T+AVK L +++ + E EF  E  ++  ++H NLV+LLG 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 75
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C       ++ EF+   +L  ++ +  NR+ ++      +   I+  + YL + +    I
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKN---FI 131
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVK 428
           HRDL A N L+      K++DFG++RL   D T +          + APE + + +FS+K
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGD-TFTAHAGAKFPIKWTAPESLAYNKFSIK 190
Query: 429 SDIFSFGVLVLEIVS 443
           SD+++FGVL+ EI +
Sbjct: 191 SDVWAFGVLLWEIAT 205

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 107/200 (53%), Gaps = 9/200 (4%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG VYKG       + +  ++  + Q    FKNEV +L + +H N++  +G+
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
               +  I V ++   +SL H +     +  M   K   I    A+G+ YLH  S   II
Sbjct: 73  STAPQLAI-VTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---II 126
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV-MHGR--F 425
           HRDLK++NI L  ++  KI DFG+A +           ++ G+  +MAPE + M  +  +
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 426 SVKSDIFSFGVLVLEIVSGQ 445
           S +SD+++FG+++ E+++GQ
Sbjct: 187 SFQSDVYAFGIVLYELMTGQ 206

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 120/221 (54%), Gaps = 27/221 (12%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGEIE-------FKNEVL 292
           +A +      ++G+GGFG V+KG ++ +   +A+K L     +GE E       F+ EV 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREH-MTWEKRYKIIEG 351
           +++ L H N+V+L G  L      +V EFVP   L H + D   + H + W  + +++  
Sbjct: 76  IMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLD 130
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDS--EMNP---KISDFGMARLFEMDQTHSDTN 406
           IA G+ Y+ ++    I+HRDL++ NI L S  E  P   K++DFG ++     Q+    +
Sbjct: 131 IALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVS 184
Query: 407 RVVGTFGYMAPEYV--MHGRFSVKSDIFSFGVLVLEIVSGQ 445
            ++G F +MAPE +      ++ K+D +SF +++  I++G+
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 133/275 (48%), Gaps = 29/275 (10%)
Query: 252 LGQGGFGAVYKGMLS----NGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G FG V +G L         +A+K L    +++   EF +E  ++ + +H N++RL 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G        +++ EF+ N +LD F+   +N    T  +   ++ GIA G+ YL E   + 
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFL--RLNDGQFTVIQLVGMLRGIASGMRYLAE---MS 136
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG---TFGYMAPEYVMHG 423
            +HRDL A NIL++S +  K+SDFG++R  E + +       +G      + APE +   
Sbjct: 137 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFR 196
Query: 424 RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGG 483
           +F+  SD +S+G+++ E++S  +R  +    +                 +N ++   R  
Sbjct: 197 KFTSASDAWSYGIVMWEVMSFGERPYWDMSNQD---------------VINAIEQDYRLP 241
Query: 484 STSEMMKCIHIGLL-CVQENVSNRPGMASVVNMLN 517
              +    +H  +L C Q++ + RP    VV+ L+
Sbjct: 242 PPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALD 276

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 107/200 (53%), Gaps = 9/200 (4%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG VYKG       + +  ++  + Q    FKNEV +L + +H N++  +G+
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
              + +  +V ++   +SL H +     +  M   K   I    A+G+ YLH  S   II
Sbjct: 73  S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---II 126
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV-MHGR--F 425
           HRDLK++NI L  ++  KI DFG+A             ++ G+  +MAPE + M  +  +
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 426 SVKSDIFSFGVLVLEIVSGQ 445
           S +SD+++FG+++ E+++GQ
Sbjct: 187 SFQSDVYAFGIVLYELMTGQ 206

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 137/280 (48%), Gaps = 23/280 (8%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLL 293
           +++   +   + +  +KLG G +G VY+G+      T+AVK L +++ + E EF  E  +
Sbjct: 250 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 308
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           +  ++H NLV+LLG C       ++ EF+   +L  ++ +  NR+ +       +   I+
Sbjct: 309 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQIS 367
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             + YL + +    IHR+L A N L+      K++DFG++RL   D T++          
Sbjct: 368 SAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIK 423
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTE-EETEDLLTYAWRNWNEGAA 472
           + APE + + +FS+KSD+++FGVL+ EI +       G +  +  +LL   +R       
Sbjct: 424 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------- 476
Query: 473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASV 512
             +  P        E+M+       C Q N S+RP  A +
Sbjct: 477 --MERPEGCPEKVYELMRA------CWQWNPSDRPSFAEI 508

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 104/200 (52%), Gaps = 9/200 (4%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG VYKG       + +  ++  + Q    FKNEV +L + +H N++  +G+
Sbjct: 29  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
                +  +V ++   +SL H +     +  M  +K   I    ARG+ YLH  S   II
Sbjct: 89  STA-PQLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAKS---II 142
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM---HGRF 425
           HRDLK++NI L  +   KI DFG+A             ++ G+  +MAPE +       +
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 426 SVKSDIFSFGVLVLEIVSGQ 445
           S +SD+++FG+++ E+++GQ
Sbjct: 203 SFQSDVYAFGIVLYELMTGQ 222

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 107/200 (53%), Gaps = 9/200 (4%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             ++G G FG VYKG       + +  ++  + Q    FKNEV +L + +H N++  +G+
Sbjct: 33  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
              + +  +V ++   +SL H +     +  M   K   I    A+G+ YLH  S   II
Sbjct: 93  S-TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---II 146
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV-MHGR--F 425
           HRDLK++NI L  ++  KI DFG+A             ++ G+  +MAPE + M  +  +
Sbjct: 147 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 206
Query: 426 SVKSDIFSFGVLVLEIVSGQ 445
           S +SD+++FG+++ E+++GQ
Sbjct: 207 SFQSDVYAFGIVLYELMTGQ 226

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 135/275 (49%), Gaps = 29/275 (10%)
Query: 252 LGQGGFGAVYKGMLS-NGET---IAVKRL-SKNSKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G FG V  G L   G+    +A+K L S  +++   +F +E  ++ +  H N++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   +    +++ EF+ N SLD F+    N    T  +   ++ GIA G+ YL +   + 
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLAD---MN 129
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG---TFGYMAPEYVMHG 423
            +HR L A NIL++S +  K+SDFG++R  E D +       +G      + APE + + 
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 189
Query: 424 RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGG 483
           +F+  SD++S+G+++ E++S  +R  +    +                 +N ++   R  
Sbjct: 190 KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---------------VINAIEQDYRLP 234
Query: 484 STSEMMKCIHIGLL-CVQENVSNRPGMASVVNMLN 517
              +    +H  +L C Q++ ++RP    +VN L+
Sbjct: 235 PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 269

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 120/221 (54%), Gaps = 27/221 (12%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGEIE-------FKNEVL 292
           +A +      ++G+GGFG V+KG ++ +   +A+K L     +GE E       F+ EV 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREH-MTWEKRYKIIEG 351
           +++ L H N+V+L G  L      +V EFVP   L H + D   + H + W  + +++  
Sbjct: 76  IMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLD 130
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDS--EMNP---KISDFGMARLFEMDQTHSDTN 406
           IA G+ Y+ ++    I+HRDL++ NI L S  E  P   K++DF +++     Q+    +
Sbjct: 131 IALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVS 184
Query: 407 RVVGTFGYMAPEYV--MHGRFSVKSDIFSFGVLVLEIVSGQ 445
            ++G F +MAPE +      ++ K+D +SF +++  I++G+
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 117/207 (56%), Gaps = 16/207 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ Y
Sbjct: 80  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 136
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGYMA 416
           L ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V     +MA
Sbjct: 137 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMA 191
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            E ++H  ++ +SD++S+GV V E+++
Sbjct: 192 LESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 117/207 (56%), Gaps = 16/207 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ Y
Sbjct: 79  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 135
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGYMA 416
           L ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V     +MA
Sbjct: 136 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMA 190
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            E ++H  ++ +SD++S+GV V E+++
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 111/201 (55%), Gaps = 10/201 (4%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           F    KLG+G +G+VYK +    G+ +A+K++   S   EI    E+ ++ +    ++V+
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEI--IKEISIMQQCDSPHVVK 88
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
             G   +  +  +V E+    S+   I   +  + +T ++   I++   +GL YLH    
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATILQSTLKGLEYLH---F 143
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
           +R IHRD+KA NILL++E + K++DFG+A   ++    +  N V+GT  +MAPE +    
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAG--QLTDXMAKRNXVIGTPFWMAPEVIQEIG 201
Query: 425 FSVKSDIFSFGVLVLEIVSGQ 445
           ++  +DI+S G+  +E+  G+
Sbjct: 202 YNCVADIWSLGITAIEMAEGK 222

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 117/207 (56%), Gaps = 16/207 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ Y
Sbjct: 77  NPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 133
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGYMA 416
           L ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V     +MA
Sbjct: 134 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMA 188
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            E ++H  ++ +SD++S+GV V E+++
Sbjct: 189 LESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 117/207 (56%), Gaps = 16/207 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ Y
Sbjct: 77  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 133
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGYMA 416
           L ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V     +MA
Sbjct: 134 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMA 188
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            E ++H  ++ +SD++S+GV V E+++
Sbjct: 189 LESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 117/207 (56%), Gaps = 16/207 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ Y
Sbjct: 76  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 132
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGYMA 416
           L ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V     +MA
Sbjct: 133 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMA 187
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            E ++H  ++ +SD++S+GV V E+++
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 117/207 (56%), Gaps = 16/207 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ Y
Sbjct: 78  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 134
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGYMA 416
           L ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V     +MA
Sbjct: 135 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMA 189
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            E ++H  ++ +SD++S+GV V E+++
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 117/206 (56%), Gaps = 16/206 (7%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 83  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 139
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGYMAP 417
            ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V     +MA 
Sbjct: 140 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMAL 194
Query: 418 EYVMHGRFSVKSDIFSFGVLVLEIVS 443
           E ++H  ++ +SD++S+GV V E+++
Sbjct: 195 ESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 74/236 (31%), Positives = 119/236 (50%), Gaps = 30/236 (12%)
Query: 213 RVGKLKLEDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETI 271
           R G LK  D +V E   K    D E +      FSD  ++G G FGAVY    + N E +
Sbjct: 34  RAGSLK--DPDVAELFFKD---DPEKL------FSDLREIGHGSFGAVYFARDVRNSEVV 82
Query: 272 AVKRLSKNSKQGEIEFKN---EVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K++S + KQ   ++++   EV  L +L+H N ++  G  L      LV E+   ++ D
Sbjct: 83  AIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD 142
Query: 329 HFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKIS 388
                 ++++ +   +   +  G  +GL YLH  +   +IHRD+KA NILL      K+ 
Sbjct: 143 LL---EVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLG 196
Query: 389 DFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM---HGRFSVKSDIFSFGVLVLEI 441
           DFG A +       +  N  VGT  +MAPE ++    G++  K D++S G+  +E+
Sbjct: 197 DFGSASIM------APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 117/207 (56%), Gaps = 16/207 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ Y
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 132
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGYMA 416
           L ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V     +MA
Sbjct: 133 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMA 187
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            E ++H  ++ +SD++S+GV V E+++
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 117/206 (56%), Gaps = 16/206 (7%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQH 299
           F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ YL
Sbjct: 102 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 158
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGYMAP 417
            ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V     +MA 
Sbjct: 159 -EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMAL 213
Query: 418 EYVMHGRFSVKSDIFSFGVLVLEIVS 443
           E ++H  ++ +SD++S+GV V E+++
Sbjct: 214 ESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 117/207 (56%), Gaps = 16/207 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ Y
Sbjct: 78  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 134
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGYMA 416
           L ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V     +MA
Sbjct: 135 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMA 189
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            E ++H  ++ +SD++S+GV V E+++
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 117/207 (56%), Gaps = 16/207 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ Y
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 132
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGYMA 416
           L ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V     +MA
Sbjct: 133 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMA 187
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            E ++H  ++ +SD++S+GV V E+++
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 117/207 (56%), Gaps = 16/207 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ Y
Sbjct: 83  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 139
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGYMA 416
           L ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V     +MA
Sbjct: 140 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMA 194
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            E ++H  ++ +SD++S+GV V E+++
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 117/207 (56%), Gaps = 16/207 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ Y
Sbjct: 79  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 135
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGYMA 416
           L ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V     +MA
Sbjct: 136 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMA 190
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            E ++H  ++ +SD++S+GV V E+++
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 117/207 (56%), Gaps = 16/207 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ Y
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 132
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGYMA 416
           L ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V     +MA
Sbjct: 133 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMA 187
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            E ++H  ++ +SD++S+GV V E+++
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 117/207 (56%), Gaps = 16/207 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ Y
Sbjct: 79  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 135
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGYMA 416
           L ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V     +MA
Sbjct: 136 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMA 190
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            E ++H  ++ +SD++S+GV V E+++
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 117/207 (56%), Gaps = 16/207 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ Y
Sbjct: 79  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 135
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGYMA 416
           L ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V     +MA
Sbjct: 136 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMA 190
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            E ++H  ++ +SD++S+GV V E+++
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 117/207 (56%), Gaps = 16/207 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ Y
Sbjct: 86  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 142
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGYMA 416
           L ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V     +MA
Sbjct: 143 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMA 197
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            E ++H  ++ +SD++S+GV V E+++
Sbjct: 198 LESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 117/207 (56%), Gaps = 16/207 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ Y
Sbjct: 70  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 126
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGYMA 416
           L ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V     +MA
Sbjct: 127 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMA 181
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            E ++H  ++ +SD++S+GV V E+++
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 106/195 (54%), Gaps = 9/195 (4%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            KLG G FG V+    +    +AVK +   S   E  F  E  ++  LQH  LV+L    
Sbjct: 21  KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHA-V 78
Query: 310 LERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           + ++   ++ EF+   SL  F+  D  +++ +   K       IA G+ ++ + +    I
Sbjct: 79  VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN---YI 133
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVK 428
           HRDL+A+NIL+ + +  KI+DFG+AR+ E D  ++          + APE +  G F++K
Sbjct: 134 HRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFTIK 192
Query: 429 SDIFSFGVLVLEIVS 443
           SD++SFG+L++EIV+
Sbjct: 193 SDVWSFGILLMEIVT 207

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 19/203 (9%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHRN 301
           FSD  ++G G FGAVY    + N E +A+K++S + KQ   ++++   EV  L +L+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
            ++  G  L      LV E+   ++ D      ++++ +   +   +  G  +GL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM 421
            +   +IHRD+KA NILL      K+ DFG A +       +  N  VGT  +MAPE ++
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184
Query: 422 ---HGRFSVKSDIFSFGVLVLEI 441
               G++  K D++S G+  +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 112/203 (55%), Gaps = 13/203 (6%)
Query: 246 FSDANKLGQGGFGAVYKGMLSN-GETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHRNLV 303
           F+  +++G+G FG VYKG+ ++  E +A+K +  + ++    + + E+ +L++     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 304 RLLGFCLERKERILVYEFVPNAS-LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           R  G  L+  +  ++ E++   S LD     P+   ++       I+  I +GL YLH +
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLHSE 135
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH 422
              R IHRD+KA+N+LL  + + K++DFG+A   ++  T    N  VGT  +MAPE +  
Sbjct: 136 ---RKIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNXFVGTPFWMAPEVIKQ 190
Query: 423 GRFSVKSDIFSFGVLVLEIVSGQ 445
             +  K+DI+S G+  +E+  G+
Sbjct: 191 SAYDFKADIWSLGITAIELAKGE 213

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 108/198 (54%), Gaps = 15/198 (7%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            KLG G FG V+    +    +AVK +   S   E  F  E  ++  LQH  LV+L    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKL--HA 250
Query: 310 LERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE---GIARGLLYLHEDSRL 365
           +  KE I ++ EF+   SL     D +  +  + +   K+I+    IA G+ ++ + +  
Sbjct: 251 VVTKEPIYIITEFMAKGSL----LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-- 304
Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRF 425
             IHRDL+A+NIL+ + +  KI+DFG+AR+ E D  ++          + APE +  G F
Sbjct: 305 -YIHRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSF 362
Query: 426 SVKSDIFSFGVLVLEIVS 443
           ++KSD++SFG+L++EIV+
Sbjct: 363 TIKSDVWSFGILLMEIVT 380

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 116/207 (56%), Gaps = 16/207 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ Y
Sbjct: 80  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 136
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGYMA 416
           L ED RL  +HRDL A N+L+ +  + KI+DFG A+L   E  + H++  +V     +MA
Sbjct: 137 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV--PIKWMA 191
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            E ++H  ++ +SD++S+GV V E+++
Sbjct: 192 LESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 116/207 (56%), Gaps = 16/207 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA G+ Y
Sbjct: 73  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAEGMNY 129
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGYMA 416
           L ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V     +MA
Sbjct: 130 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMA 184
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            E ++H  ++ +SD++S+GV V E+++
Sbjct: 185 LESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 116/207 (56%), Gaps = 16/207 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ Y
Sbjct: 78  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 134
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGYMA 416
           L ED RL  +HRDL A N+L+ +  + KI+DFG A+L   E  + H++  +V     +MA
Sbjct: 135 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV--PIKWMA 189
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            E ++H  ++ +SD++S+GV V E+++
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 138/302 (45%), Gaps = 49/302 (16%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-----MLSNGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           V+ +  +   +LGQG FG VY+G     +    ET +AVK +++++   E IEF NE  +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIF--------DPINREHMTWEKR 345
           +      ++VRLLG   + +  ++V E + +  L  ++         +P  R   T ++ 
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP-GRPPPTLQEM 132
Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
            ++   IA G+ YL+     + +HRDL A N ++  +   KI DFGM R    D   +D 
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDX 185
Query: 406 NRVVGT----FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLT 461
            R  G       +MAPE +  G F+  SD++SFGV++ EI S  ++   G   E      
Sbjct: 186 XRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------ 239
Query: 462 YAWRNWNEGAALNLMDPTMRGGSTSEMMKC----IHIGLLCVQENVSNRPGMASVVNMLN 517
                        ++   M GG   +   C      +  +C Q N + RP    +VN+L 
Sbjct: 240 ------------QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287
Query: 518 GD 519
            D
Sbjct: 288 DD 289

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 109/223 (48%), Gaps = 30/223 (13%)
Query: 251 KLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           +LG+G FG V+     N         +AVK L   +     +F+ E  LL  LQH ++V+
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 305 LLGFCLERKERILVYEFVPNASLDHF----------IFDPINRE---HMTWEKRYKIIEG 351
             G C +    I+V+E++ +  L+ F          + D   R+    +   +   I   
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           IA G++YL   +    +HRDL   N L+ + +  KI DFGM+R    D   +D  RV G 
Sbjct: 142 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGGH 194
Query: 412 ----FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSF 450
                 +M PE +M+ +F+ +SD++SFGV++ EI +  K+  F
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 237

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 116/207 (56%), Gaps = 16/207 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ Y
Sbjct: 78  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 134
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGYMA 416
           L ED RL  +HRDL A N+L+ +  + KI+DFG A+L   E  + H++  +V     +MA
Sbjct: 135 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV--PIKWMA 189
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            E ++H  ++ +SD++S+GV V E+++
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 116/207 (56%), Gaps = 16/207 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ Y
Sbjct: 78  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 134
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGYMA 416
           L ED RL  +HRDL A N+L+ +  + KI+DFG A+L   E  + H++  +V     +MA
Sbjct: 135 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV--PIKWMA 189
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            E ++H  ++ +SD++S+GV V E+++
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 116/207 (56%), Gaps = 16/207 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ Y
Sbjct: 83  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 139
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGYMA 416
           L ED RL  +HRDL A N+L+ +  + KI+DFG A+L   E  + H++  +V     +MA
Sbjct: 140 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV--PIKWMA 194
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            E ++H  ++ +SD++S+GV V E+++
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 116/207 (56%), Gaps = 16/207 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     LG G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ Y
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 132
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGYMA 416
           L ED RL  +HRDL A N+L+ +  + KI+DFG A+L   E  + H++  +V     +MA
Sbjct: 133 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV--PIKWMA 187
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            E ++H  ++ +SD++S+GV V E+++
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 137/302 (45%), Gaps = 49/302 (16%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-----MLSNGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           V+ +  +   +LGQG FG VY+G     +    ET +AVK +++++   E IEF NE  +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIF--------DPINREHMTWEKR 345
           +      ++VRLLG   + +  ++V E + +  L  ++         +P  R   T ++ 
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP-GRPPPTLQEM 132
Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
            ++   IA G+ YL+     + +HRDL A N ++  +   KI DFGM R    D   +D 
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDX 185
Query: 406 NRVVGT----FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLT 461
            R  G       +MAPE +  G F+  SD++SFGV++ EI S  ++   G   E      
Sbjct: 186 XRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------ 239
Query: 462 YAWRNWNEGAALNLMDPTMRGGSTSEMMKC----IHIGLLCVQENVSNRPGMASVVNMLN 517
                        ++   M GG   +   C      +  +C Q N   RP    +VN+L 
Sbjct: 240 ------------QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287
Query: 518 GD 519
            D
Sbjct: 288 DD 289

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 137/302 (45%), Gaps = 49/302 (16%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-----MLSNGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           V+ +  +   +LGQG FG VY+G     +    ET +AVK +++++   E IEF NE  +
Sbjct: 11  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 70
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIF--------DPINREHMTWEKR 345
           +      ++VRLLG   + +  ++V E + +  L  ++         +P  R   T ++ 
Sbjct: 71  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP-GRPPPTLQEM 129
Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
            ++   IA G+ YL+     + +HRDL A N ++  +   KI DFGM R    D   +D 
Sbjct: 130 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDX 182
Query: 406 NRVVGT----FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLT 461
            R  G       +MAPE +  G F+  SD++SFGV++ EI S  ++   G   E      
Sbjct: 183 XRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------ 236
Query: 462 YAWRNWNEGAALNLMDPTMRGGSTSEMMKC----IHIGLLCVQENVSNRPGMASVVNMLN 517
                        ++   M GG   +   C      +  +C Q N   RP    +VN+L 
Sbjct: 237 ------------QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 284
Query: 518 GD 519
            D
Sbjct: 285 DD 286

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 139/299 (46%), Gaps = 43/299 (14%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-----MLSNGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           V+ +  +   +LGQG FG VY+G     +    ET +AVK +++++   E IEF NE  +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIF--------DPINREHMTWEKR 345
           +      ++VRLLG   + +  ++V E + +  L  ++         +P  R   T ++ 
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP-GRPPPTLQEM 132
Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSD 404
            ++   IA G+ YL+     + +HRDL A N ++  +   KI DFGM R ++E D  +  
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY-YRK 188
Query: 405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAW 464
             + +    +MAPE +  G F+  SD++SFGV++ EI S  ++   G   E         
Sbjct: 189 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--------- 239
Query: 465 RNWNEGAALNLMDPTMRGGSTSEMMKC----IHIGLLCVQENVSNRPGMASVVNMLNGD 519
                     ++   M GG   +   C      +  +C Q N   RP    +VN+L  D
Sbjct: 240 ---------QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 289

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 115/241 (47%), Gaps = 33/241 (13%)
Query: 244 DNFSDANKLGQGGFGAVYK----GMLSNG--ETIAVKRLSKN-SKQGEIEFKNEVLLLAR 296
           +N      +G+G FG V++    G+L       +AVK L +  S   + +F+ E  L+A 
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI--FDP---INREHMTWEKRYK---- 347
             + N+V+LLG C   K   L++E++    L+ F+    P    +  H     R +    
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 348 ------------IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR- 394
                       I   +A G+ YL E    + +HRDL   N L+   M  KI+DFG++R 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 395 LFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEE 454
           ++  D   +D N  +    +M PE + + R++ +SD++++GV++ EI S   +  +G   
Sbjct: 224 IYSADYYKADGNDAI-PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282
Query: 455 E 455
           E
Sbjct: 283 E 283

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 116/207 (56%), Gaps = 16/207 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     L  G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ Y
Sbjct: 83  NPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 139
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGYMA 416
           L ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V     +MA
Sbjct: 140 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMA 194
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            E ++H  ++ +SD++S+GV V E+++
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 116/207 (56%), Gaps = 16/207 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     L  G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ Y
Sbjct: 83  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 139
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGYMA 416
           L ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V     +MA
Sbjct: 140 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMA 194
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            E ++H  ++ +SD++S+GV V E+++
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 116/207 (56%), Gaps = 16/207 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     LG G FG VYKG+ +  GE +    A+  L +  S +   E  +E  ++A + 
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ Y
Sbjct: 110 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 166
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGYMA 416
           L ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V     +MA
Sbjct: 167 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMA 221
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            E ++H  ++ +SD++S+GV V E+++
Sbjct: 222 LESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 135/298 (45%), Gaps = 41/298 (13%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-----MLSNGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           V+ +  +   +LGQG FG VY+G     +    ET +AVK +++++   E IEF NE  +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIF--------DPINREHMTWEKR 345
           +      ++VRLLG   + +  ++V E + +  L  ++         +P  R   T ++ 
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP-GRPPPTLQEM 132
Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
            ++   IA G+ YL+     + +HRDL A N ++  +   KI DFGM R       +   
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKG 189
Query: 406 NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWR 465
            + +    +MAPE +  G F+  SD++SFGV++ EI S  ++   G   E          
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---------- 239
Query: 466 NWNEGAALNLMDPTMRGGSTSEMMKC----IHIGLLCVQENVSNRPGMASVVNMLNGD 519
                    ++   M GG   +   C      +  +C Q N   RP    +VN+L  D
Sbjct: 240 --------QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 289

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 116/207 (56%), Gaps = 16/207 (7%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETI----AVKRLSK-NSKQGEIEFKNEVLLLARLQ 298
            F     L  G FG VYKG+ +  GE +    A+K L +  S +   E  +E  ++A + 
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ Y
Sbjct: 76  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNY 132
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF--EMDQTHSDTNRVVGTFGYMA 416
           L ED RL  +HRDL A N+L+ +  + KI+DFG+A+L   E  + H++  +V     +MA
Sbjct: 133 L-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMA 187
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            E ++H  ++ +SD++S+GV V E+++
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 139/299 (46%), Gaps = 43/299 (14%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-----MLSNGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           V+ +  +   +LGQG FG VY+G     +    ET +AVK +++++   E IEF NE  +
Sbjct: 13  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 72
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIF--------DPINREHMTWEKR 345
           +      ++VRLLG   + +  ++V E + +  L  ++         +P  R   T ++ 
Sbjct: 73  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP-GRPPPTLQEM 131
Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSD 404
            ++   IA G+ YL+     + +HRDL A N ++  +   KI DFGM R ++E D  +  
Sbjct: 132 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY-YRK 187
Query: 405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAW 464
             + +    +MAPE +  G F+  SD++SFGV++ EI S  ++   G   E         
Sbjct: 188 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--------- 238
Query: 465 RNWNEGAALNLMDPTMRGGSTSEMMKC----IHIGLLCVQENVSNRPGMASVVNMLNGD 519
                     ++   M GG   +   C      +  +C Q N   RP    +VN+L  D
Sbjct: 239 ---------QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 288

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            +LG G FG V  G       +A+K + + S   E EF  E  ++  L H  LV+L G C
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            +++   ++ E++ N  L +++ +   R     ++  ++ + +   + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLH 128
Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKS 429
           RDL A N L++ +   K+SDFG++R + +D  ++ +        +  PE +M+ +FS KS
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKS 187
Query: 430 DIFSFGVLVLEIVS 443
           DI++FGVL+ EI S
Sbjct: 188 DIWAFGVLMWEIYS 201

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 105/204 (51%), Gaps = 18/204 (8%)
Query: 252 LGQGGFG-AVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           LG+G FG A+       GE + +K L +  ++ +  F  EV ++  L+H N+++ +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           + K    + E++   +L   I   ++ ++  W +R    + IA G+ YLH    + IIHR
Sbjct: 78  KDKRLNFITEYIKGGTL-RGIIKSMDSQY-PWSQRVSFAKDIASGMAYLHS---MNIIHR 132
Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR------------VVGTFGYMAPE 418
           DL + N L+    N  ++DFG+ARL   ++T  +  R            VVG   +MAPE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 419 YVMHGRFSVKSDIFSFGVLVLEIV 442
            +    +  K D+FSFG+++ EI+
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 111/210 (52%), Gaps = 28/210 (13%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER 312
            +G FG V+K  L N E +AVK      KQ   + + EV  L  ++H N+++ +G   E+
Sbjct: 33  ARGRFGCVWKAQLLN-EYVAVKIFPIQDKQS-WQNEYEVYSLPGMKHENILQFIG--AEK 88
Query: 313 K------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED---- 362
           +      +  L+  F    SL  F+   +    ++W +   I E +ARGL YLHED    
Sbjct: 89  RGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHEDIPGL 144
Query: 363 ---SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
               +  I HRD+K+ N+LL + +   I+DFG+A  FE  ++  DT+  VGT  YMAPE 
Sbjct: 145 KDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE- 203
Query: 420 VMHGRFS------VKSDIFSFGVLVLEIVS 443
           V+ G  +      ++ D+++ G+++ E+ S
Sbjct: 204 VLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 104/196 (53%), Gaps = 11/196 (5%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            +LG G FG V  G       +A+K + + S   E EF  E  ++  L H  LV+L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            +++   ++ E++ N  L +++ +   R     ++  ++ + +   + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLH 143
Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEYVMHGRFSV 427
           RDL A N L++ +   K+SDFG++R    D+   +T+ V   F   +  PE +M+ +FS 
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---ETSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 428 KSDIFSFGVLVLEIVS 443
           KSDI++FGVL+ EI S
Sbjct: 201 KSDIWAFGVLMWEIYS 216

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 114/213 (53%), Gaps = 21/213 (9%)
Query: 241 VATDNFSDANKLGQGGFGAVY--KGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLA 295
           + +D +     LG+G FG V   K  ++ G+  AVK +SK     K  +     EV LL 
Sbjct: 29  IFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLK 87
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIAR 354
           +L H N+++L  F  ++    LV E      L    FD I +R+  +     +II  +  
Sbjct: 88  QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLS 143
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           G+ Y+H++   +I+HRDLK  N+LL+S   + N +I DFG++  FE  +   D    +GT
Sbjct: 144 GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGT 197
Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
             Y+APE V+HG +  K D++S GV++  ++SG
Sbjct: 198 AYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            +LG G FG V  G       +A+K + + S   E EF  E  ++  L H  LV+L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            +++   ++ E++ N  L +++ +   R     ++  ++ + +   + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLH 143
Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKS 429
           RDL A N L++ +   K+SDFG++R + +D  ++ +        +  PE +M+ +FS KS
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 430 DIFSFGVLVLEIVS 443
           DI++FGVL+ EI S
Sbjct: 203 DIWAFGVLMWEIYS 216

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 114/213 (53%), Gaps = 21/213 (9%)
Query: 241 VATDNFSDANKLGQGGFGAVY--KGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLA 295
           + +D +     LG+G FG V   K  ++ G+  AVK +SK     K  +     EV LL 
Sbjct: 46  IFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLK 104
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIAR 354
           +L H N+++L  F  ++    LV E      L    FD I +R+  +     +II  +  
Sbjct: 105 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLS 160
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           G+ Y+H++   +I+HRDLK  N+LL+S   + N +I DFG++  FE  +   D    +GT
Sbjct: 161 GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGT 214
Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
             Y+APE V+HG +  K D++S GV++  ++SG
Sbjct: 215 AYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 114/213 (53%), Gaps = 21/213 (9%)
Query: 241 VATDNFSDANKLGQGGFGAVY--KGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLA 295
           + +D +     LG+G FG V   K  ++ G+  AVK +SK     K  +     EV LL 
Sbjct: 47  IFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLK 105
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIAR 354
           +L H N+++L  F  ++    LV E      L    FD I +R+  +     +II  +  
Sbjct: 106 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLS 161
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           G+ Y+H++   +I+HRDLK  N+LL+S   + N +I DFG++  FE  +   D    +GT
Sbjct: 162 GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGT 215
Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
             Y+APE V+HG +  K D++S GV++  ++SG
Sbjct: 216 AYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           G CL  +   ++V  ++ +  L +FI     +P  ++ + +  +      +A+G+ +L  
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKFL-- 208
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF---EMDQTHSDTNRVVGTFGYMAPE 418
            +  + +HRDL A N +LD +   K++DFG+AR     E D  H+ T   +    +MA E
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALE 266
Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVS 443
            +   +F+ KSD++SFGVL+ E+++
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 114/213 (53%), Gaps = 21/213 (9%)
Query: 241 VATDNFSDANKLGQGGFGAVY--KGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLA 295
           + +D +     LG+G FG V   K  ++ G+  AVK +SK     K  +     EV LL 
Sbjct: 23  IFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIAR 354
           +L H N+++L  F  ++    LV E      L    FD I +R+  +     +II  +  
Sbjct: 82  QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLS 137
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           G+ Y+H++   +I+HRDLK  N+LL+S   + N +I DFG++  FE  +   D    +GT
Sbjct: 138 GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IGT 191
Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
             Y+APE V+HG +  K D++S GV++  ++SG
Sbjct: 192 AYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            +LG G FG V  G       +A+K + + S   E EF  E  ++  L H  LV+L G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            +++   ++ E++ N  L +++ +   R     ++  ++ + +   + YL      + +H
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLH 123
Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKS 429
           RDL A N L++ +   K+SDFG++R + +D  ++ +        +  PE +M+ +FS KS
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 430 DIFSFGVLVLEIVS 443
           DI++FGVL+ EI S
Sbjct: 183 DIWAFGVLMWEIYS 196

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 134/284 (47%), Gaps = 49/284 (17%)
Query: 252 LGQGGFGAVYKGMLS----NGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G FG V  G L         +A+K L    +++   +F  E  ++ +  H N+V L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREH---MTWEKRYKIIEGIARGLLYLHEDS 363
           G     K  ++V EF+ N +LD F+     R+H    T  +   ++ GIA G+ YL +  
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFL-----RKHDGQFTVIQLVGMLRGIAAGMRYLAD-- 163
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG------YMAP 417
            +  +HRDL A NIL++S +  K+SDFG++R+ E      D   V  T G      + AP
Sbjct: 164 -MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIE-----DDPEAVYTTTGGKIPVRWTAP 217
Query: 418 EYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD 477
           E + + +F+  SD++S+G+++ E++S                  Y  R + + +  +++ 
Sbjct: 218 EAIQYRKFTSASDVWSYGIVMWEVMS------------------YGERPYWDMSNQDVIK 259
Query: 478 PTMRGGSTSEMMKC---IHIGLL-CVQENVSNRPGMASVVNMLN 517
               G      M C   +H  +L C Q+  + RP    +V +L+
Sbjct: 260 AIEEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGILD 303

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            +LG G FG V  G       +A+K + + S   E EF  E  ++  L H  LV+L G C
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            +++   ++ E++ N  L +++ +   R     ++  ++ + +   + YL      + +H
Sbjct: 73  TKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLH 127
Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKS 429
           RDL A N L++ +   K+SDFG++R + +D  ++ +        +  PE +M+ +FS KS
Sbjct: 128 RDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 186
Query: 430 DIFSFGVLVLEIVS 443
           DI++FGVL+ EI S
Sbjct: 187 DIWAFGVLMWEIYS 200

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 139/298 (46%), Gaps = 41/298 (13%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-----MLSNGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           V+ +  +   +LGQG FG VY+G     +    ET +AVK +++++   E IEF NE  +
Sbjct: 14  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 73
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIF-------DPINREHMTWEKRY 346
           +      ++VRLLG   + +  ++V E + +  L  ++        +   R   T ++  
Sbjct: 74  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 133
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSDT 405
           ++   IA G+ YL+     + +HR+L A N ++  +   KI DFGM R ++E D  +   
Sbjct: 134 QMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDY-YRKG 189
Query: 406 NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWR 465
            + +    +MAPE +  G F+  SD++SFGV++ EI S  ++   G   E          
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---------- 239
Query: 466 NWNEGAALNLMDPTMRGGSTSEMMKC----IHIGLLCVQENVSNRPGMASVVNMLNGD 519
                    ++   M GG   +   C      +  +C Q N + RP    +VN+L  D
Sbjct: 240 --------QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDD 289

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            +LG G FG V  G       +A+K + + S   E EF  E  ++  L H  LV+L G C
Sbjct: 21  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            +++   ++ E++ N  L +++ +   R     ++  ++ + +   + YL      + +H
Sbjct: 80  TKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLH 134
Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKS 429
           RDL A N L++ +   K+SDFG++R + +D  ++ +        +  PE +M+ +FS KS
Sbjct: 135 RDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 193
Query: 430 DIFSFGVLVLEIVS 443
           DI++FGVL+ EI S
Sbjct: 194 DIWAFGVLMWEIYS 207

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 113/201 (56%), Gaps = 15/201 (7%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 307 GFCLERK-ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
           G CL  +   ++V  ++ +  L +FI +  +    T +        +A+G+ +L   +  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKFL---ASK 152
Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLF---EMDQTHSDTNRVVGTFGYMAPEYVMH 422
           + +HRDL A N +LD +   K++DFG+AR     E D  H+ T   +    +MA E +  
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQT 211
Query: 423 GRFSVKSDIFSFGVLVLEIVS 443
            +F+ KSD++SFGVL+ E+++
Sbjct: 212 QKFTTKSDVWSFGVLLWELMT 232

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 113/201 (56%), Gaps = 15/201 (7%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 307 GFCLERK-ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
           G CL  +   ++V  ++ +  L +FI +  +    T +        +A+G+ +L   +  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKFL---ASK 150
Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLF---EMDQTHSDTNRVVGTFGYMAPEYVMH 422
           + +HRDL A N +LD +   K++DFG+AR     E D  H+ T   +    +MA E +  
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQT 209
Query: 423 GRFSVKSDIFSFGVLVLEIVS 443
            +F+ KSD++SFGVL+ E+++
Sbjct: 210 QKFTTKSDVWSFGVLLWELMT 230

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 113/201 (56%), Gaps = 15/201 (7%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 307 GFCLERK-ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
           G CL  +   ++V  ++ +  L +FI +  +    T +        +A+G+ +L   +  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKFL---ASK 153
Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLF---EMDQTHSDTNRVVGTFGYMAPEYVMH 422
           + +HRDL A N +LD +   K++DFG+AR     E D  H+ T   +    +MA E +  
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPV-KWMALESLQT 212
Query: 423 GRFSVKSDIFSFGVLVLEIVS 443
            +F+ KSD++SFGVL+ E+++
Sbjct: 213 QKFTTKSDVWSFGVLLWELMT 233

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 140/299 (46%), Gaps = 43/299 (14%)
Query: 241 VATDNFSDANKLGQGGFGAVYKG-----MLSNGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           V+ +  +   +LGQG FG VY+G     +    ET +AVK +++++   E IEF NE  +
Sbjct: 15  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 74
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIF--------DPINREHMTWEKR 345
           +      ++VRLLG   + +  ++V E + +  L  ++         +P  R   T ++ 
Sbjct: 75  MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNP-GRPPPTLQEM 133
Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSD 404
            ++   IA G+ YL+     + +HR+L A N ++  +   KI DFGM R ++E D  +  
Sbjct: 134 IQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDY-YRK 189
Query: 405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAW 464
             + +    +MAPE +  G F+  SD++SFGV++ EI S  ++   G   E         
Sbjct: 190 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--------- 240
Query: 465 RNWNEGAALNLMDPTMRGGSTSEMMKC----IHIGLLCVQENVSNRPGMASVVNMLNGD 519
                     ++   M GG   +   C      +  +C Q N + RP    +VN+L  D
Sbjct: 241 ---------QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDD 290

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 113/201 (56%), Gaps = 15/201 (7%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 307 GFCLERK-ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
           G CL  +   ++V  ++ +  L +FI +  +    T +        +A+G+ +L   +  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKFL---ASK 152
Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLF---EMDQTHSDTNRVVGTFGYMAPEYVMH 422
           + +HRDL A N +LD +   K++DFG+AR     E D  H+ T   +    +MA E +  
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQT 211
Query: 423 GRFSVKSDIFSFGVLVLEIVS 443
            +F+ KSD++SFGVL+ E+++
Sbjct: 212 QKFTTKSDVWSFGVLLWELMT 232

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 113/201 (56%), Gaps = 15/201 (7%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 307 GFCLERK-ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
           G CL  +   ++V  ++ +  L +FI +  +    T +        +A+G+ +L   +  
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKFL---ASK 157
Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLF---EMDQTHSDTNRVVGTFGYMAPEYVMH 422
           + +HRDL A N +LD +   K++DFG+AR     E D  H+ T   +    +MA E +  
Sbjct: 158 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQT 216
Query: 423 GRFSVKSDIFSFGVLVLEIVS 443
            +F+ KSD++SFGVL+ E+++
Sbjct: 217 QKFTTKSDVWSFGVLLWELMT 237

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 130/284 (45%), Gaps = 47/284 (16%)
Query: 252 LGQGGFGAVYKGML----SNGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G  G V  G L         +A+K L    +++   +F +E  ++ +  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREH---MTWEKRYKIIEGIARGLLYLHEDS 363
           G     +  ++V E++ N SLD F+     R H    T  +   ++ G+  G+ YL   S
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL-----RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG-----YMAPE 418
            L  +HRDL A N+L+DS +  K+SDFG++R+ E D   + T     T G     + APE
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTT----TGGKIPIRWTAPE 224
Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP 478
            +    FS  SD++SFGV++ E+                  L Y  R +      +++  
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEV------------------LAYGERPYWNMTNRDVISS 266
Query: 479 TMRGGSTSEMMKCIH----IGLLCVQENVSNRPGMASVVNMLNG 518
              G      M C H    + L C  ++ + RP  + +V++L+ 
Sbjct: 267 VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA 310

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 113/201 (56%), Gaps = 15/201 (7%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 307 GFCLERK-ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
           G CL  +   ++V  ++ +  L +FI +  +    T +        +A+G+ +L   +  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKFL---ASK 153
Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLF---EMDQTHSDTNRVVGTFGYMAPEYVMH 422
           + +HRDL A N +LD +   K++DFG+AR     E D  H+ T   +    +MA E +  
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQT 212
Query: 423 GRFSVKSDIFSFGVLVLEIVS 443
            +F+ KSD++SFGVL+ E+++
Sbjct: 213 QKFTTKSDVWSFGVLLWELMT 233

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 103/194 (53%), Gaps = 7/194 (3%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            +LG G FG V  G       +A+K + + S   E EF  E  ++  L H  LV+L G C
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            +++   ++ E++ N  L +++ +   R     ++  ++ + +   + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLH 128
Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKS 429
           RDL A N L++ +   K+SDFG++R + +D  ++ +        +  PE +M+ +FS KS
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 187
Query: 430 DIFSFGVLVLEIVS 443
           DI++FGVL+ EI S
Sbjct: 188 DIWAFGVLMWEIYS 201

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 115/204 (56%), Gaps = 21/204 (10%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           G CL  +   ++V  ++ +  L +FI     +P  ++ + +  +      +A+G+ YL  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 149
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEY 419
            +  + +HRDL A N +LD +   K++DFG+AR     + +S  N+        +MA E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 420 VMHGRFSVKSDIFSFGVLVLEIVS 443
           +   +F+ KSD++SFGVL+ E+++
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 115/204 (56%), Gaps = 21/204 (10%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           G CL  +   ++V  ++ +  L +FI     +P  ++ + +  +      +A+G+ YL  
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 167
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEY 419
            +  + +HRDL A N +LD +   K++DFG+AR     + +S  N+        +MA E 
Sbjct: 168 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 226
Query: 420 VMHGRFSVKSDIFSFGVLVLEIVS 443
           +   +F+ KSD++SFGVL+ E+++
Sbjct: 227 LQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 115/204 (56%), Gaps = 21/204 (10%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           G CL  +   ++V  ++ +  L +FI     +P  ++ + +  +      +A+G+ YL  
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 168
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEY 419
            +  + +HRDL A N +LD +   K++DFG+AR     + +S  N+        +MA E 
Sbjct: 169 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 227
Query: 420 VMHGRFSVKSDIFSFGVLVLEIVS 443
           +   +F+ KSD++SFGVL+ E+++
Sbjct: 228 LQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 115/204 (56%), Gaps = 21/204 (10%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           G CL  +   ++V  ++ +  L +FI     +P  ++ + +  +      +A+G+ YL  
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 144
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEY 419
            +  + +HRDL A N +LD +   K++DFG+AR     + +S  N+        +MA E 
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 420 VMHGRFSVKSDIFSFGVLVLEIVS 443
           +   +F+ KSD++SFGVL+ E+++
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 115/204 (56%), Gaps = 21/204 (10%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           G CL  +   ++V  ++ +  L +FI     +P  ++ + +  +      +A+G+ YL  
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 141
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEY 419
            +  + +HRDL A N +LD +   K++DFG+AR     + +S  N+        +MA E 
Sbjct: 142 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 200
Query: 420 VMHGRFSVKSDIFSFGVLVLEIVS 443
           +   +F+ KSD++SFGVL+ E+++
Sbjct: 201 LQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 115/204 (56%), Gaps = 21/204 (10%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           G CL  +   ++V  ++ +  L +FI     +P  ++ + +  +      +A+G+ YL  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 149
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEY 419
            +  + +HRDL A N +LD +   K++DFG+AR     + +S  N+        +MA E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 420 VMHGRFSVKSDIFSFGVLVLEIVS 443
           +   +F+ KSD++SFGVL+ E+++
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 115/204 (56%), Gaps = 21/204 (10%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           G CL  +   ++V  ++ +  L +FI     +P  ++ + +  +      +A+G+ YL  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 148
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEY 419
            +  + +HRDL A N +LD +   K++DFG+AR     + +S  N+        +MA E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 207
Query: 420 VMHGRFSVKSDIFSFGVLVLEIVS 443
           +   +F+ KSD++SFGVL+ E+++
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 115/204 (56%), Gaps = 21/204 (10%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           G CL  +   ++V  ++ +  L +FI     +P  ++ + +  +      +A+G+ YL  
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 146
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEY 419
            +  + +HRDL A N +LD +   K++DFG+AR     + +S  N+        +MA E 
Sbjct: 147 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 205
Query: 420 VMHGRFSVKSDIFSFGVLVLEIVS 443
           +   +F+ KSD++SFGVL+ E+++
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 115/204 (56%), Gaps = 21/204 (10%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 307 GFCLERK-ERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           G CL  +   ++V  ++ +  L +FI     +P  ++ + +  +      +A+G+ YL  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKYL-- 147
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEY 419
            +  + +HRDL A N +LD +   K++DFG+AR     + +S  N+        +MA E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 206
Query: 420 VMHGRFSVKSDIFSFGVLVLEIVS 443
           +   +F+ KSD++SFGVL+ E+++
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 112/213 (52%), Gaps = 21/213 (9%)
Query: 241 VATDNFSDANKLGQGGFGAVY--KGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLA 295
           + +D +     LG+G FG V   K  ++ G+  AVK +SK     K  +     EV LL 
Sbjct: 23  IFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIAR 354
           +L H N+ +L  F  ++    LV E      L    FD I +R+  +     +II  +  
Sbjct: 82  QLDHPNIXKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLS 137
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           G+ Y H++   +I+HRDLK  N+LL+S   + N +I DFG++  FE  +   D    +GT
Sbjct: 138 GITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK---IGT 191
Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
             Y+APE V+HG +  K D++S GV++  ++SG
Sbjct: 192 AYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 130/281 (46%), Gaps = 41/281 (14%)
Query: 252 LGQGGFGAVYKGML----SNGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +G G  G V  G L         +A+K L    +++   +F +E  ++ +  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREH---MTWEKRYKIIEGIARGLLYLHEDS 363
           G     +  ++V E++ N SLD F+     R H    T  +   ++ G+  G+ YL   S
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL-----RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFE--MDQTHSDTNRVVGTFGYMAPEYVM 421
            L  +HRDL A N+L+DS +  K+SDFG++R+ E   D  ++ T   +    + APE + 
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI-PIRWTAPEAIA 227
Query: 422 HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR 481
              FS  SD++SFGV++ E+                  L Y  R +      +++     
Sbjct: 228 FRTFSSASDVWSFGVVMWEV------------------LAYGERPYWNMTNRDVISSVEE 269
Query: 482 GGSTSEMMKCIH----IGLLCVQENVSNRPGMASVVNMLNG 518
           G      M C H    + L C  ++ + RP  + +V++L+ 
Sbjct: 270 GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA 310

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 111/200 (55%), Gaps = 13/200 (6%)
Query: 252 LGQGGFGAVYKGML--SNGETI--AVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G L  ++G+ I  AVK L++ +  GE+ +F  E +++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 307 GFCLERK-ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
           G CL  +   ++V  ++ +  L +FI +  +    T +        +A+G+ YL   +  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKYL---ASK 151
Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEYVMHG 423
           + +HRDL A N +LD +   K++DFG+AR     +  S  N+        +MA E +   
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQ 211
Query: 424 RFSVKSDIFSFGVLVLEIVS 443
           +F+ KSD++SFGVL+ E+++
Sbjct: 212 KFTTKSDVWSFGVLLWELMT 231

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 106/201 (52%), Gaps = 10/201 (4%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           ++   K+GQG  G VY  M ++ G+ +A+++++   +  +    NE+L++   ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
            L   L   E  +V E++   SL     D +    M   +   +     + L +LH +  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
            ++IHRD+K+ NILL  + + K++DFG       +Q+   T  +VGT  +MAPE V    
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 192
Query: 425 FSVKSDIFSFGVLVLEIVSGQ 445
           +  K DI+S G++ +E++ G+
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGE 213

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 110/214 (51%), Gaps = 13/214 (6%)
Query: 244 DNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNS--KQGEIE-FKNEVLLLARLQH 299
           ++F   N LG+G F  VY+   +  G  +A+K + K +  K G ++  +NEV +  +L+H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            +++ L  +  +     LV E   N  ++ ++ + + +     E R+  +  I  G+LYL
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARH-FMHQIITGMLYL 128
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H      I+HRDL  SN+LL   MN KI+DFG+A   +M   H     + GT  Y++PE 
Sbjct: 129 HSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM--PHEKHYTLCGTPNYISPEI 183
Query: 420 VMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTE 453
                  ++SD++S G +   ++ G  R  F T+
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIG--RPPFDTD 215

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 109/208 (52%), Gaps = 17/208 (8%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHRN 301
           + +    K+G+G +G VYK   S G  +A+KR+  +++   I      E+ LL  L H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 302 LVRLLGFCLERKERILVYEFVPN---ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           +V L+      +   LV+EF+       LD       N+  +   +    +  + RG+ +
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEKDLKKVLDE------NKTGLQDSQIKIYLYQLLRGVAH 134
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
            H+    RI+HRDLK  N+L++S+   K++DFG+AR F +    S T+ VV T  Y AP+
Sbjct: 135 CHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TLWYRAPD 189
Query: 419 YVM-HGRFSVKSDIFSFGVLVLEIVSGQ 445
            +M   ++S   DI+S G +  E+++G+
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 99/203 (48%), Gaps = 25/203 (12%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            +LG G FG V  G       +AVK + + S   E EF  E   + +L H  LV+  G C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 310 LERKERILVYEFVPNASLDHFI------FDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            +     +V E++ N  L +++       +P     M     Y + EG+A   L  H+  
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMC----YDVCEGMA--FLESHQ-- 124
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT---FGYMAPEYV 420
               IHRDL A N L+D ++  K+SDFGM R    DQ  S     VGT     + APE  
Sbjct: 125 ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS----VGTKFPVKWSAPEVF 177
Query: 421 MHGRFSVKSDIFSFGVLVLEIVS 443
            + ++S KSD+++FG+L+ E+ S
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFS 200

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 109/208 (52%), Gaps = 17/208 (8%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHRN 301
           + +    K+G+G +G VYK   S G  +A+KR+  +++   I      E+ LL  L H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 302 LVRLLGFCLERKERILVYEFVPN---ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           +V L+      +   LV+EF+       LD       N+  +   +    +  + RG+ +
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEKDLKKVLDE------NKTGLQDSQIKIYLYQLLRGVAH 134
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
            H+    RI+HRDLK  N+L++S+   K++DFG+AR F +    S T+ VV T  Y AP+
Sbjct: 135 CHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV-TLWYRAPD 189
Query: 419 YVM-HGRFSVKSDIFSFGVLVLEIVSGQ 445
            +M   ++S   DI+S G +  E+++G+
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 122/229 (53%), Gaps = 29/229 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHF--------IFDPINREHMTWEKRYKIIEGI 352
           N+V+LL       +  LV+EF+ +  L  F        I  P+ + ++     +++++G+
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGL 123
Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF 412
           A    + H     R++HRDLK  N+L+++E   K++DFG+AR F +    + T+ VV T 
Sbjct: 124 A----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TL 174
Query: 413 GYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
            Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 175 WYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 221

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 109/210 (51%), Gaps = 27/210 (12%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLL-----G 307
            +G FG V+K  L N + +AVK      KQ   + + E+     ++H NL++ +     G
Sbjct: 24  ARGRFGCVWKAQLMN-DFVAVKIFPLQDKQS-WQSEREIFSTPGMKHENLLQFIAAEKRG 81
Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED----- 362
             LE  E  L+  F    SL  ++   I    +TW +   + E ++RGL YLHED     
Sbjct: 82  SNLE-VELWLITAFHDKGSLTDYLKGNI----ITWNELCHVAETMSRGLSYLHEDVPWCR 136
Query: 363 ---SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
               +  I HRD K+ N+LL S++   ++DFG+A  FE  +   DT+  VGT  YMAPE 
Sbjct: 137 GEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPE- 195
Query: 420 VMHGRFS------VKSDIFSFGVLVLEIVS 443
           V+ G  +      ++ D+++ G+++ E+VS
Sbjct: 196 VLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 123/232 (53%), Gaps = 29/232 (12%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARL 297
           V  +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L
Sbjct: 4   VDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHF--------IFDPINREHMTWEKRYKII 349
            H N+V+LL       +  LV+EF+ +  L  F        I  P+ + ++     ++++
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYL-----FQLL 117
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
           +G+A    + H     R++HRDLK  N+L+++E   K++DFG+AR F +    + T+ VV
Sbjct: 118 QGLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV 169
Query: 410 GTFGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
            T  Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 170 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 218

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 122/229 (53%), Gaps = 29/229 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHF--------IFDPINREHMTWEKRYKIIEGI 352
           N+V+LL       +  LV+EF+ +  L  F        I  P+ + ++     +++++G+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGL 116
Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF 412
           A    + H     R++HRDLK  N+L+++E   K++DFG+AR F +    + T+ VV T 
Sbjct: 117 A----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TL 167
Query: 413 GYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
            Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 168 WYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 214

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 106/201 (52%), Gaps = 10/201 (4%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           ++   K+GQG  G VY  M ++ G+ +A+++++   +  +    NE+L++   ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
            L   L   E  +V E++   SL     D +    M   +   +     + L +LH +  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
            ++IHRD+K+ NILL  + + K++DFG       +Q  S  + +VGT  +MAPE V    
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSEMVGTPYWMAPEVVTRKA 192
Query: 425 FSVKSDIFSFGVLVLEIVSGQ 445
           +  K DI+S G++ +E++ G+
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGE 213

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 109/221 (49%), Gaps = 20/221 (9%)
Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNE 290
           L++D+E      D   D   LG+G +G VY G  LSN   IA+K + +   +       E
Sbjct: 15  LEYDYEY-----DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEE 69
Query: 291 VLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI---FDPINREHMTWEKRYK 347
           + L   L+H+N+V+ LG   E     +  E VP  SL   +   + P+     T     K
Sbjct: 70  IALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK 129
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTN 406
               I  GL YLH++   +I+HRD+K  N+L+++     KISDFG ++   +   +  T 
Sbjct: 130 ---QILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSK--RLAGINPCTE 181
Query: 407 RVVGTFGYMAPEYVMHG--RFSVKSDIFSFGVLVLEIVSGQ 445
              GT  YMAPE +  G   +   +DI+S G  ++E+ +G+
Sbjct: 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 123/230 (53%), Gaps = 27/230 (11%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 116
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F +    + T+ VV T
Sbjct: 117 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-T 167
Query: 412 FGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
             Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 215

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 122/229 (53%), Gaps = 29/229 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHF--------IFDPINREHMTWEKRYKIIEGI 352
           N+V+LL       +  LV+EF+ +  L  F        I  P+ + ++     +++++G+
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGL 123
Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF 412
           A    + H     R++HRDLK  N+L+++E   K++DFG+AR F +    + T+ VV T 
Sbjct: 124 A----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TL 174
Query: 413 GYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
            Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 175 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 221

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 105/200 (52%), Gaps = 9/200 (4%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           + ++G G FG VYKG       + + ++   + +    F+NEV +L + +H N++  +G+
Sbjct: 41  STRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
            + +    +V ++   +SL   +     +  M   +   I    A+G+ YLH  +   II
Sbjct: 101 -MTKDNLAIVTQWCEGSSLYKHLHVQETKFQMF--QLIDIARQTAQGMDYLHAKN---II 154
Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM---HGRF 425
           HRD+K++NI L   +  KI DFG+A +           +  G+  +MAPE +    +  F
Sbjct: 155 HRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPF 214
Query: 426 SVKSDIFSFGVLVLEIVSGQ 445
           S +SD++S+G+++ E+++G+
Sbjct: 215 SFQSDVYSYGIVLYELMTGE 234

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 112/206 (54%), Gaps = 21/206 (10%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           ++LG+G FG+V    Y  +  N G  +AVK+L  +    + +F+ E+ +L  L    +V+
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 305 LLG--FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G  +   R+   LV E++P+  L  F+    +R  +   +       I +G+ YL   
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--G 132
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG-----YMAP 417
           SR R +HRDL A NIL++SE + KI+DFG+A+L  +D+ +     VV   G     + AP
Sbjct: 133 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYAP 187
Query: 418 EYVMHGRFSVKSDIFSFGVLVLEIVS 443
           E +    FS +SD++SFGV++ E+ +
Sbjct: 188 ESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 106/201 (52%), Gaps = 10/201 (4%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           ++   K+GQG  G VY  M ++ G+ +A+++++   +  +    NE+L++   ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
            L   L   E  +V E++   SL     D +    M   +   +     + L +LH +  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
            ++IHRD+K+ NILL  + + K++DFG       +Q  S  + +VGT  +MAPE V    
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSXMVGTPYWMAPEVVTRKA 192
Query: 425 FSVKSDIFSFGVLVLEIVSGQ 445
           +  K DI+S G++ +E++ G+
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGE 213

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 122/228 (53%), Gaps = 27/228 (11%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 301 NLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G+A
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA 117
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
               + H     R++HRDLK  N+L+++E   K++DFG+AR F +    + T+ VV T  
Sbjct: 118 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLW 168
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
           Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 214

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 122/228 (53%), Gaps = 27/228 (11%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 301 NLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G+A
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA 116
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
               + H     R++HRDLK  N+L+++E   K++DFG+AR F +    + T+ VV T  
Sbjct: 117 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLW 167
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
           Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 213

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 122/228 (53%), Gaps = 27/228 (11%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 301 NLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G+A
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA 117
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
               + H     R++HRDLK  N+L+++E   K++DFG+AR F +    + T+ VV T  
Sbjct: 118 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLW 168
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
           Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 214

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 122/228 (53%), Gaps = 27/228 (11%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 301 NLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G+A
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA 116
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
               + H     R++HRDLK  N+L+++E   K++DFG+AR F +    + T+ VV T  
Sbjct: 117 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLW 167
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
           Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 213

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 106/201 (52%), Gaps = 10/201 (4%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           ++   K+GQG  G VY  M ++ G+ +A+++++   +  +    NE+L++   ++ N+V 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
            L   L   E  +V E++   SL     D +    M   +   +     + L +LH +  
Sbjct: 83  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 136
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
            ++IHRD+K+ NILL  + + K++DFG       +Q  S  + +VGT  +MAPE V    
Sbjct: 137 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSXMVGTPYWMAPEVVTRKA 193
Query: 425 FSVKSDIFSFGVLVLEIVSGQ 445
           +  K DI+S G++ +E++ G+
Sbjct: 194 YGPKVDIWSLGIMAIEMIEGE 214

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 111/206 (53%), Gaps = 21/206 (10%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           ++LG+G FG+V    Y  +  N G  +AVK+L  +    + +F+ E+ +L  L    +V+
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 305 LLG--FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G  +   R E  LV E++P+  L  F+    +R  +   +       I +G+ YL   
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGMEYL--G 128
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG-----YMAP 417
           SR R +HRDL A NIL++SE + KI+DFG+A+L  +D+       VV   G     + AP
Sbjct: 129 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXX----VVREPGQSPIFWYAP 183
Query: 418 EYVMHGRFSVKSDIFSFGVLVLEIVS 443
           E +    FS +SD++SFGV++ E+ +
Sbjct: 184 ESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 112/206 (54%), Gaps = 21/206 (10%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           ++LG+G FG+V    Y  +  N G  +AVK+L  +    + +F+ E+ +L  L    +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 305 LLG--FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G  +   R+   LV E++P+  L  F+    +R  +   +       I +G+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--G 144
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG-----YMAP 417
           SR R +HRDL A NIL++SE + KI+DFG+A+L  +D+ +     VV   G     + AP
Sbjct: 145 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYAP 199
Query: 418 EYVMHGRFSVKSDIFSFGVLVLEIVS 443
           E +    FS +SD++SFGV++ E+ +
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 112/206 (54%), Gaps = 21/206 (10%)
Query: 250 NKLGQGGFGAV----YKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           ++LG+G FG+V    Y  +  N G  +AVK+L  +    + +F+ E+ +L  L    +V+
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 305 LLG--FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G  +   R+   LV E++P+  L  F+    +R  +   +       I +G+ YL   
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--G 131
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG-----YMAP 417
           SR R +HRDL A NIL++SE + KI+DFG+A+L  +D+ +     VV   G     + AP
Sbjct: 132 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYAP 186
Query: 418 EYVMHGRFSVKSDIFSFGVLVLEIVS 443
           E +    FS +SD++SFGV++ E+ +
Sbjct: 187 ESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 109/221 (49%), Gaps = 20/221 (9%)
Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNE 290
           L++D+E      D   D   LG+G +G VY G  LSN   IA+K + +   +       E
Sbjct: 1   LEYDYEY-----DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEE 55
Query: 291 VLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI---FDPINREHMTWEKRYK 347
           + L   L+H+N+V+ LG   E     +  E VP  SL   +   + P+     T     K
Sbjct: 56  IALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK 115
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTN 406
               I  GL YLH++   +I+HRD+K  N+L+++     KISDFG ++   +   +  T 
Sbjct: 116 ---QILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSK--RLAGINPCTE 167
Query: 407 RVVGTFGYMAPEYVMHG--RFSVKSDIFSFGVLVLEIVSGQ 445
              GT  YMAPE +  G   +   +DI+S G  ++E+ +G+
Sbjct: 168 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 109/218 (50%), Gaps = 38/218 (17%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSK--NSKQGEIEFK---NEVLLLARLQHRNLVRL 305
           LG G FG V+KG+ +  GE+I +    K    K G   F+   + +L +  L H ++VRL
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 306 LGFCLERKERILVYEFVPNASL-DHFIFDPINREH---------MTWEKRYKIIEGIARG 355
           LG C     + LV +++P  SL DH       R+H         + W  +      IA+G
Sbjct: 99  LGLCPGSSLQ-LVTQYLPLGSLLDHV------RQHRGALGPQLLLNWGVQ------IAKG 145
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYM 415
           + YL E     ++HR+L A N+LL S    +++DFG+A L   D      +       +M
Sbjct: 146 MYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 202
Query: 416 APEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTE 453
           A E +  G+++ +SD++S+GV V E++      +FG E
Sbjct: 203 ALESIHFGKYTHQSDVWSYGVTVWELM------TFGAE 234

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 115/223 (51%), Gaps = 13/223 (5%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H N+V+LL       +  LV+EF+     D      +    +   K Y  +  + +GL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSY--LFQLLQGLAF 121
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
            H     R++HRDLK  N+L+++E   K++DFG+AR F +    +  + VV T  Y APE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 176
Query: 419 YVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
            ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 217

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 115/223 (51%), Gaps = 13/223 (5%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H N+V+LL       +  LV+EF+     D      +    +   K Y  +  + +GL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSY--LFQLLQGLAF 118
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
            H     R++HRDLK  N+L+++E   K++DFG+AR F +    +  + VV T  Y APE
Sbjct: 119 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 173
Query: 419 YVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
            ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 214

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 12/207 (5%)
Query: 252 LGQGGFGAVYKGMLSN--GETI--AVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLL 306
           LG+G FG VY+G+ +N  GE I  AVK   K+      E F +E +++  L H ++V+L+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G  +E +   ++ E  P   L H++    N   +     Y +   I + + YL     + 
Sbjct: 76  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLES---IN 129
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS 426
            +HRD+   NIL+ S    K+ DFG++R  E D+ +   +       +M+PE +   RF+
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPESINFRRFT 188
Query: 427 VKSDIFSFGVLVLEIVSGQKRSSFGTE 453
             SD++ F V + EI+S  K+  F  E
Sbjct: 189 TASDVWMFAVCMWEILSFGKQPFFWLE 215

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 12/207 (5%)
Query: 252 LGQGGFGAVYKGMLSN--GETI--AVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLL 306
           LG+G FG VY+G+ +N  GE I  AVK   K+      E F +E +++  L H ++V+L+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G  +E +   ++ E  P   L H++    N   +     Y +   I + + YL     + 
Sbjct: 92  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLES---IN 145
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS 426
            +HRD+   NIL+ S    K+ DFG++R  E D+ +   +       +M+PE +   RF+
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPESINFRRFT 204
Query: 427 VKSDIFSFGVLVLEIVSGQKRSSFGTE 453
             SD++ F V + EI+S  K+  F  E
Sbjct: 205 TASDVWMFAVCMWEILSFGKQPFFWLE 231

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 115/223 (51%), Gaps = 13/223 (5%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H N+V+LL       +  LV+EF+     D      +    +   K Y  +  + +GL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSY--LFQLLQGLAF 120
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
            H     R++HRDLK  N+L+++E   K++DFG+AR F +    +  + VV T  Y APE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLWYRAPE 175
Query: 419 YVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
            ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 216

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 106/201 (52%), Gaps = 10/201 (4%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           ++   K+GQG  G VY  M ++ G+ +A+++++   +  +    NE+L++   ++ N+V 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
            L   L   E  +V E++   SL     D +    M   +   +     + L +LH +  
Sbjct: 83  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 136
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
            ++IHR++K+ NILL  + + K++DFG       +Q+   T  +VGT  +MAPE V    
Sbjct: 137 -QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 193
Query: 425 FSVKSDIFSFGVLVLEIVSGQ 445
           +  K DI+S G++ +E++ G+
Sbjct: 194 YGPKVDIWSLGIMAIEMIEGE 214

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 109/218 (50%), Gaps = 38/218 (17%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSK--NSKQGEIEFK---NEVLLLARLQHRNLVRL 305
           LG G FG V+KG+ +  GE+I +    K    K G   F+   + +L +  L H ++VRL
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 306 LGFCLERKERILVYEFVPNASL-DHFIFDPINREH---------MTWEKRYKIIEGIARG 355
           LG C     + LV +++P  SL DH       R+H         + W  +      IA+G
Sbjct: 81  LGLCPGSSLQ-LVTQYLPLGSLLDHV------RQHRGALGPQLLLNWGVQ------IAKG 127
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYM 415
           + YL E     ++HR+L A N+LL S    +++DFG+A L   D      +       +M
Sbjct: 128 MYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184
Query: 416 APEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTE 453
           A E +  G+++ +SD++S+GV V E++      +FG E
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELM------TFGAE 216

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 138/296 (46%), Gaps = 47/296 (15%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSN-----GET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           VA +  + + +LGQG FG VY+G+         ET +A+K +++ +   E IEF NE  +
Sbjct: 7   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 66
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM---------TWEK 344
           +      ++VRLLG   + +  +++ E +    L  ++     R  M         +  K
Sbjct: 67  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL--RPEMENNPVLAPPSLSK 124
Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD 404
             ++   IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R    D   +D
Sbjct: 125 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXETD 177
Query: 405 TNRVVGT----FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
             R  G       +M+PE +  G F+  SD++SFGV++ EI +  ++   G     E +L
Sbjct: 178 XXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--SNEQVL 235
Query: 461 TYAWRNWNEGAALNLMD--PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN 514
            +      EG  L+  D  P M      E+M+      +C Q N   RP    +++
Sbjct: 236 RFV----MEGGLLDKPDNCPDM----LLELMR------MCWQYNPKMRPSFLEIIS 277

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 108/203 (53%), Gaps = 13/203 (6%)
Query: 246 FSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLS-KNSKQGEIEFKNEVLLLARLQHRNLV 303
           F+   K+G+G FG V+KG+ +  +  +A+K +  + ++    + + E+ +L++     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 304 RLLGFCLERKERILVYEFVPNAS-LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           +  G  L+  +  ++ E++   S LD     P++   +       I+  I +GL YLH +
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLHSE 138
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH 422
            +   IHRD+KA+N+LL      K++DFG+A   ++  T    N  VGT  +MAPE +  
Sbjct: 139 KK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNXFVGTPFWMAPEVIKQ 193
Query: 423 GRFSVKSDIFSFGVLVLEIVSGQ 445
             +  K+DI+S G+  +E+  G+
Sbjct: 194 SAYDSKADIWSLGITAIELARGE 216

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 12/207 (5%)
Query: 252 LGQGGFGAVYKGMLSN--GETI--AVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLL 306
           LG+G FG VY+G+ +N  GE I  AVK   K+      E F +E +++  L H ++V+L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G  +E +   ++ E  P   L H++    N   +     Y +   I + + YL     + 
Sbjct: 80  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLES---IN 133
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS 426
            +HRD+   NIL+ S    K+ DFG++R  E D+ +   +       +M+PE +   RF+
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIE-DEDYYKASVTRLPIKWMSPESINFRRFT 192
Query: 427 VKSDIFSFGVLVLEIVSGQKRSSFGTE 453
             SD++ F V + EI+S  K+  F  E
Sbjct: 193 TASDVWMFAVCMWEILSFGKQPFFWLE 219

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 108/203 (53%), Gaps = 13/203 (6%)
Query: 246 FSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLS-KNSKQGEIEFKNEVLLLARLQHRNLV 303
           F+   K+G+G FG V+KG+ +  +  +A+K +  + ++    + + E+ +L++     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 304 RLLGFCLERKERILVYEFVPNAS-LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           +  G  L+  +  ++ E++   S LD     P++   +       I+  I +GL YLH +
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLHSE 123
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH 422
            +   IHRD+KA+N+LL      K++DFG+A   ++  T    N  VGT  +MAPE +  
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQ 178
Query: 423 GRFSVKSDIFSFGVLVLEIVSGQ 445
             +  K+DI+S G+  +E+  G+
Sbjct: 179 SAYDSKADIWSLGITAIELARGE 201

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 108/203 (53%), Gaps = 13/203 (6%)
Query: 246 FSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLS-KNSKQGEIEFKNEVLLLARLQHRNLV 303
           F+   K+G+G FG V+KG+ +  +  +A+K +  + ++    + + E+ +L++     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 304 RLLGFCLERKERILVYEFVPNAS-LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           +  G  L+  +  ++ E++   S LD     P++   +       I+  I +GL YLH +
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLHSE 123
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH 422
            +   IHRD+KA+N+LL      K++DFG+A   ++  T    N  VGT  +MAPE +  
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNXFVGTPFWMAPEVIKQ 178
Query: 423 GRFSVKSDIFSFGVLVLEIVSGQ 445
             +  K+DI+S G+  +E+  G+
Sbjct: 179 SAYDSKADIWSLGITAIELARGE 201

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 117/232 (50%), Gaps = 26/232 (11%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQH 299
           ++  F    KLG G +  VYKG+  + G  +A+K +  +S++G       E+ L+  L+H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 300 RNLVRLLGFCLERKERILVYEFVPN---ASLDHFIFDPINR-------EHMTWEKRYKII 349
            N+VRL        +  LV+EF+ N     +D        R       ++  W+      
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ------ 116
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
             + +GL + HE+   +I+HRDLK  N+L++     K+ DFG+AR F +   ++ ++ VV
Sbjct: 117 --LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP-VNTFSSEVV 170
Query: 410 GTFGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
            T  Y AP+ +M  R +S   DI+S G ++ E+++G+       +EE   L+
Sbjct: 171 -TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI 221

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 110/203 (54%), Gaps = 13/203 (6%)
Query: 246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHRNLV 303
           F+   ++G+G FG V+KG+ +   + +A+K +  + ++    + + E+ +L++     + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 304 RLLGFCLERKERILVYEFVPNAS-LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           +  G  L+  +  ++ E++   S LD     P +   +       +++ I +GL YLH +
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIA-----TMLKEILKGLDYLHSE 139
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH 422
            +   IHRD+KA+N+LL  + + K++DFG+A   ++  T    N  VGT  +MAPE +  
Sbjct: 140 KK---IHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIQQ 194
Query: 423 GRFSVKSDIFSFGVLVLEIVSGQ 445
             +  K+DI+S G+  +E+  G+
Sbjct: 195 SAYDSKADIWSLGITAIELAKGE 217

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 140/293 (47%), Gaps = 41/293 (13%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLS-----NGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           VA +  + + +LGQG FG VY+G+         ET +A+K +++ +   E IEF NE  +
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM---------TWEK 344
           +      ++VRLLG   + +  +++ E +    L  ++     R  M         +  K
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS--LRPEMENNPVLAPPSLSK 139
Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHS 403
             ++   IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R ++E D  + 
Sbjct: 140 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-YYR 195
Query: 404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA 463
              + +    +M+PE +  G F+  SD++SFGV++ EI +  ++   G     E +L + 
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--SNEQVLRFV 253
Query: 464 WRNWNEGAALNLMD--PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN 514
                EG  L+  D  P M      E+M+      +C Q N   RP    +++
Sbjct: 254 ----MEGGLLDKPDNCPDM----LFELMR------MCWQYNPKMRPSFLEIIS 292

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 122/228 (53%), Gaps = 27/228 (11%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 301 NLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G++
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLS 117
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
               + H     R++HRDLK  N+L+++E   K++DFG+AR F +    + T+ VV T  
Sbjct: 118 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLW 168
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
           Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 214

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 122/230 (53%), Gaps = 27/230 (11%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 118
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F +    +  + VV T
Sbjct: 119 LA----FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-T 169
Query: 412 FGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
             Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 217

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 113/211 (53%), Gaps = 15/211 (7%)
Query: 244 DNFSDAN-KLGQGGFGAVYKG---MLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQ 298
           DN   A+ +LG G FG+V +G   M      +A+K L + +++ + E    E  ++ +L 
Sbjct: 9   DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 68
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           +  +VRL+G C + +  +LV E      L  F+     RE +      +++  ++ G+ Y
Sbjct: 69  NPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKY 125
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMA 416
           L E +    +HRDL A N+LL +    KISDFG+++    D ++  T R  G +   + A
Sbjct: 126 LEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TARSAGKWPLKWYA 181
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS-GQK 446
           PE +   +FS +SD++S+GV + E +S GQK
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALSYGQK 212

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 29/200 (14%)
Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            KLG G FG V+    +    +AVK +   S   E  F  E  ++  LQH  LV+L    
Sbjct: 188 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHA-V 245
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE---GIARGLLYLHEDSRLR 366
           + ++   ++ EF+   SL     D +  +  + +   K+I+    IA G+ ++ + +   
Sbjct: 246 VTKEPIYIITEFMAKGSL----LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--- 298
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT---FGYMAPEYVMHG 423
            IHRDL+A+NIL+ + +  KI+DFG+AR              VG      + APE +  G
Sbjct: 299 YIHRDLRAANILVSASLVCKIADFGLAR--------------VGAKFPIKWTAPEAINFG 344
Query: 424 RFSVKSDIFSFGVLVLEIVS 443
            F++KSD++SFG+L++EIV+
Sbjct: 345 SFTIKSDVWSFGILLMEIVT 364

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 138/296 (46%), Gaps = 47/296 (15%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSN-----GET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           VA +  + + +LGQG FG VY+G+         ET +A+K +++ +   E IEF NE  +
Sbjct: 16  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM---------TWEK 344
           +      ++VRLLG   + +  +++ E +    L  ++     R  M         +  K
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL--RPEMENNPVLAPPSLSK 133
Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD 404
             ++   IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R    D   +D
Sbjct: 134 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXETD 186
Query: 405 TNRVVGT----FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
             R  G       +M+PE +  G F+  SD++SFGV++ EI +  ++   G     E +L
Sbjct: 187 XXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--SNEQVL 244
Query: 461 TYAWRNWNEGAALNLMD--PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN 514
            +      EG  L+  D  P M      E+M+      +C Q N   RP    +++
Sbjct: 245 RFV----MEGGLLDKPDNCPDM----LFELMR------MCWQYNPKMRPSFLEIIS 286

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 108/203 (53%), Gaps = 13/203 (6%)
Query: 246 FSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLS-KNSKQGEIEFKNEVLLLARLQHRNLV 303
           F+   K+G+G FG V+KG+ +  +  +A+K +  + ++    + + E+ +L++     + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 304 RLLGFCLERKERILVYEFVPNAS-LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           +  G  L+  +  ++ E++   S LD     P++   +       I+  I +GL YLH +
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLHSE 143
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH 422
            +   IHRD+KA+N+LL      K++DFG+A   ++  T    N  VGT  +MAPE +  
Sbjct: 144 KK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQ 198
Query: 423 GRFSVKSDIFSFGVLVLEIVSGQ 445
             +  K+DI+S G+  +E+  G+
Sbjct: 199 SAYDSKADIWSLGITAIELARGE 221

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 113/211 (53%), Gaps = 15/211 (7%)
Query: 244 DNFSDAN-KLGQGGFGAVYKG---MLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQ 298
           DN   A+ +LG G FG+V +G   M      +A+K L + +++ + E    E  ++ +L 
Sbjct: 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 394
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           +  +VRL+G C + +  +LV E      L  F+     RE +      +++  ++ G+ Y
Sbjct: 395 NPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKY 451
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMA 416
           L E +    +HR+L A N+LL +    KISDFG+++    D ++  T R  G +   + A
Sbjct: 452 LEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TARSAGKWPLKWYA 507
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS-GQK 446
           PE +   +FS +SD++S+GV + E +S GQK
Sbjct: 508 PECINFRKFSSRSDVWSYGVTMWEALSYGQK 538

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 141/291 (48%), Gaps = 37/291 (12%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLS-----NGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           VA +  + + +LGQG FG VY+G+         ET +A+K +++ +   E IEF NE  +
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI--FDPI--NREHMTWEKRYKII 349
           +      ++VRLLG   + +  +++ E +    L  ++    P   N   +      K+I
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 350 E---GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSDT 405
           +    IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R ++E D  +   
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-YYRKG 197
Query: 406 NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWR 465
            + +    +M+PE +  G F+  SD++SFGV++ EI +  ++   G     E +L +   
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--SNEQVLRFV-- 253
Query: 466 NWNEGAALNLMD--PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN 514
              EG  L+  D  P M      E+M+      +C Q N   RP    +++
Sbjct: 254 --MEGGLLDKPDNCPDM----LFELMR------MCWQYNPKMRPSFLEIIS 292

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 122/230 (53%), Gaps = 27/230 (11%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYL-----FQLLQG 118
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F +    +  + VV T
Sbjct: 119 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-T 169
Query: 412 FGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
             Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 217

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 122/230 (53%), Gaps = 27/230 (11%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 118
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F +    +  + VV T
Sbjct: 119 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-T 169
Query: 412 FGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
             Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 217

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 122/231 (52%), Gaps = 29/231 (12%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHF--------IFDPINREHMTWEKRYKIIE 350
           H N+V+LL       +  LV+EF+ +  L  F        I  P+ + ++     +++++
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYL-----FQLLQ 117
Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG 410
           G+A    + H     R++HRDLK  N+L+++E   K++DFG+AR F +    +  + VV 
Sbjct: 118 GLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV- 168
Query: 411 TFGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
           T  Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 169 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 217

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 122/231 (52%), Gaps = 29/231 (12%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHF--------IFDPINREHMTWEKRYKIIE 350
           H N+V+LL       +  LV+EF+ +  L  F        I  P+ + ++     +++++
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYL-----FQLLQ 116
Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG 410
           G+A    + H     R++HRDLK  N+L+++E   K++DFG+AR F +    +  + VV 
Sbjct: 117 GLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV- 167
Query: 411 TFGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
           T  Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 168 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 216

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 122/230 (53%), Gaps = 27/230 (11%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 116
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F +    +  + VV T
Sbjct: 117 LA----FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-T 167
Query: 412 FGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
             Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 215

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 122/231 (52%), Gaps = 29/231 (12%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHF--------IFDPINREHMTWEKRYKIIE 350
           H N+V+LL       +  LV+EF+ +  L  F        I  P+ + ++     +++++
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYL-----FQLLQ 116
Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG 410
           G+A    + H     R++HRDLK  N+L+++E   K++DFG+AR F +    +  + VV 
Sbjct: 117 GLA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV- 167
Query: 411 TFGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
           T  Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 168 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 216

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 121/228 (53%), Gaps = 27/228 (11%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 301 NLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           N+V+LL       +  LV+E V        +AS    I  P+ + ++     +++++G+A
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYL-----FQLLQGLA 116
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
               + H     R++HRDLK  N+L+++E   K++DFG+AR F +    + T+ VV T  
Sbjct: 117 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLW 167
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
           Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 213

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 122/230 (53%), Gaps = 27/230 (11%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 115
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F +    +  + VV T
Sbjct: 116 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-T 166
Query: 412 FGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
             Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 214

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 122/230 (53%), Gaps = 27/230 (11%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 119
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F +    +  + VV T
Sbjct: 120 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-T 170
Query: 412 FGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
             Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 218

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 13/218 (5%)
Query: 229 AKSLQFDFETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEF 287
           A  L  D    R   DNF    K+G+G  G V    + S+G+ +AVK++    +Q     
Sbjct: 139 ALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL 195
Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
            NEV+++   QH N+V +    L   E  +V EF+   +L     D +    M  E+   
Sbjct: 196 FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAA 251
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           +   + + L  LH      +IHRD+K+ +ILL  +   K+SDFG     ++ +       
Sbjct: 252 VCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKX 306
Query: 408 VVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           +VGT  +MAPE +    +  + DI+S G++V+E+V G+
Sbjct: 307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 344

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 140/293 (47%), Gaps = 41/293 (13%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLS-----NGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           VA +  + + +LGQG FG VY+G+         ET +A+K +++ +   E IEF NE  +
Sbjct: 13  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 72
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM---------TWEK 344
           +      ++VRLLG   + +  +++ E +    L  ++     R  M         +  K
Sbjct: 73  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL--RPEMENNPVLAPPSLSK 130
Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHS 403
             ++   IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R ++E D  + 
Sbjct: 131 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-YYR 186
Query: 404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA 463
              + +    +M+PE +  G F+  SD++SFGV++ EI +  ++   G     E +L + 
Sbjct: 187 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--SNEQVLRFV 244
Query: 464 WRNWNEGAALNLMD--PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN 514
                EG  L+  D  P M      E+M+      +C Q N   RP    +++
Sbjct: 245 ----MEGGLLDKPDNCPDM----LFELMR------MCWQYNPKMRPSFLEIIS 283

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 140/293 (47%), Gaps = 41/293 (13%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSN-----GET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           VA +  + + +LGQG FG VY+G+         ET +A+K +++ +   E IEF NE  +
Sbjct: 9   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM---------TWEK 344
           +      ++VRLLG   + +  +++ E +    L  ++     R  M         +  K
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL--RPEMENNPVLAPPSLSK 126
Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHS 403
             ++   IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R ++E D  + 
Sbjct: 127 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-YYR 182
Query: 404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA 463
              + +    +M+PE +  G F+  SD++SFGV++ EI +  ++   G     E +L + 
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--SNEQVLRFV 240
Query: 464 WRNWNEGAALNLMD--PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN 514
                EG  L+  D  P M      E+M+      +C Q N   RP    +++
Sbjct: 241 ----MEGGLLDKPDNCPDM----LFELMR------MCWQYNPKMRPSFLEIIS 279

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 122/230 (53%), Gaps = 27/230 (11%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 116
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F +    +  + VV T
Sbjct: 117 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-T 167
Query: 412 FGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
             Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 215

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 140/293 (47%), Gaps = 41/293 (13%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLS-----NGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           VA +  + + +LGQG FG VY+G+         ET +A+K +++ +   E IEF NE  +
Sbjct: 15  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM---------TWEK 344
           +      ++VRLLG   + +  +++ E +    L  ++     R  M         +  K
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL--RPEMENNPVLAPPSLSK 132
Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHS 403
             ++   IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R ++E D  + 
Sbjct: 133 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-YYR 188
Query: 404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA 463
              + +    +M+PE +  G F+  SD++SFGV++ EI +  ++   G     E +L + 
Sbjct: 189 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--SNEQVLRFV 246
Query: 464 WRNWNEGAALNLMD--PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN 514
                EG  L+  D  P M      E+M+      +C Q N   RP    +++
Sbjct: 247 ----MEGGLLDKPDNCPDM----LFELMR------MCWQYNPKMRPSFLEIIS 285

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 122/230 (53%), Gaps = 27/230 (11%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 115
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F +    +  + VV T
Sbjct: 116 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-T 166
Query: 412 FGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
             Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 214

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 122/230 (53%), Gaps = 27/230 (11%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 117
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F +    +  + VV T
Sbjct: 118 LA----FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-T 168
Query: 412 FGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
             Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 216

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 140/293 (47%), Gaps = 41/293 (13%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLS-----NGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           VA +  + + +LGQG FG VY+G+         ET +A+K +++ +   E IEF NE  +
Sbjct: 15  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM---------TWEK 344
           +      ++VRLLG   + +  +++ E +    L  ++     R  M         +  K
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL--RPEMENNPVLAPPSLSK 132
Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHS 403
             ++   IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R ++E D  + 
Sbjct: 133 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-YYR 188
Query: 404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA 463
              + +    +M+PE +  G F+  SD++SFGV++ EI +  ++   G     E +L + 
Sbjct: 189 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--SNEQVLRFV 246
Query: 464 WRNWNEGAALNLMD--PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN 514
                EG  L+  D  P M      E+M+      +C Q N   RP    +++
Sbjct: 247 ----MEGGLLDKPDNCPDM----LFELMR------MCWQYNPKMRPSFLEIIS 285

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 9/198 (4%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE--FKNEVLLLARLQHRNLVRLL 306
             ++G+G FG V+ G L    T+   +  + +   +++  F  E  +L +  H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G C +++   +V E V     D   F       +  +   +++   A G+ YL       
Sbjct: 179 GVCTQKQPIYIVMELVQGG--DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-FGYMAPEYVMHGRF 425
            IHRDL A N L+  +   KISDFGM+R  E D  ++ +  +      + APE + +GR+
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSRE-EADGVYAASGGLRQVPVKWTAPEALNYGRY 292
Query: 426 SVKSDIFSFGVLVLEIVS 443
           S +SD++SFG+L+ E  S
Sbjct: 293 SSESDVWSFGILLWETFS 310

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 140/293 (47%), Gaps = 41/293 (13%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSN-----GET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           VA +  + + +LGQG FG VY+G+         ET +A+K +++ +   E IEF NE  +
Sbjct: 16  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM---------TWEK 344
           +      ++VRLLG   + +  +++ E +    L  ++     R  M         +  K
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL--RPEMENNPVLAPPSLSK 133
Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHS 403
             ++   IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R ++E D  + 
Sbjct: 134 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-YYR 189
Query: 404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA 463
              + +    +M+PE +  G F+  SD++SFGV++ EI +  ++   G     E +L + 
Sbjct: 190 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--SNEQVLRFV 247
Query: 464 WRNWNEGAALNLMD--PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN 514
                EG  L+  D  P M      E+M+      +C Q N   RP    +++
Sbjct: 248 ----MEGGLLDKPDNCPDM----LFELMR------MCWQYNPKMRPSFLEIIS 286

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 122/230 (53%), Gaps = 27/230 (11%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 115
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F +    +  + VV T
Sbjct: 116 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-T 166
Query: 412 FGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
             Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 214

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 141/291 (48%), Gaps = 37/291 (12%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSN-----GET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           VA +  + + +LGQG FG VY+G+         ET +A+K +++ +   E IEF NE  +
Sbjct: 12  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 71
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI--FDPI--NREHMTWEKRYKII 349
           +      ++VRLLG   + +  +++ E +    L  ++    P   N   +      K+I
Sbjct: 72  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 131
Query: 350 E---GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSDT 405
           +    IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R ++E D  +   
Sbjct: 132 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-YYRKG 187
Query: 406 NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWR 465
            + +    +M+PE +  G F+  SD++SFGV++ EI +  ++   G     E +L +   
Sbjct: 188 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--SNEQVLRFV-- 243
Query: 466 NWNEGAALNLMD--PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN 514
              EG  L+  D  P M      E+M+      +C Q N   RP    +++
Sbjct: 244 --MEGGLLDKPDNCPDM----LFELMR------MCWQYNPKMRPSFLEIIS 282

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 122/230 (53%), Gaps = 27/230 (11%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 115
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F +    +  + VV T
Sbjct: 116 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-T 166
Query: 412 FGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
             Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 214

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 122/230 (53%), Gaps = 27/230 (11%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 116
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F +    +  + VV T
Sbjct: 117 LA----FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-T 167
Query: 412 FGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
             Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 215

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 121/228 (53%), Gaps = 27/228 (11%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 301 NLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G+A
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA 116
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
               + H     R++HRDLK  N+L+++E   K++DFG+AR F +    +  + VV T  
Sbjct: 117 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLW 167
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
           Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 213

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 121/228 (53%), Gaps = 27/228 (11%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 301 NLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G+A
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA 116
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
               + H     R++HRDLK  N+L+++E   K++DFG+AR F +    +  + VV T  
Sbjct: 117 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLW 167
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
           Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 213

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 121/228 (53%), Gaps = 27/228 (11%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+ ++  +++   +      E+ LL  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 301 NLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G+A
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA 117
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
               + H     R++HRDLK  N+L+++E   K++DFG+AR F +    + T+ VV T  
Sbjct: 118 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLW 168
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
           Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 214

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 121/228 (53%), Gaps = 27/228 (11%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+ ++  +++   +      E+ LL  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 301 NLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G+A
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA 116
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
               + H     R++HRDLK  N+L+++E   K++DFG+AR F +    + T+ VV T  
Sbjct: 117 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLW 167
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
           Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 213

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 121/228 (53%), Gaps = 27/228 (11%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 301 NLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           N+V+LL       +  LV+EF+        +AS    I  P+ + ++     +++++G+A
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL-----FQLLQGLA 118
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
               + H     R++HRDLK  N+L+++E   K++DFG+AR F +    +  + VV T  
Sbjct: 119 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-TLW 169
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
           Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 215

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 13/218 (5%)
Query: 229 AKSLQFDFETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEF 287
           A  L  D    R   DNF    K+G+G  G V    + S+G+ +AVK++    +Q     
Sbjct: 19  ALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL 75
Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
            NEV+++   QH N+V +    L   E  +V EF+   +L     D +    M  E+   
Sbjct: 76  FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAA 131
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           +   + + L  LH      +IHRD+K+ +ILL  +   K+SDFG     ++ +       
Sbjct: 132 VCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKX 186
Query: 408 VVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           +VGT  +MAPE +    +  + DI+S G++V+E+V G+
Sbjct: 187 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 224

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/271 (29%), Positives = 133/271 (49%), Gaps = 33/271 (12%)
Query: 251 KLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQGEIEFKNEVL----LLARLQHRNLVR 304
           +LG G FG V KG   +         ++ KN +  +   K+E+L    ++ +L +  +VR
Sbjct: 377 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPYIVR 435
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           ++G C E +  +LV E      L+ ++    NR H+  +   +++  ++ G+ YL E + 
Sbjct: 436 MIGIC-EAESWMLVMEMAELGPLNKYLQQ--NR-HVKDKNIIELVHQVSMGMKYLEESN- 490
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEYVMH 422
              +HRDL A N+LL ++   KISDFG+++    D+ +    +  G +   + APE + +
Sbjct: 491 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA-QTHGKWPVKWYAPECINY 547
Query: 423 GRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR 481
            +FS KSD++SFGVL+ E  S GQK        E   +L    R         +  P   
Sbjct: 548 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---------MGCPA-- 596
Query: 482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASV 512
            G   EM   ++   LC   +V NRPG A+V
Sbjct: 597 -GCPREMYDLMN---LCWTYDVENRPGFAAV 623

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 133/271 (49%), Gaps = 33/271 (12%)
Query: 251 KLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQGEIEFKNEVL----LLARLQHRNLVR 304
           +LG G FG V KG   +         ++ KN +  +   K+E+L    ++ +L +  +VR
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           ++G C E +  +LV E      L+ ++    NR H+  +   +++  ++ G+ YL E + 
Sbjct: 93  MIGIC-EAESWMLVMEMAELGPLNKYLQQ--NR-HVKDKNIIELVHQVSMGMKYLEESN- 147
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEYVMH 422
              +HRDL A N+LL ++   KISDFG+++    D+ +    +  G +   + APE + +
Sbjct: 148 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA-QTHGKWPVKWYAPECINY 204
Query: 423 GRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR 481
            +FS KSD++SFGVL+ E  S GQK        E   +L        +G  +        
Sbjct: 205 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-------EKGERMGC-----P 252
Query: 482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASV 512
            G   EM   ++   LC   +V NRPG A+V
Sbjct: 253 AGCPREMYDLMN---LCWTYDVENRPGFAAV 280

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 133/271 (49%), Gaps = 33/271 (12%)
Query: 251 KLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQGEIEFKNEVL----LLARLQHRNLVR 304
           +LG G FG V KG   +         ++ KN +  +   K+E+L    ++ +L +  +VR
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           ++G C E +  +LV E      L+ ++    NR H+  +   +++  ++ G+ YL E + 
Sbjct: 93  MIGIC-EAESWMLVMEMAELGPLNKYLQQ--NR-HVKDKNIIELVHQVSMGMKYLEESN- 147
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEYVMH 422
              +HRDL A N+LL ++   KISDFG+++    D+ +    +  G +   + APE + +
Sbjct: 148 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA-QTHGKWPVKWYAPECINY 204
Query: 423 GRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR 481
            +FS KSD++SFGVL+ E  S GQK        E   +L        +G  +        
Sbjct: 205 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-------EKGERMGC-----P 252
Query: 482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASV 512
            G   EM   ++   LC   +V NRPG A+V
Sbjct: 253 AGCPREMYDLMN---LCWTYDVENRPGFAAV 280

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 140/293 (47%), Gaps = 41/293 (13%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSN-----GET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           VA +  + + +LGQG FG VY+G+         ET +A+K +++ +   E IEF NE  +
Sbjct: 44  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 103
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM---------TWEK 344
           +      ++VRLLG   + +  +++ E +    L  ++     R  M         +  K
Sbjct: 104 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL--RPEMENNPVLAPPSLSK 161
Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHS 403
             ++   IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R ++E D  + 
Sbjct: 162 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY-YR 217
Query: 404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA 463
              + +    +M+PE +  G F+  SD++SFGV++ EI +  ++   G     E +L + 
Sbjct: 218 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--SNEQVLRFV 275
Query: 464 WRNWNEGAALNLMD--PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN 514
                EG  L+  D  P M      E+M+      +C Q N   RP    +++
Sbjct: 276 ----MEGGLLDKPDNCPDM----LFELMR------MCWQYNPKMRPSFLEIIS 314

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 125/280 (44%), Gaps = 26/280 (9%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           +G+G FG V K      + +A+K++   S++    F  E+  L+R+ H N+V+L G CL 
Sbjct: 17  VGRGAFGVVCKAKW-RAKDVAIKQIESESERKA--FIVELRQLSRVNHPNIVKLYGACL- 72
Query: 312 RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRD 371
                LV E+    SL + +       + T           ++G+ YLH      +IHRD
Sbjct: 73  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 131
Query: 372 LKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSD 430
           LK  N+LL +     KI DFG A      QTH   N+  G+  +MAPE      +S K D
Sbjct: 132 LKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK--GSAAWMAPEVFEGSNYSEKCD 186
Query: 431 IFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAAL-NLMDPTMRGGSTSEMM 489
           +FS+G+++ E+++  +R  F         + +A  N      + NL  P       S M 
Sbjct: 187 VFSWGIILWEVIT--RRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI-----ESLMT 239
Query: 490 KCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKP 529
           +C         ++ S RP M  +V ++       P   +P
Sbjct: 240 RCW-------SKDPSQRPSMEEIVKIMTHLMRYFPGADEP 272

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 13/218 (5%)
Query: 229 AKSLQFDFETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEF 287
           A  L  D    R   DNF    K+G+G  G V    + S+G+ +AVK++    +Q     
Sbjct: 17  ALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL 73
Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
            NEV+++   QH N+V +    L   E  +V EF+   +L     D +    M  E+   
Sbjct: 74  FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAA 129
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           +   + + L  LH      +IHRD+K+ +ILL  +   K+SDFG     ++ +       
Sbjct: 130 VCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKX 184
Query: 408 VVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           +VGT  +MAPE +    +  + DI+S G++V+E+V G+
Sbjct: 185 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 222

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/271 (29%), Positives = 133/271 (49%), Gaps = 33/271 (12%)
Query: 251 KLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQGEIEFKNEVL----LLARLQHRNLVR 304
           +LG G FG V KG   +         ++ KN +  +   K+E+L    ++ +L +  +VR
Sbjct: 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPYIVR 434
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           ++G C E +  +LV E      L+ ++    NR H+  +   +++  ++ G+ YL E + 
Sbjct: 435 MIGIC-EAESWMLVMEMAELGPLNKYLQQ--NR-HVKDKNIIELVHQVSMGMKYLEESN- 489
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEYVMH 422
              +HRDL A N+LL ++   KISDFG+++    D+ +    +  G +   + APE + +
Sbjct: 490 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA-QTHGKWPVKWYAPECINY 546
Query: 423 GRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR 481
            +FS KSD++SFGVL+ E  S GQK        E   +L    R         +  P   
Sbjct: 547 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---------MGCPA-- 595
Query: 482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASV 512
            G   EM   ++   LC   +V NRPG A+V
Sbjct: 596 -GCPREMYDLMN---LCWTYDVENRPGFAAV 622

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 13/218 (5%)
Query: 229 AKSLQFDFETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEF 287
           A  L  D    R   DNF    K+G+G  G V    + S+G+ +AVK++    +Q     
Sbjct: 62  ALQLVVDPGDPRSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELL 118
Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
            NEV+++   QH N+V +    L   E  +V EF+   +L     D +    M  E+   
Sbjct: 119 FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAA 174
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           +   + + L  LH      +IHRD+K+ +ILL  +   K+SDFG     ++ +       
Sbjct: 175 VCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKX 229
Query: 408 VVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           +VGT  +MAPE +    +  + DI+S G++V+E+V G+
Sbjct: 230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 267

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 13/207 (6%)
Query: 240 RVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           R   DNF    K+G+G  G V    + S+G+ +AVK++    +Q      NEV+++   Q
Sbjct: 19  RSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ 75
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H N+V +    L   E  +V EF+   +L     D +    M  E+   +   + + L  
Sbjct: 76  HENVVEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSV 131
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
           LH      +IHRD+K+ +ILL  +   K+SDFG     ++ +       +VGT  +MAPE
Sbjct: 132 LHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPE 186
Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
            +    +  + DI+S G++V+E+V G+
Sbjct: 187 LISRLPYGPEVDIWSLGIMVIEMVDGE 213

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 102/196 (52%), Gaps = 10/196 (5%)
Query: 251 KLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
           K+G+G  G V      + G  +AVK +    +Q      NEV+++   QH N+V +    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
           L  +E  ++ EF+   +L     D +++  +  E+   + E + + L YLH      +IH
Sbjct: 112 LVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIH 164
Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKS 429
           RD+K+ +ILL  +   K+SDFG     ++ +       +VGT  +MAPE +    ++ + 
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKXLVGTPYWMAPEVISRSLYATEV 222
Query: 430 DIFSFGVLVLEIVSGQ 445
           DI+S G++V+E+V G+
Sbjct: 223 DIWSLGIMVIEMVDGE 238

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 133/271 (49%), Gaps = 33/271 (12%)
Query: 251 KLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQGEIEFKNEVL----LLARLQHRNLVR 304
           +LG G FG V KG   +         ++ KN +  +   K+E+L    ++ +L +  +VR
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPYIVR 90
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           ++G C E +  +LV E      L+ ++    NR H+  +   +++  ++ G+ YL E + 
Sbjct: 91  MIGIC-EAESWMLVMEMAELGPLNKYLQQ--NR-HVKDKNIIELVHQVSMGMKYLEESN- 145
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEYVMH 422
              +HRDL A N+LL ++   KISDFG+++    D+ +    +  G +   + APE + +
Sbjct: 146 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA-QTHGKWPVKWYAPECINY 202
Query: 423 GRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR 481
            +FS KSD++SFGVL+ E  S GQK        E   +L        +G  +        
Sbjct: 203 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-------EKGERMGC-----P 250
Query: 482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASV 512
            G   EM   ++   LC   +V NRPG A+V
Sbjct: 251 AGCPREMYDLMN---LCWTYDVENRPGFAAV 278

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 125/280 (44%), Gaps = 26/280 (9%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           +G+G FG V K      + +A+K++   S++    F  E+  L+R+ H N+V+L G CL 
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESESERKA--FIVELRQLSRVNHPNIVKLYGACL- 71
Query: 312 RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRD 371
                LV E+    SL + +       + T           ++G+ YLH      +IHRD
Sbjct: 72  -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 372 LKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSD 430
           LK  N+LL +     KI DFG A      QTH   N+  G+  +MAPE      +S K D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK--GSAAWMAPEVFEGSNYSEKCD 185
Query: 431 IFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAAL-NLMDPTMRGGSTSEMM 489
           +FS+G+++ E+++  +R  F         + +A  N      + NL  P       S M 
Sbjct: 186 VFSWGIILWEVIT--RRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI-----ESLMT 238
Query: 490 KCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKP 529
           +C         ++ S RP M  +V ++       P   +P
Sbjct: 239 RCW-------SKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 13/207 (6%)
Query: 240 RVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           R   DNF    K+G+G  G V    + S+G+ +AVK++    +Q      NEV+++   Q
Sbjct: 23  RSYLDNFI---KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ 79
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H N+V +    L   E  +V EF+   +L     D +    M  E+   +   + + L  
Sbjct: 80  HENVVEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSV 135
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
           LH      +IHRD+K+ +ILL  +   K+SDFG     ++ +       +VGT  +MAPE
Sbjct: 136 LHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPE 190
Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
            +    +  + DI+S G++V+E+V G+
Sbjct: 191 LISRLPYGPEVDIWSLGIMVIEMVDGE 217

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 99/198 (50%), Gaps = 9/198 (4%)
Query: 249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE--FKNEVLLLARLQHRNLVRLL 306
             ++G+G FG V+ G L    T+   +  + +   +++  F  E  +L +  H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G C +++   +V E V     D   F       +  +   +++   A G+ YL       
Sbjct: 179 GVCTQKQPIYIVMELVQGG--DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT-FGYMAPEYVMHGRF 425
            IHRDL A N L+  +   KISDFGM+R  E D   + +  +      + APE + +GR+
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVXAASGGLRQVPVKWTAPEALNYGRY 292
Query: 426 SVKSDIFSFGVLVLEIVS 443
           S +SD++SFG+L+ E  S
Sbjct: 293 SSESDVWSFGILLWETFS 310

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 121/230 (52%), Gaps = 27/230 (11%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + +NF    K+G+G +G VYK      GE +A+K++  +++   +      E+ LL  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 299 HRNLVRLLGFCLERKERILVYEFVP-------NASLDHFIFDPINREHMTWEKRYKIIEG 351
           H N+V+LL       +  LV+E V        +AS    I  P+ + ++     +++++G
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYL-----FQLLQG 118
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +A    + H     R++HRDLK  N+L+++E   K++DFG+AR F +    +  + VV T
Sbjct: 119 LA----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYXHEVV-T 169
Query: 412 FGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
             Y APE ++  + +S   DI+S G +  E+V+  +R+ F  + E + L 
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT--RRALFPGDSEIDQLF 217

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 139/293 (47%), Gaps = 41/293 (13%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLS-----NGET-IAVKRLSKNSKQGE-IEFKNEVLL 293
           VA +  + + +LGQG FG VY+G+         ET +A+K +++ +   E IEF NE  +
Sbjct: 9   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM---------TWEK 344
           +      ++VRLLG   + +  +++ E +    L  ++     R  M         +  K
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL--RPEMENNPVLAPPSLSK 126
Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHS 403
             ++   IA G+ YL+ +   + +HRDL A N  +  +   KI DFGM R ++E D  + 
Sbjct: 127 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETD-YYR 182
Query: 404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA 463
              + +    +M+PE +  G F+  SD++SFGV++ EI +  ++   G     E +L + 
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--SNEQVLRFV 240
Query: 464 WRNWNEGAALNLMD--PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN 514
                EG  L+  D  P M      E+M+      +C Q N   RP    +++
Sbjct: 241 ----MEGGLLDKPDNCPDM----LLELMR------MCWQYNPKMRPSFLEIIS 279

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQHRN 301
           + +    K+G+G +G VYK   + GET A+K  RL K  +        E+ +L  L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +V+L      +K  +LV+E +               E +T +     +  +  G+ Y H+
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKS---FLLQLLNGIAYCHD 118
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM 421
               R++HRDLK  N+L++ E   KI+DFG+AR F +      T+ VV T  Y AP+ +M
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEVV-TLWYRAPDVLM 173
Query: 422 -HGRFSVKSDIFSFGVLVLEIVSG 444
              ++S   DI+S G +  E+V+G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQHRN 301
           + +    K+G+G +G VYK   + GET A+K  RL K  +        E+ +L  L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +V+L      +K  +LV+E +               E +T +     +  +  G+ Y H+
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKS---FLLQLLNGIAYCHD 118
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM 421
               R++HRDLK  N+L++ E   KI+DFG+AR F +      T+ VV T  Y AP+ +M
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEVV-TLWYRAPDVLM 173
Query: 422 -HGRFSVKSDIFSFGVLVLEIVSG 444
              ++S   DI+S G +  E+V+G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 133/271 (49%), Gaps = 33/271 (12%)
Query: 251 KLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQGEIEFKNEVL----LLARLQHRNLVR 304
           +LG G FG V KG   +         ++ KN +  +   K+E+L    ++ +L +  +VR
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           ++G C E +  +LV E      L+ ++    NR H+  +   +++  ++ G+ YL E + 
Sbjct: 77  MIGIC-EAESWMLVMEMAELGPLNKYLQQ--NR-HVKDKNIIELVHQVSMGMKYLEESN- 131
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEYVMH 422
              +HRDL A N+LL ++   KISDFG+++    D+ +    +  G +   + APE + +
Sbjct: 132 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA-QTHGKWPVKWYAPECINY 188
Query: 423 GRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR 481
            +FS KSD++SFGVL+ E  S GQK        E   +L        +G  +        
Sbjct: 189 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-------EKGERMGC-----P 236
Query: 482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASV 512
            G   EM   ++   LC   +V NRPG A+V
Sbjct: 237 AGCPREMYDLMN---LCWTYDVENRPGFAAV 264

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 112/232 (48%), Gaps = 25/232 (10%)
Query: 229 AKSL-QFDFETIRVATDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGEIE 286
           A+SL + D   +R     F     +G G +G VYKG  +  G+  A+K +     + E E
Sbjct: 8   ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-E 66
Query: 287 FKNEVLLLARL-QHRNLVRLLGFCLERK------ERILVYEFVPNASLDHFIFDPINREH 339
            K E+ +L +   HRN+    G  +++       +  LV EF    S+   I    N + 
Sbjct: 67  IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI---KNTKG 123
Query: 340 MTWEKRY--KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
            T ++ +   I   I RGL +LH+    ++IHRD+K  N+LL      K+ DFG++   +
Sbjct: 124 NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA--Q 178
Query: 398 MDQTHSDTNRVVGTFGYMAPEYVM-----HGRFSVKSDIFSFGVLVLEIVSG 444
           +D+T    N  +GT  +MAPE +         +  KSD++S G+  +E+  G
Sbjct: 179 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 133/271 (49%), Gaps = 33/271 (12%)
Query: 251 KLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQGEIEFKNEVL----LLARLQHRNLVR 304
           +LG G FG V KG   +         ++ KN +  +   K+E+L    ++ +L +  +VR
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           ++G C E +  +LV E      L+ ++    NR H+  +   +++  ++ G+ YL E + 
Sbjct: 83  MIGIC-EAESWMLVMEMAELGPLNKYLQQ--NR-HVKDKNIIELVHQVSMGMKYLEESN- 137
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEYVMH 422
              +HRDL A N+LL ++   KISDFG+++    D+ +    +  G +   + APE + +
Sbjct: 138 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA-QTHGKWPVKWYAPECINY 194
Query: 423 GRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR 481
            +FS KSD++SFGVL+ E  S GQK        E   +L        +G  +        
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-------EKGERMGC-----P 242
Query: 482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASV 512
            G   EM   ++   LC   +V NRPG A+V
Sbjct: 243 AGCPREMYDLMN---LCWTYDVENRPGFAAV 270

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQHRN 301
           + +    K+G+G +G VYK   + GET A+K  RL K  +        E+ +L  L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +V+L      +K  +LV+E +               E +T +     +  +  G+ Y H+
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKS---FLLQLLNGIAYCHD 118
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM 421
               R++HRDLK  N+L++ E   KI+DFG+AR F +      T+ +V T  Y AP+ +M
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIV-TLWYRAPDVLM 173
Query: 422 -HGRFSVKSDIFSFGVLVLEIVSG 444
              ++S   DI+S G +  E+V+G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 133/271 (49%), Gaps = 33/271 (12%)
Query: 251 KLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQGEIEFKNEVL----LLARLQHRNLVR 304
           +LG G FG V KG   +         ++ KN +  +   K+E+L    ++ +L +  +VR
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPYIVR 70
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           ++G C E +  +LV E      L+ ++    NR H+  +   +++  ++ G+ YL E + 
Sbjct: 71  MIGIC-EAESWMLVMEMAELGPLNKYL--QQNR-HVKDKNIIELVHQVSMGMKYLEESN- 125
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEYVMH 422
              +HRDL A N+LL ++   KISDFG+++    D+ +    +  G +   + APE + +
Sbjct: 126 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA-QTHGKWPVKWYAPECINY 182
Query: 423 GRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR 481
            +FS KSD++SFGVL+ E  S GQK        E   +L        +G  +        
Sbjct: 183 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-------EKGERMGC-----P 230
Query: 482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASV 512
            G   EM   ++   LC   +V NRPG A+V
Sbjct: 231 AGCPREMYDLMN---LCWTYDVENRPGFAAV 258

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 251 KLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
           K+G+G  G V      + G+ +AVK++    +Q      NEV+++    H N+V +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
           L   E  +V EF+   +L     D +    M  E+   +   + R L YLH      +IH
Sbjct: 112 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 164
Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKS 429
           RD+K+ +ILL S+   K+SDFG     ++ +       +VGT  +MAPE +    +  + 
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEV 222
Query: 430 DIFSFGVLVLEIVSGQ 445
           DI+S G++V+E++ G+
Sbjct: 223 DIWSLGIMVIEMIDGE 238

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 133/271 (49%), Gaps = 33/271 (12%)
Query: 251 KLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQGEIEFKNEVL----LLARLQHRNLVR 304
           +LG G FG V KG   +         ++ KN +  +   K+E+L    ++ +L +  +VR
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           ++G C E +  +LV E      L+ ++    NR H+  +   +++  ++ G+ YL E + 
Sbjct: 73  MIGIC-EAESWMLVMEMAELGPLNKYL--QQNR-HVKDKNIIELVHQVSMGMKYLEESN- 127
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEYVMH 422
              +HRDL A N+LL ++   KISDFG+++    D+ +    +  G +   + APE + +
Sbjct: 128 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA-QTHGKWPVKWYAPECINY 184
Query: 423 GRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR 481
            +FS KSD++SFGVL+ E  S GQK        E   +L        +G  +        
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-------EKGERMGC-----P 232
Query: 482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASV 512
            G   EM   ++   LC   +V NRPG A+V
Sbjct: 233 AGCPREMYDLMN---LCWTYDVENRPGFAAV 260

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 81/275 (29%), Positives = 131/275 (47%), Gaps = 41/275 (14%)
Query: 251 KLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQGEIEFKNEVL----LLARLQHRNLVR 304
           +LG G FG V KG   +         ++ KN +  +   K+E+L    ++ +L +  +VR
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           ++G C E +  +LV E      L+ ++    NR H+  +   +++  ++ G+ YL E + 
Sbjct: 77  MIGIC-EAESWMLVMEMAELGPLNKYLQQ--NR-HVKDKNIIELVHQVSMGMKYLEESN- 131
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD------QTHSDTNRVVGTFGYMAPE 418
              +HRDL A N+LL ++   KISDFG+++    D      QTH           + APE
Sbjct: 132 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKW-----PVKWYAPE 184
Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD 477
            + + +FS KSD++SFGVL+ E  S GQK        E   +L        +G  +    
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-------EKGERMGC-- 235
Query: 478 PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASV 512
                G   EM   ++   LC   +V NRPG A+V
Sbjct: 236 ---PAGCPREMYDLMN---LCWTYDVENRPGFAAV 264

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 110/224 (49%), Gaps = 28/224 (12%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D  +    LG+G FG V         K       T+AVK L  ++ + ++ +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPINR---EH 339
             + +H+N++ LLG C +     ++ E+    +L  ++           +D INR   E 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQ 153
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           MT++        +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR     
Sbjct: 154 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             + +T        +MAPE +    ++ +SD++SFGVL+ EI +
Sbjct: 211 DYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 113/225 (50%), Gaps = 30/225 (13%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D  +    LG+G FG V         K       T+AVK L  ++ + ++ +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPINR---EH 339
             + +H+N++ LLG C +     ++ E+    +L  ++           +D INR   E 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYD-INRVPEEQ 153
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEM 398
           MT++        +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR +  +
Sbjct: 154 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           D     TN  +    +MAPE +    ++ +SD++SFGVL+ EI +
Sbjct: 211 DXXKKTTNGRL-PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 131/303 (43%), Gaps = 34/303 (11%)
Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKG------MLSNGETIAVKRLSKNSKQGEI 285
           L +D        D  +    LG+G FG V +         +   T+AVK L + +   E 
Sbjct: 15  LPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH 74
Query: 286 E-FKNEVLLLARL-QHRNLVRLLGFCLERKERILV-YEFVPNASLDHFI---------FD 333
               +E+ +L  +  H N+V LLG C +    ++V  EF    +L  ++         + 
Sbjct: 75  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 334 PINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            + ++ +T E        +A+G+ +L   +  + IHRDL A NILL  +   KI DFG+A
Sbjct: 135 DLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLA 191
Query: 394 RLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTE 453
           R    D  +           +MAPE +    ++++SD++SFGVL+ EI S       G +
Sbjct: 192 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 251
Query: 454 EETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVV 513
            + E       R   EG  +   D T     T EM + +   L C     S RP  + +V
Sbjct: 252 IDEEFX-----RRLKEGTRMRAPDYT-----TPEMYQTM---LDCWHGEPSQRPTFSELV 298
Query: 514 NML 516
             L
Sbjct: 299 EHL 301

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 113/225 (50%), Gaps = 30/225 (13%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D  +    LG+G FG V         K       T+AVK L  ++ + ++ +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPINR---EH 339
             + +H+N++ LLG C +     ++ E+    +L  ++           +D INR   E 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQ 153
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEM 398
           MT++        +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR +  +
Sbjct: 154 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           D     TN  +    +MAPE +    ++ +SD++SFGVL+ EI +
Sbjct: 211 DXXKKTTNGRL-PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 28/224 (12%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D  +    LG+G FG V         K       T+AVK L  ++ + ++ +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPINR---EH 339
             + +H+N++ LLG C +     ++ E+    +L  ++           +D INR   E 
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQ 153
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           MT++        +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR     
Sbjct: 154 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +  T        +MAPE +    ++ +SD++SFGVL+ EI +
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 28/224 (12%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D  +    LG+G FG V         K       T+AVK L  ++ + ++ +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPINR---EH 339
             + +H+N++ LLG C +     ++ E+    +L  ++           +D INR   E 
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQ 153
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           MT++        +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR     
Sbjct: 154 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +  T        +MAPE +    ++ +SD++SFGVL+ EI +
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 131/303 (43%), Gaps = 34/303 (11%)
Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKG------MLSNGETIAVKRLSKNSKQGEI 285
           L +D        D  +    LG+G FG V +         +   T+AVK L + +   E 
Sbjct: 15  LPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH 74
Query: 286 E-FKNEVLLLARL-QHRNLVRLLGFCLERKERILV-YEFVPNASLDHFI---------FD 333
               +E+ +L  +  H N+V LLG C +    ++V  EF    +L  ++         + 
Sbjct: 75  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 334 PINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA 393
            + ++ +T E        +A+G+ +L   +  + IHRDL A NILL  +   KI DFG+A
Sbjct: 135 DLYKDFLTLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLA 191
Query: 394 RLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTE 453
           R    D  +           +MAPE +    ++++SD++SFGVL+ EI S       G +
Sbjct: 192 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 251
Query: 454 EETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVV 513
            + E       R   EG  +   D T     T EM + +   L C     S RP  + +V
Sbjct: 252 IDEEFC-----RRLKEGTRMRAPDYT-----TPEMYQTM---LDCWHGEPSQRPTFSELV 298
Query: 514 NML 516
             L
Sbjct: 299 EHL 301

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 116/245 (47%), Gaps = 22/245 (8%)
Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSK 278
           E+   EE  +K    + +  + A ++F     LG+G FG VY       + I A+K L K
Sbjct: 10  ENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFK 69
Query: 279 NS--KQG-EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI 335
               K G E + + EV + + L+H N++RL G+  +     L+ E+ P  +    ++  +
Sbjct: 70  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYREL 125
Query: 336 NREHMTWEKRYKI-IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +     E+R    I  +A  L Y H     R+IHRD+K  N+LL S    KI+DFG + 
Sbjct: 126 QKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS- 181
Query: 395 LFEMDQTHSDTNR---VVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFG 451
                  H+ ++R   + GT  Y+ PE +       K D++S GVL  E + G+      
Sbjct: 182 ------VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 235
Query: 452 TEEET 456
           T +ET
Sbjct: 236 TYQET 240

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 28/224 (12%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D  +    LG+G FG V         K       T+AVK L  ++ + ++ +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPINR---EH 339
             + +H+N++ LLG C +     ++ E+    +L  ++           +D INR   E 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQ 153
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           MT++        +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR     
Sbjct: 154 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +  T        +MAPE +    ++ +SD++SFGVL+ EI +
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 107/212 (50%), Gaps = 19/212 (8%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQG-EIEFKNEVLLLARL 297
           +AT  +    ++G G +G VYK     +G  +A+K +   N ++G  I    EV LL RL
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 298 Q---HRNLVRLLGFC-LERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
           +   H N+VRL+  C   R +R     LV+E V +  L  ++ D      +  E    ++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLM 118
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
               RGL +LH +    I+HRDLK  NIL+ S    K++DFG+AR++         + VV
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LDPVV 172
Query: 410 GTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEI 441
            T  Y APE ++   ++   D++S G +  E+
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 28/224 (12%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D  +    LG+G FG V         K       T+AVK L  ++ + ++ +  +E+ ++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPINR---EH 339
             + +H+N++ LLG C +     ++ E+    +L  ++           +D INR   E 
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQ 199
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           MT++        +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR     
Sbjct: 200 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 256
Query: 400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +  T        +MAPE +    ++ +SD++SFGVL+ EI +
Sbjct: 257 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 116/245 (47%), Gaps = 22/245 (8%)
Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSK 278
           E+   EE  +K    + +  + A ++F     LG+G FG VY       + I A+K L K
Sbjct: 10  ENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFK 69
Query: 279 NS--KQG-EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI 335
               K G E + + EV + + L+H N++RL G+  +     L+ E+ P  +    ++  +
Sbjct: 70  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYREL 125
Query: 336 NREHMTWEKRYKI-IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
            +     E+R    I  +A  L Y H     R+IHRD+K  N+LL S    KI+DFG + 
Sbjct: 126 QKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS- 181
Query: 395 LFEMDQTHSDTNR---VVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFG 451
                  H+ ++R   + GT  Y+ PE +       K D++S GVL  E + G+      
Sbjct: 182 ------VHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 235
Query: 452 TEEET 456
           T +ET
Sbjct: 236 TYQET 240

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 28/224 (12%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D  +    LG+G FG V         K       T+AVK L  ++ + ++ +  +E+ ++
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPINR---EH 339
             + +H+N++ LLG C +     ++ E+    +L  ++           +D INR   E 
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQ 145
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           MT++        +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR     
Sbjct: 146 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 202
Query: 400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +  T        +MAPE +    ++ +SD++SFGVL+ EI +
Sbjct: 203 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 107/212 (50%), Gaps = 19/212 (8%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQG-EIEFKNEVLLLARL 297
           +AT  +    ++G G +G VYK     +G  +A+K +   N ++G  I    EV LL RL
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 298 Q---HRNLVRLLGFC-LERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
           +   H N+VRL+  C   R +R     LV+E V +  L  ++ D      +  E    ++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLM 118
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
               RGL +LH +    I+HRDLK  NIL+ S    K++DFG+AR++      +    VV
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAP---VV 172
Query: 410 GTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEI 441
            T  Y APE ++   ++   D++S G +  E+
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 28/224 (12%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D  +    LG+G FG V         K       T+AVK L  ++ + ++ +  +E+ ++
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPINR---EH 339
             + +H+N++ LLG C +     ++ E+    +L  ++           +D INR   E 
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQ 142
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           MT++        +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR     
Sbjct: 143 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 199
Query: 400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +  T        +MAPE +    ++ +SD++SFGVL+ EI +
Sbjct: 200 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 109/224 (48%), Gaps = 28/224 (12%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D  +    LG+G FG V         K       T+AVK L  ++ + ++ +  +E+ ++
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPINR---EH 339
             + +H+N++ LLG C +     ++ E+    +L  ++           +D INR   E 
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQ 140
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           MT++        +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR     
Sbjct: 141 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNI 197
Query: 400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +  T        +MAPE +    ++ +SD++SFGVL+ EI +
Sbjct: 198 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 85/310 (27%), Positives = 133/310 (42%), Gaps = 38/310 (12%)
Query: 229 AKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKG------MLSNGETIAVKRLSKNSKQ 282
           A+ L +D        D       LG+G FG V +         +   T+AVK L + +  
Sbjct: 3   AERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH 62
Query: 283 GEIE-FKNEVLLLARL-QHRNLVRLLGFCLERKERILVY-EFVPNASLDHFI------FD 333
            E     +E+ +L  +  H N+V LLG C +    ++V  EF    +L  ++      F 
Sbjct: 63  SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFV 122
Query: 334 P-------INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPK 386
           P       + ++ +T E        +A+G+ +L   +  + IHRDL A NILL  +   K
Sbjct: 123 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVK 179
Query: 387 ISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQK 446
           I DFG+AR    D  +           +MAPE +    ++++SD++SFGVL+ EI S   
Sbjct: 180 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 239
Query: 447 RSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNR 506
               G + + E       R   EG  +   D T     T EM + +   L C     S R
Sbjct: 240 SPYPGVKIDEEFC-----RRLKEGTRMRAPDYT-----TPEMYQTM---LDCWHGEPSQR 286
Query: 507 PGMASVVNML 516
           P  + +V  L
Sbjct: 287 PTFSELVEHL 296

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 111/218 (50%), Gaps = 16/218 (7%)
Query: 235 DFETIRVATDN---FSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE-FKNE 290
           ++E +R   D    +    +LG G FG VYK        +A  ++ +   + E+E +  E
Sbjct: 7   EYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVE 66
Query: 291 VLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE 350
           + +LA   H  +V+LLG      +  ++ EF P  ++D  + + ++R  +T  +   +  
Sbjct: 67  IEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLE-LDR-GLTEPQIQVVCR 124
Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG 410
            +   L +LH     RIIHRDLKA N+L+  E + +++DFG++   +  +T    +  +G
Sbjct: 125 QMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIG 179
Query: 411 TFGYMAPEYVM-----HGRFSVKSDIFSFGVLVLEIVS 443
           T  +MAPE VM        +  K+DI+S G+ ++E+  
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ 217

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 129/311 (41%), Gaps = 47/311 (15%)
Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKG------MLSNGETIAVKRLSKNSKQGEI 285
           L +D        D  +    LG+G FG V +         +   T+AVK L + +   E 
Sbjct: 16  LPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 75
Query: 286 E-FKNEVLLLARL-QHRNLVRLLGFCLERKERILVY------------------EFVPNA 325
               +E+ +L  +  H N+V LLG C +    ++V                   EFVP  
Sbjct: 76  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 135
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP 385
           + +    D +  EH+     Y     +A+G+ +L   +  + IHRDL A NILL  +   
Sbjct: 136 TPEDLYKDFLTLEHLIC---YSF--QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVV 187
Query: 386 KISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           KI DFG+AR    D              +MAPE +    ++++SD++SFGVL+ EI S  
Sbjct: 188 KICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 247
Query: 446 KRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSN 505
                G + + E       R   EG  +   D T     T EM + +   L C     S 
Sbjct: 248 ASPYPGVKIDEEFC-----RRLKEGTRMRAPDYT-----TPEMYQTM---LDCWHGEPSQ 294
Query: 506 RPGMASVVNML 516
           RP  + +V  L
Sbjct: 295 RPTFSELVEHL 305

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 109/224 (48%), Gaps = 28/224 (12%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D  +    LG+G FG V         K       T+AVK L  ++ + ++ +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPINR---EH 339
             + +H+N++ LLG C +     ++ E+    +L  ++           +D INR   E 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-INRVPEEQ 153
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           MT++        +ARG+ YL   +  + IHRDL A N+L+      +I+DFG+AR     
Sbjct: 154 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNI 210
Query: 400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +  T        +MAPE +    ++ +SD++SFGVL+ EI +
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 104/197 (52%), Gaps = 13/197 (6%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLLGFC 309
           +LG G FG VYK        +A  ++ +   + E+E +  E+ +LA   H  +V+LLG  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
               +  ++ EF P  ++D  + + ++R  +T  +   +   +   L +LH     RIIH
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLE-LDR-GLTEPQIQVVCRQMLEALNFLHSK---RIIH 132
Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM-----HGR 424
           RDLKA N+L+  E + +++DFG++   +  +T    +  +GT  +MAPE VM        
Sbjct: 133 RDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTP 190
Query: 425 FSVKSDIFSFGVLVLEI 441
           +  K+DI+S G+ ++E+
Sbjct: 191 YDYKADIWSLGITLIEM 207

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 34/215 (15%)
Query: 252 LGQGGFGAVYKGMLSNG---ETIAVKRLSK-NSKQGEIEFKNEVLLLARLQHR-NLVRLL 306
           +G+G FG V K  +         A+KR+ +  SK    +F  E+ +L +L H  N++ LL
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 307 GFCLERKERILVYEFVPNASLDHFI-------FDPI------NREHMTWEKRYKIIEGIA 353
           G C  R    L  E+ P+ +L  F+        DP           ++ ++       +A
Sbjct: 83  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 142
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
           RG+ YL   S+ + IHRDL A NIL+      KI+DFG++R  E+         V  T G
Sbjct: 143 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--------YVKKTMG 191
Query: 414 -----YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
                +MA E + +  ++  SD++S+GVL+ EIVS
Sbjct: 192 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 105/211 (49%), Gaps = 27/211 (12%)
Query: 251 KLGQGGFGAVYKGMLSNGET---IAVKRLS-----------KNSKQGEIEFKNEVLLLAR 296
           KLG G +G V      NG +   I V + S           KN ++   E  NE+ LL  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           L H N+++L     ++K   LV EF     L   I   INR          I++ I  G+
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI---INRHKFDECDAANIMKQILSGI 159
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
            YLH+ +   I+HRD+K  NILL+++   +N KI DFG++  F  D    D    +GT  
Sbjct: 160 CYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR---LGTAY 213
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           Y+APE V+  +++ K D++S GV++  ++ G
Sbjct: 214 YIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 34/215 (15%)
Query: 252 LGQGGFGAVYKGMLSNG---ETIAVKRLSK-NSKQGEIEFKNEVLLLARLQHR-NLVRLL 306
           +G+G FG V K  +         A+KR+ +  SK    +F  E+ +L +L H  N++ LL
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 307 GFCLERKERILVYEFVPNASLDHFI-------FDPI------NREHMTWEKRYKIIEGIA 353
           G C  R    L  E+ P+ +L  F+        DP           ++ ++       +A
Sbjct: 93  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
           RG+ YL   S+ + IHRDL A NIL+      KI+DFG++R  E+         V  T G
Sbjct: 153 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--------YVKKTMG 201
Query: 414 -----YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
                +MA E + +  ++  SD++S+GVL+ EIVS
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 14/209 (6%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRL--SKNSKQGEIEFKNEVLLLARLQ 298
           + + + +   +G+G +G V K    + G  +A+K+   S + K  +     E+ LL +L+
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR-YKIIEGIARGLL 357
           H NLV LL  C ++K   LV+EFV +  LD     P   ++   +K  ++II GI  G  
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI--GFC 140
Query: 358 YLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAP 417
           + H      IIHRD+K  NIL+      K+ DFG AR         D    V T  Y AP
Sbjct: 141 HSH-----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE--VATRWYRAP 193
Query: 418 EYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
           E ++   ++    D+++ G LV E+  G+
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 130/305 (42%), Gaps = 36/305 (11%)
Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKG------MLSNGETIAVKRLSKNSKQGEI 285
           L +D        D       LG+G FG V +         +   T+AVK L + +   E 
Sbjct: 17  LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH 76
Query: 286 E-FKNEVLLLARL-QHRNLVRLLGFCLERKERILV-YEFVPNASLDHFI------FDP-- 334
               +E+ +L  +  H N+V LLG C +    ++V  EF    +L  ++      F P  
Sbjct: 77  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 136
Query: 335 ---INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG 391
              + ++ +T E        +A+G+ +L   +  + IHRDL A NILL  +   KI DFG
Sbjct: 137 PEDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFG 193
Query: 392 MARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFG 451
           +AR    D              +MAPE +    ++++SD++SFGVL+ EI S       G
Sbjct: 194 LARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253
Query: 452 TEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMAS 511
            + + E       R   EG  +   D T     T EM + +   L C     S RP  + 
Sbjct: 254 VKIDEEFC-----RRLKEGTRMRAPDYT-----TPEMYQTM---LDCWHGEPSQRPTFSE 300
Query: 512 VVNML 516
           +V  L
Sbjct: 301 LVEHL 305

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 106/223 (47%), Gaps = 22/223 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P       ++  + +     E+R    I  +A  L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGE----VYKELQKLSKFDEQRTATYITELANAL 126
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFG 413
            Y H     R+IHRD+K  N+LL S    KI+DFG +        H+ ++R   + GT  
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLD 176
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
           Y+ PE +       K D++S GVL  E + G+      T +ET
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 219

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 131/307 (42%), Gaps = 38/307 (12%)
Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKG------MLSNGETIAVKRLSKNSKQGEI 285
           L +D        D       LG+G FG V +         +   T+AVK L + +   E 
Sbjct: 15  LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 74
Query: 286 E-FKNEVLLLARL-QHRNLVRLLGFCLERKERILV-YEFVPNASLDHFI------FDP-- 334
               +E+ +L  +  H N+V LLG C +    ++V  EF    +L  ++      F P  
Sbjct: 75  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 335 -----INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD 389
                + ++ +T E        +A+G+ +L   +  + IHRDL A NILL  +   KI D
Sbjct: 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 191
Query: 390 FGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSS 449
           FG+AR    D  +           +MAPE +    ++++SD++SFGVL+ EI S      
Sbjct: 192 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251
Query: 450 FGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGM 509
            G + + E       R   EG  +   D T     T EM + +   L C     S RP  
Sbjct: 252 PGVKIDEEFC-----RRLKEGTRMRAPDYT-----TPEMYQTM---LDCWHGEPSQRPTF 298
Query: 510 ASVVNML 516
           + +V  L
Sbjct: 299 SELVEHL 305

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 114/240 (47%), Gaps = 22/240 (9%)
Query: 225 EETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--K 281
           EE  +K    + +  + A ++F     LG+G FG VY       + I A+K L K    K
Sbjct: 6   EELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK 65
Query: 282 QG-EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM 340
            G E + + EV + + L+H N++RL G+  +     L+ E+ P  +    ++  + +   
Sbjct: 66  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSK 121
Query: 341 TWEKRYKI-IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
             E+R    I  +A  L Y H     R+IHRD+K  N+LL S    KI+DFG +      
Sbjct: 122 FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS------ 172
Query: 400 QTHSDTNR---VVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
             H+ ++R   + GT  Y+ PE +       K D++S GVL  E + G+      T +ET
Sbjct: 173 -VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 231

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 131/307 (42%), Gaps = 38/307 (12%)
Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKG------MLSNGETIAVKRLSKNSKQGEI 285
           L +D        D       LG+G FG V +         +   T+AVK L + +   E 
Sbjct: 17  LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 76
Query: 286 E-FKNEVLLLARL-QHRNLVRLLGFCLERKERILV-YEFVPNASLDHFI------FDP-- 334
               +E+ +L  +  H N+V LLG C +    ++V  EF    +L  ++      F P  
Sbjct: 77  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 136
Query: 335 -----INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD 389
                + ++ +T E        +A+G+ +L   +  + IHRDL A NILL  +   KI D
Sbjct: 137 EAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 193
Query: 390 FGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSS 449
           FG+AR    D  +           +MAPE +    ++++SD++SFGVL+ EI S      
Sbjct: 194 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 253
Query: 450 FGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGM 509
            G + + E       R   EG  +   D T     T EM + +   L C     S RP  
Sbjct: 254 PGVKIDEEFC-----RRLKEGTRMRAPDYT-----TPEMYQTM---LDCWHGEPSQRPTF 300
Query: 510 ASVVNML 516
           + +V  L
Sbjct: 301 SELVEHL 307

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 22/212 (10%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS---KNSKQGEIEFKNEVLLLARLQHR 300
           NF    K+G+G F  VY+   L +G  +A+K++        +   +   E+ LL +L H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR-------YKIIEGIA 353
           N+++     +E  E  +V E      L   I      +H   +KR       +K    + 
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMI------KHFKKQKRLIPERTVWKYFVQLC 146
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             L ++H  SR R++HRD+K +N+ + +    K+ D G+ R F    T + +  +VGT  
Sbjct: 147 SALEHMH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPY 201
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           YM+PE +    ++ KSDI+S G L+ E+ + Q
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 233

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 106/223 (47%), Gaps = 22/223 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P       ++  + +     E+R    I  +A  L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGE----VYKELQKLSKFDEQRTATYITELANAL 126
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFG 413
            Y H     R+IHRD+K  N+LL S    KI+DFG +        H+ ++R   + GT  
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLXGTLD 176
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
           Y+ PE +       K D++S GVL  E + G+      T +ET
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 219

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 105/202 (51%), Gaps = 21/202 (10%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVK-----RLSKNSKQGEIEFKNEVLLLARLQ 298
           N+     LG+G FG V      + G+ +A+K      L+K+  QG IE   E+  L  L+
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 71
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H ++++L      + E I+V E+  N   D+ +     R+ M+ ++  +  + I   + Y
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEY 127
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
            H   R +I+HRDLK  N+LLD  +N KI+DFG++ +   D     T+   G+  Y APE
Sbjct: 128 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTS--CGSPNYAAPE 181
Query: 419 YVMHGRFSV--KSDIFSFGVLV 438
            V+ G+     + D++S GV++
Sbjct: 182 -VISGKLYAGPEVDVWSCGVIL 202

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 85/310 (27%), Positives = 132/310 (42%), Gaps = 38/310 (12%)
Query: 229 AKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKG------MLSNGETIAVKRLSKNSKQ 282
           A+ L +D        D       LG+G FG V +         +   T+AVK L + +  
Sbjct: 3   AERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH 62
Query: 283 GEIE-FKNEVLLLARL-QHRNLVRLLGFCLERKERILVY-EFVPNASLDHFI------FD 333
            E     +E+ +L  +  H N+V LLG C +    ++V  EF    +L  ++      F 
Sbjct: 63  SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFV 122
Query: 334 P-------INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPK 386
           P       + ++ +T E        +A+G+ +L   +  + IHRDL A NILL  +   K
Sbjct: 123 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVK 179
Query: 387 ISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQK 446
           I DFG+AR    D              +MAPE +    ++++SD++SFGVL+ EI S   
Sbjct: 180 ICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 239
Query: 447 RSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNR 506
               G + + E       R   EG  +   D T     T EM + +   L C     S R
Sbjct: 240 SPYPGVKIDEEFC-----RRLKEGTRMRAPDYT-----TPEMYQTM---LDCWHGEPSQR 286
Query: 507 PGMASVVNML 516
           P  + +V  L
Sbjct: 287 PTFSELVEHL 296

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 85/310 (27%), Positives = 132/310 (42%), Gaps = 38/310 (12%)
Query: 229 AKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKG------MLSNGETIAVKRLSKNSKQ 282
           A+ L +D        D       LG+G FG V +         +   T+AVK L + +  
Sbjct: 3   AERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH 62
Query: 283 GEIE-FKNEVLLLARL-QHRNLVRLLGFCLERKERILV-YEFVPNASLDHFI------FD 333
            E     +E+ +L  +  H N+V LLG C +    ++V  EF    +L  ++      F 
Sbjct: 63  SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 122
Query: 334 P-------INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPK 386
           P       + ++ +T E        +A+G+ +L   +  + IHRDL A NILL  +   K
Sbjct: 123 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVK 179
Query: 387 ISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQK 446
           I DFG+AR    D              +MAPE +    ++++SD++SFGVL+ EI S   
Sbjct: 180 ICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 239
Query: 447 RSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNR 506
               G + + E       R   EG  +   D T     T EM + +   L C     S R
Sbjct: 240 SPYPGVKIDEEFC-----RRLKEGTRMRAPDYT-----TPEMYQTM---LDCWHGEPSQR 286
Query: 507 PGMASVVNML 516
           P  + +V  L
Sbjct: 287 PTFSELVEHL 296

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 105/202 (51%), Gaps = 21/202 (10%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVK-----RLSKNSKQGEIEFKNEVLLLARLQ 298
           N+     LG+G FG V      + G+ +A+K      L+K+  QG IE   E+  L  L+
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 66
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H ++++L      + E I+V E+  N   D+ +     R+ M+ ++  +  + I   + Y
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEY 122
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
            H   R +I+HRDLK  N+LLD  +N KI+DFG++ +   D     T+   G+  Y APE
Sbjct: 123 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTS--CGSPNYAAPE 176
Query: 419 YVMHGRFSV--KSDIFSFGVLV 438
            V+ G+     + D++S GV++
Sbjct: 177 -VISGKLYAGPEVDVWSCGVIL 197

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 131/282 (46%), Gaps = 30/282 (10%)
Query: 252 LGQGGFGAV--YKGMLSN---GETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRL 305
           LG+G FG V  Y    +N   GE +AVK L  +   Q    +K E+ +L  L H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 306 LGFCLERKERIL--VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            G C ++ E+ L  V E+VP  SL     D + R  +   +     + I  G+ YLH   
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMAYLHSQ- 136
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLF----EMDQTHSDTNRVVGTFGYMAPEY 419
               IHR+L A N+LLD++   KI DFG+A+      E  +   D +  V  F Y APE 
Sbjct: 137 --HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV--FWY-APEC 191
Query: 420 VMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT 479
           +   +F   SD++SFGV + E+++    SS     +  +L+  A     +   L L +  
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIA---QGQMTVLRLTELL 247
Query: 480 MRGGSTSEMMKC----IHIGLLCVQENVSNRPGMASVVNMLN 517
            RG       KC     H+   C +   S RP   +++ +L 
Sbjct: 248 ERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILK 289

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 105/202 (51%), Gaps = 21/202 (10%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVK-----RLSKNSKQGEIEFKNEVLLLARLQ 298
           N+     LG+G FG V      + G+ +A+K      L+K+  QG IE   E+  L  L+
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 72
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H ++++L      + E I+V E+  N   D+ +     R+ M+ ++  +  + I   + Y
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEY 128
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
            H   R +I+HRDLK  N+LLD  +N KI+DFG++ +   D     T+   G+  Y APE
Sbjct: 129 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTS--CGSPNYAAPE 182
Query: 419 YVMHGRFSV--KSDIFSFGVLV 438
            V+ G+     + D++S GV++
Sbjct: 183 -VISGKLYAGPEVDVWSCGVIL 203

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 105/202 (51%), Gaps = 21/202 (10%)
Query: 245 NFSDANKLGQGGFGAVYKGM-LSNGETIAVK-----RLSKNSKQGEIEFKNEVLLLARLQ 298
           N+     LG+G FG V      + G+ +A+K      L+K+  QG IE   E+  L  L+
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 62
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H ++++L      + E I+V E+  N   D+ +     R+ M+ ++  +  + I   + Y
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEY 118
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
            H   R +I+HRDLK  N+LLD  +N KI+DFG++ +   D     T+   G+  Y APE
Sbjct: 119 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTS--CGSPNYAAPE 172
Query: 419 YVMHGRFSV--KSDIFSFGVLV 438
            V+ G+     + D++S GV++
Sbjct: 173 -VISGKLYAGPEVDVWSCGVIL 193

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 131/307 (42%), Gaps = 38/307 (12%)
Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKG------MLSNGETIAVKRLSKNSKQGEI 285
           L +D        D       LG+G FG V +         +   T+AVK L + +   E 
Sbjct: 6   LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 65
Query: 286 E-FKNEVLLLARL-QHRNLVRLLGFCLERKERILVY-EFVPNASLDHFI------FDP-- 334
               +E+ +L  +  H N+V LLG C +    ++V  EF    +L  ++      F P  
Sbjct: 66  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYK 125
Query: 335 -----INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD 389
                + ++ +T E        +A+G+ +L   +  + IHRDL A NILL  +   KI D
Sbjct: 126 VAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 182
Query: 390 FGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSS 449
           FG+AR    D  +           +MAPE +    ++++SD++SFGVL+ EI S      
Sbjct: 183 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 242
Query: 450 FGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGM 509
            G + + E       R   EG  +   D T     T EM + +   L C     S RP  
Sbjct: 243 PGVKIDEEFC-----RRLKEGTRMRAPDYT-----TPEMYQTM---LDCWHGEPSQRPTF 289
Query: 510 ASVVNML 516
           + +V  L
Sbjct: 290 SELVEHL 296

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 117/234 (50%), Gaps = 38/234 (16%)
Query: 238 TIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
           ++R A+D F +   LGQG FG V K   + +    A+K++ +++++      +EV+LLA 
Sbjct: 1   SLRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLAS 58
Query: 297 LQHRNLVRLLGFCLERKERI-------------LVYEFVPNASLDHFIFDPINREHMTWE 343
           L H+ +VR     LER+  +             +  E+  N +L    +D I+ E++  +
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQ 114
Query: 344 K--RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR------- 394
           +   +++   I   L Y+H      IIHRDLK  NI +D   N KI DFG+A+       
Sbjct: 115 RDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 395 LFEMDQ-----THSDTNRVVGTFGYMAPEYV-MHGRFSVKSDIFSFGVLVLEIV 442
           + ++D      +  +    +GT  Y+A E +   G ++ K D++S G++  E++
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 131/282 (46%), Gaps = 30/282 (10%)
Query: 252 LGQGGFGAV--YKGMLSN---GETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRL 305
           LG+G FG V  Y    +N   GE +AVK L  +   Q    +K E+ +L  L H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 306 LGFCLERKERIL--VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            G C ++ E+ L  V E+VP  SL     D + R  +   +     + I  G+ YLH   
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMAYLHAQ- 136
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLF----EMDQTHSDTNRVVGTFGYMAPEY 419
               IHR+L A N+LLD++   KI DFG+A+      E  +   D +  V  F Y APE 
Sbjct: 137 --HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV--FWY-APEC 191
Query: 420 VMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT 479
           +   +F   SD++SFGV + E+++    SS     +  +L+  A     +   L L +  
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIA---QGQMTVLRLTELL 247
Query: 480 MRGGSTSEMMKC----IHIGLLCVQENVSNRPGMASVVNMLN 517
            RG       KC     H+   C +   S RP   +++ +L 
Sbjct: 248 ERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILK 289

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 108/224 (48%), Gaps = 28/224 (12%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D  +    LG+G FG V         K       T+AVK L  ++ + ++ +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPINR---EH 339
             + +H+N++ LLG C +     ++  +    +L  ++           +D INR   E 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYD-INRVPEEQ 153
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           MT++        +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR     
Sbjct: 154 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +  T        +MAPE +    ++ +SD++SFGVL+ EI +
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 17/199 (8%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLL-GF 308
           +LG G FG VYK        +A  ++     + E+E +  E+ +LA   H N+V+LL  F
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII-EGIARGLLYLHEDSRLRI 367
             E    IL+ EF    ++D  + +    E    E + +++ +     L YLH++   +I
Sbjct: 104 YYENNLWILI-EFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDN---KI 156
Query: 368 IHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM-----H 422
           IHRDLKA NIL   + + K++DFG++   +  +T    +  +GT  +MAPE VM      
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 423 GRFSVKSDIFSFGVLVLEI 441
             +  K+D++S G+ ++E+
Sbjct: 215 RPYDYKADVWSLGITLIEM 233

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 106/212 (50%), Gaps = 19/212 (8%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQG-EIEFKNEVLLLARL 297
           +AT  +    ++G G +G VYK     +G  +A+K +   N ++G  I    EV LL RL
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 298 Q---HRNLVRLLGFC-LERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
           +   H N+VRL+  C   R +R     LV+E V +  L  ++ D      +  E    ++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLM 118
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
               RGL +LH +    I+HRDLK  NIL+ S    K++DFG+AR++           VV
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LFPVV 172
Query: 410 GTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEI 441
            T  Y APE ++   ++   D++S G +  E+
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 22/223 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 121
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFG 413
            Y H     R+IHRD+K  N+LL S    KI+DFG +        H+ ++R   + GT  
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLD 171
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
           Y+ PE +       K D++S GVL  E + G+      T +ET
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 22/223 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 121
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFG 413
            Y H     R+IHRD+K  N+LL S    KI+DFG +        H+ ++R   + GT  
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTELCGTLD 171
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
           Y+ PE +       K D++S GVL  E + G+      T +ET
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 22/223 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 124
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFG 413
            Y H     R+IHRD+K  N+LL S    KI+DFG +        H+ ++R   + GT  
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLD 174
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
           Y+ PE +       K D++S GVL  E + G+      T +ET
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 217

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 131/308 (42%), Gaps = 38/308 (12%)
Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKG------MLSNGETIAVKRLSKNSKQGEI 285
           L +D        D       LG+G FG V +         +   T+AVK L + +   E 
Sbjct: 52  LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 111
Query: 286 E-FKNEVLLLARL-QHRNLVRLLGFCLERKERILV-YEFVPNASLDHFI------FDP-- 334
               +E+ +L  +  H N+V LLG C +    ++V  EF    +L  ++      F P  
Sbjct: 112 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 171
Query: 335 -----INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD 389
                + ++ +T E        +A+G+ +L   +  + IHRDL A NILL  +   KI D
Sbjct: 172 VAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 228
Query: 390 FGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSS 449
           FG+AR    D  +           +MAPE +    ++++SD++SFGVL+ EI S      
Sbjct: 229 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 288
Query: 450 FGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGM 509
            G + + E       R   EG  +   D T     T EM + +   L C     S RP  
Sbjct: 289 PGVKIDEEFC-----RRLKEGTRMRAPDYT-----TPEMYQTM---LDCWHGEPSQRPTF 335
Query: 510 ASVVNMLN 517
           + +V  L 
Sbjct: 336 SELVEHLG 343

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 22/223 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 126
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFG 413
            Y H     R+IHRD+K  N+LL S    KI+DFG +        H+ ++R   + GT  
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLD 176
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
           Y+ PE +       K D++S GVL  E + G+      T +ET
Sbjct: 177 YLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 219

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 22/223 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 126
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFG 413
            Y H     R+IHRD+K  N+LL S    KI+DFG +        H+ ++R   + GT  
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLD 176
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
           Y+ PE +       K D++S GVL  E + G+      T +ET
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 219

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 22/223 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 123
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFG 413
            Y H     R+IHRD+K  N+LL S    KI+DFG +        H+ ++R   + GT  
Sbjct: 124 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTLD 173
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
           Y+ PE +       K D++S GVL  E + G+      T +ET
Sbjct: 174 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 216

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 22/223 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 124
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFG 413
            Y H     R+IHRD+K  N+LL S    KI+DFG +        H+ ++R   + GT  
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRAALCGTLD 174
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
           Y+ PE +       K D++S GVL  E + G+      T +ET
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 217

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 106/201 (52%), Gaps = 20/201 (9%)
Query: 252 LGQGGFGAVYK--GMLSNGETIAVKRLSKNSKQGE--IEFKNEVLLLARLQHRNLVRLLG 307
           LG+G FG V K    ++  E  AVK ++K S + +       EV LL +L H N+++L  
Sbjct: 30  LGKGSFGEVLKCKDRITQQE-YAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 308 FCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
              +     +V E      L    FD I  R+  +     +II+ +  G+ Y+H+ +   
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 367 IIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
           I+HRDLK  NILL+S   + + KI DFG++  F+ +    D    +GT  Y+APE V+ G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPE-VLRG 197
Query: 424 RFSVKSDIFSFGVLVLEIVSG 444
            +  K D++S GV++  ++SG
Sbjct: 198 TYDEKCDVWSAGVILYILLSG 218

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 22/223 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 121
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFG 413
            Y H     R+IHRD+K  N+LL S    KI+DFG +        H+ ++R   + GT  
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLD 171
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
           Y+ PE +       K D++S GVL  E + G+      T +ET
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 11/207 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ + A L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GT  Y+APE 
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 420 VMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           +    F  +  D++S G+++  +++G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 22/223 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 121
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFG 413
            Y H     R+IHRD+K  N+LL S    KI+DFG +        H+ ++R   + GT  
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLD 171
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
           Y+ PE +       K D++S GVL  E + G+      T +ET
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 117/234 (50%), Gaps = 38/234 (16%)
Query: 238 TIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
           ++R A+D F +   LGQG FG V K   + +    A+K++ +++++      +EV+LLA 
Sbjct: 1   SLRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLAS 58
Query: 297 LQHRNLVRLLGFCLERKERI-------------LVYEFVPNASLDHFIFDPINREHMTWE 343
           L H+ +VR     LER+  +             +  E+  N +L    +D I+ E++  +
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTL----YDLIHSENLNQQ 114
Query: 344 K--RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR------- 394
           +   +++   I   L Y+H      IIHRDLK  NI +D   N KI DFG+A+       
Sbjct: 115 RDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 395 LFEMDQ-----THSDTNRVVGTFGYMAPEYV-MHGRFSVKSDIFSFGVLVLEIV 442
           + ++D      +  +    +GT  Y+A E +   G ++ K D++S G++  E++
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 22/223 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 122
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFG 413
            Y H     R+IHRD+K  N+LL S    KI+DFG +        H+ ++R   + GT  
Sbjct: 123 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDTLCGTLD 172
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
           Y+ PE +       K D++S GVL  E + G+      T +ET
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 215

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 22/223 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 122
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFG 413
            Y H     R+IHRD+K  N+LL S    KI+DFG +        H+ ++R   + GT  
Sbjct: 123 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLD 172
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
           Y+ PE +       K D++S GVL  E + G+      T +ET
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 215

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 106/212 (50%), Gaps = 20/212 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQGEIEFKN--EVLLLARL 297
           A   +    ++G+G +G V+K   + + G  +A+KR+   + +  +      EV +L  L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 298 Q---HRNLVRLLGFC-LERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
           +   H N+VRL   C + R +R     LV+E V +  L  ++ D +    +  E    ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
             + RGL +LH     R++HRDLK  NIL+ S    K++DFG+AR++           VV
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVV 180
Query: 410 GTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEI 441
            T  Y APE ++   ++   D++S G +  E+
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 22/223 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 126
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFG 413
            Y H     R+IHRD+K  N+LL S    KI+DFG +        H+ ++R   + GT  
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLD 176
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
           Y+ PE +       K D++S GVL  E + G+      T +ET
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 219

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 106/201 (52%), Gaps = 20/201 (9%)
Query: 252 LGQGGFGAVYK--GMLSNGETIAVKRLSKNSKQGE--IEFKNEVLLLARLQHRNLVRLLG 307
           LG+G FG V K    ++  E  AVK ++K S + +       EV LL +L H N+++L  
Sbjct: 30  LGKGSFGEVLKCKDRITQQE-YAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 308 FCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
              +     +V E      L    FD I  R+  +     +II+ +  G+ Y+H+ +   
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 367 IIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
           I+HRDLK  NILL+S   + + KI DFG++  F+ +    D    +GT  Y+APE V+ G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPE-VLRG 197
Query: 424 RFSVKSDIFSFGVLVLEIVSG 444
            +  K D++S GV++  ++SG
Sbjct: 198 TYDEKCDVWSAGVILYILLSG 218

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 22/223 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 124
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFG 413
            Y H     R+IHRD+K  N+LL S    KI+DFG +        H+ ++R   + GT  
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCGTLD 174
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
           Y+ PE +       K D++S GVL  E + G+      T +ET
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 217

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 22/223 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 120
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFG 413
            Y H     R+IHRD+K  N+LL S    KI+DFG +        H+ ++R   + GT  
Sbjct: 121 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLD 170
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
           Y+ PE +       K D++S GVL  E + G+      T +ET
Sbjct: 171 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 213

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 106/201 (52%), Gaps = 20/201 (9%)
Query: 252 LGQGGFGAVYK--GMLSNGETIAVKRLSKNSKQGE--IEFKNEVLLLARLQHRNLVRLLG 307
           LG+G FG V K    ++  E  AVK ++K S + +       EV LL +L H N+++L  
Sbjct: 30  LGKGSFGEVLKCKDRITQQE-YAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 308 FCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
              +     +V E      L    FD I  R+  +     +II+ +  G+ Y+H+ +   
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 367 IIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
           I+HRDLK  NILL+S   + + KI DFG++  F+ +    D    +GT  Y+APE V+ G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPE-VLRG 197
Query: 424 RFSVKSDIFSFGVLVLEIVSG 444
            +  K D++S GV++  ++SG
Sbjct: 198 TYDEKCDVWSAGVILYILLSG 218

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 22/223 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 121
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFG 413
            Y H     R+IHRD+K  N+LL S    KI+DFG +        H+ ++R   + GT  
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRAALCGTLD 171
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
           Y+ PE +       K D++S GVL  E + G+      T +ET
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 108/224 (48%), Gaps = 28/224 (12%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D  +    LG+G FG V         K       T+AVK L  ++ + ++ +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPINR---EH 339
             + +H+N++ LLG C +     ++  +    +L  ++           +D INR   E 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYD-INRVPEEQ 153
Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           MT++        +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR     
Sbjct: 154 MTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +  T        +MAPE +    ++ +SD++SFGVL+ EI +
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 22/223 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 121
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFG 413
            Y H     R+IHRD+K  N+LL S    KI+DFG +        H+ ++R   + GT  
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTXLCGTLD 171
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
           Y+ PE +       K D++S GVL  E + G+      T +ET
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 130/307 (42%), Gaps = 38/307 (12%)
Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKG------MLSNGETIAVKRLSKNSKQGEI 285
           L +D        D       LG+G FG V +         +   T+AVK L + +   E 
Sbjct: 15  LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 74
Query: 286 E-FKNEVLLLARL-QHRNLVRLLGFCLERKERILV-YEFVPNASLDHFI------FDP-- 334
               +E+ +L  +  H N+V LLG C +    ++V  EF    +L  ++      F P  
Sbjct: 75  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 335 -----INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD 389
                + ++ +T E        +A+G+ +L   +  + IHRDL A NILL  +   KI D
Sbjct: 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 191
Query: 390 FGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSS 449
           FG+AR    D              +MAPE +    ++++SD++SFGVL+ EI S      
Sbjct: 192 FGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251
Query: 450 FGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGM 509
            G + + E       R   EG  +   D T     T EM + +   L C     S RP  
Sbjct: 252 PGVKIDEEFC-----RRLKEGTRMRAPDYT-----TPEMYQTM---LDCWHGEPSQRPTF 298
Query: 510 ASVVNML 516
           + +V  L
Sbjct: 299 SELVEHL 305

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 22/223 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 121
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFG 413
            Y H     R+IHRD+K  N+LL S    KI+DFG +        H+ ++R   + GT  
Sbjct: 122 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTLD 171
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
           Y+ PE +       K D++S GVL  E + G+      T +ET
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 214

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 22/223 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 125
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFG 413
            Y H     R+IHRD+K  N+LL S    KI+DFG +        H+ ++R   + GT  
Sbjct: 126 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLD 175
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
           Y+ PE +       K D++S GVL  E + G+      T +ET
Sbjct: 176 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 218

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 32/223 (14%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
           DN      +G+G +GAVYKG L +   +AVK  S  ++Q  I  KN +  +  ++H N+ 
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKN-IYRVPLMEHDNIA 70
Query: 304 RLLG-----FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           R +          R E +LV E+ PN SL  ++    +     W    ++   + RGL Y
Sbjct: 71  RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRLAHSVTRGLAY 126
Query: 359 LH------EDSRLRIIHRDLKASNILLDSEMNPKISDFGMA------RLFEMDQTHSDTN 406
           LH      +  +  I HRDL + N+L+ ++    ISDFG++      RL    +  +   
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 407 RVVGTFGYMAPEYVMHGRFSVKS--------DIFSFGVLVLEI 441
             VGT  YMAPE V+ G  +++         D+++ G++  EI
Sbjct: 187 SEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 130/307 (42%), Gaps = 38/307 (12%)
Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKG------MLSNGETIAVKRLSKNSKQGEI 285
           L +D        D       LG+G FG V +         +   T+AVK L + +   E 
Sbjct: 15  LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 74
Query: 286 E-FKNEVLLLARL-QHRNLVRLLGFCLERKERILV-YEFVPNASLDHFI------FDP-- 334
               +E+ +L  +  H N+V LLG C +    ++V  EF    +L  ++      F P  
Sbjct: 75  RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 335 -----INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD 389
                + ++ +T E        +A+G+ +L   +  + IHRDL A NILL  +   KI D
Sbjct: 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 191
Query: 390 FGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSS 449
           FG+AR    D              +MAPE +    ++++SD++SFGVL+ EI S      
Sbjct: 192 FGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251
Query: 450 FGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGM 509
            G + + E       R   EG  +   D T     T EM + +   L C     S RP  
Sbjct: 252 PGVKIDEEFC-----RRLKEGTRMRAPDYT-----TPEMYQTM---LDCWHGEPSQRPTF 298
Query: 510 ASVVNML 516
           + +V  L
Sbjct: 299 SELVEHL 305

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 106/212 (50%), Gaps = 20/212 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQGEIEFKN--EVLLLARL 297
           A   +    ++G+G +G V+K   + + G  +A+KR+   + +  +      EV +L  L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 298 Q---HRNLVRLLGFC-LERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
           +   H N+VRL   C + R +R     LV+E V +  L  ++ D +    +  E    ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
             + RGL +LH     R++HRDLK  NIL+ S    K++DFG+AR++           VV
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVV 180
Query: 410 GTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEI 441
            T  Y APE ++   ++   D++S G +  E+
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 34/215 (15%)
Query: 252 LGQGGFGAVYKGMLSNG---ETIAVKRLSK-NSKQGEIEFKNEVLLLARLQHR-NLVRLL 306
           +G+G FG V K  +         A+KR+ +  SK    +F  E+ +L +L H  N++ LL
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 307 GFCLERKERILVYEFVPNASLDHFI-------FDPI------NREHMTWEKRYKIIEGIA 353
           G C  R    L  E+ P+ +L  F+        DP           ++ ++       +A
Sbjct: 90  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 149
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
           RG+ YL   S+ + IHR+L A NIL+      KI+DFG++R  E+         V  T G
Sbjct: 150 RGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEV--------YVKKTMG 198
Query: 414 -----YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
                +MA E + +  ++  SD++S+GVL+ EIVS
Sbjct: 199 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 106/212 (50%), Gaps = 20/212 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQGEIEFKN--EVLLLARL 297
           A   +    ++G+G +G V+K   + + G  +A+KR+   + +  +      EV +L  L
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 298 Q---HRNLVRLLGFC-LERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
           +   H N+VRL   C + R +R     LV+E V +  L  ++ D +    +  E    ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
             + RGL +LH     R++HRDLK  NIL+ S    K++DFG+AR++           VV
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVV 180
Query: 410 GTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEI 441
            T  Y APE ++   ++   D++S G +  E+
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 22/223 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 124
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFG 413
            Y H     R+IHRD+K  N+LL S    KI+DFG +        H+ ++R   + GT  
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLD 174
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
           Y+ PE +       K D++S GVL  E + G+      T +ET
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 217

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 22/223 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 124
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFG 413
            Y H     R+IHRD+K  N+LL S    KI+DFG +        H+ ++R   + GT  
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTLD 174
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
           Y+ PE +       K D++S GVL  E + G+      T +ET
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 217

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 108/223 (48%), Gaps = 22/223 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY     N + I A+K L K    K G E + + EV + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 121
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFG 413
            Y H     ++IHRD+K  N+LL S    KI+DFG +        H+ ++R   + GT  
Sbjct: 122 SYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRAALCGTLD 171
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
           Y+ PE +       K D++S GVL  E + G+      T ++T
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDT 214

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 109/230 (47%), Gaps = 37/230 (16%)
Query: 245 NFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSKQGEI-EFKNEVLLLARL 297
           N      LG+G FG V K         +   T+AVK L +N+   E+ +  +E  +L ++
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI---------------------FDPIN 336
            H ++++L G C +    +L+ E+    SL  F+                      D  +
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 337 REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-L 395
              +T          I++G+ YL E   ++++HRDL A NIL+      KISDFG++R +
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 396 FEMDQTHSDTNRVVGTF--GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           +E D   S   R  G     +MA E +    ++ +SD++SFGVL+ EIV+
Sbjct: 201 YEED---SXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 22/223 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 122
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFG 413
            Y H     R+IHRD+K  N+LL S    KI+DFG +        H+ ++R   + GT  
Sbjct: 123 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------CHAPSSRRTTLSGTLD 172
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
           Y+ PE +       K D++S GVL  E + G+      T +ET
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 215

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 102/199 (51%), Gaps = 17/199 (8%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLL-GF 308
           +LG G FG VYK        +A  ++     + E+E +  E+ +LA   H N+V+LL  F
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII-EGIARGLLYLHEDSRLRI 367
             E    IL+ EF    ++D  + +    E    E + +++ +     L YLH++   +I
Sbjct: 104 YYENNLWILI-EFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDN---KI 156
Query: 368 IHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM-----H 422
           IHRDLKA NIL   + + K++DFG++          D+   +GT  +MAPE VM      
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDS--FIGTPYWMAPEVVMCETSKD 214
Query: 423 GRFSVKSDIFSFGVLVLEI 441
             +  K+D++S G+ ++E+
Sbjct: 215 RPYDYKADVWSLGITLIEM 233

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 110/221 (49%), Gaps = 13/221 (5%)
Query: 224 VEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG 283
           +E T+A   +F      +          +G+G FG V  G    G  +AVK + KN    
Sbjct: 173 MEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI-KNDATA 230
Query: 284 EIEFKNEVLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTW 342
           +  F  E  ++ +L+H NLV+LLG  +E K  + +V E++   SL  ++     R  +  
Sbjct: 231 Q-AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGG 288
Query: 343 EKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
           +   K    +   + YL  ++    +HRDL A N+L+  +   K+SDFG+ +  E   T 
Sbjct: 289 DCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQ 343
Query: 403 SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            DT ++     + APE +   +FS KSD++SFG+L+ EI S
Sbjct: 344 -DTGKL--PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  FC +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 97  PFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 147
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT  
Sbjct: 148 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 204
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           Y++PE +        SD+++ G ++ ++V+G
Sbjct: 205 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 22/213 (10%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLA 295
           +   D+F     LG+G FG VY       + I A+K L K+   K+G E + + E+ + +
Sbjct: 11  KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 70
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR-YKIIEGIAR 354
            L+H N++R+  +  +RK   L+ EF P   L    +  + +     E+R    +E +A 
Sbjct: 71  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELAD 126
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGT 411
            L Y HE    ++IHRD+K  N+L+  +   KI+DFG +        H+ + R   + GT
Sbjct: 127 ALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCGT 176
Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
             Y+ PE +       K D++  GVL  E + G
Sbjct: 177 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GT  Y+APE 
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 420 VMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           +    F  +  D++S G+++  +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 108/213 (50%), Gaps = 17/213 (7%)
Query: 240 RVATDNFSDANKLGQGGFGAVY--KGMLSNGETIAVKRL---SKNSKQGEIEFKNEVLLL 294
           ++  + +   +KLG GG   VY  +  + N + +A+K +    +  ++    F+ EV   
Sbjct: 7   KIINERYKIVDKLGGGGMSTVYLAEDTILNIK-VAIKAIFIPPREKEETLKRFEREVHNS 65
Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREH--MTWEKRYKIIEGI 352
           ++L H+N+V ++    E     LV E++   +L  +I       H  ++ +        I
Sbjct: 66  SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-----ESHGPLSVDTAINFTNQI 120
Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF 412
             G+ + H+   +RI+HRD+K  NIL+DS    KI DFG+A+    + + + TN V+GT 
Sbjct: 121 LDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTV 176
Query: 413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
            Y +PE          +DI+S G+++ E++ G+
Sbjct: 177 QYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 22/213 (10%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLA 295
           +   D+F     LG+G FG VY       + I A+K L K+   K+G E + + E+ + +
Sbjct: 10  KFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR-YKIIEGIAR 354
            L+H N++R+  +  +RK   L+ EF P   L    +  + +     E+R    +E +A 
Sbjct: 70  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELAD 125
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGT 411
            L Y HE    ++IHRD+K  N+L+  +   KI+DFG +        H+ + R   + GT
Sbjct: 126 ALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCGT 175
Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
             Y+ PE +       K D++  GVL  E + G
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GT  Y+APE 
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 420 VMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           +    F  +  D++S G+++  +++G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 107/227 (47%), Gaps = 31/227 (13%)
Query: 245 NFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSKQGEI-EFKNEVLLLARL 297
           N      LG+G FG V K         +   T+AVK L +N+   E+ +  +E  +L ++
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI---------------------FDPIN 336
            H ++++L G C +    +L+ E+    SL  F+                      D  +
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 337 REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
              +T          I++G+ YL E   ++++HRDL A NIL+      KISDFG++R  
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 397 EMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             + ++   ++      +MA E +    ++ +SD++SFGVL+ EIV+
Sbjct: 201 YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 22/223 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 118
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFG 413
            Y H     R+IHRD+K  N+LL S    KI+DFG +        H+ ++R   + GT  
Sbjct: 119 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLD 168
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
           Y+ PE +       K D++S GVL  E + G+      T +ET
Sbjct: 169 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 211

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 21/204 (10%)
Query: 252 LGQGGFGAVYKG----MLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLL 306
           +G+G FG VY G       N    A+K LS+ ++  ++E F  E LL+  L H N++ L+
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 307 GFCL--ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           G  L  E    +L+  ++ +  L  FI  P  + + T +        +ARG+ YL E   
Sbjct: 89  GIMLPPEGLPHVLL-PYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQ-- 143
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMA-----RLFEMDQTHSDTNRVVGTFGYMAPEY 419
            + +HRDL A N +LD     K++DFG+A     R +   Q H      V    + A E 
Sbjct: 144 -KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV---KWTALES 199
Query: 420 VMHGRFSVKSDIFSFGVLVLEIVS 443
           +   RF+ KSD++SFGVL+ E+++
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GT  Y+APE 
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 420 VMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           +    F  +  D++S G+++  +++G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GT  Y+APE 
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 420 VMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           +    F  +  D++S G+++  +++G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GT  Y+APE 
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 420 VMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           +    F  +  D++S G+++  +++G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GT  Y+APE 
Sbjct: 120 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 420 VMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           +    F  +  D++S G+++  +++G+
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 129/282 (45%), Gaps = 30/282 (10%)
Query: 252 LGQGGFGAV--YKGMLSN---GETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRL 305
           LG+G FG V  Y    +N   GE +AVK L  ++  Q    +K E+ +L  L H ++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 306 LGFCLER--KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            G C +       LV E+VP  SL     D + R  +   +     + I  G+ YLH   
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEGMAYLHAQ- 153
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLF----EMDQTHSDTNRVVGTFGYMAPEY 419
               IHRDL A N+LLD++   KI DFG+A+      E  +   D +  V  F Y APE 
Sbjct: 154 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPV--FWY-APEC 208
Query: 420 VMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT 479
           +   +F   SD++SFGV + E+++    SS     +  +L+  A     +   L L +  
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIA---QGQMTVLRLTELL 264
Query: 480 MRGGSTSEMMKC----IHIGLLCVQENVSNRPGMASVVNMLN 517
            RG       KC     H+   C +   S RP   +++ +L 
Sbjct: 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 109/230 (47%), Gaps = 22/230 (9%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNS--KQG-EIEFKNE 290
           D  T     D+F     LG+G FG VY          +A+K L K+   K+G E + + E
Sbjct: 14  DILTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRRE 73
Query: 291 VLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK-II 349
           + + A L H N++RL  +  +R+   L+ E+ P   L    +  + +     E+R   I+
Sbjct: 74  IEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGEL----YKELQKSCTFDEQRTATIM 129
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR-- 407
           E +A  L+Y H     ++IHRD+K  N+LL  +   KI+DFG +        H+ + R  
Sbjct: 130 EELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWS-------VHAPSLRRK 179
Query: 408 -VVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
            + GT  Y+ PE +     + K D++  GVL  E++ G       +  ET
Sbjct: 180 TMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNET 229

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 103/199 (51%), Gaps = 17/199 (8%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLL-GF 308
           +LG G FG VYK        +A  ++     + E+E +  E+ +LA   H N+V+LL  F
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII-EGIARGLLYLHEDSRLRI 367
             E    IL+ EF    ++D  + +    E    E + +++ +     L YLH++   +I
Sbjct: 104 YYENNLWILI-EFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDN---KI 156
Query: 368 IHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM-----H 422
           IHRDLKA NIL   + + K++DFG++   +  +     +  +GT  +MAPE VM      
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDXFIGTPYWMAPEVVMCETSKD 214
Query: 423 GRFSVKSDIFSFGVLVLEI 441
             +  K+D++S G+ ++E+
Sbjct: 215 RPYDYKADVWSLGITLIEM 233

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GT  Y+APE 
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 420 VMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           +    F  +  D++S G+++  +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GT  Y+APE 
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 420 VMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           +    F  +  D++S G+++  +++G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GT  Y+APE 
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 420 VMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           +    F  +  D++S G+++  +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 107/223 (47%), Gaps = 22/223 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 123
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFG 413
            Y H     R+IHRD+K  N+LL S    KI++FG +        H+ ++R   + GT  
Sbjct: 124 SYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS-------VHAPSSRRTTLCGTLD 173
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
           Y+ PE +       K D++S GVL  E + G+      T +ET
Sbjct: 174 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 216

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GT  Y+APE 
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 420 VMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           +    F  +  D++S G+++  +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GT  Y+APE 
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 420 VMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           +    F  +  D++S G+++  +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 108/233 (46%), Gaps = 24/233 (10%)
Query: 241 VATDNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLL 294
           +AT  +    ++G G +G VYK      G     +++ V           I    EV LL
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 295 ARLQ---HRNLVRLLGFC-LERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRY 346
            RL+   H N+VRL+  C   R +R     LV+E V +  L  ++ D      +  E   
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIK 123
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            ++    RGL +LH +    I+HRDLK  NIL+ S    K++DFG+AR++      +   
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP-- 178
Query: 407 RVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDL 459
            VV T  Y APE ++   ++   D++S G +  E+   +++  F    E + L
Sbjct: 179 -VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF--RRKPLFCGNSEADQL 228

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GT  Y+APE 
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 420 VMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           +    F  +  D++S G+++  +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GT  Y+APE 
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 420 VMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           +    F  +  D++S G+++  +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 108/230 (46%), Gaps = 37/230 (16%)
Query: 245 NFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSKQGEI-EFKNEVLLLARL 297
           N      LG+G FG V K         +   T+AVK L +N+   E+ +  +E  +L ++
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI---------------------FDPIN 336
            H ++++L G C +    +L+ E+    SL  F+                      D  +
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 337 REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-L 395
              +T          I++G+ YL E S   ++HRDL A NIL+      KISDFG++R +
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 396 FEMDQTHSDTNRVVGTF--GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           +E D   S   R  G     +MA E +    ++ +SD++SFGVL+ EIV+
Sbjct: 201 YEED---SXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GT  Y+APE 
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 420 VMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           +    F  +  D++S G+++  +++G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GT  Y+APE 
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 420 VMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           +    F  +  D++S G+++  +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 116/225 (51%), Gaps = 42/225 (18%)
Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLS---KNSKQGEIEFKNEVLLLARLQ-HRNLVRL 305
           KLG+G +G V+K +    GE +AVK++    +NS   +  F+ E+++L  L  H N+V L
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNL 74
Query: 306 LGFCLERKER--ILVYEFVP---NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
           L       +R   LV++++    +A +   I +P++++++     Y++I+ I     YLH
Sbjct: 75  LNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVV----YQLIKVIK----YLH 126
Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF-------------------EMDQT 401
                 ++HRD+K SNILL++E + K++DFG++R F                     D  
Sbjct: 127 SGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 402 HSDTNRVVGTFGYMAPEYVM-HGRFSVKSDIFSFGVLVLEIVSGQ 445
                  V T  Y APE ++   +++   D++S G ++ EI+ G+
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 121/231 (52%), Gaps = 22/231 (9%)
Query: 246 FSDANKLGQGGFGAVYKG-MLSNGETIAVKR-LSKNSKQG-EIEFKNEVLLLARLQHRNL 302
           +    K+GQG FG V+K      G+ +A+K+ L +N K+G  I    E+ +L  L+H N+
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 303 VRLLGFCLER-------KERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR 354
           V L+  C  +       K  I LV++F  +  L   + + + +  ++  KR  +++ +  
Sbjct: 80  VNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLN 136
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM---DQTHSDTNRVVGT 411
           GL Y+H   R +I+HRD+KA+N+L+  +   K++DFG+AR F +    Q +   NRVV T
Sbjct: 137 GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-T 192
Query: 412 FGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLT 461
             Y  PE ++  R +    D++  G ++ E+ +        TE+    L++
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 243

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GT  Y+APE 
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 420 VMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           +    F  +  D++S G+++  +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 108/233 (46%), Gaps = 41/233 (17%)
Query: 244 DNFSDANKLGQGGFGAVYK----GMLSNGETI--AVKRLSKNSKQGEIE-FKNEVLLLAR 296
           +N      LG G FG V      G+   G +I  AVK L + +   E E   +E+ ++ +
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASL--------DHFIFDPINREH-------- 339
           L  H N+V LLG C       L++E+     L        + F  D I  E+        
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 340 ----MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL 395
               +T+E        +A+G+ +L   S    +HRDL A N+L+      KI DFG+AR 
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLAR- 220
Query: 396 FEMDQTHSDTNRVVGT-----FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
                  SD+N VV         +MAPE +  G +++KSD++S+G+L+ EI S
Sbjct: 221 ----DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 120/246 (48%), Gaps = 30/246 (12%)
Query: 243 TDNFSDANKLGQGGFGAVY--KGMLSNGE-TIAVKRLSKNSKQGEIEFKNEVLLLARLQH 299
           ++ +    KLG G +G V   +  +++ E  I + R +  S     +   EV +L  L H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLY 358
            N+++L  F  +++   LV E      L    FD I +R          II+ +  G+ Y
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAAVIIKQVLSGVTY 151
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQTHSDTNRVVGTFGYM 415
           LH+ +   I+HRDLK  N+LL+S+      KI DFG++ +FE           +GT  Y+
Sbjct: 152 LHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE---NQKKMKERLGTAYYI 205
Query: 416 APEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDL-------LTY---AWR 465
           APE V+  ++  K D++S GV++  +++G     FG + + E L        T+    W+
Sbjct: 206 APE-VLRKKYDEKCDVWSIGVILFILLAG--YPPFGGQTDQEILRKVEKGKYTFDSPEWK 262
Query: 466 NWNEGA 471
           N +EGA
Sbjct: 263 NVSEGA 268

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 118/226 (52%), Gaps = 22/226 (9%)
Query: 251 KLGQGGFGAVYKG-MLSNGETIAVKR-LSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLG 307
           K+GQG FG V+K      G+ +A+K+ L +N K+G  I    E+ +L  L+H N+V L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 308 FCLERKERI--------LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            C  +            LV++F  +  L   + + + +  ++  KR  +++ +  GL Y+
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYYI 141
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM---DQTHSDTNRVVGTFGYMA 416
           H   R +I+HRD+KA+N+L+  +   K++DFG+AR F +    Q +   NRVV T  Y  
Sbjct: 142 H---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYRP 197
Query: 417 PEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLT 461
           PE ++  R +    D++  G ++ E+ +        TE+    L++
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 243

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 102/193 (52%), Gaps = 13/193 (6%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           +G+G FG V  G    G  +AVK + KN    +  F  E  ++ +L+H NLV+LLG  +E
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQ-AFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 312 RKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
            K  + +V E++   SL  ++     R  +  +   K    +   + YL  ++    +HR
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 141
Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSD 430
           DL A N+L+  +   K+SDFG+ +  E   T  DT ++     + APE +   +FS KSD
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK--EASSTQ-DTGKL--PVKWTAPEALREKKFSTKSD 196
Query: 431 IFSFGVLVLEIVS 443
           ++SFG+L+ EI S
Sbjct: 197 VWSFGILLWEIYS 209

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GT  Y+APE 
Sbjct: 121 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 420 VMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           +    F  +  D++S G+++  +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GT  Y+APE 
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 177
Query: 420 VMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           +    F  +  D++S G+++  +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G +G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GT  Y+APE 
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPEL 178
Query: 420 VMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           +    F  +  D++S G+++  +++G+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 102/193 (52%), Gaps = 13/193 (6%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           +G+G FG V  G    G  +AVK + KN    +  F  E  ++ +L+H NLV+LLG  +E
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQ-AFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 312 RKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
            K  + +V E++   SL  ++     R  +  +   K    +   + YL  ++    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 126
Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSD 430
           DL A N+L+  +   K+SDFG+ +  E   T  DT ++     + APE +   +FS KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK--EASSTQ-DTGKL--PVKWTAPEALREKKFSTKSD 181
Query: 431 IFSFGVLVLEIVS 443
           ++SFG+L+ EI S
Sbjct: 182 VWSFGILLWEIYS 194

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 107/223 (47%), Gaps = 22/223 (9%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARL 297
           A ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGL 356
           +H N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANAL 124
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFG 413
            Y H     R+IHRD+K  N+LL S    KI++FG +        H+ ++R   + GT  
Sbjct: 125 SYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS-------VHAPSSRRTTLCGTLD 174
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
           Y+ PE +       K D++S GVL  E + G+      T +ET
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 217

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 119/231 (51%), Gaps = 22/231 (9%)
Query: 246 FSDANKLGQGGFGAVYKG-MLSNGETIAVKR-LSKNSKQG-EIEFKNEVLLLARLQHRNL 302
           +    K+GQG FG V+K      G+ +A+K+ L +N K+G  I    E+ +L  L+H N+
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 303 VRLLGFCLERKERI--------LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR 354
           V L+  C  +            LV++F  +  L   + + + +  ++  KR  +++ +  
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLN 136
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM---DQTHSDTNRVVGT 411
           GL Y+H   R +I+HRD+KA+N+L+  +   K++DFG+AR F +    Q +   NRVV T
Sbjct: 137 GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-T 192
Query: 412 FGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLT 461
             Y  PE ++  R +    D++  G ++ E+ +        TE+    L++
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 243

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 86/280 (30%), Positives = 127/280 (45%), Gaps = 31/280 (11%)
Query: 232 LQFDF-ETIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ---GEIE 286
           LQ+ + E   V  + F     LG+GGFG V    + + G+  A K+L K   +   GE  
Sbjct: 171 LQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM 230
Query: 287 FKNEVLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKR 345
             NE  +L ++  R +V L  +  E K+ + LV   +    L   I+  + +      + 
Sbjct: 231 ALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYH-MGQAGFPEARA 288
Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
                 I  GL  LH   R RI++RDLK  NILLD   + +ISD G+A      QT    
Sbjct: 289 VFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---I 342
Query: 406 NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG----QKRSSFGTEEETEDLLT 461
              VGT GYMAPE V + R++   D ++ G L+ E+++G    Q+R      EE E L+ 
Sbjct: 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK 402
Query: 462 YAWRNWNE---------GAALNLMDPT----MRGGSTSEM 488
                ++E          + L   DP      RGGS  E+
Sbjct: 403 EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREV 442

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 112/225 (49%), Gaps = 22/225 (9%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
           D +    +LG G F  V K      G+    + I  KR +K+S++G    + + EV +L 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            +QH N++ L      + + IL+ E V    L  F+ +   +E +T E+  + ++ I  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNG 126
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPK----ISDFGMARLFEMDQTHSDTNRVVGT 411
           + YLH    L+I H DLK  NI+L     PK    I DFG+A   +     ++   + GT
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGT 180
Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
             ++APE V +    +++D++S GV+   ++SG       T++ET
Sbjct: 181 PAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 225

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 103/204 (50%), Gaps = 22/204 (10%)
Query: 252 LGQGGFGAV--YKGMLSN---GETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRL 305
           LG+G FG V  Y    +N   GE +AVK L +    Q    ++ E+ +L  L H ++V+ 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 306 LGFCLERKERI--LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            G C ++ E+   LV E+VP  SL     D + R  +   +     + I  G+ YLH   
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLR----DYLPRHCVGLAQLLLFAQQICEGMAYLHAQ- 131
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLF----EMDQTHSDTNRVVGTFGYMAPEY 419
               IHR L A N+LLD++   KI DFG+A+      E  +   D +  V  F Y APE 
Sbjct: 132 --HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV--FWY-APEC 186
Query: 420 VMHGRFSVKSDIFSFGVLVLEIVS 443
           +   +F   SD++SFGV + E+++
Sbjct: 187 LKECKFYYASDVWSFGVTLYELLT 210

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/193 (32%), Positives = 101/193 (52%), Gaps = 13/193 (6%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           +G+G FG V  G    G  +AVK + KN    +  F  E  ++ +L+H NLV+LLG  +E
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQ-AFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 312 RKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
            K  + +V E++   SL  ++     R  +  +   K    +   + YL  ++    +HR
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 132
Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSD 430
           DL A N+L+  +   K+SDFG+ +  E   T  DT ++     + APE +    FS KSD
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTK--EASSTQ-DTGKL--PVKWTAPEALREAAFSTKSD 187
Query: 431 IFSFGVLVLEIVS 443
           ++SFG+L+ EI S
Sbjct: 188 VWSFGILLWEIYS 200

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 103/204 (50%), Gaps = 22/204 (10%)
Query: 252 LGQGGFGAV--YKGMLSN---GETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRL 305
           LG+G FG V  Y    +N   GE +AVK L +    Q    ++ E+ +L  L H ++V+ 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 306 LGFCLERKER--ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            G C ++ E+   LV E+VP  SL     D + R  +   +     + I  G+ YLH   
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLR----DYLPRHCVGLAQLLLFAQQICEGMAYLHAQ- 130
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLF----EMDQTHSDTNRVVGTFGYMAPEY 419
               IHR L A N+LLD++   KI DFG+A+      E  +   D +  V  F Y APE 
Sbjct: 131 --HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV--FWY-APEC 185
Query: 420 VMHGRFSVKSDIFSFGVLVLEIVS 443
           +   +F   SD++SFGV + E+++
Sbjct: 186 LKECKFYYASDVWSFGVTLYELLT 209

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 119/231 (51%), Gaps = 22/231 (9%)
Query: 246 FSDANKLGQGGFGAVYKG-MLSNGETIAVKR-LSKNSKQG-EIEFKNEVLLLARLQHRNL 302
           +    K+GQG FG V+K      G+ +A+K+ L +N K+G  I    E+ +L  L+H N+
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 78
Query: 303 VRLLGFCLERKERI--------LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR 354
           V L+  C  +            LV++F  +  L   + + + +  ++  KR  +++ +  
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLN 135
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM---DQTHSDTNRVVGT 411
           GL Y+H   R +I+HRD+KA+N+L+  +   K++DFG+AR F +    Q +   NRVV T
Sbjct: 136 GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-T 191
Query: 412 FGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLT 461
             Y  PE ++  R +    D++  G ++ E+ +        TE+    L++
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 72/214 (33%), Positives = 101/214 (47%), Gaps = 33/214 (15%)
Query: 251 KLGQGGFGAVYKGMLS--NGETI--AVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLV 303
           KLG G FG V +G     +G+T+  AVK L  +     +   +F  EV  +  L HRNL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 304 RLLGFCLERKERILVYEFVPNASL--------DHFIFDPINREHMTWEKRYKIIEGIARG 355
           RL G  L    + +V E  P  SL         HF+   ++R        Y +   +A G
Sbjct: 85  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--------YAV--QVAEG 133
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS--DTNRVVGTFG 413
           + YL      R IHRDL A N+LL +    KI DFG+ R    +  H     +R V  F 
Sbjct: 134 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFA 189
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQK 446
           + APE +    FS  SD + FGV + E+ + GQ+
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 105/221 (47%), Gaps = 22/221 (9%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARLQH 299
           ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGLLY 358
            N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L Y
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSRFDEQRTATYITELANALSY 127
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFGYM 415
            H     R+IHRD+K  N+LL S    KI+DFG +        H+ ++R   + GT  Y+
Sbjct: 128 CHSK---RVIHRDIKPENLLLGSNGELKIADFGWS-------VHAPSSRRDTLCGTLDYL 177
Query: 416 APEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
            PE +       K D++S GVL  E + G       T +ET
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQET 218

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 105/221 (47%), Gaps = 22/221 (9%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNS--KQG-EIEFKNEVLLLARLQH 299
           ++F     LG+G FG VY       + I A+K L K    K G E + + EV + + L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGLLY 358
            N++RL G+  +     L+ E+ P  +    ++  + +     E+R    I  +A  L Y
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSRFDEQRTATYITELANALSY 127
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFGYM 415
            H     R+IHRD+K  N+LL S    KI+DFG +        H+ ++R   + GT  Y+
Sbjct: 128 CHSK---RVIHRDIKPENLLLGSNGELKIADFGWS-------VHAPSSRRTTLCGTLDYL 177
Query: 416 APEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
            PE +       K D++S GVL  E + G       T +ET
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQET 218

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 72/232 (31%), Positives = 114/232 (49%), Gaps = 33/232 (14%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLSN----GETIAVKRLSKNS--KQGEIEFKN-EVL 292
           RV   +F+    LG+G FG V   ML++     E  A+K L K+   +  ++E    E  
Sbjct: 15  RVKLTDFNFLMVLGKGSFGKV---MLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKR 71
Query: 293 LLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG 351
           +LA L     +  L  C +  +R+  V E+V    L +         H+    ++K  + 
Sbjct: 72  VLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMY---------HIQQVGKFKEPQA 122
Query: 352 ------IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
                 I+ GL +LH+     II+RDLK  N++LDSE + KI+DFGM +   MD     T
Sbjct: 123 VFYAAEISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV--TT 177
Query: 406 NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE 457
               GT  Y+APE + +  +    D +++GVL+ E+++GQ    F  E+E E
Sbjct: 178 REFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ--PPFDGEDEDE 227

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/214 (33%), Positives = 101/214 (47%), Gaps = 33/214 (15%)
Query: 251 KLGQGGFGAVYKGMLS--NGETI--AVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLV 303
           KLG G FG V +G     +G+T+  AVK L  +     +   +F  EV  +  L HRNL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 304 RLLGFCLERKERILVYEFVPNASL--------DHFIFDPINREHMTWEKRYKIIEGIARG 355
           RL G  L    + +V E  P  SL         HF+   ++R        Y +   +A G
Sbjct: 79  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--------YAV--QVAEG 127
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH--SDTNRVVGTFG 413
           + YL      R IHRDL A N+LL +    KI DFG+ R    +  H     +R V  F 
Sbjct: 128 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFA 183
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQK 446
           + APE +    FS  SD + FGV + E+ + GQ+
Sbjct: 184 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 217

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 124/268 (46%), Gaps = 34/268 (12%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIE---FKNEVLL 293
           R+  DNF     LG+G FG V    +   G+  AVK L K+   +  ++E    +  +L 
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 294 LARLQHRNLVRLLGFCLERKERIL-VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
           LAR  H  L +L   C +  +R+  V EFV    L   I    +R       R+   E I
Sbjct: 79  LAR-NHPFLTQLFC-CFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAE-I 133
Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF 412
              L++LH+     II+RDLK  N+LLD E + K++DFGM +  E       T    GT 
Sbjct: 134 ISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTP 188
Query: 413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRN------ 466
            Y+APE +    +    D ++ GVL+ E++ G   + F  E E ED L  A  N      
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH--APF--EAENEDDLFEAILNDEVVYP 244
Query: 467 -WNEGAALNLM------DPTMRGGSTSE 487
            W    A  ++      +PTMR GS ++
Sbjct: 245 TWLHEDATGILKSFMTKNPTMRLGSLTQ 272

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 110/234 (47%), Gaps = 53/234 (22%)
Query: 245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
           +F +   +G GGFG V+K     +G+T  ++R+  N+++ E     EV  LA+L H N+V
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAE----REVKALAKLDHVNIV 68
Query: 304 RLLGFCLERKERILVYEFVP---NASLDHFIFDPINREHMT------------------- 341
              G C +       +++ P   + SL+   +DP N ++ +                   
Sbjct: 69  HYNG-CWDG------FDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTL 121
Query: 342 --W-EKR----------YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKIS 388
             W EKR           ++ E I +G+ Y+H     ++IHRDLK SNI L      KI 
Sbjct: 122 EQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIG 178
Query: 389 DFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIV 442
           DFG+    + D   +   R  GT  YM+PE +    +  + D+++ G+++ E++
Sbjct: 179 DFGLVTSLKNDGKRT---RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 251 KLGQGGFGAVYKGMLSN-GETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLV--RLL 306
           +LG GGFG V + +  + GE +A+K+  +  S +    +  E+ ++ +L H N+V  R +
Sbjct: 22  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 81
Query: 307 GFCLERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
              L++       +L  E+     L  ++    N   +       ++  I+  L YLHE+
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 141
Query: 363 SRLRIIHRDLKASNILLD---SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
              RIIHRDLK  NI+L      +  KI D G A+  E+DQ    T   VGT  Y+APE 
Sbjct: 142 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTE-FVGTLQYLAPEL 195
Query: 420 VMHGRFSVKSDIFSFGVLVLEIVSG 444
           +   +++V  D +SFG L  E ++G
Sbjct: 196 LEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 112/225 (49%), Gaps = 22/225 (9%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
           D +    +LG G F  V K      G+    + I  KR +K+S++G    + + EV +L 
Sbjct: 11  DYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            +QH N++ L      + + IL+ E V    L  F+ +   +E +T E+  + ++ I  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNG 126
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPK----ISDFGMARLFEMDQTHSDTNRVVGT 411
           + YLH    L+I H DLK  NI+L     PK    I DFG+A   +     ++   + GT
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGT 180
Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
             ++APE V +    +++D++S GV+   ++SG       T++ET
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 225

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 86/280 (30%), Positives = 127/280 (45%), Gaps = 31/280 (11%)
Query: 232 LQFDF-ETIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ---GEIE 286
           LQ+ + E   V  + F     LG+GGFG V    + + G+  A K+L K   +   GE  
Sbjct: 171 LQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM 230
Query: 287 FKNEVLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKR 345
             NE  +L ++  R +V L  +  E K+ + LV   +    L   I+  + +      + 
Sbjct: 231 ALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYH-MGQAGFPEARA 288
Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
                 I  GL  LH   R RI++RDLK  NILLD   + +ISD G+A      QT    
Sbjct: 289 VFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---I 342
Query: 406 NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG----QKRSSFGTEEETEDLLT 461
              VGT GYMAPE V + R++   D ++ G L+ E+++G    Q+R      EE E L+ 
Sbjct: 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK 402
Query: 462 YAWRNWNEG---------AALNLMDPT----MRGGSTSEM 488
                ++E          + L   DP      RGGS  E+
Sbjct: 403 EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREV 442

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 251 KLGQGGFGAVYKGMLSN-GETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLV--RLL 306
           +LG GGFG V + +  + GE +A+K+  +  S +    +  E+ ++ +L H N+V  R +
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 307 GFCLERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
              L++       +L  E+     L  ++    N   +       ++  I+  L YLHE+
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 363 SRLRIIHRDLKASNILLD---SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
              RIIHRDLK  NI+L      +  KI D G A+  E+DQ    T   VGT  Y+APE 
Sbjct: 141 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTE-FVGTLQYLAPEL 194
Query: 420 VMHGRFSVKSDIFSFGVLVLEIVSG 444
           +   +++V  D +SFG L  E ++G
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 100/218 (45%), Gaps = 32/218 (14%)
Query: 251 KLGQGGFGAVYKGMLS--NGETI--AVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLV 303
           KLG G FG V +G     +G+T+  AVK L  +     +   +F  EV  +  L HRNL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 304 RLLGFCLERKERILVYEFVPNASL--------DHFIFDPINREHMTWEKRYKIIEGIARG 355
           RL G  L    + +V E  P  SL         HF+   ++R        Y +   +A G
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--------YAV--QVAEG 123
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS--DTNRVVGTFG 413
           + YL      R IHRDL A N+LL +    KI DFG+ R    +  H     +R V  F 
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFA 179
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFG 451
           + APE +    FS  SD + FGV + E+ +  +    G
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 217

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAE--------IV 142
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 199
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           Y++PE +     S  SD+++ G ++ ++V+G
Sbjct: 200 YVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 112/225 (49%), Gaps = 22/225 (9%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
           D +    +LG G F  V K      G+    + I  KR +K+S++G    + + EV +L 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 68
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            +QH N++ L      + + IL+ E V    L  F+ +   +E +T E+  + ++ I  G
Sbjct: 69  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNG 125
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPK----ISDFGMARLFEMDQTHSDTNRVVGT 411
           + YLH    L+I H DLK  NI+L     PK    I DFG+A   +     ++   + GT
Sbjct: 126 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGT 179
Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
             ++APE V +    +++D++S GV+   ++SG       T++ET
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 224

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 112/225 (49%), Gaps = 22/225 (9%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
           D +    +LG G F  V K      G+    + I  KR +K+S++G    + + EV +L 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            +QH N++ L      + + IL+ E V    L  F+ +   +E +T E+  + ++ I  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNG 126
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPK----ISDFGMARLFEMDQTHSDTNRVVGT 411
           + YLH    L+I H DLK  NI+L     PK    I DFG+A   +     ++   + GT
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGT 180
Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
             ++APE V +    +++D++S GV+   ++SG       T++ET
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 225

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 112/225 (49%), Gaps = 22/225 (9%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
           D +    +LG G F  V K      G+    + I  KR +K+S++G    + + EV +L 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 68
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            +QH N++ L      + + IL+ E V    L  F+ +   +E +T E+  + ++ I  G
Sbjct: 69  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNG 125
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPK----ISDFGMARLFEMDQTHSDTNRVVGT 411
           + YLH    L+I H DLK  NI+L     PK    I DFG+A   +     ++   + GT
Sbjct: 126 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGT 179
Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
             ++APE V +    +++D++S GV+   ++SG       T++ET
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 224

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/214 (33%), Positives = 101/214 (47%), Gaps = 33/214 (15%)
Query: 251 KLGQGGFGAVYKGMLS--NGETI--AVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLV 303
           KLG G FG V +G     +G+T+  AVK L  +     +   +F  EV  +  L HRNL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 304 RLLGFCLERKERILVYEFVPNASL--------DHFIFDPINREHMTWEKRYKIIEGIARG 355
           RL G  L    + +V E  P  SL         HF+   ++R        Y +   +A G
Sbjct: 85  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--------YAV--QVAEG 133
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH--SDTNRVVGTFG 413
           + YL      R IHRDL A N+LL +    KI DFG+ R    +  H     +R V  F 
Sbjct: 134 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFA 189
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQK 446
           + APE +    FS  SD + FGV + E+ + GQ+
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 118/224 (52%), Gaps = 15/224 (6%)
Query: 230 KSLQFDF-ETIRVATDNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEF 287
           + LQ+ + E   +  D F D   LG+GGFG V+   M + G+  A K+L+K   +    +
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY 229
Query: 288 KNEVL---LLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWE 343
           +  ++   +LA++  R +V L  +  E K  + LV   +    + + I++ ++ ++  ++
Sbjct: 230 QGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYN-VDEDNPGFQ 287
Query: 344 KRYKII--EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
           +   I     I  GL +LH+ +   II+RDLK  N+LLD + N +ISD G+A   E+   
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA--VELKAG 342
Query: 402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
            + T    GT G+MAPE ++   +    D F+ GV + E+++ +
Sbjct: 343 QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 100/218 (45%), Gaps = 32/218 (14%)
Query: 251 KLGQGGFGAVYKGMLS--NGETI--AVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLV 303
           KLG G FG V +G     +G+T+  AVK L  +     +   +F  EV  +  L HRNL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 304 RLLGFCLERKERILVYEFVPNASL--------DHFIFDPINREHMTWEKRYKIIEGIARG 355
           RL G  L    + +V E  P  SL         HF+   ++R        Y +   +A G
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--------YAV--QVAEG 123
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH--SDTNRVVGTFG 413
           + YL      R IHRDL A N+LL +    KI DFG+ R    +  H     +R V  F 
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFA 179
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFG 451
           + APE +    FS  SD + FGV + E+ +  +    G
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 217

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 112/225 (49%), Gaps = 22/225 (9%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
           D +    +LG G F  V K      G+    + I  KR +K+S++G    + + EV +L 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            +QH N++ L      + + IL+ E V    L  F+ +   +E +T E+  + ++ I  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNG 126
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPK----ISDFGMARLFEMDQTHSDTNRVVGT 411
           + YLH    L+I H DLK  NI+L     PK    I DFG+A   +     ++   + GT
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGT 180
Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
             ++APE V +    +++D++S GV+   ++SG       T++ET
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 225

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 112/225 (49%), Gaps = 22/225 (9%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
           D +    +LG G F  V K      G+    + I  KR +K+S++G    + + EV +L 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            +QH N++ L      + + IL+ E V    L  F+ +   +E +T E+  + ++ I  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNG 126
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPK----ISDFGMARLFEMDQTHSDTNRVVGT 411
           + YLH    L+I H DLK  NI+L     PK    I DFG+A   +     ++   + GT
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGT 180
Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
             ++APE V +    +++D++S GV+   ++SG       T++ET
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 225

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 11/207 (5%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHR 300
            +++     LG+G  G V   +     E +AVK +  K +       K E+ +   L H 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYL 359
           N+V+  G   E   + L  E+     L    FD I  +  M      +    +  G++YL
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H    + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GT  Y+APE 
Sbjct: 121 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 177
Query: 420 VMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           +    F  +  D++S G+++  +++G+
Sbjct: 178 LKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 112/225 (49%), Gaps = 22/225 (9%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
           D +    +LG G F  V K      G+    + I  KR +K+S++G    + + EV +L 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            +QH N++ L      + + IL+ E V    L  F+ +   +E +T E+  + ++ I  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNG 126
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPK----ISDFGMARLFEMDQTHSDTNRVVGT 411
           + YLH    L+I H DLK  NI+L     PK    I DFG+A   +     ++   + GT
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGT 180
Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
             ++APE V +    +++D++S GV+   ++SG       T++ET
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 225

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 125/245 (51%), Gaps = 15/245 (6%)
Query: 209 CIFLRVGKLKLEDENVEETIAKSLQFDF-ETIRVATDNFSDANKLGQGGFGAVYK-GMLS 266
            +   +G+   ++    +   + LQ+ + E   +  D F D   LG+GGFG V+   M +
Sbjct: 149 AVLAHLGQAPFQEFLDSKYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKA 208
Query: 267 NGETIAVKRLSKNSKQGEIEFKNEVL---LLARLQHRNLVRLLGFCLERKERI-LVYEFV 322
            G+  A K+L+K   +    ++  ++   +LA++  R +V L  +  E K  + LV   +
Sbjct: 209 TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIM 267
Query: 323 PNASLDHFIFDPINREHMTWEKRYKII--EGIARGLLYLHEDSRLRIIHRDLKASNILLD 380
               + + I++ ++ ++  +++   I     I  GL +LH+ +   II+RDLK  N+LLD
Sbjct: 268 NGGDIRYHIYN-VDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLD 323
Query: 381 SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLE 440
            + N +ISD G+A   E+    + T    GT G+MAPE ++   +    D F+ GV + E
Sbjct: 324 DDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYE 381
Query: 441 IVSGQ 445
           +++ +
Sbjct: 382 MIAAR 386

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 112/225 (49%), Gaps = 22/225 (9%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
           D +    +LG G F  V K      G+    + I  KR +K+S++G    + + EV +L 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            +QH N++ L      + + IL+ E V    L  F+ +   +E +T E+  + ++ I  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNG 126
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPK----ISDFGMARLFEMDQTHSDTNRVVGT 411
           + YLH    L+I H DLK  NI+L     PK    I DFG+A   +     ++   + GT
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGT 180
Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
             ++APE V +    +++D++S GV+   ++SG       T++ET
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 225

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 112/225 (49%), Gaps = 22/225 (9%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
           D +    +LG G F  V K      G+    + I  KR +K+S++G    + + EV +L 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            +QH N++ L      + + IL+ E V    L  F+ +   +E +T E+  + ++ I  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNG 126
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPK----ISDFGMARLFEMDQTHSDTNRVVGT 411
           + YLH    L+I H DLK  NI+L     PK    I DFG+A   +     ++   + GT
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGT 180
Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
             ++APE V +    +++D++S GV+   ++SG       T++ET
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 225

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 112/225 (49%), Gaps = 22/225 (9%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
           D +    +LG G F  V K      G+    + I  KR +K+S++G    + + EV +L 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            +QH N++ L      + + IL+ E V    L  F+ +   +E +T E+  + ++ I  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNG 126
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPK----ISDFGMARLFEMDQTHSDTNRVVGT 411
           + YLH    L+I H DLK  NI+L     PK    I DFG+A   +     ++   + GT
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGT 180
Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
             ++APE V +    +++D++S GV+   ++SG       T++ET
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 225

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/214 (33%), Positives = 101/214 (47%), Gaps = 33/214 (15%)
Query: 251 KLGQGGFGAVYKGMLS--NGETI--AVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLV 303
           KLG G FG V +G     +G+T+  AVK L  +     +   +F  EV  +  L HRNL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 304 RLLGFCLERKERILVYEFVPNASL--------DHFIFDPINREHMTWEKRYKIIEGIARG 355
           RL G  L    + +V E  P  SL         HF+   ++R        Y +   +A G
Sbjct: 79  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--------YAV--QVAEG 127
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH--SDTNRVVGTFG 413
           + YL      R IHRDL A N+LL +    KI DFG+ R    +  H     +R V  F 
Sbjct: 128 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFA 183
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQK 446
           + APE +    FS  SD + FGV + E+ + GQ+
Sbjct: 184 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 217

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 10/200 (5%)
Query: 252 LGQGGFGAVYK-GMLSNGETIAVKRLSKNS-KQGEIE-FKNEVLLLARLQHRNLVRLLGF 308
           +G G +G   K    S+G+ +  K L   S  + E +   +EV LL  L+H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 309 CLERKERIL--VYEFVPNASLDHFIFDPIN-REHMTWEKRYKIIEGIARGLLYLHE--DS 363
            ++R    L  V E+     L   I      R+++  E   +++  +   L   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
              ++HRDLK +N+ LD + N K+ DFG+AR+   D + + T   VGT  YM+PE +   
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNRM 191
Query: 424 RFSVKSDIFSFGVLVLEIVS 443
            ++ KSDI+S G L+ E+ +
Sbjct: 192 SYNEKSDIWSLGCLLYELCA 211

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 112/225 (49%), Gaps = 22/225 (9%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
           D +    +LG G F  V K      G+    + I  KR +K+S++G    + + EV +L 
Sbjct: 11  DYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            +QH N++ L      + + IL+ E V    L  F+ +   +E +T E+  + ++ I  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNG 126
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPK----ISDFGMARLFEMDQTHSDTNRVVGT 411
           + YLH    L+I H DLK  NI+L     PK    I DFG+A   +     ++   + GT
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGT 180
Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
             ++APE V +    +++D++S GV+   ++SG       T++ET
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 225

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 118/224 (52%), Gaps = 15/224 (6%)
Query: 230 KSLQFDF-ETIRVATDNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEF 287
           + LQ+ + E   +  D F D   LG+GGFG V+   M + G+  A K+L+K   +    +
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY 229
Query: 288 KNEVL---LLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWE 343
           +  ++   +LA++  R +V L  +  E K  + LV   +    + + I++ ++ ++  ++
Sbjct: 230 QGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYN-VDEDNPGFQ 287
Query: 344 KRYKII--EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
           +   I     I  GL +LH+ +   II+RDLK  N+LLD + N +ISD G+A   E+   
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA--VELKAG 342
Query: 402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
            + T    GT G+MAPE ++   +    D F+ GV + E+++ +
Sbjct: 343 QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 118/224 (52%), Gaps = 15/224 (6%)
Query: 230 KSLQFDF-ETIRVATDNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEF 287
           + LQ+ + E   +  D F D   LG+GGFG V+   M + G+  A K+L+K   +    +
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY 229
Query: 288 KNEVL---LLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWE 343
           +  ++   +LA++  R +V L  +  E K  + LV   +    + + I++ ++ ++  ++
Sbjct: 230 QGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYN-VDEDNPGFQ 287
Query: 344 KRYKII--EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
           +   I     I  GL +LH+ +   II+RDLK  N+LLD + N +ISD G+A   E+   
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA--VELKAG 342
Query: 402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
            + T    GT G+MAPE ++   +    D F+ GV + E+++ +
Sbjct: 343 QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/233 (31%), Positives = 115/233 (49%), Gaps = 18/233 (7%)
Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVY----KGMLSNGETIAVKR 275
           +DE V + I+ +      + +    +F     LGQG FG V+         +G   A+K 
Sbjct: 4   KDEGVLKEISITHHVKAGSEKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKV 63
Query: 276 LSKNSKQ--GEIEFKNEVLLLARLQHRNLVRL-LGFCLERKERILVYEFVPNASLDHFIF 332
           L K + +    +  K E  +LA + H  +V+L   F  E K   L+ +F+    L    F
Sbjct: 64  LKKATLKVRDRVRTKMERDILADVNHPFVVKLHYAFQTEGK-LYLILDFLRGGDL----F 118
Query: 333 DPINREHMTWEKRYKI-IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG 391
             +++E M  E+  K  +  +A GL +LH    L II+RDLK  NILLD E + K++DFG
Sbjct: 119 TRLSKEVMFTEEDVKFYLAELALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFG 175
Query: 392 MARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           +++  E            GT  YMAPE V     S  +D +S+GVL+ E+++G
Sbjct: 176 LSK--EAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 114/234 (48%), Gaps = 38/234 (16%)
Query: 238 TIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
           ++R A+D F +   LGQG FG V K   + +    A+K++ +++++      +EV LLA 
Sbjct: 1   SLRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLAS 58
Query: 297 LQHRNLVRLLGFCLERKERI-------------LVYEFVPNASLDHFIFDPINREHMTWE 343
           L H+ +VR     LER+  +             +  E+  N +L    +D I+ E++  +
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTL----YDLIHSENLNQQ 114
Query: 344 K--RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR------- 394
           +   +++   I   L Y+H      IIHR+LK  NI +D   N KI DFG+A+       
Sbjct: 115 RDEYWRLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 395 LFEMDQ-----THSDTNRVVGTFGYMAPEYV-MHGRFSVKSDIFSFGVLVLEIV 442
           + ++D      +  +    +GT  Y+A E +   G ++ K D +S G++  E +
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 111/224 (49%), Gaps = 28/224 (12%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D       LG+G FG V         K   +    +AVK L  ++ + ++ +  +E+ ++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPIN--REHM 340
             + +H+N++ LLG C +     ++ E+    +L  ++           F+P +   E +
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQL 147
Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
           + +        +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR +  +D
Sbjct: 148 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
                TN  +    +MAPE +    ++ +SD++SFGVL+ EI +
Sbjct: 205 XXKKTTNGRL-PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 112/225 (49%), Gaps = 22/225 (9%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
           D +    +LG G F  V K      G+    + I  KR +K+S++G    + + EV +L 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            +QH N++ L      + + IL+ E V    L  F+ +   +E +T E+  + ++ I  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNG 126
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPK----ISDFGMARLFEMDQTHSDTNRVVGT 411
           + YLH    L+I H DLK  NI+L     PK    I DFG+A   +     ++   + GT
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGT 180
Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
             ++APE V +    +++D++S GV+   ++SG       T++ET
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 225

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 24/228 (10%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIE-FKN 289
           E      +N      LG G FG V +      G       +AVK L   +   E E   +
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98
Query: 290 EVLLLARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPIN- 336
           E+ +++ L QH N+V LLG C      +++ E+     L +F+           ++P + 
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHN 158
Query: 337 -REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL 395
             E ++          +A+G+ +L   +    IHRD+ A N+LL +    KI DFG+AR 
Sbjct: 159 PEEQLSSRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARD 215
Query: 396 FEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
              D  +           +MAPE +    ++V+SD++S+G+L+ EI S
Sbjct: 216 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/214 (33%), Positives = 101/214 (47%), Gaps = 33/214 (15%)
Query: 251 KLGQGGFGAVYKGMLS--NGETI--AVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLV 303
           KLG G FG V +G     +G+T+  AVK L  +     +   +F  EV  +  L HRNL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 304 RLLGFCLERKERILVYEFVPNASL--------DHFIFDPINREHMTWEKRYKIIEGIARG 355
           RL G  L    + +V E  P  SL         HF+   ++R        Y +   +A G
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--------YAV--QVAEG 123
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH--SDTNRVVGTFG 413
           + YL      R IHRDL A N+LL +    KI DFG+ R    +  H     +R V  F 
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFA 179
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQK 446
           + APE +    FS  SD + FGV + E+ + GQ+
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 110/208 (52%), Gaps = 15/208 (7%)
Query: 246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNLV 303
           +++ + +G+G +G V     + N   +A+K++S    Q   +    E+ +L R +H N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 304 RLLGFC----LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            +        +E+ + + +   +  A L    +  +  +H++ +     +  I RGL Y+
Sbjct: 105 GINDIIRAPTIEQMKDVYLVTHLMGADL----YKLLKTQHLSNDHICYFLYQILRGLKYI 160
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD-TNRVVGTFGYMAPE 418
           H  +   ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+      V T  Y APE
Sbjct: 161 HSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 217
Query: 419 YVMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
            +++ +   KS DI+S G ++ E++S +
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 112/225 (49%), Gaps = 22/225 (9%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
           D +    +LG G F  V K      G+    + I  KR +K+S++G    + + EV +L 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            +QH N++ L      + + IL+ E V    L  F+ +   +E +T E+  + ++ I  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAE---KESLTEEEATEFLKQILNG 126
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPK----ISDFGMARLFEMDQTHSDTNRVVGT 411
           + YLH    L+I H DLK  NI+L     PK    I DFG+A   +     ++   + GT
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGT 180
Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
             ++APE V +    +++D++S GV+   ++SG       T++ET
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 225

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 108/229 (47%), Gaps = 17/229 (7%)
Query: 229 AKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGE----TIAVKRLS-KNSKQG 283
           ++ LQ   E + +  +       LG+G FG+V +G L   +     +AVK +   NS Q 
Sbjct: 19  SEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR 78
Query: 284 EIE-FKNEVLLLARLQHRNLVRLLGFCLERKER-----ILVYEFVPNASLDHFIFDP--- 334
           EIE F +E   +    H N++RLLG C+E   +     +++  F+    L  ++      
Sbjct: 79  EIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLE 138
Query: 335 INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
              +H+  +   K +  IA G+ YL   S    +HRDL A N +L  +M   ++DFG+++
Sbjct: 139 TGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195
Query: 395 LFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
                  +           ++A E +    ++ KSD+++FGV + EI +
Sbjct: 196 KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 108/206 (52%), Gaps = 11/206 (5%)
Query: 246 FSDANKLGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRN 301
           +++ + +G+G +G V   Y  +  N   +A+K++S    Q   +    E+ +L R +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++ +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD-TNRVVGTFGYMAPEYV 420
            +   ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+      V T  Y APE +
Sbjct: 147 AN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 421 MHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           ++ +   KS DI+S G ++ E++S +
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 108/206 (52%), Gaps = 11/206 (5%)
Query: 246 FSDANKLGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRN 301
           +++ + +G+G +G V   Y  +  N   +A+K++S    Q   +    E+ +L R +H N
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 87
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++ +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H 
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 147
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD-TNRVVGTFGYMAPEYV 420
            +   ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+      V T  Y APE +
Sbjct: 148 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 204
Query: 421 MHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           ++ +   KS DI+S G ++ E++S +
Sbjct: 205 LNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 108/206 (52%), Gaps = 11/206 (5%)
Query: 246 FSDANKLGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRN 301
           +++ + +G+G +G V   Y  +  N   +A+K++S    Q   +    E+ +L R +H N
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 88
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++ +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H 
Sbjct: 89  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 148
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD-TNRVVGTFGYMAPEYV 420
            +   ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+      V T  Y APE +
Sbjct: 149 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 205
Query: 421 MHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           ++ +   KS DI+S G ++ E++S +
Sbjct: 206 LNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 108/206 (52%), Gaps = 11/206 (5%)
Query: 246 FSDANKLGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRN 301
           +++ + +G+G +G V   Y  +  N   +A+K++S    Q   +    E+ +L R +H N
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 79
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++ +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H 
Sbjct: 80  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 139
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD-TNRVVGTFGYMAPEYV 420
            +   ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+      V T  Y APE +
Sbjct: 140 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 196
Query: 421 MHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           ++ +   KS DI+S G ++ E++S +
Sbjct: 197 LNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 108/206 (52%), Gaps = 11/206 (5%)
Query: 246 FSDANKLGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRN 301
           +++ + +G+G +G V   Y  +  N   +A+K++S    Q   +    E+ +L R +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++ +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD-TNRVVGTFGYMAPEYV 420
            +   ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+      V T  Y APE +
Sbjct: 147 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 421 MHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           ++ +   KS DI+S G ++ E++S +
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 108/206 (52%), Gaps = 11/206 (5%)
Query: 246 FSDANKLGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRN 301
           +++ + +G+G +G V   Y  +  N   +A+K++S    Q   +    E+ +L R +H N
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 80
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++ +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H 
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 140
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD-TNRVVGTFGYMAPEYV 420
            +   ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+      V T  Y APE +
Sbjct: 141 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 197
Query: 421 MHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           ++ +   KS DI+S G ++ E++S +
Sbjct: 198 LNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 107/204 (52%), Gaps = 7/204 (3%)
Query: 246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNLV 303
           +++ + +G+G +G V     + N   +A+K++S    Q   +    E+ +L R +H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD-TNRVVGTFGYMAPEYVMH 422
              ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+      V T  Y APE +++
Sbjct: 145 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 423 GRFSVKS-DIFSFGVLVLEIVSGQ 445
            +   KS DI+S G ++ E++S +
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 40/221 (18%)
Query: 245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
           +F +   +G GGFG V+K     +G+T  +KR+  N+++ E     EV  LA+L H N+V
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE----REVKALAKLDHVNIV 67
Query: 304 RLLGFCLE-----------------RKERILVYEFVPNASLDHFIFDPINREHMTWEKRY 346
              G C +                  K   +  EF    +L+ +I      E    EK  
Sbjct: 68  HYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI------EKRRGEKLD 120
Query: 347 KII-----EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
           K++     E I +G+ Y+H     ++I+RDLK SNI L      KI DFG+    + D  
Sbjct: 121 KVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-- 175
Query: 402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIV 442
                R  GT  YM+PE +    +  + D+++ G+++ E++
Sbjct: 176 -GKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 108/206 (52%), Gaps = 11/206 (5%)
Query: 246 FSDANKLGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRN 301
           +++ + +G+G +G V   Y  +  N   +A+K++S    Q   +    E+ +L R +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHEN 86
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++ +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD-TNRVVGTFGYMAPEYV 420
            +   ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+      V T  Y APE +
Sbjct: 147 AN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 421 MHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           ++ +   KS DI+S G ++ E++S +
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 108/206 (52%), Gaps = 11/206 (5%)
Query: 246 FSDANKLGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRN 301
           +++ + +G+G +G V   Y  +  N   +A+K++S    Q   +    E+ +L R +H N
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 80
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++ +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H 
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 140
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD-TNRVVGTFGYMAPEYV 420
            +   ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+      V T  Y APE +
Sbjct: 141 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 197
Query: 421 MHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           ++ +   KS DI+S G ++ E++S +
Sbjct: 198 LNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 107/204 (52%), Gaps = 7/204 (3%)
Query: 246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNLV 303
           +++ + +G+G +G V     + N   +A+K++S    Q   +    E+ +L R +H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H  +
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD-TNRVVGTFGYMAPEYVMH 422
              ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+      V T  Y APE +++
Sbjct: 147 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 423 GRFSVKS-DIFSFGVLVLEIVSGQ 445
            +   KS DI+S G ++ E++S +
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 70  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 120
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT  
Sbjct: 121 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 177
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           Y++PE +        SD+++ G ++ ++V+G
Sbjct: 178 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 111/225 (49%), Gaps = 21/225 (9%)
Query: 243 TDNFSDANKLGQGGFGAVY--KGMLSNGETIA--VKRLSKNSKQGEIEFKNEVLLLARLQ 298
           +D +    KLG G +G V   K  L+  E     +K+ S  +        +EV +L +L 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPIN-REHMTWEKRYKIIEGIARGLL 357
           H N+++L  F  +++   LV E      L    FD I  R+  +      I++ +  G  
Sbjct: 80  HPNIMKLYEFFEDKRNYYLVMEVYRGGEL----FDEIILRQKFSEVDAAVIMKQVLSGTT 135
Query: 358 YLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQTHSDTNRVVGTFGY 414
           YLH+ +   I+HRDLK  N+LL+S+      KI DFG++  FE+     +    +GT  Y
Sbjct: 136 YLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER---LGTAYY 189
Query: 415 MAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDL 459
           +APE V+  ++  K D++S GV++  ++ G     FG + + E L
Sbjct: 190 IAPE-VLRKKYDEKCDVWSCGVILYILLCGY--PPFGGQTDQEIL 231

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 107/204 (52%), Gaps = 7/204 (3%)
Query: 246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNLV 303
           +++ + +G+G +G V     + N   +A+K++S    Q   +    E+ +L R +H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD-TNRVVGTFGYMAPEYVMH 422
              ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+      V T  Y APE +++
Sbjct: 145 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 423 GRFSVKS-DIFSFGVLVLEIVSGQ 445
            +   KS DI+S G ++ E++S +
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 108/206 (52%), Gaps = 11/206 (5%)
Query: 246 FSDANKLGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRN 301
           +++ + +G+G +G V   Y  +  N   +A+K++S    Q   +    E+ +L R +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++ +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD-TNRVVGTFGYMAPEYV 420
            +   ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+      V T  Y APE +
Sbjct: 147 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIM 203
Query: 421 MHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           ++ +   KS DI+S G ++ E++S +
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 108/206 (52%), Gaps = 11/206 (5%)
Query: 246 FSDANKLGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRN 301
           +++ + +G+G +G V   Y  +  N   +A+K++S    Q   +    E+ +L R +H N
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 87
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++ +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H 
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 147
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD-TNRVVGTFGYMAPEYV 420
            +   ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+      V T  Y APE +
Sbjct: 148 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIM 204
Query: 421 MHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           ++ +   KS DI+S G ++ E++S +
Sbjct: 205 LNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
           +N      LG G FG V +      G       +AVK L   +   E E   +E+ +++ 
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-------FDPINREHMTWEKRYKI 348
           L QH N+V LLG C      +++ E+     L +F+        D  +   +        
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 157
Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV 408
              +A+G+ +L   +    IHRD+ A N+LL +    KI DFG+AR    D  +      
Sbjct: 158 SSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 214
Query: 409 VGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
                +MAPE +    ++V+SD++S+G+L+ EI S
Sbjct: 215 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 107/204 (52%), Gaps = 7/204 (3%)
Query: 246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNLV 303
           +++ + +G+G +G V     + N   +A+K++S    Q   +    E+ +L R +H N++
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H  +
Sbjct: 93  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 152
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD-TNRVVGTFGYMAPEYVMH 422
              ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+      V T  Y APE +++
Sbjct: 153 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 209
Query: 423 GRFSVKS-DIFSFGVLVLEIVSGQ 445
            +   KS DI+S G ++ E++S +
Sbjct: 210 SKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 107/204 (52%), Gaps = 7/204 (3%)
Query: 246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNLV 303
           +++ + +G+G +G V     + N   +A+K++S    Q   +    E+ +L R +H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD-TNRVVGTFGYMAPEYVMH 422
              ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+      V T  Y APE +++
Sbjct: 145 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 423 GRFSVKS-DIFSFGVLVLEIVSGQ 445
            +   KS DI+S G ++ E++S +
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 69  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 119
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT  
Sbjct: 120 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 176
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           Y++PE +        SD+++ G ++ ++V+G
Sbjct: 177 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 107/204 (52%), Gaps = 7/204 (3%)
Query: 246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNLV 303
           +++ + +G+G +G V     + N   +A+K++S    Q   +    E+ +L R +H N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H  +
Sbjct: 105 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 164
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD-TNRVVGTFGYMAPEYVMH 422
              ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+      V T  Y APE +++
Sbjct: 165 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 423 GRFSVKS-DIFSFGVLVLEIVSGQ 445
            +   KS DI+S G ++ E++S +
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 110/208 (52%), Gaps = 15/208 (7%)
Query: 246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNLV 303
           +++ + +G+G +G V     + N   +A+K++S    Q   +    E+ +L R +H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 304 RLLGFC----LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            +        +E+ + + + + +    L    +  +  +H++ +     +  I RGL Y+
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDL----YKLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD-TNRVVGTFGYMAPE 418
           H  +   ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+      V T  Y APE
Sbjct: 141 HSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 419 YVMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
            +++ +   KS DI+S G ++ E++S +
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 95  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 145
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT  
Sbjct: 146 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 202
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           Y++PE +        SD+++ G ++ ++V+G
Sbjct: 203 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 93  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 143
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT  
Sbjct: 144 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 200
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           Y++PE +        SD+++ G ++ ++V+G
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 22/219 (10%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
           +N      LG G FG V +      G       +AVK L   +   E E   +E+ +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI--------FDP---INREHMTWEK 344
           L QH N+V LLG C      +++ E+     L +F+         DP   I    ++   
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRD 165
Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD 404
                  +A+G+ +L   +    IHRD+ A N+LL +    KI DFG+AR    D  +  
Sbjct: 166 LLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
                    +MAPE +    ++V+SD++S+G+L+ EI S
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 93  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 143
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT  
Sbjct: 144 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 200
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           Y++PE +        SD+++ G ++ ++V+G
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 142
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           Y++PE +        SD+++ G ++ ++V+G
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 67  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 117
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT  
Sbjct: 118 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 174
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           Y++PE +        SD+++ G ++ ++V+G
Sbjct: 175 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 140
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT  
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           Y++PE +        SD+++ G ++ ++V+G
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 110/208 (52%), Gaps = 15/208 (7%)
Query: 246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNLV 303
           +++ + +G+G +G V     + N   +A+K++S    Q   +    E+ +L R +H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 304 RLLGFC----LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            +        +E+ + + + + +    L    +  +  +H++ +     +  I RGL Y+
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDL----YKLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD-TNRVVGTFGYMAPE 418
           H  +   ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+      V T  Y APE
Sbjct: 141 HSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 419 YVMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
            +++ +   KS DI+S G ++ E++S +
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 108/206 (52%), Gaps = 11/206 (5%)
Query: 246 FSDANKLGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRN 301
           +++ + +G+G +G V   Y  +  N   +A+K++S    Q   +    E+ +L R +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++ +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHS 146
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD-TNRVVGTFGYMAPEYV 420
            +   ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+      V T  Y APE +
Sbjct: 147 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 421 MHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           ++ +   KS DI+S G ++ E++S +
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 142
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           Y++PE +        SD+++ G ++ ++V+G
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 142
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           Y++PE +        SD+++ G ++ ++V+G
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 68  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 118
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT  
Sbjct: 119 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 175
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           Y++PE +        SD+++ G ++ ++V+G
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 140
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT  
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           Y++PE +        SD+++ G ++ ++V+G
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 109/228 (47%), Gaps = 20/228 (8%)
Query: 242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQ 298
           + D +    KLG+G +G VYK + +   ET+A+KR+    ++  +      EV LL  LQ
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ 91
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           HRN++ L           L++E+  N    +   +P     +     Y++I G+     +
Sbjct: 92  HRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVN----F 147
Query: 359 LHEDSRLRIIHRDLKASNILL---DSEMNP--KISDFGMARLFEMDQTHSDTNRVVGTFG 413
            H  SR R +HRDLK  N+LL   D+   P  KI DFG+AR F +      T+ ++ T  
Sbjct: 148 CH--SR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFTHEII-TLW 202
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
           Y  PE ++  R +S   DI+S   +  E++   K   F  + E + L 
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWAEML--MKTPLFPGDSEIDQLF 248

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 142
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           Y++PE +        SD+++ G ++ ++V+G
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
           +N      LG G FG V +      G       +AVK L   +   E E   +E+ +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-------FDPINREHMTWEKRYKI 348
           L QH N+V LLG C      +++ E+     L +F+        D  +   +        
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 165
Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV 408
              +A+G+ +L   +    IHRD+ A N+LL +    KI DFG+AR    D  +      
Sbjct: 166 SSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 222
Query: 409 VGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
                +MAPE +    ++V+SD++S+G+L+ EI S
Sbjct: 223 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 142
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT  
Sbjct: 143 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           Y++PE +        SD+++ G ++ ++V+G
Sbjct: 200 YVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 107/223 (47%), Gaps = 26/223 (11%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D       LG+G FG V         K   +    +AVK L  ++ + ++ +  +E+ ++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPIN--REHM 340
             + +H+N++ LLG C +     ++ E+    +L  ++           ++P +   E +
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 132
Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           + +        +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR      
Sbjct: 133 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 401 THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            +  T        +MAPE +    ++ +SD++SFGVL+ EI +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 140
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT  
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQ 197
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           Y++PE +        SD+++ G ++ ++V+G
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 111/220 (50%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + +   + +G G +G+V     + +G  IAVK+LS+   Q  I  K    E+ 
Sbjct: 44  KTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSR-PFQSIIHAKRTYRELR 102
Query: 293 LLARLQHRNLVRLL-----GFCLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 103 LLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 158
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 159 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 209
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   +++  DI+S G ++ E+++G+
Sbjct: 210 GYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 108/206 (52%), Gaps = 11/206 (5%)
Query: 246 FSDANKLGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRN 301
           +++ + +G+G +G V   Y  +  N   +A++++S    Q   +    E+ +L R +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++ +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD-TNRVVGTFGYMAPEYV 420
            +   ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+      V T  Y APE +
Sbjct: 147 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 421 MHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           ++ +   KS DI+S G ++ E++S +
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 111/224 (49%), Gaps = 28/224 (12%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D       LG+G FG V         K   +    +AVK L  ++ + ++ +  +E+ ++
Sbjct: 21  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 80
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPIN--REHM 340
             + +H+N++ LLG C +     ++ E+    +L  ++           ++P +   E +
Sbjct: 81  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 140
Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
           + +        +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR +  +D
Sbjct: 141 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 197
Query: 400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
                TN  +    +MAPE +    ++ +SD++SFGVL+ EI +
Sbjct: 198 YYKKTTNGRL-PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 111/224 (49%), Gaps = 28/224 (12%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D       LG+G FG V         K   +    +AVK L  ++ + ++ +  +E+ ++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPIN--REHM 340
             + +H+N++ LLG C +     ++ E+    +L  ++           ++P +   E +
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 147
Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
           + +        +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR +  +D
Sbjct: 148 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
                TN  +    +MAPE +    ++ +SD++SFGVL+ EI +
Sbjct: 205 YYKKTTNGRL-PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 111/224 (49%), Gaps = 28/224 (12%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D       LG+G FG V         K   +    +AVK L  ++ + ++ +  +E+ ++
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPIN--REHM 340
             + +H+N++ LLG C +     ++ E+    +L  ++           ++P +   E +
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
           + +        +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR +  +D
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
                TN  +    +MAPE +    ++ +SD++SFGVL+ EI +
Sbjct: 246 YYKKTTNGRL-PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 111/224 (49%), Gaps = 28/224 (12%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D       LG+G FG V         K   +    +AVK L  ++ + ++ +  +E+ ++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPIN--REHM 340
             + +H+N++ LLG C +     ++ E+    +L  ++           ++P +   E +
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQL 147
Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
           + +        +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR +  +D
Sbjct: 148 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
                TN  +    +MAPE +    ++ +SD++SFGVL+ EI +
Sbjct: 205 YYKKTTNGRL-PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 111/224 (49%), Gaps = 28/224 (12%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D       LG+G FG V         K   +    +AVK L  ++ + ++ +  +E+ ++
Sbjct: 20  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 79
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPIN--REHM 340
             + +H+N++ LLG C +     ++ E+    +L  ++           ++P +   E +
Sbjct: 80  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 139
Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
           + +        +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR +  +D
Sbjct: 140 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 196
Query: 400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
                TN  +    +MAPE +    ++ +SD++SFGVL+ EI +
Sbjct: 197 YYKKTTNGRL-PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 111/224 (49%), Gaps = 28/224 (12%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D       LG+G FG V         K   +    +AVK L  ++ + ++ +  +E+ ++
Sbjct: 17  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 76
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPIN--REHM 340
             + +H+N++ LLG C +     ++ E+    +L  ++           ++P +   E +
Sbjct: 77  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 136
Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
           + +        +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR +  +D
Sbjct: 137 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 193
Query: 400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
                TN  +    +MAPE +    ++ +SD++SFGVL+ EI +
Sbjct: 194 YYKKTTNGRL-PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 244 DNFSDANKLGQGGFGA-VYKGMLSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F   V    L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 140
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT  
Sbjct: 141 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           Y++PE +        SD+++ G ++ ++V+G
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 111/224 (49%), Gaps = 28/224 (12%)
Query: 244 DNFSDANKLGQGGFGAVY--------KGMLSNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D       LG+G FG V         K   +    +AVK L  ++ + ++ +  +E+ ++
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI-----------FDPIN--REHM 340
             + +H+N++ LLG C +     ++ E+    +L  ++           ++P +   E +
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 147
Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMD 399
           + +        +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR +  +D
Sbjct: 148 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
                TN  +    +MAPE +    ++ +SD++SFGVL+ EI +
Sbjct: 205 YYKKTTNGRL-PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 109/230 (47%), Gaps = 17/230 (7%)
Query: 244 DNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL 302
           D++    +LG G FG V++    + G   A K +    +  +   + E+  ++ L+H  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREH--MTWEKRYKIIEGIARGLLYLH 360
           V L     +  E +++YEF+    L    F+ +  EH  M+ ++  + +  + +GL ++H
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 361 EDSRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
           E++    +H DLK  NI+  ++ +   K+ DFG+    +  Q+        GT  + APE
Sbjct: 273 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPE 326
Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWN 468
                     +D++S GVL   ++SG   S FG E + E L      +WN
Sbjct: 327 VAEGKPVGYYTDMWSVGVLSYILLSGL--SPFGGENDDETLRNVKSCDWN 374

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 74  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 124
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT  
Sbjct: 125 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 181
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           Y++PE +        SD+++ G ++ ++V+G
Sbjct: 182 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 10/200 (5%)
Query: 252 LGQGGFGAVYK-GMLSNGETIAVKRLSKNS-KQGEIE-FKNEVLLLARLQHRNLVRLLGF 308
           +G G +G   K    S+G+ +  K L   S  + E +   +EV LL  L+H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 309 CLERKERIL--VYEFVPNASLDHFIFDPIN-REHMTWEKRYKIIEGIARGLLYLHE--DS 363
            ++R    L  V E+     L   I      R+++  E   +++  +   L   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
              ++HRDLK +N+ LD + N K+ DFG+AR+   D + +     VGT  YM+PE +   
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSPEQMNRM 191
Query: 424 RFSVKSDIFSFGVLVLEIVS 443
            ++ KSDI+S G L+ E+ +
Sbjct: 192 SYNEKSDIWSLGCLLYELCA 211

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 10/200 (5%)
Query: 252 LGQGGFGAVYK-GMLSNGETIAVKRLSKNS-KQGEIE-FKNEVLLLARLQHRNLVRLLGF 308
           +G G +G   K    S+G+ +  K L   S  + E +   +EV LL  L+H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 309 CLERKERIL--VYEFVPNASLDHFIFDPIN-REHMTWEKRYKIIEGIARGLLYLHE--DS 363
            ++R    L  V E+     L   I      R+++  E   +++  +   L   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
              ++HRDLK +N+ LD + N K+ DFG+AR+   D+  +     VGT  YM+PE +   
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFA--KEFVGTPYYMSPEQMNRM 191
Query: 424 RFSVKSDIFSFGVLVLEIVS 443
            ++ KSDI+S G L+ E+ +
Sbjct: 192 SYNEKSDIWSLGCLLYELCA 211

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 89  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 139
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT  
Sbjct: 140 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 196
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           Y++PE +        SD+++ G ++ ++V+G
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEF-KNEVLLLARLQH 299
           ++F     LG+G F  V     L+     A+K L K    K+ ++ +   E  +++RL H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 300 RNLVRLLGFCLERKERILV-YEFVPNASLDHFI-----FDPINREHMTWEKRYKIIEGIA 353
              V+L  F  +  E++     +  N  L  +I     FD       T E        I 
Sbjct: 89  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IV 139
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT  
Sbjct: 140 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 196
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           Y++PE +        SD+++ G ++ ++V+G
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 19/210 (9%)
Query: 243 TDNFSDANKLGQGGFGAVY--KGMLSNGETIA--VKRLSKNSKQGEIEFKNEVLLLARLQ 298
           +D +    KLG G +G V   K  L+  E     +K+ S  +        +EV +L +L 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPIN-REHMTWEKRYKIIEGIARGLL 357
           H N+++L  F  +++   LV E      L    FD I  R+  +      I++ +  G  
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGEL----FDEIILRQKFSEVDAAVIMKQVLSGTT 118
Query: 358 YLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQTHSDTNRVVGTFGY 414
           YLH+ +   I+HRDLK  N+LL+S+      KI DFG++  FE+          +GT  Y
Sbjct: 119 YLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG---GKMKERLGTAYY 172
Query: 415 MAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           +APE V+  ++  K D++S GV++  ++ G
Sbjct: 173 IAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 22/219 (10%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
           +N      LG G FG V +      G       +AVK L   +   E E   +E+ +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI--------FDP---INREHMTWEK 344
           L QH N+V LLG C      +++ E+     L +F+         DP   I     +   
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD 404
                  +A+G+ +L   +    IHRD+ A N+LL +    KI DFG+AR    D  +  
Sbjct: 166 LLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
                    +MAPE +    ++V+SD++S+G+L+ EI S
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 243 TDNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
           +DN+    +LG+G F  V +      G+    + I  K+LS    Q   + + E  +  +
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRK 61
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           LQH N+VRL     E     LV++ V    L     D + RE  +       I+ I   +
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESI 118
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMN---PKISDFGMARLFEMDQTHSDTNRVVGTFG 413
            Y H +    I+HR+LK  N+LL S+      K++DFG+A   E++ + +  +   GT G
Sbjct: 119 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTPG 172
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           Y++PE +    +S   DI++ GV++  ++ G
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 243 TDNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
           +DN+    +LG+G F  V +      G+    + I  K+LS    Q   + + E  +  +
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRK 60
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           LQH N+VRL     E     LV++ V    L     D + RE  +       I+ I   +
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESI 117
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMN---PKISDFGMARLFEMDQTHSDTNRVVGTFG 413
            Y H +    I+HR+LK  N+LL S+      K++DFG+A   E++ + +  +   GT G
Sbjct: 118 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTPG 171
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           Y++PE +    +S   DI++ GV++  ++ G
Sbjct: 172 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 109/230 (47%), Gaps = 17/230 (7%)
Query: 244 DNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL 302
           D++    +LG G FG V++    + G   A K +    +  +   + E+  ++ L+H  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREH--MTWEKRYKIIEGIARGLLYLH 360
           V L     +  E +++YEF+    L    F+ +  EH  M+ ++  + +  + +GL ++H
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 166
Query: 361 EDSRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
           E++    +H DLK  NI+  ++ +   K+ DFG+    +  Q+        GT  + APE
Sbjct: 167 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPE 220
Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWN 468
                     +D++S GVL   ++SG   S FG E + E L      +WN
Sbjct: 221 VAEGKPVGYYTDMWSVGVLSYILLSGL--SPFGGENDDETLRNVKSCDWN 268

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 14/212 (6%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRN 301
           D++     +G G    V     +   E +A+KR++    Q  + E   E+  +++  H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINR-EHMTWEKRYKIIEGIAR----GL 356
           +V      + + E  LV + +   S+   I   + + EH +       I  I R    GL
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM--DQTHSDTNRV-VGTFG 413
            YLH++ +   IHRD+KA NILL  + + +I+DFG++       D T +   +  VGT  
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSG 444
           +MAPE +   R +  K+DI+SFG+  +E+ +G
Sbjct: 187 WMAPEVMEQVRGYDFKADIWSFGITAIELATG 218

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 243 TDNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
           +DN+    +LG+G F  V +      G+    + I  K+LS    Q   + + E  +  +
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRK 84
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           LQH N+VRL     E     LV++ V    L     D + RE  +       I+ I   +
Sbjct: 85  LQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESI 141
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQTHSDTNRVVGTFG 413
            Y H +    I+HR+LK  N+LL S+      K++DFG+A   E++ + +  +   GT G
Sbjct: 142 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTPG 195
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           Y++PE +    +S   DI++ GV++  ++ G
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVK---RLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG V++G+  + E  A+    +  KN     +  +F  E L + +  H ++V+L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   E    I++ E      L  F+   + +  +           ++  L YL      R
Sbjct: 106 GVITENPVWIIM-ELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 159
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS 426
            +HRD+ A N+L+ S    K+ DFG++R  E D T+   ++      +MAPE +   RF+
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRFT 218
Query: 427 VKSDIFSFGVLVLEIV 442
             SD++ FGV + EI+
Sbjct: 219 SASDVWMFGVCMWEIL 234

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 243 TDNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
           +DN+    +LG+G F  V +      G+    + I  K+LS    Q   + + E  +  +
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRK 61
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           LQH N+VRL     E     LV++ V    L     D + RE  +       I+ I   +
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESI 118
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMN---PKISDFGMARLFEMDQTHSDTNRVVGTFG 413
            Y H +    I+HR+LK  N+LL S+      K++DFG+A   E++ + +  +   GT G
Sbjct: 119 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEA-WHGFAGTPG 172
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           Y++PE +    +S   DI++ GV++  ++ G
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVK---RLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG V++G+  + E  A+    +  KN     +  +F  E L + +  H ++V+L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   E    I++ E      L  F+   + +  +           ++  L YL      R
Sbjct: 83  GVITENPVWIIM-ELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 136
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS 426
            +HRD+ A N+L+ S    K+ DFG++R  E D T+   ++      +MAPE +   RF+
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRFT 195
Query: 427 VKSDIFSFGVLVLEIV 442
             SD++ FGV + EI+
Sbjct: 196 SASDVWMFGVCMWEIL 211

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVK---RLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG V++G+  + E  A+    +  KN     +  +F  E L + +  H ++V+L+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   E    I++ E      L  F+   + +  +           ++  L YL      R
Sbjct: 80  GVITENPVWIIM-ELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 133
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS 426
            +HRD+ A N+L+ S    K+ DFG++R  E D T+   ++      +MAPE +   RF+
Sbjct: 134 FVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRFT 192
Query: 427 VKSDIFSFGVLVLEIV 442
             SD++ FGV + EI+
Sbjct: 193 SASDVWMFGVCMWEIL 208

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 14/212 (6%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRN 301
           D++     +G G    V     +   E +A+KR++    Q  + E   E+  +++  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINR-EHMTWEKRYKIIEGIAR----GL 356
           +V      + + E  LV + +   S+   I   + + EH +       I  I R    GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM--DQTHSDTNRV-VGTFG 413
            YLH++ +   IHRD+KA NILL  + + +I+DFG++       D T +   +  VGT  
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSG 444
           +MAPE +   R +  K+DI+SFG+  +E+ +G
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATG 223

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVK---RLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG V++G+  + E  A+    +  KN     +  +F  E L + +  H ++V+L+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   E    I++ E      L  F+   + +  +           ++  L YL      R
Sbjct: 81  GVITENPVWIIM-ELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 134
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS 426
            +HRD+ A N+L+ S    K+ DFG++R  E D T+   ++      +MAPE +   RF+
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRFT 193
Query: 427 VKSDIFSFGVLVLEIV 442
             SD++ FGV + EI+
Sbjct: 194 SASDVWMFGVCMWEIL 209

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVK---RLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG V++G+  + E  A+    +  KN     +  +F  E L + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   E    I++ E      L  F+   + +  +           ++  L YL      R
Sbjct: 78  GVITENPVWIIM-ELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS 426
            +HRD+ A N+L+ S    K+ DFG++R  E D T+   ++      +MAPE +   RF+
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 427 VKSDIFSFGVLVLEIV 442
             SD++ FGV + EI+
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVK---RLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG V++G+  + E  A+    +  KN     +  +F  E L + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   E    I++ E      L  F+   + +  +           ++  L YL      R
Sbjct: 78  GVITENPVWIIM-ELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS 426
            +HRD+ A N+L+ S    K+ DFG++R  E D T+   ++      +MAPE +   RF+
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 427 VKSDIFSFGVLVLEIV 442
             SD++ FGV + EI+
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 110/225 (48%), Gaps = 17/225 (7%)
Query: 239 IRVATDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNS--KQGEIE---FKNEVL 292
           I++  ++F     LG+G FG V+        +  A+K L K+      ++E    +  VL
Sbjct: 13  IKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 72
Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
            LA  +H  L  +      ++    V E++    L + I    ++  ++    Y     I
Sbjct: 73  SLA-WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAA--EI 128
Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF 412
             GL +LH      I++RDLK  NILLD + + KI+DFGM +  E     + TN   GT 
Sbjct: 129 ILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNEFCGTP 183
Query: 413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE 457
            Y+APE ++  +++   D +SFGVL+ E++ GQ  S F  ++E E
Sbjct: 184 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ--SPFHGQDEEE 226

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVK---RLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG V++G+  + E  A+    +  KN     +  +F  E L + +  H ++V+L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   E    I++ E      L  F+   + +  +           ++  L YL      R
Sbjct: 75  GVITENPVWIIM-ELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 128
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS 426
            +HRD+ A N+L+ S    K+ DFG++R  E D T+   ++      +MAPE +   RF+
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 427 VKSDIFSFGVLVLEIV 442
             SD++ FGV + EI+
Sbjct: 188 SASDVWMFGVCMWEIL 203

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 180
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELR 93
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 94  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 149
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 150 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 200
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 201 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 106/204 (51%), Gaps = 7/204 (3%)
Query: 246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNLV 303
           +++ + +G+G +G V     + N   +A+K++S    Q   +    E+ +L   +H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H  +
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD-TNRVVGTFGYMAPEYVMH 422
              ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+      V T  Y APE +++
Sbjct: 147 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 423 GRFSVKS-DIFSFGVLVLEIVSGQ 445
            +   KS DI+S G ++ E++S +
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
           LL  ++H N++ LL        LE    + +   +  A L++ +      + +T +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KXQKLTDDHVQF 129
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +   
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTG 181
Query: 408 VVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
            V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELR 92
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 93  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 148
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 149 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 199
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 200 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LSK   Q  I  K    E+ 
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSK-PFQSIIHAKRTYRELR 85
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 86  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 141
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 142 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 192
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 193 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELR 69
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 70  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 125
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 126 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 176
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 252 LGQGGFG-AVYKGMLSNGETIAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLGFC 309
           LG G F   V     + G+  AVK + K + +G E   +NE+ +L +++H N+V L    
Sbjct: 30  LGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIY 89
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK-IIEGIARGLLYLHEDSRLRII 368
                  LV + V    L    FD I  +    EK    +I  +   + YLH   R+ I+
Sbjct: 90  ESPNHLYLVMQLVSGGEL----FDRIVEKGFYTEKDASTLIRQVLDAVYYLH---RMGIV 142
Query: 369 HRDLKASNILL---DSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRF 425
           HRDLK  N+L    D E    ISDFG+++   M+      +   GT GY+APE +    +
Sbjct: 143 HRDLKPENLLYYSQDEESKIMISDFGLSK---MEGKGDVMSTACGTPGYVAPEVLAQKPY 199
Query: 426 SVKSDIFSFGVLVLEIVSG 444
           S   D +S GV+   ++ G
Sbjct: 200 SKAVDCWSIGVIAYILLCG 218

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 180
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 181 GYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELR 93
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 94  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 149
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 150 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMX 200
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 201 GXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
           LL  ++H N++ LL        LE    + +   +  A L++ +      + +T +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KXQKLTDDHVQF 129
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +   
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 181
Query: 408 VVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
            V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMA 180
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 181 GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELR 79
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 80  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 135
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 136 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 186
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 106/204 (51%), Gaps = 7/204 (3%)
Query: 246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNLV 303
           +++ + +G+G +G V     + N   +A+K++S    Q   +    E+ +L   +H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            +           +   ++    ++  ++  +  +H++ +     +  I RGL Y+H  +
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD-TNRVVGTFGYMAPEYVMH 422
              ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+      V T  Y APE +++
Sbjct: 147 ---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 423 GRFSVKS-DIFSFGVLVLEIVSGQ 445
            +   KS DI+S G ++ E++S +
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELR 69
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 70  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQF---- 125
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 126 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 176
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 108/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + +   +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 25  KTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELR 83
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 84  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 139
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 140 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 190
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 191 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 18/199 (9%)
Query: 252 LGQGGFGAVY--KGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
           LG G F  V+  K  L+ G+  A+K + K+    +   +NE+ +L +++H N+V L    
Sbjct: 17  LGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK-IIEGIARGLLYLHEDSRLRII 368
                  LV + V    L    FD I    +  EK    +I+ +   + YLHE+    I+
Sbjct: 76  ESTTHYYLVMQLVSGGEL----FDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IV 128
Query: 369 HRDLKASNIL-LDSEMNPK--ISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRF 425
           HRDLK  N+L L  E N K  I+DFG++++    + +   +   GT GY+APE +    +
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVLAQKPY 184
Query: 426 SVKSDIFSFGVLVLEIVSG 444
           S   D +S GV+   ++ G
Sbjct: 185 SKAVDCWSIGVITYILLCG 203

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRN 301
           D+F   ++LG G  G V K        I  ++L     +  I  +   E+ +L       
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +V   G      E  +  E +   SLD  + +    + +  E   K+   + RGL YL E
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLRE 132
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM 421
             + +I+HRD+K SNIL++S    K+ DFG++         S  N  VGT  YMAPE + 
Sbjct: 133 --KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMAPERLQ 186
Query: 422 HGRFSVKSDIFSFGVLVLEIVSGQ 445
              +SV+SDI+S G+ ++E+  G+
Sbjct: 187 GTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMA 180
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 181 GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELR 69
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
           LL  ++H N++ LL        LE    + +   +  A L++ +      + +T +    
Sbjct: 70  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQF 125
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +   
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAG 177
Query: 408 VVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
            V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 178 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 20  KTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 78
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 79  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 134
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 135 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMT 185
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 25/213 (11%)
Query: 245 NFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L + GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 109
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVVGTFG 413
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++ +   + + +   + 
Sbjct: 168 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY- 221
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQ 445
           Y APE +     ++   D++S G ++ E++ GQ
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 110/225 (48%), Gaps = 17/225 (7%)
Query: 239 IRVATDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNS--KQGEIE---FKNEVL 292
           I++  ++F     LG+G FG V+        +  A+K L K+      ++E    +  VL
Sbjct: 12  IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 71
Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
            LA  +H  L  +      ++    V E++    L + I    ++  ++    Y     I
Sbjct: 72  SLA-WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYA--AEI 127
Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF 412
             GL +LH      I++RDLK  NILLD + + KI+DFGM +  E     + TN   GT 
Sbjct: 128 ILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNXFCGTP 182
Query: 413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE 457
            Y+APE ++  +++   D +SFGVL+ E++ GQ  S F  ++E E
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ--SPFHGQDEEE 225

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 20/215 (9%)
Query: 238 TIRVATDNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
           ++ V  D+     +LG+G +G V K   + +G+ +AVKR+       E   +  +L+   
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE---QKRLLMDLD 57
Query: 297 LQHRNL-----VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY-KIIE 350
           +  R +     V   G      +  +  E + + SLD F    I++     E    KI  
Sbjct: 58  ISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAV 116
Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG 410
            I + L +LH  S+L +IHRD+K SN+L+++    K+ DFG++  + +D    D +   G
Sbjct: 117 SIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISG-YLVDDVAKDID--AG 171
Query: 411 TFGYMAPEYV----MHGRFSVKSDIFSFGVLVLEI 441
              YMAPE +        +SVKSDI+S G+ ++E+
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 25/213 (11%)
Query: 245 NFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L + GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 103
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 161
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVVGTFG 413
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++ +   + + +   + 
Sbjct: 162 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY- 215
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQ 445
           Y APE +     ++   D++S G ++ E++ GQ
Sbjct: 216 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 25/213 (11%)
Query: 245 NFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L + GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 109
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVVGTFG 413
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++ +   + + +   + 
Sbjct: 168 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY- 221
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQ 445
           Y APE +     ++   D++S G ++ E++ GQ
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 25/213 (11%)
Query: 245 NFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L + GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 111
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 169
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVVGTFG 413
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++ +   + + +   + 
Sbjct: 170 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY- 223
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQ 445
           Y APE +     ++   D++S G ++ E++ GQ
Sbjct: 224 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 84
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 85  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 140
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 141 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMT 191
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 192 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 80
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 136
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 137 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 187
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 180
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 75
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 76  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 131
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 132 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 182
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 78
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 79  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 134
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 135 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMT 185
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 25/213 (11%)
Query: 245 NFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L + GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 113
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 171
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVVGTFG 413
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++ +   + + +   + 
Sbjct: 172 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY- 225
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQ 445
           Y APE +     ++   D++S G ++ E++ GQ
Sbjct: 226 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 180
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 11/215 (5%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGE-IEFKNEVLLLARLQHRN 301
           + +   +KLG+G +  VYKG        +A+K +    ++G       EV LL  L+H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +V L       K   LV+E++ +  L  ++ D  N  +M   K +  +  + RGL Y H 
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLF--LFQLLRGLAYCH- 117
Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM 421
             R +++HRDLK  N+L++     K++DFG+AR   +  T +  N VV T  Y  P+ ++
Sbjct: 118 --RQKVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVV-TLWYRPPDILL 173
Query: 422 HGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEE 455
               +S + D++  G +  E+ +G+      T EE
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE 208

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 13  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 71
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 72  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 127
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 128 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 178
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 179 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 80
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 136
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 137 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMT 187
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 180
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 80
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 136
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 137 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMT 187
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 78
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 79  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 134
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 135 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 185
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 14  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 72
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 73  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 128
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 129 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 179
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 180 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 85
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 86  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 141
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 142 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 192
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 193 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 85
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 86  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 141
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 142 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 192
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 193 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 180
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 181 GXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 180
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 75
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 76  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 131
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 132 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 182
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 180
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 80
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 136
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 137 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMT 187
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 84
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 85  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 140
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 141 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 191
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 192 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 93
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 94  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 149
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 150 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 200
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 201 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 75
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 76  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 131
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 132 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 182
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 180
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 79
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 80  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 135
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 136 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 186
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 92
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 93  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 148
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 149 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 199
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 200 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 180
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 96
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 97  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 152
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 153 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 203
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 204 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 69
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 70  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 125
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 126 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 176
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 70
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 71  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 126
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 127 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 177
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 178 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 94/196 (47%), Gaps = 12/196 (6%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVK---RLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG V++G+  + E  A+    +  KN     +  +F  E L + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   E    I++ E      L  F+   + +  +           ++  L YL      R
Sbjct: 78  GVITENPVWIIM-ELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS 426
            +HRD+ A N+L+ S    K+ DFG++R  E D T    ++      +MAPE +   RF+
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTXXKASKGKLPIKWMAPESINFRRFT 190
Query: 427 VKSDIFSFGVLVLEIV 442
             SD++ FGV + EI+
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 78
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 79  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 134
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 135 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 185
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 25/213 (11%)
Query: 245 NFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L + GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 154
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 212
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVVGTFG 413
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++ +   + + +   + 
Sbjct: 213 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY- 266
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQ 445
           Y APE +     ++   D++S G ++ E++ GQ
Sbjct: 267 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 70
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 71  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 126
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 127 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 177
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 178 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 75
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 76  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 131
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 132 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-----HTDDEMT 182
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 120/240 (50%), Gaps = 24/240 (10%)
Query: 241 VATDNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVL 292
           +  D++    +LG G F  V K      G     + I  +RLS +S++G    E + EV 
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLS-SSRRGVSREEIEREVN 60
Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
           +L  ++H N++ L      + + +L+ E V    L  F+ +   +E +T ++  + ++ I
Sbjct: 61  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE---KESLTEDEATQFLKQI 117
Query: 353 ARGLLYLHEDSRLRIIHRDLKASNI-LLDSEM-NPKIS--DFGMARLFEMDQTHSDTNRV 408
             G+ YLH     RI H DLK  NI LLD  + NP+I   DFG+A   E     ++   +
Sbjct: 118 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE---AGNEFKNI 171
Query: 409 VGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWN 468
            GT  ++APE V +    +++D++S GV+   ++SG   S F  E + E L   +  N++
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA--SPFLGETKQETLTNISAVNYD 229

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 25/213 (11%)
Query: 245 NFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L + GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 80
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 138
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVVGTFG 413
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++ +   + + +   + 
Sbjct: 139 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY- 192
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQ 445
           Y APE +     ++   D++S G ++ E++ GQ
Sbjct: 193 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 96
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 97  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 152
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 153 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMX 203
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 204 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 25/213 (11%)
Query: 245 NFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L + GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 83
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 141
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVVGTFG 413
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++ +   + + +   + 
Sbjct: 142 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY- 195
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQ 445
           Y APE +     ++   D++S G ++ E++ GQ
Sbjct: 196 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 79
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 80  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 135
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 136 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-----HTDDEMT 186
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 25/213 (11%)
Query: 245 NFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L + GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 94
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 152
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVVGTFG 413
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++ +   + + +   + 
Sbjct: 153 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY- 206
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQ 445
           Y APE +     ++   D++S G ++ E++ GQ
Sbjct: 207 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 73/232 (31%), Positives = 109/232 (46%), Gaps = 33/232 (14%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLS----NGETIAVKRLSKNS--KQGEIEFKN-EVL 292
           R+   +F+    LG+G FG V   MLS      E  AVK L K+   +  ++E    E  
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR 393
Query: 293 LLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYK---- 347
           +LA       +  L  C +  +R+  V E+V    L +         H+    R+K    
Sbjct: 394 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMY---------HIQQVGRFKEPHA 444
Query: 348 --IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
                 IA GL +L       II+RDLK  N++LDSE + KI+DFGM +    D     T
Sbjct: 445 VFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TT 499
Query: 406 NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE 457
               GT  Y+APE + +  +    D ++FGVL+ E+++GQ  + F  E+E E
Sbjct: 500 KXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ--APFEGEDEDE 549

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 25/213 (11%)
Query: 245 NFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L + GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 87
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 145
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVVGTFG 413
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++ +   + + +   + 
Sbjct: 146 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY- 199
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQ 445
           Y APE +     ++   D++S G ++ E++ GQ
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 15/198 (7%)
Query: 252 LGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           LG G FG V+K    + G  +A K +     + + E KNE+ ++ +L H NL++L     
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 311 ERKERILVYEFVPNASLDHFIFDPINRE--HMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
            + + +LV E+V    L    FD I  E  ++T       ++ I  G+ ++H+   + I+
Sbjct: 157 SKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYIL 209
Query: 369 HRDLKASNILL--DSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS 426
           H DLK  NIL         KI DFG+AR +   +         GT  ++APE V +   S
Sbjct: 210 HLDLKPENILCVNRDAKQIKIIDFGLARRY---KPREKLKVNFGTPEFLAPEVVNYDFVS 266
Query: 427 VKSDIFSFGVLVLEIVSG 444
             +D++S GV+   ++SG
Sbjct: 267 FPTDMWSVGVIAYMLLSG 284

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 25/213 (11%)
Query: 245 NFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L + GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 87
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 145
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVVGTFG 413
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++ +   + + +   + 
Sbjct: 146 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY- 199
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQ 445
           Y APE +     ++   D++S G ++ E++ GQ
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVK---RLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG V++G+  + E  A+    +  KN     +  +F  E L + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   E    I++ E      L  F+   + +  +           ++  L YL      R
Sbjct: 78  GVITENPVWIIM-ELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS 426
            +HRD+ A N+L+ +    K+ DFG++R  E D T+   ++      +MAPE +   RF+
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 427 VKSDIFSFGVLVLEIV 442
             SD++ FGV + EI+
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 25/213 (11%)
Query: 245 NFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L + GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 88
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 146
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVVGTFG 413
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++ +   + + +   + 
Sbjct: 147 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY- 200
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQ 445
           Y APE +     ++   D++S G ++ E++ GQ
Sbjct: 201 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 39/218 (17%)
Query: 246 FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHRN 301
           + D   +G G +GAV   +    G  +A+K+L +   Q E+  K    E+ LL  ++H N
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHEN 85
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHF-------------IFDPINREHMTWEKRYKI 348
           ++ LL              F P+ +LD F             +   +  E +  ++   +
Sbjct: 86  VIGLLDV------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFL 133
Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV 408
           +  + +GL Y+H      IIHRDLK  N+ ++ +   KI DFG+AR     Q  S+    
Sbjct: 134 VYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGX 185
Query: 409 VGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
           V T  Y APE +++  R++   DI+S G ++ E+++G+
Sbjct: 186 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVK---RLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG V++G+  + E  A+    +  KN     +  +F  E L + +  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   E    I++ E      L  F+   + +  +           ++  L YL      R
Sbjct: 458 GVITENPVWIIM-ELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS 426
            +HRD+ A N+L+ S    K+ DFG++R  E D T+   ++      +MAPE +   RF+
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 427 VKSDIFSFGVLVLEIV 442
             SD++ FGV + EI+
Sbjct: 571 SASDVWMFGVCMWEIL 586

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 102/201 (50%), Gaps = 18/201 (8%)
Query: 252 LGQGGFGAVYKGMLSNG----ETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRL 305
           LGQG FG V+     +G    +  A+K L K + +    +  K E  +L  + H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 306 -LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGLLYLHEDS 363
              F  E K   L+ +F+    L    F  +++E M  E+  K  +  +A  L +LH   
Sbjct: 92  HYAFQTEGK-LYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLHS-- 144
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
            L II+RDLK  NILLD E + K++DFG+++  E            GT  YMAPE V   
Sbjct: 145 -LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRR 201
Query: 424 RFSVKSDIFSFGVLVLEIVSG 444
             +  +D +SFGVL+ E+++G
Sbjct: 202 GHTQSADWWSFGVLMFEMLTG 222

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 119/237 (50%), Gaps = 24/237 (10%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLA 295
           D++    +LG G F  V K      G     + I  +RLS +S++G    E + EV +L 
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLS-SSRRGVSREEIEREVNILR 70
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            ++H N++ L      + + +L+ E V    L  F+ +   +E +T ++  + ++ I  G
Sbjct: 71  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDG 127
Query: 356 LLYLHEDSRLRIIHRDLKASNI-LLDSEM-NPKIS--DFGMARLFEMDQTHSDTNRVVGT 411
           + YLH     RI H DLK  NI LLD  + NP+I   DFG+A   E     ++   + GT
Sbjct: 128 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE---AGNEFKNIFGT 181
Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWN 468
             ++APE V +    +++D++S GV+   ++SG   S F  E + E L   +  N++
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA--SPFLGETKQETLTNISAVNYD 236

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 25/213 (11%)
Query: 245 NFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L + GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 75
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVVGTFG 413
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++ +   + + +   + 
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY- 187
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQ 445
           Y APE +     ++   D++S G ++ E++ GQ
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 245 NFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHR 300
           N+     +G+G F  V     +  G+ +AVK + K   NS   +  F+ EV ++  L H 
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 66
Query: 301 NLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           N+V+L       K   LV E+     + D+ +     +E     K  +I+  +     Y 
Sbjct: 67  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQ----YC 122
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H+     I+HRDLKA N+LLD++MN KI+DFG +  F      +  +   G+  Y APE 
Sbjct: 123 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG---NKLDTFCGSPPYAAPEL 176
Query: 420 VMHGRFS-VKSDIFSFGVLVLEIVSG 444
               ++   + D++S GV++  +VSG
Sbjct: 177 FQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 104/204 (50%), Gaps = 7/204 (3%)
Query: 246 FSDANKLGQGGFGAVYKGMLSNGET-IAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNLV 303
           ++    +G+G +G V        +T +A+K++S    Q   +    E+ +L R +H N++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            +           +   ++    ++  ++  +  + ++ +     +  I RGL Y+H  +
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN 164
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD-TNRVVGTFGYMAPEYVMH 422
              ++HRDLK SN+L+++  + KI DFG+AR+ + +  H+      V T  Y APE +++
Sbjct: 165 ---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLN 221
Query: 423 GRFSVKS-DIFSFGVLVLEIVSGQ 445
            +   KS DI+S G ++ E++S +
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 42/213 (19%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHRNLVRLLG 307
           +G G +G+V   +   +GE +A+K+LS+   Q EI  K    E+LLL  +QH N++ LL 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLD 90
Query: 308 FCLERKERILVYEFVPNASL----DHFIFDPINREHM--------TWEKRYKIIEGIARG 355
                        F P +SL    D ++  P  +  +        + EK   ++  + +G
Sbjct: 91  V------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKG 138
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV--VGTFG 413
           L Y+H      ++HRDLK  N+ ++ +   KI DFG+AR       H+D      V T  
Sbjct: 139 LKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRW 188
Query: 414 YMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
           Y APE ++    ++   DI+S G ++ E+++G+
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 79
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 80  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 135
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR      T  +  
Sbjct: 136 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMT 186
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 245 NFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHR 300
           N+     +G+G F  V     +  G+ +AVK + K   NS   +  F+ EV ++  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 301 NLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           N+V+L       K   LV E+     + D+ +     +E     K  +I+  +     Y 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ----YC 129
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H+     I+HRDLKA N+LLD++MN KI+DFG +  F      +  +   G+  Y APE 
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG---NKLDTFCGSPPYAAPEL 183
Query: 420 VMHGRFS-VKSDIFSFGVLVLEIVSG 444
               ++   + D++S GV++  +VSG
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 25/213 (11%)
Query: 245 NFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L + GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 76
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 134
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVVGTFG 413
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++ +   + + +   + 
Sbjct: 135 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY- 188
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQ 445
           Y APE +     ++   D++S G ++ E++ GQ
Sbjct: 189 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 25/213 (11%)
Query: 245 NFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L + GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 75
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVVGTFG 413
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++ +   + + +   + 
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY- 187
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQ 445
           Y APE +     ++   D++S G ++ E++ GQ
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 25/213 (11%)
Query: 245 NFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L + GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 79
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 137
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVVGTFG 413
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++ +   + + +   + 
Sbjct: 138 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY- 191
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQ 445
           Y APE +     ++   D++S G ++ E++ GQ
Sbjct: 192 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 22/214 (10%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ-----GEIEFKNEVLL 293
           RV   ++   + LG G FG V  G     G  +AVK L++   +     G+I  + E+  
Sbjct: 12  RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKI--RREIQN 69
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR-YKIIEGI 352
           L   +H ++++L        +  +V E+V    L    FD I +     EK   ++ + I
Sbjct: 70  LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQI 125
Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF 412
             G+ Y H   R  ++HRDLK  N+LLD+ MN KI+DFG++ +    +         G+ 
Sbjct: 126 LSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRXSCGSP 179
Query: 413 GYMAPEYVMHGRFSV--KSDIFSFGVLVLEIVSG 444
            Y APE V+ GR     + DI+S GV++  ++ G
Sbjct: 180 NYAAPE-VISGRLYAGPEVDIWSSGVILYALLCG 212

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 20/213 (9%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ-----GEIEFKNEVLL 293
           RV   ++   + LG G FG V  G     G  +AVK L++   +     G+I  K E+  
Sbjct: 7   RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKI--KREIQN 64
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           L   +H ++++L        +  +V E+V    L  +I      E M  E R ++ + I 
Sbjct: 65  LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM--EAR-RLFQQIL 121
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             + Y H   R  ++HRDLK  N+LLD+ MN KI+DFG++ +    +   D+    G+  
Sbjct: 122 SAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS---CGSPN 175
Query: 414 YMAPEYVMHGRFSV--KSDIFSFGVLVLEIVSG 444
           Y APE V+ GR     + DI+S GV++  ++ G
Sbjct: 176 YAAPE-VISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 245 NFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHR 300
           N+     +G+G F  V     +  G+ +AVK + K   NS   +  F+ EV ++  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 301 NLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           N+V+L       K   LV E+     + D+ +     +E     K  +I+  +     Y 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ----YC 129
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H+     I+HRDLKA N+LLD++MN KI+DFG +  F      +  +   G+  Y APE 
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG---NKLDTFCGSPPYAAPEL 183
Query: 420 VMHGRFS-VKSDIFSFGVLVLEIVSG 444
               ++   + D++S GV++  +VSG
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 110/223 (49%), Gaps = 34/223 (15%)
Query: 239 IRVATDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNS---KQGEIEFKNEVLLL 294
           I +  ++FS    +G+GGFG VY    ++ G+  A+K L K     KQGE    NE ++L
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTW-----------E 343
           + +   +   ++  C+        Y F     L  FI D +N   + +           +
Sbjct: 244 SLVSTGDCPFIV--CMS-------YAFHTPDKLS-FILDLMNGGDLHYHLSQHGVFSEAD 293
Query: 344 KRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
            R+   E I  GL ++H  +R  +++RDLK +NILLD   + +ISD G+A  F   + H+
Sbjct: 294 MRFYAAE-IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 349
Query: 404 DTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
                VGT GYMAPE +  G  +   +D FS G ++ +++ G 
Sbjct: 350 S----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 110/223 (49%), Gaps = 34/223 (15%)
Query: 239 IRVATDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNS---KQGEIEFKNEVLLL 294
           I +  ++FS    +G+GGFG VY    ++ G+  A+K L K     KQGE    NE ++L
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTW-----------E 343
           + +   +   ++  C+        Y F     L  FI D +N   + +           +
Sbjct: 244 SLVSTGDCPFIV--CMS-------YAFHTPDKLS-FILDLMNGGDLHYHLSQHGVFSEAD 293
Query: 344 KRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
            R+   E I  GL ++H  +R  +++RDLK +NILLD   + +ISD G+A  F   + H+
Sbjct: 294 MRFYAAE-IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 349
Query: 404 DTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
                VGT GYMAPE +  G  +   +D FS G ++ +++ G 
Sbjct: 350 S----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 42/213 (19%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHRNLVRLLG 307
           +G G +G+V   +   +GE +A+K+LS+   Q EI  K    E+LLL  +QH N++ LL 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLD 108
Query: 308 FCLERKERILVYEFVPNASL----DHFIFDPINREHM--------TWEKRYKIIEGIARG 355
                        F P +SL    D ++  P  +  +        + EK   ++  + +G
Sbjct: 109 V------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKG 156
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV--VGTFG 413
           L Y+H      ++HRDLK  N+ ++ +   KI DFG+AR       H+D      V T  
Sbjct: 157 LKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRW 206
Query: 414 YMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
           Y APE ++    ++   DI+S G ++ E+++G+
Sbjct: 207 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 25/213 (11%)
Query: 245 NFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L + GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 75
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVVGTFG 413
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++ +   + + +   + 
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY- 187
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQ 445
           Y APE +     ++   D++S G ++ E++ GQ
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 110/223 (49%), Gaps = 34/223 (15%)
Query: 239 IRVATDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNS---KQGEIEFKNEVLLL 294
           I +  ++FS    +G+GGFG VY    ++ G+  A+K L K     KQGE    NE ++L
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 242
Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTW-----------E 343
           + +   +   ++  C+        Y F     L  FI D +N   + +           +
Sbjct: 243 SLVSTGDCPFIV--CMS-------YAFHTPDKLS-FILDLMNGGDLHYHLSQHGVFSEAD 292
Query: 344 KRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
            R+   E I  GL ++H  +R  +++RDLK +NILLD   + +ISD G+A  F   + H+
Sbjct: 293 MRFYAAE-IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 348
Query: 404 DTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
                VGT GYMAPE +  G  +   +D FS G ++ +++ G 
Sbjct: 349 S----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 387

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 110/223 (49%), Gaps = 34/223 (15%)
Query: 239 IRVATDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNS---KQGEIEFKNEVLLL 294
           I +  ++FS    +G+GGFG VY    ++ G+  A+K L K     KQGE    NE ++L
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTW-----------E 343
           + +   +   ++  C+        Y F     L  FI D +N   + +           +
Sbjct: 244 SLVSTGDCPFIV--CMS-------YAFHTPDKLS-FILDLMNGGDLHYHLSQHGVFSEAD 293
Query: 344 KRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS 403
            R+   E I  GL ++H  +R  +++RDLK +NILLD   + +ISD G+A  F   + H+
Sbjct: 294 MRFYAAE-IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 349
Query: 404 DTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
                VGT GYMAPE +  G  +   +D FS G ++ +++ G 
Sbjct: 350 S----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 109/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D+G+AR      T  +  
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR-----HTDDEMT 180
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 73/232 (31%), Positives = 109/232 (46%), Gaps = 33/232 (14%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLS----NGETIAVKRLSKNS--KQGEIEFKN-EVL 292
           R+   +F+    LG+G FG V   MLS      E  AVK L K+   +  ++E    E  
Sbjct: 16  RMKLTDFNFLMVLGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR 72
Query: 293 LLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYK---- 347
           +LA       +  L  C +  +R+  V E+V    L +         H+    R+K    
Sbjct: 73  VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMY---------HIQQVGRFKEPHA 123
Query: 348 --IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
                 IA GL +L       II+RDLK  N++LDSE + KI+DFGM +  E       T
Sbjct: 124 VFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTT 178
Query: 406 NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE 457
               GT  Y+APE + +  +    D ++FGVL+ E+++GQ  + F  E+E E
Sbjct: 179 KXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ--APFEGEDEDE 228

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 98/228 (42%), Gaps = 31/228 (13%)
Query: 244 DNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
           +N      LG G FG V +      G       +AVK L   +   E E   +E+ +++ 
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI--------------------FDPI 335
           L QH N+V LLG C      +++ E+     L +F+                     D  
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 336 NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL 395
           +   +           +A+G+ +L   +    IHRD+ A N+LL +    KI DFG+AR 
Sbjct: 151 DGRPLELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 396 FEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
              D  +           +MAPE +    ++V+SD++S+G+L+ EI S
Sbjct: 208 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 107/219 (48%), Gaps = 23/219 (10%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
           LL  ++H N++ LL        LE    + +   +  A L++ +      + +T +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KSQKLTDDHVQF 129
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+ R      T  +   
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR-----HTDDEMTG 181
Query: 408 VVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
            V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 102/201 (50%), Gaps = 18/201 (8%)
Query: 252 LGQGGFGAVYKGMLSNG----ETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRL 305
           LGQG FG V+     +G    +  A+K L K + +    +  K E  +L  + H  +V+L
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 92
Query: 306 -LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGLLYLHEDS 363
              F  E K   L+ +F+    L    F  +++E M  E+  K  +  +A  L +LH   
Sbjct: 93  HYAFQTEGK-LYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLHS-- 145
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
            L II+RDLK  NILLD E + K++DFG+++  E            GT  YMAPE V   
Sbjct: 146 -LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRR 202
Query: 424 RFSVKSDIFSFGVLVLEIVSG 444
             +  +D +SFGVL+ E+++G
Sbjct: 203 GHTQSADWWSFGVLMFEMLTG 223

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 17/206 (8%)
Query: 245 NFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHR 300
           N+     +G+G F  V     +  G+ +AVK + K   NS   +  F+ EV ++  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 301 NLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           N+V+L       K   LV E+     + D+ +     +E     K  +I+  +     Y 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ----YC 129
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H+     I+HRDLKA N+LLD++MN KI+DFG +  F      +  +   G   Y APE 
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG---NKLDAFCGAPPYAAPEL 183
Query: 420 VMHGRFS-VKSDIFSFGVLVLEIVSG 444
               ++   + D++S GV++  +VSG
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 102/201 (50%), Gaps = 18/201 (8%)
Query: 252 LGQGGFGAVYKGMLSNG----ETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRL 305
           LGQG FG V+     +G    +  A+K L K + +    +  K E  +L  + H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 306 -LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI-IEGIARGLLYLHEDS 363
              F  E K   L+ +F+    L    F  +++E M  E+  K  +  +A  L +LH   
Sbjct: 92  HYAFQTEGK-LYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLHS-- 144
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
            L II+RDLK  NILLD E + K++DFG+++  E            GT  YMAPE V   
Sbjct: 145 -LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRR 201
Query: 424 RFSVKSDIFSFGVLVLEIVSG 444
             +  +D +SFGVL+ E+++G
Sbjct: 202 GHTQSADWWSFGVLMFEMLTG 222

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 25/213 (11%)
Query: 245 NFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L + GE +A+K++ ++ +     FKN E+ ++ +L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNI 75
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVVGTFG 413
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++ +   + + +   + 
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY- 187
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQ 445
           Y APE +     ++   D++S G ++ E++ GQ
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 119/239 (49%), Gaps = 22/239 (9%)
Query: 241 VATDNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSK----NSKQG--EIEFKNEVLL 293
           +  D++    +LG G F  V K      G+  A K + K    +S++G    E + EV +
Sbjct: 23  MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNI 82
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           L  ++H N++ L      + + +L+ E V    L  F+ +   +E +T ++  + ++ I 
Sbjct: 83  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE---KESLTEDEATQFLKQIL 139
Query: 354 RGLLYLHEDSRLRIIHRDLKASNI-LLDSEM-NPKIS--DFGMARLFEMDQTHSDTNRVV 409
            G+ YLH     RI H DLK  NI LLD  + NP+I   DFG+A   E     ++   + 
Sbjct: 140 DGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE---AGNEFKNIF 193
Query: 410 GTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWN 468
           GT  ++APE V +    +++D++S GV+   ++SG   S F  E + E L   +  N++
Sbjct: 194 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA--SPFLGETKQETLTNISAVNYD 250

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 101/205 (49%), Gaps = 9/205 (4%)
Query: 242 ATDNFSDANKLGQGGFG-AVYKGMLSNGETIAVKRL--SKNSKQGEIEFKNEVLLLARLQ 298
           + + +    K+G+G FG A+      +G    +K +  S+ S +   E + EV +LA ++
Sbjct: 22  SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK 81
Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H N+V+      E     +V ++     L    F  IN +     +  +I++   +  L 
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDL----FKRINAQKGVLFQEDQILDWFVQICLA 137
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
           L      +I+HRD+K+ NI L  +   ++ DFG+AR+  ++ T       +GT  Y++PE
Sbjct: 138 LKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYYLSPE 195
Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVS 443
              +  ++ KSDI++ G ++ E+ +
Sbjct: 196 ICENKPYNNKSDIWALGCVLYELCT 220

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 245 NFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHR 300
           N+     +G+G F  V     +  G+ +AV+ + K   NS   +  F+ EV ++  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 301 NLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           N+V+L       K   LV E+     + D+ +     +E     K  +I+  +     Y 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ----YC 129
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H+     I+HRDLKA N+LLD++MN KI+DFG +  F      +  +   G+  Y APE 
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG---NKLDEFCGSPPYAAPEL 183
Query: 420 VMHGRFS-VKSDIFSFGVLVLEIVSG 444
               ++   + D++S GV++  +VSG
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVK---RLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLL 306
           +G+G FG V++G+  + E  A+    +  KN     +  +F  E L + +  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G   E    I++ E      L  F+   + +  +           ++  L YL      R
Sbjct: 458 GVITENPVWIIM-ELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS 426
            +HRD+ A N+L+ +    K+ DFG++R  E D T+   ++      +MAPE +   RF+
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 427 VKSDIFSFGVLVLEIV 442
             SD++ FGV + EI+
Sbjct: 571 SASDVWMFGVCMWEIL 586

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 244 DNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR-- 300
           D+F   ++LG G  G V+K     +G  +A K +    K      +N+++   ++ H   
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA---IRNQIIRELQVLHECN 124
Query: 301 --NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
              +V   G      E  +  E +   SLD  +        +  +   K+   + +GL Y
Sbjct: 125 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTY 181
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
           L E  + +I+HRD+K SNIL++S    K+ DFG++         S  N  VGT  YM+PE
Sbjct: 182 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPE 235
Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
            +    +SV+SDI+S G+ ++E+  G+
Sbjct: 236 RLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 17/206 (8%)
Query: 245 NFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHR 300
           N+     +G+G F  V     +  G  +A+K + K   N    +  F+ EV ++  L H 
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHP 71
Query: 301 NLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           N+V+L       K   L+ E+     + D+ +     +E     K  +I+  +     Y 
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ----YC 127
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H+    RI+HRDLKA N+LLD++MN KI+DFG +  F +       +   G+  Y APE 
Sbjct: 128 HQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDTFCGSPPYAAPEL 181
Query: 420 VMHGRFS-VKSDIFSFGVLVLEIVSG 444
               ++   + D++S GV++  +VSG
Sbjct: 182 FQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 240 RVATDNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSKN--SKQGEIEFKN-EVLLLA 295
           + +  +F     LG G FG V+      NG   A+K L K    +  ++E  N E L+L+
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IAR 354
            + H  ++R+ G   + ++  ++ +++    L    F  + +         K     +  
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL----FSLLRKSQRFPNPVAKFYAAEVCL 117
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY 414
            L YLH      II+RDLK  NILLD   + KI+DFG A+ +  D T+     + GT  Y
Sbjct: 118 ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-YVPDVTYX----LCGTPDY 169
Query: 415 MAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           +APE V    ++   D +SFG+L+ E+++G
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 245 NFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHR 300
           N+     +G+G F  V     +  G+ +AV+ + K   NS   +  F+ EV ++  L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHP 73
Query: 301 NLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           N+V+L       K   LV E+     + D+ +     +E     K  +I+  +     Y 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ----YC 129
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H+     I+HRDLKA N+LLD++MN KI+DFG +  F      +  +   G+  Y APE 
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG---NKLDTFCGSPPYAAPEL 183
Query: 420 VMHGRFS-VKSDIFSFGVLVLEIVSG 444
               ++   + D++S GV++  +VSG
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 245 NFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHR 300
           N+     +G+G F  V     +  G  +A+K + K   N    +  F+ EV ++  L H 
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHP 74
Query: 301 NLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           N+V+L       K   L+ E+     + D+ +     +E     K  +I+  +     Y 
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ----YC 130
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H+    RI+HRDLKA N+LLD++MN KI+DFG +  F +       +   G   Y APE 
Sbjct: 131 HQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---GKLDAFCGAPPYAAPEL 184
Query: 420 VMHGRFS-VKSDIFSFGVLVLEIVSG 444
               ++   + D++S GV++  +VSG
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 20/216 (9%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLA 295
           +   V  D+     +LG+G +G V K   + +G+ +AVKR+       E   +  +L+  
Sbjct: 44  QNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE---QKRLLMDL 100
Query: 296 RLQHRNL-----VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY-KII 349
            +  R +     V   G      +  +  E + + SLD F    I++     E    KI 
Sbjct: 101 DISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIA 159
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
             I + L +LH  S+L +IHRD+K SN+L+++    K+ DFG++  + +D      +   
Sbjct: 160 VSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISG-YLVDSVAKTID--A 214
Query: 410 GTFGYMAPEYV----MHGRFSVKSDIFSFGVLVLEI 441
           G   YMAPE +        +SVKSDI+S G+ ++E+
Sbjct: 215 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 250

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 115/237 (48%), Gaps = 21/237 (8%)
Query: 218 KLEDENVEETIAKSLQ-FDFETIRVAT---DNFSDANKLGQGGFGAVYK-GMLSNGETIA 272
           KLE+  ++E   K L+ F  +  +V     D+F   ++LG G  G V+K     +G  +A
Sbjct: 3   KLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMA 62
Query: 273 VKRLSKNSKQGEIEFKNEVLLLARLQHR----NLVRLLGFCLERKERILVYEFVPNASLD 328
            K +    K      +N+++   ++ H      +V   G      E  +  E +   SLD
Sbjct: 63  RKLIHLEIKPA---IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 119
Query: 329 HFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKIS 388
             +     R  +  +   K+   + +GL YL E  + +I+HRD+K SNIL++S    K+ 
Sbjct: 120 Q-VLKKAGR--IPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLC 174
Query: 389 DFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           DFG++         S  N  VGT  YM+PE +    +SV+SDI+S G+ ++E+  G+
Sbjct: 175 DFGVSGQL----IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS--KNSKQGEIEFKNEVLLLARLQH 299
           TD +     +G+G F  V + + L  G   A K ++  K S +   + + E  +   L+H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            N+VRL     E     LV++ V    L     D + RE+ +       I+ I   +L+ 
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAVLHC 119
Query: 360 HEDSRLRIIHRDLKASNILLDSEMN---PKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
           H+   + ++HRDLK  N+LL S+      K++DFG+A   + DQ         GT GY++
Sbjct: 120 HQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQ--QAWFGFAGTPGYLS 174
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           PE +    +    DI++ GV++  ++ G
Sbjct: 175 PEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 110/213 (51%), Gaps = 25/213 (11%)
Query: 245 NFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L + GE +A+K++     QG+  FKN E+ ++ +L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QGK-AFKNRELQIMRKLDHCNI 75
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVVGTFG 413
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++ +   + + +   + 
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY- 187
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQ 445
           Y APE +     ++   D++S G ++ E++ GQ
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 108/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DF +AR      T  +  
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR-----HTDDEMT 180
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 110/213 (51%), Gaps = 25/213 (11%)
Query: 245 NFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L + GE +A+K++     QG+  FKN E+ ++ +L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QGK-AFKNRELQIMRKLDHCNI 75
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVVGTFG 413
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++ +   + + +   + 
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRY- 187
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQ 445
           Y APE +     ++   D++S G ++ E++ GQ
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 110/213 (51%), Gaps = 25/213 (11%)
Query: 245 NFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKN-EVLLLARLQHRNL 302
           +++D   +G G FG VY+  L + GE +A+K++     QG+  FKN E+ ++ +L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QGK-AFKNRELQIMRKLDHCNI 75
Query: 303 VRLLGFCL---ERKERI---LVYEFVPNASLDHFIFDPINREHMTWEKRYK--IIEGIAR 354
           VRL  F     E+K+ +   LV ++VP     + +    +R   T    Y    +  + R
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATV--YRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVVGTFG 413
            L Y+H      I HRD+K  N+LLD +    K+ DFG A+  ++ +   + + +   + 
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXICSRY- 187
Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQ 445
           Y APE +     ++   D++S G ++ E++ GQ
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE--FKNEVLLLARLQHR 300
           + +    K+G+G +G V+K      G+ +A+K+  ++     I+     E+ +L +L+H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINR------EHMTWEKRYKIIEGIAR 354
           NLV LL     ++   LV+E+      DH +   ++R      EH+     ++ ++ +  
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYC-----DHTVLHELDRYQRGVPEHLVKSITWQTLQAVN- 116
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY 414
              + H+ +    IHRD+K  NIL+      K+ DFG ARL      + D    V T  Y
Sbjct: 117 ---FCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--VATRWY 168
Query: 415 MAPEYVM-HGRFSVKSDIFSFGVLVLEIVSG 444
            +PE ++   ++    D+++ G +  E++SG
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 11/209 (5%)
Query: 239 IRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLAR 296
           + +  D+F   ++LG G  G V+K        +  ++L     +  I  +   E+ +L  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
                +V   G      E  +  E +   SLD  +     R  +  +   K+   + +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGR--IPEQILGKVSIAVIKGL 117
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            YL E  + +I+HRD+K SNIL++S    K+ DFG++         S  N  VGT  YM+
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMS 171
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           PE +    +SV+SDI+S G+ ++E+  G+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 104/231 (45%), Gaps = 32/231 (13%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           +G+G FG V++G    GE +AVK  S   ++     + E+     L+H N+   LGF   
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENI---LGFIAA 104
Query: 312 -------RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-- 362
                    +  LV ++  + SL    FD +NR  +T E   K+    A GL +LH +  
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 363 ---SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE--MDQTHSDTNRVVGTFGYMAP 417
               +  I HRDLK+ NIL+       I+D G+A   +   D      N  VGT  YMAP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 418 EYV------MHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTY 462
           E +       H     ++DI++ G++  EI    +R S G   E   L  Y
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIA---RRCSIGGIHEDYQLPYY 268

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 104/231 (45%), Gaps = 32/231 (13%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           +G+G FG V++G    GE +AVK  S   ++     + E+     L+H N+   LGF   
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENI---LGFIAA 66
Query: 312 -------RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-- 362
                    +  LV ++  + SL    FD +NR  +T E   K+    A GL +LH +  
Sbjct: 67  DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 122
Query: 363 ---SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE--MDQTHSDTNRVVGTFGYMAP 417
               +  I HRDLK+ NIL+       I+D G+A   +   D      N  VGT  YMAP
Sbjct: 123 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 182
Query: 418 EYV------MHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTY 462
           E +       H     ++DI++ G++  EI    +R S G   E   L  Y
Sbjct: 183 EVLDDSINMKHFESFKRADIYAMGLVFWEIA---RRCSIGGIHEDYQLPYY 230

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 11/209 (5%)
Query: 239 IRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLAR 296
           + +  D+F   ++LG G  G V+K        +  ++L     +  I  +   E+ +L  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
                +V   G      E  +  E +   SLD  +     R  +  +   K+   + +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGR--IPEQILGKVSIAVIKGL 117
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            YL E  + +I+HRD+K SNIL++S    K+ DFG++         S  N  VGT  YM+
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMS 171
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           PE +    +SV+SDI+S G+ ++E+  G+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 11/209 (5%)
Query: 239 IRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLAR 296
           + +  D+F   ++LG G  G V+K        +  ++L     +  I  +   E+ +L  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
                +V   G      E  +  E +   SLD  +     R  +  +   K+   + +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGR--IPEQILGKVSIAVIKGL 117
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            YL E  + +I+HRD+K SNIL++S    K+ DFG++         S  N  VGT  YM+
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMS 171
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           PE +    +SV+SDI+S G+ ++E+  G+
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 119/247 (48%), Gaps = 43/247 (17%)
Query: 215 GKLKLEDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAV 273
           GKLK+  E           +DF       ++  D  ++G+G +G+V K +   +G+ +AV
Sbjct: 7   GKLKISPEQ---------HWDF-----TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAV 52
Query: 274 KRLSKNSKQGEIEFKNEVLLLARLQHRN-----LVRLLGFCLERKERILVYEFVPNASLD 328
           KR+     + E   + ++L+   +  R+     +V+  G      +  +  E + + S D
Sbjct: 53  KRIRSTVDEKE---QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFD 108
Query: 329 HF------IFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE 382
            F      + D +  E +      KI     + L +L E+  L+IIHRD+K SNILLD  
Sbjct: 109 KFYKYVYSVLDDVIPEEILG----KITLATVKALNHLKEN--LKIIHRDIKPSNILLDRS 162
Query: 383 MNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV----MHGRFSVKSDIFSFGVLV 438
            N K+ DFG++   ++  + + T R  G   YMAPE +        + V+SD++S G+ +
Sbjct: 163 GNIKLCDFGISG--QLVDSIAKT-RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITL 219
Query: 439 LEIVSGQ 445
            E+ +G+
Sbjct: 220 YELATGR 226

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 104/231 (45%), Gaps = 32/231 (13%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           +G+G FG V++G    GE +AVK  S   ++     + E+     L+H N+   LGF   
Sbjct: 37  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENI---LGFIAA 91
Query: 312 -------RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-- 362
                    +  LV ++  + SL    FD +NR  +T E   K+    A GL +LH +  
Sbjct: 92  DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 147
Query: 363 ---SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE--MDQTHSDTNRVVGTFGYMAP 417
               +  I HRDLK+ NIL+       I+D G+A   +   D      N  VGT  YMAP
Sbjct: 148 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 207
Query: 418 EYV------MHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTY 462
           E +       H     ++DI++ G++  EI    +R S G   E   L  Y
Sbjct: 208 EVLDDSINMKHFESFKRADIYAMGLVFWEIA---RRCSIGGIHEDYQLPYY 255

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 23/219 (10%)
Query: 238 TIRVATD------NFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSK---NSKQGEIEF 287
           +I  ATD      N+     +G+G F  V     +  G  +AVK + K   N    +  F
Sbjct: 3   SITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLF 62
Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRY 346
           + EV ++  L H N+V+L       K   LV E+     + D+ +     +E     K  
Sbjct: 63  R-EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR 121
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
           +I+  +     Y H+     I+HRDLKA N+LLD +MN KI+DFG +  F +    +  +
Sbjct: 122 QIVSAVQ----YCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVG---NKLD 171
Query: 407 RVVGTFGYMAPEYVMHGRFS-VKSDIFSFGVLVLEIVSG 444
              G+  Y APE     ++   + D++S GV++  +VSG
Sbjct: 172 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 104/231 (45%), Gaps = 32/231 (13%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           +G+G FG V++G    GE +AVK  S   ++     + E+     L+H N+   LGF   
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENI---LGFIAA 71
Query: 312 -------RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-- 362
                    +  LV ++  + SL    FD +NR  +T E   K+    A GL +LH +  
Sbjct: 72  DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 127
Query: 363 ---SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE--MDQTHSDTNRVVGTFGYMAP 417
               +  I HRDLK+ NIL+       I+D G+A   +   D      N  VGT  YMAP
Sbjct: 128 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 187
Query: 418 EYV------MHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTY 462
           E +       H     ++DI++ G++  EI    +R S G   E   L  Y
Sbjct: 188 EVLDDSINMKHFESFKRADIYAMGLVFWEIA---RRCSIGGIHEDYQLPYY 235

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 104/231 (45%), Gaps = 32/231 (13%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           +G+G FG V++G    GE +AVK  S   ++     + E+     L+H N+   LGF   
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENI---LGFIAA 65
Query: 312 -------RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-- 362
                    +  LV ++  + SL    FD +NR  +T E   K+    A GL +LH +  
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 363 ---SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE--MDQTHSDTNRVVGTFGYMAP 417
               +  I HRDLK+ NIL+       I+D G+A   +   D      N  VGT  YMAP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 418 EYV------MHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTY 462
           E +       H     ++DI++ G++  EI    +R S G   E   L  Y
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIA---RRCSIGGIHEDYQLPYY 229

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 104/231 (45%), Gaps = 32/231 (13%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           +G+G FG V++G    GE +AVK  S   ++     + E+     L+H N+   LGF   
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENI---LGFIAA 68
Query: 312 -------RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-- 362
                    +  LV ++  + SL    FD +NR  +T E   K+    A GL +LH +  
Sbjct: 69  DNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 124
Query: 363 ---SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE--MDQTHSDTNRVVGTFGYMAP 417
               +  I HRDLK+ NIL+       I+D G+A   +   D      N  VGT  YMAP
Sbjct: 125 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 184
Query: 418 EYV------MHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTY 462
           E +       H     ++DI++ G++  EI    +R S G   E   L  Y
Sbjct: 185 EVLDDSINMKHFESFKRADIYAMGLVFWEIA---RRCSIGGIHEDYQLPYY 232

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 108/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI  FG+AR      T  +  
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR-----HTDDEMT 180
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 110/224 (49%), Gaps = 27/224 (12%)
Query: 236 FETIRVATDNFSDANK------LGQGGFGAVYKGMLSN-GETIAVKRLSK---NSKQGEI 285
           F ++ VA   F+   +      +G G  G V     +  G  +AVK+LS+   N    + 
Sbjct: 10  FYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKR 69
Query: 286 EFKNEVLLLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFIFDPINREHM 340
            ++ E++LL  + H+N++ LL        LE  + + +   + +A+L   I   ++ E M
Sbjct: 70  AYR-ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERM 128
Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           ++     ++  +  G+ +LH      IIHRDLK SNI++ S+   KI DFG+AR      
Sbjct: 129 SY-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAC 177
Query: 401 THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           T+      V T  Y APE ++   ++   DI+S G ++ E+V G
Sbjct: 178 TNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 108/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D G+AR      T  +  
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR-----HTDDEMT 180
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 20/213 (9%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ-----GEIEFKNEVLL 293
           RV   ++   + LG G FG V  G     G  +AVK L++   +     G+I  K E+  
Sbjct: 7   RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKI--KREIQN 64
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           L   +H ++++L        +  +V E+V    L  +I      E M  E R ++ + I 
Sbjct: 65  LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM--EAR-RLFQQIL 121
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
             + Y H   R  ++HRDLK  N+LLD+ MN KI+DFG++ +   D     T+   G+  
Sbjct: 122 SAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTS--CGSPN 175
Query: 414 YMAPEYVMHGRFSV--KSDIFSFGVLVLEIVSG 444
           Y APE V+ GR     + DI+S GV++  ++ G
Sbjct: 176 YAAPE-VISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 239 IRVATDNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL 297
           + +  D+F   ++LG G  G V+K     +G  +A K +    K      +N+++   ++
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA---IRNQIIRELQV 57
Query: 298 QHR----NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
            H      +V   G      E  +  E +   SLD  +     R  +  +   K+   + 
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGR--IPEQILGKVSIAVI 114
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
           +GL YL E  + +I+HRD+K SNIL++S    K+ DFG++         S  N  VGT  
Sbjct: 115 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRS 168
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           YM+PE +    +SV+SDI+S G+ ++E+  G+
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 239 IRVATDNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL 297
           + +  D+F   ++LG G  G V+K     +G  +A K +    K      +N+++   ++
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA---IRNQIIRELQV 57
Query: 298 QHR----NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
            H      +V   G      E  +  E +   SLD  +     R  +  +   K+   + 
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGR--IPEQILGKVSIAVI 114
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
           +GL YL E  + +I+HRD+K SNIL++S    K+ DFG++         S  N  VGT  
Sbjct: 115 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRS 168
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           YM+PE +    +SV+SDI+S G+ ++E+  G+
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 252 LGQGGFGAVYKGMLSNGET-------IAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           LG+GGF   ++  +S+ +T       I  K L     Q E +   E+ +   L H+++V 
Sbjct: 29  LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAHQHVVG 85
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
             GF  +     +V E     SL         R+ +T  +    +  I  G  YLH   R
Sbjct: 86  FHGFFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLH---R 139
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
            R+IHRDLK  N+ L+ ++  KI DFG+A   E D     T  + GT  Y+APE +    
Sbjct: 140 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKG 197
Query: 425 FSVKSDIFSFGVLVLEIVSGQ 445
            S + D++S G ++  ++ G+
Sbjct: 198 HSFEVDVWSIGCIMYTLLVGK 218

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 252 LGQGGFGAVYKGMLSNGET-------IAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           LG+GGF   ++  +S+ +T       I  K L     Q E +   E+ +   L H+++V 
Sbjct: 25  LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAHQHVVG 81
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
             GF  +     +V E     SL         R+ +T  +    +  I  G  YLH   R
Sbjct: 82  FHGFFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLH---R 135
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
            R+IHRDLK  N+ L+ ++  KI DFG+A   E D     T  + GT  Y+APE +    
Sbjct: 136 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKG 193
Query: 425 FSVKSDIFSFGVLVLEIVSGQ 445
            S + D++S G ++  ++ G+
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGK 214

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 252 LGQGGFGAVYKGMLSNGET-------IAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           LG+GGF   ++  +S+ +T       I  K L     Q E +   E+ +   L H+++V 
Sbjct: 25  LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAHQHVVG 81
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
             GF  +     +V E     SL         R+ +T  +    +  I  G  YLH   R
Sbjct: 82  FHGFFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLH---R 135
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
            R+IHRDLK  N+ L+ ++  KI DFG+A   E D     T  + GT  Y+APE +    
Sbjct: 136 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKG 193
Query: 425 FSVKSDIFSFGVLVLEIVSGQ 445
            S + D++S G ++  ++ G+
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGK 214

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 20/216 (9%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGEIEFKNEVLLLA 295
           E   V  D+     +LG+G +G V K   + +G+  AVKR+       E   +  +L   
Sbjct: 27  ENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQE---QKRLLXDL 83
Query: 296 RLQHRNL-----VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY-KII 349
            +  R +     V   G  L R+  + +   + + SLD F    I++     E    KI 
Sbjct: 84  DISXRTVDCPFTVTFYG-ALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIA 142
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
             I + L +LH  S+L +IHRD+K SN+L+++    K  DFG++  + +D    D +   
Sbjct: 143 VSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISG-YLVDDVAKDID--A 197
Query: 410 GTFGYMAPEYV----MHGRFSVKSDIFSFGVLVLEI 441
           G   Y APE +        +SVKSDI+S G+  +E+
Sbjct: 198 GCKPYXAPERINPELNQKGYSVKSDIWSLGITXIEL 233

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 30/225 (13%)
Query: 244 DNFSDANKLGQGGFGAVYK----GMLSN--GETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
           +  S    LG G FG V +    G++ +    T+AVK L  ++   E E   +E+ +L+ 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII------ 349
           L  H N+V LLG C      +++ E+     L +F+     R+     K    I      
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRR--KRDSFICSKTSPAIMEDDEL 163
Query: 350 -----------EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM 398
                        +A+G+ +L   +    IHRDL A NILL      KI DFG+AR  + 
Sbjct: 164 ALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARHIKN 220
Query: 399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           D  +           +MAPE + +  ++ +SD++S+G+ + E+ S
Sbjct: 221 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           LG+GGF   Y+   +   E  A K + K+       + +   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTW-EKRYKIIEGIARGLLYLHEDSRLR 366
           F  +     +V E     SL         R+ +T  E RY + + I +G+ YLH +   R
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTI-QGVQYLHNN---R 162
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS 426
           +IHRDLK  N+ L+ +M+ KI DFG+A   E D     T  + GT  Y+APE +     S
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT--LCGTPNYIAPEVLCKKGHS 220
Query: 427 VKSDIFSFGVLVLEIVSGQ 445
            + DI+S G ++  ++ G+
Sbjct: 221 FEVDIWSLGCILYTLLVGK 239

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSNGET-IAVKRLSKNSKQG-EIEFKNEVLLL 294
           E IR   D F D   LG G F  V        +  +A+K ++K + +G E   +NE+ +L
Sbjct: 14  EDIRDIYD-FRDV--LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVL 70
Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY-KIIEGIA 353
            +++H N+V L           L+ + V    L    FD I  +    E+   ++I  + 
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVL 126
Query: 354 RGLLYLHEDSRLRIIHRDLKASNIL---LDSEMNPKISDFGMARLFEMDQTHSDTNRVVG 410
             + YLH+   L I+HRDLK  N+L   LD +    ISDFG+++   M+   S  +   G
Sbjct: 127 DAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACG 180
Query: 411 TFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           T GY+APE +    +S   D +S GV+   ++ G
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSNGET-IAVKRLSKNSKQG-EIEFKNEVLLL 294
           E IR   D F D   LG G F  V        +  +A+K ++K + +G E   +NE+ +L
Sbjct: 14  EDIRDIYD-FRDV--LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 70
Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY-KIIEGIA 353
            +++H N+V L           L+ + V    L    FD I  +    E+   ++I  + 
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVL 126
Query: 354 RGLLYLHEDSRLRIIHRDLKASNIL---LDSEMNPKISDFGMARLFEMDQTHSDTNRVVG 410
             + YLH+   L I+HRDLK  N+L   LD +    ISDFG+++   M+   S  +   G
Sbjct: 127 DAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACG 180
Query: 411 TFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           T GY+APE +    +S   D +S GV+   ++ G
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 30/225 (13%)
Query: 244 DNFSDANKLGQGGFGAVYK----GMLSN--GETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
           +  S    LG G FG V +    G++ +    T+AVK L  ++   E E   +E+ +L+ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII------ 349
           L  H N+V LLG C      +++ E+     L +F+     R+     K    I      
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRR--KRDSFICSKTSPAIMEDDEL 140
Query: 350 -----------EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM 398
                        +A+G+ +L   +    IHRDL A NILL      KI DFG+AR  + 
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           D  +           +MAPE + +  ++ +SD++S+G+ + E+ S
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 108/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D G+AR      T  +  
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR-----HTDDEMT 180
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 30/225 (13%)
Query: 244 DNFSDANKLGQGGFGAVYK----GMLSN--GETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
           +  S    LG G FG V +    G++ +    T+AVK L  ++   E E   +E+ +L+ 
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII------ 349
           L  H N+V LLG C      +++ E+     L +F+     R+     K    I      
Sbjct: 99  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRR--KRDSFICSKTSPAIMEDDEL 156
Query: 350 -----------EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM 398
                        +A+G+ +L   +    IHRDL A NILL      KI DFG+AR  + 
Sbjct: 157 ALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKN 213
Query: 399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           D  +           +MAPE + +  ++ +SD++S+G+ + E+ S
Sbjct: 214 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 30/225 (13%)
Query: 244 DNFSDANKLGQGGFGAVYK----GMLSN--GETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
           +  S    LG G FG V +    G++ +    T+AVK L  ++   E E   +E+ +L+ 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII------ 349
           L  H N+V LLG C      +++ E+     L +F+     R+     K    I      
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRR--KRDSFICSKTSPAIMEDDEL 163
Query: 350 -----------EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM 398
                        +A+G+ +L   +    IHRDL A NILL      KI DFG+AR  + 
Sbjct: 164 ALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKN 220
Query: 399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           D  +           +MAPE + +  ++ +SD++S+G+ + E+ S
Sbjct: 221 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSNGET-IAVKRLSKNSKQG-EIEFKNEVLLL 294
           E IR   D F D   LG G F  V        +  +A+K ++K + +G E   +NE+ +L
Sbjct: 14  EDIRDIYD-FRDV--LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVL 70
Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY-KIIEGIA 353
            +++H N+V L           L+ + V    L    FD I  +    E+   ++I  + 
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVL 126
Query: 354 RGLLYLHEDSRLRIIHRDLKASNIL---LDSEMNPKISDFGMARLFEMDQTHSDTNRVVG 410
             + YLH+   L I+HRDLK  N+L   LD +    ISDFG+++   M+   S  +   G
Sbjct: 127 DAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACG 180
Query: 411 TFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           T GY+APE +    +S   D +S GV+   ++ G
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 103/200 (51%), Gaps = 22/200 (11%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVF 92
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++   Y+++ GI     +LH    
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-LLYQMLVGIK----HLHSAG- 146
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
             IIHRDLK SNI++ S+   KI DFG+AR      +   T  VV  + Y APE ++   
Sbjct: 147 --IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRY-YRAPEVILGMG 201
Query: 425 FSVKSDIFSFGVLVLEIVSG 444
           +    DI+S GV++ E++ G
Sbjct: 202 YKENVDIWSVGVIMGEMIKG 221

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 108/220 (49%), Gaps = 25/220 (11%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVL 292
           +TI    + + + + +G G +G+V        G  +AVK+LS+   Q  I  K    E+ 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 73
Query: 293 LLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRY 346
           LL  ++H N++ LL        LE    + +   +  A L++ +    +  +H+ +    
Sbjct: 74  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF---- 129
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI D G+AR      T  +  
Sbjct: 130 -LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR-----HTDDEMT 180
Query: 407 RVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 17/207 (8%)
Query: 244 DNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR-- 300
           D+F   ++LG G  G V+K     +G  +A K +    K      +N+++   ++ H   
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA---IRNQIIRELQVLHECN 65
Query: 301 --NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
              +V   G      E  +  E +   SLD  +     R  +  +   K+   + +GL Y
Sbjct: 66  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGR--IPEQILGKVSIAVIKGLTY 122
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
           L E  + +I+HRD+K SNIL++S    K+ DFG++    +D+     N  VGT  YM+PE
Sbjct: 123 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDEM---ANEFVGTRSYMSPE 176
Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
            +    +SV+SDI+S G+ ++E+  G+
Sbjct: 177 RLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 23/207 (11%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG---EIEFKNEVLLLARLQHRNLVRLLGF 308
           +G+G +G V++G L +GE++AVK  S   +Q    E E  N VLL    +H N++  +  
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTVLL----RHDNILGFIAS 70
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-----S 363
            +  +        + +      ++D + R+ +      ++    A GL +LH +      
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQG 130
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD--TNRVVGTFGYMAPEYVM 421
           +  I HRD K+ N+L+ S +   I+D G+A +      + D   N  VGT  YMAPE V+
Sbjct: 131 KPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPE-VL 189
Query: 422 HGRFSVK-------SDIFSFGVLVLEI 441
             +           +DI++FG+++ EI
Sbjct: 190 DEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 22/200 (11%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVF 92
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++     ++  +  G+ +LH    
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-----LLYQMLVGIKHLHSAG- 146
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
             IIHRDLK SNI++ S+   KI DFG+AR      +   T  VV  + Y APE ++   
Sbjct: 147 --IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRY-YRAPEVILGMG 201
Query: 425 FSVKSDIFSFGVLVLEIVSG 444
           +    DI+S GV++ E++ G
Sbjct: 202 YKENVDIWSVGVIMGEMIKG 221

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 30/225 (13%)
Query: 244 DNFSDANKLGQGGFGAVYK----GMLSN--GETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
           +  S    LG G FG V +    G++ +    T+AVK L  ++   E E   +E+ +L+ 
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII------ 349
           L  H N+V LLG C      +++ E+     L +F+     R+     K    I      
Sbjct: 101 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRR--KRDSFICSKTSPAIMEDDEL 158
Query: 350 -----------EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM 398
                        +A+G+ +L   +    IHRDL A NILL      KI DFG+AR  + 
Sbjct: 159 ALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKN 215
Query: 399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           D  +           +MAPE + +  ++ +SD++S+G+ + E+ S
Sbjct: 216 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 71/230 (30%), Positives = 110/230 (47%), Gaps = 13/230 (5%)
Query: 244 DNFSDANKLGQGGFGAVY-KGMLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRN 301
           D F    KLG G FG V+     S+G    +K ++K+  Q  +E  + E+ +L  L H N
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY-KIIEGIARGLLYLH 360
           ++++     +     +V E      L   I     R     E    ++++ +   L Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 361 EDSRLRIIHRDLKASNILLD--SEMNP-KISDFGMARLFEMDQTHSDTNRVVGTFGYMAP 417
                 ++H+DLK  NIL    S  +P KI DFG+A LF+ D+ HS TN   GT  YMAP
Sbjct: 142 SQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE-HS-TN-AAGTALYMAP 195
Query: 418 EYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNW 467
           E V     + K DI+S GV++  +++G    +  + EE +   TY   N+
Sbjct: 196 E-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY 244

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 112/226 (49%), Gaps = 31/226 (13%)
Query: 236 FETIRVATDNFSDANK------LGQGGFG---AVYKGMLSNGETIAVKRLSK---NSKQG 283
           F +++VA   F+   +      +G G  G   A +  +L  G  +AVK+LS+   N    
Sbjct: 8   FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHA 65
Query: 284 EIEFKNEVLLLARLQHRNLVRLLGF-----CLERKERILVYEFVPNASLDHFIFDPINRE 338
           +  ++ E++LL  + H+N++ LL        LE  + + +   + +A+L   I   ++ E
Sbjct: 66  KRAYR-ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHE 124
Query: 339 HMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM 398
            M++     ++  +  G+ +LH      IIHRDLK SNI++ S+   KI DFG+AR    
Sbjct: 125 RMSY-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---T 173
Query: 399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
             T+      V T  Y APE ++   +    DI+S G ++ E+V G
Sbjct: 174 ASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 106/244 (43%), Gaps = 24/244 (9%)
Query: 228 IAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI-- 285
           I+  L+   E + +    F+    LG+G FG+V +  L   +   VK   K  K   I  
Sbjct: 7   ISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS 66
Query: 286 ----EFKNEVLLLARLQHRNLVRLLGFCLERKER------ILVYEFVPNASLDHFIF--- 332
               EF  E   +    H ++ +L+G  L  + +      +++  F+ +  L  F+    
Sbjct: 67  SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASR 126
Query: 333 ---DPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD 389
              +P N   +  +   + +  IA G+ YL   S    IHRDL A N +L  +M   ++D
Sbjct: 127 IGENPFN---LPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVAD 180
Query: 390 FGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSS 449
           FG++R       +           ++A E +    ++V SD+++FGV + EI++  +   
Sbjct: 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240
Query: 450 FGTE 453
            G E
Sbjct: 241 AGIE 244

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSNGET-IAVKRLSKNSKQG-EIEFKNEVLLL 294
           E IR   D F D   LG G F  V        +  +A+K ++K + +G E   +NE+ +L
Sbjct: 14  EDIRDIYD-FRDV--LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVL 70
Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY-KIIEGIA 353
            +++H N+V L           L+ + V    L    FD I  +    E+   ++I  + 
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDASRLIFQVL 126
Query: 354 RGLLYLHEDSRLRIIHRDLKASNIL---LDSEMNPKISDFGMARLFEMDQTHSDTNRVVG 410
             + YLH+   L I+HRDLK  N+L   LD +    ISDFG+++   M+   S  +   G
Sbjct: 127 DAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACG 180
Query: 411 TFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           T GY+APE +    +S   D +S GV+   ++ G
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 85/313 (27%), Positives = 135/313 (43%), Gaps = 39/313 (12%)
Query: 244 DNFSDANKLGQGGFGAVYK-----GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLAR 296
           D +    +LG G F  V K       L        KR S+ S++G    E + EV +L +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           + H N++ L      R + +L+ E V    L  F+     +E ++ E+    I+ I  G+
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMARLFEMDQTHSDTNRVVGTF 412
            YLH     +I H DLK  NI+L  +  P    K+ DFG+A   E      +   + GT 
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE---DGVEFKNIFGTP 182
Query: 413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNE--- 469
            ++APE V +    +++D++S GV+   ++SG       T++ET   +T    +++E   
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF 242
Query: 470 GAALNLMDPTMRGGSTSEMMKCIHIGLLCVQEN--------VSNRPGMA---SVVNMLNG 518
                L    +R     E  K      L +QE         V N+  M    SVVN+ N 
Sbjct: 243 SQTSELAKDFIRKLLVKETRKR-----LTIQEALRHPWITPVDNQQAMVRRESVVNLENF 297
Query: 519 DTVTLPAPSKPAF 531
               +   SK AF
Sbjct: 298 RKQYVRRRSKLAF 310

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 30/228 (13%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLS-KNSKQGEIEFKNEVLLLARL 297
           R  TD F     LG+GGFG V++      +   A+KR+   N +    +   EV  LA+L
Sbjct: 2   RYLTD-FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 60
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM--------TWEKRYK-- 347
           +H  +VR     LE+     +    P   L +       +E++        T E+R +  
Sbjct: 61  EHPGIVRYFNAWLEKNTTEKLQPSSPKVYL-YIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 348 ---IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ---- 400
              I   IA  + +LH      ++HRDLK SNI    +   K+ DFG+    + D+    
Sbjct: 120 CLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 401 ------THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIV 442
                  ++     VGT  YM+PE +    +S K DIFS G+++ E++
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHRNL 302
           +    K+G+G +G V+K       E +A+KR+  +     +      E+ LL  L+H+N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           VRL       K+  LV+EF  +  L  + FD  N + +  E     +  + +GL + H  
Sbjct: 64  VRLHDVLHSDKKLTLVFEFC-DQDLKKY-FDSCNGD-LDPEIVKSFLFQLLKGLGFCHSR 120
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH 422
           +   ++HRDLK  N+L++     K++DFG+AR F +      +  VV T  Y  P+ +  
Sbjct: 121 N---VLHRDLKPQNLLINRNGELKLADFGLARAFGI-PVRCYSAEVV-TLWYRPPDVLFG 175
Query: 423 GR-FSVKSDIFSFGVLVLEIVSGQK 446
            + +S   D++S G +  E+ +  +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAAR 200

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 244 DNFSDANKLGQGGFGAVYK-----GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLAR 296
           D +    +LG G F  V K       L        KR S+ S++G    E + EV +L +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           + H N++ L      R + +L+ E V    L  F+     +E ++ E+    I+ I  G+
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMARLFEMDQTHSDTNRVVGTF 412
            YLH     +I H DLK  NI+L  +  P    K+ DFG+A   E      +   + GT 
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE---DGVEFKNIFGTP 182
Query: 413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
            ++APE V +    +++D++S GV+   ++SG       T++ET
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 226

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 17/206 (8%)
Query: 245 NFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHR 300
           N+     +G+G F  V     +  G+ +AVK + K   NS   +  F+ EV +   L H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIXKVLNHP 73
Query: 301 NLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           N+V+L       K   LV E+     + D+ +     +E     K  +I+  +     Y 
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQ----YC 129
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H+     I+HRDLKA N+LLD++ N KI+DFG +  F      +  +   G   Y APE 
Sbjct: 130 HQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFG---NKLDAFCGAPPYAAPEL 183
Query: 420 VMHGRFS-VKSDIFSFGVLVLEIVSG 444
               ++   + D++S GV++  +VSG
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 111/237 (46%), Gaps = 20/237 (8%)
Query: 244 DNFSDANKLGQGGFGAVYK-----GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLAR 296
           D +    +LG G F  V K       L        KR S+ S++G    E + EV +L +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           + H N++ L      R + +L+ E V    L  F+     +E ++ E+    I+ I  G+
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMARLFEMDQTHSDTNRVVGTF 412
            YLH     +I H DLK  NI+L  +  P    K+ DFG+A   E      +   + GT 
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE---DGVEFKNIFGTP 182
Query: 413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNE 469
            ++APE V +    +++D++S GV+   ++SG       T++ET   +T    +++E
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE 239

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 251 KLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           +LG+G F  V +      G     + I  K+LS    Q   + + E  +   L+H N+VR
Sbjct: 29  ELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQ---KLEREARICRLLKHPNIVR 85
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           L     E     L+++ V    L     D + RE+ +       I+ I   +L+ H+   
Sbjct: 86  LHDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAVLHCHQ--- 139
Query: 365 LRIIHRDLKASNILLDSEMN---PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM 421
           + ++HRDLK  N+LL S++     K++DFG+A   E++          GT GY++PE + 
Sbjct: 140 MGVVHRDLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGYLSPEVLR 197
Query: 422 HGRFSVKSDIFSFGVLVLEIVSG 444
              +    D+++ GV++  ++ G
Sbjct: 198 KDPYGKPVDLWACGVILYILLVG 220

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 104/229 (45%), Gaps = 17/229 (7%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL 302
           D +    +LG G FG V++ +  + G     K ++      +   KNE+ ++ +L H  L
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 110
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE--HMTWEKRYKIIEGIARGLLYLH 360
           + L     ++ E +L+ EF+    L    FD I  E   M+  +    +     GL ++H
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGEL----FDRIAAEDYKMSEAEVINYMRQACEGLKHMH 166
Query: 361 EDSRLRIIHRDLKASNILLDSEM--NPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
           E S   I+H D+K  NI+ +++   + KI DFG+A     D+          T  + APE
Sbjct: 167 EHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPE 220
Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNW 467
            V        +D+++ GVL   ++SG   S F  E++ E L      +W
Sbjct: 221 IVDREPVGFYTDMWAIGVLGYVLLSG--LSPFAGEDDLETLQNVKRCDW 267

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 244 DNFSDANKLGQGGFGAVYK-----GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLAR 296
           D +    +LG G F  V K       L        KR S+ S++G    E + EV +L +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           + H N++ L      R + +L+ E V    L  F+     +E ++ E+    I+ I  G+
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMARLFEMDQTHSDTNRVVGTF 412
            YLH     +I H DLK  NI+L  +  P    K+ DFG+A   E      +   + GT 
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE---DGVEFKNIFGTP 182
Query: 413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
            ++APE V +    +++D++S GV+   ++SG       T++ET
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 226

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-----LSNGETIAVKRLSKNSKQG--EIEFKNEVLLLAR 296
           D +    +LG G F  V K       L        KR S+ S++G    E + EV +L +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           + H N++ L      R + +L+ E V    L  F+     +E ++ E+    I+ I  G+
Sbjct: 72  VLHPNIITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMARLFEMDQTHSDTNRVVGTF 412
            YLH     +I H DLK  NI+L  +  P    K+ DFG+A   E      +   + GT 
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE---DGVEFKNIFGTP 182
Query: 413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
            ++APE V +    +++D++S GV+   ++SG       T++ET
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 226

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 244 DNFSDANKLGQGGFGAVYK-----GMLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLAR 296
           D +    +LG G F  V K       L        KR S+ S++G    E + EV +L +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           + H N++ L      R + +L+ E V    L  F+     +E ++ E+    I+ I  G+
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGV 128
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMARLFEMDQTHSDTNRVVGTF 412
            YLH     +I H DLK  NI+L  +  P    K+ DFG+A   E      +   + GT 
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE---DGVEFKNIFGTP 182
Query: 413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
            ++APE V +    +++D++S GV+   ++SG       T++ET
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 226

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 98/212 (46%), Gaps = 15/212 (7%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE---IEFKNEVLLLARLQ 298
           +D +     LG GG   V+    L +   +AVK L  +  +     + F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 299 HRNLVRLLGFCLERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR 354
           H  +V +               +V E+V   +L   +        MT ++  ++I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSDTNRVVGTFG 413
            L + H++    IIHRD+K +NIL+ +    K+ DFG+AR + +   +   T  V+GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQ 184
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           Y++PE         +SD++S G ++ E+++G+
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 244 DNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR-- 300
           D+F   ++LG G  G V+K     +G  +A K +    K      +N+++   ++ H   
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA---IRNQIIRELQVLHECN 81
Query: 301 --NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
              +V   G      E  +  E +   SLD  +     R  +  +   K+   + +GL Y
Sbjct: 82  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGR--IPEQILGKVSIAVIKGLTY 138
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
           L E  + +I+HRD+K SNIL++S    K+ DFG++         S  N  VGT  YM+PE
Sbjct: 139 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPE 192
Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
            +    +SV+SDI+S G+ ++E+  G+
Sbjct: 193 RLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE---IEFKNEVLLLARLQ 298
           +D +     LG GG   V+    L +   +AVK L  +  +     + F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 299 HRNLVRLLGFCLERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR 354
           H  +V +               +V E+V   +L   +        MT ++  ++I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSDTNRVVGTFG 413
            L + H++    IIHRD+K +NI++ +    K+ DFG+AR + +   + + T  V+GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           Y++PE         +SD++S G ++ E+++G+
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE---IEFKNEVLLLARLQ 298
           +D +     LG GG   V+    L +   +AVK L  +  +     + F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 299 HRNLVRLLGFCLERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR 354
           H  +V +               +V E+V   +L   +        MT ++  ++I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSDTNRVVGTFG 413
            L + H++    IIHRD+K +NI++ +    K+ DFG+AR + +   + + T  V+GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           Y++PE         +SD++S G ++ E+++G+
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 252 LGQGGFGAVYKGMLSNGET-------IAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           LG+GGF   ++  +S+ +T       I  K L     Q E +   E+ +   L H+++V 
Sbjct: 49  LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAHQHVVG 105
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
             GF  +     +V E     SL         R+ +T  +    +  I  G  YLH   R
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLH---R 159
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
            R+IHRDLK  N+ L+ ++  KI DFG+A   E D        + GT  Y+APE +    
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKG 217
Query: 425 FSVKSDIFSFGVLVLEIVSGQ 445
            S + D++S G ++  ++ G+
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGK 238

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 252 LGQGGFGAVYKGMLSNGET-------IAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           LG+GGF   ++  +S+ +T       I  K L     Q E +   E+ +   L H+++V 
Sbjct: 47  LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAHQHVVG 103
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
             GF  +     +V E     SL         R+ +T  +    +  I  G  YLH   R
Sbjct: 104 FHGFFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLH---R 157
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
            R+IHRDLK  N+ L+ ++  KI DFG+A   E D        + GT  Y+APE +    
Sbjct: 158 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKG 215
Query: 425 FSVKSDIFSFGVLVLEIVSGQ 445
            S + D++S G ++  ++ G+
Sbjct: 216 HSFEVDVWSIGCIMYTLLVGK 236

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           LG+GGF   Y+   +   E  A K + K+       + +   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTW-EKRYKIIEGIARGLLYLHEDSRLR 366
           F  +     +V E     SL         R+ +T  E RY + + I +G+ YLH +   R
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTI-QGVQYLHNN---R 162
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS 426
           +IHRDLK  N+ L+ +M+ KI DFG+A   E D        + GT  Y+APE +     S
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK--KXLCGTPNYIAPEVLCKKGHS 220
Query: 427 VKSDIFSFGVLVLEIVSGQ 445
            + DI+S G ++  ++ G+
Sbjct: 221 FEVDIWSLGCILYTLLVGK 239

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 13/207 (6%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG-EIEFKNEVLLLARLQHRNLVRLLGFC 309
           K+G+G +G VYK    +G+      L +    G  +    E+ LL  L+H N++ L    
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY-----LHEDSR 364
           L   +R  V+     A  D +     +R     +K  ++  G+ + LLY     +H    
Sbjct: 88  LSHADR-KVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 146
Query: 365 LRIIHRDLKASNILLDSE----MNPKISDFGMARLFEMD-QTHSDTNRVVGTFGYMAPEY 419
             ++HRDLK +NIL+  E       KI+D G ARLF    +  +D + VV TF Y APE 
Sbjct: 147 NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL 206
Query: 420 VMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           ++  R   K+ DI++ G +  E+++ +
Sbjct: 207 LLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 243 TDNFSDANKLGQGGFGAVYK------GMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
           T+ +    +LG+G F  V +      G       I  K+LS    Q   + + E  +   
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ---KLEREARICRL 66
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           L+H N+VRL     E     L+++ V    L     D + RE+ +       I+ I   +
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAV 123
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMN---PKISDFGMARLFEMDQTHSDTNRVVGTFG 413
           L+ H+   + ++HR+LK  N+LL S++     K++DFG+A   E++          GT G
Sbjct: 124 LHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPG 178
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           Y++PE +    +    D+++ GV++  ++ G
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           LG+GGF   Y+   +   E  A K + K+       + +   E+ +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTW-EKRYKIIEGIARGLLYLHEDSRLR 366
           F  +     +V E     SL         R+ +T  E RY + + I +G+ YLH +   R
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTI-QGVQYLHNN---R 162
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS 426
           +IHRDLK  N+ L+ +M+ KI DFG+A   E D        + GT  Y+APE +     S
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK--KDLCGTPNYIAPEVLCKKGHS 220
Query: 427 VKSDIFSFGVLVLEIVSGQ 445
            + DI+S G ++  ++ G+
Sbjct: 221 FEVDIWSLGCILYTLLVGK 239

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 22/200 (11%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVF 92
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++     ++  +  G+ +LH    
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-----LLYQMLVGIKHLHSAG- 146
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
             IIHRDLK SNI++ S+   KI DFG+AR      T       V T  Y APE ++   
Sbjct: 147 --IIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 425 FSVKSDIFSFGVLVLEIVSG 444
           +    DI+S G ++ E++ G
Sbjct: 202 YKENVDIWSVGCIMGEMIKG 221

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL 302
           +D F   ++LG+G    VY+      +     ++ K +   +I  + E+ +L RL H N+
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI-VRTEIGVLLRLSHPNI 110
Query: 303 VRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++L        E  LV E V    L D  +      E    +   +I+E +A    YLHE
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVA----YLHE 166
Query: 362 DSRLRIIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
           +    I+HRDLK  N+L  +   +   KI+DFG++++ E  Q    T  V GT GY APE
Sbjct: 167 NG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-HQVLMKT--VCGTPGYCAPE 220
Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVSG 444
            +    +  + D++S G++   ++ G
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS--KNSKQGEIEFKNEVLLLARLQH 299
           TD +    +LG+G F  V + M +  G+  A K ++  K S +   + + E  +   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            N+VRL     E     LV++ V    L     D + RE+ +       I+ I   + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 360 HEDSRLRIIHRDLKASNILLDSEMN---PKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
           H +    I+HRDLK  N+LL S+      K++DFG+A   + DQ         GT GY++
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ--QAWFGFAGTPGYLS 174
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           PE +    +    D+++ GV++  ++ G
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 252 LGQGGFGAVYKGMLSNGET-------IAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           LG+GGF   ++  +S+ +T       I  K L     Q E +   E+ +   L H+++V 
Sbjct: 23  LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAHQHVVG 79
Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
             GF  +     +V E     SL         R+ +T  +    +  I  G  YLH   R
Sbjct: 80  FHGFFEDNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLH---R 133
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
            R+IHRDLK  N+ L+ ++  KI DFG+A   E D        + GT  Y+APE +    
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKG 191
Query: 425 FSVKSDIFSFGVLVLEIVSGQ 445
            S + D++S G ++  ++ G+
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGK 212

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 243 TDNFSDANKLGQGGFGA--VYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           +D +     +G G FG   + +   SN E +AVK + +  K  E   K E++    L+H 
Sbjct: 17  SDRYELVKDIGSGNFGVARLMRDKQSN-ELVAVKYIERGEKIDE-NVKREIINHRSLRHP 74
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYL 359
           N+VR     L      +V E+     L    F+ I N    + ++     + +  G+ Y 
Sbjct: 75  NIVRFKEVILTPTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLISGVSYC 130
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTHSDTNRVVGTFGYMAP 417
           H    +++ HRDLK  N LLD    P  KI DFG ++       HS     VGT  Y+AP
Sbjct: 131 HA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAP 184
Query: 418 EYVMHGRFSVK-SDIFSFGVLVLEIVSG 444
           E ++   +  K +D++S GV +  ++ G
Sbjct: 185 EVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           LG+GGF   Y+   +   E  A K + K+       + +   E+ +   L + ++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTW-EKRYKIIEGIARGLLYLHEDSRLR 366
           F  +     +V E     SL         R+ +T  E RY + + I +G+ YLH +   R
Sbjct: 94  FFEDDDFVYVVLEICRRRSLLEL---HKRRKAVTEPEARYFMRQTI-QGVQYLHNN---R 146
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS 426
           +IHRDLK  N+ L+ +M+ KI DFG+A   E D        + GT  Y+APE +     S
Sbjct: 147 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK--KDLCGTPNYIAPEVLCKKGHS 204
Query: 427 VKSDIFSFGVLVLEIVSGQ 445
            + DI+S G ++  ++ G+
Sbjct: 205 FEVDIWSLGCILYTLLVGK 223

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 243 TDNFSDANKLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
           TD++    +LG+G F  V + +          + I  K+LS    Q   + + E  +   
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQ---KLEREARICRL 86
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           L+H N+VRL     E     LV++ V    L     D + RE+ +       I  I   +
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIHQILESV 143
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMN---PKISDFGMARLFEMDQTHSDTNRVVGTFG 413
            ++H+     I+HRDLK  N+LL S+      K++DFG+A   E+           GT G
Sbjct: 144 NHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGEQQAWFGFAGTPG 198
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           Y++PE +    +    DI++ GV++  ++ G
Sbjct: 199 YLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 243 TDNFSDANKLGQGGFGA--VYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           +D +     +G G FG   + +   +N E +AVK + +  K  E   K E++    L+H 
Sbjct: 18  SDRYELVKDIGAGNFGVARLMRDKQAN-ELVAVKYIERGEKIDE-NVKREIINHRSLRHP 75
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYL 359
           N+VR     L      +V E+     L    F+ I N    + ++     + +  G+ Y 
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLISGVSYA 131
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTHSDTNRVVGTFGYMAP 417
           H    +++ HRDLK  N LLD    P  KI+DFG ++   +   HS     VGT  Y+AP
Sbjct: 132 HA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVL---HSQPKSAVGTPAYIAP 185
Query: 418 EYVMHGRFSVK-SDIFSFGVLVLEIVSG 444
           E ++   +  K +D++S GV +  ++ G
Sbjct: 186 EVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 100/201 (49%), Gaps = 19/201 (9%)
Query: 252 LGQGGFGAV-----YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLL 306
           LG+G FG V     YK           ++L K S    +  + E+  L  L+H ++++L 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDM-HMRVEREISYLKLLRHPHIIKLY 75
Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
                  + ++V E+      D+ +     ++ MT ++  +  + I   + Y H   R +
Sbjct: 76  DVITTPTDIVMVIEYAGGELFDYIV----EKKRMTEDEGRRFFQQIICAIEYCH---RHK 128
Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS 426
           I+HRDLK  N+LLD  +N KI+DFG++ +   D     T+   G+  Y APE V++G+  
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLKTS--CGSPNYAAPE-VINGKLY 184
Query: 427 V--KSDIFSFGVLVLEIVSGQ 445
              + D++S G+++  ++ G+
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGR 205

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 29/207 (14%)
Query: 252 LGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHRNLVRL 305
           +G G +G+V   Y   L   + +AVK+LS+   Q  I  +    E+ LL  L+H N++ L
Sbjct: 28  VGSGAYGSVCSAYDARLR--QKVAVKKLSR-PFQSLIHARRTYRELRLLKHLKHENVIGL 84
Query: 306 L-----GFCLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRYKIIEGIARGLLYL 359
           L        +E    + +   +  A L++ +    ++ EH+ +     ++  + RGL Y+
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-----LVYQLLRGLKYI 139
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H      IIHRDLK SN+ ++ +   +I DFG+AR     Q   +    V T  Y APE 
Sbjct: 140 HSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADEEMTGYVATRWYRAPEI 191
Query: 420 VMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
           +++   ++   DI+S G ++ E++ G+
Sbjct: 192 MLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE---IEFKNEVLLLARLQ 298
           +D +     LG GG   V+    L     +AVK L  +  +     + F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 299 HRNLVRLLGFCLERKER------ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
           H  +V +  +     E        +V E+V   +L   +        MT ++  ++I   
Sbjct: 71  HPAIVAV--YATGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADA 125
Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSDTNRVVGT 411
            + L + H++    IIHRD+K +NI++ +    K+ DFG+AR + +   + + T  V+GT
Sbjct: 126 CQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
             Y++PE         +SD++S G ++ E+++G+
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 22/200 (11%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVF 92
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++     ++  +  G+ +LH    
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG- 146
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
             IIHRDLK SNI++ S+   KI DFG+AR      T       V T  Y APE ++   
Sbjct: 147 --IIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 425 FSVKSDIFSFGVLVLEIVSG 444
           +    DI+S G ++ E++ G
Sbjct: 202 YKENVDIWSVGCIMGEMIKG 221

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS--KNSKQGEIEFKNEVLLLARLQH 299
           TD +    +LG+G F  V + M +  G+  A K ++  K S +   + + E  +   L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            N+VRL     E     LV++ V    L     D + RE+ +       I+ I   + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 360 HEDSRLRIIHRDLKASNILLDSEMN---PKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
           H +    I+HRDLK  N+LL S+      K++DFG+A   + DQ         GT GY++
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ--QAWFGFAGTPGYLS 174
Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           PE +    +    D+++ GV++  ++ G
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 77/166 (46%), Gaps = 16/166 (9%)
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +A+G+ +L   +  + IHRDL A NILL  +   KI DFG+AR    D  +         
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGA 471
             +MAPE +    ++++SD++SFGVL+ EI S       G + + E       R   EG 
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----FCRRLKEGT 320
Query: 472 ALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
            +   D T     T EM + +   L C     S RP  + +V  L 
Sbjct: 321 RMRAPDYT-----TPEMYQTM---LDCWHGEPSQRPTFSELVEHLG 358

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 77/166 (46%), Gaps = 16/166 (9%)
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +A+G+ +L   +  + IHRDL A NILL  +   KI DFG+AR    D  +         
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGA 471
             +MAPE +    ++++SD++SFGVL+ EI S       G + + E       R   EG 
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----FCRRLKEGT 318
Query: 472 ALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
            +   D T     T EM + +   L C     S RP  + +V  L 
Sbjct: 319 RMRAPDYT-----TPEMYQTM---LDCWHGEPSQRPTFSELVEHLG 356

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 77/166 (46%), Gaps = 16/166 (9%)
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +A+G+ +L   +  + IHRDL A NILL  +   KI DFG+AR    D  +         
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGA 471
             +MAPE +    ++++SD++SFGVL+ EI S       G + + E       R   EG 
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-----RRLKEGT 313
Query: 472 ALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
            +   D T     T EM + +   L C     S RP  + +V  L 
Sbjct: 314 RMRAPDYT-----TPEMYQTM---LDCWHGEPSQRPTFSELVEHLG 351

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 29/207 (14%)
Query: 252 LGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHRNLVRL 305
           +G G +G+V   Y   L   + +AVK+LS+   Q  I  +    E+ LL  L+H N++ L
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSR-PFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 306 L-----GFCLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRYKIIEGIARGLLYL 359
           L        +E    + +   +  A L++ +    ++ EH+ +     ++  + RGL Y+
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQF-----LVYQLLRGLKYI 147
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H      IIHRDLK SN+ ++ +   +I DFG+AR     Q   +    V T  Y APE 
Sbjct: 148 HSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYRAPEI 199
Query: 420 VMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
           +++   ++   DI+S G ++ E++ G+
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 15/211 (7%)
Query: 239 IRVATDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKN-----EVL 292
           ++     +   + LG+G F  VYK    N  + +A+K++    +    +  N     E+ 
Sbjct: 5   VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
           LL  L H N++ LL     +    LV++F+    L+  I D  N   +T       +   
Sbjct: 65  LLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKD--NSLVLTPSHIKAYMLMT 121
Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF 412
            +GL YLH+     I+HRDLK +N+LLD     K++DFG+A+ F      +  ++VV T 
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYXHQVV-TR 176
Query: 413 GYMAPEYVMHGR-FSVKSDIFSFGVLVLEIV 442
            Y APE +   R + V  D+++ G ++ E++
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 29/207 (14%)
Query: 252 LGQGGFGAV---YKGMLSNGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQHRNLVRL 305
           +G G +G+V   Y   L   + +AVK+LS+   Q  I  +    E+ LL  L+H N++ L
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSR-PFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 306 L-----GFCLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRYKIIEGIARGLLYL 359
           L        +E    + +   +  A L++ +    ++ EH+ +     ++  + RGL Y+
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-----LVYQLLRGLKYI 147
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H      IIHRDLK SN+ ++ +   +I DFG+AR     Q   +    V T  Y APE 
Sbjct: 148 HSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYRAPEI 199
Query: 420 VMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
           +++   ++   DI+S G ++ E++ G+
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 77/166 (46%), Gaps = 16/166 (9%)
Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +A+G+ +L   +  + IHRDL A NILL  +   KI DFG+AR    D  +         
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGA 471
             +MAPE +    ++++SD++SFGVL+ EI S       G + + E       R   EG 
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-----RRLKEGT 311
Query: 472 ALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
            +   D T     T EM + +   L C     S RP  + +V  L 
Sbjct: 312 RMRAPDYT-----TPEMYQTM---LDCWHGEPSQRPTFSELVEHLG 349

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 12/203 (5%)
Query: 246 FSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFK--NEVLLLARLQHRNL 302
           +    K+G+G +G V+K       E +A+KR+  +     +      E+ LL  L+H+N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           VRL       K+  LV+EF  +  L  + FD  N + +  E     +  + +GL + H  
Sbjct: 64  VRLHDVLHSDKKLTLVFEFC-DQDLKKY-FDSCNGD-LDPEIVKSFLFQLLKGLGFCHSR 120
Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH 422
           +   ++HRDLK  N+L++     K+++FG+AR F +      +  VV T  Y  P+ +  
Sbjct: 121 N---VLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVV-TLWYRPPDVLFG 175
Query: 423 GR-FSVKSDIFSFGVLVLEIVSG 444
            + +S   D++S G +  E+ + 
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANA 198

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 24/199 (12%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNVF 92
Query: 310 LERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
             +K      +  LV E + +A+L   I   ++ E M++     ++  +  G+ +LH   
Sbjct: 93  TPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSY-----LLYQMLXGIKHLHSAG 146
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
              IIHRDLK SNI++ S+   KI DFG+AR      T       V T  Y APE ++  
Sbjct: 147 ---IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 424 RFSVKSDIFSFGVLVLEIV 442
            +    DI+S G ++ E+V
Sbjct: 201 GYKENVDIWSVGCIMGEMV 219

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 101/200 (50%), Gaps = 22/200 (11%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVF 92
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++     ++  +  G+ +LH    
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG- 146
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
             IIHRDLK SNI++ S+   KI DFG+AR      +   T  VV  + Y APE ++   
Sbjct: 147 --IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRY-YRAPEVILGMG 201
Query: 425 FSVKSDIFSFGVLVLEIVSG 444
           +    DI+S G ++ E++ G
Sbjct: 202 YKENVDIWSVGCIMGEMIKG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 101/200 (50%), Gaps = 22/200 (11%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVF 92
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++     ++  +  G+ +LH    
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG- 146
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
             IIHRDLK SNI++ S+   KI DFG+AR      +   T  VV  + Y APE ++   
Sbjct: 147 --IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPEVVTRY-YRAPEVILGMG 201
Query: 425 FSVKSDIFSFGVLVLEIVSG 444
           +    DI+S G ++ E++ G
Sbjct: 202 YKENVDIWSVGCIMGEMIKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 22/200 (11%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVF 92
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++     ++  +  G+ +LH    
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG- 146
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
             IIHRDLK SNI++ S+   KI DFG+AR      T       V T  Y APE ++   
Sbjct: 147 --IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 425 FSVKSDIFSFGVLVLEIVSG 444
           +    DI+S G ++ E++ G
Sbjct: 202 YKENVDIWSVGCIMGEMIKG 221

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 97/220 (44%), Gaps = 26/220 (11%)
Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH 299
           +V  +NF     LG G +G V+     +G         K  K+  I  K +     R + 
Sbjct: 50  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 300 RNLVRLLGFCLERKERILV---YEFVPNASLDHFIFDPIN----------REHMTWEKRY 346
           + L  +      R+   LV   Y F     L H I D IN          RE  T  +  
Sbjct: 110 QVLEHI------RQSPFLVTLHYAFQTETKL-HLILDYINGGELFTHLSQRERFTEHEVQ 162
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
             +  I   L +LH   +L II+RD+K  NILLDS  +  ++DFG+++ F  D+T    +
Sbjct: 163 IYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 219
Query: 407 RVVGTFGYMAPEYVMHGR--FSVKSDIFSFGVLVLEIVSG 444
              GT  YMAP+ V  G        D +S GVL+ E+++G
Sbjct: 220 -FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 134/309 (43%), Gaps = 52/309 (16%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQ--HRNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 77  IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 126
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +   GT  Y  
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSP 182
Query: 417 PEYVMHGRFSVKS-DIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNL 475
           PE++ + R+  +S  ++S G+L+ ++V G     F  +EE              G     
Sbjct: 183 PEWIRYHRYHGRSAAVWSLGILLYDMVCGD--IPFEHDEEI-----------IRGQVF-- 227
Query: 476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKPAFFMKC 535
                R   +SE   C H+   C+    S+RP    + N      V LP  +        
Sbjct: 228 ----FRQRVSSE---CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 280
Query: 536 SVIPETSSP 544
           S  P  S P
Sbjct: 281 SPGPSKSGP 289

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 98/212 (46%), Gaps = 15/212 (7%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE---IEFKNEVLLLARLQ 298
           +D +     LG GG   V+    L     +AVK L  +  +     + F+ E    A L 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 299 HRNLVRLLGFCLERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR 354
           H  +V +               +V E+V   +L   +        MT ++  ++I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 127
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSDTNRVVGTFG 413
            L + H++    IIHRD+K +NI++ +    K+ DFG+AR + +   + + T  V+GT  
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           Y++PE         +SD++S G ++ E+++G+
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 17/200 (8%)
Query: 252 LGQGGFGAVYKGMLSNGETI-AVKRLSKNSKQGEIEFKNEV----LLLARLQHRNLVRLL 306
           +G+G FG V        E   AVK L K +   + E K+ +    +LL  ++H  LV L 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 104
Query: 307 GFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSR 364
            F  +  +++  V +++    L    F  + RE    E R +     IA  L YLH    
Sbjct: 105 HFSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAEIASALGYLHS--- 157
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
           L I++RDLK  NILLDS+ +  ++DFG+ +  E  + +S T+   GT  Y+APE +    
Sbjct: 158 LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVLHKQP 215
Query: 425 FSVKSDIFSFGVLVLEIVSG 444
           +    D +  G ++ E++ G
Sbjct: 216 YDRTVDWWCLGAVLYEMLYG 235

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 22/200 (11%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVF 92
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++     ++  +  G+ +LH    
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG- 146
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
             IIHRDLK SNI++ S+   KI DFG+AR      T       V T  Y APE ++   
Sbjct: 147 --IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 425 FSVKSDIFSFGVLVLEIVSG 444
           +    DI+S G ++ E++ G
Sbjct: 202 YKENVDIWSVGCIMGEMIKG 221

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 243 TDNFSDANKLGQGGFGA--VYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           +D +     +G G FG   + +   SN E +AVK + +  K      K E++    L+H 
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSN-ELVAVKYIERGEKIAA-NVKREIINHRSLRHP 75
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYL 359
           N+VR     L      +V E+     L    F+ I N    + ++     + +  G+ Y 
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTHSDTNRVVGTFGYMAP 417
           H    +++ HRDLK  N LLD    P  KI DFG ++   +   HS     VGT  Y+AP
Sbjct: 132 HA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAP 185
Query: 418 EYVMHGRFSVK-SDIFSFGVLVLEIVSG 444
           E ++   +  K +D++S GV +  ++ G
Sbjct: 186 EVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 22/200 (11%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 37  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVF 93
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++     ++  +  G+ +LH    
Sbjct: 94  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG- 147
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
             IIHRDLK SNI++ S+   KI DFG+AR      T       V T  Y APE ++   
Sbjct: 148 --IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 202
Query: 425 FSVKSDIFSFGVLVLEIVSG 444
           +    DI+S G ++ E++ G
Sbjct: 203 YKENVDIWSVGCIMGEMIKG 222

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 30/219 (13%)
Query: 236 FETIRVATDNFSDANKLGQGGFGAVYK----GMLSNGETIAVKRLSK----NSKQGEIEF 287
           FE +RV          LG+GG+G V++       + G+  A+K L K     + +     
Sbjct: 19  FELLRV----------LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT 68
Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR-- 345
           K E  +L  ++H  +V L+       +  L+ E++    L    F  + RE +  E    
Sbjct: 69  KAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTAC 124
Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
           + + E I+  L +LH+     II+RDLK  NI+L+ + + K++DFG+ +  E     + T
Sbjct: 125 FYLAE-ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVT 178
Query: 406 NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           +   GT  YMAPE +M    +   D +S G L+ ++++G
Sbjct: 179 HXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 24/199 (12%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVF 92
Query: 310 LERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
             +K      +  LV E + +A+L   I   ++ E M++     ++  +  G+ +LH   
Sbjct: 93  TPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSY-----LLYQMLXGIKHLHSAG 146
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
              IIHRDLK SNI++ S+   KI DFG+AR      T       V T  Y APE ++  
Sbjct: 147 ---IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 424 RFSVKSDIFSFGVLVLEIV 442
            +    DI+S G ++ E+V
Sbjct: 201 GYKENVDIWSVGCIMGEMV 219

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 106/219 (48%), Gaps = 30/219 (13%)
Query: 236 FETIRVATDNFSDANKLGQGGFGAVYK----GMLSNGETIAVKRLSK----NSKQGEIEF 287
           FE +RV          LG+GG+G V++       + G+  A+K L K     + +     
Sbjct: 19  FELLRV----------LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT 68
Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR-- 345
           K E  +L  ++H  +V L+       +  L+ E++    L    F  + RE +  E    
Sbjct: 69  KAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTAC 124
Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
           + + E I+  L +LH+     II+RDLK  NI+L+ + + K++DFG+ +    D T + T
Sbjct: 125 FYLAE-ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT 180
Query: 406 NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
               GT  YMAPE +M    +   D +S G L+ ++++G
Sbjct: 181 --FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 243 TDNFSDANKLGQGGFGA--VYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           +D +     +G G FG   + +  L+  E +AVK + + +   E   + E++    L+H 
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTK-ELVAVKYIERGAAIDE-NVQREIINHRSLRHP 76
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
           N+VR     L      ++ E+     L   I    N    + ++     + +  G+ Y H
Sbjct: 77  NIVRFKEVILTPTHLAIIMEYASGGELYERI---CNAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 361 EDSRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
               ++I HRDLK  N LLD    P  KI DFG ++   +   HS     VGT  Y+APE
Sbjct: 134 S---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPE 187
Query: 419 YVMHGRFSVK-SDIFSFGVLVLEIVSG 444
            ++   +  K +D++S GV +  ++ G
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 22/200 (11%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVF 92
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++     ++  +  G+ +LH    
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG- 146
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
             IIHRDLK SNI++ S+   KI DFG+AR      T       V T  Y APE ++   
Sbjct: 147 --IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 425 FSVKSDIFSFGVLVLEIVSG 444
           +    DI+S G ++ E++ G
Sbjct: 202 YKENVDIWSVGCIMGEMIKG 221

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG---EIEFKNEVLLLARLQHRNLVRLLGF 308
           +G+G +G V++G    GE +AVK  S   ++    E E  N V+L    +H N++  +  
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIAS 99
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH-----EDS 363
            +  +        + +      ++D +    +      +I+  IA GL +LH        
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQG 159
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT--NRVVGTFGYMAPEYVM 421
           +  I HRDLK+ NIL+       I+D G+A +        D   N  VGT  YMAPE V+
Sbjct: 160 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE-VL 218
Query: 422 HGRFSV-------KSDIFSFGVLVLEI 441
                V       + DI++FG+++ E+
Sbjct: 219 DETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 24/199 (12%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 29  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVF 85
Query: 310 LERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
             +K      +  LV E + +A+L   I   ++ E M++     ++  +  G+ +LH   
Sbjct: 86  TPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSY-----LLYQMLXGIKHLHSAG 139
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
              IIHRDLK SNI++ S+   KI DFG+AR      T       V T  Y APE ++  
Sbjct: 140 ---IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 424 RFSVKSDIFSFGVLVLEIV 442
            +    DI+S G ++ E+V
Sbjct: 194 GYKENVDIWSVGCIMGEMV 212

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 100/198 (50%), Gaps = 22/198 (11%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNVF 92
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++     ++  +  G+ +LH    
Sbjct: 93  TPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG- 146
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
             IIHRDLK SNI++ S+   KI DFG+AR      +   T  VV  + Y APE ++   
Sbjct: 147 --IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRY-YRAPEVILGMG 201
Query: 425 FSVKSDIFSFGVLVLEIV 442
           +    DI+S G ++ E+V
Sbjct: 202 YKENVDIWSVGCIMGEMV 219

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 43/216 (19%)
Query: 251 KLGQGGFGAVYKGMLSNGETIAV-------KRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
           ++G+G F  VYKG L    T+ V       ++L+K+ +Q    FK E   L  LQH N+V
Sbjct: 33  EIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNIV 88
Query: 304 RLL----GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE--------- 350
           R           +K  +LV E   + +L  ++            KR+K+ +         
Sbjct: 89  RFYDSWESTVKGKKCIVLVTELXTSGTLKTYL------------KRFKVXKIKVLRSWCR 136
Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVV 409
            I +GL +LH  +   IIHRDLK  NI +       KI D G+A L    +  S    V+
Sbjct: 137 QILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVI 191
Query: 410 GTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           GT  + APE     ++    D+++FG   LE  + +
Sbjct: 192 GTPEFXAPE-XYEEKYDESVDVYAFGXCXLEXATSE 226

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 98/212 (46%), Gaps = 15/212 (7%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE---IEFKNEVLLLARLQ 298
           +D +     LG GG   V+    L     +AVK L  +  +     + F+ E    A L 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 299 HRNLVRLLGFCLERKER----ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR 354
           H  +V +               +V E+V   +L   +        MT ++  ++I    +
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 144
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSDTNRVVGTFG 413
            L + H++    IIHRD+K +NI++ +    K+ DFG+AR + +   + + T  V+GT  
Sbjct: 145 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 201
Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           Y++PE         +SD++S G ++ E+++G+
Sbjct: 202 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 24/199 (12%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 74  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVF 130
Query: 310 LERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
             +K      +  LV E + +A+L   I   ++ E M++     ++  +  G+ +LH   
Sbjct: 131 TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG 184
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
              IIHRDLK SNI++ S+   KI DFG+AR      +   T  VV  + Y APE ++  
Sbjct: 185 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-YRAPEVILGM 238
Query: 424 RFSVKSDIFSFGVLVLEIV 442
            +    DI+S G ++ E+V
Sbjct: 239 GYKENVDIWSVGCIMGEMV 257

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 105/235 (44%), Gaps = 37/235 (15%)
Query: 224 VEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG 283
           V+ TIAK +Q                 ++G+G +G V+ G    GE +AVK     +++ 
Sbjct: 31  VQRTIAKQIQM--------------VKQIGKGRYGEVWMGKW-RGEKVAVKVFF-TTEEA 74
Query: 284 EIEFKNEVLLLARLQHRNLVRLLGFCLE----RKERILVYEFVPNASLDHFIFDPINREH 339
               + E+     ++H N++  +   ++      +  L+ ++  N SL    +D +    
Sbjct: 75  SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSL----YDYLKSTT 130
Query: 340 MTWEKRYKIIEGIARGLLYLHED-----SRLRIIHRDLKASNILLDSEMNPKISDFGMAR 394
           +  +   K+      GL +LH +      +  I HRDLK+ NIL+       I+D G+A 
Sbjct: 131 LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190
Query: 395 LFEMDQTHSDT--NRVVGTFGYMAPEYV------MHGRFSVKSDIFSFGVLVLEI 441
            F  D    D   N  VGT  YM PE +       H +  + +D++SFG+++ E+
Sbjct: 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 22/200 (11%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 38  AQGIVCAAYDAILER--NVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVF 94
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++     ++  +  G+ +LH    
Sbjct: 95  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG- 148
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
             IIHRDLK SNI++ S+   KI DFG+AR      T       V T  Y APE ++   
Sbjct: 149 --IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMVPFVVTRYYRAPEVILGMG 203
Query: 425 FSVKSDIFSFGVLVLEIVSG 444
           +    DI+S G ++ E++ G
Sbjct: 204 YKENVDIWSVGCIMGEMIKG 223

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 108/242 (44%), Gaps = 39/242 (16%)
Query: 230 KSLQFDFETIRVATDNFSDANKLGQGGFGAV--YKGMLSNGETIAVKRLSKNSKQGEIEF 287
           ++L F    + +   ++    KLG+GGF  V   +G L +G   A+KR+  + +Q   E 
Sbjct: 15  ENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEA 73
Query: 288 KNEVLLLARLQHRNLVRLLGFCLE----RKERILVYEFVPNASLDHFIFDPINR-----E 338
           + E  +     H N++RL+ +CL     + E  L+  F    +L    ++ I R      
Sbjct: 74  QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTL----WNEIERLKDKGN 129
Query: 339 HMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM 398
            +T ++   ++ GI RGL  +H        HRDLK +NILL  E  P + D G      M
Sbjct: 130 FLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLG-----SM 181
Query: 399 DQT--HSDTNRVV----------GTFGYMAPEYV---MHGRFSVKSDIFSFGVLVLEIVS 443
           +Q   H + +R             T  Y APE      H     ++D++S G ++  ++ 
Sbjct: 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMF 241
Query: 444 GQ 445
           G+
Sbjct: 242 GE 243

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/111 (36%), Positives = 57/111 (51%), Gaps = 3/111 (2%)
Query: 333 DPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM 392
           D   +E +T E        +ARG+ +L   S  + IHRDL A NILL      KI DFG+
Sbjct: 189 DGFYKEPITMEDLISYSFQVARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGL 245
Query: 393 ARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           AR    +  +           +MAPE +    +S KSD++S+GVL+ EI S
Sbjct: 246 ARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQHR 300
           ++  +  ++G G  G V+K      G  IAVK  R S N ++ +    +  ++L      
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 301 NLVRLLGFCLERKERILVYEFVPNAS--LDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
            +V+  G  +   +  +  E +   +  L   +  PI    +      K+   I + L Y
Sbjct: 85  YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTVAIVKALYY 139
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
           L E  +  +IHRD+K SNILLD     K+ DFG++     D+     +R  G   YMAPE
Sbjct: 140 LKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAYMAPE 194
Query: 419 YV-----MHGRFSVKSDIFSFGVLVLEIVSGQ 445
            +         + +++D++S G+ ++E+ +GQ
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG---EIEFKNEVLLLARLQHRNLVRLLGF 308
           +G+G +G V++G    GE +AVK  S   ++    E E  N V+L    +H N++  +  
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIAS 70
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH-----EDS 363
            +  +        + +      ++D +    +      +I+  IA GL +LH        
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQG 130
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT--NRVVGTFGYMAPEYVM 421
           +  I HRDLK+ NIL+       I+D G+A +        D   N  VGT  YMAPE V+
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE-VL 189
Query: 422 HGRFSV-------KSDIFSFGVLVLEI 441
                V       + DI++FG+++ E+
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 81/311 (26%), Positives = 136/311 (43%), Gaps = 52/311 (16%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQ--HRNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 77  IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 126
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +   GT  Y  
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSP 182
Query: 417 PEYVMHGRFSVKS-DIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNL 475
           PE++ + R+  +S  ++S G+L+ ++V G     F  +EE              G     
Sbjct: 183 PEWIRYHRYHGRSAAVWSLGILLYDMVCGD--IPFEHDEEI-----------IRGQVF-- 227
Query: 476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKPAFFMKC 535
                R   +SE   C H+   C+    S+RP    + N      V LP  +        
Sbjct: 228 ----FRQRVSSE---CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 280
Query: 536 SVIPETSSPLD 546
           S  P  ++ L+
Sbjct: 281 SPGPSKAAALE 291

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG---EIEFKNEVLLLARLQHRNLVRLLGF 308
           +G+G +G V++G    GE +AVK  S   ++    E E  N V+L    +H N++  +  
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIAS 70
Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH-----EDS 363
            +  +        + +      ++D +    +      +I+  IA GL +LH        
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQG 130
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT--NRVVGTFGYMAPEYVM 421
           +  I HRDLK+ NIL+       I+D G+A +        D   N  VGT  YMAPE V+
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE-VL 189
Query: 422 HGRFSV-------KSDIFSFGVLVLEI 441
                V       + DI++FG+++ E+
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 243 TDNFSDANKLGQGGFGA--VYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           +D +     +G G FG   + +   SN E +AVK + +  K  E   K E++    L+H 
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSN-ELVAVKYIERGEKIDE-NVKREIINHRSLRHP 75
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYL 359
           N+VR     L      +V E+     L    F+ I N    + ++     + +  G+ Y 
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTHSDTNRVVGTFGYMAP 417
           H    +++ HRDLK  N LLD    P  KI  FG ++   +   HS     VGT  Y+AP
Sbjct: 132 HA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVL---HSQPKSTVGTPAYIAP 185
Query: 418 EYVMHGRFSVK-SDIFSFGVLVLEIVSG 444
           E ++   +  K +D++S GV +  ++ G
Sbjct: 186 EVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 69
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  EIE   NE  +L  +    LV+L     +     +V E+ P   + 
Sbjct: 70  AMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM- 128
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+++D +   K+
Sbjct: 129 ---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 182
Query: 388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           +DFG+A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 183 TDFGLAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 30/209 (14%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQ--HRNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 91  IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 140
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +   GT  Y  
Sbjct: 141 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSP 196
Query: 417 PEYVMHGRFSVKS-DIFSFGVLVLEIVSG 444
           PE++ + R+  +S  ++S G+L+ ++V G
Sbjct: 197 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 30/209 (14%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQ--HRNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 92  IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 141
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +   GT  Y  
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSP 197
Query: 417 PEYVMHGRFSVKS-DIFSFGVLVLEIVSG 444
           PE++ + R+  +S  ++S G+L+ ++V G
Sbjct: 198 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 22/198 (11%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNVF 92
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++     ++  +  G+ +LH    
Sbjct: 93  TPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG- 146
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
             IIHRDLK SNI++ S+   KI DFG+AR      T       V T  Y APE ++   
Sbjct: 147 --IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 425 FSVKSDIFSFGVLVLEIV 442
           +    DI+S G ++ E+V
Sbjct: 202 YKENVDIWSVGCIMGEMV 219

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 30/209 (14%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQ--HRNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 92  IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 141
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +   GT  Y  
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSP 197
Query: 417 PEYVMHGRFSVKS-DIFSFGVLVLEIVSG 444
           PE++ + R+  +S  ++S G+L+ ++V G
Sbjct: 198 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 24/199 (12%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 74  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVF 130
Query: 310 LERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
             +K      +  LV E + +A+L   I   ++ E M++     ++  +  G+ +LH   
Sbjct: 131 TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG 184
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
              IIHRDLK SNI++ S+   KI DFG+AR      T       V T  Y APE ++  
Sbjct: 185 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGM 238
Query: 424 RFSVKSDIFSFGVLVLEIV 442
            +    DI+S G ++ E+V
Sbjct: 239 GYKENVDIWSVGCIMGEMV 257

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 110/236 (46%), Gaps = 23/236 (9%)
Query: 219 LEDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSK 278
           L+D N    + K L  D +T       +++   +G G FG V++  L   + +A+K++ +
Sbjct: 18  LDDPN---KVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ 74
Query: 279 NSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCL---ERKERI---LVYEFVPNASLDHFI 331
           + +     FKN  L + R+ +H N+V L  F     ++K+ +   LV E+VP        
Sbjct: 75  DKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASR 129
Query: 332 FDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDF 390
                ++ M        +  + R L Y+H    + I HRD+K  N+LLD      K+ DF
Sbjct: 130 HYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDF 186
Query: 391 GMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
           G A++    + +      + +  Y APE +     ++   DI+S G ++ E++ GQ
Sbjct: 187 GSAKILIAGEPNVSX---ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 30/209 (14%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQ--HRNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 91  IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 140
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +   GT  Y  
Sbjct: 141 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSP 196
Query: 417 PEYVMHGRFSVKS-DIFSFGVLVLEIVSG 444
           PE++ + R+  +S  ++S G+L+ ++V G
Sbjct: 197 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 243 TDNFSDANKLGQGGFGA--VYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR 300
           +D +     +G G FG   + +   SN E +AVK + +  K  E   K E++    L+H 
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSN-ELVAVKYIERGEKIDE-NVKREIINHRSLRHP 75
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYL 359
           N+VR     L      +V E+     L    F+ I N    + ++     + +  G+ Y 
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 360 HEDSRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTHSDTNRVVGTFGYMAP 417
           H    +++ HRDLK  N LLD    P  KI  FG ++   +   HS     VGT  Y+AP
Sbjct: 132 HA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVL---HSQPKDTVGTPAYIAP 185
Query: 418 EYVMHGRFSVK-SDIFSFGVLVLEIVSG 444
           E ++   +  K +D++S GV +  ++ G
Sbjct: 186 EVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
           + +  A  LG+G FG V++ + ++ +   + +  K     ++  K E+ +L   +HRN++
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI--IEGIARGLLYLHE 361
            L       +E ++++EF+  + LD  IF+ IN       +R  +  +  +   L +LH 
Sbjct: 65  HLHESFESMEELVMIFEFI--SGLD--IFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 362 DSRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTHSDTNRVVGTF-GYMAPE 418
            +   I H D++  NI+  +  +   KI +FG AR  +      D  R++ T   Y APE
Sbjct: 121 HN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP----GDNFRLLFTAPEYYAPE 173
Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVSG 444
              H   S  +D++S G LV  ++SG
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSG 199

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 30/209 (14%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQ--HRNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 92  IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 141
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +   GT  Y  
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSP 197
Query: 417 PEYVMHGRFSVKS-DIFSFGVLVLEIVSG 444
           PE++ + R+  +S  ++S G+L+ ++V G
Sbjct: 198 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 69
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP   + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM- 128
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +   ++
Sbjct: 129 ---FSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           +DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 183 TDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 12  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 70
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP   + 
Sbjct: 71  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM- 129
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +   ++
Sbjct: 130 ---FSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 183
Query: 388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           +DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 184 TDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 30/209 (14%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQ--HRNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 105 IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 154
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +   GT  Y  
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSP 210
Query: 417 PEYVMHGRFSVKS-DIFSFGVLVLEIVSG 444
           PE++ + R+  +S  ++S G+L+ ++V G
Sbjct: 211 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 30/202 (14%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVF 92
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++     ++  +  G+ +LH    
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG- 146
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARL----FEMDQTHSDTNRVVGTFGYMAPEYV 420
             IIHRDLK SNI++ S+   KI DFG+AR     F M+         V T  Y APE +
Sbjct: 147 --IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPE-------VVTRYYRAPEVI 197
Query: 421 MHGRFSVKSDIFSFGVLVLEIV 442
           +   +    DI+S G ++ E+V
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMV 219

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 30/209 (14%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQ--HRNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 111 IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 160
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +   GT  Y  
Sbjct: 161 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSP 216
Query: 417 PEYVMHGRFSVKS-DIFSFGVLVLEIVSG 444
           PE++ + R+  +S  ++S G+L+ ++V G
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 24/199 (12%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 35  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVF 91
Query: 310 LERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
             +K      +  LV E + +A+L   I   ++ E M++     ++  +  G+ +LH   
Sbjct: 92  TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG 145
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
              IIHRDLK SNI++ S+   KI DFG+AR      T       V T  Y APE ++  
Sbjct: 146 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGM 199
Query: 424 RFSVKSDIFSFGVLVLEIV 442
            +    DI+S G ++ E+V
Sbjct: 200 GYKENVDIWSVGCIMGEMV 218

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 24/199 (12%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVF 92
Query: 310 LERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
             +K      +  LV E + +A+L   I   ++ E M++     ++  +  G+ +LH   
Sbjct: 93  TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG 146
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
              IIHRDLK SNI++ S+   KI DFG+AR      T       V T  Y APE ++  
Sbjct: 147 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 424 RFSVKSDIFSFGVLVLEIV 442
            +    DI+S G ++ E+V
Sbjct: 201 GYKENVDIWSVGCIMGEMV 219

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 109/233 (46%), Gaps = 23/233 (9%)
Query: 246 FSDANKLGQGGFGAVYKGMLSNGETI--AVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
           ++  N +G+G +G V K  +  G  I  A K++ K   +    FK E+ ++  L H N++
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 304 RLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           RL     +  +  LV E      L +  +   + RE        +I++ +   + Y H  
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRE----SDAARIMKDVLSAVAYCH-- 123
Query: 363 SRLRIIHRDLKASNILL--DSEMNP-KISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
            +L + HRDLK  N L   DS  +P K+ DFG+A  F+  +        VGT  Y++P+ 
Sbjct: 124 -KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---VGTPYYVSPQ- 178
Query: 420 VMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET-----EDLLTYAWRNW 467
           V+ G +  + D +S GV++  ++ G    S  T+ E      E   T+  ++W
Sbjct: 179 VLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDW 231

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 30/209 (14%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQ--HRNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 105 IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 154
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +   GT  Y  
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSP 210
Query: 417 PEYVMHGRFSVKS-DIFSFGVLVLEIVSG 444
           PE++ + R+  +S  ++S G+L+ ++V G
Sbjct: 211 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 30/209 (14%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQ--HRNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 104 IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 153
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +   GT  Y  
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSP 209
Query: 417 PEYVMHGRFSVKS-DIFSFGVLVLEIVSG 444
           PE++ + R+  +S  ++S G+L+ ++V G
Sbjct: 210 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 24/199 (12%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 37  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVF 93
Query: 310 LERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
             +K      +  LV E + +A+L   I   ++ E M++     ++  +  G+ +LH   
Sbjct: 94  TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG 147
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
              IIHRDLK SNI++ S+   KI DFG+AR      T       V T  Y APE ++  
Sbjct: 148 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGM 201
Query: 424 RFSVKSDIFSFGVLVLEIV 442
            +    DI+S G ++ E+V
Sbjct: 202 GYKENVDIWSVGCIMGEMV 220

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 30/209 (14%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQ--HRNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 104 IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 153
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +   GT  Y  
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSP 209
Query: 417 PEYVMHGRFSVKS-DIFSFGVLVLEIVSG 444
           PE++ + R+  +S  ++S G+L+ ++V G
Sbjct: 210 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 30/209 (14%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQ--HRNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 105 IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 154
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +   GT  Y  
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSP 210
Query: 417 PEYVMHGRFSVKS-DIFSFGVLVLEIVSG 444
           PE++ + R+  +S  ++S G+L+ ++V G
Sbjct: 211 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     +G G FG V     +  G   
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHY 69
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP   + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM- 128
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +   K+
Sbjct: 129 ---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKV 182
Query: 388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           +DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 183 ADFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 69
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP   + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM- 128
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +   ++
Sbjct: 129 ---FSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           +DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 183 TDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 24/199 (12%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 29  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVF 85
Query: 310 LERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
             +K      +  LV E + +A+L   I   ++ E M++     ++  +  G+ +LH   
Sbjct: 86  TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG 139
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
              IIHRDLK SNI++ S+   KI DFG+AR      T       V T  Y APE ++  
Sbjct: 140 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 424 RFSVKSDIFSFGVLVLEIV 442
            +    DI+S G ++ E+V
Sbjct: 194 GYKENVDIWSVGCIMGEMV 212

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 24/199 (12%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 37  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVF 93
Query: 310 LERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
             +K      +  LV E + +A+L   I   ++ E M++     ++  +  G+ +LH   
Sbjct: 94  TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG 147
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
              IIHRDLK SNI++ S+   KI DFG+AR      T       V T  Y APE ++  
Sbjct: 148 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGM 201
Query: 424 RFSVKSDIFSFGVLVLEIV 442
            +    DI+S G ++ E+V
Sbjct: 202 GYKENVDIWSVGCIMGEMV 220

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 30/209 (14%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQ--HRNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 104 IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 153
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +   GT  Y  
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSP 209
Query: 417 PEYVMHGRFSVKS-DIFSFGVLVLEIVSG 444
           PE++ + R+  +S  ++S G+L+ ++V G
Sbjct: 210 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 24/199 (12%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVF 92
Query: 310 LERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
             +K      +  LV E + +A+L   I   ++ E M++     ++  +  G+ +LH   
Sbjct: 93  TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG 146
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
              IIHRDLK SNI++ S+   KI DFG+AR      T       V T  Y APE ++  
Sbjct: 147 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 424 RFSVKSDIFSFGVLVLEIV 442
            +    DI+S G ++ E+V
Sbjct: 201 GYKENVDIWSVGCIMGEMV 219

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 24/199 (12%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 30  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVF 86
Query: 310 LERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
             +K      +  LV E + +A+L   I   ++ E M++     ++  +  G+ +LH   
Sbjct: 87  TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG 140
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
              IIHRDLK SNI++ S+   KI DFG+AR      T       V T  Y APE ++  
Sbjct: 141 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGM 194
Query: 424 RFSVKSDIFSFGVLVLEIV 442
            +    DI+S G ++ E+V
Sbjct: 195 GYKENVDIWSVGCIMGEMV 213

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 24/199 (12%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 30  AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVF 86
Query: 310 LERK------ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
             +K      +  LV E + +A+L   I   ++ E M++     ++  +  G+ +LH   
Sbjct: 87  TPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG 140
Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
              IIHRDLK SNI++ S+   KI DFG+AR      T       V T  Y APE ++  
Sbjct: 141 ---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGM 194
Query: 424 RFSVKSDIFSFGVLVLEIV 442
            +    DI+S G ++ E+V
Sbjct: 195 GYKENVDIWSVGCIMGEMV 213

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 30/209 (14%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQ--HRNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 105 IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 154
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +   GT  Y  
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSP 210
Query: 417 PEYVMHGRFSVKS-DIFSFGVLVLEIVSG 444
           PE++ + R+  +S  ++S G+L+ ++V G
Sbjct: 211 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 30/209 (14%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQ--HRNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 104 IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 153
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +   GT  Y  
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSP 209
Query: 417 PEYVMHGRFSVKS-DIFSFGVLVLEIVSG 444
           PE++ + R+  +S  ++S G+L+ ++V G
Sbjct: 210 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 30/209 (14%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQ--HRNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 119 IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 168
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +   GT  Y  
Sbjct: 169 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSP 224
Query: 417 PEYVMHGRFSVKS-DIFSFGVLVLEIVSG 444
           PE++ + R+  +S  ++S G+L+ ++V G
Sbjct: 225 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 30/209 (14%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQ--HRNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 119 IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 168
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +   GT  Y  
Sbjct: 169 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSP 224
Query: 417 PEYVMHGRFSVKS-DIFSFGVLVLEIVSG 444
           PE++ + R+  +S  ++S G+L+ ++V G
Sbjct: 225 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 106/236 (44%), Gaps = 28/236 (11%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE----FKNE 290
           DF+ +RV          +G+G +  V    L   + I   R+ K     + E     + E
Sbjct: 53  DFDLLRV----------IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTE 102
Query: 291 VLLLARLQHRNLVRLLGFCLERKERIL-VYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
             +  +  +   +  L  C + + R+  V E+V    L   +F    +  +  E      
Sbjct: 103 KHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYS 159
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
             I+  L YLHE     II+RDLK  N+LLDSE + K++D+GM +  E  +    T+   
Sbjct: 160 AEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFC 214
Query: 410 GTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQK-----RSSFGTEEETEDLL 460
           GT  Y+APE +    +    D ++ GVL+ E+++G+       SS   ++ TED L
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 270

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 109/233 (46%), Gaps = 23/233 (9%)
Query: 246 FSDANKLGQGGFGAVYKGMLSNGETI--AVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
           ++  N +G+G +G V K  +  G  I  A K++ K   +    FK E+ ++  L H N++
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 304 RLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           RL     +  +  LV E      L +  +   + RE        +I++ +   + Y H  
Sbjct: 87  RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRE----SDAARIMKDVLSAVAYCH-- 140
Query: 363 SRLRIIHRDLKASNILL--DSEMNP-KISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
            +L + HRDLK  N L   DS  +P K+ DFG+A  F+  +        VGT  Y++P+ 
Sbjct: 141 -KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK---VGTPYYVSPQ- 195
Query: 420 VMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET-----EDLLTYAWRNW 467
           V+ G +  + D +S GV++  ++ G    S  T+ E      E   T+  ++W
Sbjct: 196 VLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDW 248

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 12  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 70
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP   + 
Sbjct: 71  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM- 129
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +   ++
Sbjct: 130 ---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 183
Query: 388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           +DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 184 TDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 112/239 (46%), Gaps = 45/239 (18%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKN-------------------- 279
           V  + ++  +++G+G +G V      N  T  A+K LSK                     
Sbjct: 10  VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPA 69
Query: 280 -----SKQGEIE-FKNEVLLLARLQHRNLVRLLGFCLERKERIL--VYEFVPNASLDHF- 330
                  +G IE    E+ +L +L H N+V+L+    +  E  L  V+E V    +    
Sbjct: 70  PGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP 129
Query: 331 IFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDF 390
              P++ +   +       + + +G+ YLH     +IIHRD+K SN+L+  + + KI+DF
Sbjct: 130 TLKPLSEDQARF-----YFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 391 GMARLFE-MDQTHSDTNRVVGTFGYMAPEYVMHGR--FSVKS-DIFSFGVLVLEIVSGQ 445
           G++  F+  D   S+T   VGT  +MAPE +   R  FS K+ D+++ GV +   V GQ
Sbjct: 182 GVSNEFKGSDALLSNT---VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 30/209 (14%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQ--HRNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 77  IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 126
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +   GT  Y  
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSP 182
Query: 417 PEYVMHGRFSVKS-DIFSFGVLVLEIVSG 444
           PE++ + R+  +S  ++S G+L+ ++V G
Sbjct: 183 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 69
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP   + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM- 128
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +   ++
Sbjct: 129 ---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           +DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 183 TDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 69
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP   + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM- 128
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +   ++
Sbjct: 129 ---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           +DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 183 TDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 12  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 70
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP   + 
Sbjct: 71  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM- 129
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +   ++
Sbjct: 130 ---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 183
Query: 388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           +DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 184 TDFGFAK-----RVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 30/209 (14%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQ--HRNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 76  IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 125
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +   GT  Y  
Sbjct: 126 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSP 181
Query: 417 PEYVMHGRFSVKS-DIFSFGVLVLEIVSG 444
           PE++ + R+  +S  ++S G+L+ ++V G
Sbjct: 182 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 69
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP   + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM- 128
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +   ++
Sbjct: 129 ---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           +DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 183 TDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 30/209 (14%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQ--HRNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 124 IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 173
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +   GT  Y  
Sbjct: 174 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSP 229
Query: 417 PEYVMHGRFSVKS-DIFSFGVLVLEIVSG 444
           PE++ + R+  +S  ++S G+L+ ++V G
Sbjct: 230 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 106/240 (44%), Gaps = 31/240 (12%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF              D F     LG G FG V   ML      G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP  
Sbjct: 67  NHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            +++DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 180 IQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 106/240 (44%), Gaps = 31/240 (12%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF              D F     LG G FG V   ML      G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP  
Sbjct: 67  NHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            +++DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 180 IQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 125/299 (41%), Gaps = 36/299 (12%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE 311
           +G+G FG VY G       I +  + ++++     FK EV+   + +H N+V  +G C+ 
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 312 RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRD 371
                ++       +L   + D   +  +   K  +I + I +G+ YLH      I+H+D
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 372 LKASNILLDSEMNPKISDFGMARLFEMDQT--HSDTNRVV-GTFGYMAPEYVMHGR---- 424
           LK+ N+  D+     I+DFG+  +  + Q     D  R+  G   ++APE +        
Sbjct: 156 LKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 425 -----FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAAL--NLMD 477
                FS  SD+F+ G +  E+ +  +   F T +  E ++      W  G  +  NL  
Sbjct: 215 EDKLPFSKHSDVFALGTIWYELHA--REWPFKT-QPAEAII------WQMGTGMKPNLSQ 265
Query: 478 PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKPAFFMKCS 536
             M G   S+++      L C       RP    +++ML          S P  F K +
Sbjct: 266 IGM-GKEISDIL------LFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKSA 317

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 22/198 (11%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 41  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVF 97
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++     ++  +  G+ +LH    
Sbjct: 98  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG- 151
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
             IIHRDLK SNI++ S+   KI DFG+AR      T       V T  Y APE ++   
Sbjct: 152 --IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 206
Query: 425 FSVKSDIFSFGVLVLEIV 442
           +    D++S G ++ E+V
Sbjct: 207 YKENVDLWSVGCIMGEMV 224

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 106/240 (44%), Gaps = 31/240 (12%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF              D F     LG G FG V   ML      G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP  
Sbjct: 67  NHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            +++DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 180 IQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 30/209 (14%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQ--HRNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 75  IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 124
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +   GT  Y  
Sbjct: 125 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSP 180
Query: 417 PEYVMHGRFSVKS-DIFSFGVLVLEIVSG 444
           PE++ + R+  +S  ++S G+L+ ++V G
Sbjct: 181 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 30/209 (14%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQ--HRNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 72  IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 121
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +   GT  Y  
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSP 177
Query: 417 PEYVMHGRFSVKS-DIFSFGVLVLEIVSG 444
           PE++ + R+  +S  ++S G+L+ ++V G
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 69
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  EIE   NE  +L  +    LV+L     +     +V E+ P   + 
Sbjct: 70  AMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM- 128
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+++D +   ++
Sbjct: 129 ---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQV 182
Query: 388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           +DFG+A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 183 TDFGLAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 30/209 (14%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQ--HRNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 72  IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 121
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +   GT  Y  
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSP 177
Query: 417 PEYVMHGRFSVKS-DIFSFGVLVLEIVSG 444
           PE++ + R+  +S  ++S G+L+ ++V G
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 30/202 (14%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 36  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVF 92
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++     ++  +  G+ +LH    
Sbjct: 93  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG- 146
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARL----FEMDQTHSDTNRVVGTFGYMAPEYV 420
             IIHRDLK SNI++ S+   KI DFG+AR     F M+         V T  Y APE +
Sbjct: 147 --IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPE-------VVTRYYRAPEVI 197
Query: 421 MHGRFSVKSDIFSFGVLVLEIV 442
           +   +    D++S G ++ E+V
Sbjct: 198 LGMGYKENVDLWSVGCIMGEMV 219

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 30/209 (14%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQ--HRNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 99  IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 148
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +   GT  Y  
Sbjct: 149 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSP 204
Query: 417 PEYVMHGRFSVKS-DIFSFGVLVLEIVSG 444
           PE++ + R+  +S  ++S G+L+ ++V G
Sbjct: 205 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 109/240 (45%), Gaps = 31/240 (12%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    E+    T   D F     LG G FG V   ML      G
Sbjct: 12  EQESVKEFLAKAKE-DFLKKWESPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETG 67
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP  
Sbjct: 68  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG 127
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 128 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 180
Query: 385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            +++DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 181 IQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 22/198 (11%)
Query: 253 GQGGFGAVYKGMLSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQHRNLVRLLGF- 308
            QG   A Y  +L     +A+K+LS+   N    +  ++ E++L+  + H+N++ LL   
Sbjct: 30  AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVF 86
Query: 309 ----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
                LE  + + +   + +A+L   I   ++ E M++     ++  +  G+ +LH    
Sbjct: 87  TPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHSAG- 140
Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
             IIHRDLK SNI++ S+   KI DFG+AR      T       V T  Y APE ++   
Sbjct: 141 --IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMG 195
Query: 425 FSVKSDIFSFGVLVLEIV 442
           +    D++S G ++ E+V
Sbjct: 196 YKENVDLWSVGCIMGEMV 213

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 109/240 (45%), Gaps = 31/240 (12%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    E+    T   D F     LG G FG V   ML      G
Sbjct: 32  EQESVKEFLAKAKE-DFLKKWESPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETG 87
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP  
Sbjct: 88  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG 147
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 148 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 200
Query: 385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            +++DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 201 IQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 30/209 (14%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQ--HRNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY---- 358
           +RLL +  ER +  ++    P    D  +FD I        +R  + E +AR   +    
Sbjct: 72  IRLLDW-FERPDSFVLILERPEPVQD--LFDFIT-------ERGALQEELARSFFWQVLE 121
Query: 359 -LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +   GT  Y  
Sbjct: 122 AVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYSP 177
Query: 417 PEYVMHGRFSVKS-DIFSFGVLVLEIVSG 444
           PE++ + R+  +S  ++S G+L+ ++V G
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 109/240 (45%), Gaps = 31/240 (12%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    E+    T   D F     LG G FG V   ML      G
Sbjct: 12  EQESVKEFLAKAKE-DFLKKWESPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETG 67
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP  
Sbjct: 68  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG 127
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 128 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 180
Query: 385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            +++DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 181 IQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 109/240 (45%), Gaps = 31/240 (12%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    E+    T   D F     LG G FG V   ML      G
Sbjct: 12  EQESVKEFLAKAKE-DFLKKWESPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETG 67
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+VP  
Sbjct: 68  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGG 127
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 128 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 180
Query: 385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            +++DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 181 IQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 102/230 (44%), Gaps = 47/230 (20%)
Query: 238 TIRVATDNFSDANKLGQGGFGA-VYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
            + V   +F   + LG G  G  VY+GM  N + +AVKR+          F +  + L R
Sbjct: 18  VVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRD-VAVKRILPEC----FSFADREVQLLR 72
Query: 297 L--QHRNLVRLLGFCLERKERILVY-----------EFVPNASLDHFIFDPINREHMTWE 343
              +H N++R   FC E K+R   Y           E+V      H   +PI        
Sbjct: 73  ESDEHPNVIRY--FCTE-KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPIT------- 122
Query: 344 KRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD-----SEMNPKISDFGMARLFEM 398
               +++    GL +LH    L I+HRDLK  NIL+       ++   ISDFG+ +   +
Sbjct: 123 ----LLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175
Query: 399 DQTHSDTNR--VVGTFGYMAPEYVMHG---RFSVKSDIFSFGVLVLEIVS 443
            + HS + R  V GT G++APE +        +   DIFS G +   ++S
Sbjct: 176 GR-HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 20/225 (8%)
Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKNSKQGEIEFKN---EVLLLAR 296
           V  D+F     +G+G FG V     ++ + + A+K ++K       E +N   E+ ++  
Sbjct: 12  VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           L+H  LV L     + ++  +V + +    L + +   +   H   E     I  +   L
Sbjct: 72  LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMAL 128
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            YL      RIIHRD+K  NILLD   +  I+DF +A +   +   +    + GT  YMA
Sbjct: 129 DYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---TQITTMAGTKPYMA 182
Query: 417 PEYVMHGR---FSVKSDIFSFGVLVLEIVSGQK----RSSFGTEE 454
           PE     +   +S   D +S GV   E++ G++    RSS  ++E
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE 227

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 104/237 (43%), Gaps = 25/237 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 69
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+ P   + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM- 128
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+++D +   K+
Sbjct: 129 ---FSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 182
Query: 388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           +DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 183 TDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     +G G FG V     +  G   
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHY 69
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E++P   + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM- 128
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +   K+
Sbjct: 129 ---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKV 182
Query: 388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           +DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 183 ADFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGFC 309
           LG+G +  V   + L NG+  AVK + K +         EV  L + Q ++N++ L+ F 
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            +     LV+E +   S+   I     ++H    +  +++  +A  L +LH      I H
Sbjct: 81  EDDTRFYLVFEKLQGGSILAHI---QKQKHFNEREASRVVRDVAAALDFLHTKG---IAH 134
Query: 370 RDLKASNILLDS--EMNP-KISDFGMARLFEMDQ-----THSDTNRVVGTFGYMAPEYV- 420
           RDLK  NIL +S  +++P KI DF +    +++      T  +     G+  YMAPE V 
Sbjct: 135 RDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVE 194
Query: 421 ----MHGRFSVKSDIFSFGVLVLEIVSG 444
                   +  + D++S GV++  ++SG
Sbjct: 195 VFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     +G G FG V     +  G   
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHY 69
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E++P   + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM- 128
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +   K+
Sbjct: 129 ---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKV 182
Query: 388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           +DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 183 ADFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 104/237 (43%), Gaps = 25/237 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 69
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+ P   + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM- 128
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+++D +   K+
Sbjct: 129 ---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 182
Query: 388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           +DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 183 TDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 106/236 (44%), Gaps = 28/236 (11%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE----FKNE 290
           DF+ +RV          +G+G +  V    L   + I   ++ K     + E     + E
Sbjct: 10  DFDLLRV----------IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTE 59
Query: 291 VLLLARLQHRNLVRLLGFCLERKERIL-VYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
             +  +  +   +  L  C + + R+  V E+V    L   +F    +  +  E      
Sbjct: 60  KHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYS 116
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
             I+  L YLHE     II+RDLK  N+LLDSE + K++D+GM +  E  +    T+   
Sbjct: 117 AEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFC 171
Query: 410 GTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQK-----RSSFGTEEETEDLL 460
           GT  Y+APE +    +    D ++ GVL+ E+++G+       SS   ++ TED L
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 227

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 17/206 (8%)
Query: 244 DNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQH 299
           D F     LG G FG V     +  G   A+K L K    K  +IE   NE  +L  +  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLY 358
             LV+L     +     +V E+VP   +    F  + R     E   +     I     Y
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 142
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
           LH    L +I+RDLK  N+L+D +   +++DFG A+     +    T  + GT  Y+APE
Sbjct: 143 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEYLAPE 194
Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVSG 444
            ++   ++   D ++ GVL+ E+ +G
Sbjct: 195 IILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 244 DNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNS--KQGEIEFK-NEVLLLAR 296
           D F     LG G FG V   ML      G   A+K L K    K  +IE   NE  +L  
Sbjct: 34  DQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARG 355
           +    LV+L     +     +V E+VP   +    F  + R     E   +     I   
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQIVLT 146
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYM 415
             YLH    L +I+RDLK  N+L+D +   +++DFG A+     +    T  + GT  Y+
Sbjct: 147 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 198
Query: 416 APEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 199 APEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 108/221 (48%), Gaps = 20/221 (9%)
Query: 236 FETIRVATDNFSDANKLGQGGFGAVYKGM---------LSNGETIAVKRLSKNSKQGEIE 286
           F  IR     F+++  LGQG F  ++KG+         L   E + +K L K  +     
Sbjct: 2   FHKIRNEDLIFNES--LGQGTFTKIFKGVRREVGDYGQLHETEVL-LKVLDKAHRNYSES 58
Query: 287 FKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY 346
           F     ++++L H++LV   G C+   E ILV EFV   SLD ++    N  ++ W  + 
Sbjct: 59  FFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KL 116
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE--MDQTHSD 404
           ++ + +A  + +L E++   +IH ++ A NILL  E + K  +    +L +  +  T   
Sbjct: 117 EVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP 173
Query: 405 TNRVVGTFGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSG 444
            + +     ++ PE + + +  ++ +D +SFG  + EI SG
Sbjct: 174 KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 106/236 (44%), Gaps = 28/236 (11%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE----FKNE 290
           DF+ +RV          +G+G +  V    L   + I   ++ K     + E     + E
Sbjct: 21  DFDLLRV----------IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTE 70
Query: 291 VLLLARLQHRNLVRLLGFCLERKERIL-VYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
             +  +  +   +  L  C + + R+  V E+V    L   +F    +  +  E      
Sbjct: 71  KHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYS 127
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
             I+  L YLHE     II+RDLK  N+LLDSE + K++D+GM +  E  +    T+   
Sbjct: 128 AEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFC 182
Query: 410 GTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQK-----RSSFGTEEETEDLL 460
           GT  Y+APE +    +    D ++ GVL+ E+++G+       SS   ++ TED L
Sbjct: 183 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 238

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 109/240 (45%), Gaps = 31/240 (12%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            +++DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 180 IQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 108/240 (45%), Gaps = 31/240 (12%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    E+    T   D F     LG G FG V   ML      G
Sbjct: 12  EQESVKEFLAKAKE-DFLKKWESPAQNTAHLDQFERIKTLGTGSFGRV---MLVKHKETG 67
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+ P  
Sbjct: 68  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGG 127
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+++D +  
Sbjct: 128 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGY 180
Query: 385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            K++DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 181 IKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 109/240 (45%), Gaps = 31/240 (12%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 32  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 87
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 88  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 147
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 148 EM----FSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 200
Query: 385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            +++DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 201 IQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 32/210 (15%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEI----EFKNEVLLLARLQ--HRNL 302
           LG GGFG+VY G+ +S+   +A+K + K+  S  GE+        EV+LL ++      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 303 VRLLGFCLERKERILVYEFV-PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY--- 358
           +RLL +       +L+ E + P   L  FI            +R  + E +AR   +   
Sbjct: 76  IRLLDWFERPDSFVLILERMEPVQDLFDFI-----------TERGALQEELARSFFWQVL 124
Query: 359 --LHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYM 415
             +       ++HRD+K  NIL+D +    K+ DFG   L + D  ++D +   GT  Y 
Sbjct: 125 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD---GTRVYS 180
Query: 416 APEYVMHGRFSVKS-DIFSFGVLVLEIVSG 444
            PE++ + R+  +S  ++S G+L+ ++V G
Sbjct: 181 PPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 106/236 (44%), Gaps = 28/236 (11%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE----FKNE 290
           DF+ +RV          +G+G +  V    L   + I   ++ K     + E     + E
Sbjct: 6   DFDLLRV----------IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTE 55
Query: 291 VLLLARLQHRNLVRLLGFCLERKERIL-VYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
             +  +  +   +  L  C + + R+  V E+V    L   +F    +  +  E      
Sbjct: 56  KHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYS 112
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
             I+  L YLHE     II+RDLK  N+LLDSE + K++D+GM +  E  +    T+   
Sbjct: 113 AEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFC 167
Query: 410 GTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQK-----RSSFGTEEETEDLL 460
           GT  Y+APE +    +    D ++ GVL+ E+++G+       SS   ++ TED L
Sbjct: 168 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 223

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 244 DNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNS--KQGEIEFK-NEVLLLAR 296
           D F     LG G FG V   ML      G   A+K L K    K  +IE   NE  +L  
Sbjct: 34  DQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARG 355
           +    LV+L     +     +V E+VP   +    F  + R     E   +     I   
Sbjct: 91  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 146
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYM 415
             YLH    L +I+RDLK  N+L+D +   +++DFG A+     +    T  + GT  Y+
Sbjct: 147 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 198
Query: 416 APEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 199 APEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 109/240 (45%), Gaps = 31/240 (12%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            +++DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 180 IQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 20/221 (9%)
Query: 236 FETIRVATDNFSDANKLGQGGFGAVYKGM---------LSNGETIAVKRLSKNSKQGEIE 286
           F  IR     F+++  LGQG F  ++KG+         L   E + +K L K  +     
Sbjct: 2   FHKIRNEDLIFNES--LGQGTFTKIFKGVRREVGDYGQLHETEVL-LKVLDKAHRNYSES 58
Query: 287 FKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY 346
           F     ++++L H++LV   G C    E ILV EFV   SLD ++    N  ++ W  + 
Sbjct: 59  FFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KL 116
Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE--MDQTHSD 404
           ++ + +A  + +L E++   +IH ++ A NILL  E + K  +    +L +  +  T   
Sbjct: 117 EVAKQLAWAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP 173
Query: 405 TNRVVGTFGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSG 444
            + +     ++ PE + + +  ++ +D +SFG  + EI SG
Sbjct: 174 KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 109/240 (45%), Gaps = 31/240 (12%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            +++DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 180 IQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 109/240 (45%), Gaps = 31/240 (12%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            +++DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 180 IQVTDFGFAK-----RVKGRTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN------EVLLLARLQ----HR 300
           LG+GGFG V+ G  L++   +A+K + +N   G     +      EV LL ++     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYL 359
            ++RLL +  E +E  ++    P  + D  +FD I  +    E   +   G +   + + 
Sbjct: 99  GVIRLLDW-FETQEGFMLVLERPLPAQD--LFDYITEKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 360 HEDSRLRIIHRDLKASNILLDSEMN-PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
           H      ++HRD+K  NIL+D      K+ DFG   L   D+ ++D +   GT  Y  PE
Sbjct: 156 HSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYTDFD---GTRVYSPPE 208
Query: 419 YV-MHGRFSVKSDIFSFGVLVLEIVSG 444
           ++  H   ++ + ++S G+L+ ++V G
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 109/240 (45%), Gaps = 31/240 (12%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            +++DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 180 IQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 109/240 (45%), Gaps = 31/240 (12%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 32  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 87
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 88  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 147
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 148 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 200
Query: 385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            +++DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 201 IQVTDFGFAK-----RVKGATWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 109/240 (45%), Gaps = 31/240 (12%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFAEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            +++DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 180 IQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 109/240 (45%), Gaps = 31/240 (12%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 6   EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 61
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 62  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 121
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 122 EM----FSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 174
Query: 385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            +++DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 175 IQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 109/240 (45%), Gaps = 31/240 (12%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 12  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 67
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 68  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 127
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 128 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 180
Query: 385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            +++DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 181 IQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 109/240 (45%), Gaps = 31/240 (12%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            +++DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 180 IQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 109/240 (45%), Gaps = 31/240 (12%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            +++DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 180 IQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 109/240 (45%), Gaps = 31/240 (12%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            +++DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 180 IQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 109/227 (48%), Gaps = 20/227 (8%)
Query: 249 ANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSK----QGEIEFKNEVLLLARLQHRNLV 303
           + +LG+G F  V + +  S G+  A K L K  +    + EI  +  VL LA+   R ++
Sbjct: 34  SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR-VI 92
Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            L        E IL+ E+     +      P   E ++     ++I+ I  G+ YLH+++
Sbjct: 93  NLHEVYENTSEIILILEYAAGGEIFSLCL-PELAEMVSENDVIRLIKQILEGVYYLHQNN 151
Query: 364 RLRIIHRDLKASNILLDSEM---NPKISDFGMARLFEMDQTHS-DTNRVVGTFGYMAPEY 419
              I+H DLK  NILL S     + KI DFGM+R       H+ +   ++GT  Y+APE 
Sbjct: 152 ---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI----GHACELREIMGTPEYLAPEI 204
Query: 420 VMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRN 466
           + +   +  +D+++ G++   +++    S F  E+  E  L  +  N
Sbjct: 205 LNYDPITTATDMWNIGIIAYMLLT--HTSPFVGEDNQETYLNISQVN 249

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 103/237 (43%), Gaps = 25/237 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 12  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 70
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    L +L     +     +V E+ P   + 
Sbjct: 71  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM- 129
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+++D +   K+
Sbjct: 130 ---FSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 183
Query: 388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           +DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 184 TDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 109/240 (45%), Gaps = 31/240 (12%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            +++DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 180 IQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 252 LGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNLVRLLGFC 309
           LGQG    V++G     G+  A+K  +  S    ++ +  E  +L +L H+N+V+L  F 
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL--FA 74
Query: 310 LER----KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
           +E     + ++L+ EF P  SL   + +P N   +   +   ++  +  G+ +L E+   
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 366 RIIHRDLKASNILL----DSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV- 420
            I+HR++K  NI+     D +   K++DFG AR  E D+       + GT  Y+ P+   
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV---XLYGTEEYLHPDMYE 188
Query: 421 -------MHGRFSVKSDIFSFGVLVLEIVSG 444
                     ++    D++S GV      +G
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 109/240 (45%), Gaps = 31/240 (12%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            +++DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 180 IQVTDFGFAK-----RVKGRTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 104/237 (43%), Gaps = 25/237 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 69
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+ P   + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM- 128
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+++D +   ++
Sbjct: 129 ---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQV 182
Query: 388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           +DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 183 TDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 103/237 (43%), Gaps = 25/237 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 12  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 70
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    L +L     +     +V E+ P   + 
Sbjct: 71  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM- 129
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+++D +   K+
Sbjct: 130 ---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 183
Query: 388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           +DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 184 TDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 103/237 (43%), Gaps = 25/237 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 12  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 70
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    L +L     +     +V E+ P   + 
Sbjct: 71  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM- 129
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+++D +   K+
Sbjct: 130 ---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 183
Query: 388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           +DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 184 TDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 104/214 (48%), Gaps = 22/214 (10%)
Query: 243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHR 300
           + +F   + LG+G +G V        GE +A+K++    K    +    E+ +L   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 301 NLVRLLGFCLERKERILVYE--FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           N++ +  F ++R +    +   ++    +   +   I+ + ++ +     I    R +  
Sbjct: 70  NIITI--FNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN----------RV 408
           LH  +   +IHRDLK SN+L++S  + K+ DFG+AR+  +D++ +D +            
Sbjct: 128 LHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQSGMVEF 182
Query: 409 VGTFGYMAPEYVM-HGRFSVKSDIFSFGVLVLEI 441
           V T  Y APE ++   ++S   D++S G ++ E+
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 252 LGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGEIEFK-NEVLLLARLQHRNLVRLLGFC 309
           LGQG    V++G     G+  A+K  +  S    ++ +  E  +L +L H+N+V+L  F 
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL--FA 74
Query: 310 LER----KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
           +E     + ++L+ EF P  SL   + +P N   +   +   ++  +  G+ +L E+   
Sbjct: 75  IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 366 RIIHRDLKASNILL----DSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV- 420
            I+HR++K  NI+     D +   K++DFG AR  E D+       + GT  Y+ P+   
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS---LYGTEEYLHPDMYE 188
Query: 421 -------MHGRFSVKSDIFSFGVLVLEIVSG 444
                     ++    D++S GV      +G
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 104/214 (48%), Gaps = 22/214 (10%)
Query: 243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHR 300
           + +F   + LG+G +G V        GE +A+K++    K    +    E+ +L   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 301 NLVRLLGFCLERKERILVYE--FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           N++ +  F ++R +    +   ++    +   +   I+ + ++ +     I    R +  
Sbjct: 70  NIITI--FNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN----------RV 408
           LH  +   +IHRDLK SN+L++S  + K+ DFG+AR+  +D++ +D +            
Sbjct: 128 LHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQSGMTEX 182
Query: 409 VGTFGYMAPEYVM-HGRFSVKSDIFSFGVLVLEI 441
           V T  Y APE ++   ++S   D++S G ++ E+
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 272 AVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
           AVK + K+ +    E +   +LL   QH N++ L     + K   LV E +    L    
Sbjct: 56  AVKVIDKSKRDPSEEIE---ILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGEL---- 108
Query: 332 FDPINREHMTWEKRYK-IIEGIARGLLYLHEDSRLRIIHRDLKASNIL-LDSEMNP---K 386
            D I R+    E+    ++  I + + YLH      ++HRDLK SNIL +D   NP   +
Sbjct: 109 LDKILRQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLR 165
Query: 387 ISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQK 446
           I DFG A+    +     T      F  +APE +    +    DI+S G+L+  +++G  
Sbjct: 166 ICDFGFAKQLRAENGLLMTPCYTANF--VAPEVLKRQGYDEGCDIWSLGILLYTMLAGYT 223
Query: 447 RSSFGTEEETEDLL--------TYAWRNWN 468
             + G  +  E++L        T +  NWN
Sbjct: 224 PFANGPSDTPEEILTRIGSGKFTLSGGNWN 253

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 272 AVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
           AVK + K+ +    E +   +LL   QH N++ L     + K   LV E +    L    
Sbjct: 56  AVKVIDKSKRDPSEEIE---ILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGEL---- 108
Query: 332 FDPINREHMTWEKRYK-IIEGIARGLLYLHEDSRLRIIHRDLKASNIL-LDSEMNP---K 386
            D I R+    E+    ++  I + + YLH      ++HRDLK SNIL +D   NP   +
Sbjct: 109 LDKILRQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLR 165
Query: 387 ISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQK 446
           I DFG A+    +     T      F  +APE +    +    DI+S G+L+  +++G  
Sbjct: 166 ICDFGFAKQLRAENGLLMTPCYTANF--VAPEVLKRQGYDEGCDIWSLGILLYTMLAGYT 223
Query: 447 RSSFGTEEETEDLL--------TYAWRNWN 468
             + G  +  E++L        T +  NWN
Sbjct: 224 PFANGPSDTPEEILTRIGSGKFTLSGGNWN 253

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 104/214 (48%), Gaps = 22/214 (10%)
Query: 243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHR 300
           + +F   + LG+G +G V        GE +A+K++    K    +    E+ +L   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 301 NLVRLLGFCLERKERILVYE--FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           N++ +  F ++R +    +   ++    +   +   I+ + ++ +     I    R +  
Sbjct: 70  NIITI--FNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN----------RV 408
           LH  +   +IHRDLK SN+L++S  + K+ DFG+AR+  +D++ +D +            
Sbjct: 128 LHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQSGMTEY 182
Query: 409 VGTFGYMAPEYVM-HGRFSVKSDIFSFGVLVLEI 441
           V T  Y APE ++   ++S   D++S G ++ E+
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 114/270 (42%), Gaps = 60/270 (22%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-----QHRNLVRLL 306
           LG G  G V       G  +AVKR+        I+F +  L+  +L      H N++R  
Sbjct: 41  LGYGSSGTVVFQGSFQGRPVAVKRML-------IDFCDIALMEIKLLTESDDHPNVIRY- 92
Query: 307 GFCLERKERILVYEF-VPNASLDHFIFDP-INREHMTWEKRY---KIIEGIARGLLYLHE 361
            +C E  +R L     + N +L   +    ++ E++  +K Y    ++  IA G+ +LH 
Sbjct: 93  -YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 362 DSRLRIIHRDLKASNILLDSE-------------MNPKISDFGMARLFEMDQT--HSDTN 406
              L+IIHRDLK  NIL+ +              +   ISDFG+ +  +  Q     + N
Sbjct: 152 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 208
Query: 407 RVVGTFGYMAPEYVMHG---RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA 463
              GT G+ APE +      R +   DIFS G +   I+S  K   FG +   E  +   
Sbjct: 209 NPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH-PFGDKYSRESNI--- 264
Query: 464 WRNWNEGAALNLMDPTMRGGSTSEMMKCIH 493
                           +RG  + + MKC+H
Sbjct: 265 ----------------IRGIFSLDEMKCLH 278

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 114/270 (42%), Gaps = 60/270 (22%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-----QHRNLVRLL 306
           LG G  G V       G  +AVKR+        I+F +  L+  +L      H N++R  
Sbjct: 41  LGYGSSGTVVFQGSFQGRPVAVKRML-------IDFCDIALMEIKLLTESDDHPNVIRY- 92
Query: 307 GFCLERKERILVYEF-VPNASLDHFIFDP-INREHMTWEKRY---KIIEGIARGLLYLHE 361
            +C E  +R L     + N +L   +    ++ E++  +K Y    ++  IA G+ +LH 
Sbjct: 93  -YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 362 DSRLRIIHRDLKASNILLDSE-------------MNPKISDFGMARLFEMDQT--HSDTN 406
              L+IIHRDLK  NIL+ +              +   ISDFG+ +  +  Q     + N
Sbjct: 152 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 208
Query: 407 RVVGTFGYMAPEYVMHG---RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA 463
              GT G+ APE +      R +   DIFS G +   I+S  K   FG +   E  +   
Sbjct: 209 NPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH-PFGDKYSRESNI--- 264
Query: 464 WRNWNEGAALNLMDPTMRGGSTSEMMKCIH 493
                           +RG  + + MKC+H
Sbjct: 265 ----------------IRGIFSLDEMKCLH 278

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 109/240 (45%), Gaps = 31/240 (12%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            +++DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ ++ +G
Sbjct: 180 IQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 115/274 (41%), Gaps = 64/274 (23%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-----QHRNLVRLL 306
           LG G  G V       G  +AVKR+        I+F +  L+  +L      H N++R  
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRML-------IDFCDIALMEIKLLTESDDHPNVIRY- 74
Query: 307 GFCLERKERILVYEF-VPNASLDHFIFDP-INREHMTWEKRY---KIIEGIARGLLYLHE 361
            +C E  +R L     + N +L   +    ++ E++  +K Y    ++  IA G+ +LH 
Sbjct: 75  -YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 362 DSRLRIIHRDLKASNILLDSE-------------MNPKISDFGMARLFEMDQT--HSDTN 406
              L+IIHRDLK  NIL+ +              +   ISDFG+ +  +  Q+   ++ N
Sbjct: 134 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 407 RVVGTFGYMAPEYVMHG-------RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDL 459
              GT G+ APE +          R +   DIFS G +   I+S  K   FG +   E  
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH-PFGDKYSRE-- 247
Query: 460 LTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIH 493
                               +RG  + + MKC+H
Sbjct: 248 -----------------SNIIRGIFSLDEMKCLH 264

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 104/237 (43%), Gaps = 25/237 (10%)
Query: 220 EDENVEETIAKSLQFDF-------ETIRVATDNFSDANKLGQGGFGAV-YKGMLSNGETI 271
           E E+V+E +AK+ + DF              D F     LG G FG V     +  G   
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHY 69
Query: 272 AVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLD 328
           A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V    + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM- 128
Query: 329 HFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
              F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +   ++
Sbjct: 129 ---FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           +DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 183 TDFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 107/233 (45%), Gaps = 44/233 (18%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGE-TIAVKRLSKNSKQGEIEFKN---EVLLLARLQH 299
           DN+   + +G+G +G VY     N E  +A+K++++   +  I+ K    E+ +L RL+ 
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-MFEDLIDCKRILREITILNRLKS 84
Query: 300 RNLVRLLGFC-----LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR 354
             ++RL         L+  E  +V E + ++ L      PI    +T E    I+  +  
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLE-IADSDLKKLFKTPI---FLTEEHIKTILYNLLL 140
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV------ 408
           G  ++HE     IIHRDLK +N LL+ + + K+ DFG+AR      +  DTN V      
Sbjct: 141 GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTI---NSEKDTNIVNDLEEN 194
Query: 409 -----------------VGTFGYMAPEYVMHGRFSVKS-DIFSFGVLVLEIVS 443
                            V T  Y APE ++      KS DI+S G +  E+++
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 109/240 (45%), Gaps = 31/240 (12%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+++D +  
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLIIDQQGY 179
Query: 385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            +++DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 180 IQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 107/240 (44%), Gaps = 31/240 (12%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    E+    T   D F     LG G FG V   ML      G
Sbjct: 12  EQESVKEFLAKAKE-DFLKKWESPAQNTAHLDQFERIRTLGTGSFGRV---MLVKHKETG 67
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +   +    LV+L     +     +V E+ P  
Sbjct: 68  NHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGG 127
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 128 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 180
Query: 385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            K++DFG A+     +    T  + GT  Y+APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 181 IKVADFGFAK-----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 18/200 (9%)
Query: 252 LGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGFC 309
           LG+G F    K +   + +  AVK +SK   + E   + E+  L   + H N+V+L    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 310 LERKERILVYEFVPNASLDHFIFDPINRE-HMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
            ++    LV E +    L    F+ I ++ H +  +   I+  +   + ++H+   + ++
Sbjct: 76  HDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHD---VGVV 128
Query: 369 HRDLKASNILLDSE---MNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRF 425
           HRDLK  N+L   E   +  KI DFG ARL   D     T     T  Y APE +    +
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP--CFTLHYAAPELLNQNGY 186
Query: 426 SVKSDIFSFGVLVLEIVSGQ 445
               D++S GV++  ++SGQ
Sbjct: 187 DESCDLWSLGVILYTMLSGQ 206

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVK-----RLSKNSKQGEIEFKNEVLLLARL 297
           D +     +G+G F  V + +    G+  AVK     + + +      + K E  +   L
Sbjct: 24  DVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLL 357
           +H ++V LL          +V+EF+  A L    F+ + R    +     +     R +L
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 358 ----YLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQTHSDTNRVVG 410
               Y H+++   IIHRD+K  N+LL S+ N    K+ DFG+A   ++ ++       VG
Sbjct: 141 EALRYCHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVA--IQLGESGLVAGGRVG 195
Query: 411 TFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           T  +MAPE V    +    D++  GV++  ++SG
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 13/211 (6%)
Query: 240 RVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           RV  + F     LG+G FG V      + G   A+K L K     + E  + +     LQ
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 65
Query: 299 HRN--LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IAR 354
           +     +  L +  +  +R+  V E+     L    F  ++RE +  E R +     I  
Sbjct: 66  NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVS 121
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY 414
            L YLH  S   +++RDLK  N++LD + + KI+DFG+ +  E  +  +      GT  Y
Sbjct: 122 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEY 177
Query: 415 MAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           +APE +    +    D +  GV++ E++ G+
Sbjct: 178 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 108/240 (45%), Gaps = 31/240 (12%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            +++DFG A+     +    T  + GT  Y+AP  ++   ++   D ++ GVL+ E+ +G
Sbjct: 180 IQVTDFGFAK-----RVKGRTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 13/211 (6%)
Query: 240 RVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           RV  + F     LG+G FG V      + G   A+K L K     + E  + +     LQ
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 63
Query: 299 HRN--LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IAR 354
           +     +  L +  +  +R+  V E+     L    F  ++RE +  E R +     I  
Sbjct: 64  NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVS 119
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY 414
            L YLH  S   +++RDLK  N++LD + + KI+DFG+ +  E  +  +      GT  Y
Sbjct: 120 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEY 175
Query: 415 MAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           +APE +    +    D +  GV++ E++ G+
Sbjct: 176 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 13/211 (6%)
Query: 240 RVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           RV  + F     LG+G FG V      + G   A+K L K     + E  + +     LQ
Sbjct: 5   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 64
Query: 299 HRN--LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IAR 354
           +     +  L +  +  +R+  V E+     L    F  ++RE +  E R +     I  
Sbjct: 65  NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVS 120
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY 414
            L YLH  S   +++RDLK  N++LD + + KI+DFG+ +  E  +  +      GT  Y
Sbjct: 121 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEY 176
Query: 415 MAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           +APE +    +    D +  GV++ E++ G+
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 114/255 (44%), Gaps = 36/255 (14%)
Query: 215 GKLKLEDENVEETIA-KSLQF----DFETIRVATDNFSDANKLGQGGFGAVYKGMLS-NG 268
           G +K E  +   ++A K+L       F+      D +     +G G +G V        G
Sbjct: 21  GPVKAEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTG 80
Query: 269 ETIAVKRLSK------NSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL------ERKERI 316
           + +A+K++        N+K+   E K    +L   +H N++ +           E K   
Sbjct: 81  QQVAIKKIPNAFDVVTNAKRTLRELK----ILKHFKHDNIIAIKDILRPTVPYGEFKSVY 136
Query: 317 LVYEFVPNASLDHFIF--DPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKA 374
           +V + +  + L   I    P+  EH+    RY + + + RGL Y+H     ++IHRDLK 
Sbjct: 137 VVLDLM-ESDLHQIIHSSQPLTLEHV----RYFLYQ-LLRGLKYMHS---AQVIHRDLKP 187
Query: 375 SNILLDSEMNPKISDFGMAR-LFEMDQTHSD-TNRVVGTFGYMAPEYVMH-GRFSVKSDI 431
           SN+L++     KI DFGMAR L      H       V T  Y APE ++    ++   D+
Sbjct: 188 SNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDL 247
Query: 432 FSFGVLVLEIVSGQK 446
           +S G +  E+++ ++
Sbjct: 248 WSVGCIFGEMLARRQ 262

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 101/222 (45%), Gaps = 23/222 (10%)
Query: 230 KSLQFDF-ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEF 287
           K + +++ E +  AT       +LG+G FG V++      G   AVK++       E+  
Sbjct: 63  KPVDYEYREEVHWATHQL----RLGRGSFGEVHRMEDKQTGFQCAVKKVRL-----EVFR 113
Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
             E++  A L    +V L G   E     +  E +   SL   +      +    E R  
Sbjct: 114 AEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV----KEQGCLPEDRAL 169
Query: 348 IIEGIA-RGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMARLFEMDQTHSDT 405
              G A  GL YLH  SR RI+H D+KA N+LL S+  +  + DFG A   + D    D 
Sbjct: 170 YYLGQALEGLEYLH--SR-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDL 226
Query: 406 ---NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
              + + GT  +MAPE V+      K D++S   ++L +++G
Sbjct: 227 LTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 244 DNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNS--KQGEIEFK-NEVLLLAR 296
           D F     LG G FG V   ML     +G   A+K L K    K  +IE   NE  +L  
Sbjct: 28  DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 84
Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IARG 355
           +    LV+L     +     +V E+V    +    F  + R     E   +     I   
Sbjct: 85  VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 140
Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYM 415
             YLH    L +I+RDLK  N+L+D +   +++DFG A+     +    T  + GT  Y+
Sbjct: 141 FEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 192
Query: 416 APEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 193 APEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 13/211 (6%)
Query: 240 RVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           RV  + F     LG+G FG V      + G   A+K L K     + E  + +     LQ
Sbjct: 147 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 206
Query: 299 HRN--LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IAR 354
           +     +  L +  +  +R+  V E+     L    F  ++RE +  E R +     I  
Sbjct: 207 NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVS 262
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY 414
            L YLH  S   +++RDLK  N++LD + + KI+DFG+ +  E  +  +      GT  Y
Sbjct: 263 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEY 318
Query: 415 MAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           +APE +    +    D +  GV++ E++ G+
Sbjct: 319 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 13/211 (6%)
Query: 240 RVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           RV  + F     LG+G FG V      + G   A+K L K     + E  + +     LQ
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 203
Query: 299 HRN--LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IAR 354
           +     +  L +  +  +R+  V E+     L    F  ++RE +  E R +     I  
Sbjct: 204 NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVS 259
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY 414
            L YLH  S   +++RDLK  N++LD + + KI+DFG+ +  E  +  +      GT  Y
Sbjct: 260 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEY 315
Query: 415 MAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           +APE +    +    D +  GV++ E++ G+
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 107/233 (45%), Gaps = 26/233 (11%)
Query: 223 NVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETI-AVKRLSKN-- 279
           N  E I K ++     +++  +++     +G+G FG V        + + A+K LSK   
Sbjct: 58  NRYEKIVKKIR----GLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEM 113
Query: 280 -SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE 338
             +     F  E  ++A      +V+L     + K   +V E++P   L + + +    E
Sbjct: 114 IKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE 173
Query: 339 HMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM 398
              W K Y      A  +L L     + +IHRD+K  N+LLD   + K++DFG     +M
Sbjct: 174 --KWAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKM 224
Query: 399 DQT---HSDTNRVVGTFGYMAPEYVM----HGRFSVKSDIFSFGVLVLEIVSG 444
           D+T   H DT   VGT  Y++PE +      G +  + D +S GV + E++ G
Sbjct: 225 DETGMVHCDT--AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 83/163 (50%), Gaps = 16/163 (9%)
Query: 289 NEVLLLARLQ-HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
            EV +L ++  H N+++L           LV++ +    L  ++ + +    ++ ++  K
Sbjct: 59  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRK 115
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           I+  +   +  LH   +L I+HRDLK  NILLD +MN K++DFG +   +  +       
Sbjct: 116 IMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LRE 169
Query: 408 VVGTFGYMAPEYVM------HGRFSVKSDIFSFGVLVLEIVSG 444
           V GT  Y+APE +       H  +  + D++S GV++  +++G
Sbjct: 170 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 113/274 (41%), Gaps = 64/274 (23%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-----QHRNLVRLL 306
           LG G  G V       G  +AVKR+        I+F +  L+  +L      H N++R  
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRML-------IDFCDIALMEIKLLTESDDHPNVIRY- 74
Query: 307 GFCLERKERILVYEF-VPNASLDHFIFDP-INREHMTWEKRY---KIIEGIARGLLYLHE 361
            +C E  +R L     + N +L   +    ++ E++  +K Y    ++  IA G+ +LH 
Sbjct: 75  -YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 362 DSRLRIIHRDLKASNILLDSE-------------MNPKISDFGMARLFEMDQT--HSDTN 406
              L+IIHRDLK  NIL+ +              +   ISDFG+ +  +  Q     + N
Sbjct: 134 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 190
Query: 407 RVVGTFGYMAPEYVMHG-------RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDL 459
              GT G+ APE +          R +   DIFS G +   I+S  K   FG +   E  
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH-PFGDKYSRE-- 247
Query: 460 LTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIH 493
                               +RG  + + MKC+H
Sbjct: 248 -----------------SNIIRGIFSLDEMKCLH 264

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 107/244 (43%), Gaps = 28/244 (11%)
Query: 224 VEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGM--LSNGETIAVKRLSKNSK 281
           V++    S+QF        TD +     +G G +    + +   +N E  AVK + K+ +
Sbjct: 10  VQQLHRNSIQF--------TDGYEVKEDIGVGSYSVCKRCIHKATNXE-FAVKIIDKSKR 60
Query: 282 QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMT 341
               E +   +LL   QH N++ L     + K   +V E      L     D I R+   
Sbjct: 61  DPTEEIE---ILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGEL----LDKILRQKFF 113
Query: 342 WEKRYK-IIEGIARGLLYLHEDSRLRIIHRDLKASNIL-LDSEMNP---KISDFGMARLF 396
            E+    ++  I + + YLH      ++HRDLK SNIL +D   NP   +I DFG A+  
Sbjct: 114 SEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170
Query: 397 EMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
             +     T      F  +APE +    +    DI+S GVL+   ++G    + G ++  
Sbjct: 171 RAENGLLXTPCYTANF--VAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTP 228
Query: 457 EDLL 460
           E++L
Sbjct: 229 EEIL 232

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 83/163 (50%), Gaps = 16/163 (9%)
Query: 289 NEVLLLARLQ-HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
            EV +L ++  H N+++L           LV++ +    L  ++ + +    ++ ++  K
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRK 128
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           I+  +   +  LH   +L I+HRDLK  NILLD +MN K++DFG +   +  +       
Sbjct: 129 IMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LRE 182
Query: 408 VVGTFGYMAPEYVM------HGRFSVKSDIFSFGVLVLEIVSG 444
           V GT  Y+APE +       H  +  + D++S GV++  +++G
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 109/244 (44%), Gaps = 28/244 (11%)
Query: 224 VEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGM--LSNGETIAVKRLSKNSK 281
           V++    S+QF        TD +     +G G +    + +   +N E  AVK + K+ +
Sbjct: 10  VQQLHRNSIQF--------TDGYEVKEDIGVGSYSVCKRCIHKATNME-FAVKIIDKSKR 60
Query: 282 QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMT 341
               E +   +LL   QH N++ L     + K   +V E +    L     D I R+   
Sbjct: 61  DPTEEIE---ILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFF 113
Query: 342 WEKRYK-IIEGIARGLLYLHEDSRLRIIHRDLKASNIL-LDSEMNP---KISDFGMARLF 396
            E+    ++  I + + YLH      ++HRDLK SNIL +D   NP   +I DFG A+  
Sbjct: 114 SEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170
Query: 397 EMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
             +     T      F  +APE +    +    DI+S GVL+  +++G    + G ++  
Sbjct: 171 RAENGLLMTPCYTANF--VAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP 228
Query: 457 EDLL 460
           E++L
Sbjct: 229 EEIL 232

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 83/163 (50%), Gaps = 16/163 (9%)
Query: 289 NEVLLLARLQ-HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
            EV +L ++  H N+++L           LV++ +    L  ++ + +    ++ ++  K
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRK 128
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           I+  +   +  LH   +L I+HRDLK  NILLD +MN K++DFG +   +  +       
Sbjct: 129 IMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LRS 182
Query: 408 VVGTFGYMAPEYVM------HGRFSVKSDIFSFGVLVLEIVSG 444
           V GT  Y+APE +       H  +  + D++S GV++  +++G
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 107/236 (45%), Gaps = 41/236 (17%)
Query: 244 DNFSDANKLGQGGFGAVYKGMLSNG-ETIAVKRLSKNSKQGEIEFKN---EVLLLARLQH 299
           DN+   + +G+G +G VY     N  + +A+K++++   +  I+ K    E+ +L RL+ 
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMF-EDLIDCKRILREITILNRLKS 86
Query: 300 RNLVRLLGFC-----LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR 354
             ++RL         L+  E  +V E + ++ L      PI    +T +    I+  +  
Sbjct: 87  DYIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTPI---FLTEQHVKTILYNLLL 142
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV------ 408
           G  ++HE     IIHRDLK +N LL+ + + KI DFG+AR    D+     N +      
Sbjct: 143 GEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEEN 199
Query: 409 -----------------VGTFGYMAPEYV-MHGRFSVKSDIFSFGVLVLEIVSGQK 446
                            V T  Y APE + +   ++   DI+S G +  E+++  K
Sbjct: 200 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMK 255

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/240 (29%), Positives = 108/240 (45%), Gaps = 31/240 (12%)
Query: 220 EDENVEETIAKSLQFDF----ETIRVAT---DNFSDANKLGQGGFGAVYKGML----SNG 268
           E E+V+E +AK+ + DF    ET    T   D F     LG G FG V   ML     +G
Sbjct: 11  EQESVKEFLAKAKE-DFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESG 66
Query: 269 ETIAVKRLSKNS--KQGEIEFK-NEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
              A+K L K    K  +IE   NE  +L  +    LV+L     +     +V E+V   
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 326 SLDHFIFDPINREHMTWEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMN 384
            +    F  + R     E   +     I     YLH    L +I+RDLK  N+L+D +  
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            +++DFG A+     +    T  + GT   +APE ++   ++   D ++ GVL+ E+ +G
Sbjct: 180 IQVTDFGFAK-----RVKGRTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 108/232 (46%), Gaps = 28/232 (12%)
Query: 246 FSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           + D   LG GG G V+  + ++  + +A+K++     Q       E+ ++ RL H N+V+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 305 L--------------LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE 350
           +              +G   E     +V E++     +     P+  EH         + 
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL-----FMY 127
Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMARLFEMDQTHS-DTNRV 408
            + RGL Y+H  +   ++HRDLK +N+ +++E +  KI DFG+AR+ +   +H    +  
Sbjct: 128 QLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 409 VGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDL 459
           + T  Y +P  ++    ++   D+++ G +  E+++G  ++ F    E E +
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG--KTLFAGAHELEQM 234

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 23/222 (10%)
Query: 230 KSLQFDF-ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEF 287
           K + +++ E +  AT       +LG+G FG V++      G   AVK++       E+  
Sbjct: 82  KPVDYEYREEVHWATHQL----RLGRGSFGEVHRMEDKQTGFQCAVKKVRL-----EVFR 132
Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
             E++  A L    +V L G   E     +  E +   SL   +      +    E R  
Sbjct: 133 AEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV----KEQGCLPEDRAL 188
Query: 348 IIEGIA-RGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMARLFEMD---QTH 402
              G A  GL YLH  SR RI+H D+KA N+LL S+  +  + DFG A   + D   ++ 
Sbjct: 189 YYLGQALEGLEYLH--SR-RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSL 245
Query: 403 SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
              + + GT  +MAPE V+      K D++S   ++L +++G
Sbjct: 246 LTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 114/255 (44%), Gaps = 36/255 (14%)
Query: 215 GKLKLEDENVEETIA-KSLQF----DFETIRVATDNFSDANKLGQGGFGAVYKGMLS-NG 268
           G +K E  +   ++A K+L       F+      D +     +G G +G V        G
Sbjct: 20  GPVKAEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTG 79
Query: 269 ETIAVKRLSK------NSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL------ERKERI 316
           + +A+K++        N+K+   E K    +L   +H N++ +           E K   
Sbjct: 80  QQVAIKKIPNAFDVVTNAKRTLRELK----ILKHFKHDNIIAIKDILRPTVPYGEFKSVY 135
Query: 317 LVYEFVPNASLDHFIF--DPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKA 374
           +V + +  + L   I    P+  EH+    RY + + + RGL Y+H     ++IHRDLK 
Sbjct: 136 VVLDLM-ESDLHQIIHSSQPLTLEHV----RYFLYQ-LLRGLKYMHS---AQVIHRDLKP 186
Query: 375 SNILLDSEMNPKISDFGMAR-LFEMDQTHSD-TNRVVGTFGYMAPEYVMH-GRFSVKSDI 431
           SN+L++     KI DFGMAR L      H       V T  Y APE ++    ++   D+
Sbjct: 187 SNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDL 246
Query: 432 FSFGVLVLEIVSGQK 446
           +S G +  E+++ ++
Sbjct: 247 WSVGCIFGEMLARRQ 261

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 32/211 (15%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSK-------QGEIEFKNEVLLLARLQHRNLVR 304
           LG+G +G V + +  + ET+  + +    K        GE   K E+ LL RL+H+N+++
Sbjct: 13  LGEGSYGKVKEVL--DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 305 LLGFCL--ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG------IARGL 356
           L+      E+++  +V E+      +     P        EKR+ + +       +  GL
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP--------EKRFPVCQAHGYFCQLIDGL 122
Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            YLH      I+H+D+K  N+LL +    KIS  G+A                G+  +  
Sbjct: 123 EYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 417 PEYVMHG--RFS-VKSDIFSFGVLVLEIVSG 444
           PE + +G   FS  K DI+S GV +  I +G
Sbjct: 180 PE-IANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 240 RVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           +V  ++F     LG+G FG V      + G   A+K L K     + E  + V     LQ
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 299 HRN--LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IAR 354
           +     +  L +  +  +R+  V E+     L    F  ++RE +  E+R +     I  
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAEIVS 116
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY 414
            L YLH      +++RD+K  N++LD + + KI+DFG+ +  E     +      GT  Y
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEY 171
Query: 415 MAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           +APE +    +    D +  GV++ E++ G+
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 240 RVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           +V  ++F     LG+G FG V      + G   A+K L K     + E  + V     LQ
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 63
Query: 299 HRN--LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IAR 354
           +     +  L +  +  +R+  V E+     L    F  ++RE +  E+R +     I  
Sbjct: 64  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAEIVS 119
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY 414
            L YLH      +++RD+K  N++LD + + KI+DFG+ +  E     +      GT  Y
Sbjct: 120 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEY 174
Query: 415 MAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           +APE +    +    D +  GV++ E++ G+
Sbjct: 175 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 240 RVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           +V  ++F     LG+G FG V      + G   A+K L K     + E  + V     LQ
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 299 HRN--LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IAR 354
           +     +  L +  +  +R+  V E+     L    F  ++RE +  E+R +     I  
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAEIVS 116
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY 414
            L YLH      +++RD+K  N++LD + + KI+DFG+ +  E     +      GT  Y
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEY 171
Query: 415 MAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           +APE +    +    D +  GV++ E++ G+
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 240 RVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           +V  ++F     LG+G FG V      + G   A+K L K     + E  + V     LQ
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 299 HRN--LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IAR 354
           +     +  L +  +  +R+  V E+     L    F  ++RE +  E+R +     I  
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAEIVS 116
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY 414
            L YLH      +++RD+K  N++LD + + KI+DFG+ +  E     +      GT  Y
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEY 171
Query: 415 MAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           +APE +    +    D +  GV++ E++ G+
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 240 RVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           +V  ++F     LG+G FG V      + G   A+K L K     + E  + V     LQ
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 65
Query: 299 HRN--LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IAR 354
           +     +  L +  +  +R+  V E+     L    F  ++RE +  E+R +     I  
Sbjct: 66  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAEIVS 121
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY 414
            L YLH      +++RD+K  N++LD + + KI+DFG+ +  E     +      GT  Y
Sbjct: 122 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEY 176
Query: 415 MAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           +APE +    +    D +  GV++ E++ G+
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 240 RVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           +V  ++F     LG+G FG V      + G   A+K L K     + E  + V     LQ
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 299 HRN--LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IAR 354
           +     +  L +  +  +R+  V E+     L    F  ++RE +  E+R +     I  
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAEIVS 116
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY 414
            L YLH      +++RD+K  N++LD + + KI+DFG+ +  E     +      GT  Y
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEY 171
Query: 415 MAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           +APE +    +    D +  GV++ E++ G+
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 240 RVATDNFSDANKLGQGGFGAV-YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           +V  ++F     LG+G FG V      + G   A+K L K     + E  + V     LQ
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 299 HRN--LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG-IAR 354
           +     +  L +  +  +R+  V E+     L    F  ++RE +  E+R +     I  
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAEIVS 116
Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY 414
            L YLH      +++RD+K  N++LD + + KI+DFG+ +  E     +      GT  Y
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEY 171
Query: 415 MAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           +APE +    +    D +  GV++ E++ G+
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/124 (30%), Positives = 60/124 (48%), Gaps = 18/124 (14%)
Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ------- 400
           I   IA  + +LH      ++HRDLK SNI    +   K+ DFG+    + D+       
Sbjct: 169 IFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 401 ---THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE 457
               ++     VGT  YM+PE +    +S K DIFS G+++ E++      SF T+ E  
Sbjct: 226 PMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL-----YSFSTQMERV 280
Query: 458 DLLT 461
            ++T
Sbjct: 281 RIIT 284

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 88/195 (45%), Gaps = 24/195 (12%)
Query: 236 FETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVK--RLSKNSKQGEIEFKNEVLL 293
           F+++ V    +S   ++G GG   V++ +    +  A+K   L +   Q    ++NE+  
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 294 LARLQHRN--LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG 351
           L +LQ  +  ++RL  + +  +   +V E   N  L+            +W K+ K I+ 
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLN------------SWLKKKKSIDP 126
Query: 352 IARGLLY------LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
             R   +      +H   +  I+H DLK +N L+   M  K+ DFG+A   + D T    
Sbjct: 127 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVK 185
Query: 406 NRVVGTFGYMAPEYV 420
           +  VGT  YM PE +
Sbjct: 186 DSQVGTVNYMPPEAI 200

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 85/183 (46%), Gaps = 30/183 (16%)
Query: 266 SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNA 325
           SN + I++K     SK  +  FKNE+ ++  +++   +   G      E  ++YE++ N 
Sbjct: 76  SNNDKISIK-----SKYDD--FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMEND 128
Query: 326 SLDHFIFDPINREHMTWEKRYK----------IIEGIARGLLYLHEDSRLRIIHRDLKAS 375
           S+  F     +      +K Y           II+ +     Y+H +    I HRD+K S
Sbjct: 129 SILKF-----DEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPS 181
Query: 376 NILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH--GRFSVKSDIFS 433
           NIL+D     K+SDFG +  + +D+    +    GT+ +M PE+  +       K DI+S
Sbjct: 182 NILMDKNGRVKLSDFGESE-YMVDKKIKGSR---GTYEFMPPEFFSNESSYNGAKVDIWS 237
Query: 434 FGV 436
            G+
Sbjct: 238 LGI 240

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 64/121 (52%), Gaps = 13/121 (10%)
Query: 331 IFDPINREHMTWEKRYK-IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD 389
           +FD +  +    EK  + I+  +   + +LH ++   I+HRDLK  NILLD  M  ++SD
Sbjct: 187 LFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSD 243
Query: 390 FGMARLFEMDQTHSDTNRVVGTFGYMAPEYV------MHGRFSVKSDIFSFGVLVLEIVS 443
           FG +   E  +       + GT GY+APE +       H  +  + D+++ GV++  +++
Sbjct: 244 FGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA 300
Query: 444 G 444
           G
Sbjct: 301 G 301

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 85/194 (43%), Gaps = 24/194 (12%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVK--RLSKNSKQGEIEFKNEVLLL 294
           E I V    +S   ++G GG   V++ +    +  A+K   L +   Q    ++NE+  L
Sbjct: 5   ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 64
Query: 295 ARLQHRN--LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
            +LQ  +  ++RL             Y++       + + +  N +  +W K+ K I+  
Sbjct: 65  NKLQQHSDKIIRL-------------YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPW 111
Query: 353 ARGLLY------LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            R   +      +H   +  I+H DLK +N L+   M  K+ DFG+A   + D T    +
Sbjct: 112 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKD 170
Query: 407 RVVGTFGYMAPEYV 420
             VGT  YM PE +
Sbjct: 171 SQVGTVNYMPPEAI 184

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 98/230 (42%), Gaps = 25/230 (10%)
Query: 233 QFDF--ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN 289
           Q DF  +T+ +          L +GGF  VY+   + +G   A+KRL  N ++       
Sbjct: 15  QSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ 74
Query: 290 EVLLLARLQ-HRNLVRLLGFCLERKER-------ILVYEFVPNASLDHFIFDPINREHMT 341
           EV  + +L  H N+V+        KE         L+   +    L  F+    +R  ++
Sbjct: 75  EVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLS 134
Query: 342 WEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM--D 399
            +   KI     R + ++H   +  IIHRDLK  N+LL ++   K+ DFG A       D
Sbjct: 135 CDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPD 193
Query: 400 QTHSDTNRVV--------GTFGYMAPEYV-MHGRFSV--KSDIFSFGVLV 438
            + S   R +         T  Y  PE + ++  F +  K DI++ G ++
Sbjct: 194 YSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 86/194 (44%), Gaps = 24/194 (12%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVK--RLSKNSKQGEIEFKNEVLLL 294
           E I V    +S   ++G GG   V++ +    +  A+K   L +   Q    ++NE+  L
Sbjct: 49  ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 295 ARLQHRN--LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
            +LQ  +  ++RL  + +  +   +V E   N  L+            +W K+ K I+  
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLN------------SWLKKKKSIDPW 155
Query: 353 ARGLLY------LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            R   +      +H   +  I+H DLK +N L+   M  K+ DFG+A   + D T    +
Sbjct: 156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKD 214
Query: 407 RVVGTFGYMAPEYV 420
             VGT  YM PE +
Sbjct: 215 SQVGTVNYMPPEAI 228

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 96/216 (44%), Gaps = 19/216 (8%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLL 293
           D+E  R      +   +LG+G FG V++      G   AVK++       E+    E++ 
Sbjct: 64  DYE-YREEVHWMTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKVRL-----EVFRVEELVA 117
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
            A L    +V L G   E     +  E +   SL   I     +     E R     G A
Sbjct: 118 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQA 173
Query: 354 -RGLLYLHEDSRLRIIHRDLKASNILLDSEMN-PKISDFGMARLFEMD---QTHSDTNRV 408
             GL YLH     RI+H D+KA N+LL S+ +   + DFG A   + D   ++    + +
Sbjct: 174 LEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 230
Query: 409 VGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            GT  +MAPE VM      K DI+S   ++L +++G
Sbjct: 231 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 85/194 (43%), Gaps = 24/194 (12%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVK--RLSKNSKQGEIEFKNEVLLL 294
           E I V    +S   ++G GG   V++ +    +  A+K   L +   Q    ++NE+  L
Sbjct: 1   ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 60
Query: 295 ARLQHRN--LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
            +LQ  +  ++RL             Y++       + + +  N +  +W K+ K I+  
Sbjct: 61  NKLQQHSDKIIRL-------------YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPW 107
Query: 353 ARGLLY------LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            R   +      +H   +  I+H DLK +N L+   M  K+ DFG+A   + D T    +
Sbjct: 108 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKD 166
Query: 407 RVVGTFGYMAPEYV 420
             VGT  YM PE +
Sbjct: 167 SQVGTVNYMPPEAI 180

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 86/194 (44%), Gaps = 24/194 (12%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVK--RLSKNSKQGEIEFKNEVLLL 294
           E I V    +S   ++G GG   V++ +    +  A+K   L +   Q    ++NE+  L
Sbjct: 49  ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 295 ARLQHRN--LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
            +LQ  +  ++RL  + +  +   +V E   N  L+            +W K+ K I+  
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLN------------SWLKKKKSIDPW 155
Query: 353 ARGLLY------LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            R   +      +H   +  I+H DLK +N L+   M  K+ DFG+A   + D T    +
Sbjct: 156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKD 214
Query: 407 RVVGTFGYMAPEYV 420
             VGT  YM PE +
Sbjct: 215 SQVGTVNYMPPEAI 228

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 86/194 (44%), Gaps = 24/194 (12%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVK--RLSKNSKQGEIEFKNEVLLL 294
           E I V    +S   ++G GG   V++ +    +  A+K   L +   Q    ++NE+  L
Sbjct: 2   ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61
Query: 295 ARLQHRN--LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
            +LQ  +  ++RL  + +  +   +V E   N  L+            +W K+ K I+  
Sbjct: 62  NKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLN------------SWLKKKKSIDPW 108
Query: 353 ARGLLY------LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            R   +      +H   +  I+H DLK +N L+   M  K+ DFG+A   + D T    +
Sbjct: 109 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKD 167
Query: 407 RVVGTFGYMAPEYV 420
             VGT  YM PE +
Sbjct: 168 SQVGTVNYMPPEAI 181

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 110/250 (44%), Gaps = 18/250 (7%)
Query: 208 ICIFLRVGKLKLEDE-NVEETI--AKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGM 264
           IC++       L  E N+ E +  AK      + +R+  ++F     +G+G FG V    
Sbjct: 35  ICLYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVK 94
Query: 265 LSNGETI-AVKRLSKNSKQGEIE---FKNEVLLLARLQHRNLVRLLGFCLERKERILVYE 320
           L N + + A+K L+K       E   F+ E  +L     + +  L     +     LV +
Sbjct: 95  LKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMD 154
Query: 321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD 380
           +     L   +    +R      + Y     +A  ++ +    +L  +HRD+K  NIL+D
Sbjct: 155 YYVGGDLLTLLSKFEDRLPEEMARFY-----LAEMVIAIDSVHQLHYVHRDIKPDNILMD 209
Query: 381 SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM-----HGRFSVKSDIFSFG 435
              + +++DFG   L  M+     ++  VGT  Y++PE +       GR+  + D +S G
Sbjct: 210 MNGHIRLADFGSC-LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLG 268
Query: 436 VLVLEIVSGQ 445
           V + E++ G+
Sbjct: 269 VCMYEMLYGE 278

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 34/211 (16%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI-----------EFKNEVLLLARLQHR 300
           +  G +GAV  G+ S G  +A+KR+      G                 E+ LL    H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 301 NLVRLLGFCLERKE----RILVYEFVPNASLDHFIFDP---INREHMTWEKRYKIIEGIA 353
           N++ L    +  +E    ++ +   +    L   I D    I+ +H+ +      +  I 
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQY-----FMYHIL 144
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR--LFEMDQTHSDTNRVVGT 411
            GL  LHE     ++HRDL   NILL    +  I DF +AR    + ++TH  T+R    
Sbjct: 145 LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR---- 197
Query: 412 FGYMAPEYVMHGR-FSVKSDIFSFGVLVLEI 441
             Y APE VM  + F+   D++S G ++ E+
Sbjct: 198 -WYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 36/212 (16%)
Query: 252 LGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI-----------EFKNEVLLLARLQHR 300
           +  G +GAV  G+ S G  +A+KR+      G                 E+ LL    H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 301 NLVRLLGFCLERKE-----RILVYEFVPNASLDHFIFDP---INREHMTWEKRYKIIEGI 352
           N++ L    +  +E       LV E +    L   I D    I+ +H+ +      +  I
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQY-----FMYHI 143
Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR--LFEMDQTHSDTNRVVG 410
             GL  LHE     ++HRDL   NILL    +  I DF +AR    + ++TH  T+R   
Sbjct: 144 LLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR--- 197
Query: 411 TFGYMAPEYVMHGR-FSVKSDIFSFGVLVLEI 441
              Y APE VM  + F+   D++S G ++ E+
Sbjct: 198 --WYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 87/195 (44%), Gaps = 24/195 (12%)
Query: 236 FETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVK--RLSKNSKQGEIEFKNEVLL 293
           F+++ V    +S   ++G GG   V++ +    +  A+K   L +   Q    ++NE+  
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 294 LARLQHRN--LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG 351
           L +LQ  +  ++RL  + +  +   +V E   N  L+            +W K+ K I+ 
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLN------------SWLKKKKSIDP 126
Query: 352 IARGLLY------LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
             R   +      +H   +  I+H DLK +N L+   M  K+ DFG+A   + D      
Sbjct: 127 WERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVK 185
Query: 406 NRVVGTFGYMAPEYV 420
           +  VGT  YM PE +
Sbjct: 186 DSQVGTVNYMPPEAI 200

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 107/236 (45%), Gaps = 49/236 (20%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLL-- 293
           E  R   D F      GQG FG V  G   S G ++A+K++ ++ +     F+N  L   
Sbjct: 16  ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-----FRNRELQIM 70
Query: 294 --LARLQHRNLVRLLGFCLERKERI-------LVYEFVPNASLDHFIFDPINREHMTWEK 344
             LA L H N+V+L  +     ER        +V E+VP         D ++R    + +
Sbjct: 71  QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---------DTLHRCCRNYYR 121
Query: 345 R-------------YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL-DSEMNPKISDF 390
           R             +++I  I  G L+L     + + HRD+K  N+L+ +++   K+ DF
Sbjct: 122 RQVAPPPILIKVFLFQLIRSI--GCLHL---PSVNVCHRDIKPHNVLVNEADGTLKLCDF 176
Query: 391 GMARLFEMDQTHSDTNRVVGTFGYMAPEYVM-HGRFSVKSDIFSFGVLVLEIVSGQ 445
           G A+  ++  +  +   +   + Y APE +  +  ++   DI+S G +  E++ G+
Sbjct: 177 GSAK--KLSPSEPNVAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 25/219 (11%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLL 293
           D+E  R      +   ++G+G FG V++      G   AVK++       E+    E++ 
Sbjct: 66  DYE-YREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL-----EVFRVEELVA 119
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKII 349
            A L    +V L G   E     +  E +   SL   I      P +R        Y + 
Sbjct: 120 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDR------ALYYLG 173
Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN-PKISDFGMARLFEMD---QTHSDT 405
           + +  GL YLH     RI+H D+KA N+LL S+ +   + DFG A   + D   ++    
Sbjct: 174 QAL-EGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 229
Query: 406 NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           + + GT  +MAPE VM      K DI+S   ++L +++G
Sbjct: 230 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 19/216 (8%)
Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLL 293
           D+E  R      +   ++G+G FG V++      G   AVK++       E+    E++ 
Sbjct: 50  DYE-YREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL-----EVFRVEELVA 103
Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
            A L    +V L G   E     +  E +   SL   I     +     E R     G A
Sbjct: 104 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQA 159
Query: 354 -RGLLYLHEDSRLRIIHRDLKASNILLDSEMN-PKISDFGMARLFEMD---QTHSDTNRV 408
             GL YLH     RI+H D+KA N+LL S+ +   + DFG A   + D   ++    + +
Sbjct: 160 LEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216
Query: 409 VGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            GT  +MAPE VM      K DI+S   ++L +++G
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 106/217 (48%), Gaps = 27/217 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSK------NSKQGE--IEFKNEVLLL 294
           D +  +  LG G  G V         + +A+K +SK      ++++ +  +  + E+ +L
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIA 353
            +L H  ++++  F  + ++  +V E +    L D  + +   +E       Y+++  + 
Sbjct: 76  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 134
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQTHSDTNRVVG 410
               YLHE+    IIHRDLK  N+LL S+      KI+DFG +++  + +T S    + G
Sbjct: 135 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGET-SLMRTLCG 184
Query: 411 TFGYMAPEYVMH---GRFSVKSDIFSFGVLVLEIVSG 444
           T  Y+APE ++      ++   D +S GV++   +SG
Sbjct: 185 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 26/214 (12%)
Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSK----------NSKQGEIEFKNEV 291
           +  +S  + LG G FG V+  +     + + VK + K          + K G++    E+
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL--EI 80
Query: 292 LLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK-IIE 350
            +L+R++H N++++L     +    LV E    + LD F F  I+R     E     I  
Sbjct: 81  AILSRVEHANIIKVLDIFENQGFFQLVME-KHGSGLDLFAF--IDRHPRLDEPLASYIFR 137
Query: 351 GIARGLLYLHEDSRLR-IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
            +   + YL    RL+ IIHRD+K  NI++  +   K+ DFG A   E  +         
Sbjct: 138 QLVSAVGYL----RLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF---YTFC 190
Query: 410 GTFGYMAPEYVMHGRF-SVKSDIFSFGVLVLEIV 442
           GT  Y APE +M   +   + +++S GV +  +V
Sbjct: 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 106/217 (48%), Gaps = 27/217 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSK------NSKQGE--IEFKNEVLLL 294
           D +  +  LG G  G V         + +A+K +SK      ++++ +  +  + E+ +L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIA 353
            +L H  ++++  F  + ++  +V E +    L D  + +   +E       Y+++  + 
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQTHSDTNRVVG 410
               YLHE+    IIHRDLK  N+LL S+      KI+DFG +++  + +T S    + G
Sbjct: 129 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGET-SLMRTLCG 178
Query: 411 TFGYMAPEYVMH---GRFSVKSDIFSFGVLVLEIVSG 444
           T  Y+APE ++      ++   D +S GV++   +SG
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 106/217 (48%), Gaps = 27/217 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSK------NSKQGE--IEFKNEVLLL 294
           D +  +  LG G  G V         + +A+K +SK      ++++ +  +  + E+ +L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIA 353
            +L H  ++++  F  + ++  +V E +    L D  + +   +E       Y+++  + 
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQTHSDTNRVVG 410
               YLHE+    IIHRDLK  N+LL S+      KI+DFG +++  + +T S    + G
Sbjct: 129 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGET-SLMRTLCG 178
Query: 411 TFGYMAPEYVMH---GRFSVKSDIFSFGVLVLEIVSG 444
           T  Y+APE ++      ++   D +S GV++   +SG
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 106/217 (48%), Gaps = 27/217 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSK------NSKQGE--IEFKNEVLLL 294
           D +  +  LG G  G V         + +A+K +SK      ++++ +  +  + E+ +L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIA 353
            +L H  ++++  F  + ++  +V E +    L D  + +   +E       Y+++  + 
Sbjct: 70  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQTHSDTNRVVG 410
               YLHE+    IIHRDLK  N+LL S+      KI+DFG +++  + +T S    + G
Sbjct: 129 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGET-SLMRTLCG 178
Query: 411 TFGYMAPEYVMH---GRFSVKSDIFSFGVLVLEIVSG 444
           T  Y+APE ++      ++   D +S GV++   +SG
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 106/217 (48%), Gaps = 27/217 (12%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSK------NSKQGE--IEFKNEVLLL 294
           D +  +  LG G  G V         + +A+K +SK      ++++ +  +  + E+ +L
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASL-DHFIFDPINREHMTWEKRYKIIEGIA 353
            +L H  ++++  F  + ++  +V E +    L D  + +   +E       Y+++  + 
Sbjct: 69  KKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 127
Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQTHSDTNRVVG 410
               YLHE+    IIHRDLK  N+LL S+      KI+DFG +++  + +T S    + G
Sbjct: 128 ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGET-SLMRTLCG 177
Query: 411 TFGYMAPEYVMH---GRFSVKSDIFSFGVLVLEIVSG 444
           T  Y+APE ++      ++   D +S GV++   +SG
Sbjct: 178 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 30/227 (13%)
Query: 242 ATDNFS---------DANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEV 291
           +TD+FS           + LG+G    V   + L   +  AVK + K           EV
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 292 LLLARLQ-HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE 350
            +L + Q HRN++ L+ F  E     LV+E +   S+   I     R H    +   +++
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH---KRRHFNELEASVVVQ 118
Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLD--SEMNP-KISDFGMARLFEMDQTHSDTN- 406
            +A  L +LH      I HRDLK  NIL +  ++++P KI DFG+    +++   S  + 
Sbjct: 119 DVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPIST 175
Query: 407 ----RVVGTFGYMAPEYV-----MHGRFSVKSDIFSFGVLVLEIVSG 444
                  G+  YMAPE V         +  + D++S GV++  ++SG
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 21/214 (9%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVK-----RLSKNSKQGEIEFKNEVLLLARL 297
           D +     +G+G F  V + +    G+  AVK     + + +      + K E  +   L
Sbjct: 26  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 85
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLL 357
           +H ++V LL          +V+EF+  A L    F+ + R    +     +     R +L
Sbjct: 86  KHPHIVELLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQIL 142
Query: 358 ----YLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQTHSDTNRVVG 410
               Y H+++   IIHRD+K   +LL S+ N    K+  FG+A   ++ ++       VG
Sbjct: 143 EALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA--IQLGESGLVAGGRVG 197
Query: 411 TFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           T  +MAPE V    +    D++  GV++  ++SG
Sbjct: 198 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 85/194 (43%), Gaps = 24/194 (12%)
Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVK--RLSKNSKQGEIEFKNEVLLL 294
           E I V    +S   ++G GG   V++ +    +  A+K   L +   Q    ++NE+  L
Sbjct: 49  ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 295 ARLQHRN--LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
            +LQ  +  ++RL  + +  +   +V E   N  L+            +W K+ K I+  
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLN------------SWLKKKKSIDPW 155
Query: 353 ARGLLY------LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            R   +      +H   +  I+H DLK +N L+   M  K+ DFG+A   + D T    +
Sbjct: 156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKD 214
Query: 407 RVVGTFGYMAPEYV 420
             VG   YM PE +
Sbjct: 215 SQVGAVNYMPPEAI 228

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 21/214 (9%)
Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVK-----RLSKNSKQGEIEFKNEVLLLARL 297
           D +     +G+G F  V + +    G+  AVK     + + +      + K E  +   L
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLL 357
           +H ++V LL          +V+EF+  A L    F+ + R    +     +     R +L
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 358 ----YLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQTHSDTNRVVG 410
               Y H+++   IIHRD+K   +LL S+ N    K+  FG+A   ++ ++       VG
Sbjct: 141 EALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA--IQLGESGLVAGGRVG 195
Query: 411 TFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           T  +MAPE V    +    D++  GV++  ++SG
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	577
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-156
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-148
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-131
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-94
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-73
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-63
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-62
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	6e-60
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-59
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-57
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-56
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-55
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-54
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-53
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-52
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-52
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-51
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-51
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-47
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-47
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-47
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	8e-47
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-46
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-46
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-45
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-45
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-45
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-45
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	7e-45
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-44
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-44
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-44
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-44
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-44
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-44
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-44
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-44
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-44
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-44
4aoj_A	329	High affinity nerve growth factor receptor; transf	9e-44
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	9e-44
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-43
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-43
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-43
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-43
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	7e-43
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-43
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	8e-43
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	9e-43
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-42
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-42
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-42
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-42
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-42
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-41
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-41
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-41
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	7e-41
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-41
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-40
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-40
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-40
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-40
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-40
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-40
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-40
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-40
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-40
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-39
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-39
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-39
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-39
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-39
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-39
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-39
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-39
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-39
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-39
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-38
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-38
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-38
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-38
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-37
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-37
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-37
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-36
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-36
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-35
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-35
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-35
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-35
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-35
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-35
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-35
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-35
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-34
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-34
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-34
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-34
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-34
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-34
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-34
3aln_A	327	Dual specificity mitogen-activated protein kinase;	9e-34
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	9e-34
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-33
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-33
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-33
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-33
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-33
3fme_A	290	Dual specificity mitogen-activated protein kinase;	8e-33
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-32
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-32
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-32
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-32
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-32
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-32
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-32
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-32
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-32
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-32
3an0_A	340	Dual specificity mitogen-activated protein kinase;	7e-32
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-32
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-32
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-31
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-31
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-31
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-31
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-31
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-30
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-30
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-30
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-30
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-29
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-29
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-29
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-29
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-29
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-29
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	9e-29
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	9e-29
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-28
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-28
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-28
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-28
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-28
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-28
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-28
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-28
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	7e-28
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	8e-28
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-27
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-27
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-27
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-27
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-27
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-27
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-27
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-27
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-27
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-27
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-27
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-27
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	9e-27
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-26
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-26
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-26
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-26
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-26
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	8e-26
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	9e-26
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-25
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-25
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-25
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-25
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	8e-25
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	9e-25
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-24
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-24
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-24
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	1e-23
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	9e-07
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-23
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-23
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-23
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-23
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-23
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-22
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-22
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-22
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-22
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	8e-22
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	9e-22
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	9e-22
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-21
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-21
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-21
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-21
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-21
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-21
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-21
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-21
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-21
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-21
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	6e-21
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-21
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-21
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-21
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-20
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-20
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-20
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-20
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-19
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-19
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-19
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	8e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-18
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-18
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-17
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-17
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-16
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-16
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-15
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	8e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-13
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-13
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-12
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-11
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-10
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-10
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	9e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-08

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  448 bits (1154), Expect = e-156
 Identities = 109/315 (34%), Positives = 174/315 (55%), Gaps = 20/315 (6%)

Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSD------ANKLGQGGFGAVYKGMLSNGETIAV 273
           E++++E +  +   F F  ++  T+NF +       NK+G+GGFG VYKG + N  T+AV
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59

Query: 274 KRLSK----NSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDH 329
           K+L+      +++ + +F  E+ ++A+ QH NLV LLGF  +  +  LVY ++PN SL  
Sbjct: 60  KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119

Query: 330 FIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD 389
            +        ++W  R KI +G A G+ +LHE+     IHRD+K++NILLD     KISD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176

Query: 390 FGMARLF-EMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRS 448
           FG+AR   +  QT   T+R+VGT  YMAPE  + G  + KSDI+SFGV++LEI++G    
Sbjct: 177 FGLARASEKFAQTV-MTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITG--LP 232

Query: 449 SFGTEEETEDLLTYAWRNWNEGAAL-NLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRP 507
           +     E + LL       +E   + + +D  M    ++ +     +   C+ E  + RP
Sbjct: 233 AVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRP 292

Query: 508 GMASVVNMLNGDTVT 522
            +  V  +L   T +
Sbjct: 293 DIKKVQQLLQEMTAS 307

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  429 bits (1106), Expect = e-148
 Identities = 120/293 (40%), Positives = 181/293 (61%), Gaps = 6/293 (2%)

Query: 234 FDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG-EIEFKNEVL 292
           F    ++VA+DNFS+ N LG+GGFG VYKG L++G  +AVKRL +   QG E++F+ EV 
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEG 351
           +++   HRNL+RL GFC+   ER+LVY ++ N S+   + +   ++  + W KR +I  G
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            ARGL YLH+    +IIHRD+KA+NILLD E    + DFG+A+L +   TH  T  V GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198

Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQK--RSSFGTEEETEDLLTYAWRNWNE 469
            G++APEY+  G+ S K+D+F +GV++LE+++GQ+    +    ++   LL +      E
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258

Query: 470 GAALNLMDPTMRGG-STSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTV 521
                L+D  ++G     E+ + I + LLC Q +   RP M+ VV ML GD +
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  386 bits (994), Expect = e-131
 Identities = 108/294 (36%), Positives = 165/294 (56%), Gaps = 7/294 (2%)

Query: 230 KSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKN 289
           +S +     +  AT+NF     +G G FG VYKG+L +G  +A+KR +  S QG  EF+ 
Sbjct: 25  ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFET 84

Query: 290 EVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDP-INREHMTWEKRYKI 348
           E+  L+  +H +LV L+GFC ER E IL+Y+++ N +L   ++   +    M+WE+R +I
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144

Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF-EMDQTHSDTNR 407
             G ARGL YLH  +   IIHRD+K+ NILLD    PKI+DFG+++   E+DQTH  T  
Sbjct: 145 CIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST-V 200

Query: 408 VVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNW 467
           V GT GY+ PEY + GR + KSD++SFGV++ E++  +         E  +L  +A  + 
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260

Query: 468 NEGAALNLMDPTMRGG-STSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDT 520
           N G    ++DP +        + K     + C+  +  +RP M  V+  L    
Sbjct: 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  290 bits (743), Expect = 4e-94
 Identities = 73/310 (23%), Positives = 124/310 (40%), Gaps = 29/310 (9%)

Query: 231 SLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNE 290
            +    E +   +          +G FG V+K  L   E +AVK      KQ   + + E
Sbjct: 11  GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-QNEYE 68

Query: 291 VLLLARLQHRNLVRLLGFCLE----RKERILVYEFVPNASLDHFIFDPINREHMTWEKRY 346
           V  L  ++H N+++ +G          +  L+  F    SL  F+        ++W +  
Sbjct: 69  VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELC 124

Query: 347 KIIEGIARGLLYLHED-------SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
            I E +ARGL YLHED        +  I HRD+K+ N+LL + +   I+DFG+A  FE  
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184

Query: 400 QTHSDTNRVVGTFGYMAPEYVMHG-----RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEE 454
           ++  DT+  VGT  YMAPE +           ++ D+++ G+++ E+ S    +    +E
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244

Query: 455 ETEDLLTYAWRNWN-----EGAALNLMDPTMRG--GSTSEMMKCIHIGLLCVQENVSNRP 507
                     ++ +     E        P +R      + M         C   +   R 
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304

Query: 508 GMASVVNMLN 517
               V   + 
Sbjct: 305 SAGCVGERIT 314

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  237 bits (605), Expect = 2e-73
 Identities = 69/323 (21%), Positives = 120/323 (37%), Gaps = 46/323 (14%)

Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNE- 290
           ++       +  DN      +G+G +GAVYKG L +   +AVK  S  ++Q    F NE 
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEK 56

Query: 291 -VLLLARLQHRNLVRLLGFCLE-----RKERILVYEFVPNASLDHFIFDPINREHMTWEK 344
            +  +  ++H N+ R +          R E +LV E+ PN SL  ++    +     W  
Sbjct: 57  NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVS 112

Query: 345 RYKIIEGIARGLLYLHED------SRLRIIHRDLKASNILLDSEMNPKISDFGMARLF-- 396
             ++   + RGL YLH +       +  I HRDL + N+L+ ++    ISDFG++     
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172

Query: 397 ----EMDQTHSDTNRVVGTFGYMAPEYVM-------HGRFSVKSDIFSFGVLVLEIVSGQ 445
                  +  +     VGT  YMAPE +              + D+++ G++  EI    
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232

Query: 446 KRSSFGTEEETEDLLTYAWRNWNEGAALNLMD--------PTMRGGSTSEMMKCIHIGLL 497
                G E   E  + +     N     ++          P          +    +   
Sbjct: 233 TDLFPG-ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291

Query: 498 ---CVQENVSNRPGMASVVNMLN 517
              C  ++   R         + 
Sbjct: 292 IEDCWDQDAEARLTAQXAEERMA 314

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  210 bits (537), Expect = 1e-63
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 6/198 (3%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLLG 307
            K+G G FG V++    +G  +AVK L +     E   EF  EV ++ RL+H N+V  +G
Sbjct: 43  EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
              +     +V E++   SL   +     RE +   +R  +   +A+G+ YLH      I
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160

Query: 368 IHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSV 427
           +HR+LK+ N+L+D +   K+ DFG++R      T   +    GT  +MAPE +     + 
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218

Query: 428 KSDIFSFGVLVLEIVSGQ 445
           KSD++SFGV++ E+ + Q
Sbjct: 219 KSDVYSFGVILWELATLQ 236

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  206 bits (527), Expect = 3e-62
 Identities = 72/300 (24%), Positives = 125/300 (41%), Gaps = 24/300 (8%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
                   +G+G FG V K      + +A+K++   S+     F  E+  L+R+ H N+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIV 64

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
           +L G CL      LV E+    SL + +       + T           ++G+ YLH   
Sbjct: 65  KLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 364 RLRIIHRDLKASNILLDSEMN-PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH 422
              +IHRDLK  N+LL +     KI DFG A   +   T++      G+  +MAPE    
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-----KGSAAWMAPEVFEG 177

Query: 423 GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG 482
             +S K D+FS+G+++ E+++          +  +++   A+R     A  N   P +  
Sbjct: 178 SNYSEKCDVFSWGIILWEVITR--------RKPFDEIGGPAFR--IMWAVHNGTRPPLIK 227

Query: 483 GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKPAFFMKCSVIPETS 542
                +   +     C  ++ S RP M  +V ++       P   +P  +     +P   
Sbjct: 228 NLPKPIESLMT---RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGE 284

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  200 bits (511), Expect = 6e-60
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 18/210 (8%)

Query: 250 NKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
             LG+G FG   K      GE + +K L +  ++ +  F  EV ++  L+H N+++ +G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
             + K    + E++   +L   I          W +R    + IA G+ YLH    + II
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHS---MNII 130

Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR------------VVGTFGYMA 416
           HRDL + N L+    N  ++DFG+ARL   ++T  +  R            VVG   +MA
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVSGQK 446
           PE +    +  K D+FSFG+++ EI+    
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  197 bits (502), Expect = 4e-59
 Identities = 69/208 (33%), Positives = 110/208 (52%), Gaps = 21/208 (10%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRL----SKNSKQGEIEFKNEVLLLARLQHRNLVRL 305
             +G GGFG VY+     G+ +AVK       ++  Q     + E  L A L+H N++ L
Sbjct: 13  EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 306 LGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
            G CL+     LV EF     L+  +    + + +  +        IARG+ YLH+++ +
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 366 RIIHRDLKASNILLDSEMNP--------KISDFGMARLFEMDQTHSDTNRVVGTFGYMAP 417
            IIHRDLK+SNIL+  ++          KI+DFG+AR  E  +T   +    G + +MAP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKMSA--AGAYAWMAP 183

Query: 418 EYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           E +    FS  SD++S+GVL+ E+++G+
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE 211

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  192 bits (491), Expect = 3e-57
 Identities = 73/287 (25%), Positives = 135/287 (47%), Gaps = 45/287 (15%)

Query: 250 NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEI-------EFKNEVLLLARLQHRN 301
            ++G+GGFG V+KG  + +   +A+K L     +GE        EF+ EV +++ L H N
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +V+L G         +V EFVP   L H + D      + W  + +++  IA G+ Y+  
Sbjct: 85  IVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQ- 139

Query: 362 DSRLRIIHRDLKASNILLDS-----EMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
           +    I+HRDL++ NI L S      +  K++DFG+++      +      ++G F +MA
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSG-----LLGNFQWMA 194

Query: 417 PEYVMHGR---FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAAL 473
           PE  +      ++ K+D +SF +++  I++G+    F  +E +   + +      EG   
Sbjct: 195 PE-TIGAEEESYTEKADTYSFAMILYTILTGEG--PF--DEYSYGKIKFINMIREEGLRP 249

Query: 474 NL---MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
            +     P +R      +++      LC   +   RP  + +V  L+
Sbjct: 250 TIPEDCPPRLR-----NVIE------LCWSGDPKKRPHFSYIVKELS 285

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  187 bits (478), Expect = 2e-55
 Identities = 63/202 (31%), Positives = 106/202 (52%), Gaps = 15/202 (7%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLLG 307
            ++G G FG VYKG   +G+ +AVK L+  +   +    FKNEV +L + +H N++  +G
Sbjct: 30  QRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 308 FCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           +      ++ +V ++   +SL H +           +K   I    ARG+ YLH      
Sbjct: 88  YS--TAPQLAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLH---AKS 140

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE---YVMHG 423
           IIHRDLK++NI L  +   KI DFG+A             ++ G+  +MAPE        
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200

Query: 424 RFSVKSDIFSFGVLVLEIVSGQ 445
            +S +SD+++FG+++ E+++GQ
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQ 222

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  184 bits (469), Expect = 3e-54
 Identities = 59/280 (21%), Positives = 110/280 (39%), Gaps = 41/280 (14%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLLG 307
            KL +   G ++KG    G  I VK L           +F  E   L    H N++ +LG
Sbjct: 16  TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 308 FCLERKERIL--VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
            C          +  ++P  SL + + +  N   +   +  K    +ARG+ +LH    L
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMAFLHTLEPL 133

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH--- 422
            I    L + ++++D +M  +IS   +   F+           +    ++APE +     
Sbjct: 134 -IPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-------MYAPAWVAPEALQKKPE 185

Query: 423 GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWN-----EGAALNLMD 477
                 +D++SF VL+ E+V+ +                  + + +        AL  + 
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREV----------------PFADLSNMEIGMKVALEGLR 229

Query: 478 PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
           PT+  G +  + K + I   C+ E+ + RP    +V +L 
Sbjct: 230 PTIPPGISPHVSKLMKI---CMNEDPAKRPKFDMIVPILE 266

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  182 bits (463), Expect = 8e-53
 Identities = 65/303 (21%), Positives = 117/303 (38%), Gaps = 44/303 (14%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRNLVRLLG 307
             +G+G FG VY G   +GE +A++ +       +    FK EV+   + +H N+V  +G
Sbjct: 39  ELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
            C+      ++       +L   + D   +  +   K  +I + I +G+ YLH      I
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151

Query: 368 IHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVGTFGYMAPEYVMHGR 424
           +H+DLK+ N+  D      I+DFG+  +  + Q     ++     G   ++APE +    
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 425 ---------FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAAL-- 473
                    FS  SD+F+ G +  E+ + +                  ++     A +  
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREW----------------PFKTQPAEAIIWQ 254

Query: 474 --NLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKPAF 531
               M P +      + +    I L C       RP    +++ML          S P  
Sbjct: 255 MGTGMKPNLSQIGMGKEIS--DILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGH 312

Query: 532 FMK 534
           F K
Sbjct: 313 FWK 315

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  179 bits (456), Expect = 4e-52
 Identities = 58/240 (24%), Positives = 99/240 (41%), Gaps = 41/240 (17%)

Query: 224 VEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG 283
           ++ T+A+ +                   +G+G +G V++G    GE +AVK  S    + 
Sbjct: 2   MQRTVARDITLL--------------ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RD 43

Query: 284 EIEFKNE--VLLLARLQHRNLVRLLGFCL----ERKERILVYEFVPNASLDHFIFDPINR 337
           E  +  E  +     L+H N++  +   +       +  L+  +    SL    +D +  
Sbjct: 44  EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSL----YDYLQL 99

Query: 338 EHMTWEKRYKIIEGIARGLLYLHEDSRLR-----IIHRDLKASNILLDSEMNPKISDFGM 392
             +      +I+  IA GL +LH +         I HRDLK+ NIL+       I+D G+
Sbjct: 100 TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159

Query: 393 ARLFEMDQTHSDT--NRVVGTFGYMAPE------YVMHGRFSVKSDIFSFGVLVLEIVSG 444
           A +        D   N  VGT  YMAPE       V       + DI++FG+++ E+   
Sbjct: 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  180 bits (459), Expect = 5e-52
 Identities = 59/243 (24%), Positives = 99/243 (40%), Gaps = 41/243 (16%)

Query: 221 DENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS 280
              V+ TIAK +Q                 ++G+G +G V+ G    GE +AVK      
Sbjct: 28  PLLVQRTIAKQIQMV--------------KQIGKGRYGEVWMGKW-RGEKVAVKVFFT-- 70

Query: 281 KQGEIEFKNE--VLLLARLQHRNLVRLLGFCLERKERI----LVYEFVPNASLDHFIFDP 334
              E  +  E  +     ++H N++  +   ++         L+ ++  N SL  ++   
Sbjct: 71  -TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--- 126

Query: 335 INREHMTWEKRYKIIEGIARGLLYLHEDSRLR-----IIHRDLKASNILLDSEMNPKISD 389
                +  +   K+      GL +LH +         I HRDLK+ NIL+       I+D
Sbjct: 127 -KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185

Query: 390 FGMARLFEMDQTHSD--TNRVVGTFGYMAPE------YVMHGRFSVKSDIFSFGVLVLEI 441
            G+A  F  D    D   N  VGT  YM PE         H +  + +D++SFG+++ E+
Sbjct: 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

Query: 442 VSG 444
              
Sbjct: 246 ARR 248

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  177 bits (451), Expect = 7e-51
 Identities = 66/251 (26%), Positives = 106/251 (42%), Gaps = 41/251 (16%)

Query: 224 VEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG 283
           V+ TIA+++                   +G+G FG V++G    GE +AVK  S    + 
Sbjct: 36  VQRTIARTIVLQ--------------ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---RE 77

Query: 284 EIEFKNE--VLLLARLQHRNLVRLLGFCLERKERI----LVYEFVPNASLDHFIFDPINR 337
           E  +  E  +     L+H N++  +    +         LV ++  + SL    FD +NR
Sbjct: 78  ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNR 133

Query: 338 EHMTWEKRYKIIEGIARGLLYLHED-----SRLRIIHRDLKASNILLDSEMNPKISDFGM 392
             +T E   K+    A GL +LH +      +  I HRDLK+ NIL+       I+D G+
Sbjct: 134 YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193

Query: 393 ARLFEMDQTHSDT--NRVVGTFGYMAPE------YVMHGRFSVKSDIFSFGVLVLEIVSG 444
           A   +      D   N  VGT  YMAPE       + H     ++DI++ G++  EI   
Sbjct: 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253

Query: 445 QKRSSFGTEEE 455
                   + +
Sbjct: 254 CSIGGIHEDYQ 264

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  169 bits (430), Expect = 2e-47
 Identities = 59/197 (29%), Positives = 94/197 (47%), Gaps = 11/197 (5%)

Query: 251 KLGQGGFGAVYKGMLSNGET-IAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           ++G+G FG V+ G L    T +AVK   +      + +F  E  +L +  H N+VRL+G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180

Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C +++   +V E V       F+        +  +   +++   A G+ YL        I
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLES---KCCI 235

Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY--MAPEYVMHGRFS 426
           HRDL A N L+  +   KISDFGM+R        +              APE + +GR+S
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGL--RQVPVKWTAPEALNYGRYS 293

Query: 427 VKSDIFSFGVLVLEIVS 443
            +SD++SFG+L+ E  S
Sbjct: 294 SESDVWSFGILLWETFS 310

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  167 bits (424), Expect = 2e-47
 Identities = 77/283 (27%), Positives = 126/283 (44%), Gaps = 26/283 (9%)

Query: 250 NKLGQGGFGAVYKGML-----SNGETIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLV 303
             LG+G FG V          + GE +AVK L   S    I + K E+ +L  L H N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 304 RLLGFCLERKER--ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +  G C E       L+ EF+P+ SL  ++  P N+  +  +++ K    I +G+ YL  
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS 144

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT--HSDTNRVVGTFGYMAPEY 419
               + +HRDL A N+L++SE   KI DFG+ +  E D+       +R    F + APE 
Sbjct: 145 ---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF-WYAPEC 200

Query: 420 VMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP 478
           +M  +F + SD++SFGV + E+++     SS           T+            L++ 
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR-----LVNT 255

Query: 479 TMRGGSTSEMMKC---IH-IGLLCVQENVSNRPGMASVVNMLN 517
              G        C   ++ +   C +   SNR    +++    
Sbjct: 256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  165 bits (421), Expect = 4e-47
 Identities = 77/284 (27%), Positives = 131/284 (46%), Gaps = 28/284 (9%)

Query: 250 NKLGQGGFGAVYKGML-----SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V          + GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 305 LLGFCLERKER--ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C     R   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT- 132

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG-----YMAP 417
              R IHRDL   NIL+++E   KI DFG+ ++   D+        V   G     + AP
Sbjct: 133 --KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF----KVKEPGESPIFWYAP 186

Query: 418 EYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD 477
           E +   +FSV SD++SFGV++ E+ +  ++S     E    +              +L++
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI---VFHLIE 243

Query: 478 PTMRGGSTSEMMKC---IH-IGLLCVQENVSNRPGMASVVNMLN 517
                G       C   I+ I   C   NV+ RP    +   ++
Sbjct: 244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  166 bits (421), Expect = 8e-47
 Identities = 77/284 (27%), Positives = 132/284 (46%), Gaps = 28/284 (9%)

Query: 250 NKLGQGGFGAVYKGML-----SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +LG+G FG+V          + GE +AVK+L  ++++   +F+ E+ +L  LQH N+V+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 305 LLGFCLERKER--ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G C     R   L+ E++P  SL  ++    ++E +   K  +    I +G+ YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT- 163

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG-----YMAP 417
              R IHRDL   NIL+++E   KI DFG+ ++   D+ +      V   G     + AP
Sbjct: 164 --KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYAP 217

Query: 418 EYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD 477
           E +   +FSV SD++SFGV++ E+ +  ++S     E    +              +L++
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI---VFHLIE 274

Query: 478 PTMRGGSTSEMMKC---IH-IGLLCVQENVSNRPGMASVVNMLN 517
                G       C   I+ I   C   NV+ RP    +   ++
Sbjct: 275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  165 bits (420), Expect = 1e-46
 Identities = 74/285 (25%), Positives = 129/285 (45%), Gaps = 31/285 (10%)

Query: 250 NKLGQGGFGAVYKGML-----SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
           ++LG+G FG+V          + G  +AVK+L  +    + +F+ E+ +L  L    +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 305 LLGFCLERKER--ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G       +   LV E++P+  L  F+    +R  +   +       I +G+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS- 145

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG-----YMAP 417
              R +HRDL A NIL++SE + KI+DFG+A+L  +D+ +     VV   G     + AP
Sbjct: 146 --RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYAP 199

Query: 418 EYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM 476
           E +    FS +SD++SFGV++ E+ +   K  S   E              +      L+
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR-----LL 254

Query: 477 DPTMRGGSTSEMMKC---IH-IGLLCVQENVSNRPGMASVVNMLN 517
           +    G        C   +H +  LC   +  +RP  +++   L+
Sbjct: 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  164 bits (416), Expect = 3e-46
 Identities = 74/286 (25%), Positives = 118/286 (41%), Gaps = 34/286 (11%)

Query: 250 NKLGQGGFGAVYKGMLSN-----GETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLV 303
             LG+G FG V            GE +AVK L  +   Q    +K E+ +L  L H +++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 304 RLLGFCLERKER--ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +  G C +       LV E+VP  SL  ++     R  +   +     + I  G+ YLH 
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA 152

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG-----YMA 416
                 IHRDL A N+LLD++   KI DFG+A+       +      V   G     + A
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWYA 205

Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNL 475
           PE +   +F   SD++SFGV + E+++      S  T+      +              L
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR-----L 260

Query: 476 MDPTMRGGSTSEMMKC---IH-IGLLCVQENVSNRPGMASVVNMLN 517
            +   RG       KC   ++ +   C +   S RP   +++ +L 
Sbjct: 261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  160 bits (407), Expect = 2e-45
 Identities = 64/196 (32%), Positives = 95/196 (48%), Gaps = 11/196 (5%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            ++G G FG V+ G   N + +A+K + +     E +F  E  ++ +L H  LV+L G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
           LE+    LV EF+ +  L  ++     R     E    +   +  G+ YL       +IH
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYL---EEACVIH 127

Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY--MAPEYVMHGRFSV 427
           RDL A N L+      K+SDFGM R    DQ    T+     F     +PE     R+S 
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQY---TSSTGTKFPVKWASPEVFSFSRYSS 184

Query: 428 KSDIFSFGVLVLEIVS 443
           KSD++SFGVL+ E+ S
Sbjct: 185 KSDVWSFGVLMWEVFS 200

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  162 bits (411), Expect = 2e-45
 Identities = 57/204 (27%), Positives = 106/204 (51%), Gaps = 13/204 (6%)

Query: 250 NKLGQGGFGAVYKGMLSNGE-----TIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLV 303
             LG G FG VYKG+           +A+K L + +      E  +E  ++A + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
           RLLG CL      L+ + +P   L  ++ +  +++++  +        IA+G+ YL    
Sbjct: 81  RLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL---E 134

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
             R++HRDL A N+L+ +  + KI+DFG+A+L   ++             +MA E ++H 
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194

Query: 424 RFSVKSDIFSFGVLVLEIVS-GQK 446
            ++ +SD++S+GV V E+++ G K
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSK 218

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  161 bits (409), Expect = 4e-45
 Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 13/201 (6%)

Query: 250 NKLGQGGFGAVYKGML---SNGET-IAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVR 304
             +G G  G V  G L      +  +A+K L    +++   +F +E  ++ +  H N++R
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           L G     +  ++V E++ N SLD F+    +    T  +   ++ G+  G+ YL   S 
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYL---SD 169

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY--MAPEYVMH 422
           L  +HRDL A N+L+DS +  K+SDFG++R+ E D   +      G       APE +  
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE-DDPDAAYTTTGGKIPIRWTAPEAIAF 228

Query: 423 GRFSVKSDIFSFGVLVLEIVS 443
             FS  SD++SFGV++ E+++
Sbjct: 229 RTFSSASDVWSFGVVMWEVLA 249

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  159 bits (405), Expect = 6e-45
 Identities = 59/196 (30%), Positives = 102/196 (52%), Gaps = 11/196 (5%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            +LG G FG V  G       +A+K + + S   + EF  E  ++  L H  LV+L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            +++   ++ E++ N  L +++ +   R     ++  ++ + +   + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLH 143

Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY--MAPEYVMHGRFSV 427
           RDL A N L++ +   K+SDFG++R    D+    T+ V   F      PE +M+ +FS 
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSS 200

Query: 428 KSDIFSFGVLVLEIVS 443
           KSDI++FGVL+ EI S
Sbjct: 201 KSDIWAFGVLMWEIYS 216

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  159 bits (404), Expect = 7e-45
 Identities = 58/195 (29%), Positives = 97/195 (49%), Gaps = 11/195 (5%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           +LG G FG V  G       +AVK + + S   + EF  E   + +L H  LV+  G C 
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYGVCS 73

Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR 370
           +     +V E++ N  L +++    + + +   +  ++   +  G+ +L      + IHR
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHR 128

Query: 371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY--MAPEYVMHGRFSVK 428
           DL A N L+D ++  K+SDFGM R    DQ     + V   F     APE   + ++S K
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQY---VSSVGTKFPVKWSAPEVFHYFKYSSK 185

Query: 429 SDIFSFGVLVLEIVS 443
           SD+++FG+L+ E+ S
Sbjct: 186 SDVWAFGILMWEVFS 200

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  160 bits (407), Expect = 1e-44
 Identities = 60/201 (29%), Positives = 110/201 (54%), Gaps = 14/201 (6%)

Query: 251 KLGQGGFGAVYKGMLSNGE-----TIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVR 304
            +G G FG VYKGML          +A+K L    +++  ++F  E  ++ +  H N++R
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           L G   + K  +++ E++ N +LD F+ +       +  +   ++ GIA G+ YL   + 
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYL---AN 165

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY--MAPEYVMH 422
           +  +HRDL A NIL++S +  K+SDFG++R+ E D   +      G       APE + +
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEATYTTSGGKIPIRWTAPEAISY 224

Query: 423 GRFSVKSDIFSFGVLVLEIVS 443
            +F+  SD++SFG+++ E+++
Sbjct: 225 RKFTSASDVWSFGIVMWEVMT 245

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  158 bits (401), Expect = 2e-44
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 18/205 (8%)

Query: 251 KLGQGGFGAVYKGMLSNGE---TIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRL 305
           +LG G FG V KG     +   T+AVK L         + E   E  ++ +L +  +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 306 LGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           +G C    E   LV E      L+ ++       H+  +   +++  ++ G+ YL     
Sbjct: 84  IGICE--AESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---EE 135

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEYVMH 422
              +HRDL A N+LL ++   KISDFG+++    D+ +    +  G +   + APE + +
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-YKAQTHGKWPVKWYAPECINY 194

Query: 423 GRFSVKSDIFSFGVLVLEIVS-GQK 446
            +FS KSD++SFGVL+ E  S GQK
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQK 219

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  158 bits (401), Expect = 3e-44
 Identities = 62/203 (30%), Positives = 102/203 (50%), Gaps = 14/203 (6%)

Query: 251 KLGQGGFGAVYKGML-SNGETI--AVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +LG G FG+V +G+     + I  A+K L +   K    E   E  ++ +L +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G C      + V E      L  F+     RE +      +++  ++ G+ YL       
Sbjct: 77  GVCQAEALML-VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EEKN 130

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEYVMHGR 424
            +HRDL A N+LL +    KISDFG+++    D ++  T R  G +   + APE +   +
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY-YTARSAGKWPLKWYAPECINFRK 189

Query: 425 FSVKSDIFSFGVLVLEIVS-GQK 446
           FS +SD++S+GV + E +S GQK
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQK 212

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  158 bits (402), Expect = 3e-44
 Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 21/206 (10%)

Query: 250 NKLGQGGFGAVYKGMLSNGE----TIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVR 304
             +G+G FG VY G L + +      AVK L++ +  GE+ +F  E +++    H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 305 LLGFCLERKERIL-VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
           LLG CL  +   L V  ++ +  L +FI +     + T +        +A+G+ YL    
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLAS-- 146

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG------YMAP 417
             + +HRDL A N +LD +   K++DFG+AR         +   V    G      +MA 
Sbjct: 147 -KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY----DKEYYSVHNKTGAKLPVKWMAL 201

Query: 418 EYVMHGRFSVKSDIFSFGVLVLEIVS 443
           E +   +F+ KSD++SFGVL+ E+++
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMT 227

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  157 bits (399), Expect = 4e-44
 Identities = 63/197 (31%), Positives = 105/197 (53%), Gaps = 11/197 (5%)

Query: 250 NKLGQGGFGAVYKGMLSNGET-IAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +KLG G +G VY+G+       +AVK L +++ + E EF  E  ++  ++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 77

Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C       ++ EF+   +L  ++ +  NR+ ++      +   I+  + YL    +   I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL---EKKNFI 133

Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY--MAPEYVMHGRFS 426
           HRDL A N L+      K++DFG++RL   D     T      F     APE + + +FS
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESLAYNKFS 190

Query: 427 VKSDIFSFGVLVLEIVS 443
           +KSD+++FGVL+ EI +
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  157 bits (400), Expect = 4e-44
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 32/218 (14%)

Query: 250 NKLGQGGFGAVYKGMLSNGE------TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
            +LG+G FG V+     N         +AVK L   +     +F+ E  LL  LQH ++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 304 RLLGFCLERKERILVYEFVPNASLDHF-------------IFDPINREHMTWEKRYKIIE 350
           +  G C +    I+V+E++ +  L+ F                   +  +   +   I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG 410
            IA G++YL   +    +HRDL   N L+ + +  KI DFGM+R    D   +D  R VG
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYR-VG 192

Query: 411 TFG-----YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
                   +M PE +M+ +F+ +SD++SFGV++ EI +
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  161 bits (410), Expect = 6e-44
 Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 17/197 (8%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
             +G+G FG V  G    G  +AVK +  ++      F  E  ++ +L+H NLV+LLG  
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 310 LERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           +E K  + +V E++   SL  ++     R  +  +   K    +   + YL        +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL---EGNNFV 311

Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY--MAPEYVMHGRFS 426
           HRDL A N+L+  +   K+SDFG+ +        + + +  G       APE +   +FS
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 364

Query: 427 VKSDIFSFGVLVLEIVS 443
            KSD++SFG+L+ EI S
Sbjct: 365 TKSDVWSFGILLWEIYS 381

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  159 bits (404), Expect = 6e-44
 Identities = 60/201 (29%), Positives = 106/201 (52%), Gaps = 13/201 (6%)

Query: 250 NKLGQGGFGAVYKGMLSNGE----TIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVR 304
             +G G FG V  G L        ++A+K L    +++   +F  E  ++ +  H N++R
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           L G   + K  ++V E++ N SLD F+    +    T  +   ++ GIA G+ YL   S 
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYL---SD 165

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY--MAPEYVMH 422
           +  +HRDL A NIL++S +  K+SDFG+ R+ E D   +      G       +PE + +
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLE-DDPEAAYTTRGGKIPIRWTSPEAIAY 224

Query: 423 GRFSVKSDIFSFGVLVLEIVS 443
            +F+  SD++S+G+++ E++S
Sbjct: 225 RKFTSASDVWSYGIVLWEVMS 245

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  156 bits (397), Expect = 8e-44
 Identities = 70/196 (35%), Positives = 108/196 (55%), Gaps = 11/196 (5%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+ LVRL    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVV 77

Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            +    I + E++ N SL  F+  P +   +T  K   +   IA G+ ++        IH
Sbjct: 78  TQEPIYI-ITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFI---EERNYIH 132

Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY--MAPEYVMHGRFSV 427
           RDL+A+NIL+   ++ KI+DFG+ARL E ++    T R    F     APE + +G F++
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTI 189

Query: 428 KSDIFSFGVLVLEIVS 443
           KSD++SFG+L+ EIV+
Sbjct: 190 KSDVWSFGILLTEIVT 205

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  157 bits (398), Expect = 8e-44
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 13/202 (6%)

Query: 250 NKLGQGGFGAVYKGMLSNGE----TIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVR 304
             +G+G FG VY G   +        A+K LS+ ++  ++  F  E LL+  L H N++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 305 LLGFCLERKERIL-VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
           L+G  L  +     +  ++ +  L  FI     + + T +        +ARG+ YL   +
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYL---A 141

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEYVM 421
             + +HRDL A N +LD     K++DFG+AR     + +S            + A E + 
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201

Query: 422 HGRFSVKSDIFSFGVLVLEIVS 443
             RF+ KSD++SFGVL+ E+++
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLT 223

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  157 bits (400), Expect = 9e-44
 Identities = 63/217 (29%), Positives = 108/217 (49%), Gaps = 31/217 (14%)

Query: 250 NKLGQGGFGAVYKGMLSNGE------TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
            +LG+G FG V+     N         +AVK L + S+    +F+ E  LL  LQH+++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 304 RLLGFCLERKERILVYEFVPNASLDHF------------IFDPINREHMTWEKRYKIIEG 351
           R  G C E +  ++V+E++ +  L+ F              + +    +   +   +   
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +A G++YL   + L  +HRDL   N L+   +  KI DFGM+R    D   +D  R VG 
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYR-VGG 218

Query: 412 FG-----YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
                  +M PE +++ +F+ +SD++SFGV++ EI +
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  156 bits (396), Expect = 9e-44
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 20/202 (9%)

Query: 251 KLGQGGFGAVYKGML--SNGETI--AVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRL 305
            LG+G FG VY+G+     GE I  AVK   K+ +   + +F +E +++  L H ++V+L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 306 LGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           +G     +E   ++ E  P   L H++    N+  +           I + + YL     
Sbjct: 79  IGIIE--EEPTWIIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYL---ES 131

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT---FGYMAPEYVM 421
           +  +HRD+   NIL+ S    K+ DFG++R  E +    D  +   T     +M+PE + 
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE----DYYKASVTRLPIKWMSPESIN 187

Query: 422 HGRFSVKSDIFSFGVLVLEIVS 443
             RF+  SD++ F V + EI+S
Sbjct: 188 FRRFTTASDVWMFAVCMWEILS 209

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  160 bits (406), Expect = 2e-43
 Identities = 64/196 (32%), Positives = 98/196 (50%), Gaps = 11/196 (5%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            KLG G FG V+    +    +AVK + K        F  E  ++  LQH  LV+L    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            +    I + EF+   SL  F+            K       IA G+ ++    +   IH
Sbjct: 253 TKEPIYI-ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIH 307

Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY--MAPEYVMHGRFSV 427
           RDL+A+NIL+ + +  KI+DFG+AR+ E ++    T R    F     APE +  G F++
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFTI 364

Query: 428 KSDIFSFGVLVLEIVS 443
           KSD++SFG+L++EIV+
Sbjct: 365 KSDVWSFGILLMEIVT 380

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  155 bits (394), Expect = 2e-43
 Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 17/197 (8%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
             +G+G FG V  G    G  +AVK +  ++      F  E  ++ +L+H NLV+LLG  
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 310 LERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           +E K  + +V E++   SL  ++     R  +  +   K    +   + YL        +
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL---EGNNFV 139

Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY--MAPEYVMHGRFS 426
           HRDL A N+L+  +   K+SDFG+ +    + + +      G       APE +   +FS
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDT---GKLPVKWTAPEALREKKFS 192

Query: 427 VKSDIFSFGVLVLEIVS 443
            KSD++SFG+L+ EI S
Sbjct: 193 TKSDVWSFGILLWEIYS 209

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  154 bits (391), Expect = 6e-43
 Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 33/219 (15%)

Query: 250 NKLGQGGFGAVYKGMLSNGE------TIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNL 302
            +LG+  FG VYKG L           +A+K L          EF++E +L ARLQH N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHF-------------IFDPINREHMTWEKRYKII 349
           V LLG   + +   +++ +  +  L  F               D   +  +       ++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
             IA G+ YL   S   ++H+DL   N+L+  ++N KISD G+ R        +D  + +
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY----AADYYK-L 186

Query: 410 GTFG-----YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
                    +MAPE +M+G+FS+ SDI+S+GV++ E+ S
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  155 bits (394), Expect = 6e-43
 Identities = 57/204 (27%), Positives = 106/204 (51%), Gaps = 13/204 (6%)

Query: 250 NKLGQGGFGAVYKGMLSNGE-----TIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLV 303
             LG G FG VYKG+           +A+K L + +      E  +E  ++A + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
           RLLG CL      L+ + +P   L  ++ +  +++++  +        IA+G+ YL    
Sbjct: 81  RLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL---E 134

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
             R++HRDL A N+L+ +  + KI+DFG+A+L   ++             +MA E ++H 
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194

Query: 424 RFSVKSDIFSFGVLVLEIVS-GQK 446
            ++ +SD++S+GV V E+++ G K
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSK 218

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  153 bits (390), Expect = 7e-43
 Identities = 51/201 (25%), Positives = 88/201 (43%), Gaps = 18/201 (8%)

Query: 251 KLGQGGFGAVYKGML---SNGET-IAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRL 305
            +G+G FG V++G+     N    +A+K      S     +F  E L + +  H ++V+L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 306 LGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           +G     +  + ++ E      L  F+     +  +           ++  L YL     
Sbjct: 82  IGVIT--ENPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYL---ES 134

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEYVMH 422
            R +HRD+ A N+L+ S    K+ DFG++R  E            G     +MAPE +  
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY---YKASKGKLPIKWMAPESINF 191

Query: 423 GRFSVKSDIFSFGVLVLEIVS 443
            RF+  SD++ FGV + EI+ 
Sbjct: 192 RRFTSASDVWMFGVCMWEILM 212

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  155 bits (394), Expect = 7e-43
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 13/204 (6%)

Query: 250 NKLGQGGFGAVYKGML----SNGET-IAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLV 303
             LG G FG V+KG+      + +  + +K +   S +Q      + +L +  L H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
           RLLG C     ++ V +++P  SL   +    +R  +  +        IA+G+ YL    
Sbjct: 79  RLLGLCPGSSLQL-VTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYL---E 132

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
              ++HR+L A N+LL S    +++DFG+A L   D      +       +MA E +  G
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192

Query: 424 RFSVKSDIFSFGVLVLEIVS-GQK 446
           +++ +SD++S+GV V E+++ G +
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGAE 216

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  154 bits (390), Expect = 8e-43
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 21/205 (10%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLG 307
           ++G+G F  VYKG+       +A    +  K +K     FK E  +L  LQH N+VR   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 308 FCLERKER----ILVYEFVPNASLDHFIFDPINREH--MTWEKRYKIIEGIARGLLYLHE 361
                 +     +LV E + + +L  ++     +    M  +        I +GL +LH 
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL-----KRFKVMKIKVLRSWCRQILKGLQFLHT 147

Query: 362 DSRLRIIHRDLKASNILLDSEM-NPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV 420
            +   IIHRDLK  NI +     + KI D G+A L       +    V+GT  +MAPE  
Sbjct: 148 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAPEMY 202

Query: 421 MHGRFSVKSDIFSFGVLVLEIVSGQ 445
               +    D+++FG+ +LE+ + +
Sbjct: 203 EEK-YDESVDVYAFGMCMLEMATSE 226

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  153 bits (390), Expect = 9e-43
 Identities = 66/207 (31%), Positives = 95/207 (45%), Gaps = 19/207 (9%)

Query: 251 KLGQGGFGAVYKGML--SNGETI--AVKRL---SKNSKQGEIEFKNEVLLLARLQHRNLV 303
           KLG G FG V +G     +G+T+  AVK L     +  +   +F  EV  +  L HRNL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 304 RLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           RL G  L     + +V E  P  SL   +    ++ H       +    +A G+ YL   
Sbjct: 85  RLYGVVLT--PPMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYL--- 137

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY--MAPEYV 420
              R IHRDL A N+LL +    KI DFG+ R    +  H    +      +   APE +
Sbjct: 138 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY-VMQEHRKVPFAWCAPESL 196

Query: 421 MHGRFSVKSDIFSFGVLVLEIVS-GQK 446
               FS  SD + FGV + E+ + GQ+
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQE 223

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  153 bits (389), Expect = 1e-42
 Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 41/220 (18%)

Query: 251 KLGQGGFGAVYKGMLSNGE--------TIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL 302
            LGQG F  ++KG+              + +K L K  +     F     ++++L H++L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           V   G C+   E ILV EFV   SLD ++    N+  +    + ++ + +A  + +L   
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFL--- 129

Query: 363 SRLRIIHRDLKASNILLDSEMNP--------KISDFGMARLFEMDQTHSDTNRVVGTFGY 414
               +IH ++ A NILL  E +         K+SD G++                     
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------------IL 177

Query: 415 ------MAPEYVMHGR-FSVKSDIFSFGVLVLEIVS-GQK 446
                 + PE + + +  ++ +D +SFG  + EI S G K
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  153 bits (389), Expect = 2e-42
 Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 17/202 (8%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           LG+G +G VY G  LSN   IA+K + +   +       E+ L   L+H+N+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR----GLLYLHEDSRLR 366
           E     +  E VP  SL       +  +    +   + I    +    GL YLH++   +
Sbjct: 90  ENGFIKIFMEQVPGGSLSAL----LRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---Q 142

Query: 367 IIHRDLKASNILLDSEM-NPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR- 424
           I+HRD+K  N+L+++     KISDFG ++   +   +  T    GT  YMAPE +  G  
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSK--RLAGINPCTETFTGTLQYMAPEIIDKGPR 200

Query: 425 -FSVKSDIFSFGVLVLEIVSGQ 445
            +   +DI+S G  ++E+ +G+
Sbjct: 201 GYGKAADIWSLGCTIIEMATGK 222

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  157 bits (399), Expect = 3e-42
 Identities = 60/195 (30%), Positives = 101/195 (51%), Gaps = 7/195 (3%)

Query: 250 NKLGQGGFGAVYKGMLSNGET-IAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +KLG G +G VY+G+       +AVK L K       EF  E  ++  ++H NLV+LLG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
           C       ++ EF+   +L  ++ +  NR+ ++      +   I+  + YL    +   I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL---EKKNFI 340

Query: 369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVK 428
           HR+L A N L+      K++DFG++RL   D   +          + APE + + +FS+K
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIK 399

Query: 429 SDIFSFGVLVLEIVS 443
           SD+++FGVL+ EI +
Sbjct: 400 SDVWAFGVLLWEIAT 414

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  154 bits (392), Expect = 3e-42
 Identities = 61/202 (30%), Positives = 107/202 (52%), Gaps = 13/202 (6%)

Query: 250 NKLGQGGFGAVYKGMLSNGE----TIAVKRLSKNSKQGEI-EFKNEVLLLARLQHRNLVR 304
             +G+G FG VY G L + +      AVK L++ +  GE+ +F  E +++    H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 305 LLGFCLERKERIL-VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
           LLG CL  +   L V  ++ +  L +FI +     + T +        +A+G+ +L   +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFL---A 209

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF--GYMAPEYVM 421
             + +HRDL A N +LD +   K++DFG+AR     +  S  N+        +MA E + 
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269

Query: 422 HGRFSVKSDIFSFGVLVLEIVS 443
             +F+ KSD++SFGVL+ E+++
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMT 291

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  159 bits (403), Expect = 4e-42
 Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 14/203 (6%)

Query: 251 KLGQGGFGAVYKGML--SNGET-IAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLL 306
           +LG G FG+V +G+      +  +A+K L +   K    E   E  ++ +L +  +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
           G C   +  +LV E      L  F+     RE +      +++  ++ G+ YL       
Sbjct: 403 GVCQ-AEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EEKN 456

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY--MAPEYVMHGR 424
            +HR+L A N+LL +    KISDFG+++    D ++  T R  G +     APE +   +
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY-YTARSAGKWPLKWYAPECINFRK 515

Query: 425 FSVKSDIFSFGVLVLEIVS-GQK 446
           FS +SD++S+GV + E +S GQK
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQK 538

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  151 bits (383), Expect = 2e-41
 Identities = 50/228 (21%), Positives = 102/228 (44%), Gaps = 23/228 (10%)

Query: 233 QFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNE 290
              F+++ V    +S   ++G GG   V++ +    +  A+K ++      +    ++NE
Sbjct: 17  NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNE 76

Query: 291 VLLLARLQHRNL--VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI 348
           +  L +LQ  +   +RL  + +  +   +V E   N  L+ ++     ++ +   +R   
Sbjct: 77  IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSY 132

Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV 408
            + +   +  +H+     I+H DLK +N L+  +   K+ DFG+A   + D T    +  
Sbjct: 133 WKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQ 188

Query: 409 VGTFGYMAPEYVM-----------HGRFSVKSDIFSFGVLVLEIVSGQ 445
           VGT  YM PE +              + S KSD++S G ++  +  G+
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  154 bits (390), Expect = 3e-41
 Identities = 63/195 (32%), Positives = 106/195 (54%), Gaps = 9/195 (4%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            E    I V E++   SL  F+      +++   +   +   IA G+ Y+    R+  +H
Sbjct: 249 SEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 303

Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQ-THSDTNRVVGTFGYMAPEYVMHGRFSVK 428
           RDL+A+NIL+   +  K++DFG+ARL E ++ T     +      + APE  ++GRF++K
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIK 361

Query: 429 SDIFSFGVLVLEIVS 443
           SD++SFG+L+ E+ +
Sbjct: 362 SDVWSFGILLTELTT 376

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  150 bits (382), Expect = 3e-41
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 27/213 (12%)

Query: 250 NKLGQGGFGAVYKGMLSNGE------TIAVKRLSKNSKQGE-IEFKNEVLLLARLQHRNL 302
            +LGQG FG VY+G+            +A+K +++ +   E IEF NE  ++      ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHF-------IFDPINREHMTWEKRYKIIEGIARG 355
           VRLLG   + +  +++ E +    L  +       + +       +  K  ++   IA G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY- 414
           + YL+     + +HRDL A N ++  +   KI DFGM R    D   +D  R  G  G  
Sbjct: 151 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR-KGGKGLL 202

Query: 415 ----MAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
               M+PE +  G F+  SD++SFGV++ EI +
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  149 bits (379), Expect = 7e-41
 Identities = 67/213 (31%), Positives = 95/213 (44%), Gaps = 27/213 (12%)

Query: 250 NKLGQGGFGAVYKGMLSNGE------TIAVKRLSKNSKQGE-IEFKNEVLLLARLQHRNL 302
             LG G FG VY+G +S          +AVK L +   + + ++F  E L++++  H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLY 358
           VR +G  L+   R ++ E +    L  F+      P     +       +   IA G  Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 359 LHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMARLFEMDQTHSDTNRVVGTFGY- 414
           L        IHRD+ A N LL         KI DFGMAR    D   +   R  G     
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYR-KGGCAML 207

Query: 415 ----MAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
               M PE  M G F+ K+D +SFGVL+ EI S
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  154 bits (391), Expect = 8e-41
 Identities = 63/195 (32%), Positives = 106/195 (54%), Gaps = 9/195 (4%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV+L    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            E    I V E++   SL  F+      +++   +   +   IA G+ Y+    R+  +H
Sbjct: 332 SEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 386

Query: 370 RDLKASNILLDSEMNPKISDFGMARLFEMDQ-THSDTNRVVGTFGYMAPEYVMHGRFSVK 428
           RDL+A+NIL+   +  K++DFG+ARL E ++ T     +      + APE  ++GRF++K
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIK 444

Query: 429 SDIFSFGVLVLEIVS 443
           SD++SFG+L+ E+ +
Sbjct: 445 SDVWSFGILLTELTT 459

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  148 bits (375), Expect = 1e-40
 Identities = 61/240 (25%), Positives = 103/240 (42%), Gaps = 38/240 (15%)

Query: 225 EETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQG 283
             T+ K    DF+ I            +G GGFG V+K     +G+T  +KR+  N++  
Sbjct: 2   AHTVDKRFGMDFKEIE----------LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE-- 49

Query: 284 EIEFKNEVLLLARLQHRNLVRLLGFCLERKERI----------------LVYEFVPNASL 327
             + + EV  LA+L H N+V   G                         +  EF    +L
Sbjct: 50  --KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTL 107

Query: 328 DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
           + +I +    E +      ++ E I +G+ Y+H     ++I+RDLK SNI L      KI
Sbjct: 108 EQWI-EKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKI 163

Query: 388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKR 447
            DFG+    + D       R  GT  YM+PE +    +  + D+++ G+++ E++     
Sbjct: 164 GDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  149 bits (379), Expect = 1e-40
 Identities = 51/224 (22%), Positives = 100/224 (44%), Gaps = 23/224 (10%)

Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEI--EFKNEVLLL 294
           E I V    +S   ++G GG   V++ +    +  A+K ++      +    ++NE+  L
Sbjct: 2   ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61

Query: 295 ARLQHRNL--VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
            +LQ  +   +RL  + +  +   +V E   N  L+ ++     ++ +   +R    + +
Sbjct: 62  NKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNM 117

Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF 412
              +  +H+     I+H DLK +N L+  +   K+ DFG+A   + D T    +  VGT 
Sbjct: 118 LEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 173

Query: 413 GYMAPEYVM-----------HGRFSVKSDIFSFGVLVLEIVSGQ 445
            YM PE +              + S KSD++S G ++  +  G+
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  150 bits (380), Expect = 1e-40
 Identities = 70/213 (32%), Positives = 97/213 (45%), Gaps = 27/213 (12%)

Query: 250 NKLGQGGFGAVYKGMLSNGE------TIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNL 302
             LG G FG VY+G +S          +AVK L +  S+Q E++F  E L++++  H+N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLY 358
           VR +G  L+   R ++ E +    L  F+      P     +       +   IA G  Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 359 LHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMARLFEMDQTHSDTNRVVGTFGY- 414
           L        IHRD+ A N LL         KI DFGMAR    D   +   R  G     
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYR-KGGCAML 248

Query: 415 ----MAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
               M PE  M G F+ K+D +SFGVL+ EI S
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  148 bits (377), Expect = 1e-40
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 34/217 (15%)

Query: 250 NKLGQGGFGAVYKGMLSNGE---TIAVKRLSKNSKQGE-IEFKNEVLLLARL-QHRNLVR 304
           + +G+G FG V K  +         A+KR+ + + + +  +F  E+ +L +L  H N++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 305 LLGFCLERKERILVYEFVPNASLDHF-------------IFDPINREHMTWEKRYKIIEG 351
           LLG C  R    L  E+ P+ +L  F                      ++ ++       
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +ARG+ YL   S+ + IHRDL A NIL+      KI+DFG++R             V  T
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVKKT 199

Query: 412 FG-----YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            G     +MA E + +  ++  SD++S+GVL+ EIVS
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  148 bits (376), Expect = 2e-40
 Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 27/213 (12%)

Query: 250 NKLGQGGFGAVYKGMLSNGE----TIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLV 303
             LG+G FG+V +G L   +     +AVK +  +  S++   EF +E   +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 304 RLLGFCLERKERI-----LVYEFVPNASLDHFI---FDPINREHMTWEKRYKIIEGIARG 355
           RLLG C+E   +      ++  F+    L  ++         +H+  +   K +  IA G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG-- 413
           + YL   S    +HRDL A N +L  +M   ++DFG+++         D  R  G     
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIY----SGDYYR-QGRIAKM 211

Query: 414 ---YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
              ++A E +    ++ KSD+++FGV + EI +
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  148 bits (376), Expect = 3e-40
 Identities = 56/227 (24%), Positives = 100/227 (44%), Gaps = 41/227 (18%)

Query: 250 NKLGQGGFGAVYKGMLSNGE------TIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNL 302
             +G+G FG V++              +AVK L +  S   + +F+ E  L+A   + N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHF---------------------IFDPINREHMT 341
           V+LLG C   K   L++E++    L+ F                              ++
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 342 WEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
             ++  I   +A G+ YL   S  + +HRDL   N L+   M  KI+DFG++R    +  
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR----NIY 225

Query: 402 HSDTNRVVGTFGY-----MAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            +D  +            M PE + + R++ +SD++++GV++ EI S
Sbjct: 226 SADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  147 bits (374), Expect = 4e-40
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 22/204 (10%)

Query: 250 NKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHRNLVRLLG 307
            ++G+G FG V++      G   AVK++  +  +  E+         A L    +V L G
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELV------ACAGLSSPRIVPLYG 117

Query: 308 FCLERKERILVYEFVPNASLDHFI--FDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
              E     +  E +   SL   I     +  +          +     GL YLH     
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL-----YYLGQALEGLEYLHTR--- 169

Query: 366 RIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQ---THSDTNRVVGTFGYMAPEYVM 421
           RI+H D+KA N+LL S+ +   + DFG A   + D    +    + + GT  +MAPE VM
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229

Query: 422 HGRFSVKSDIFSFGVLVLEIVSGQ 445
                 K DI+S   ++L +++G 
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGC 253

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  147 bits (373), Expect = 4e-40
 Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 28/214 (13%)

Query: 250 NKLGQGGFGAVYKGMLSNGE----TIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLV 303
             LG+G FG+V +  L   +     +AVK L  +  +     EF  E   +    H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 304 RLLGFCLERKERI------LVYEFVPNASLDHFIFD---PINREHMTWEKRYKIIEGIAR 354
           +L+G  L  + +       ++  F+ +  L  F+       N  ++  +   + +  IA 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG- 413
           G+ YL   S    IHRDL A N +L  +M   ++DFG++R         D  R  G    
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYR-QGCASK 200

Query: 414 ----YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
               ++A E +    ++V SD+++FGV + EI++
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  153 bits (389), Expect = 5e-40
 Identities = 60/266 (22%), Positives = 110/266 (41%), Gaps = 15/266 (5%)

Query: 183 PRKKNHTILITVIVSVVASVILITGICIFLRVGKLKLEDENVEETIAKSLQFDFETIRVA 242
           P+K+    L ++          +    + +       E  + E+T       D+E  R  
Sbjct: 332 PQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQR-- 389

Query: 243 TDNFSDANKLGQGGFGAVYKGMLSNGE----TIAVKRLSKN-SKQGEIEFKNEVLLLARL 297
            +       +G+G FG V++G+  + E     +A+K      S     +F  E L + + 
Sbjct: 390 -ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF 448

Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLL 357
            H ++V+L+G   E     ++ E      L  F+     +  +           ++  L 
Sbjct: 449 DHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALA 505

Query: 358 YLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAP 417
           YL      R +HRD+ A N+L+ S    K+ DFG++R  E    +  +   +    +MAP
Sbjct: 506 YL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAP 561

Query: 418 EYVMHGRFSVKSDIFSFGVLVLEIVS 443
           E +   RF+  SD++ FGV + EI+ 
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEILM 587

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  146 bits (370), Expect = 1e-39
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 10/207 (4%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVK--RLSKNSKQGEIEF-KNEVLLLARLQH 299
            NF    K+G+G F  VY+   L +G  +A+K  ++              E+ LL +L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR-YKIIEGIARGLLY 358
            N+++     +E  E  +V E      L   I     ++ +  E+  +K    +   L +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
           +H     R++HRD+K +N+ + +    K+ D G+ R F    T + +  +VGT  YM+PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206

Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
            +    ++ KSDI+S G L+ E+ + Q
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQ 233

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  146 bits (370), Expect = 1e-39
 Identities = 61/227 (26%), Positives = 106/227 (46%), Gaps = 41/227 (18%)

Query: 250 NKLGQGGFGAVYKGMLSNGE------TIAVKRLSKNSKQGE-IEFKNEVLLLARLQHRNL 302
             LG+G FG V K    + +      T+AVK L +N+   E  +  +E  +L ++ H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHF---------------------IFDPINREHMT 341
           ++L G C +    +L+ E+    SL  F                       D  +   +T
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 342 WEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
                     I++G+ YL   + ++++HRDL A NIL+      KISDFG++R       
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD-----V 200

Query: 402 HSDTNRVVGTFG-----YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           + + + V  + G     +MA E +    ++ +SD++SFGVL+ EIV+
Sbjct: 201 YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  145 bits (369), Expect = 1e-39
 Identities = 66/248 (26%), Positives = 111/248 (44%), Gaps = 44/248 (17%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN 301
             +F +   LGQG FG V K     +    A+K++    ++      +EV+LLA L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLNHQY 63

Query: 302 LVRLLGFCLERKERI-------------LVYEFVPNASLDHFIFDPINREHMTWEKRY-- 346
           +VR     LER+  +             +  E+  N +L    +D I+ E++  ++    
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYW 119

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE--------- 397
           ++   I   L Y+H      IIHRDLK  NI +D   N KI DFG+A+            
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 398 ---MDQTHSDTNRVVGTFGYMAPEYVMHGR--FSVKSDIFSFGVLVLEIVSGQKRSSFGT 452
              +  +  +    +GT  Y+A E V+ G   ++ K D++S G++  E++       F T
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIYP-----FST 230

Query: 453 EEETEDLL 460
             E  ++L
Sbjct: 231 GMERVNIL 238

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  145 bits (369), Expect = 3e-39
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 36/222 (16%)

Query: 250 NKLGQGGFGAVYKGMLSNGE--------TIAVKRLSKNSKQGE-IEFKNEVLLLARL-QH 299
             LG+G FG V        +        T+AVK L  ++ + +  +  +E+ ++  + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHF-------------IFDPINREHMTWEKRY 346
           +N++ LLG C +     ++ E+    +L  +               + +  E MT++   
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
                +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR       ++   
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD-----INNIDY 212

Query: 407 RVVGTFG-----YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
               T G     +MAPE +    ++ +SD++SFGVL+ EI +
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  147 bits (372), Expect = 3e-39
 Identities = 51/224 (22%), Positives = 99/224 (44%), Gaps = 23/224 (10%)

Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKN--SKQGEIEFKNEVLLL 294
           E I V    +S   ++G GG   V++ +    +  A+K ++      Q    ++NE+  L
Sbjct: 49  ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108

Query: 295 ARLQHRNL--VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
            +LQ  +   +RL  + +  +   +V E   N  L+ ++     ++ +   +R    + +
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNM 164

Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF 412
              +  +H+     I+H DLK +N L+  +   K+ DFG+A   + D T    +  VG  
Sbjct: 165 LEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAV 220

Query: 413 GYMAPEYVM-----------HGRFSVKSDIFSFGVLVLEIVSGQ 445
            YM PE +              + S KSD++S G ++  +  G+
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  145 bits (368), Expect = 4e-39
 Identities = 53/233 (22%), Positives = 103/233 (44%), Gaps = 28/233 (12%)

Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVK--RL 276
            D   E    +S++  +  ++          K+G+G FG         +G    +K   +
Sbjct: 11  VDLGTENLYFQSME-KYVRLQ----------KIGEGSFGKAILVKSTEDGRQYVIKEINI 59

Query: 277 SKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI----F 332
           S+ S +   E + EV +LA ++H N+V+      E     +V ++     L   I     
Sbjct: 60  SRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG 119

Query: 333 DPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM 392
               +E             I   L ++H+    +I+HRD+K+ NI L  +   ++ DFG+
Sbjct: 120 VLF-QEDQIL----DWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGI 171

Query: 393 ARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           AR+  ++ T       +GT  Y++PE   +  ++ KSDI++ G ++ E+ + +
Sbjct: 172 ARV--LNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  146 bits (370), Expect = 4e-39
 Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 36/222 (16%)

Query: 250 NKLGQGGFGAVYKGMLSNGE--------TIAVKRLSKNSKQGE-IEFKNEVLLLARL-QH 299
             LG+G FG V        +        T+AVK L  ++ + +  +  +E+ ++  + +H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHF-------------IFDPINREHMTWEKRY 346
           +N++ LLG C +     ++ E+    +L  +               + +  E MT++   
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
                +ARG+ YL   +  + IHRDL A N+L+      KI+DFG+AR       ++   
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD-----INNIDY 258

Query: 407 RVVGTFG-----YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
               T G     +MAPE +    ++ +SD++SFGVL+ EI +
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  144 bits (364), Expect = 4e-39
 Identities = 63/242 (26%), Positives = 101/242 (41%), Gaps = 32/242 (13%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRN 301
            +F     LG+GGFG V++     +    A+KR+   +++   E    EV  LA+L+H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 302 LVRLLGFCLE---------RKERILVY---EFVPNASLDHFIFDPINREHMTWEKRYKII 349
           +VR     LE            ++ +Y   +     +L  ++      E         I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV- 408
             IA  + +LH      ++HRDLK SNI    +   K+ DFG+    + D+         
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 409 ---------VGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDL 459
                    VGT  YM+PE +    +S K DIFS G+++ E++       F T+ E    
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-----YPFSTQMERVRT 236

Query: 460 LT 461
           LT
Sbjct: 237 LT 238

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  143 bits (364), Expect = 7e-39
 Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 36/222 (16%)

Query: 250 NKLGQGGFGAVYKGMLSNGE------TIAVKRLSKNSKQGE-IEFKNEVLLLARL-QHRN 301
             LG G FG V +             T+AVK L  ++   E     +E+ +L+ L  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHF---------------IFDPINREHMTWEKRY 346
           +V LLG C      +++ E+     L +F                    +   +  E   
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
                +A+G+ +L   +    IHRDL A NILL      KI DFG+AR        +D+N
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIKNDSN 200

Query: 407 RVVGTFG-----YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            VV         +MAPE + +  ++ +SD++S+G+ + E+ S
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  144 bits (365), Expect = 7e-39
 Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 35/221 (15%)

Query: 250 NKLGQGGFGAVYKGMLSNGE------TIAVKRLSKNSKQGE-IEFKNEVLLLARL-QHRN 301
             LG+G FG V +      +      T+AVK L + +   E     +E+ +L  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 302 LVRLLGFCLERKERILV-YEFVPNASLDHF-------------IFDPINREHMTWEKRYK 347
           +V LLG C +    ++V  EF    +L  +               + + ++ +T E    
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
               +A+G+ +L   +  + IHRDL A NILL  +   KI DFG+AR       + D + 
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD-----IYKDPDY 204

Query: 408 VVGTFG-----YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
           V          +MAPE +    ++++SD++SFGVL+ EI S
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  143 bits (364), Expect = 1e-38
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 32/218 (14%)

Query: 250 NKLGQGGFGAVYKGML-----SNGET-IAVKRLSKNSKQGE-IEFKNEVLLLARL-QHRN 301
             LG G FG V +         +    +AVK L   +   E     +E+ +++ L QH N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHF-----------IFDPINREHMTWEKRYKIIE 350
           +V LLG C      +++ E+     L +F               I     +         
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVG 410
            +A+G+ +L   +    IHRD+ A N+LL +    KI DFG+AR        +D+N +V 
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIVK 223

Query: 411 TFG-----YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
                   +MAPE +    ++V+SD++S+G+L+ EI S
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  144 bits (365), Expect = 2e-38
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 36/222 (16%)

Query: 250 NKLGQGGFGAVYKGML--------SNGETIAVKRLSKNSKQGE-IEFKNEVLLLARL-QH 299
             LG+G FG V             +    +AVK L  ++ + +  +  +E+ ++  + +H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHF-------------IFDPINREHMTWEKRY 346
           +N++ LLG C +     ++ E+    +L  +                    E ++ +   
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
                +ARG+ YL   +  + IHRDL A N+L+  +   KI+DFG+AR       H    
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD-----IHHIDY 246

Query: 407 RVVGTFG-----YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
               T G     +MAPE +    ++ +SD++SFGVL+ EI +
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  141 bits (358), Expect = 4e-38
 Identities = 53/209 (25%), Positives = 79/209 (37%), Gaps = 18/209 (8%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEIEFKNEVLLLARL-QH 299
            +F   ++LG G +G V+K     +G   AVKR        +       EV    ++ QH
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINR--EHMTWEKRYKIIEGIARGLL 357
              VRL     E     L  E     SL            E   W      +      L 
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVW----GYLRDTLLALA 171

Query: 358 YLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAP 417
           +LH      ++H D+K +NI L      K+ DFG+        T        G   YMAP
Sbjct: 172 HLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGDPRYMAP 225

Query: 418 EYVMHGRFSVKSDIFSFGVLVLEIVSGQK 446
           E ++ G +   +D+FS G+ +LE+    +
Sbjct: 226 E-LLQGSYGTAADVFSLGLTILEVACNME 253

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  144 bits (365), Expect = 6e-38
 Identities = 57/240 (23%), Positives = 102/240 (42%), Gaps = 29/240 (12%)

Query: 216 KLKLEDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKR 275
              LE ++ +E        +   + V   +F   + LG G  G +    + +   +AVKR
Sbjct: 4   SPSLEQDDGDE--------ETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKR 55

Query: 276 LSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDP 334
           +             EV LL    +H N++R      +R+ + +  E    A+L  ++   
Sbjct: 56  ILPECFSFA---DREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV--- 108

Query: 335 INREHMTWEKR-YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL-----DSEMNPKIS 388
             ++          +++    GL +LH    L I+HRDLK  NIL+       ++   IS
Sbjct: 109 EQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMIS 165

Query: 389 DFGMARLFEMDQ-THSDTNRVVGTFGYMAPEYV---MHGRFSVKSDIFSFGVLVLEIVSG 444
           DFG+ +   + + + S  + V GT G++APE +        +   DIFS G +   ++S 
Sbjct: 166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  140 bits (356), Expect = 2e-37
 Identities = 61/227 (26%), Positives = 99/227 (43%), Gaps = 41/227 (18%)

Query: 250 NKLGQGGFGAVYKGMLSNGE------TIAVKRLSKNSKQGE-IEFKNEVLLLARL-QHRN 301
             LG G FG V                +AVK L + +   E     +E+ ++ +L  H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHF------IFDPINREHMTWEKRYKIIEG---- 351
           +V LLG C       L++E+     L ++       F     E+   ++  +  +     
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 352 ----------IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
                     +A+G+ +L        +HRDL A N+L+      KI DFG+AR       
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR-----DI 222

Query: 402 HSDTNRVVGTFG-----YMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
            SD+N VV         +MAPE +  G +++KSD++S+G+L+ EI S
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  138 bits (350), Expect = 6e-37
 Identities = 57/224 (25%), Positives = 95/224 (42%), Gaps = 19/224 (8%)

Query: 238 TIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR 296
            + +   ++    KLG+GGF  V     L +G   A+KR+  + +Q   E + E  +   
Sbjct: 23  MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL 82

Query: 297 LQHRNLVRLLGFCLERKER----ILVYEFVPNASLDHFIFD-PINREHMTWEKRYKIIEG 351
             H N++RL+ +CL  +       L+  F    +L + I         +T ++   ++ G
Sbjct: 83  FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD-------QTHSD 404
           I RGL  +H        HRDLK +NILL  E  P + D G      +         T  D
Sbjct: 143 ICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199

Query: 405 TNRVVGTFGYMAPEYV---MHGRFSVKSDIFSFGVLVLEIVSGQ 445
                 T  Y APE      H     ++D++S G ++  ++ G+
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  137 bits (348), Expect = 6e-37
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 10/210 (4%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQHR 300
           +++     +G G +G   K    S+G+ +  K       ++  +    +EV LL  L+H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 301 NLVRLLGFCLERKERIL--VYEFVPNASLDHFIFDPINREHMTWEKR-YKIIEGIARGLL 357
           N+VR     ++R    L  V E+     L   I           E+   +++  +   L 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 358 YLHE--DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYM 415
             H   D    ++HRDLK +N+ LD + N K+ DFG+AR+   D + + T   VGT  YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183

Query: 416 APEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           +PE +    ++ KSDI+S G L+ E+ +  
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALM 213

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  137 bits (346), Expect = 2e-36
 Identities = 52/221 (23%), Positives = 97/221 (43%), Gaps = 22/221 (9%)

Query: 241 VATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQ 298
            +   +  ++ LGQG    V++G     G+  A+K  +  S    ++    E  +L +L 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 299 HRNLVRLLGF--CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           H+N+V+L         + ++L+ EF P  SL   + +P N   +   +   ++  +  G+
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 357 LYLHEDSRLRIIHRDLKASNILL----DSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF 412
            +L E     I+HR++K  NI+     D +   K++DFG AR  E D     +  + GT 
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTE 179

Query: 413 GYMAPEYV--------MHGRFSVKSDIFSFGVLVLEIVSGQ 445
            Y+ P+             ++    D++S GV      +G 
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  136 bits (344), Expect = 3e-36
 Identities = 54/205 (26%), Positives = 106/205 (51%), Gaps = 12/205 (5%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN 301
              ++   K+GQG  G VY  M ++ G+ +A+++++   +  +    NE+L++   ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRYKIIEGIARGLLYLH 360
           +V  L   L   E  +V E++   SL   +    ++   +       +     + L +LH
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLH 133

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV 420
            +   ++IHRD+K+ NILL  + + K++DFG     ++    S  + +VGT  +MAPE V
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVV 188

Query: 421 MHGRFSVKSDIFSFGVLVLEIVSGQ 445
               +  K DI+S G++ +E++ G+
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGE 213

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  134 bits (340), Expect = 1e-35
 Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 16/199 (8%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIE-FKNEVLLLARLQHRNLVRLLG 307
           LG+GGF   ++       E  A K + K+   K  + E    E+ +   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 308 FCLERKERI-LVYEFVPNASLDHFIFDPINREHMT-WEKRYKIIEGIARGLLYLHEDSRL 365
              E  + + +V E     SL         R+ +T  E RY + + I  G  YLH   R 
Sbjct: 83  -FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQ-IVLGCQYLH---RN 134

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRF 425
           R+IHRDLK  N+ L+ ++  KI DFG+A   E D        + GT  Y+APE +     
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGH 192

Query: 426 SVKSDIFSFGVLVLEIVSG 444
           S + D++S G ++  ++ G
Sbjct: 193 SFEVDVWSIGCIMYTLLVG 211

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  135 bits (342), Expect = 1e-35
 Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 16/199 (8%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIE-FKNEVLLLARLQHRNLVRLLG 307
           LG+GGF   ++       E  A K + K+   K  + E    E+ +   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 308 FCLERKERI-LVYEFVPNASLDHFIFDPINREHMT-WEKRYKIIEGIARGLLYLHEDSRL 365
              E  + + +V E     SL         R+ +T  E RY + + I  G  YLH   R 
Sbjct: 109 -FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQ-IVLGCQYLH---RN 160

Query: 366 RIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRF 425
           R+IHRDLK  N+ L+ ++  KI DFG+A   E D        + GT  Y+APE +     
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGH 218

Query: 426 SVKSDIFSFGVLVLEIVSG 444
           S + D++S G ++  ++ G
Sbjct: 219 SFEVDVWSIGCIMYTLLVG 237

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  135 bits (341), Expect = 1e-35
 Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 10/204 (4%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN 301
                   K+G+G  G V       +G  +AVK +    +Q      NEV+++   QH N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +V +    L  +E  ++ EF+   +L     D +++  +  E+   + E + + L YLH 
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA 159

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM 421
                +IHRD+K+ +ILL  +   K+SDFG     ++ +       +VGT  +MAPE + 
Sbjct: 160 Q---GVIHRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVIS 214

Query: 422 HGRFSVKSDIFSFGVLVLEIVSGQ 445
              ++ + DI+S G++V+E+V G+
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDGE 238

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  136 bits (345), Expect = 1e-35
 Identities = 52/221 (23%), Positives = 97/221 (43%), Gaps = 22/221 (9%)

Query: 241 VATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQ 298
            +   +  ++ LGQG    V++G     G+  A+K  +  S    ++    E  +L +L 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 299 HRNLVRLLGF--CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           H+N+V+L         + ++L+ EF P  SL   + +P N   +   +   ++  +  G+
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 357 LYLHEDSRLRIIHRDLKASNILL----DSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF 412
            +L E     I+HR++K  NI+     D +   K++DFG AR  E D     +  + GT 
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTE 179

Query: 413 GYMAPEYV--------MHGRFSVKSDIFSFGVLVLEIVSGQ 445
            Y+ P+             ++    D++S GV      +G 
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  138 bits (349), Expect = 2e-35
 Identities = 73/218 (33%), Positives = 113/218 (51%), Gaps = 23/218 (10%)

Query: 239 IRVATDNFSDA----NKLGQGGFGAVYKG-MLSNGETIAVKRLSKN---SKQGEIEFKNE 290
           ++ +T  FSD       LG+G FG V        G+  AVK +SK     K  +     E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 291 VLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKII 349
           V LL +L H N+++L  F  ++    LV E      L    FD I +R+  +     +II
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARII 132

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSDTN 406
             +  G+ Y+H+    +I+HRDLK  N+LL+S   + N +I DFG++  FE  +   D  
Sbjct: 133 RQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD-- 187

Query: 407 RVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
             +GT  Y+APE V+HG +  K D++S GV++  ++SG
Sbjct: 188 -KIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  137 bits (348), Expect = 3e-35
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 22/217 (10%)

Query: 239 IRVATDNFSDA----NKLGQGGFGAVYKG-MLSNGETIAVKRLSKN--SKQGEIEFKNEV 291
           I     + S+      KLG G +G V            A+K + K   S     +   EV
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87

Query: 292 LLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIE 350
            +L  L H N+++L  F  +++   LV E      L    FD I +R          II+
Sbjct: 88  AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAAVIIK 143

Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSDTNR 407
            +  G+ YLH+     I+HRDLK  N+LL+S   +   KI DFG++ +FE  +   +   
Sbjct: 144 QVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE--- 197

Query: 408 VVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            +GT  Y+APE V+  ++  K D++S GV++  +++G
Sbjct: 198 RLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAG 233

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  132 bits (335), Expect = 5e-35
 Identities = 54/229 (23%), Positives = 85/229 (37%), Gaps = 36/229 (15%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKR--LSKNSKQGEIEFKNEVLLLARL-Q 298
           T  F +  K+G G FG+V+K +   +G   A+KR          E     EV   A L Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR-YKIIEGIARGLL 357
           H ++VR      E    ++  E+    SL   I +         E     ++  + RGL 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 358 YLHEDSRLRIIHRDLKASNILLDSEMNP-------------------KISDFGMARLFEM 398
           Y+H      ++H D+K SNI +     P                   KI D G       
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 399 DQTHSDTNRVVGTFGYMAPEYVMHGRFS--VKSDIFSFGVLVLEIVSGQ 445
            Q         G   ++A E V+   ++   K+DIF+  + V+     +
Sbjct: 187 PQV------EEGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAE 228

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  132 bits (335), Expect = 7e-35
 Identities = 58/206 (28%), Positives = 107/206 (51%), Gaps = 13/206 (6%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHR 300
            + F+   K+G+G FG V+KG+     + +A+K +     + EIE  + E+ +L++    
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRYKIIEGIARGLLYL 359
            + +  G  L+  +  ++ E++   S    +   P++   +       I+  I +GL YL
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-----ILREILKGLDYL 135

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H +   + IHRD+KA+N+LL      K++DFG+A   ++  T    N  VGT  +MAPE 
Sbjct: 136 HSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEV 190

Query: 420 VMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           +    +  K+DI+S G+  +E+  G+
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGE 216

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  133 bits (336), Expect = 1e-34
 Identities = 64/236 (27%), Positives = 111/236 (47%), Gaps = 19/236 (8%)

Query: 218 KLEDENVEETIAKS----LQFDFETIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIA 272
           KLE+  ++E   K     L    +   +  D+F   ++LG G  G V+K     +G  +A
Sbjct: 3   KLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMA 62

Query: 273 VKRLSKNSKQGEIEF-KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI 331
            K +    K         E+ +L       +V   G      E  +  E +   SLD  +
Sbjct: 63  RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL 122

Query: 332 --FDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD 389
                I  + +      K+   + +GL YL E    +I+HRD+K SNIL++S    K+ D
Sbjct: 123 KKAGRIPEQILG-----KVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCD 175

Query: 390 FGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           FG++   ++  + +++   VGT  YM+PE +    +SV+SDI+S G+ ++E+  G+
Sbjct: 176 FGVSG--QLIDSMANSF--VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  131 bits (331), Expect = 2e-34
 Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 23/205 (11%)

Query: 243 TDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHR 300
            D F    KLG G FG V+     S+G    +K ++K+  Q  +E  + E+ +L  L H 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY------KIIEGIAR 354
           N++++     +     +V E      L     + I        K        ++++ +  
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGEL----LERI-VSAQARGKALSEGYVAELMKQMMN 135

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            L Y H      ++H+DLK  NIL          KI DFG+A LF+ D+  ++     GT
Sbjct: 136 ALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN---AAGT 189

Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGV 436
             YMAPE V     + K DI+S GV
Sbjct: 190 ALYMAPE-VFKRDVTFKCDIWSAGV 213

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  130 bits (329), Expect = 2e-34
 Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 19/201 (9%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIE-FKNEVLLLARLQHRNLVRLLG 307
           LG+G F  VY+   +  G  +A+K + K +  K G ++  +NEV +  +L+H +++ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 308 FCLERKERI-LVYEFVPNASLDHFIFDPINREHMT---WEKRYKIIEGIARGLLYLHEDS 363
              E    + LV E   N  +       +          E R+ + + I  G+LYLH   
Sbjct: 79  -YFEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEARHFMHQ-IITGMLYLH--- 129

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
              I+HRDL  SN+LL   MN KI+DFG+A   +M      T  + GT  Y++PE     
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRS 187

Query: 424 RFSVKSDIFSFGVLVLEIVSG 444
              ++SD++S G +   ++ G
Sbjct: 188 AHGLESDVWSLGCMFYTLLIG 208

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  136 bits (344), Expect = 3e-34
 Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 17/206 (8%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLL-- 306
           +LG GGFG V + +    GE +A+K+  +       E +  E+ ++ +L H N+V     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 307 ----GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
                        +L  E+     L  ++    N   +       ++  I+  L YLHE 
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE- 139

Query: 363 SRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
              RIIHRDLK  NI+L         KI D G A+  +           VGT  Y+APE 
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTE--FVGTLQYLAPEL 194

Query: 420 VMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           +   +++V  D +SFG L  E ++G 
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGF 220

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  134 bits (340), Expect = 3e-34
 Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 22/213 (10%)

Query: 243 TDNFSDA----NKLGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGE--IEFKNEVLLLA 295
              F++       LG+G FG V K       +  AVK ++K S + +       EV LL 
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIAR 354
           +L H N+++L     +     +V E      L    FD I  R+  +     +II+ +  
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFS 132

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           G+ Y+H+     I+HRDLK  NILL+S   + + KI DFG++  F+ +    D    +GT
Sbjct: 133 GITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---RIGT 186

Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
             Y+APE V+ G +  K D++S GV++  ++SG
Sbjct: 187 AYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  129 bits (327), Expect = 4e-34
 Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 24/214 (11%)

Query: 240 RVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEIE-FKNEVLLLA 295
           + A ++F     LG+G FG VY      +   +A+K L K    K G     + EV + +
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64

Query: 296 RLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKR-YKIIEGIA 353
            L+H N++RL G+      R+ L+ E+ P  ++    +  + +     E+R    I  +A
Sbjct: 65  HLRHPNILRLYGY-FHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELA 119

Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR---VVG 410
             L Y H     R+IHRD+K  N+LL S    KI+DFG +        H+ ++R   + G
Sbjct: 120 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCG 169

Query: 411 TFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
           T  Y+ PE +       K D++S GVL  E + G
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  129 bits (326), Expect = 5e-34
 Identities = 49/203 (24%), Positives = 88/203 (43%), Gaps = 20/203 (9%)

Query: 243 TDNFSDA----NKLGQGGFGAVYKG-MLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL 297
             + +      N +G+G +G V            A K++ K   +    FK E+ ++  L
Sbjct: 4   KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL 63

Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGL 356
            H N++RL     +  +  LV E      L    F+ + ++         +I++ +   +
Sbjct: 64  DHPNIIRLYETFEDNTDIYLVMELCTGGEL----FERVVHKRVFRESDAARIMKDVLSAV 119

Query: 357 LYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
            Y H+   L + HRDLK  N L  +   +   K+ DFG+A  F+  +        VGT  
Sbjct: 120 AYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT---KVGTPY 173

Query: 414 YMAPEYVMHGRFSVKSDIFSFGV 436
           Y++P+ V+ G +  + D +S GV
Sbjct: 174 YVSPQ-VLEGLYGPECDEWSAGV 195

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  130 bits (328), Expect = 9e-34
 Identities = 57/225 (25%), Positives = 106/225 (47%), Gaps = 16/225 (7%)

Query: 231 SLQFDFE-TIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-F 287
            L+   E       ++  D  ++G+G +G+V K +   +G+ +AVKR+     + E +  
Sbjct: 8   KLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQL 67

Query: 288 KNEV-LLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY 346
             ++ +++       +V+  G      +  +  E + + S D F     +       +  
Sbjct: 68  LMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEI 126

Query: 347 --KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD 404
             KI     + L +L E+  L+IIHRD+K SNILLD   N K+ DFG++   ++  + + 
Sbjct: 127 LGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISG--QLVDSIAK 182

Query: 405 TNRVVGTFGYMAPE----YVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           T    G   YMAPE          + V+SD++S G+ + E+ +G+
Sbjct: 183 TR-DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  133 bits (337), Expect = 9e-34
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 33/228 (14%)

Query: 239 IRVATDNFSDA----NKLGQGGFGAVYKG-MLSNGETIAVKRLSKN-------------S 280
           +R       ++     KLG G +G V      +     A+K + K+              
Sbjct: 27  VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86

Query: 281 KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREH 339
           ++   E  NE+ LL  L H N+++L     ++K   LV EF     L    F+ I NR  
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHK 142

Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMARLF 396
                   I++ I  G+ YLH+     I+HRD+K  NILL++    +N KI DFG++  F
Sbjct: 143 FDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199

Query: 397 EMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
             D    D    +GT  Y+APE V+  +++ K D++S GV++  ++ G
Sbjct: 200 SKDYKLRD---RLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  129 bits (326), Expect = 1e-33
 Identities = 59/207 (28%), Positives = 108/207 (52%), Gaps = 16/207 (7%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN 301
            + F    KLG+G +G+VYK +    G+ +A+K++   S   EI    E+ ++ +    +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEII--KEISIMQQCDSPH 85

Query: 302 LVRLLGFCLERKERILVYEFVPNASLD---HFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           +V+  G   +  +  +V E+    S+          +  + +       I++   +GL Y
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT-----ILQSTLKGLEY 140

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
           LH     R IHRD+KA NILL++E + K++DFG+A   ++  T +  N V+GT  +MAPE
Sbjct: 141 LHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAG--QLTDTMAKRNTVIGTPFWMAPE 195

Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
            +    ++  +DI+S G+  +E+  G+
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGK 222

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  128 bits (324), Expect = 1e-33
 Identities = 64/193 (33%), Positives = 97/193 (50%), Gaps = 18/193 (9%)

Query: 251 KLGQGGFGAVYKG-MLSNGETIAVKRLSKNS-KQGEIE-FKNEVLLLARLQHRNLVRLLG 307
            LG+G FG V K       +  AVK ++K S K  +      EV LL +L H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
              +     +V E      L    FD I  R+  +     +II+ +  G+ Y+H+     
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HN 141

Query: 367 IIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
           I+HRDLK  NILL+S   + + KI DFG++  F+ +    D    +GT  Y+APE V+ G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---RIGTAYYIAPE-VLRG 197

Query: 424 RFSVKSDIFSFGV 436
            +  K D++S GV
Sbjct: 198 TYDEKCDVWSAGV 210

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  131 bits (332), Expect = 2e-33
 Identities = 66/281 (23%), Positives = 99/281 (35%), Gaps = 51/281 (18%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNL 302
           +       LG G  G V       G  +AVKR+  +          E+ LL     H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDDHPNV 71

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGLLY 358
           +R        +   +  E   N +L   +        N +         ++  IA G+ +
Sbjct: 72  IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNP-------------KISDFGMARLFEMDQT--HS 403
           LH    L+IIHRDLK  NIL+ +                  ISDFG+ +  +  Q+   +
Sbjct: 131 LHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 404 DTNRVVGTFGYMAPE-------YVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
           + N   GT G+ APE            R +   DIFS G +   I+S   +  FG +   
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK-GKHPFGDKYSR 246

Query: 457 E--------DLLTYAWRNWNE--GAALNL------MDPTMR 481
           E         L      +       A +L       DP  R
Sbjct: 247 ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKR 287

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  130 bits (328), Expect = 3e-33
 Identities = 56/231 (24%), Positives = 99/231 (42%), Gaps = 22/231 (9%)

Query: 216 KLKLEDENVEETIAKSLQFDFETIRVATDNFSD----ANKLGQGGFGAVYKGM-LSNGET 270
           K+   D+  E+   K   +  + + V   +  D      +LG G FG V++ +  + G  
Sbjct: 22  KINDYDKFYEDIWKK---YVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRV 78

Query: 271 IAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHF 330
              K ++      +   KNE+ ++ +L H  L+ L     ++ E +L+ EF+    L   
Sbjct: 79  FVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL--- 135

Query: 331 IFDPI-NREHMTWEKR-YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP--K 386
            FD I   ++   E      +     GL ++HE     I+H D+K  NI+ +++     K
Sbjct: 136 -FDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVK 191

Query: 387 ISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVL 437
           I DFG+A     D+          T  + APE V        +D+++ GVL
Sbjct: 192 IIDFGLATKLNPDEIVKV---TTATAEFAAPEIVDREPVGFYTDMWAIGVL 239

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  127 bits (320), Expect = 6e-33
 Identities = 57/212 (26%), Positives = 100/212 (47%), Gaps = 19/212 (8%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN 301
            + +    +LG G FG VYK      G   A K +   S++   ++  E+ +LA   H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 302 LVRLLGFCLERKERILVYEFVPNASLD---HFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           +V+LLG      +  ++ EF P  ++D     +   +    +       +   +   L +
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-----VCRQMLEALNF 132

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
           LH     RIIHRDLKA N+L+  E + +++DFG++   +  +T    +  +GT  +MAPE
Sbjct: 133 LHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPE 187

Query: 419 YVMHGRFS-----VKSDIFSFGVLVLEIVSGQ 445
            VM           K+DI+S G+ ++E+   +
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  126 bits (319), Expect = 8e-33
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 14/216 (6%)

Query: 238 TIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEV-LLL 294
           ++ V  D+     +LG+G +G V K   + +G+ +AVKR+       E +    ++ + +
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60

Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY-KIIEGIA 353
             +     V   G      +  +  E + + SLD F    I++     E    KI   I 
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119

Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
           + L +LH  S+L +IHRD+K SN+L+++    K+ DFG++    +    +  +   G   
Sbjct: 120 KALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVA-KDIDAGCKP 174

Query: 414 YMAPE----YVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           YMAPE     +    +SVKSDI+S G+ ++E+   +
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  131 bits (330), Expect = 1e-32
 Identities = 50/215 (23%), Positives = 96/215 (44%), Gaps = 19/215 (8%)

Query: 233 QFDFETIRVATDNFSD----ANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEF 287
           Q+  + + +  D+  D      +LG G FG V++    + G   A K +    +  +   
Sbjct: 142 QYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV 201

Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI--NREHMTWEKR 345
           + E+  ++ L+H  LV L     +  E +++YEF+    L    F+ +      M+ ++ 
Sbjct: 202 RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEA 257

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTHS 403
            + +  + +GL ++HE      +H DLK  NI+  ++ +   K+ DFG+    +  Q+  
Sbjct: 258 VEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314

Query: 404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLV 438
                 GT  + APE          +D++S GVL 
Sbjct: 315 V---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  126 bits (319), Expect = 2e-32
 Identities = 55/231 (23%), Positives = 95/231 (41%), Gaps = 23/231 (9%)

Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLA 295
           +T+ +          L +GGF  VY+   + +G   A+KRL  N ++       EV  + 
Sbjct: 21  QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMK 80

Query: 296 RLQ-HRNLVRLLGFCLERKER-------ILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
           +L  H N+V+        KE         L+   +    L  F+    +R  ++ +   K
Sbjct: 81  KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140

Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS---- 403
           I     R + ++H   +  IIHRDLK  N+LL ++   K+ DFG A        +S    
Sbjct: 141 IFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199

Query: 404 ------DTNRVVGTFGYMAPEYV-MHGRFSV--KSDIFSFGVLVLEIVSGQ 445
                 +      T  Y  PE + ++  F +  K DI++ G ++  +   Q
Sbjct: 200 RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  125 bits (316), Expect = 2e-32
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 22/207 (10%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEI------EFKNEVLLLA 295
            D++    +LG G F  V K      G+  A K + K             E + EV +L 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIAR 354
            ++H N++ L      + + +L+ E V    L    FD +  +E +T ++  + ++ I  
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQILD 119

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMARLFEMDQTHSDTNRVVG 410
           G+ YLH     RI H DLK  NI+L  +  P    K+ DFG+A   E      +   + G
Sbjct: 120 GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFG 173

Query: 411 TFGYMAPEYVMHGRFSVKSDIFSFGVL 437
           T  ++APE V +    +++D++S GV+
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVI 200

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  127 bits (320), Expect = 2e-32
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 21/215 (9%)

Query: 234 FDFETIRVATDNFSD------ANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE 286
           FD   +       +          LG G FG V+K    + G  +A K +     + + E
Sbjct: 73  FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE 132

Query: 287 FKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE--HMTWEK 344
            KNE+ ++ +L H NL++L      + + +LV E+V    L    FD I  E  ++T   
Sbjct: 133 VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELD 188

Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTH 402
               ++ I  G+ ++H+   + I+H DLK  NIL  +      KI DFG+AR ++  +  
Sbjct: 189 TILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245

Query: 403 SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVL 437
                  GT  ++APE V +   S  +D++S GV+
Sbjct: 246 KV---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVI 277

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  124 bits (314), Expect = 3e-32
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 28/216 (12%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKN--SKQGEIE-FKNE 290
           DF+  R           LG+G FG VY      N   +A+K L K+   K+G     + E
Sbjct: 15  DFDIGRP----------LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRRE 64

Query: 291 VLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKR-YKI 348
           + + + L+H N++R+  +    ++RI L+ EF P   L    +  + +     E+R    
Sbjct: 65  IEIQSHLRHPNILRMYNY-FHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATF 119

Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV 408
           +E +A  L Y H     ++IHRD+K  N+L+  +   KI+DFG +      +  +    +
Sbjct: 120 MEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT----M 172

Query: 409 VGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG 444
            GT  Y+ PE +       K D++  GVL  E + G
Sbjct: 173 CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  125 bits (316), Expect = 3e-32
 Identities = 54/191 (28%), Positives = 87/191 (45%), Gaps = 16/191 (8%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
            LG G F  V+       G+  A+K + K+    +   +NE+ +L +++H N+V L    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 310 LERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
                  LV + V    L    FD I  R   T +    +I+ +   + YLHE     I+
Sbjct: 76  ESTTHYYLVMQLVSGGEL----FDRILERGVYTEKDASLVIQQVLSAVKYLHE---NGIV 128

Query: 369 HRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRF 425
           HRDLK  N+L  +        I+DFG++++ +     +      GT GY+APE +    +
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST----ACGTPGYVAPEVLAQKPY 184

Query: 426 SVKSDIFSFGV 436
           S   D +S GV
Sbjct: 185 SKAVDCWSIGV 195

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  125 bits (316), Expect = 4e-32
 Identities = 47/200 (23%), Positives = 87/200 (43%), Gaps = 16/200 (8%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN 301
            + +  A  LG+G FG V++ +  S+ +T   K +       ++  K E+ +L   +HRN
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRN 62

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINRE--HMTWEKRYKIIEGIARGLLYL 359
           ++ L       +E ++++EF+    +    F+ IN     +   +    +  +   L +L
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQFL 118

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTHSDTNRVVGTFGYMAP 417
           H      I H D++  NI+  +  +   KI +FG AR  +          +     Y AP
Sbjct: 119 HS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAP 172

Query: 418 EYVMHGRFSVKSDIFSFGVL 437
           E   H   S  +D++S G L
Sbjct: 173 EVHQHDVVSTATDMWSLGTL 192

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  125 bits (316), Expect = 4e-32
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 26/211 (12%)

Query: 243 TDNFSDA----NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEI------EFKNEV 291
                D      +LG G F  V K    S G   A K + K   +         E + EV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66

Query: 292 LLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIE 350
            +L ++ H N++ L      R + +L+ E V    L    FD +  +E ++ E+    I+
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIK 122

Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMARLFEMDQTHSDTN 406
            I  G+ YLH     +I H DLK  NI+L  +  P    K+ DFG+A   E      +  
Sbjct: 123 QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-- 177

Query: 407 RVVGTFGYMAPEYVMHGRFSVKSDIFSFGVL 437
            + GT  ++APE V +    +++D++S GV+
Sbjct: 178 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  125 bits (315), Expect = 5e-32
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 26/211 (12%)

Query: 243 TDNFSDA----NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEI------EFKNEV 291
            +N  D      +LG G F  V K    S G   A K + K   +         + + EV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 292 LLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIE 350
            +L  +QH N++ L      + + IL+ E V    L    FD +  +E +T E+  + ++
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLK 121

Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMARLFEMDQTHSDTN 406
            I  G+ YLH    L+I H DLK  NI+L     P    KI DFG+A   +      +  
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-- 176

Query: 407 RVVGTFGYMAPEYVMHGRFSVKSDIFSFGVL 437
            + GT  ++APE V +    +++D++S GV+
Sbjct: 177 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  124 bits (313), Expect = 5e-32
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 14/213 (6%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRN 301
           D++     +G G    V         E +A+KR++    Q  ++    E+  +++  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKRYKIIEGIAR----GL 356
           +V      + + E  LV + +   S+   I       EH +       I  I R    GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM-ARLFEMDQTHSDTNR--VVGTFG 413
            YLH++     IHRD+KA NILL  + + +I+DFG+ A L        +  R   VGT  
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 414 YMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQ 445
           +MAPE +   R +  K+DI+SFG+  +E+ +G 
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  125 bits (316), Expect = 8e-32
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 26/211 (12%)

Query: 243 TDNFSDA----NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEI------EFKNEV 291
                D      +LG G F  V K    S G   A K + K   +         E + EV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66

Query: 292 LLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIE 350
            +L ++ H N++ L      R + +L+ E V    L    FD +  +E ++ E+    I+
Sbjct: 67  SILRQVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIK 122

Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMARLFEMDQTHSDTN 406
            I  G+ YLH     +I H DLK  NI+L  +  P    K+ DFG+A   E      +  
Sbjct: 123 QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-- 177

Query: 407 RVVGTFGYMAPEYVMHGRFSVKSDIFSFGVL 437
            + GT  ++APE V +    +++D++S GV+
Sbjct: 178 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  129 bits (326), Expect = 9e-32
 Identities = 45/203 (22%), Positives = 76/203 (37%), Gaps = 24/203 (11%)

Query: 251 KLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLLG 307
            +  GG G +Y       NG  + +K L  +           E   LA + H ++V++  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 308 FCLERKERI-----LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           F             +V E+V   SL          + +   +    +  I   L YLH  
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYLH-- 199

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH 422
             + +++ DLK  NI+L  E   K+ D G           +    + GT G+ APE V  
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS------RINSFGYLYGTPGFQAPEIVR- 250

Query: 423 GRFSVKSDIFSFGVLVLEIVSGQ 445
              +V +DI++ G  +  +    
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDL 273

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  122 bits (309), Expect = 1e-31
 Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 21/205 (10%)

Query: 243 TDNFSDA----NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS-KQGEIE-FKNEVLLLA 295
           +  FSD      +LG+G F  V + +  + G   A K ++       + +  + E  +  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIAR 354
           +LQH N+VRL     E     LV++ V    L    F+ I  RE  +       I+ I  
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHCIQQILE 116

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQTHSDTNRVVGT 411
            + Y H      I+HR+LK  N+LL S+      K++DFG+A      +         GT
Sbjct: 117 SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGT 170

Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGV 436
            GY++PE +    +S   DI++ GV
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGV 195

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  124 bits (313), Expect = 2e-31
 Identities = 48/263 (18%), Positives = 87/263 (33%), Gaps = 40/263 (15%)

Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM------LSNGETIAVKRLSKNSKQGEIEFKNE 290
              ++ +      + LG+G F  VY+          N +   +K     +     EF   
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIG 114

Query: 291 VLLLARLQ---HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY- 346
             L+ RL+       ++     L +   +LV E     +L     + IN    T EK   
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTL----LNAINLYKNTPEKVMP 170

Query: 347 -----KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP-----------KISDF 390
                     +   +  +H+     IIH D+K  N +L +                + D 
Sbjct: 171 QGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDL 227

Query: 391 GMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ--KRS 448
           G +   ++    +       T G+   E + +  ++ + D F     V  ++ G   K  
Sbjct: 228 GQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287

Query: 449 SFGTEEETEDLLTYAWRN--WNE 469
           + G E + E L         WNE
Sbjct: 288 NEGGECKPEGLFRRLPHLDMWNE 310

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  121 bits (307), Expect = 3e-31
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 11/199 (5%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEI---EFKNEVLLLARLQHRNLVRLL 306
           KLG GG   VY          +A+K +    ++ E     F+ EV   ++L H+N+V ++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
               E     LV E++   +L  +I        ++ +        I  G+ + H    +R
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAH---DMR 131

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS 426
           I+HRD+K  NIL+DS    KI DFG+A+    + + + TN V+GT  Y +PE        
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEATD 190

Query: 427 VKSDIFSFGVLVLEIVSGQ 445
             +DI+S G+++ E++ G+
Sbjct: 191 ECTDIYSIGIVLYEMLVGE 209

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  123 bits (310), Expect = 4e-31
 Identities = 48/222 (21%), Positives = 92/222 (41%), Gaps = 39/222 (17%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEF-----------------KNEVLL 293
            L QG F  +      + +  A+K+  K+  + + +F                 KNE+ +
Sbjct: 38  TLNQGKFNKIILC-EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 294 LARLQHRNLVRLLGFCLERKERI-LVYEFVPNASL-----DHFIFDPINREHMTWEKRYK 347
           +  +++   +   G  +   + + ++YE++ N S+       F+ D      +  +    
Sbjct: 97  ITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155

Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
           II+ +     Y+H  +   I HRD+K SNIL+D     K+SDFG +      +       
Sbjct: 156 IIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG---- 209

Query: 408 VVGTFGYMAPEYVM-----HGRFSVKSDIFSFGVLVLEIVSG 444
             GT+ +M PE+       +G    K DI+S G+ +  +   
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGA---KVDIWSLGICLYVMFYN 248

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  122 bits (309), Expect = 6e-31
 Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 23/212 (10%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFK---NEVLLLARLQ 298
              FSD  ++G G FGAVY    + N E +A+K++S + KQ   +++    EV  L +L+
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLD--HFIFDPINREHMTWEKRYKIIEGIARGL 356
           H N ++  G  L      LV E+   ++ D       P+    +       +  G  +GL
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA-----VTHGALQGL 167

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            YLH      +IHRD+KA NILL      K+ DFG A         +  N  VGT  +MA
Sbjct: 168 AYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANSFVGTPYWMA 218

Query: 417 PEYVMH---GRFSVKSDIFSFGVLVLEIVSGQ 445
           PE ++    G++  K D++S G+  +E+   +
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERK 250

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  121 bits (306), Expect = 2e-30
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 21/211 (9%)

Query: 237 ETIRVATDNFSDA----NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS-KQGEIE-FKN 289
           E +  A+  FSD      +LG+G F  V + +  + G   A K ++       + +  + 
Sbjct: 18  EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77

Query: 290 EVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKI 348
           E  +  +LQH N+VRL     E     LV++ V    L    F+ I  RE  +       
Sbjct: 78  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADASHC 133

Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQTHSDT 405
           I+ I   + Y H      I+HR+LK  N+LL S+      K++DFG+A      +     
Sbjct: 134 IQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG- 189

Query: 406 NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGV 436
               GT GY++PE +    +S   DI++ GV
Sbjct: 190 --FAGTPGYLSPEVLKKDPYSKPVDIWACGV 218

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  118 bits (299), Expect = 4e-30
 Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 32/217 (14%)

Query: 242 ATDNFSDA----NKLGQGGFGAVYKGM-LSNGETIAVKRLSK---------NSKQGEIEF 287
           +T  F +       LG+G    V + +     +  AVK +             ++     
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70

Query: 288 KNEVLLLARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKR 345
             EV +L ++  H N+++L           LV++ +    L    FD +  +  ++ ++ 
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKET 126

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
            KI+  +   +  LH+   L I+HRDLK  NILLD +MN K++DFG +   +  +   + 
Sbjct: 127 RKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE- 182

Query: 406 NRVVGTFGYMAPE------YVMHGRFSVKSDIFSFGV 436
             V GT  Y+APE         H  +  + D++S GV
Sbjct: 183 --VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  119 bits (299), Expect = 6e-30
 Identities = 51/225 (22%), Positives = 97/225 (43%), Gaps = 22/225 (9%)

Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKN 289
           L    +  +   ++  +  ++G G  G V+K      G  IAVK++ ++  + E +    
Sbjct: 13  LTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILM 72

Query: 290 EV-LLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFI---FDPINREHMTWEKR 345
           ++ ++L       +V+  G  +   +  +  E +     +        PI    +     
Sbjct: 73  DLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILG---- 127

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
            K+   I + L YL E     +IHRD+K SNILLD     K+ DFG++    +    +  
Sbjct: 128 -KMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISG--RLVDDKAKD 182

Query: 406 NRVVGTFGYMAPE-----YVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
               G   YMAPE           + +++D++S G+ ++E+ +GQ
Sbjct: 183 R-SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  119 bits (301), Expect = 7e-30
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 21/203 (10%)

Query: 243 TDNFSDA----NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL 297
            D  SD     ++LG+G    VY+       +  A+K L K     +   + E+ +L RL
Sbjct: 48  RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRL 105

Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGL 356
            H N+++L        E  LV E V    L    FD I  + + +       ++ I   +
Sbjct: 106 SHPNIIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAADAVKQILEAV 161

Query: 357 LYLHEDSRLRIIHRDLKASNILL---DSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFG 413
            YLHE     I+HRDLK  N+L      +   KI+DFG++++ E          V GT G
Sbjct: 162 AYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT---VCGTPG 215

Query: 414 YMAPEYVMHGRFSVKSDIFSFGV 436
           Y APE +    +  + D++S G+
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGI 238

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  118 bits (298), Expect = 1e-29
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 25/210 (11%)

Query: 243 TDNFSD-----ANKLGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEIEFKNEVLLL 294
            +NF++     + +LG+G F  V + +  S G+  A K L K    +    E  +E+ +L
Sbjct: 23  MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVL 82

Query: 295 ARLQHR-NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI---NREHMTWEKRYKIIE 350
              +    ++ L        E IL+ E+     +    F        E ++     ++I+
Sbjct: 83  ELAKSCPRVINLHEVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVIRLIK 138

Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMARLFEMDQTHSDTNR 407
            I  G+ YLH+     I+H DLK  NILL S     + KI DFGM+R         +   
Sbjct: 139 QILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--- 192

Query: 408 VVGTFGYMAPEYVMHGRFSVKSDIFSFGVL 437
           ++GT  Y+APE + +   +  +D+++ G++
Sbjct: 193 IMGTPEYLAPEILNYDPITTATDMWNIGII 222

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  120 bits (303), Expect = 1e-29
 Identities = 51/207 (24%), Positives = 96/207 (46%), Gaps = 20/207 (9%)

Query: 241 VATDNFSDA----NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS-KQGEIE-FKNEVLL 293
           +    F++      +LG+G F  V + + +  G+  A   ++       + +  + E  +
Sbjct: 4   ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI 63

Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGI 352
              L+H N+VRL     E     L+++ V    L    F+ I  RE+ +       I+ I
Sbjct: 64  CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCIQQI 119

Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQTHSDTNRVV 409
              +L+ H+   + ++HR+LK  N+LL S++     K++DFG+A   E +Q         
Sbjct: 120 LEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FA 174

Query: 410 GTFGYMAPEYVMHGRFSVKSDIFSFGV 436
           GT GY++PE +    +    D+++ GV
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACGV 201

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  117 bits (295), Expect = 2e-29
 Identities = 55/202 (27%), Positives = 83/202 (41%), Gaps = 23/202 (11%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGFC 309
           LG+G    V   + L   +  AVK + K           EV +L + Q HRN++ L+ F 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 310 LERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
            E     LV+E +   S+       I  R H    +   +++ +A  L +LH      I 
Sbjct: 81  EEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEASVVVQDVASALDFLHN---KGIA 133

Query: 369 HRDLKASNILLDSEMNP---KISDFGMARLFEMDQTHSDTNR-----VVGTFGYMAPEYV 420
           HRDLK  NIL +        KI DF +    +++   S  +        G+  YMAPE V
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193

Query: 421 MHGRFSVKS-----DIFSFGVL 437
                         D++S GV+
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVI 215

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  117 bits (294), Expect = 3e-29
 Identities = 63/225 (28%), Positives = 101/225 (44%), Gaps = 20/225 (8%)

Query: 234 FDFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVL 292
            D   +R     F     +G G +G VYKG  +  G+  A+K +   +   E E K E+ 
Sbjct: 14  IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEIN 72

Query: 293 LLARL-QHRNLVRLLGFCLERKERI------LVYEFVPNASLDHFIFDPINREHMTWEKR 345
           +L +   HRN+    G  +++          LV EF    S+   +        +  E  
Sbjct: 73  MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWI 131

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
             I   I RGL +LH+    ++IHRD+K  N+LL      K+ DFG++   ++D+T    
Sbjct: 132 AYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRR 186

Query: 406 NRVVGTFGYMAPEYVMHGRFS-----VKSDIFSFGVLVLEIVSGQ 445
           N  +GT  +MAPE +            KSD++S G+  +E+  G 
Sbjct: 187 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  118 bits (296), Expect = 4e-29
 Identities = 22/229 (9%), Positives = 51/229 (22%), Gaps = 43/229 (18%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE---FKNEVLLLARLQHRNLVRLLG 307
           L  G    V+    +   E  A+K  +  ++    E           ARL   +      
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 308 FC--------------------------LERKERILVYEFVP---NASLDHFIFDPINRE 338
                                             +L+                F  + R 
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189

Query: 339 HMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM 398
                  + +   + R    L       ++H      N+ +  +    + D         
Sbjct: 190 DEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW---- 242

Query: 399 DQTHSDTNRVVGTFGYMAPEYVMHGR--FSVKSDIFSFGVLVLEIVSGQ 445
            +  +          Y   E++      F+   + +  G+ +  +    
Sbjct: 243 -KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  117 bits (295), Expect = 5e-29
 Identities = 50/216 (23%), Positives = 94/216 (43%), Gaps = 31/216 (14%)

Query: 242 ATDNFSDA----NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE--------FK 288
           A   F       + +G+G    V + +  + G   AVK +   +++   E         +
Sbjct: 88  AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147

Query: 289 NEVLLLARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRY 346
            E  +L ++  H +++ L+          LV++ +    L    FD +  +  ++ ++  
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETR 203

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            I+  +   + +LH      I+HRDLK  NILLD  M  ++SDFG +   E  +   +  
Sbjct: 204 SIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE-- 258

Query: 407 RVVGTFGYMAPE------YVMHGRFSVKSDIFSFGV 436
            + GT GY+APE         H  +  + D+++ GV
Sbjct: 259 -LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  116 bits (292), Expect = 6e-29
 Identities = 44/199 (22%), Positives = 80/199 (40%), Gaps = 11/199 (5%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE--IE-FKNEVLLLARLQHRNLVRLL 306
            +G+GG G VY+         +A+K +S+            + E     RLQ  ++V + 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 307 GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
            F     +  +    +    L   +     +  +   +   I+  I   L   H      
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAA---G 154

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS 426
             HRD+K  NIL+ ++    + DFG+A     D+  +     VGT  YMAPE       +
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSESHAT 213

Query: 427 VKSDIFSFGVLVLEIVSGQ 445
            ++DI++   ++ E ++G 
Sbjct: 214 YRADIYALTCVLYECLTGS 232

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  116 bits (293), Expect = 9e-29
 Identities = 51/202 (25%), Positives = 81/202 (40%), Gaps = 25/202 (12%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVK-----RLSKNSKQGEIEFKNEVLLLARLQHRNLVR 304
            +G+G F  V + +    G+  AVK     + + +      + K E  +   L+H ++V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY------KIIEGIARGLLY 358
           LL          +V+EF+  A L       I  +       Y        +  I   L Y
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADL----CFEIV-KRADAGFVYSEAVASHYMRQILEALRY 145

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQTHSDTNRVVGTFGYM 415
            H+     IIHRD+K   +LL S+ N    K+  FG+A         +     VGT  +M
Sbjct: 146 CHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFM 200

Query: 416 APEYVMHGRFSVKSDIFSFGVL 437
           APE V    +    D++  GV+
Sbjct: 201 APEVVKREPYGKPVDVWGCGVI 222

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  117 bits (294), Expect = 9e-29
 Identities = 47/220 (21%), Positives = 84/220 (38%), Gaps = 26/220 (11%)

Query: 243 TDNFSDANKLGQG--GFGAVYKGM-LSNGETIAVKR--LSKNSKQGEIEFKNEVLLLARL 297
              +     +G+G      V        GE + V+R  L   S +     + E+ +    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIA 353
            H N+V      +   E  +V  F+   S    I     D +N   + +     I++G+ 
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY-----ILQGVL 138

Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG-MARLFEMDQ----THSDTNRV 408
           + L Y+H       +HR +KAS+IL+  +    +S       +    Q     H      
Sbjct: 139 KALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195

Query: 409 VGTFGYMAPEYVMHGR---FSVKSDIFSFGVLVLEIVSGQ 445
           V    +++PE V+      +  KSDI+S G+   E+ +G 
Sbjct: 196 VKVLPWLSPE-VLQQNLQGYDAKSDIYSVGITACELANGH 234

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  115 bits (290), Expect = 1e-28
 Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 28/221 (12%)

Query: 242 ATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKN----EVLLLA 295
           AT  +    ++G G +G VYK     +G  +A+K +   N   G          EV LL 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 296 RLQ---HRNLVRLL----GFCLERKERI-LVYEFVPNASLDH---FIFDPINREHMTWEK 344
           RL+   H N+VRL+        +R+ ++ LV+E      +D       D      +  E 
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAET 121

Query: 345 RYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD 404
              ++    RGL +LH +    I+HRDLK  NIL+ S    K++DFG+AR++        
Sbjct: 122 IKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-- 176

Query: 405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           T  VV T  Y APE ++   ++   D++S G +  E+   +
Sbjct: 177 TPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  117 bits (295), Expect = 1e-28
 Identities = 57/251 (22%), Positives = 100/251 (39%), Gaps = 38/251 (15%)

Query: 215 GKLKLEDENVEETIAKSLQFDF-------ETIRVATDNFSD----ANKLGQGGFGAVYKG 263
           GK +  + N E  ++ S    F       +   V      D    +  LG G  G V   
Sbjct: 95  GKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLA 154

Query: 264 M-LSNGETIAVKRLSKN--------SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE 314
                 + +A++ +SK              +  + E+ +L +L H  ++++  F  + ++
Sbjct: 155 FERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAED 213

Query: 315 RILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLK 373
             +V E +    L    FD +   + +           +   + YLHE     IIHRDLK
Sbjct: 214 YYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLK 266

Query: 374 ASNILLDSEMNP---KISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE---YVMHGRFSV 427
             N+LL S+      KI+DFG +++            + GT  Y+APE    V    ++ 
Sbjct: 267 PENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGTPTYLAPEVLVSVGTAGYNR 323

Query: 428 KSDIFSFGVLV 438
             D +S GV++
Sbjct: 324 AVDCWSLGVIL 334

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  115 bits (289), Expect = 1e-28
 Identities = 65/293 (22%), Positives = 100/293 (34%), Gaps = 81/293 (27%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVL 292
           DFE I+           +G+GGFG V++     +    A+KR+   +++   E    EV 
Sbjct: 7   DFEPIQC----------MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVK 56

Query: 293 LLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKI---- 348
            LA+L+H  +VR     LE        E       D     P++          KI    
Sbjct: 57  ALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMD 116

Query: 349 -----------IEGIARGLLYLH-----------------------EDSRLRI------- 367
                           +  LY+                            L I       
Sbjct: 117 PFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEA 176

Query: 368 ---------IHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN----------RV 408
                    +HRDLK SNI    +   K+ DFG+    + D+                  
Sbjct: 177 VEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ 236

Query: 409 VGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLT 461
           VGT  YM+PE +    +S K DIFS G+++ E++       F T+ E   ++T
Sbjct: 237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS-----FSTQMERVRIIT 284

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  114 bits (288), Expect = 2e-28
 Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 15/204 (7%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEI---EFKNEVLLLARLQHRNLVRLL 306
            LG GG   V+    L +   +AVK L  +  +       F+ E    A L H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 307 --GFCLERKERI--LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
             G        +  +V E+V   +L   +        MT ++  ++I    + L + H  
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSH-- 133

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMAR-LFEMDQTHSDTNRVVGTFGYMAPEYVM 421
            +  IIHRD+K +NI++ +    K+ DFG+AR + +   + + T  V+GT  Y++PE   
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

Query: 422 HGRFSVKSDIFSFGVLVLEIVSGQ 445
                 +SD++S G ++ E+++G+
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGE 216

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  114 bits (288), Expect = 2e-28
 Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 26/218 (11%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLSKNS--KQGEIEF-KNE 290
           DF+  ++          LG+G F  V     L+     A+K L K    K+ ++ +   E
Sbjct: 31  DFKFGKI----------LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE 80

Query: 291 VLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYK-- 347
             +++RL H   V+L  F  +  E++     +  N  L       I +     E   +  
Sbjct: 81  RDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGEL----LKYIRKIGSFDETCTRFY 135

Query: 348 IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR 407
             E I   L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N 
Sbjct: 136 TAE-IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 191

Query: 408 VVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
            VGT  Y++PE +        SD+++ G ++ ++V+G 
Sbjct: 192 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  118 bits (297), Expect = 2e-28
 Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 22/217 (10%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN---SKQGEIEFKNE 290
            F   RV          LG+GGFG V+   + + G+  A K+L+K     ++G      E
Sbjct: 186 WFLDFRV----------LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVE 235

Query: 291 VLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKI- 348
             +LA++  R +V L  +  E K  + LV   +    + + I++         E R    
Sbjct: 236 KKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294

Query: 349 IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRV 408
              I  GL +LH+     II+RDLK  N+LLD + N +ISD G+A   +  QT   T   
Sbjct: 295 TAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGY 349

Query: 409 VGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
            GT G+MAPE ++   +    D F+ GV + E+++ +
Sbjct: 350 AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  114 bits (287), Expect = 3e-28
 Identities = 50/202 (24%), Positives = 84/202 (41%), Gaps = 27/202 (13%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKN--------SKQGEIEFKNEVLLLARLQHRN 301
            LG G  G V         + +A+K +SK              +  + E+ +L +L H  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLH 360
           ++++  F  + ++  +V E +    L    FD +   + +           +   + YLH
Sbjct: 77  IIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLH 131

Query: 361 EDSRLRIIHRDLKASNILLDS---EMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAP 417
           E     IIHRDLK  N+LL S   +   KI+DFG +++            + GT  Y+AP
Sbjct: 132 E---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGTPTYLAP 185

Query: 418 E---YVMHGRFSVKSDIFSFGV 436
           E    V    ++   D +S GV
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGV 207

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  118 bits (296), Expect = 4e-28
 Identities = 65/239 (27%), Positives = 109/239 (45%), Gaps = 37/239 (15%)

Query: 219 LEDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRLS 277
            + +NVE  I  ++  DF   R+          +G+GGFG VY       G+  A+K L 
Sbjct: 175 CQWKNVELNIHLTMN-DFSVHRI----------IGRGGFGEVYGCRKADTGKMYAMKCLD 223

Query: 278 KN---SKQGEIEFKNEVLLLARL---QHRNLVRLLGFCLERKERI-LVYEFVPNASLDHF 330
           K     KQGE    NE ++L+ +       +V +  +     +++  + + +    L   
Sbjct: 224 KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDL--- 279

Query: 331 IFDPINREHMTWEKRYKI-IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD 389
               +++  +  E   +     I  GL ++H      +++RDLK +NILLD   + +ISD
Sbjct: 280 -HYHLSQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISD 335

Query: 390 FGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR---FSVKSDIFSFGVLVLEIVSGQ 445
            G+A  F   + H+     VGT GYMAPE +  G     S   D FS G ++ +++ G 
Sbjct: 336 LGLACDFSKKKPHA----SVGTHGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGH 388

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  112 bits (282), Expect = 7e-28
 Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 21/202 (10%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLLGFC 309
           LG+G +G V   +     E +AVK +         E  K E+ +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 310 LERKERILVYEFVPNASLDHFIFDPI-NREHMT-WEKRYK---IIEGIARGLLYLHEDSR 364
            E   + L  E+     L    FD I     M   + +     ++ G+     YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
           + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GT  Y+APE ++  R
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-LLKRR 182

Query: 425 --FSVKSDIFSFGVLVLEIVSG 444
              +   D++S G+++  +++G
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAG 204

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  112 bits (283), Expect = 8e-28
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 28/209 (13%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSK----NSKQGEIEFKNEVLLLARLQHRNLVRLL 306
           LG+G +G V + +        AVK L K        GE   K E+ LL RL+H+N+++L+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 307 G-FCLERKERI-LVYEFVPNASLDHFIFDPINREHMT-WEKRYK---IIEGIARGLLYLH 360
                E K+++ +V E+      +  + D +  +     +       +I+G+     YLH
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH 126

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV 420
                 I+H+D+K  N+LL +    KIS  G+A                G+  +  PE  
Sbjct: 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183

Query: 421 M-----HGRFSVKSDIFSFGVLVLEIVSG 444
                  G    K DI+S GV +  I +G
Sbjct: 184 NGLDTFSGF---KVDIWSAGVTLYNITTG 209

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  112 bits (283), Expect = 1e-27
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 22/215 (10%)

Query: 242 ATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQG-------EIEFKNEVLL 293
           ++  F    KLG G +  VYKG+  + G  +A+K +  +S++G       EI       L
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS------L 56

Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPN--ASLDHFIFDPINREHMTWEKRYKIIEG 351
           +  L+H N+VRL        +  LV+EF+ N                 +           
Sbjct: 57  MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           + +GL + HE+   +I+HRDLK  N+L++     K+ DFG+AR F     ++ ++ VV T
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVNTFSSEVV-T 171

Query: 412 FGYMAPEYVMHGRF-SVKSDIFSFGVLVLEIVSGQ 445
             Y AP+ +M  R  S   DI+S G ++ E+++G+
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  112 bits (283), Expect = 1e-27
 Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 23/211 (10%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQG-------EIEFKNEVLLLA 295
           + +   +KLG+G +  VYKG        +A+K +    ++G       E+       LL 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS------LLK 55

Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            L+H N+V L       K   LV+E++    L  ++ D  N  +M   K +  +  + RG
Sbjct: 56  DLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLF--LFQLLRG 112

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYM 415
           L Y H     +++HRDLK  N+L++     K++DFG+AR      T +  N VV T  Y 
Sbjct: 113 LAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYDNEVV-TLWYR 167

Query: 416 APEYVMHGR-FSVKSDIFSFGVLVLEIVSGQ 445
            P+ ++    +S + D++  G +  E+ +G+
Sbjct: 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  116 bits (291), Expect = 1e-27
 Identities = 71/224 (31%), Positives = 102/224 (45%), Gaps = 39/224 (17%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN---SKQGEIEFKNE 290
            F   RV          LG+GGFG V    + + G+  A K+L K     ++GE    NE
Sbjct: 185 TFRQYRV----------LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE 234

Query: 291 VLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
             +L ++  R +V L  +  E K+ + LV   +    L  F        H+    +    
Sbjct: 235 KQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDL-KF--------HIYHMGQAGFP 284

Query: 350 EGIAR--------GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
           E  A         GL  LH     RI++RDLK  NILLD   + +ISD G+A      QT
Sbjct: 285 EARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341

Query: 402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
                  VGT GYMAPE V + R++   D ++ G L+ E+++GQ
Sbjct: 342 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  112 bits (282), Expect = 2e-27
 Identities = 58/194 (29%), Positives = 89/194 (45%), Gaps = 21/194 (10%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRNLVRLLGFC 309
           LG+G +G V   +     E +AVK +         E  K E+ +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 310 LERKERILVYEFVPNASLDHFIFDPI-NREHMT-WEKRYK---IIEGIARGLLYLHEDSR 364
            E   + L  E+     L    FD I     M   + +     ++ G+     YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
           + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GT  Y+APE ++  R
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-LLKRR 182

Query: 425 F--SVKSDIFSFGV 436
              +   D++S G+
Sbjct: 183 EFHAEPVDVWSCGI 196

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  111 bits (281), Expect = 2e-27
 Identities = 51/206 (24%), Positives = 86/206 (41%), Gaps = 24/206 (11%)

Query: 243 TDNFSDA----NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL 297
           +  F+D       +G G +    + +  +     AVK + K+ +        E+ +L R 
Sbjct: 17  SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEEIEILLRY 72

Query: 298 -QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARG 355
            QH N++ L     + K   +V E +    L     D I  ++  +  +   ++  I + 
Sbjct: 73  GQHPNIITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREASAVLFTITKT 128

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMARLFEMDQTHSDTNRVVGT 411
           + YLH      ++HRDLK SNIL   E       +I DFG A+    +     T     T
Sbjct: 129 VEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYT 183

Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVL 437
             ++APE +    +    DI+S GVL
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVL 209

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  111 bits (280), Expect = 3e-27
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 23/211 (10%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLS-KNSKQG-------EIEFKNEVLLLA 295
           + +    K+G+G +G VYK   S G  +A+KR+      +G       EI       LL 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREIS------LLK 74

Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            L H N+V L+      +   LV+EF+    L   + +  N+  +   +    +  + RG
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRG 131

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYM 415
           + + H+    RI+HRDLK  N+L++S+   K++DFG+AR F      S T+ VV T  Y 
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG-IPVRSYTHEVV-TLWYR 186

Query: 416 APEYVMHGRF-SVKSDIFSFGVLVLEIVSGQ 445
           AP+ +M  +  S   DI+S G +  E+++G+
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  111 bits (279), Expect = 5e-27
 Identities = 60/224 (26%), Positives = 110/224 (49%), Gaps = 36/224 (16%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKN----EVLLLARL 297
             +    K+GQG FG V+K      G+ +A+K++  +N K+G   F      E+ +L  L
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLL 73

Query: 298 QHRNLVRLLGFCLERKERI--------LVYEFVPNASLDH----FIFDPINREHMTWEKR 345
           +H N+V L+  C  +            LV++F      +H     + +       T  + 
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDF-----CEHDLAGLLSNV--LVKFTLSEI 126

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD- 404
            ++++ +  GL Y+H +   +I+HRD+KA+N+L+  +   K++DFG+AR F + +     
Sbjct: 127 KRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183

Query: 405 --TNRVVGTFGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQ 445
             TNRVV T  Y  PE ++  R +    D++  G ++ E+ +  
Sbjct: 184 RYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  109 bits (276), Expect = 5e-27
 Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 23/211 (10%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLS-KNSKQG-------EIEFKNEVLLLA 295
           + +    K+G+G +G VYK   + GET A+K++  +   +G       EI       +L 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREIS------ILK 55

Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
            L+H N+V+L      +K  +LV+E +    L   +            K +  +  +  G
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSF--LLQLLNG 112

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYM 415
           + Y H+    R++HRDLK  N+L++ E   KI+DFG+AR F        T+ +V T  Y 
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEIV-TLWYR 167

Query: 416 APEYVMHGRF-SVKSDIFSFGVLVLEIVSGQ 445
           AP+ +M  +  S   DI+S G +  E+V+G 
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  110 bits (278), Expect = 6e-27
 Identities = 59/219 (26%), Positives = 108/219 (49%), Gaps = 30/219 (13%)

Query: 244 DNFSDANKLGQGGFGAVYKG--MLSNGETIAVKRLS-KNSKQG-------EIEFKNEVLL 293
             +    ++G+G +G V+K   + + G  +A+KR+  +  ++G       E+      +L
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA-----VL 65

Query: 294 --LARLQHRNLVRLL----GFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRY 346
             L   +H N+VRL         +R+ ++ LV+E V    L  ++ D +    +  E   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTETIK 123

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            ++  + RGL +LH     R++HRDLK  NIL+ S    K++DFG+AR++        T+
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TS 178

Query: 407 RVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
            VV T  Y APE ++   ++   D++S G +  E+   +
Sbjct: 179 VVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  111 bits (279), Expect = 6e-27
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 21/212 (9%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN--------EVLLL 294
             +   + LG+G F  VYK    +  + +A+K++         E K+        E+ LL
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTALREIKLL 66

Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR 354
             L H N++ LL     +    LV++F+    L+  I D      +T       +    +
Sbjct: 67  QELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQ 123

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY 414
           GL YLH+     I+HRDLK +N+LLD     K++DFG+A+ F      + T++VV T  Y
Sbjct: 124 GLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVV-TRWY 178

Query: 415 MAPEYVMHGRF-SVKSDIFSFGVLVLEIVSGQ 445
            APE +   R   V  D+++ G ++ E++   
Sbjct: 179 RAPELLFGARMYGVGVDMWAVGCILAELLLRV 210

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  110 bits (276), Expect = 9e-27
 Identities = 52/193 (26%), Positives = 87/193 (45%), Gaps = 18/193 (9%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGF 308
            LG+G F    K +   + +  AVK +SK  +      + E+  L   + H N+V+L   
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEA---NTQKEITALKLCEGHPNIVKLHEV 74

Query: 309 CLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRI 367
             ++    LV E +    L    F+ I  ++H +  +   I+  +   + ++H+   + +
Sbjct: 75  FHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHD---VGV 127

Query: 368 IHRDLKASNILLDSEMNP---KISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
           +HRDLK  N+L   E +    KI DFG ARL   D     T     T  Y APE +    
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLNQNG 185

Query: 425 FSVKSDIFSFGVL 437
           +    D++S GV+
Sbjct: 186 YDESCDLWSLGVI 198

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  110 bits (277), Expect = 9e-27
 Identities = 54/276 (19%), Positives = 94/276 (34%), Gaps = 54/276 (19%)

Query: 219 LEDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVK--- 274
           +   +   +  ++L F   ++      +     +GQG +G V   +        A+K   
Sbjct: 1   MHHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60

Query: 275 --RLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIF 332
             ++ + + +     K EV L+ +L H N+ RL     + +   LV E      L   + 
Sbjct: 61  KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120

Query: 333 DPINREHMTWEKRY-------------------------------------KIIEGIARG 355
             I+                                                I+  I   
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDS--EMNPKISDFGMARLFEMDQTHSDT--NRVVGT 411
           L YLH      I HRD+K  N L  +      K+ DFG+++ F               GT
Sbjct: 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237

Query: 412 FGYMAPEYVMHG---RFSVKSDIFSFGVLVLEIVSG 444
             ++APE V++     +  K D +S GVL+  ++ G
Sbjct: 238 PYFVAPE-VLNTTNESYGPKCDAWSAGVLLHLLLMG 272

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  109 bits (274), Expect = 1e-26
 Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 24/213 (11%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQG-------EIEFKNEVLLL 294
             +    K+G+G +G V+K       E +A+KR+   +  +G       EI       LL
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC------LL 55

Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR 354
             L+H+N+VRL       K+  LV+EF     L  +             K +  +  + +
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSF--LFQLLK 112

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGY 414
           GL + H      ++HRDLK  N+L++     K+++FG+AR F        +  VV T  Y
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVV-TLWY 167

Query: 415 MAPEYVMHGRF-SVKSDIFSFGVLVLEIVSGQK 446
             P+ +   +  S   D++S G +  E+ +  +
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  109 bits (274), Expect = 2e-26
 Identities = 52/209 (24%), Positives = 96/209 (45%), Gaps = 18/209 (8%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---EVLLLARLQH 299
           + +    K+G+G +G V+K      G+ +A+K+    S+   +  K    E+ +L +L+H
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKH 61

Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            NLV LL     ++   LV+E+  + ++ H +     +  +       I     + + + 
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDR--YQRGVPEHLVKSITWQTLQAVNFC 118

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H   +   IHRD+K  NIL+      K+ DFG ARL     +    + V  T  Y +PE 
Sbjct: 119 H---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLT-GPSDYYDDEVA-TRWYRSPEL 173

Query: 420 VMHGRF---SVKSDIFSFGVLVLEIVSGQ 445
           ++        V  D+++ G +  E++SG 
Sbjct: 174 LVGDTQYGPPV--DVWAIGCVFAELLSGV 200

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  109 bits (274), Expect = 2e-26
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 20/210 (9%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN----EVLLLARLQ 298
           + + +   +G+G +G V K      G  +A+K+    S   ++  K     E+ LL +L+
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKM-VKKIAMREIKLLKQLR 82

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H NLV LL  C ++K   LV+EFV + ++   +        + ++   K +  I  G+ +
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLEL--FPNGLDYQVVQKYLFQIINGIGF 139

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
            H      IIHRD+K  NIL+      K+ DFG AR           + V  T  Y APE
Sbjct: 140 CHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYDDEVA-TRWYRAPE 194

Query: 419 YVMHGRF---SVKSDIFSFGVLVLEIVSGQ 445
            ++       +V  D+++ G LV E+  G+
Sbjct: 195 LLVGDVKYGKAV--DVWAIGCLVTEMFMGE 222

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  110 bits (276), Expect = 2e-26
 Identities = 34/233 (14%), Positives = 62/233 (26%), Gaps = 43/233 (18%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE---FKNEVLLLARLQH-------- 299
           LGQ    A  +      GE+  V       +         K EVL L  L+         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 300 --------RNLVRLLGFCL--------ERKERILVYEFVPNASLDHFIF------DPINR 337
                    +LV+                   +  +   P    +   F           
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 338 EHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
           + +    R ++   + R L  LH      ++H  L+  +I+LD      ++ F      +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR-D 261

Query: 398 MDQTHSDTNRVVGTFGYMAPEYV-----MHGRFSVKSDIFSFGVLVLEIVSGQ 445
                S   R        A   +          +   D ++ G+ +  I    
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  109 bits (274), Expect = 3e-26
 Identities = 33/238 (13%), Positives = 66/238 (27%), Gaps = 54/238 (22%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE---FKNEVLLLARLQ--------- 298
           LGQ    A  +      GE+  V       +         K EVL L  L+         
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 299 ----------------HRNLVRLLGFC--LERKERILVYEFVPNASLDHF--IFD-PINR 337
                            + ++R+      +    R  +Y  + +        +       
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 338 EHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE 397
           + +    R ++   + R L  LH      ++H  L+  +I+LD      ++ F       
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257

Query: 398 MDQTHSDTNRVVGTFGYMAPEYVMH-----------GRFSVKSDIFSFGVLVLEIVSG 444
                        + G+  PE                  +   D ++ G+++  I   
Sbjct: 258 ARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  108 bits (271), Expect = 4e-26
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 40/214 (18%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN------EVLLLARLQHR--NL 302
           LG GGFG+VY G+ +S+   +A+K + K+      E  N      EV+LL ++      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 303 VRLLGFCLERKERI-LVYEFV-PNASLDHFIFDPINREHMTWEKRYKIIEGIAR------ 354
           +RLL +  ER +   L+ E   P   L    FD I        +R  + E +AR      
Sbjct: 111 IRLLDW-FERPDSFVLILERPEPVQDL----FDFI-------TERGALQEELARSFFWQV 158

Query: 355 --GLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMARLFEMDQTHSDTNRVVGT 411
              + + H      ++HRD+K  NIL+D      K+ DFG   L  +  T        GT
Sbjct: 159 LEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL--LKDTVYTD--FDGT 211

Query: 412 FGYMAPEYVMHGRFS-VKSDIFSFGVLVLEIVSG 444
             Y  PE++ + R+    + ++S G+L+ ++V G
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  108 bits (272), Expect = 8e-26
 Identities = 57/226 (25%), Positives = 107/226 (47%), Gaps = 32/226 (14%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKN-EVLL 293
           D +T       +++   +G G FG V++  L   + +A+K++ +     +  FKN E+ +
Sbjct: 31  DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQI 85

Query: 294 LARLQHRNLVRLLGFCLERKERI------LVYEFVP---NASLDHFIF--DPINREHMTW 342
           +  ++H N+V L  F     ++       LV E+VP     +  H+      +    +  
Sbjct: 86  MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLI-- 143

Query: 343 EKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQT 401
            K Y  +  + R L Y+H    + I HRD+K  N+LLD      K+ DFG A++    + 
Sbjct: 144 -KLY--MYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP 197

Query: 402 HSDTNRVVGTFGYMAPEYVMHG--RFSVKSDIFSFGVLVLEIVSGQ 445
           +   + +  +  Y APE ++ G   ++   DI+S G ++ E++ GQ
Sbjct: 198 N--VSYIC-SRYYRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  107 bits (268), Expect = 9e-26
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 42/216 (19%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN------EVLLLARL----QHR 300
           LG+GGFG V+ G  L++   +A+K + +N   G     +      EV LL ++     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 301 NLVRLLGFCLERKERI-LVYEF-VPNASLDHFIFDPINREHMTWEKRYKIIEGIAR---- 354
            ++RLL +  E +E   LV E  +P   L    FD I        ++  + EG +R    
Sbjct: 99  GVIRLLDW-FETQEGFMLVLERPLPAQDL----FDYI-------TEKGPLGEGPSRCFFG 146

Query: 355 ----GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVV 409
                + + H      ++HRD+K  NIL+D      K+ DFG   L  +           
Sbjct: 147 QVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL--LHDEPYTD--FD 199

Query: 410 GTFGYMAPEYVMHGRFS-VKSDIFSFGVLVLEIVSG 444
           GT  Y  PE++   ++  + + ++S G+L+ ++V G
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  107 bits (270), Expect = 2e-25
 Identities = 58/218 (26%), Positives = 107/218 (49%), Gaps = 25/218 (11%)

Query: 240 RVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKN-EVLLLARL 297
           R    +++D   +G G FG VY+  L  +GE +A+K++ ++ +     FKN E+ ++ +L
Sbjct: 50  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKL 104

Query: 298 QHRNLVRLLGFCLERKERI------LVYEFVPNASLDHFI-FDPINREHMTWEKRYKIIE 350
            H N+VRL  F     E+       LV ++VP  ++          ++ +        + 
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMY 163

Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVV 409
            + R L Y+H      I HRD+K  N+LLD +    K+ DFG A+     + +   + + 
Sbjct: 164 QLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYIC 218

Query: 410 GTFGYMAPEYVMHG--RFSVKSDIFSFGVLVLEIVSGQ 445
            +  Y APE ++ G   ++   D++S G ++ E++ GQ
Sbjct: 219 -SRYYRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  106 bits (266), Expect = 2e-25
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 19/200 (9%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGF 308
           +G+G F  V     +  G  +A+K + K   +     +   EV ++  L H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE- 81

Query: 309 CLERKERI-LVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLR 366
            +E ++ + L+ E+     +    FD +     M  ++       I   + Y H   + R
Sbjct: 82  VIETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQYCH---QKR 134

Query: 367 IIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS 426
           I+HRDLKA N+LLD++MN KI+DFG +  F +       +   G   Y APE +  G+  
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPE-LFQGKKY 190

Query: 427 V--KSDIFSFGVLVLEIVSG 444
              + D++S GV++  +VSG
Sbjct: 191 DGPEVDVWSLGVILYTLVSG 210

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  107 bits (269), Expect = 3e-25
 Identities = 57/193 (29%), Positives = 88/193 (45%), Gaps = 40/193 (20%)

Query: 251 KLGQGGFGAVYKGM---LSNGETIAVKRLSKN----SKQGEIEFKNEVLLLARLQHRNLV 303
           K+G+G +G VYK       + +  A+K++       S   EI       LL  L+H N++
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIA------LLRELKHPNVI 81

Query: 304 RLLGFCLERKERI--LVYEFVPNASLDH---FIFDPINREHMTWEKRYKIIEG------- 351
            L    L   +R   L++++      +H    I    +R     +K  ++  G       
Sbjct: 82  SLQKVFLSHADRKVWLLFDY-----AEHDLWHIIK-FHRASKANKKPVQLPRGMVKSLLY 135

Query: 352 -IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMARLF-EMDQTHSDT 405
            I  G+ YLH +    ++HRDLK +NIL+  E       KI+D G ARLF    +  +D 
Sbjct: 136 QILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192

Query: 406 NRVVGTFGYMAPE 418
           + VV TF Y APE
Sbjct: 193 DPVVVTFWYRAPE 205

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  105 bits (265), Expect = 3e-25
 Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 38/221 (17%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQG-------EIEFKNEVLLL 294
           D +    KLG+G +G VYK +     ET+A+KR+  ++ ++G       E+       LL
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVS------LL 87

Query: 295 ARLQHRNLVRLLGFCLERKERILVYEFVPN---ASLDHFI-FDPINREHMTWEKRYKIIE 350
             LQHRN++ L           L++E+  N     +D          +   ++       
Sbjct: 88  KELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQ------- 140

Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP-----KISDFGMARLFEMDQTHSDT 405
            +  G+ + H     R +HRDLK  N+LL           KI DFG+AR F        T
Sbjct: 141 -LINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG-IPIRQFT 195

Query: 406 NRVVGTFGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQ 445
           + ++ T  Y  PE ++  R +S   DI+S   +  E++   
Sbjct: 196 HEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  104 bits (262), Expect = 8e-25
 Identities = 49/225 (21%), Positives = 85/225 (37%), Gaps = 33/225 (14%)

Query: 230 KSLQFDFETIRVATDNFSD-----ANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQG 283
             L+  F+         +D        LG G  G V +      G+  A+K L  + K  
Sbjct: 10  SGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-- 67

Query: 284 EIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERI----LVYEFVPNASLDHFIFDPI-NR 337
               + EV    +     ++V +L              ++ E +    L    F  I  R
Sbjct: 68  ---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL----FSRIQER 120

Query: 338 EHMTWEKRY--KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGM 392
               + +R   +I+  I   + +LH      I HRD+K  N+L  S+      K++DFG 
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177

Query: 393 ARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVL 437
           A+    +   +       T  Y+APE +   ++    D++S GV+
Sbjct: 178 AKETTQNALQT----PCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  104 bits (261), Expect = 9e-25
 Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 24/206 (11%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEIEFKN------EVLLLARLQHRNL 302
           LG G FG V+  +     + + VK + K    +   IE         E+ +L+R++H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 303 VRLLGFCLERKERI-LVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLH 360
           +++L    E +    LV E   +  LD  +F  I     +       I   +   + YL 
Sbjct: 92  IKVLDI-FENQGFFQLVMEKHGSG-LD--LFAFIDRHPRLDEPLASYIFRQLVSAVGYLR 147

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV 420
                 IIHRD+K  NI++  +   K+ DFG A   E  +         GT  Y APE V
Sbjct: 148 ---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPE-V 200

Query: 421 MHGR--FSVKSDIFSFGVLVLEIVSG 444
           + G      + +++S GV +  +V  
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVFE 226

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  103 bits (260), Expect = 1e-24
 Identities = 54/220 (24%), Positives = 105/220 (47%), Gaps = 24/220 (10%)

Query: 234 FDFETIRVA---TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN 289
           +D+E+  V     D++    KLG+G +  V++ + ++N E + VK L    K+   + K 
Sbjct: 23  WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKR 79

Query: 290 EVLLLARLQ-HRNLVRLLGFCLERKER--ILVYEFVPNASLDHFIFDPINREHMTWEKRY 346
           E+ +L  L+   N++ L     +   R   LV+E V N      ++  +    +    R+
Sbjct: 80  EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF-KQLYQTLTDYDI----RF 134

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMARLFEMDQTHSDT 405
            + E I + L Y H  S   I+HRD+K  N+++D E    ++ D+G+A  +   Q +   
Sbjct: 135 YMYE-ILKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--N 188

Query: 406 NRVVGTFGYMAPEYVMHGRFSVKS-DIFSFGVLVLEIVSG 444
            RV  +  +  PE ++  +    S D++S G ++  ++  
Sbjct: 189 VRVA-SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 227

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  104 bits (261), Expect = 2e-24
 Identities = 56/230 (24%), Positives = 100/230 (43%), Gaps = 35/230 (15%)

Query: 236 FETIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKN----E 290
            E  R   D F      GQG FG V  G     G ++A+K++ ++ +     F+N     
Sbjct: 15  DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-----FRNRELQI 69

Query: 291 VLLLARLQHRNLVRLLGFCLERKER-------ILVYEFVP---NASLDHFIF--DPINRE 338
           +  LA L H N+V+L  +     ER        +V E+VP   +    ++          
Sbjct: 70  MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPI 129

Query: 339 HMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP-KISDFGMARLFE 397
            +   K +  +  + R +  LH  S + + HRD+K  N+L++      K+ DFG A+   
Sbjct: 130 LI---KVF--LFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183

Query: 398 MDQTHSDTNRVVGTFGYMAPEYVMHG--RFSVKSDIFSFGVLVLEIVSGQ 445
             + +      + +  Y APE ++ G   ++   DI+S G +  E++ G+
Sbjct: 184 PSEPNVAY---ICSRYYRAPE-LIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  103 bits (258), Expect = 6e-24
 Identities = 53/200 (26%), Positives = 86/200 (43%), Gaps = 29/200 (14%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGF 308
            LG G  G V +       E  A+K L    K      + EV L  R     ++VR++  
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 123

Query: 309 C----LERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRY--KIIEGIARGLLYLHE 361
                  RK  ++V E +    L    F  I +R    + +R   +I++ I   + YLH 
Sbjct: 124 YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 179

Query: 362 DSRLRIIHRDLKASNILLDSEMNP----KISDFGMARLFEMDQTHSDTNRVVGTFGYMAP 417
              + I HRD+K  N+L  S+  P    K++DFG A+      + +       T  Y+AP
Sbjct: 180 ---INIAHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYVAP 232

Query: 418 EYVMHGRFSVKSDIFSFGVL 437
           E +   ++    D++S GV+
Sbjct: 233 EVLGPEKYDKSCDMWSLGVI 252

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  100 bits (251), Expect = 1e-23
 Identities = 51/221 (23%), Positives = 92/221 (41%), Gaps = 49/221 (22%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEF----------------------- 287
           +G+G +G V      ++    A+K LSK     +  F                       
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 288 ---KNEVLLLARLQHRNLVRLLGFCLE------RKERILVYEFVPNASLDHFIFDPINRE 338
                E+ +L +L H N+V+L+    E           +V+E V    +     +    +
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLV----EVLDDPNEDHLYMVFELVNQGPV----MEVPTLK 132

Query: 339 HMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM 398
            ++ ++     + + +G+ YLH     +IIHRD+K SN+L+  + + KI+DFG++  F+ 
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189

Query: 399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSV---KSDIFSFGV 436
                     VGT  +MAPE +   R        D+++ GV
Sbjct: 190 SDALLSN--TVGTPAFMAPESLSETRKIFSGKALDVWAMGV 228

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  102 bits (255), Expect = 1e-23
 Identities = 59/226 (26%), Positives = 98/226 (43%), Gaps = 42/226 (18%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNS--KQGEIEF- 287
            FE +R           +G+G FG V    +       +  A+K ++K    ++ E+   
Sbjct: 16  HFEILRA----------IGKGSFGKV---CIVQKNDTKKMYAMKYMNKQKCVERNEVRNV 62

Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRY 346
             E+ ++  L+H  LV L  +  + +E + +V + +    L       + +     E+  
Sbjct: 63  FKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDL----RYHLQQNVHFKEETV 117

Query: 347 K--IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD 404
           K  I E +   L YL      RIIHRD+K  NILLD   +  I+DF +A +   +     
Sbjct: 118 KLFICE-LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ--- 170

Query: 405 TNRVVGTFGYMAPEYVMHGR-----FSVKSDIFSFGVLVLEIVSGQ 445
              + GT  YMAPE     +     F+V  D +S GV   E++ G+
Sbjct: 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAV--DWWSLGVTAYELLRGR 214

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  100 bits (251), Expect = 2e-23
 Identities = 68/224 (30%), Positives = 111/224 (49%), Gaps = 38/224 (16%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVY----KGMLSNGETIAVKRLSKNS--KQGEIEFK 288
            FE ++V          LGQG FG V+           +  A+K L K +   +  +  K
Sbjct: 25  QFELLKV----------LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTK 74

Query: 289 NEVLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
            E  +L  + H  +V+L  +  + + ++ L+ +F+    L    F  +++E M  E+  K
Sbjct: 75  MERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVK 129

Query: 348 I-IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR--LFEMDQTHSD 404
             +  +A  L +LH    L II+RDLK  NILLD E + K++DFG+++  +    + +S 
Sbjct: 130 FYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS- 185

Query: 405 TNRVVGTFGYMAPEYVM---HGRFSVKSDIFSFGVLVLEIVSGQ 445
                GT  YMAPE V    H + S   D +SFGVL+ E+++G 
Sbjct: 186 ---FCGTVEYMAPEVVNRRGHTQ-SA--DWWSFGVLMFEMLTGT 223

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 98.0 bits (245), Expect = 5e-23
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 32/207 (15%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIE-FKNEVLLLARLQHRNLVRLLG 307
           LG G FG V  G     G  +AVK L++        +   K E+  L   +H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 308 FCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEK---RY--KIIEGIARGLLYLHE 361
             +       +V E+V    L    FD I +     E    R   +I+  +     Y H 
Sbjct: 79  -VISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVD----YCH- 128

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM 421
             R  ++HRDLK  N+LLD+ MN KI+DFG++ +    +    +    G+  Y APE + 
Sbjct: 129 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPEVIS 183

Query: 422 ----HGRFSVKSDIFSFGVLVLEIVSG 444
                G    + DI+S GV++  ++ G
Sbjct: 184 GRLYAGP---EVDIWSCGVILYALLCG 207

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  100 bits (251), Expect = 6e-23
 Identities = 57/231 (24%), Positives = 94/231 (40%), Gaps = 50/231 (21%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYK-GMLSNGETIAVKRLSKNS--KQGEIE-FKNE 290
           D+E ++V          +G+G FG V      S  +  A+K LSK    K+ +   F  E
Sbjct: 70  DYEVVKV----------IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 119

Query: 291 VLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
             ++A      +V+L  +  +    + +V E++P   L            +     Y + 
Sbjct: 120 RDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL------------VNLMSNYDVP 166

Query: 350 EGIAR--------GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
           E  AR         L  +H    +  IHRD+K  N+LLD   + K++DFG       +  
Sbjct: 167 EKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223

Query: 402 HSDTNRVVGTFGYMAPE-------YVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
               +  VGT  Y++PE          +GR     D +S GV + E++ G 
Sbjct: 224 -VRCDTAVGTPDYISPEVLKSQGGDGYYGR-EC--DWWSVGVFLYEMLVGD 270

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 98.0 bits (245), Expect = 1e-22
 Identities = 63/226 (27%), Positives = 109/226 (48%), Gaps = 40/226 (17%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVY----KGMLSNGETIAVKRLSKNS---KQGEIEF 287
            FE +RV          LG+GG+G V+        + G+  A+K L K        +   
Sbjct: 18  CFELLRV----------LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH 67

Query: 288 -KNEVLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKR 345
            K E  +L  ++H  +V L+ +  +   ++ L+ E++    L    F  + RE +  E  
Sbjct: 68  TKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDT 122

Query: 346 YKI-IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR--LFEMDQTH 402
               +  I+  L +LH+     II+RDLK  NI+L+ + + K++DFG+ +  + +   TH
Sbjct: 123 ACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH 179

Query: 403 SDTNRVVGTFGYMAPEYVM---HGRFSVKSDIFSFGVLVLEIVSGQ 445
           +      GT  YMAPE +M   H R +V  D +S G L+ ++++G 
Sbjct: 180 T----FCGTIEYMAPEILMRSGHNR-AV--DWWSLGALMYDMLTGA 218

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 98.6 bits (246), Expect = 2e-22
 Identities = 62/242 (25%), Positives = 107/242 (44%), Gaps = 25/242 (10%)

Query: 220 EDENVEETI--AKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKG-MLSNGETIAVKRL 276
           +D+ V + +  A+ +    + +R+  D+F     +G+G F  V    M   G+  A+K +
Sbjct: 35  QDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM 94

Query: 277 SKNS--KQGEIE-FKNEVLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFI- 331
           +K    K+GE+  F+ E  +L     R + +L  F  + +  + LV E+     L   + 
Sbjct: 95  NKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS 153

Query: 332 -FDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDF 390
            F       M    R+ + E I   +  +H    L  +HRD+K  NILLD   + +++DF
Sbjct: 154 KFGERIPAEMA---RFYLAE-IVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADF 206

Query: 391 GMARLFEMDQTHSDTNRVVGTFGYMAPE-------YVMHGRFSVKSDIFSFGVLVLEIVS 443
           G       D T   +   VGT  Y++PE           G +  + D ++ GV   E+  
Sbjct: 207 GSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265

Query: 444 GQ 445
           GQ
Sbjct: 266 GQ 267

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 97.4 bits (243), Expect = 3e-22
 Identities = 53/196 (27%), Positives = 85/196 (43%), Gaps = 28/196 (14%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
           +G G FG           E +AVK + + +   E   + E++    L+H N+VR     L
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE-NVQREIINHRSLRHPNIVRFKEVIL 86

Query: 311 ERKERILVYEFVPNASLDHFIFDPI-NREHMT-WEKRYK---IIEGIARGLLYLHEDSRL 365
                 ++ E+     L    ++ I N    +  E R+    ++ G++    Y H    +
Sbjct: 87  TPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVS----YCH---SM 135

Query: 366 RIIHRDLKASNILLDS--EMNPKISDFGMARLFEMDQT-HSDTNRVVGTFGYMAPEYVMH 422
           +I HRDLK  N LLD       KI DFG ++   +     S     VGT  Y+APE V+ 
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----TVGTPAYIAPE-VLL 190

Query: 423 GRF--SVKSDIFSFGV 436
            +      +D++S GV
Sbjct: 191 RQEYDGKIADVWSCGV 206

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 96.4 bits (241), Expect = 4e-22
 Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 43/224 (19%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNS--KQGEIE-F 287
           DF+ +R           LG G FG V    L     NG   A+K L K    +  ++E  
Sbjct: 7   DFQILRT----------LGTGSFGRV---HLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT 53

Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRY 346
            +E L+L+ + H  ++R+     +  ++I ++ +++    L    F  + +         
Sbjct: 54  NDERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGEL----FSLLRKSQRFPNPVA 108

Query: 347 K--IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD 404
           K    E +   L YLH      II+RDLK  NILLD   + KI+DFG A+    D T++ 
Sbjct: 109 KFYAAE-VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTYT- 162

Query: 405 TNRVVGTFGYMAPEYVM---HGRFSVKSDIFSFGVLVLEIVSGQ 445
              + GT  Y+APE V    + + S+  D +SFG+L+ E+++G 
Sbjct: 163 ---LCGTPDYIAPEVVSTKPYNK-SI--DWWSFGILIYEMLAGY 200

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 96.7 bits (241), Expect = 9e-22
 Identities = 49/253 (19%), Positives = 102/253 (40%), Gaps = 58/253 (22%)

Query: 236 FETIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKN-EVLL 293
            ET    +  +S    LG G FG V +     +G+  A+K++ ++ +     +KN E+ +
Sbjct: 2   LETS---SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDI 53

Query: 294 LARLQHRNLVRLLGF---CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKR----- 345
           +  L H N+++L+ +     + + +        N           + + +          
Sbjct: 54  MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113

Query: 346 -----------YKIIEG-------------------IARGLLYLHEDSRLRIIHRDLKAS 375
                      +K+++                    + R + ++H    L I HRD+K  
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQ 170

Query: 376 NILLDSEMNP-KISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG--RFSVKSDIF 432
           N+L++S+ N  K+ DFG A+     +        + +  Y APE +M G   ++   D++
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSEPSVAY---ICSRFYRAPE-LMLGATEYTPSIDLW 226

Query: 433 SFGVLVLEIVSGQ 445
           S G +  E++ G+
Sbjct: 227 SIGCVFGELILGK 239

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 97.5 bits (243), Expect = 9e-22
 Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 45/227 (19%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNSKQGEIEFKNE 290
           +FE +++          LG+G FG V   +L    + G   A+K L K      I  K+E
Sbjct: 149 EFEYLKL----------LGKGTFGKV---ILVKEKATGRYYAMKILKK----EVIVAKDE 191

Query: 291 V-------LLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTW 342
           V        +L   +H  L  L  +  +  +R+  V E+     L    F  ++RE +  
Sbjct: 192 VAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGEL----FFHLSRERVFS 246

Query: 343 EKRYKI-IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
           E R +     I   L YLH  S   +++RDLK  N++LD + + KI+DFG+ +   +   
Sbjct: 247 EDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDG 303

Query: 402 HSDTNRVVGTFGYMAPEYVM---HGRFSVKSDIFSFGVLVLEIVSGQ 445
            +      GT  Y+APE +    +GR +V  D +  GV++ E++ G+
Sbjct: 304 AT-MKTFCGTPEYLAPEVLEDNDYGR-AV--DWWGLGVVMYEMMCGR 346

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 95.4 bits (238), Expect = 1e-21
 Identities = 62/241 (25%), Positives = 109/241 (45%), Gaps = 52/241 (21%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNSKQGEIEFKNE 290
           DF+ +++          LG+G FG V   +L    + G   A+K L K      I  K+E
Sbjct: 6   DFDYLKL----------LGKGTFGKV---ILVREKATGRYYAMKILRK----EVIIAKDE 48

Query: 291 VL-------LLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTW 342
           V        +L   +H  L  L  +  +  +R+  V E+     L    F  ++RE +  
Sbjct: 49  VAHTVTESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGEL----FFHLSRERVFT 103

Query: 343 EKRYKI-IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR--LFEMD 399
           E+R +     I   L YLH      +++RD+K  N++LD + + KI+DFG+ +  + +  
Sbjct: 104 EERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160

Query: 400 QTHSDTNRVVGTFGYMAPEYVM---HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
              +      GT  Y+APE +    +GR +V  D +  GV++ E++ G+    F  ++  
Sbjct: 161 TMKT----FCGTPEYLAPEVLEDNDYGR-AV--DWWGLGVVMYEMMCGR--LPFYNQDHE 211

Query: 457 E 457
            
Sbjct: 212 R 212

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 96.7 bits (241), Expect = 1e-21
 Identities = 57/243 (23%), Positives = 111/243 (45%), Gaps = 29/243 (11%)

Query: 220 EDENVEETIAKSLQFDFET--IRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAV 273
            ++N+ E +  +  F  +   +R+  ++F     +G+G FG V    +    +  +  A+
Sbjct: 48  REKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEV---AVVKLKNADKVFAM 104

Query: 274 KRLSKNS--KQGEIE-FKNEVLLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDH 329
           K L+K    K+ E   F+ E  +L     + +  L  +  +    + LV ++     L  
Sbjct: 105 KILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLT 163

Query: 330 FI--FDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI 387
            +  F+    E M    R+ + E +   +  +H+   L  +HRD+K  NIL+D   + ++
Sbjct: 164 LLSKFEDRLPEEMA---RFYLAE-MVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRL 216

Query: 388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM-----HGRFSVKSDIFSFGVLVLEIV 442
           +DFG       D T   ++  VGT  Y++PE +       GR+  + D +S GV + E++
Sbjct: 217 ADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML 275

Query: 443 SGQ 445
            G+
Sbjct: 276 YGE 278

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 97.2 bits (242), Expect = 1e-21
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 28/205 (13%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIE-FKNEVLLLARLQHRNLVRLLG 307
           LG G FG V  G     G  +AVK L++        +   + E+  L   +H ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 308 FCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEK---RY--KIIEGIARGLLYLHE 361
             +     I +V E+V    L    FD I +     EK   R   +I+ G+     Y H 
Sbjct: 84  V-ISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVD----YCH- 133

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM 421
             R  ++HRDLK  N+LLD+ MN KI+DFG++ +    +    +    G+  Y APE V+
Sbjct: 134 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPE-VI 187

Query: 422 HGRF--SVKSDIFSFGVLVLEIVSG 444
            GR     + DI+S GV++  ++ G
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCG 212

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 94.6 bits (236), Expect = 2e-21
 Identities = 77/288 (26%), Positives = 119/288 (41%), Gaps = 68/288 (23%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNSKQGEIEFKNE 290
           DF   ++          LG+G FG V    L       +  A+K L K      +   ++
Sbjct: 18  DFILHKM----------LGKGSFGKV---FLAEFKKTNQFFAIKALKK----DVVLMDDD 60

Query: 291 V--------LLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMT 341
           V        +L    +H  L  +     + KE +  V E++    L       I   H  
Sbjct: 61  VECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDL----MYHIQSCHKF 115

Query: 342 WEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR--LFEM 398
              R       I  GL +LH      I++RDLK  NILLD + + KI+DFGM +  +   
Sbjct: 116 DLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172

Query: 399 DQTHSDTNRVVGTFGYMAPEYVM---HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEE 455
            +T++      GT  Y+APE ++   +   SV  D +SFGVL+ E++ GQ  S F  ++E
Sbjct: 173 AKTNT----FCGTPDYIAPEILLGQKYNH-SV--DWWSFGVLLYEMLIGQ--SPFHGQDE 223

Query: 456 TE-------DLLTYAWRNWNEGAALNLM------DPTMRGGSTSEMMK 490
            E       D   Y    W E  A +L+      +P  R G   ++ +
Sbjct: 224 EELFHSIRMDNPFY--PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 39/222 (17%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNS--KQGEIE-F 287
            F+ I+           LG G FG V   ML     +G   A+K L K    K  +IE  
Sbjct: 42  QFDRIKT----------LGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHT 88

Query: 288 KNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYK 347
            NE  +L  +    LV+L     +     +V E+V    +    F  + R     E   +
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHAR 144

Query: 348 IIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
                I     YLH    L +I+RDLK  N+L+D +   +++DFG A+     +    T 
Sbjct: 145 FYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTW 196

Query: 407 RVVGTFGYMAPEYVM---HGRFSVKSDIFSFGVLVLEIVSGQ 445
            + GT   +APE ++   + + +V  D ++ GVL+ E+ +G 
Sbjct: 197 TLCGTPEALAPEIILSKGYNK-AV--DWWALGVLIYEMAAGY 235

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 94.7 bits (236), Expect = 3e-21
 Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 38/220 (17%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---------EVL 292
              +     +G G +G+V   +   +GE +A+K+LS+        F++         E+L
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-------PFQSEIFAKRAYRELL 75

Query: 293 LLARLQHRNLVRLL------GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY 346
           LL  +QH N++ LL             +  LV  F+    L   +    + E +    +Y
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGLKFSEEKI----QY 130

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            ++  + +GL Y+H      ++HRDLK  N+ ++ +   KI DFG+AR  + + T     
Sbjct: 131 -LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG---- 182

Query: 407 RVVGTFGYMAPEYVM-HGRFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE ++    ++   DI+S G ++ E+++G+
Sbjct: 183 -YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 93.8 bits (234), Expect = 4e-21
 Identities = 73/242 (30%), Positives = 109/242 (45%), Gaps = 53/242 (21%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNSKQGEIEFKNE 290
           DF  + V          LG+G FG V   ML       E  AVK L K      +   ++
Sbjct: 21  DFNFLMV----------LGKGSFGKV---MLSERKGTDELYAVKILKK----DVVIQDDD 63

Query: 291 V--------LLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMT 341
           V        +L    +   L +L   C +  +R+  V E+V    L       I +    
Sbjct: 64  VECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRF 118

Query: 342 WEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR--LFEM 398
            E         IA GL +L       II+RDLK  N++LDSE + KI+DFGM +  +++ 
Sbjct: 119 KEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175

Query: 399 DQTHSDTNRVVGTFGYMAPEYVM---HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEE 455
             T +      GT  Y+APE +    +G+ SV  D ++FGVL+ E+++GQ  + F  E+E
Sbjct: 176 VTTKT----FCGTPDYIAPEIIAYQPYGK-SV--DWWAFGVLLYEMLAGQ--APFEGEDE 226

Query: 456 TE 457
            E
Sbjct: 227 DE 228

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 93.8 bits (234), Expect = 4e-21
 Identities = 73/242 (30%), Positives = 106/242 (43%), Gaps = 53/242 (21%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNSKQGEIEFKNE 290
           +FE IRV          LG+G FG V   ML      G+  AVK L K      I   ++
Sbjct: 24  NFEFIRV----------LGKGSFGKV---MLARVKETGDLYAVKVLKK----DVILQDDD 66

Query: 291 V--------LLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMT 341
           V        +L     H  L +L   C +  +R+  V EFV    L       I +    
Sbjct: 67  VECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDL----MFHIQKSRRF 121

Query: 342 WEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA--RLFEM 398
            E R +     I   L++LH+     II+RDLK  N+LLD E + K++DFGM    +   
Sbjct: 122 DEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178

Query: 399 DQTHSDTNRVVGTFGYMAPEYVM---HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEE 455
             T +      GT  Y+APE +    +G  +V  D ++ GVL+ E++ G   + F  E E
Sbjct: 179 VTTAT----FCGTPDYIAPEILQEMLYGP-AV--DWWAMGVLLYEMLCGH--APFEAENE 229

Query: 456 TE 457
            +
Sbjct: 230 DD 231

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 94.0 bits (234), Expect = 5e-21
 Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 35/219 (15%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---------EVL 292
              + +   +G G  G V           +A+K+LS+        F+N         E++
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-------PFQNQTHAKRAYRELV 76

Query: 293 LLARLQHRNLVRLL------GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY 346
           L+  + H+N++ LL          E ++  +V E +  A+L   I   ++ E M     Y
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERM----SY 131

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            ++  +  G+ +LH      IIHRDLK SNI++ S+   KI DFG+AR        +   
Sbjct: 132 -LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY- 186

Query: 407 RVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE ++   +    DI+S G ++ E++ G 
Sbjct: 187 --VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 93.4 bits (233), Expect = 5e-21
 Identities = 69/250 (27%), Positives = 110/250 (44%), Gaps = 56/250 (22%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNSKQGEIEFKNE 290
           DF+ +RV          +G+G +  V   +L          A+K + K      +    +
Sbjct: 10  DFDLLRV----------IGRGSYAKV---LLVRLKKTDRIYAMKVVKK----ELVNDDED 52

Query: 291 V--------LLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMT 341
           +        +      H  LV L   C + + R+  V E+V    L       + R+   
Sbjct: 53  IDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDL----MFHMQRQRKL 107

Query: 342 WEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR--LFEM 398
            E+  +     I+  L YLHE     II+RDLK  N+LLDSE + K++D+GM +  L   
Sbjct: 108 PEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164

Query: 399 DQTHSDTNRVVGTFGYMAPEYVM---HGRFSVKSDIFSFGVLVLEIVSGQ-----KRSSF 450
           D T +      GT  Y+APE +    +G  SV  D ++ GVL+ E+++G+       SS 
Sbjct: 165 DTTST----FCGTPNYIAPEILRGEDYGF-SV--DWWALGVLMFEMMAGRSPFDIVGSSD 217

Query: 451 GTEEETEDLL 460
             ++ TED L
Sbjct: 218 NPDQNTEDYL 227

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 93.1 bits (232), Expect = 6e-21
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 31/206 (15%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNS-KQGEIEFK--NEVLLLARLQHRNLVRLLG 307
           LG+G FG V         + +A+K +S+   K+ ++  +   E+  L  L+H ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 308 FCLERKERILVYEFVPNASLDHFIFDPINREHMTWEK---RY--KIIEGIARGLLYLHED 362
                 + ++V E+         +FD I  +    E    R+  +II  I     Y H  
Sbjct: 77  VITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTEDEGRRFFQQIICAIE----YCH-- 125

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM- 421
            R +I+HRDLK  N+LLD  +N KI+DFG++ +         T+   G+  Y APE +  
Sbjct: 126 -RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTS--CGSPNYAAPEVING 181

Query: 422 ---HGRFSVKSDIFSFGVLVLEIVSG 444
               G    + D++S G+++  ++ G
Sbjct: 182 KLYAGP---EVDVWSCGIVLYVMLVG 204

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 93.5 bits (233), Expect = 6e-21
 Identities = 63/227 (27%), Positives = 106/227 (46%), Gaps = 38/227 (16%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVY----KGMLSNGETIAVKRLSKN---SKQGEIEF 287
           +FE ++V          LG G +G V+          G+  A+K L K     K    E 
Sbjct: 55  NFELLKV----------LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH 104

Query: 288 -KNEVLLLARLQHRN-LVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEK 344
            + E  +L  ++    LV L  +  + + ++ L+ +++    L    F  +++     E 
Sbjct: 105 TRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGEL----FTHLSQRERFTEH 159

Query: 345 RYK--IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
             +  + E I   L +LH+   L II+RD+K  NILLDS  +  ++DFG+++ F  D+T 
Sbjct: 160 EVQIYVGE-IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 215

Query: 403 SDTNRVVGTFGYMAPEYVMHGR----FSVKSDIFSFGVLVLEIVSGQ 445
                  GT  YMAP+ V  G      +V  D +S GVL+ E+++G 
Sbjct: 216 R-AYDFCGTIEYMAPDIVRGGDSGHDKAV--DWWSLGVLMYELLTGA 259

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 94.9 bits (236), Expect = 6e-21
 Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 35/219 (15%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---------EVL 292
              + +   +G G  G V           +A+K+LS+        F+N         E++
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-------PFQNQTHAKRAYRELV 113

Query: 293 LLARLQHRNLVRLL------GFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY 346
           L+  + H+N++ LL          E ++  LV E +  A+L   I   ++ E M     Y
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERM----SY 168

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN 406
            + + +  G+ +LH      IIHRDLK SNI++ S+   KI DFG+AR        +   
Sbjct: 169 LLYQ-MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY- 223

Query: 407 RVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
             V T  Y APE ++   +    DI+S G ++ E+V  +
Sbjct: 224 --VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 93.1 bits (232), Expect = 8e-21
 Identities = 57/230 (24%), Positives = 91/230 (39%), Gaps = 32/230 (13%)

Query: 236 FETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIE--FKN---- 289
              +      ++    +  G +GAV  G+ S G  +A+KR+      G       +    
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73

Query: 290 -----EVLLLARLQHRNLVRLLGFCL-----ERKERILVYEFVPNASLDHFI---FDPIN 336
                E+ LL    H N++ L    +        +  LV E +    L   I      I+
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVIS 132

Query: 337 REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF 396
            +H+    +Y  +  I  GL  LHE     ++HRDL   NILL    +  I DF +AR  
Sbjct: 133 PQHI----QY-FMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLARED 184

Query: 397 EMDQTHSDTNRVVGTFGYMAPEYVM-HGRFSVKSDIFSFGVLVLEIVSGQ 445
             D   +     V    Y APE VM    F+   D++S G ++ E+ + +
Sbjct: 185 TADANKTHY---VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 92.7 bits (231), Expect = 1e-20
 Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 51/230 (22%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNSKQGEIEFKNE 290
           DF  ++V          +G+G FG V   +L    +     AVK L K +    I  K E
Sbjct: 39  DFHFLKV----------IGKGSFGKV---LLARHKAEEVFYAVKVLQKKA----ILKKKE 81

Query: 291 V--------LLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMT 341
                    +LL  ++H  LV L  F  +  +++  V +++    L    F  + RE   
Sbjct: 82  EKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGEL----FYHLQRERCF 136

Query: 342 WEKRYKI-IEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR--LFEM 398
            E R +     IA  L YLH    L I++RDLK  NILLDS+ +  ++DFG+ +  +   
Sbjct: 137 LEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193

Query: 399 DQTHSDTNRVVGTFGYMAPEYVM---HGRFSVKSDIFSFGVLVLEIVSGQ 445
             T +      GT  Y+APE +    + R +V  D +  G ++ E++ G 
Sbjct: 194 STTST----FCGTPEYLAPEVLHKQPYDR-TV--DWWCLGAVLYEMLYGL 236

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 93.2 bits (232), Expect = 1e-20
 Identities = 68/250 (27%), Positives = 110/250 (44%), Gaps = 56/250 (22%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNSKQGEIEFKNE 290
           DF+ +RV          +G+G +  V   +L          A++ + K      +    +
Sbjct: 53  DFDLLRV----------IGRGSYAKV---LLVRLKKTDRIYAMRVVKK----ELVNDDED 95

Query: 291 V--------LLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMT 341
           +        +      H  LV L   C + + R+  V E+V    L       + R+   
Sbjct: 96  IDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDL----MFHMQRQRKL 150

Query: 342 WEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR--LFEM 398
            E+  +     I+  L YLHE     II+RDLK  N+LLDSE + K++D+GM +  L   
Sbjct: 151 PEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207

Query: 399 DQTHSDTNRVVGTFGYMAPEYVM---HGRFSVKSDIFSFGVLVLEIVSGQ-----KRSSF 450
           D T +      GT  Y+APE +    +G  SV  D ++ GVL+ E+++G+       SS 
Sbjct: 208 DTTST----FCGTPNYIAPEILRGEDYGF-SV--DWWALGVLMFEMMAGRSPFDIVGSSD 260

Query: 451 GTEEETEDLL 460
             ++ TED L
Sbjct: 261 NPDQNTEDYL 270

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 94.7 bits (235), Expect = 1e-20
 Identities = 73/242 (30%), Positives = 109/242 (45%), Gaps = 53/242 (21%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNSKQGEIEFKNE 290
           DF  + V          LG+G FG V   ML       E  AVK L K      +   ++
Sbjct: 342 DFNFLMV----------LGKGSFGKV---MLSERKGTDELYAVKILKK----DVVIQDDD 384

Query: 291 V--------LLLARLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMT 341
           V        +L    +   L +L   C +  +R+  V E+V    L       I +    
Sbjct: 385 VECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRF 439

Query: 342 WEKRYKIIEG-IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR--LFEM 398
            E         IA GL +L       II+RDLK  N++LDSE + KI+DFGM +  +++ 
Sbjct: 440 KEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496

Query: 399 DQTHSDTNRVVGTFGYMAPEYVM---HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEE 455
             T +      GT  Y+APE +    +G+ SV  D ++FGVL+ E+++GQ  + F  E+E
Sbjct: 497 VTTKT----FCGTPDYIAPEIIAYQPYGK-SV--DWWAFGVLLYEMLAGQ--APFEGEDE 547

Query: 456 TE 457
            E
Sbjct: 548 DE 549

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 90.8 bits (226), Expect = 6e-20
 Identities = 57/245 (23%), Positives = 113/245 (46%), Gaps = 37/245 (15%)

Query: 220 EDENVEETIAKSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSK 278
              ++    A   +     +      +++ + +G+G +G V       N   +A+K++S 
Sbjct: 3   HHHHMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP 62

Query: 279 NSKQGEIEFKN---------EVLLLARLQHRNLVRLLGFCL-----ERKERILVYEFVPN 324
                   F++         E+ +L R +H N++ +          + K+  +V + +  
Sbjct: 63  --------FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME- 113

Query: 325 ASLDHFIF-DPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM 383
             L   +    ++ +H+     Y  +  I RGL Y+H  +   ++HRDLK SN+LL++  
Sbjct: 114 TDLYKLLKTQHLSNDHI----CY-FLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTC 165

Query: 384 NPKISDFGMARLFEMDQTHSD--TNRVVGTFGYMAPEYVM-HGRFSVKSDIFSFGVLVLE 440
           + KI DFG+AR+ + D  H+   T  V  T  Y APE ++    ++   DI+S G ++ E
Sbjct: 166 DLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 224

Query: 441 IVSGQ 445
           ++S +
Sbjct: 225 MLSNR 229

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 52/232 (22%), Positives = 104/232 (44%), Gaps = 48/232 (20%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---------EVL 292
              + D   LG GG G V+  +     + +A+K++            +         E+ 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60

Query: 293 LLARLQHRNLVRLL--------------GFCLERKERILVYEFVPNASLDHFIF-DPINR 337
           ++ RL H N+V++               G   E     +V E++    L + +   P+  
Sbjct: 61  IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLE 119

Query: 338 EHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMARLF 396
           EH     R   +  + RGL Y+H  +   ++HRDLK +N+ +++E +  KI DFG+AR+ 
Sbjct: 120 EHA----RL-FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIM 171

Query: 397 EMDQTHSD--TNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQ 445
           +   +H    +  +V T  Y +P  ++    ++   D+++ G +  E+++G+
Sbjct: 172 DPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 90.3 bits (224), Expect = 2e-19
 Identities = 39/199 (19%), Positives = 80/199 (40%), Gaps = 33/199 (16%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---------EVL 292
            D +   + +G G +G V +         +A+K++ +        F++         E+ 
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104

Query: 293 LLARLQHRNLVRLL-----GFCLERKERILVYEFVPNASLDHFI--FDPINREHMTWEKR 345
           +L RL H ++V++L         +  E  +V E    +           +   H     +
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYLTELH----IK 159

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
             ++  +  G+ Y+H  S   I+HRDLK +N L++ + + K+ DFG+AR  +  +  +  
Sbjct: 160 T-LLYNLLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215

Query: 406 NRVVGTFGYMAPEYVMHGR 424
             +      M      H +
Sbjct: 216 LPISPREDDMNLVTFPHTK 234

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 88.8 bits (220), Expect = 2e-19
 Identities = 35/92 (38%), Positives = 53/92 (57%), Gaps = 3/92 (3%)

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           +A+G+ +L   +  + IHRDL A NILL  +   KI DFG+AR    D  +         
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258

Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             +MAPE +    ++++SD++SFGVL+ EI S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 87.4 bits (217), Expect = 8e-19
 Identities = 55/221 (24%), Positives = 103/221 (46%), Gaps = 39/221 (17%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---------EVL 292
              + D   +G G +GAV   +    G  +A+K+L +        F++         E+ 
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-------PFQSELFAKRAYRELR 76

Query: 293 LLARLQHRNLVRLL------GFCLERKERILVYEFVPNASLDHFI-FDPINREHMTWEKR 345
           LL  ++H N++ LL          +  +  LV  F+    L   +  + +  + +    +
Sbjct: 77  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRI----Q 131

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
           + ++  + +GL Y+H      IIHRDLK  N+ ++ +   KI DFG+AR  + + T    
Sbjct: 132 F-LVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY-- 185

Query: 406 NRVVGTFGYMAPEYVM-HGRFSVKSDIFSFGVLVLEIVSGQ 445
              V T  Y APE ++   R++   DI+S G ++ E+++G+
Sbjct: 186 ---VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 84.0 bits (208), Expect = 4e-18
 Identities = 25/201 (12%), Positives = 55/201 (27%), Gaps = 45/201 (22%)

Query: 251 KLGQGGFGAVYKG---MLSNGETIAVKRLSKNSKQGEI---EFKNEVLLLARLQHRNLVR 304
             G       ++     L     +A+  +       +    E  +  L L+R+    + R
Sbjct: 38  FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSR 364
           +L     R   ++V E++   SL             +     + ++ +A      H   R
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---R 147

Query: 365 LRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR 424
             +       S +         +S  G                V+     M         
Sbjct: 148 AGVALSIDHPSRVR--------VSIDGDV--------------VLAYPATMPDA------ 179

Query: 425 FSVKSDIFSFGVLVLEIVSGQ 445
            + + DI   G  +  ++  +
Sbjct: 180 -NPQDDIRGIGASLYALLVNR 199

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 84.2 bits (209), Expect = 8e-18
 Identities = 54/235 (22%), Positives = 98/235 (41%), Gaps = 44/235 (18%)

Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN------ 289
             +   + +F   + LG+G +G V        GE +A+K++          F        
Sbjct: 4   RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALR 55

Query: 290 ---EVLLLARLQHRNLVRLL-----GFCLERKERILVYEFVPNASLDHFI-FDPINREHM 340
              E+ +L   +H N++ +             E  ++ E +    L   I    ++ +H+
Sbjct: 56  TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQMLSDDHI 114

Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
               +Y  I    R +  LH  +   +IHRDLK SN+L++S  + K+ DFG+AR+ +   
Sbjct: 115 ----QY-FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166

Query: 401 THSDTNRV--------VGTFGYMAPEYVM--HGRFSVKSDIFSFGVLVLEIVSGQ 445
             +             V T  Y APE VM    ++S   D++S G ++ E+   +
Sbjct: 167 ADNSEPTGQQSGMVEFVATRWYRAPE-VMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 83.9 bits (208), Expect = 1e-17
 Identities = 61/221 (27%), Positives = 107/221 (48%), Gaps = 39/221 (17%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---------EVL 292
            + + + + +G G +G+V        G  +AVK+LS+        F++         E+ 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80

Query: 293 LLARLQHRNLVRLL-----GFCLERKERI-LVYEFVPNASLDHFI-FDPINREHMTWEKR 345
           LL  ++H N++ LL        LE    + LV   +  A L++ +    +  +H+    +
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHV----Q 135

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
           + +I  I RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR    + T    
Sbjct: 136 F-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG--- 188

Query: 406 NRVVGTFGYMAPEYVM-HGRFSVKSDIFSFGVLVLEIVSGQ 445
              V T  Y APE ++    ++   DI+S G ++ E+++G+
Sbjct: 189 --YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 83.6 bits (207), Expect = 2e-17
 Identities = 44/204 (21%), Positives = 86/204 (42%), Gaps = 42/204 (20%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN---------EVL 292
            DN+   + +G+G +G VY     +  + +A+K++++        F++         E+ 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-------MFEDLIDCKRILREIT 77

Query: 293 LLARLQHRNLVRLLGFCL-----ERKERILVYEFVPNASLDHFI--FDPINREHMTWEKR 345
           +L RL+   ++RL    +     +  E  +V E    + L         +  EH+    +
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHI----K 132

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
             I+  +  G  ++HE     IIHRDLK +N LL+ + + K+ DFG+AR    ++  +  
Sbjct: 133 T-ILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188

Query: 406 NRVVGTFGYMAP---------EYV 420
           N +                   +V
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHV 212

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 48/203 (23%), Positives = 76/203 (37%), Gaps = 56/203 (27%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGF 308
            LG G  G V +       E  A+K L    K      + EV L  R  Q  ++VR++  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 79

Query: 309 C----LERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRY------KIIEGIARGLL 357
                  RK  ++V E +    L    F  I +R      + +      +I++ I   + 
Sbjct: 80  YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGD----QAFTEREASEIMKSIGEAIQ 131

Query: 358 YLHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMARLFEMDQTHSDTNRVVGTFGY 414
           YLH    + I HRD+K  N+L  S+      K++DFG                       
Sbjct: 132 YLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFG----------------------- 165

Query: 415 MAPEYVMHGRFSVKSDIFSFGVL 437
            A E     ++    D++S GV+
Sbjct: 166 FAKE-TTGEKYDKSCDMWSLGVI 187

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 79.0 bits (195), Expect = 6e-16
 Identities = 55/236 (23%), Positives = 98/236 (41%), Gaps = 70/236 (29%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ----------- 298
           KLG G F  V+    + N   +A+K + +  K      ++E+ LL R+            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREH--MTWE----------KRY 346
             ++++LL                     DHF     N  H  M +E          K+Y
Sbjct: 85  ANHILKLL---------------------DHFNHKGPNGVHVVMVFEVLGENLLALIKKY 123

Query: 347 K-------IIEGIAR----GLLYLHEDSRLRIIHRDLKASNILLDSEMNP------KISD 389
           +        ++ I++    GL Y+H   R  IIH D+K  N+L++   +P      KI+D
Sbjct: 124 EHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIAD 181

Query: 390 FGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
            G A     D+ +++    + T  Y +PE ++   +   +DI+S   L+ E+++G 
Sbjct: 182 LGNACW--YDEHYTN---SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 51/206 (24%), Positives = 93/206 (45%), Gaps = 38/206 (18%)

Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN------ 289
              R     +    KLG+G +G V+K +    GE +AVK++          F+N      
Sbjct: 2   RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-------AFQNSTDAQR 54

Query: 290 ---EVLLLARLQ-HRNLVRLLGFCL--ERKERILVYEFVPNASLDHFIF-DPINREHMTW 342
              E+++L  L  H N+V LL        ++  LV++++    L   I  + +   H   
Sbjct: 55  TFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHK-- 111

Query: 343 EKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH 402
             +Y ++  + + + YLH  S   ++HRD+K SNILL++E + K++DFG++R F   +  
Sbjct: 112 --QY-VVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165

Query: 403 SDTNRVVGTFGYMAP--------EYV 420
           ++   +                 +YV
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYV 191

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 72.4 bits (178), Expect = 8e-14
 Identities = 57/227 (25%), Positives = 96/227 (42%), Gaps = 36/227 (15%)

Query: 250 NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSK----QGEIEFKNEVLLLARLQHR---- 300
           + +G+G FG V K       E +A+K + KN K    Q +IE    V LL  +       
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIK-IIKNKKAFLNQAQIE----VRLLELMNKHDTEM 114

Query: 301 --NLVRLLGFCLERKERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIAR 354
              +V L    + R    LV+E + + +L   +    F  ++          K  + +  
Sbjct: 115 KYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLT-----RKFAQQMCT 168

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTHSDTNRVVGTF 412
            LL+L     L IIH DLK  NILL +      KI DFG +      Q      + + + 
Sbjct: 169 ALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQL-GQRIY---QYIQSR 222

Query: 413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDL 459
            Y +PE ++   + +  D++S G +++E+ +G     F    E + +
Sbjct: 223 FYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG--EPLFSGANEVDQM 267

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 71.8 bits (175), Expect = 1e-13
 Identities = 28/199 (14%), Positives = 62/199 (31%), Gaps = 46/199 (23%)

Query: 241 VATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRL--------SKNSKQGEIEFKNEVL 292
           + T+      K+G+G FG V++ +  +   +A+K +        + + ++   E   E++
Sbjct: 17  LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 293 LLARLQ---------HRNLVRLLGFCLER----KERILVYE----------FVPNASLDH 329
           +   L              + L      +       +  ++            P+   D 
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 330 FIF------------DPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNI 377
            +F            + +  +  +      I+  +   L        LR  HRDL   N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNV 193

Query: 378 LLDSEMNPKISDFGMARLF 396
           LL      K+      +  
Sbjct: 194 LLKKTSLKKLHYTLNGKSS 212

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 70.1 bits (172), Expect = 5e-13
 Identities = 55/225 (24%), Positives = 96/225 (42%), Gaps = 38/225 (16%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSK----QGEIEFKNEVLLLARLQHR------ 300
           +G+G FG V K       + +A+K + +N K    Q   E +    +L  L+ +      
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIR----ILEHLRKQDKDNTM 159

Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGL 356
           N++ +L     R    + +E + + +L   I    F   +   +      K    I + L
Sbjct: 160 NVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLV-----RKFAHSILQCL 213

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTHSDTNRVVGTFGY 414
             LH   + RIIH DLK  NILL  +     K+ DFG +      Q        + +  Y
Sbjct: 214 DALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVY---TYIQSRFY 265

Query: 415 MAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDL 459
            APE ++  R+ +  D++S G ++ E+++G        E+E + L
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTGY--PLLPGEDEGDQL 308

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 66.2 bits (162), Expect = 4e-12
 Identities = 40/175 (22%), Positives = 76/175 (43%), Gaps = 18/175 (10%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH-RNLVRLLGF 308
           K+G G FG +Y G  ++ GE +A+K     +K  ++    E  +   +Q    +  +   
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIPTIRWC 73

Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
             E    ++V E +   SL+  +F+  +R   + +    + + +   + Y+H  +    I
Sbjct: 74  GAEGDYNVMVMELL-GPSLED-LFNFCSR-KFSLKTVLLLADQMISRIEYIHSKN---FI 127

Query: 369 HRDLKASNILLDSEMNPK---ISDFGMARLFEMDQTHS-----DTNRVVGTFGYM 415
           HRD+K  N L+          I DFG+A+ +   +TH      +   + GT  Y 
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 40/175 (22%), Positives = 78/175 (44%), Gaps = 18/175 (10%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV-RLLGF 308
           K+G G FG +Y G  +   E +A+K  +  +K  ++ +  E  +   LQ    +  +  F
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIPNVRWF 71

Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII 368
            +E    +LV + +   SL+  +F+  +R  ++ +    + + +   + ++H  S    +
Sbjct: 72  GVEGDYNVLVMDLL-GPSLED-LFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS---FL 125

Query: 369 HRDLKASNILLDSEMNPK---ISDFGMARLFEMDQTHS-----DTNRVVGTFGYM 415
           HRD+K  N L+          I DFG+A+ +    TH      +   + GT  Y 
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 49/244 (20%), Positives = 92/244 (37%), Gaps = 56/244 (22%)

Query: 251 KLGQGGFGAVYKGM--LSNGETIAVKRLSKNSK----QGEIEFKNEVLLLARLQHR---- 300
            LG+G FG V + +        +A+K + +N         +E      +L +++ +    
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKII-RNVGKYREAARLEIN----VLKKIKEKDKEN 80

Query: 301 --NLVRLLGFCLERKERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIAR 354
               V +  +        + +E +   +   F+    F P    H+       +   +  
Sbjct: 81  KFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHV-----RHMAYQLCH 134

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNP-------------------KISDFGMARL 395
            L +LHE    ++ H DLK  NIL  +                       +++DFG A  
Sbjct: 135 ALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA-T 190

Query: 396 FEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEE 455
           F+  + H+    +V T  Y  PE ++   ++   D++S G ++ E   G   + F T E 
Sbjct: 191 FD-HEHHT---TIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF--TLFQTHEN 244

Query: 456 TEDL 459
            E L
Sbjct: 245 REHL 248

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 52/275 (18%), Positives = 86/275 (31%), Gaps = 108/275 (39%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH-------RNL 302
           KLG G F  V+    +   + +A+K +       E    +E+ LL  +++       R +
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREM 102

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM------------TWEKRYK--- 347
           V  L                    LD F    +N  H+             W  +     
Sbjct: 103 VVQL--------------------LDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQG 142

Query: 348 --------IIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE----------------- 382
                   II+ + +GL YLH  ++ RIIH D+K  NILL                    
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRS 200

Query: 383 --------------------------------MNPKISDFGMARLFEMDQTHSDTNRVVG 410
                                           +  KI+D G A       T       + 
Sbjct: 201 GAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTED-----IQ 255

Query: 411 TFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           T  Y + E ++   ++  +DI+S   +  E+ +G 
Sbjct: 256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGD 290

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 63/248 (25%), Positives = 101/248 (40%), Gaps = 60/248 (24%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSK----QGEIEFKNEVLLLARLQHR----- 300
           K+G G FG V     + N +  AVK + +N K      +IE      +L ++Q+      
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVV-RNIKKYTRSAKIEAD----ILKKIQNDDINNN 96

Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFI----FDPINREHMTWEKRYKIIEGIARGL 356
           N+V+  G  +      L++E +   SL   I    ++  + E +           I + L
Sbjct: 97  NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDI-----KLYCIEILKAL 150

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNP-------------------------KISDFG 391
            YL +   + + H DLK  NILLD                              K+ DFG
Sbjct: 151 NYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207

Query: 392 MARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFG 451
            A  F+    H     ++ T  Y APE +++  + V SD++SFG ++ E+ +G     F 
Sbjct: 208 CA-TFK-SDYHG---SIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS--LLFR 260

Query: 452 TEEETEDL 459
           T E  E L
Sbjct: 261 THEHMEHL 268

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 40/181 (22%), Positives = 75/181 (41%), Gaps = 28/181 (15%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH-RNLVRLLGF 308
           ++G+G FG +++G  L N + +A+K   + S   ++    E      L     +  +  F
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTGIPNVYYF 74

Query: 309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLL----YLHEDSR 364
             E    +LV + +   SL+  + D   R   +     K +   A+ +L     +HE S 
Sbjct: 75  GQEGLHNVLVIDLLG-PSLED-LLDLCGR-KFS----VKTVAMAAKQMLARVQSIHEKS- 126

Query: 365 LRIIHRDLKASNILLDSEMNPK-----ISDFGMARLFEMDQTHS-----DTNRVVGTFGY 414
             +++RD+K  N L+    +       + DFGM + +    T       +   + GT  Y
Sbjct: 127 --LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184

Query: 415 M 415
           M
Sbjct: 185 M 185

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 42/180 (23%), Positives = 73/180 (40%), Gaps = 26/180 (14%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
           K+G G FG +  G  L   E +A+K     S+  ++  +             + ++  F 
Sbjct: 16  KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGIPQVYYFG 74

Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLL----YLHEDSRL 365
              K   +V E +   SL+  +FD  +R   +     K +  IA  L+    Y+H  +  
Sbjct: 75  PCGKYNAMVLELL-GPSLED-LFDLCDR-TFS----LKTVLMIAIQLISRMEYVHSKN-- 125

Query: 366 RIIHRDLKASNILLDSEMNPK-----ISDFGMARLFEMDQTHS-----DTNRVVGTFGYM 415
            +I+RD+K  N L+    N       I DF +A+ +   +T       +   + GT  YM
Sbjct: 126 -LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM 184

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 31/175 (17%), Positives = 64/175 (36%), Gaps = 27/175 (15%)

Query: 250 NKLGQGGFGAVYKGM---------LSNGETIAVKRLSKNSKQ-GEIEF------KNEVLL 293
           +   +   G +Y+               +  ++K  +K+ +   E  F        +V  
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107

Query: 294 LARLQHRNLV---RLLGF-CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
             +L    L+     +GF   + K R LV   +   SL     D   +  ++     ++ 
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVLSERSVLQVA 165

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI--SDFGMARLFEMDQTH 402
             +   L +LHE+     +H ++ A NI +D E   ++  + +G A  +     H
Sbjct: 166 CRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH 217

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 60.8 bits (148), Expect = 3e-10
 Identities = 61/256 (23%), Positives = 93/256 (36%), Gaps = 80/256 (31%)

Query: 251 KLGQGGFGAVYKG--MLSNGETIAVKRLSKNSK----QGEIEFK-----NE--------- 290
            LG+G FG V +     + G  +AVK + KN          E +     N          
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIV-KNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79

Query: 291 VLLLARLQHRN---LV-RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRY 346
           V +L   +H     +V  LLG           Y+F     +    F P   +H       
Sbjct: 80  VQMLEWFEHHGHICIVFELLGLST--------YDF-----IKENGFLPFRLDH------- 119

Query: 347 KIIEGIARGLL----YLHEDSRLRIIHRDLKASNILLDSEMNP----------------- 385
             I  +A  +     +LH     ++ H DLK  NIL                        
Sbjct: 120 --IRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174

Query: 386 --KISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             K+ DFG A  ++ D+ HS    +V T  Y APE ++   +S   D++S G +++E   
Sbjct: 175 DIKVVDFGSA-TYD-DEHHS---TLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229

Query: 444 GQKRSSFGTEEETEDL 459
           G   + F T +  E L
Sbjct: 230 GF--TVFPTHDSKEHL 243

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 59.8 bits (145), Expect = 9e-10
 Identities = 34/179 (18%), Positives = 73/179 (40%), Gaps = 37/179 (20%)

Query: 251 KLGQGGFGAVYKGMLSNGETI------AVKRLSKNSKQGEIEFK-----NEVLLLARLQH 299
            +GQGGFG +Y   +++ E++       VK    ++     E K      +   + +   
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 300 RNLVRLLGFC----------LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
              ++ LG              +  R ++ +    + L   I++   +   +     K +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQK-IYEANAK-RFS----RKTV 154

Query: 350 EGIARGLL----YLHEDSRLRIIHRDLKASNILLDSEMNPKI--SDFGMARLFEMDQTH 402
             ++  +L    Y+HE      +H D+KASN+LL+ +   ++   D+G+A  +  +  H
Sbjct: 155 LQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 56.4 bits (135), Expect = 2e-08
 Identities = 66/500 (13%), Positives = 140/500 (28%), Gaps = 126/500 (25%)

Query: 6   CR-DCINVARKNLTSLCPNKVTAIGGYDDRGYNNCM------------LRYANYDIFGLM 52
            R       R+ L  L P K   I G         +                +Y +   M
Sbjct: 132 SRLQPYLKLRQALLELRPAKNVLIDG---------VLGSGKTWVALDVCL--SYKVQCKM 180

Query: 53  ENAPYFFVYAESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYAT--GKEAVSDIVTM 110
           +   ++      N  E ++E  Q     ++  ++  +   S  K      +  +  ++  
Sbjct: 181 DFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKS 240

Query: 111 YALVQC--------TPDLSEA---DCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRY-- 157
                C              A    CK  L  TT+      D        + S       
Sbjct: 241 KPYENCLLVLLNVQNAKAWNAFNLSCKILL--TTRFKQ-VTDFLSAATTTHISLDHHSMT 297

Query: 158 ----ETNKFFKPSIAGPPGSPDPVTPEPPPRKKNHTILITVIVSVVASVILITGICIFLR 213
               E        +   P         P      +   +++I                +R
Sbjct: 298 LTPDEVKSLLLKYLDCRPQD------LPREVLTTNPRRLSIIAE-------------SIR 338

Query: 214 VGK------LKLEDENVEETIAKSL-QFDFETIRVATDNFS----DAN---KLGQGGFGA 259
            G         +  + +   I  SL   +    R   D  S     A+    L       
Sbjct: 339 DGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTIL----LSL 394

Query: 260 VYKGMLSNGETIAVKRLSKNS---KQGE----------IEFKNEVLLLARLQHRNLVR-- 304
           ++  ++ +   + V +L K S   KQ +          +E K ++     L HR++V   
Sbjct: 395 IWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL-HRSIVDHY 453

Query: 305 --LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
                F  +        + +P   LD + +  I   H+   +  + +       ++L  D
Sbjct: 454 NIPKTFDSD--------DLIPP-YLDQYFYSHIGH-HLKNIEHPERMTLFRM--VFL--D 499

Query: 363 SRLRIIHRDLKASNILLD--SEMNPKISDFGMARLFEMDQTHSDTNRVVGT---FGYMAP 417
              R + + ++  +   +    +   +      + +  D       R+V     F     
Sbjct: 500 --FRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDN-DPKYERLVNAILDFLPKIE 556

Query: 418 EYVMHGRFSVKSDIFSFGVL 437
           E ++  ++   +D+    ++
Sbjct: 557 ENLICSKY---TDLLRIALM 573

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.1 bits (129), Expect = 1e-07
 Identities = 64/529 (12%), Positives = 139/529 (26%), Gaps = 129/529 (24%)

Query: 7   RDCINVARKNLTSLC--PNKVTA--IGGYDDRGYNNCMLRYANYDIFGLMENAPYFFVYA 62
           +D ++   +   +L     ++    +       Y   M           M    Y  +  
Sbjct: 58  KDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMY--IEQ 115

Query: 63  ES---NISENLIEFNQTRQRLLERLFSEAAARPSPNKYAT-------GK-----EAVSDI 107
                N ++   ++N +R +   +L  +A     P K          GK     +     
Sbjct: 116 RDRLYNDNQVFAKYNVSRLQPYLKL-RQALLELRPAKNVLIDGVLGSGKTWVALDVCLS- 173

Query: 108 VTMYALVQCTPD----LSEADCKECLHDTTKLMSKCCDRRQGGRVINPSCSFRY-----E 158
              Y +          L+  +C        +++ K   +           S         
Sbjct: 174 ---YKVQCKMDFKIFWLNLKNCNS-PETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS 229

Query: 159 TNKFFKPSIAGPPGSP-----DPVTPEPPPRKKNH---------TILITVIVSVVASVIL 204
                +  +   P          V      +              +L T    V   +  
Sbjct: 230 IQAELRRLLKSKPYENCLLVLLNV------QNAKAWNAFNLSCKILLTTRFKQVTDFLSA 283

Query: 205 ITGICIFLRVGKLKLEDENVEETIAKSLQFDFETI-RVATDNFSDANKLGQGGFGAVYKG 263
            T   I L    + L  + V+  + K L    + + R         N           + 
Sbjct: 284 ATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT----NPRRLSIIAESIRD 339

Query: 264 MLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVP 323
            L+            N K    +    ++  +       + +L     RK    +++   
Sbjct: 340 GLA---------TWDNWKHVNCDKLTTIIESS-------LNVLEPAEYRK----MFD--- 376

Query: 324 NASLDHFIFD-----PINREHMTW-EKRYKIIEGIA-----RGLLYLH-EDSRLRI--IH 369
                  +F      P     + W +     +  +        L+    ++S + I  I+
Sbjct: 377 ----RLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY 432

Query: 370 RDLKASNILLDSEMNPKISD-FGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH------ 422
            +LK   +  +  ++  I D + + + F+ D              Y    ++ H      
Sbjct: 433 LELKV-KLENEYALHRSIVDHYNIPKTFDSDDLIPPYL-----DQYFY-SHIGHHLKNIE 485

Query: 423 --GRFSVKSDI---FSFGVLVLE---IVSGQKRSSFGTEEET-EDLLTY 462
              R ++   +   F F    LE          ++ G+   T + L  Y
Sbjct: 486 HPERMTLFRMVFLDFRF----LEQKIRHDSTAWNASGSILNTLQQLKFY 530

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 52.9 bits (126), Expect = 2e-07
 Identities = 54/351 (15%), Positives = 106/351 (30%), Gaps = 106/351 (30%)

Query: 261 YKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH-------RNLVRLLGFCLERK 313
           YK +LS  E   V        Q   +    +L    + H        +    L + L  K
Sbjct: 18  YKDILSVFEDAFVDNFDCKDVQ---DMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSK 74

Query: 314 ERILVYEFVPNA-SLDH-FIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRD 371
           +  +V +FV     +++ F+  PI  E        +         +Y+ +  RL   + D
Sbjct: 75  QEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTR---------MYIEQRDRL---YND 122

Query: 372 LKASNILLDSEMNPKISDFGMARLFEMDQTHS-----DTNRVVGTFGYMAPEYVMHGRFS 426
                       N   + + ++RL    +           + V   G       + G  S
Sbjct: 123 ------------NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDG-------VLG--S 161

Query: 427 VKSDIFSFGVLVLEIVSGQKRS----------SFGTEEETEDLLTYAWR-------NWNE 469
            K+       + L++    K            +       E +L    +       NW  
Sbjct: 162 GKT------WVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTS 215

Query: 470 GAALNLMDPTMRGGSTSEMMKCI-----HIGLLCVQENVSNRPGMASVVNMLNGDTVTLP 524
             + +  +  +R  S    ++ +     +   L V  NV N    A   N          
Sbjct: 216 R-SDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQN----AKAWN---------- 260

Query: 525 APSKPAFFMKCSVIPET--SSPLDVITGSTESGGHGIGNVPLSKNEASITE 573
                AF + C ++  T      D ++ +T +      ++ L  +  ++T 
Sbjct: 261 -----AFNLSCKILLTTRFKQVTDFLSAATTT------HISLDHHSMTLTP 300

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 33/179 (18%), Positives = 66/179 (36%), Gaps = 40/179 (22%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLS-KNSKQGEIEFKNEVLLLARLQHRNLV----- 303
           K+G GGFG +Y     +  E  A   +  +  + G +   +E+    R+  ++ +     
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF--SELKFYQRVAKKDCIKKWIE 101

Query: 304 ----------RLLGF----CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
                        G        R  R +V E +    L   I                 +
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQK-ISGQNGTFKK------STV 153

Query: 350 EGIARGLL----YLHEDSRLRIIHRDLKASNILLDSEMNPKI--SDFGMARLFEMDQTH 402
             +   +L    Y+HE+     +H D+KA+N+LL  +   ++  +D+G++  +  +  H
Sbjct: 154 LQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	577
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.87
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.87
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.8
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.68
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.36
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.23
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.11
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	98.98
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.97
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	98.89
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.73
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.57
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.53
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.45
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.4
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.39
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.05
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.04
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.0
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.0
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.66
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.63
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.46
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.45
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.37
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.37
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.31
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.17
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.09
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.01
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.38
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.04
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	93.89
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.44
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	82.29
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	80.66
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	80.34

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.2e-56  Score=447.78  Aligned_cols=257  Identities=27%  Similarity=0.453  Sum_probs=212.1

Q ss_pred             cCCccccccccCCcEEEEEeEec------CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      ++|.+.++||+|+||+||+|.+.      +++.||||+++........+|.+|+.+|++++|||||+++|+|.+++..+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            57888999999999999999863      477899999988777777789999999999999999999999999999999


Q ss_pred             EEEecCCCCcccccccC----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEE
Q 008108          318 VYEFVPNASLDHFIFDP----------INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI  387 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~----------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl  387 (577)
                      |||||++|+|.++|...          .....++|.+++.|+.||++||.|||+++   |+||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            99999999999998642          12357999999999999999999999987   999999999999999999999


Q ss_pred             eccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhh
Q 008108          388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRN  466 (577)
Q Consensus       388 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~  466 (577)
                      +|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||......+   ++....  
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~i~--  244 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIECIT--  244 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHHHH--
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH--
Confidence            99999997665444444445679999999999999999999999999999999999 899986544332   222211  


Q ss_pred             cccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          467 WNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       467 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                        .+....     .....+.   .+.+++..||+.||++||||+||+++|+.
T Consensus       245 --~~~~~~-----~p~~~~~---~~~~li~~cl~~dP~~RPs~~~i~~~L~~  286 (299)
T 4asz_A          245 --QGRVLQ-----RPRTCPQ---EVYELMLGCWQREPHMRKNIKGIHTLLQN  286 (299)
T ss_dssp             --HTCCCC-----CCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --cCCCCC-----CCccchH---HHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence              111111     1112223   45577889999999999999999999975

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=9.3e-56  Score=446.33  Aligned_cols=257  Identities=27%  Similarity=0.435  Sum_probs=210.0

Q ss_pred             cCCccccccccCCcEEEEEeEec------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  316 (577)
                      .+++..++||+|+||+||+|.+.      +++.||||+++... .....+|.+|+.+|++++|||||+++|+|.+++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            45667889999999999999862      46789999997643 334567999999999999999999999999999999


Q ss_pred             EEEEecCCCCcccccccCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC
Q 008108          317 LVYEFVPNASLDHFIFDPI-------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM  383 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~  383 (577)
                      ||||||++|+|.++|....             ....++|..++.|+.|||+||.|||+++   ||||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            9999999999999985421             1346999999999999999999999987   99999999999999999


Q ss_pred             CeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhh
Q 008108          384 NPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTY  462 (577)
Q Consensus       384 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~  462 (577)
                      .+||+|||+++...............||+.|||||++.++.|+.++|||||||+||||+| |+.||......+   ++..
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~~~  259 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VVEM  259 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HHHH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HHHH
Confidence            999999999997765544444556789999999999999999999999999999999999 888886544332   2222


Q ss_pred             hhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          463 AWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       463 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      +.    .+....     .....+.   .+.+++..||+.||++||||.||++.|+.
T Consensus       260 i~----~~~~~~-----~p~~~~~---~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          260 IR----NRQVLP-----CPDDCPA---WVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             HH----TTCCCC-----CCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HH----cCCCCC-----CcccchH---HHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            11    111111     1112223   45578889999999999999999999975

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.4e-55  Score=449.15  Aligned_cols=257  Identities=26%  Similarity=0.420  Sum_probs=204.0

Q ss_pred             cCCccccccccCCcEEEEEeEec------CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      ++|...++||+|+||+||+|.+.      +++.||||+++........+|.+|+.+|++++|||||+++|+|.+.+..+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            56778899999999999999864      478899999988777777789999999999999999999999999999999


Q ss_pred             EEEecCCCCcccccccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCe
Q 008108          318 VYEFVPNASLDHFIFDPI------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP  385 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~  385 (577)
                      |||||++|+|.++|....            ....++|.+++.|+.||++||.|||+++   |+||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            999999999999986532            2346999999999999999999999987   9999999999999999999


Q ss_pred             EEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhh
Q 008108          386 KISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAW  464 (577)
Q Consensus       386 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~  464 (577)
                      ||+|||+++...............||+.|||||++.+..|+.++|||||||+||||+| |+.||......+.   +....
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~~i~  274 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---IDCIT  274 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---HHHHH
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---HHHHH
Confidence            9999999997765544444455789999999999999999999999999999999999 8999865443322   22111


Q ss_pred             hhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          465 RNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       465 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                          .+..     +......+.   .+.+|+.+||+.||++||||.||+++|+.
T Consensus       275 ----~g~~-----~~~p~~~~~---~~~~li~~cl~~dP~~RPs~~ei~~~L~~  316 (329)
T 4aoj_A          275 ----QGRE-----LERPRACPP---EVYAIMRGCWQREPQQRHSIKDVHARLQA  316 (329)
T ss_dssp             ----HTCC-----CCCCTTCCH---HHHHHHHHHCCSSTTTSCCHHHHHHHHHH
T ss_pred             ----cCCC-----CCCcccccH---HHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence                1111     111112223   45577889999999999999999999975

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.1e-55  Score=439.99  Aligned_cols=258  Identities=25%  Similarity=0.429  Sum_probs=199.2

Q ss_pred             hcCCccccccccCCcEEEEEeEecCCcEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      .+++++.++||+|+||+||+|++.  ..||||+++..  ......+|.+|+.+|++++|||||+++|++.+ +..+||||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            467888999999999999999875  36999998654  33445679999999999999999999998865 56899999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      ||++|+|.++|..  ....++|.+++.|+.|||+||.|||+++   ||||||||+||||++++.+||+|||+|+......
T Consensus       112 y~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          112 WCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             CCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             cCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            9999999999854  3457999999999999999999999987   9999999999999999999999999998765444


Q ss_pred             ccccccccccCCCCcChhhhhc---CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccccc
Q 008108          401 THSDTNRVVGTFGYMAPEYVMH---GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD  477 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  477 (577)
                      .........||+.|||||++..   +.|+.++|||||||+||||+||+.||.......  .+........        ..
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~--~~~~~~~~~~--------~~  256 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD--QIIFMVGRGY--------AS  256 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHHHHTTC--------CC
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH--HHHHHHhcCC--------CC
Confidence            3344455789999999999964   468999999999999999999999986443221  1111111111        11


Q ss_pred             CcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          478 PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       478 ~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      |.+..........+.+++..||+.||++||||.||++.|+.
T Consensus       257 p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~  297 (307)
T 3omv_A          257 PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL  297 (307)
T ss_dssp             CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred             CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            11111111112345577789999999999999999998864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.7e-53  Score=432.15  Aligned_cols=249  Identities=24%  Similarity=0.365  Sum_probs=205.4

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      +.|+..++||+|+||+||+|... +|+.||||++..........+.+|+.+|++++|||||++++++.+++..|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            56999999999999999999964 69999999997655555556889999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      ++|+|.+++.    +..+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+.+..... 
T Consensus       154 ~gg~L~~~l~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-  225 (346)
T 4fih_A          154 EGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  225 (346)
T ss_dssp             TTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred             CCCcHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence            9999999874    356999999999999999999999998   99999999999999999999999999997654322 


Q ss_pred             ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCC
Q 008108          403 SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG  482 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  482 (577)
                       .....+||+.|||||++.+..|+.++|||||||++|||++|+.||......+....+   ....         .+.+..
T Consensus       226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i---~~~~---------~~~~~~  292 (346)
T 4fih_A          226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNL---------PPRLKN  292 (346)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHSS---------CCCCSC
T ss_pred             -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH---HcCC---------CCCCCc
Confidence             234478999999999999999999999999999999999999998654432222111   1111         011110


Q ss_pred             CChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          483 GSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       483 ~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                       .......+.+++..||+.||++|||+.|+++
T Consensus       293 -~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          293 -LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             -GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             0011124456778999999999999998875

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.8e-53  Score=432.74  Aligned_cols=250  Identities=22%  Similarity=0.343  Sum_probs=199.8

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      ++|+++++||+|+||+||+|.. .+|+.||||++.+..  ......+.+|+.+|++++|||||++++++.+++..|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            6899999999999999999995 469999999997653  3344568999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      ||+||+|.++|.. .+...+++.+++.|+.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+.+....
T Consensus       104 y~~gg~L~~~i~~-~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          104 YCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             CCTTCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             CCCCCcHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            9999999999854 23456899999999999999999999998   9999999999999999999999999998764321


Q ss_pred             ccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                        ......+||+.|||||++.+..|+.++|||||||+||||+||+.||......+   ++.....    +..     +.+
T Consensus       180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~i~~----~~~-----~~~  245 (350)
T 4b9d_A          180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN---LVLKIIS----GSF-----PPV  245 (350)
T ss_dssp             --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHH----TCC-----CCC
T ss_pred             --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHHHc----CCC-----CCC
Confidence              12234689999999999999999999999999999999999999997544322   2221111    110     111


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ....+.   .+.+++.+||+.||++|||+.|+++
T Consensus       246 ~~~~s~---~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          246 SLHYSY---DLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CccCCH---HHHHHHHHHccCChhHCcCHHHHhc
Confidence            112223   3456777999999999999999975

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.8e-53  Score=427.07  Aligned_cols=269  Identities=24%  Similarity=0.317  Sum_probs=199.8

Q ss_pred             cCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC----eEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK----ERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  319 (577)
                      ++|.+.++||+|+||+||+|.+ +|+.||||++...... ...++.|+..+.+++|||||+++|++.+++    .++|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4577889999999999999998 5899999999754332 223445676777899999999999998654    579999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----CCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-----SRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-----~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      |||++|+|.++|.    +..++|..+++++.|+++||.|||++     ..++|+||||||+||||+.++++||+|||+|+
T Consensus        81 Ey~~~gsL~~~l~----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           81 DYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            9999999999984    35699999999999999999999986     23459999999999999999999999999998


Q ss_pred             cccCCCccc--cccccccCCCCcChhhhhcC------CCCccccEEecchhHhHHhhCCCCCCCCCcccc--chhhh--h
Q 008108          395 LFEMDQTHS--DTNRVVGTFGYMAPEYVMHG------RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET--EDLLT--Y  462 (577)
Q Consensus       395 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~--~~l~~--~  462 (577)
                      .........  ......||+.|||||++.+.      .++.++|||||||+||||+||+.|+........  ..+..  .
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            776443222  22346899999999998754      467899999999999999999887653322110  00000  0


Q ss_pred             hhhhcccCCccccccCcCCCC--ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          463 AWRNWNEGAALNLMDPTMRGG--STSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       463 ~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ....+........++|.+...  ..+....+.+++.+||+.||++||||.||+++|+.
T Consensus       237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  294 (303)
T 3hmm_A          237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            000000000111223333222  23445567789999999999999999999999864

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=7.5e-53  Score=432.53  Aligned_cols=271  Identities=28%  Similarity=0.422  Sum_probs=217.5

Q ss_pred             cCCCChHHHHHHhcCCccccccccCCcEEEEEeEecC------CcEEEEEEeccCChh-hHHHHHHHHHHHHhcCC-CCe
Q 008108          231 SLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQH-RNL  302 (577)
Q Consensus       231 ~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h-~ni  302 (577)
                      .+.++.+.++...++|++.++||+|+||+||+|.+..      ++.||||++...... ...+|.+|+.+|.+++| |||
T Consensus        51 ~lp~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnI  130 (353)
T 4ase_A           51 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV  130 (353)
T ss_dssp             GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             cCCCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcE
Confidence            3456667777778899999999999999999998542      367999999876443 34569999999999965 899


Q ss_pred             EEEEeEEEcC-CeEEEEEEecCCCCcccccccCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEE
Q 008108          303 VRLLGFCLER-KERILVYEFVPNASLDHFIFDPIN-------------REHMTWEKRYKIIEGIARGLLYLHEDSRLRII  368 (577)
Q Consensus       303 v~l~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ii  368 (577)
                      |+++|+|.+. +..+||||||++|+|.++|.....             +..++|..++.++.|||+||.|||+++   ||
T Consensus       131 V~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---ii  207 (353)
T 4ase_A          131 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CI  207 (353)
T ss_dssp             CCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred             EEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---ee
Confidence            9999999765 568999999999999999864321             345899999999999999999999997   99


Q ss_pred             EeccCCCcEEEcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCC
Q 008108          369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKR  447 (577)
Q Consensus       369 HrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p  447 (577)
                      ||||||+||||++++.+||+|||+|+....+.....+....||+.|||||++.++.|+.++|||||||+||||+| |+.|
T Consensus       208 HRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~P  287 (353)
T 4ase_A          208 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP  287 (353)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             cCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCC
Confidence            999999999999999999999999997765554444556789999999999999999999999999999999998 8999


Q ss_pred             CCCCCccccchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          448 SSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       448 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      |.......  .+..    ....+...     ......+.   ++.+++..||+.||++|||+.||++.|+.
T Consensus       288 f~~~~~~~--~~~~----~i~~g~~~-----~~p~~~~~---~~~~li~~c~~~dP~~RPt~~eil~~L~~  344 (353)
T 4ase_A          288 YPGVKIDE--EFCR----RLKEGTRM-----RAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGN  344 (353)
T ss_dssp             STTCCCSH--HHHH----HHHHTCCC-----CCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCHHH--HHHH----HHHcCCCC-----CCCccCCH---HHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence            86433221  1111    11111111     11112223   45577789999999999999999998864

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.9e-53  Score=424.02  Aligned_cols=248  Identities=23%  Similarity=0.323  Sum_probs=207.4

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|++.++||+|+||+||+++. .+|+.||||++.+..   ......+.+|+++|++++|||||++++++.+++..||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5699999999999999999995 478999999997642   233456899999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++|+|.++|.   +.+.+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+.+...
T Consensus       112 Ey~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            9999999999984   3567999999999999999999999998   999999999999999999999999999987655


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                      .........+||+.|||||++.+..|+.++|||||||++|||+||+.||......+.   +.....    +.      ..
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~~~i~~----~~------~~  252 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI---FAKIIK----LE------YD  252 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH----TC------CC
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHc----CC------CC
Confidence            544455567999999999999999999999999999999999999999965443222   221111    10      11


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVV  513 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~  513 (577)
                      +......   .+.+++..|++.||++|||+.|++
T Consensus       253 ~p~~~s~---~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          253 FPEKFFP---KARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             CCTTCCH---HHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             CCcccCH---HHHHHHHHHccCCHhHCcChHHHc
Confidence            1112223   345677899999999999999863

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.7e-52  Score=423.54  Aligned_cols=251  Identities=22%  Similarity=0.246  Sum_probs=201.6

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      +.|+..++||+|+||+||+|... +|+.||||+++....     ..+|+.+|++++|||||++++++.+++..+||||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            56888899999999999999964 689999999976532     247999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC-CeEEeccCCcccccCCCc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-NPKISDFGMARLFEMDQT  401 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~-~~kl~DfGla~~~~~~~~  401 (577)
                      +||+|.++|.   ..+.+++..+..++.||+.||.|||+++   |+||||||+||||+.++ .+||+|||+|+.+..+..
T Consensus       133 ~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          133 EGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             TTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             CCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            9999999984   3567999999999999999999999998   99999999999999987 699999999997764332


Q ss_pred             c---ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          402 H---SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       402 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      .   ......+||+.|||||++.+..|+.++|||||||++|||+||+.||...........+.   .   .....    .
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~---~---~~~~~----~  276 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA---S---EPPPI----R  276 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH---H---SCCGG----G
T ss_pred             ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH---c---CCCCc----h
Confidence            2   12334689999999999999999999999999999999999999997544333221111   1   00000    0


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .+....+.   .+.+++..||+.||++|||+.|+++.|..
T Consensus       277 ~~~~~~s~---~~~~li~~~L~~dP~~R~sa~el~~~l~~  313 (336)
T 4g3f_A          277 EIPPSCAP---LTAQAIQEGLRKEPVHRASAMELRRKVGK  313 (336)
T ss_dssp             GSCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hcCccCCH---HHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence            11112223   34467779999999999999999988754

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.9e-52  Score=433.18  Aligned_cols=247  Identities=24%  Similarity=0.376  Sum_probs=206.0

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      +.|+..++||+|+||+||+|... +|+.||||++..........+.+|+.+|++++|||||++++++.+++.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999999964 69999999997765555556899999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      ++|+|.+++.    ...+++..+..|+.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+.+..... 
T Consensus       231 ~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-  302 (423)
T 4fie_A          231 EGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  302 (423)
T ss_dssp             TTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-
T ss_pred             CCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc-
Confidence            9999999873    356999999999999999999999998   99999999999999999999999999987654322 


Q ss_pred             ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC-
Q 008108          403 SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR-  481 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-  481 (577)
                       .....+||+.|||||++.+..|+.++|||||||++|||++|+.||......+....+   ....         .+.+. 
T Consensus       303 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i---~~~~---------~~~~~~  369 (423)
T 4fie_A          303 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNL---------PPRLKN  369 (423)
T ss_dssp             -CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHSC---------CCCCSC
T ss_pred             -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH---HcCC---------CCCCcc
Confidence             234578999999999999999999999999999999999999998654432222111   1111         11111 


Q ss_pred             -CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          482 -GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       482 -~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                       .....   .+.+++..||+.||++|||+.|+++
T Consensus       370 ~~~~s~---~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          370 LHKVSP---SLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             TTSSCH---HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccCCH---HHHHHHHHHcCCChhHCcCHHHHhc
Confidence             11222   3456777999999999999998875

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.8e-52  Score=414.07  Aligned_cols=246  Identities=27%  Similarity=0.401  Sum_probs=194.7

Q ss_pred             ccccccccCCcEEEEEeEec-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEc----CCeEEEEE
Q 008108          247 SDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE----RKERILVY  319 (577)
Q Consensus       247 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  319 (577)
                      +..++||+|+||+||+|... +++.||+|++...  .......|.+|+.+|++++|||||++++++.+    +...+|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            56678999999999999964 6889999999654  33344568999999999999999999999865    34579999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC-CCCeEEeccCCcccccC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS-EMNPKISDFGMARLFEM  398 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~-~~~~kl~DfGla~~~~~  398 (577)
                      |||++|+|.++|.   +...+++..+..|+.||+.||.|||+++ ++|+||||||+||||+. ++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            9999999999984   3567999999999999999999999875 35999999999999985 78999999999986432


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      .    .....+||+.|||||++. +.|+.++|||||||+||||+||+.||......  ..+...    ...+.....+++
T Consensus       185 ~----~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~~~~~----i~~~~~~~~~~~  253 (290)
T 3fpq_A          185 S----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRR----VTSGVKPASFDK  253 (290)
T ss_dssp             T----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHH----HTTTCCCGGGGG
T ss_pred             C----ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH--HHHHHH----HHcCCCCCCCCc
Confidence            2    233468999999999875 57999999999999999999999998643221  112211    111111111111


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                          ....   .+.+++..||+.||++|||+.|+++
T Consensus       254 ----~~~~---~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          254 ----VAIP---EVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ----CCCH---HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----cCCH---HHHHHHHHHccCChhHCcCHHHHhc
Confidence                1122   3556778999999999999999875

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.3e-51  Score=406.28  Aligned_cols=245  Identities=24%  Similarity=0.380  Sum_probs=188.2

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++.+..   ......+.+|+.+|++++|||||++++++.+++..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            6899999999999999999995 469999999997643   233456899999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+ +|+|.+++.   +++.+++..+..++.||+.||.|||+++   |+||||||+||||++++++||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 678888874   3567999999999999999999999998   999999999999999999999999999876533


Q ss_pred             CccccccccccCCCCcChhhhhcCCC-CccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRF-SVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      .   .....+||+.|||||++.+..+ +.++|||||||++|||+||+.||.......   +.....    .+.      +
T Consensus       166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~---~~~~i~----~~~------~  229 (275)
T 3hyh_A          166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV---LFKNIS----NGV------Y  229 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----HTC------C
T ss_pred             C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHH----cCC------C
Confidence            2   2234689999999999988876 579999999999999999999996543322   222111    111      0


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .+....+.   .+.+++..|++.||++|||+.|+++
T Consensus       230 ~~p~~~s~---~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          230 TLPKFLSP---GAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             CCCTTSCH---HHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCH---HHHHHHHHHccCChhHCcCHHHHHc
Confidence            11111223   3456778999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.2e-51  Score=413.76  Aligned_cols=242  Identities=28%  Similarity=0.328  Sum_probs=191.4

Q ss_pred             cCCccccccccCCcEEEEEeEe----cCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      ++|++.++||+|+||+||+|+.    .+++.||||++.+..  ......+.+|+.+|++++|||||++++++.+++..+|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            5799999999999999999985    247889999997642  1223357889999999999999999999999999999


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      |||||+||+|.++|.   +.+.+++.++..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            999999999999984   3567999999999999999999999998   9999999999999999999999999998654


Q ss_pred             CCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccccc
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD  477 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  477 (577)
                      ...  ......+||+.|||||++.+..|+.++|||||||++|||+||+.||......+.   +.....    +.      
T Consensus       178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~---~~~i~~----~~------  242 (304)
T 3ubd_A          178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET---MTMILK----AK------  242 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH----CC------
T ss_pred             CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH---HHHHHc----CC------
Confidence            322  223347899999999999999999999999999999999999999975443322   221111    00      


Q ss_pred             CcCCCCChHHHHHHHHHHHhcccCCCCCCCCH
Q 008108          478 PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGM  509 (577)
Q Consensus       478 ~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~  509 (577)
                      +.+....+.   .+.+++..||+.||++|||+
T Consensus       243 ~~~p~~~s~---~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          243 LGMPQFLSP---EAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             CCCCTTSCH---HHHHHHHHHTCSSGGGSTTC
T ss_pred             CCCCCcCCH---HHHHHHHHHcccCHHHCCCC
Confidence            011111223   34567789999999999984

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5e-50  Score=403.33  Aligned_cols=251  Identities=25%  Similarity=0.371  Sum_probs=187.4

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC--------
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERK--------  313 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  313 (577)
                      ++|++++.||+|+||+||+|... +|+.||||++..... .....+.+|+.+|++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46999999999999999999964 689999999976543 33456899999999999999999999987544        


Q ss_pred             ----eEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEec
Q 008108          314 ----ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD  389 (577)
Q Consensus       314 ----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~D  389 (577)
                          ..++|||||++|+|.+++..........+..++.|+.||++||.|||+++   |+||||||+||||+.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence                36899999999999999865444445678889999999999999999998   99999999999999999999999


Q ss_pred             cCCcccccCCCccc----------cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchh
Q 008108          390 FGMARLFEMDQTHS----------DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDL  459 (577)
Q Consensus       390 fGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l  459 (577)
                      ||+|+.+.......          .....+||+.|||||++.+..|+.++|||||||++|||++   ||..  ..+....
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~--~~~~~~~  236 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST--QMERVRT  236 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS--HHHHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC--ccHHHHH
Confidence            99999776433211          1233579999999999999999999999999999999996   5531  1111111


Q ss_pred             hhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          460 LTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       460 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      +.    ..........        .......+..++..||+.||++|||+.|+++
T Consensus       237 ~~----~~~~~~~p~~--------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          237 LT----DVRNLKFPPL--------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HH----HHHTTCCCHH--------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HH----HHhcCCCCCC--------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11    1111111000        1112223456888999999999999999886

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.9e-47  Score=390.16  Aligned_cols=280  Identities=36%  Similarity=0.626  Sum_probs=240.3

Q ss_pred             hHHHHHHhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeE
Q 008108          236 FETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (577)
Q Consensus       236 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  315 (577)
                      +.++...+++|+..+.||+|+||.||+|...+++.||||++..........+.+|+.+++.++||||+++++++.+.+..
T Consensus        31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  110 (321)
T 2qkw_B           31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM  110 (321)
T ss_dssp             CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred             HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            33445567899999999999999999999888999999999877666667899999999999999999999999999999


Q ss_pred             EEEEEecCCCCcccccccCCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          316 ILVYEFVPNASLDHFIFDPIN-REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      ++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  187 (321)
T 2qkw_B          111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK  187 (321)
T ss_dssp             EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred             EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccc
Confidence            999999999999999865322 236999999999999999999999987   9999999999999999999999999998


Q ss_pred             cccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccc
Q 008108          395 LFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALN  474 (577)
Q Consensus       395 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  474 (577)
                      ...............||+.|+|||++.++.++.++||||||+++|||++|+.|+......+......|.......+....
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (321)
T 2qkw_B          188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ  267 (321)
T ss_dssp             ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence            65543333333445789999999999999999999999999999999999999987666665666666665556666667


Q ss_pred             cccCcCCCC-ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          475 LMDPTMRGG-STSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       475 ~~d~~l~~~-~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .+++.+... .......+.+++..||+.||++|||+.||++.|+.
T Consensus       268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  312 (321)
T 2qkw_B          268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY  312 (321)
T ss_dssp             SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            777766554 56667778899999999999999999999999975

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.2e-47  Score=396.46  Aligned_cols=264  Identities=21%  Similarity=0.301  Sum_probs=199.4

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEc------CCe
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLE------RKE  314 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  314 (577)
                      ++|++.++||+|+||+||+|.. .+|+.||||++.+..  ......+.+|+.+|+.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            6799999999999999999996 479999999997643  3334568899999999999999999998764      357


Q ss_pred             EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      .|||||||+ |+|.+++.   +.+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+
T Consensus       134 ~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence            899999996 67888874   4568999999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCc--cccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhccc--
Q 008108          395 LFEMDQT--HSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNE--  469 (577)
Q Consensus       395 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--  469 (577)
                      .+.....  .......+||+.|||||++.+. .++.++||||+||++|||++|+.||......+....+.........  
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            7643321  2233457899999999998875 5699999999999999999999999765443322222111000000  


Q ss_pred             ------CCcccccc--CcCCCCChHH-----HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          470 ------GAALNLMD--PTMRGGSTSE-----MMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       470 ------~~~~~~~d--~~l~~~~~~~-----~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                            ......+.  +.........     ...+.+++..||+.||++|||+.|+++
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                  00000000  0000001111     134567888999999999999998875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.8e-46  Score=383.57  Aligned_cols=290  Identities=41%  Similarity=0.743  Sum_probs=240.2

Q ss_pred             ccCCCChHHHHHHhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChh-hHHHHHHHHHHHHhcCCCCeEEEEeE
Q 008108          230 KSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGF  308 (577)
Q Consensus       230 ~~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~  308 (577)
                      ....+++.++....++|+..+.||+|+||.||+|...+|+.||||++...... ....+.+|+.+++.++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            34568899999999999999999999999999999888999999999765322 22368899999999999999999999


Q ss_pred             EEcCCeEEEEEEecCCCCcccccccCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEE
Q 008108          309 CLERKERILVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI  387 (577)
Q Consensus       309 ~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl  387 (577)
                      +.+.+..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+....+|+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            999999999999999999999886533 3345999999999999999999999982223999999999999999999999


Q ss_pred             eccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCC--ccccchhhhhhhh
Q 008108          388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGT--EEETEDLLTYAWR  465 (577)
Q Consensus       388 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~--~~~~~~l~~~~~~  465 (577)
                      +|||+++........ ......||+.|+|||++.++.++.++||||||+++|||++|+.||....  .........|...
T Consensus       176 ~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (326)
T 3uim_A          176 GDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG  254 (326)
T ss_dssp             CCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred             ccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence            999999876543322 2334569999999999999999999999999999999999999985321  1222334455555


Q ss_pred             hcccCCccccccCcCCCC-ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCCC
Q 008108          466 NWNEGAALNLMDPTMRGG-STSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDT  520 (577)
Q Consensus       466 ~~~~~~~~~~~d~~l~~~-~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~~  520 (577)
                      ...........+..+... .......+.+++.+|++.||++|||+.||+++|++..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence            555666666677666555 5677788889999999999999999999999998754

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.5e-46  Score=386.40  Aligned_cols=202  Identities=22%  Similarity=0.353  Sum_probs=172.2

Q ss_pred             HHHhcCCccccccccCCcEEEEEeEec----CCcEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCe
Q 008108          240 RVATDNFSDANKLGQGGFGAVYKGMLS----NGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKE  314 (577)
Q Consensus       240 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  314 (577)
                      ....++|++.++||+|+||+||+|..+    +++.||||++.+...  ...+.+|+++|+.+ +|||||++++++.+.+.
T Consensus        17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            345688999999999999999999853    467899999876543  34678999999998 69999999999999999


Q ss_pred             EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCC-CCeEEeccCCc
Q 008108          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMA  393 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~-~~~kl~DfGla  393 (577)
                      .+|||||+++|+|.+++      +.+++.++..++.||+.||.|||+++   |+||||||+||||+.+ +.+||+|||+|
T Consensus        95 ~~lvmE~~~g~~L~~~~------~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla  165 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDIL------NSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLA  165 (361)
T ss_dssp             EEEEEECCCCCCHHHHH------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEeCCCcccHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence            99999999999998887      24899999999999999999999998   9999999999999877 79999999999


Q ss_pred             ccccCCCcc--------------------------ccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCC
Q 008108          394 RLFEMDQTH--------------------------SDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQK  446 (577)
Q Consensus       394 ~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~  446 (577)
                      +........                          ......+||+.|||||++.+. .|+.++||||+||++|||+||+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~  245 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY  245 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence            865432210                          112235799999999999876 58999999999999999999999


Q ss_pred             CCCCCC
Q 008108          447 RSSFGT  452 (577)
Q Consensus       447 p~~~~~  452 (577)
                      ||....
T Consensus       246 Pf~~~~  251 (361)
T 4f9c_A          246 PFYKAS  251 (361)
T ss_dssp             SSSCCS
T ss_pred             CCCCCC
Confidence            986444

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.7e-46  Score=408.87  Aligned_cols=252  Identities=23%  Similarity=0.372  Sum_probs=207.5

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      .++|++.+.||+|+||+||++... +|+.||||++..........+.+|+.+|+.++|||||++++++.+....+|||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            368999999999999999999964 6999999999877666667789999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCC--CCeEEeccCCcccccCC
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE--MNPKISDFGMARLFEMD  399 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~--~~~kl~DfGla~~~~~~  399 (577)
                      |++|+|.++|.+  ....+++.++..++.||+.||.|||+++   |+||||||+||||+.+  +.+||+|||+|+.+...
T Consensus       236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            999999888743  3457999999999999999999999998   9999999999999865  78999999999987643


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                      ..   ....+||+.|||||++.+..|+.++|||||||++|||++|+.||......+....+...  .+   .    +++.
T Consensus       311 ~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~--~~---~----~~~~  378 (573)
T 3uto_A          311 QS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC--DW---N----MDDS  378 (573)
T ss_dssp             SE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT--CC---C----CCSG
T ss_pred             Cc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhC--CC---C----CCcc
Confidence            32   23368999999999999999999999999999999999999998754433322211110  00   0    0011


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .......   .+.+|+..||+.||++|||+.|+++
T Consensus       379 ~~~~~s~---~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          379 AFSGISE---DGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             GGTTSCH---HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cccCCCH---HHHHHHHHHccCChhHCcCHHHHhc
Confidence            1111222   3456778999999999999999987

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.4e-45  Score=401.31  Aligned_cols=248  Identities=24%  Similarity=0.329  Sum_probs=197.1

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHH---HHHHHHHHhcCCCCeEEEEeEEEcCCeE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEF---KNEVLLLARLQHRNLVRLLGFCLERKER  315 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~  315 (577)
                      -++|++.++||+|+||+||++... +|+.||||++.+..   ......+   .+++.+++.++|||||++++++.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            368999999999999999999964 69999999997542   1122223   3446667778999999999999999999


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      ||||||++||+|.++|.   +.+.+++..+..++.||+.||.|||+++   ||||||||+||||+.+|.+||+|||+|+.
T Consensus       268 ylVmEy~~GGdL~~~l~---~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEEECCCCSCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence            99999999999999984   3567999999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCccccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccc
Q 008108          396 FEMDQTHSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALN  474 (577)
Q Consensus       396 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  474 (577)
                      +....    ....+||+.|||||++.. ..|+.++|||||||+||||++|+.||......+...+.......        
T Consensus       342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~--------  409 (689)
T 3v5w_A          342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--------  409 (689)
T ss_dssp             CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC--------
T ss_pred             cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC--------
Confidence            65432    334689999999999975 47999999999999999999999999644333222222211110        


Q ss_pred             cccCcCCCCChHHHHHHHHHHHhcccCCCCCCCC-----HHHHH
Q 008108          475 LMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPG-----MASVV  513 (577)
Q Consensus       475 ~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt-----~~ev~  513 (577)
                        ...+......   .+.+++..|++.||++|++     +.||.
T Consensus       410 --~~~~p~~~S~---~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~  448 (689)
T 3v5w_A          410 --AVELPDSFSP---ELRSLLEGLLQRDVNRRLGCLGRGAQEVK  448 (689)
T ss_dssp             --CCCCCTTSCH---HHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred             --CCCCCccCCH---HHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence              0111112223   3456777999999999998     56665

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.1e-44  Score=363.66  Aligned_cols=283  Identities=36%  Similarity=0.589  Sum_probs=230.1

Q ss_pred             ccCCCChHHHHHHhcCCccc------cccccCCcEEEEEeEecCCcEEEEEEeccCC----hhhHHHHHHHHHHHHhcCC
Q 008108          230 KSLQFDFETIRVATDNFSDA------NKLGQGGFGAVYKGMLSNGETIAVKRLSKNS----KQGEIEFKNEVLLLARLQH  299 (577)
Q Consensus       230 ~~~~~~~~~~~~~~~~f~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h  299 (577)
                      ....|++.++..++++|...      ++||+|+||.||+|.. +++.||||++....    ......+.+|+.++++++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            34568899999999999887      8999999999999987 58899999986532    2335578999999999999


Q ss_pred             CCeEEEEeEEEcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEE
Q 008108          300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL  379 (577)
Q Consensus       300 ~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl  379 (577)
                      |||+++++++.+.+..++||||+++++|.+++........+++..++.++.||+.||.|||+.+   |+||||||+|||+
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence            9999999999999999999999999999998865444567999999999999999999999998   9999999999999


Q ss_pred             cCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchh
Q 008108          380 DSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDL  459 (577)
Q Consensus       380 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l  459 (577)
                      +.++.+||+|||+++...............||+.|+|||.+. +.++.++||||||+++|||++|+.|+...........
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  245 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD  245 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT-TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhc-CCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence            999999999999998765433333344567999999999875 4689999999999999999999999875443322111


Q ss_pred             hhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          460 LTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       460 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      +.... ........+.+++.+..........+.+++..||+.+|++|||+.+|++.|+.
T Consensus       246 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~  303 (307)
T 2nru_A          246 IKEEI-EDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE  303 (307)
T ss_dssp             HHHHH-HTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             HHHHh-hhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            11100 01122233445555554456666778889999999999999999999999874

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=8.7e-45  Score=370.72  Aligned_cols=267  Identities=27%  Similarity=0.391  Sum_probs=206.5

Q ss_pred             hcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC----eEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK----ERILV  318 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv  318 (577)
                      .++|++.++||+|+||+||+|... ++.||||++...... ...+.+|+.++.+++||||+++++++.+..    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            467999999999999999999875 799999999765433 334567999999999999999999998754    46999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC----------CCCcEEEeccCCCcEEEcCCCCeEEe
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED----------SRLRIIHRDLKASNILLDSEMNPKIS  388 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~----------~~~~iiHrDlkp~NiLl~~~~~~kl~  388 (577)
                      |||+++|+|.+++.    ...+++..++.++.||+.||.|||+.          +   |+||||||+|||++.++.+||+
T Consensus       101 ~e~~~~g~L~~~l~----~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A          101 TAFHEKGSLSDFLK----ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EECCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred             EecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence            99999999999984    34599999999999999999999987          6   9999999999999999999999


Q ss_pred             ccCCcccccCCCccccccccccCCCCcChhhhhcC-----CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhh
Q 008108          389 DFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG-----RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA  463 (577)
Q Consensus       389 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~  463 (577)
                      |||+++...............||+.|+|||++.+.     .++.++||||||+++|||+||+.||...............
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            99999877655444444456899999999999763     4567899999999999999999998754332211111100


Q ss_pred             hh-----hcccCCccccccCcCCCC--ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          464 WR-----NWNEGAALNLMDPTMRGG--STSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       464 ~~-----~~~~~~~~~~~d~~l~~~--~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ..     .+..........+.+...  .......+.+++..||+.||++|||+.||++.|+.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  315 (322)
T 3soc_A          254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ  315 (322)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            00     000000001111111111  22344567789999999999999999999999874

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.4e-44  Score=365.29  Aligned_cols=263  Identities=26%  Similarity=0.410  Sum_probs=202.5

Q ss_pred             HHHHhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEE
Q 008108          239 IRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (577)
Q Consensus       239 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  316 (577)
                      +....++|++.++||+|+||+||+|.. +|+.||||++....  .....++.+|+.++++++||||+++++++.+.+..+
T Consensus        32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 3p86_A           32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS  110 (309)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred             ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence            344567899999999999999999987 58899999997654  333456889999999999999999999999999999


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccc
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~  396 (577)
                      +||||+++|+|.+++........+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus       111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred             EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence            99999999999999865333345999999999999999999999875 34999999999999999999999999999865


Q ss_pred             cCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          397 EMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       397 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      ....  .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.   .....       
T Consensus       190 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~---~~~~~-------  257 (309)
T 3p86_A          190 ASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG---FKCKR-------  257 (309)
T ss_dssp             --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH---HSCCC-------
T ss_pred             cccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCC-------
Confidence            4322  12234679999999999999999999999999999999999999986544332211111   00000       


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCC
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD  519 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~  519 (577)
                       ..+......   .+.+++..||+.||++|||+.++++.|+.-
T Consensus       258 -~~~~~~~~~---~l~~li~~~l~~dP~~Rps~~~ll~~L~~~  296 (309)
T 3p86_A          258 -LEIPRNLNP---QVAAIIEGCWTNEPWKRPSFATIMDLLRPL  296 (309)
T ss_dssp             -CCCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCCccCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             011111222   355777899999999999999999999764

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=7e-44  Score=371.06  Aligned_cols=258  Identities=28%  Similarity=0.403  Sum_probs=208.8

Q ss_pred             hcCCccccccccCCcEEEEEeEec--------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcC
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS--------NGETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNLVRLLGFCLER  312 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  312 (577)
                      .++|++.+.||+|+||.||+|...        ++..||||++..... .....+.+|+.+++++ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            478999999999999999999852        356799999976543 3445689999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCCcccccccCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEE
Q 008108          313 KERILVYEFVPNASLDHFIFDPI-------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL  379 (577)
Q Consensus       313 ~~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl  379 (577)
                      +..++||||+++|+|.+++....             ....+++..++.++.||+.||.|||+++   |+||||||+||||
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            99999999999999999886432             1245899999999999999999999998   9999999999999


Q ss_pred             cCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccch
Q 008108          380 DSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETED  458 (577)
Q Consensus       380 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~  458 (577)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+......+...
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~  316 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK  316 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999999999987665443334444567899999999999999999999999999999999 888886544332221


Q ss_pred             hhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          459 LLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       459 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .+.       .+..     +.......   ..+.+++..||+.||++||++.|+++.|+.
T Consensus       317 ~~~-------~~~~-----~~~~~~~~---~~l~~li~~~l~~dP~~Rpt~~ell~~L~~  361 (370)
T 2psq_A          317 LLK-------EGHR-----MDKPANCT---NELYMMMRDCWHAVPSQRPTFKQLVEDLDR  361 (370)
T ss_dssp             HHH-------TTCC-----CCCCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHh-------cCCC-----CCCCCCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            111       1110     01111122   245567789999999999999999999875

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=8.6e-44  Score=359.13  Aligned_cols=250  Identities=24%  Similarity=0.394  Sum_probs=205.2

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      .++|+..++||+|+||+||+|.. .+++.||||++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46899999999999999999995 57899999999776655666789999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++|+|.+++.    ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++........
T Consensus        99 ~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           99 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             CTTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            99999999884    346999999999999999999999998   99999999999999999999999999987654332


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR  481 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  481 (577)
                        ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+   ......    ....    
T Consensus       172 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---~~~~~~----~~~~----  238 (297)
T 3fxz_A          172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---ATNGTP----ELQN----  238 (297)
T ss_dssp             --CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHHCSC----CCSC----
T ss_pred             --ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhCCCC----CCCC----
Confidence              233467999999999999999999999999999999999999998654332211111   100000    0000    


Q ss_pred             CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       482 ~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                        .......+.+++..||+.||++|||+.|+++
T Consensus       239 --~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          239 --PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             --GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence              0111123557788999999999999999875

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=359.81  Aligned_cols=259  Identities=26%  Similarity=0.436  Sum_probs=209.2

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      .++|...++||+|+||+||++... +++.||+|++..........+.+|+.++++++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            367889999999999999999964 6899999999877777777899999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        89 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           89 IKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CTTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            999999999854  2457999999999999999999999998   99999999999999999999999999987654322


Q ss_pred             cc------------cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhccc
Q 008108          402 HS------------DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNE  469 (577)
Q Consensus       402 ~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  469 (577)
                      ..            ......||+.|+|||++.+..++.++||||||+++|||++|..|+.............        
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~--------  235 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN--------  235 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC--------
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh--------
Confidence            11            1114579999999999999999999999999999999999998876443322111000        


Q ss_pred             CCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCC
Q 008108          470 GAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD  519 (577)
Q Consensus       470 ~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~  519 (577)
                        ....++.......+.   .+.+++..|++.||++|||+.|+++.|+.-
T Consensus       236 --~~~~~~~~~~~~~~~---~l~~li~~~l~~dP~~Rps~~~l~~~L~~l  280 (310)
T 3s95_A          236 --VRGFLDRYCPPNCPP---SFFPITVRCCDLDPEKRPSFVKLEHWLETL  280 (310)
T ss_dssp             --HHHHHHHTCCTTCCT---THHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --hhccccccCCCCCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence              000111111111122   345677899999999999999999998753

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.2e-43  Score=360.20  Aligned_cols=261  Identities=24%  Similarity=0.357  Sum_probs=212.0

Q ss_pred             CCCChHHHHHHhcC----------CccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCC
Q 008108          232 LQFDFETIRVATDN----------FSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR  300 (577)
Q Consensus       232 ~~~~~~~~~~~~~~----------f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  300 (577)
                      ..+++++++.+++.          |...++||+|+||.||+|... +|+.||||++..........+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            45777888777764          677789999999999999976 7999999999877666667789999999999999


Q ss_pred             CeEEEEeEEEcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEc
Q 008108          301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD  380 (577)
Q Consensus       301 niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~  380 (577)
                      ||+++++++...+..++||||+++++|.+++.    +..+++..+..++.||+.||.|||+.+   |+||||||+|||++
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~  175 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT  175 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence            99999999999999999999999999999873    346999999999999999999999987   99999999999999


Q ss_pred             CCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhh
Q 008108          381 SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL  460 (577)
Q Consensus       381 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~  460 (577)
                      .++.+||+|||+++.......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||........   .
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~---~  250 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---M  250 (321)
T ss_dssp             TTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---H
T ss_pred             CCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H
Confidence            999999999999987654322  22346799999999999999999999999999999999999999865433221   1


Q ss_pred             hhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          461 TYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       461 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .....    ..     .+.+.. .......+.+++..||+.||++|||+.|+++
T Consensus       251 ~~~~~----~~-----~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          251 KRLRD----SP-----PPKLKN-SHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             HHHHH----SS-----CCCCTT-GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHhc----CC-----CCCcCc-cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11111    00     011110 0011123556777999999999999999986

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.6e-43  Score=361.99  Aligned_cols=247  Identities=24%  Similarity=0.387  Sum_probs=203.5

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++...  .......+.+|+.+++.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46899999999999999999996 57999999999764  3334456889999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++|+|.+++..   .+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        94 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             ECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            99999999998843   467999999999999999999999998   999999999999999999999999999876543


Q ss_pred             CccccccccccCCCCcChhhhhcCCCC-ccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFS-VKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      ..   .....||+.|+|||++.+..+. .++||||||+++|||++|+.||...........+.   .    +.      .
T Consensus       168 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~---~----~~------~  231 (328)
T 3fe3_A          168 GK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL---R----GK------Y  231 (328)
T ss_dssp             CG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H----CC------C
T ss_pred             Cc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH---h----CC------C
Confidence            32   2346799999999999888875 79999999999999999999986544332221111   1    00      0


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .+.....   ..+.+++..|++.||++|||+.|+++
T Consensus       232 ~~p~~~s---~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          232 RIPFYMS---TDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             CCCTTSC---HHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             CCCCCCC---HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0111112   23556778999999999999999875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.2e-43  Score=360.82  Aligned_cols=256  Identities=26%  Similarity=0.453  Sum_probs=204.5

Q ss_pred             hcCCccccccccCCcEEEEEeEec----CCcEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS----NGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      .++|++.+.||+|+||.||+|...    .+..||||++... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            357889999999999999999974    3456999999765 33445578999999999999999999999999999999


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      ||||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus       128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999853  3457999999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcc-ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCcccc
Q 008108          398 MDQTH-SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNL  475 (577)
Q Consensus       398 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  475 (577)
                      ..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+....+.   ....       
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~---~~~~-------  272 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE---EGYR-------  272 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH---TTCC-------
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH---cCCC-------
Confidence            43221 12223456788999999999999999999999999999999 999986544332221111   1100       


Q ss_pred             ccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       476 ~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                        .......+   ..+.+++..||+.||++|||+.||+++|+.
T Consensus       273 --~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~eil~~L~~  310 (325)
T 3kul_A          273 --LPAPMGCP---HALHQLMLDCWHKDRAQRPRFSQIVSVLDA  310 (325)
T ss_dssp             --CCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCCCCCcC---HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence              00111122   245577889999999999999999999975

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.7e-43  Score=362.04  Aligned_cols=255  Identities=26%  Similarity=0.478  Sum_probs=198.6

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcE----EEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGET----IAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  316 (577)
                      .++|+..++||+|+||+||+|... +++.    ||+|.+.... .....++.+|+.++++++||||+++++++.+.. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            367899999999999999999953 4443    5888876433 344567899999999999999999999998765 78


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccc
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~  396 (577)
                      +|+||+++|+|.+++..  ....+++..++.|+.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            99999999999998854  3457999999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCcccc
Q 008108          397 EMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNL  475 (577)
Q Consensus       397 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  475 (577)
                      .............||+.|+|||++.++.++.++||||||+++|||+| |+.||...........+...       ...  
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-------~~~--  238 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-------ERL--  238 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-------CCC--
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC-------CCC--
Confidence            65544444444567889999999999999999999999999999999 99998755443332222211       000  


Q ss_pred             ccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       476 ~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                         ..   .......+.+++..||+.+|++||++.||++.|+.
T Consensus       239 ---~~---~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~  275 (327)
T 3poz_A          239 ---PQ---PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK  275 (327)
T ss_dssp             ---CC---CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHH
T ss_pred             ---CC---CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence               00   11122356678889999999999999999998864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=8.3e-43  Score=356.21  Aligned_cols=254  Identities=25%  Similarity=0.393  Sum_probs=202.5

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      .++|++.++||+|+||+||++... +++.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            368999999999999999999965 789999999865433 223458899999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |+++++|.+++.   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            999999999884   3556999999999999999999999998   9999999999999999999999999998765444


Q ss_pred             ccccccccccCCCCcChhhhhcCCC-CccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGRF-SVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                      .........||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ ....     +.....  ...+ 
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~-----~~~~~~--~~~~-  230 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSD-----WKEKKT--YLNP-  230 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHH-----HHTTCT--TSTT-
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHH-----Hhcccc--cCCc-
Confidence            4333445789999999999988775 7899999999999999999999865433211 1111     111100  0000 


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                          .......+.+++..|++.||++|||+.|+++.
T Consensus       231 ----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          231 ----WKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ----cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence                01111244577889999999999999998753

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2e-43  Score=365.79  Aligned_cols=271  Identities=28%  Similarity=0.418  Sum_probs=215.0

Q ss_pred             cCCCChHHHHHHhcCCccccccccCCcEEEEEeEe------cCCcEEEEEEeccCCh-hhHHHHHHHHHHHHhc-CCCCe
Q 008108          231 SLQFDFETIRVATDNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNL  302 (577)
Q Consensus       231 ~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~ni  302 (577)
                      ...++...+....++|++.++||+|+||.||+|.+      .+++.||||++..... .....+.+|+.++.++ +||||
T Consensus         9 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni   88 (359)
T 3vhe_A            9 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV   88 (359)
T ss_dssp             GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             hCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce
Confidence            45667777788889999999999999999999973      2467899999976543 3445689999999999 79999


Q ss_pred             EEEEeEEEcCCe-EEEEEEecCCCCcccccccCCC---------------------------------------------
Q 008108          303 VRLLGFCLERKE-RILVYEFVPNASLDHFIFDPIN---------------------------------------------  336 (577)
Q Consensus       303 v~l~~~~~~~~~-~~lv~E~~~~gsL~~~l~~~~~---------------------------------------------  336 (577)
                      +++++++.+.+. .++||||+++|+|.+++.....                                             
T Consensus        89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (359)
T 3vhe_A           89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV  168 (359)
T ss_dssp             CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred             eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence            999999987654 8999999999999998865322                                             


Q ss_pred             ------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          337 ------------------REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       337 ------------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                                        +..+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  245 (359)
T 3vhe_A          169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYK  245 (359)
T ss_dssp             ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred             cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence                              122899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCcccccc
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD  477 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  477 (577)
                      ...........||+.|+|||++.+..++.++||||||+++|||+| |+.||........  +..    ....+..     
T Consensus       246 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~----~~~~~~~-----  314 (359)
T 3vhe_A          246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCR----RLKEGTR-----  314 (359)
T ss_dssp             CTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HHH----HHHHTCC-----
T ss_pred             cccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HHH----HHHcCCC-----
Confidence            444334445678999999999999999999999999999999998 9999865432211  111    1111110     


Q ss_pred             CcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          478 PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       478 ~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      +........   .+.+++..||+.||++|||+.||++.|+.
T Consensus       315 ~~~~~~~~~---~l~~li~~~l~~dP~~Rps~~ell~~L~~  352 (359)
T 3vhe_A          315 MRAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGN  352 (359)
T ss_dssp             CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCCCH---HHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence            011111222   45577789999999999999999999874

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1e-43  Score=370.96  Aligned_cols=256  Identities=26%  Similarity=0.429  Sum_probs=206.0

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      .++|...++||+|+||.||+|... +++.||||.+..... ....++.+|+.+|++++||||+++++++.+.+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            467889999999999999999975 789999999876532 233468899999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |+++|+|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++......
T Consensus       193 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          193 LVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             CCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            9999999998853  2346999999999999999999999998   9999999999999999999999999998654332


Q ss_pred             ccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                      .........++..|+|||.+..+.++.++||||||+++|||+| |+.|+...........+.       .+...     .
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~~~~-----~  335 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-------KGGRL-----P  335 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-------TTCCC-----C
T ss_pred             eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCCC-----C
Confidence            2222222346788999999999999999999999999999998 888876544332221111       11100     0


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .....+.   .+.+++..||+.||++|||+.+|++.|+.
T Consensus       336 ~~~~~~~---~l~~li~~cl~~dP~~Rps~~~i~~~L~~  371 (377)
T 3cbl_A          336 CPELCPD---AVFRLMEQCWAYEPGQRPSFSTIYQELQS  371 (377)
T ss_dssp             CCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCH---HHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence            1111223   34567789999999999999999999864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=4.4e-44  Score=360.58  Aligned_cols=263  Identities=27%  Similarity=0.444  Sum_probs=202.0

Q ss_pred             hcCCccccccccCCcEEEEEeEe-----cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC--CeE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-----SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KER  315 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  315 (577)
                      .++|++.++||+|+||+||++.+     .+++.||||++..........+.+|+.++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            46799999999999999999984     36889999999887776677899999999999999999999998654  458


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      ++||||+++|+|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        89 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEEECCTTCBHHHHHHH--CGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEEeCCCCCHHHHHHh--cccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            999999999999999854  2345999999999999999999999988   99999999999999999999999999987


Q ss_pred             ccCCCcc-ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccc---------hhhhhhhh
Q 008108          396 FEMDQTH-SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE---------DLLTYAWR  465 (577)
Q Consensus       396 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~---------~l~~~~~~  465 (577)
                      ....... .......+|..|+|||.+.+..++.++||||||+++|||+||..|+.........         ........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  243 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence            6543322 1222345778899999999999999999999999999999999887532211000         00000011


Q ss_pred             hcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          466 NWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       466 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ....+..     .......+   ..+.+++..||+.||++|||+.|+++.|+.
T Consensus       244 ~~~~~~~-----~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~el~~~L~~  288 (295)
T 3ugc_A          244 LLKNNGR-----LPRPDGCP---DEIYMIMTECWNNNVNQRPSFRDLALRVDQ  288 (295)
T ss_dssp             HHHTTCC-----CCCCTTCC---HHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             HHhccCc-----CCCCcCcC---HHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence            1111100     00111122   345567789999999999999999999875

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.8e-43  Score=349.88  Aligned_cols=254  Identities=29%  Similarity=0.490  Sum_probs=207.5

Q ss_pred             hcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      .++|+..+.||+|+||.||++...+++.||+|++..... ....+.+|+.++++++||||+++++++.+....++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            367899999999999999999988899999999976543 3356899999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      ++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....... 
T Consensus        88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  161 (269)
T 4hcu_A           88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-  161 (269)
T ss_dssp             TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred             CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-
Confidence            99999998853  3456999999999999999999999998   99999999999999999999999999986543221 


Q ss_pred             ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC
Q 008108          403 SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR  481 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  481 (577)
                      .......+|+.|+|||.+....++.++||||||+++|||++ |+.|+...........+.   ...      ....+   
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~---~~~------~~~~~---  229 (269)
T 4hcu_A          162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS---TGF------RLYKP---  229 (269)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH---TTC------CCCCC---
T ss_pred             ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh---cCc------cCCCC---
Confidence            22233567888999999999999999999999999999999 888886544332211111   110      00011   


Q ss_pred             CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       482 ~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ....   ..+.+++..|++.||++||++.|+++.|+.
T Consensus       230 ~~~~---~~~~~li~~~l~~~p~~Rps~~~ll~~l~~  263 (269)
T 4hcu_A          230 RLAS---THVYQIMNHCWRERPEDRPAFSRLLRQLAE  263 (269)
T ss_dssp             TTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CcCC---HHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence            1112   245577789999999999999999999864

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.8e-43  Score=347.84  Aligned_cols=255  Identities=27%  Similarity=0.418  Sum_probs=208.3

Q ss_pred             HhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ..++|++.+.||+|+||.||++...++..||+|++..... ...++.+|+.++.+++||||+++++++.+....++||||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            3467999999999999999999988888999999976543 345689999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        85 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  159 (268)
T 3sxs_A           85 ISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY  159 (268)
T ss_dssp             CTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred             cCCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence            999999998854  2346999999999999999999999998   99999999999999999999999999987654332


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                      . ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+...........+..       +.  ....+. 
T Consensus       160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-------~~--~~~~~~-  228 (268)
T 3sxs_A          160 V-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ-------GH--RLYRPH-  228 (268)
T ss_dssp             E-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-------TC--CCCCCT-
T ss_pred             h-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc-------CC--CCCCCC-
Confidence            2 2233456788999999999999999999999999999999 9888865443322111110       00  000111 


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                        ..+.   .+.+++..|++.||++|||+.|+++.|+.
T Consensus       229 --~~~~---~l~~li~~~l~~~p~~Rps~~~ll~~L~~  261 (268)
T 3sxs_A          229 --LASD---TIYQIMYSCWHELPEKRPTFQQLLSSIEP  261 (268)
T ss_dssp             --TSCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHGG
T ss_pred             --cChH---HHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence              1122   45577889999999999999999999975

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=8.2e-43  Score=361.23  Aligned_cols=251  Identities=25%  Similarity=0.346  Sum_probs=203.4

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChh------hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ------GEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  315 (577)
                      .++|++.+.||+|+||.||++... +|+.||+|.+.+....      ....+.+|+.++++++||||+++++++.+....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467999999999999999999965 6899999999765322      345789999999999999999999999999999


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC----CeEEeccC
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM----NPKISDFG  391 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~----~~kl~DfG  391 (577)
                      ++||||+++|+|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            99999999999999984   3567999999999999999999999998   99999999999998877    79999999


Q ss_pred             CcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCC
Q 008108          392 MARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGA  471 (577)
Q Consensus       392 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  471 (577)
                      +++......   ......||+.|+|||++.+..++.++|||||||++|||++|..||......+....+.       ...
T Consensus       165 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~-------~~~  234 (361)
T 2yab_A          165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT-------AVS  234 (361)
T ss_dssp             SCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH-------TTC
T ss_pred             CceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------hcC
Confidence            998765432   2234679999999999999999999999999999999999999986544322211111       000


Q ss_pred             ccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          472 ALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       472 ~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .  .+++.......   ..+.+++..|++.||++|||+.|+++
T Consensus       235 ~--~~~~~~~~~~s---~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          235 Y--DFDEEFFSQTS---ELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             C--CCCHHHHTTSC---HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             C--CCCchhccCCC---HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0  00000001112   23456778999999999999999875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.6e-43  Score=367.11  Aligned_cols=256  Identities=27%  Similarity=0.466  Sum_probs=194.5

Q ss_pred             hcCCccccccccCCcEEEEEeEec----CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS----NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      .++|++.+.||+|+||.||+|...    ++..||||++.... .....++.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357899999999999999999864    56789999997653 3345578999999999999999999999999999999


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      ||||+++|+|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus       124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            9999999999999853  3457999999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCccc-cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCcccc
Q 008108          398 MDQTHS-DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNL  475 (577)
Q Consensus       398 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  475 (577)
                      ...... ......+|+.|+|||++.++.++.++||||||+++|||++ |+.|+......+.   .........       
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~---~~~i~~~~~-------  268 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV---IKAVDEGYR-------  268 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH---HHHHHTTEE-------
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCCC-------
Confidence            432211 1222345788999999999999999999999999999998 9998865433222   111111100       


Q ss_pred             ccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       476 ~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                        ...   .......+.+++..||+.||++||++.+|+++|+.
T Consensus       269 --~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~  306 (373)
T 2qol_A          269 --LPP---PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDK  306 (373)
T ss_dssp             --CCC---CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCC---CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHH
Confidence              000   11112345678889999999999999999999864

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=354.60  Aligned_cols=251  Identities=25%  Similarity=0.361  Sum_probs=203.0

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChh------hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ------GEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  315 (577)
                      .++|.+.+.||+|+||.||++... +|+.||+|.+......      ....+.+|+.++++++||||+++++++.+....
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            356899999999999999999965 6899999998764321      356789999999999999999999999999999


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC----CeEEeccC
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM----NPKISDFG  391 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~----~~kl~DfG  391 (577)
                      ++||||+++++|.+++.   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        90 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           90 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            99999999999999884   3567999999999999999999999998   99999999999999887    79999999


Q ss_pred             CcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCC
Q 008108          392 MARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGA  471 (577)
Q Consensus       392 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  471 (577)
                      +++.......   .....||+.|+|||++....++.++||||||+++|||++|+.||......+....+.   . ... .
T Consensus       164 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~---~-~~~-~  235 (326)
T 2y0a_A          164 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS---A-VNY-E  235 (326)
T ss_dssp             TCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH---H-TCC-C
T ss_pred             CCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH---h-cCC-C
Confidence            9987654322   234679999999999999999999999999999999999999986543322111111   0 000 0


Q ss_pred             ccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          472 ALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       472 ~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .    .+......+   ..+.+++..|++.||++|||+.|+++
T Consensus       236 ~----~~~~~~~~~---~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          236 F----EDEYFSNTS---ALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             C----CHHHHTTSC---HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             c----CccccccCC---HHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0    000000111   23457778999999999999999987

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-43  Score=355.45  Aligned_cols=251  Identities=20%  Similarity=0.294  Sum_probs=203.1

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      .++|++.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            468999999999999999999965 58889999987553 3345688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC--CCCeEEeccCCcccccCC
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS--EMNPKISDFGMARLFEMD  399 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~--~~~~kl~DfGla~~~~~~  399 (577)
                      +++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.  ++.+||+|||+++.....
T Consensus        83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            999999998843  3346999999999999999999999998   999999999999987  789999999999876543


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                      ..   .....||+.|+|||++.+..++.++||||||+++|||++|+.||........   +......    ...  .++.
T Consensus       158 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~----~~~--~~~~  225 (321)
T 1tki_A          158 DN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI---IENIMNA----EYT--FDEE  225 (321)
T ss_dssp             CE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHHT----CCC--CCHH
T ss_pred             Cc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH---HHHHHcC----CCC--CChh
Confidence            32   2235799999999999988899999999999999999999999865443222   1111110    000  0000


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .....+   ..+.+++..|++.||++|||+.|+++
T Consensus       226 ~~~~~s---~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          226 AFKEIS---IEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHTTSC---HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhccCC---HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            000111   24557788999999999999999987

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-43  Score=359.95  Aligned_cols=261  Identities=26%  Similarity=0.450  Sum_probs=209.5

Q ss_pred             HHhcCCccccccccCCcEEEEEeEec------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK  313 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  313 (577)
                      ...++|++.+.||+|+||.||+|...      +++.||||++.... ......+.+|+.++++++||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            44578999999999999999999974      34789999997654 334456899999999999999999999999999


Q ss_pred             eEEEEEEecCCCCcccccccCCC---------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEecc
Q 008108          314 ERILVYEFVPNASLDHFIFDPIN---------------------REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDL  372 (577)
Q Consensus       314 ~~~lv~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDl  372 (577)
                      ..++||||+++|+|.+++.....                     ...+++.+++.++.||++||.|||+++   |+||||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl  200 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL  200 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            99999999999999998854211                     257999999999999999999999998   999999


Q ss_pred             CCCcEEEcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCC
Q 008108          373 KASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFG  451 (577)
Q Consensus       373 kp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~  451 (577)
                      ||+|||++.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+| |+.|+...
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            99999999999999999999987654333333344678999999999999999999999999999999999 88888654


Q ss_pred             CccccchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCC
Q 008108          452 TEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD  519 (577)
Q Consensus       452 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~  519 (577)
                      ...+.   ...    ...+...     ......+.   .+.+++..||+.||++||++.+|++.|+.-
T Consensus       281 ~~~~~---~~~----~~~~~~~-----~~~~~~~~---~l~~li~~~l~~~p~~Rps~~~~~~~L~~~  333 (343)
T 1luf_A          281 AHEEV---IYY----VRDGNIL-----ACPENCPL---ELYNLMRLCWSKLPADRPSFCSIHRILQRM  333 (343)
T ss_dssp             CHHHH---HHH----HHTTCCC-----CCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             ChHHH---HHH----HhCCCcC-----CCCCCCCH---HHHHHHHHHcccCcccCCCHHHHHHHHHHH
Confidence            33221   111    1111111     11111222   455777899999999999999999999864

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-43  Score=366.46  Aligned_cols=258  Identities=30%  Similarity=0.472  Sum_probs=206.9

Q ss_pred             hcCCccccccccCCcEEEEEeEec------CCcEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  315 (577)
                      .++|++.++||+|+||+||+|.+.      +++.||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            467899999999999999999843      4678999999754 344455788999999999999999999999999999


Q ss_pred             EEEEEecCCCCcccccccCC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC---CeEEe
Q 008108          316 ILVYEFVPNASLDHFIFDPI----NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM---NPKIS  388 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~---~~kl~  388 (577)
                      ++||||+++|+|.+++....    ....+++..++.++.||+.||.|||+++   |+||||||+||||+.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999885422    2246999999999999999999999998   99999999999999555   59999


Q ss_pred             ccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhc
Q 008108          389 DFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNW  467 (577)
Q Consensus       389 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~  467 (577)
                      |||+++...............||+.|+|||++.++.++.++|||||||++|||++ |+.||........   +.....  
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~---~~~i~~--  301 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---LEFVTS--  301 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HHHHHT--
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHc--
Confidence            9999986644333333444678999999999999999999999999999999998 8888865443322   211111  


Q ss_pred             ccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          468 NEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       468 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                        +..     +......+.   .+.+++..||+.||++||++.+|++.|+.
T Consensus       302 --~~~-----~~~~~~~~~---~l~~li~~~l~~dP~~Rps~~eil~~l~~  342 (367)
T 3l9p_A          302 --GGR-----MDPPKNCPG---PVYRIMTQCWQHQPEDRPNFAIILERIEY  342 (367)
T ss_dssp             --TCC-----CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCC-----CCCCccCCH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence              110     001111222   45577889999999999999999999864

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=363.20  Aligned_cols=260  Identities=27%  Similarity=0.388  Sum_probs=210.1

Q ss_pred             HhcCCccccccccCCcEEEEEeEec--------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhc-CCCCeEEEEeEEEc
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLS--------NGETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNLVRLLGFCLE  311 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  311 (577)
                      ..++|.+.++||+|+||.||+|...        .+..||||++..... .....+.+|+.+++++ +||||+++++++.+
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            3478999999999999999999852        235799999976543 3445688999999999 99999999999999


Q ss_pred             CCeEEEEEEecCCCCcccccccCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEE
Q 008108          312 RKERILVYEFVPNASLDHFIFDPIN-------------REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNIL  378 (577)
Q Consensus       312 ~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiL  378 (577)
                      .+..++||||+++|+|.+++.....             ...+++..++.|+.||+.||.|||+.+   |+||||||+|||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence            9999999999999999998854321             246999999999999999999999998   999999999999


Q ss_pred             EcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccc
Q 008108          379 LDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETE  457 (577)
Q Consensus       379 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~  457 (577)
                      |+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+......+..
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~  303 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  303 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999999987665444344445678899999999999999999999999999999999 88888654433221


Q ss_pred             hhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCC
Q 008108          458 DLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD  519 (577)
Q Consensus       458 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~  519 (577)
                      ..+.       .+...     ........   .+.+++..||+.||++|||+.||++.|+..
T Consensus       304 ~~~~-------~~~~~-----~~~~~~~~---~l~~li~~~l~~dP~~Rps~~ell~~L~~~  350 (382)
T 3tt0_A          304 KLLK-------EGHRM-----DKPSNCTN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  350 (382)
T ss_dssp             HHHH-------TTCCC-----CCCSSCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHH-------cCCCC-----CCCccCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1111       11100     01111222   455777899999999999999999999764

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1e-42  Score=348.28  Aligned_cols=255  Identities=26%  Similarity=0.417  Sum_probs=205.3

Q ss_pred             HhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ..++|+..++||+|+||.||++...++..||+|++...... ..++.+|+.++.+++||||+++++++.+....++||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            34678999999999999999999988889999999765433 35789999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus       101 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  175 (283)
T 3gen_A          101 MANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  175 (283)
T ss_dssp             CTTCBHHHHHHC--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred             cCCCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence            999999998854  2456999999999999999999999998   99999999999999999999999999986643221


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                       .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...........+....            ....
T Consensus       176 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~------------~~~~  242 (283)
T 3gen_A          176 -TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL------------RLYR  242 (283)
T ss_dssp             -HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC------------CCCC
T ss_pred             -ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhccc------------CCCC
Confidence             12223457888999999999999999999999999999998 998886544332222111100            0001


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .....   ..+.+++..||+.+|++|||+.|+++.|..
T Consensus       243 ~~~~~---~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  277 (283)
T 3gen_A          243 PHLAS---EKVYTIMYSCWHEKADERPTFKILLSNILD  277 (283)
T ss_dssp             CTTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCcCC---HHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence            11112   245577889999999999999999999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=7e-42  Score=347.49  Aligned_cols=264  Identities=24%  Similarity=0.343  Sum_probs=199.6

Q ss_pred             hcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      .++|++.++||+|+||+||++...+|+.||+|++.....  .....+.+|+.++++++||||+++++++.+....++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            478999999999999999999998899999999975432  223568899999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |+++ +|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A          100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            9985 67666643  3456999999999999999999999998   9999999999999999999999999998765322


Q ss_pred             ccccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccc----
Q 008108          401 THSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNL----  475 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~----  475 (577)
                      .  ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+...........+...    
T Consensus       174 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          174 R--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             C-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             c--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence            2  2233578999999999876 56899999999999999999999998755443322111110000000000000    


Q ss_pred             -----ccCcCCCCCh-----HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          476 -----MDPTMRGGST-----SEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       476 -----~d~~l~~~~~-----~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                           ..........     .....+.+++..|++.||++|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                 0000000000     11134567888999999999999999885

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.1e-42  Score=348.54  Aligned_cols=271  Identities=21%  Similarity=0.297  Sum_probs=210.4

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC--eEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK--ERILV  318 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv  318 (577)
                      .++|++.++||+|+||+||+|... +++.||||++.... ......+.+|+.++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            367999999999999999999965 58999999997643 233456789999999999999999999998765  77999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEE----cCCCCeEEeccCCcc
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL----DSEMNPKISDFGMAR  394 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl----~~~~~~kl~DfGla~  394 (577)
                      |||+++++|.+++........+++..++.++.||+.||.|||+.+   |+||||||+||||    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999866444455999999999999999999999998   9999999999999    788889999999998


Q ss_pred             cccCCCccccccccccCCCCcChhhhh--------cCCCCccccEEecchhHhHHhhCCCCCCCCCcc-ccchhhhhhhh
Q 008108          395 LFEMDQTHSDTNRVVGTFGYMAPEYVM--------HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEE-ETEDLLTYAWR  465 (577)
Q Consensus       395 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~-~~~~l~~~~~~  465 (577)
                      .......   .....||..|+|||++.        +..++.++||||||+++|||++|+.||...... .....+.....
T Consensus       165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            7654332   22357999999999986        477899999999999999999999998643322 22222222221


Q ss_pred             hcccCCcccc---------ccCcCCC--C-ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCC
Q 008108          466 NWNEGAALNL---------MDPTMRG--G-STSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD  519 (577)
Q Consensus       466 ~~~~~~~~~~---------~d~~l~~--~-~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~  519 (577)
                      .........+         .++.+..  . .......+..++..|++.||++|||+.|+++-...+
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            1111111100         0111111  1 234445566788999999999999999999987643

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.1e-42  Score=357.13  Aligned_cols=248  Identities=22%  Similarity=0.270  Sum_probs=202.3

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      .++|+..+.||+|+||+||++... +|+.||+|++.+..   ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            368999999999999999999965 68999999997642   23345678999999999999999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+++|+|..++.   ....+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus        84 ~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            99999999988874   3457999999999999999999999998   99999999999999999999999999986432


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      ..  .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+   ..    ..      .
T Consensus       158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i---~~----~~------~  222 (337)
T 1o6l_A          158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI---LM----EE------I  222 (337)
T ss_dssp             TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH----CC------C
T ss_pred             CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH---Hc----CC------C
Confidence            22  2233468999999999999999999999999999999999999998654332221111   10    00      0


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRP-----GMASVVN  514 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RP-----t~~ev~~  514 (577)
                      .+......   .+.+++..|++.||++||     ++.|+++
T Consensus       223 ~~p~~~s~---~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          223 RFPRTLSP---EAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CCCTTSCH---HHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCCCCCH---HHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            11111222   345677799999999999     8888875

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.5e-42  Score=358.25  Aligned_cols=253  Identities=25%  Similarity=0.349  Sum_probs=202.3

Q ss_pred             HhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      ..++|++.+.||+|+||.||++... +|+.||+|++....  ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3568999999999999999999964 68999999997543  33345688999999999999999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC---CeEEeccCCccc
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM---NPKISDFGMARL  395 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~---~~kl~DfGla~~  395 (577)
                      |||+++|+|.+++.   .+..+++..+..++.||+.||.|||+++   |+||||||+|||++.++   .+||+|||+++.
T Consensus       107 ~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          107 FDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             ECCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            99999999988874   3567999999999999999999999998   99999999999998654   599999999987


Q ss_pred             ccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccc
Q 008108          396 FEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNL  475 (577)
Q Consensus       396 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  475 (577)
                      ......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.       .+.. ..
T Consensus       181 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~-------~~~~-~~  249 (362)
T 2bdw_A          181 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK-------AGAY-DY  249 (362)
T ss_dssp             CTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HTCC-CC
T ss_pred             ecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------hCCC-CC
Confidence            653322   234679999999999999899999999999999999999999986543322111111       0100 00


Q ss_pred             ccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       476 ~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      ..+.. ....   ..+.+++..|++.||++|||+.|+++.
T Consensus       250 ~~~~~-~~~~---~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          250 PSPEW-DTVT---PEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             CTTGG-GGSC---HHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             Ccccc-cCCC---HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00000 0112   245577789999999999999998753

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.1e-42  Score=353.10  Aligned_cols=259  Identities=27%  Similarity=0.399  Sum_probs=209.6

Q ss_pred             HhcCCccccccccCCcEEEEEeEe------cCCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCe
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE  314 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  314 (577)
                      ..++|.+.+.||+|+||.||++..      .+++.||||++.... ......+.+|+.++++++||||+++++++.+.+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            357899999999999999999985      245789999997653 3344568899999999999999999999999999


Q ss_pred             EEEEEEecCCCCcccccccCCC---------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccC
Q 008108          315 RILVYEFVPNASLDHFIFDPIN---------------------REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLK  373 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk  373 (577)
                      .++||||+++++|.+++.....                     ...+++..++.++.||++||.|||+++   |+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence            9999999999999999865322                     234899999999999999999999998   9999999


Q ss_pred             CCcEEEcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCC
Q 008108          374 ASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGT  452 (577)
Q Consensus       374 p~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~  452 (577)
                      |+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+....
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987655444333444567889999999999999999999999999999999 998886544


Q ss_pred             ccccchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          453 EEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       453 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .......+.       .+..     +......+.   .+.+++..|++.||++||++.|+++.|+.
T Consensus       258 ~~~~~~~~~-------~~~~-----~~~~~~~~~---~~~~li~~~l~~dp~~Rps~~~l~~~l~~  308 (314)
T 2ivs_A          258 PERLFNLLK-------TGHR-----MERPDNCSE---EMYRLMLQCWKQEPDKRPVFADISKDLEK  308 (314)
T ss_dssp             GGGHHHHHH-------TTCC-----CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHhh-------cCCc-----CCCCccCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            433222211       1110     011111222   45577789999999999999999999864

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.1e-42  Score=355.73  Aligned_cols=254  Identities=28%  Similarity=0.430  Sum_probs=200.7

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcE----EEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGET----IAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      ++|+..++||+|+||+||+|... +++.    ||+|.+.... ......+.+|+.++.+++||||+++++++. ++..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            57899999999999999999954 4443    7888875443 222335678999999999999999999986 456899


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      ||||+++|+|.+++..  .+..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        92 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence            9999999999998854  2457999999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      ............||..|+|||++.++.++.++||||||+++|||+| |+.||...........+.....    .......
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~  242 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER----LAQPQIC  242 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB----CCCCTTB
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC----CCCCCcC
Confidence            5544444455678899999999999999999999999999999999 9999875544333222221110    0000111


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .+           .+.+++..||+.||++||++.|+++.|+.
T Consensus       243 ~~-----------~~~~li~~~l~~dp~~Rps~~el~~~l~~  273 (325)
T 3kex_A          243 TI-----------DVYMVMVKCWMIDENIRPTFKELANEFTR  273 (325)
T ss_dssp             CT-----------TTTHHHHHHTCSCTTTSCCHHHHHHHHHH
T ss_pred             cH-----------HHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            11           23467789999999999999999999875

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.3e-42  Score=350.05  Aligned_cols=259  Identities=24%  Similarity=0.369  Sum_probs=202.4

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      .++|++.++||+|+||.||++... +++.||+|.+....   ......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            467999999999999999999954 68999999985543   33345688999999999999999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+++++|.+++.   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        90 ~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            99999999999884   3457999999999999999999999998   99999999999999999999999999987653


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      ... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........  .    ....... .... ..
T Consensus       164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--~----~~~~~~~-~~~~-~~  234 (294)
T 4eqm_A          164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--A----IKHIQDS-VPNV-TT  234 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH--H----HHHHSSC-CCCH-HH
T ss_pred             ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--H----HHHhhcc-CCCc-ch
Confidence            321 223346799999999999999999999999999999999999999865432211  1    1111111 0000 01


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHhcCC
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRP-GMASVVNMLNGD  519 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RP-t~~ev~~~L~~~  519 (577)
                      ......+   ..+.+++.+|++.||++|| ++.++.+.|...
T Consensus       235 ~~~~~~~---~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~  273 (294)
T 4eqm_A          235 DVRKDIP---QSLSNVILRATEKDKANRYKTIQEMKDDLSSV  273 (294)
T ss_dssp             HSCTTSC---HHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred             hcccCCC---HHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence            1111122   2455677899999999998 899999999864

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=9.4e-43  Score=372.50  Aligned_cols=258  Identities=27%  Similarity=0.441  Sum_probs=208.2

Q ss_pred             HHHhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          240 RVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       240 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      +...++|+..++||+|+||+||+|.+.++..||||++..... ....|.+|+.+|++++||||+++++++. .+..++||
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~  261 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT  261 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc-cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence            344578899999999999999999998889999999986543 4567999999999999999999999986 56789999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++|+|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus       262 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~  337 (454)
T 1qcf_A          262 EFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN  337 (454)
T ss_dssp             CCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred             eecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence            999999999998532 2246899999999999999999999998   999999999999999999999999999876432


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      .. .......+|..|+|||++..+.++.++||||||+++|||+| |+.|+......+....+.   .....         
T Consensus       338 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~---~~~~~---------  404 (454)
T 1qcf_A          338 EY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE---RGYRM---------  404 (454)
T ss_dssp             HH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH---HTCCC---------
T ss_pred             ce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCCCC---------
Confidence            21 11223456889999999999999999999999999999999 999886544322221111   11100         


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCC
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD  519 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~  519 (577)
                      ......+   ..+.+++..||+.||++|||+.+|+++|+.-
T Consensus       405 ~~~~~~~---~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~  442 (454)
T 1qcf_A          405 PRPENCP---EELYNIMMRCWKNRPEERPTFEYIQSVLDDF  442 (454)
T ss_dssp             CCCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             CCCCCCC---HHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            0011122   2455777899999999999999999999874

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.5e-42  Score=348.40  Aligned_cols=259  Identities=24%  Similarity=0.332  Sum_probs=198.2

Q ss_pred             HhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHh--cCCCCeEEEEeEEEcC----CeE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR--LQHRNLVRLLGFCLER----KER  315 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~  315 (577)
                      ..++|++.++||+|+||+||+|.. +++.||||++....   ...+..|.+++..  ++||||+++++++...    ...
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            357899999999999999999987 68999999996543   3345566666666  7999999999987543    457


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCcEEEeccCCCcEEEcCCCCeEE
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH--------EDSRLRIIHRDLKASNILLDSEMNPKI  387 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH--------~~~~~~iiHrDlkp~NiLl~~~~~~kl  387 (577)
                      ++||||+++|+|.+++.    ...+++..++.++.||+.||.|||        +.+   |+||||||+|||++.++.+||
T Consensus        82 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             EEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred             EEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence            99999999999999983    457999999999999999999999        665   999999999999999999999


Q ss_pred             eccCCcccccCCCccc--cccccccCCCCcChhhhhcC------CCCccccEEecchhHhHHhhC----------CCCCC
Q 008108          388 SDFGMARLFEMDQTHS--DTNRVVGTFGYMAPEYVMHG------RFSVKSDIFSFGVLVLEIVSG----------QKRSS  449 (577)
Q Consensus       388 ~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGvil~elltG----------~~p~~  449 (577)
                      +|||+++.........  ......||+.|+|||++.+.      .++.++||||||+++|||+||          +.||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            9999998765433221  12335799999999999877      455799999999999999999          66664


Q ss_pred             CCCcccc-chhhhhhhhhcccCCccccccCcCCCC--ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          450 FGTEEET-EDLLTYAWRNWNEGAALNLMDPTMRGG--STSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       450 ~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ....... ...+.   ......    ...+.+...  .......+.+++..||+.||++|||+.||++.|+.
T Consensus       235 ~~~~~~~~~~~~~---~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          235 DVVPNDPSFEDMR---KVVCVD----QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             TTSCSSCCHHHHH---HHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             ccCCCCcchhhhh---HHHhcc----CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            3322111 11111   111000    011111111  12345667789999999999999999999999864

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.3e-42  Score=367.99  Aligned_cols=265  Identities=20%  Similarity=0.264  Sum_probs=207.6

Q ss_pred             CChHHHHHHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChh---hHHHHHHHHHHHHhcCCCCeEEEEeEE
Q 008108          234 FDFETIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ---GEIEFKNEVLLLARLQHRNLVRLLGFC  309 (577)
Q Consensus       234 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~  309 (577)
                      +.+.+++...++|++.++||+|+||+||+|... +++.||+|++.+....   ....+.+|..++..++||||+++++++
T Consensus        64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  143 (437)
T 4aw2_A           64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF  143 (437)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            345566677889999999999999999999976 4788999999753221   122378999999999999999999999


Q ss_pred             EcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEec
Q 008108          310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD  389 (577)
Q Consensus       310 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~D  389 (577)
                      .+.+..+|||||+++|+|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|
T Consensus       144 ~~~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~D  218 (437)
T 4aw2_A          144 QDDNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLAD  218 (437)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred             eeCCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcc
Confidence            999999999999999999999854  2457999999999999999999999998   99999999999999999999999


Q ss_pred             cCCcccccCCCccccccccccCCCCcChhhhh-----cCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhh
Q 008108          390 FGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM-----HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAW  464 (577)
Q Consensus       390 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~  464 (577)
                      ||+++........ ......||+.|+|||++.     .+.++.++|||||||++|||++|+.||......+....+....
T Consensus       219 FGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~  297 (437)
T 4aw2_A          219 FGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK  297 (437)
T ss_dssp             CTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred             hhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc
Confidence            9999876543322 233468999999999997     5678999999999999999999999997544333222111100


Q ss_pred             hhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 008108          465 RNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSN--RPGMASVVNM  515 (577)
Q Consensus       465 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~--RPt~~ev~~~  515 (577)
                      ....        -|........+   +.+++..|++.+|++  ||++.|+++-
T Consensus       298 ~~~~--------~p~~~~~~s~~---~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          298 ERFQ--------FPTQVTDVSEN---AKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             HHCC--------CCSSCCCSCHH---HHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             cccc--------CCcccccCCHH---HHHHHHHHhcccccccCCCCHHHHhCC
Confidence            0000        01111112233   445666888888887  9999998863

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-42  Score=359.15  Aligned_cols=253  Identities=23%  Similarity=0.315  Sum_probs=205.1

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      .++|++.++||+|+||.||+|... +|+.||+|.+..........+.+|+.+|+.++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            468999999999999999999965 6899999999877666666789999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC--CCCeEEeccCCcccccCC
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS--EMNPKISDFGMARLFEMD  399 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~--~~~~kl~DfGla~~~~~~  399 (577)
                      +++|+|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||+++.....
T Consensus       130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            999999988743  2346999999999999999999999998   999999999999974  467999999999876543


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                      ..   .....||+.|+|||++.+..++.++||||||+++|||++|+.||........   +......    ..  .+++.
T Consensus       205 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~---~~~i~~~----~~--~~~~~  272 (387)
T 1kob_A          205 EI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---LQNVKRC----DW--EFDED  272 (387)
T ss_dssp             SC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHHHHC----CC--CCCSS
T ss_pred             cc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH---HHHHHhC----CC--CCCcc
Confidence            22   2234799999999999999999999999999999999999999865433221   1111110    00  01111


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      .......   .+.+++..||+.||++|||+.|+++-
T Consensus       273 ~~~~~s~---~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          273 AFSSVSP---EAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             TTTTSCH---HHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ccccCCH---HHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            1111222   45577789999999999999999863

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.1e-42  Score=366.31  Aligned_cols=253  Identities=23%  Similarity=0.316  Sum_probs=201.8

Q ss_pred             HhcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      ..++|++.++||+|+||.||++.. .+|+.+|+|++.....  .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            457899999999999999999985 4789999999976542  3344688999999999999999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEc---CCCCeEEeccCCccc
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD---SEMNPKISDFGMARL  395 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~---~~~~~kl~DfGla~~  395 (577)
                      |||+++|+|.+.+..   +..+++..+..++.||+.||.|||+++   |+||||||+|||++   .++.+||+|||+++.
T Consensus        89 ~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           89 FDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             ECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            999999999888743   567999999999999999999999998   99999999999998   457899999999987


Q ss_pred             ccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccc
Q 008108          396 FEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNL  475 (577)
Q Consensus       396 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  475 (577)
                      ......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..       +.. ..
T Consensus       163 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~-------~~~-~~  232 (444)
T 3soa_A          163 VEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA-------GAY-DF  232 (444)
T ss_dssp             CCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-------TCC-CC
T ss_pred             ecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh-------CCC-CC
Confidence            654322  22346799999999999999999999999999999999999999865433222111111       100 00


Q ss_pred             ccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       476 ~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ..+.. ...+.   .+.+++..|++.||++|||+.|+++
T Consensus       233 ~~~~~-~~~s~---~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          233 PSPEW-DTVTP---EAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             CTTTT-TTSCH---HHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             Ccccc-ccCCH---HHHHHHHHHcCCChhHCCCHHHHhc
Confidence            01100 11222   3456778999999999999999986

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.8e-43  Score=357.09  Aligned_cols=261  Identities=23%  Similarity=0.383  Sum_probs=191.3

Q ss_pred             HHHhcCCccccccccCCcEEEEEeEecCC----cEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC
Q 008108          240 RVATDNFSDANKLGQGGFGAVYKGMLSNG----ETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK  313 (577)
Q Consensus       240 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  313 (577)
                      ....++|++.+.||+|+||.||+|.....    ..||||++...  .......+.+|+.++++++||||+++++++....
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            34557899999999999999999996543    27999999765  3344567899999999999999999999998876


Q ss_pred             eE------EEEEEecCCCCcccccccCC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCC
Q 008108          314 ER------ILVYEFVPNASLDHFIFDPI---NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN  384 (577)
Q Consensus       314 ~~------~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~  384 (577)
                      ..      ++||||+++|+|.+++....   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence            55      99999999999999885422   1226999999999999999999999998   999999999999999999


Q ss_pred             eEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhh
Q 008108          385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYA  463 (577)
Q Consensus       385 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~  463 (577)
                      +||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...........+   
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~---  252 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL---  252 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH---
Confidence            99999999987655443333334567889999999999999999999999999999999 88888654433221111   


Q ss_pred             hhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          464 WRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       464 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .    .+..     ........   ..+.+++..|++.||++|||+.++++.|+.
T Consensus       253 ~----~~~~-----~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~l~~  295 (323)
T 3qup_A          253 I----GGNR-----LKQPPECM---EEVYDLMYQCWSADPKQRPSFTCLRMELEN  295 (323)
T ss_dssp             H----TTCC-----CCCCTTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             h----cCCC-----CCCCCccC---HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            1    1100     00111122   345678889999999999999999999875

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.4e-42  Score=374.78  Aligned_cols=257  Identities=28%  Similarity=0.456  Sum_probs=209.1

Q ss_pred             HhcCCccccccccCCcEEEEEeEecC-CcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      ..++|++.++||+|+||.||+|.+.. +..||||.+..... ...+|.+|+.+|++++||||+++++++.+.+..+||||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            34678889999999999999999764 88999999976543 35578999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |+++|+|.+++.. .....+++..++.|+.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++......
T Consensus       297 ~~~~g~L~~~l~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          297 FMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             CCTTCBHHHHHHH-SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred             ccCCCCHHHHHHh-cCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence            9999999999854 23456999999999999999999999998   9999999999999999999999999998765332


Q ss_pred             ccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                      . .......+|..|+|||++..+.++.++||||||+++|||+| |+.|+...........+.   ....         ..
T Consensus       373 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~---~~~~---------~~  439 (495)
T 1opk_A          373 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---KDYR---------ME  439 (495)
T ss_dssp             E-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH---TTCC---------CC
T ss_pred             e-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCCC---------CC
Confidence            2 22233456789999999999999999999999999999999 888876544332222111   1100         00


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCC
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD  519 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~  519 (577)
                      .....+.   .+.+++..||+.||++|||+.+|+++|+.-
T Consensus       440 ~~~~~~~---~l~~li~~cl~~dP~~RPs~~el~~~L~~~  476 (495)
T 1opk_A          440 RPEGCPE---KVYELMRACWQWNPSDRPSFAEIHQAFETM  476 (495)
T ss_dssp             CCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             CCCCCCH---HHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            1111222   455677899999999999999999999863

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.1e-42  Score=371.53  Aligned_cols=258  Identities=26%  Similarity=0.418  Sum_probs=202.4

Q ss_pred             HhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ..++|+..++||+|+||.||+|.+.++..||||++..... ...+|.+|+.+|++++||||+++++++.+ +..++||||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            4467888999999999999999998888899999976543 34578999999999999999999999876 678999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++|+|.+++.. .....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus       260 ~~~gsL~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          260 MSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             CTTCBHHHHHSH-HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             hcCCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            999999999853 12346999999999999999999999998   99999999999999999999999999987653322


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                       .......+|..|+|||.+..+.++.++||||||+++|||++ |+.|+......+.   +.....    +..     ...
T Consensus       336 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~~i~~----~~~-----~~~  402 (452)
T 1fmk_A          336 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LDQVER----GYR-----MPC  402 (452)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHHHT----TCC-----CCC
T ss_pred             -ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHc----CCC-----CCC
Confidence             12223457889999999999999999999999999999999 8888864433222   211111    100     001


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCCCC
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTV  521 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~~~  521 (577)
                      ....+   ..+.+++..||+.||++|||+.+|+++|+.-..
T Consensus       403 ~~~~~---~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          403 PPECP---ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             CCCCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence            11122   245577789999999999999999999987543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=6e-42  Score=345.60  Aligned_cols=249  Identities=22%  Similarity=0.309  Sum_probs=194.0

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChh--------------------------hHHHHHHHHHHHH
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ--------------------------GEIEFKNEVLLLA  295 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~  295 (577)
                      .++|++.+.||+|+||.||+|... +++.||||++......                          ....+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            368999999999999999999964 6889999998754321                          1235789999999


Q ss_pred             hcCCCCeEEEEeEEEc--CCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccC
Q 008108          296 RLQHRNLVRLLGFCLE--RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLK  373 (577)
Q Consensus       296 ~l~h~niv~l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk  373 (577)
                      +++||||+++++++.+  ....++||||+++++|.+++    ....+++..++.++.||+.||.|||+++   |+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            9999999999999987  56789999999999998875    3457999999999999999999999998   9999999


Q ss_pred             CCcEEEcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCC---CCccccEEecchhHhHHhhCCCCCCC
Q 008108          374 ASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR---FSVKSDIFSFGVLVLEIVSGQKRSSF  450 (577)
Q Consensus       374 p~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvil~elltG~~p~~~  450 (577)
                      |+|||++.++.+||+|||+++.......  ......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||..
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            9999999999999999999987654322  123357999999999987665   37889999999999999999999864


Q ss_pred             CCccccchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          451 GTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       451 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ......   ......    ... ..  +. ......   .+.+++.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~---~~~~~~----~~~-~~--~~-~~~~~~---~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          243 ERIMCL---HSKIKS----QAL-EF--PD-QPDIAE---DLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SSHHHH---HHHHHH----CCC-CC--CS-SSCCCH---HHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccHHHH---HHHHhc----ccC-CC--CC-ccccCH---HHHHHHHHHhhcChhhCCCHHHHhc
Confidence            332211   111100    000 00  00 111222   3556778999999999999999864

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.2e-42  Score=355.33  Aligned_cols=252  Identities=24%  Similarity=0.357  Sum_probs=198.2

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC-------
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERK-------  313 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  313 (577)
                      .++|++.++||+|+||.||+|... +|+.||||++..... .....+.+|+.++++++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            467999999999999999999975 799999999975443 34557899999999999999999999986543       


Q ss_pred             --------------------------------------------------eEEEEEEecCCCCcccccccCCCCCCCCHH
Q 008108          314 --------------------------------------------------ERILVYEFVPNASLDHFIFDPINREHMTWE  343 (577)
Q Consensus       314 --------------------------------------------------~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~  343 (577)
                                                                        ..++||||+++++|.+++.........++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              279999999999999998765555667888


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc----------ccccccccCCC
Q 008108          344 KRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH----------SDTNRVVGTFG  413 (577)
Q Consensus       344 ~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~----------~~~~~~~gt~~  413 (577)
                      .++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            89999999999999999998   999999999999999999999999999876643211          12234579999


Q ss_pred             CcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHH
Q 008108          414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIH  493 (577)
Q Consensus       414 y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~  493 (577)
                      |+|||++.+..++.++||||||+++|||++|..|+.     ........    ........        ........+.+
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~----~~~~~~~~--------~~~~~~~~~~~  304 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITD----VRNLKFPL--------LFTQKYPQEHM  304 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHH----HHTTCCCH--------HHHHHCHHHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHH----hhccCCCc--------ccccCChhHHH
Confidence            999999999999999999999999999999876431     11111111    11110000        01122234567


Q ss_pred             HHHhcccCCCCCCCCHHHHHH
Q 008108          494 IGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       494 l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ++..||+.||++|||+.|+++
T Consensus       305 li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          305 MVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCCCCcCCCHHHHhh
Confidence            888999999999999999986

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=5e-42  Score=357.30  Aligned_cols=246  Identities=26%  Similarity=0.353  Sum_probs=195.6

Q ss_pred             cccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCCCC
Q 008108          248 DANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNAS  326 (577)
Q Consensus       248 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs  326 (577)
                      ..+.||+|+||.||+|.. .+|+.||+|++.........++.+|+.++++++||||+++++++.+.+..+|||||+++++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            357899999999999996 4689999999988776667789999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEE--cCCCCeEEeccCCcccccCCCcccc
Q 008108          327 LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL--DSEMNPKISDFGMARLFEMDQTHSD  404 (577)
Q Consensus       327 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl--~~~~~~kl~DfGla~~~~~~~~~~~  404 (577)
                      |.+++.+  ....+++..++.++.||+.||.|||+.+   |+||||||+|||+  +.++.+||+|||+++.......   
T Consensus       173 L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---  244 (373)
T 2x4f_A          173 LFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---  244 (373)
T ss_dssp             EHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred             HHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence            9888753  3456999999999999999999999998   9999999999999  5677899999999987654322   


Q ss_pred             ccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccc-hhhhhhhhhcccCCccccccCcCCCC
Q 008108          405 TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE-DLLTYAWRNWNEGAALNLMDPTMRGG  483 (577)
Q Consensus       405 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~  483 (577)
                      .....||+.|+|||++..+.++.++||||||+++|||++|+.||......+.. .++..   .+..       .+.....
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~---~~~~-------~~~~~~~  314 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC---RWDL-------EDEEFQD  314 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT---CCCS-------CSGGGTT
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---cCCC-------Chhhhcc
Confidence            22357999999999999899999999999999999999999998654432211 11111   1100       0000011


Q ss_pred             ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          484 STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       484 ~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ..   ..+.+++..|++.||++|||+.|+++
T Consensus       315 ~~---~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          315 IS---EEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             SC---HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CC---HHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            12   24557788999999999999999986

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5e-42  Score=345.10  Aligned_cols=261  Identities=23%  Similarity=0.333  Sum_probs=198.2

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      ++|+..++||+|+||+||+|... +++.||||++....  ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57899999999999999999965 68999999997543  2334568899999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |++++.+..+. .  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~l~~~~~-~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQDLKKYFD-S--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHH-H--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCCCHHHHHH-h--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            99874444433 2  3467999999999999999999999998   9999999999999999999999999998765322


Q ss_pred             ccccccccccCCCCcChhhhhcCC-CCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhccc---CCccc--
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNE---GAALN--  474 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~--  474 (577)
                        .......||+.|+|||++.+.. ++.++||||||+++|||++|+.|+......  .+.+.........   ..+..  
T Consensus       156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHhCCCChhhhhhhc
Confidence              2223457899999999998766 899999999999999999999886433321  1122211111100   00000  


Q ss_pred             -ccc----------CcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          475 -LMD----------PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       475 -~~d----------~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                       ..+          ..+..........+.+++..|++.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence             000          0000001112234557788999999999999999885

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6.1e-42  Score=340.32  Aligned_cols=253  Identities=28%  Similarity=0.442  Sum_probs=194.1

Q ss_pred             hcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCCh----hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSK----QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      .++|+..++||+|+||.||+|... ++.||||++.....    .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            367999999999999999999974 88999999876432    2245688999999999999999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC--------CCCeEEecc
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS--------EMNPKISDF  390 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~--------~~~~kl~Df  390 (577)
                      |||+++++|.+++.    ...+++..++.++.|++.||.|||+++..+|+||||||+|||++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999998873    457999999999999999999999987556999999999999986        678999999


Q ss_pred             CCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccC
Q 008108          391 GMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEG  470 (577)
Q Consensus       391 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  470 (577)
                      |+++......    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..........      ......
T Consensus       161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~~~~  230 (271)
T 3dtc_A          161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY------GVAMNK  230 (271)
T ss_dssp             CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH------HHHTSC
T ss_pred             Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------hhhcCC
Confidence            9998654322    223578999999999999999999999999999999999999986433221111      010010


Q ss_pred             CccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          471 AALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       471 ~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .     ........+.   .+.+++..|++.||++|||+.|+++.|+.
T Consensus       231 ~-----~~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          231 L-----ALPIPSTCPE---PFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             C-----CCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             C-----CCCCCcccCH---HHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            0     0111111222   45577789999999999999999999864

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.5e-42  Score=351.81  Aligned_cols=259  Identities=17%  Similarity=0.211  Sum_probs=207.0

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      .++|++.++||+|+||+||+|.. .+|+.||||++......  ..+.+|+.+++++ +||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS--CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            46799999999999999999995 57899999998755332  2578999999999 99999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCC-----eEEeccCCccc
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN-----PKISDFGMARL  395 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~-----~kl~DfGla~~  395 (577)
                      |+ +++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.     +||+|||+++.
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 99999988542  457999999999999999999999998   999999999999998887     99999999987


Q ss_pred             ccCCCccc-----cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccC
Q 008108          396 FEMDQTHS-----DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEG  470 (577)
Q Consensus       396 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  470 (577)
                      +.......     ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+......-...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  239 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT  239 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence            65433211     1235689999999999999999999999999999999999999997654433332222211100000


Q ss_pred             CccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          471 AALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       471 ~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                       ..+    .+....+    .+.+++..|++.+|.+||++.+|++.|+.
T Consensus       240 -~~~----~~~~~~p----~~~~li~~~l~~~p~~RP~~~~l~~~l~~  278 (330)
T 2izr_A          240 -PIE----VLCENFP----EMATYLRYVRRLDFFEKPDYDYLRKLFTD  278 (330)
T ss_dssp             -CHH----HHTTTCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             -CHH----HHhccCh----HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence             000    0011112    56678889999999999999999998863

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=358.88  Aligned_cols=250  Identities=26%  Similarity=0.331  Sum_probs=197.4

Q ss_pred             HHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeE
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKER  315 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  315 (577)
                      ...++|++.++||+|+||+||++... +|+.||||++.+..   ......+.+|..++..+ +||||+++++++.+.+..
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            34578999999999999999999965 68999999997642   23344578899999988 799999999999999999


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      ++||||+++|+|..++..   ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.
T Consensus       100 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceee
Confidence            999999999999988843   467999999999999999999999998   99999999999999999999999999985


Q ss_pred             ccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccc
Q 008108          396 FEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNL  475 (577)
Q Consensus       396 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  475 (577)
                      .....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+   ..    +.    
T Consensus       174 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i---~~----~~----  240 (353)
T 3txo_A          174 GICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI---LN----DE----  240 (353)
T ss_dssp             SCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH----CC----
T ss_pred             cccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH---Hc----CC----
Confidence            43222  2233468999999999999999999999999999999999999998754433221111   11    00    


Q ss_pred             ccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCH------HHHHH
Q 008108          476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGM------ASVVN  514 (577)
Q Consensus       476 ~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~------~ev~~  514 (577)
                        .........   .+..++..|++.||++||++      .|+++
T Consensus       241 --~~~p~~~~~---~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          241 --VVYPTWLHE---DATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             --CCCCTTSCH---HHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             --CCCCCCCCH---HHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence              001111222   34567779999999999998      66664

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1e-41  Score=343.44  Aligned_cols=261  Identities=15%  Similarity=0.224  Sum_probs=207.4

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      .++|++.+.||+|+||.||+|.. .+++.||||++......  ..+.+|+.++..+ +|+|++++++++.+....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc--HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            46799999999999999999995 57899999998654322  2478899999999 89999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCC-----eEEeccCCccc
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN-----PKISDFGMARL  395 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~-----~kl~DfGla~~  395 (577)
                      |+ +++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.     +||+|||+++.
T Consensus        87 ~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           87 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            99 9999999854  2346999999999999999999999988   999999999999987776     99999999987


Q ss_pred             ccCCCcc-----ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccC
Q 008108          396 FEMDQTH-----SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEG  470 (577)
Q Consensus       396 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  470 (577)
                      .......     .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+..........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  240 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence            6543322     12344679999999999999999999999999999999999999997654333322222211111000


Q ss_pred             CccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCC
Q 008108          471 AALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD  519 (577)
Q Consensus       471 ~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~  519 (577)
                      ...+     +....+   ..+.+++..|++.||++||++.+|++.|+..
T Consensus       241 ~~~~-----~~~~~~---~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~  281 (298)
T 1csn_A          241 PLRE-----LCAGFP---EEFYKYMHYARNLAFDATPDYDYLQGLFSKV  281 (298)
T ss_dssp             CHHH-----HTTTSC---HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             cHHH-----HHhhCc---HHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence            0000     011112   2455777899999999999999999999753

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=6.6e-42  Score=365.44  Aligned_cols=250  Identities=26%  Similarity=0.409  Sum_probs=201.6

Q ss_pred             HhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC-eEEEEEE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK-ERILVYE  320 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~E  320 (577)
                      ..++|+..++||+|+||.||+|... |+.||||+++...  ....|.+|+.+|++++||||+++++++.+.+ ..++|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            3467889999999999999999985 7899999997654  3457899999999999999999999987765 7899999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |+++|+|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++..... 
T Consensus       268 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  342 (450)
T ss_dssp             CCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             ecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence            99999999998542 2345899999999999999999999998   999999999999999999999999999854321 


Q ss_pred             ccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                          .....++..|+|||++.++.++.++||||||+++|||+| |+.|+......+....+.       .+..     ..
T Consensus       343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-------~~~~-----~~  406 (450)
T 1k9a_A          343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGYK-----MD  406 (450)
T ss_dssp             --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-------TTCC-----CC
T ss_pred             ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCC-----CC
Confidence                112357889999999999999999999999999999999 999886544332221111       1110     01


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .....+.   .+.+++..||+.||++|||+.++++.|+.
T Consensus       407 ~p~~~~~---~l~~li~~cl~~dp~~Rpt~~~l~~~L~~  442 (450)
T 1k9a_A          407 APDGCPP---AVYDVMKNCWHLDAATRPTFLQLREQLEH  442 (450)
T ss_dssp             CCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCcCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            1111223   44567789999999999999999999864

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5.7e-42  Score=344.08  Aligned_cols=263  Identities=24%  Similarity=0.384  Sum_probs=197.6

Q ss_pred             cCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChh--hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ++|+..++||+|+||+||+|...+|+.||+|++......  ....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            578999999999999999999988999999999755322  235678999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++ +|.+++..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence            986 88777643  2457999999999999999999999998   99999999999999999999999999987643221


Q ss_pred             cccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhh-----hhcccCCcccc
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAW-----RNWNEGAALNL  475 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~-----~~~~~~~~~~~  475 (577)
                        ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......+....+....     ..|........
T Consensus       156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T 1ob3_A          156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence              22235789999999998764 58999999999999999999999986544322111110000     00110000011


Q ss_pred             ccCcCCCC--------ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          476 MDPTMRGG--------STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       476 ~d~~l~~~--------~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .++.+...        .......+.+++..|++.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            11111100        0011234557788999999999999999875

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6.8e-42  Score=351.06  Aligned_cols=259  Identities=27%  Similarity=0.406  Sum_probs=207.3

Q ss_pred             HhcCCccccccccCCcEEEEEeEe--------cCCcEEEEEEeccCCh-hhHHHHHHHHHHHHhc-CCCCeEEEEeEEEc
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGML--------SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNLVRLLGFCLE  311 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  311 (577)
                      ..++|++.+.||+|+||.||+|..        .+++.||||++..... .....+.+|+.+++++ +||||+++++++.+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            457899999999999999999985        3467899999976543 3445688999999999 89999999999999


Q ss_pred             CCeEEEEEEecCCCCcccccccCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEE
Q 008108          312 RKERILVYEFVPNASLDHFIFDPIN-------------REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNIL  378 (577)
Q Consensus       312 ~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiL  378 (577)
                      .+..++||||+++|+|.+++.....             ...+++..++.++.||+.||.|||+.+   |+||||||+|||
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence            9999999999999999999865321             235899999999999999999999998   999999999999


Q ss_pred             EcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccc
Q 008108          379 LDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETE  457 (577)
Q Consensus       379 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~  457 (577)
                      ++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+......+..
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  269 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  269 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence            99999999999999987665443333444567889999999999999999999999999999999 98888654332221


Q ss_pred             hhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          458 DLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       458 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ..+.   .    +..     +........   .+.+++..||+.+|++|||+.|+++.|+.
T Consensus       270 ~~~~---~----~~~-----~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~  315 (334)
T 2pvf_A          270 KLLK---E----GHR-----MDKPANCTN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDR  315 (334)
T ss_dssp             HHHH---H----TCC-----CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHh---c----CCC-----CCCCccCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            1111   1    100     011111222   45567789999999999999999999875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.6e-42  Score=351.94  Aligned_cols=262  Identities=25%  Similarity=0.375  Sum_probs=206.5

Q ss_pred             HHhcCCccccccccCCcEEEEEeEe------cCCcEEEEEEeccCC-hhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcC
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLER  312 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  312 (577)
                      ...++|+..+.||+|+||.||+|..      .+++.||||++.... ......+.+|+.++.++ +||||+++++++...
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            3457899999999999999999985      245689999997543 22345688999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCCcccccccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEecc
Q 008108          313 KERILVYEFVPNASLDHFIFDPIN--------------------REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDL  372 (577)
Q Consensus       313 ~~~~lv~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDl  372 (577)
                      +..++||||+++|+|.+++.....                    ...+++..++.++.||+.||.|||+++   |+||||
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di  198 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL  198 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence            999999999999999998865321                    134899999999999999999999998   999999


Q ss_pred             CCCcEEEcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCC
Q 008108          373 KASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFG  451 (577)
Q Consensus       373 kp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~  451 (577)
                      ||+||||+.++.+||+|||+++...............||+.|+|||.+.++.++.++||||||+++|||+| |+.||...
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            99999999999999999999987655443333444677889999999999999999999999999999998 99888654


Q ss_pred             CccccchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCC
Q 008108          452 TEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD  519 (577)
Q Consensus       452 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~  519 (577)
                      .....  ......    .+.     .+......+.   .+..++..||+.||++|||+.||++.|+..
T Consensus       279 ~~~~~--~~~~~~----~~~-----~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  332 (344)
T 1rjb_A          279 PVDAN--FYKLIQ----NGF-----KMDQPFYATE---EIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ  332 (344)
T ss_dssp             CCSHH--HHHHHH----TTC-----CCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CcHHH--HHHHHh----cCC-----CCCCCCCCCH---HHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            32211  111111    110     0111111222   455677899999999999999999999753

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.7e-42  Score=347.50  Aligned_cols=264  Identities=26%  Similarity=0.416  Sum_probs=200.8

Q ss_pred             cCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecC
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVP  323 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  323 (577)
                      ++|++.+.||+|+||+||++... ++.||||++....  ....+.+|+.++++++||||+++++++.+  ..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            57889999999999999999875 7889999986543  34568999999999999999999998874  4799999999


Q ss_pred             CCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCC-eEEeccCCcccccCCCcc
Q 008108          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN-PKISDFGMARLFEMDQTH  402 (577)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~-~kl~DfGla~~~~~~~~~  402 (577)
                      +++|.+++........+++..++.++.||++||.|||+.+..+|+||||||+|||++.++. +||+|||++......   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999865444446899999999999999999999943234999999999999998887 799999999765422   


Q ss_pred             ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCC
Q 008108          403 SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG  482 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  482 (577)
                        .....||+.|+|||++.+..++.++||||||+++|||++|+.||........ ..   .+... .+..     +.+..
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~---~~~~~-~~~~-----~~~~~  227 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-RI---MWAVH-NGTR-----PPLIK  227 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-HH---HHHHH-TTCC-----CCCBT
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-HH---HHHHh-cCCC-----CCccc
Confidence              2234699999999999999999999999999999999999999864332211 11   11111 1111     11111


Q ss_pred             CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCCCCCCCCCCCCc
Q 008108          483 GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKPA  530 (577)
Q Consensus       483 ~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~~~~~~~p~~p~  530 (577)
                      ..+.   .+.+++..|++.||++|||+.|+++.|+.....++.+..|.
T Consensus       228 ~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~  272 (307)
T 2eva_A          228 NLPK---PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL  272 (307)
T ss_dssp             TCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCC
T ss_pred             ccCH---HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcc
Confidence            2222   34567789999999999999999999987555555544444

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.1e-42  Score=363.60  Aligned_cols=260  Identities=20%  Similarity=0.265  Sum_probs=205.1

Q ss_pred             hHHHHHHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEc
Q 008108          236 FETIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLE  311 (577)
Q Consensus       236 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  311 (577)
                      +..++...++|++.++||+|+||+||++... +++.||+|++.+...   .....+.+|+.++..++||||+++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            3445556789999999999999999999965 588999999965321   112247889999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccC
Q 008108          312 RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG  391 (577)
Q Consensus       312 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfG  391 (577)
                      .+..++||||+++|+|.+++.    +..+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG  213 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMS----NYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG  213 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence            999999999999999999874    346999999999999999999999998   9999999999999999999999999


Q ss_pred             CcccccCCCccccccccccCCCCcChhhhhcCC----CCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhc
Q 008108          392 MARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR----FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNW  467 (577)
Q Consensus       392 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~  467 (577)
                      +++....... .......||+.|+|||++....    ++.++|||||||++|||++|+.||...........+.......
T Consensus       214 ~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~  292 (410)
T 3v8s_A          214 TCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL  292 (410)
T ss_dssp             TCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred             eeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc
Confidence            9987654322 1233468999999999998765    7899999999999999999999997544332222111100000


Q ss_pred             ccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 008108          468 NEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSN--RPGMASVVNM  515 (577)
Q Consensus       468 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~--RPt~~ev~~~  515 (577)
                      .        -|. ......   .+.+++..|++.+|++  ||++.||++-
T Consensus       293 ~--------~p~-~~~~s~---~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          293 T--------FPD-DNDISK---EAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             C--------CCT-TCCCCH---HHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             c--------CCC-cccccH---HHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            0        000 001223   3446667899999988  9999999864

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.2e-42  Score=355.14  Aligned_cols=254  Identities=24%  Similarity=0.292  Sum_probs=200.7

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC-----hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS-----KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  316 (577)
                      .++|++.+.||+|+||+||++... +|+.||||++....     ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            357999999999999999999864 68999999986432     123567899999999999999999999999999999


Q ss_pred             EEEEecCCCCcccccccCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCC---eEEeccCC
Q 008108          317 LVYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN---PKISDFGM  392 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~---~kl~DfGl  392 (577)
                      +||||+++++|.+++.... ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999987774422 2345899999999999999999999998   999999999999987655   99999999


Q ss_pred             cccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCc
Q 008108          393 ARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAA  472 (577)
Q Consensus       393 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  472 (577)
                      ++.......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....    .+.....    .+..
T Consensus       180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~i~----~~~~  249 (351)
T 3c0i_A          180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFEGII----KGKY  249 (351)
T ss_dssp             CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHHHHH----HTCC
T ss_pred             eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHHHHH----cCCC
Confidence            987654322  22345799999999999999999999999999999999999999864321    1111111    0100


Q ss_pred             cccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       473 ~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .  +++.......   ..+.+++..|++.||++|||+.|+++
T Consensus       250 ~--~~~~~~~~~s---~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          250 K--MNPRQWSHIS---ESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             C--CCHHHHTTSC---HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             C--CCccccccCC---HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0  0000000112   24557778999999999999999985

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8e-43  Score=356.85  Aligned_cols=270  Identities=26%  Similarity=0.391  Sum_probs=207.5

Q ss_pred             cCCccccccccCCcEEEEEeEe-----cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEE--cCCeEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-----SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL--ERKERI  316 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~  316 (577)
                      ++|+..++||+|+||.||++.+     .+++.||||++..........+.+|+.++++++||||+++++++.  +....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            6789999999999999999983     468899999998877776777999999999999999999999987  455689


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccc
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~  396 (577)
                      +||||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       103 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEeecCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence            99999999999998853  2346999999999999999999999988   999999999999999999999999999876


Q ss_pred             cCCCcc-ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccc
Q 008108          397 EMDQTH-SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNL  475 (577)
Q Consensus       397 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  475 (577)
                      ...... .......||..|+|||++.+..++.++||||||+++|||++|+.|+......... ...............+.
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-MMGCERDVPALSRLLEL  256 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HCC----CCHHHHHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-hcccccccccHHHHHHH
Confidence            543322 2233456888999999999999999999999999999999999987532211000 00000000000000001


Q ss_pred             ccCcCCCC-ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCC
Q 008108          476 MDPTMRGG-STSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD  519 (577)
Q Consensus       476 ~d~~l~~~-~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~  519 (577)
                      +....... .......+.+++..|++.||++|||+.|+++.|+..
T Consensus       257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  301 (327)
T 3lxl_A          257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML  301 (327)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred             hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11111000 111223455777899999999999999999999864

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.3e-42  Score=354.26  Aligned_cols=266  Identities=25%  Similarity=0.449  Sum_probs=211.8

Q ss_pred             hHHHHHHhcCCccccccccCCcEEEEEeEec------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeE
Q 008108          236 FETIRVATDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGF  308 (577)
Q Consensus       236 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~  308 (577)
                      .++++...++|++.+.||+|+||.||+|...      +++.||||.+..... .....+.+|+.+++.++||||++++++
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   96 (322)
T 1p4o_A           17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV   96 (322)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            3444566788999999999999999999854      367899999976533 344568899999999999999999999


Q ss_pred             EEcCCeEEEEEEecCCCCcccccccCC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC
Q 008108          309 CLERKERILVYEFVPNASLDHFIFDPI-------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS  381 (577)
Q Consensus       309 ~~~~~~~~lv~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~  381 (577)
                      +.+.+..++||||+++|+|.+++....       ....+++..++.++.||+.||.|||+++   |+||||||+|||++.
T Consensus        97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~  173 (322)
T 1p4o_A           97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAE  173 (322)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECT
T ss_pred             EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcC
Confidence            999999999999999999999885421       1246799999999999999999999998   999999999999999


Q ss_pred             CCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhh
Q 008108          382 EMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLL  460 (577)
Q Consensus       382 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~  460 (577)
                      ++.+||+|||+++...............||+.|+|||++.++.++.++||||||+++|||++ |+.|+........   .
T Consensus       174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~  250 (322)
T 1p4o_A          174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV---L  250 (322)
T ss_dssp             TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH---H
T ss_pred             CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH---H
Confidence            99999999999986654433333334567899999999999999999999999999999999 7777754332221   1


Q ss_pred             hhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCC
Q 008108          461 TYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD  519 (577)
Q Consensus       461 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~  519 (577)
                      ....    .+....     .....+.   .+.+++..|++.||++|||+.|+++.|+..
T Consensus       251 ~~~~----~~~~~~-----~~~~~~~---~l~~li~~~l~~dp~~Rps~~e~l~~L~~~  297 (322)
T 1p4o_A          251 RFVM----EGGLLD-----KPDNCPD---MLFELMRMCWQYNPKMRPSFLEIISSIKEE  297 (322)
T ss_dssp             HHHH----TTCCCC-----CCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             HHHH----cCCcCC-----CCCCCCH---HHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence            1111    111100     1111222   355677899999999999999999999864

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=6.2e-42  Score=347.52  Aligned_cols=260  Identities=24%  Similarity=0.375  Sum_probs=208.8

Q ss_pred             HhcCCccccccccCCcEEEEEeEe------cCCcEEEEEEeccCCh-hhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCC
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNLVRLLGFCLERK  313 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  313 (577)
                      ..++|+..+.||+|+||.||+|..      .+++.||||++..... .....+.+|+.++.++ +||||+++++++.+.+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            446899999999999999999984      3467899999976543 3445689999999999 9999999999999999


Q ss_pred             eEEEEEEecCCCCcccccccCCC---------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEE
Q 008108          314 ERILVYEFVPNASLDHFIFDPIN---------------REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNIL  378 (577)
Q Consensus       314 ~~~lv~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiL  378 (577)
                      ..++||||+++|+|.+++.....               ...+++..++.++.||+.||.|||+++   |+||||||+|||
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence            99999999999999998864321               125999999999999999999999998   999999999999


Q ss_pred             EcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccc
Q 008108          379 LDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETE  457 (577)
Q Consensus       379 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~  457 (577)
                      ++.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+| |+.|+........ 
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-  256 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-  256 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-
Confidence            99999999999999987765444333444567889999999999999999999999999999999 8888764432211 


Q ss_pred             hhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          458 DLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       458 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                       ..........         +......+   ..+.+++..|++.||++|||+.|+++.|+.
T Consensus       257 -~~~~~~~~~~---------~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~ell~~L~~  304 (313)
T 1t46_A          257 -FYKMIKEGFR---------MLSPEHAP---AEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (313)
T ss_dssp             -HHHHHHHTCC---------CCCCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -HHHHhccCCC---------CCCcccCC---HHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence             1111111100         01111122   245577789999999999999999999975

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.5e-42  Score=340.38  Aligned_cols=254  Identities=28%  Similarity=0.448  Sum_probs=206.6

Q ss_pred             hcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      .++|+..+.||+|+||.||++...+++.||+|++...... ...+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            3678899999999999999999888899999999765433 357899999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      ++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++...... .
T Consensus        86 ~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~  159 (267)
T 3t9t_A           86 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-Y  159 (267)
T ss_dssp             TTCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-H
T ss_pred             CCCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc-c
Confidence            99999998854  2456899999999999999999999998   9999999999999999999999999998654321 1


Q ss_pred             ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC
Q 008108          403 SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR  481 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  481 (577)
                      .......+|..|+|||.+.+..++.++||||||+++|||++ |+.|+........   .........         +...
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~i~~~~~---------~~~~  227 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---VEDISTGFR---------LYKP  227 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHHTTCC---------CCCC
T ss_pred             cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH---HHHHhcCCc---------CCCC
Confidence            12223567889999999999999999999999999999999 8888765433221   111111100         0001


Q ss_pred             CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       482 ~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ....   ..+.+++..|++.||++||++.++++.|+.
T Consensus       228 ~~~~---~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  261 (267)
T 3t9t_A          228 RLAS---THVYQIMNHCWRERPEDRPAFSRLLRQLAE  261 (267)
T ss_dssp             TTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ccCc---HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            1112   245577789999999999999999999864

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=8.6e-42  Score=357.12  Aligned_cols=250  Identities=23%  Similarity=0.299  Sum_probs=196.3

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChh---hHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ---GEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  317 (577)
                      .++|++.++||+|+||+||++... +++.||+|++.+....   ....+.+|..++.++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            468999999999999999999965 5788999999765322   223478899999887 89999999999999999999


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      ||||+++|+|..++..   ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus       131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            9999999999888843   467999999999999999999999998   9999999999999999999999999998533


Q ss_pred             CCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccc--hhhhhhhhhcccCCcccc
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE--DLLTYAWRNWNEGAALNL  475 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~~  475 (577)
                      ..  ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+..  ..............    
T Consensus       205 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----  278 (396)
T 4dc2_A          205 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----  278 (396)
T ss_dssp             CT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC----
T ss_pred             cC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc----
Confidence            22  12234578999999999999999999999999999999999999999643321110  00111111111110    


Q ss_pred             ccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCH
Q 008108          476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGM  509 (577)
Q Consensus       476 ~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~  509 (577)
                        ..+......   .+.+++..||+.||++||++
T Consensus       279 --~~~p~~~s~---~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          279 --IRIPRSLSV---KAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             --CCCCTTSCH---HHHHHHHHHTCSCTTTSTTC
T ss_pred             --cCCCCcCCH---HHHHHHHHHhcCCHhHcCCC
Confidence              111111222   44567789999999999996

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.3e-42  Score=355.62  Aligned_cols=251  Identities=25%  Similarity=0.360  Sum_probs=201.3

Q ss_pred             HHHHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCC
Q 008108          239 IRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERK  313 (577)
Q Consensus       239 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  313 (577)
                      .....++|.+.+.||+|+||.||++... +|+.||||++.+..   ......+.+|..++..+ +||||+++++++.+.+
T Consensus        12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~   91 (345)
T 1xjd_A           12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   91 (345)
T ss_dssp             ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence            3455689999999999999999999965 68899999997642   22344577899999887 9999999999999999


Q ss_pred             eEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCc
Q 008108          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (577)
Q Consensus       314 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla  393 (577)
                      ..++||||+++|+|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||++
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a  165 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMC  165 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhh
Confidence            99999999999999998843   457999999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcc
Q 008108          394 RLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAAL  473 (577)
Q Consensus       394 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  473 (577)
                      +......  .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.   .    .   
T Consensus       166 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~---~----~---  233 (345)
T 1xjd_A          166 KENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR---M----D---  233 (345)
T ss_dssp             BCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H----C---
T ss_pred             hhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH---h----C---
Confidence            8643322  22345689999999999999999999999999999999999999986544322211111   0    0   


Q ss_pred             ccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 008108          474 NLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMA-SVV  513 (577)
Q Consensus       474 ~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~-ev~  513 (577)
                         .+.+......   .+.+++..|++.||++||++. ++.
T Consensus       234 ---~~~~p~~~s~---~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          234 ---NPFYPRWLEK---EAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             ---CCCCCTTSCH---HHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ---CCCCCcccCH---HHHHHHHHHhcCCHhHcCCChHHHH
Confidence               0111111222   345677799999999999997 654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=351.41  Aligned_cols=251  Identities=23%  Similarity=0.338  Sum_probs=187.4

Q ss_pred             HhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      ..++|++.+.||+|+||.||+|... +++.||||++....  ....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            3578999999999999999999975 57899999997653  23457899999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC---CCCeEEeccCCccccc
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMARLFE  397 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~---~~~~kl~DfGla~~~~  397 (577)
                      |+++++|.+++.   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+++...
T Consensus       129 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          129 LVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             eCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            999999998884   3456999999999999999999999998   999999999999975   8899999999998654


Q ss_pred             CCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccccc
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD  477 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  477 (577)
                      ...   ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......  .++....    .... ....
T Consensus       203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~i~----~~~~-~~~~  272 (349)
T 2w4o_A          203 HQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMFRRIL----NCEY-YFIS  272 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHHHHHH----TTCC-CCCT
T ss_pred             ccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHHHHHH----hCCC-ccCC
Confidence            322   1233679999999999999999999999999999999999999986443321  1111111    1000 0011


Q ss_pred             CcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          478 PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       478 ~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      +. .....   ..+.+++..|++.||++|||+.|+++
T Consensus       273 ~~-~~~~~---~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          273 PW-WDEVS---LNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             TT-TTTSC---HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ch-hhhCC---HHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11 11122   24557778999999999999999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6e-42  Score=360.38  Aligned_cols=263  Identities=22%  Similarity=0.268  Sum_probs=205.4

Q ss_pred             CChHHHHHHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChh---hHHHHHHHHHHHHhcCCCCeEEEEeEE
Q 008108          234 FDFETIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ---GEIEFKNEVLLLARLQHRNLVRLLGFC  309 (577)
Q Consensus       234 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~  309 (577)
                      +.+.+++...++|++.++||+|+||+||++... +|+.||||++.+....   ....+.+|..++..++||||+++++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            344555666789999999999999999999974 6899999999754221   222478899999999999999999999


Q ss_pred             EcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEec
Q 008108          310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD  389 (577)
Q Consensus       310 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~D  389 (577)
                      .+.+..+|||||+++|+|.+++..  ....+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~D  205 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLAD  205 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHH--HSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEee
Confidence            999999999999999999999853  2347999999999999999999999998   99999999999999999999999


Q ss_pred             cCCcccccCCCccccccccccCCCCcChhhhh-------cCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhh
Q 008108          390 FGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM-------HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTY  462 (577)
Q Consensus       390 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~  462 (577)
                      ||+++....... .......||+.|+|||++.       .+.++.++|||||||++|||++|+.||......+....+..
T Consensus       206 FGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  284 (412)
T 2vd5_A          206 FGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH  284 (412)
T ss_dssp             CTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred             chhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            999987654322 1223468999999999997       35689999999999999999999999975443332211111


Q ss_pred             hhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCC---CCHHHHHH
Q 008108          463 AWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNR---PGMASVVN  514 (577)
Q Consensus       463 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~R---Pt~~ev~~  514 (577)
                      ....+.        -|......+.   .+.+++..|++ +|++|   |++.|+++
T Consensus       285 ~~~~~~--------~p~~~~~~s~---~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          285 YKEHLS--------LPLVDEGVPE---EARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HHHHCC--------CC----CCCH---HHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             cccCcC--------CCccccCCCH---HHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            000010        0111112223   34466779998 99998   58888875

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.5e-41  Score=345.98  Aligned_cols=263  Identities=25%  Similarity=0.401  Sum_probs=187.8

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChh-hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      .++|+..++||+|+||.||+|... +|+.||+|++...... ....+.+|+.++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467999999999999999999864 6899999999755432 33467899999999999999999999999999999999


Q ss_pred             ecCCCCcccccccC---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          321 FVPNASLDHFIFDP---INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       321 ~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      |++ ++|.+++...   .....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 5888877432   12245999999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCccccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhh--------hhhcc
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA--------WRNWN  468 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~  468 (577)
                      ....  ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......+....+...        |....
T Consensus       160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            3221  22335789999999998764 6899999999999999999999998755443222111110        00000


Q ss_pred             c-------------CCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          469 E-------------GAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       469 ~-------------~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .             ....+.+.+.......   ..+.+++..|++.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLD---GNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCC---HHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhcccccccccchhHHHhhcccccccCC---HHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            0             0000011111111112   24567888999999999999998874

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.8e-42  Score=353.77  Aligned_cols=245  Identities=20%  Similarity=0.335  Sum_probs=198.4

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|.+.+.||+|+||.||+|.. .+++.||||++.....   .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            6799999999999999999996 5789999999865421   22346889999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+ +|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        89 E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           89 EYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             CCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             ECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            999 6788777743   467999999999999999999999998   999999999999999999999999999876543


Q ss_pred             CccccccccccCCCCcChhhhhcCCC-CccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRF-SVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      ..   .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||...........+.       ...      .
T Consensus       162 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~-------~~~------~  225 (336)
T 3h4j_B          162 NF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN-------SCV------Y  225 (336)
T ss_dssp             BT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCC-------SSC------C
T ss_pred             cc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHH-------cCC------C
Confidence            22   233579999999999987776 689999999999999999999986433222111110       000      0


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .+....+.   .+.+++..|++.||++|||+.|+++
T Consensus       226 ~~p~~~s~---~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          226 VMPDFLSP---GAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             CCCTTSCH---HHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             CCcccCCH---HHHHHHHHHcCCChhHCcCHHHHHh
Confidence            01111222   3456778999999999999999875

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=8.3e-42  Score=355.98  Aligned_cols=250  Identities=23%  Similarity=0.339  Sum_probs=202.3

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      .++|++.+.||+|+||.||++... +++.||+|++.+..   ......+.+|+.+|+.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            367999999999999999999965 58899999986542   23345688999999999999999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+++|+|..++.   ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++....
T Consensus        94 ~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             ECCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            99999999999884   3557999999999999999999999998   99999999999999999999999999987653


Q ss_pred             CCccccccccccCCCCcChhhhhc---CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccc
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMH---GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNL  475 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  475 (577)
                      ..   ......||+.|+|||++..   ..++.++|||||||++|||++|+.||..........++.......        
T Consensus       168 ~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~--------  236 (384)
T 4fr4_A          168 ET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV--------  236 (384)
T ss_dssp             TC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC--------
T ss_pred             CC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc--------
Confidence            32   2334689999999999864   458999999999999999999999997554433333322211100        


Q ss_pred             ccCcCCCCChHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 008108          476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPG-MASVVN  514 (577)
Q Consensus       476 ~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt-~~ev~~  514 (577)
                        ........   ..+..++..||+.||++||+ +.+|.+
T Consensus       237 --~~~p~~~s---~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          237 --VTYPSAWS---QEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             --CCCCTTSC---HHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             --cCCCCcCC---HHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence              00111122   24557778999999999998 777664

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=351.15  Aligned_cols=252  Identities=20%  Similarity=0.329  Sum_probs=193.9

Q ss_pred             hcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCC--CCeEEEEeEEEcCCeEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQH--RNLVRLLGFCLERKERILV  318 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv  318 (577)
                      .++|++.++||+|+||.||++...+++.||||++....  ......+.+|+.++.+++|  +||+++++++.+....++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            46799999999999999999998889999999987543  3344578999999999976  9999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      || +.+++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+ ++.+||+|||+++....
T Consensus        88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            99 568899998843   567999999999999999999999998   99999999999997 57899999999987765


Q ss_pred             CCccccccccccCCCCcChhhhhc-----------CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhc
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMH-----------GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNW  467 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~  467 (577)
                      ...........||+.|+|||++.+           +.++.++||||||+++|||++|+.||.......     .......
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~~~  234 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLHAII  234 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHHH
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-----HHHHHHh
Confidence            443333445689999999999875           678999999999999999999999986432211     1111111


Q ss_pred             ccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          468 NEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       468 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      ......     .......   ..+.+++..||+.||++|||+.|+++.
T Consensus       235 ~~~~~~-----~~~~~~~---~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          235 DPNHEI-----EFPDIPE---KDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             CTTSCC-----CCCCCSC---HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCccc-----CCcccCC---HHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            111000     0111112   245577789999999999999999864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.9e-42  Score=343.72  Aligned_cols=250  Identities=24%  Similarity=0.426  Sum_probs=201.9

Q ss_pred             hcCCccccccccCCcEEEEEeEecC-C-------cEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSN-G-------ETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE  314 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  314 (577)
                      .++|.+.+.||+|+||+||+|.... +       ..||+|++..........+.+|+.++++++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            4678999999999999999998543 3       4799999987776677789999999999999999999999999999


Q ss_pred             EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCC--------eE
Q 008108          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN--------PK  386 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~--------~k  386 (577)
                      .++||||+++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.        +|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence            9999999999999999854  2345999999999999999999999998   999999999999998887        99


Q ss_pred             EeccCCcccccCCCccccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhh
Q 008108          387 ISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWR  465 (577)
Q Consensus       387 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~  465 (577)
                      |+|||++......      ....||+.|+|||++.+ ..++.++||||||+++|||++|..|+........  .... ..
T Consensus       162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~--~~~~-~~  232 (289)
T 4fvq_A          162 LSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR--KLQF-YE  232 (289)
T ss_dssp             ECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHH-HH
T ss_pred             eccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH--HHHH-hh
Confidence            9999999754321      22468999999999987 6799999999999999999997666543322211  1110 00


Q ss_pred             hcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCC
Q 008108          466 NWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD  519 (577)
Q Consensus       466 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~  519 (577)
                        ....        +......   .+.+++..||+.||++|||+.|+++.|+.-
T Consensus       233 --~~~~--------~~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~l~~l  273 (289)
T 4fvq_A          233 --DRHQ--------LPAPKAA---ELANLINNCMDYEPDHRPSFRAIIRDLNSL  273 (289)
T ss_dssp             --TTCC--------CCCCSSC---TTHHHHHHHSCSSGGGSCCHHHHHHHHHTC
T ss_pred             --ccCC--------CCCCCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence              0000        0001111   244677899999999999999999999864

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=9.9e-42  Score=347.24  Aligned_cols=245  Identities=25%  Similarity=0.336  Sum_probs=201.0

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      .++|++.+.||+|+||+||++... +|+.||+|++.+..   ......+.+|..+++.++||||+++++++.+....++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            367999999999999999999965 68999999997642   12344678899999999999999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+++|+|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            999999999998843   457999999999999999999999988   99999999999999999999999999986542


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                           ......||+.|+|||++.+..++.++||||||+++|||++|+.||........   ......    ..      .
T Consensus       159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~----~~------~  220 (318)
T 1fot_A          159 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT---YEKILN----AE------L  220 (318)
T ss_dssp             -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHH----CC------C
T ss_pred             -----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HHHHHh----CC------C
Confidence                 22346799999999999999999999999999999999999999865433221   111110    00      0


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRP-----GMASVVN  514 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RP-----t~~ev~~  514 (577)
                      .+......   .+.+++..|++.||++||     ++.|+++
T Consensus       221 ~~p~~~~~---~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          221 RFPPFFNE---DVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             CCCTTSCH---HHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCCCH---HHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            11111222   345677799999999999     8888874

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.3e-42  Score=348.94  Aligned_cols=262  Identities=27%  Similarity=0.424  Sum_probs=201.4

Q ss_pred             cCCccccccccCCcEEEEEeEe-----cCCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC--CeE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-----SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KER  315 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  315 (577)
                      +.|+..++||+|+||.||++.+     .+++.||||++.... ......+.+|+.++++++||||+++++++.+.  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            5588899999999999999983     468899999997543 33445789999999999999999999999876  668


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      ++||||+++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       101 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence            999999999999998843  3456999999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCcc-ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccc--------cchhhhhhhhh
Q 008108          396 FEMDQTH-SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEE--------TEDLLTYAWRN  466 (577)
Q Consensus       396 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~--------~~~l~~~~~~~  466 (577)
                      ....... .......||..|+|||.+.+..++.++||||||+++|||++|+.|+.......        ...........
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT  255 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence            6644322 22334578889999999999999999999999999999999998753211000        00000000011


Q ss_pred             cccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          467 WNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       467 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ...+.     ........+   ..+.+++..||+.||++|||+.|++++|+.
T Consensus       256 ~~~~~-----~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          256 LKEGK-----RLPCPPNCP---DEVYQLMRKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             HHTTC-----CCCCCTTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HhccC-----CCCCCCCCC---HHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            11110     001111122   345577889999999999999999999863

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.7e-42  Score=345.06  Aligned_cols=257  Identities=28%  Similarity=0.453  Sum_probs=209.7

Q ss_pred             HHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ...++|++.++||+|+||.||+|... +++.||+|.+..... ....+.+|+.++++++||||+++++++.+.+..++||
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST-HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            45678999999999999999999975 488899999976543 3457889999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++++|.+++.. .....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        89 e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           89 EFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             ECCTTEEHHHHHHH-CCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             EcCCCCcHHHHHHh-cccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            99999999998854 23456999999999999999999999998   999999999999999999999999999876543


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      .. .......+|+.|+|||.+.+..++.++||||||+++|||++ |..|+...........+..   ...         .
T Consensus       165 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~---~~~---------~  231 (288)
T 3kfa_A          165 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYR---------M  231 (288)
T ss_dssp             SS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT---TCC---------C
T ss_pred             cc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc---cCC---------C
Confidence            32 22233567889999999999999999999999999999999 8888765443332222211   100         0


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ......+   ..+.+++..|++.||++|||+.|+++.|+.
T Consensus       232 ~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~~~~~l~~  268 (288)
T 3kfa_A          232 ERPEGCP---EKVYELMRACWQWNPSDRPSFAEIHQAFET  268 (288)
T ss_dssp             CCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCC---HHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence            1111122   245577789999999999999999999864

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.5e-42  Score=352.32  Aligned_cols=254  Identities=23%  Similarity=0.356  Sum_probs=191.4

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCe----
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE----  314 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  314 (577)
                      .++|++.++||+|+||.||++.. .+++.||||++.....   .....+.+|+.++.+++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46899999999999999999995 5789999999976532   233468899999999999999999999876543    


Q ss_pred             EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      .++||||+++++|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            4999999999999998843   457999999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCcc-ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcc
Q 008108          395 LFEMDQTH-SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAAL  473 (577)
Q Consensus       395 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  473 (577)
                      ........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||........   .   +.........
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~---~---~~~~~~~~~~  238 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV---A---YQHVREDPIP  238 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---H---HHHHHCCCCC
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH---H---HHHhcCCCCC
Confidence            76543221 223346799999999999999999999999999999999999999865433221   1   1111111000


Q ss_pred             ccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          474 NLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       474 ~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .   .......+   ..+.+++..||+.||++||+..+++.
T Consensus       239 ~---~~~~~~~~---~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          239 P---SARHEGLS---ADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             H---HHHSTTCC---HHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             c---ccccCCCC---HHHHHHHHHHHhcCHhhChhhHHHHH
Confidence            0   00001112   24557778999999999997666553

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=7.8e-42  Score=347.24  Aligned_cols=272  Identities=28%  Similarity=0.416  Sum_probs=214.8

Q ss_pred             ccCCCChHHHHHHhcCCccccccccCCcEEEEEeEe------cCCcEEEEEEeccCCh-hhHHHHHHHHHHHHhc-CCCC
Q 008108          230 KSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRN  301 (577)
Q Consensus       230 ~~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~n  301 (577)
                      ....++........++|++.+.||+|+||.||+|..      .+++.||||++..... .....+.+|+.++.++ +|||
T Consensus        13 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~   92 (316)
T 2xir_A           13 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN   92 (316)
T ss_dssp             GGSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred             hhccccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCC
Confidence            344566777777789999999999999999999974      3468899999976543 3345688999999999 7999


Q ss_pred             eEEEEeEEEcCC-eEEEEEEecCCCCcccccccCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcE
Q 008108          302 LVRLLGFCLERK-ERILVYEFVPNASLDHFIFDPIN-------------REHMTWEKRYKIIEGIARGLLYLHEDSRLRI  367 (577)
Q Consensus       302 iv~l~~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~i  367 (577)
                      |+++++++...+ ..++||||+++++|.+++.....             +..+++..++.++.||+.||.|||+.+   |
T Consensus        93 iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i  169 (316)
T 2xir_A           93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---C  169 (316)
T ss_dssp             BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred             eeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence            999999987755 48999999999999999865322             223899999999999999999999998   9


Q ss_pred             EEeccCCCcEEEcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCC
Q 008108          368 IHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQK  446 (577)
Q Consensus       368 iHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~  446 (577)
                      +||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||+| |+.
T Consensus       170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~  249 (316)
T 2xir_A          170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS  249 (316)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999987654443333444678899999999999999999999999999999998 888


Q ss_pred             CCCCCCccccchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          447 RSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       447 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      |+.......  .+...    ...+..     ........   ..+.+++..||+.||++|||+.||++.|+.
T Consensus       250 p~~~~~~~~--~~~~~----~~~~~~-----~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~ell~~L~~  307 (316)
T 2xir_A          250 PYPGVKIDE--EFCRR----LKEGTR-----MRAPDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGN  307 (316)
T ss_dssp             SSTTCCCSH--HHHHH----HHHTCC-----CCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCcccchhH--HHHHH----hccCcc-----CCCCCCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            886433221  11111    111110     01111122   245577789999999999999999999864

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.3e-41  Score=339.29  Aligned_cols=250  Identities=21%  Similarity=0.296  Sum_probs=201.6

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      .++|++.++||+|+||.||+|... ++..||+|++..........+.+|+.++++++||||+++++++.+....++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            467999999999999999999965 5778999999876656667899999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEE---cCCCCeEEeccCCcccccC
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL---DSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl---~~~~~~kl~DfGla~~~~~  398 (577)
                      +++++|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||++.....
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           88 CTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            999999888743   456999999999999999999999998   9999999999999   7888999999999987654


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      ...   .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+....+.       .+... ....
T Consensus       162 ~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-------~~~~~-~~~~  229 (277)
T 3f3z_A          162 GKM---MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIR-------EGTFT-FPEK  229 (277)
T ss_dssp             TSC---BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HCCCC-CCHH
T ss_pred             ccc---hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------hCCCC-CCch
Confidence            332   233579999999998754 59999999999999999999999986544322111111       00000 0000


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      . ....   ...+.+++..|++.||++|||+.|+++
T Consensus       230 ~-~~~~---~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          230 D-WLNV---SPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             H-HTTS---CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             h-hhcC---CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0 0001   134557788999999999999999874

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.4e-42  Score=373.72  Aligned_cols=260  Identities=26%  Similarity=0.429  Sum_probs=208.5

Q ss_pred             HHHHhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          239 IRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       239 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      ++...++|++.++||+|+||.||+|.+.++..||||++..... ...+|.+|+.+|++++|+||+++++++.+ +..+||
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv  339 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  339 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence            3345567888999999999999999998888899999976543 34578999999999999999999999876 678999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+++|+|.++|... ....+++..++.|+.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus       340 ~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  415 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED  415 (535)
T ss_dssp             ECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred             eehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence            9999999999998531 2346999999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCcccccc
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD  477 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  477 (577)
                      ... .......++..|+|||++..+.++.++||||||++||||++ |+.|+......+.   +.....    +...    
T Consensus       416 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~---~~~i~~----~~~~----  483 (535)
T 2h8h_A          416 NEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LDQVER----GYRM----  483 (535)
T ss_dssp             HHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH---HHHHHT----TCCC----
T ss_pred             Cce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHc----CCCC----
Confidence            211 12223457889999999999999999999999999999999 8888864433222   211111    1000    


Q ss_pred             CcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCCC
Q 008108          478 PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDT  520 (577)
Q Consensus       478 ~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~~  520 (577)
                       ........   .+.+++..||+.||++|||+.+|+++|+.-.
T Consensus       484 -~~~~~~~~---~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          484 -PCPPECPE---SLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             -CCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             -CCCCCCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence             01111222   4556778999999999999999999998743

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.1e-42  Score=354.82  Aligned_cols=266  Identities=17%  Similarity=0.220  Sum_probs=202.1

Q ss_pred             HhcCCccccccccCCcEEEEEeEecC------CcEEEEEEeccCChhhHH-----------HHHHHHHHHHhcCCCCeEE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLSN------GETIAVKRLSKNSKQGEI-----------EFKNEVLLLARLQHRNLVR  304 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~-----------~~~~E~~~l~~l~h~niv~  304 (577)
                      ..++|++.++||+|+||.||+|.+..      ++.||||++.........           .+..|+..+..++|+||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34689999999999999999998754      478999998766432211           2334666777888999999


Q ss_pred             EEeEEEcC----CeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEc
Q 008108          305 LLGFCLER----KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD  380 (577)
Q Consensus       305 l~~~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~  380 (577)
                      +++++...    ...+|||||+ +++|.+++..  ....+++..++.|+.||+.||.|||+++   |+||||||+||||+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence            99998765    4579999999 9999998854  3467999999999999999999999998   99999999999999


Q ss_pred             --CCCCeEEeccCCcccccCCCccc-----cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCc
Q 008108          381 --SEMNPKISDFGMARLFEMDQTHS-----DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTE  453 (577)
Q Consensus       381 --~~~~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~  453 (577)
                        .++.+||+|||+++.+.......     ......||+.|+|||++.+..++.++||||||+++|||+||+.||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              88999999999998765432221     11335699999999999999999999999999999999999999874322


Q ss_pred             cccchhhhhhhhhcccCCccccccCcCCC-CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCC
Q 008108          454 EETEDLLTYAWRNWNEGAALNLMDPTMRG-GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD  519 (577)
Q Consensus       454 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~  519 (577)
                      ..  ..+......+ .....+++++.+.. ..+.   .+.+++..||+.+|++||++.+|++.|+..
T Consensus       267 ~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~---~~~~li~~cl~~~p~~RP~~~~l~~~l~~~  327 (364)
T 3op5_A          267 DP--KYVRDSKIRY-RENIASLMDKCFPAANAPG---EIAKYMETVKLLDYTEKPLYENLRDILLQG  327 (364)
T ss_dssp             CH--HHHHHHHHHH-HHCHHHHHHHHSCTTCCCH---HHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             CH--HHHHHHHHHh-hhhHHHHHHHhcccccCHH---HHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence            21  1111111111 11222333333321 2333   344667799999999999999999998753

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.5e-41  Score=342.31  Aligned_cols=245  Identities=22%  Similarity=0.306  Sum_probs=190.7

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  318 (577)
                      .++|+..++||+|+||+||+|... +|+.||||++....  ......+..|+..+.++ +|+||+++++++.+.+..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            367999999999999999999975 79999999986543  23333455666666655 999999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+ +++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++....
T Consensus       136 ~e~~-~~~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          136 TELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EECC-CCBHHHHHHH--HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             Eecc-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            9999 6688887754  2456999999999999999999999987   99999999999999999999999999987643


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      ..   ......||+.|+|||++.+ .++.++||||||+++|||++|..++....  .        +..+..+.....+. 
T Consensus       210 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~--~--------~~~~~~~~~~~~~~-  274 (311)
T 3p1a_A          210 AG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE--G--------WQQLRQGYLPPEFT-  274 (311)
T ss_dssp             --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH--H--------HHHHTTTCCCHHHH-
T ss_pred             CC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc--H--------HHHHhccCCCcccc-
Confidence            22   2233569999999998765 79999999999999999999987653211  1        11111111111111 


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                         ....   ..+.+++..|++.||++|||+.|+++
T Consensus       275 ---~~~~---~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          275 ---AGLS---SELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             ---TTSC---HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---cCCC---HHHHHHHHHHcCCChhhCcCHHHHHh
Confidence               1112   34557778999999999999999985

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.3e-41  Score=339.63  Aligned_cols=255  Identities=30%  Similarity=0.492  Sum_probs=205.0

Q ss_pred             HhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ..++|++.+.||+|+||.||+|...+++.||||.+..... ....+.+|+.++++++||||+++++++.+ +..++||||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   88 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence            3468899999999999999999988888999999976543 34578999999999999999999999864 568999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++.......
T Consensus        89 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           89 MENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             CTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             CCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence            9999999988431 1236999999999999999999999998   99999999999999999999999999987654322


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                       .......++..|+|||.+.++.++.++||||||+++|||++ |+.|+......+.   +........         +..
T Consensus       165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~~~~~~~---------~~~  231 (279)
T 1qpc_A          165 -TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---IQNLERGYR---------MVR  231 (279)
T ss_dssp             -ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHHHTTCC---------CCC
T ss_pred             -ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH---HHHHhcccC---------CCC
Confidence             22233467889999999999999999999999999999999 8888764433221   111111100         011


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ....+.   .+.+++..|++.||++|||+.+++++|+.
T Consensus       232 ~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~l~~  266 (279)
T 1qpc_A          232 PDNCPE---ELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (279)
T ss_dssp             CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cccccH---HHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence            111222   45567789999999999999999999875

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.1e-41  Score=348.48  Aligned_cols=248  Identities=24%  Similarity=0.317  Sum_probs=192.3

Q ss_pred             hcCCccccccccCCcEEEEEeEe----cCCcEEEEEEeccCC----hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNS----KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE  314 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  314 (577)
                      .++|++.+.||+|+||.||++..    .+|+.||+|++.+..    ......+.+|+.+++.++||||+++++++.+.+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46899999999999999999986    478999999997653    2233457889999999999999999999999999


Q ss_pred             EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      .++||||+++++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            9999999999999988843   457999999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccc
Q 008108          395 LFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALN  474 (577)
Q Consensus       395 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  474 (577)
                      .......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||........   +......    .   
T Consensus       170 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~----~---  237 (327)
T 3a62_A          170 ESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT---IDKILKC----K---  237 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHT----C---
T ss_pred             ccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHhC----C---
Confidence            5432221  23346799999999999999999999999999999999999999865433221   1111110    0   


Q ss_pred             cccCcCCCCChHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 008108          475 LMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRP-----GMASVVN  514 (577)
Q Consensus       475 ~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RP-----t~~ev~~  514 (577)
                         ..+......   .+.+++..||+.||++||     ++.|+++
T Consensus       238 ---~~~p~~~~~---~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          238 ---LNLPPYLTQ---EARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ---CCCCTTSCH---HHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ---CCCCCCCCH---HHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence               011111222   445677799999999999     6677765

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.9e-41  Score=337.85  Aligned_cols=251  Identities=24%  Similarity=0.352  Sum_probs=202.0

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      .++|++.++||+|+||.||+|... +++.||+|++....  ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            478999999999999999999964 58999999986543  334456889999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCC---eEEeccCCcccc
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN---PKISDFGMARLF  396 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~---~kl~DfGla~~~  396 (577)
                      ||+++++|.+++.   .+..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.   +||+|||++...
T Consensus        85 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            9999999988774   3467999999999999999999999998   999999999999987665   999999999866


Q ss_pred             cCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          397 EMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       397 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      .....   .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...........+...  .+      ...
T Consensus       159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--~~------~~~  227 (284)
T 3kk8_A          159 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG--AY------DYP  227 (284)
T ss_dssp             CSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CC------CCC
T ss_pred             ccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhc--cc------cCC
Confidence            53322   23367999999999999999999999999999999999999998654432221111110  00      000


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .+.. .....   .+.+++..|++.||++|||+.|+++
T Consensus       228 ~~~~-~~~~~---~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          228 SPEW-DTVTP---EAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             TTTT-TTSCH---HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             chhh-cccCH---HHHHHHHHHcccChhhCCCHHHHhc
Confidence            0100 11222   3557778999999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.1e-42  Score=352.39  Aligned_cols=265  Identities=27%  Similarity=0.394  Sum_probs=201.6

Q ss_pred             CccccccccCCcEEEEEeEe-----cCCcEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC--CeEEE
Q 008108          246 FSDANKLGQGGFGAVYKGML-----SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KERIL  317 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  317 (577)
                      |++.++||+|+||+||++.+     .+++.||||++..... .....+.+|+.++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            48899999999999988864     2688999999986543 3455689999999999999999999999874  57899


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      ||||+++++|.+++.    ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       113 v~e~~~~~~L~~~l~----~~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLP----RHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGG----GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHh----hCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            999999999999884    345999999999999999999999998   9999999999999999999999999998775


Q ss_pred             CCCcc-ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          398 MDQTH-SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       398 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      ..... .......||..|+|||++.+..++.++||||||+++|||++|+.|+...... ......+...........+.+
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-FLELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-HHHHHCSCCHHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh-hhhhhcccccchhHHHHHHHH
Confidence            43322 1233456888999999999999999999999999999999999987532211 000111000000000011111


Q ss_pred             cCcCCCC-ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          477 DPTMRGG-STSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       477 d~~l~~~-~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      +...... .......+.+++..||+.||++|||+.|+++.|+.
T Consensus       265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  307 (318)
T 3lxp_A          265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT  307 (318)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            1111100 11122355677889999999999999999999975

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.1e-41  Score=342.28  Aligned_cols=259  Identities=27%  Similarity=0.480  Sum_probs=191.7

Q ss_pred             HhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ..++|++.++||+|+||+||+|...  ..||||++....  ......+.+|+.++++++||||+++++++ .....++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            3578999999999999999999864  469999987543  33445689999999999999999999965 456689999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        99 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A           99 QWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             ECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             EecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence            99999999988843  3457999999999999999999999998   999999999999999999999999999866543


Q ss_pred             CccccccccccCCCCcChhhhh---cCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVM---HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      ..........||+.|+|||.+.   ...++.++||||||+++|||++|+.||......+  .+......    +.....+
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~----~~~~~~~  247 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMVGR----GSLSPDL  247 (289)
T ss_dssp             ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHHHHHH----TSCCCCT
T ss_pred             cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHHHhcc----cccCcch
Confidence            3333334467999999999986   5678899999999999999999999986543321  11111111    1100000


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                       +.+....+   ..+.+++..|++.+|++|||+.|++++|+.
T Consensus       248 -~~~~~~~~---~~l~~li~~~l~~~p~~Rps~~ell~~L~~  285 (289)
T 3og7_A          248 -SKVRSNCP---KRMKRLMAECLKKKRDERPSFPRILAEIEE  285 (289)
T ss_dssp             -TSSCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -hhccccCC---HHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence             01111122   345577789999999999999999999975

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-41  Score=349.99  Aligned_cols=262  Identities=22%  Similarity=0.271  Sum_probs=199.7

Q ss_pred             HHHHHhcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccC-----ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEc
Q 008108          238 TIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN-----SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE  311 (577)
Q Consensus       238 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  311 (577)
                      .+....++|++.++||+|+||.||+|.. .+++.||+|++...     .......+.+|+.++++++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            3456678899999999999999999996 46889999998654     22344578999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCcccccccCC-------------------------------------CCCCCCHHHHHHHHHHHHH
Q 008108          312 RKERILVYEFVPNASLDHFIFDPI-------------------------------------NREHMTWEKRYKIIEGIAR  354 (577)
Q Consensus       312 ~~~~~lv~E~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~  354 (577)
                      .+..++||||+++|+|.+++....                                     ....+++..++.++.||+.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            999999999999999988874210                                     0123467788999999999


Q ss_pred             HHHHhhcCCCCcEEEeccCCCcEEEcCCC--CeEEeccCCcccccCCCcc--ccccccccCCCCcChhhhhc--CCCCcc
Q 008108          355 GLLYLHEDSRLRIIHRDLKASNILLDSEM--NPKISDFGMARLFEMDQTH--SDTNRVVGTFGYMAPEYVMH--GRFSVK  428 (577)
Q Consensus       355 gl~yLH~~~~~~iiHrDlkp~NiLl~~~~--~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~  428 (577)
                      ||.|||+.+   |+||||||+||||+.++  .+||+|||+++.+......  .......||+.|+|||++.+  ..++.+
T Consensus       180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            999999998   99999999999998776  8999999999866432221  12334679999999999975  678999


Q ss_pred             ccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCC
Q 008108          429 SDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPG  508 (577)
Q Consensus       429 ~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt  508 (577)
                      +||||||+++|||++|+.||......+.   +.....   ....  ...+..    ......+.+++..|++.||++||+
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~---~~~~--~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps  324 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDADT---ISQVLN---KKLC--FENPNY----NVLSPLARDLLSNLLNRNVDERFD  324 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH---CCCC--TTSGGG----GGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHHH---HHHHHh---cccc--cCCccc----ccCCHHHHHHHHHHcCCChhHCCC
Confidence            9999999999999999999865443221   111111   0000  000000    011234557788999999999999


Q ss_pred             HHHHHH
Q 008108          509 MASVVN  514 (577)
Q Consensus       509 ~~ev~~  514 (577)
                      +.|+++
T Consensus       325 ~~~~l~  330 (345)
T 3hko_A          325 AMRALQ  330 (345)
T ss_dssp             HHHHHH
T ss_pred             HHHHhc
Confidence            999986

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.2e-41  Score=339.32  Aligned_cols=254  Identities=28%  Similarity=0.541  Sum_probs=199.7

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhH-------HHHHHHHHHHHhcCCCCeEEEEeEEEcCCe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGE-------IEFKNEVLLLARLQHRNLVRLLGFCLERKE  314 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  314 (577)
                      .++|+..+.||+|+||+||+|.. .+++.||+|++........       ..+.+|+.++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            46899999999999999999996 4789999999865432211       46889999999999999999999987665 


Q ss_pred             EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCC-----eEEec
Q 008108          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN-----PKISD  389 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~-----~kl~D  389 (577)
                       ++||||+++++|.+++.+  ....+++..++.++.|++.||.|||+++ .+|+||||||+|||++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             699999999999887754  3457999999999999999999999875 34999999999999988776     99999


Q ss_pred             cCCcccccCCCccccccccccCCCCcChhhhh--cCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhc
Q 008108          390 FGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM--HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNW  467 (577)
Q Consensus       390 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~  467 (577)
                      ||+++....     ......||+.|+|||++.  ...++.++||||||+++|||++|+.||.......... ......  
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~--  244 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF-INMIRE--  244 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH-HHHHHH--
T ss_pred             CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH-HHHHhc--
Confidence            999975432     223367999999999983  4567899999999999999999999986544332211 111111  


Q ss_pred             ccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          468 NEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       468 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                       .+     ..+.+....+.   .+.+++..||+.||++|||+.|+++.|+.
T Consensus       245 -~~-----~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          245 -EG-----LRPTIPEDCPP---RLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             -SC-----CCCCCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             -cC-----CCCCCCcccCH---HHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence             00     11111112222   45577789999999999999999999864

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5.2e-42  Score=355.51  Aligned_cols=212  Identities=28%  Similarity=0.357  Sum_probs=182.2

Q ss_pred             cCCCChHHHHHHhcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcC-----CCCeEE
Q 008108          231 SLQFDFETIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-----HRNLVR  304 (577)
Q Consensus       231 ~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~  304 (577)
                      ...+++.......++|++.++||+|+||+||+|.. .+++.||||++... ......+..|+.+++.++     ||||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            34555666666778999999999999999999996 46899999999753 333446788999999996     999999


Q ss_pred             EEeEEEcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC---
Q 008108          305 LLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS---  381 (577)
Q Consensus       305 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~---  381 (577)
                      +++++...+..++||||+ +++|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.   
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~  175 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF  175 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence            999999999999999999 89999988542 2345999999999999999999999998   999999999999975   


Q ss_pred             ----------------------CCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHh
Q 008108          382 ----------------------EMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVL  439 (577)
Q Consensus       382 ----------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~  439 (577)
                                            ++.+||+|||+++.....     .....||+.|+|||++.+..++.++||||||+++|
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  250 (360)
T 3llt_A          176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA  250 (360)
T ss_dssp             CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred             cccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence                                  788999999999864422     22467999999999999999999999999999999


Q ss_pred             HHhhCCCCCCCCCc
Q 008108          440 EIVSGQKRSSFGTE  453 (577)
Q Consensus       440 elltG~~p~~~~~~  453 (577)
                      ||++|+.||.....
T Consensus       251 ell~g~~pf~~~~~  264 (360)
T 3llt_A          251 ELYTGSLLFRTHEH  264 (360)
T ss_dssp             HHHHSSCSCCCSSH
T ss_pred             HHHHCCCCCCCCcH
Confidence            99999999875443

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.5e-41  Score=348.54  Aligned_cols=265  Identities=17%  Similarity=0.221  Sum_probs=197.1

Q ss_pred             cCCccccccccCCcEEEEEeEec----CCcEEEEEEeccCChhh-----------HHHHHHHHHHHHhcCCCCeEEEEeE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS----NGETIAVKRLSKNSKQG-----------EIEFKNEVLLLARLQHRNLVRLLGF  308 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~~  308 (577)
                      ++|++.++||+|+||.||+|...    ++..+|||++.......           ...+.+|+..+..++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            67899999999999999999975    57889999987654321           1135678889999999999999999


Q ss_pred             EEc----CCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC-
Q 008108          309 CLE----RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-  383 (577)
Q Consensus       309 ~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~-  383 (577)
                      +..    ....++||||+ +++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+||||+.++ 
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSST
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCC
Confidence            987    67889999999 9999999843   347999999999999999999999998   99999999999999887 


Q ss_pred             -CeEEeccCCcccccCCCccc-----cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccc
Q 008108          384 -NPKISDFGMARLFEMDQTHS-----DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE  457 (577)
Q Consensus       384 -~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~  457 (577)
                       .+||+|||+++.+.......     ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ 
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-  268 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV-  268 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH-
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH-
Confidence             99999999998765432211     11345799999999999999999999999999999999999999853221111 


Q ss_pred             hhhhhhhhhcccCCccccccCcCC-CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCCCC
Q 008108          458 DLLTYAWRNWNEGAALNLMDPTMR-GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTV  521 (577)
Q Consensus       458 ~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~~~  521 (577)
                       .+......+... ....+..... ...+.   .+.+++..||+.||++||++.+|++.|+....
T Consensus       269 -~~~~~~~~~~~~-~~~~~~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          269 -AVQTAKTNLLDE-LPQSVLKWAPSGSSCC---EIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             -HHHHHHHHHHHT-TTHHHHHHSCTTSCCH---HHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             -HHHHHHHhhccc-ccHHHHhhccccccHH---HHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence             111111111110 0000000000 01222   45567779999999999999999999987544

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.6e-41  Score=344.78  Aligned_cols=251  Identities=25%  Similarity=0.347  Sum_probs=203.2

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChh------hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ------GEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  315 (577)
                      .++|++.+.||+|+||.||++... +|+.||+|.+......      ...++.+|+.++++++||||+++++++.+....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            467999999999999999999965 6899999998764321      356789999999999999999999999999999


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC----CeEEeccC
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM----NPKISDFG  391 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~----~~kl~DfG  391 (577)
                      ++||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            999999999999999843   457999999999999999999999998   99999999999999888    79999999


Q ss_pred             CcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCC
Q 008108          392 MARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGA  471 (577)
Q Consensus       392 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  471 (577)
                      +++.......   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+.       ...
T Consensus       165 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~-------~~~  234 (321)
T 2a2a_A          165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT-------SVS  234 (321)
T ss_dssp             TCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH-------TTC
T ss_pred             cceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------hcc
Confidence            9987654322   234579999999999999999999999999999999999999986543322111111       000


Q ss_pred             ccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          472 ALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       472 ~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .  ..++......+   ..+.+++..|++.||++|||+.|+++
T Consensus       235 ~--~~~~~~~~~~~---~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          235 Y--DFDEEFFSHTS---ELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             C--CCCHHHHTTCC---HHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             c--ccChhhhcccC---HHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0  00000001112   23557788999999999999999986

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.1e-41  Score=340.67  Aligned_cols=255  Identities=22%  Similarity=0.353  Sum_probs=192.3

Q ss_pred             HhcCCccccccccCCcEEEEEeEecC----CcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLSN----GETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  316 (577)
                      ..++|++.+.||+|+||.||+|....    +..||+|++.... ......+.+|+.++++++||||+++++++. ++..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            34678999999999999999998642    4569999987643 334456899999999999999999999984 56789


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccc
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~  396 (577)
                      +||||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        92 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             EEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence            99999999999998853  2346999999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCcccc
Q 008108          397 EMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNL  475 (577)
Q Consensus       397 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  475 (577)
                      ...... ......+|+.|+|||.+....++.++||||||+++|||++ |+.||......+....+.       .+..   
T Consensus       167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~-------~~~~---  235 (281)
T 1mp8_A          167 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-------NGER---  235 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTCC---
T ss_pred             Cccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-------cCCC---
Confidence            543221 2223457889999999999999999999999999999997 888886544332211111       1100   


Q ss_pred             ccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       476 ~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                        ..+....+.   .+.+++..|++.||++|||+.|+++.|+.
T Consensus       236 --~~~~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~l~~  273 (281)
T 1mp8_A          236 --LPMPPNCPP---TLYSLMTKCWAYDPSRRPRFTELKAQLST  273 (281)
T ss_dssp             --CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCCCCCCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence              011112222   44567789999999999999999999864

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.4e-41  Score=352.51  Aligned_cols=252  Identities=22%  Similarity=0.330  Sum_probs=191.5

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      .++|++.++||+|+||+||++... +++.||||++...... ...+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            468999999999999999999965 7899999999765433 24678999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCC--eEEeccCCcccccCC
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN--PKISDFGMARLFEMD  399 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~--~kl~DfGla~~~~~~  399 (577)
                      +++|+|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+||||+.++.  +||+|||+++.....
T Consensus        98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            999999988843   457999999999999999999999998   999999999999987775  999999999753322


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCcc-ccEEecchhHhHHhhCCCCCCCCCccc-cchhhhhhhhhcccCCcccccc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVK-SDIFSFGVLVLEIVSGQKRSSFGTEEE-TEDLLTYAWRNWNEGAALNLMD  477 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~SlGvil~elltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~d  477 (577)
                         .......||+.|+|||++.+..++.+ +||||||+++|||++|+.||....... ....+.....   .. . ...+
T Consensus       172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~---~~-~-~~~~  243 (361)
T 3uc3_A          172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS---VK-Y-SIPD  243 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT---TC-C-CCCT
T ss_pred             ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc---CC-C-CCCC
Confidence               12234579999999999988888665 899999999999999999986543322 1112211110   00 0 0000


Q ss_pred             CcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          478 PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       478 ~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                       .  ....   ..+.+++.+||+.||++|||+.|+++-
T Consensus       244 -~--~~~s---~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          244 -D--IRIS---PECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             -T--SCCC---HHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             -c--CCCC---HHHHHHHHHHccCChhHCcCHHHHHhC
Confidence             0  0112   245577889999999999999999863

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5e-41  Score=359.44  Aligned_cols=246  Identities=23%  Similarity=0.368  Sum_probs=202.1

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|.+.+.||+|+||.||+|... +|+.||||++.....   .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            67999999999999999999965 799999999975422   23456889999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++|+|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        96 E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           96 EYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             ECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            9999999999884   3567999999999999999999999988   999999999999999999999999999876543


Q ss_pred             CccccccccccCCCCcChhhhhcCCC-CccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRF-SVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      ..   .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||........   .....    .+..      
T Consensus       170 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~---~~~i~----~~~~------  233 (476)
T 2y94_A          170 EF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL---FKKIC----DGIF------  233 (476)
T ss_dssp             CC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH---HHHHH----TTCC------
T ss_pred             cc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH---HHHHh----cCCc------
Confidence            22   233579999999999988765 6899999999999999999999865433222   11111    1100      


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ........   .+.+++..|++.||++|||+.|+++
T Consensus       234 ~~p~~~s~---~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          234 YTPQYLNP---SVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             CCCTTCCH---HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCccCCH---HHHHHHHHHcCCCchhCcCHHHHHh
Confidence            00111122   3556778999999999999999986

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5e-41  Score=340.78  Aligned_cols=263  Identities=21%  Similarity=0.323  Sum_probs=198.1

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChh--hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ--GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      ++|++.++||+|+||+||+|... +|+.||||++......  ....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            67999999999999999999975 5899999998665432  34567899999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |+++++|..++.   ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           83 YCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             CCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             eCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            999999988763   3456999999999999999999999998   9999999999999999999999999998765322


Q ss_pred             ccccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhh--------hhcccCC
Q 008108          401 THSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAW--------RNWNEGA  471 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~~~  471 (577)
                      .  ......||..|+|||++.+ ..++.++||||||+++|||++|+.||......+....+....        ..+....
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (311)
T 4agu_A          157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ  234 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred             c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence            2  2233578999999999976 578999999999999999999999987655433222221110        0000000


Q ss_pred             c---cccccCcCCCC----ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          472 A---LNLMDPTMRGG----STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       472 ~---~~~~d~~l~~~----~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .   ....++.....    .......+.+++..|++.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0   00111110000    0111234567888999999999999999985

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.6e-41  Score=348.17  Aligned_cols=249  Identities=23%  Similarity=0.307  Sum_probs=196.5

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  318 (577)
                      ++|+..+.||+|+||.||++... +++.||+|++.+..   ......+.+|..++.++ +||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            67999999999999999999965 58899999997653   23344578899999988 899999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+++|+|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus        89 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            999999999988843   457999999999999999999999998   99999999999999999999999999985432


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccc--hhhhhhhhhcccCCccccc
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE--DLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~~~  476 (577)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ..............     
T Consensus       163 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~-----  235 (345)
T 3a8x_A          163 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-----  235 (345)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-----
T ss_pred             CC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-----
Confidence            21  2234468999999999999999999999999999999999999998643221110  00011111111110     


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCH
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGM  509 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~  509 (577)
                       ..+......   .+.+++..|++.||++||++
T Consensus       236 -~~~p~~~s~---~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          236 -IRIPRSLSV---KAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             -CCCCTTSCH---HHHHHHHHHTCSSTTTSTTC
T ss_pred             -CCCCCCCCH---HHHHHHHHHhcCCHhHCCCC
Confidence             011111222   44567779999999999996

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.2e-41  Score=353.47  Aligned_cols=251  Identities=20%  Similarity=0.326  Sum_probs=194.5

Q ss_pred             cCCccccccccCCcEEEEEeEecCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcC--CCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQ--HRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|++.++||+|+||.||++...+++.||||++....  ......+.+|+.+|.+++  |+||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            4699999999999999999998889999999986543  344567899999999996  599999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      | +.+++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+ ++.+||+|||+++.+...
T Consensus       136 E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          136 E-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             E-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             e-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            9 568899998853   457899999999999999999999988   99999999999996 578999999999877544


Q ss_pred             CccccccccccCCCCcChhhhhc-----------CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMH-----------GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWN  468 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~  468 (577)
                      ..........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.......  ..+.   ....
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--~~~~---~~~~  282 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SKLH---AIID  282 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHH---HHHC
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH--HHHH---HHhC
Confidence            43333345689999999999875           468999999999999999999999986432211  1111   1111


Q ss_pred             cCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          469 EGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       469 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      ....     ........   ..+.+++..||+.||++|||+.|+++.
T Consensus       283 ~~~~-----~~~~~~~~---~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          283 PNHE-----IEFPDIPE---KDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             TTSC-----CCCCCCSC---HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccc-----CCCCccch---HHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            1100     00111112   245577789999999999999999864

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=9.6e-42  Score=346.48  Aligned_cols=270  Identities=24%  Similarity=0.390  Sum_probs=198.6

Q ss_pred             CCCChHHHHHHhcCCccccccccCCcEEEEEeEec----CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEE
Q 008108          232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKGMLS----NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRL  305 (577)
Q Consensus       232 ~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l  305 (577)
                      ++-.+..+....++|.+.+.||+|+||.||+|...    +++.||+|++....  ......+.+|+.++++++||||+++
T Consensus        22 l~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~  101 (313)
T 3brb_A           22 LQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL  101 (313)
T ss_dssp             --CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred             hhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeee
Confidence            33444555556788999999999999999999854    34579999987543  3344568999999999999999999


Q ss_pred             EeEEEcCCe-----EEEEEEecCCCCcccccccC---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcE
Q 008108          306 LGFCLERKE-----RILVYEFVPNASLDHFIFDP---INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNI  377 (577)
Q Consensus       306 ~~~~~~~~~-----~~lv~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~Ni  377 (577)
                      ++++.+...     .++||||+++++|.+++...   .....+++..++.++.||+.||.|||+++   |+||||||+||
T Consensus       102 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NI  178 (313)
T 3brb_A          102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNC  178 (313)
T ss_dssp             CEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGE
T ss_pred             eEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceE
Confidence            999987653     49999999999999887432   23457999999999999999999999987   99999999999


Q ss_pred             EEcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCcccc
Q 008108          378 LLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEET  456 (577)
Q Consensus       378 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~  456 (577)
                      |++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+........
T Consensus       179 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  258 (313)
T 3brb_A          179 MLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM  258 (313)
T ss_dssp             EECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             EEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH
Confidence            999999999999999987654433333334567889999999999999999999999999999999 7778765443322


Q ss_pred             chhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCC
Q 008108          457 EDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD  519 (577)
Q Consensus       457 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~  519 (577)
                      ...+   ..    +..     +......+   ..+.+++..|++.||++|||+.++++.|+.-
T Consensus       259 ~~~~---~~----~~~-----~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l  306 (313)
T 3brb_A          259 YDYL---LH----GHR-----LKQPEDCL---DELYEIMYSCWRTDPLDRPTFSVLRLQLEKL  306 (313)
T ss_dssp             HHHH---HT----TCC-----CCCBTTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHH---Hc----CCC-----CCCCcccc---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1111   11    100     01111122   2455777899999999999999999999753

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.5e-41  Score=350.43  Aligned_cols=245  Identities=23%  Similarity=0.274  Sum_probs=201.5

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      .++|+..+.||+|+||.||++... +|+.||||++.+..   ......+.+|+.+++.++||||+++++++.+....++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            368999999999999999999965 68999999996542   22345678999999999999999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+++|+|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus       120 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence            999999999998843   456999999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      .     .....||+.|+|||++.+..++.++||||||+++|||++|+.||........   .....    .+.      .
T Consensus       194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~i~----~~~------~  255 (350)
T 1rdq_E          194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI---YEKIV----SGK------V  255 (350)
T ss_dssp             C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH----HCC------C
T ss_pred             C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH---HHHHH----cCC------C
Confidence            2     2346799999999999999999999999999999999999999865433222   11111    110      0


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPG-----MASVVN  514 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt-----~~ev~~  514 (577)
                      .+......   .+.+++..|++.||++||+     +.|+++
T Consensus       256 ~~p~~~~~---~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          256 RFPSHFSS---DLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCCTTCCH---HHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCCCH---HHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            11111222   3456777999999999998     787764

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=348.35  Aligned_cols=255  Identities=27%  Similarity=0.474  Sum_probs=196.6

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcE----EEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGET----IAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  316 (577)
                      .++|++.++||+|+||+||+|... +++.    ||+|.+... ......++.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            367999999999999999999954 4443    578877543 3345567899999999999999999999998765 78


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccc
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~  396 (577)
                      +|+||+++|+|.+++..  ....+++..++.|+.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            99999999999998854  3456999999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCcccc
Q 008108          397 EMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNL  475 (577)
Q Consensus       397 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  475 (577)
                      .............||+.|+|||.+.+..++.++||||||+++|||++ |+.||...........+..       +..   
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~-------~~~---  237 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-------GER---  237 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-------TCC---
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-------CCC---
Confidence            54443333334567889999999999999999999999999999999 9999875544333222211       000   


Q ss_pred             ccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       476 ~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                        ........   ..+.+++..||+.||++||++.|+++.|+.
T Consensus       238 --~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~ell~~L~~  275 (327)
T 3lzb_A          238 --LPQPPICT---IDVYMIMRKCWMIDADSRPKFRELIIEFSK  275 (327)
T ss_dssp             --CCCCTTBC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCCCccCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence              00011112   245577889999999999999999999875

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.8e-41  Score=340.63  Aligned_cols=265  Identities=26%  Similarity=0.357  Sum_probs=196.6

Q ss_pred             HhcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCCh-----hhHHHHHHHHHHHHhcC---CCCeEEEEeEEEcC
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK-----QGEIEFKNEVLLLARLQ---HRNLVRLLGFCLER  312 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  312 (577)
                      ..++|++.++||+|+||+||+|.. .+++.||||++.....     .....+.+|+.++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            467899999999999999999995 5789999999864321     11235667777777764   99999999999875


Q ss_pred             C-----eEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEE
Q 008108          313 K-----ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKI  387 (577)
Q Consensus       313 ~-----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl  387 (577)
                      .     ..++||||++ ++|.+++.. .....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDK-APPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHT-CCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence            5     4789999997 599888754 22344999999999999999999999998   999999999999999999999


Q ss_pred             eccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhc
Q 008108          388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNW  467 (577)
Q Consensus       388 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~  467 (577)
                      +|||+++......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+....+.......
T Consensus       162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  238 (308)
T 3g33_A          162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP  238 (308)
T ss_dssp             CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999998664322   2234679999999999999999999999999999999999999987554433221111111000


Q ss_pred             ccCCccc-------cccCcCCCC----ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          468 NEGAALN-------LMDPTMRGG----STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       468 ~~~~~~~-------~~d~~l~~~----~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ....+..       .+.+.....    .......+.+++..|++.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            0000000       000000000    0111234567888999999999999999875

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=9.7e-41  Score=332.42  Aligned_cols=253  Identities=25%  Similarity=0.404  Sum_probs=203.1

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      .++|++.+.||+|+||.||++... +++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467999999999999999999965 68999999986543 3344578999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |+++++|.+++.   ....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            999999999884   3457999999999999999999999998   9999999999999999999999999998765443


Q ss_pred             ccccccccccCCCCcChhhhhcCCC-CccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGRF-SVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                      .........||..|+|||.+.+..+ +.++||||||+++|||++|+.||........ ...     .+......  ..+ 
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~-----~~~~~~~~--~~~-  230 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYS-----DWKEKKTY--LNP-  230 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHH-----HHHTTCTT--STT-
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHH-----Hhhhcccc--cCc-
Confidence            3333345679999999999987765 7899999999999999999999865433211 111     11111000  000 


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                       .....   ..+.+++..|++.||++|||+.|+++
T Consensus       231 -~~~~~---~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          231 -WKKID---SAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             -GGGSC---HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -hhhcC---HHHHHHHHHHCCCCchhCCCHHHHhc
Confidence             00112   24456788999999999999998875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-41  Score=336.71  Aligned_cols=255  Identities=27%  Similarity=0.450  Sum_probs=204.2

Q ss_pred             cCCcccc-ccccCCcEEEEEeEec---CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          244 DNFSDAN-KLGQGGFGAVYKGMLS---NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       244 ~~f~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      ++|.+.. .||+|+||.||+|...   ++..||||++.... ......+.+|+.++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            5566666 8999999999999853   57889999998753 34455789999999999999999999999 55678999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            999999999998853  3456999999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCcc-ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          399 DQTH-SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       399 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      .... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||......+....+.       .+..    
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~-------~~~~----  231 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-------QGKR----  231 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-------TTCC----
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh-------cCCc----
Confidence            3322 22233457899999999999999999999999999999999 999986544332221111       1110    


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCC
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD  519 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~  519 (577)
                       +......+.   .+.+++..||+.+|++||++.++++.|...
T Consensus       232 -~~~~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  270 (287)
T 1u59_A          232 -MECPPECPP---ELYALMSDCWIYKWEDRPDFLTVEQRMRAC  270 (287)
T ss_dssp             -CCCCTTCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCCCCcCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             111112223   455677899999999999999999998753

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.8e-41  Score=352.18  Aligned_cols=206  Identities=20%  Similarity=0.284  Sum_probs=177.4

Q ss_pred             hcCCccccccccC--CcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          243 TDNFSDANKLGQG--GFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       243 ~~~f~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      .++|++.++||+|  +||+||++... +|+.||||++....  ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4679999999999  99999999965 68999999997543  3334568889999999999999999999999999999


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      ||||+++|+|.+++... ....+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||++....
T Consensus       104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            99999999999988542 2356999999999999999999999998   9999999999999999999999999987543


Q ss_pred             CCCc-----cccccccccCCCCcChhhhhc--CCCCccccEEecchhHhHHhhCCCCCCCCC
Q 008108          398 MDQT-----HSDTNRVVGTFGYMAPEYVMH--GRFSVKSDIFSFGVLVLEIVSGQKRSSFGT  452 (577)
Q Consensus       398 ~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltG~~p~~~~~  452 (577)
                      ....     ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||....
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  241 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP  241 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence            2211     111223478999999999987  578999999999999999999999986543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.5e-41  Score=350.60  Aligned_cols=250  Identities=26%  Similarity=0.301  Sum_probs=200.1

Q ss_pred             HHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeE
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKER  315 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  315 (577)
                      ...++|+..+.||+|+||+||++... +|+.||||++.+..   ......+.+|..++..+ +||||+++++++.+.+..
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            34578999999999999999999975 47889999997642   23344678899999888 899999999999999999


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      ++||||+++|+|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.
T Consensus        97 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            999999999999998843   457999999999999999999999998   99999999999999999999999999985


Q ss_pred             ccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccc
Q 008108          396 FEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNL  475 (577)
Q Consensus       396 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  475 (577)
                      .....  .......||+.|+|||++.+..++.++||||||+++|||++|+.||........   ......    ..    
T Consensus       171 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~~~i~~----~~----  237 (353)
T 2i0e_A          171 NIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---FQSIME----HN----  237 (353)
T ss_dssp             CCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH----CC----
T ss_pred             cccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH---HHHHHh----CC----
Confidence            43222  223346899999999999999999999999999999999999999865433222   211111    00    


Q ss_pred             ccCcCCCCChHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 008108          476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPG-----MASVVN  514 (577)
Q Consensus       476 ~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt-----~~ev~~  514 (577)
                        ..+......   .+.+++..|++.||++||+     +.|+++
T Consensus       238 --~~~p~~~s~---~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          238 --VAYPKSMSK---EAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             --CCCCTTSCH---HHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             --CCCCCCCCH---HHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence              011111222   4456777999999999996     466553

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.8e-41  Score=348.46  Aligned_cols=251  Identities=16%  Similarity=0.166  Sum_probs=200.6

Q ss_pred             HHhcCCccccccccCCcEEEEEeE------ecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcC---CCCeEEEEeEEEc
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGM------LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ---HRNLVRLLGFCLE  311 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~  311 (577)
                      ...++|.+.++||+|+||+||+|.      ..+++.||||++.....   .++..|+.++.+++   |+||+++++++..
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            445789999999999999999994      45688999999976543   36778888888886   9999999999999


Q ss_pred             CCeEEEEEEecCCCCcccccccC--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC--------
Q 008108          312 RKERILVYEFVPNASLDHFIFDP--INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS--------  381 (577)
Q Consensus       312 ~~~~~lv~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~--------  381 (577)
                      .+..+|||||+++|+|.+++...  .....+++..++.|+.||+.||.|||+.+   |+||||||+||||+.        
T Consensus       139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~  215 (365)
T 3e7e_A          139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE  215 (365)
T ss_dssp             SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred             CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence            99999999999999999998532  13457999999999999999999999987   999999999999998        


Q ss_pred             ---CCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccch
Q 008108          382 ---EMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETED  458 (577)
Q Consensus       382 ---~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~  458 (577)
                         ++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+||+.||.......   
T Consensus       216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---  292 (365)
T 3e7e_A          216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---  292 (365)
T ss_dssp             ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred             ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence               89999999999986553333333445689999999999999999999999999999999999999874221110   


Q ss_pred             hhhhhhhhcccCCccccccCcCCC-CChHHHHHHHHHHHhcccCCCCCC-CCHHHHHHHhcC
Q 008108          459 LLTYAWRNWNEGAALNLMDPTMRG-GSTSEMMKCIHIGLLCVQENVSNR-PGMASVVNMLNG  518 (577)
Q Consensus       459 l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~~~l~~~C~~~~p~~R-Pt~~ev~~~L~~  518 (577)
                              +.       ++..+.. ...+.   +.+++..|++.+|.+| |++.++.+.|+.
T Consensus       293 --------~~-------~~~~~~~~~~~~~---~~~~~~~~l~~~p~~r~~~~~~l~~~l~~  336 (365)
T 3e7e_A          293 --------CK-------PEGLFRRLPHLDM---WNEFFHVMLNIPDCHHLPSLDLLRQKLKK  336 (365)
T ss_dssp             --------EE-------ECSCCTTCSSHHH---HHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred             --------ee-------echhccccCcHHH---HHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence                    00       1111111 12233   3356668899999999 678888877764

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.9e-41  Score=347.35  Aligned_cols=263  Identities=24%  Similarity=0.356  Sum_probs=208.3

Q ss_pred             HHHHhcCCccccccccCCcEEEEEeEecC------CcEEEEEEeccCCh-hhHHHHHHHHHHHHhc-CCCCeEEEEeEEE
Q 008108          239 IRVATDNFSDANKLGQGGFGAVYKGMLSN------GETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNLVRLLGFCL  310 (577)
Q Consensus       239 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  310 (577)
                      +....++|+..+.||+|+||.||+|....      ...||+|.+..... .....+.+|+.+++.+ +||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            44556789999999999999999998642      24799999976543 3445689999999999 8999999999999


Q ss_pred             cCCeEEEEEEecCCCCcccccccCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEE
Q 008108          311 ERKERILVYEFVPNASLDHFIFDPI-----------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL  379 (577)
Q Consensus       311 ~~~~~~lv~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl  379 (577)
                      +.+..++||||+++|+|.+++....           ....+++..++.++.||+.||.|||+++   |+||||||+|||+
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL  197 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence            9999999999999999999885421           1346899999999999999999999998   9999999999999


Q ss_pred             cCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccch
Q 008108          380 DSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETED  458 (577)
Q Consensus       380 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~  458 (577)
                      +.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+| |..|+........  
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--  275 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--  275 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--
T ss_pred             CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--
Confidence            9999999999999987654443333344567889999999999999999999999999999999 8888764332211  


Q ss_pred             hhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          459 LLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       459 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ..........         +......+   ..+.+++..||+.||++|||+.||++.|+.
T Consensus       276 ~~~~~~~~~~---------~~~~~~~~---~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  323 (333)
T 2i1m_A          276 FYKLVKDGYQ---------MAQPAFAP---KNIYSIMQACWALEPTHRPTFQQICSFLQE  323 (333)
T ss_dssp             HHHHHHHTCC---------CCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHhcCCC---------CCCCCCCC---HHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence            1111111100         00111122   245577789999999999999999999864

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5e-41  Score=335.91  Aligned_cols=251  Identities=25%  Similarity=0.371  Sum_probs=199.7

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh------hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK------QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  315 (577)
                      .++|++.+.||+|+||.||++... +++.||+|.+.....      .....+.+|+.++++++||||+++++++.+....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            357899999999999999999975 689999999875432      1356789999999999999999999999999999


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC----CeEEeccC
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM----NPKISDFG  391 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~----~~kl~DfG  391 (577)
                      ++||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+||+++.++    .+||+|||
T Consensus        84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            999999999999998843   457999999999999999999999998   99999999999998877    89999999


Q ss_pred             CcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCC
Q 008108          392 MARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGA  471 (577)
Q Consensus       392 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  471 (577)
                      ++........   .....||+.|+|||.+....++.++||||||+++|||++|+.||...........+.    ..... 
T Consensus       158 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~-  229 (283)
T 3bhy_A          158 IAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS----AVNYD-  229 (283)
T ss_dssp             TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH----TTCCC-
T ss_pred             cceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhH----hcccC-
Confidence            9987643322   223578999999999999999999999999999999999999986543322111111    00000 


Q ss_pred             ccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          472 ALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       472 ~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                          .++......+   ..+.+++..|++.||++|||+.|+++
T Consensus       230 ----~~~~~~~~~~---~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          230 ----FDEEYFSNTS---ELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             ----CCHHHHTTCC---HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----CcchhcccCC---HHHHHHHHHHccCCHhHCcCHHHHHh
Confidence                0000001112   24557788999999999999999986

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.9e-41  Score=344.57  Aligned_cols=260  Identities=23%  Similarity=0.308  Sum_probs=195.8

Q ss_pred             cCCccc-cccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEEEEE
Q 008108          244 DNFSDA-NKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       244 ~~f~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      +.|++. +.||+|+||+||++.. .+++.||||++..........+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            567774 7899999999999995 47899999999876655666789999999985 79999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCC---eEEeccCCccccc
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN---PKISDFGMARLFE  397 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~---~kl~DfGla~~~~  397 (577)
                      |+++++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.   +||+|||+++...
T Consensus        92 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           92 KMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             cCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            9999999998843   457999999999999999999999998   999999999999998776   9999999998654


Q ss_pred             CCCcc-----ccccccccCCCCcChhhhhc-----CCCCccccEEecchhHhHHhhCCCCCCCCCccccchh--------
Q 008108          398 MDQTH-----SDTNRVVGTFGYMAPEYVMH-----GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDL--------  459 (577)
Q Consensus       398 ~~~~~-----~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l--------  459 (577)
                      .....     .......||+.|+|||++..     ..++.++||||||+++|||++|+.||......+....        
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  245 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC  245 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence            32211     11223469999999999875     5688999999999999999999999875443221000        


Q ss_pred             hhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          460 LTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       460 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ..........+.. ...+... ...   ...+.+++.+|++.||++|||+.|+++
T Consensus       246 ~~~~~~~i~~~~~-~~~~~~~-~~~---~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          246 QNMLFESIQEGKY-EFPDKDW-AHI---SCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHHCCC-CCCHHHH-TTS---CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHhccCc-ccCchhc-ccC---CHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            0000011111100 0000000 001   134567888999999999999999987

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1e-41  Score=348.44  Aligned_cols=249  Identities=24%  Similarity=0.318  Sum_probs=176.4

Q ss_pred             ccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcC-CCCeEEEEeEEEcCCeEEEEEEecCCCC
Q 008108          249 ANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERILVYEFVPNAS  326 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gs  326 (577)
                      .++||+|+||.||++... +++.||||++.+.   ....+.+|+.++..++ ||||+++++++.+....++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            378999999999999965 6899999999654   3346788999999997 9999999999999999999999999999


Q ss_pred             cccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC---CeEEeccCCcccccCCCccc
Q 008108          327 LDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM---NPKISDFGMARLFEMDQTHS  403 (577)
Q Consensus       327 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~---~~kl~DfGla~~~~~~~~~~  403 (577)
                      |.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++   .+||+|||+++.......  
T Consensus        93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--  164 (325)
T 3kn6_A           93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--  164 (325)
T ss_dssp             HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--
Confidence            9998843   467999999999999999999999998   99999999999997765   799999999986553322  


Q ss_pred             cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCC
Q 008108          404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGG  483 (577)
Q Consensus       404 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  483 (577)
                      ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....................+...      ....
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~~~  238 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FEGE  238 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CCSH
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CCcc
Confidence            2233578999999999999999999999999999999999999987543321111111111111111110      0000


Q ss_pred             C-hHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          484 S-TSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       484 ~-~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      . ......+.+++..|++.||++|||+.|+++
T Consensus       239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             cccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            0 011234567888999999999999998873

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-41  Score=345.11  Aligned_cols=255  Identities=28%  Similarity=0.495  Sum_probs=197.5

Q ss_pred             cCCccccccccCCcEEEEEeEecC-----CcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSN-----GETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      ++|...+.||+|+||.||+|....     +..||||++.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            567888999999999999998643     2359999997653 3344568899999999999999999999999999999


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      ||||+++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       124 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          124 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            9999999999999854  3457999999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCccc-cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCcccc
Q 008108          398 MDQTHS-DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNL  475 (577)
Q Consensus       398 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  475 (577)
                      ...... ......+|+.|+|||.+....++.++||||||+++|||++ |+.||......+.   .....    .+..   
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~---~~~~~----~~~~---  268 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---MKAIN----DGFR---  268 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHH----TTCC---
T ss_pred             cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH---HHHHH----CCCc---
Confidence            432211 1223456889999999999999999999999999999999 9998864433221   11111    1100   


Q ss_pred             ccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       476 ~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                        .......+.   .+.+++.+||+.||++||++.++++.|+.
T Consensus       269 --~~~~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~L~~  306 (333)
T 1mqb_A          269 --LPTPMDCPS---AIYQLMMQCWQQERARRPKFADIVSILDK  306 (333)
T ss_dssp             --CCCCTTCBH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             --CCCcccCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence              001111222   45577789999999999999999999875

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.8e-41  Score=337.26  Aligned_cols=247  Identities=27%  Similarity=0.395  Sum_probs=198.8

Q ss_pred             HhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      +.++|++.+.||+|+||.||++... +++.||+|++....   ......+.+|+.++++++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3478999999999999999999865 57789999986542   2234568899999999999999999999999999999


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      ||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        87 v~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             EECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            9999999999988843   456999999999999999999999987   9999999999999999999999999986543


Q ss_pred             CCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccccc
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD  477 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  477 (577)
                      ...    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+...             .
T Consensus       161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------~  223 (279)
T 3fdn_A          161 SSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------------E  223 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-------------C
T ss_pred             ccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC-------------C
Confidence            221    23357899999999999999999999999999999999999998654332221111110             0


Q ss_pred             CcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          478 PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       478 ~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ..+......   .+.+++..|++.||++|||+.|+++
T Consensus       224 ~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          224 FTFPDFVTE---GARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             CCCCTTSCH---HHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCCCCcCCH---HHHHHHHHHhccChhhCCCHHHHhh
Confidence            111111222   3456778999999999999999996

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4e-41  Score=336.50  Aligned_cols=255  Identities=25%  Similarity=0.403  Sum_probs=200.6

Q ss_pred             HhcCCccccccccCCcEEEEEeEecC----CcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLSN----GETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  316 (577)
                      ..++|...+.||+|+||.||+|...+    +..||+|.+.... ......+.+|+.++++++||||+++++++.+ +..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            35789999999999999999998543    3359999997653 3445678999999999999999999999865 4568


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccc
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~  396 (577)
                      +||||+++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        89 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           89 IIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             EEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             EEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence            99999999999998853  3456999999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCcccc
Q 008108          397 EMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNL  475 (577)
Q Consensus       397 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  475 (577)
                      ...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+..       +..   
T Consensus       164 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~-------~~~---  232 (281)
T 3cc6_A          164 EDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK-------GDR---  232 (281)
T ss_dssp             ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHH-------TCC---
T ss_pred             cccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhc-------CCC---
Confidence            543221 2223467889999999999999999999999999999998 9999865443332221111       000   


Q ss_pred             ccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       476 ~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                        .......+   ..+.+++..|++.||++||++.|+++.|+.
T Consensus       233 --~~~~~~~~---~~l~~li~~~l~~~p~~Rps~~ell~~L~~  270 (281)
T 3cc6_A          233 --LPKPDLCP---PVLYTLMTRCWDYDPSDRPRFTELVCSLSD  270 (281)
T ss_dssp             --CCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCCCCCCC---HHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence              00011122   235577789999999999999999999864

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.1e-41  Score=352.81  Aligned_cols=270  Identities=21%  Similarity=0.303  Sum_probs=208.0

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC--eEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERK--ERILV  318 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv  318 (577)
                      .++|.+.++||+|+||+||+|... +|+.||||++..... .....+.+|+.++++++||||+++++++.+..  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            367999999999999999999965 589999999976432 33456789999999999999999999998765  67999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEE----cCCCCeEEeccCCcc
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL----DSEMNPKISDFGMAR  394 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl----~~~~~~kl~DfGla~  394 (577)
                      |||+++|+|.+++........+++..++.++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999865444445999999999999999999999998   9999999999999    777889999999998


Q ss_pred             cccCCCccccccccccCCCCcChhhhhc--------CCCCccccEEecchhHhHHhhCCCCCCCCCc-cccchhhhhhhh
Q 008108          395 LFEMDQTHSDTNRVVGTFGYMAPEYVMH--------GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTE-EETEDLLTYAWR  465 (577)
Q Consensus       395 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~SlGvil~elltG~~p~~~~~~-~~~~~l~~~~~~  465 (577)
                      ......   ......||..|+|||++..        ..++.++||||||+++|||++|+.||..... ......+.....
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            765432   2233679999999999875        5678899999999999999999999864332 222222221111


Q ss_pred             hcccCCcccc---------ccCcCCC--C-ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          466 NWNEGAALNL---------MDPTMRG--G-STSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       466 ~~~~~~~~~~---------~d~~l~~--~-~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ......+...         ....+..  . .......+..++..|++.||++||++.|+++.+..
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~  306 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence            1111111000         0011111  1 23444556678899999999999999999888754

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=347.80  Aligned_cols=265  Identities=25%  Similarity=0.381  Sum_probs=193.7

Q ss_pred             hcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHH--HHHHHhcCCCCeEEEEeEEEc-----CCeE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNE--VLLLARLQHRNLVRLLGFCLE-----RKER  315 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E--~~~l~~l~h~niv~l~~~~~~-----~~~~  315 (577)
                      .++|++.++||+|+||.||+|.. +++.||||++......   .+..|  +..+..++|+||+++++.+..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~---~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchh---hHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            47899999999999999999977 6899999999754332   33334  444556899999999986542     2356


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC---------CCCcEEEeccCCCcEEEcCCCCeE
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED---------SRLRIIHRDLKASNILLDSEMNPK  386 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~---------~~~~iiHrDlkp~NiLl~~~~~~k  386 (577)
                      ++||||+++|+|.+++.    ...+++..++.++.||+.||.|||+.         +   |+||||||+||||+.++.+|
T Consensus        88 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLS----LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred             EEEEecCCCCcHHHHHh----hcccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence            89999999999999983    34469999999999999999999998         6   99999999999999999999


Q ss_pred             EeccCCcccccCCCc------cccccccccCCCCcChhhhhc-------CCCCccccEEecchhHhHHhhCCCCCCCCCc
Q 008108          387 ISDFGMARLFEMDQT------HSDTNRVVGTFGYMAPEYVMH-------GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTE  453 (577)
Q Consensus       387 l~DfGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlGvil~elltG~~p~~~~~~  453 (577)
                      |+|||+++.+.....      ........||+.|+|||++.+       ..++.++||||||+++|||++|+.|+.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            999999987653321      112224579999999999876       3566799999999999999999887654332


Q ss_pred             ccc-chhhhhhhhhcccC------CccccccCcCCC---CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          454 EET-EDLLTYAWRNWNEG------AALNLMDPTMRG---GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       454 ~~~-~~l~~~~~~~~~~~------~~~~~~d~~l~~---~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ... ...+..........      .......+.+..   ........+.+++..||+.||++|||+.||++.|+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~  315 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE  315 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence            211 11111000000000      000001111111   123345567788999999999999999999999875

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=8.9e-42  Score=364.26  Aligned_cols=248  Identities=22%  Similarity=0.269  Sum_probs=192.8

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      .++|++.++||+|+||.||++.. .+|+.||||++...   .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            36799999999999999999995 46899999999754   223334577899999999999999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE-DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      |||+++|+|.+++..   ...+++..+..++.||+.||.|||+ .+   |+||||||+||||+.++.+||+|||+++...
T Consensus       227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            999999999888843   4579999999999999999999998 77   9999999999999999999999999998643


Q ss_pred             CCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccccc
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD  477 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  477 (577)
                      ...  .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.   ..  .        
T Consensus       301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~---~~--~--------  365 (446)
T 4ejn_A          301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL---ME--E--------  365 (446)
T ss_dssp             C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HC--C--------
T ss_pred             CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHH---hC--C--------
Confidence            222  22334689999999999999999999999999999999999999986544332222111   00  0        


Q ss_pred             CcCCCCChHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 008108          478 PTMRGGSTSEMMKCIHIGLLCVQENVSNRP-----GMASVVN  514 (577)
Q Consensus       478 ~~l~~~~~~~~~~~~~l~~~C~~~~p~~RP-----t~~ev~~  514 (577)
                      ..+......   .+.+++..||+.||++||     ++.|+++
T Consensus       366 ~~~p~~~~~---~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          366 IRFPRTLGP---EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             CCCCTTSCH---HHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCCccCCH---HHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            001111222   445677899999999999     9999885

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.6e-42  Score=349.50  Aligned_cols=263  Identities=27%  Similarity=0.435  Sum_probs=204.5

Q ss_pred             hcCCccccccccCCcEEEEEeEe-----cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC--eE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-----SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK--ER  315 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~  315 (577)
                      .++|++.++||+|+||.||++..     .+++.||||++..........+.+|+.++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35688999999999999999983     368899999998776666678999999999999999999999987654  67


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      ++||||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       120 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEEECCCTTCBHHHHHHH--STTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            999999999999999854  2356999999999999999999999988   99999999999999999999999999987


Q ss_pred             ccCCCccc-cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCcccc---------chhhhhhhh
Q 008108          396 FEMDQTHS-DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET---------EDLLTYAWR  465 (577)
Q Consensus       396 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~---------~~l~~~~~~  465 (577)
                      ........ ......++..|+|||.+.+..++.++||||||+++|||+||..|+......-.         .........
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  274 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence            65443221 12334678889999999999999999999999999999999987642211000         000000000


Q ss_pred             hcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          466 NWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       466 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ....+..     .......+   ..+.+++..||+.||++|||+.||++.|+.
T Consensus       275 ~~~~~~~-----~~~~~~~~---~~l~~li~~cl~~dP~~Rps~~el~~~L~~  319 (326)
T 2w1i_A          275 LLKNNGR-----LPRPDGCP---DEIYMIMTECWNNNVNQRPSFRDLALRVDQ  319 (326)
T ss_dssp             HHHTTCC-----CCCCTTCC---HHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             HhhcCCC-----CCCCCccc---HHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            1111000     00111122   345567789999999999999999999874

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.7e-41  Score=332.86  Aligned_cols=252  Identities=23%  Similarity=0.341  Sum_probs=200.8

Q ss_pred             hcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC--CeEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER--KERILV  318 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  318 (577)
                      .++|+..++||+|+||.||+|... ++.||||++....  ......+.+|+.++++++||||+++++++.+.  ...++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            367899999999999999999985 8899999997653  34445789999999999999999999999887  778999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+++|+|.+++.. .....+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.++|+|||++.....
T Consensus        88 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           88 THWMPYGSLYNVLHE-GTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             EECCTTCBHHHHHHS-CSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             ecccCCCcHHHHHhh-cccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            999999999999854 22336999999999999999999999875 3499999999999999999999999988754321


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCc---cccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccc
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSV---KSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNL  475 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  475 (577)
                             ....||+.|+|||.+.+..++.   ++||||||+++|||++|+.||........   .....   ..+     
T Consensus       166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~---~~~-----  227 (271)
T 3kmu_A          166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI---GMKVA---LEG-----  227 (271)
T ss_dssp             -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH---HHHHH---HSC-----
T ss_pred             -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH---HHHHH---hcC-----
Confidence                   2356899999999998765544   89999999999999999999864433221   11111   011     


Q ss_pred             ccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       476 ~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ..+.+....+.   .+.+++..||+.||++|||+.|+++.|+.
T Consensus       228 ~~~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~~il~~L~~  267 (271)
T 3kmu_A          228 LRPTIPPGISP---HVSKLMKICMNEDPAKRPKFDMIVPILEK  267 (271)
T ss_dssp             CCCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            01111112223   35567779999999999999999999874

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.4e-41  Score=371.86  Aligned_cols=254  Identities=27%  Similarity=0.454  Sum_probs=198.4

Q ss_pred             cCCcccc-ccccCCcEEEEEeEec---CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          244 DNFSDAN-KLGQGGFGAVYKGMLS---NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       244 ~~f~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      +++.+.+ +||+|+||.||+|.+.   ++..||||+++... .....++.+|+.+|++++|||||++++++.. +..++|
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  413 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV  413 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence            3444444 7999999999999864   45679999997653 3355679999999999999999999999976 568999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+++|+|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus       414 ~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          414 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             EECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             EEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            999999999998854  3557999999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCcc-ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          399 DQTH-SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       399 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      .... .......+|+.|+|||++..+.++.++|||||||++|||++ |+.||......+....+.       .+....  
T Consensus       489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-------~~~~~~--  559 (613)
T 2ozo_A          489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-------QGKRME--  559 (613)
T ss_dssp             -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-------TTCCCC--
T ss_pred             CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cCCCCC--
Confidence            3221 11222346789999999999999999999999999999998 999987554433222111       111111  


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                         .....+   ..+.+++..||+.+|++||++.+|++.|+.
T Consensus       560 ---~p~~~~---~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  595 (613)
T 2ozo_A          560 ---CPPECP---PELYALMSDCWIYKWEDRPDFLTVEQRMRA  595 (613)
T ss_dssp             ---CCTTCC---HHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred             ---CCCcCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence               111122   345577789999999999999999999975

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.7e-41  Score=345.54  Aligned_cols=259  Identities=30%  Similarity=0.469  Sum_probs=201.8

Q ss_pred             HhcCCccccccccCCcEEEEEeEe------cCCcEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCe
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE  314 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  314 (577)
                      ..++|++.+.||+|+||.||+|..      .+++.||||++... ......++.+|+.++++++||||+++++++.+...
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            347899999999999999999984      35778999999754 34445578999999999999999999999999999


Q ss_pred             EEEEEEecCCCCcccccccCCC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC---CCCeEE
Q 008108          315 RILVYEFVPNASLDHFIFDPIN----REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKI  387 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~---~~~~kl  387 (577)
                      .++||||+++++|.+++.....    ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.   +..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence            9999999999999999865321    245999999999999999999999998   999999999999984   446999


Q ss_pred             eccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhh
Q 008108          388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRN  466 (577)
Q Consensus       388 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~  466 (577)
                      +|||+++...............||+.|+|||.+.++.++.++||||||+++|||+| |+.|+........   ...... 
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~~~~-  260 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---LEFVTS-  260 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HHHHHT-
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH---HHHHhc-
Confidence            99999986654433333344678999999999999999999999999999999998 8888765433221   211111 


Q ss_pred             cccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          467 WNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       467 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                         +..     +......+.   .+.+++..||+.||++||++.+|++.|..
T Consensus       261 ---~~~-----~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~l~~  301 (327)
T 2yfx_A          261 ---GGR-----MDPPKNCPG---PVYRIMTQCWQHQPEDRPNFAIILERIEY  301 (327)
T ss_dssp             ---TCC-----CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCC-----CCCCCCCCH---HHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence               100     001111222   45567789999999999999999999874

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-40  Score=342.06  Aligned_cols=271  Identities=21%  Similarity=0.302  Sum_probs=199.7

Q ss_pred             CChHHHHHHhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHh--cCCCCeEEEEeEEEc
Q 008108          234 FDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR--LQHRNLVRLLGFCLE  311 (577)
Q Consensus       234 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~  311 (577)
                      ..........++|++.++||+|+||.||+|... ++.||||++.....   ..+..|.+++..  ++||||+++++++..
T Consensus        27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~  102 (337)
T 3mdy_A           27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIK  102 (337)
T ss_dssp             SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             CCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence            444445556689999999999999999999875 89999999865432   234455555554  499999999999988


Q ss_pred             C----CeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCcEEEeccCCCcEEEcCC
Q 008108          312 R----KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS-----RLRIIHRDLKASNILLDSE  382 (577)
Q Consensus       312 ~----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-----~~~iiHrDlkp~NiLl~~~  382 (577)
                      .    ...++||||+++|+|.+++.    ...+++..++.++.|++.||.|||++.     ..+|+||||||+|||++.+
T Consensus       103 ~~~~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~  178 (337)
T 3mdy_A          103 GTGSWTQLYLITDYHENGSLYDYLK----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN  178 (337)
T ss_dssp             SCGGGCEEEEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred             CCCCCCceEEEEeccCCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC
Confidence            7    68899999999999999983    346999999999999999999999870     1139999999999999999


Q ss_pred             CCeEEeccCCcccccCCCccc--cccccccCCCCcChhhhhcCCCCcc------ccEEecchhHhHHhhCC---------
Q 008108          383 MNPKISDFGMARLFEMDQTHS--DTNRVVGTFGYMAPEYVMHGRFSVK------SDIFSFGVLVLEIVSGQ---------  445 (577)
Q Consensus       383 ~~~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~SlGvil~elltG~---------  445 (577)
                      +.+||+|||+++.+.......  ......||+.|+|||++.+...+.+      +||||||+++|||+||.         
T Consensus       179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~  258 (337)
T 3mdy_A          179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY  258 (337)
T ss_dssp             SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence            999999999998665433221  1224579999999999988776665      99999999999999994         


Q ss_pred             -CCCCCCCccccchhhhhhhhhcccCCccccccCcCCCC--ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          446 -KRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGG--STSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       446 -~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                       .|+.........  ..........    ....+.+...  .......+.+++..||+.||++|||+.||++.|+.
T Consensus       259 ~~p~~~~~~~~~~--~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  328 (337)
T 3mdy_A          259 QLPYHDLVPSDPS--YEDMREIVCI----KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK  328 (337)
T ss_dssp             CCTTTTTSCSSCC--HHHHHHHHTT----SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             cccHhhhcCCCCc--hhhhHHHHhh----hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence             444322111100  0000000000    0111111111  12345567789999999999999999999999975

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1e-40  Score=350.61  Aligned_cols=251  Identities=23%  Similarity=0.282  Sum_probs=187.9

Q ss_pred             cCCccc-cccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHh-cCCCCeEEEEeEEEc----CCeEE
Q 008108          244 DNFSDA-NKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLAR-LQHRNLVRLLGFCLE----RKERI  316 (577)
Q Consensus       244 ~~f~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~~  316 (577)
                      ++|.+. +.||+|+||+||++... +|+.||||++...     ..+.+|+.++.+ .+||||+++++++..    ....+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            566666 68999999999999965 6899999999643     246778888754 489999999999875    56789


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC---CCCeEEeccCCc
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMA  393 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~---~~~~kl~DfGla  393 (577)
                      |||||+++|+|.+++.. .....+++..+..|+.||+.||.|||+.+   |+||||||+||||+.   ++.+||+|||++
T Consensus       136 lv~E~~~gg~L~~~l~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEECCCSEEHHHHHHC-C---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence            99999999999999854 22346999999999999999999999988   999999999999998   788999999999


Q ss_pred             ccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccc-hhhhhhhhhcccCCc
Q 008108          394 RLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE-DLLTYAWRNWNEGAA  472 (577)
Q Consensus       394 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~  472 (577)
                      +......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......    ..+..
T Consensus       212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i----~~~~~  284 (400)
T 1nxk_A          212 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQY  284 (400)
T ss_dssp             EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----HHTCC
T ss_pred             cccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----HcCcc
Confidence            8654322   223467899999999999999999999999999999999999998654432211 111111    00000


Q ss_pred             cccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       473 ~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                       ....+.. ....   ..+.+++..||+.||++|||+.|+++-
T Consensus       285 -~~~~~~~-~~~s---~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          285 -EFPNPEW-SEVS---EEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             -CCCTTTT-TTSC---HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -cCCCccc-ccCC---HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence             0000000 1122   245577889999999999999999873

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.4e-40  Score=334.72  Aligned_cols=260  Identities=18%  Similarity=0.288  Sum_probs=202.9

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEE-EcCCeEEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC-LERKERILVYE  320 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~E  320 (577)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++......  .++.+|+.+++.++|++++..+.++ .+....++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            47899999999999999999995 57899999998765433  2578999999999988866655554 66778899999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEE---cCCCCeEEeccCCccccc
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL---DSEMNPKISDFGMARLFE  397 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl---~~~~~~kl~DfGla~~~~  397 (577)
                      |+ +++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||+++...
T Consensus        86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 9999998843  2457999999999999999999999998   9999999999999   588899999999998766


Q ss_pred             CCCccc-----cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCc
Q 008108          398 MDQTHS-----DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAA  472 (577)
Q Consensus       398 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  472 (577)
                      ......     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+........... 
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-  238 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-  238 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc-
Confidence            443211     12346799999999999999999999999999999999999999875443332222221111100000 


Q ss_pred             cccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       473 ~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .    +.+....+   ..+.+++..||+.||++|||+.+|++.|+.
T Consensus       239 ~----~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~l~~  277 (296)
T 3uzp_A          239 I----EVLCKGYP---SEFATYLNFCRSLRFDDKPDYSYLRQLFRN  277 (296)
T ss_dssp             H----HHHTTTSC---HHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred             h----HHHHhhCC---HHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence            0    00011112   245577889999999999999999999975

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.9e-41  Score=335.93  Aligned_cols=249  Identities=26%  Similarity=0.435  Sum_probs=180.9

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      .++|++.+.||+|+||.||+|.. .+|+.||||.+.....   .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            36799999999999999999996 5789999999965422   2235688999999999999999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            999999999998853  3357999999999999999999999998   99999999999999999999999999987653


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      ...  ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+...........+       ...      +.
T Consensus       165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~------~~  229 (278)
T 3cok_A          165 PHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV-------VLA------DY  229 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C-------CSS------CC
T ss_pred             CCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH-------hhc------cc
Confidence            222  122357899999999999889999999999999999999999998654322211100       000      01


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .+......   .+.+++.+|++.||++|||+.++++
T Consensus       230 ~~~~~~~~---~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          230 EMPSFLSI---EAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CCCTTSCH---HHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCccccCH---HHHHHHHHHcccCHhhCCCHHHHhc
Confidence            11111222   4457778999999999999998875

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=6.9e-41  Score=363.54  Aligned_cols=254  Identities=26%  Similarity=0.368  Sum_probs=203.6

Q ss_pred             HhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      ..++|+..+.||+|+||.||++... +|+.||||++.+..   ......+.+|+.+|..++||||+++++++.+.+..++
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            3567999999999999999999964 69999999996542   2334567899999999999999999999999999999


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      ||||+++|+|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus       262 VmEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence            99999999999888542 2345999999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccccc
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD  477 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  477 (577)
                      ....   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+........         
T Consensus       338 ~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~---------  405 (576)
T 2acx_A          338 EGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP---------  405 (576)
T ss_dssp             TTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC---------
T ss_pred             cCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc---------
Confidence            4322   2235899999999999998999999999999999999999999875443221111111111110         


Q ss_pred             CcCCCCChHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 008108          478 PTMRGGSTSEMMKCIHIGLLCVQENVSNRP-----GMASVVN  514 (577)
Q Consensus       478 ~~l~~~~~~~~~~~~~l~~~C~~~~p~~RP-----t~~ev~~  514 (577)
                      ..+......   .+.+++..|++.||++||     ++.||++
T Consensus       406 ~~~p~~~s~---~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          406 EEYSERFSP---QARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             CCCCTTSCH---HHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ccCCccCCH---HHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            011111222   445677799999999999     6777764

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1e-40  Score=335.64  Aligned_cols=261  Identities=18%  Similarity=0.288  Sum_probs=199.6

Q ss_pred             HhcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEE-EcCCeEEEEE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC-LERKERILVY  319 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~  319 (577)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++......  ..+.+|+.++..++|++++..++++ .+.+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999995 57899999987554322  2478899999999988877666655 6677889999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEE---cCCCCeEEeccCCcccc
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL---DSEMNPKISDFGMARLF  396 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl---~~~~~~kl~DfGla~~~  396 (577)
                      ||+ +++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||+++..
T Consensus        85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Ecc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            999 9999998753  2456999999999999999999999998   9999999999999   78999999999999876


Q ss_pred             cCCCcc-----ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCC
Q 008108          397 EMDQTH-----SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGA  471 (577)
Q Consensus       397 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  471 (577)
                      ......     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+...........
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            544321     122346899999999999999999999999999999999999999975444333222221111100000


Q ss_pred             ccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          472 ALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       472 ~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                       ..    .+....+   ..+.+++..|++.||++|||+.+|++.|+.
T Consensus       239 -~~----~~~~~~~---~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (296)
T 4hgt_A          239 -IE----VLCKGYP---SEFATYLNFCRSLRFDDKPDYSYLRQLFRN  277 (296)
T ss_dssp             -HH----HHTTTSC---HHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred             -hh----hhhccCC---HHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence             00    0001112   245577789999999999999999999875

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.5e-41  Score=337.85  Aligned_cols=252  Identities=25%  Similarity=0.360  Sum_probs=196.1

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      .++|.+.++||+|+||.||++... +++.+|+|++.... ......+.+|+.++++++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            367899999999999999999964 68899999987653 3345678999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEE---cCCCCeEEeccCCcccc
Q 008108          321 FVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL---DSEMNPKISDFGMARLF  396 (577)
Q Consensus       321 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl---~~~~~~kl~DfGla~~~  396 (577)
                      |+++++|.+++... .....+++..++.++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||+++..
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999998887542 12367999999999999999999999998   9999999999999   45678999999999876


Q ss_pred             cCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          397 EMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       397 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      .....   .....||+.|+|||.+. +.++.++||||||+++|||++|+.||..............     .......  
T Consensus       178 ~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~-----~~~~~~~--  246 (285)
T 3is5_A          178 KSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY-----KEPNYAV--  246 (285)
T ss_dssp             ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-----CCCCCCC--
T ss_pred             CCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc-----CCccccc--
Confidence            54322   23457999999999875 6789999999999999999999999865443322111111     0000000  


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                        . .....   ..+.+++..|++.||++|||+.|+++
T Consensus       247 --~-~~~~~---~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          247 --E-CRPLT---PQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             -----CCCC---HHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             --c-cCcCC---HHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0 00112   24457778999999999999999885

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=9.7e-41  Score=341.50  Aligned_cols=261  Identities=22%  Similarity=0.312  Sum_probs=202.9

Q ss_pred             ChHHHHHHhcCCccc-cccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhc-CCCCeEEEEeEE
Q 008108          235 DFETIRVATDNFSDA-NKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARL-QHRNLVRLLGFC  309 (577)
Q Consensus       235 ~~~~~~~~~~~f~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  309 (577)
                      .+.......+.|.+. ++||+|+||.||++... +++.||+|++....  .....++.+|+.++..+ +||||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            344455566778877 88999999999999965 68999999987643  33356789999999999 569999999999


Q ss_pred             EcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC---CCCeE
Q 008108          310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS---EMNPK  386 (577)
Q Consensus       310 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~---~~~~k  386 (577)
                      .+.+..++||||+++|+|.+++.. .....+++..++.++.||+.||.|||+++   |+||||||+|||++.   ++.+|
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~k  174 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIK  174 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEE
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEE
Confidence            999999999999999999998844 23467999999999999999999999998   999999999999998   78999


Q ss_pred             EeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhh
Q 008108          387 ISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRN  466 (577)
Q Consensus       387 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~  466 (577)
                      |+|||+++.......   .....||+.|+|||++....++.++||||||+++|||++|+.||...........+...   
T Consensus       175 L~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~---  248 (327)
T 3lm5_A          175 IVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV---  248 (327)
T ss_dssp             ECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT---
T ss_pred             EeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc---
Confidence            999999987653322   23357999999999999999999999999999999999999998654432221111110   


Q ss_pred             cccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          467 WNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       467 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                       ....     .........   ..+.+++..|++.||++|||+.|+++
T Consensus       249 -~~~~-----~~~~~~~~~---~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          249 -NVDY-----SEETFSSVS---QLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             -CCCC-----CTTTTTTSC---HHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -cccc-----CchhhcccC---HHHHHHHHHHcCCChhhCcCHHHHhC
Confidence             0000     000001112   23556778999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.7e-41  Score=337.70  Aligned_cols=246  Identities=26%  Similarity=0.442  Sum_probs=200.5

Q ss_pred             HhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEc---------
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE---------  311 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  311 (577)
                      ...+|+..+.||+|+||.||++... +++.||+|++.....    .+.+|+.++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG----GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            3467999999999999999999975 789999999976543    46789999999999999999998864         


Q ss_pred             -------CCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCC
Q 008108          312 -------RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN  384 (577)
Q Consensus       312 -------~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~  384 (577)
                             ....++||||+++++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence                   44579999999999999998542 3457999999999999999999999998   999999999999999999


Q ss_pred             eEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhh
Q 008108          385 PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAW  464 (577)
Q Consensus       385 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~  464 (577)
                      +||+|||++........   .....||+.|+|||.+.+..++.++||||||+++|||++|..|+..     ....    +
T Consensus       161 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-----~~~~----~  228 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-----TSKF----F  228 (284)
T ss_dssp             EEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH-----HHHH----H
T ss_pred             EEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh-----HHHH----H
Confidence            99999999987654322   2235799999999999999999999999999999999999987531     1111    1


Q ss_pred             hhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          465 RNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       465 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .....+.        +....+.   .+.+++..|++.||++|||+.|+++.|..
T Consensus       229 ~~~~~~~--------~~~~~~~---~~~~li~~~l~~dp~~Rps~~e~l~~l~~  271 (284)
T 2a19_B          229 TDLRDGI--------ISDIFDK---KEKTLLQKLLSKKPEDRPNTSEILRTLTV  271 (284)
T ss_dssp             HHHHTTC--------CCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHhhccc--------ccccCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            1111111        1111222   34567789999999999999999999875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=9.9e-41  Score=338.53  Aligned_cols=258  Identities=23%  Similarity=0.377  Sum_probs=193.9

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|++.+.||+|+||.||+|.. .+|+.||||++...   .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            5789999999999999999995 47899999999753   2334556889999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          320 EFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      ||+++++|.+++.... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            9999999998875321 2456999999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      ...  ......||..|+|||.+.+..++.++||||||+++|||++|+.||...... ...+...    .......    +
T Consensus       189 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~----~~~~~~~----~  257 (310)
T 2wqm_A          189 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKK----IEQCDYP----P  257 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-HHHHHHH----HHTTCSC----C
T ss_pred             CCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-HHHHHHH----hhcccCC----C
Confidence            222  222357899999999999999999999999999999999999998643221 1111111    1111110    0


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ........   .+.+++..||+.||++|||+.+|++.|+.
T Consensus       258 ~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~il~~l~~  294 (310)
T 2wqm_A          258 LPSDHYSE---ELRQLVNMCINPDPEKRPDVTYVYDVAKR  294 (310)
T ss_dssp             CCTTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CcccccCH---HHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence            00111222   45567779999999999999999999975

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.6e-41  Score=350.54  Aligned_cols=204  Identities=27%  Similarity=0.465  Sum_probs=164.1

Q ss_pred             HHhcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccC--ChhhHHHHHHHHHHHHhcC-CCCeEEEEeEEEcCC--e
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERK--E  314 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~  314 (577)
                      ...++|++.++||+|+||.||+|.. .+|+.||||++...  .......+.+|+.++..+. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3457899999999999999999985 46899999998653  3344456789999999997 999999999997544  6


Q ss_pred             EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      .++||||++ ++|..++.    ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus        86 ~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIR----ANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEEECCS-EEHHHHHH----HTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecccC-cCHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            899999997 58887773    357999999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCc-------------------cccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCC
Q 008108          395 LFEMDQT-------------------HSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGT  452 (577)
Q Consensus       395 ~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~  452 (577)
                      .+.....                   ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  235 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS  235 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            6543111                   111234589999999999976 678999999999999999999999987544

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=7.8e-41  Score=358.04  Aligned_cols=261  Identities=22%  Similarity=0.274  Sum_probs=193.2

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC------C
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER------K  313 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  313 (577)
                      .++|++.++||+|+||+||++... +|+.||||++...  .......+.+|+.+|+.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            468999999999999999999854 6899999999764  334455688999999999999999999999654      3


Q ss_pred             eEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCc
Q 008108          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (577)
Q Consensus       314 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla  393 (577)
                      ..+|||||++++ |.+.+     ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       141 ~~~lv~E~~~~~-l~~~~-----~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVI-----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSEE-HHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCCC-HHHHH-----hhcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            579999999875 44444     234999999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhh-hhh-------hh
Q 008108          394 RLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL-TYA-------WR  465 (577)
Q Consensus       394 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~-~~~-------~~  465 (577)
                      +......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+ ...       +.
T Consensus       212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          212 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             -----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             eecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            8765322   233468999999999999999999999999999999999999998654432211111 100       00


Q ss_pred             hc-------cc-------CCccccccCcCCCC-C---hHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          466 NW-------NE-------GAALNLMDPTMRGG-S---TSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       466 ~~-------~~-------~~~~~~~d~~l~~~-~---~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      .+       ..       ......+...+... .   ......+.+++..||+.||++|||+.|+++-
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00       00       00000011111001 0   1113456788899999999999999998863

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.6e-40  Score=345.11  Aligned_cols=255  Identities=20%  Similarity=0.354  Sum_probs=202.4

Q ss_pred             HHHHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh--------hhHHHHHHHHHHHHhc-CCCCeEEEEeE
Q 008108          239 IRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK--------QGEIEFKNEVLLLARL-QHRNLVRLLGF  308 (577)
Q Consensus       239 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~~~  308 (577)
                      .....++|++.+.||+|+||.||+|... +|+.||||++.....        .....+.+|+.++.++ +||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            3445678999999999999999999975 799999999865431        1133578899999999 79999999999


Q ss_pred             EEcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEe
Q 008108          309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKIS  388 (577)
Q Consensus       309 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~  388 (577)
                      +......++||||+++++|.+++.+   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~  242 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS  242 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence            9999999999999999999998843   457999999999999999999999998   9999999999999999999999


Q ss_pred             ccCCcccccCCCccccccccccCCCCcChhhhhcC------CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhh
Q 008108          389 DFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG------RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTY  462 (577)
Q Consensus       389 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~  462 (577)
                      |||++........   .....||+.|+|||++.+.      .++.++||||||+++|||++|+.||.......   .+..
T Consensus       243 DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~  316 (365)
T 2y7j_A          243 DFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL---MLRM  316 (365)
T ss_dssp             CCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH
T ss_pred             ecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH---HHHH
Confidence            9999987654322   2346799999999998643      58889999999999999999999986433221   1111


Q ss_pred             hhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          463 AWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       463 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ...    +.. ....+.. ...   ...+.+++..|++.||++|||+.|+++
T Consensus       317 i~~----~~~-~~~~~~~-~~~---~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          317 IME----GQY-QFSSPEW-DDR---SSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHH----TCC-CCCHHHH-SSS---CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHh----CCC-CCCCccc-ccC---CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            110    000 0000000 011   124557888999999999999999986

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.1e-41  Score=339.76  Aligned_cols=250  Identities=23%  Similarity=0.354  Sum_probs=199.9

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      .++|.+.+.||+|+||.||++... +|+.||+|.+..........+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            467899999999999999999965 6899999999876555556788999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEE---cCCCCeEEeccCCcccccC
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL---DSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl---~~~~~~kl~DfGla~~~~~  398 (577)
                      +++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||+++....
T Consensus        88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            999999888743   457999999999999999999999998   9999999999999   7888999999999976432


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      .    ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........   .........     . +..
T Consensus       162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~-----~-~~~  228 (304)
T 2jam_A          162 G----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL---FEKIKEGYY-----E-FES  228 (304)
T ss_dssp             B----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHHCCC-----C-CCT
T ss_pred             C----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHHcCCC-----C-CCc
Confidence            2    12235689999999999999999999999999999999999999865433222   111111000     0 001


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ......+   ..+.+++..|++.||++|||+.|+++
T Consensus       229 ~~~~~~~---~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          229 PFWDDIS---ESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             TTTTTSC---HHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cccccCC---HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1111122   34557778999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-41  Score=351.05  Aligned_cols=255  Identities=26%  Similarity=0.438  Sum_probs=189.2

Q ss_pred             CCccccccccCCcEEEEEeEecC--C--cEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEc-CCeEEEE
Q 008108          245 NFSDANKLGQGGFGAVYKGMLSN--G--ETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLE-RKERILV  318 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv  318 (577)
                      .|...++||+|+||+||+|...+  +  ..||||.+.... .....++.+|+.++++++||||+++++++.+ ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            46677899999999999998642  2  358999987543 3445678999999999999999999998754 4578999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+++|+|.+++..  ....+++..++.++.||++||.|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus       170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence            999999999999853  3456899999999999999999999998   99999999999999999999999999986643


Q ss_pred             CCccc--cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhC-CCCCCCCCccccchhhhhhhhhcccCCcccc
Q 008108          399 DQTHS--DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSG-QKRSSFGTEEETEDLLTYAWRNWNEGAALNL  475 (577)
Q Consensus       399 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  475 (577)
                      .....  ......+|+.|+|||++.+..++.++||||||+++|||+|| ..|+......+.   .....    .+..  .
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~~~~----~~~~--~  315 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYLL----QGRR--L  315 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HHHHH----TTCC--C
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HHHHH----cCCC--C
Confidence            32211  12334678899999999999999999999999999999995 555543332221   11111    1110  0


Q ss_pred             ccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCC
Q 008108          476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD  519 (577)
Q Consensus       476 ~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~  519 (577)
                      ..+   ...+.   .+.+++..||+.||++|||+.|+++.|+..
T Consensus       316 ~~p---~~~~~---~l~~li~~cl~~dp~~RPs~~ell~~L~~i  353 (373)
T 3c1x_A          316 LQP---EYCPD---PLYEVMLKCWHPKAEMRPSFSELVSRISAI  353 (373)
T ss_dssp             CCC---TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC---CCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111   11222   455777899999999999999999999753

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.1e-40  Score=342.80  Aligned_cols=269  Identities=25%  Similarity=0.313  Sum_probs=207.3

Q ss_pred             CCChHHHHHHhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHh--cCCCCeEEEEeEEE
Q 008108          233 QFDFETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLAR--LQHRNLVRLLGFCL  310 (577)
Q Consensus       233 ~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~  310 (577)
                      ..++..-....++|.+.+.||+|+||.||+|.. +|+.||||++....   ...+.+|.+++..  ++||||+++++++.
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~  106 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADN  106 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence            444555566778999999999999999999998 58999999996543   3467788888887  79999999999998


Q ss_pred             cCC----eEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCcEEEeccCCCcEE
Q 008108          311 ERK----ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH--------EDSRLRIIHRDLKASNIL  378 (577)
Q Consensus       311 ~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH--------~~~~~~iiHrDlkp~NiL  378 (577)
                      ...    ..++||||+++|+|.+++.    +..+++..++.++.||+.||.|||        +.+   |+||||||+|||
T Consensus       107 ~~~~~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIl  179 (342)
T 1b6c_B          107 KDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNIL  179 (342)
T ss_dssp             CCCSSCCCEEEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEE
T ss_pred             ccCCccceeEEEEeecCCCcHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEE
Confidence            876    7899999999999999984    346999999999999999999999        665   999999999999


Q ss_pred             EcCCCCeEEeccCCcccccCCCccc--cccccccCCCCcChhhhhcCC------CCccccEEecchhHhHHhhC------
Q 008108          379 LDSEMNPKISDFGMARLFEMDQTHS--DTNRVVGTFGYMAPEYVMHGR------FSVKSDIFSFGVLVLEIVSG------  444 (577)
Q Consensus       379 l~~~~~~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~SlGvil~elltG------  444 (577)
                      |+.++.+||+|||+++.........  ......||+.|+|||++.+..      ++.++||||||+++|||+||      
T Consensus       180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~  259 (342)
T 1b6c_B          180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  259 (342)
T ss_dssp             ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred             ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence            9999999999999998765433221  233457999999999987662      34789999999999999999      


Q ss_pred             ----CCCCCCCCccccchhhhhhhhhcccCCccccccCcCCC--CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          445 ----QKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG--GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       445 ----~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                          +.||.........  ...........    .+.+.+..  ........+.+++.+||+.||++|||+.||++.|+.
T Consensus       260 ~~~~~~p~~~~~~~~~~--~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~  333 (342)
T 1b6c_B          260 HEDYQLPYYDLVPSDPS--VEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  333 (342)
T ss_dssp             CCCCCCTTTTTSCSSCC--HHHHHHHHTTS----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             ccccccCccccCcCccc--HHHHHHHHHHH----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence                5565433221110  00011111111    11111111  123445567789999999999999999999999874

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=7.5e-41  Score=344.30  Aligned_cols=251  Identities=23%  Similarity=0.343  Sum_probs=198.2

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      .++|++.+.||+|+||.||++... +|+.||||++.+....    ..+|++++.++ +||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            467999999999999999999965 6889999999765432    35678888888 79999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCC-C---CeEEeccCCcccc
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE-M---NPKISDFGMARLF  396 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~-~---~~kl~DfGla~~~  396 (577)
                      |+++|+|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||+.++ +   .+||+|||+++..
T Consensus        97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            9999999988843   457999999999999999999999998   9999999999998543 3   4999999999876


Q ss_pred             cCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          397 EMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       397 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      .....  ......||+.|+|||++.+..++.++||||||+++|||++|+.||..........++.....    +...  +
T Consensus       171 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~----~~~~--~  242 (342)
T 2qr7_A          171 RAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS----GKFS--L  242 (342)
T ss_dssp             BCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH----CCCC--C
T ss_pred             cCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc----CCcc--c
Confidence            54322  22346789999999999888899999999999999999999999875433333333322111    1100  0


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ..........   .+.+++..|++.||++|||+.|+++
T Consensus       243 ~~~~~~~~s~---~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          243 SGGYWNSVSD---TAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             CSTTTTTSCH---HHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CccccccCCH---HHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0001111222   3456777999999999999999875

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.5e-40  Score=336.05  Aligned_cols=248  Identities=25%  Similarity=0.422  Sum_probs=203.1

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      +.|+..++||+|+||.||+|.. .+++.||||++.... ......+.+|+.+++.++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            5689999999999999999985 468999999997553 33456789999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|.+++.    ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus       102 ~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A          102 LGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             CTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred             CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence            99999999873    357999999999999999999999998   99999999999999999999999999987654322


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR  481 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  481 (577)
                        ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+...........+   ..    ..     .+.+.
T Consensus       175 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~----~~-----~~~~~  240 (303)
T 3a7i_A          175 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI---PK----NN-----PPTLE  240 (303)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HH----SC-----CCCCC
T ss_pred             --ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh---hc----CC-----CCCCc
Confidence              223467899999999999999999999999999999999999998644322211111   11    00     11111


Q ss_pred             CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       482 ~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      ...+.   .+..++..||+.||++|||+.|+++.
T Consensus       241 ~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          241 GNYSK---PLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             SSCCH---HHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             cccCH---HHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            12223   35567789999999999999998863

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.3e-41  Score=351.87  Aligned_cols=247  Identities=23%  Similarity=0.269  Sum_probs=191.0

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHHH-HHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLL-LARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      ++|++.+.||+|+||.||++... +++.||||++.+...   .....+.+|..+ ++.++||||+++++++.+.+..++|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            67999999999999999999965 588999999976532   223345667666 4678999999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+++|+|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus       118 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          118 LDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            999999999988843   457999999999999999999999998   99999999999999999999999999986432


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      ..  .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.   ......    ..      .
T Consensus       192 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~~~i~~----~~------~  256 (373)
T 2r5t_A          192 HN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YDNILN----KP------L  256 (373)
T ss_dssp             CC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH---HHHHHH----SC------C
T ss_pred             CC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHh----cc------c
Confidence            22  233457899999999999999999999999999999999999999865433221   111111    00      0


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .+......   .+.+++..|++.||++||++.+.++
T Consensus       257 ~~~~~~~~---~~~~li~~lL~~dp~~R~~~~~~~~  289 (373)
T 2r5t_A          257 QLKPNITN---SARHLLEGLLQKDRTKRLGAKDDFM  289 (373)
T ss_dssp             CCCSSSCH---HHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred             CCCCCCCH---HHHHHHHHHcccCHHhCCCCCCCHH
Confidence            01111222   3456777999999999999864433

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9.7e-41  Score=335.97  Aligned_cols=248  Identities=24%  Similarity=0.360  Sum_probs=202.4

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      .++|...+.||+|+||.||++... +++.||+|++....   ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            367899999999999999999965 57889999986542   33445688999999999999999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        94 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            99999999998873   3457999999999999999999999998   99999999999999999999999999987653


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      ...  ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+......+....+       ....      .
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------~~~~------~  232 (294)
T 2rku_A          168 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI-------KKNE------Y  232 (294)
T ss_dssp             TTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-------HTTC------C
T ss_pred             Ccc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------hhcc------C
Confidence            322  223367999999999999889999999999999999999999998654332211111       0110      0


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .+......   .+.+++..|++.||++|||+.|+++
T Consensus       233 ~~~~~~~~---~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          233 SIPKHINP---VAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             CCCTTSCH---HHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CCccccCH---HHHHHHHHHcccChhhCcCHHHHhh
Confidence            11111222   3456778999999999999999886

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5.1e-41  Score=346.46  Aligned_cols=245  Identities=28%  Similarity=0.430  Sum_probs=196.0

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      +.|+..+.||+|+||+||+|.. .+|+.||||++.....   .....+.+|+.++++++||||+++++++.+.+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588899999999999999995 5789999999975432   23346889999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||++ |+|.+++..  .+..+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus       134 e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             ECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             ecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            9997 577666632  3457999999999999999999999998   999999999999999999999999999865422


Q ss_pred             CccccccccccCCCCcChhhhh---cCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVM---HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                            ....||+.|+|||++.   .+.++.++||||||+++|||++|+.|+........   +.....    +.     
T Consensus       208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---~~~~~~----~~-----  269 (348)
T 1u5q_A          208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHIAQ----NE-----  269 (348)
T ss_dssp             ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHH----SC-----
T ss_pred             ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHh----cC-----
Confidence                  2357999999999985   56789999999999999999999999864332211   111110    00     


Q ss_pred             cCcCCC-CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          477 DPTMRG-GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       477 d~~l~~-~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      .+.+.. ..+.   .+.+++..||+.||++|||+.++++.
T Consensus       270 ~~~~~~~~~~~---~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          270 SPALQSGHWSE---YFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             CCCCCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CCCCCCCCCCH---HHHHHHHHHcccChhhCcCHHHHhhC
Confidence            011111 1222   34467779999999999999998753

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=9.2e-41  Score=336.68  Aligned_cols=255  Identities=26%  Similarity=0.427  Sum_probs=197.5

Q ss_pred             cCCccccccccCCcEEEEEeEecC----CcEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEE-cCCeEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSN----GETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCL-ERKERIL  317 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~l  317 (577)
                      .+|+..++||+|+||.||+|...+    ...+|+|.+..... .....+.+|+.++++++||||+++++++. .++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            568889999999999999998542    23589999876443 34456899999999999999999999865 4567899


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      ||||+++|+|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       105 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             EEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             EEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence            9999999999999853  3456899999999999999999999998   9999999999999999999999999998665


Q ss_pred             CCCcc--ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCC-CCCccccchhhhhhhhhcccCCccc
Q 008108          398 MDQTH--SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSS-FGTEEETEDLLTYAWRNWNEGAALN  474 (577)
Q Consensus       398 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~-~~~~~~~~~l~~~~~~~~~~~~~~~  474 (577)
                      .....  .......||+.|+|||.+.+..++.++||||||+++|||++|..|+. .....+.   ......    +..  
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~~~~~~----~~~--  250 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYLLQ----GRR--  250 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---HHHHHT----TCC--
T ss_pred             ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---HHHHhc----CCC--
Confidence            43221  12233567889999999999999999999999999999999665543 2222111   111111    000  


Q ss_pred             cccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          475 LMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       475 ~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ...+   ...+.   .+.+++..|++.||++|||+.|+++.|+.
T Consensus       251 ~~~~---~~~~~---~l~~li~~~l~~~p~~Rps~~ell~~L~~  288 (298)
T 3f66_A          251 LLQP---EYCPD---PLYEVMLKCWHPKAEMRPSFSELVSRISA  288 (298)
T ss_dssp             CCCC---TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCC---ccCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            0001   11222   45577789999999999999999999975

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=6e-41  Score=337.08  Aligned_cols=254  Identities=30%  Similarity=0.474  Sum_probs=200.0

Q ss_pred             hcCCcccc-ccccCCcEEEEEeEe---cCCcEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEE
Q 008108          243 TDNFSDAN-KLGQGGFGAVYKGML---SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (577)
Q Consensus       243 ~~~f~~~~-~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  316 (577)
                      .++|.+.+ .||+|+||.||+|..   .+++.||||++.....  ....++.+|+.+++.++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            45677777 999999999999964   3468899999976532  2345789999999999999999999999 566789


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccc
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~  396 (577)
                      +||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            99999999999999843   456999999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCccc-cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccc
Q 008108          397 EMDQTHS-DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALN  474 (577)
Q Consensus       397 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  474 (577)
                      ....... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+...........+.       .+..  
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-------~~~~--  238 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGER--  238 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTCC--
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCCC--
Confidence            5433221 1223456789999999999999999999999999999999 999986544332211111       1110  


Q ss_pred             cccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          475 LMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       475 ~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                         +......+.   .+.+++..||+.||++||++.+|++.|+.
T Consensus       239 ---~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~L~~  276 (291)
T 1xbb_A          239 ---MGCPAGCPR---EMYDLMNLCWTYDVENRPGFAAVELRLRN  276 (291)
T ss_dssp             ---CCCCTTCCH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ---CCCCCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence               111111222   45567789999999999999999999874

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.9e-41  Score=341.77  Aligned_cols=263  Identities=24%  Similarity=0.326  Sum_probs=202.2

Q ss_pred             HhcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEE----cCCeEE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL----ERKERI  316 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~  316 (577)
                      ..++|++.++||+|+||.||++.. .+++.||||++..........+.+|+.+++.++||||+++++++.    .....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            346799999999999999999996 578999999997776666778999999999999999999999987    344789


Q ss_pred             EEEEecCCCCcccccccC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          317 LVYEFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      +||||+++|+|.+++... .....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            999999999999887542 12467999999999999999999999998   99999999999999999999999999876


Q ss_pred             ccCCCccc-------cccccccCCCCcChhhhhcCC---CCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhh
Q 008108          396 FEMDQTHS-------DTNRVVGTFGYMAPEYVMHGR---FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWR  465 (577)
Q Consensus       396 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~  465 (577)
                      ........       ......||+.|+|||.+....   ++.++||||||+++|||++|+.||.......  ..+.....
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~  261 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG--DSVALAVQ  261 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT--SCHHHHHH
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc--chhhHHhh
Confidence            53211110       012245799999999987554   6899999999999999999999874211100  00110000


Q ss_pred             hcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCCC
Q 008108          466 NWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDT  520 (577)
Q Consensus       466 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~~  520 (577)
                         ...  ..  +. .....   ..+.+++..||+.||++|||+.+|++.|+...
T Consensus       262 ---~~~--~~--~~-~~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          262 ---NQL--SI--PQ-SPRHS---SALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             ---CC----C--CC-CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             ---ccC--CC--Cc-cccCC---HHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence               000  00  00 01122   34557788999999999999999999998643

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=8.8e-41  Score=353.45  Aligned_cols=253  Identities=22%  Similarity=0.331  Sum_probs=189.8

Q ss_pred             HHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh--------hhHHHHHHHHHHHHhcCCCCeEEEEeEEEc
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK--------QGEIEFKNEVLLLARLQHRNLVRLLGFCLE  311 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  311 (577)
                      ...++|.+.++||+|+||+||+|... +++.||||++.+...        .....+.+|+.+|++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            44688999999999999999999864 689999999875421        112247899999999999999999999754


Q ss_pred             CCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC---CeEEe
Q 008108          312 RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM---NPKIS  388 (577)
Q Consensus       312 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~---~~kl~  388 (577)
                       +..++||||+++|+|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++   .+||+
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             -CceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence             56899999999999998884   3567999999999999999999999998   99999999999997544   59999


Q ss_pred             ccCCcccccCCCccccccccccCCCCcChhhhhc---CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhh
Q 008108          389 DFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH---GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWR  465 (577)
Q Consensus       389 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~  465 (577)
                      |||+++......   ......||+.|+|||++..   ..++.++||||||+++|||++|+.||.......  .+....  
T Consensus       285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i--  357 (419)
T 3i6u_A          285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI--  357 (419)
T ss_dssp             CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHH--
T ss_pred             ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHH--
Confidence            999998765322   2234679999999999853   678899999999999999999999986433221  111110  


Q ss_pred             hcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          466 NWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       466 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                        ..+... .. +......   ...+.+++..|++.||++|||+.|+++
T Consensus       358 --~~~~~~-~~-~~~~~~~---~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          358 --TSGKYN-FI-PEVWAEV---SEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             --HTTCCC-CC-HHHHTTS---CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --hcCCCC-CC-chhhccc---CHHHHHHHHHHccCChhHCcCHHHHhC
Confidence              011000 00 0000011   234567888999999999999999886

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.5e-41  Score=345.11  Aligned_cols=243  Identities=23%  Similarity=0.312  Sum_probs=198.4

Q ss_pred             HhcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChh--------hHHHHHHHHHHHHhcCCCCeEEEEeEEEcC
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ--------GEIEFKNEVLLLARLQHRNLVRLLGFCLER  312 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  312 (577)
                      ..++|++.++||+|+||.||+|.. .+++.||||++......        ....+.+|+.++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            457899999999999999999985 46889999999765321        222467899999999999999999999999


Q ss_pred             CeEEEEEEecCCC-CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccC
Q 008108          313 KERILVYEFVPNA-SLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG  391 (577)
Q Consensus       313 ~~~~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfG  391 (577)
                      +..++||||+.+| +|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999777 8988874   3457999999999999999999999998   9999999999999999999999999


Q ss_pred             CcccccCCCccccccccccCCCCcChhhhhcCCC-CccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccC
Q 008108          392 MARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRF-SVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEG  470 (577)
Q Consensus       392 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  470 (577)
                      +++.......   .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....     ...         
T Consensus       176 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~---------  238 (335)
T 3dls_A          176 SAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----TVE---------  238 (335)
T ss_dssp             TCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----GTT---------
T ss_pred             cceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----HHh---------
Confidence            9987654322   223579999999999988876 8899999999999999999999853110     000         


Q ss_pred             CccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          471 AALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       471 ~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                         ..+.+  ......   .+.+++..|++.||++|||+.|+++-
T Consensus       239 ---~~~~~--~~~~~~---~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          239 ---AAIHP--PYLVSK---ELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ---TCCCC--SSCCCH---HHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ---hccCC--CcccCH---HHHHHHHHHccCChhhCcCHHHHhcC
Confidence               00000  001222   35577789999999999999999874

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=9.2e-41  Score=342.84  Aligned_cols=247  Identities=24%  Similarity=0.361  Sum_probs=201.9

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|.+.+.||+|+||.||++... +++.||+|++....   ......+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            57888999999999999999965 57889999987542   334456889999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       121 e~~~~~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          121 ELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             CCCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             ecCCCCCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            9999999998874   3467999999999999999999999998   999999999999999999999999999876533


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                      ..  ......||..|+|||++.+..++.++||||||+++|||++|+.||......+....+.       ...      ..
T Consensus       195 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-------~~~------~~  259 (335)
T 2owb_A          195 GE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK-------KNE------YS  259 (335)
T ss_dssp             TC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-------HTC------CC
T ss_pred             cc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh-------cCC------CC
Confidence            22  2234679999999999999999999999999999999999999986543322111110       000      01


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      +......   .+.+++..||+.||++||++.|+++
T Consensus       260 ~~~~~~~---~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          260 IPKHINP---VAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             CCTTSCH---HHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CCccCCH---HHHHHHHHHccCChhHCcCHHHHhc
Confidence            1111222   3456778999999999999999986

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-41  Score=347.66  Aligned_cols=254  Identities=25%  Similarity=0.348  Sum_probs=200.4

Q ss_pred             hcCCccccccccCCcEEEEEeEe----cCCcEEEEEEeccCC----hhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCC
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNS----KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERK  313 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  313 (577)
                      .++|++.++||+|+||.||++..    .+++.||||++....    ......+.+|+.++.++ +||||+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            36899999999999999999996    478999999987542    12233567899999999 6999999999999999


Q ss_pred             eEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCc
Q 008108          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (577)
Q Consensus       314 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla  393 (577)
                      ..++||||+++++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            99999999999999998843   457999999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCccccccccccCCCCcChhhhhcC--CCCccccEEecchhHhHHhhCCCCCCCCCccccc-hhhhhhhhhcccC
Q 008108          394 RLFEMDQTHSDTNRVVGTFGYMAPEYVMHG--RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE-DLLTYAWRNWNEG  470 (577)
Q Consensus       394 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~  470 (577)
                      +.+...... ......||+.|+|||++.++  .++.++||||||+++|||++|+.||......... .+.......    
T Consensus       207 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~----  281 (355)
T 1vzo_A          207 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS----  281 (355)
T ss_dssp             EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC----
T ss_pred             eecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc----
Confidence            866433222 23346799999999999863  4789999999999999999999998754432221 111111110    


Q ss_pred             CccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHh
Q 008108          471 AALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRP-----GMASVVNML  516 (577)
Q Consensus       471 ~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RP-----t~~ev~~~L  516 (577)
                            .+.......   ..+.+++..||+.||++||     ++.|+++..
T Consensus       282 ------~~~~~~~~~---~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          282 ------EPPYPQEMS---ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             ------CCCCCTTSC---HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             ------CCCCCcccC---HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                  011111122   2345677899999999999     899988653

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.7e-41  Score=343.37  Aligned_cols=263  Identities=24%  Similarity=0.372  Sum_probs=192.9

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhH-HHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGE-IEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ++|...++||+|+||+||+|... +++.||||++........ ..+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57899999999999999999965 789999999975432221 1345799999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      ++ |+|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            97 488777743  2456999999999999999999999998   99999999999999999999999999986543221


Q ss_pred             cccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccccc---
Q 008108          402 HSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD---  477 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d---  477 (577)
                        ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+...........+.....   
T Consensus       156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          156 --TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             --ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence              2223578999999999876 5689999999999999999999999876544332222211111001111111100   


Q ss_pred             ------CcCCCC-----ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          478 ------PTMRGG-----STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       478 ------~~l~~~-----~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                            +.....     .......+.+++..|++.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                  000000     0011134567888999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-40  Score=335.02  Aligned_cols=256  Identities=25%  Similarity=0.344  Sum_probs=200.5

Q ss_pred             CCccccccccCCcEEEEEeEec-CC---cEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeE-EEE
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NG---ETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKER-ILV  318 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv  318 (577)
                      .|...++||+|+||+||+|... ++   ..||+|.+..... .....+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4566789999999999999853 22   3799999976443 3445688999999999999999999999877665 999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+.+++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            999999999998854  3467899999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCc--cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          399 DQT--HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       399 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      ...  ........+|..|+|||.+.+..++.++||||||+++|||++|+.|+......  ..+.........        
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~--------  246 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTHFLAQGRR--------  246 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHHHHHTTCC--------
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHHHhhcCCC--------
Confidence            321  12233457889999999999999999999999999999999977765432221  111111111000        


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCC
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD  519 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~  519 (577)
                       .......+   ..+.+++..|++.||++|||+.+++++|+..
T Consensus       247 -~~~~~~~~---~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          247 -LPQPEYCP---DSLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             -CCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCCccch---HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             00011122   2455777899999999999999999999763

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.4e-40  Score=331.77  Aligned_cols=253  Identities=26%  Similarity=0.406  Sum_probs=198.1

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      ++|.....||+|+||.||+|.. .+++.||||.+..........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            3455567999999999999995 468899999998766655667899999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC-CCCeEEeccCCcccccCCCc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS-EMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~-~~~~kl~DfGla~~~~~~~~  401 (577)
                      ++++|.+++........+++..+..++.||+.||.|||+.+   |+||||||+|||++. ++.+||+|||+++.......
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~  178 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP  178 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence            99999999865444456789999999999999999999998   999999999999987 89999999999987643221


Q ss_pred             cccccccccCCCCcChhhhhcCC--CCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGR--FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                        ......||+.|+|||++.++.  ++.++||||||+++|||++|+.||........ ......  ..       ...+.
T Consensus       179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~--~~-------~~~~~  246 (295)
T 2clq_A          179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-AMFKVG--MF-------KVHPE  246 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-HHHHHH--HH-------CCCCC
T ss_pred             --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-HHHhhc--cc-------ccccc
Confidence              223457899999999997754  88999999999999999999999853222111 111100  00       01111


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      +......   .+.+++..||+.||++||++.|+++
T Consensus       247 ~~~~~~~---~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          247 IPESMSA---EAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCTTSCH---HHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ccccCCH---HHHHHHHHHccCChhhCCCHHHHhc
Confidence            2222223   4456778999999999999999885

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4e-40  Score=340.17  Aligned_cols=265  Identities=22%  Similarity=0.372  Sum_probs=199.5

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC--------
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLER--------  312 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  312 (577)
                      ++|++.++||+|+||.||+|.. .+|+.||||++.....  .....+.+|+.+++.++||||+++++++...        
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            6799999999999999999996 5789999999865432  2234678999999999999999999998873        


Q ss_pred             CeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCC
Q 008108          313 KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (577)
Q Consensus       313 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGl  392 (577)
                      +..++||||+++ +|...+..  ....+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence            468999999986 66555533  2356999999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCc--cccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhccc
Q 008108          393 ARLFEMDQT--HSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNE  469 (577)
Q Consensus       393 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  469 (577)
                      ++.+.....  ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+.........
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  250 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  250 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            987653222  122234678999999999876 45899999999999999999999998765443332222211111111


Q ss_pred             CCc--------cccccCcC--CCCChHHH------HHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          470 GAA--------LNLMDPTM--RGGSTSEM------MKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       470 ~~~--------~~~~d~~l--~~~~~~~~------~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ...        .+.+....  ........      ..+.+++..|++.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            110        00000000  00011111      23567888999999999999999886

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3e-40  Score=357.60  Aligned_cols=249  Identities=27%  Similarity=0.378  Sum_probs=200.6

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      .++|...+.||+|+||.||++... +|+.||+|++.+...   .....+.+|+.++++++||||+++++++.+....++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999975 699999999975432   2345688999999999999999999999999999999


Q ss_pred             EEecCCCCcccccccCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          319 YEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      |||+++|+|.+++.... ....+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999998885432 2457999999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCcccc-chhhhhhhhhcccCCccccc
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET-EDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~  476 (577)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+......    ..     
T Consensus       341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~----~~-----  409 (543)
T 3c4z_A          341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE----QA-----  409 (543)
T ss_dssp             TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH----CC-----
T ss_pred             CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh----cc-----
Confidence            4322  22345899999999999999999999999999999999999999875432211 112211111    00     


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCH
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGM  509 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~  509 (577)
                       .........   .+..++..|++.||++||++
T Consensus       410 -~~~p~~~s~---~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          410 -VTYPDKFSP---ASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             -CCCCTTSCH---HHHHHHHHHSCSSGGGSCCC
T ss_pred             -cCCCcccCH---HHHHHHHHhccCCHhHCCCC
Confidence             011111222   34467779999999999976

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.7e-40  Score=358.82  Aligned_cols=250  Identities=26%  Similarity=0.386  Sum_probs=195.4

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      .++|+..++||+|+||+||++... +++.||+|++.+..  ......+.+|+.+++.++||||+++++++.+....++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            356899999999999999999965 68899999997643  233456889999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCC---CCeEEeccCCcccc
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMARLF  396 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~---~~~kl~DfGla~~~  396 (577)
                      ||+++|+|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++..   +.+||+|||+++.+
T Consensus       116 e~~~~g~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          116 ECYKGGELFDEII---HRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            9999999988774   3467999999999999999999999998   9999999999999764   45999999999876


Q ss_pred             cCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          397 EMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       397 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      ....   ......||+.|+|||++. +.++.++|||||||++|+|++|+.||......+....+......+        .
T Consensus       190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--------~  257 (494)
T 3lij_A          190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTF--------D  257 (494)
T ss_dssp             BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--------C
T ss_pred             CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--------C
Confidence            5432   223467999999999875 679999999999999999999999987544332221111100000        0


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .+.. ...+.   .+.+++..||+.||++|||+.|+++
T Consensus       258 ~~~~-~~~s~---~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          258 SPEW-KNVSE---GAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             SGGG-TTSCH---HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             chhc-ccCCH---HHHHHHHHHCCCChhhCccHHHHhc
Confidence            0000 11122   3456778999999999999999874

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=7.6e-41  Score=342.80  Aligned_cols=263  Identities=25%  Similarity=0.395  Sum_probs=197.4

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      ++|+..+.||+|+||.||++... +|+.||||++.....  .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            67899999999999999999965 589999999865433  234457899999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |+++++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       105 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          105 FVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             CCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             cCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            999999988763   3456999999999999999999999998   9999999999999999999999999998654322


Q ss_pred             ccccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhh--------hhhhcccCC
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTY--------AWRNWNEGA  471 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~~~~  471 (577)
                      .  ......||..|+|||++.+. .++.++||||||+++|||++|+.||......+....+..        .+..+....
T Consensus       179 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          179 E--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             c--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence            2  22335789999999999875 789999999999999999999999865543221111100        000000000


Q ss_pred             -ccccccCcCCCC-C-----hHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          472 -ALNLMDPTMRGG-S-----TSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       472 -~~~~~d~~l~~~-~-----~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                       ......+.+... .     ......+.+++..||+.||++|||+.|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence             000011111110 0     111235667888999999999999999875

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.8e-41  Score=344.08  Aligned_cols=268  Identities=22%  Similarity=0.317  Sum_probs=192.7

Q ss_pred             HHHHHhcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhh--HHHHHHHHHHHHhcCCCCeEEEEeEEEcCCe
Q 008108          238 TIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQG--EIEFKNEVLLLARLQHRNLVRLLGFCLERKE  314 (577)
Q Consensus       238 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  314 (577)
                      ......++|++.++||+|+||+||++.. .+++.||||++.......  ...+.+|+.++++++||||+++++++.+.+.
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (329)
T 3gbz_A           28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR  107 (329)
T ss_dssp             ----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred             CcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence            3344567899999999999999999985 478999999997654322  3457799999999999999999999999999


Q ss_pred             EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEc-----CCCCeEEec
Q 008108          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD-----SEMNPKISD  389 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~-----~~~~~kl~D  389 (577)
                      .++||||+++ +|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+||||+     .++.+||+|
T Consensus       108 ~~lv~e~~~~-~L~~~~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~D  180 (329)
T 3gbz_A          108 LHLIFEYAEN-DLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGD  180 (329)
T ss_dssp             EEEEEECCSE-EHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred             EEEEEecCCC-CHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECc
Confidence            9999999985 8888874   3456999999999999999999999998   99999999999994     455599999


Q ss_pred             cCCcccccCCCccccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcc
Q 008108          390 FGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWN  468 (577)
Q Consensus       390 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~  468 (577)
                      ||+++.......  ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......+....+........
T Consensus       181 fg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  258 (329)
T 3gbz_A          181 FGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPD  258 (329)
T ss_dssp             TTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             CCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCc
Confidence            999987653322  22335789999999999875 489999999999999999999999865443221111110000000


Q ss_pred             cCCcc--------ccccCcCCCCChH------HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          469 EGAAL--------NLMDPTMRGGSTS------EMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       469 ~~~~~--------~~~d~~l~~~~~~------~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .....        ....+........      ....+.+++..|++.||++|||+.|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            00000        0000111111111      1134567888999999999999999985

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6.7e-41  Score=371.36  Aligned_cols=247  Identities=31%  Similarity=0.490  Sum_probs=194.9

Q ss_pred             cccccCCcEEEEEeEec---CCcEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCC
Q 008108          250 NKLGQGGFGAVYKGMLS---NGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPN  324 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  324 (577)
                      ++||+|+||.||+|.+.   .++.||||+++....  ....++.+|+.+|.+++|||||++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999753   467899999976432  335679999999999999999999999964 568899999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc-c
Q 008108          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH-S  403 (577)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~-~  403 (577)
                      |+|.+++.   ....+++..++.|+.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus       454 g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            99999984   3567999999999999999999999998   999999999999999999999999999876543321 2


Q ss_pred             cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCC
Q 008108          404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG  482 (577)
Q Consensus       404 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  482 (577)
                      ......+|+.|+|||++....++.++|||||||++|||++ |+.||......+....+.       .+...     ....
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-------~~~~~-----~~p~  595 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERM-----GCPA  595 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTCCC-----CCCT
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCCC-----CCCC
Confidence            2233457889999999999999999999999999999998 999986554433222221       11110     1111


Q ss_pred             CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          483 GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       483 ~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ..+   ..+.+++..||+.||++||++.+|+++|+.
T Consensus       596 ~~~---~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          596 GCP---REMYDLMNLCWTYDVENRPGFAAVELRLRN  628 (635)
T ss_dssp             TCC---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCC---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            122   345567789999999999999999999874

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-40  Score=356.35  Aligned_cols=194  Identities=23%  Similarity=0.429  Sum_probs=154.0

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC-----CeE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER-----KER  315 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  315 (577)
                      ++|++.++||+|+||+||+|... +++.||||++...  .......+.+|+.+|++++||||+++++++...     ...
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            68999999999999999999854 6899999999654  333445688999999999999999999998543     568


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      ++||||+ +++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.
T Consensus       133 ~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             EEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence            9999998 468888773   3467999999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCcc-------------------------ccccccccCCCCcChhhh-hcCCCCccccEEecchhHhHHhhC
Q 008108          396 FEMDQTH-------------------------SDTNRVVGTFGYMAPEYV-MHGRFSVKSDIFSFGVLVLEIVSG  444 (577)
Q Consensus       396 ~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGvil~elltG  444 (577)
                      .......                         ......+||+.|+|||++ ....++.++|||||||+||||++|
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            6532211                         122345789999999986 456799999999999999999995

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=9.6e-41  Score=346.09  Aligned_cols=201  Identities=28%  Similarity=0.400  Sum_probs=176.6

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      .++|++.++||+|+||.||++... +++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            467999999999999999999965 68999999997653 3344568999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      |+++++|.+++..   ...+++..+..++.||+.||.|||+. +   |+||||||+|||++.++.+||+|||++......
T Consensus       112 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            9999999999843   45799999999999999999999985 6   999999999999999999999999999765322


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTE  453 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~  453 (577)
                          ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus       186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  235 (360)
T 3eqc_A          186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA  235 (360)
T ss_dssp             ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred             ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence                22335799999999999999999999999999999999999999875543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.3e-41  Score=340.08  Aligned_cols=257  Identities=18%  Similarity=0.240  Sum_probs=195.8

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      .++|++.++||+|+||.||++... +++.||+|++.....   .....+.+|+.++.+++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            478999999999999999999965 688999999976532   2345688999999999999999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       113 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          113 MRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            999999999998843   457999999999999999999999998   99999999999999999999999999986653


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      ... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+.   .   .......   
T Consensus       187 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~---~~~~~~~---  256 (309)
T 2h34_A          187 EKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN---Q---AIPRPST---  256 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH---S---CCCCGGG---
T ss_pred             ccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc---c---CCCCccc---
Confidence            321 12234578999999999999999999999999999999999999986433221111110   0   0000001   


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHhcCC
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRP-GMASVVNMLNGD  519 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RP-t~~ev~~~L~~~  519 (577)
                       .....+.   .+.+++..||+.||++|| ++.++++.|+..
T Consensus       257 -~~~~~~~---~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~  294 (309)
T 2h34_A          257 -VRPGIPV---AFDAVIARGMAKNPEDRYVTCGDLSAAAHAA  294 (309)
T ss_dssp             -TSTTCCT---HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred             -cCCCCCH---HHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence             1111222   345677799999999999 999999999864

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.4e-40  Score=340.29  Aligned_cols=254  Identities=29%  Similarity=0.436  Sum_probs=199.7

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcE--EEEEEeccCC-hhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGET--IAVKRLSKNS-KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  318 (577)
                      ++|+..+.||+|+||.||+|... ++..  +|+|.+.... ......+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            67999999999999999999964 4554  4999987532 33344688999999999 999999999999999999999


Q ss_pred             EEecCCCCcccccccCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCe
Q 008108          319 YEFVPNASLDHFIFDPI-------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP  385 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~  385 (577)
                      |||+++++|.+++....             ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999985432             2347999999999999999999999998   9999999999999999999


Q ss_pred             EEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhh
Q 008108          386 KISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAW  464 (577)
Q Consensus       386 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~  464 (577)
                      ||+|||+++.....   .......+++.|+|||++.+..++.++||||||+++|||++ |+.||...........+    
T Consensus       182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~----  254 (327)
T 1fvr_A          182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL----  254 (327)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG----
T ss_pred             EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh----
Confidence            99999999743321   12223457889999999999999999999999999999998 99998654432221111    


Q ss_pred             hhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          465 RNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       465 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                         ..+.     .+......+   ..+.+++..|++.||++|||+.|+++.|+.
T Consensus       255 ---~~~~-----~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~ell~~L~~  297 (327)
T 1fvr_A          255 ---PQGY-----RLEKPLNCD---DEVYDLMRQCWREKPYERPSFAQILVSLNR  297 (327)
T ss_dssp             ---GGTC-----CCCCCTTBC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---hcCC-----CCCCCCCCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence               1110     001111122   245577789999999999999999999875

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.5e-40  Score=358.47  Aligned_cols=250  Identities=26%  Similarity=0.387  Sum_probs=197.6

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh-------------hhHHHHHHHHHHHHhcCCCCeEEEEeE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK-------------QGEIEFKNEVLLLARLQHRNLVRLLGF  308 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~~  308 (577)
                      .++|.+.++||+|+||+||++... +++.||||++.....             .....+.+|+.++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            478999999999999999999965 578999999876432             234568899999999999999999999


Q ss_pred             EEcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC---Ce
Q 008108          309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM---NP  385 (577)
Q Consensus       309 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~---~~  385 (577)
                      +.+....++||||+++|+|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++   .+
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence            9999999999999999999888743   467999999999999999999999998   99999999999998876   69


Q ss_pred             EEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhh
Q 008108          386 KISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWR  465 (577)
Q Consensus       386 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~  465 (577)
                      ||+|||+++.......   .....||+.|+|||++. +.++.++||||||+++|+|++|+.||......+....+..   
T Consensus       189 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~---  261 (504)
T 3q5i_A          189 KIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK---  261 (504)
T ss_dssp             EECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---
T ss_pred             EEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---
Confidence            9999999987654322   23357999999999876 5799999999999999999999999875443322211111   


Q ss_pred             hcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          466 NWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       466 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                          +...  ++.......+   ..+.+++..|++.||++|||+.|+++
T Consensus       262 ----~~~~--~~~~~~~~~s---~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          262 ----GKYY--FDFNDWKNIS---DEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             ----CCCC--CCHHHHTTSC---HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----CCCC--CCccccCCCC---HHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                1000  0000000111   24557778999999999999999885

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.2e-41  Score=355.38  Aligned_cols=242  Identities=15%  Similarity=0.169  Sum_probs=186.3

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccC---ChhhHHHHHHHH---HHHHhcCCCCeEEEE-------eE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN---SKQGEIEFKNEV---LLLARLQHRNLVRLL-------GF  308 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~  308 (577)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++...   .......+.+|+   .++++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788999999999999999995 56999999999743   333455788999   455566899999998       66


Q ss_pred             EEcCC-----------------eEEEEEEecCCCCcccccccCC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcE
Q 008108          309 CLERK-----------------ERILVYEFVPNASLDHFIFDPI----NREHMTWEKRYKIIEGIARGLLYLHEDSRLRI  367 (577)
Q Consensus       309 ~~~~~-----------------~~~lv~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~i  367 (577)
                      +.+.+                 ..++||||+ +|+|.+++....    ....+++..++.|+.||+.||.|||+++   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            55543                 278999999 689999885321    1123446889999999999999999998   9


Q ss_pred             EEeccCCCcEEEcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcC-----------CCCccccEEecch
Q 008108          368 IHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG-----------RFSVKSDIFSFGV  436 (577)
Q Consensus       368 iHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~SlGv  436 (577)
                      +||||||+||||+.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999985332     2233567 999999999887           8999999999999


Q ss_pred             hHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          437 LVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       437 il~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ++|||++|+.||...........+   ...+              ...+.   .+.+++..||+.||++|||+.|+++
T Consensus       302 il~elltg~~Pf~~~~~~~~~~~~---~~~~--------------~~~~~---~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGSEWI---FRSC--------------KNIPQ---PVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHSSCCC------CCSGGG---GSSC--------------CCCCH---HHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHCCCCCcccccccchhhh---hhhc--------------cCCCH---HHHHHHHHHcCCCchhCCCHHHHhh
Confidence            999999999998643322211111   1000              11222   4556778999999999999999885

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=7.4e-41  Score=342.90  Aligned_cols=258  Identities=24%  Similarity=0.291  Sum_probs=187.7

Q ss_pred             HhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcC-CCCeEEEEeEEE--------c
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGFCL--------E  311 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~  311 (577)
                      ...+|++.++||+|+||.||++... +++.||||++..........+.+|+.++.++. ||||+++++++.        .
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            3457899999999999999999964 78999999997777666778899999999996 999999999984        3


Q ss_pred             CCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccC
Q 008108          312 RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFG  391 (577)
Q Consensus       312 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfG  391 (577)
                      ....++||||+. |+|.+++........+++..++.++.||+.||.|||+.+ ++|+||||||+||||+.++.+||+|||
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence            345799999996 688888754344567999999999999999999999874 349999999999999999999999999


Q ss_pred             CcccccCCCccc----------cccccccCCCCcChhhh---hcCCCCccccEEecchhHhHHhhCCCCCCCCCccccch
Q 008108          392 MARLFEMDQTHS----------DTNRVVGTFGYMAPEYV---MHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETED  458 (577)
Q Consensus       392 la~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~  458 (577)
                      +++.........          ......||+.|+|||++   .+..++.++||||||+++|||++|+.||.......   
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---  260 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---  260 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH---
Confidence            998765432211          11134689999999998   56678999999999999999999999985432211   


Q ss_pred             hhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCC
Q 008108          459 LLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD  519 (577)
Q Consensus       459 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~  519 (577)
                      ++...   +.         .........   .+..++..||+.||++|||+.|+++.|...
T Consensus       261 ~~~~~---~~---------~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~e~l~~l~~~  306 (337)
T 3ll6_A          261 IVNGK---YS---------IPPHDTQYT---VFHSLIRAMLQVNPEERLSIAEVVHQLQEI  306 (337)
T ss_dssp             --------CC---------CCTTCCSSG---GGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhcCc---cc---------CCcccccch---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            11100   00         000011111   244677899999999999999999999754

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=6.4e-41  Score=334.48  Aligned_cols=249  Identities=25%  Similarity=0.406  Sum_probs=194.0

Q ss_pred             hcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC-CeEEEEEEe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER-KERILVYEF  321 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~E~  321 (577)
                      .++|+..+.||+|+||.||++... |+.||||++....  ....+.+|+.++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            467999999999999999999874 8899999997553  345688999999999999999999997654 478999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++.....  
T Consensus        97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--  170 (278)
T 1byg_A           97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  170 (278)
T ss_dssp             CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence            9999999988431 2234899999999999999999999998   999999999999999999999999999865432  


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                         .....++..|+|||.+.+..++.++||||||+++|||+| |+.|+......+....+       ..+.     .+..
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~-------~~~~-----~~~~  235 (278)
T 1byg_A          171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-------EKGY-----KMDA  235 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH-------TTTC-----CCCC
T ss_pred             ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------hcCC-----CCCC
Confidence               122457889999999999999999999999999999998 99888654332221111       1111     0111


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ....+.   .+.+++..||+.||++||++.|+++.|+.
T Consensus       236 ~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~L~~  270 (278)
T 1byg_A          236 PDGCPP---AVYEVMKNCWHLDAAMRPSFLQLREQLEH  270 (278)
T ss_dssp             CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cccCCH---HHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence            112223   44567779999999999999999999864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.9e-40  Score=332.10  Aligned_cols=246  Identities=25%  Similarity=0.374  Sum_probs=201.1

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      .++|++.+.||+|+||.||++... +++.||||++....   ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            367999999999999999999965 57889999986542   22345688999999999999999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           93 LEFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            999999999988843   456999999999999999999999988   99999999999999999999999999976543


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      ..    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+.       ..      +.
T Consensus       167 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-------~~------~~  229 (284)
T 2vgo_A          167 LR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV-------NV------DL  229 (284)
T ss_dssp             SC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-------TT------CC
T ss_pred             cc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh-------cc------cc
Confidence            21    233578999999999999999999999999999999999999986543322111110       00      11


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .+......   .+.+++..|++.||++||++.|+++
T Consensus       230 ~~~~~~~~---~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          230 KFPPFLSD---GSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             CCCTTSCH---HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCcCCH---HHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            11111222   3456778999999999999999985

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.4e-40  Score=350.38  Aligned_cols=200  Identities=26%  Similarity=0.429  Sum_probs=167.0

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC-----Ce
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER-----KE  314 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  314 (577)
                      .++|++.+.||+|+||.||+|... +++.||||++...  .......+.+|+.+|++++|+||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999999964 6888999999764  333445788999999999999999999999776     57


Q ss_pred             EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      .++||||++ ++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999986 58988873   3457999999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCcc--------------------ccccccccCCCCcChhhh-hcCCCCccccEEecchhHhHHhhCCCCCC
Q 008108          395 LFEMDQTH--------------------SDTNRVVGTFGYMAPEYV-MHGRFSVKSDIFSFGVLVLEIVSGQKRSS  449 (577)
Q Consensus       395 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGvil~elltG~~p~~  449 (577)
                      ........                    .......||+.|+|||++ ....++.++|||||||++|||++|..|+.
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            76543211                    112456899999999986 45679999999999999999998755543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-40  Score=340.98  Aligned_cols=264  Identities=24%  Similarity=0.323  Sum_probs=194.7

Q ss_pred             HHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhh-----HHHHHHHHHHHHhcCCCCeEEEEeEEEcCCe
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQG-----EIEFKNEVLLLARLQHRNLVRLLGFCLERKE  314 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  314 (577)
                      ...++|+..+.||+|+||.||+|... +|+.||||++.......     ...+.+|+.++++++||||+++++++.+.+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999964 58999999987543221     2357899999999999999999999999999


Q ss_pred             EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      .++||||+++ +|..++..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence            9999999986 78777643  3456899999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCccccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcc---cC
Q 008108          395 LFEMDQTHSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWN---EG  470 (577)
Q Consensus       395 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~---~~  470 (577)
                      .+.....  ......||+.|+|||++.+. .++.++||||||+++|||++|..|+......+.   +...+....   ..
T Consensus       161 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~---~~~i~~~~~~~~~~  235 (346)
T 1ua2_A          161 SFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEE  235 (346)
T ss_dssp             TTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTT
T ss_pred             eccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHcCCCChh
Confidence            7643222  22346789999999998764 589999999999999999999988765443221   111111110   00


Q ss_pred             Ccc------ccccC-cCCCCC-----hHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          471 AAL------NLMDP-TMRGGS-----TSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       471 ~~~------~~~d~-~l~~~~-----~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      .+.      +.+.. ......     ......+.+++..|++.||++|||+.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            000      00000 000001     1112356678889999999999999999875

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.4e-40  Score=332.79  Aligned_cols=246  Identities=24%  Similarity=0.369  Sum_probs=195.6

Q ss_pred             HhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  317 (577)
                      ..++|++.++||+|+||+||++... +++.||||++....  .....++.+|+..+..+ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3467999999999999999999975 78999999987642  33455688999999999 99999999999999999999


Q ss_pred             EEEecCCCCcccccccCCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCC--------------
Q 008108          318 VYEFVPNASLDHFIFDPIN-REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE--------------  382 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~--------------  382 (577)
                      ||||+++++|.+++..... ...+++..++.++.||+.||.|||+++   |+||||||+|||++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999999999854211 256999999999999999999999998   9999999999999844              


Q ss_pred             -----CCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCcccc
Q 008108          383 -----MNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET  456 (577)
Q Consensus       383 -----~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~  456 (577)
                           ..+||+|||++.......      ...||+.|+|||.+.+. .++.++||||||+++|||++|..++....  . 
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~-  236 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD--Q-  236 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH--H-
T ss_pred             ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh--H-
Confidence                 479999999998764322      24589999999999776 56789999999999999999987653211  1 


Q ss_pred             chhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          457 EDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       457 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                             +.....+..     +.+......   .+.+++..|++.||++|||+.|+++
T Consensus       237 -------~~~~~~~~~-----~~~~~~~~~---~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          237 -------WHEIRQGRL-----PRIPQVLSQ---EFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             -------HHHHHTTCC-----CCCSSCCCH---HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------HHHHHcCCC-----CCCCcccCH---HHHHHHHHHhCCCcccCCCHHHHhh
Confidence                   111111111     111112223   3456777999999999999999875

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=5.1e-40  Score=331.14  Aligned_cols=252  Identities=21%  Similarity=0.317  Sum_probs=200.8

Q ss_pred             HhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---------hhhHHHHHHHHHHHHhcC-CCCeEEEEeEEE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---------KQGEIEFKNEVLLLARLQ-HRNLVRLLGFCL  310 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  310 (577)
                      ..++|++.+.||+|+||.||++... +|+.||||++....         ......+.+|+.++++++ ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3578999999999999999999965 68899999986543         122345789999999995 999999999999


Q ss_pred             cCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEecc
Q 008108          311 ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDF  390 (577)
Q Consensus       311 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~Df  390 (577)
                      +....++||||+++++|.+++..   +..+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence            99999999999999999998843   457999999999999999999999998   999999999999999999999999


Q ss_pred             CCcccccCCCccccccccccCCCCcChhhhh------cCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhh
Q 008108          391 GMARLFEMDQTHSDTNRVVGTFGYMAPEYVM------HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAW  464 (577)
Q Consensus       391 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~  464 (577)
                      |++........   .....||+.|+|||++.      ...++.++||||||+++|||++|+.|+...........+.   
T Consensus       169 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---  242 (298)
T 1phk_A          169 GFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM---  242 (298)
T ss_dssp             TTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---
T ss_pred             cchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHh---
Confidence            99987654322   23357899999999985      4568899999999999999999999986543322111111   


Q ss_pred             hhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          465 RNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       465 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .    +.. ....+.    .......+.+++..|++.||++|||+.|+++
T Consensus       243 ~----~~~-~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          243 S----GNY-QFGSPE----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             H----TCC-CCCTTT----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             c----CCc-ccCccc----ccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            0    000 000000    0111234567888999999999999999875

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.3e-40  Score=358.92  Aligned_cols=250  Identities=28%  Similarity=0.386  Sum_probs=200.8

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      .++|+..++||+|+||.||++... +|+.||||++....   ......+.+|+.++++++||||+++++++.+....++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            467999999999999999999965 78999999986542   33456789999999999999999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEE---cCCCCeEEeccCCccc
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL---DSEMNPKISDFGMARL  395 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl---~~~~~~kl~DfGla~~  395 (577)
                      |||+.+|+|.+++.   .+..+++..++.++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||+++.
T Consensus       105 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          105 GEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             ECCCCSCBHHHHHH---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            99999999988874   3567999999999999999999999998   9999999999999   5678999999999987


Q ss_pred             ccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccc
Q 008108          396 FEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNL  475 (577)
Q Consensus       396 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  475 (577)
                      +.....   .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+.   +.....    +.... 
T Consensus       179 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~----~~~~~-  246 (484)
T 3nyv_A          179 FEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI---LKKVEK----GKYTF-  246 (484)
T ss_dssp             BCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH----CCCCC-
T ss_pred             cccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHHc----CCCCC-
Confidence            654332   223579999999998865 799999999999999999999999875443222   211111    10000 


Q ss_pred             ccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       476 ~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ..+..    ......+.+++..|++.||++|||+.|+++
T Consensus       247 ~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          247 ELPQW----KKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             CSGGG----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            00000    011124557778999999999999999885

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=6.5e-41  Score=334.35  Aligned_cols=259  Identities=24%  Similarity=0.335  Sum_probs=201.0

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEc--CCeEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLE--RKERIL  317 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  317 (577)
                      .++|++.+.||+|+||.||++... +++.||+|.+....  ......+.+|+.++++++||||+++++++.+  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468999999999999999999965 68999999997543  3344568999999999999999999998854  567899


Q ss_pred             EEEecCCCCcccccccCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          318 VYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDS--RLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~--~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      ||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+  ..+|+||||||+|||++.++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999885422 2345999999999999999999999875  1249999999999999999999999999998


Q ss_pred             cccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccc
Q 008108          395 LFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALN  474 (577)
Q Consensus       395 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  474 (577)
                      .......  ......||..|+|||.+.+..++.++||||||+++|||++|+.|+........   ....    ..+... 
T Consensus       165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~i----~~~~~~-  234 (279)
T 2w5a_A          165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---AGKI----REGKFR-  234 (279)
T ss_dssp             HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH----HHTCCC-
T ss_pred             eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH---HHHH----hhcccc-
Confidence            7653221  11235789999999999999999999999999999999999999865433221   1111    111110 


Q ss_pred             cccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          475 LMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       475 ~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                          .+....+.   .+.+++..||+.||++||++.||++.+..
T Consensus       235 ----~~~~~~~~---~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          235 ----RIPYRYSD---ELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             ----CCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ----cCCcccCH---HHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence                11111222   45567789999999999999999986643

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.2e-40  Score=345.67  Aligned_cols=270  Identities=22%  Similarity=0.281  Sum_probs=196.5

Q ss_pred             hHHHHHHhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCCh-----------hhHHHHHHHHHHHHhcCCCCeEE
Q 008108          236 FETIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSK-----------QGEIEFKNEVLLLARLQHRNLVR  304 (577)
Q Consensus       236 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~  304 (577)
                      ..++....++|++.++||+|+||.||+|...+|+.||||++.....           .....+.+|+.++++++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            5667788899999999999999999999988899999999865322           12356899999999999999999


Q ss_pred             EEeEEEc-----CCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEE
Q 008108          305 LLGFCLE-----RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL  379 (577)
Q Consensus       305 l~~~~~~-----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl  379 (577)
                      +++++..     ....++||||++ |+|.+++..  .+..+++..+..++.||+.||.|||+++   |+||||||+|||+
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL  167 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence            9999854     236799999998 577776643  3457999999999999999999999998   9999999999999


Q ss_pred             cCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccch
Q 008108          380 DSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETED  458 (577)
Q Consensus       380 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~  458 (577)
                      +.++.+||+|||+++......   ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+...
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  244 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN  244 (362)
T ss_dssp             CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             cCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999999999997544322   2234578999999999877 678999999999999999999999987544322111


Q ss_pred             -hhhhhh-------hhcccCCccccccCcC---CCC-----ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          459 -LLTYAW-------RNWNEGAALNLMDPTM---RGG-----STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       459 -l~~~~~-------~~~~~~~~~~~~d~~l---~~~-----~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                       +.....       ..+......+.+...+   ...     .......+.+++..|++.||++|||+.|+++
T Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence             111000       0000000000000000   000     0111234567888999999999999999985

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=329.92  Aligned_cols=252  Identities=22%  Similarity=0.306  Sum_probs=196.4

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC----hhhHHHHHHHHHHHHhcCCCCeEEEEeEEE--cCCeE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS----KQGEIEFKNEVLLLARLQHRNLVRLLGFCL--ERKER  315 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~  315 (577)
                      .++|++.+.||+|+||.||++... +++.||+|++....    ......+.+|+.++++++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            478999999999999999999964 68899999997642    233557899999999999999999999984  44578


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      ++||||++++ |.+++.. .....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDS-VPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHH-STTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHh-CcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999887 5555533 23567999999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCccccccccccCCCCcChhhhhcCC--CCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcc
Q 008108          396 FEMDQTHSDTNRVVGTFGYMAPEYVMHGR--FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAAL  473 (577)
Q Consensus       396 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  473 (577)
                      ..............||..|+|||++.+..  ++.++||||||+++|||++|+.|+...........+.       .+.  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~-------~~~--  229 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG-------KGS--  229 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-------HCC--
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHh-------cCC--
Confidence            65433333333467999999999987654  3789999999999999999999986543222111111       110  


Q ss_pred             ccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          474 NLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       474 ~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                          ..+......   .+.+++.+|++.||++|||+.|+++.
T Consensus       230 ----~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          230 ----YAIPGDCGP---PLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             ----CCCCSSSCH---HHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ----CCCCCccCH---HHHHHHHHHccCChhhCCCHHHHhcC
Confidence                011111222   34567779999999999999999964

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.3e-39  Score=333.15  Aligned_cols=252  Identities=20%  Similarity=0.326  Sum_probs=196.6

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcC-CCCeEEEEeEEEc--CCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLE--RKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~  319 (577)
                      ++|++.++||+|+||+||+|.. .+++.||||++....   ...+.+|+.++++++ ||||+++++++.+  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            6799999999999999999985 578999999997544   346889999999997 9999999999987  56789999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC-CeEEeccCCcccccC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-NPKISDFGMARLFEM  398 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~-~~kl~DfGla~~~~~  398 (577)
                      ||+++++|.+++.      .+++..+..++.||+.||.|||+++   |+||||||+|||++.++ .+||+|||+++....
T Consensus       113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            9999999988762      3899999999999999999999998   99999999999999777 899999999987654


Q ss_pred             CCccccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhh--------hhh---
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA--------WRN---  466 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~--------~~~---  466 (577)
                      ...   .....||..|+|||++.+ ..++.++||||||+++|||++|+.||........ .+....        +..   
T Consensus       184 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          184 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDYIDK  259 (330)
T ss_dssp             TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHHHHHH
T ss_pred             CCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCchhhhHHHH
Confidence            332   233578999999999877 6789999999999999999999999854432211 111000        000   


Q ss_pred             ---------------cccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          467 ---------------WNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       467 ---------------~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                                     .....+........   .......+.+++..|++.||++|||+.|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFVHSEN---QHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGCCTTT---GGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hccccccchhhhhhhccccchhhhccccc---cccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                           00000111111110   0111235567888999999999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3e-40  Score=356.33  Aligned_cols=251  Identities=25%  Similarity=0.353  Sum_probs=198.7

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      .++|++.++||+|+||+||++... +++.||||++.+..  ......+.+|+.++++++||||+++++++.+....++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            467999999999999999999965 78999999986532  233557889999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEc---CCCCeEEeccCCcccc
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD---SEMNPKISDFGMARLF  396 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~---~~~~~kl~DfGla~~~  396 (577)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++   .++.+||+|||+++.+
T Consensus       101 e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          101 ELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            99999999888743   467999999999999999999999998   99999999999995   4567999999999876


Q ss_pred             cCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          397 EMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       397 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      .....   .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+....+.   .    +..... 
T Consensus       175 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---~----~~~~~~-  242 (486)
T 3mwu_A          175 QQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE---T----GKYAFD-  242 (486)
T ss_dssp             CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H----TCCCSC-
T ss_pred             CCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---h----CCCCCC-
Confidence            54322   233579999999998864 69999999999999999999999986544322211111   1    000000 


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      .+.. ...+   ..+.+++..||+.||++|||+.|+++-
T Consensus       243 ~~~~-~~~s---~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          243 LPQW-RTIS---DDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             SGGG-GGSC---HHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             Cccc-CCCC---HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0000 0111   245577889999999999999999863

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.5e-40  Score=335.51  Aligned_cols=266  Identities=24%  Similarity=0.356  Sum_probs=186.1

Q ss_pred             HHHhcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          240 RVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       240 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      ....++|++.+.||+|+||.||++.. .+++.||||++.... .....++.+|+.++.+++||||+++++++...+..++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            34467899999999999999999985 468999999986543 2334568899999999999999999999999999999


Q ss_pred             EEEecCCCCcccccccC-----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCC
Q 008108          318 VYEFVPNASLDHFIFDP-----INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGl  392 (577)
                      ||||+++++|.+++...     .....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence            99999999999887531     12456999999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCcc---ccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcc
Q 008108          393 ARLFEMDQTH---SDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWN  468 (577)
Q Consensus       393 a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~  468 (577)
                      +.........   .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||........   .........
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~  244 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV---LMLTLQNDP  244 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HHHHHTSSC
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH---HHHHhccCC
Confidence            9866533211   11233579999999999876 5789999999999999999999999865443221   111111111


Q ss_pred             cCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          469 EGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       469 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ........++.+......   .+.+++..||+.||++||++.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~---~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          245 PSLETGVQDKEMLKKYGK---SFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CCTTC-----CCCCCCCH---HHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CccccccccchhhhhhhH---HHHHHHHHHccCChhhCcCHHHHhh
Confidence            111111112222222233   3456777999999999999999985

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=7.3e-40  Score=351.05  Aligned_cols=260  Identities=18%  Similarity=0.282  Sum_probs=203.9

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCC-CCeEEEEeEEEcCCeEEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH-RNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E  320 (577)
                      .++|++.++||+|+||.||+|.. .+++.||||++......  .++.+|+.++..++| +++..+..++.+.+..+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46899999999999999999995 57899999988654432  247889999999976 566667777788888999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEE---cCCCCeEEeccCCccccc
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL---DSEMNPKISDFGMARLFE  397 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl---~~~~~~kl~DfGla~~~~  397 (577)
                      |+ +++|.+++..  ....+++..++.|+.||+.||.|||+++   |+||||||+||||   +.++.+||+|||+++.+.
T Consensus        84 ~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 9999998853  2457999999999999999999999998   9999999999999   688999999999998766


Q ss_pred             CCCcc-----ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCc
Q 008108          398 MDQTH-----SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAA  472 (577)
Q Consensus       398 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  472 (577)
                      .....     .......||..|+|||++.+..++.++||||||++||||++|+.||...........+............
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI  237 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence            44322     1223568999999999999999999999999999999999999999765443333322222111100000


Q ss_pred             cccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       473 ~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ..+.     ...+   .++.+++..||+.+|++||++.+|+++|+.
T Consensus       238 ~~l~-----~~~p---~~l~~li~~cl~~dP~~RPs~~el~~~L~~  275 (483)
T 3sv0_A          238 EALC-----RGYP---TEFASYFHYCRSLRFDDKPDYSYLKRLFRD  275 (483)
T ss_dssp             HHHH-----TTSC---HHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             HHHh-----cCCc---HHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            0000     1112   245677889999999999999999998763

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.3e-40  Score=329.89  Aligned_cols=247  Identities=22%  Similarity=0.348  Sum_probs=193.2

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      .++|.+.+.||+|+||.||+|... +|+.||||++....   ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            368999999999999999999975 78999999986542   22345688999999999999999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+++++|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            999999999998843   456999999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCccccccccccCCCCcChhhhhcCCC-CccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccccc
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRF-SVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD  477 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  477 (577)
                      ...   .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.|+........   .....    .+.      
T Consensus       164 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~----~~~------  227 (276)
T 2h6d_A          164 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL---FKKIR----GGV------  227 (276)
T ss_dssp             ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH----HCC------
T ss_pred             Ccc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---HHHhh----cCc------
Confidence            322   223578999999999987765 6899999999999999999999864332221   11111    110      


Q ss_pred             CcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          478 PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       478 ~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ..+......   .+.+++..|++.||++|||+.|+++
T Consensus       228 ~~~~~~~~~---~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          228 FYIPEYLNR---SVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             CCCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCchhcCH---HHHHHHHHHccCChhhCCCHHHHHh
Confidence            001111222   3456778999999999999999987

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.8e-40  Score=339.73  Aligned_cols=262  Identities=21%  Similarity=0.298  Sum_probs=202.1

Q ss_pred             hcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhh-----------------HHHHHHHHHHHHhcCCCCeEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQG-----------------EIEFKNEVLLLARLQHRNLVRL  305 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l  305 (577)
                      .++|++.+.||+|+||.||++.. +|+.||||++.......                 ...+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 89999999986542211                 1578999999999999999999


Q ss_pred             EeEEEcCCeEEEEEEecCCCCcccc------cccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCcEEEeccCCCcEE
Q 008108          306 LGFCLERKERILVYEFVPNASLDHF------IFDPINREHMTWEKRYKIIEGIARGLLYLHE-DSRLRIIHRDLKASNIL  378 (577)
Q Consensus       306 ~~~~~~~~~~~lv~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlkp~NiL  378 (577)
                      ++++.+.+..++||||+++++|.++      +.. .....+++..++.++.||+.||.|||+ .+   |+||||||+|||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence            9999999999999999999999998      432 225679999999999999999999998 77   999999999999


Q ss_pred             EcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcC-CCCc-cccEEecchhHhHHhhCCCCCCCCCc-cc
Q 008108          379 LDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG-RFSV-KSDIFSFGVLVLEIVSGQKRSSFGTE-EE  455 (577)
Q Consensus       379 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~SlGvil~elltG~~p~~~~~~-~~  455 (577)
                      ++.++.+||+|||++......    ......||..|+|||.+.+. .++. ++||||||+++|||++|+.||..... .+
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            999999999999999876433    22346799999999999877 6666 99999999999999999999875443 21


Q ss_pred             cchhhhhhhhhcccCCccccccCcCCC----CChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          456 TEDLLTYAWRNWNEGAALNLMDPTMRG----GSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       456 ~~~l~~~~~~~~~~~~~~~~~d~~l~~----~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ....+......+.... .....+....    ........+.+++..||+.||++|||+.|+++
T Consensus       261 ~~~~i~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          261 LFNNIRTKNIEYPLDR-NHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHHHTSCCCCCCCSS-SSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHhccCcCCccch-hhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111111000000000 0000000000    00111234557788999999999999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-40  Score=343.12  Aligned_cols=259  Identities=23%  Similarity=0.351  Sum_probs=191.9

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC------
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK------  313 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  313 (577)
                      .++|+..+.||+|+||.||+|.. .+|+.||||++...  .......+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            36799999999999999999996 46899999999653  2333456889999999999999999999997653      


Q ss_pred             eEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCc
Q 008108          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (577)
Q Consensus       314 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla  393 (577)
                      ..++||||+ +++|.+++.    ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            469999999 789988873    356999999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCccccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhh--------h
Q 008108          394 RLFEMDQTHSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA--------W  464 (577)
Q Consensus       394 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~--------~  464 (577)
                      +.....     .....||..|+|||++.+ ..++.++||||||+++|||++|+.||......+....+...        +
T Consensus       176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  250 (367)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            875432     234678999999999887 67999999999999999999999998754432211111000        0


Q ss_pred             hhcccCCccccc-------cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          465 RNWNEGAALNLM-------DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       465 ~~~~~~~~~~~~-------d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ..+........+       ...+..........+.+++..|++.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            000000000000       00000000111234557778999999999999999987

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=344.91  Aligned_cols=260  Identities=17%  Similarity=0.205  Sum_probs=200.8

Q ss_pred             hcCCccccccccCCcEEEEEeEecC---------CcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEE---------
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSN---------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVR---------  304 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------  304 (577)
                      .++|.+.+.||+|+||.||+|....         ++.||||.+...     ..+.+|+.++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3689999999999999999999753         788999998755     25789999999999999887         


Q ss_pred             ------EEeEEEc-CCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcE
Q 008108          305 ------LLGFCLE-RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNI  377 (577)
Q Consensus       305 ------l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~Ni  377 (577)
                            +++++.. +...++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                  6777765 67889999999 99999998542 2367999999999999999999999998   99999999999


Q ss_pred             EEcCCC--CeEEeccCCcccccCCCcc-----ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCC
Q 008108          378 LLDSEM--NPKISDFGMARLFEMDQTH-----SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSF  450 (577)
Q Consensus       378 Ll~~~~--~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~  450 (577)
                      |++.++  .+||+|||+++.+......     .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  8999999999876543221     112345899999999999999999999999999999999999999865


Q ss_pred             CCccccchhhhhhhhhcccCCccccccCcCCC-CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          451 GTEEETEDLLTYAWRNWNEGAALNLMDPTMRG-GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       451 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ..... ..+... ...+.. ....+.+..... ..+   ..+.+++..||+.||++||++.+|+++|+.
T Consensus       271 ~~~~~-~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  333 (352)
T 2jii_A          271 CLPNT-EDIMKQ-KQKFVD-KPGPFVGPCGHWIRPS---ETLQKYLKVVMALTYEEKPPYAMLRNNLEA  333 (352)
T ss_dssp             GTTCH-HHHHHH-HHHHHH-SCCCEECTTSCEECCC---HHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             CCcCH-HHHHHH-HHhccC-ChhhhhhhccccCCCc---HHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence            43211 111111 111111 111111111110 122   345567779999999999999999999975

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=6.2e-40  Score=329.41  Aligned_cols=249  Identities=27%  Similarity=0.393  Sum_probs=195.6

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEc----CCeEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE----RKERI  316 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  316 (577)
                      +.|.+.++||+|+||.||+|... ++..||+|.+...  .......+.+|+.++++++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            34778889999999999999864 6788999998754  33445568999999999999999999999865    35689


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEc-CCCCeEEeccCCccc
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARL  395 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~-~~~~~kl~DfGla~~  395 (577)
                      +||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+|||++..
T Consensus       106 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            99999999999999843   467999999999999999999999875 3499999999999998 788999999999975


Q ss_pred             ccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccc
Q 008108          396 FEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNL  475 (577)
Q Consensus       396 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  475 (577)
                      .....    .....||+.|+|||++. +.++.++||||||+++|||++|+.||.......  .....    ...+.....
T Consensus       182 ~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~----~~~~~~~~~  250 (290)
T 1t4h_A          182 KRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRR----VTSGVKPAS  250 (290)
T ss_dssp             CCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHH----HTTTCCCGG
T ss_pred             ccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH--HHHHH----HhccCCccc
Confidence            44322    22357999999999775 569999999999999999999999986433211  11111    111111111


Q ss_pred             ccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       476 ~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ++.    ...   ..+.+++..||+.||++|||+.|+++
T Consensus       251 ~~~----~~~---~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          251 FDK----VAI---PEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GGG----CCC---HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCC----CCC---HHHHHHHHHHccCChhhCCCHHHHhh
Confidence            111    111   24567788999999999999999985

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=5.1e-40  Score=335.25  Aligned_cols=252  Identities=22%  Similarity=0.320  Sum_probs=193.6

Q ss_pred             HhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh--------hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK--------QGEIEFKNEVLLLARLQHRNLVRLLGFCLER  312 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  312 (577)
                      ..++|.+.+.||+|+||.||+|... +++.||||++.....        .....+.+|+.++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3467999999999999999999964 588999999875421        1223478999999999999999999998766


Q ss_pred             CeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCC---eEEec
Q 008108          313 KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN---PKISD  389 (577)
Q Consensus       313 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~---~kl~D  389 (577)
                      . .++||||+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence            5 899999999999988874   3567999999999999999999999998   999999999999987664   99999


Q ss_pred             cCCcccccCCCccccccccccCCCCcChhhhh---cCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhh
Q 008108          390 FGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM---HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRN  466 (577)
Q Consensus       390 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~  466 (577)
                      ||+++......   ......||+.|+|||++.   ...++.++||||||+++|||++|+.||.......  .+.....  
T Consensus       161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~--  233 (322)
T 2ycf_A          161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQIT--  233 (322)
T ss_dssp             CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHH--
T ss_pred             Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHH--
Confidence            99998764321   122357899999999974   4678999999999999999999999986443221  1111110  


Q ss_pred             cccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          467 WNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       467 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                        .+... . .+......   ...+.+++..|++.||++||++.|+++
T Consensus       234 --~~~~~-~-~~~~~~~~---~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          234 --SGKYN-F-IPEVWAEV---SEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             --HTCCC-C-CHHHHTTS---CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             --hCccc-c-Cchhhhhc---CHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence              00000 0 00000111   134557888999999999999999884

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.1e-39  Score=342.10  Aligned_cols=261  Identities=22%  Similarity=0.271  Sum_probs=198.5

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcC--------CCCeEEEEeEEE---
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ--------HRNLVRLLGFCL---  310 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~---  310 (577)
                      .++|++.++||+|+||+||+|.. .+++.||||++... ......+.+|+.+++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            47899999999999999999985 46889999999754 333456889999999996        788999999987   


Q ss_pred             -cCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCcEEEeccCCCcEEEcCCC-----
Q 008108          311 -ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-SRLRIIHRDLKASNILLDSEM-----  383 (577)
Q Consensus       311 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiHrDlkp~NiLl~~~~-----  383 (577)
                       +....++||||+. ++|.+++.. .....+++..++.++.||+.||.|||++ +   |+||||||+||||+.++     
T Consensus       115 ~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          115 VNGTHICMVFEVLG-HHLLKWIIK-SNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TTEEEEEEEECCCC-CBHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCceEEEEEeccC-ccHHHHHHh-cccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence             5668899999994 455555433 2335699999999999999999999998 7   99999999999999775     


Q ss_pred             --------------------------------------------CeEEeccCCcccccCCCccccccccccCCCCcChhh
Q 008108          384 --------------------------------------------NPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY  419 (577)
Q Consensus       384 --------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~  419 (577)
                                                                  .+||+|||+++.....     .....||+.|+|||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence                                                        8999999999875432     233579999999999


Q ss_pred             hhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccc---hhhhhhhhh------------------ccc-CCcccccc
Q 008108          420 VMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE---DLLTYAWRN------------------WNE-GAALNLMD  477 (577)
Q Consensus       420 ~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~---~l~~~~~~~------------------~~~-~~~~~~~d  477 (577)
                      +.+..++.++|||||||++|||++|+.||.........   ..+......                  +.. +....+.+
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            99999999999999999999999999999754433211   111111000                  000 00000000


Q ss_pred             Cc----------CCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          478 PT----------MRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       478 ~~----------l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ..          ...........+.+++.+||+.||++|||+.|+++
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            00          00113445567788999999999999999999885

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=9.7e-40  Score=340.04  Aligned_cols=261  Identities=21%  Similarity=0.282  Sum_probs=190.2

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC------
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK------  313 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  313 (577)
                      .++|+..+.||+|+||.||+|... +++.||||++...  .......+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            368999999999999999999854 6889999999754  2334456889999999999999999999997665      


Q ss_pred             eEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCc
Q 008108          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (577)
Q Consensus       314 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla  393 (577)
                      ..++||||+++ +|.+++.     ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            78999999975 6766662     35899999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccch-hhhh-------hhh
Q 008108          394 RLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETED-LLTY-------AWR  465 (577)
Q Consensus       394 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~-l~~~-------~~~  465 (577)
                      +......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+... ++..       .+.
T Consensus       175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  251 (371)
T 2xrw_A          175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  251 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred             ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            8654321   2233679999999999999999999999999999999999999986544322111 1000       000


Q ss_pred             hc--------------ccCCccccccCcCCCC----ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          466 NW--------------NEGAALNLMDPTMRGG----STSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       466 ~~--------------~~~~~~~~~d~~l~~~----~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      .+              ........+.....+.    .......+.+++..|++.||++|||+.|+++-
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence            00              0000000000000011    01123456788899999999999999999863

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.7e-40  Score=367.82  Aligned_cols=250  Identities=26%  Similarity=0.302  Sum_probs=201.0

Q ss_pred             HHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeE
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKER  315 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  315 (577)
                      ...++|++.++||+|+||.||++... +++.||||++.+..   ......+..|..++..+ +||||+++++++.+.+..
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            34568999999999999999999965 68889999997542   22334577899999887 799999999999999999


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      +|||||+++|+|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.
T Consensus       418 ~lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~  491 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE  491 (674)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred             EEEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeec
Confidence            999999999999998843   457999999999999999999999998   99999999999999999999999999986


Q ss_pred             ccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccc
Q 008108          396 FEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNL  475 (577)
Q Consensus       396 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  475 (577)
                      .....  .......||+.|+|||++.+..++.++|||||||+||||++|+.||......+.   ......    ..    
T Consensus       492 ~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~---~~~i~~----~~----  558 (674)
T 3pfq_A          492 NIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---FQSIME----HN----  558 (674)
T ss_dssp             CCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHS----SC----
T ss_pred             cccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH---HHHHHh----CC----
Confidence            43322  223457899999999999999999999999999999999999999875443322   211111    00    


Q ss_pred             ccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 008108          476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGM-----ASVVN  514 (577)
Q Consensus       476 ~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~-----~ev~~  514 (577)
                        ..+......   .+.+++..||+.||++||++     .||.+
T Consensus       559 --~~~p~~~s~---~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          559 --VAYPKSMSK---EAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             --CCCCTTSCH---HHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             --CCCCccCCH---HHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence              011111222   44567779999999999997     66653

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.3e-40  Score=334.25  Aligned_cols=252  Identities=25%  Similarity=0.387  Sum_probs=195.9

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      .++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.++..++||||+++++++.+.+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            468999999999999999999975 5899999999877666667889999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....... 
T Consensus        98 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  171 (302)
T 2j7t_A           98 CPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-  171 (302)
T ss_dssp             CTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred             CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence            999999988743  2456999999999999999999999998   9999999999999999999999999986432111 


Q ss_pred             cccccccccCCCCcChhhhh-----cCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          402 HSDTNRVVGTFGYMAPEYVM-----HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                       .......||..|+|||++.     ...++.++||||||+++|||++|+.|+........   +.....    .......
T Consensus       172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~----~~~~~~~  243 (302)
T 2j7t_A          172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV---LLKIAK----SDPPTLL  243 (302)
T ss_dssp             -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHH----SCCCCCS
T ss_pred             -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---HHHHhc----cCCcccC
Confidence             1122357899999999984     56789999999999999999999999865432211   111110    0000000


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .      .......+.+++..|++.||++|||+.++++
T Consensus       244 ~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          244 T------PSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             S------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             C------ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0      0111124557788999999999999998875

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.7e-40  Score=331.79  Aligned_cols=256  Identities=28%  Similarity=0.409  Sum_probs=193.8

Q ss_pred             hcCCccccccccCCcEEEEEeEec--CCc--EEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS--NGE--TIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  315 (577)
                      .++|++.++||+|+||+||+|.+.  +++  .||||++....   ......+.+|+.++++++||||+++++++.+.. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            367999999999999999999853  333  68999987542   234457889999999999999999999998765 8


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      ++||||+++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        96 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHh--ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence            899999999999998854  2356999999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCcc-ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCcc
Q 008108          396 FEMDQTH-SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAAL  473 (577)
Q Consensus       396 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  473 (577)
                      ....... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||.......   ++.....   .... 
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~---~~~~-  243 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKIDK---EGER-  243 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHT---SCCC-
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH---HHHHHHc---cCCC-
Confidence            6543322 12233567889999999999999999999999999999999 999886544322   1111111   0000 


Q ss_pred             ccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          474 NLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       474 ~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                          .......+   ..+.+++..|++.||++|||+.++++.|+.
T Consensus       244 ----~~~~~~~~---~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  281 (291)
T 1u46_A          244 ----LPRPEDCP---QDIYNVMVQCWAHKPEDRPTFVALRDFLLE  281 (291)
T ss_dssp             ----CCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CCCCcCcC---HHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence                00111122   345577789999999999999999999975

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.6e-40  Score=344.34  Aligned_cols=253  Identities=9%  Similarity=0.018  Sum_probs=178.0

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhc--CCCCeEEEE-------eEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARL--QHRNLVRLL-------GFCL  310 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~~  310 (577)
                      .+|...++||+|+||.||+|... +|+.||||++.....   .....+.+|+.++..+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45889999999999999999964 789999999987543   2334577886555555  699988865       3443


Q ss_pred             cC-----------------CeEEEEEEecCCCCcccccccCCCCCCCCHHHH------HHHHHHHHHHHHHhhcCCCCcE
Q 008108          311 ER-----------------KERILVYEFVPNASLDHFIFDPINREHMTWEKR------YKIIEGIARGLLYLHEDSRLRI  367 (577)
Q Consensus       311 ~~-----------------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~gl~yLH~~~~~~i  367 (577)
                      ..                 ...+|||||++ |+|.+++...  ...+.+..+      +.++.||+.||.|||+++   |
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i  215 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG---L  215 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence            22                 34799999999 8999998542  234556666      788899999999999998   9


Q ss_pred             EEeccCCCcEEEcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhc--CCCCccccEEecchhHhHHhhCC
Q 008108          368 IHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH--GRFSVKSDIFSFGVLVLEIVSGQ  445 (577)
Q Consensus       368 iHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltG~  445 (577)
                      +||||||+||||+.++.+||+|||+++.....     .....+|+.|+|||++.+  ..++.++|||||||++|||++|+
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~  290 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF  290 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence            99999999999999999999999999865421     113467799999999987  67999999999999999999999


Q ss_pred             CCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          446 KRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       446 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .||..............   ............+.. ...+   ..+.+++..||+.||++|||+.|+++
T Consensus       291 ~Pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~-~~~~---~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          291 LPFGLVTPGIKGSWKRP---SLRVPGTDSLAFGSC-TPLP---DFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             CSTTBCCTTCTTCCCBC---CTTSCCCCSCCCTTS-SCCC---HHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCcCcccccchhhh---hhhhccccccchhhc-cCCC---HHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            99875433211110000   000000000001100 1122   34556777999999999999999874

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.3e-40  Score=334.05  Aligned_cols=264  Identities=20%  Similarity=0.329  Sum_probs=192.5

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEE-----------
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL-----------  310 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----------  310 (577)
                      .++|+..+.||+|+||.||+|... +++.||||++..........+.+|+.++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            367999999999999999999976 48999999998777666678899999999999999999999874           


Q ss_pred             ---cCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEc-CCCCeE
Q 008108          311 ---ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD-SEMNPK  386 (577)
Q Consensus       311 ---~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~-~~~~~k  386 (577)
                         +....++||||++ |+|.+++.    ...+++..++.++.||+.||.|||+++   |+||||||+|||++ +++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence               3467899999998 58988873    457999999999999999999999998   99999999999997 567899


Q ss_pred             EeccCCcccccCCCc-cccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhh
Q 008108          387 ISDFGMARLFEMDQT-HSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAW  464 (577)
Q Consensus       387 l~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~  464 (577)
                      |+|||+++....... ........+|..|+|||.+.. ..++.++||||||+++|||++|+.||...........+....
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  241 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI  241 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            999999987643221 112234567999999998876 678999999999999999999999987554322211111000


Q ss_pred             hhcccCCcccc-------ccCcCC-C-CC-----hHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          465 RNWNEGAALNL-------MDPTMR-G-GS-----TSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       465 ~~~~~~~~~~~-------~d~~l~-~-~~-----~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .........++       +..... . ..     ......+.+++..|++.||++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            00000000000       000000 0 00     011234567888999999999999999985

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.2e-39  Score=338.49  Aligned_cols=264  Identities=22%  Similarity=0.324  Sum_probs=198.7

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC-----CeE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER-----KER  315 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  315 (577)
                      .++|++.++||+|+||.||++... +++.||||++.... ......+.+|+.++.+++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468999999999999999999954 68889999997543 33345688999999999999999999999765     368


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      ++||||++ ++|.+++.    ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.
T Consensus       106 ~iv~e~~~-~~L~~~l~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC-cCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            99999997 48888773    356999999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCccc-cccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhh--------hh
Q 008108          396 FEMDQTHS-DTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA--------WR  465 (577)
Q Consensus       396 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~--------~~  465 (577)
                      ........ ......||+.|+|||++.++ .++.++||||||+++|||++|+.||......+....+...        +.
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  257 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  257 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            65432221 12346899999999987654 5899999999999999999999998755433322111100        00


Q ss_pred             hcccCCcccccc--CcCCCCC-----hHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          466 NWNEGAALNLMD--PTMRGGS-----TSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       466 ~~~~~~~~~~~d--~~l~~~~-----~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .+..........  +......     ......+.+++..|++.||++|||+.|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000000000000  0000000     011234567888999999999999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=9.1e-40  Score=339.50  Aligned_cols=259  Identities=25%  Similarity=0.356  Sum_probs=181.7

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC------C
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER------K  313 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  313 (577)
                      .++|+..+.||+|+||.||+|.. .+|+.||||++...  .......+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            36899999999999999999985 46899999999654  233445688999999999999999999998754      5


Q ss_pred             eEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCc
Q 008108          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (577)
Q Consensus       314 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla  393 (577)
                      ..++|+||+ +++|.+++.    ...+++..+..++.||++||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence            679999999 789988873    357999999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCccccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhh--------h
Q 008108          394 RLFEMDQTHSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA--------W  464 (577)
Q Consensus       394 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~--------~  464 (577)
                      +.....     .....||..|+|||++.+ ..++.++||||||+++|||++|+.||......+....+...        +
T Consensus       180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  254 (367)
T 2fst_X          180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  254 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            865422     233679999999999887 67899999999999999999999998654432221111100        0


Q ss_pred             hhcccCCccccccC--cCCCCChH-----HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          465 RNWNEGAALNLMDP--TMRGGSTS-----EMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       465 ~~~~~~~~~~~~d~--~l~~~~~~-----~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ...........+..  ........     ....+.+++..|++.||++|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            00000000000000  00000111     1134567888999999999999999986

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=330.60  Aligned_cols=252  Identities=25%  Similarity=0.396  Sum_probs=196.8

Q ss_pred             HHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ...++|++.+.||+|+||.||+|... +|+.||||.+....  ....+.+|+.++.+++||||+++++++.+.+..++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            34578999999999999999999965 58999999997643  2346889999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus       104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            99999999998742  3457999999999999999999999998   999999999999999999999999999866532


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                      ..  ......||..|+|||.+.+..++.++||||||+++|||++|+.||...........+   ..    ...     +.
T Consensus       179 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~----~~~-----~~  244 (314)
T 3com_A          179 MA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI---PT----NPP-----PT  244 (314)
T ss_dssp             BS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HH----SCC-----CC
T ss_pred             cc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---hc----CCC-----cc
Confidence            22  223457899999999999999999999999999999999999998643322111000   00    000     00


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      +. ........+.+++..|++.||++|||+.++++
T Consensus       245 ~~-~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          245 FR-KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             CS-SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cC-CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            00 00011124557788999999999999999875

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.5e-40  Score=341.59  Aligned_cols=271  Identities=21%  Similarity=0.244  Sum_probs=189.1

Q ss_pred             HHHHHHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCe-
Q 008108          237 ETIRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE-  314 (577)
Q Consensus       237 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-  314 (577)
                      .......++|++.++||+|+||.||+|... +|+.||||++....... ..+.+|+..+..++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-NRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC-CHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc-HHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            445667789999999999999999999964 68999999986553322 245678888899999999999999876443 


Q ss_pred             ------EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhh--cCCCCcEEEeccCCCcEEEcC-CCCe
Q 008108          315 ------RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH--EDSRLRIIHRDLKASNILLDS-EMNP  385 (577)
Q Consensus       315 ------~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH--~~~~~~iiHrDlkp~NiLl~~-~~~~  385 (577)
                            .++||||++++.+..+.........+++..+..++.||+.||.|||  +.+   |+||||||+||||+. ++.+
T Consensus        95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred             cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence                  7899999987533222211234567999999999999999999999  776   999999999999997 8999


Q ss_pred             EEeccCCcccccCCCccccccccccCCCCcChhhhhcCC-CCccccEEecchhHhHHhhCCCCCCCCCccccchhhhh--
Q 008108          386 KISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTY--  462 (577)
Q Consensus       386 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~--  462 (577)
                      ||+|||+++.......   .....||+.|+|||++.+.. ++.++||||||+++|||++|+.||...........+..  
T Consensus       172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~  248 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL  248 (360)
T ss_dssp             EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             EEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence            9999999987654332   22357899999999987654 89999999999999999999999876543322111110  


Q ss_pred             ------hhhhcccCC-ccccccC-------cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          463 ------AWRNWNEGA-ALNLMDP-------TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       463 ------~~~~~~~~~-~~~~~d~-------~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                            .+..+.... .....+.       .+..........+.+++..||+.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence                  011111000 0000000       000111123346678888999999999999999885

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.5e-40  Score=347.25  Aligned_cols=261  Identities=21%  Similarity=0.317  Sum_probs=193.5

Q ss_pred             cCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCe------EEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE------RIL  317 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~l  317 (577)
                      .+|+..++||+|+||.||+|....+..+|+|++......    ..+|+.+++.++||||+++++++.....      .++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            468899999999999999999877777999998654332    2468999999999999999999865433      789


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEc-CCCCeEEeccCCcccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLF  396 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~-~~~~~kl~DfGla~~~  396 (577)
                      ||||++++.+............+++..+..++.||++||.|||+.+   |+||||||+||||+ .++.+||+|||+++..
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            9999987655433322223567999999999999999999999998   99999999999999 7899999999999876


Q ss_pred             cCCCccccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccc-hhhhhh-------hhhc
Q 008108          397 EMDQTHSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE-DLLTYA-------WRNW  467 (577)
Q Consensus       397 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~-~l~~~~-------~~~~  467 (577)
                      .....   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.. .++...       +...
T Consensus       193 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~  269 (394)
T 4e7w_A          193 IAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM  269 (394)
T ss_dssp             CTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             cCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            54332   2235789999999998765 5899999999999999999999998754432211 111100       0000


Q ss_pred             ccCCccccccCcCCCCCh------HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          468 NEGAALNLMDPTMRGGST------SEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       468 ~~~~~~~~~d~~l~~~~~------~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      ... ..+..-+.......      .....+.+++..||+.||++|||+.|+++-
T Consensus       270 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          270 NPN-YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             CGG-GSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             Chh-hhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            000 00000011111111      112356678889999999999999999863

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.4e-39  Score=333.38  Aligned_cols=261  Identities=20%  Similarity=0.287  Sum_probs=201.7

Q ss_pred             hcCCccccccccCCcEEEEEeEe--cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCC------eEEEEeEEEcCCe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML--SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN------LVRLLGFCLERKE  314 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  314 (577)
                      .++|++.++||+|+||+||++..  .+++.||||++.... .....+.+|+.++..++|+|      ++++++++.+.+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46899999999999999999986  368899999997543 33456789999999987664      9999999999999


Q ss_pred             EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC-------------
Q 008108          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS-------------  381 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~-------------  381 (577)
                      .++||||+ +++|.+++.. .....+++..++.++.||+.||.|||+++   |+||||||+|||++.             
T Consensus        92 ~~lv~e~~-~~~l~~~l~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKE-NGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEEcCC-CCCHHHHHHh-cCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence            99999999 8899888754 22346899999999999999999999998   999999999999987             


Q ss_pred             ------CCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccc
Q 008108          382 ------EMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEE  455 (577)
Q Consensus       382 ------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~  455 (577)
                            ++.+||+|||+++.....     .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence                  678999999999864422     223579999999999999999999999999999999999999987655433


Q ss_pred             cchhhhhhhh--------hcccCCcc------------------ccccCc--CCCCChHHHHHHHHHHHhcccCCCCCCC
Q 008108          456 TEDLLTYAWR--------NWNEGAAL------------------NLMDPT--MRGGSTSEMMKCIHIGLLCVQENVSNRP  507 (577)
Q Consensus       456 ~~~l~~~~~~--------~~~~~~~~------------------~~~d~~--l~~~~~~~~~~~~~l~~~C~~~~p~~RP  507 (577)
                      ....+.....        ........                  ....+.  ...........+.+++..|++.||++||
T Consensus       242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence            2222211110        00000000                  000000  0011233455677889999999999999


Q ss_pred             CHHHHHH
Q 008108          508 GMASVVN  514 (577)
Q Consensus       508 t~~ev~~  514 (577)
                      |+.|+++
T Consensus       322 t~~ell~  328 (339)
T 1z57_A          322 TLREALK  328 (339)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHhc
Confidence            9999874

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-40  Score=337.07  Aligned_cols=259  Identities=28%  Similarity=0.424  Sum_probs=196.6

Q ss_pred             ChHHHHHHhcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEc-
Q 008108          235 DFETIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLE-  311 (577)
Q Consensus       235 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-  311 (577)
                      ++..+....++|++.+.||+|+||.||+|.. .+|+.||||++..... ....+.+|+.++.++ +||||+++++++.. 
T Consensus        15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            3444455678899999999999999999996 4789999999875543 334788999999999 89999999999977 


Q ss_pred             -----CCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeE
Q 008108          312 -----RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPK  386 (577)
Q Consensus       312 -----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~k  386 (577)
                           ....++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+|
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k  169 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK  169 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence                 46789999999999999988542 3457999999999999999999999998   99999999999999999999


Q ss_pred             EeccCCcccccCCCccccccccccCCCCcChhhhh-----cCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhh
Q 008108          387 ISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM-----HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLT  461 (577)
Q Consensus       387 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~  461 (577)
                      |+|||++.......  .......||+.|+|||++.     ...++.++||||||+++|||++|+.|+........   +.
T Consensus       170 l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~  244 (326)
T 2x7f_A          170 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA---LF  244 (326)
T ss_dssp             ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HH
T ss_pred             EeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---HH
Confidence            99999998654322  1223357899999999987     56789999999999999999999999864332211   11


Q ss_pred             hhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          462 YAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       462 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ....    .......    ......   .+.+++..||+.||++||++.++++
T Consensus       245 ~~~~----~~~~~~~----~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          245 LIPR----NPAPRLK----SKKWSK---KFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHH----SCCCCCS----CSCSCH---HHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             Hhhc----CccccCC----ccccCH---HHHHHHHHHhccChhhCCCHHHHhh
Confidence            1000    0000010    111222   4456777999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.3e-39  Score=344.66  Aligned_cols=259  Identities=22%  Similarity=0.348  Sum_probs=190.9

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC------CeEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER------KERI  316 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~  316 (577)
                      .+|+..+.||+|+||.||+|... +|+.||||++......    +.+|+++|++++||||+++++++...      ...+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh----HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46888999999999999999975 6899999998654322    34799999999999999999988542      2357


Q ss_pred             EEEEecCCCCccccccc-CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCC-CCeEEeccCCcc
Q 008108          317 LVYEFVPNASLDHFIFD-PINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMAR  394 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~-~~~kl~DfGla~  394 (577)
                      +||||+++ +|.+.+.. ......+++..+..++.||++||.|||+++   |+||||||+||||+.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999986 45444322 123467999999999999999999999988   9999999999999965 568999999998


Q ss_pred             cccCCCccccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCcccc-chhhhh-------hhh
Q 008108          395 LFEMDQTHSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET-EDLLTY-------AWR  465 (577)
Q Consensus       395 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~-~~l~~~-------~~~  465 (577)
                      .+.....   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+. ..++..       .+.
T Consensus       206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~  282 (420)
T 1j1b_A          206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  282 (420)
T ss_dssp             ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            7654322   2235789999999998765 799999999999999999999999875443221 111110       000


Q ss_pred             hcccCCccccccCcCCCCChH------HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          466 NWNEGAALNLMDPTMRGGSTS------EMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       466 ~~~~~~~~~~~d~~l~~~~~~------~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .... ...+...+.+......      ....+.+++.+||+.||++|||+.|+++
T Consensus       283 ~~~~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          283 EMNP-NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHCS-CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhCh-hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            0100 0111111111111111      1235667888999999999999999985

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-39  Score=341.27  Aligned_cols=263  Identities=19%  Similarity=0.291  Sum_probs=193.0

Q ss_pred             HHHhcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC------
Q 008108          240 RVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER------  312 (577)
Q Consensus       240 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  312 (577)
                      ....++|++.++||+|+||+||+|.. .+|+.||||++......    ..+|+.+++.++||||+++++++...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            45668899999999999999999985 57899999998765332    24799999999999999999998543      


Q ss_pred             --------------------------------CeEEEEEEecCCCCcccccccC-CCCCCCCHHHHHHHHHHHHHHHHHh
Q 008108          313 --------------------------------KERILVYEFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYL  359 (577)
Q Consensus       313 --------------------------------~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yL  359 (577)
                                                      ...++||||+++ +|.+.+... .....+++..+..++.||++||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                            347899999984 776665431 2346799999999999999999999


Q ss_pred             hcCCCCcEEEeccCCCcEEEc-CCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcC-CCCccccEEecchh
Q 008108          360 HEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVL  437 (577)
Q Consensus       360 H~~~~~~iiHrDlkp~NiLl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvi  437 (577)
                      |+.+   |+||||||+|||++ .++.+||+|||+++.......   .....||..|+|||.+.+. .++.++||||||++
T Consensus       158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9988   99999999999998 688999999999987654332   2235789999999998775 48999999999999


Q ss_pred             HhHHhhCCCCCCCCCccccc-hhhhhh-------hhhcccCCccccccCcCCCCCh------HHHHHHHHHHHhcccCCC
Q 008108          438 VLEIVSGQKRSSFGTEEETE-DLLTYA-------WRNWNEGAALNLMDPTMRGGST------SEMMKCIHIGLLCVQENV  503 (577)
Q Consensus       438 l~elltG~~p~~~~~~~~~~-~l~~~~-------~~~~~~~~~~~~~d~~l~~~~~------~~~~~~~~l~~~C~~~~p  503 (577)
                      +|||++|+.||......+.. .++...       +..... ...+..-+.+.....      .....+.+++..|++.||
T Consensus       232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  310 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNP-HYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP  310 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCT-TC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCc-ccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence            99999999998754432211 111100       000000 000000011110000      011245678889999999


Q ss_pred             CCCCCHHHHHH
Q 008108          504 SNRPGMASVVN  514 (577)
Q Consensus       504 ~~RPt~~ev~~  514 (577)
                      ++|||+.|+++
T Consensus       311 ~~R~t~~e~l~  321 (383)
T 3eb0_A          311 DLRINPYEAMA  321 (383)
T ss_dssp             GGSCCHHHHHT
T ss_pred             hhCCCHHHHhc
Confidence            99999999884

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4e-40  Score=330.43  Aligned_cols=252  Identities=25%  Similarity=0.353  Sum_probs=183.6

Q ss_pred             HhcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCCh-hhHH-HHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK-QGEI-EFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~-~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      ..++|++.++||+|+||+||++.. .+|+.||||++..... .... .+.++...++.++||||+++++++.+.+..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            357899999999999999999996 4789999999976532 2222 344555567888999999999999999999999


Q ss_pred             EEecCCCCcccccccC-CCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCcEEEeccCCCcEEEcCCCCeEEeccCCcccc
Q 008108          319 YEFVPNASLDHFIFDP-INREHMTWEKRYKIIEGIARGLLYLHED-SRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~  396 (577)
                      |||+++ +|.+++... .....+++..++.++.||+.||.|||++ +   |+||||||+|||++.++.+||+|||+++..
T Consensus        85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999975 776665431 2346799999999999999999999997 7   999999999999999999999999999876


Q ss_pred             cCCCccccccccccCCCCcChhhh----hcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCc
Q 008108          397 EMDQTHSDTNRVVGTFGYMAPEYV----MHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAA  472 (577)
Q Consensus       397 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  472 (577)
                      .....   .....||+.|+|||++    ....++.++||||||+++|||++|+.|+.......  ..+.....   ... 
T Consensus       161 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~---~~~-  231 (290)
T 3fme_A          161 VDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF--QQLKQVVE---EPS-  231 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH--HHHHHHHH---SCC-
T ss_pred             ccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH--HHHHHHhc---cCC-
Confidence            54322   2234799999999996    55678999999999999999999999986432211  11111111   000 


Q ss_pred             cccccCcCC-CCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          473 LNLMDPTMR-GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       473 ~~~~d~~l~-~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                           +... ...+   ..+.+++..|++.||++|||+.|+++
T Consensus       232 -----~~~~~~~~~---~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          232 -----PQLPADKFS---AEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             -----CCCCTTTSC---HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -----CCcccccCC---HHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                 0111 1122   24557778999999999999999875

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.8e-39  Score=342.89  Aligned_cols=200  Identities=24%  Similarity=0.332  Sum_probs=171.4

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhc------CCCCeEEEEeEEEcCCeE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARL------QHRNLVRLLGFCLERKER  315 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~  315 (577)
                      ..+|++.++||+|+||+||+|... +++.||||++.... .....+.+|+.++..+      +|+||+++++++......
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            357999999999999999999864 58899999997543 3344677888888887      567999999999999999


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCC--eEEeccCCc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN--PKISDFGMA  393 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~--~kl~DfGla  393 (577)
                      ++||||+. ++|.+++.. .....+++..+..|+.||+.||.|||+.+   |+||||||+||||+.++.  +||+|||++
T Consensus       175 ~lv~e~~~-~~L~~~l~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKK-NKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEECCCC-CBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEeccC-CCHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence            99999996 588887754 23345999999999999999999999998   999999999999999987  999999999


Q ss_pred             ccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCc
Q 008108          394 RLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTE  453 (577)
Q Consensus       394 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~  453 (577)
                      +.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            764321     2235789999999999999999999999999999999999999865543

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.7e-40  Score=336.53  Aligned_cols=269  Identities=23%  Similarity=0.372  Sum_probs=197.9

Q ss_pred             HHHhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          240 RVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       240 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      ....++|++.+.||+|+||.||+|...+  .+|+|.+.....  .....+.+|+.++++++|+||+++++++.+.+..++
T Consensus        29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  106 (319)
T 2y4i_B           29 DIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI  106 (319)
T ss_dssp             SSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred             cCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence            3445789999999999999999998753  499999875422  222357789999999999999999999999999999


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      ||||+++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++ ++.+||+|||+++...
T Consensus       107 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISG  180 (319)
T ss_dssp             ECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred             EeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence            9999999999999853  3346999999999999999999999998   99999999999998 6799999999987653


Q ss_pred             CCCc---cccccccccCCCCcChhhhhc---------CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhh
Q 008108          398 MDQT---HSDTNRVVGTFGYMAPEYVMH---------GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWR  465 (577)
Q Consensus       398 ~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~  465 (577)
                      ....   ........||+.|+|||.+..         ..++.++||||||+++|||++|+.||........   ..... 
T Consensus       181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~-  256 (319)
T 2y4i_B          181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI---IWQMG-  256 (319)
T ss_dssp             -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH---HHHHH-
T ss_pred             cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHhc-
Confidence            2211   122233568999999999864         4578999999999999999999999865443221   11111 


Q ss_pred             hcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCCCCCCCCCCCCc
Q 008108          466 NWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKPA  530 (577)
Q Consensus       466 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~~~~~~~p~~p~  530 (577)
                         .+........    ..+.   .+.+++..||+.||++|||+.+++++|+.-.........|.
T Consensus       257 ---~~~~~~~~~~----~~~~---~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~  311 (319)
T 2y4i_B          257 ---TGMKPNLSQI----GMGK---EISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPG  311 (319)
T ss_dssp             ---TTCCCCCCCS----SCCT---THHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----------
T ss_pred             ---cCCCCCCCcC----CCCH---HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCc
Confidence               1111111110    1112   34577789999999999999999999987554433333333

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.6e-39  Score=331.74  Aligned_cols=262  Identities=25%  Similarity=0.423  Sum_probs=197.2

Q ss_pred             HhcCCccccccccCCcEEEEEeEe--cCCcEEEEEEeccCChh--hHHHHHHHHHHHHhc---CCCCeEEEEeEEE----
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGML--SNGETIAVKRLSKNSKQ--GEIEFKNEVLLLARL---QHRNLVRLLGFCL----  310 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~----  310 (577)
                      ..++|++.+.||+|+||.||++..  .+|+.||+|++......  ....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457899999999999999999997  46889999998653221  122456777777766   8999999999987    


Q ss_pred             -cCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEec
Q 008108          311 -ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD  389 (577)
Q Consensus       311 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~D  389 (577)
                       .....++||||++ |+|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence             5567899999998 5998887542 3345999999999999999999999998   99999999999999999999999


Q ss_pred             cCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccch-hhhhh----h
Q 008108          390 FGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETED-LLTYA----W  464 (577)
Q Consensus       390 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~-l~~~~----~  464 (577)
                      ||+++......   ......||..|+|||++.+..++.++||||||+++|||++|+.||.......... ++...    .
T Consensus       164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (326)
T 1blx_A          164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  240 (326)
T ss_dssp             CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred             CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence            99998654322   2234678999999999999999999999999999999999999987544322211 11100    0


Q ss_pred             hhcccCCcc--cccc----C---cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          465 RNWNEGAAL--NLMD----P---TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       465 ~~~~~~~~~--~~~d----~---~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ..|......  ..+.    .   .+.....   ..+.+++..||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          241 EDWPRDVALPRQAFHSKSAQPIEKFVTDID---ELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCC---HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCccccccchhhhcccCcchhhhccccCC---HHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            011100000  0000    0   0111122   34457778999999999999999984

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.4e-39  Score=328.87  Aligned_cols=255  Identities=21%  Similarity=0.330  Sum_probs=194.1

Q ss_pred             HHHHhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcC--CCCeEEEEeEEEcCCe
Q 008108          239 IRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQ--HRNLVRLLGFCLERKE  314 (577)
Q Consensus       239 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  314 (577)
                      +....++|++.+.||+|+||.||++...+++.||||++....  ......+.+|+.++.+++  |+||+++++++.+.+.
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~  102 (313)
T 3cek_A           23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  102 (313)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred             eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence            334457799999999999999999998889999999986543  334557899999999997  5999999999999999


Q ss_pred             EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      .++||| +.+++|.+++..   ...+++..++.++.||++||.|||+++   |+||||||+|||+++ +.+||+|||+++
T Consensus       103 ~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~  174 (313)
T 3cek_A          103 IYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIAN  174 (313)
T ss_dssp             EEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred             EEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccc
Confidence            999999 668899998843   457999999999999999999999998   999999999999965 789999999998


Q ss_pred             cccCCCccccccccccCCCCcChhhhhc-----------CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhh
Q 008108          395 LFEMDQTHSDTNRVVGTFGYMAPEYVMH-----------GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA  463 (577)
Q Consensus       395 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~  463 (577)
                      ...............||+.|+|||.+..           ..++.++||||||+++|||++|+.||.......  ..+.  
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~--  250 (313)
T 3cek_A          175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SKLH--  250 (313)
T ss_dssp             C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHHH--
T ss_pred             cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH--HHHH--
Confidence            7654433333334679999999999875           478899999999999999999999986433211  1111  


Q ss_pred             hhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          464 WRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       464 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                       ........     .........   .+.+++..||+.||++||++.|+++
T Consensus       251 -~~~~~~~~-----~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          251 -AIIDPNHE-----IEFPDIPEK---DLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             -HHHCTTSC-----CCCCCCSCH---HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -HHHhcccc-----cCCcccchH---HHHHHHHHHccCCcccCcCHHHHhc
Confidence             11111100     011111222   4556777999999999999999985

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.4e-39  Score=334.33  Aligned_cols=264  Identities=20%  Similarity=0.305  Sum_probs=196.5

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC-----CeE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER-----KER  315 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  315 (577)
                      .++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            478999999999999999999965 68999999997543 33345678999999999999999999988764     678


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      ++||||++ ++|.+++.    ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIS----TQMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            99999997 58888773    356999999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCccc--------cccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhh
Q 008108          396 FEMDQTHS--------DTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRN  466 (577)
Q Consensus       396 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~  466 (577)
                      ........        ......||+.|+|||++.. ..++.++||||||+++|||++|+.||...........+......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  241 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT  241 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            65332111        1223578999999998765 67899999999999999999999998754432211111100000


Q ss_pred             cc-cCCc--------ccccc--CcCCCCC-----hHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          467 WN-EGAA--------LNLMD--PTMRGGS-----TSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       467 ~~-~~~~--------~~~~d--~~l~~~~-----~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .. ....        .+.+.  +......     ......+.+++.+|++.||++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00 0000        00000  0000000     011234567888999999999999999986

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.5e-39  Score=324.62  Aligned_cols=252  Identities=26%  Similarity=0.362  Sum_probs=199.5

Q ss_pred             HHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      ...++|++.++||+|+||.||++... +++.||||++....  ......+.+|+.++++++||||+++++++.+....++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            34578999999999999999999975 68999999986542  2345578899999999999999999999999999999


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCC---CCeEEeccCCcc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMAR  394 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~---~~~kl~DfGla~  394 (577)
                      ||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+||+++.+   +.+||+|||++.
T Consensus        99 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A           99 VGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            9999999999888743   457999999999999999999999998   9999999999999764   469999999998


Q ss_pred             cccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccc
Q 008108          395 LFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALN  474 (577)
Q Consensus       395 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  474 (577)
                      .......   .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.|+......+.   +....    .+....
T Consensus       173 ~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~----~~~~~~  241 (287)
T 2wei_A          173 CFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI---LKRVE----TGKYAF  241 (287)
T ss_dssp             TBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH----HCCCCC
T ss_pred             eecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHH----cCCCCC
Confidence            6653322   223468999999998764 589999999999999999999999865433221   11111    111000


Q ss_pred             cccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          475 LMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       475 ~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .. +.. ...+   ..+.+++..|++.||++|||+.|+++
T Consensus       242 ~~-~~~-~~~~---~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          242 DL-PQW-RTIS---DDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CS-GGG-TTSC---HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             Cc-hhh-hhcC---HHHHHHHHHHcccChhhCcCHHHHhc
Confidence            00 000 1112   24557778999999999999999986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=5.6e-39  Score=331.92  Aligned_cols=258  Identities=23%  Similarity=0.341  Sum_probs=193.1

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCe-----
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE-----  314 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  314 (577)
                      .++|...+.||+|+||.||+|... +|+.||||++....  ......+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            367999999999999999999964 68999999997643  2334568899999999999999999999987654     


Q ss_pred             -EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCc
Q 008108          315 -RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (577)
Q Consensus       315 -~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla  393 (577)
                       .++||||++ ++|.+++     ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIM-----GLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999997 5887776     235999999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCccccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhh--------h
Q 008108          394 RLFEMDQTHSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA--------W  464 (577)
Q Consensus       394 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~--------~  464 (577)
                      +.....     .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....+...        +
T Consensus       174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  248 (353)
T 3coi_A          174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  248 (353)
T ss_dssp             TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred             cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            865422     223578999999999877 67899999999999999999999998754432211111000        0


Q ss_pred             hhcccCCc-------cccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          465 RNWNEGAA-------LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       465 ~~~~~~~~-------~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ..+.....       .....+.+..........+.+++..|++.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00000000       000000011001112234567778999999999999999885

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=7.6e-39  Score=333.30  Aligned_cols=258  Identities=24%  Similarity=0.372  Sum_probs=192.9

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeE----
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKER----  315 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  315 (577)
                      .++|...+.||+|+||.||+|... +|+.||||++....  ......+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            367899999999999999999954 68999999997643  33345688999999999999999999999877654    


Q ss_pred             --EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCc
Q 008108          316 --ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (577)
Q Consensus       316 --~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla  393 (577)
                        ++||||+. ++|.+++     ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIM-----GMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999997 5777765     334999999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCccccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccch-hhhhh-------h
Q 008108          394 RLFEMDQTHSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETED-LLTYA-------W  464 (577)
Q Consensus       394 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~-l~~~~-------~  464 (577)
                      +.....     .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+... ++...       +
T Consensus       192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (371)
T 4exu_A          192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  266 (371)
T ss_dssp             -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence            865422     233578999999999987 688999999999999999999999986544322111 11100       0


Q ss_pred             hhcccCCccccc---cCcCCCC----ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          465 RNWNEGAALNLM---DPTMRGG----STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       465 ~~~~~~~~~~~~---d~~l~~~----~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ..+........+   .......    .......+.+++..|++.||++|||+.|+++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            000000000000   0000000    0011235567888999999999999999885

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.9e-39  Score=340.53  Aligned_cols=202  Identities=28%  Similarity=0.452  Sum_probs=153.5

Q ss_pred             CCcc-ccccccCCcEEEEEeEec---CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEc--CCeEEEE
Q 008108          245 NFSD-ANKLGQGGFGAVYKGMLS---NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE--RKERILV  318 (577)
Q Consensus       245 ~f~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  318 (577)
                      .|+. .++||+|+||+||+|...   +++.||||++......  ..+.+|+.+|++++||||+++++++..  ....++|
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC--HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC--HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            4555 458999999999999965   5788999999755332  357899999999999999999999954  6688999


Q ss_pred             EEecCCCCcccccccC------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEE----cCCCCeEEe
Q 008108          319 YEFVPNASLDHFIFDP------INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL----DSEMNPKIS  388 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl----~~~~~~kl~  388 (577)
                      |||+++ +|.+++...      .....+++..++.|+.||+.||.|||+.+   |+||||||+||||    +.++.+||+
T Consensus        99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            999975 666655321      12235999999999999999999999998   9999999999999    778899999


Q ss_pred             ccCCcccccCCCc-cccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCC
Q 008108          389 DFGMARLFEMDQT-HSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGT  452 (577)
Q Consensus       389 DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~  452 (577)
                      |||+++.+..... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            9999987653221 1223346899999999999874 58999999999999999999999986543

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.6e-38  Score=332.29  Aligned_cols=205  Identities=26%  Similarity=0.353  Sum_probs=171.7

Q ss_pred             HHHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcC-CC-----CeEEEEeEEEcC
Q 008108          240 RVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HR-----NLVRLLGFCLER  312 (577)
Q Consensus       240 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~  312 (577)
                      ....++|++.++||+|+||+||+|... +++.||||++.... ....++.+|+.++..++ |+     +|+++++++...
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            344678999999999999999999965 68889999997543 33446778899988885 55     499999999999


Q ss_pred             CeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEc--CCCCeEEecc
Q 008108          313 KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD--SEMNPKISDF  390 (577)
Q Consensus       313 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~--~~~~~kl~Df  390 (577)
                      +..++||||++ ++|.+++... ....+++..+..++.||+.||.|||.+. .+|+||||||+||||+  .++.+||+||
T Consensus       129 ~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          129 NHLCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             TEEEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             CceEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            99999999996 4898887542 2346999999999999999999999531 2499999999999994  4778999999


Q ss_pred             CCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCc
Q 008108          391 GMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTE  453 (577)
Q Consensus       391 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~  453 (577)
                      |+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       206 G~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          206 GSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             TTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999876422     2236789999999999999999999999999999999999999875543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.3e-39  Score=358.20  Aligned_cols=256  Identities=22%  Similarity=0.345  Sum_probs=199.7

Q ss_pred             HHhcCCccccccccCCcEEEEEeEec----CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeE
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGMLS----NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  315 (577)
                      ...++|++.+.||+|+||.||+|...    .+..||||++.... ......+.+|+.++++++||||+++++++. ++..
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~  465 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV  465 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence            34567888999999999999999864    24679999987643 334457899999999999999999999985 4568


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      ++||||+++|+|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       466 ~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             EEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred             EEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCee
Confidence            999999999999998853  2346999999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccc
Q 008108          396 FEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALN  474 (577)
Q Consensus       396 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  474 (577)
                      ....... ......+|+.|+|||++....++.++||||||+++|||++ |..||......+.   +.....    +..  
T Consensus       541 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~~~i~~----~~~--  610 (656)
T 2j0j_A          541 MEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIEN----GER--  610 (656)
T ss_dssp             CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHHH----TCC--
T ss_pred             cCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHc----CCC--
Confidence            6533221 2223467889999999999999999999999999999997 8888764433222   211111    100  


Q ss_pred             cccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          475 LMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       475 ~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                         +.+....+   ..+.+++..||+.||++|||+.||++.|+.
T Consensus       611 ---~~~~~~~~---~~l~~li~~~l~~dP~~RPs~~el~~~L~~  648 (656)
T 2j0j_A          611 ---LPMPPNCP---PTLYSLMTKCWAYDPSRRPRFTELKAQLST  648 (656)
T ss_dssp             ---CCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCCCcccc---HHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence               01111122   245577789999999999999999999864

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.4e-38  Score=328.41  Aligned_cols=261  Identities=17%  Similarity=0.264  Sum_probs=197.7

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CC-cEEEEEEeccCChhhHHHHHHHHHHHHhcCCCC------eEEEEeEEEcCCe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NG-ETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN------LVRLLGFCLERKE  314 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  314 (577)
                      .++|++.++||+|+||+||++... ++ +.||+|++.... .....+.+|+.++++++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            468999999999999999999964 34 689999997543 33456788999999998766      9999999999999


Q ss_pred             EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEE---------------
Q 008108          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL---------------  379 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl---------------  379 (577)
                      .++||||+ +++|.+++.. .....+++..++.++.||+.||.|||+++   |+||||||+||||               
T Consensus        97 ~~lv~e~~-~~~l~~~l~~-~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKE-NNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEecc-CCChHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence            99999999 5566555543 22356999999999999999999999987   9999999999999               


Q ss_pred             ----cCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccc
Q 008108          380 ----DSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEE  455 (577)
Q Consensus       380 ----~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~  455 (577)
                          +.++.+||+|||+++.....     .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                66789999999999864322     233579999999999999999999999999999999999999987554332


Q ss_pred             cchhhhhhhh--------hcccCCcc--------c----------cccC--cCCCCChHHHHHHHHHHHhcccCCCCCCC
Q 008108          456 TEDLLTYAWR--------NWNEGAAL--------N----------LMDP--TMRGGSTSEMMKCIHIGLLCVQENVSNRP  507 (577)
Q Consensus       456 ~~~l~~~~~~--------~~~~~~~~--------~----------~~d~--~l~~~~~~~~~~~~~l~~~C~~~~p~~RP  507 (577)
                      ....+.....        .+......        .          ...+  ........+...+.+++..||+.||++||
T Consensus       247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence            2211111100        00000000        0          0000  00011223345677889999999999999


Q ss_pred             CHHHHHH
Q 008108          508 GMASVVN  514 (577)
Q Consensus       508 t~~ev~~  514 (577)
                      |+.|+++
T Consensus       327 t~~e~l~  333 (355)
T 2eu9_A          327 TLAEALL  333 (355)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHhc
Confidence            9999874

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=5.7e-39  Score=323.62  Aligned_cols=252  Identities=27%  Similarity=0.443  Sum_probs=189.0

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEc----------
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE----------  311 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----------  311 (577)
                      .++|+..+.||+|+||.||+|... +++.||||++... ......+.+|+.++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            467999999999999999999964 7899999999653 3334568899999999999999999998865          


Q ss_pred             ---CCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEe
Q 008108          312 ---RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKIS  388 (577)
Q Consensus       312 ---~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~  388 (577)
                         ....++||||+++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence               3567999999999999999854  2346889999999999999999999998   9999999999999999999999


Q ss_pred             ccCCcccccCCCc------------cccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccc
Q 008108          389 DFGMARLFEMDQT------------HSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEE  455 (577)
Q Consensus       389 DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~  455 (577)
                      |||+++.......            ........||..|+|||++.+. .++.++||||||+++|||++   |+..  ..+
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~--~~~  233 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST--GME  233 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS--HHH
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC--chh
Confidence            9999986543210            1122345789999999998764 78999999999999999998   3321  111


Q ss_pred             cchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          456 TEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       456 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .........    ...  ..+.+.+.   ......+.+++..|++.||++|||+.++++
T Consensus       234 ~~~~~~~~~----~~~--~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          234 RVNILKKLR----SVS--IEFPPDFD---DNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHHHHHHH----STT--CCCCTTCC---TTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcc----ccc--cccCcccc---ccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            111111111    100  00111111   112234557788999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=8.3e-39  Score=328.45  Aligned_cols=252  Identities=21%  Similarity=0.288  Sum_probs=169.7

Q ss_pred             hcCCcccc-ccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEc----CCeEE
Q 008108          243 TDNFSDAN-KLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE----RKERI  316 (577)
Q Consensus       243 ~~~f~~~~-~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  316 (577)
                      .++|.+.+ .||+|+||+||++... +|+.||||++.....    ...+....+..++||||+++++++..    ....+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            46788855 6999999999999965 689999999965421    12223334566799999999999876    44589


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCC---CCeEEeccCCc
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE---MNPKISDFGMA  393 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~---~~~kl~DfGla  393 (577)
                      +||||+++|+|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.+   +.+||+|||++
T Consensus       103 lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            999999999999998542 3357999999999999999999999998   9999999999999764   45999999999


Q ss_pred             ccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcc
Q 008108          394 RLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAAL  473 (577)
Q Consensus       394 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  473 (577)
                      +......    .....||+.|+|||++....++.++||||||+++|||++|+.||.............   ....... .
T Consensus       179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~~-~  250 (336)
T 3fhr_A          179 KETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---RRIRLGQ-Y  250 (336)
T ss_dssp             EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             eeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---Hhhhccc-c
Confidence            8654322    223578999999999988889999999999999999999999986443322111000   0000000 0


Q ss_pred             ccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          474 NLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       474 ~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ....+.. ....   ..+.+++..|++.||++|||+.|+++
T Consensus       251 ~~~~~~~-~~~~---~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          251 GFPNPEW-SEVS---EDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             CCCTTTS-TTCC---HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccCchhh-ccCC---HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0000000 1122   34557778999999999999999997

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.1e-38  Score=331.97  Aligned_cols=261  Identities=21%  Similarity=0.297  Sum_probs=196.0

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcC-----------CCCeEEEEeEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-----------HRNLVRLLGFCL  310 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~  310 (577)
                      .++|++.++||+|+||+||+|.. .+++.||||++.... .....+.+|+.++.+++           |+||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            36799999999999999999995 468999999997543 33456788999999886           899999999988


Q ss_pred             cCC----eEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCcEEEeccCCCcEEEc-----
Q 008108          311 ERK----ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-SRLRIIHRDLKASNILLD-----  380 (577)
Q Consensus       311 ~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiHrDlkp~NiLl~-----  380 (577)
                      ..+    ..++||||+ +++|.+++... ....+++..++.++.||+.||.|||++ +   |+||||||+||||+     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence            654    789999999 88998887542 345699999999999999999999998 7   99999999999994     


Q ss_pred             -CCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCcccc---
Q 008108          381 -SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET---  456 (577)
Q Consensus       381 -~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~---  456 (577)
                       ..+.+||+|||+++.....     .....||+.|+|||++.+..++.++||||||+++|||++|+.||........   
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence             4447999999999876432     2235789999999999999999999999999999999999999875432211   


Q ss_pred             chhhhhhhhh------------------cccCCccccccC-----------cCCCCChHHHHHHHHHHHhcccCCCCCCC
Q 008108          457 EDLLTYAWRN------------------WNEGAALNLMDP-----------TMRGGSTSEMMKCIHIGLLCVQENVSNRP  507 (577)
Q Consensus       457 ~~l~~~~~~~------------------~~~~~~~~~~d~-----------~l~~~~~~~~~~~~~l~~~C~~~~p~~RP  507 (577)
                      ...+......                  +........+..           ............+.+++..||+.||++||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence            1111111000                  000000000000           00011234456677899999999999999


Q ss_pred             CHHHHHH
Q 008108          508 GMASVVN  514 (577)
Q Consensus       508 t~~ev~~  514 (577)
                      |+.|+++
T Consensus       327 t~~ell~  333 (373)
T 1q8y_A          327 DAGGLVN  333 (373)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhh
Confidence            9999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6.2e-39  Score=327.89  Aligned_cols=255  Identities=25%  Similarity=0.392  Sum_probs=175.3

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh-hhHHHHHHHHH-HHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK-QGEIEFKNEVL-LLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      .++|+..+.||+|+||.||++... +|+.||||++..... ....++..|+. +++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            378899999999999999999974 689999999976532 33345556665 677789999999999999999999999


Q ss_pred             EecCCCCccccccc--CCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCcEEEeccCCCcEEEcCCCCeEEeccCCcccc
Q 008108          320 EFVPNASLDHFIFD--PINREHMTWEKRYKIIEGIARGLLYLHED-SRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (577)
Q Consensus       320 E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~  396 (577)
                      ||+++ +|.+++..  ......+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+++..
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99986 77666532  11256799999999999999999999998 7   999999999999999999999999999866


Q ss_pred             cCCCccccccccccCCCCcChhhh----hcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCc
Q 008108          397 EMDQTHSDTNRVVGTFGYMAPEYV----MHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAA  472 (577)
Q Consensus       397 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  472 (577)
                      .....   .....||+.|+|||++    .+..++.++||||||+++|||++|+.||......  ...+.    ....+..
T Consensus       177 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~----~~~~~~~  247 (327)
T 3aln_A          177 VDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--FDQLT----QVVKGDP  247 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------C----CCCCSCC
T ss_pred             ccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH--HHHHH----HHhcCCC
Confidence            43221   2234799999999998    4567899999999999999999999998643211  01110    0001111


Q ss_pred             cccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       473 ~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ..+ .........   ..+.+++..||+.||++|||+.|+++
T Consensus       248 ~~~-~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          248 PQL-SNSEEREFS---PSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCC-CCCSSCCCC---HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCC-CCcccccCC---HHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            011 000111122   34557778999999999999999875

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.2e-38  Score=336.58  Aligned_cols=253  Identities=24%  Similarity=0.281  Sum_probs=184.5

Q ss_pred             cCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      +.|...+.||+|+||+||.+...+|+.||||++....   ...+.+|+.++.++ +||||+++++++.+.+..++||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            3455578899999999987766789999999986543   33568899999887 8999999999999999999999999


Q ss_pred             CCCCcccccccCCCCC----CCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCC-------------CCe
Q 008108          323 PNASLDHFIFDPINRE----HMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE-------------MNP  385 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~-------------~~~  385 (577)
                      + |+|.+++.......    ..++..++.++.||+.||.|||+++   |+||||||+||||+.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence            6 69999885422111    1234456789999999999999998   9999999999999754             479


Q ss_pred             EEeccCCcccccCCCccc--cccccccCCCCcChhhhhc-------CCCCccccEEecchhHhHHhh-CCCCCCCCCccc
Q 008108          386 KISDFGMARLFEMDQTHS--DTNRVVGTFGYMAPEYVMH-------GRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEE  455 (577)
Q Consensus       386 kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~  455 (577)
                      ||+|||+++.........  ......||+.|+|||++.+       ..++.++|||||||++|||+| |+.|+.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            999999999776433221  2234579999999999975       678999999999999999999 888885433221


Q ss_pred             cchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          456 TEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       456 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                       ..++..   .......     +  ..........+.+++.+|++.||++|||+.||++
T Consensus       248 -~~i~~~---~~~~~~~-----~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 -SNIIRG---IFSLDEM-----K--CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             -HHHHHT---CCCCCCC-----T--TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HHHhcC---CCCcccc-----c--ccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence             111111   0000000     0  0012333456778889999999999999999985

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=6e-39  Score=325.71  Aligned_cols=242  Identities=23%  Similarity=0.416  Sum_probs=188.7

Q ss_pred             HHhcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChh------hHHHHHHHHHHHHhc----CCCCeEEEEeEE
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ------GEIEFKNEVLLLARL----QHRNLVRLLGFC  309 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~~~~  309 (577)
                      ...++|++.+.||+|+||.||+|.. .+++.||||++......      ....+.+|+.++.++    +|+||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            3457899999999999999999985 46889999999765332      122356799999998    899999999999


Q ss_pred             EcCCeEEEEEEe-cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEc-CCCCeEE
Q 008108          310 LERKERILVYEF-VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD-SEMNPKI  387 (577)
Q Consensus       310 ~~~~~~~lv~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~-~~~~~kl  387 (577)
                      .+.+..++|||| +.+++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++ .++.+||
T Consensus       108 ~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          108 ETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred             ecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence            999999999999 789999998843   456999999999999999999999998   99999999999999 8899999


Q ss_pred             eccCCcccccCCCccccccccccCCCCcChhhhhcCCCC-ccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhh
Q 008108          388 SDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFS-VKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRN  466 (577)
Q Consensus       388 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~  466 (577)
                      +|||+++......    .....||..|+|||++.+..+. .++||||||+++|||++|+.||....     .....   .
T Consensus       182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~---~  249 (312)
T 2iwi_A          182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EILEA---E  249 (312)
T ss_dssp             CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHHT---C
T ss_pred             EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----HHhhh---c
Confidence            9999998765432    2335699999999999877764 58999999999999999999875311     11110   0


Q ss_pred             cccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          467 WNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       467 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                                 ..+......   .+.+++..|++.||++|||+.|+++
T Consensus       250 -----------~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          250 -----------LHFPAHVSP---DCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             -----------CCCCTTSCH---HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----------cCCcccCCH---HHHHHHHHHccCChhhCcCHHHHhc
Confidence                       001111222   4457778999999999999999987

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-38  Score=336.25  Aligned_cols=250  Identities=24%  Similarity=0.350  Sum_probs=184.8

Q ss_pred             hcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ..+|+..+.||+|+||+|+.....+|+.||||++......   .+.+|+.+|+++ +||||+++++++.+....+|||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            4568889999999999976555667999999999765432   246899999999 899999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC-----CCCeEEeccCCcccc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS-----EMNPKISDFGMARLF  396 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~-----~~~~kl~DfGla~~~  396 (577)
                      ++ |+|.+++..  ....+.+..++.++.||+.||.|||+.+   |+||||||+||||+.     ...+||+|||+++..
T Consensus       100 ~~-g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A          100 CA-ATLQEYVEQ--KDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             CS-EEHHHHHHS--SSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             CC-CCHHHHHHh--cCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            96 589888754  2234555667899999999999999998   999999999999943     336889999999876


Q ss_pred             cCCCcc-ccccccccCCCCcChhhhh---cCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCC
Q 008108          397 EMDQTH-SDTNRVVGTFGYMAPEYVM---HGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGA  471 (577)
Q Consensus       397 ~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~  471 (577)
                      ...... .......||+.|+|||++.   ...++.++|||||||++|||++ |..|+..........+.        ...
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~--------~~~  245 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL--------GAC  245 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHT--------TCC
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHh--------ccC
Confidence            543221 2233467999999999987   4567889999999999999999 88887433222111110        000


Q ss_pred             ccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          472 ALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       472 ~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ......     ........+.+++..||+.||++|||+.||++
T Consensus       246 ~~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          246 SLDCLH-----PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CCTTSC-----TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CccccC-----ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            000011     11122334567888999999999999999984

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5.5e-38  Score=319.15  Aligned_cols=251  Identities=23%  Similarity=0.387  Sum_probs=176.4

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChh-hH-HHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ-GE-IEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      .++|+..+.||+|+||.||++... +|+.||||++...... .. ..+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            367888999999999999999975 6899999999765432 22 23445556778889999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      ||+ ++.+..+..  .....+++..++.++.||+.||.|||++ +   |+||||||+|||++.++.+||+|||++.....
T Consensus       104 e~~-~~~~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLKK--RMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHHH--HhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 445544432  1245799999999999999999999985 7   99999999999999999999999999976543


Q ss_pred             CCccccccccccCCCCcChhhhh-----cCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcc
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVM-----HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAAL  473 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  473 (577)
                      ...   .....||+.|+|||++.     ...++.++||||||+++|||++|+.||......  ...+........    .
T Consensus       178 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~----~  248 (318)
T 2dyl_A          178 DKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVLTKVLQEEP----P  248 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHHHHSCC----C
T ss_pred             Ccc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHHHHHHhccCC----C
Confidence            322   22357899999999984     567889999999999999999999998643221  111111111100    0


Q ss_pred             ccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          474 NLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       474 ~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ..  +. ....+.   .+.+++..||+.||.+||++.|+++
T Consensus       249 ~~--~~-~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          249 LL--PG-HMGFSG---DFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CC--CS-SSCCCH---HHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CC--Cc-cCCCCH---HHHHHHHHHccCChhHCcCHHHHhh
Confidence            00  00 001222   4556778999999999999999875

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=9.5e-39  Score=325.72  Aligned_cols=242  Identities=25%  Similarity=0.425  Sum_probs=195.9

Q ss_pred             HHhcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChh------hHHHHHHHHHHHHhcC--CCCeEEEEeEEEc
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ------GEIEFKNEVLLLARLQ--HRNLVRLLGFCLE  311 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~  311 (577)
                      ...++|++.+.||+|+||.||+|.. .+++.||||++......      ....+.+|+.++++++  |+||+++++++.+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            3457899999999999999999985 46889999998754321      1234678999999996  5999999999999


Q ss_pred             CCeEEEEEEecCC-CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEc-CCCCeEEec
Q 008108          312 RKERILVYEFVPN-ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD-SEMNPKISD  389 (577)
Q Consensus       312 ~~~~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~-~~~~~kl~D  389 (577)
                      .+..++||||+.+ ++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++ +++.+||+|
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred             CCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence            9999999999976 899988843   467999999999999999999999998   99999999999999 778999999


Q ss_pred             cCCcccccCCCccccccccccCCCCcChhhhhcCCC-CccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcc
Q 008108          390 FGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRF-SVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWN  468 (577)
Q Consensus       390 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~  468 (577)
                      ||+++......    .....||+.|+|||++....+ +.++||||||+++|||++|+.||....     .....      
T Consensus       194 fg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~~~------  258 (320)
T 3a99_A          194 FGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIRG------  258 (320)
T ss_dssp             CTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHHC------
T ss_pred             Ccccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hhhcc------
Confidence            99998765322    223579999999999987776 688999999999999999999985321     11100      


Q ss_pred             cCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          469 EGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       469 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                        .      .......+.   .+.+++.+||+.||++|||+.|+++
T Consensus       259 --~------~~~~~~~~~---~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          259 --Q------VFFRQRVSS---ECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             --C------CCCSSCCCH---HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --c------ccccccCCH---HHHHHHHHHccCChhhCcCHHHHhc
Confidence              0      001111222   4557778999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.6e-38  Score=345.61  Aligned_cols=258  Identities=23%  Similarity=0.332  Sum_probs=195.7

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEc------CCe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE------RKE  314 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  314 (577)
                      .++|++.++||+|+||.||+|.. .+|+.||||++... .......+.+|+.++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            37899999999999999999996 46899999998765 33445568999999999999999999998765      667


Q ss_pred             EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCC---eEEeccC
Q 008108          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMN---PKISDFG  391 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~---~kl~DfG  391 (577)
                      .++||||+++|+|.+++........+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence            8999999999999999876545557999999999999999999999988   999999999999997765   9999999


Q ss_pred             CcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCC
Q 008108          392 MARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGA  471 (577)
Q Consensus       392 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  471 (577)
                      +++.......   .....||+.|+|||++.+..++.++||||||+++|||++|+.||......     ..|.........
T Consensus       170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~  241 (676)
T 3qa8_A          170 YAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSN  241 (676)
T ss_dssp             CCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC----
T ss_pred             cccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccc
Confidence            9987654322   23467999999999999999999999999999999999999998643211     111000000000


Q ss_pred             ----cccc------ccCcC---CCCChHHHHHHHHHHHhcccCCCCCCCCHHH
Q 008108          472 ----ALNL------MDPTM---RGGSTSEMMKCIHIGLLCVQENVSNRPGMAS  511 (577)
Q Consensus       472 ----~~~~------~d~~l---~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~e  511 (577)
                          ..+.      +...+   ..........+.+++..|++.||++|||+.|
T Consensus       242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence                0000      00000   0112234456678888999999999999966

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.2e-37  Score=345.92  Aligned_cols=236  Identities=20%  Similarity=0.287  Sum_probs=188.5

Q ss_pred             hcCCccccccccCCcEEEEEeEec--CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCe-----
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS--NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKE-----  314 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  314 (577)
                      .++|++.++||+|+||.||++...  +|+.||||++.... ......+.+|+.++.+++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            368999999999999999999975  58999999987543 3444568899999999999999999999987665     


Q ss_pred             EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      .+|||||+++++|.+++.     ..+++..++.|+.||+.||.|||+++   |+||||||+||||+.+ .+||+|||+++
T Consensus       159 ~~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence            799999999999988762     27999999999999999999999998   9999999999999986 89999999998


Q ss_pred             cccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccc
Q 008108          395 LFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALN  474 (577)
Q Consensus       395 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  474 (577)
                      .....      ....||+.|+|||++.++. +.++||||||+++|||++|..|+........           .      
T Consensus       230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-----------~------  285 (681)
T 2pzi_A          230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----------P------  285 (681)
T ss_dssp             ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------C------
T ss_pred             hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-----------c------
Confidence            75432      3367999999999987664 8999999999999999999876542110000           0      


Q ss_pred             cccCcCCCC-ChHHHHHHHHHHHhcccCCCCCCCC-HHHHHHHhc
Q 008108          475 LMDPTMRGG-STSEMMKCIHIGLLCVQENVSNRPG-MASVVNMLN  517 (577)
Q Consensus       475 ~~d~~l~~~-~~~~~~~~~~l~~~C~~~~p~~RPt-~~ev~~~L~  517 (577)
                            ... .......+.+++..|++.||++||+ +.++...|.
T Consensus       286 ------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          286 ------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             ------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             ------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence                  000 0111234567888999999999995 555655554

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.4e-36  Score=302.87  Aligned_cols=227  Identities=11%  Similarity=0.057  Sum_probs=178.7

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|++.++||+|+||.||+|... +++.||||++.....   .....+.+|+.++.+++||||+++++++.+.+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            57999999999999999999975 489999999976533   23356889999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++++|.+++..     .....++.+|+.||+.||.|||+++   |+||||||+||||+.++.+||+++|        
T Consensus       111 e~~~g~~L~~~l~~-----~~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~--------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA--------  174 (286)
T ss_dssp             ECCCEEEHHHHHTT-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred             EecCCCCHHHHHhc-----CCChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc--------
Confidence            99999999999832     2466678999999999999999998   9999999999999999999997543        


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCC-ccccccC
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGA-ALNLMDP  478 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~d~  478 (577)
                                    |++       .++.++||||||+++|||+||+.||.........   ........... ....+  
T Consensus       175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~~~--  228 (286)
T 3uqc_A          175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL---APAERDTAGQPIEPADI--  228 (286)
T ss_dssp             --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS---EECCBCTTSCBCCHHHH--
T ss_pred             --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh---HHHHHHhccCCCChhhc--
Confidence                          333       3688999999999999999999998754432211   00000000000 00001  


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                        ....+.   .+.+++..||+.||++| |+.|+++.|+.
T Consensus       229 --~~~~~~---~l~~li~~~l~~dP~~R-s~~el~~~L~~  262 (286)
T 3uqc_A          229 --DRDIPF---QISAVAARSVQGDGGIR-SASTLLNLMQQ  262 (286)
T ss_dssp             --CTTSCH---HHHHHHHHHHCTTSSCC-CHHHHHHHHHH
T ss_pred             --ccCCCH---HHHHHHHHHcccCCccC-CHHHHHHHHHH
Confidence              111222   35577789999999999 99999999975

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.2e-36  Score=303.02  Aligned_cols=230  Identities=22%  Similarity=0.284  Sum_probs=174.0

Q ss_pred             cCCccc-cccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHH-HhcCCCCeEEEEeEEEc----CCeEE
Q 008108          244 DNFSDA-NKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLL-ARLQHRNLVRLLGFCLE----RKERI  316 (577)
Q Consensus       244 ~~f~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~  316 (577)
                      ++|.+. +.||+|+||.||++.. .+++.||+|++...     ..+.+|+.++ +.++||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            567776 7799999999999996 46899999998643     2467788888 55599999999999876    66789


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC---CCCeEEeccCCc
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGMA  393 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~---~~~~kl~DfGla  393 (577)
                      +||||+++|+|.+++.. .....+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||++
T Consensus        92 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEECCCCSCBHHHHHHH-CTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            99999999999998854 23346999999999999999999999998   999999999999998   788999999998


Q ss_pred             ccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcc
Q 008108          394 RLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAAL  473 (577)
Q Consensus       394 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  473 (577)
                      ....                        +..++.++||||||+++|||++|+.||.............   ....... .
T Consensus       168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~---~~~~~~~-~  219 (299)
T 3m2w_A          168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---TRIRMGQ-Y  219 (299)
T ss_dssp             EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC---CSSCTTC-C
T ss_pred             cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH---HHHhhcc-c
Confidence            7532                        1346779999999999999999999986433221110000   0000000 0


Q ss_pred             ccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          474 NLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       474 ~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ....+. ....   ...+.+++..|++.||++|||+.|+++
T Consensus       220 ~~~~~~-~~~~---~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          220 EFPNPE-WSEV---SEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             SSCHHH-HTTS---CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCCchh-cccC---CHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            000000 0011   234557778999999999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=7.1e-37  Score=322.88  Aligned_cols=240  Identities=17%  Similarity=0.176  Sum_probs=176.0

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChh---hHHHHHHHHHHHHhcCC-CCe---------------E
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ---GEIEFKNEVLLLARLQH-RNL---------------V  303 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h-~ni---------------v  303 (577)
                      .+|...+.||+|+||+||+|.. .+|+.||||++......   ....+.+|+.++..++| +|.               +
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            4577789999999999999994 57999999998744322   24568899999999987 221               1


Q ss_pred             E------EEeEEEc-----CCeEEEEEEecCCCCccccccc----CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEE
Q 008108          304 R------LLGFCLE-----RKERILVYEFVPNASLDHFIFD----PINREHMTWEKRYKIIEGIARGLLYLHEDSRLRII  368 (577)
Q Consensus       304 ~------l~~~~~~-----~~~~~lv~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~ii  368 (577)
                      .      ++.++..     ....+++|+++ +++|.+++..    ......+++..++.++.||++||.|||+++   |+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence            1      1111111     12456777765 6788887731    123456889999999999999999999998   99


Q ss_pred             EeccCCCcEEEcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhh----------hcCCCCccccEEecchhH
Q 008108          369 HRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV----------MHGRFSVKSDIFSFGVLV  438 (577)
Q Consensus       369 HrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~SlGvil  438 (577)
                      ||||||+||||+.++.+||+|||+++.....     .....| +.|+|||++          ....++.++|||||||++
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            9999999999999999999999999865432     333567 999999999          444588899999999999


Q ss_pred             hHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 008108          439 LEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVV  513 (577)
Q Consensus       439 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~  513 (577)
                      |||++|+.||........   ....+..+              ...+   ..+.+++..||+.||++||++.+++
T Consensus       308 ~elltg~~Pf~~~~~~~~---~~~~~~~~--------------~~~~---~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALGG---SEWIFRSC--------------KNIP---QPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHSSCCCCTTGGGSC---SGGGGSSC--------------CCCC---HHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHCCCCCCCcchhhh---HHHHHhhc--------------ccCC---HHHHHHHHHHccCChhhCcCHHHHH
Confidence            999999999864432221   11111100              0122   2455777799999999999977764

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.3e-36  Score=308.95  Aligned_cols=190  Identities=18%  Similarity=0.196  Sum_probs=159.8

Q ss_pred             hcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCCh--------hhHHHHHHHHHHHHhcC---------CCCeEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSK--------QGEIEFKNEVLLLARLQ---------HRNLVRL  305 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------h~niv~l  305 (577)
                      .++|++.++||+|+||+||+|.. +|+.||||++.....        .....+.+|+.++++++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46788999999999999999998 689999999976532        22356889999998886         7777777


Q ss_pred             EeEEE------------------------------cCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHH
Q 008108          306 LGFCL------------------------------ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG  355 (577)
Q Consensus       306 ~~~~~------------------------------~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g  355 (577)
                      .+.+.                              +....+|||||+++|++.+.+.    +..+++..+..++.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence            76542                              2678999999999997766552    3568999999999999999


Q ss_pred             HHHhh-cCCCCcEEEeccCCCcEEEcCCC--------------------CeEEeccCCcccccCCCccccccccccCCCC
Q 008108          356 LLYLH-EDSRLRIIHRDLKASNILLDSEM--------------------NPKISDFGMARLFEMDQTHSDTNRVVGTFGY  414 (577)
Q Consensus       356 l~yLH-~~~~~~iiHrDlkp~NiLl~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y  414 (577)
                      |.||| +.+   |+||||||+||||+.++                    .+||+|||+|+.....       ...||+.|
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y  243 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS  243 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence            99999 887   99999999999999887                    8999999999876532       24799999


Q ss_pred             cChhhhhcCCCCccccEEecchh-HhHHhhCCCCC
Q 008108          415 MAPEYVMHGRFSVKSDIFSFGVL-VLEIVSGQKRS  448 (577)
Q Consensus       415 ~aPE~~~~~~~~~~~Dv~SlGvi-l~elltG~~p~  448 (577)
                      +|||++.+.. +.++||||||++ .+++++|..|+
T Consensus       244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~  277 (336)
T 2vuw_A          244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPY  277 (336)
T ss_dssp             TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTH
T ss_pred             cChhhhcCCC-ccceehhhhhCCCCcccccccCCC
Confidence            9999987655 899999998777 88899998876

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=6.2e-31  Score=287.37  Aligned_cols=185  Identities=19%  Similarity=0.188  Sum_probs=131.4

Q ss_pred             ccccCCcEEEEEeE-ecCCcEEEEEEeccCC----------hhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEEE
Q 008108          251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNS----------KQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       251 ~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  318 (577)
                      .++.|++|.+..+. ..-|+.+++|.+.+..          .....+|.+|+++|+++ .|+||+++++++.++...|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            45667777666554 3358899999997642          12334689999999999 799999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||++|++|.++|.+   .+.++..   +|+.||+.||.|||+++   ||||||||+||||++++++||+|||+|+....
T Consensus       321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            999999999999843   4567664   47899999999999998   99999999999999999999999999987654


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCC
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKR  447 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p  447 (577)
                      +..  .....+||+.|||||++. +.+..++|+||+|++++++.+|..+
T Consensus       392 ~~~--~~~t~vGTp~YmAPE~l~-g~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DCS--WPTNLVQSFFVFVNELFA-ENKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             --C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCc--cccCceechhhccHHHhC-CCCCCcccccccccchhhhccccch
Confidence            322  233468999999999876 4677889999999999998876543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=8.3e-28  Score=261.20  Aligned_cols=185  Identities=17%  Similarity=0.224  Sum_probs=144.7

Q ss_pred             ccccccccCCcEEEEEeEecCCcEEEEEEeccCChh--------hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          247 SDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQ--------GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       247 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      ...++||+|+||+||++.. .++.+++|+.......        ....+.+|+.++++++||||+++..++...+..+||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3467899999999999954 5788999986543211        123478999999999999999666666677788999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+++++|.+++..           +..++.||++||.|||+++   |+||||||+|||++.  .+||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999998843           5689999999999999998   999999999999999  999999999997754


Q ss_pred             CCccc-----cccccccCCCCcChhhhhc--CCCCccccEEecchhHhHHhhCCCCC
Q 008108          399 DQTHS-----DTNRVVGTFGYMAPEYVMH--GRFSVKSDIFSFGVLVLEIVSGQKRS  448 (577)
Q Consensus       399 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvil~elltG~~p~  448 (577)
                      .....     ......||+.|||||++..  ..|+..+|+||..+-.++-+.++.++
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            32211     1234689999999999976  56888999999999888888777654

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=2.3e-24  Score=214.91  Aligned_cols=151  Identities=17%  Similarity=0.107  Sum_probs=120.6

Q ss_pred             HHHHhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCCh------------------hhHHHHHHHHHHHHhcCCC
Q 008108          239 IRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSK------------------QGEIEFKNEVLLLARLQHR  300 (577)
Q Consensus       239 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~  300 (577)
                      +......|++.+.||+|+||.||+|...+|+.||||.+.....                  .....+.+|+.++++++| 
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~-  163 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG-  163 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC-
Confidence            3344456778899999999999999997799999999965321                  124468899999999994 


Q ss_pred             CeEEEEeEEEcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEc
Q 008108          301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD  380 (577)
Q Consensus       301 niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~  380 (577)
                        +++.+++.. +..++||||+++++|.+ +..         .....++.||+.||.|||+.+   |+||||||+||||+
T Consensus       164 --~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~  227 (282)
T 1zar_A          164 --LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS  227 (282)
T ss_dssp             --SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred             --CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence              555554433 55699999999999988 411         234579999999999999998   99999999999999


Q ss_pred             CCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhc
Q 008108          381 SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH  422 (577)
Q Consensus       381 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  422 (577)
                       ++.+||+|||+++.               +..++|||++..
T Consensus       228 -~~~vkl~DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          228 -EEGIWIIDFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             -TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred             -CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence             99999999999963               345789998753

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.87  E-value=2.6e-22  Score=168.25  Aligned_cols=106  Identities=24%  Similarity=0.402  Sum_probs=94.5

Q ss_pred             CCCceeecccCCcccchHHHHHHHHHHHHHHHHHhhcCCCCCceeeeeeccCCCcceeEEEecCCCCChhchhHHHHHHH
Q 008108           54 NAPYFFVYAESNISENLIEFNQTRQRLLERLFSEAAARPSPNKYATGKEAVSDIVTMYALVQCTPDLSEADCKECLHDTT  133 (577)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~f~~~~~~ll~~l~~~a~~~~~~~~~a~~~~~~~~~~~vy~l~qC~~dls~~~C~~Cl~~~~  133 (577)
                      +...+..||..+++ +.+.|+.+++.||+.|..+|+.+  ..+|+++..+..+.++||||+||+||+++++|+.||+.++
T Consensus         3 t~~v~~~Cn~~~~t-~~s~f~~nl~~ll~~L~~~a~~s--~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~   79 (108)
T 3a2e_A            3 TAFVSSACNTQKIP-SGSPFNRNLRAMLADLRQNTAFS--GYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLV   79 (108)
T ss_dssp             CCEEEEEECSSBCC-TTCTHHHHHHHHHHHHHHHGGGT--TSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHH
T ss_pred             cceeeeecCCCccC-CCChHHHHHHHHHHHHHhhCccc--cCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHH
Confidence            34456789888887 56889999999999999988764  3578888777667789999999999999999999999999


Q ss_pred             HhhhhhcCCCCCeEEeCCCCCCccccCcc
Q 008108          134 KLMSKCCDRRQGGRVINPSCSFRYETNKF  162 (577)
Q Consensus       134 ~~~~~~c~~~~gg~v~~~~C~~ry~~~~f  162 (577)
                      .+++.+|++++||+++.++|++||++++|
T Consensus        80 ~~~~~~C~~~~g~~i~~~~C~lRY~~~~F  108 (108)
T 3a2e_A           80 NRIFSICNNAIGARVQLVDCFIQYEQRSF  108 (108)
T ss_dssp             TTHHHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred             HHHHHHCCCCceEEEECCCEEEEEeCCcC
Confidence            99999999999999999999999999987

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.80  E-value=4.7e-20  Score=181.34  Aligned_cols=136  Identities=18%  Similarity=0.195  Sum_probs=105.2

Q ss_pred             CccccccccCCcEEEEEeEe-cCCcE--EEEEEeccCChh------------------------hHHHHHHHHHHHHhcC
Q 008108          246 FSDANKLGQGGFGAVYKGML-SNGET--IAVKRLSKNSKQ------------------------GEIEFKNEVLLLARLQ  298 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  298 (577)
                      |++.+.||+|+||.||+|.. .+|+.  ||||++......                        ....+.+|+..|.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56788999999999999997 68999  999987543111                        1135788999999998


Q ss_pred             CCCe--EEEEeEEEcCCeEEEEEEecCC-C----CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCCcEEEe
Q 008108          299 HRNL--VRLLGFCLERKERILVYEFVPN-A----SLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH-EDSRLRIIHR  370 (577)
Q Consensus       299 h~ni--v~l~~~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH-~~~~~~iiHr  370 (577)
                      |+++  ..++++    ...+|||||+.+ |    +|.+++.      ..++..+..++.||+.+|.||| +.+   |+||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr  195 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR------ELKELDVEGIFNDVVENVKRLYQEAE---LVHA  195 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG------GGGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh------ccChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence            8754  344432    356899999952 4    4443321      1234567889999999999999 887   9999


Q ss_pred             ccCCCcEEEcCCCCeEEeccCCcccc
Q 008108          371 DLKASNILLDSEMNPKISDFGMARLF  396 (577)
Q Consensus       371 Dlkp~NiLl~~~~~~kl~DfGla~~~  396 (577)
                      ||||+|||++.  .++|+|||+|...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.68  E-value=1e-17  Score=171.59  Aligned_cols=134  Identities=16%  Similarity=0.185  Sum_probs=99.7

Q ss_pred             CccccccccCCcEEEEEeEecCCcEEEEEEeccCCh-----------------hhH-----HHHHHHHHHHHhcCCCCeE
Q 008108          246 FSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSK-----------------QGE-----IEFKNEVLLLARLQHRNLV  303 (577)
Q Consensus       246 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------------~~~-----~~~~~E~~~l~~l~h~niv  303 (577)
                      |++.+.||+|+||.||+|...+|+.||||+++....                 ...     .....|...|.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            889999999999999999998999999998753210                 000     1123466677777554432


Q ss_pred             --EEEeEEEcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC
Q 008108          304 --RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS  381 (577)
Q Consensus       304 --~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~  381 (577)
                        ..+++    ...+|||||+++++|.++..         ......++.||+.+|.|||+.+   ||||||||.||||++
T Consensus       177 vp~p~~~----~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~  240 (397)
T 4gyi_A          177 VPEPIAQ----SRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIRE  240 (397)
T ss_dssp             CCCEEEE----ETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEE
T ss_pred             CCeeeec----cCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeC
Confidence              22222    12379999999998866541         1134567899999999999988   999999999999988


Q ss_pred             CCC----------eEEeccCCccc
Q 008108          382 EMN----------PKISDFGMARL  395 (577)
Q Consensus       382 ~~~----------~kl~DfGla~~  395 (577)
                      ++.          +.|+||+-+..
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCCcccccccccceEEEEeCCccc
Confidence            773          89999997754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.36  E-value=1.3e-12  Score=128.09  Aligned_cols=146  Identities=18%  Similarity=0.124  Sum_probs=114.3

Q ss_pred             HHHhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcC-CCCeEEEEeEEEcCCeEEEE
Q 008108          240 RVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       240 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  318 (577)
                      ....+.|+....++.|+.+.||+.... ++.+++|+...........+.+|+.+++.+. +..+.++++++.+.+..++|
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            344567888888999999999999854 6899999987532222235789999999984 67788999999988899999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC------------------------------------
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED------------------------------------  362 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~------------------------------------  362 (577)
                      |||++|.+|.+.+.        +......++.+++++|..||+.                                    
T Consensus        89 ~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           89 MSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             EEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            99999999876531        1122347888999999999981                                    


Q ss_pred             --------------------CCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          363 --------------------SRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       363 --------------------~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                                          .+..++|+|++|.|||++++..+.|+||+.+.
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                11459999999999999876666799998875

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.23  E-value=1.1e-11  Score=120.99  Aligned_cols=138  Identities=18%  Similarity=0.133  Sum_probs=102.8

Q ss_pred             cCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCC--eEEEEeEEEcCCeEEEEEEe
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN--LVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~E~  321 (577)
                      .++......+.|..+.||++...+|+.+++|......   ...+.+|+.+++.+.+.+  +.+++++....+..++||||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            3455433334566699999987778889999976542   234678999999986545  45688888888888999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--------------------------------------
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS--------------------------------------  363 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~--------------------------------------  363 (577)
                      ++|.+|.  ...      .+   ...++.++++.|..||+..                                      
T Consensus        97 i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           97 VPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             CSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             cCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            9999884  211      11   2357788888899998743                                      


Q ss_pred             -----------------CCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          364 -----------------RLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       364 -----------------~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                                       +..++|+|++|.|||++++..+.|+|||.+..
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                             12399999999999998876677999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.11  E-value=2.8e-10  Score=116.90  Aligned_cols=142  Identities=16%  Similarity=0.274  Sum_probs=108.3

Q ss_pred             cccccccCCcEEEEEeEecCCcEEEEEEec--cCCh-hhHHHHHHHHHHHHhcC--CCCeEEEEeEEEcC---CeEEEEE
Q 008108          248 DANKLGQGGFGAVYKGMLSNGETIAVKRLS--KNSK-QGEIEFKNEVLLLARLQ--HRNLVRLLGFCLER---KERILVY  319 (577)
Q Consensus       248 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~  319 (577)
                      ..+.|+.|.++.||+.... +..+++|+..  .... .....+.+|+.+++.+.  +..+.+++.++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            4678999999999999875 4678888776  3321 22345788999999997  45578889888776   4579999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC------------------------------------
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS------------------------------------  363 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~------------------------------------  363 (577)
                      ||++|..+.+..     -..++...+..++.++++.|..||+..                                    
T Consensus       121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999998885422     234788889999999999999999731                                    


Q ss_pred             -------------------CCcEEEeccCCCcEEEcCCCC--eEEeccCCccc
Q 008108          364 -------------------RLRIIHRDLKASNILLDSEMN--PKISDFGMARL  395 (577)
Q Consensus       364 -------------------~~~iiHrDlkp~NiLl~~~~~--~kl~DfGla~~  395 (577)
                                         ...++|+|+++.|||++.++.  +.|.||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               256999999999999997753  68999998864

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=98.98  E-value=2.7e-10  Score=95.05  Aligned_cols=43  Identities=21%  Similarity=0.538  Sum_probs=41.3

Q ss_pred             CChhhhHHHHHHHHHHHhhcCCCCceeEEEecCCCCceeEEEecCCCC
Q 008108            1 MEPSSCRDCINVARKNLTSLCPNKVTAIGGYDDRGYNNCMLRYANYDI   48 (577)
Q Consensus         1 ~~~~~C~~C~~~a~~~~~~~C~~~~~a~~~~d~~~~~~C~lrys~~~f   48 (577)
                      +++++|..|++.|++++.+.||++++|+||||     .|+||||+++|
T Consensus        66 ls~~~C~~Cl~~a~~~~~~~C~~~~g~~i~~~-----~C~lRY~~~~F  108 (108)
T 3a2e_A           66 ISQSDCTACLSNLVNRIFSICNNAIGARVQLV-----DCFIQYEQRSF  108 (108)
T ss_dssp             SCHHHHHHHHHHHHTTHHHHTTSBSSEEEEET-----TEEEEEESSCC
T ss_pred             CCHHHHHHHHHHHHHHHHHHCCCCceEEEECC-----CEEEEEeCCcC
Confidence            47899999999999999999999999999999     99999999998

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.97  E-value=1.9e-10  Score=115.41  Aligned_cols=187  Identities=18%  Similarity=0.221  Sum_probs=123.2

Q ss_pred             ccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCC--eEEEEeEEEcCC---eEEEEEEec
Q 008108          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRN--LVRLLGFCLERK---ERILVYEFV  322 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~l~~~~~~~~---~~~lv~E~~  322 (577)
                      .+.++.|....||+..    ..+++|+....  .....+.+|..+|+.+ .+..  +.+++......+   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            5678999999999873    56888986433  3345688999999888 3333  344555443333   347899999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED----------------------------------------  362 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~----------------------------------------  362 (577)
                      +|.+|.....     ..++..++..++.++++.|..||+.                                        
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9988865331     3477888888999999999999861                                        


Q ss_pred             ---------------CCCcEEEeccCCCcEEEcC--CCCeEEeccCCcccccCCCccccccc------------cccCCC
Q 008108          363 ---------------SRLRIIHRDLKASNILLDS--EMNPKISDFGMARLFEMDQTHSDTNR------------VVGTFG  413 (577)
Q Consensus       363 ---------------~~~~iiHrDlkp~NiLl~~--~~~~kl~DfGla~~~~~~~~~~~~~~------------~~gt~~  413 (577)
                                     ..+.++|+|++|.||++++  +..+.|+||+.+..-...........            .....+
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                           1245899999999999998  45688999999875332110000000            000111


Q ss_pred             CcC-hhhhhcCCCCccccEEecchhHhHHhhCCCCC
Q 008108          414 YMA-PEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRS  448 (577)
Q Consensus       414 y~a-PE~~~~~~~~~~~Dv~SlGvil~elltG~~p~  448 (577)
                      ... |+.....  ....+.|++|.++|++.+|..++
T Consensus       254 ~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          254 HKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence            122 2222111  12358899999999999998653

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.53  E-value=4.6e-07  Score=90.64  Aligned_cols=136  Identities=21%  Similarity=0.179  Sum_probs=97.3

Q ss_pred             ccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCC---CeEEEEeEEE-cCCeEEEEEEecCC
Q 008108          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR---NLVRLLGFCL-ERKERILVYEFVPN  324 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~E~~~~  324 (577)
                      .+.++.|....||+.    |+.+++|+..  .......+.+|..+|..+.+.   .+.+++.+.. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            466888999999988    5678888853  223345688999999999653   3556666664 44567899999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC------------------------------------------
Q 008108          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED------------------------------------------  362 (577)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~------------------------------------------  362 (577)
                      ..|.....     ..++..+...++.++++.|..||+.                                          
T Consensus        98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            88865321     2345566666666666666666643                                          


Q ss_pred             ---------------CCCcEEEeccCCCcEEEcC---CCC-eEEeccCCccc
Q 008108          363 ---------------SRLRIIHRDLKASNILLDS---EMN-PKISDFGMARL  395 (577)
Q Consensus       363 ---------------~~~~iiHrDlkp~NiLl~~---~~~-~kl~DfGla~~  395 (577)
                                     .++.++|+|+++.|||++.   ++. +.|.||+.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           2235799999999999987   455 48999998864

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.45  E-value=4.3e-07  Score=92.88  Aligned_cols=147  Identities=9%  Similarity=0.077  Sum_probs=92.4

Q ss_pred             cccc-ccCCcEEEEEeEec-------CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcC-C--CCeEEEEeEEEcC--
Q 008108          249 ANKL-GQGGFGAVYKGMLS-------NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQ-H--RNLVRLLGFCLER--  312 (577)
Q Consensus       249 ~~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~--  312 (577)
                      .+.| +.|....+|+....       +++.+++|+.....   ......+.+|+.+++.+. +  -.+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4667 88989999998764       26788999865432   101234678888888884 3  3467788887665  


Q ss_pred             -CeEEEEEEecCCCCcccccccCCC---CCCCCHHHHHHHHHHHHHHHHHhh----------------------------
Q 008108          313 -KERILVYEFVPNASLDHFIFDPIN---REHMTWEKRYKIIEGIARGLLYLH----------------------------  360 (577)
Q Consensus       313 -~~~~lv~E~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~ia~gl~yLH----------------------------  360 (577)
                       +..++||||++|..+.+.+.....   ...++..++..++.++++.|.-||                            
T Consensus       105 ~g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~~~~~~l~~~~~~~~~~~~~~~~~~~  184 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIPNAQNTFSFLTQGRTSDTTLHRHFNW  184 (357)
T ss_dssp             TSSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCSSHHHHTGGGC-----CCHHHHHHHH
T ss_pred             cCCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCCCccCChhhccCCCCCCchHHHHHHH
Confidence             356899999999887653200000   001222222333333333333333                            


Q ss_pred             --------------------------cC-------CCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          361 --------------------------ED-------SRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       361 --------------------------~~-------~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                                                +.       .+..++|+|+.+.|||++++..+.|.||+.+..
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          185 VRSWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             HHHHHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             HHHHHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence                                      11       135699999999999999644578999998753

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.40  E-value=5.9e-07  Score=87.93  Aligned_cols=135  Identities=17%  Similarity=0.184  Sum_probs=95.5

Q ss_pred             ccccCCcE-EEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcC-CCCeEEEEeEEEcCCeEEEEEEecCCCCc
Q 008108          251 KLGQGGFG-AVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERILVYEFVPNASL  327 (577)
Q Consensus       251 ~lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gsL  327 (577)
                      .+..|..| .||+.... ++..+++|+-...   ....+.+|...|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            34455555 68987754 4667899986533   3346788999998884 33467888999999999999999999877


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC---------------------------------------------
Q 008108          328 DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED---------------------------------------------  362 (577)
Q Consensus       328 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~---------------------------------------------  362 (577)
                      .+....       .......+..+++..|.-||..                                             
T Consensus       108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            554311       1122344566667777777731                                             


Q ss_pred             ----------CCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          363 ----------SRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       363 ----------~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                                ....++|+|+.+.|||++.++.+-|.||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                      122489999999999999877777999998753

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.05  E-value=2.5e-05  Score=78.89  Aligned_cols=141  Identities=16%  Similarity=0.228  Sum_probs=81.0

Q ss_pred             ccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCC--CCeEEEEe------EEEcCCeEEEEEE
Q 008108          249 ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH--RNLVRLLG------FCLERKERILVYE  320 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~E  320 (577)
                      .+.|+.|..+.||+....+| .+++|+.....    .++..|..++..+..  -.+.+++.      +....+..+++||
T Consensus        37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EEECC----CEEEEEEETTE-EEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeeccccccCcEEEEEeCCC-CEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            45576677899999987654 58999887521    233445555555531  12333333      1234567899999


Q ss_pred             ecCCCCcccc--------------cccC---C--C------CCCCCHHHHH-----------------------------
Q 008108          321 FVPNASLDHF--------------IFDP---I--N------REHMTWEKRY-----------------------------  346 (577)
Q Consensus       321 ~~~~gsL~~~--------------l~~~---~--~------~~~l~~~~~~-----------------------------  346 (577)
                      |++|..+...              ++..   .  .      .....|...+                             
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            9998766410              1100   0  0      0112332211                             


Q ss_pred             --HHHHHHHHHHHHhhc----------CCCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          347 --KIIEGIARGLLYLHE----------DSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       347 --~i~~~ia~gl~yLH~----------~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                        .+...+...+.+|++          ..+..++|+|+++.|||++.++.+.|+||+.+.
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence              111223445666663          123469999999999999888899999999774

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.04  E-value=1.4e-05  Score=79.05  Aligned_cols=80  Identities=21%  Similarity=0.294  Sum_probs=59.0

Q ss_pred             cCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCC---CeEEEEeEEEcCCeEEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHR---NLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lv~E  320 (577)
                      ......+.+|.|..+.||+..+.+|+.|++|+-..........|..|...|+.|...   -+.+++++.    ..++|||
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e   90 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME   90 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence            345667889999999999999999999999987655443334578899999888422   244555542    3478999


Q ss_pred             ecCCCCc
Q 008108          321 FVPNASL  327 (577)
Q Consensus       321 ~~~~gsL  327 (577)
                      |++++..
T Consensus        91 ~l~~~~~   97 (288)
T 3f7w_A           91 WVDERPP   97 (288)
T ss_dssp             CCCCCCC
T ss_pred             eecccCC
Confidence            9987654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.00  E-value=4.8e-05  Score=75.95  Aligned_cols=140  Identities=17%  Similarity=0.164  Sum_probs=94.1

Q ss_pred             ccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcC---CCCeEEEEeEEEcCCeEEEEEEecC
Q 008108          247 SDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ---HRNLVRLLGFCLERKERILVYEFVP  323 (577)
Q Consensus       247 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~E~~~  323 (577)
                      ...+.|+.|....+|+... ++..+++|+....   ....+..|...|+.|.   ...+.+++.+....+..++||||++
T Consensus        39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            4457799999999999886 4678889987543   2446788999888883   3567888988888888999999999


Q ss_pred             CCCcccc-----------cccCCC-------------------CCCCCHHHHH---HHH----------------HHHHH
Q 008108          324 NASLDHF-----------IFDPIN-------------------REHMTWEKRY---KII----------------EGIAR  354 (577)
Q Consensus       324 ~gsL~~~-----------l~~~~~-------------------~~~l~~~~~~---~i~----------------~~ia~  354 (577)
                      +..+..-           |+....                   .-.-+|....   ++.                ..+..
T Consensus       115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~  194 (312)
T 3jr1_A          115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ  194 (312)
T ss_dssp             CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence            9876321           111110                   0012455332   111                11222


Q ss_pred             HH-HHhhc-CCCCcEEEeccCCCcEEEcCCCCeEEeccC
Q 008108          355 GL-LYLHE-DSRLRIIHRDLKASNILLDSEMNPKISDFG  391 (577)
Q Consensus       355 gl-~yLH~-~~~~~iiHrDlkp~NiLl~~~~~~kl~DfG  391 (577)
                      -+ ..|.. ..++.++|+|+.+.|++++.++ +.|.||.
T Consensus       195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            22 23432 2356799999999999999887 8899973

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.00  E-value=1.5e-05  Score=82.71  Aligned_cols=75  Identities=15%  Similarity=0.162  Sum_probs=49.5

Q ss_pred             ccccccCCcEEEEEeEec-CCcEEEEEEeccCCh-------hhHHHHHHHHHHHHhcCC--CC-eEEEEeEEEcCCeEEE
Q 008108          249 ANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK-------QGEIEFKNEVLLLARLQH--RN-LVRLLGFCLERKERIL  317 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~l  317 (577)
                      .+.||.|..+.||++... +++.++||.......       .....+..|.+++..+..  +. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            568999999999999754 468899998654321       112345778888887742  33 4455544  3445689


Q ss_pred             EEEecCCC
Q 008108          318 VYEFVPNA  325 (577)
Q Consensus       318 v~E~~~~g  325 (577)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.66  E-value=0.00011  Score=76.79  Aligned_cols=74  Identities=14%  Similarity=0.240  Sum_probs=46.4

Q ss_pred             cccccccCCcEEEEEeEecCCcEEEEEEeccC-----Ch----hhHHHHHHHHHHHHh-cCCCCeEEEEeEEEcCCeEEE
Q 008108          248 DANKLGQGGFGAVYKGMLSNGETIAVKRLSKN-----SK----QGEIEFKNEVLLLAR-LQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       248 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-----~~----~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~l  317 (577)
                      ..+.||.|....||++.. +++.++||.....     ..    .....+..|+..+.. .....+.+++.+.  .+..++
T Consensus        38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l  114 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI  114 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred             EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence            357799999999999965 4678999943221     00    122234444433322 2234566677665  466799


Q ss_pred             EEEec-CC
Q 008108          318 VYEFV-PN  324 (577)
Q Consensus       318 v~E~~-~~  324 (577)
                      ||||+ ++
T Consensus       115 v~e~l~~g  122 (420)
T 2pyw_A          115 GMRYLEPP  122 (420)
T ss_dssp             EECCCCTT
T ss_pred             EEeecCCc
Confidence            99999 76

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.63  E-value=0.00023  Score=71.17  Aligned_cols=157  Identities=13%  Similarity=0.103  Sum_probs=86.1

Q ss_pred             ChHHHHHHhcCCcc-----ccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCC--eEEEEe
Q 008108          235 DFETIRVATDNFSD-----ANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN--LVRLLG  307 (577)
Q Consensus       235 ~~~~~~~~~~~f~~-----~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~  307 (577)
                      +.+++......|..     .+.|+.|....+|+....+| .+++|.......  ...+..|+.++..+...+  +.+++.
T Consensus         8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~--~~~l~~e~~~l~~L~~~g~~vP~~~~   84 (322)
T 2ppq_A            8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLP   84 (322)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC--HHHHHHHHHHHHHHHHCCCCCCcccC
Confidence            34444444444433     45677888899999987655 688998865311  124556777777764222  233332


Q ss_pred             E------EEcCCeEEEEEEecCCCCcccc--------------cccCC---CCC---C---CCHHHHHHH----------
Q 008108          308 F------CLERKERILVYEFVPNASLDHF--------------IFDPI---NRE---H---MTWEKRYKI----------  348 (577)
Q Consensus       308 ~------~~~~~~~~lv~E~~~~gsL~~~--------------l~~~~---~~~---~---l~~~~~~~i----------  348 (577)
                      .      ....+..+++|+|++|..+...              ++...   ...   .   ..|...+.-          
T Consensus        85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~  164 (322)
T 2ppq_A           85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  164 (322)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence            1      1223567899999998765431              11000   000   0   123221110          


Q ss_pred             --HHHHHHHHHHhhcC----CCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          349 --IEGIARGLLYLHED----SRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       349 --~~~ia~gl~yLH~~----~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                        ...+.+.+..|++.    .+..++|+|+.+.|||++++..+.|+||+.+.
T Consensus       165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence              01133445555421    23469999999999999987656899998775

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.46  E-value=0.00038  Score=72.76  Aligned_cols=74  Identities=18%  Similarity=0.280  Sum_probs=51.2

Q ss_pred             ccccccCCcEEEEEeEecC--------CcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCe-EEEEeEEEcCCeEEEEE
Q 008108          249 ANKLGQGGFGAVYKGMLSN--------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL-VRLLGFCLERKERILVY  319 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~  319 (577)
                      .+.|+.|....+|+....+        ++.+++|+.....  ....+.+|..++..+...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            4678889899999998653        5789999884421  11345578888888853333 567766542    3899


Q ss_pred             EecCCCCcc
Q 008108          320 EFVPNASLD  328 (577)
Q Consensus       320 E~~~~gsL~  328 (577)
                      ||++|.+|.
T Consensus       152 e~l~G~~l~  160 (429)
T 1nw1_A          152 EYIPSRPLS  160 (429)
T ss_dssp             CCCCEEECC
T ss_pred             EEeCCcccC
Confidence            999876654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.45  E-value=0.00035  Score=69.23  Aligned_cols=130  Identities=15%  Similarity=0.176  Sum_probs=77.2

Q ss_pred             ccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCe-EEEEeEEEcCCeEEEEEEec-CC
Q 008108          247 SDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL-VRLLGFCLERKERILVYEFV-PN  324 (577)
Q Consensus       247 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~-~~  324 (577)
                      .-.+.|+.|....+|+.     +.+++|+....... .....+|+.+++.+...++ .+++++  +.+.-++++||+ ++
T Consensus        21 ~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g   92 (301)
T 3dxq_A           21 TGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGA   92 (301)
T ss_dssp             CSCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTC
T ss_pred             cceeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCC
Confidence            33678999999999998     56888887653211 1123567777777743233 355554  333457899999 66


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-------------------------------------------
Q 008108          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE-------------------------------------------  361 (577)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-------------------------------------------  361 (577)
                      .+|......          .+..++.++++.|.-||+                                           
T Consensus        93 ~~l~~~~~~----------~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l  162 (301)
T 3dxq_A           93 QTMSPEKFK----------TRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGV  162 (301)
T ss_dssp             EECCHHHHH----------HSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHH
T ss_pred             ccCCHhhHh----------hhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHH
Confidence            555321000          000122222222222222                                           


Q ss_pred             -------CCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          362 -------DSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       362 -------~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                             ..+..++|+|+.+.||| ..++.+.|+||..+..
T Consensus       163 ~~~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          163 RSALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             HHHHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence                   12345899999999999 5667789999988764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.37  E-value=0.00062  Score=69.73  Aligned_cols=142  Identities=18%  Similarity=0.182  Sum_probs=84.7

Q ss_pred             ccccccCCcEEEEEeEec--------CCcEEEEEEeccCChhhHHHHHHHHHHHHhcC-CCCeEEEEeEEEcCCeEEEEE
Q 008108          249 ANKLGQGGFGAVYKGMLS--------NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  319 (577)
                      .+.|..|-...+|+....        +++.+++|+..... .....+.+|..+++.+. +.-..++++++.+    .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            456777888899998864        24789999864322 23445678999998884 3223566766543    2999


Q ss_pred             EecCCCCcccc-cc----------------cC--CCCCCC--CHHHHHHHHHHHHH-------------------HHHHh
Q 008108          320 EFVPNASLDHF-IF----------------DP--INREHM--TWEKRYKIIEGIAR-------------------GLLYL  359 (577)
Q Consensus       320 E~~~~gsL~~~-l~----------------~~--~~~~~l--~~~~~~~i~~~ia~-------------------gl~yL  359 (577)
                      ||++|..|..- +.                ..  .-....  -|.++.++..++..                   .+..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998776421 10                00  001112  24555555544322                   12222


Q ss_pred             ----hcC-CCCcEEEeccCCCcEEEcCC----CCeEEeccCCccc
Q 008108          360 ----HED-SRLRIIHRDLKASNILLDSE----MNPKISDFGMARL  395 (577)
Q Consensus       360 ----H~~-~~~~iiHrDlkp~NiLl~~~----~~~kl~DfGla~~  395 (577)
                          ... .+..++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                222 23469999999999999876    6899999988753

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.37  E-value=0.0015  Score=65.27  Aligned_cols=142  Identities=17%  Similarity=0.146  Sum_probs=83.0

Q ss_pred             cccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCC--eEEEEeE-----EEcCCeEEEEEEec
Q 008108          250 NKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN--LVRLLGF-----CLERKERILVYEFV  322 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lv~E~~  322 (577)
                      ..|+ |....||+....+|+.+++|....... ....+..|..++..+....  +++++..     ....+..+++|||+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4566 788899998877787899999864321 2345667888887774222  3444443     12244568899999


Q ss_pred             CCCCcccc--------------ccc------CCCCCCCCHHHH----------------------HHHHHHHHHHHHHhh
Q 008108          323 PNASLDHF--------------IFD------PINREHMTWEKR----------------------YKIIEGIARGLLYLH  360 (577)
Q Consensus       323 ~~gsL~~~--------------l~~------~~~~~~l~~~~~----------------------~~i~~~ia~gl~yLH  360 (577)
                      +|..+...              ++.      .......++...                      ...+..++..+.-+.
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            98665420              000      001112232211                      111122222222221


Q ss_pred             c-CCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          361 E-DSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       361 ~-~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      . ..+..++|+|+++.|||++ + .+.|.||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            1 1234589999999999999 4 899999988753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.31  E-value=0.00085  Score=70.57  Aligned_cols=75  Identities=13%  Similarity=0.115  Sum_probs=49.8

Q ss_pred             ccccccCCcEEEEEeEecC-CcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCe-EEEEeEEEcCCeEEEEEEecCCCC
Q 008108          249 ANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL-VRLLGFCLERKERILVYEFVPNAS  326 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~gs  326 (577)
                      .+.|+.|-...+|+....+ +..+++|+....... .....+|..++..+...++ .++++++.  +  .+||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            5678889899999998765 478889887543211 1122578889998865555 46777663  2  25999999866


Q ss_pred             cc
Q 008108          327 LD  328 (577)
Q Consensus       327 L~  328 (577)
                      |.
T Consensus       188 l~  189 (458)
T 2qg7_A          188 LS  189 (458)
T ss_dssp             CC
T ss_pred             CC
Confidence            64

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.17  E-value=0.0011  Score=66.64  Aligned_cols=142  Identities=16%  Similarity=0.117  Sum_probs=71.9

Q ss_pred             ccccccCCcEE-EEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCC--CCeEEEEeEEEcCCeEEEEEEecCCC
Q 008108          249 ANKLGQGGFGA-VYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH--RNLVRLLGFCLERKERILVYEFVPNA  325 (577)
Q Consensus       249 ~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~~~~g  325 (577)
                      .+.|+.|.... +|+....+|+.+++|.......   ..+..|+.++..+..  -.+.+++.+..+.+  +++||++++.
T Consensus        23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~   97 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA   97 (333)
T ss_dssp             ECC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred             eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence            45676665554 6677654467788876544321   123456666666632  23455666543333  7899999775


Q ss_pred             CcccccccC---------------------C--CCCCCCHHHHH-------HH-------------HHHHHHHHHHhh--
Q 008108          326 SLDHFIFDP---------------------I--NREHMTWEKRY-------KI-------------IEGIARGLLYLH--  360 (577)
Q Consensus       326 sL~~~l~~~---------------------~--~~~~l~~~~~~-------~i-------------~~~ia~gl~yLH--  360 (577)
                      .+.+++...                     .  ....++.....       .+             ...+...+..|.  
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            553322100                     0  00111111100       00             001111222221  


Q ss_pred             -cCCCCcEEEeccCCCcEEEcCC----CCeEEeccCCccc
Q 008108          361 -EDSRLRIIHRDLKASNILLDSE----MNPKISDFGMARL  395 (577)
Q Consensus       361 -~~~~~~iiHrDlkp~NiLl~~~----~~~kl~DfGla~~  395 (577)
                       ......++|||+.+.|||++.+    ..+.|.||+.+..
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence             1123469999999999999875    6789999998864

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.09  E-value=0.00086  Score=68.50  Aligned_cols=74  Identities=11%  Similarity=0.095  Sum_probs=45.2

Q ss_pred             ccccccCCcEEEEEeEecC---------CcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCC-eEEEEeEEEcCCeEEEE
Q 008108          249 ANKLGQGGFGAVYKGMLSN---------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN-LVRLLGFCLERKERILV  318 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv  318 (577)
                      .+.|+.|....+|+....+         ++.+++|+....... ......|..++..+...+ ..++++..  .  -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            4567888888999998654         268888887543221 112367888888774333 34666544  2  2689


Q ss_pred             EEecCCCCc
Q 008108          319 YEFVPNASL  327 (577)
Q Consensus       319 ~E~~~~gsL  327 (577)
                      |||++|..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999998655

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.01  E-value=0.0039  Score=62.85  Aligned_cols=68  Identities=10%  Similarity=0.123  Sum_probs=43.6

Q ss_pred             ccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcC---CCCeEEEEeE------EEcCCeEEEEEEecC
Q 008108          253 GQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ---HRNLVRLLGF------CLERKERILVYEFVP  323 (577)
Q Consensus       253 G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~------~~~~~~~~lv~E~~~  323 (577)
                      |.|....||+....+| .+++|+......      ..|+.++..|.   -+++.+++..      ....+..+++|||++
T Consensus        32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~  104 (339)
T 3i1a_A           32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH  104 (339)
T ss_dssp             TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred             cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence            3344679999987777 899998765442      34555555552   1224444432      233567799999999


Q ss_pred             CCCc
Q 008108          324 NASL  327 (577)
Q Consensus       324 ~gsL  327 (577)
                      |..+
T Consensus       105 G~~~  108 (339)
T 3i1a_A          105 APNG  108 (339)
T ss_dssp             CCBT
T ss_pred             CCcC
Confidence            8766

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.04  E-value=0.023  Score=58.93  Aligned_cols=141  Identities=16%  Similarity=0.180  Sum_probs=85.6

Q ss_pred             ccccccCCcEEEEEeEecC--------CcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCC-eEEEEeEEEcCCeEEEEE
Q 008108          249 ANKLGQGGFGAVYKGMLSN--------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN-LVRLLGFCLERKERILVY  319 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  319 (577)
                      .+.|..|-...+|+....+        ++.+++|+...... ......+|..+++.+...+ ..++++.+.    -++||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            4667778888999998753        57899998654321 1122467888888874323 345555332    27899


Q ss_pred             EecCCCCcccc-ccc------------------C-----C---CCCCCCHHHHHHHHHHH-------------------H
Q 008108          320 EFVPNASLDHF-IFD------------------P-----I---NREHMTWEKRYKIIEGI-------------------A  353 (577)
Q Consensus       320 E~~~~gsL~~~-l~~------------------~-----~---~~~~l~~~~~~~i~~~i-------------------a  353 (577)
                      ||++|..|..- +.+                  .     .   .+.+.-|.++.++..++                   .
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            99999776321 100                  0     0   11112345444444332                   1


Q ss_pred             HHHHHhh---------------------cCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          354 RGLLYLH---------------------EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       354 ~gl~yLH---------------------~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      ..+..|.                     ...+..++|+|+.+.||+ +.++.+.|+||..+..
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            2223322                     112346899999999999 7788999999988853

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=93.89  E-value=0.35  Score=44.73  Aligned_cols=101  Identities=13%  Similarity=0.074  Sum_probs=63.0

Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccccc
Q 008108          326 SLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT  405 (577)
Q Consensus       326 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~  405 (577)
                      +|.+.|.-  ...+++++++|.++.|.+..|.-+-.... + ..+=+.|..|+|..+|++.+.+ +.+.           
T Consensus        34 SL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             cHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-----------
Confidence            56666632  45789999999999999999887621110 0 1223457899999999988753 1110           


Q ss_pred             cccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCC
Q 008108          406 NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQK  446 (577)
Q Consensus       406 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~  446 (577)
                         .....+.|||... ...+.+.=|||||++||.-+-=..
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL  134 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL  134 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence               1122456787642 345678889999999999885443

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.44  E-value=0.11  Score=53.25  Aligned_cols=30  Identities=27%  Similarity=0.398  Sum_probs=25.0

Q ss_pred             cEEEeccCCCcEEE------cCCCCeEEeccCCccc
Q 008108          366 RIIHRDLKASNILL------DSEMNPKISDFGMARL  395 (577)
Q Consensus       366 ~iiHrDlkp~NiLl------~~~~~~kl~DfGla~~  395 (577)
                      .++|+|+.+.|||+      +++..++++||-+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46899999999999      4566799999988753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=82.29  E-value=2.2  Score=39.27  Aligned_cols=85  Identities=11%  Similarity=0.074  Sum_probs=61.8

Q ss_pred             CCCCeEEEEeEEEcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcE
Q 008108          298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNI  377 (577)
Q Consensus       298 ~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~Ni  377 (577)
                      .||+++.. ..-.+++.+.+.|+.-+  +...|-    .-..++...+++++.+|+.-..+++.     -+|--|.|+|+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCc--ccCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence            68888866 45566666666666433  222221    23458889999999999988866654     37888999999


Q ss_pred             EEcCCCCeEEeccCCcc
Q 008108          378 LLDSEMNPKISDFGMAR  394 (577)
Q Consensus       378 Ll~~~~~~kl~DfGla~  394 (577)
                      +++.++.+++.=.|+-.
T Consensus       111 ~f~~~~~p~i~~RGik~  127 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQN  127 (215)
T ss_dssp             EECTTSCEEESCCEETT
T ss_pred             EEcCCCCEEEEEccCcc
Confidence            99999999998777644

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=80.66  E-value=3.1  Score=38.36  Aligned_cols=84  Identities=10%  Similarity=0.058  Sum_probs=59.9

Q ss_pred             CCCCeEEEEeEEEcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHH-HhhcCCCCcEEEeccCCCc
Q 008108          298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLL-YLHEDSRLRIIHRDLKASN  376 (577)
Q Consensus       298 ~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~-yLH~~~~~~iiHrDlkp~N  376 (577)
                      .||++  -...-.+++.+.+.|+.-+++  ..|-    .-..++...+++++.+|+.-.. +++.     -+|--|.|+|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~--~~f~----~i~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSF--LTFA----AIRKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTC--EEHH----HHHTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCccc--CcHH----HHHhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence            68888  344446777777777654332  1111    1245888999999999888777 5654     4788899999


Q ss_pred             EEEcCCCCeEEeccCCcc
Q 008108          377 ILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       377 iLl~~~~~~kl~DfGla~  394 (577)
                      |++|.++.++|.-.|+-.
T Consensus       115 L~f~~~~~p~i~hRGi~~  132 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVKE  132 (219)
T ss_dssp             EEECTTCCEEESCCEETT
T ss_pred             EEEeCCCcEEEEEcCCcc
Confidence            999999999998777644

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=80.34  E-value=0.18  Score=52.75  Aligned_cols=62  Identities=6%  Similarity=0.075  Sum_probs=19.1

Q ss_pred             ccccccccCCcEEEEEeEecC-CcEEEE------EEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEc
Q 008108          247 SDANKLGQGGFGAVYKGMLSN-GETIAV------KRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLE  311 (577)
Q Consensus       247 ~~~~~lG~G~~g~Vy~~~~~~-~~~vav------K~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  311 (577)
                      ...++||   ||.||+|.+.. ..+|||      |......  .+....+.+|..++..++|+|+++.+++...
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            3456777   99999999754 357888      7665432  2223357788899999999999999887653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	577
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-72
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-68
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-67
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-67
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	8e-66
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-65
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-65
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-64
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	8e-64
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-63
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-63
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-62
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-61
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-61
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-61
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-60
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-60
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-60
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-59
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-59
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-58
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-58
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-58
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	8e-58
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-57
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-57
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-57
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-56
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-55
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-53
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-53
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-52
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-52
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-50
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	8e-49
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-48
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-47
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-47
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-46
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-46
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-46
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	9e-46
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-45
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-45
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-43
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-43
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-43
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-42
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-41
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-41
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-41
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-41
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-40
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-40
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-39
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-37
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-36
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-35
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-33
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-33
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-30
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	5e-27

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (590), Expect = 2e-72
 Identities = 65/284 (22%), Positives = 128/284 (45%), Gaps = 19/284 (6%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
              +   ++G G FG VYKG       + +  ++  + Q    FKNEV +L + +H N++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
             +G+     +  +V ++   +SL H +            K   I    A+G+ YLH  S
Sbjct: 68  LFMGYS-TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS 124

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH- 422
              IIHRDLK++NI L  ++  KI DFG+A +           ++ G+  +MAPE +   
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 423 --GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM 480
               +S +SD+++FG+++ E+++G  +  +      + ++    R +        + P +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTG--QLPYSNINNRDQIIFMVGRGY--------LSPDL 231

Query: 481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLP 524
               ++       +   C+++    RP    ++  +     +LP
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (560), Expect = 3e-68
 Identities = 77/273 (28%), Positives = 131/273 (47%), Gaps = 21/273 (7%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
           +      +LG G FG V+ G  +    +AVK L + S   +  F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLV 71

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
           RL     + +   ++ E++ N SL  F+  P +   +T  K   +   IA G+ ++ E +
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
               IHRDL+A+NIL+   ++ KI+DFG+ARL E ++  +          + APE + +G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185

Query: 424 RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGG 483
            F++KSD++SFG+L+ EIV+  +    G             +N   G  +   D      
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VIQNLERGYRMVRPDNCPE-- 237

Query: 484 STSEMMKCIHIGLLCVQENVSNRPGMASVVNML 516
                 +   +  LC +E   +RP    + ++L
Sbjct: 238 ------ELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (555), Expect = 1e-67
 Identities = 74/274 (27%), Positives = 119/274 (43%), Gaps = 23/274 (8%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
              +   ++G G FG V+ G   N + +A+K + +     E +F  E  ++ +L H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
           +L G CLE+    LV+EF+ +  L  ++     R     E    +   +  G+ YL E  
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE-- 119

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
              +IHRDL A N L+      K+SDFGM R    DQ    +        + +PE     
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177

Query: 424 RFSVKSDIFSFGVLVLEIVSGQKRSSFG-TEEETEDLLTYAWRNWNEGAALNLMDPTMRG 482
           R+S KSD++SFGVL+ E+ S  K      +  E  + ++  +R         L  P +  
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR---------LYKPRL-- 226

Query: 483 GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNML 516
                      I   C +E   +RP  + ++  L
Sbjct: 227 ----ASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (557), Expect = 5e-67
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 13/226 (5%)

Query: 239 IRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
           + +  D+F   ++LG G  G V+K     +G  +A K +    K         E+ +L  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
                +V   G      E  +  E +   SLD  +        +  +   K+   + +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGL 117

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            YL    + +I+HRD+K SNIL++S    K+ DFG++        +S     VGT  YM+
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF----VGTRSYMS 171

Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTY 462
           PE +    +SV+SDI+S G+ ++E+  G  R      +  E  L +
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVG--RYPIPPPDAKELELMF 215

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (546), Expect = 8e-66
 Identities = 67/290 (23%), Positives = 114/290 (39%), Gaps = 29/290 (10%)

Query: 251 KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCL 310
            +G+G FG V++G    GE +AVK  S   ++     + E+     L+H N++  +    
Sbjct: 10  SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67

Query: 311 ER----KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED---- 362
           +      +  LV ++  + SL  +    +NR  +T E   K+    A GL +LH +    
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDY----LNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 363 -SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE--MDQTHSDTNRVVGTFGYMAPEY 419
             +  I HRDLK+ NIL+       I+D G+A   +   D      N  VGT  YMAPE 
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 420 ------VMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET----EDLLTYAWRNWNE 469
                 + H     ++DI++ G++  EI           + +           +     +
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 470 GAALNLMDPTM--RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
                 + P +  R  S   +     I   C   N + R     +   L+
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  214 bits (545), Expect = 1e-65
 Identities = 75/302 (24%), Positives = 136/302 (45%), Gaps = 38/302 (12%)

Query: 234 FDFETIRVATDNFSDA---------NKLGQGGFGAVYKGML----SNGETIAVKRLSKN- 279
           F FE    A   F+             +G G FG V  G L         +A+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 280 SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREH 339
           +++   +F +E  ++ +  H N++ L G   +    +++ EF+ N SLD F+    N   
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQ 124

Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
            T  +   ++ GIA G+ YL     +  +HRDL A NIL++S +  K+SDFG++R  E D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 400 QTHSDTNRVVG---TFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET 456
            +       +G      + APE + + +F+  SD++S+G+++ E++S  +R         
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP-------- 233

Query: 457 EDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMK-CIHIGLLCVQENVSNRPGMASVVNM 515
                  + +      +N ++   R     +       + L C Q++ ++RP    +VN 
Sbjct: 234 -------YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

Query: 516 LN 517
           L+
Sbjct: 287 LD 288

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (542), Expect = 2e-65
 Identities = 68/288 (23%), Positives = 127/288 (44%), Gaps = 23/288 (7%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
           ++     KLGQG FG V+ G  +    +A+K L   +   E  F  E  ++ +L+H  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLV 75

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
           +L       +   +V E++   SL  F+      +++   +   +   IA G+ Y+    
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE--- 130

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
           R+  +HRDL+A+NIL+   +  K++DFG+ARL E ++  +          + APE  ++G
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYG 189

Query: 424 RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGG 483
           RF++KSD++SFG+L+ E+ +  +                 +        L+ ++   R  
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMP 234

Query: 484 STSEMMK-CIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKPA 530
              E  +    +   C ++    RP    +   L     +     +P 
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 1e-64
 Identities = 66/274 (24%), Positives = 118/274 (43%), Gaps = 23/274 (8%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
            + +   +LG G FG V  G       +A+K + + S   E EF  E  ++  L H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
           +L G C +++   ++ E++ N  L +++ +   R     ++  ++ + +   + YL    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK- 119

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
             + +HRDL A N L++ +   K+SDFG++R    D+  S          +  PE +M+ 
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFPVRWSPPEVLMYS 176

Query: 424 RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGG 483
           +FS KSDI++FGVL+ EI S  K                 +  +        +   +R  
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKM---------------PYERFTNSETAEHIAQGLRLY 221

Query: 484 STSEMM-KCIHIGLLCVQENVSNRPGMASVVNML 516
                  K   I   C  E    RP    +++ +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  209 bits (532), Expect = 8e-64
 Identities = 72/286 (25%), Positives = 129/286 (45%), Gaps = 23/286 (8%)

Query: 233 QFDFETIRVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEV 291
             +++   +   + +  +KLG G +G VY+G+      T+AVK L +++ + E EF  E 
Sbjct: 6   SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEA 64

Query: 292 LLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG 351
            ++  ++H NLV+LLG C       ++ EF+   +L  ++ +  NR+ ++      +   
Sbjct: 65  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQ 123

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           I+  + YL    +   IHRDL A N L+      K++DFG++RL   D   +        
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFP 179

Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGA 471
             + APE + + +FS+KSD+++FGVL+ EI +                    +   +   
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDLSQ 224

Query: 472 ALNLMDPTMRGGSTSEMM-KCIHIGLLCVQENVSNRPGMASVVNML 516
              L++   R         K   +   C Q N S+RP  A +    
Sbjct: 225 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  207 bits (527), Expect = 5e-63
 Identities = 66/313 (21%), Positives = 128/313 (40%), Gaps = 45/313 (14%)

Query: 232 LQFDFETIRVATDNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKN-SKQGE 284
           L     ++    +N      +G+G FG V++              +AVK L +  S   +
Sbjct: 1   LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60

Query: 285 IEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD----------- 333
            +F+ E  L+A   + N+V+LLG C   K   L++E++    L+ F+             
Sbjct: 61  ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120

Query: 334 ----------PINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM 383
                           ++  ++  I   +A G+ YL E    + +HRDL   N L+   M
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENM 177

Query: 384 NPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS 443
             KI+DFG++R       +           +M PE + + R++ +SD++++GV++ EI S
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237

Query: 444 GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENV 503
              +  +G                +E     + D  +     +  ++  ++  LC  +  
Sbjct: 238 YGLQPYYG--------------MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLP 283

Query: 504 SNRPGMASVVNML 516
           ++RP   S+  +L
Sbjct: 284 ADRPSFCSIHRIL 296

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 9e-63
 Identities = 65/301 (21%), Positives = 129/301 (42%), Gaps = 28/301 (9%)

Query: 239 IRVATDNFSDAN-KLGQGGFGAVYKGML---SNGETIAVKRLSKNSKQGEIE-FKNEVLL 293
           + +  DN   A+ +LG G FG+V +G+         +A+K L + +++ + E    E  +
Sbjct: 3   LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62

Query: 294 LARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIA 353
           + +L +  +VRL+G C + +  +LV E      L  F+     RE +      +++  ++
Sbjct: 63  MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVS 119

Query: 354 RGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF-EMDQTHSDTNRVVGTF 412
            G+ YL        +HRDL A N+LL +    KISDFG+++     D  ++  +      
Sbjct: 120 MGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176

Query: 413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAA 472
            + APE +   +FS +SD++S+GV + E +S  ++                ++       
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK---------------PYKKMKGPEV 221

Query: 473 LNLMDPTMRGGSTSEM-MKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKPAF 531
           +  ++   R     E   +   +   C      +RP   +V   +     +L +  +   
Sbjct: 222 MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 281

Query: 532 F 532
            
Sbjct: 282 H 282

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 5e-62
 Identities = 72/288 (25%), Positives = 134/288 (46%), Gaps = 26/288 (9%)

Query: 238 TIRVATDNFSDANKLGQGGFGAVYKGMLSNGE-----TIAVKRLSKNSKQGE-IEFKNEV 291
           T  +     +    +G G FG VYKGML          +A+K L     + + ++F  E 
Sbjct: 1   TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60

Query: 292 LLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEG 351
            ++ +  H N++RL G   + K  +++ E++ N +LD F+ +       +  +   ++ G
Sbjct: 61  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRG 118

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT-NRVVG 410
           IA G+ YL     +  +HRDL A NIL++S +  K+SDFG++R+ E D   + T +    
Sbjct: 119 IAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175

Query: 411 TFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEG 470
              + APE + + +F+  SD++SFG+++ E+++  +R                W   N  
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER--------------PYWELSNHE 221

Query: 471 AALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG 518
               + D                + + C Q+  + RP  A +V++L+ 
Sbjct: 222 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  204 bits (520), Expect = 1e-61
 Identities = 73/279 (26%), Positives = 122/279 (43%), Gaps = 33/279 (11%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEI---EFKNEVLLLARLQ 298
              FSD  ++G G FGAVY    + N E +A+K++S + KQ      +   EV  L +L+
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H N ++  G  L      LV E+   ++ D      ++++ +   +   +  G  +GL Y
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAY 130

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
           LH      +IHRD+KA NILL      K+ DFG A +       +  N  VGT  +MAPE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181

Query: 419 YVM---HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNL 475
            ++    G++  K D++S G+  +E+     +           L                
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAER--KPPLFNMNAMSALY----------HIAQN 229

Query: 476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN 514
             P ++ G  SE  +  +    C+Q+   +RP    ++ 
Sbjct: 230 ESPALQSGHWSEYFR--NFVDSCLQKIPQDRPTSEVLLK 266

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 2e-61
 Identities = 72/277 (25%), Positives = 125/277 (45%), Gaps = 29/277 (10%)

Query: 248 DANKLGQGGFGAVYKGMLSN---GETIAVKRLSKNSKQGEI--EFKNEVLLLARLQHRNL 302
           +  +LG G FG V KG        +T+AVK L   +    +  E   E  ++ +L +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           VR++G C E +  +LV E      L+ ++       H+  +   +++  ++ G+ YL   
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLE-- 124

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTN-RVVGTFGYMAPEYVM 421
                +HRDL A N+LL ++   KISDFG+++    D+ +            + APE + 
Sbjct: 125 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183

Query: 422 HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR 481
           + +FS KSD++SFGVL+ E  S  ++                +R         +++   R
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQK---------------PYRGMKGSEVTAMLEKGER 228

Query: 482 GGSTSEMMK-CIHIGLLCVQENVSNRPGMASVVNMLN 517
            G  +   +    +  LC   +V NRPG A+V   L 
Sbjct: 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 3e-61
 Identities = 64/274 (23%), Positives = 109/274 (39%), Gaps = 27/274 (9%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLV 303
                   +G+G FG V  G    G  +AVK +  ++      F  E  ++ +L+H NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA--FLAEASVMTQLRHSNLV 63

Query: 304 RLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           +LLG  +E K  + +V E++   SL  ++     R  +  +   K    +   + YL   
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE-- 120

Query: 363 SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH 422
                +HRDL A N+L+  +   K+SDFG+ +     Q             + APE +  
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALRE 174

Query: 423 GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG 482
            +FS KSD++SFG+L+ EI S  +        +             +G  ++  D     
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMDAPDGCPP- 227

Query: 483 GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNML 516
                      +   C   + + RP    +   L
Sbjct: 228 -------AVYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 3e-60
 Identities = 66/274 (24%), Positives = 114/274 (41%), Gaps = 22/274 (8%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHRN 301
           +++     LG+G +G V   +     E +AVK +         E  K E+ +   L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +V+  G   E   + L  E+     L   I        M      +    +  G++YLH 
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM 421
              + I HRD+K  N+LLD   N KISDFG+A +F  +      N++ GT  Y+APE + 
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 422 HGRF-SVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM 480
              F +   D++S G+++  +++G+      ++   E      + +W E          +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKKTYLNPWKKI 232

Query: 481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN 514
                S  +  +H     + EN S R  +  +  
Sbjct: 233 ----DSAPLALLH---KILVENPSARITIPDIKK 259

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 4e-60
 Identities = 67/281 (23%), Positives = 122/281 (43%), Gaps = 29/281 (10%)

Query: 245 NFSDANKLGQGGFGAVYKGMLSN----GETIAVKRLSKNSKQGEIE-FKNEVLLLARLQH 299
           +F+    +G+G FG VY G L +        AVK L++ +  GE+  F  E +++    H
Sbjct: 30  HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 300 RNLVRLLGFCLERKERI-LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
            N++ LLG CL  +    +V  ++ +  L +FI +  +   +     + +          
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG----- 142

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNR--VVGTFGYMA 416
           +   +  + +HRDL A N +LD +   K++DFG+AR     +  S  N+        +MA
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202

Query: 417 PEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM 476
            E +   +F+ KSD++SFGVL+ E+++         +  T D+  Y  +           
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGRRLLQPEYCP 260

Query: 477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
           DP               + L C       RP  + +V+ ++
Sbjct: 261 DP------------LYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 7e-60
 Identities = 68/299 (22%), Positives = 117/299 (39%), Gaps = 39/299 (13%)

Query: 244 DNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
           +  S    LG G FG V +             T+AVK L  ++   E E   +E+ +L+ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFD---------------PINREHM 340
           L  H N+V LLG C      +++ E+     L +F+                   +   +
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
             E        +A+G+ +L        IHRDL A NILL      KI DFG+AR  + D 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 401 THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
            +           +MAPE + +  ++ +SD++S+G+ + E+ S       G   +++   
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256

Query: 461 TYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD 519
              ++   EG    ++ P           +   I   C   +   RP    +V ++   
Sbjct: 257 --FYKMIKEG--FRMLSP------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 2e-59
 Identities = 69/324 (21%), Positives = 138/324 (42%), Gaps = 42/324 (12%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGET----IAVKRLSK-NSKQGEIEFKNEVLLLARL 297
             F     LG G FG VYKG+ +  GE     +A+K L +  S +   E  +E  ++A +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 298 QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLL 357
            + ++ RLLG CL    + L+ + +P   L  ++ +  +++++  +        IA+G+ 
Sbjct: 69  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMN 125

Query: 358 YLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAP 417
           YL      R++HRDL A N+L+ +  + KI+DFG+A+L   ++             +MA 
Sbjct: 126 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182

Query: 418 EYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD 477
           E ++H  ++ +SD++S+GV V E+++   +                +         ++++
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSK---------------PYDGIPASEISSILE 227

Query: 478 PTMRGGSTSEMMK-CIHIGLLCVQENVSNRPGMASVVNML--------------NGDTVT 522
              R             I + C   +  +RP    ++                   + + 
Sbjct: 228 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMH 287

Query: 523 LPAPSKPAFFMKCSVIPETSSPLD 546
           LP+P+   F+       +    +D
Sbjct: 288 LPSPTDSNFYRALMDEEDMDDVVD 311

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 3e-59
 Identities = 65/279 (23%), Positives = 120/279 (43%), Gaps = 25/279 (8%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHR 300
           +++     +G G +G   K    S+G+ +  K L   S  +  +    +EV LL  L+H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 301 NLVRLLGFCLERKERIL--VYEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLL 357
           N+VR     ++R    L  V E+     L   I      R+++  E   +++  +   L 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 358 YLHE--DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYM 415
             H   D    ++HRDLK +N+ LD + N K+ DFG+AR+   D + +     VGT  YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYM 181

Query: 416 APEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNL 475
           +PE +    ++ KSDI+S G L+ E+ +     +  +++E    +               
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI------------REG 229

Query: 476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN 514
               +    + E+ + I      +     +RP +  ++ 
Sbjct: 230 KFRRIPYRYSDELNEII---TRMLNLKDYHRPSVEEILE 265

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 2e-58
 Identities = 66/273 (24%), Positives = 117/273 (42%), Gaps = 30/273 (10%)

Query: 250 NKLGQGGFGAVYKGML-SNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLL 306
            ++G+G F  VYKG+       +A   L     +K     FK E  +L  LQH N+VR  
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 307 GFCLE----RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
                    +K  +LV E + + +L  ++      + M  +        I +GL +LH  
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 363 SRLRIIHRDLKASNILLDSE-MNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM 421
           +   IIHRDLK  NI +     + KI D G+A L       +    V+GT  +MAPE + 
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAPE-MY 185

Query: 422 HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR 481
             ++    D+++FG+ +LE+ +      +   +    +    +R    G    +   +  
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATS--EYPYSECQNAAQI----YRRVTSG----VKPASFD 235

Query: 482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN 514
             +  E+ + I     C+++N   R  +  ++N
Sbjct: 236 KVAIPEVKEII---EGCIRQNKDERYSIKDLLN 265

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 2e-58
 Identities = 64/278 (23%), Positives = 116/278 (41%), Gaps = 26/278 (9%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN 301
            D +    +LG G FG VYK          A K +   S++   ++  E+ +LA   H N
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +V+LL          ++ EF    ++D  + +      +T  +   + +     L YLH+
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHD 128

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM 421
               +IIHRDLKA NIL   + + K++DFG++          D+   +GT  +MAPE VM
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 183

Query: 422 -----HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM 476
                   +  K+D++S G+ ++E+   +                       +     L 
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-------LLKIAKSEPPTLA 236

Query: 477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN 514
            P+    +  + +K       C+++NV  R   + ++ 
Sbjct: 237 QPSRWSSNFKDFLKK------CLEKNVDARWTTSQLLQ 268

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 2e-58
 Identities = 67/302 (22%), Positives = 116/302 (38%), Gaps = 44/302 (14%)

Query: 244 DNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSKQGEIE-FKNEVLLLAR 296
           +N      LG G FG V                +AVK L + +   E E   +E+ ++ +
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 297 L-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREH---------------- 339
           L  H N+V LLG C       L++E+     L +++     +                  
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 340 ----MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARL 395
               +T+E        +A+G+ +L        +HRDL A N+L+      KI DFG+AR 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 396 FEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEE 455
              D  +           +MAPE +  G +++KSD++S+G+L+ EI S       G   +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 456 TEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM 515
                   ++    G  ++           +E +    I   C   +   RP   ++ + 
Sbjct: 274 AN-----FYKLIQNGFKMDQPF------YATEEIY--IIMQSCWAFDSRKRPSFPNLTSF 320

Query: 516 LN 517
           L 
Sbjct: 321 LG 322

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 8e-58
 Identities = 65/273 (23%), Positives = 120/273 (43%), Gaps = 23/273 (8%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRN 301
              ++   K+GQG  G VY  M ++ G+ +A+++++   +  +    NE+L++   ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +V  L   L   E  +V E++   SL     D +    M   +   +     + L +LH 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSL----TDVVTETCMDEGQIAAVCRECLQALEFLHS 134

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM 421
               ++IHRD+K+ NILL  + + K++DFG       +Q+   T  +VGT  +MAPE V 
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189

Query: 422 HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMR 481
              +  K DI+S G++ +E++ G     +  E     L               L +P   
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEG--EPPYLNENPLRAL-----YLIATNGTPELQNPE-- 240

Query: 482 GGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN 514
               S + +       C+  +V  R     ++ 
Sbjct: 241 --KLSAIFR--DFLNRCLDMDVEKRGSAKELLQ 269

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 1e-57
 Identities = 67/275 (24%), Positives = 111/275 (40%), Gaps = 30/275 (10%)

Query: 244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQH 299
           ++F     LG+G FG VY      +   +A+K L K        E + + EV + + L+H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
            N++RL G+  +     L+ E+ P  ++   +           ++    I  +A  L Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYC 122

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H     R+IHRD+K  N+LL S    KI+DFG +      +       + GT  Y+ PE 
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEM 175

Query: 420 VMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT 479
           +       K D++S GVL  E + G  +  F      E               ++ ++ T
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVG--KPPFEANTYQETY-----------KRISRVEFT 222

Query: 480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN 514
                T      I      ++ N S RP +  V+ 
Sbjct: 223 FPDFVTEGARDLI---SRLLKHNPSQRPMLREVLE 254

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 2e-57
 Identities = 70/304 (23%), Positives = 131/304 (43%), Gaps = 33/304 (10%)

Query: 244 DNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSKQGE-IEFKNEVLLLAR 296
           +  + + +LGQG FG VY+G+            +A+K +++ +   E IEF NE  ++  
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIF-------DPINREHMTWEKRYKII 349
               ++VRLLG   + +  +++ E +    L  ++        +       +  K  ++ 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
             IA G+ YL+ +   + +HRDL A N ++  +   KI DFGM R       +    + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 410 GTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNE 469
               +M+PE +  G F+  SD++SFGV++ EI +  ++   G   E         R   E
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ------VLRFVME 250

Query: 470 GAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKP 529
           G  L+  D                +  +C Q N   RP    +++ +  +    P   + 
Sbjct: 251 GGLLDKPDNCPD--------MLFELMRMCWQYNPKMRPSFLEIISSIKEE--MEPGFREV 300

Query: 530 AFFM 533
           +F+ 
Sbjct: 301 SFYY 304

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 5e-57
 Identities = 72/292 (24%), Positives = 109/292 (37%), Gaps = 37/292 (12%)

Query: 238 TIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSK---NSKQGEIEFKNE 290
           T  +   +     KLG G FG V +G          ++AVK L     +  +   +F  E
Sbjct: 2   TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61

Query: 291 VLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIE 350
           V  +  L HRNL+RL G  L    ++ V E  P  SL   +    ++ H       +   
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK--HQGHFLLGTLSRYAV 118

Query: 351 GIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSD-TNRVV 409
            +A G+ YL      R IHRDL A N+LL +    KI DFG+ R    +  H        
Sbjct: 119 QVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175

Query: 410 GTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNE 469
             F + APE +    FS  SD + FGV + E                  + TY    W  
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWE------------------MFTYGQEPWIG 217

Query: 470 GAALNLMDPTMRGGSTSEM-----MKCIHIGLLCVQENVSNRPGMASVVNML 516
                ++    + G              ++ + C      +RP   ++ + L
Sbjct: 218 LNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 1e-56
 Identities = 73/292 (25%), Positives = 122/292 (41%), Gaps = 38/292 (13%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGET---IAVKRLSKN-SKQGEIEFKNEVLLLARL-Q 298
           ++    + +G+G FG V K  +         A+KR+ +  SK    +F  E+ +L +L  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFI-------------FDPINREHMTWEKR 345
           H N++ LLG C  R    L  E+ P+ +L  F+                     ++ ++ 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 346 YKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT 405
                 +ARG+ YL +    + IHRDL A NIL+      KI+DFG++R  E    +   
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQE---VYVKK 183

Query: 406 NRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWR 465
                   +MA E + +  ++  SD++S+GVL+ EIVS       G      +L     +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG--MTCAELYEKLPQ 241

Query: 466 NWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
            +     LN  D            +   +   C +E    RP  A ++  LN
Sbjct: 242 GYRLEKPLNCDD------------EVYDLMRQCWREKPYERPSFAQILVSLN 281

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 1e-55
 Identities = 75/296 (25%), Positives = 119/296 (40%), Gaps = 38/296 (12%)

Query: 244 DNFSDANKLGQGGFGAVYKGM------LSNGETIAVKRLSKNSKQGEIE--FKNEVLLLA 295
           D       LG+G FG V +         +   T+AVK L + +   E         +L+ 
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 296 RLQHRNLVRLLGFCLERKERI-LVYEFVPNASLDHFIF-------------DPINREHMT 341
              H N+V LLG C +    + ++ EF    +L  ++              + + ++ +T
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 342 WEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT 401
            E        +A+G+ +L      + IHRDL A NILL  +   KI DFG+AR    D  
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLT 461
           +           +MAPE +    ++++SD++SFGVL+ EI S       G + + E    
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---- 245

Query: 462 YAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
              R   EG  +   D T          +     L C     S RP  + +V  L 
Sbjct: 246 -FCRRLKEGTRMRAPDYTTP--------EMYQTMLDCWHGEPSQRPTFSELVEHLG 292

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 1e-53
 Identities = 60/288 (20%), Positives = 110/288 (38%), Gaps = 29/288 (10%)

Query: 235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLSN----GETIAVKRLSKNSKQGEIE-FKN 289
           D+E   +  +       +G+G FG V++G+  +       +A+K     +     E F  
Sbjct: 1   DYE---IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 57

Query: 290 EVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKII 349
           E L + +  H ++V+L+G   E     ++ E      L  F+        +         
Sbjct: 58  EALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYA 114

Query: 350 EGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVV 409
             ++  L YL      R +HRD+ A N+L+ S    K+ DFG++R  E    +   ++  
Sbjct: 115 YQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-ASKGK 170

Query: 410 GTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNE 469
               +MAPE +   RF+  SD++ FGV + EI+    +   G +                
Sbjct: 171 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIEN 224

Query: 470 GAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
           G  L +        +    +    +   C   + S RP    +   L+
Sbjct: 225 GERLPMPP------NCPPTLY--SLMTKCWAYDPSRRPRFTELKAQLS 264

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  181 bits (461), Expect = 8e-53
 Identities = 64/274 (23%), Positives = 118/274 (43%), Gaps = 23/274 (8%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL 302
           D++    +LG G FG V++    + G   A K +    +  +   + E+  ++ L+H  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           V L     +  E +++YEF+    L   + D      M+ ++  + +  + +GL ++HE 
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE- 142

Query: 363 SRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV 420
                +H DLK  NI+  ++ +   K+ DFG+    +  Q+   T    GT  + APE  
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT---TGTAEFAAPEVA 197

Query: 421 MHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM 480
                   +D++S GVL   ++SG   S FG E + E L      +WN       MD + 
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSG--LSPFGGENDDETLRNVKSCDWN-------MDDSA 248

Query: 481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN 514
             G + +    I      +  + + R  +   + 
Sbjct: 249 FSGISEDGKDFI---RKLLLADPNTRMTIHQALE 279

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 3e-52
 Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 10/210 (4%)

Query: 240 RVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKN---SKQGEIEFKNEVLLLA 295
           +   ++F     LG+G F  V     L+     A+K L K     +        E  +++
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
           RL H   V+L     + ++      +  N  L  +I                    I   
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSA 120

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYM 415
           L YLH      IIHRDLK  NILL+ +M+ +I+DFG A++   +   +  N  VGT  Y+
Sbjct: 121 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177

Query: 416 APEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           +PE +        SD+++ G ++ ++V+G 
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGL 207

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 4e-52
 Identities = 65/297 (21%), Positives = 119/297 (40%), Gaps = 40/297 (13%)

Query: 244 DNFSDANKLGQGGFGAVYKGML--------SNGETIAVKRLSKNSKQGEI-EFKNEVLLL 294
           D       LG+G FG V             +    +AVK L  ++ + ++ +  +E+ ++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 295 ARL-QHRNLVRLLGFCLERKERILVYEFVPNASLDHFIF-------------DPINREHM 340
             + +H+N++ LLG C +     ++ E+    +L  ++                   E +
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           + +        +ARG+ YL      + IHRDL A N+L+  +   KI+DFG+AR      
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 401 THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL 460
            +  T        +MAPE +    ++ +SD++SFGVL+ EI +       G   E     
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 245

Query: 461 TYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
              ++   EG  ++               +   +   C     S RP    +V  L+
Sbjct: 246 --LFKLLKEGHRMDKPSNCTN--------ELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  174 bits (441), Expect = 6e-50
 Identities = 67/296 (22%), Positives = 117/296 (39%), Gaps = 25/296 (8%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL 302
           D +    +LG G FG V++ +  + G     K ++      +   KNE+ ++ +L H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           + L     ++ E +L+ EF+    L   I        M+  +    +     GL ++HE 
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHE- 145

Query: 363 SRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV 420
               I+H D+K  NI+ +++     KI DFG+A     D+          T  + APE V
Sbjct: 146 --HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200

Query: 421 MHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM 480
                   +D+++ GVL   ++SG   S F  E++ E L      +W         D   
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSG--LSPFAGEDDLETLQNVKRCDWE-------FDEDA 251

Query: 481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM--LNGDTVTLPAPSKPAFFMK 534
               + E    I      +Q+    R  +   +    L GD   L +    + + K
Sbjct: 252 FSSVSPEAKDFIK---NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNK 304

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 8e-49
 Identities = 53/207 (25%), Positives = 104/207 (50%), Gaps = 7/207 (3%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHR 300
              +++ + +G+G +G V       N   +A+K++S    Q   +    E+ +L R +H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
           N++ +           +   ++    +   ++  +  +H++ +     +  I RGL Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDT-NRVVGTFGYMAPEY 419
                 ++HRDLK SN+LL++  + KI DFG+AR+ + D  H+      V T  Y APE 
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 420 VMHGRFSVKS-DIFSFGVLVLEIVSGQ 445
           +++ +   KS DI+S G ++ E++S +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNR 210

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  169 bits (428), Expect = 7e-48
 Identities = 63/269 (23%), Positives = 108/269 (40%), Gaps = 30/269 (11%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSK---NSKQGEIEFKNEVLLLARLQ- 298
           ++FS    +G+GGFG VY       G+  A+K L K     KQGE    NE ++L+ +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 299 --HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
                +V +        +   + + +    L + +         +          I  GL
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMA 416
            ++H      +++RDLK +NILLD   + +ISD G+A  F   + H      VGT GYMA
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMA 173

Query: 417 PEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNE------ 469
           PE +  G  +   +D FS G ++ +++ G         ++  ++         E      
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 233

Query: 470 GAALNLM------DPTMRGGSTSEMMKCI 492
               +L+      D   R G      + +
Sbjct: 234 PELRSLLEGLLQRDVNRRLGCLGRGAQEV 262

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 6e-47
 Identities = 48/205 (23%), Positives = 89/205 (43%), Gaps = 12/205 (5%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL 302
           + +  A  LG+G FG V++ +  S+ +T   K +       ++  K E+ +L   +HRN+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNI 63

Query: 303 VRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED 362
           + L       +E ++++EF+    +   I    +   +   +    +  +   L +LH  
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHS- 120

Query: 363 SRLRIIHRDLKASNILLDSEMNP--KISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV 420
               I H D++  NI+  +  +   KI +FG AR  +                Y APE  
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEYYAPEVH 175

Query: 421 MHGRFSVKSDIFSFGVLVLEIVSGQ 445
            H   S  +D++S G LV  ++SG 
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGI 200

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  164 bits (415), Expect = 8e-47
 Identities = 51/289 (17%), Positives = 102/289 (35%), Gaps = 27/289 (9%)

Query: 239 IRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL 297
           +RV  + +    K+G G FG +Y G  ++ GE +A+K     +K  +     E  +   +
Sbjct: 3   LRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMM 59

Query: 298 QHRNLVRLLGFCLERKER-ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           Q    +  + +C    +  ++V E +  +  D F F        + +    + + +   +
Sbjct: 60  QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRI 116

Query: 357 LYLHEDSRLRIIHRDLKASNIL---LDSEMNPKISDFGMARLFEMDQTHSD-----TNRV 408
            Y+H       IHRD+K  N L           I DFG+A+ +   +TH          +
Sbjct: 117 EYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173

Query: 409 VGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWN 468
            GT  Y +    +    S + D+ S G +++    G                        
Sbjct: 174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK- 232

Query: 469 EGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
               ++     +  G  SE    ++    C      ++P  + +  +  
Sbjct: 233 ----MSTPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  162 bits (410), Expect = 2e-46
 Identities = 63/280 (22%), Positives = 116/280 (41%), Gaps = 27/280 (9%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGE---IEFKNEVLLLARLQ 298
           +D +     LG GG   V+    L     +AVK L  +  +     + F+ E    A L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 299 HRNLVRLLGFCLERKERI----LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIAR 354
           H  +V +               +V E+V   +L   +        MT ++  ++I    +
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 122

Query: 355 GLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH-SDTNRVVGTFG 413
            L + H+     IIHRD+K +NI++ +    K+ DFG+AR         + T  V+GT  
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 414 YMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAAL 473
           Y++PE         +SD++S G ++ E+++G     F  +          +++  E    
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTG--EPPFTGDSPVSVA----YQHVRE---- 229

Query: 474 NLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVV 513
           + + P+ R    S  +    + L  + +N  NR   A+ +
Sbjct: 230 DPIPPSARHEGLSADLD--AVVLKALAKNPENRYQTAAEM 267

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  162 bits (412), Expect = 4e-46
 Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 15/207 (7%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKN---SKQGEIEFKNEVLLLARLQH 299
            +F     LG G FG V+      NG   A+K L K      +      +E L+L+ + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
             ++R+ G   + ++  ++ +++    L   +       +   +     +       L L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
                  II+RDLK  NILLD   + KI+DFG A+             + GT  Y+APE 
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEV 172

Query: 420 VMHGRFSVKSDIFSFGVLVLEIVSGQK 446
           V    ++   D +SFG+L+ E+++G  
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  161 bits (409), Expect = 7e-46
 Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 14/208 (6%)

Query: 243 TDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-FKNEVLLLARLQHR 300
            D +   + LG G F  V         + +A+K ++K + +G+    +NE+ +L +++H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
           N+V L           L+ + V    L   I   + +   T     ++I  +   + YLH
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124

Query: 361 EDSRLRIIHRDLKASNILL---DSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAP 417
           +     I+HRDLK  N+L    D +    ISDFG++++ +        +   GT GY+AP
Sbjct: 125 DL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAP 178

Query: 418 EYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           E +    +S   D +S GV+   ++ G 
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGY 206

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 9e-46
 Identities = 65/263 (24%), Positives = 116/263 (44%), Gaps = 26/263 (9%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN----EVLLLARLQ 298
           ++F     LG+G FG V+        +  A+K L K+    + + +     + +L    +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 299 HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLY 358
           H  L  +      ++    V E++    L + I    +       +       I  GL +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118

Query: 359 LHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE 418
           LH      I++RDLK  NILLD + + KI+DFGM +   +    ++T    GT  Y+APE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173

Query: 419 YVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL-----TYAWRNWNEGAAL 473
            ++  +++   D +SFGVL+ E++ G  +S F  ++E E           +  W E  A 
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIG--QSPFHGQDEEELFHSIRMDNPFYPRWLEKEAK 231

Query: 474 NLM------DPTMRGGSTSEMMK 490
           +L+      +P  R G   ++ +
Sbjct: 232 DLLVKLFVREPEKRLGVRGDIRQ 254

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  158 bits (401), Expect = 4e-45
 Identities = 52/219 (23%), Positives = 99/219 (45%), Gaps = 26/219 (11%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNS---------KQGEIEFKNEVLL 293
           +N+     LG+G    V + +     +  AVK +             ++       EV +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 294 LARLQ-HRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
           L ++  H N+++L           LV++ +    L  ++     +  ++ ++  KI+  +
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119

Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF 412
              +  LH+   L I+HRDLK  NILLD +MN K++DFG +   +  +       V GT 
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTP 173

Query: 413 GYMAPEYVM------HGRFSVKSDIFSFGVLVLEIVSGQ 445
            Y+APE +       H  +  + D++S GV++  +++G 
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  158 bits (401), Expect = 5e-45
 Identities = 65/287 (22%), Positives = 117/287 (40%), Gaps = 24/287 (8%)

Query: 244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVK--RLSKNSKQGEIEFKNEVLLLARLQHRN 301
           + +    K+G+G +G VYK   + GET A+K  RL K  +        E+ +L  L+H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           +V+L      +K  +LV+E +                 +        +  +  G+ Y H+
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 362 DSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVM 421
               R++HRDLK  N+L++ E   KI+DFG+AR F +          + T  Y AP+ +M
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLM 173

Query: 422 -HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL--------TYAWRNWNEGAA 472
              ++S   DI+S G +  E+V+G       +E +    +        +  W N  E   
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233

Query: 473 LNLMDPTMRGGSTSEMMKCIHIGLL-----CVQENVSNRPGMASVVN 514
            +              +K +    +      ++ + + R      + 
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 2e-43
 Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 19/215 (8%)

Query: 240 RVATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ 298
           R    +++D   +G G FG VY+  L  +GE +A+K++ ++ +        E+ ++ +L 
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLD 71

Query: 299 HRNLVRLLGFCLERKER------ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
           H N+VRL  F     E+       LV ++VP             ++ +        +  +
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131

Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMARLFEMDQTHSDTNRVVGT 411
            R L Y+H      I HRD+K  N+LLD +    K+ DFG A+     + +      + +
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICS 185

Query: 412 FGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQ 445
             Y APE +     ++   D++S G ++ E++ GQ
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 3e-43
 Identities = 67/290 (23%), Positives = 117/290 (40%), Gaps = 28/290 (9%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHR 300
           +NF    K+G+G +G VYK      GE +A+K++  +  ++        E+ LL  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
           N+V+LL       +  LV+EF+          D      +        +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPE-Y 419
                R++HRDLK  N+L+++E   K++DFG+AR F +          V T  Y APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEIL 174

Query: 420 VMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL----------TYAWRNWNE 469
           +    +S   DI+S G +  E+V+   R+ F  + E + L              W     
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTR--RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232

Query: 470 GAALNLMDPTMRGGSTSEMMKCIHIGLL-----CVQENVSNRPGMASVVN 514
                   P       S+++  +           +  + + R    + + 
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 5e-43
 Identities = 64/294 (21%), Positives = 119/294 (40%), Gaps = 27/294 (9%)

Query: 242 ATDNFSDANKLGQGGFGAVYKG--MLSNGETIAVKRLSKNSKQG--EIEFKNEVLLLARL 297
           A   +    ++G+G +G V+K   + + G  +A+KR+   + +    +    EV +L  L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 298 ---QHRNLVRLLGFCLERKERILVYEFVPNASLDH---FIFDPINREHMTWEKRYKIIEG 351
              +H N+VRL   C   +        +    +D       D +    +  E    ++  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 352 IARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGT 411
           + RGL +LH     R++HRDLK  NIL+ S    K++DFG+AR++           VV T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVT 178

Query: 412 FGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEET-----EDLLTYAWRN 466
             Y APE ++   ++   D++S G +  E+   +      ++ +      + +      +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 467 WNEGAALNLMDPTMRGGSTSEMM------KCIHIGLLCVQENVSNRPGMASVVN 514
           W    AL       +     E            + L C+  N + R    S ++
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 1e-42
 Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 15/203 (7%)

Query: 250 NKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE-----FKNEVLLLARLQHRNLV 303
           + LG+G F  VYK    +  + +A+K++    +    +        E+ LL  L H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 304 RLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDS 363
            LL     +    LV++F+             N   +T       +    +GL YLH+  
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 364 RLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHG 423
              I+HRDLK +N+LLD     K++DFG+A+       +      V T  Y APE +   
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGA 175

Query: 424 R-FSVKSDIFSFGVLVLEIVSGQ 445
           R + V  D+++ G ++ E++   
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRV 198

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 1e-41
 Identities = 72/282 (25%), Positives = 117/282 (41%), Gaps = 32/282 (11%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEI------EFKNEVLLLAR 296
           D +    +LG G F  V K    S G   A K + K   +         + + EV +L  
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 297 LQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGL 356
           +QH N++ L      + + IL+ E V    L  F+     +E +T E+  + ++ I  G+
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGV 126

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSEMNP----KISDFGMARLFEMDQTHSDTNRVVGTF 412
            YLH    L+I H DLK  NI+L     P    KI DFG+A   +          + GT 
Sbjct: 127 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180

Query: 413 GYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAA 472
            ++APE V +    +++D++S GV+   ++SG       T++ET         N +    
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-------LANVSAV-- 231

Query: 473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN 514
            N         +TS + K     LL    +   R  +   + 
Sbjct: 232 -NYEFEDEYFSNTSALAKDFIRRLLVK--DPKKRMTIQDSLQ 270

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  149 bits (378), Expect = 1e-41
 Identities = 39/278 (14%), Positives = 92/278 (33%), Gaps = 26/278 (9%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
           ++G+G FG +++G  L N + +A+K   + S   +   ++E      L     +  + + 
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTGIPNVYYF 69

Query: 310 LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIH 369
            +     ++   +   SL+  +         + +      + +   +  +HE     +++
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHE---KSLVY 124

Query: 370 RDLKASNILLDSEMNP-----KISDFGMARLFEMDQTHS-----DTNRVVGTFGYMAPEY 419
           RD+K  N L+    +       + DFGM + +    T       +   + GT  YM+   
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184

Query: 420 VMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT 479
            +    S + D+ + G + +  + G                             +     
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT-----NKQKYERIGEKKQSTPLRE 239

Query: 480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN 517
           +  G   E  K +H             P    +  + +
Sbjct: 240 LCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFS 274

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 5e-41
 Identities = 60/275 (21%), Positives = 107/275 (38%), Gaps = 42/275 (15%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIE------FKNEVLLLARLQ--HRN 301
            LG GGFG+VY G+ +S+   +A+K + K+      E         EV+LL ++      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 302 LVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE 361
           ++RLL +       +L+ E                R  +  E        +   + + H 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRHCHN 128

Query: 362 DSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV 420
                ++HRD+K  NIL+D +    K+ DFG   L +            GT  Y  PE++
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----FDGTRVYSPPEWI 181

Query: 421 MHGRF-SVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT 479
            + R+    + ++S G+L+ ++V G     F  +EE      +  +  +           
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCG--DIPFEHDEEIIRGQVFFRQRVSS---------- 229

Query: 480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN 514
                     +C H+   C+    S+RP    + N
Sbjct: 230 ----------ECQHLIRWCLALRPSDRPTFEEIQN 254

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 6e-41
 Identities = 52/210 (24%), Positives = 88/210 (41%), Gaps = 12/210 (5%)

Query: 240 RVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKN---SKQGEIEFKNEVLLLA 295
           +V  ++F     LG+G FG V      + G   A+K L K    +K        E  +L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60

Query: 296 RLQHRNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARG 355
             +H  L  L            V E+     L    F  ++RE +  E+R +     A  
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFY--GAEI 114

Query: 356 LLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYM 415
           +  L       +++RD+K  N++LD + + KI+DFG+ +    D          GT  Y+
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYL 172

Query: 416 APEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           APE +    +    D +  GV++ E++ G+
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 4e-40
 Identities = 61/306 (19%), Positives = 114/306 (37%), Gaps = 43/306 (14%)

Query: 252 LGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFC 309
           LG G  G V +       E  A+K L    K      + EV L  R  Q  ++VR++   
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDVY 74

Query: 310 ----LERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRL 365
                 RK  ++V E +    L   I D  ++   T  +  +I++ I   + YLH    +
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHS---I 130

Query: 366 RIIHRDLKASNILLDSEMNP---KISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMH 422
            I HRD+K  N+L  S+      K++DFG A+      + +       T  Y+APE +  
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187

Query: 423 GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG 482
            ++    D++S GV++  ++ G     F +       ++   +           +P    
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCG--YPPFYSNHGLA--ISPGMKTRIRMGQYEFPNPEWSE 243

Query: 483 GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTVTLPAPSKPAFFMKCSVIPETS 542
            S         +    ++   + R  +   +N                + M+ + +P+T 
Sbjct: 244 VSEE----VKMLIRNLLKTEPTQRMTITEFMNH--------------PWIMQSTKVPQTP 285

Query: 543 SPLDVI 548
                +
Sbjct: 286 LHTSRV 291

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 5e-40
 Identities = 52/216 (24%), Positives = 102/216 (47%), Gaps = 20/216 (9%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQG--EIEFKNEVLLLARLQHR 300
             +    K+GQG FG V+K      G+ +A+K++   +++    I    E+ +L  L+H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 301 NLVRLLGFCLERKERI--------LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
           N+V L+  C  +            LV++F  +                T  +  ++++ +
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQML 126

Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT--HSDTNRVVG 410
             GL Y+H +   +I+HRD+KA+N+L+  +   K++DFG+AR F + +    +     V 
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 411 TFGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQ 445
           T  Y  PE ++  R +    D++  G ++ E+ +  
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 3e-39
 Identities = 60/288 (20%), Positives = 111/288 (38%), Gaps = 24/288 (8%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSK--NSKQGEIEFKNEVLLLARLQHR 300
             +    K+G+G +G V+K       E +A+KR+    + +        E+ LL  L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 301 NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLH 360
           N+VRL       K+  LV+EF       +F         +  E     +  + +GL + H
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 361 EDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYV 420
                 ++HRDLK  N+L++     K+++FG+AR F +      +  VV  +        
Sbjct: 119 ---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVLF 174

Query: 421 MHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEE------TEDLLTYAWRNWNEGAALN 474
               +S   D++S G +  E+ +  +    G + +         L T     W     L 
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234

Query: 475 LMDPTMRGGSTSEMMKCIH------IGLL--CVQENVSNRPGMASVVN 514
              P     +T+ ++  +         LL   ++ N   R      + 
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  140 bits (354), Expect = 1e-37
 Identities = 60/236 (25%), Positives = 98/236 (41%), Gaps = 21/236 (8%)

Query: 220 EDENVEETIAKS---LQFDFETIRVAT---DNFSDANKLGQGGFGAVYKGM-LSNGETIA 272
           E E+V+E +AK+       +ET    T   D F     LG G FG V       +G   A
Sbjct: 11  EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYA 70

Query: 273 VKRLSKNSKQGEIE---FKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPNASLDH 329
           +K L K       +     NE  +L  +    LV+L     +     +V E+V    +  
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130

Query: 330 FIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISD 389
            +         +          I     YLH    L +I+RDLK  N+L+D +   +++D
Sbjct: 131 HLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTD 184

Query: 390 FGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           FG A+     +    T  + GT   +APE ++   ++   D ++ GVL+ E+ +G 
Sbjct: 185 FGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 2e-36
 Identities = 54/207 (26%), Positives = 99/207 (47%), Gaps = 13/207 (6%)

Query: 244 DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSK--NSKQGEIEFKNEVLLLARLQHR 300
             + D   +G G +GAV   +    G  +A+K+L +   S+        E+ LL  ++H 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 301 NLVRLLGFCLERKERILVYEF-VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           N++ LL      +      +F +    +   +   +  E +  ++   ++  + +GL Y+
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEY 419
           H      IIHRDLK  N+ ++ +   KI DFG+AR     Q  S+    V T  Y APE 
Sbjct: 138 HA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEV 189

Query: 420 VM-HGRFSVKSDIFSFGVLVLEIVSGQ 445
           ++   R++   DI+S G ++ E+++G+
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGK 216

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  132 bits (332), Expect = 6e-35
 Identities = 51/221 (23%), Positives = 102/221 (46%), Gaps = 24/221 (10%)

Query: 234 FDFETIRVAT---DNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKN 289
           +D+E+  V     D++    KLG+G +  V++ + ++N E + VK L    K+   + K 
Sbjct: 22  WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKR 78

Query: 290 EVLLLARLQ-HRNLVRLLGFCLERKER--ILVYEFVPNASLDHFIFDPINREHMTWEKRY 346
           E+ +L  L+   N++ L     +   R   LV+E V N             + +T     
Sbjct: 79  EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIR 132

Query: 347 KIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMARLFEMDQTHSDT 405
             +  I + L Y H    + I+HRD+K  N+++D E    ++ D+G+A  +   Q +   
Sbjct: 133 FYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--- 186

Query: 406 NRVVGTFGYMAPEYVM-HGRFSVKSDIFSFGVLVLEIVSGQ 445
           N  V +  +  PE ++ +  +    D++S G ++  ++  +
Sbjct: 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 227

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 1e-33
 Identities = 55/226 (24%), Positives = 96/226 (42%), Gaps = 27/226 (11%)

Query: 235 DFETIRVATDNFSDANK------LGQGGFGAVYKGM-LSNGETIAVKRLSK--NSKQGEI 285
            F ++ V    F+   +      +G G  G V           +A+K+LS+   ++    
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61

Query: 286 EFKNEVLLLARLQHRNLVRLLGFCL------ERKERILVYEFVPNASLDHFIFDPINREH 339
               E++L+  + H+N++ LL          E ++  LV E +              +  
Sbjct: 62  RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QME 115

Query: 340 MTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD 399
           +  E+   ++  +  G+ +LH      IIHRDLK SNI++ S+   KI DFG+AR     
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172

Query: 400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
                    V T  Y APE ++   +    DI+S G ++ E+V  +
Sbjct: 173 FM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 4e-33
 Identities = 77/342 (22%), Positives = 126/342 (36%), Gaps = 53/342 (15%)

Query: 230 KSLQFDFETIRVATDNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSK----NSK 281
           ++        +V  +NF     LG G +G V+          G+  A+K L K       
Sbjct: 10  RTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA 69

Query: 282 QGEIEFKNEVLLLARLQHR-NLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHM 340
           +     + E  +L  ++    LV L        +  L+ +++    L   +     RE  
Sbjct: 70  KTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS---QRERF 126

Query: 341 TWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ 400
           T  +    +  I   L +LH+   L II+RD+K  NILLDS  +  ++DFG+++ F  D+
Sbjct: 127 TEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 183

Query: 401 THSDTNRVVGTFGYMAPEYVMHGR--FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETED 458
           T        GT  YMAP+ V  G        D +S GVL+ E+++G   S F  + E   
Sbjct: 184 TE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG--ASPFTVDGEKNS 240

Query: 459 LLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASV------ 512
               + R           +P      ++     I      + ++   R G          
Sbjct: 241 QAEISRRILKS-------EPPYPQEMSALAKDLI---QRLLMKDPKKRLGCGPRDADEIK 290

Query: 513 ----VNMLNGDTV---TLPAPSKPAFFMKCSVIPETSSPLDV 547
                  +N D +    +PAP            P     LDV
Sbjct: 291 EHLFFQKINWDDLAAKKVPAP----------FKPVIRDELDV 322

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  121 bits (304), Expect = 7e-31
 Identities = 41/210 (19%), Positives = 80/210 (38%), Gaps = 18/210 (8%)

Query: 251 KLGQGGFGAVYKGM-LSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFC 309
           KLG G F  V+    + N   +A+K +  +    E   ++E+ LL R+   +  +     
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQRVNDADNTKEDSMG 78

Query: 310 LERKERILVYEFVPNASLDHFIFDP-------------INREHMTWEKRYKIIEGIARGL 356
                ++L +      +  H +                     +      +I + +  GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 357 LYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFGMARLFEMDQTHSDTNRVVGTFGYM 415
            Y+H   R  IIH D+K  N+L++       +    +A L             + T  Y 
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 416 APEYVMHGRFSVKSDIFSFGVLVLEIVSGQ 445
           +PE ++   +   +DI+S   L+ E+++G 
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 2e-30
 Identities = 57/214 (26%), Positives = 103/214 (48%), Gaps = 13/214 (6%)

Query: 237 ETIRVATDNFSDANKLGQGGFGAVYKGM-LSNGETIAVKRLSKN--SKQGEIEFKNEVLL 293
           +TI    + + + + +G G +G+V        G  +AVK+LS+   S         E+ L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70

Query: 294 LARLQHRNLVRLLGFCL-ERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGI 352
           L  ++H N++ LL      R        ++    +   + + +  + +T +    +I  I
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130

Query: 353 ARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTF 412
            RGL Y+H      IIHRDLK SN+ ++ +   KI DFG+AR  + + T     R     
Sbjct: 131 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----- 182

Query: 413 GYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQ 445
            Y APE +++   ++   DI+S G ++ E+++G+
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score =  106 bits (264), Expect = 5e-27
 Identities = 37/205 (18%), Positives = 68/205 (33%), Gaps = 33/205 (16%)

Query: 250 NKLGQGGFGAVYKGMLSNGETIAVK--RLSKNSKQ--------GEIEFKNEVLLLARLQH 299
             +G+G   AV+           VK  ++   S +        G++ F    +  AR + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 300 RNLVRLLGFCLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYL 359
           R L +L G  + +      Y +  NA L   I               ++++ I   +   
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119

Query: 360 HEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE----MDQTHSDTNRVVGTFGYM 415
           +      I+H DL   N+L+  E    I DF  +         +    D   ++  F   
Sbjct: 120 YHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS-- 173

Query: 416 APEYVMHGRFSVKSDIFSFGVLVLE 440
                    +  + DI S    +L+
Sbjct: 174 -------RTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	577
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.89
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.61
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.23
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.56
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.3
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.04
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.09

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=412.67  Aligned_cols=254  Identities=28%  Similarity=0.473  Sum_probs=197.9

Q ss_pred             cCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecC
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVP  323 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  323 (577)
                      ++|+..++||+|+||+||+|.+.+++.||||++..... ...+|.+|+.++++++|||||+++|++.+++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            57889999999999999999998889999999976543 34579999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccc
Q 008108          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS  403 (577)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~  403 (577)
                      +|+|.+++..  ....+++..++.|+.||+.||.|||+++   |+||||||+||||++++.+||+|||+++........ 
T Consensus        84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-  157 (263)
T d1sm2a_          84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-  157 (263)
T ss_dssp             TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence            9999998754  3467999999999999999999999987   999999999999999999999999999876543322 


Q ss_pred             cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCCC
Q 008108          404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGG  483 (577)
Q Consensus       404 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  483 (577)
                      ......||+.|||||++.++.++.++|||||||++|||+||+.|+......  ..++........      ...|.   .
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~--~~~~~~i~~~~~------~~~p~---~  226 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDISTGFR------LYKPR---L  226 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH--HHHHHHHHHTCC------CCCCT---T
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH--HHHHHHHHhcCC------CCCcc---c
Confidence            223457899999999999999999999999999999999966555432221  122222111111      11111   1


Q ss_pred             ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          484 STSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       484 ~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .+   .++.+++..||+.||++||||+||++.|++
T Consensus       227 ~~---~~l~~li~~cl~~~p~~Rps~~~il~~L~~  258 (263)
T d1sm2a_         227 AS---THVYQIMNHCWKERPEDRPAFSRLLRQLAE  258 (263)
T ss_dssp             SC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cC---HHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence            22   245578889999999999999999999874

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-53  Score=417.28  Aligned_cols=258  Identities=27%  Similarity=0.450  Sum_probs=199.2

Q ss_pred             hcCCccccccccCCcEEEEEeEecCCcEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      .++|++.++||+|+||+||+|+++  ..||||++...  .......|.+|+.+|++++|||||++++++.+ +..+||||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            467899999999999999999864  46999998754  33445679999999999999999999998754 56899999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |+++|+|.+++..  ....+++..++.|+.||++||.|||+++   |+||||||+||||+.++.+||+|||+|+......
T Consensus        84 y~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             cCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            9999999998854  3456999999999999999999999987   9999999999999999999999999998776544


Q ss_pred             ccccccccccCCCCcChhhhhc---CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccccc
Q 008108          401 THSDTNRVVGTFGYMAPEYVMH---GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD  477 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  477 (577)
                      .........||+.|||||++..   +.|+.++|||||||++|||+||+.||........  +..............    
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--~~~~~~~~~~~p~~~----  232 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIFMVGRGYLSPDLS----  232 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHHHHHHTSCCCCGG----
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH--HHHHHhcCCCCCcch----
Confidence            4444455789999999999864   3589999999999999999999999865433221  111111111111100    


Q ss_pred             CcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          478 PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       478 ~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                       .+....++   .+.+++.+||+.||++||||+||++.|+.
T Consensus       233 -~~~~~~~~---~l~~li~~cl~~dp~~RPt~~~il~~Le~  269 (276)
T d1uwha_         233 -KVRSNCPK---AMKRLMAECLKKKRDERPLFPQILASIEL  269 (276)
T ss_dssp             -GSCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -hccccchH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence             11112223   45567789999999999999999999875

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-52  Score=411.32  Aligned_cols=252  Identities=25%  Similarity=0.405  Sum_probs=202.3

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ++|++.++||+|+||+||+|+.. +|+.||||++..... .....+.+|+.+|++++|||||++++++.+++..+|||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            67999999999999999999964 689999999976532 2334689999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++|+|.++|.   .+..+++..+..++.||+.||.|||+++   |+||||||+||||++++.+||+|||+|+....+..
T Consensus        85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            99999999984   4567999999999999999999999998   99999999999999999999999999998765544


Q ss_pred             cccccccccCCCCcChhhhhcCCC-CccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRF-SVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                      .......+||+.|||||++.+..+ +.++|||||||++|||+||+.||.........  ..    .+.......  .+  
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~--~~----~~~~~~~~~--~~--  228 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YS----DWKEKKTYL--NP--  228 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH--HH----HHHTTCTTS--TT--
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH--HH----HHhcCCCCC--Cc--
Confidence            444455789999999999988876 57899999999999999999998654332111  11    010000000  00  


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ....+   ..+.+++.+||+.||++|||++|+++
T Consensus       229 ~~~~s---~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         229 WKKID---SAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             GGGSC---HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccCC---HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            00112   23456778999999999999998864

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-52  Score=410.86  Aligned_cols=255  Identities=29%  Similarity=0.472  Sum_probs=205.7

Q ss_pred             hcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      .++|++.++||+|+||+||+|.+++++.||||++..... ...+|.+|+.+|++++|||||+++|++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            467889999999999999999998889999999976543 34579999999999999999999998865 5679999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      ++|+|.+++.. .....+++..++.|+.||++||.|||+++   |+||||||+||||++++.+||+|||+|+........
T Consensus        90 ~~g~L~~~~~~-~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          90 ENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             TTCBHHHHTTS-HHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCcHHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc
Confidence            99999887643 23346999999999999999999999987   999999999999999999999999999987644322


Q ss_pred             ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCC
Q 008108          403 SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG  482 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  482 (577)
                       ......||+.|||||++.++.++.++|||||||++|||+||+.|+......  ..++....    .+.     .+....
T Consensus       166 -~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~~~~i~----~~~-----~~~~p~  233 (272)
T d1qpca_         166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQNLE----RGY-----RMVRPD  233 (272)
T ss_dssp             -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHH----TTC-----CCCCCT
T ss_pred             -cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHHHHHHH----hcC-----CCCCcc
Confidence             233467999999999999999999999999999999999987765433221  12222111    111     111111


Q ss_pred             CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          483 GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       483 ~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ..+.   .+.+++.+||+.||++||||+||+++|+.
T Consensus       234 ~~~~---~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         234 NCPE---ELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             TCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cChH---HHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence            2233   35567789999999999999999998863

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-52  Score=417.19  Aligned_cols=260  Identities=27%  Similarity=0.427  Sum_probs=211.0

Q ss_pred             HHHHhcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          239 IRVATDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       239 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      ++...++|++.++||+|+||+||+|.+. +|+.||||+++.+.. ...+|.+|+.+|++++|||||++++++.+++..++
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence            3344578999999999999999999975 588999999976543 34579999999999999999999999999999999


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      ||||+++|+|.+++.. .....+++..++.|+.||++||.|||+++   |+||||||+||||++++.+||+|||+|+...
T Consensus        91 v~E~~~~g~l~~~l~~-~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_          91 ITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT  166 (287)
T ss_dssp             EEECCTTCBHHHHHHH-SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred             EeecccCcchHHHhhh-ccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecC
Confidence            9999999999998854 23467999999999999999999999987   9999999999999999999999999999765


Q ss_pred             CCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccccc
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD  477 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  477 (577)
                      .+... ......||+.|||||++.++.++.++|||||||++|||++|+.|+.......  .+.....    .+..     
T Consensus       167 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~--~~~~~i~----~~~~-----  234 (287)
T d1opja_         167 GDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLE----KDYR-----  234 (287)
T ss_dssp             SSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHH----TTCC-----
T ss_pred             CCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH--HHHHHHh----cCCC-----
Confidence            43322 2333568999999999999999999999999999999999887765333211  1111111    1110     


Q ss_pred             CcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          478 PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       478 ~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      +......+.   .+.+++..||+.||++||||.||++.|+.
T Consensus       235 ~~~~~~~~~---~l~~li~~cl~~dP~~Rps~~ei~~~L~~  272 (287)
T d1opja_         235 MERPEGCPE---KVYELMRACWQWNPSDRPSFAEIHQAFET  272 (287)
T ss_dssp             CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCccchH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            111112223   45578889999999999999999998864

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-51  Score=408.72  Aligned_cols=249  Identities=25%  Similarity=0.400  Sum_probs=204.8

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      ++|+..++||+|+||+||+|.. .+|+.||||++..........+.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            4799999999999999999995 469999999998765555667899999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      ++|+|.+++.    +..+++.++..++.||+.||.|||+++   |+||||||+||||+.++++||+|||+|+.+..... 
T Consensus       100 ~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-  171 (293)
T d1yhwa1         100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (293)
T ss_dssp             TTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence            9999998763    346999999999999999999999998   99999999999999999999999999997654332 


Q ss_pred             ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCC
Q 008108          403 SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG  482 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  482 (577)
                       ......||+.|||||++.++.++.++|||||||++|||+||+.||.......   .+......   +. ...   ....
T Consensus       172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~~~~~---~~-~~~---~~~~  240 (293)
T d1yhwa1         172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---ALYLIATN---GT-PEL---QNPE  240 (293)
T ss_dssp             -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHH---CS-CCC---SSGG
T ss_pred             -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH---HHHHHHhC---CC-CCC---CCcc
Confidence             2334689999999999999999999999999999999999999986433222   11111111   00 000   0000


Q ss_pred             CChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          483 GSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       483 ~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ..+   ..+.+++.+||+.||++|||+.|+++
T Consensus       241 ~~s---~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         241 KLS---AIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             GSC---HHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cCC---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            112   24556778999999999999999864

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-51  Score=400.36  Aligned_cols=252  Identities=28%  Similarity=0.460  Sum_probs=210.0

Q ss_pred             cCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecC
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVP  323 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  323 (577)
                      ++|+..++||+|+||+||+|++++++.||||++++... ...+|.+|+.++++++||||++++|++.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            68999999999999999999998888999999987544 34579999999999999999999999999999999999999


Q ss_pred             CCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCccc
Q 008108          324 NASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTHS  403 (577)
Q Consensus       324 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~  403 (577)
                      +|+|..++..  ....+++..+++++.||++||.|||+.+   |+||||||+||||++++.+||+|||+++........ 
T Consensus        83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-  156 (258)
T d1k2pa_          83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-  156 (258)
T ss_dssp             TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred             CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence            9999888643  4567999999999999999999999987   999999999999999999999999999876544332 


Q ss_pred             cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCC
Q 008108          404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG  482 (577)
Q Consensus       404 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  482 (577)
                      ......||+.|+|||.+..+.++.++||||||+++|||+| |+.||......+....+.   .    +.  ....|.   
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~---~----~~--~~~~p~---  224 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA---Q----GL--RLYRPH---  224 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH---T----TC--CCCCCT---
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH---h----CC--CCCCcc---
Confidence            3334679999999999999999999999999999999998 788886554433222221   1    11  011111   


Q ss_pred             CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          483 GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       483 ~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                      ..+.   .+.+++..||+.||++|||++|+++.|.
T Consensus       225 ~~~~---~l~~li~~cl~~dP~~RPt~~eil~~L~  256 (258)
T d1k2pa_         225 LASE---KVYTIMYSCWHEKADERPTFKILLSNIL  256 (258)
T ss_dssp             TCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             cccH---HHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence            1222   4557788999999999999999999884

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-51  Score=404.14  Aligned_cols=245  Identities=27%  Similarity=0.384  Sum_probs=203.4

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|++.+.||+|+||+||+|... +++.||+|++.+..   ......+.+|+.++++++|||||++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999964 68999999987532   233456889999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++|+|.+++.   ....+++..+..++.||++||.|||+++   |+||||||+||||+.++.+||+|||+|+.....
T Consensus        86 Ey~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            9999999999884   3567999999999999999999999998   999999999999999999999999999865532


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                      .    .....||+.|||||++.+..++.++|||||||++|||++|+.||......+.   +....    ...      +.
T Consensus       160 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~~i~----~~~------~~  222 (263)
T d2j4za1         160 R----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---YKRIS----RVE------FT  222 (263)
T ss_dssp             C----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHH----TTC------CC
T ss_pred             c----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH---HHHHH----cCC------CC
Confidence            2    2346799999999999999999999999999999999999999865443322   21111    110      11


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      +....++   .+.+++..||+.||++|||+.|+++
T Consensus       223 ~p~~~s~---~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         223 FPDFVTE---GARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCccCCH---HHHHHHHHHccCCHhHCcCHHHHHc
Confidence            1111223   3446777999999999999999975

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.2e-51  Score=411.78  Aligned_cols=255  Identities=27%  Similarity=0.463  Sum_probs=194.1

Q ss_pred             cCCccccccccCCcEEEEEeEec-CC---cEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NG---ETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      ++|++.++||+|+||+||+|.+. ++   ..||||++.... .....+|.+|+.+|++++|||||+++|++.+.+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            45777899999999999999964 23   258999987653 34455799999999999999999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+++|+|++++..  ....++|.+++.|+.||++||.|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus       106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence            999999999998753  3457999999999999999999999987   99999999999999999999999999997764


Q ss_pred             CCcccc---ccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccc
Q 008108          399 DQTHSD---TNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALN  474 (577)
Q Consensus       399 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  474 (577)
                      ......   .....||+.|||||.+.++.++.++|||||||++|||+| |+.||......+   ++........      
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~~~~i~~~~~------  251 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---VINAIEQDYR------  251 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTTCC------
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCC------
Confidence            433221   223467999999999999999999999999999999998 888886544332   2222111110      


Q ss_pred             cccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          475 LMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       475 ~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                         +......+.   .+.+++.+||+.||++||||.||++.|+.
T Consensus       252 ---~~~~~~~~~---~l~~li~~cl~~~P~~RPs~~ei~~~L~~  289 (299)
T d1jpaa_         252 ---LPPPMDCPS---ALHQLMLDCWQKDRNHRPKFGQIVNTLDK  289 (299)
T ss_dssp             ---CCCCTTCCH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ---CCCCccchH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence               001111223   45577889999999999999999999864

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=405.91  Aligned_cols=254  Identities=26%  Similarity=0.366  Sum_probs=192.4

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEc--CCeEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLE--RKERILV  318 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  318 (577)
                      ++|++.+.||+|+||+||+|.. .+|+.||||.+....  ......+.+|+.+|++++|||||++++++.+  ....++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            6899999999999999999996 468999999997653  3334568899999999999999999999875  4567999


Q ss_pred             EEecCCCCcccccccCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCC--CcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          319 YEFVPNASLDHFIFDPI-NREHMTWEKRYKIIEGIARGLLYLHEDSR--LRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~yLH~~~~--~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      |||+++|+|.+++.... .+..+++..++.++.||+.||.|||+++.  .+|+||||||+||||+.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            99999999999885422 34579999999999999999999998642  3599999999999999999999999999998


Q ss_pred             ccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccc
Q 008108          396 FEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNL  475 (577)
Q Consensus       396 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  475 (577)
                      +..+..  ......||+.|||||++.+..++.++|||||||++|||+||+.||......+   +....    ..+...  
T Consensus       164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~~~i----~~~~~~--  232 (269)
T d2java1         164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGKI----REGKFR--  232 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHH----HHTCCC--
T ss_pred             cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HHHHH----HcCCCC--
Confidence            754322  2334689999999999999999999999999999999999999986543322   22111    111111  


Q ss_pred             ccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       476 ~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                         .+....++   .+.+++.+||+.||++|||+.|+++
T Consensus       233 ---~~~~~~s~---~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         233 ---RIPYRYSD---ELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ---CCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCCcccCH---HHHHHHHHHcCCChhHCcCHHHHHh
Confidence               11112233   3456777999999999999999874

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-51  Score=404.94  Aligned_cols=258  Identities=26%  Similarity=0.425  Sum_probs=202.8

Q ss_pred             hcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      .++|++.++||+|+||+||+|.+++++.||||++.... .....|.+|+.+|++++|||||+++|++.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            36799999999999999999999888899999997554 345679999999999999999999999854 5689999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      ++|+|..++.. .....++|.+++.++.||+.||.|||+++   |+||||||+||||+.++++||+|||+++....... 
T Consensus        94 ~~g~l~~~~~~-~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-  168 (285)
T d1fmka3          94 SKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  168 (285)
T ss_dssp             TTCBHHHHHSH-HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCCchhhhhhh-cccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence            99999888754 23456999999999999999999999998   99999999999999999999999999987654332 


Q ss_pred             ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCC
Q 008108          403 SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG  482 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  482 (577)
                      .......||+.|+|||++..+.++.++||||||+++|||+||+.|+......  ..++.......         .+....
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i~~~~---------~~~~~~  237 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERGY---------RMPCPP  237 (285)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTC---------CCCCCT
T ss_pred             eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHhcC---------CCCCCc
Confidence            2233467999999999999999999999999999999999987776543322  22222211111         111111


Q ss_pred             CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCCCC
Q 008108          483 GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGDTV  521 (577)
Q Consensus       483 ~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~~~  521 (577)
                      ..++   ++.+++.+||+.||++||+|++|+++|+.-..
T Consensus       238 ~~~~---~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         238 ECPE---SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             TSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             ccCH---HHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence            2223   45577889999999999999999999987443

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=402.29  Aligned_cols=254  Identities=27%  Similarity=0.460  Sum_probs=204.3

Q ss_pred             cCCcccc-ccccCCcEEEEEeEec---CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          244 DNFSDAN-KLGQGGFGAVYKGMLS---NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       244 ~~f~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      ++|...+ +||+|+||+||+|.+.   ++..||||+++... .....+|.+|+.+|++++|||||+++|++.+ +..+||
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            4566666 4999999999999853   35579999997654 3345679999999999999999999999865 468999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+++|+|.+++..  .+..+++..++.++.||++||.|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus        87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence            999999999998743  3467999999999999999999999987   99999999999999999999999999997765


Q ss_pred             CCcc-ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          399 DQTH-SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       399 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      .... .......||+.|||||++..+.++.++|||||||++|||+| |+.||......+....+.       .+...   
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-------~~~~~---  231 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-------QGKRM---  231 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-------TTCCC---
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCCC---
Confidence            4322 22334578999999999999999999999999999999998 899987544332222211       11111   


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                        ......+.   .+.+++..||+.||++||||.+|++.|+.
T Consensus       232 --~~p~~~~~---~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         232 --ECPPECPP---ELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             --CCCTTCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCCCcCCH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence              11112233   44577789999999999999999999874

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-51  Score=405.24  Aligned_cols=251  Identities=25%  Similarity=0.372  Sum_probs=202.9

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      +.|++.++||+|+||+||+|... +|+.||||++..........+.+|+.+|++++|||||++++++.+++..+|||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            56899999999999999999964 68999999998766666667899999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      ++|+|.+++.+  ....+++..+..++.||+.||.|||+++   |+||||||+||||+.++++||+|||+|+......  
T Consensus        92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--  164 (288)
T d2jfla1          92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--  164 (288)
T ss_dssp             TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred             CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence            99999988743  2456999999999999999999999998   9999999999999999999999999997654221  


Q ss_pred             ccccccccCCCCcChhhhh-----cCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccccc
Q 008108          403 SDTNRVVGTFGYMAPEYVM-----HGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD  477 (577)
Q Consensus       403 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  477 (577)
                      .......||+.|||||++.     ...|+.++|||||||++|||+||+.||......+.   +.....    +....+..
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~---~~~i~~----~~~~~~~~  237 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV---LLKIAK----SEPPTLAQ  237 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HHHHHH----SCCCCCSS
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH---HHHHHc----CCCCCCCc
Confidence            1223468999999999984     45689999999999999999999999865443221   111111    10000000


Q ss_pred             CcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          478 PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       478 ~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      +   ...+   ..+.+++..||+.||++|||+.|+++
T Consensus       238 ~---~~~s---~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         238 P---SRWS---SNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             G---GGSC---HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             c---ccCC---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0   0112   24556778999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-50  Score=401.08  Aligned_cols=256  Identities=27%  Similarity=0.494  Sum_probs=198.1

Q ss_pred             cCCccccccccCCcEEEEEeEecCC-----cEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSNG-----ETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      +.|+..++||+|+||+||+|.+.++     ..||||++..... ....+|.+|+.++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            5688899999999999999997542     3699999976543 334568999999999999999999999999999999


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      ||||+.+++|.+++..  ....++|.++++++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus        87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999887643  3467999999999999999999999987   9999999999999999999999999999765


Q ss_pred             CCCccc-cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          398 MDQTHS-DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       398 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      ...... ......||+.|||||++.++.++.++|||||||++|||++|+.|+......  ..+.....    .+..    
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~~i~----~~~~----  231 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAIN----DGFR----  231 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHH----TTCC----
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHHHHHh----ccCC----
Confidence            433222 233457899999999999999999999999999999999987776543322  12222111    1110    


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                       +......+   ..+.+++.+||+.||++||||.||+++|+.
T Consensus       232 -~~~~~~~~---~~l~~li~~cl~~~p~~RPt~~eil~~L~~  269 (283)
T d1mqba_         232 -LPTPMDCP---SAIYQLMMQCWQQERARRPKFADIVSILDK  269 (283)
T ss_dssp             -CCCCTTCB---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             -CCCchhhH---HHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence             11111122   345678889999999999999999999864

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=411.20  Aligned_cols=258  Identities=26%  Similarity=0.387  Sum_probs=204.7

Q ss_pred             HhcCCccccccccCCcEEEEEeEecC-C-----cEEEEEEeccCCh-hhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCC
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGMLSN-G-----ETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNLVRLLGFCLERK  313 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  313 (577)
                      ..++|++.++||+|+||+||+|.... +     ..||+|++..... .....+.+|+.+|.++ +|||||++++++.+.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            34689999999999999999998643 2     3699999876433 3344688999999998 8999999999999999


Q ss_pred             eEEEEEEecCCCCcccccccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccC
Q 008108          314 ERILVYEFVPNASLDHFIFDPIN--------------------REHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLK  373 (577)
Q Consensus       314 ~~~lv~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlk  373 (577)
                      ..++||||+++|+|.++|.....                    ...+++..++.++.||++||.|||+++   |+|||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK  191 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  191 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence            99999999999999999864321                    235899999999999999999999987   9999999


Q ss_pred             CCcEEEcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCC
Q 008108          374 ASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGT  452 (577)
Q Consensus       374 p~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~  452 (577)
                      |+|||++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |+.||....
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987665544444445678999999999999999999999999999999998 888886433


Q ss_pred             ccc-cchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhc
Q 008108          453 EEE-TEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLN  517 (577)
Q Consensus       453 ~~~-~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~  517 (577)
                      ... ...++.       .+.     .+......++   .+.+|+..||+.||++||||+||++.|.
T Consensus       272 ~~~~~~~~~~-------~~~-----~~~~p~~~~~---~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         272 VDANFYKLIQ-------NGF-----KMDQPFYATE---EIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CSHHHHHHHH-------TTC-----CCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHHh-------cCC-----CCCCCCcCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            321 111111       110     0111111223   4557788999999999999999999985

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-50  Score=400.64  Aligned_cols=247  Identities=31%  Similarity=0.492  Sum_probs=195.7

Q ss_pred             cccccCCcEEEEEeEecC---CcEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEecCC
Q 008108          250 NKLGQGGFGAVYKGMLSN---GETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFVPN  324 (577)
Q Consensus       250 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  324 (577)
                      ++||+|+||+||+|.+.+   ++.||||+++....  ....+|.+|+.+|++++|||||+++|++.+ +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            579999999999998643   46799999975432  334579999999999999999999999865 467899999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc-c
Q 008108          325 ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH-S  403 (577)
Q Consensus       325 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~-~  403 (577)
                      |+|.+++.   ....+++..++.|+.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus        92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            99999884   3567999999999999999999999987   999999999999999999999999999876544332 2


Q ss_pred             cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcCCC
Q 008108          404 DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTMRG  482 (577)
Q Consensus       404 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  482 (577)
                      ......||+.|||||.+.++.++.++|||||||++|||+| |+.||......+....+.       .+...     ....
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-------~~~~~-----~~p~  233 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERM-----GCPA  233 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTCCC-----CCCT
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-------cCCCC-----CCCc
Confidence            2334679999999999999999999999999999999998 899986544332222221       11111     1111


Q ss_pred             CChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          483 GSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       483 ~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ..+.   .+.+++.+||+.||++||||++|+++|+.
T Consensus       234 ~~~~---~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         234 GCPR---EMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             TCCH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ccCH---HHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            2233   44567789999999999999999998863

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-51  Score=412.05  Aligned_cols=201  Identities=29%  Similarity=0.406  Sum_probs=178.2

Q ss_pred             HhcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          242 ATDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       242 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ..++|++.++||+|+||+||+|.. .+|+.||+|++..... .....+.+|+.+|++++|||||+++++|.+.+..+|||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            457899999999999999999996 4689999999976533 33457899999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-SRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      ||+++|+|.+++.+   ...+++..+..++.||+.||.|||++ +   |+||||||+||||++++++||+|||+|+.+..
T Consensus        84 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          84 EHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             ECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            99999999999843   45799999999999999999999974 6   99999999999999999999999999987643


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCC
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGT  452 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~  452 (577)
                      .    .....+||+.|||||++.+..|+.++|||||||++|||++|+.||....
T Consensus       158 ~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         158 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             H----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred             C----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            2    2234689999999999999999999999999999999999999997544

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-51  Score=404.27  Aligned_cols=248  Identities=23%  Similarity=0.317  Sum_probs=201.1

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++.+..   ......+.+|+.+|++++||||+++++++.+++..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            6799999999999999999996 468999999997542   223456899999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++|+|.+++.   ..+.+++..+..++.||+.||.|||+++   |+||||||+||||++++.+||+|||+|+.+...
T Consensus        88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            9999999988874   3567999999999999999999999998   999999999999999999999999999987654


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                      ..........||+.|||||++.+..++.++|||||||++|||++|+.||........   .....    ...      ..
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~~~i~----~~~------~~  228 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI---FQKII----KLE------YD  228 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH----TTC------CC
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH---HHHHH----cCC------CC
Confidence            444444557899999999999999999999999999999999999999875433222   11111    110      11


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVV  513 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~  513 (577)
                      +......   .+.+++..||+.||++|||++|++
T Consensus       229 ~p~~~s~---~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         229 FPEKFFP---KARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             CCTTCCH---HHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             CCccCCH---HHHHHHHHHccCCHhHCcCHHHHc
Confidence            1112223   345677899999999999999864

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.7e-49  Score=405.89  Aligned_cols=252  Identities=23%  Similarity=0.342  Sum_probs=206.4

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEec
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEFV  322 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  322 (577)
                      ++|++.++||+|+||+||+|.. .+|+.||||++..........+.+|+.+|++++|||||++++++.+++..+|||||+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            6899999999999999999996 468999999998877666677899999999999999999999999999999999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC--CCCeEEeccCCcccccCCC
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS--EMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~--~~~~kl~DfGla~~~~~~~  400 (577)
                      ++|+|.+++.+  ....+++..+..|+.||+.||.|||+++   |+||||||+||||+.  ++.+||+|||+++.+....
T Consensus       106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             CCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            99999988743  3456999999999999999999999998   999999999999964  5789999999998765433


Q ss_pred             ccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                      .   .....||+.|||||++.+..++.++|||||||++|||++|+.||......+.   +.......  ..    +++..
T Consensus       181 ~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~~i~~~~--~~----~~~~~  248 (350)
T d1koaa2         181 S---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET---LRNVKSCD--WN----MDDSA  248 (350)
T ss_dssp             C---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHTC--CC----SCCGG
T ss_pred             c---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH---HHHHHhCC--CC----CCccc
Confidence            2   2236899999999999999999999999999999999999999865433222   21111100  00    00000


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM  515 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~  515 (577)
                      ....++   .+.+++.+||+.||++|||+.|+++.
T Consensus       249 ~~~~s~---~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         249 FSGISE---DGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             GGGCCH---HHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ccCCCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence            011122   44567789999999999999999873

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-50  Score=394.81  Aligned_cols=246  Identities=27%  Similarity=0.401  Sum_probs=193.9

Q ss_pred             ccccccccCCcEEEEEeEec-CCcEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEc----CCeEEEEE
Q 008108          247 SDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE----RKERILVY  319 (577)
Q Consensus       247 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  319 (577)
                      +..++||+|+||+||+|... +++.||+|++...  .......+.+|+++|++++|||||++++++.+    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            56678999999999999964 6889999998654  33344568999999999999999999999865    34679999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEc-CCCCeEEeccCCcccccC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD-SEMNPKISDFGMARLFEM  398 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~-~~~~~kl~DfGla~~~~~  398 (577)
                      ||+++|+|.+++.   +...+++..+..++.||++||.|||+++ ++|+||||||+||||+ +++.+||+|||+|+....
T Consensus        92 E~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHh---ccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            9999999999884   3567999999999999999999999875 4599999999999996 578999999999986443


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      .    ......||+.|||||++. +.++.++|||||||++|||++|+.||......  ..+...    ...+.....++ 
T Consensus       168 ~----~~~~~~GT~~Y~aPE~~~-~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--~~~~~~----i~~~~~~~~~~-  235 (270)
T d1t4ha_         168 S----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRR----VTSGVKPASFD-  235 (270)
T ss_dssp             T----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHH----HTTTCCCGGGG-
T ss_pred             C----ccCCcccCccccCHHHhC-CCCCCcCchhhHHHHHHHHHHCCCCCCCcccH--HHHHHH----HHcCCCCcccC-
Confidence            2    223468999999999876 46999999999999999999999998643321  112211    11111111111 


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                         .....   .+.+++.+||+.||++|||+.|+++
T Consensus       236 ---~~~~~---~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         236 ---KVAIP---EVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             ---GCCCH---HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---ccCCH---HHHHHHHHHccCCHhHCcCHHHHhC
Confidence               11222   3456788999999999999999875

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3e-50  Score=404.45  Aligned_cols=262  Identities=25%  Similarity=0.453  Sum_probs=209.6

Q ss_pred             HHHHhcCCccccccccCCcEEEEEeEec------CCcEEEEEEeccCChh-hHHHHHHHHHHHHhcCCCCeEEEEeEEEc
Q 008108          239 IRVATDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLE  311 (577)
Q Consensus       239 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~  311 (577)
                      ++...++|++.++||+|+||+||+|+..      +++.||||++...... ...+|.+|+.+|++++||||+++++++.+
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            3445678999999999999999999864      3578999999765433 35579999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCcccccccCC---------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEe
Q 008108          312 RKERILVYEFVPNASLDHFIFDPI---------------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHR  370 (577)
Q Consensus       312 ~~~~~lv~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHr  370 (577)
                      ....+++|||+++|+|.+++....                     ....+++..++.|+.||+.||+|||+++   |+||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHr  164 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR  164 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEee
Confidence            999999999999999999885321                     1235899999999999999999999987   9999


Q ss_pred             ccCCCcEEEcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCC-CC
Q 008108          371 DLKASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKR-SS  449 (577)
Q Consensus       371 Dlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p-~~  449 (577)
                      ||||+|||||.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++|..| +.
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            99999999999999999999999876554444444456789999999999999999999999999999999999754 44


Q ss_pred             CCCccccchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          450 FGTEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       450 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .....+   ++..+    ..+....     .....+   ..+.+|+..||+.+|++||||.||+++|++
T Consensus       245 ~~~~~e---~~~~v----~~~~~~~-----~p~~~~---~~~~~li~~cl~~~P~~RPt~~ev~~~L~~  298 (301)
T d1lufa_         245 GMAHEE---VIYYV----RDGNILA-----CPENCP---LELYNLMRLCWSKLPADRPSFCSIHRILQR  298 (301)
T ss_dssp             TSCHHH---HHHHH----HTTCCCC-----CCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCHHH---HHHHH----HcCCCCC-----CCccch---HHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            332222   22211    1111111     111122   245678889999999999999999999975

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.2e-50  Score=402.24  Aligned_cols=251  Identities=22%  Similarity=0.312  Sum_probs=188.3

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChh-hHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQ-GEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      .+.|++.+.||+|+||+||+|... +|+.||||++.+.... ....+.+|+.+|++++|||||++++++.+++..+||||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            366999999999999999999964 6899999999765432 33457899999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEc---CCCCeEEeccCCccccc
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD---SEMNPKISDFGMARLFE  397 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~---~~~~~kl~DfGla~~~~  397 (577)
                      |+++|+|.++|.   ....+++..+..++.||+.||.|||+++   |+||||||+|||+.   +++.+||+|||+++...
T Consensus        88 ~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          88 LVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             ccCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            999999999884   3567999999999999999999999998   99999999999994   57899999999998765


Q ss_pred             CCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccccc
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMD  477 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  477 (577)
                      ....   .....||+.|||||++.+..++.++|||||||++|||++|+.||......+..   .....    +.. . ++
T Consensus       162 ~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~---~~i~~----~~~-~-~~  229 (307)
T d1a06a_         162 PGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF---EQILK----AEY-E-FD  229 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHT----TCC-C-CC
T ss_pred             CCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH---HHHhc----cCC-C-CC
Confidence            4322   23467999999999999999999999999999999999999998654432221   11111    000 0 01


Q ss_pred             CcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          478 PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       478 ~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .......+.   .+.+++..||+.||++|||+.|+++
T Consensus       230 ~~~~~~~s~---~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         230 SPYWDDISD---SAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             TTTTTTSCH---HHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CccccCCCH---HHHHHHHHHccCCHhHCcCHHHHhc
Confidence            111111222   4557778999999999999999987

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.6e-49  Score=403.79  Aligned_cols=257  Identities=24%  Similarity=0.327  Sum_probs=208.3

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      .++|++.++||+|+||+||+|.. .+|+.||||++..........+.+|+.+|++++|||||++++++.+++..+|||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            36799999999999999999996 47999999999877666666789999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEc--CCCCeEEeccCCcccccCC
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD--SEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~--~~~~~kl~DfGla~~~~~~  399 (577)
                      +++|+|.+++..  ....+++.+++.|+.||+.||.|||+++   |+||||||+||||+  .++.+||+|||+|+.+...
T Consensus       108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence            999999877632  3446999999999999999999999998   99999999999998  5789999999999987643


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                      ..   .....||+.|||||++.+..++.++|||||||++|||+||+.||........   +.......  ..    +...
T Consensus       183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~~i~~~~--~~----~~~~  250 (352)
T d1koba_         183 EI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---LQNVKRCD--WE----FDED  250 (352)
T ss_dssp             SC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHHHHCC--CC----CCSS
T ss_pred             Cc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhCC--CC----CCcc
Confidence            32   2236799999999999999999999999999999999999999865433222   21111100  00    0111


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hcCC
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNM--LNGD  519 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~--L~~~  519 (577)
                      .....+.   .+.+++..||+.||++|||+.|+++-  +++.
T Consensus       251 ~~~~~s~---~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         251 AFSSVSP---EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             TTTTSCH---HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             cccCCCH---HHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            1111222   34567789999999999999999873  5443

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-49  Score=393.73  Aligned_cols=251  Identities=25%  Similarity=0.352  Sum_probs=203.4

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCCh------hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK------QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKER  315 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  315 (577)
                      .++|++.++||+|+||+||+|.. .+|+.||||++.+...      .....+.+|+.+|++++|||||++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            36799999999999999999996 4789999999865422      2356789999999999999999999999999999


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC----CeEEeccC
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM----NPKISDFG  391 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~----~~kl~DfG  391 (577)
                      +|||||+++|+|.++|..   .+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++    .+||+|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence            999999999999998843   457999999999999999999999998   99999999999998876    49999999


Q ss_pred             CcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCC
Q 008108          392 MARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGA  471 (577)
Q Consensus       392 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  471 (577)
                      +++.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.   . .. ..
T Consensus       163 ~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~---~-~~-~~  234 (293)
T d1jksa_         163 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS---A-VN-YE  234 (293)
T ss_dssp             TCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---T-TC-CC
T ss_pred             hhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHH---h-cC-CC
Confidence            9987654332   234679999999999999999999999999999999999999987544332211111   0 00 00


Q ss_pred             ccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          472 ALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       472 ~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ......+    ..+   ..+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~----~~s---~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         235 FEDEYFS----NTS---ALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             CCHHHHT----TSC---HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCchhcC----CCC---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000001    111   24457778999999999999999986

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-49  Score=399.06  Aligned_cols=244  Identities=28%  Similarity=0.434  Sum_probs=198.3

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      +.|+.+++||+|+||+||+|.. .+|+.||||++.....   .....+.+|+.+|++++|||||++++++.+++..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            3489999999999999999995 4688999999976543   23346889999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      |||++|+|+.++.   .+..+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+.... 
T Consensus        95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            9999999976653   3567999999999999999999999998   99999999999999999999999999986542 


Q ss_pred             CccccccccccCCCCcChhhhhc---CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMH---GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                           .....||+.|||||++.+   +.|+.++|||||||++|||++|+.||......+   .+.....    +.     
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~---~~~~i~~----~~-----  230 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHIAQ----NE-----  230 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHH----SC-----
T ss_pred             -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHh----CC-----
Confidence                 223679999999999864   468999999999999999999999986433221   1111111    11     


Q ss_pred             cCcCCC-CChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          477 DPTMRG-GSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       477 d~~l~~-~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .+.+.. ..++   .+.+++..||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~s~---~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         231 SPALQSGHWSE---YFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CCCCSCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCCCCH---HHHHHHHHHCcCChhHCcCHHHHHh
Confidence            011111 1223   3456777999999999999999875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-49  Score=398.10  Aligned_cols=254  Identities=27%  Similarity=0.481  Sum_probs=198.5

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCc----EEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGE----TIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      ++|+++++||+|+||+||+|.+. +|+    +||+|++... ......+|.+|+.++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46999999999999999999864 444    5899988654 334566799999999999999999999999875 5678


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      ++||+.+|+|.+++..  ....+++..+++++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus        88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            8999999999887754  4567999999999999999999999987   9999999999999999999999999999876


Q ss_pred             CCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      ............||+.|||||++.++.++.++|||||||++|||+| |+.|+......+....+..       +..    
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~-------~~~----  231 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-------GER----  231 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHH-------TCC----
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-------CCC----
Confidence            6555444455679999999999999999999999999999999999 6777654443332222221       110    


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                       +......+   ..+.+++.+||+.||++|||+.||++.|..
T Consensus       232 -~~~p~~~~---~~~~~li~~cl~~dP~~RPs~~eil~~l~~  269 (317)
T d1xkka_         232 -LPQPPICT---IDVYMIMVKCWMIDADSRPKFRELIIEFSK  269 (317)
T ss_dssp             -CCCCTTBC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CCCCcccC---HHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence             00111122   245578889999999999999999988753

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=392.32  Aligned_cols=267  Identities=27%  Similarity=0.398  Sum_probs=199.5

Q ss_pred             ChHHHHHHhcCCccccccccCCcEEEEEeEec------CCcEEEEEEeccCCh-hhHHHHHHHHHHHHhc-CCCCeEEEE
Q 008108          235 DFETIRVATDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNLVRLL  306 (577)
Q Consensus       235 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~  306 (577)
                      +...++...++|++.++||+|+||+||+|...      +++.||||++..... ....++.+|...+.++ +|+||+.++
T Consensus         4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            34444455678999999999999999999853      346899999976543 3445678888888877 689999999


Q ss_pred             eEEEcC-CeEEEEEEecCCCCcccccccCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEecc
Q 008108          307 GFCLER-KERILVYEFVPNASLDHFIFDPI-------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDL  372 (577)
Q Consensus       307 ~~~~~~-~~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDl  372 (577)
                      +++.+. ...++||||+++|+|.++|....             ....+++..++.++.||++||.|||+++   |+||||
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDl  160 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL  160 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcC
Confidence            988765 46899999999999999985432             1345899999999999999999999988   999999


Q ss_pred             CCCcEEEcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCC-CCCCC
Q 008108          373 KASNILLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQK-RSSFG  451 (577)
Q Consensus       373 kp~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~-p~~~~  451 (577)
                      ||+||||++++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+||.. |+...
T Consensus       161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~  240 (299)
T d1ywna1         161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  240 (299)
T ss_dssp             CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999997765555445556789999999999999999999999999999999999865 44332


Q ss_pred             CccccchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          452 TEEETEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       452 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ....  .+..    ....+...     ......+.   ++.+++.+||+.||++|||+.||++.|+.
T Consensus       241 ~~~~--~~~~----~~~~~~~~-----~~~~~~~~---~l~~li~~cl~~dP~~Rpt~~eil~~L~~  293 (299)
T d1ywna1         241 KIDE--EFCR----RLKEGTRM-----RAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGN  293 (299)
T ss_dssp             CCSH--HHHH----HHHHTCCC-----CCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CHHH--HHHH----HHhcCCCC-----CCCccCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            2211  1111    11111111     11111222   45577889999999999999999999864

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-49  Score=386.66  Aligned_cols=249  Identities=25%  Similarity=0.403  Sum_probs=194.6

Q ss_pred             hcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC-CeEEEEEEe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER-KERILVYEF  321 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~E~  321 (577)
                      .++|+..++||+|+||.||+|.++ |+.||||+++...  ....|.+|+.++++++||||++++|++.+. +..++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            357888999999999999999984 7899999997643  335689999999999999999999998654 568999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +++|+|.++|.. .....++|..+++|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  
T Consensus        83 ~~~g~L~~~l~~-~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--  156 (262)
T d1byga_          83 MAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  156 (262)
T ss_dssp             CTTEEHHHHHHH-HHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             cCCCCHHHHHHh-cCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC--
Confidence            999999999854 22345999999999999999999999987   999999999999999999999999999865432  


Q ss_pred             cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                         .....+|..|+|||++.++.++.++||||||+++|||+| |+.|+......+   ++....    .+..     +.+
T Consensus       157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i~----~~~~-----~~~  221 (262)
T d1byga_         157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVE----KGYK-----MDA  221 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHT----TTCC-----CCC
T ss_pred             ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHH----cCCC-----CCC
Confidence               223468999999999999999999999999999999999 566655433332   222221    1111     111


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ....+.   ++.+++.+||+.||++||||.||+++|+.
T Consensus       222 ~~~~~~---~~~~li~~cl~~dP~~Rps~~~l~~~L~~  256 (262)
T d1byga_         222 PDGCPP---AVYEVMKNCWHLDAAMRPSFLQLREQLEH  256 (262)
T ss_dssp             CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CccCCH---HHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            112223   44567789999999999999999999864

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=385.44  Aligned_cols=254  Identities=22%  Similarity=0.359  Sum_probs=192.9

Q ss_pred             hcCCccccccccCCcEEEEEeEecC----CcEEEEEEeccCCh-hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSN----GETIAVKRLSKNSK-QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERIL  317 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  317 (577)
                      .++|++.+.||+|+||+||+|.+..    +..||||.+..... .....|.+|+.+|++++|||||+++|++. ++..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            4679999999999999999998642    35689999875443 33456899999999999999999999986 467899


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCccccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFE  397 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~  397 (577)
                      ||||+++|+|.+++..  ....+++..++.++.||++||.|||+++   |+||||||+|||+++++.+||+|||+++...
T Consensus        85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence            9999999999887643  3457999999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccccc
Q 008108          398 MDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALNLM  476 (577)
Q Consensus       398 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  476 (577)
                      ..... ......||+.|+|||++..+.++.++|||||||++|||+| |..|+......+.   .....    .+...   
T Consensus       160 ~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~---~~~i~----~~~~~---  228 (273)
T d1mp8a_         160 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIE----NGERL---  228 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHH----TTCCC---
T ss_pred             CCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH---HHHHH----cCCCC---
Confidence            43322 2334678999999999999999999999999999999998 7878765444332   22111    11111   


Q ss_pred             cCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          477 DPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       477 d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                        .+....++   .+.+++..||+.||++|||+.||++.|+.
T Consensus       229 --~~~~~~~~---~~~~li~~cl~~dp~~Rps~~ei~~~L~~  265 (273)
T d1mp8a_         229 --PMPPNCPP---TLYSLMTKCWAYDPSRRPRFTELKAQLST  265 (273)
T ss_dssp             --CCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCCCCCCH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence              11112233   35567789999999999999999998863

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-48  Score=393.98  Aligned_cols=248  Identities=22%  Similarity=0.274  Sum_probs=204.0

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      -++|++++.||+|+||+||+++. .+|+.||||++.+..   ......+.+|+.+|++++||||+++++++.+.+..++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            36899999999999999999996 579999999997642   23345688999999999999999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+++|+|..++.   ....+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+....
T Consensus        84 ~ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          84 MEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eeccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            99999999998884   3567999999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      ..  ......+||+.|||||++.+..|+.++|||||||++|||++|+.||........   ......    +.      .
T Consensus       158 ~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~---~~~i~~----~~------~  222 (337)
T d1o6la_         158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FELILM----EE------I  222 (337)
T ss_dssp             TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH----CC------C
T ss_pred             CC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH---HHHHhc----CC------C
Confidence            22  223347899999999999999999999999999999999999999875543322   211111    10      1


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPG-----MASVVN  514 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt-----~~ev~~  514 (577)
                      .+......   .+.+++..||+.||++||+     +.|+++
T Consensus       223 ~~p~~~s~---~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         223 RFPRTLSP---EAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CCCTTSCH---HHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCccCCH---HHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            11112223   3456778999999999995     677764

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-48  Score=387.99  Aligned_cols=258  Identities=26%  Similarity=0.396  Sum_probs=205.3

Q ss_pred             hcCCccccccccCCcEEEEEeEecC--------CcEEEEEEeccCCh-hhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcC
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLSN--------GETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNLVRLLGFCLER  312 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  312 (577)
                      .++|++.++||+|+||.||+|....        +..||||++.+... ....++.+|+..+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            4688999999999999999998532        34799999977654 3446788999999888 899999999999999


Q ss_pred             CeEEEEEEecCCCCcccccccCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEE
Q 008108          313 KERILVYEFVPNASLDHFIFDPI-------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILL  379 (577)
Q Consensus       313 ~~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl  379 (577)
                      +..++||||+++|+|.++|....             ....+++.+++.++.||+.||+|||+.+   |+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence            99999999999999999985432             1346999999999999999999999998   9999999999999


Q ss_pred             cCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccch
Q 008108          380 DSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETED  458 (577)
Q Consensus       380 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~  458 (577)
                      +.++.+||+|||+++...............||+.|+|||.+.++.|+.++||||||+++|||++ |+.|+.......   
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~---  245 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---  245 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---
Confidence            9999999999999998776655555566789999999999999999999999999999999998 566665433322   


Q ss_pred             hhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          459 LLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       459 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      +..    .+..+...     ......++   .+.+++.+||+.||++|||+.||+++|++
T Consensus       246 ~~~----~i~~~~~~-----~~p~~~~~---~l~~li~~cl~~dP~~Rps~~eil~~L~~  293 (299)
T d1fgka_         246 LFK----LLKEGHRM-----DKPSNCTN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDR  293 (299)
T ss_dssp             HHH----HHHTTCCC-----CCCSSCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHH----HHHcCCCC-----CCCccchH---HHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence            111    11111111     11112223   45678889999999999999999999965

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-48  Score=390.06  Aligned_cols=261  Identities=26%  Similarity=0.446  Sum_probs=210.4

Q ss_pred             HHhcCCccccccccCCcEEEEEeEec------CCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGMLS------NGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK  313 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  313 (577)
                      ...++|+..++||+|+||+||+|.+.      +++.||||++.... ......|.+|+.++++++|||||+++|++..++
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~   96 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   96 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence            33478899999999999999999863      35789999997653 334456899999999999999999999999999


Q ss_pred             eEEEEEEecCCCCcccccccC-------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeE
Q 008108          314 ERILVYEFVPNASLDHFIFDP-------INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPK  386 (577)
Q Consensus       314 ~~~lv~E~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~k  386 (577)
                      ..++||||+++|+|.+++...       .....+++..+.+++.||++||.|||+++   |+||||||+||||++++++|
T Consensus        97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~K  173 (308)
T d1p4oa_          97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK  173 (308)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred             ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEE
Confidence            999999999999999887532       12245799999999999999999999987   99999999999999999999


Q ss_pred             EeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCC-CCCCCCccccchhhhhhhh
Q 008108          387 ISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQK-RSSFGTEEETEDLLTYAWR  465 (577)
Q Consensus       387 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~-p~~~~~~~~~~~l~~~~~~  465 (577)
                      |+|||+++...............||+.|+|||.+.++.++.++||||||+++|||+||+. |+......+   .+.... 
T Consensus       174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~---~~~~i~-  249 (308)
T d1p4oa_         174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---VLRFVM-  249 (308)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---HHHHHH-
T ss_pred             EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH-
Confidence            999999997765555445555679999999999999999999999999999999999965 443322222   222111 


Q ss_pred             hcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCC
Q 008108          466 NWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD  519 (577)
Q Consensus       466 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~  519 (577)
                         .+.....     ....+   ..+.+++.+||+.+|++||||.+|+++|++.
T Consensus       250 ---~~~~~~~-----p~~~~---~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         250 ---EGGLLDK-----PDNCP---DMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             ---TTCCCCC-----CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             ---hCCCCCC-----cccch---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence               1111111     11122   2466788899999999999999999999874

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.1e-47  Score=379.93  Aligned_cols=250  Identities=21%  Similarity=0.311  Sum_probs=200.9

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChh---------hHHHHHHHHHHHHhcC-CCCeEEEEeEEEcC
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ---------GEIEFKNEVLLLARLQ-HRNLVRLLGFCLER  312 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  312 (577)
                      ++|++.+.||+|+||+||+++. .+|+.||||++.+....         ....+.+|+.+|++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6899999999999999999996 47899999998764321         1235789999999997 99999999999999


Q ss_pred             CeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCC
Q 008108          313 KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (577)
Q Consensus       313 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGl  392 (577)
                      +..+|||||+++|+|.++|.   .+..+++..+..++.||++||.|||+++   |+||||||+||||+.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence            99999999999999999984   3567999999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCccccccccccCCCCcChhhhhc------CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhh
Q 008108          393 ARLFEMDQTHSDTNRVVGTFGYMAPEYVMH------GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRN  466 (577)
Q Consensus       393 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~  466 (577)
                      ++.......   .....||+.|+|||++.+      ..++.++||||+||++|||++|+.||...........+.     
T Consensus       157 a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~-----  228 (277)
T d1phka_         157 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM-----  228 (277)
T ss_dssp             CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----
T ss_pred             eeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHH-----
Confidence            997764332   233679999999999864      346889999999999999999999997544322211111     


Q ss_pred             cccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          467 WNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       467 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                        .+.. ....+ .....+   .++.+++.+||+.||++|||+.||++
T Consensus       229 --~~~~-~~~~~-~~~~~s---~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         229 --SGNY-QFGSP-EWDDYS---DTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             --HTCC-CCCTT-TGGGSC---HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             --hCCC-CCCCc-ccccCC---HHHHHHHHHHccCChhHCcCHHHHHc
Confidence              1100 00000 000112   24557788999999999999999864

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-48  Score=390.35  Aligned_cols=269  Identities=24%  Similarity=0.318  Sum_probs=198.3

Q ss_pred             cCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC----eEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK----ERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  319 (577)
                      ++|...++||+|+||+||+|++ +|+.||||++...... ...++.|+..+..++|||||++++++.+.+    .+++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4677789999999999999997 5899999999654322 222344566667789999999999998654    579999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----CCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED-----SRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-----~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      ||+++|+|.++|.    +..++|..++.++.|++.||.|||+.     ...+|+||||||+||||+.++.+||+|||+++
T Consensus        81 Ey~~~g~L~~~l~----~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          81 DYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecccCCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            9999999999984    34699999999999999999999974     12459999999999999999999999999999


Q ss_pred             cccCCCccc--cccccccCCCCcChhhhhcCC------CCccccEEecchhHhHHhhCCCCCCCCCccccc--hhhhh--
Q 008108          395 LFEMDQTHS--DTNRVVGTFGYMAPEYVMHGR------FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE--DLLTY--  462 (577)
Q Consensus       395 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~--~l~~~--  462 (577)
                      .........  ......||+.|||||++....      ++.++|||||||+||||+||..|+.........  .....  
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            776543222  234568999999999987543      577999999999999999998876543322110  00000  


Q ss_pred             hhhhcccCCccccccCcCCCC--ChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          463 AWRNWNEGAALNLMDPTMRGG--STSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       463 ~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ...........+.++|.+...  ..+....+.+++.+||+.||++||||.||+++|+.
T Consensus       237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~  294 (303)
T d1vjya_         237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            000000000111122222211  22344567789999999999999999999999863

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-48  Score=383.52  Aligned_cols=255  Identities=29%  Similarity=0.415  Sum_probs=193.9

Q ss_pred             cCCccccccccCCcEEEEEeEec--CC--cEEEEEEeccC---ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS--NG--ETIAVKRLSKN---SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERI  316 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  316 (577)
                      ++|++.+.||+|+||+||+|...  ++  ..||||++.+.   ......+|.+|+.+|++++|||||+++|++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            67999999999999999999853  22  36899998754   23344578999999999999999999999976 4678


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccc
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~  396 (577)
                      +||||+++|+|.+++..  ....+++..++.++.||++||.|||+++   |+||||||+||||+.++.+||+|||+++..
T Consensus        87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence            99999999999887643  3456999999999999999999999987   999999999999999999999999999987


Q ss_pred             cCCCccc-cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhh-CCCCCCCCCccccchhhhhhhhhcccCCccc
Q 008108          397 EMDQTHS-DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVS-GQKRSSFGTEEETEDLLTYAWRNWNEGAALN  474 (577)
Q Consensus       397 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  474 (577)
                      ....... ......||..|+|||++.+..++.++|||||||++|||+| |+.||......+   .+....   ..+... 
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~~~i~---~~~~~~-  234 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKID---KEGERL-  234 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHH---TSCCCC-
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HHHHHH---hCCCCC-
Confidence            5543322 2334568889999999999999999999999999999998 888886443322   222211   111111 


Q ss_pred             cccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          475 LMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       475 ~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                          ......+.   .+.+++..||+.||++||||.||+++|+.
T Consensus       235 ----~~~~~~~~---~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         235 ----PRPEDCPQ---DIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             ----CCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CCcccccH---HHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence                11112223   35577789999999999999999999864

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-48  Score=387.67  Aligned_cols=260  Identities=25%  Similarity=0.371  Sum_probs=209.8

Q ss_pred             HHhcCCccccccccCCcEEEEEeEe------cCCcEEEEEEeccCCh-hhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcC
Q 008108          241 VATDNFSDANKLGQGGFGAVYKGML------SNGETIAVKRLSKNSK-QGEIEFKNEVLLLARL-QHRNLVRLLGFCLER  312 (577)
Q Consensus       241 ~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  312 (577)
                      ...++|++.++||+|+||.||+|++      .+++.||||+++.... ....+|.+|+.+++++ +|||||++++++.+.
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            3447888999999999999999985      2467899999976543 3445689999999999 699999999999999


Q ss_pred             CeEEEEEEecCCCCcccccccCC---------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcE
Q 008108          313 KERILVYEFVPNASLDHFIFDPI---------------NREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNI  377 (577)
Q Consensus       313 ~~~~lv~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~Ni  377 (577)
                      +..++||||+++|+|.+++....               ....+++..++.++.||++||.|||+++   |+||||||+||
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NI  176 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI  176 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccc
Confidence            99999999999999999886432               2346999999999999999999999998   99999999999


Q ss_pred             EEcCCCCeEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCcc-c-
Q 008108          378 LLDSEMNPKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEE-E-  455 (577)
Q Consensus       378 Ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~-~-  455 (577)
                      |++.++.+||+|||+++...............||+.|+|||++..+.++.++||||||+++|||+|++.|+...... + 
T Consensus       177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~  256 (311)
T d1t46a_         177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (311)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999999876655555555678999999999999999999999999999999999966555432221 1 


Q ss_pred             cchhhhhhhhhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          456 TEDLLTYAWRNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       456 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ...++..       +.     .+......+   ..+.+|+.+||+.||++||||.||+++|++
T Consensus       257 ~~~~i~~-------~~-----~~~~~~~~~---~~l~~Li~~cl~~dP~~RPs~~~il~~L~~  304 (311)
T d1t46a_         257 FYKMIKE-------GF-----RMLSPEHAP---AEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (311)
T ss_dssp             HHHHHHH-------TC-----CCCCCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHhc-------CC-----CCCCccccc---HHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            1112211       10     011111122   345678889999999999999999999975

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.6e-48  Score=388.54  Aligned_cols=244  Identities=25%  Similarity=0.345  Sum_probs=201.5

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|++.++||+|+||+||+|.. .+|+.||||++.+..   ......+.+|+.+|++++|||||++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5799999999999999999996 468999999997542   233456889999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+++|+|..++.   ....+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+.....
T Consensus        84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            9999999988874   4567899999999999999999999998   999999999999999999999999999876432


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                           .....||+.|||||++.+..++.++|||||||++|||+||+.||......+....+   ..    +.      ..
T Consensus       158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i---~~----~~------~~  219 (316)
T d1fota_         158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI---LN----AE------LR  219 (316)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---HH----CC------CC
T ss_pred             -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHH---Hc----CC------CC
Confidence                 23468999999999999999999999999999999999999998754432221111   10    00      01


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRP-----GMASVVN  514 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RP-----t~~ev~~  514 (577)
                      +....+.   .+.+++.+|++.||++||     |++|+++
T Consensus       220 ~p~~~s~---~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         220 FPPFFNE---DVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             CCTTSCH---HHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCCH---HHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            1111223   345677799999999996     8998875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1e-47  Score=381.45  Aligned_cols=257  Identities=23%  Similarity=0.334  Sum_probs=196.8

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCCh---hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC----e
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK---QGEIEFKNEVLLLARLQHRNLVRLLGFCLERK----E  314 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~  314 (577)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++++...   .....+.+|+.+++.++|||||++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46799999999999999999995 5799999999976533   33446899999999999999999999987654    3


Q ss_pred             EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      .+|||||+++++|.+++.   ..+.+++.+++.++.||+.||.|||+++   |+||||||+||||+.++..+|+|||++.
T Consensus        86 ~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence            789999999999988874   3567999999999999999999999998   9999999999999999999999999987


Q ss_pred             cccCCCc-cccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcc
Q 008108          395 LFEMDQT-HSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAAL  473 (577)
Q Consensus       395 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  473 (577)
                      ....... ........||+.|||||++.+..++.++|||||||++|||+||+.||......+   ++.   .........
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~---~~~~~~~~~  233 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS---VAY---QHVREDPIP  233 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH---HHHHCCCCC
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH---HHH---HHHhcCCCC
Confidence            6543322 223344689999999999999999999999999999999999999986443221   111   111111110


Q ss_pred             ccccCcCCCCChHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHhc
Q 008108          474 NLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRP-GMASVVNMLN  517 (577)
Q Consensus       474 ~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RP-t~~ev~~~L~  517 (577)
                         ........+.   .+.+++.+|++.||++|| |++++++.|.
T Consensus       234 ---~~~~~~~~s~---~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         234 ---PSARHEGLSA---DLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             ---GGGTSSSCCH---HHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             ---CchhccCCCH---HHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence               0011111223   445677799999999999 8999988774

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-47  Score=383.96  Aligned_cols=252  Identities=27%  Similarity=0.458  Sum_probs=199.5

Q ss_pred             ccccccCCcEEEEEeEecCC----cEEEEEEeccC-ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEc-CCeEEEEEEec
Q 008108          249 ANKLGQGGFGAVYKGMLSNG----ETIAVKRLSKN-SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE-RKERILVYEFV  322 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~E~~  322 (577)
                      .++||+|+||+||+|.+.++    ..||||++++. ......+|.+|+++|++++||||++++|++.+ +...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999996432    25899999754 44455679999999999999999999999875 45889999999


Q ss_pred             CCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCcc
Q 008108          323 PNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQTH  402 (577)
Q Consensus       323 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~~  402 (577)
                      ++|+|.+++..  ....+++..++.++.|+++||.|||+.+   |+||||||+||||++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999998754  4556889999999999999999999987   999999999999999999999999999976544332


Q ss_pred             c--cccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCcC
Q 008108          403 S--DTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPTM  480 (577)
Q Consensus       403 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  480 (577)
                      .  ......||+.|+|||.+..+.++.++||||||+++|||+||+.|+.....  ..++......    +..  ...|  
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~i~~----g~~--~~~p--  256 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYLLQ----GRR--LLQP--  256 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHT----TCC--CCCC--
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHHHHc----CCC--CCCc--
Confidence            2  22345789999999999999999999999999999999998888754332  1122222211    111  1111  


Q ss_pred             CCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcCC
Q 008108          481 RGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNGD  519 (577)
Q Consensus       481 ~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~~  519 (577)
                       ...++   .+.+++.+||+.||++||+|.||++.|++.
T Consensus       257 -~~~~~---~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         257 -EYCPD---PLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             -TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -ccCcH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             11223   455778899999999999999999999753

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=386.87  Aligned_cols=254  Identities=29%  Similarity=0.419  Sum_probs=200.1

Q ss_pred             cCCccccccccCCcEEEEEeEecC-Cc--EEEEEEeccC-ChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEcCCeEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSN-GE--TIAVKRLSKN-SKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  318 (577)
                      ++|++.++||+|+||+||+|.+.+ |.  .||||++... ......+|.+|+.+|.++ +|||||+++|++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            688899999999999999999753 44  4788888654 333445789999999999 799999999999999999999


Q ss_pred             EEecCCCCcccccccC-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCe
Q 008108          319 YEFVPNASLDHFIFDP-------------INREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNP  385 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~  385 (577)
                      |||+++|+|.++|...             .....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999998643             23467999999999999999999999987   9999999999999999999


Q ss_pred             EEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCC-CCCCCccccchhhhhhh
Q 008108          386 KISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKR-SSFGTEEETEDLLTYAW  464 (577)
Q Consensus       386 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p-~~~~~~~~~~~l~~~~~  464 (577)
                      ||+|||+++......   ......||..|+|||.+.++.++.++|||||||++|||++|..| +......+   +...+.
T Consensus       167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~~~i~  240 (309)
T d1fvra_         167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKLP  240 (309)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHGG
T ss_pred             EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---HHHHHH
Confidence            999999998654322   22335689999999999999999999999999999999998764 44332222   222221


Q ss_pred             hhcccCCccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          465 RNWNEGAALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       465 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      .    +.     .+......++   .+.+++.+||+.||++||||+||++.|++
T Consensus       241 ~----~~-----~~~~~~~~~~---~~~~li~~cl~~dP~~RPs~~eil~~L~~  282 (309)
T d1fvra_         241 Q----GY-----RLEKPLNCDD---EVYDLMRQCWREKPYERPSFAQILVSLNR  282 (309)
T ss_dssp             G----TC-----CCCCCTTBCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             h----cC-----CCCCCccCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            1    11     0111111223   45567789999999999999999998875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-47  Score=383.21  Aligned_cols=259  Identities=22%  Similarity=0.288  Sum_probs=194.1

Q ss_pred             cccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhh-----HHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          248 DANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQG-----EIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       248 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      .+++||+|+||+||+|.. .+|+.||||++.......     ...+.+|+.+|++++|||||++++++.+++..+|||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            467899999999999996 468999999987543221     23578999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      ++++++..++   ..+..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            9998877665   34567999999999999999999999998   99999999999999999999999999987654322


Q ss_pred             cccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhh-----hhcccCCcc-c
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAW-----RNWNEGAAL-N  474 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~-----~~~~~~~~~-~  474 (577)
                        ......||+.|+|||++..+ .++.++|||||||++|||+||+.||......+....+....     ..|...... .
T Consensus       156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ua2a_         156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD  233 (299)
T ss_dssp             --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             --cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence              22346799999999998755 57999999999999999999998886544332211111100     001000000 0


Q ss_pred             cc-cCcCCCCCh-----HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          475 LM-DPTMRGGST-----SEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       475 ~~-d~~l~~~~~-----~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .. -........     .....+.+++..|++.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            00 000000011     11234667888999999999999999986

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-47  Score=385.65  Aligned_cols=251  Identities=20%  Similarity=0.281  Sum_probs=203.0

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      .++|++.+.||+|+||+||+|... +|+.||||.+...... ...+.+|+.+|+.++|||||++++++.+++..+|||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            468999999999999999999964 6889999999776543 34688999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCC--CCeEEeccCCcccccCC
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE--MNPKISDFGMARLFEMD  399 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~--~~~kl~DfGla~~~~~~  399 (577)
                      +++|+|.++|..  ....+++.++..|+.||+.||.|||+++   |+||||||+|||++.+  ..+||+|||+++.....
T Consensus        83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            999999998843  2346999999999999999999999998   9999999999999854  47999999999876543


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                      ..   .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+.   +......  .........+ 
T Consensus       158 ~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~---~~~i~~~--~~~~~~~~~~-  228 (321)
T d1tkia_         158 DN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI---IENIMNA--EYTFDEEAFK-  228 (321)
T ss_dssp             CE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHHT--CCCCCHHHHT-
T ss_pred             Cc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhC--CCCCChhhcc-
Confidence            32   2235789999999999999999999999999999999999999875443322   1111110  0000000001 


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                         ..+   ..+.+++..|++.||++|||+.|+++
T Consensus       229 ---~~s---~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         229 ---EIS---IEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ---TSC---HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---CCC---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence               111   23557788999999999999999987

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5.5e-47  Score=389.56  Aligned_cols=248  Identities=25%  Similarity=0.347  Sum_probs=197.2

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHH---HHHHHHhcCCCCeEEEEeEEEcCCeEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKN---EVLLLARLQHRNLVRLLGFCLERKERI  316 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~  316 (577)
                      ++|++.++||+|+||+||+|... +|+.||||++.+..   ......+.+   |+.+++.++|||||++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            68999999999999999999964 69999999986532   122223344   466677778999999999999999999


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccc
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~  396 (577)
                      +||||+++|+|.++|.   +...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+.+
T Consensus        84 ivmE~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHH---hcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            9999999999999884   3567899999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCccccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcccc
Q 008108          397 EMDQTHSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNL  475 (577)
Q Consensus       397 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  475 (577)
                      ....    .....||+.|||||++..+ .++.++|||||||++|||+||+.||......+...+.....   ..      
T Consensus       158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~---~~------  224 (364)
T d1omwa3         158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---TM------  224 (364)
T ss_dssp             SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS---SC------
T ss_pred             CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---cC------
Confidence            5432    2346799999999999754 68999999999999999999999997554433322222111   00      


Q ss_pred             ccCcCCCCChHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 008108          476 MDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPG-----MASVVN  514 (577)
Q Consensus       476 ~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt-----~~ev~~  514 (577)
                       .+.+....+.   .+.+++..||+.||++|||     ++|+++
T Consensus       225 -~~~~~~~~s~---~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         225 -AVELPDSFSP---ELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             -CCCCCSSSCH---HHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             -CCCCCCCCCH---HHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence             0111111223   3456777999999999999     577764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.9e-47  Score=388.55  Aligned_cols=244  Identities=23%  Similarity=0.273  Sum_probs=201.6

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC---hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS---KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  319 (577)
                      ++|+++++||+|+||+||+|.. .+|+.||||++.+..   ......+.+|+.+|+.++|||||++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            6899999999999999999996 479999999986532   223346889999999999999999999999999999999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMD  399 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~  399 (577)
                      ||+.+|+|..++.   ..+.+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+.....
T Consensus       121 e~~~~g~l~~~l~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            9999999998884   3457999999999999999999999998   999999999999999999999999999876532


Q ss_pred             CccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccCc
Q 008108          400 QTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDPT  479 (577)
Q Consensus       400 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  479 (577)
                           .....||+.|||||++.+..++.++|||||||++|||+||+.||.......   ++......    .      +.
T Consensus       195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i~~~----~------~~  256 (350)
T d1rdqe_         195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IYEKIVSG----K------VR  256 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHC----C------CC
T ss_pred             -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH---HHHHHhcC----C------CC
Confidence                 234689999999999999999999999999999999999999986543222   22211111    0      01


Q ss_pred             CCCCChHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 008108          480 MRGGSTSEMMKCIHIGLLCVQENVSNRP-----GMASVVN  514 (577)
Q Consensus       480 l~~~~~~~~~~~~~l~~~C~~~~p~~RP-----t~~ev~~  514 (577)
                      .......   .+.+++..||+.||++|+     |++|+++
T Consensus       257 ~p~~~s~---~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         257 FPSHFSS---DLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCTTCCH---HHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCccCCH---HHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            1111223   345677799999999994     8999875

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-47  Score=385.61  Aligned_cols=247  Identities=26%  Similarity=0.359  Sum_probs=200.2

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC---hhhHHHHHHHHHHHH-hcCCCCeEEEEeEEEcCCeEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS---KQGEIEFKNEVLLLA-RLQHRNLVRLLGFCLERKERILV  318 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv  318 (577)
                      ++|++.++||+|+||+||+|+.. +|+.||||++.+..   ......+..|..++. .++|||||++++++.+++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            67999999999999999999964 68999999997542   223345566777665 68999999999999999999999


Q ss_pred             EEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccC
Q 008108          319 YEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEM  398 (577)
Q Consensus       319 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~  398 (577)
                      |||+++|+|.+++.   ....+++.++..++.||+.||.|||+++   |+||||||+|||+++++++||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            99999999999984   3567999999999999999999999998   99999999999999999999999999986554


Q ss_pred             CCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCccccccC
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAALNLMDP  478 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  478 (577)
                      ...  ......||+.|+|||++.++.++.++|||||||++|||+||+.||...........+.       .+      .+
T Consensus       156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~-------~~------~~  220 (320)
T d1xjda_         156 GDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR-------MD------NP  220 (320)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HC------CC
T ss_pred             ccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH-------cC------CC
Confidence            322  2334689999999999999999999999999999999999999997544332221111       11      11


Q ss_pred             cCCCCChHHHHHHHHHHHhcccCCCCCCCCHH-HHHH
Q 008108          479 TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMA-SVVN  514 (577)
Q Consensus       479 ~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~-ev~~  514 (577)
                      .+....+.   .+.+++.+||+.||++|||+. |+++
T Consensus       221 ~~p~~~s~---~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         221 FYPRWLEK---EAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CCCTTSCH---HHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CCCccCCH---HHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            11112223   345677799999999999995 6753

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-46  Score=375.45  Aligned_cols=264  Identities=23%  Similarity=0.340  Sum_probs=197.7

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      ++|+++++||+|+||+||+|+. .+|+.||||++.....  .....+.+|+.+|++++|||||++++++.+.+..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            6899999999999999999996 5799999999965432  234568899999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      |+.++.+.... . .....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+......
T Consensus        82 ~~~~~~~~~~~-~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKKFMD-A-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHHHHH-H-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchhhhhh-h-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            99775554332 2 24567999999999999999999999998   9999999999999999999999999998765332


Q ss_pred             ccccccccccCCCCcChhhhhcCC-CCccccEEecchhHhHHhhCCCCCCCCCccccch-hhhh-------hhhhcccCC
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETED-LLTY-------AWRNWNEGA  471 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~-l~~~-------~~~~~~~~~  471 (577)
                        .......||+.|+|||.+.... ++.++|||||||++|||++|+.||......+... ....       .|.......
T Consensus       157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence              2233467999999999887765 5789999999999999999999987544322111 1100       000000000


Q ss_pred             ccccccCcCCCCCh-----HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          472 ALNLMDPTMRGGST-----SEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       472 ~~~~~d~~l~~~~~-----~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .....-+.......     .....+.+++.+|++.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            00000000000000     11134567888999999999999999986

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=383.17  Aligned_cols=251  Identities=22%  Similarity=0.258  Sum_probs=194.8

Q ss_pred             hcCCcccc-ccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhc-CCCCeEEEEeEEEc----CCeE
Q 008108          243 TDNFSDAN-KLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARL-QHRNLVRLLGFCLE----RKER  315 (577)
Q Consensus       243 ~~~f~~~~-~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~  315 (577)
                      .++|.+.. .||+|+||+||+|.. .+++.||||++...     ..+.+|+.++.++ +|||||++++++.+    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            36788875 599999999999995 57899999998643     2467899887655 89999999999875    4568


Q ss_pred             EEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC---CCCeEEeccCC
Q 008108          316 ILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS---EMNPKISDFGM  392 (577)
Q Consensus       316 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~---~~~~kl~DfGl  392 (577)
                      ++|||||+||+|.++|.+ .....+++.++..|+.||+.||.|||+++   |+||||||+|||++.   ++.+||+|||+
T Consensus        85 ~ivmEy~~gg~L~~~i~~-~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEECCCSEEHHHHHHS-CSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEECCCCCcHHHHHHh-cCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence            999999999999999854 22357999999999999999999999998   999999999999986   45799999999


Q ss_pred             cccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCc
Q 008108          393 ARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAA  472 (577)
Q Consensus       393 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  472 (577)
                      |+.......   .....||+.|||||++.+..|+.++|||||||++|||+||+.||...........+   ......+. 
T Consensus       161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---~~~i~~~~-  233 (335)
T d2ozaa1         161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMGQ-  233 (335)
T ss_dssp             CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS-
T ss_pred             eeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---HHHHhcCC-
Confidence            987654332   23468999999999999999999999999999999999999998644332211111   00000000 


Q ss_pred             cccccCcCCCCC-hHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          473 LNLMDPTMRGGS-TSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       473 ~~~~d~~l~~~~-~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                           ..+.... ..-...+.+++..|++.||++|||+.|+++
T Consensus       234 -----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         234 -----YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -----SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -----CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                 0010000 111234667888999999999999999987

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=9.5e-46  Score=368.98  Aligned_cols=263  Identities=24%  Similarity=0.373  Sum_probs=199.0

Q ss_pred             cCCccccccccCCcEEEEEeEecCCcEEEEEEeccCCh--hhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEEe
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSK--QGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYEF  321 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  321 (577)
                      ++|+.+++||+|+||+||+|..++|+.||||++.....  .....+.+|+.+|++++|||||++++++.+.+..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            68999999999999999999998999999999976532  2245789999999999999999999999999999999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCCc
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQT  401 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~~  401 (577)
                      +.++.+..+.   ...+.+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++........
T Consensus        82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            9888777665   34577999999999999999999999987   99999999999999999999999999987654322


Q ss_pred             cccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhh-----hhcccCCcccc
Q 008108          402 HSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAW-----RNWNEGAALNL  475 (577)
Q Consensus       402 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~-----~~~~~~~~~~~  475 (577)
                        ......|++.|+|||.+... .++.++|||||||++|||++|+.||......+....+....     ..|........
T Consensus       156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence              22335789999999998765 56899999999999999999999986544322111110000     00000000000


Q ss_pred             ccCcCC---CC-----ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          476 MDPTMR---GG-----STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       476 ~d~~l~---~~-----~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .+....   ..     ...-...+.+++.+|++.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000000   00     0011134567788999999999999999873

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-45  Score=370.49  Aligned_cols=261  Identities=25%  Similarity=0.390  Sum_probs=194.3

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cC-CcEEEEEEeccCCh--hhHHHHHHHHHHHHhc---CCCCeEEEEeEEEc----
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SN-GETIAVKRLSKNSK--QGEIEFKNEVLLLARL---QHRNLVRLLGFCLE----  311 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----  311 (577)
                      .++|+++++||+|+||+||+|.. .+ ++.||||++.....  .....+.+|+.+|+.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            47899999999999999999996 34 56799999865322  1122456777777665   79999999999853    


Q ss_pred             -CCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEecc
Q 008108          312 -RKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDF  390 (577)
Q Consensus       312 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~Df  390 (577)
                       ....+++|||++++++.....  .....+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence             346789999999887754432  34567999999999999999999999998   999999999999999999999999


Q ss_pred             CCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhh-----hh
Q 008108          391 GMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA-----WR  465 (577)
Q Consensus       391 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~-----~~  465 (577)
                      |+++......   ......||+.|||||++.+..|+.++|||||||++|||++|+.||......+....+...     ..
T Consensus       161 g~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  237 (305)
T d1blxa_         161 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  237 (305)
T ss_dssp             CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             hhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence            9998654322   233468999999999999999999999999999999999999999755433221111110     00


Q ss_pred             hcccCCcc--ccc----c---CcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          466 NWNEGAAL--NLM----D---PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       466 ~~~~~~~~--~~~----d---~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      .|......  ...    .   +.+.....   ..+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s---~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEKFVTDID---ELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCC---HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccccccchhhhhccccccchhhccccCC---HHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            11110000  000    0   00111112   23456778999999999999999875

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-46  Score=367.79  Aligned_cols=240  Identities=25%  Similarity=0.425  Sum_probs=192.5

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChh------hHHHHHHHHHHHHhcC--CCCeEEEEeEEEcCC
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQ------GEIEFKNEVLLLARLQ--HRNLVRLLGFCLERK  313 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~  313 (577)
                      .++|++.++||+|+||+||+|.. .+|+.||||++.+....      ...++.+|+.+|++++  |||||++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            36799999999999999999996 47899999998754211      1123678999999996  899999999999999


Q ss_pred             eEEEEEEecCC-CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCC-CCeEEeccC
Q 008108          314 ERILVYEFVPN-ASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSE-MNPKISDFG  391 (577)
Q Consensus       314 ~~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~-~~~kl~DfG  391 (577)
                      ..++||||+.+ +++.+++.   .+..+++..+..++.||+.||.|||+++   |+||||||+||||+.+ +.+||+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence            99999999976 56666663   3567999999999999999999999998   9999999999999854 789999999


Q ss_pred             CcccccCCCccccccccccCCCCcChhhhhcCCC-CccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccC
Q 008108          392 MARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRF-SVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEG  470 (577)
Q Consensus       392 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  470 (577)
                      +|+.....    ......||+.|+|||++.+..+ +.++|||||||++|||+||+.||....     .+....       
T Consensus       157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i~~~~-------  220 (273)
T d1xwsa_         157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIRGQ-------  220 (273)
T ss_dssp             TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHHCC-------
T ss_pred             cceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HHhhcc-------
Confidence            99865432    2234679999999999988775 577899999999999999999985321     111100       


Q ss_pred             CccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          471 AALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       471 ~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                             ..+....++   .+.+++.+||+.||++|||++|+++
T Consensus       221 -------~~~~~~~s~---~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         221 -------VFFRQRVSS---ECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             -------CCCSSCCCH---HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------cCCCCCCCH---HHHHHHHHHccCCHhHCcCHHHHhc
Confidence                   011112223   3456777999999999999999875

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-44  Score=363.30  Aligned_cols=265  Identities=21%  Similarity=0.345  Sum_probs=196.5

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccC--ChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEc--------C
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKN--SKQGEIEFKNEVLLLARLQHRNLVRLLGFCLE--------R  312 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~  312 (577)
                      ++|+++++||+|+||+||+|+. .+|+.||||++...  .......+.+|+.+|++++||||+++++.+..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            6899999999999999999996 57999999998654  22334568899999999999999999998865        3


Q ss_pred             CeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCC
Q 008108          313 KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGM  392 (577)
Q Consensus       313 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGl  392 (577)
                      ...++||||++++.+..+.   .....+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+
T Consensus        90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence            4578999999988776554   34567999999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCCcc--ccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhccc
Q 008108          393 ARLFEMDQTH--SDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNE  469 (577)
Q Consensus       393 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  469 (577)
                      ++.+......  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9876543322  122335799999999998765 6899999999999999999999998654433332222221111111


Q ss_pred             CCcc--------ccccCcC-CCCChHH-------HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          470 GAAL--------NLMDPTM-RGGSTSE-------MMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       470 ~~~~--------~~~d~~l-~~~~~~~-------~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ....        ..+.... ......+       ...+++++.+||+.||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            1100        0010000 0011111       123456888999999999999999885

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-44  Score=368.19  Aligned_cols=260  Identities=22%  Similarity=0.308  Sum_probs=192.1

Q ss_pred             CCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC------CeEEE
Q 008108          245 NFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNLVRLLGFCLER------KERIL  317 (577)
Q Consensus       245 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l  317 (577)
                      +|+..++||+|+||+||+|+.. +|+.||||++......    +.+|+.+|++++|+||+++++++...      ...+|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5888999999999999999964 6999999999765432    34799999999999999999998543      24789


Q ss_pred             EEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC-CeEEeccCCcccc
Q 008108          318 VYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-NPKISDFGMARLF  396 (577)
Q Consensus       318 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~-~~kl~DfGla~~~  396 (577)
                      ||||++++.+..+.........+++..+..++.||+.||+|||+++   |+||||||+||||+.++ .+||+|||+++.+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987755444322234567999999999999999999999988   99999999999999775 8999999999876


Q ss_pred             cCCCccccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhh-h-------hhhhhc
Q 008108          397 EMDQTHSDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLL-T-------YAWRNW  467 (577)
Q Consensus       397 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~-~-------~~~~~~  467 (577)
                      ......   ....||..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+ .       ..+...
T Consensus       174 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         174 VRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             CTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             cCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence            543322   23579999999998875 46899999999999999999999998655432221111 0       011111


Q ss_pred             ccCC----cccccc-CcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          468 NEGA----ALNLMD-PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       468 ~~~~----~~~~~d-~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ....    ...... +............+.+++.+|++.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1100    000000 0000001111224557778999999999999999985

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.8e-44  Score=356.65  Aligned_cols=259  Identities=18%  Similarity=0.252  Sum_probs=194.1

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCe-EEEEeEEEcCCeEEEEEEe
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL-VRLLGFCLERKERILVYEF  321 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~  321 (577)
                      ++|++.++||+|+||+||+|.. .+|+.||||++......  .++..|+++++.++|+|+ +.+.++..+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            5799999999999999999996 46899999998765433  247889999999987765 4555666778889999999


Q ss_pred             cCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEc---CCCCeEEeccCCcccccC
Q 008108          322 VPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLD---SEMNPKISDFGMARLFEM  398 (577)
Q Consensus       322 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~---~~~~~kl~DfGla~~~~~  398 (577)
                      +.+ +|...+..  ....+++..++.++.|++.||+|||+++   |+||||||+|||++   .+..+||+|||+|+.+..
T Consensus        85 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          85 LGP-SLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             CCC-BHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             cCC-chhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            954 55544432  3457999999999999999999999998   99999999999985   355799999999998764


Q ss_pred             CCcc-----ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCcc
Q 008108          399 DQTH-----SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAAL  473 (577)
Q Consensus       399 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  473 (577)
                      ....     .......||+.|||||.+.+..++.++|||||||++|||+||+.||...........+............ 
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-  237 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-  237 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH-
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh-
Confidence            4322     1234568999999999999999999999999999999999999999765443332222111110000000 


Q ss_pred             ccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          474 NLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       474 ~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                          +.+....+.   .+.+++..|++.+|++||+++++.+.|+.
T Consensus       238 ----~~~~~~~p~---~~~~li~~cl~~~p~~RP~~~~i~~~l~~  275 (299)
T d1ckia_         238 ----EVLCKGYPS---EFATYLNFCRSLRFDDKPDYSYLRQLFRN  275 (299)
T ss_dssp             ----HHHTTTSCH---HHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred             ----hHhccCCCH---HHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence                011111223   34567779999999999999999888764

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-43  Score=361.78  Aligned_cols=265  Identities=22%  Similarity=0.307  Sum_probs=195.7

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC-hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC----eEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS-KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK----ERI  316 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~  316 (577)
                      +++|+++++||+|+||+||+|.. .+|+.||||++.+.. ......+.+|+.+|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            35799999999999999999985 579999999997654 333456889999999999999999999987653    335


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccc
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLF  396 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~  396 (577)
                      ++++|+.+|+|.+++.    ...+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++..
T Consensus        87 ~l~~~~~~g~L~~~l~----~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            5566778999999883    346999999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCcc-ccccccccCCCCcChhhhhc-CCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCC---
Q 008108          397 EMDQTH-SDTNRVVGTFGYMAPEYVMH-GRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGA---  471 (577)
Q Consensus       397 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---  471 (577)
                      ...... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+................   
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence            543322 22345679999999999854 4678999999999999999999999865443222111111100000000   


Q ss_pred             -----cccc--ccCcCCCCChHH-----HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          472 -----ALNL--MDPTMRGGSTSE-----MMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       472 -----~~~~--~d~~l~~~~~~~-----~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                           ....  ..+.........     ..++.+++..|++.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 0000  000000001111     124667888999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-43  Score=351.94  Aligned_cols=261  Identities=23%  Similarity=0.331  Sum_probs=201.1

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCCeEEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  320 (577)
                      ++|+++++||+|+||+||+|+. .+|+.||||+++...  ......+.+|+.+|+.++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5799999999999999999996 578999999986543  2334578999999999999999999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcccccCCC
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMARLFEMDQ  400 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~~~~~~  400 (577)
                      ++.+++|..++.   ..+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++......
T Consensus        82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            999999887763   4567899999999999999999999998   9999999999999999999999999998765433


Q ss_pred             ccccccccccCCCCcChhhhhcCC-CCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcc---cCCc---c
Q 008108          401 THSDTNRVVGTFGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWN---EGAA---L  473 (577)
Q Consensus       401 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~---~~~~---~  473 (577)
                      .  ......++..|+|||.+.... ++.++|||||||++|||++|+.|+.......  +.+......+.   ....   .
T Consensus       156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGG
T ss_pred             c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCChhhhhhhh
Confidence            2  222356788999999987665 6899999999999999999999975433321  11111111100   0000   0


Q ss_pred             cc--------cc--CcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          474 NL--------MD--PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       474 ~~--------~d--~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ..        ..  .............+.+++.+|++.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00        00  0000001111234556778999999999999999875

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=363.39  Aligned_cols=256  Identities=22%  Similarity=0.352  Sum_probs=189.9

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcCC------
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLERK------  313 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  313 (577)
                      .++|+++++||+|+||+||+|.. .+|+.||||++.+..  ......+.+|+.+|+.++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            46899999999999999999995 469999999997542  233456889999999999999999999997654      


Q ss_pred             eEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCc
Q 008108          314 ERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMA  393 (577)
Q Consensus       314 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla  393 (577)
                      ..++||||+ +.+|..++    +...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~lv~e~~-~~~l~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLM----KHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHH----HhccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence            569999999 55666654    3457999999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCccccccccccCCCCcChhhhhcC-CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhh--------h
Q 008108          394 RLFEMDQTHSDTNRVVGTFGYMAPEYVMHG-RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYA--------W  464 (577)
Q Consensus       394 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~--------~  464 (577)
                      +.....     .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||...............        +
T Consensus       169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence            875432     2346799999999998764 5689999999999999999999998654432221111100        0


Q ss_pred             hhcccCC-------cccccc---CcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          465 RNWNEGA-------ALNLMD---PTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       465 ~~~~~~~-------~~~~~d---~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ..+....       ..+...   +.+.....   ..+.+++.+|++.||++|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s---~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFASILTNAS---PLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCC---HHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhhcchhhhhhhccCCcccccchHHhccCCC---HHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0000000       000000   00011112   23456778999999999999999987

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.2e-43  Score=351.48  Aligned_cols=260  Identities=15%  Similarity=0.229  Sum_probs=202.2

Q ss_pred             hcCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCChhhHHHHHHHHHHHHhcCC-CCeEEEEeEEEcCCeEEEEEE
Q 008108          243 TDNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH-RNLVRLLGFCLERKERILVYE  320 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E  320 (577)
                      .++|++.++||+|+||+||+|+.. +|+.||||++......  ..+.+|++++..++| +|++.+++++.+....++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc--HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            368999999999999999999954 6899999998654322  246789999999965 899999999999999999999


Q ss_pred             ecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcC-----CCCeEEeccCCccc
Q 008108          321 FVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDS-----EMNPKISDFGMARL  395 (577)
Q Consensus       321 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~-----~~~~kl~DfGla~~  395 (577)
                      |+ +++|.+++..  ....+++.++..++.|++.||.|||+++   |+||||||+||||+.     ++.+||+|||+|+.
T Consensus        82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            99 6788887743  3457999999999999999999999998   999999999999974     56799999999997


Q ss_pred             ccCCCcc-----ccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccC
Q 008108          396 FEMDQTH-----SDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEG  470 (577)
Q Consensus       396 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  470 (577)
                      +......     .......||+.|||||++.+..++.++|||||||++|||+||+.||..................-...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            6543221     12334689999999999999999999999999999999999999997554433322222111110000


Q ss_pred             CccccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhcC
Q 008108          471 AALNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPGMASVVNMLNG  518 (577)
Q Consensus       471 ~~~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~~L~~  518 (577)
                      ...+     +....+.   ++.+++..|++.+|++||+++.+.+.|+.
T Consensus       236 ~~~~-----l~~~~p~---~l~~ii~~~~~~~~~~rP~y~~l~~~l~~  275 (293)
T d1csna_         236 PLRE-----LCAGFPE---EFYKYMHYARNLAFDATPDYDYLQGLFSK  275 (293)
T ss_dssp             CHHH-----HTTTSCH---HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             ChHH-----hcCCCCH---HHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence            0001     1112223   34566678999999999999888877754

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.2e-42  Score=353.38  Aligned_cols=256  Identities=19%  Similarity=0.331  Sum_probs=194.5

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcC-CCCeEEEEeEEEcC--CeEEEEE
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLER--KERILVY  319 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~  319 (577)
                      ++|+++++||+|+||+||+|+. .+|+.||||+++...   ...+.+|+.+|+.++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            6899999999999999999996 578999999997644   346789999999995 99999999999744  4689999


Q ss_pred             EecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCC-CeEEeccCCcccccC
Q 008108          320 EFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEM-NPKISDFGMARLFEM  398 (577)
Q Consensus       320 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~-~~kl~DfGla~~~~~  398 (577)
                      ||+++++|..+.      +.+++..+..++.||+.||.|||+++   |+||||||+||||+.++ .+||+|||+|+....
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999997653      35999999999999999999999998   99999999999998765 599999999987654


Q ss_pred             CCccccccccccCCCCcChhhhhcCC-CCccccEEecchhHhHHhhCCCCCCCCCccccc-hhhhh--------hh-hhc
Q 008108          399 DQTHSDTNRVVGTFGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE-DLLTY--------AW-RNW  467 (577)
Q Consensus       399 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~-~l~~~--------~~-~~~  467 (577)
                      ...   .....||+.|+|||.+.+.. ++.++||||+|+++|||++|+.|+......... ..+..        .+ ...
T Consensus       183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  259 (328)
T d3bqca1         183 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  259 (328)
T ss_dssp             TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             CCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence            332   23467899999999987754 799999999999999999999998755432111 00000        00 000


Q ss_pred             ccCC---ccccc--------cCcCCCC-ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          468 NEGA---ALNLM--------DPTMRGG-STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       468 ~~~~---~~~~~--------d~~l~~~-~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                      ....   .....        ....... .......+.+++.+|++.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000   00000        0000000 0111134567788999999999999999975

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-43  Score=358.28  Aligned_cols=252  Identities=25%  Similarity=0.344  Sum_probs=198.6

Q ss_pred             cCCccccccccCCcEEEEEeEe----cCCcEEEEEEeccCC----hhhHHHHHHHHHHHHhcCC-CCeEEEEeEEEcCCe
Q 008108          244 DNFSDANKLGQGGFGAVYKGML----SNGETIAVKRLSKNS----KQGEIEFKNEVLLLARLQH-RNLVRLLGFCLERKE  314 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  314 (577)
                      ++|++.++||+|+||+||+|..    .+|+.||||.+.+..    ......+.+|+.+|++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            7799999999999999999984    247899999986542    1223457899999999976 899999999999999


Q ss_pred             EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      .+++|||+.+|+|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            999999999999998884   3556889999999999999999999988   9999999999999999999999999998


Q ss_pred             cccCCCccccccccccCCCCcChhhhhcC--CCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhhcccCCc
Q 008108          395 LFEMDQTHSDTNRVVGTFGYMAPEYVMHG--RFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRNWNEGAA  472 (577)
Q Consensus       395 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  472 (577)
                      .+...... ......|++.|+|||.+...  .++.++|||||||+||||++|+.||......+....+.......     
T Consensus       178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~-----  251 (322)
T d1vzoa_         178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-----  251 (322)
T ss_dssp             ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-----
T ss_pred             hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC-----
Confidence            76543322 23346799999999999765  46889999999999999999999987655443322222111110     


Q ss_pred             cccccCcCCCCChHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 008108          473 LNLMDPTMRGGSTSEMMKCIHIGLLCVQENVSNRPG-----MASVVN  514 (577)
Q Consensus       473 ~~~~d~~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt-----~~ev~~  514 (577)
                          .+.+......   ++.+++..|++.||++|||     ++|+++
T Consensus       252 ----~~~~~~~~s~---~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 ----EPPYPQEMSA---LAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ----CCCCCTTSCH---HHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ----CCCCcccCCH---HHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                0111111223   4456777999999999995     778774

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-42  Score=355.57  Aligned_cols=259  Identities=20%  Similarity=0.251  Sum_probs=188.7

Q ss_pred             cCCccccccccCCcEEEEEeEec-CCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEc------CCe
Q 008108          244 DNFSDANKLGQGGFGAVYKGMLS-NGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLE------RKE  314 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  314 (577)
                      ++|+++++||+|+||+||+|... +|+.||||++....  ......+.+|+.++++++|||||++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            67999999999999999999965 69999999997543  3334468899999999999999999999964      367


Q ss_pred             EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      .++||||+.++.+..+      ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~~l~~~~------~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHHHhh------hcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence            8999999987665543      245899999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccchhhhh-h----hhhccc
Q 008108          395 LFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTY-A----WRNWNE  469 (577)
Q Consensus       395 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~-~----~~~~~~  469 (577)
                      ......   ......||+.|+|||++.+..++.++||||+||++|||++|+.||...........+.. .    ...|..
T Consensus       168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             cccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence            665432   23346799999999999999999999999999999999999999865443221111100 0    000000


Q ss_pred             ----------C-------CccccccCcC-CCC---ChHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          470 ----------G-------AALNLMDPTM-RGG---STSEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       470 ----------~-------~~~~~~d~~l-~~~---~~~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                                .       .....+.... ...   .......+.+++.+|++.||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                      0       0000111111 111   1223445678899999999999999999974

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-42  Score=356.66  Aligned_cols=260  Identities=23%  Similarity=0.327  Sum_probs=193.1

Q ss_pred             hcCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCC--hhhHHHHHHHHHHHHhcCCCCeEEEEeEEEcC-----Ce
Q 008108          243 TDNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNS--KQGEIEFKNEVLLLARLQHRNLVRLLGFCLER-----KE  314 (577)
Q Consensus       243 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  314 (577)
                      .++|+++++||+|+||+||+|.. .+|+.||||++.+..  ......+.+|+.+|++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            46899999999999999999995 579999999997653  33345688999999999999999999998643     34


Q ss_pred             EEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          315 RILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       315 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      .+++++|+.+|+|.+++.    .+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            567788889999999873    356999999999999999999999998   9999999999999999999999999997


Q ss_pred             cccCCCccccccccccCCCCcChhhhhcCC-CCccccEEecchhHhHHhhCCCCCCCCCccccchhhhhhhhh-------
Q 008108          395 LFEMDQTHSDTNRVVGTFGYMAPEYVMHGR-FSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETEDLLTYAWRN-------  466 (577)
Q Consensus       395 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~-------  466 (577)
                      ....     ......||..|+|||.+.+.. ++.++|||||||++|||++|+.||...........+......       
T Consensus       170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            5432     223367899999999877654 689999999999999999999998654433222221111000       


Q ss_pred             -cccCCcccccc--CcCCCCCh-----HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 008108          467 -WNEGAALNLMD--PTMRGGST-----SEMMKCIHIGLLCVQENVSNRPGMASVVN  514 (577)
Q Consensus       467 -~~~~~~~~~~d--~~l~~~~~-----~~~~~~~~l~~~C~~~~p~~RPt~~ev~~  514 (577)
                       +..........  +.......     .....+.+++.+|++.||++|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence             00000000000  00000000     01124567788999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-37  Score=320.47  Aligned_cols=262  Identities=20%  Similarity=0.249  Sum_probs=189.1

Q ss_pred             cCCccccccccCCcEEEEEeEe-cCCcEEEEEEeccCChhhHHHHHHHHHHHHhcC-----------CCCeEEEEeEEEc
Q 008108          244 DNFSDANKLGQGGFGAVYKGML-SNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-----------HRNLVRLLGFCLE  311 (577)
Q Consensus       244 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  311 (577)
                      .+|+++++||+|+||+||+|+. .+|+.||||++.+.... ...+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~-~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH-HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc-hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            3599999999999999999996 57999999999765432 346788998888875           5789999998764


Q ss_pred             C--CeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCcEEEeccCCCcEEEcCCCC----
Q 008108          312 R--KERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE-DSRLRIIHRDLKASNILLDSEMN----  384 (577)
Q Consensus       312 ~--~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlkp~NiLl~~~~~----  384 (577)
                      .  ...+++|+++..+..............+++..+..++.||+.||.|||+ .+   |+||||||+||||+.++.    
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence            3  4567777777665443333233456679999999999999999999997 65   999999999999987654    


Q ss_pred             --eEEeccCCcccccCCCccccccccccCCCCcChhhhhcCCCCccccEEecchhHhHHhhCCCCCCCCCccccc---hh
Q 008108          385 --PKISDFGMARLFEMDQTHSDTNRVVGTFGYMAPEYVMHGRFSVKSDIFSFGVLVLEIVSGQKRSSFGTEEETE---DL  459 (577)
Q Consensus       385 --~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvil~elltG~~p~~~~~~~~~~---~l  459 (577)
                        +|++|||.+.....     ......||+.|+|||++....++.++||||+||+++||++|+.||.........   +.
T Consensus       169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence              99999999986542     223467999999999999999999999999999999999999998643321111   00


Q ss_pred             hhhhhhh------------------cccCCccccccC-----------cCCCCChHHHHHHHHHHHhcccCCCCCCCCHH
Q 008108          460 LTYAWRN------------------WNEGAALNLMDP-----------TMRGGSTSEMMKCIHIGLLCVQENVSNRPGMA  510 (577)
Q Consensus       460 ~~~~~~~------------------~~~~~~~~~~d~-----------~l~~~~~~~~~~~~~l~~~C~~~~p~~RPt~~  510 (577)
                      +......                  +........+..           ............+.+++..|++.||++|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            0000000                  000000000000           00011344556778899999999999999999


Q ss_pred             HHHH
Q 008108          511 SVVN  514 (577)
Q Consensus       511 ev~~  514 (577)
                      |+++
T Consensus       324 e~L~  327 (362)
T d1q8ya_         324 GLVN  327 (362)
T ss_dssp             HHHT
T ss_pred             HHhc
Confidence            9875

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.89  E-value=3.2e-24  Score=199.10  Aligned_cols=164  Identities=18%  Similarity=0.164  Sum_probs=121.0

Q ss_pred             ccccccccCCcEEEEEeEecCCcEEEEEEeccCCh------------------hhHHHHHHHHHHHHhcCCCCeEEEEeE
Q 008108          247 SDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSK------------------QGEIEFKNEVLLLARLQHRNLVRLLGF  308 (577)
Q Consensus       247 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~  308 (577)
                      .+.++||+|+||+||+|...+|+.||||++.....                  ........|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            45789999999999999988999999998753211                  011234568889999999999988765


Q ss_pred             EEcCCeEEEEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCcEEEeccCCCcEEEcCCCCeEEe
Q 008108          309 CLERKERILVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHEDSRLRIIHRDLKASNILLDSEMNPKIS  388 (577)
Q Consensus       309 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~~~iiHrDlkp~NiLl~~~~~~kl~  388 (577)
                      .    ..+++|||+++..+.+          +++.....++.|++++|.|||+++   |+||||||+|||+++++ ++|+
T Consensus        83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEEC
T ss_pred             c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEE
Confidence            3    2379999998865533          333445678999999999999998   99999999999999764 8999


Q ss_pred             ccCCcccccCCCccccccccccCCCCcC------hhhhhcCCCCccccEEecchhHh
Q 008108          389 DFGMARLFEMDQTHSDTNRVVGTFGYMA------PEYVMHGRFSVKSDIFSFGVLVL  439 (577)
Q Consensus       389 DfGla~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~Dv~SlGvil~  439 (577)
                      |||+|+........          .|..      .| ...+.|+.++|+||..--++
T Consensus       145 DFG~a~~~~~~~~~----------~~l~rd~~~~~~-~f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         145 DFPQSVEVGEEGWR----------EILERDVRNIIT-YFSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CCTTCEETTSTTHH----------HHHHHHHHHHHH-HHHHHHCCCCCHHHHHHHHH
T ss_pred             ECCCcccCCCCCcH----------HHHHHHHHHHHH-HHcCCCCCcccHHHHHHHHh
Confidence            99999764422111          1111      11 12356788999999765443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.61  E-value=5.1e-08  Score=92.74  Aligned_cols=149  Identities=18%  Similarity=0.134  Sum_probs=102.6

Q ss_pred             HHHHHhcCCccccccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcC-CCCeEEEEeEEEcCCeEE
Q 008108          238 TIRVATDNFSDANKLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQ-HRNLVRLLGFCLERKERI  316 (577)
Q Consensus       238 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  316 (577)
                      +++..-..|+..+..+.+....||+... +++.+++|+...........+.+|...+..+. +--+.+++.+..+++..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            3445556777766655555678999865 46678889887654444445678888888774 434567888888888899


Q ss_pred             EEEEecCCCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 008108          317 LVYEFVPNASLDHFIFDPINREHMTWEKRYKIIEGIARGLLYLHED----------------------------------  362 (577)
Q Consensus       317 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~----------------------------------  362 (577)
                      +||+++++.++......        ......++.++++.|..||+.                                  
T Consensus        87 lv~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          87 LLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             EEEEecccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            99999999877543311        111233455566666666631                                  


Q ss_pred             ----------------------CCCcEEEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          363 ----------------------SRLRIIHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       363 ----------------------~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                                            ....++|+|+.|.|||+++++.+-|.||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                  112379999999999999876677999988753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.23  E-value=2.9e-06  Score=79.69  Aligned_cols=130  Identities=19%  Similarity=0.163  Sum_probs=88.4

Q ss_pred             ccccCCc-EEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCC--CCeEEEEeEEEcCCeEEEEEEecCCCCc
Q 008108          251 KLGQGGF-GAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQH--RNLVRLLGFCLERKERILVYEFVPNASL  327 (577)
Q Consensus       251 ~lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~~~~gsL  327 (577)
                      .+..|.. ..||+....++..+++|........   .+..|...++.+..  -.+.+++.+..+++..++||||++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            3445553 6799999888888999987654332   35677888877743  3356778888888889999999998776


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHHHHHhhc----------------------------------------------
Q 008108          328 DHFIFDPINREHMTWEKRYKIIEGIARGLLYLHE----------------------------------------------  361 (577)
Q Consensus       328 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~----------------------------------------------  361 (577)
                      ....        ++.   ..++.++++.|.-||+                                              
T Consensus        94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            5432        111   1122334444444442                                              


Q ss_pred             ---------CCCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          362 ---------DSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       362 ---------~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                               ..++.++|+|+.|.|||++++..+-|+||+.+.
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                     112348999999999999987667899998775

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.56  E-value=7.1e-05  Score=74.89  Aligned_cols=77  Identities=14%  Similarity=0.176  Sum_probs=48.4

Q ss_pred             ccccccCCcEEEEEeEecC-CcEEEEEEeccCC-------hhhHHHHHHHHHHHHhc-CC--CCeEEEEeEEEcCCeEEE
Q 008108          249 ANKLGQGGFGAVYKGMLSN-GETIAVKRLSKNS-------KQGEIEFKNEVLLLARL-QH--RNLVRLLGFCLERKERIL  317 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l-~h--~niv~l~~~~~~~~~~~l  317 (577)
                      .+.||.|....||+....+ ++.++||.-....       .....+...|...|..+ .+  ..+.+++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            4578999999999998654 6789999754311       11112345677777766 22  345566654  4456689


Q ss_pred             EEEecCCCCc
Q 008108          318 VYEFVPNASL  327 (577)
Q Consensus       318 v~E~~~~gsL  327 (577)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999977543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.30  E-value=0.00026  Score=68.65  Aligned_cols=135  Identities=17%  Similarity=0.128  Sum_probs=79.7

Q ss_pred             EEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCe--EEEEe-----EEEcCCeEEEEEEecCCCCcccc
Q 008108          258 GAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL--VRLLG-----FCLERKERILVYEFVPNASLDHF  330 (577)
Q Consensus       258 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~E~~~~gsL~~~  330 (577)
                      -.||++..++|+.+++|...... ....++..|...+..|...++  +..+.     .....+..+.++++++|..++..
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            47999999999999999886542 234567788888888753322  11111     22345667889999987655321


Q ss_pred             cc--------------------cCCCCCCCCHHH----------------------HHHHHHHHHHHHHHh-hcCCCCcE
Q 008108          331 IF--------------------DPINREHMTWEK----------------------RYKIIEGIARGLLYL-HEDSRLRI  367 (577)
Q Consensus       331 l~--------------------~~~~~~~l~~~~----------------------~~~i~~~ia~gl~yL-H~~~~~~i  367 (577)
                      -.                    ....+..+++..                      ....+..+...+.-+ .+..+..+
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence            00                    001112222221                      112222333332222 22234568


Q ss_pred             EEeccCCCcEEEcCCCCeEEeccCCccc
Q 008108          368 IHRDLKASNILLDSEMNPKISDFGMARL  395 (577)
Q Consensus       368 iHrDlkp~NiLl~~~~~~kl~DfGla~~  395 (577)
                      ||+|+.+.|||++++  ..+.||+.+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999754  46899998753

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.04  E-value=0.0013  Score=65.27  Aligned_cols=74  Identities=18%  Similarity=0.287  Sum_probs=51.2

Q ss_pred             ccccccCCcEEEEEeEecC--------CcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCe-EEEEeEEEcCCeEEEEE
Q 008108          249 ANKLGQGGFGAVYKGMLSN--------GETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL-VRLLGFCLERKERILVY  319 (577)
Q Consensus       249 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~  319 (577)
                      ++.|+.|-.=.+|+...++        .+.|.+++....  .......+|..+++.+.-.++ .++++++.+    .+||
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            4678888889999998654        345777766532  223456789999888843344 477777643    6899


Q ss_pred             EecCCCCcc
Q 008108          320 EFVPNASLD  328 (577)
Q Consensus       320 E~~~~gsL~  328 (577)
                      ||+++..|.
T Consensus       121 efi~g~~l~  129 (395)
T d1nw1a_         121 EYIPSRPLS  129 (395)
T ss_dssp             CCCCEEECC
T ss_pred             EEeccccCC
Confidence            999886654

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.09  E-value=0.032  Score=52.83  Aligned_cols=157  Identities=13%  Similarity=0.059  Sum_probs=81.3

Q ss_pred             ChHHHHHHhcCCcccc-----ccccCCcEEEEEeEecCCcEEEEEEeccCChhhHHHHHHHHHHHHhcCCCCe--EEEEe
Q 008108          235 DFETIRVATDNFSDAN-----KLGQGGFGAVYKGMLSNGETIAVKRLSKNSKQGEIEFKNEVLLLARLQHRNL--VRLLG  307 (577)
Q Consensus       235 ~~~~~~~~~~~f~~~~-----~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~  307 (577)
                      +.+++.....+|.+.+     .|..|---+.|+....+|+ +++|+.......  .++..|+.+|..+...++  ...+-
T Consensus         4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~--~~l~~~~~~l~~L~~~g~pvp~pi~   80 (316)
T d2ppqa1           4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEK--NDLPFFLGLMQHLAAKGLSCPLPLP   80 (316)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---C--CHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCH--HHHHHHHHHHHhhhhccccccccce
Confidence            4455666666676533     3446666788999877654 899988654222  234556667776643222  11111


Q ss_pred             ------EEEcCCeEEEEEEecCCCCccccccc--------------------CCCCCCCCH------------------H
Q 008108          308 ------FCLERKERILVYEFVPNASLDHFIFD--------------------PINREHMTW------------------E  343 (577)
Q Consensus       308 ------~~~~~~~~~lv~E~~~~gsL~~~l~~--------------------~~~~~~l~~------------------~  343 (577)
                            +.........++.+..+......-..                    .........                  .
T Consensus        81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (316)
T d2ppqa1          81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  160 (316)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence                  11223455667777766544321100                    000000000                  0


Q ss_pred             HHHHHHHHHHHHHHHhhc-CCCCcEEEeccCCCcEEEcCCCCeEEeccCCcc
Q 008108          344 KRYKIIEGIARGLLYLHE-DSRLRIIHRDLKASNILLDSEMNPKISDFGMAR  394 (577)
Q Consensus       344 ~~~~i~~~ia~gl~yLH~-~~~~~iiHrDlkp~NiLl~~~~~~kl~DfGla~  394 (577)
                      .....+..+...+.-.+. .-+..+||+|+.+.||+++.+...-|.||+.+.
T Consensus       161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            111222222233333322 123469999999999999988777899999875